PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tumis, ME; Sawant, DV; Szymczak-Workman, AL; Andrews, LP; Delgoffe, GM; Yano, H; Beres, AJ; Vogel, P; Workman, CJ; Vignali, DAA				Tumis, Meghan E.; Sawant, Deepali V.; Szymczak-Workman, Andrea L.; Andrews, Lawrence P.; Delgoffe, Greg M.; Yano, Hiroshi; Beres, Amy J.; Vogel, Peter; Workman, Creg J.; Vignali, Dario A. A.			Interleukin-35 Limits Anti-Tumor Immunity	IMMUNITY			English	Article							REGULATORY T-CELLS; EXHAUSTION; CANCER; EXPRESSION; GROWTH; PD-1; PATHWAYS; CTLA-4	Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune sequelae limits its utility in the clinic and highlights the need for limiting Treg cell activity within the tumor microenvironment. Interleukin-35 (IL-35) is a Treg cell-secreted cytokine that inhibits T cell proliferation and function. Using an IL-35 reporter mouse, we observed substantial enrichment of IL-35(+) Treg cells in tumors. Neutralization with an IL-35-specific antibody or Treg cell-restricted deletion of IL-35 production limited tumor growth in multiple murine models of human cancer. Limiting intratumoral IL-35 enhanced T cell proliferation, effector function, antigen-specific responses, and long-term T cell memory. Treg cell-derived IL-35 promoted the expression of multiple inhibitory receptors (PD1, TIM3, LAG3), thereby facilitating intratumoral T cell exhaustion. These findings reveal previously unappreciated roles for IL-35 in limiting anti-tumor immunity and contributing to T cell dysfunction in the tumor microenvironment.	[Sawant, Deepali V.; Szymczak-Workman, Andrea L.; Andrews, Lawrence P.; Yano, Hiroshi; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Tumis, Meghan E.; Sawant, Deepali V.; Szymczak-Workman, Andrea L.; Delgoffe, Greg M.; Beres, Amy J.; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Delgoffe, Greg M.; Vignali, Dario A. A.] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Tumis, Meghan E.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Beres, Amy J.] Immucor Inc, Waukesha, WI 53186 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital	Vignali, DAA (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.; Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Vignali, DAA (corresponding author), Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	Delgoffe, Greg M./HCH-2805-2022; Vogel, Peter/N-2490-2018; Sawant, Deepali/K-1088-2015	Delgoffe, Greg M./0000-0002-2957-8135; Vogel, Peter/0000-0002-7535-0545; Sawant, Deepali/0000-0002-8119-1106; Yano, Hiroshi/0000-0002-3098-2629; Beres, Amy/0000-0003-4653-0368; Sawant, Deepali/0000-0002-3655-6081	National Institutes of Health [R01 AI091977, F32 CA168294, F32 AI098383]; NCI Comprehensive Cancer Center Support CORE grant [CA21765]; ALSAC; NATIONAL CANCER INSTITUTE [R01CA203689, P30CA021765, F32CA168294, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091977, F32AI098383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank Kris Hogquist (University of Minnesota) for Nur77 mice, Merle Elloso (Janssen Research and Development) for Il27a<SUP>-/-</SUP> mice, and Catherine Uyttenhove and Jacques Van Snick (Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium) who made and provided the anti-p28 mAb. The authors also thank Mary Jo Turk (Dartmouth Medical School) for advice regarding tumor experiments, Amanda Burton for assistance in the generation of the Ebi3 conditional reporter mice, Kate Vignali for technical assistance with the targeting constructs, Christopher Calabrese and the St Jude Animal Imaging Core for assistance with MRI measurements of the KP model, Greig Lennon, Richard Cross, and Parker Ingle of the St. Jude Immunology Flow Lab, and Hongmei Shen, Dewayne Falkner, Aarika Yates at University of Pittsburgh flow facility for cell sorting; Abby Overacre and David Gravano for help with tumor harvests; Kristia Hamilton for lung metastasis counts; Erin Brunnazi, Amy McKenna, and Karen Forbes for maintenance, breeding, and genotyping of mouse colonies; the Veterinary Pathology Core at St. Jude Children's Research Hospital for histological preparation; and the staff of the Animal Resource Center at St. Jude Children's Research Hospital and Division of Laboratory Animal Resources at University of Pittsburgh for animal husbandry and assistance. This work was supported by the National Institutes of Health (R01 AI091977 to D.A.A.V.; F32 CA168294 to M.E.T.; F32 AI098383 to G.M.D.), NCI Comprehensive Cancer Center Support CORE grant (CA21765, to D.A.A.V.), and ALSAC (to D.A.A.V.)	Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Cao XF, 2010, IMMUNOL RES, V46, P79, DOI 10.1007/s12026-009-8124-7; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Gonin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024617; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Long J, 2013, BIOCHEM BIOPH RES CO, V430, P364, DOI 10.1016/j.bbrc.2012.11.004; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Nishino R, 2011, CLIN CANCER RES, V17, P6272, DOI 10.1158/1078-0432.CCR-11-0060; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Olson BM, 2012, J IMMUNOL, V189, P5590, DOI 10.4049/jimmunol.1201744; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Shen P., 2014, 35 PRODUCING B CELLS; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turk MJ, 2002, IMMUNOL REV, V188, P122, DOI 10.1034/j.1600-065X.2002.18811.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620	37	192	204	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					316	329		10.1016/j.immuni.2016.01.013	http://dx.doi.org/10.1016/j.immuni.2016.01.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26872697	Bronze, Green Accepted			2022-12-18	WOS:000370294000014
J	Kool, M; van Loo, G; Waelput, W; De Prijck, S; Muskens, F; Sze, M; van Praet, J; Branco-Madeira, F; Janssens, S; Reizis, B; Elewaut, D; Beyaert, R; Hammad, H; Lambrecht, BN				Kool, Mirjam; van Loo, Geert; Waelput, Wim; De Prijck, Sofie; Muskens, Femke; Sze, Mozes; van Praet, Jens; Branco-Madeira, Filipe; Janssens, Sophie; Reizis, Boris; Elewaut, Dirk; Beyaert, Rudi; Hammad, Hamida; Lambrecht, Bart N.			The Ubiquitin-Editing Protein A20 Prevents Dendritic Cell Activation, Recognition of Apoptotic Cells, and Systemic Autoimmunity	IMMUNITY			English	Article							NF-KAPPA-B; LUPUS-ERYTHEMATOSUS; MARGINAL ZONE; IN-VIVO; IMMUNE-RESPONSES; T-CELLS; DIFFERENTIATION; HOMEOSTASIS; TOLERANCE; ANTIGENS	Dendritic cells (DCs) regulate both immunity and tolerance. Here we have shown that the ubiquitin editing enzyme A20 (Tnfaip3) determines the activation threshold of DCs, via control of canonical NF-kappa B activation. Tnfaip3(fl)/(fl)Cd11c-cre(+) mice lacking A20 in DCs demonstrated spontaneous proliferation of conventional and double-negative T cells, their conversion to interferon-gamma (IFN-gamma)-producing effector cells, and expansion of plasma cells. They developed ds-DNA antibodies, nephritis, the antiphospholipid syndrome, and lymphosplenomegaly-features of systemic lupus erythematosus-and extramedullary hematopoiesis. A20-deficient DCs were resistant to apoptosis, caused by increased sensitivity to CD40L and RANKL prosurvival signals and upregulation of antiapoptotic proteins Bcl-2 and Bcl-x. They captured injected apoptotic cells more efficiently, resisted the inhibitory effects of apoptotic cells, and induced self-reactive effector lymphocytes. Because genetic polymorphisms in TNFAIP3 are associated with human autoimmune disorders, these findings identify A20-mediated control of DC activation as a crucial checkpoint in the development of systemic autoimmunity.	[Kool, Mirjam; Waelput, Wim; De Prijck, Sofie; Branco-Madeira, Filipe; Janssens, Sophie; Hammad, Hamida; Lambrecht, Bart N.] Ghent Univ Hosp, Immunoregulat Lab, Dept Pulm Med, B-9000 Ghent, Belgium; [Kool, Mirjam; van Loo, Geert; Sze, Mozes; Beyaert, Rudi] VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Kool, Mirjam; van Loo, Geert; Sze, Mozes; Beyaert, Rudi] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Kool, Mirjam; Muskens, Femke; Lambrecht, Bart N.] Erasmus Univ, Dept Pulm Med, Med Ctr, NL-3015 GE Rotterdam, Netherlands; [Waelput, Wim] Univ Antwerp Hosp, Dept Pathol, B-2650 Edegem, Belgium; [van Praet, Jens; Elewaut, Dirk] Ghent Univ Hosp, Lab Mol Immunol, Dept Rheumatol, B-9000 Ghent, Belgium; [Reizis, Boris] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA	Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC; University of Antwerp; Ghent University; Ghent University Hospital; Columbia University	Lambrecht, BN (corresponding author), Ghent Univ Hosp, Immunoregulat Lab, Dept Pulm Med, B-9000 Ghent, Belgium.	bart.lambrecht@ugent.be	van Loo, Geert/C-1505-2009; Elewaut, Dirk/K-6831-2014; , van Loo Geert/AAD-1220-2019; Lambrecht, Bart N/K-2484-2014; Janssens, Sophie/HHN-1756-2022; Beyaert, Rudi/B-2589-2009; Hammad, Hamida/J-9391-2015; Van Praet, Jens/L-9906-2019	, van Loo Geert/0000-0002-8427-4775; Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603; Beyaert, Rudi/0000-0002-5704-582X; Reizis, Boris/0000-0003-1140-7853; Van Praet, Jens Tomas/0000-0002-7125-7001; Waelput, Wim/0000-0002-4433-5852	Marie Curie fellowship; FWO Odysseus; Interuniversity Attraction Poles program [IAP6/18]; Belgian Foundation against Cancer; IWT; Charcot Foundation; Concerted Research Actions of Ghent University; NIH [R21]; FWO; ERC; Ghent University	Marie Curie fellowship(European Commission); FWO Odysseus; Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Belgian Foundation against Cancer; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Charcot Foundation; Concerted Research Actions of Ghent University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FWO(FWO); ERC(European Research Council (ERC)European Commission); Ghent University(Ghent University)	M.K. is supported by a Marie Curie fellowship. G.v.L. is supported by an FWO Odysseus Grant and by grants from the Interuniversity Attraction Poles program (IAP6/18), the Belgian Foundation against Cancer, the IWT, the Charcot Foundation, and the Concerted Research Actions of Ghent University. H.H. is supported by a R21 NIH grant and a FWO grant. B.N.L. is supported by an FWO Odysseus grant, an ERC Starting grant, and the "Group-ID MRP" grant of Ghent University. Thanks to M. Linterman for advice on Tfh cell staining.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P349, DOI 10.1016/j.jaut.2010.01.001; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	44	192	197	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					82	96		10.1016/j.immuni.2011.05.013	http://dx.doi.org/10.1016/j.immuni.2011.05.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21723156	Bronze			2022-12-18	WOS:000293107300012
J	Wirth, TC; Xue, HH; Rai, D; Sabel, JT; Bair, T; Harty, JT; Badovinac, VP				Wirth, Thomas C.; Xue, Hai-Hui; Rai, Deepa; Sabel, Jaime T.; Bair, Tom; Harty, John T.; Badovinac, Vladimir P.			Repetitive Antigen Stimulation Induces Stepwise Transcriptome Diversification but Preserves a Core Signature of Memory CD8(+) T Cell Differentiation	IMMUNITY			English	Article							EFFECTOR; RESPONSES; ACTIVATION; PHENOTYPE; INFECTION; EFFICACY; IMMUNITY	Repetitive antigen stimulation by prime-boost vaccination or pathogen reencounter increases memory CD8(+) T cell numbers, but the impact on memory CD8(+) T cell differentiation is unknown. Here we showed that repetitive antigen stimulations induced accumulation of memory CD8(+) T cells with uniform effector memory characteristics. However, genome-wide microarray analyses revealed that each additional antigen challenge resulted in the differential regulation of several hundred new genes in the ensuing memory CD8(+) T cell populations and, therefore, in stepwise diversification of CD8(+) T cell transcriptomes. Thus, primary and repeatedly stimulated (secondary, tertiary, and quaternary) memory CD8(+) T cells differed substantially in their molecular signature while sharing expression of a small group of genes and biological pathways, which may constitute a core signature of memory differentiation. These results reveal the complex regulation of memory CD8(+) T cell differentiation and identify potential new molecular targets to dissect the function of memory cells generated by repeated antigen stimulation.	[Wirth, Thomas C.; Xue, Hai-Hui; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Rai, Deepa; Sabel, Jaime T.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Bair, Tom] Univ Iowa, DNA Facil, Iowa City, IA 52242 USA; [Xue, Hai-Hui; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Wirth, Thomas C.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Hannover Medical School	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu; vladimir-badovinac@uiowa.edu	Sabel, Jaime/B-5607-2016; badovinac, Vladimir/O-7760-2015	Sabel, Jaime/0000-0002-7569-9368; Harty, John/0000-0001-7266-2802; Badovinac, Vladimir/0000-0003-3180-2439; Xue, Hai-Hui/0000-0002-9163-7669	Department of Pathology; National Institutes of Health [AI83286, AI42767, AI46653, AI50073, AI59752, AI077504, HL095540]; Deutsche Forschungsgemeinschaft (DFG) [WI 3308/1-1]; University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042767, R01AI042767, R01AI059752, R21AI077504, R01AI083286, R01AI050073, R37AI042767, R01AI046653] Funding Source: NIH RePORTER	Department of Pathology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Colgan (University of Iowa) for advice with cell sorting, G. Hauser for microarray analysis (DNA Facility, University of Iowa), and S. Perlman (University of Iowa) for critically reviewing the manuscript. The data presented herein were in part obtained at the Flow Cytometry Facility, which is a Carver College of Medicine Core Research Facilities/Holden Comprehensive Cancer Center Core Laboratory at the University of Iowa. This work was supported by startup funds from the Department of Pathology, University of Iowa (V.P.B.), National Institutes of Health grants AI83286 (V.P.B.), AI42767, AI46653, AI50073, AI59752 (J.T.H.), AI077504, and HL095540 (H.-H.X.), and the Deutsche Forschungsgemeinschaft (DFG) fellowship WI 3308/1-1 (T.C.W.).	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chtanova T, 2005, J IMMUNOL, V175, P7837, DOI 10.4049/jimmunol.175.12.7837; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Reeves M, 2008, CURR TOP MICROBIOL, V325, P297; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandau MM, 2010, J IMMUNOL, V184, P35, DOI 10.4049/jimmunol.0803355; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199	46	192	195	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					128	140		10.1016/j.immuni.2010.06.014	http://dx.doi.org/10.1016/j.immuni.2010.06.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20619696	Green Accepted, Bronze			2022-12-18	WOS:000280418100016
J	Kallies, A; Hasbold, J; Fairfax, K; Pridans, C; Emslie, D; McKenzie, BS; Lew, AM; Corcoran, LM; Hodgkin, PD; Tarlinton, DM; Nutt, SL				Kallies, Axel; Hasbold, Jhagvaral; Fairfax, Kirsten; Pridans, Clare; Emslie, Dianne; McKenzie, Brent S.; Lew, Andrew M.; Corcoran, Lynn M.; Hodgkin, Philip D.; Tarlinton, David M.; Nutt, Stephen L.			Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1	IMMUNITY			English	Article							RESTING B-CELLS; GENE-EXPRESSION; LYMPHOCYTE DIFFERENTIATION; SECRETING CELLS; FACTOR XBP-1; MATURE B; REPRESSION; PROTEIN; PAX5; MATURATION	Blimp-1 is considered an essential regulator of the terminal differentiation of B cells into antibody-secreting plasma cells. We show here that Rag1(-/-) mice reconstituted with fetal liver cells homozygous for a DNA-binding-deficient mutant of Prdm1 (the gene encoding Blimp-1) lack a defined plasma-cell compartment, yet show detectable amounts of all immunoglobulin isotypes. In vitro analysis revealed that Blimp-1 is not required for the initiation of antibody secretion but is essential for subsequent high immunoglobulin production. Blimp-1-independent differentiation was blocked at a pre-plasmablast stage characterized by decreased Pax5 expression and the activation of plasma-cell genes. Analysis of Blimp-1-sufficient differentiation revealed a phase prior to Blimp-1 expression in which several genes normally repressed by Pax5 are re-expressed, suggesting that plasma-cell differentiation is initiated by the inhibition of Pax5 function. Our results indicate that full plasma-cell differentiation but not commitment to the plasma-cell fate requires the expression of functional Blimp-1.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Expt Med, Parkville, Vic 3052, Australia; Univ WEstern Sydney, Richmond, NW 2753, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Western Sydney University	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	nutt@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Pridans, Clare/AAF-9953-2020; Corcoran, Lynn M/C-9316-2013; Lew, Andrew M/C-7248-2013	Nutt, Stephen L/0000-0002-0020-6637; Pridans, Clare/0000-0001-9423-557X; Lew, Andrew M/0000-0002-2198-8164; Kallies, Axel/0000-0002-6312-6968; Tarlinton, David/0000-0001-9928-686X; Hodgkin, Philip/0000-0002-8604-1940; Fairfax, Kirsten/0000-0002-8394-137X				Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fairfax KA, 2007, J IMMUNOL, V178, P4104, DOI 10.4049/jimmunol.178.7.4104; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Roque MC, 1996, MOL CELL BIOL, V16, P3138; Savitsky D, 2006, J EXP MED, V203, P2305, DOI 10.1084/jem.20060411; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stephenson LM, 2006, J IMMUNOL, V177, P8620, DOI 10.4049/jimmunol.177.12.8620; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Visan I, 2003, EUR J IMMUNOL, V33, P1163, DOI 10.1002/eji.200323747	43	192	198	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					555	566		10.1016/j.immuni.2007.04.007	http://dx.doi.org/10.1016/j.immuni.2007.04.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17509907	Green Published, Bronze			2022-12-18	WOS:000246895900009
J	Dick, TP; Bangia, N; Peaper, DR; Cresswell, P				Dick, TP; Bangia, N; Peaper, DR; Cresswell, P			Disulfide bond isomerization and the assembly of MHC class I-Peptide complexes	IMMUNITY			English	Article							HLA CLASS-I; ANTIGEN PRESENTATION; LOADING COMPLEX; MELANOMA-CELLS; B2M GENE; T-CELLS; TAPASIN; EXPRESSION; TAP; MOLECULES	The presence of a disulfide bond inside the peptide binding groove of MHC class I molecules and of the thiol oxidoreductase ERp57 in the class I loading complex suggests that disulfide bond isomerization may play a role in peptide loading. Here we show that ERp57 and tapasin are disulfide linked inside the loading complex. Mutagenesis of cysteine 95 in tapasin not only abolishes formation of the ERp57-tapasin bond but also prevents complete oxidation of the class I heavy chain in the loading complex. The resulting MHC class I-beta(2)m heterodimers are poorly loaded with high-affinity peptides in the ER but nevertheless escape to the cell surface where they are unstable. These findings suggest a role for disulfide bond isomerization in tapasin-mediated peptide loading.	Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, 310 Cedar St, New Haven, CT 06520 USA.			Bangia, Naveen/0000-0003-0631-2323				ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; DICK TP, 2001, IN PRESS METHODS ENZ; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Farmery MR, 2000, J BIOL CHEM, V275, P14933, DOI 10.1074/jbc.275.20.14933; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Harris MR, 2001, J IMMUNOL, V166, P6686, DOI 10.4049/jimmunol.166.11.6686; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; KALTOFT MB, 1992, HYBRIDOMA, V11, P507, DOI 10.1089/hyb.1992.11.507; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; MAIO M, 1991, J CLIN INVEST, V88, P282, DOI 10.1172/JCI115289; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MOOTS RJ, 1991, IMMUNOGENETICS, V34, P141; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Solheim JC, 1997, J IMMUNOL, V158, P2236; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n	50	192	194	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					87	98		10.1016/S1074-7613(02)00263-7	http://dx.doi.org/10.1016/S1074-7613(02)00263-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825568	Bronze			2022-12-18	WOS:000173575700009
J	Waldmann, H; Cobbold, S				Waldmann, H; Cobbold, S			Regulating the immune response to transplants: A role for CD4(+) regulatory cells?	IMMUNITY			English	Review							IMMUNOLOGICAL SELF-TOLERANCE; ANERGIC T-CELLS; INCOMPATIBLE CARDIAC ALLOGRAFTS; ANTI-CD4 MONOCLONAL-ANTIBODY; INFECTIOUS TOLERANCE; INTESTINAL INFLAMMATION; AUTOIMMUNE-DISEASES; LINKED SUPPRESSION; CUTTING EDGE; IN-VITRO		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Waldmann, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		waldmann, herman/W-8051-2019; waldmann, herman/F-7412-2011	Cobbold, Stephen/0000-0003-1206-4880; Waldmann, Herman/0000-0001-7519-6720				Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bemelman F, 1998, J IMMUNOL, V160, P2645; Bushell A, 1999, J IMMUNOL, V162, P1359; Chai JG, 1999, EUR J IMMUNOL, V29, P686, DOI 10.1002/(SICI)1521-4141(199902)29:02<686::AID-IMMU686>3.0.CO;2-N; Chen ZHK, 1996, TRANSPLANTATION, V62, P1200, DOI 10.1097/00007890-199611150-00002; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; COBBOLD SP, 1996, IMMUNOL REV, V148, P1; COHEN IR, 1992, IMMUNOL TODAY, V13, P490, DOI 10.1016/0167-5699(92)90024-2; Davies JD, 1996, J IMMUNOL, V156, P3602; Davies JD, 1999, J IMMUNOL, V163, P5353; Davies JD, 1996, J IMMUNOL, V157, P529; FLYNN JC, 1991, CLIN IMMUNOL IMMUNOP, V60, P484, DOI 10.1016/0090-1229(91)90103-H; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Graca L, 2000, J IMMUNOL, V165, P4783, DOI 10.4049/jimmunol.165.9.4783; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; HALL BM, 1985, J EXP MED, V162, P1683, DOI 10.1084/jem.162.5.1683; Hall BM, 2000, CRIT REV IMMUNOL, V20, P267; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Hall BM, 1998, J IMMUNOL, V161, P5147; Hamano K, 1997, TRANSPLANT INT, V10, P293, DOI 10.1007/s001470050060; Herbelin A, 1998, J IMMUNOL, V161, P2620; Honey K, 1999, J IMMUNOL, V163, P4805; Itoh M, 1999, J IMMUNOL, V162, P5317; Ke BB, 2000, J IMMUNOL, V164, P5739, DOI 10.4049/jimmunol.164.11.5739; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; MAEDA H, 2000, PNAS 97, P13257; Marshall SE, 1996, TRANSPLANTATION, V62, P1614, DOI 10.1097/00007890-199612150-00015; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; Onodera K, 1996, J IMMUNOL, V157, P1944; Plain KM, 1997, TRANSPLANTATION, V64, P1559, DOI 10.1097/00007890-199712150-00009; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Saitovitch D, 1996, TRANSPLANTATION, V61, P1642, DOI 10.1097/00007890-199606150-00016; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SCULLY R, 1994, EUR J IMMUNOL, V24, P2383, DOI 10.1002/eji.1830241019; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Taams LS, 1998, EUR J IMMUNOL, V28, P2902, DOI 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; WALDMANN H, 1992, J AUTOIMMUN, V5, P93, DOI 10.1016/0896-8411(92)90024-K; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; WALDMANN H, 2000, CURR OPIN ORGAN TRAN, V5, P83; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wise MP, 1998, J IMMUNOL, V161, P5813; Wong W, 1997, TRANSPLANTATION, V63, P1490, DOI 10.1097/00007890-199705270-00020; YIN DP, 1995, J IMMUNOL, V154, P6339; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2	52	192	208	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					399	406		10.1016/S1074-7613(01)00120-0	http://dx.doi.org/10.1016/S1074-7613(01)00120-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336685	Bronze			2022-12-18	WOS:000168246700007
J	Fahmy, TM; Bieler, JG; Edidin, M; Schneck, JP				Fahmy, TM; Bieler, JG; Edidin, M; Schneck, JP			Increased TCR avidity after T cell activation: A mechanism for sensing low-density antigen	IMMUNITY			English	Article							IMMUNOLOGICAL SYNAPSE; LIPID RAFTS; MULTIVALENT STRUCTURE; RECEPTOR INTERACTIONS; MHC COMPLEX; BINDING; AFFINITY; RECOGNITION; MOLECULES; RESPONSES	While activated T cells are known to have enhanced biological responses to antigen stimulation, the biophysical basis of this increased sensitivity remains unknown. Here, we show that, on activated T cells, the TCR avidity for peptide-MHC complexes is 20- to 50-fold higher than the TCR avidity of naive T cells. This increased avidity for peptide-MHC depends on TCR reorganization and is sensitive to the cholesterol content of the T cell membrane. Analysis of the binding data indicates the enhanced avidity is due to increases in cross-linking of TCR on activated T cells. Activation-induced membrane (AIM) changes in TCR avidity represent a previously unrecognized means of increasing the sensitivity of activated T cells to small amounts of antigen in the periphery.	Johns Hopkins Univ, Dept Pathol & Med, Div Immunopathol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fahmy, TM (corresponding author), Johns Hopkins Univ, Dept Pathol & Med, Div Immunopathol, Baltimore, MD 21218 USA.	tarekf2000@yahoo.com; jschneck@welchlink.welch.jhu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014584, R01AI029575, R01AI044129, R01AI014584] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-29575, AI-14584, AI-44129] Funding Source: Medline; CSR NIH HHS [RG 2637 A2/1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSR NIH HHS		Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Bachmann MF, 1998, EUR J IMMUNOL, V28, P2571, DOI 10.1002/(SICI)1521-4141(199808)28:08<2571::AID-IMMU2571>3.0.CO;2-T; Bachmann MF, 1999, IMMUNOL TODAY, V20, P568, DOI 10.1016/S0167-5699(99)01543-1; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DELISI C, 1979, BIOPHYSICS-USSR, V1, P117; Dubey C, 1996, J IMMUNOL, V157, P3280; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hayashi RJ, 1998, J IMMUNOL, V160, P33; IEZZI G, 1995, IMMUNITY, V8, P89; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; KUBO RT, 1989, J IMMUNOL, V142, P2736; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P133; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perelson A. S., 1984, CELL SURFACE DYNAMIC, P223; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Schneck Jonathan P., 2000, Immunological Investigations, V29, P163, DOI 10.3109/08820130009062300; SCHNECK JP, 2000, CURR PROTOCOLS IMM S, V35; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Udaka K, 1996, J IMMUNOL, V157, P670; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WOFSY C, 1992, MATH BIOSCI, V112, P115, DOI 10.1016/0025-5564(92)90090-J; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	51	192	198	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2001	14	2					135	143		10.1016/S1074-7613(09)00099-5	http://dx.doi.org/10.1016/S1074-7613(09)00099-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239446				2022-12-18	WOS:000167092500004
J	Kurosaki, T; Tsukada, S				Kurosaki, T; Tsukada, S			BLNK: Connecting Syk and Btk to calcium signals	IMMUNITY			English	Review							T-CELL RECEPTOR; BRUTONS TYROSINE KINASE; PHOSPHOLIPASE C-GAMMA; ANTIGEN RECEPTOR; MEDIATED ACTIVATION; MOLECULAR-CLONING; FAMILY KINASES; PHOSPHORYLATION; PROTEIN; PLC-GAMMA-1		Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan; Osaka Univ, Sch Med, Dept Mol Med, Osaka 5650871, Japan	Kansai Medical University; Osaka University	Kurosaki, T (corresponding author), Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan.	kurosaki@mxr.mesh.ne.jp	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Weber JR, 1998, J EXP MED, V187, P1157, DOI 10.1084/jem.187.7.1157; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	39	192	193	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2000	12	1					1	5		10.1016/S1074-7613(00)80153-3	http://dx.doi.org/10.1016/S1074-7613(00)80153-3			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661400	Bronze			2022-12-18	WOS:000085011900001
J	Sugawara, T; Moriguchi, T; Nishida, E; Takahama, Y				Sugawara, T; Moriguchi, T; Nishida, E; Takahama, Y			Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; CELL ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; CD4(+)CD8(+) THYMOCYTES; LINEAGE COMMITMENT; TCR; APOPTOSIS; THYMUS; EXPRESSION; INHIBITOR	Clonal selection of T lymphocytes is essential for establishing self/non-self discrimination of immune recognition. It is known that cell surface signals such as avidity and valency of TCR-ligand interactions influence the fate of individual thymocytes, founding a primary repertoire of T cells. However, intracellular signals that govern positive and negative selection in the thymus have been unclear. The present study using the retroviral gene transfer technique shows that MKK1 activation in developing T cells is sufficient for providing positive selection signals. We also show that the MKK6-p38 signaling pathway is critically involved in inducing negative selection of thymocytes. These results suggest that intracellular signals through different MAP kinase cascades selectively guide positive and negative selection of T lymphocytes.	Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Tsukuba, Ibaraki 3058577, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol Project, Tsukuba, Ibaraki 3058577, Japan	University of Tsukuba; Kyoto University; Japan Science & Technology Agency (JST)	Takahama, Y (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Immunol, Tsukuba, Ibaraki 3058577, Japan.		Moriguchi, Tetsuo/D-7061-2012; Takahama, Yousuke/A-5863-2010; Sugawara, Takehiko/K-2906-2012	Moriguchi, Tetsuo/0000-0002-9598-4991; Takahama, Yousuke/0000-0002-4992-9174; Sugawara, Takehiko/0000-0002-9925-3619				AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Benoist C, 1997, CURR OPIN IMMUNOL, V9, P245, DOI 10.1016/S0952-7915(97)80143-4; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Ghendler Y, 1997, EUR J IMMUNOL, V27, P2279, DOI 10.1002/eji.1830270923; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; LECLERCQ G, 1992, EUR J IMMUNOL, V22, P2189, DOI 10.1002/eji.1830220902; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; SEGER R, 1994, J BIOL CHEM, V269, P25699; SEGER R, 1992, J BIOL CHEM, V267, P25628; Sen J, 1996, J IMMUNOL, V156, P4535; Shao H, 1997, J IMMUNOL, V159, P5773; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Sugawara T, 1998, J IMMUNOL, V161, P2888; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Takahama Y, 1996, J IMMUNOL, V157, P1508; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Tokoro Y, 1996, EUR J IMMUNOL, V26, P1012, DOI 10.1002/eji.1830260509; Tsuda S, 1996, J IMMUNOL, V156, P3233; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; WU J, 1995, MOL CELL BIOL, V15, P4337; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	56	192	197	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1998	9	4					565	574		10.1016/S1074-7613(00)80639-1	http://dx.doi.org/10.1016/S1074-7613(00)80639-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806642	Bronze, Green Submitted			2022-12-18	WOS:000076680700014
J	Fransen, F; Zagato, E; Mazzini, E; Fosso, B; Manzari, C; El Aidy, S; Chiavelli, A; D'Erchia, AM; Sethi, MK; Pabst, O; Marzano, M; Moretti, S; Romani, L; Penna, G; Pesole, G; Rescigno, M				Fransen, Floris; Zagato, Elena; Mazzini, Elisa; Fosso, Bruno; Manzari, Caterina; El Aidy, Sahar; Chiavelli, Andrea; D'Erchia, Anna Maria; Sethi, Maya K.; Pabst, Oliver; Marzano, Marinella; Moretti, Silvia; Romani, Luigina; Penna, Giuseppe; Pesole, Graziano; Rescigno, Maria			BALB/c and C57BL/6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; CD103(+) DENDRITIC CELLS; IMMUNOGLOBULIN-A; SECRETORY ANTIBODIES; MUCOSAL SURFACES; IMMUNE-RESPONSE; GUT MICROBIOTA; SALMONELLA; HOMEOSTASIS; SYSTEM	The interrelationship between IgAs and microbiota diversity is still unclear. Here we show that BALB/c mice had higher abundance and diversity of IgAs than C57BL/6 mice and that this correlated with increased microbiota diversity. We show that polyreactive IgAs mediated the entrance of non-invasive bacteria to Peyer's patches, independently of CX3CR1(+) phagocytes. This allowed the induction of bacteria-specific IgA and the establishment of a positive feedback loop of IgA production. Cohousing of mice or fecal transplantation had little or no influence on IgA production and had only partial impact on microbiota composition. Germ-free BALB/c, but not C57BL/6, mice already had polyreactive IgAs that influenced microbiota diversity and selection after colonization. Together, these data suggest that genetic predisposition to produce polyreactive IgAs has a strong impact on the generation of antigenspecific IgAs and the selection and maintenance of microbiota diversity.	[Fransen, Floris; Zagato, Elena; Mazzini, Elisa; El Aidy, Sahar; Chiavelli, Andrea; Penna, Giuseppe; Rescigno, Maria] IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy; [Fransen, Floris; Zagato, Elena; Mazzini, Elisa; El Aidy, Sahar; Chiavelli, Andrea; Penna, Giuseppe; Rescigno, Maria] IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy; [Fosso, Bruno; Manzari, Caterina; Marzano, Marinella; Pesole, Graziano] IEO, Immunotherapy Programme, I-20139 Milan, Italy; [El Aidy, Sahar] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [D'Erchia, Anna Maria; Pesole, Graziano] Univ Groningen, Fac Math & Nat Sci, Groningen Biomol Sci & Biotechnol, NL-9700 CC Groningen, Netherlands; [Sethi, Maya K.] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Pabst, Oliver] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Moretti, Silvia; Romani, Luigina] Rhein Westfal TH Aachen, Inst Mol Med, D-52074 Aachen, Germany; [Rescigno, Maria] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy; Univ Milan, Dipartimento Sci Salute, I-20142 Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); Consiglio Nazionale delle Ricerche (CNR); University of Groningen; Universita degli Studi di Bari Aldo Moro; Hannover Medical School; RWTH Aachen University; University of Perugia; University of Milan	Rescigno, M (corresponding author), IEO, Dept Expt Oncol, I-20139 Milan, Italy.	maria.rescigno@ieo.eu	Marzano, Marinella/T-7306-2018; Penna, Giuseppe/AAB-8784-2019; Pabst, Oliver/H-5014-2016; Zagato, Elena/AAN-1997-2021; Pesole, Graziano/K-5283-2019; Zagato, Elena/N-1285-2017; Aidy, Sahar El/J-5246-2017; Rescigno, Maria/J-9704-2012; Fosso, Bruno/P-1538-2018; Romani, Luigina/O-9987-2018; D'Erchia, Anna maria/K-9001-2016	Penna, Giuseppe/0000-0003-3534-7090; Pabst, Oliver/0000-0002-5533-883X; Zagato, Elena/0000-0001-6756-3674; Zagato, Elena/0000-0001-6756-3674; Aidy, Sahar El/0000-0001-8950-4392; Rescigno, Maria/0000-0002-6464-509X; Fosso, Bruno/0000-0003-2324-086X; MORETTI, Silvia/0000-0002-8177-7254; Marzano, Marinella/0000-0002-9996-8817; D'ERCHIA, Anna Maria/0000-0002-4627-0626; Romani, Luigina/0000-0002-1356-525X	European Research Council (Dendroworld, HomeoGUT); Italian Association for Cancer Research (AIRC); Italian Ministry of Health (Ricerca finalizzata); Italian Ministry of Education, University and Research [PON01_02589]; Consiglio Nazionale delle Ricerche of Italy (progetto strategico "Medicina personalizzata"); Marie Curie program (Sipod); Fondazione Umberto Veronesi (FUV); AIRC fellowships	European Research Council (Dendroworld, HomeoGUT); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (Ricerca finalizzata)(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche of Italy (progetto strategico "Medicina personalizzata"); Marie Curie program (Sipod); Fondazione Umberto Veronesi (FUV)(Fondazione Umberto Veronesi); AIRC fellowships(Fondazione AIRC per la ricerca sul cancro)	This work was funded by the European Research Council (Dendroworld, HomeoGUT), the Italian Association for Cancer Research (AIRC) and the Italian Ministry of Health (Ricerca finalizzata), the Italian Ministry of Education, University and Research (PON01_02589, Micromap), and Consiglio Nazionale delle Ricerche of Italy (progetto strategico "Medicina personalizzata"). F.F. received a fellowship of a Cofunded Marie Curie program (Sipod) and of Fondazione Umberto Veronesi (FUV). E.Z. and E.M. received AIRC fellowships. We thank Dr. Blaise Corthesy (Internal Medicine Department Immunology and Allergy, University of Lausanne) for providing IgA antibodies specific for S. Typhimurium (Sal-4) or Rotavirus (7D9).	Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Buhnik-Rosenblau K, 2011, APPL ENVIRON MICROB, V77, P6531, DOI 10.1128/AEM.00324-11; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Manzari C., 2014, FEMS MICROBIOL LETT; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; Moon C., 2015, NATURE, V521, P90; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rochereau N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001658; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Roy B, 2013, EUR J IMMUNOL, V43, P2023, DOI 10.1002/eji.201243070; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093	40	191	193	3	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					527	540		10.1016/j.immuni.2015.08.011	http://dx.doi.org/10.1016/j.immuni.2015.08.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26362264	Bronze			2022-12-18	WOS:000370965900005
J	Boisson, B; Wang, CH; Pedergnana, V; Wu, L; Cypowyj, S; Rybojad, M; Belkadi, A; Picard, C; Abel, L; Fieschi, C; Puel, A; Li, XX; Casanova, JL				Boisson, Bertrand; Wang, Chenhui; Pedergnana, Vincent; Wu, Ling; Cypowyj, Sophie; Rybojad, Michel; Belkadi, Aziz; Picard, Capucine; Abel, Laurent; Fieschi, Claire; Puel, Anne; Li, Xiaoxia; Casanova, Jean-Laurent			An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans with Chronic Mucocutaneous Candidiasis	IMMUNITY			English	Article							SEQUENCING-BASED DISCOVERY; FUNCTION STAT1 MUTATIONS; HYPER-IGE SYNDROME; SIGNAL TRANSDUCER; ADAPTER PROTEIN; ATOPIC-DERMATITIS; IL-17 IMMUNITY; INBORN-ERRORS; RECEPTOR; DISEASE	Patients with inborn errors of interleukin-17F (IL-17F) or IL-17RA display chronic mucocutaneous candidiasis (CMC). We report a biallelic missense mutation (T536I) in the adaptor molecule ACT1 in two siblings with CMC. The mutation, located in the SEFIR domain, abolished the homotypic interaction of ACT1 with IL-17 receptors, with no effect on homo-dimerization. The patients' fibroblasts failed to respond to IL-17A and IL-17F, and their T cells to IL-17E. By contrast, healthy individuals homozygous for the common variant D10N, located in the ACT1 tumor necrosis factor receptor-associated factor-interacting domain and previously associated with psoriasis, had impaired, but not abolished, responses to IL-17 cytokines. SEFIR-independent interactions of ACT1 with other proteins, such as CD40, heat shock protein 70 (HSP70) and HSP90, were not affected by the T536I mutation. Overall, human IL-17A and IL-17F depend on ACT1 to mediate protective mucocutaneous immunity. Moreover, other ACT1-dependent IL-17 cytokines seem to be largely redundant in host defense.	[Boisson, Bertrand; Cypowyj, Sophie; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Wang, Chenhui; Wu, Ling; Li, Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Pedergnana, Vincent; Belkadi, Aziz; Picard, Capucine; Abel, Laurent; Puel, Anne; Casanova, Jean-Laurent] INSERM U980, Necker Med Sch, Lab Human Genet Infect Dis, Necker Branch, F-75015 Paris, France; [Rybojad, Michel] St Louis Hosp, Dermatol Unit, F-75010 Paris, France; [Picard, Capucine] Necker Enfants Malades Hosp, AP HP, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Fieschi, Claire] St Louis Hosp, Adult Immunopathol Unit, F-75010 Paris, France; [Fieschi, Claire] Paris Diderot Univ, F-75013 Paris, France	Rockefeller University; Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Boisson, B (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	bebo283@rockefeller.edu; casanova@rockefeller.edu	Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; Boisson, Bertrand/AAC-6058-2019; Abel, Laurent/H-8888-2017; Picard, Capucine/H-3914-2017; Boisson, Bertrand/I-2485-2017	Puel, Anne/0000-0003-2603-0323; Boisson, Bertrand/0000-0001-5240-3555; Abel, Laurent/0000-0001-7016-6493; Picard, Capucine/0000-0001-8788-5056; Boisson, Bertrand/0000-0001-5240-3555; Pedergnana, Vincent/0000-0002-7852-5339; Wang, Chenhui/0000-0002-3186-3066; Casanova, Jean-Laurent/0000-0002-7782-4169	European Research Council [ERC-2010-AdG-268777]; Institut National de la Sante et de la Recherche Medicale; University Paris Descartes; St. Giles Foundation; National Center for Research Resources; National Center for Advancing Sciences (NCATS) from National Institutes of Health [8UL1TR000043]; Jeffrey Modell Foundation; Rockefeller University; AXA Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, UL1TR000004, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; St. Giles Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Sciences (NCATS) from National Institutes of Health; Jeffrey Modell Foundation; Rockefeller University; AXA Research Fund(AXA Research Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and their family for participating in the study and all the members of both branches of the laboratory for discussions, especially Maya Chrabieh, Malik Bensifi, Marcela Moncada Velez, Tatiana Kochetkov, Minji Byun, Fanny Lanternier, Stephanie Boisson-Dupuis, Dusan Bogunovic, and Alexandre Bolze. We thank Yelena Nemiroskaya, Eric Anderson, and Tiffany Nivare for their assistance. We also thank the Alison North and Kaye Thomas from the Bio-Imaging Resource Center at The Rockefeller University. The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the European Research Council (ERC-2010-AdG-268777), Institut National de la Sante et de la Recherche Medicale, University Paris Descartes, the St. Giles Foundation, the National Center for Research Resources, and the National Center for Advancing Sciences (NCATS) grant number 8UL1TR000043 from the National Institutes of Health, the Jeffrey Modell Foundation, and The Rockefeller University. S. C. was supported by the AXA Research Fund.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Atkinson TP, 2001, AM J HUM GENET, V69, P791, DOI 10.1086/323611; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; CANALES L, 1969, LANCET, V2, P567; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Glocker E, 2010, CURR OPIN ALLERGY CL, V10, P542, DOI 10.1097/ACI.0b013e32833fd74f; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hori T, 2012, J CLIN IMMUNOL, V32, P1213, DOI 10.1007/s10875-012-9744-6; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; KIRKPATRICK CH, 1971, CLIN EXP IMMUNOL, V9, P733; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; LEROY D, 1989, DERMATOLOGICA, V178, P43, DOI 10.1159/000248386; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lilic D, 2012, CURR OPIN MICROBIOL, V15, P420, DOI 10.1016/j.mib.2012.06.003; Liu CN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001843; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Matsushima Y, 2010, J IMMUNOL, V185, P2340, DOI 10.4049/jimmunol.0900694; Mauro C, 2003, BIOCHEM BIOPH RES CO, V309, P84, DOI 10.1016/S0006-291X(03)01532-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellett M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2127; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Puel A, 2012, CURR OPIN ALLERGY CL, V12, P616, DOI 10.1097/ACI.0b013e328358cc0b; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2008, EUR J IMMUNOL, V38, P2219, DOI 10.1002/eji.200738113; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Romberg N, 2013, J ALLERGY CLIN IMMUN, V131, P1691, DOI 10.1016/j.jaci.2013.01.004; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Shi YG, 2000, J BIOL CHEM, V275, P19167, DOI 10.1074/jbc.M910228199; Smeekens SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029248; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Takezaki S, 2012, J IMMUNOL, V189, P1521, DOI 10.4049/jimmunol.1200926; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479; Wang XW, 2013, J ALLERGY CLIN IMMUN, V131, P1242, DOI 10.1016/j.jaci.2012.11.005; WELLS RS, 1972, J MED GENET, V9, P302, DOI 10.1136/jmg.9.3.302; WELLS RS, 1970, P ROY SOC MED, V63, P890, DOI 10.1177/003591577006300913; WILLIAMSON DM, 1969, BRIT J DERMATOL, V81, P125, DOI 10.1111/j.1365-2133.1969.tb15992.x; Zhang B, 2013, J IMMUNOL, V190, P2320, DOI 10.4049/jimmunol.1202922; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	71	191	197	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					676	686		10.1016/j.immuni.2013.09.002	http://dx.doi.org/10.1016/j.immuni.2013.09.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24120361	Green Accepted, Bronze			2022-12-18	WOS:000330950000009
J	Rao, RR; Li, QS; Bupp, MRG; Shrikant, PA				Rao, Rajesh R.; Li, Qingsheng; Bupp, Melanie R. Gubbels; Shrikant, Protul A.			Transcription Factor Foxo1 Represses T-bet-Mediated Effector Functions and Promotes Memory CD8(+) T Cell Differentiation	IMMUNITY			English	Article							ACTIVATION; EXPRESSION; MTORC2; KINASE; PROLIFERATION; EOMESODERMIN; HOMEOSTASIS; METABOLISM; RIBOSOME; GROWTH	The evolutionary conserved Foxo transcription factors are important regulators of quiescence and longevity. Although, Foxo1 is known to be important in regulating CD8(+) T cell trafficking and homeostasis, its role in functional differentiation of antigen-stimulated CD8(+) T cells is unclear. Herein, we demonstrate that inactivation of Foxo1 was essential for instructing T-bet transcription factor-mediated effector differentiation of CD8(+) T cells. The Foxo1 inactivation was dependent on mTORC1 kinase, given that blockade of mTORC1 abrogated mTORC2-mediated Akt (Ser473) kinase phosphorylation, resulting in Foxo1-dependent switch from T-bet to Eomesodermin transcription factor activation and increase in memory precursors. Silencing Foxo1 ablated interleukin-12- and rapamycin-enhanced CD8(+) T cell memory responses and restored T-bet-mediated effector functions. These results demonstrate an essential role of Foxo1 in actively repressing effector or terminal differentiation processes to promote memory CD8(+) T cell development and identify the functionally diverse mechanisms utilized by Foxo1 to promote quiescence and longevity.	[Rao, Rajesh R.; Li, Qingsheng; Shrikant, Protul A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Bupp, Melanie R. Gubbels] Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA	Roswell Park Cancer Institute	Shrikant, PA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Elm St, Buffalo, NY 14263 USA.	protul.shrikant@roswellpark.org			NIH-NCI [RO1 CA104645]; NATIONAL CANCER INSTITUTE [R01CA104645] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M.S. Schlissel (Univ. of Berkeley, CA) for Foxo1-ER-Thy1.1 and Foxo1 shRNA-hCD2 vector; L. Gapin (National Jewish, Univ. of Colorado) for T-bet-ER-GFP vector; R. Ahmed (Emory Univ, GA) for Raptor RNAi vector, and members of the Shrikant laboratory for their help and discussions. This work was supported by the NIH-NCI (RO1 CA104645) grant.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie XD, 2011, CELL, V144, P640, DOI 10.1016/j.cell.2011.02.029; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	30	191	193	2	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					374	387		10.1016/j.immuni.2012.01.015	http://dx.doi.org/10.1016/j.immuni.2012.01.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22425248	Green Accepted, Bronze			2022-12-18	WOS:000302048400010
J	Macintyre, AN; Finlay, D; Preston, G; Sinclair, LV; Waugh, CM; Tamas, P; Feijoo, C; Okkenhaug, K; Cantrell, DA				Macintyre, Andrew N.; Finlay, David; Preston, Gavin; Sinclair, Linda V.; Waugh, Caryll M.; Tamas, Peter; Feijoo, Carmen; Okkenhaug, Klaus; Cantrell, Doreen A.			Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism	IMMUNITY			English	Article							INTERLEUKIN-7 RECEPTOR; GENE-EXPRESSION; L-SELECTIN; SURVIVAL; MEMORY; EFFECTOR; GLUCOSE; DIFFERENTIATION; ACTIVATION; GENERATION	In cytotoxic T cells (CTL), Akt, also known as protein kinase B, is activated by the T cell antigen receptor (TCR) and the cytokine interleukin 2 (IL-2). Akt can control cell metabolism in many cell types but whether this role is important for CTL function has not been determined. Here we have shown that Akt does not mediate IL-2- or TCR-induced cell metabolic responses; rather, this role is assumed by other Akt-related kinases. There is, however, a nonredundant role for sustained and strong activation of Akt in CTL to coordinate the TCR- and IL-2-induced transcriptional programs that control expression of key cytolytic effector molecules, adhesion molecules, and cytokine and chemokine receptors that distinguish effector versus memory and naive T cells. Akt is thus dispensable for metabolism, but the strength and duration of Akt activity dictates the CTL transcriptional program and determines CTL fate.	[Macintyre, Andrew N.; Finlay, David; Preston, Gavin; Sinclair, Linda V.; Waugh, Caryll M.; Tamas, Peter; Feijoo, Carmen; Cantrell, Doreen A.] Univ Dundee, Div Cell Biol & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Okkenhaug, Klaus] Babraham Res Inst, Cambridge CB22 3AT, England	University of Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Cantrell, DA (corresponding author), Univ Dundee, Div Cell Biol & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk	Finlay, David/H-5840-2018; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Finlay, David/0000-0003-2716-6679; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Macintyre, Andrew/0000-0002-5297-0207; Cantrell, Doreen/0000-0001-7525-3350	Wellcome Trust [065975/Z/01/A]; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236, BB/C509890/1] Funding Source: researchfish; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank members of the Biological Services Unit; R. Clarke of the Flow Cytometry Facility; and members of the D.A.C. laboratory for critical reading of the manuscript. We thank D. Alessi at the University of Dundee for providing mice carrying PDK1 floxed alleles and the Finnish DNA Microarray Centre at the Centre for Biotechnology (Turku, Finland) for the microarray analysis. This project was supported by a Wellcome Trust Principal Research Fellowship and Program grant (065975/Z/01/A). A.N.M was supported by a Wellcome Trust PhD studentship.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; Hendricks J, 2003, J EXP MED, V198, P1369, DOI 10.1084/jem.20030916; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Jarmin SJ, 2008, J CLIN INVEST, V118, P1154, DOI 10.1172/JCI33267; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lin JX, 2008, BLOOD, V111, P525, DOI 10.1182/blood-2007-02-072207; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saibil SD, 2007, J IMMUNOL, V178, P2932, DOI 10.4049/jimmunol.178.5.2932; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	50	191	195	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					224	236		10.1016/j.immuni.2011.01.012	http://dx.doi.org/10.1016/j.immuni.2011.01.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21295499	Green Published, hybrid			2022-12-18	WOS:000287989500012
J	Crellin, NK; Trifari, S; Kaplan, CD; Satoh-Takayama, N; Di Santo, JP; Spits, H				Crellin, Natasha K.; Trifari, Sara; Kaplan, Charles D.; Satoh-Takayama, Naoko; Di Santo, James P.; Spits, Hergen			Regulation of Cytokine Secretion in Human CD127(+) LTi-like Innate Lymphoid Cells by Toll-like Receptor 2	IMMUNITY			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; IMMUNE CELLS; GENERATION; IL-22; DIFFERENTIATION; PRECURSORS; POPULATION; ENGAGEMENT; EXPRESSION	Lymphoid tissue inducer cells are members of an emerging family of innate lymphoid cells (ILC). Although these cells were originally reported to produce cytokines such as interleukin-17 (IL-17) and IL-22, we demonstrate here that human CD127(+)RORC(+) and CD56(+)CD127(+) LTi-like ILC also express IL-2, IL-5, and IL-13 after activation with physiologic stimuli such as common gamma-chain cytokines, Toll-like receptor (TLR) 2 ligands, or IL-23. Whereas TLR2 signaling induced IL-5, IL-13, and IL-22 expression in a nuclear factor kappa B (NF-kappa B)-dependent manner, IL-23 costimulation induced only IL-22 production. CD127(+) LTi-like ILC displayed clonal heterogeneity for IL-13 and IL-5 production, suggesting in vivo polarization. Finally, we identified a role for autocrine IL-2 signaling in mediating the effects of TLR2 stimulation on CD56(+)CD127(+) and CD127(+) LTi-like ILC. These results indicate that human LTi-like ILC can directly sense bacterial components and unravel a previously unrecognized functional heterogeneity among this important population of innate lymphoid cells.	[Crellin, Natasha K.; Trifari, Sara; Kaplan, Charles D.; Spits, Hergen] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Satoh-Takayama, Naoko; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75015 Paris, France; [Satoh-Takayama, Naoko; Di Santo, James P.] Inserm U668, F-75015 Paris, France	Roche Holding; Genentech; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Spits, H (corresponding author), Acad Med Ctr, NL-1105 BK Amsterdam, Netherlands.	hergen.spits@amc.uva.nl	Di Santo, James P/M-4298-2014; Spits, Hergen/N-2581-2019	Di Santo, James P/0000-0002-7146-1862; Spits, Hergen/0000-0003-3269-8338				Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chinen H, 2007, GASTROENTEROLOGY, V133, P559, DOI 10.1053/j.gastro.2007.05.017; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; Mercier BC, 2009, J IMMUNOL, V182, P1860, DOI 10.4049/jimmunol.0801167; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Sawaki J, 2007, INT IMMUNOL, V19, P311, DOI 10.1093/intimm/dxl148; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Spits H., 2010, NAT IMMUNOL IN PRESS; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	191	194	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 24	2010	33	5					752	764		10.1016/j.immuni.2010.10.012	http://dx.doi.org/10.1016/j.immuni.2010.10.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21055975	Bronze			2022-12-18	WOS:000286082600013
J	Scholer, A; Hugues, S; Boissonnas, A; Fetler, L; Amigorena, S				Scholer, Alix; Hugues, Stephanie; Boissonnas, Alexandre; Fetler, Luc; Amigorena, Sebastian			Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8(+) T cell memory	IMMUNITY			English	Article							IN-VIVO; LYMPH-NODES; INTERFERON-GAMMA; ANTIGEN PRESENTATION; SOLID TUMOR; TOLERANCE; ACTIVATION; RESPONSES; DYNAMICS; LEADS	The initiation of cytotoxic immune responses requires the direct interaction between naive CD8(+) T lymphocytes and dendritic cells (DCs). Multiphoton imaging in intact lymph nodes (LNs) showed that during priming, naive T cells and DCs establish sequentially brief (i.e., minutes) and long (hours) antigen-specific contacts. We show here that the expression of the Intercellular Adhesion Molecule-1 (ICAM-1) by mature DCs is critical for long-lasting contacts with CD8(+) T cells but dispensable for short-lived antigen-specific interactions. Serial brief DC-T cell contacts induced early CD8(+) T cell activation, proliferation, and differentiation into effector cytotoxic T lymphocytes in the first few days after immunization. ICAM-1-deficient mature DCs, however, failed to induce fully effective priming, because CD8(+) T cells produced reduced amounts of interferon gamma and were clonally depleted after 2 weeks. In addition, Icam1(-/-) micefailed to respond to rechallenge. We conclude that ICAM-1 dependent long-lasting interactions between mature DCs and naive CD8(+) T cells determine the survival of activated CD8(+) T cells and the establishment of effective memory.	[Scholer, Alix; Hugues, Stephanie; Boissonnas, Alexandre; Fetler, Luc; Amigorena, Sebastian] Ctr Rech, Inst Curie, F-75248 Paris, France; [Scholer, Alix; Hugues, Stephanie; Boissonnas, Alexandre; Amigorena, Sebastian] Inst Natl Sante & Rech Med, Immunite & Canc, U653, F-75248 Paris, France; [Fetler, Luc] Ctr Nacl Rech Sci, Unite Mixte Rech 168, Lab Phys Chim Curie, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Amigorena, S (corresponding author), Ctr Rech, Inst Curie, F-75248 Paris, France.	sebastian.amigorena@curie.fr	Scholer-Dahirel, Alix/G-5858-2014; Fetler, luc/M-9034-2018; Boissonnas, Alexandre/A-2801-2016	Boissonnas, Alexandre/0000-0002-7770-7210; Amigorena, Sebastian/0000-0001-8583-8416; hugues, stephanie/0000-0002-1031-5909				Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; He YK, 2000, HUM GENE THER, V11, P547, DOI 10.1089/10430340050015734; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Parameswaran N, 2005, J IMMUNOL, V175, P2201, DOI 10.4049/jimmunol.175.4.2201; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Sercan O, 2006, J IMMUNOL, V176, P735, DOI 10.4049/jimmunol.176.2.735; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Whitmire JK, 2007, J IMMUNOL, V179, P1190, DOI 10.4049/jimmunol.179.2.1190; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	39	191	198	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					258	270		10.1016/j.immuni.2007.12.016	http://dx.doi.org/10.1016/j.immuni.2007.12.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275834	Bronze			2022-12-18	WOS:000253275000015
J	Nombela-Arrieta, C; Lacalle, RA; Montoya, MC; Kunisaki, Y; Megias, D; Marques, M; Carrera, AC; Manes, S; Fukui, Y; Martinez-A, C; Stein, JV				Nombela-Arrieta, C; Lacalle, RA; Montoya, MC; Kunisaki, Y; Megias, D; Marques, M; Carrera, AC; Manes, S; Fukui, Y; Martinez-A, C; Stein, JV			Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing	IMMUNITY			English	Article							CELL-ADHESION; PHOSPHATIDYLINOSITOL 3-KINASE; INTEGRIN ACTIVATION; PROTEIN DOCK2; LIPID RAFTS; MIGRATION; CHEMOKINES; POLARIZATION; CHEMOTAXIS; GAMMA	Chemokines guide lymphocytes from blood to secondary lymphoid organs by triggering integrin-dependent firm adhesion under vascular flow and directed migration of T and B lymphocytes within lymphoid tissue. Here, we analyze the roles of DOCK2, a mammalian homolog of Caenorhabditis elegans CED-5 and Drosophila melanogaster Myoblast City, and phosphoinositide-3-kinase (PI3K) during lymphocyte recirculation. DOCK2 mediated efficient lymphocyte migration in a largely PI3K-independent manner, although a minor, PI3K-dependent pathway for migration was observed in wild-type and DOCK2-deficient lymphocytes. In T cells, this residual migration depended mainly on PI3Kgamma, whereas other PI3K isoforms were implicated in B cells. In vitro adhesion assays and intravital microscopy of lymphoid organ vasculature uncovered an unexpected defect in integrin activation in DOCK2(-/-) B cells, whereas lack of DOCK2 did not affect chemokine-triggered integrin activation in T cells. DOCK2 and PI3Kgamma thus play distinct roles during T and B cell integrin activation and migration.	Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain; Spanish Natl Canc Ctr, Biotechnol Program, Confocal Microscopy Unit, E-28049 Madrid, Spain; Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan	Centro Nacional de Investigaciones Oncologicas (CNIO); Kyushu University	Stein, JV (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, Campus Cantoblanco, E-28049 Madrid, Spain.	jstein@cnb.uam.es	Manes, Santos/E-4725-2011; Megías, Diego/L-6008-2014; Montoya, María/N-1558-2014; Marqués, Miriam/AAN-6642-2020	Montoya, María/0000-0001-8878-7028; Marqués, Miriam/0000-0003-1550-3033; Manes, Santos/0000-0001-8023-957X; Lacalle, Rosa Ana/0000-0003-0082-167X; Stein, Jens V/0000-0002-8199-9586; Carrera, Ana/0000-0002-3999-5434; Megias, Diego/0000-0003-0755-0518; Fukui, Yoshinori/0000-0003-2335-8745; Nombela-Arrieta, Cesar/0000-0003-0415-259X				Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Curnock AP, 2003, J IMMUNOL, V170, P4021, DOI 10.4049/jimmunol.170.8.4021; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; HONDA S, 1994, J IMMUNOL, V152, P4026; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Manes S, 2003, TRENDS IMMUNOL, V24, P320, DOI 10.1016/S1471-4906(03)00137-6; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Parent CA, 2002, CELL, V109, P541, DOI 10.1016/S0092-8674(02)00765-1; Peterson AC, 2003, EUR J IMMUNOL, V33, P2687, DOI 10.1002/eji.200324294; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez-Borlado L, 2003, J IMMUNOL, V170, P4475, DOI 10.4049/jimmunol.170.9.4475; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Stein JV, 2003, BLOOD, V101, P38, DOI 10.1182/blood-2002-03-0841; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TURNER L, 1995, J IMMUNOL, V155, P2437; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Zhang WV, 1999, EUR J IMMUNOL, V29, P2875, DOI 10.1002/(SICI)1521-4141(199909)29:09<2875::AID-IMMU2875>3.3.CO;2-9	51	191	197	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2004	21	3					429	441		10.1016/j.immuni.2004.07.012	http://dx.doi.org/10.1016/j.immuni.2004.07.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357953	Bronze			2022-12-18	WOS:000224034900013
J	Rosette, C; Werlen, G; Daniels, MA; Holman, PO; Alam, SM; Travers, PJ; Gascoigne, NRJ; Palmer, E; Jameson, SC				Rosette, C; Werlen, G; Daniels, MA; Holman, PO; Alam, SM; Travers, PJ; Gascoigne, NRJ; Palmer, E; Jameson, SC			The impact of duration versus extent of TCR occupancy on T cell activation: A revision of the kinetic proofreading model	IMMUNITY			English	Article							ALPHA-BETA; RECEPTOR ANTAGONISTS; PEPTIDE BINDING; LIGANDS; ZETA; SIGNAL; PHOSPHORYLATION; PROLIFERATION; STIMULATION; RECOGNITION	The widely accepted kinetic proofreading theory proposes that rapid TOR dissociation from a peptide/MHC ligand allows for stimulation of early but not late T cell activation events, explaining why low-affinity TCR ligands are poor agonists. We identified a low-affinity TCR ligand which stimulated late T cell responses but, contrary to predictions from kinetic proofreading, inefficiently induced early activation events. Furthermore, responses induced by this ligand were kinetically delayed compared to its high-affinity counterpart. Using peptide/MHC tetramers, we showed that activation characteristics could be dissociated from TOR occupancy by the peptide/MHC ligands. Our data argue that T cell responses are triggered by a cumulative signal which is reached at different time points for different TCR ligands.	Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Royal Free Hosp, Anthony Nolan Bone Marrow Trust, London NW3 2QG, England	University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@tc.umn.edu	Jameson, Stephen C/D-9892-2013; Alam, S. Munir/AAC-6711-2019	Jameson, Stephen C/0000-0001-9137-1146; Daniels, Mark/0000-0002-5175-9901	NIAID NIH HHS [T32 AI-07313, AI38903] Funding Source: Medline; NIGMS NIH HHS [GM394766] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038903, R29AI038903, T32AI007313, R37AI038903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Ardouin L, 1999, IMMUNITY, V10, P409, DOI 10.1016/S1074-7613(00)80041-2; Bachmann MF, 1999, IMMUNOL TODAY, V20, P568, DOI 10.1016/S0167-5699(99)01543-1; Baker BM, 2000, IMMUNITY, V13, P475, DOI 10.1016/S1074-7613(00)00047-9; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Chen YZ, 1998, EUR J IMMUNOL, V28, P3929, DOI 10.1002/(SICI)1521-4141(199812)28:12<3929::AID-IMMU3929>3.0.CO;2-8; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Garboczi DN, 1996, J IMMUNOL, V157, P5403; GASCOIGNE NRJ, 2001, EXP REV MOL MED; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hemmer B, 1998, J IMMUNOL, V160, P5807; HIAVACEK WS, 2001, P NATL ACAD SCI USA, V98, P7295; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu ZJ, 2001, P NATL ACAD SCI USA, V98, P7289, DOI 10.1073/pnas.121171998; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wang B, 2000, J IMMUNOL, V164, P1216, DOI 10.4049/jimmunol.164.3.1216; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	50	191	194	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					59	70		10.1016/S1074-7613(01)00173-X	http://dx.doi.org/10.1016/S1074-7613(01)00173-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485738	Bronze			2022-12-18	WOS:000170153300007
J	Raab, M; daSilva, AJ; Findell, PR; Rudd, CE				Raab, M; daSilva, AJ; Findell, PR; Rudd, CE			Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; VAV PROTOONCOGENE PRODUCT; T-CELL; PROTEIN-TYROSINE; GROWTH-FACTOR; SH2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; ZETA-CHAIN; CD5 ACTS; B-CELLS	T cell activation stimulates p56(lck), p59(fyn), ZAP-70, Vav-SLP-76 binding, and IL-2 transcription. Major questions concern the tyrosine-kinase and relevant site(s) needed for Vav-SLP-76 complex formation and its role in IL-2 production. Here, we show that of the three kinases, only ZAP-70 phosphorylates SLP-76 at specific sites that allow Vav SH2 domain binding. Therefore, while p56(lck) regulates proximal events, ZAP-70 acts downstream on targets such as SLP-76. We also show by in vitro and in vivo analysis that two SLP-76 pYESP motifs (Y113 and Y128) mediate binding, the first being more efficient. A third pYEPP motif (Y145) failed to bind. Finally, TCR zeta/CD3 ligation of T cell hybridoma DC27.10 induces IL-2 production without detectable Vav-SLP-76 binding. Therefore, despite effects of Vav-SLP-76 on IL-2 expression, Vav-SLP-76 binding per se is not essential for IL-2 production in all T cells.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; ROCHE BIOSCI,PALO ALTO,CA 94304	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Roche Holding			Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; 	NATIONAL CANCER INSTITUTE [R01CA051887] Funding Source: NIH RePORTER; NCI NIH HHS [CA5 1887-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BROWN M, 1977, J GEN VIROL, V36, P361, DOI 10.1099/0022-1317-36-2-361; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; BUSTELO XR, 1994, ONCOGENE, V9, P2405; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; daSilva AJ, 1997, J IMMUNOL, V158, P2007; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GILLIS S, 1978, J IMMUNOL, V120, P2027; GOUY H, 1995, EUR J IMMUNOL, V25, P3030, DOI 10.1002/eji.1830251107; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KATZAV S, 1994, J BIOL CHEM, V269, P32579; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MCKENNEY DW, 1995, J BIOL CHEM, V270, P24949, DOI 10.1074/jbc.270.42.24949; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RAAB M, 1994, MOL CELL BIOL, V14, P2862, DOI 10.1128/MCB.14.5.2862; Raab M, 1996, BIOCHEM BIOPH RES CO, V222, P50, DOI 10.1006/bbrc.1996.0696; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; YE ZS, 1994, P NATL ACAD SCI USA, V91, P12629, DOI 10.1073/pnas.91.26.12629; YUNCAI C, 1995, IMMUNITY, V3, P417; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	46	191	195	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1997	6	2					155	164		10.1016/S1074-7613(00)80422-7	http://dx.doi.org/10.1016/S1074-7613(00)80422-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047237	Bronze			2022-12-18	WOS:A1997XC61600005
J	THOMPSON, CB				THOMPSON, CB			NEW INSIGHTS INTO V(D)J RECOMBINATION AND ITS ROLE IN THE EVOLUTION OF THE IMMUNE-SYSTEM	IMMUNITY			English	Review							BROKEN DNA-MOLECULES; B-CELL DEVELOPMENT; LIGHT-CHAIN GENES; IMMUNOGLOBULIN SUPERFAMILY; TRANSPOSABLE ELEMENTS; N-REGIONS; CHICKEN; SEQUENCES; DIVERSITY; DIVERSIFICATION		UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637	Howard Hughes Medical Institute; University of Chicago	THOMPSON, CB (corresponding author), UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT MED,GWEN KNAPP CTR LUPUS & IMMUNOL RES,CHICAGO,IL 60637, USA.							BERNSTEIN RM, 1994, BIOCHEM BIOPH RES CO, V205, P687, DOI 10.1006/bbrc.1994.2720; BEZOUSKA K, 1994, NATURE, V372, P150, DOI 10.1038/372150a0; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BRETTING H, 1979, CELL TISSUE RES, V201, P487; CARLSON LM, 1991, CELL, V64, P201, DOI 10.1016/0092-8674(91)90221-J; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; COOPER EL, 1992, SCAND J IMMUNOL, V35, P247, DOI 10.1111/j.1365-3083.1992.tb02857.x; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DREYFUS DH, 1992, MOL IMMUNOL, V29, P807, DOI 10.1016/0161-5890(92)90191-Y; Du Pasquier Louis, 1993, P199; DUPASQUIER L, 1993, CURR OPIN IMMUNOL, V5, P185, DOI 10.1016/0952-7915(93)90003-B; FEDOROFF NV, 1989, MOBILE DNA, P275; FEENEY AJ, 1993, J IMMUNOL, V151, P3094; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; FULOP GM, 1990, NATURE, V37, P479; Galas D, 1989, MOBILE DNA, P109; GAMULIN V, 1994, BIOL CHEM H-S, V375, P583; GANGLOFF S, 1994, EXPERIENTIA, V50, P261, DOI 10.1007/BF01924009; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOBEL TWF, 1994, P NATL ACAD SCI USA, V91, P1094, DOI 10.1073/pnas.91.3.1094; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P10603, DOI 10.1073/pnas.90.22.10603; GREENHALGH P, 1993, J IMMUNOL, V151, P3100; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HAVRAN WL, 1994, CURR OPIN IMMUNOL, V6, P441; HERZENBERG LA, 1992, ANN NY ACAD SCI, V651, P1; HILDEMANN WH, 1974, NATURE, V250, P116, DOI 10.1038/250116a0; HINDS KR, 1986, NATURE, V320, P546, DOI 10.1038/320546a0; HOHMAN VS, 1993, P NATL ACAD SCI USA, V90, P9882, DOI 10.1073/pnas.90.21.9882; HSIEH CL, 1992, J BIOL CHEM, V267, P15613; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; LECLERC M, 1980, DEV COMP IMMUNOL, V4, P605, DOI 10.1016/S0145-305X(80)80063-2; LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIEBSON PJ, 1995, IMMUNITY, V3, P5; LITMAN GW, 1993, MOL BIOL EVOL, V10, P60; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; MARCHALONIS JJ, 1990, SCAND J IMMUNOL, V32, P13, DOI 10.1111/j.1365-3083.1990.tb02886.x; MARCHALONIS JJ, 1990, BIOSCIENCE, V40, P758, DOI 10.2307/1311509; MATSUNAGA T, 1987, SCAND J IMMUNOL, V25, P485, DOI 10.1111/j.1365-3083.1987.tb02220.x; MCBLANE JF, 1995, IN PRESS CELL; MCCORMACK WT, 1991, P NATL ACAD SCI USA, V88, P7699, DOI 10.1073/pnas.88.17.7699; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OTA T, 1994, MOL BIOL EVOL, V11, P469; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; ROTHEL JS, 1992, AUST VET J, V69, P1, DOI 10.1111/j.1751-0813.1992.tb09848.x; SADOFSKY MJ, 1995, GENE DEV, V9, P2193, DOI 10.1101/gad.9.17.2193; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SCHATZ DG, 1992, NEW BIOL, V4, P188; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHWAGER J, 1991, EMBO J, V10, P2461, DOI 10.1002/j.1460-2075.1991.tb07785.x; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733, DOI 10.1002/j.1460-2075.1989.tb08549.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SIMA P, 1993, CRIT REV IMMUNOL, V13, P83; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; VANDEVYVER G, 1983, J EXP ZOOL, V227, P1, DOI 10.1002/jez.1402270102; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; WEILL JC, 1992, CURR OPIN IMMUNOL, V4, P177, DOI 10.1016/0952-7915(92)90009-4; Weissman I L, 1988, Int Rev Immunol, V3, P397, DOI 10.3109/08830188809051207; WEISSMAN IL, 1994, IMMUNITY, V1, P529, DOI 10.1016/1074-7613(94)90042-6; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9	78	191	197	0	15	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					531	539		10.1016/1074-7613(95)90124-8	http://dx.doi.org/10.1016/1074-7613(95)90124-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584143	Bronze			2022-12-18	WOS:A1995TG28100001
J	Roco, JA; Mesin, L; Binder, SC; Nefzger, C; Gonzalez-Figueroa, P; Canete, PF; Ellyard, J; Shen, Q; Robert, PA; Cappello, J; Vohra, H; Zhang, Y; Nowosad, CR; Schiepers, A; Corcoran, LM; Toellner, KM; Polo, JM; Meyer-Hermann, M; Victora, GD; Vinuesa, CG				Roco, Jonathan A.; Mesin, Luka; Binder, Sebastian C.; Nefzger, Christian; Gonzalez-Figueroa, Paula; Canete, Pablo F.; Ellyard, Julia; Shen, Qian; Robert, Philippe A.; Cappello, Jean; Vohra, Harpreet; Zhang, Yang; Nowosad, Carla R.; Schiepers, Arien; Corcoran, Lynn M.; Toellner, Kai-Michael; Polo, Jose M.; Meyer-Hermann, Michael; Victora, Gabriel D.; Vinuesa, Carola G.			Class-Switch Recombination Occurs Infrequently in Germinal Centers	IMMUNITY			English	Article							MEMORY B-CELLS; SOMATIC HYPERMUTATION; CLONAL SELECTION; GENE-EXPRESSION; PLASMA-CELL; DNA BREAKS; IN-SITU; DIFFERENTIATION; REPAIR; TRANSCRIPTS	Class-switch recombination (CSR) is a DNA recombination process that replaces the immunoglobulin (Ig) constant region for the isotype that can best protect against the pathogen. Dysregulation of CSR can cause self-reactive BCRs and B cell lymphomas; understanding the timing and location of CSR is therefore important. Although CSR commences upon T cell priming, it is generally considered a hallmark of germinal centers (GCs). Here, we have used multiple approaches to show that CSR is triggered prior to differentiation into GC B cells or plasmablasts and is greatly diminished in GCs. Despite finding a small percentage of GC B cells expressing germline transcripts, phylogenetic trees of GC BCRs from secondary lymphoid organs revealed that the vast majority of CSR events occurred prior to the onset of somatic hypermutation. As such, we have demonstrated the existence of IgM-dominated GCs, which are unlikely to occur under the assumption of ongoing switching.	[Roco, Jonathan A.; Gonzalez-Figueroa, Paula; Canete, Pablo F.; Ellyard, Julia; Shen, Qian; Cappello, Jean; Vohra, Harpreet; Vinuesa, Carola G.] Australian Natl Univ, Dept Immunol & Infect Dis, Canberra, ACT 0200, Australia; [Roco, Jonathan A.; Gonzalez-Figueroa, Paula; Canete, Pablo F.; Ellyard, Julia; Shen, Qian; Cappello, Jean; Vohra, Harpreet; Vinuesa, Carola G.] Australian Natl Univ, Ctr Personalised Immunol, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Mesin, Luka; Nowosad, Carla R.; Schiepers, Arien; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA; [Binder, Sebastian C.; Robert, Philippe A.; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Rebenring 56, D-38106 Braunschweig, Germany; [Binder, Sebastian C.; Robert, Philippe A.; Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, Rebenring 56, D-38106 Braunschweig, Germany; [Meyer-Hermann, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Braunschweig, Germany; [Nefzger, Christian; Polo, Jose M.] Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic 3800, Australia; [Nefzger, Christian; Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Wellington Rd, Clayton, Vic 3800, Australia; [Zhang, Yang; Toellner, Kai-Michael] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Corcoran, Lynn M.] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic, Australia; [Corcoran, Lynn M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Vinuesa, Carola G.] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Dept Rheumatol, Shanghai, Peoples R China	Australian National University; Australian National University; John Curtin School of Medical Research; Rockefeller University; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; Monash University; Australian Regenerative Medicine Institute; Monash University; University of Birmingham; Walter & Eliza Hall Institute; University of Melbourne; Shanghai Jiao Tong University	Vinuesa, CG (corresponding author), Australian Natl Univ, Dept Immunol & Infect Dis, Canberra, ACT 0200, Australia.; Vinuesa, CG (corresponding author), Australian Natl Univ, Ctr Personalised Immunol, John Curtin Sch Med Res, Canberra, ACT 0200, Australia.; Vinuesa, CG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Dept Rheumatol, Shanghai, Peoples R China.	carola.vinuesa@anu.edu.au	Canete, Pablo/HGB-5944-2022; Gonzalez-Figueroa, Paula/W-3654-2018; Canete, Pablo F/AAO-5341-2020; Robert, Philippe A./Z-2816-2019; Vinuesa, Carola G/B-1108-2010; Canete, Pablo F/E-3305-2019; Toellner, Kai-Michael/F-1519-2011	Gonzalez-Figueroa, Paula/0000-0001-8270-552X; Canete, Pablo F/0000-0002-6167-4186; Robert, Philippe A./0000-0003-1345-5015; Vinuesa, Carola G/0000-0001-9799-0298; Nefzger, Christian/0000-0003-4631-5633; Toellner, Kai-Michael/0000-0001-8404-645X; Schiepers, Arien/0000-0002-5185-364X; Zhang, Yang/0000-0002-4201-3702	Australian National Health and Medical Research Council [APP1117812, APP1113577]; Human Frontier Science Program [RGP0033/2015]; NIH/NIAID [R01AI119006, R01AI139117]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119006, R01AI139117] Funding Source: NIH RePORTER; BBSRC [BB/S003800/1, BB/M025292/1] Funding Source: UKRI; MRC [G1001390] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank R. Brink for providing HEL<SUP>2x</SUP> and HEL<SUP>3x</SUP> protein and Sw<INF>HEL</INF> mice; M. Nussenzweig for providing B1-8<SUP>hi</SUP> tdTomato mice, S. Casola for providing C gamma 1Cre:mT/mG mice, A. Prins for preparing histological samples, C. Gillespie for microscopy analysis, E. Bartlett for reviewing the manuscript, A. Wilson and A.-M. Hatch for assistance with obtaining tonsil samples and clinical data, the Australian Cancer Research Foundation (ACRF) Biomolecular Resource Facility (BRF) and the Australian Phenomics Facility (APF) for their technical support, the Imaging and Cytometry Facility at The John Curtin School of Medical Research-especially M. Devoy-for FACS sorting, W. Shi for analysis of RNA-seq data, and D. Kitamura and G. Kelsoe for kindly providing Nojima cells. C.G.V. is supported by fellowship, project, and program grants from the Australian National Health and Medical Research Council (APP1117812 and APP1113577). The Human Frontier Science Program (RGP0033/2015) supports M.M.-H., G.D.V., and C.G.V. G.D.V. is funded by NIH/NIAID grants R01AI119006 and R01AI139117.	Al-Safi Rasha I, 2012, Curr Mol Pharmacol, V5, P14; Audzevich T, 2013, J IMMUNOL, V190, P4946, DOI 10.4049/jimmunol.1203014; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Binder SC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00593; Brink R, 2015, METHODS MOL BIOL, V1291, P103, DOI 10.1007/978-1-4939-2498-1_9; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cogne M, 2004, MOL BIOL B CELLS, P289; DeWitt WS, 2018, MOL BIOL EVOL, V35, P1253, DOI 10.1093/molbev/msy020; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; He JS, 2015, CURR TOP MICROBIOL, V388, P1, DOI 10.1007/978-3-319-13725-4_1; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Meyer-Hermann M, 2014, J IMMUNOL, V193, P5414, DOI 10.4049/jimmunol.1401828; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nefzger CM, 2016, STEM CELL REP, V6, P321, DOI 10.1016/j.stemcr.2016.01.014; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Sabouri Z, 2009, INT IMMUNOL, V21, P947, DOI 10.1093/intimm/dxp061; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Shinkura R, 1996, INT IMMUNOL, V8, P1067, DOI 10.1093/intimm/8.7.1067; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stavnezer J, 2014, P NATL ACAD SCI USA, V111, P9217, DOI 10.1073/pnas.1405590111; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xu JL, 2014, P NATL ACAD SCI USA, V111, P17242, DOI 10.1073/pnas.1420221111	71	190	192	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					337	+		10.1016/j.immuni.2019.07.001	http://dx.doi.org/10.1016/j.immuni.2019.07.001			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31375460	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000482088500016
J	Morita, H; Arae, K; Unno, H; Miyauchi, K; Toyama, S; Nambu, A; Oboki, K; Ohno, T; Motomura, K; Matsuda, A; Yamaguchi, S; Narushima, S; Kajiwara, N; Iikura, M; Suto, H; McKenzie, ANJ; Takahashi, T; Karasuyama, H; Okumura, K; Azuma, M; Moro, K; Akdis, CA; Galli, SJ; Koyasu, S; Kubo, M; Sudo, K; Saito, H; Matsumoto, K; Nakae, S				Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Miyauchi, Kousuke; Toyama, Sumika; Nambu, Aya; Oboki, Keisuke; Ohno, Tatsukuni; Motomura, Kenichiro; Matsuda, Akira; Yamaguchi, Sachiko; Narushima, Seiko; Kajiwara, Naoki; Iikura, Motoyasu; Suto, Hajime; McKenzie, Andrew N. J.; Takahashi, Takao; Karasuyama, Hajime; Okumura, Ko; Azuma, Miyuki; Moro, Kazuyo; Akdis, Cezmi A.; Galli, Stephen J.; Koyasu, Shigeo; Kubo, Masato; Sudo, Katsuko; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu			An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers	IMMUNITY			English	Article							DUST MITE ALLERGEN; MAST-CELLS; ST2 COMPRISE; IL-33; MECHANISM; RESPONSES; INITIATION; EXPRESSION; CYTOKINES; PROTEIN	House dust mite-derived proteases contribute to allergic disorders in part by disrupting epithelial barrier function. Interleukin-33 (IL-33), produced by lung cells after exposure to protease allergens, can induce innate-type airway eosinophilia by activating natural helper (NH) cells, a member of group 2 innate lymphoid cells (ILC2), to secrete Th2 type-cytokines. Because IL-33 also can induce mast cells (MCs) to secrete Th2 type-cytokines, MCs are thought to cooperate with NH cells in enhancing protease or IL-33-mediated innate-type airway eosinophilia. However, we found that MC-deficient Kit(W-sh/W-sh) mice exhibited exacerbated protease-induced lung inflammation associated with reduced numbers of regulatory T (Treg) cells. Moreover, IL-2 produced by IL-33-stimulated MCs promoted expansion of numbers of Treg cells, thereby suppressing development of papain-or IL-33-induced airway eosinophilia. We have thus identified a unique anti-inflammatory pathway that can limit induction of innate-type allergic airway inflammation mediated by NH cells.	[Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Toyama, Sumika; Oboki, Keisuke; Ohno, Tatsukuni; Motomura, Kenichiro; Kajiwara, Naoki; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan; [Morita, Hideaki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Morita, Hideaki; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland; [Arae, Ken] Kyorin Univ, Fac Hlth Sci, Dept Immunol, Tokyo 1928508, Japan; [Unno, Hirotoshi] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan; [Miyauchi, Kousuke; Kubo, Masato] RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa 2300045, Japan; [Toyama, Sumika; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138510, Japan; [Nambu, Aya; Yamaguchi, Sachiko; Narushima, Seiko; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo 1088639, Japan; [Ohno, Tatsukuni; Azuma, Miyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Immunol, Tokyo 1138510, Japan; [Matsuda, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 1138421, Japan; [Iikura, Motoyasu] Natl Ctr Global Hlth & Med, Dept Resp Med, Tokyo 1628655, Japan; [Nambu, Aya; Suto, Hajime; Okumura, Ko] Juntendo Univ, Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan; [McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Karasuyama, Hajime] Japan Sci & Technol Agcy, CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Moro, Kazuyo; Koyasu, Shigeo] RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo; Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ, CH-7270 Davos, Switzerland; [Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba 2780022, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo 1608402, Japan	National Center for Child Health & Development - Japan; Keio University; Swiss Institute of Allergy & Asthma Research; University of Zurich; Kyorin University; Jikei University; RIKEN; Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo Medical & Dental University (TMDU); Juntendo University; National Center for Global Health & Medicine - Japan; Juntendo University; MRC Laboratory Molecular Biology; Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST); Stanford University; Stanford University; Tokyo University of Science; Tokyo Medical University	Nakae, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 1578535, Japan.	snakae@ims.u-tokyo.ac.jp	Oboki, Keisuke/AAR-1813-2020; Kubo, Masato/A-5918-2016; Morita, Hideaki/S-2214-2016; Moro, Kazuyo/A-5987-2016; Akdis, Cezmi/AAV-4844-2020; Matsuda, Akira/A-9981-2010; Azuma, Miyuki/AAT-8928-2021; Koyasu, Shigeo/J-5583-2015; Karasuyama, Hajime/A-7966-2011; Morita, Hideaki/ADL-2008-2022	Morita, Hideaki/0000-0003-0928-8322; Akdis, Cezmi/0000-0001-8020-019X; Matsuda, Akira/0000-0002-0792-3663; Azuma, Miyuki/0000-0002-3529-4585; Koyasu, Shigeo/0000-0001-9585-3038; Karasuyama, Hajime/0000-0003-0689-0836; Nambu, Aya/0000-0002-2797-6420; Saito, Hirohisa/0000-0002-6630-8337; Moro, Kazuyo/0000-0002-7377-1303	Japan Society for the Promotion of Science; Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; Banyu Life Science Foundation International; Swiss National Science Foundation [320030-140772]; NIH [AI070813, AI023990, CA072074, U19AI104209]; MRC [MC_U105178805] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070813, R01AI023990, U19AI104209, R37AI023990] Funding Source: NIH RePORTER; Medical Research Council [MC_U105178805] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15H01267, 15H02515, 15H05786, 15H04866] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Improvement of Research Environment for Young Researchers; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Banyu Life Science Foundation International(Banyu Life Science Foundation International); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of NCH (M. Fujiwara, H. Wakita, Y. Shimamoto, S. Fukuda, M. Yamada, N. Hashimoto, K. Takeda, and N. Okada), IMSUT (W. Nakanishi, N. Hiraishi, E. Shimura, and A. Shibui), RIKEN (M. Mochizuki and N. Takeno), SIAF (B. Stanic and T. Kubo), and Dr. Jenny Mjosberg (Karolinska Institutet) for their technical assistance, and Drs. P. Besmer (Cornell University), S. Akira (Osaka University), K. Nakanishi (Hyogo College), S. Koyasu (RIKEN), and S. Ishido (RIKEN) for providing Kit<SUP>W-sh/W-sh</SUP>, myd88<SUP>-/-</SUP>, Il1rl1<SUP>-/-</SUP>, Il2<SUP>-/-</SUP>, and H2-Ab1<SUP>-/-</SUP> mice, respectively. We are grateful to Lawrence W. Stiver (Tokyo, Japan) for critical reading of the manuscript. This work was supported by Grants-in-Aid for Young Scientists (B) (H. M., T.O., and K.O.), a Grant-in-Aid for Scientific Research (B) (H. Saito and K. Matsumoto) and (S) (S.K.), a Grant-in-Aid for Challenging Exploratory Research (S. K.), PRESTO, the Japan Science and Technology Agency (K. Moro and S. Nakae) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas (K. Moro) and the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S. Nakae) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (H. Saito, S. Nakae, and K. Matsumoto), Banyu Life Science Foundation International (H.M.), Swiss National Science Foundation No. 320030-140772 (C.A.A.), and NIH grants AI070813, AI023990, CA072074, and U19AI104209 (S.J.G.).	Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chapman RW, 2008, PULM PHARMACOL THER, V21, P731, DOI 10.1016/j.pupt.2008.01.003; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Leveson-Gower DB, 2013, BLOOD, V122, P3659, DOI 10.1182/blood-2013-08-519157; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Nakamura T, 2006, J INVEST DERMATOL, V126, P2719, DOI 10.1038/sj.jid.5700584; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	38	190	194	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					175	186		10.1016/j.immuni.2015.06.021	http://dx.doi.org/10.1016/j.immuni.2015.06.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200013	Green Accepted, Bronze			2022-12-18	WOS:000360101100019
J	Hadeiba, H; Lahl, K; Edalati, A; Oderup, C; Habtezion, A; Pachynski, R; Nguyen, L; Ghodsi, A; Adler, S; Butcher, EC				Hadeiba, Husein; Lahl, Katharina; Edalati, Abdolhossein; Oderup, Cecilia; Habtezion, Aida; Pachynski, Russell; Nguyen, Linh; Ghodsi, Asma; Adler, Sarah; Butcher, Eugene C.			Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central Tolerance	IMMUNITY			English	Article							T-CELLS; EPITHELIAL-CELLS; HEMATOPOIETIC PROGENITORS; SMALL-INTESTINE; ADULT THYMUS; LYMPH-NODE; EXPRESSION; SELECTION; CCR9; MIGRATION	Central tolerance can be mediated by peripheral dendritic cells (DCs) that transport innocuous antigens (Ags) to the thymus for presentation to developing T cells, but the responsible DC subsets remained poorly defined. Immature plasmacytoid DCs (pDCs) express CCR9, a chemokine receptor involved in migration of T cell precursors to the thymus. We show here that CCR9 mediated efficient thymic entry of endogenous or i.v. transfused pDCs. pDCs activated by Toll-like receptor (TLR) ligands downregulated CCR9 and lost their ability to home to the thymus. Moreover, endogenous pDCs took up subcutaneously injected fluorescent Ag and, in the absence of TLR signals, transported Ag to the thymus in a CCR9-dependent fashion. Injected, Ag-loaded pDCs effectively deleted Ag-specific thymocytes, and this thymic clonal deletion required CCR9-mediated homing and was prevented by infectious signals. Thus, peripheral pDCs can contribute to immune tolerance through CCR9-dependent transport of peripheral Ags and subsequent deletion of Ag-reactive thymocytes.	[Hadeiba, Husein; Lahl, Katharina; Edalati, Abdolhossein; Oderup, Cecilia; Habtezion, Aida; Pachynski, Russell; Nguyen, Linh; Ghodsi, Asma; Adler, Sarah; Butcher, Eugene C.] Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA; [Hadeiba, Husein; Lahl, Katharina; Edalati, Abdolhossein; Oderup, Cecilia; Habtezion, Aida; Pachynski, Russell; Nguyen, Linh; Ghodsi, Asma; Adler, Sarah; Butcher, Eugene C.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hadeiba, H (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Lab Immunol & Vasc Biol, Stanford, CA 94305 USA.	hadeiba@stanford.edu; ebutcher@stanford.edu	Lahl, Katharina/AAA-1909-2021	Lahl, Katharina/0000-0003-4919-331X; Pachynski, Russell/0000-0002-8966-7631	Arthritis Foundation; NIH [AI107290, DK085426, R01AI093981, AI047822, DK084647]; Wenner-Gren Foundation; Crohn's & Colitis Foundation; Stanford Digestive Disease Center [DK056339]; Department of Veterans Affairs	Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundation; Crohn's & Colitis Foundation; Stanford Digestive Disease Center; Department of Veterans Affairs(US Department of Veterans Affairs)	We thank L. Rott for assistance and G. Dranoff for the Flt3L-expressing B16 melanoma line. H.H. is a recipient of an Investigator Career Award from the Arthritis Foundation and was a fellow under the NIH Training Grant AI107290; K.L. is a fellow of the Deutsche Forschungsgemeinschaft, DFG; C.O. was supported by Fellowships from the Wenner-Gren Foundation and the Crohn's & Colitis Foundation; and A.H. was supported by NIH grant DK085426. The work was supported by NIH grants R01AI093981, AI047822, and DK084647 to E.C.B., the Stanford Digestive Disease Center under DK056339, and a Merit Award from the Department of Veterans Affairs.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atibalentja DF, 2009, J IMMUNOL, V183, P7909, DOI 10.4049/jimmunol.0902632; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Donskoy E, 2003, J IMMUNOL, V170, P3514, DOI 10.4049/jimmunol.170.7.3514; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Pabst O, 2004, J EXP MED, V199, P411, DOI 10.1084/jem.20030996; Proietto AI, 2009, IMMUNOL CELL BIOL, V87, P39, DOI 10.1038/icb.2008.86; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Relland LM, 2009, J IMMUNOL, V182, P1341, DOI 10.4049/jimmunol.182.3.1341; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Song F, 2006, J IMMUNOL, V177, P1500, DOI 10.4049/jimmunol.177.3.1500; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	35	190	198	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					438	450		10.1016/j.immuni.2012.01.017	http://dx.doi.org/10.1016/j.immuni.2012.01.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444632	Green Accepted, Bronze			2022-12-18	WOS:000302048400015
J	Turchinovich, G; Hayday, AC				Turchinovich, Gleb; Hayday, Adrian C.			Skint-1 Identifies a Common Molecular Mechanism for the Development of Interferon-gamma-Secreting versus Interleukin-17-Secreting gamma delta T Cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; ALPHA-BETA; THYMOCYTE DEVELOPMENT; ANTIGEN RECEPTORS; THYMIC SELECTION; IMMUNE-RESPONSE; TH17 CELLS; INNATE; EXPRESSION; PROMOTES	Murine T cell development begins with the generation of a unique V gamma 5(+)V delta 1(+) epidermal gamma delta T cell compartment and a unique, more broadly distributed V gamma 6(+)V delta 1(+) subset that is an important source of interleukin-17 (IL-17). This study showed that these respective functional programs were determined by Skint-1, a thymic epithelial cell determinant. By engaging Skint-1+ cells, V gamma 5(+)V delta 1(+) thymocytes induced an Egr3-mediated pathway, provoking differentiation and the potential to produce IFN-gamma while suppressing the gamma delta T cell lineage factor, Sox13, and a ROR gamma t transcription factor-associated IL-17-producing capacity. Hence, the functions of the earliest T cells are substantially preprogrammed in the thymus. Additionally, the phenotype of Skint-1-selected fetal thymocytes permitted identification in the adult thymus of an analogous gene regulatory network regulated by the gamma delta T cell receptor. Hence, these observations describe a molecular pathway by which distinct stress-responsive lymphocyte repertoires may emerge throughout ontogeny and offer parallels with emerging perspectives on the functional selection of other lymphoid cells.	[Turchinovich, Gleb; Hayday, Adrian C.] Kings Coll London, Sch Med, Guys Hosp, London Res Inst, London SE1 9RT, England; [Turchinovich, Gleb; Hayday, Adrian C.] Kings Coll London, Sch Med, Guys Hosp, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, AC (corresponding author), Kings Coll London, Sch Med, Guys Hosp, London Res Inst, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793	Wellcome Trust; Medical Research Council [G0600698B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the following for reagents, ideas, experimental assistance, and other key inputs: R. Tigelaar, A. Behrens, P. Costello, A. Jandke, R. Nicolas, M. Woodward, M.-L. Michel, the staffs of the Flow Cytometry and BSU Core Facilities (London Research Institute), P. Ellis and C. Langford (Sanger Centre), T. Kreslavsky (Harvard University), M. Karin (UCSD), and D. van Essen (MPI for Immunobiology, Freiburg). We acknowledge financial support from a Wellcome Trust Programme Grant (G.T., A.C.H.).	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Baccala R, 2005, J IMMUNOL, V174, P4606, DOI 10.4049/jimmunol.174.8.4606; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Boismenu R, 1996, J IMMUNOL, V157, P985; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Costello P, 2010, J IMMUNOL, V185, P1082, DOI 10.4049/jimmunol.1000472; De Rosa SC, 2004, J IMMUNOL, V172, P1637, DOI 10.4049/jimmunol.172.3.1637; Di Santo JP, 2009, NAT IMMUNOL, V10, P1051, DOI 10.1038/ni1009-1051; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; HEYBORNE K, 1993, J IMMUNOL, V151, P4523; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kang J, 1999, J EXP MED, V190, P973, DOI 10.1084/jem.190.7.973; Kisielow J, 2008, J IMMUNOL, V181, P1710, DOI 10.4049/jimmunol.181.3.1710; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Mages HW, 1998, MOL CELL BIOL, V18, P7157, DOI 10.1128/MCB.18.12.7157; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; McGargill MA, 2009, J IMMUNOL, V183, P4838, DOI 10.4049/jimmunol.0902208; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Ondr JK, 2004, J BIOL CHEM, V279, P27525, DOI 10.1074/jbc.M400304200; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Park K, 2010, EMBO J, V29, P2329, DOI 10.1038/emboj.2010.113; Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Simonian PL, 2009, J IMMUNOL, V182, P6540, DOI 10.4049/jimmunol.0900013; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Travers H, 2001, J IMMUNOL METHODS, V253, P209, DOI 10.1016/S0022-1759(01)00391-X; Tretter T, 2003, J EXP MED, V198, P1863, DOI 10.1084/jem.20030729; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023	64	190	193	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					59	68		10.1016/j.immuni.2011.04.018	http://dx.doi.org/10.1016/j.immuni.2011.04.018			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21737317	Bronze			2022-12-18	WOS:000293107300010
J	Ghosh, HS; Cisse, B; Bunin, A; Lewis, KL; Reizis, B				Ghosh, Hiyaa S.; Cisse, Babacar; Bunin, Anna; Lewis, Kanako L.; Reizis, Boris			Continuous Expression of the Transcription Factor E2-2 Maintains the Cell Fate of Mature Plasmacytoid Dendritic Cells	IMMUNITY			English	Article							BONE-MARROW; T-CELLS; LYMPHOCYTE DEVELOPMENT; B-CELLS; MOUSE; ORIGIN; E2A; DIFFERENTIATE; PROGENITORS; HOMEOSTASIS	The interferon-producing plasmacytoid dendritic cells (pDCs) share common progenitors with antigen-presenting classical dendritic cells (cDCs), yet they possess distinct morphology and molecular features resembling those of lymphocytes. It is unclear whether the unique cell fate of pDCs is actively maintained in the steady state. We report that the deletion of transcription factor E2-2 from mature peripheral pDCs caused their spontaneous differentiation into cells with cDC properties. This included the loss of pDC markers, increase in MHC class II expression and T cell priming capacity, acquisition of dendritic morphology, and induction of cDC signature genes. Genome-wide chromatin immunoprecipitation revealed direct binding of E2-2 to key pDC-specific and lymphoid genes, as well as to certain genes enriched in cDCs. Thus, E2-2 actively maintains the cell fate of mature pDCs and opposes the "default" cDC fate, in part through direct regulation of lineage-specific gene expression programs.	[Ghosh, Hiyaa S.; Cisse, Babacar; Bunin, Anna; Lewis, Kanako L.; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	bvr2101@columbia.edu		Reizis, Boris/0000-0003-1140-7853	SPAR-American Asthma Foundation; NIH [AI072571, AI072571-S1, AI085439, AI007161, GM007367, AI080184]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI080184, R21AI085439, R01AI072571, T32AI007161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	SPAR-American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Holmberg, Y. Zhuang, T. Ludwig, and F. Costantini for animal strains, T. Maeda for CAL-1 cells, C. Murre for E2-2 antibody, P. Tucker and S. Jung for communicating unpublished data, and all members of the B.R. lab for help and discussions. Supported by the SPAR-American Asthma Foundation Award (B.R.), NIH awards AI072571, AI072571-S1, and AI085439 (B.R.), and NIH training awards AI007161 (K.L.L.) and GM007367 and AI080184 (B.C.).	Al-Alwan MM, 2001, J IMMUNOL, V166, P338, DOI 10.4049/jimmunol.166.1.338; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; D'Cruz LM, 2010, NAT IMMUNOL, V11, P240, DOI 10.1038/ni.1845; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Marafioti T, 2008, BLOOD, V111, P3778, DOI 10.1182/blood-2007-10-117531; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Soumelis V, 2006, EUR J IMMUNOL, V36, P2286, DOI 10.1002/eji.200636026; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	50	190	192	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 22	2010	33	6					905	916		10.1016/j.immuni.2010.11.023	http://dx.doi.org/10.1016/j.immuni.2010.11.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21145760	Bronze, Green Accepted			2022-12-18	WOS:000286293900011
J	Baron, JL; Gardiner, L; Nishimura, S; Shinkai, K; Locksley, R; Ganem, D				Baron, JL; Gardiner, L; Nishimura, S; Shinkai, K; Locksley, R; Ganem, D			Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection	IMMUNITY			English	Article							LARGE ENVELOPE POLYPEPTIDE; KILLER T-CELLS; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; MICE; REPLICATION; SURFACE; DETERMINANT; CLEARANCE	NKT cells are specialized cells of the immune system that bear both T cell and NK cell markers. Classical NKT cells display TCRs of restricted heterogeneity (Valpha14-Jalpha281) and recognize lipid antigens (e.g., alpha-galactosyl ceramide) presented by nonpolymorphic CD1 molecules. Recently, other nonclassical NKT subsets have been recognized, including NKT cells not reactive with CD1d-alpha-galactosyl ceramide complexes. The biological functions of these cells are unknown. Here, we show that nonclassical NKT cells that are CD1d restricted but nonreactive to alpha-GalCer are activated in response to hepatocytes expressing hepatitis B viral antigens in a transgenic mouse model of acute hepatitis B virus infection. Our results document the first in vivo function for such nonclassical NKT cells and suggest a role for these cells in the host response to HBV infection.	Univ Calif San Francisco, Med Ctr, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Ctr, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Ctr, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, Med Ctr, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu						Behar SM, 2000, SEMIN IMMUNOL, V12, P551, DOI 10.1006/smim.2000.0273; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Chen HJ, 1997, J IMMUNOL, V158, P5112; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; Chiu NM, 1999, J EXP MED, V190, P423, DOI 10.1084/jem.190.3.423; COLLIGAN JJ, 1999, CURRENT PROTOCOLS IM; Dao T, 1998, J IMMUNOL, V161, P2217; ERNOTO Y, 1997, INFECT IMMUN, V65, P5003; Ganem D., 1996, FIELDS VIROLOGY, V3rd; GILLES PN, 1992, HEPATOLOGY, V16, P655, DOI 10.1002/hep.1840160308; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guidotti LG, 1999, CURR OPIN MICROBIOL, V2, P388; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; GUILHOT S, 1993, J VIROL, V67, P7444, DOI 10.1128/JVI.67.12.7444-7449.1993; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Kakimi K, 2001, J IMMUNOL, V167, P6701, DOI 10.4049/jimmunol.167.12.6701; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; KUBO RT, 1989, J IMMUNOL, V142, P2736; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NECKER A, 1991, EUR J IMMUNOL, V21, P3035, DOI 10.1002/eji.1830211220; OKADA CY, 1990, J IMMUNOL, V144, P3473; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; STAERZ UD, 1985, J IMMUNOL, V134, P3994; Tsui LV, 1995, P NATL ACAD SCI USA, V92, P12398, DOI 10.1073/pnas.92.26.12398; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WIRTH S, 1995, J IMMUNOL, V154, P2504; Yokoyama M, 1993, DRUG DELIV, V1, P11	41	190	208	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					583	594		10.1016/S1074-7613(02)00305-9	http://dx.doi.org/10.1016/S1074-7613(02)00305-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970881	Bronze			2022-12-18	WOS:000175109600009
J	Eckstein, DA; Penn, ML; Korin, YD; Scripture-Adams, DD; Zack, JA; Kreisberg, JF; Roederer, M; Sherman, MP; Chin, PS; Goldsmith, MA				Eckstein, DA; Penn, ML; Korin, YD; Scripture-Adams, DD; Zack, JA; Kreisberg, JF; Roederer, M; Sherman, MP; Chin, PS; Goldsmith, MA			HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOCYTES IN-VITRO; ANTIRETROVIRAL THERAPY; CD45RO ISOFORMS; CORECEPTOR USE; AMINO-ACIDS; INFECTION; TYPE-1; CYCLE; MEMORY	Although HIV-1 gene expression is detected in naive, resting T cells in vivo, such cells are resistant to productive infection in vitro. However, we found that the endogenous. microenvironment of human lymphoid tissues supports de novo infection and depletion of this population. Cell cycle analysis and DNA labeling experiments established that these cells were definitively quiescent and thus infected de novo. Quantitation of the "burst size" within naive cells further demonstrated that these cells were productively infected and contributed to the local viral burden. These findings demonstrate that lymphoid tissues support active HIV-1 replication in resting, naive T cells. Moreover, these cells are not solely reservoirs of latent virus but are permissive hosts for viral replication that likely targets them for elimination.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94141 USA; Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA	Goldsmith, MA (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.		Roederer, Mario/G-1887-2011	Kreisberg, Jason/0000-0002-3616-079X; Scripture-Adams, Deirdre/0000-0002-3676-1771	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005021, R01AI043695, R01AI036554, R37AI036059, ZIAAI005021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296] Funding Source: NIH RePORTER; NIAID NIH HHS [R37-AI36059, R01-AI43695, R01-AI36554] Funding Source: Medline; NIDCR NIH HHS [T32-DEO7296] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; BORVAK J, 1995, J IMMUNOL, V155, P3196; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chou CS, 1997, P NATL ACAD SCI USA, V94, P1361, DOI 10.1073/pnas.94.4.1361; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; DARZYNKIEWICZ Z, 1980, P NATL ACAD SCI-BIOL, V77, P6696, DOI 10.1073/pnas.77.11.6696; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; GILBERT KM, 1992, CELL IMMUNOL, V141, P362, DOI 10.1016/0008-8749(92)90155-I; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; Grivel JC, 2000, J VIROL, V74, P5347, DOI 10.1128/JVI.74.11.5347-5351.2000; Hamann D, 1996, BLOOD, V88, P3513, DOI 10.1182/blood.V88.9.3513.bloodjournal8893513; Helbert MR, 1997, CLIN EXP IMMUNOL, V107, P300, DOI 10.1111/j.1365-2249.1997.280-ce1170.x; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; LASALLE JM, 1991, CELL IMMUNOL, V138, P197, DOI 10.1016/0008-8749(91)90144-Z; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; LUFTIG R, 1990, RETROVIRAL PROTEASES, P141; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Penn ML, 1999, P NATL ACAD SCI USA, V96, P663, DOI 10.1073/pnas.96.2.663; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Schmid I, 2000, CYTOMETRY, V39, P108, DOI 10.1002/(SICI)1097-0320(20000201)39:2<108::AID-CYTO3>3.0.CO;2-4; SCHNITTMAN SM, 1990, P NATL ACAD SCI USA, V87, P6058, DOI 10.1073/pnas.87.16.6058; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Schols D, 1998, J VIROL, V72, P4032, DOI 10.1128/JVI.72.5.4032-4037.1998; Schramm B, 2000, J VIROL, V74, P184, DOI 10.1128/JVI.74.1.184-192.2000; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; TANG SB, 1995, J VIROL, V69, P5659, DOI 10.1128/JVI.69.9.5659-5665.1995; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	45	190	193	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					671	682		10.1016/S1074-7613(01)00217-5	http://dx.doi.org/10.1016/S1074-7613(01)00217-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672548	Bronze			2022-12-18	WOS:000171757800017
J	Poignard, P; Sabbe, R; Picchio, GR; Wang, M; Gulizia, RJ; Katinger, H; Parren, PWHI; Mosier, DE; Burtons, DR				Poignard, P; Sabbe, R; Picchio, GR; Wang, M; Gulizia, RJ; Katinger, H; Parren, PWHI; Mosier, DE; Burtons, DR			Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PBL-SCID MICE; HUMAN MONOCLONAL-ANTIBODY; DYNAMICS IN-VIVO; PASSIVE-IMMUNIZATION; TYPE-1; GP120; EPITOPE; THERAPY; CD4	Neutralizing antibodies can protect against challenge with HIV-1 in vivo if present at appropriate concentrations at the time of viral challenge, but any role in the control of established infection is unclear. Here, we show that high serum concentrations of neutralizing monoclonal antibodies, either singly or as a cocktail, have little sustained effect on viral load in established HIV-1 infection in hu-PBL-SCID mice. In some instances, virus replication of neutralization-sensitive virus continues even in the presence of high levels of neutralizing antibody. In most instances, neutralization escape occurs in a few days, even from a cocktail of three antibodies that recognize distinct epitopes. The results imply that humoral immunity is unlikely to play a significant role in the control of established HIV-1 infection in humans.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Agr Univ Vienna, Inst Appl Microbiol, A-1190 Vienna, Austria	Scripps Research Institute; Scripps Research Institute; University of Natural Resources & Life Sciences, Vienna	Burtons, DR (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.		poignard, pascal/N-6678-2013; poignard, pascal/AAB-4613-2020	Poignard, Pascal/0000-0002-0021-7192; Parren, Paul/0000-0002-4365-3859	NHLBI NIH HHS [HL59727] Funding Source: Medline; NIAID NIH HHS [AI33292, AI 40377] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI033292, R29AI040377] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Burton DR, 1997, AIDS, V11, pS87; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; GAUDUIN MC, 1995, J INFECT DIS, V171, P1203, DOI 10.1093/infdis/171.5.1203; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gunthard HF, 1998, J VIROL, V72, P2422; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Mo HM, 1997, J VIROL, V71, P6869, DOI 10.1128/JVI.71.9.6869-6874.1997; Moore J P, 1995, AIDS, V9 Suppl A, pS117; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MOSIER DE, 1993, SCIENCE, V260, P689, DOI 10.1126/science.8097595; MOSIER DE, 1991, SCIENCE, V251, P791, DOI 10.1126/science.1990441; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; PANTALEO G, 1995, EUR J IMMUNOL, V25, P226, DOI 10.1002/eji.1830250137; Parren PWHI, 1998, J VIROL, V72, P10270, DOI 10.1128/JVI.72.12.10270-10274.1998; PARREN PWHI, 1995, AIDS, V9, pF1, DOI 10.1097/00002030-199506000-00001; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pettoello-Mantovani M, 1998, J INFECT DIS, V177, P337, DOI 10.1086/514214; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Pulito VL, 1996, J IMMUNOL, V156, P2840; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SAFRIT JT, 1993, AIDS, V7, P15, DOI 10.1097/00002030-199301000-00002; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Schonning K, 1998, J ACQ IMMUN DEF SYND, V18, P195, DOI 10.1097/00042560-199807010-00001; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Rompay KKA, 1998, J INFECT DIS, V177, P1247, DOI 10.1086/515270	35	190	213	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1999	10	4					431	438		10.1016/S1074-7613(00)80043-6	http://dx.doi.org/10.1016/S1074-7613(00)80043-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	190XB	10229186	Bronze			2022-12-18	WOS:000079989600004
J	Saura, M; Zaragoza, C; McMillan, A; Quick, RA; Hohenadl, C; Lowenstein, JM; Lowenstein, CJ				Saura, M; Zaragoza, C; McMillan, A; Quick, RA; Hohenadl, C; Lowenstein, JM; Lowenstein, CJ			An antiviral mechanism of nitric oxide: Inhibition of a viral protease	IMMUNITY			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; STREPTOCOCCUS-PYOGENES; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; VIRUS-INFECTION; PORPHYROMONAS-GINGIVALIS; TRYPANOSOMA-CRUZI; SYNTHASE ACTIVITY	Although nitric oxide (NO) kills or inhibits the replication of a variety of intracellular pathogens, the antimicrobial mechanisms of NO are unknown. Here, we identify a viral protease as a target of NO. The life cycle of many viruses depends upon viral proteases that cleave viral polyproteins into individual polypeptides. NO inactivates the Coxsackievirus protease 3C, an enzyme necessary for the replication of Coxsackievirus. NO S-nitrosylates the cysteine residue in the active site of protease 3C, inhibiting protease activity and interrupting the viral life cycle. Substituting a serine residue for the active site cysteine renders protease 3C resistant to NO inhibition. Since cysteine proteases are critical for virulence or replication of many viruses, bacteria, and parasites, S-nitrosylation of pathogen cysteine proteases may be a general mechanism of antimicrobial host defenses.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Virol, D-85758 Oberschleissheim, Germany; Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Johns Hopkins University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Brandeis University	Lowenstein, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	clowenst@welchlink.welch.jhu.edu	Zaragoza, Carlos/AAH-9275-2019; Zaragoza Sanchez, Carlos/G-8718-2011	Lowenstein, Charles/0000-0003-0485-7514; Zaragoza, Carlos/0000-0002-1706-8592	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052315, R01HL053615] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL52315, R01 HL53615] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; AKARID K, 1995, J VIROL, V69, P7001, DOI 10.1128/JVI.69.11.7001-7005.1995; ALDAPE K, 1994, EXP PARASITOL, V78, P230, DOI 10.1006/expr.1994.1023; Babe LM, 1997, CELL, V91, P427, DOI 10.1016/S0092-8674(00)80426-2; BAILLY E, 1992, J PROTOZOOL, V39, P593, DOI 10.1111/j.1550-7408.1992.tb04856.x; BEDI GS, 1994, J BIOL CHEM, V269, P599; BI ZB, 1995, J VIROL, V69, P2208, DOI 10.1128/JVI.69.4.2208-2213.1995; BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735; CROEN KD, 1993, J CLIN INVEST, V91, P2446, DOI 10.1172/JCI116479; Dominguez JN, 1997, J MED CHEM, V40, P2726, DOI 10.1021/jm970266p; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Flynn D L, 1997, Drug Des Discov, V15, P3; GAUNTT CJ, 1979, J MED VIROL, V3, P207, DOI 10.1002/jmv.1890030307; Ghosh S, 1996, GENE, V176, P249, DOI 10.1016/0378-1119(96)00260-0; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; GORBALENYA AE, 1983, BIOCHEMISTRY-MOSCOW+, V48, P385; Gubba S, 1998, INFECT IMMUN, V66, P765, DOI 10.1128/IAI.66.2.765-770.1998; Haddad IY, 1997, AM J RESP CELL MOL, V16, P501, DOI 10.1165/ajrcmb.16.5.9160832; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; HELLEN CUT, 1989, BIOCHEMISTRY-US, V28, P9881, DOI 10.1021/bi00452a001; HOLZMAN TF, 1980, P NATL ACAD SCI-BIOL, V77, P6363, DOI 10.1073/pnas.77.11.6363; HOOPER DC, 1995, P NATL ACAD SCI USA, V92, P5312, DOI 10.1073/pnas.92.12.5312; IVANOFF LA, 1986, P NATL ACAD SCI USA, V83, P5392, DOI 10.1073/pnas.83.15.5392; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; KLUMP WM, 1990, J VIROL, V64, P1573, DOI 10.1128/JVI.64.4.1573-1583.1990; Komatsu T, 1996, J NEUROIMMUNOL, V68, P101, DOI 10.1016/0165-5728(96)00083-5; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Kreil TR, 1996, VIROLOGY, V219, P304, DOI 10.1006/viro.1996.0252; KUMAR S, 1994, J PARASITOL, V80, P414, DOI 10.2307/3283412; Kuramitsu H, 1997, J PERIODONTAL RES, V32, P140, DOI 10.1111/j.1600-0765.1997.tb01395.x; LAWSON MA, 1990, CURR TOP MICROBIOL, V161, P49; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li Z, 1994, CHEM BIOL, V1, P31, DOI 10.1016/1074-5521(94)90038-8; LIU RH, 1992, CANCER RES, V52, P4139; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; Mannick JB, 1995, RES IMMUNOL, V146, P693, DOI 10.1016/0923-2494(96)84920-0; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; MELKOVA Z, 1995, J IMMUNOL, V155, P5711; Mikami S, 1996, BIOCHEM BIOPH RES CO, V220, P983, DOI 10.1006/bbrc.1996.0519; MIYASHITA K, 1993, PROTEIN ENG, V6, P189, DOI 10.1093/protein/6.2.189; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; ORR DC, 1989, J GEN VIROL, V70, P2931, DOI 10.1099/0022-1317-70-11-2931; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Reiss CS, 1998, J VIROL, V72, P4547, DOI 10.1128/JVI.72.6.4547-4551.1998; Rolph MS, 1996, VIROLOGY, V217, P470, DOI 10.1006/viro.1996.0141; SAKANARI JA, 1997, EXP PARASITOL, V87, P212; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Thompson JF, 1997, J BIOL CHEM, V272, P18766, DOI 10.1074/jbc.272.30.18766; Tucker PC, 1996, J VIROL, V70, P3972, DOI 10.1128/JVI.70.6.3972-3977.1996; VANDAM AM, 1995, J NEUROSCI RES, V40, P251, DOI 10.1002/jnr.490400214; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Zaragoza C, 1997, J CLIN INVEST, V100, P1760, DOI 10.1172/JCI119702; Zaragoza C, 1998, P NATL ACAD SCI USA, V95, P2469, DOI 10.1073/pnas.95.5.2469; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271	68	190	199	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1999	10	1					21	28		10.1016/S1074-7613(00)80003-5	http://dx.doi.org/10.1016/S1074-7613(00)80003-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	163WE	10023767	Green Published, Bronze			2022-12-18	WOS:000078428700003
J	Kondo, M; Akashi, K; Domen, J; Sugamura, K; Weissman, IL				Kondo, M; Akashi, K; Domen, J; Sugamura, K; Weissman, IL			Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IL-2 RECEPTOR; INTERLEUKIN-7 RECEPTOR; FUNCTIONAL COMPONENT; LINEAGE CELLS; DIFFERENTIATION; THYMOCYTES; EXPRESSION; GROWTH; GENE	The common cytokine receptor gamma chain (gamma(c)) is an indispensable subunit for the formation of lymphoid-related cytokine receptors, including IL-7 and IL-15 receptors, that mediate nonredundant or critical signals for the differentiation of T and B cells and natural killer (NK) cells, respectively. We introduced the bcl-2 transgene driven by E mu or H-2K promoters into gamma(c)-deficient mice that lack all three lymphoid subclasses. The forced expression of Bcl-2 restored all stages of T lymphopoiesis, but not B or NK cell development, indicating that a primary function of gamma(c)-mediated signals in the T lineage might be to maintain cell survival. Therefore, the development of T, B, and NK cells may be influenced by distinct intracytoplasmic signaling cascades that are activated by coupling of gamma(c)-related receptors.	STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305; TOHOKU UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,SENDAI,MIYAGI 98077,JAPAN	Stanford University; Tohoku University	Kondo, M (corresponding author), STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305, USA.				NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NCI NIH HHS [CA42551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MACDONNEL TJ, 1989, CELL, V57, P79; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; REICHMANFRIED M, 1993, INT IMMUNOL, V5, P303, DOI 10.1093/intimm/5.3.303; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1992, CELL, V69, P139, DOI 10.1016/0092-8674(92)90125-V; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHERWOOD PJ, 1990, INT IMMUNOL, V2, P399, DOI 10.1093/intimm/2.5.399; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDA T, 1991, J IMMUNOL, V146, P3068; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	51	190	190	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					155	162		10.1016/S1074-7613(00)80518-X	http://dx.doi.org/10.1016/S1074-7613(00)80518-X			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252128	Bronze			2022-12-18	WOS:A1997XN69300014
J	Lanier, LL				Lanier, LL			Natural killer cells: From no receptors to too many	IMMUNITY			English	Review							MHC CLASS-I; INTEGRAL MEMBRANE-PROTEINS; LY-49 MULTIGENE FAMILY; LECTIN-LIKE RECEPTORS; HLA-B MOLECULES; IMMUNOGLOBULIN-SUPERFAMILY; NK CELLS; CARBOHYDRATE-RECOGNITION; ANTIGEN EXPRESSION; SURFACE-ANTIGEN				Lanier, LL (corresponding author), DNAX RES INST MOL & CELLULAR BIOL INC,DEPT IMMUNOL,901 CALIF AVE,PALO ALTO,CA 94304, USA.		Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				ADAMKIEWICZ TV, 1994, IMMUNOGENETICS, V39, P218; ARM JP, 1991, J BIOL CHEM, V266, P15966; BAKER E, 1995, CHROMOSOME RES, V3, P511; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; BEZOUSKA K, 1994, J BIOL CHEM, V269, P16945; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; BLASSONI R, 1995, J EXP MED, V182, P605; Bottino C, 1996, EUR J IMMUNOL, V26, P1816, DOI 10.1002/eji.1830260823; Brennan J, 1996, J EXP MED, V183, P1553, DOI 10.1084/jem.183.4.1553; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; BRENNAN J, 1995, J BIOL CHEM, V270, P9691, DOI 10.1074/jbc.270.17.9691; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Campbell KS, 1996, J EXP MED, V184, P93, DOI 10.1084/jem.184.1.93; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; CHAN PY, 1989, J IMMUNOL, V142, P1727; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; CORREA I, 1995, IMMUNITY, V2, P61, DOI 10.1016/1074-7613(95)90079-9; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DANDREA A, 1995, J IMMUNOL, V155, P2306; DANIELS BF, 1994, IMMUNITY, V1, P785, DOI 10.1016/S1074-7613(94)80020-0; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; Dissen E, 1996, J EXP MED, V183, P2197, DOI 10.1084/jem.183.5.2197; Dohring C, 1996, EUR J IMMUNOL, V26, P365, DOI 10.1002/eji.1830260215; Dohring C, 1996, J IMMUNOL, V156, P3098; Dorfman JR, 1996, EUR J IMMUNOL, V26, P151, DOI 10.1002/eji.1830260123; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Fry AM, 1996, J EXP MED, V184, P295, DOI 10.1084/jem.184.1.295; Galandrini R, 1996, J EXP MED, V183, P179, DOI 10.1084/jem.183.1.179; GIORDA R, 1991, J IMMUNOL, V147, P1701; GIORDA R, 1992, J IMMUNOL, V149, P1957; Gumperz JE, 1996, J EXP MED, V183, P1817, DOI 10.1084/jem.183.4.1817; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HERBERMAN RB, 1975, INT J CANCER, V16, P230, DOI 10.1002/ijc.2910160205; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; LANIER LL, 1995, J IMMUNOL, V154, P3320; LANIER LL, 1994, J IMMUNOL, V153, P2417; LANLER LL, 1997, IMMUNOL REV, V155, P145; Lazetic S, 1996, J IMMUNOL, V157, P4741; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Long EO, 1996, IMMUNOL TODAY, V17, P100, DOI 10.1016/0167-5699(96)80590-1; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MAndelboim O, 1996, SCIENCE, V274, P2097, DOI 10.1126/science.274.5295.2097; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; MAUDSLEY DJ, 1991, IMMUNOL TODAY, V12, P429, DOI 10.1016/0167-5699(91)90013-J; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; Motto DG, 1996, MOL CELL BIOL, V16, P2823; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Olcese L, 1996, J IMMUNOL, V156, P4531; OLSSON MY, 1995, P NATL ACAD SCI USA, V92, P1649, DOI 10.1073/pnas.92.5.1649; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; Peruzzi M, 1996, J EXP MED, V184, P1585, DOI 10.1084/jem.184.4.1585; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; PLONTEK GE, 1985, J IMMUNOL, V135, P4281; Poggi A, 1996, EUR J IMMUNOL, V26, P1266, DOI 10.1002/eji.1830260613; Raulet D H, 1995, Semin Immunol, V7, P103, DOI 10.1006/smim.1995.0014; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; Rojo S, 1997, J IMMUNOL, V158, P9; RYAN JC, 1995, J EXP MED, V181, P1911, DOI 10.1084/jem.181.5.1911; RYAN JC, 1992, J IMMUNOL, V149, P1631; Ryan JC, 1997, IMMUNOL REV, V155, P79, DOI 10.1111/j.1600-065X.1997.tb00941.x; SCHARENBERG AM, 1996, IMMUNITY, V87, P961; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; SENTMAN CL, 1994, J IMMUNOL, V153, P5482; Sentman CL, 1996, EUR J IMMUNOL, V26, P2127, DOI 10.1002/eji.1830260925; SHIMIZU Y, 1989, EUR J IMMUNOL, V19, P447, DOI 10.1002/eji.1830190306; SIEH M, 1994, MOL CELL BIOL, V14, P4436; Silver ET, 1996, IMMUNOGENETICS, V44, P478, DOI 10.1007/s002510050156; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; SMITH HRC, 1994, J IMMUNOL, V153, P1068; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; Sundback J, 1996, J IMMUNOL, V157, P3936; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; Valiante NM, 1996, J EXP MED, V184, P2243, DOI 10.1084/jem.184.6.2243; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wang LL, 1997, J IMMUNOL, V158, P13; WONG S, 1991, J IMMUNOL, V147, P1417; YABE T, 1993, IMMUNOGENETICS, V37, P455; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; YOKOYAMA WM, 1989, J IMMUNOL, V143, P1379; YOKOYAMA WM, 1991, J IMMUNOL, V147, P3229; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YU YYL, 1994, INT IMMUNOL, V6, P1297, DOI 10.1093/intimm/6.9.1297; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X	109	190	198	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					371	378		10.1016/S1074-7613(00)80280-0	http://dx.doi.org/10.1016/S1074-7613(00)80280-0			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133416	Bronze			2022-12-18	WOS:A1997XC61900002
J	Sarin, A; Williams, MS; AlexanderMiller, MA; Berzofsky, JA; Zacharchuk, CM; Henkart, PA				Sarin, A; Williams, MS; AlexanderMiller, MA; Berzofsky, JA; Zacharchuk, CM; Henkart, PA			Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases	IMMUNITY			English	Article							REQUIRE GRANZYME-B; INTERLEUKIN-1-BETA-CONVERTING ENZYME; MEDIATED CYTOTOXICITY; DNA FRAGMENTATION; RAPID INDUCTION; APOPTOSIS; INHIBITION; DEATH; ACTIVATION; PROTEIN	Activation of ICE/Ced-3 family proteases (caspases) has been proposed to mediate both the granule exocytosis and Fas-Fas ligand pathways of rapid target cell death by cytotoxic T lymphocytes. In agreement with this model, two peptide fluoromethyl ketone caspase inhibitors and baculovirus p35 blocked apoptotic nuclear damage and target cell lysis by the CTL-mediated Fas-Fas ligand pathway. The peptide caspase inhibitors also blocked drug-induced apoptotic cell death in tumor cells. In contrast, the caspase inhibitors blocked CTL granule exocytosis-induced target apoptotic nuclear damage, but did not inhibit target lysis. These results are consistent with recent demonstrations that granzyme B can activate caspases leading to apoptotic nuclear damage, but show that target cell lysis by CTL granule exocytosis occurs by a caspase-independent pathway.	NCI, EXPT IMMUNOL BRANCH, NIH, BETHESDA, MD 20892 USA; NCI, METAB BRANCH, NIH, BETHESDA, MD 20892 USA; NCI, IMMUNE CELL BIOL LAB, NIH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BROMME D, 1989, BIOCHEM J, V264, P475; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chinnaiyan AM, 1996, CURR BIOL, V6, P897, DOI 10.1016/S0960-9822(02)00614-0; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; DARMON AJ, 1994, J BIOL CHEM, V269, P32043; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Gu Y, 1996, J BIOL CHEM, V271, P10816, DOI 10.1074/jbc.271.18.10816; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Martin SJ, 1996, EMBO J, V15, P2407, DOI 10.1002/j.1460-2075.1996.tb00598.x; MEMON SA, 1995, J IMMUNOL, V155, P4644; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; NAKAJIMA H, 1994, J IMMUNOL, V152, P1057; NAKAJIMA H, 1995, J EXP MED, V181, P1905, DOI 10.1084/jem.181.5.1905; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; NAKAJIMA H, 1995, TECHNIQUES APOPTOSIS, P175; NISHIOKA WK, 1992, J EXP MED, V175, P23, DOI 10.1084/jem.175.1.23; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Sarin A, 1996, J EXP MED, V184, P2445, DOI 10.1084/jem.184.6.2445; SEGAL DM, 1988, CANCER INVEST, V6, P83, DOI 10.3109/07357908809077031; SELLINS KS, 1991, J IMMUNOL, V147, P795; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; WILLIAMS MS, 1994, J IMMUNOL, V153, P4247; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0	40	190	192	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1997	6	2					209	215		10.1016/S1074-7613(00)80427-6	http://dx.doi.org/10.1016/S1074-7613(00)80427-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047242	Bronze			2022-12-18	WOS:A1997XC61600010
J	Sengupta, S; Siliciano, RF				Sengupta, Srona; Siliciano, Robert F.			Targeting the Latent Reservoir for HIV-1	IMMUNITY			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; BROADLY NEUTRALIZING ANTIBODIES; LONG TERMINAL REPEAT; ACTIVE ANTIRETROVIRAL THERAPY; NATURAL-KILLER-CELLS; NF-KAPPA-B; CELLULAR IMMUNE-RESPONSES; HIGHLY PATHOGENIC SIV; GENE-EXPRESSION	Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4(+) T cells that harbor latent HIV-1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV-1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way.	[Sengupta, Srona; Siliciano, Robert F.] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Sengupta, Srona] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; [Sengupta, Srona] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Siliciano, RF (corresponding author), Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu			NIH [UM1 AI126603, UM1 AI126620, UM1 AI12661]; Johns Hopkins Center for AIDS Research [P30AI094189]; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation [OPP1115715]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051178, UM1AI126603, UM1AI126620, P30AI094189, UM1AI126611, R01AI043222, P01AI131306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Center for AIDS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Janet Siliciano, Kevin Shenderov, and Andrew Timmons for advice on the manuscript. This work was supported by the NIH Martin Delaney I4C (UM1 AI126603), Beat-HIV (UM1 AI126620), and DARE (UM1 AI12661) collaboratories, by the Johns Hopkins Center for AIDS Research (P30AI094189), and by the Howard Hughes Medical Institute and the Bill and Melinda Gates Foundation (OPP1115715).	Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, NAT REV MICROBIOL, V12, P750, DOI 10.1038/nrmicro3352; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Asquith B, 2009, TRENDS IMMUNOL, V30, P182, DOI 10.1016/j.it.2009.01.003; Avalos CR, 2016, J VIROL, V90, P5643, DOI 10.1128/JVI.00290-16; Badamchi-Zadeh A, 2018, J VIROL, V92, DOI 10.1128/JVI.01925-17; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Baxter AE, 2014, CELL HOST MICROBE, V16, P711, DOI 10.1016/j.chom.2014.10.010; Berro R, 2007, J BIOL CHEM, V282, P8207, DOI 10.1074/jbc.M606324200; Bertagnolli L. N., 2018, NATURE; Besnard E, 2016, CELL HOST MICROBE, V20, P785, DOI 10.1016/j.chom.2016.11.001; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Boritz EA, 2016, CELL, V166, P1004, DOI 10.1016/j.cell.2016.06.039; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bouchat S, 2016, EMBO MOL MED, V8, P117, DOI 10.15252/emmm.201505557; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bruel T, 2015, J VIROL, V89, P3542, DOI 10.1128/JVI.03723-14; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Calantone N, 2014, IMMUNITY, V41, P493, DOI 10.1016/j.immuni.2014.08.014; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Caskey M, 2016, NEW ENGL J MED, V375, P2019, DOI 10.1056/NEJMp1613362; Cassidy SA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00133; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Ciudad MT, 2017, J LEUKOCYTE BIOL, V101, P15, DOI 10.1189/jlb.6HI0216-069R; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Clayton Kiera L, 2017, Pathog Immun, V2, P179, DOI 10.20411/pai.v2i2.204; Cockerham LR, 2014, AIDS, V28, P1749, DOI 10.1097/QAD.0000000000000314; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Cohn LB, 2018, NAT MED, V24, P604, DOI 10.1038/s41591-018-0017-7; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Conway JM, 2015, P NATL ACAD SCI USA, V112, P5467, DOI 10.1073/pnas.1419162112; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Cribbs SK, 2015, AIDS RES HUM RETROV, V31, P64, DOI [10.1089/aid.2014.0133, 10.1089/AID.2014.0133]; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Cummins NW, 2016, J VIROL, V90, P4032, DOI 10.1128/JVI.03179-15; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Demoustier A, 2002, AIDS, V16, P1749, DOI 10.1097/00002030-200209060-00006; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710; DiNapoli SR, 2016, J VIROL, V90, P7596, DOI 10.1128/JVI.00672-16; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Fulda S, 2015, SEMIN CELL DEV BIOL, V39, P132, DOI 10.1016/j.semcdb.2014.12.005; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Garcia-Vidal E, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01368-17; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Gavegnano C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006740; Gay CL, 2017, J INFECT DIS, V215, P1725, DOI 10.1093/infdis/jix191; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gornalusse GG, 2015, P NATL ACAD SCI USA, V112, pE4762, DOI 10.1073/pnas.1423228112; Gutierrez C, 2016, AIDS, V30, P1385, DOI 10.1097/QAD.0000000000001064; Guzzo C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam7341; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hammarlund E, 2010, J VIROL, V84, P12754, DOI 10.1128/JVI.01763-10; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Henrich TJ, 2017, J INFECT DIS, V216, P254, DOI 10.1093/infdis/jix265; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hiener B, 2017, CELL REP, V21, P813, DOI 10.1016/j.celrep.2017.09.081; Hill AL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005535; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319; Horwitz JA, 2017, CELL, V170, P637, DOI 10.1016/j.cell.2017.06.048; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Hsia SCV, 2002, MOL CELL BIOL, V22, P4043, DOI 10.1128/MCB.22.12.4043-4052.2002; Hua S, 2018, CLIN INFECT DIS, V66, P1910, DOI 10.1093/cid/cix1111; Huang SH, 2018, J CLIN INVEST, V128, P876, DOI [10.1172/jci97555, 10.1172/JCI97555]; Huot N, 2017, NAT MED, V23, P1277, DOI 10.1038/nm.4421; Igarashi T, 2003, J VIROL, V77, P13042, DOI 10.1128/JVI.77.24.13042-13052.2003; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Jiang GC, 2015, AIDS RES HUM RETROV, V31, P4, DOI [10.1089/AID.2014.0199, 10.1089/aid.2014.0199]; Jones RB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005545; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Jones RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004287; Joosten SA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2695396; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kandathil AJ, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0323-4; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kaufmann IR, 2004, ANTIVIR THER, V9, P263; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kim Y, 2018, CELL HOST MICROBE, V23, P14, DOI 10.1016/j.chom.2017.12.004; Kiniry BE, 2017, MUCOSAL IMMUNOL, V10, P1008, DOI 10.1038/mi.2016.100; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Koizumi Y, 2017, P NATL ACAD SCI USA, V114, P1922, DOI 10.1073/pnas.1610197114; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Kwaa AK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174516; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Laskey SB, 2014, NAT REV MICROBIOL, V12, P772, DOI 10.1038/nrmicro3351; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; LAUGHLIN MA, 1993, VIROLOGY, V196, P496, DOI 10.1006/viro.1993.1505; Lee GQ, 2017, J CLIN INVEST, V127, P2689, DOI 10.1172/JCI93289; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenardo MJ, 2002, J VIROL, V76, P5082, DOI 10.1128/JVI.76.10.5082-5093.2002; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Lerner P, 2011, J VIROL, V85, P4772, DOI 10.1128/JVI.02409-10; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Li PL, 2016, NAT MED, V22, P807, DOI 10.1038/nm.4124; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lu PP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16816-1; Lucas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013121; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marban C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00397; Martin AR, 2017, J CLIN INVEST, V127, P651, DOI 10.1172/JCI89552; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; McGary CS, 2017, IMMUNITY, V47, P776, DOI 10.1016/j.immuni.2017.09.018; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; Mujib S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93684; Mujib S, 2017, J VIROL, V91, DOI 10.1128/JVI.00634-17; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Neumann S, 2015, VIRUS RES, V209, P45, DOI 10.1016/j.virusres.2015.02.026; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; Olesen R, 2015, J VIROL, V89, P10176, DOI 10.1128/JVI.01484-15; Pankrac J, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0177-4; Parada CA, 1996, NATURE, V384, P375, DOI 10.1038/384375a0; Peng H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01143; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Pollack RA, 2017, CELL HOST MICROBE, V21, P494, DOI 10.1016/j.chom.2017.03.008; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Rainho JN, 2015, J VIROL, V89, P10625, DOI 10.1128/JVI.01699-15; Ramsuran V, 2018, SCIENCE, V359, P86, DOI 10.1126/science.aam8825; Ranasinghe S, 2016, IMMUNITY, V45, P917, DOI 10.1016/j.immuni.2016.09.015; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reuter MA, 2017, CELL REP, V21, P3458, DOI 10.1016/j.celrep.2017.11.075; Rice AP, 2017, CURR PHARM DESIGN, V23, P4098, DOI 10.2174/1381612823666170704130635; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rosenbloom DIS, 2017, NATURE, V551, pE6, DOI 10.1038/nature24634; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Russell RA, 2017, CELL REP, V18, P1473, DOI 10.1016/j.celrep.2017.01.027; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sedaghat AR, 2007, PLOS PATHOG, V3, P1165, DOI 10.1371/journal.ppat.0030122; Shan L, 2017, IMMUNITY, V47, P766, DOI 10.1016/j.immuni.2017.09.014; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Shasha D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00162; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Shedlock DJ, 2008, APOPTOSIS, V13, P1088, DOI 10.1007/s10495-008-0239-0; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Sloan DD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005233; SODROSKI J, 1985, SCIENCE, V227, P171, DOI 10.1126/science.2981427; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spivak AM, 2018, ANNU REV MED, V69, P421, DOI 10.1146/annurev-med-052716-031710; Spivak AM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0319-0; Stewart SA, 2000, J VIROL, V74, P3105, DOI 10.1128/JVI.74.7.3105-3111.2000; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sung JA, 2017, EBIOMEDICINE, V23, P52, DOI 10.1016/j.ebiom.2017.07.019; Sung JA, 2015, J INFECT DIS, V212, P258, DOI 10.1093/infdis/jiv022; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tamaru H, 2010, GENE DEV, V24, P1465, DOI 10.1101/gad.1941010; Tapia G, 2017, J INFECTION, V75, P555, DOI 10.1016/j.jinf.2017.09.004; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tsai A, 2017, J VIROL, V91, DOI [10.1128/JVI.02166-16, 10.1128/jvi.02166-16]; UNAIDS, 2021, CONFR IN LESS PAND R; UNAIDS, 2017, UNAIDS DAT 2017; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Van Zyl GU, 2017, J CLIN INVEST, V127, P3827, DOI [10.1172/jci94582, 10.1172/JCI94582]; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Vojnov L, 2012, J VIROL, V86, P4682, DOI 10.1128/JVI.06324-11; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Walker B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007054; Walker-Sperling VE, 2016, EBIOMEDICINE, V8, P217, DOI 10.1016/j.ebiom.2016.04.019; Wang Z, 2018, P NATL ACAD SCI USA, V115, pE2575, DOI 10.1073/pnas.1720665115; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yukl SA, 2014, AIDS, V28, P439, DOI 10.1097/QAD.0000000000000166; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zalar A, 2010, ANTIVIR RES, V87, P269, DOI 10.1016/j.antiviral.2010.05.005; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	316	189	195	3	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					872	895		10.1016/j.immuni.2018.04.030	http://dx.doi.org/10.1016/j.immuni.2018.04.030			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768175	Green Accepted, Bronze			2022-12-18	WOS:000432488600010
J	Man, K; Gabriel, SS; Liao, Y; Gloury, R; Preston, S; Henstridge, DC; Pellegrini, M; Zehn, D; Berberich-Siebelt, F; Febbraio, MA; Shi, W; Kallies, A				Man, Kevin; Gabriel, Sarah S.; Liao, Yang; Gloury, Renee; Preston, Simon; Henstridge, Darren C.; Pellegrini, Marc; Zehn, Dietmar; Berberich-Siebelt, Friederike; Febbraio, Mark A.; Shi, Wei; Kallies, Axel			Transcription Factor IRF4 Promotes CD8(+) T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection	IMMUNITY			English	Article							INHIBITORY RECEPTOR PD-1; REGULATORY ELEMENT; EXPRESSION; DIFFERENTIATION; CHECKPOINT; RESPONSES; MITOCHONDRIA; ACTIVATION; EXPANSION; DRIVER	During chronic stimulation, CD8(+) T cells acquire an exhausted phenotype characterized by expression of inhibitory receptors, down-modulation of effector function, and metabolic impairments. T cell exhaustion protects from excessive immunopathology but limits clearance of virus-infected or tumor cells. We transcriptionally profiled antigen-specific T cells from mice infected with lymphocytic choriomeningitis virus strains that cause acute or chronic disease. T cell exhaustion during chronic infection was driven by high amounts of T cell receptor (TCR)-induced transcription factors IRF4, BATF, and NFATc1. These regulators promoted expression of inhibitory receptors, including PD-1, and mediated impaired cellular metabolism. Furthermore, they repressed the expression of TCF1, a transcription factor required for memory T cell differentiation. Reducing IRF4 expression restored the functional and metabolic properties of antigen-specific T cells and promoted memory-like T cell development. These findings indicate that IRF4 functions as a central node in a TCR-responsive transcriptional circuit that establishes and sustains T cell exhaustion during chronic infection.	[Man, Kevin; Gabriel, Sarah S.; Liao, Yang; Gloury, Renee; Preston, Simon; Pellegrini, Marc; Shi, Wei; Kallies, Axel] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Man, Kevin; Liao, Yang; Preston, Simon; Pellegrini, Marc; Shi, Wei] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Henstridge, Darren C.] Baker Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Zehn, Dietmar] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, D-85354 Freising Weihenstephan, Germany; [Berberich-Siebelt, Friederike] Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany; [Berberich-Siebelt, Friederike] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany; [Febbraio, Mark A.] Garvan Inst, Cellular & Mol Metab, Sydney, NSW 2010, Australia; [Gabriel, Sarah S.; Gloury, Renee; Kallies, Axel] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Gabriel, Sarah S.; Gloury, Renee; Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia; [Man, Kevin] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Walter & Eliza Hall Institute; University of Melbourne; Technical University of Munich; University of Wurzburg; University of Wurzburg; Garvan Institute of Medical Research; University of Melbourne; University of Melbourne; University of California System; University of California San Francisco	Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.; Kallies, A (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Kallies, A (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia.	kallies@wehi.edu.au	Febbraio, Mark/AAE-9632-2019	Pellegrini, Marc/0000-0003-3627-3126; Preston, Simon/0000-0001-8969-8297; Gabriel, Sarah Sharon/0000-0002-6359-485X; Febbraio, Mark/0000-0002-9296-4418; Man, Kevin/0000-0002-6585-9532; Kallies, Axel/0000-0002-6312-6968	National Health and Medical Research Council of Australia [1032850, 1085151, 1006592, 1045549, 1065626, 1023454, 1021168, 1116936]; Walter and Eliza Hall Institute Centenary Fellowship - CSL; Swiss National Science Foundation; Novartis Foundation for Medical-Biological Research; Sylvia and Charles Viertel Foundation; Fritz Thyssen Stiftung [10.13.2.215]; Wilhelm Sander-Stiftung [2012.047.1]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Walter and Eliza Hall Institute Centenary Fellowship - CSL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sylvia and Charles Viertel Foundation; Fritz Thyssen Stiftung; Wilhelm Sander-Stiftung	We wish to thank Liana Mackiewicz, Carolina Alvarado, and Benjamin Lunz for expert technical support, and Stephen Nutt, Edgar Serfling, and Stefan Klein-Hessling for scientific discussion. We thank Anjana Rao, Laurie Glimcher, Pamela Ohashi, Tak Mak, Ulf Klein, Mark Chong, and Daniel Gray for mice. This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (project grants 1032850 and 1085151 to A.K., 1006592, 1045549, and 1065626 to M.P., 1023454 to W.S., Senior Research Fellowship 1021168 and Senior Principal Research Fellowship 1116936 to M.A.F.), the Walter and Eliza Hall Institute Centenary Fellowship funded by CSL (to W.S.), the Swiss National Science Foundation and the Novartis Foundation for Medical-Biological Research (fellowships to S.S.G.), and the Sylvia and Charles Viertel Foundation (Senior Medical Research Fellowships to A.K. and M.P.). Further funding was provided by the Fritz Thyssen Stiftung (10.13.2.215) and the Wilhelm Sander-Stiftung (2012.047.1) to F.B.-S. This study was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.	Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Klein-Hessling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00612-6; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; PIRCHER H, 1990, EUR J IMMUNOL, V20, P417, DOI 10.1002/eji.1830200227; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Vaeth M, 2016, IMMUNITY, V44, P1350, DOI 10.1016/j.immuni.2016.04.013; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	65	189	192	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1129	+		10.1016/j.immuni.2017.11.021	http://dx.doi.org/10.1016/j.immuni.2017.11.021			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29246443	Bronze			2022-12-18	WOS:000418486500016
J	O'Sullivan, TE; Rapp, MY; Fan, XY; Weizman, OE; Bhardwaj, P; Adams, NM; Walzer, T; Dannenberg, AJ; Sun, JC				O'Sullivan, Timothy E.; Rapp, Moritz; Fan, Xiying; Weizman, Orr-El; Bhardwaj, Priya; Adams, Nicholas M.; Walzer, Thierry; Dannenberg, Andrew J.; Sun, Joseph C.			Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance	IMMUNITY			English	Article							TISSUE MACROPHAGE INFILTRATION; NATURAL-KILLER-CELLS; DIET-INDUCED OBESITY; CD4(+) T-CELLS; CHRONIC INFLAMMATION; ADAPTIVE IMMUNITY; INTERFERON-GAMMA; NKT CELLS; HOMEOSTASIS; CANCER	Innate lymphoid cells (ILCs) function to protect epithelial barriers against pathogens and maintain tissue homeostasis in both barrier and non-barrier tissues. Here, utilizing Eomes reporter mice, we identify a subset of adipose group 1 ILC (ILC1) and demonstrate a role for these cells in metabolic disease. Adipose ILC1s were dependent on the transcription factors Nfil3 and T-bet but phenotypically and functionally distinct from adipose mature natural killer (NK) and immature NK cells. Analysis of parabiotic mice revealed that adipose ILC1s maintained long-term tissue residency. Diet-induced obesity drove early production of interleukin (IL)-12 in adipose tissue depots and led to the selective proliferation and accumulation of adipose-resident ILC1s in a manner dependent on the IL-12 receptor and STAT4. ILC1-derived interferon-g was necessary and sufficient to drive proinflammatory macrophage polarization to promote obesity-associated insulin resistance. Thus, adipose-resident ILC1s contribute to obesity-related pathology in response to dysregulated local proinflammatory cytokine production.	[O'Sullivan, Timothy E.; Rapp, Moritz; Fan, Xiying; Weizman, Orr-El; Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Bhardwaj, Priya; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Walzer, Thierry] CIRI, F-69007 Lyon, France; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Ecole Normale Superieure de Lyon (ENS de LYON); Cornell University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org	Bhardwaj, Priya/CAJ-2736-2022; Walzer, Thierry/L-9418-2014; O'Sullivan, Timothy/D-3422-2018	Bhardwaj, Priya/0000-0001-8740-0143; Walzer, Thierry/0000-0002-0857-8179; Rapp, Moritz/0000-0001-5104-7683; Fan, Xiying/0000-0003-3090-381X; O'Sullivan, Timothy/0000-0003-1435-8188; Adams, Nicholas/0000-0001-5751-0480	American Cancer Society; DAAD (Germany); NIH Medical Scientist Training Program [T32GM07739]; NIH [1R01CA154481-01A1, AI100874, P30CA008748]; Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; Ludwig Center for Cancer Immunotherapy; Searle Scholars Program; Cancer Research Institute; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA154481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100874, F30AI122721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); DAAD (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; Ludwig Center for Cancer Immunotherapy; Searle Scholars Program; Cancer Research Institute; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sun lab for comments, discussions, technical support, and experimental assistance. We thank Lewis Lanier and Alexander Rudensky for helpful discussions. T.E.O. was supported by the American Cancer Society. M.R. was supported by a fellowship from the DAAD (Germany). X.F. and N.M.A. were supported by the NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. A.J.D. was supported by grants from the NIH (1R01CA154481-01A1), the Breast Cancer Research Foundation, and the Botwinick-Wolfensohn Foundation. J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the Searle Scholars Program, the Cancer Research Institute, the Starr Cancer Consortium, and grants from the NIH (AI100874 and P30CA008748).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chan IH, 2014, MUCOSAL IMMUNOL, V7, P842, DOI 10.1038/mi.2013.101; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Liou YH, 2014, J IMMUNOL, V193, P1747, DOI 10.4049/jimmunol.1400868; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Morris DL, 2013, DIABETES, V62, P2762, DOI 10.2337/db12-1404; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Rourke RW, 2014, OBESITY, V22, P2109, DOI 10.1002/oby.20823; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wong N, 2011, ENDOCRINOLOGY, V152, P3690, DOI 10.1210/en.2011-0288; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	55	189	195	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					428	441		10.1016/j.immuni.2016.06.016	http://dx.doi.org/10.1016/j.immuni.2016.06.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496734	Green Accepted, Bronze			2022-12-18	WOS:000382267300022
J	Park, SH; Rehermann, B				Park, Su-Hyung; Rehermann, Barbara			Immune Responses to HCV and Other Hepatitis Viruses	IMMUNITY			English	Review							T-CELL RESPONSES; INTERFERON REGULATORY FACTOR-3; SINGLE-SOURCE OUTBREAK; HIGHLY PATHOGENIC SIV; NATURAL-KILLER-CELLS; INJECTION-DRUG USERS; C-VIRUS; GENETIC-VARIATION; VIRAL CLEARANCE; INFECTED-CELLS	Five human hepatitis viruses cause most of the acute and chronic liver disease worldwide. Over the past 25 years, hepatitis C virus (HCV) in particular has received much interest because of its ability to persist in most immunocompetent adults and because of the lack of a protective vaccine. Here we examine innate and adaptive immune responses to HCV infection. Although HCV activates an innate immune response, it employs an elaborate set of mechanisms to evade interferon (IFN)-based antiviral immunity. By comparing innate and adaptive immune responses to HCV with those to hepatitis A and B viruses, we suggest that prolonged innate immune activation by HCV impairs the development of successful adaptive immune responses. Comparative immunology provides insights into the maintenance of immune protection. We conclude by discussing prospects for an HCV vaccine and future research needs for the hepatitis viruses.	[Park, Su-Hyung; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, NIH,DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rehermann, B (corresponding author), NIDDK, Immunol Sect, Liver Dis Branch, NIH,DHHS, Bethesda, MD 20892 USA.	rehermann@nih.gov	Cheng, Yushao/E-6256-2011; Park, Su-Hyung/N-3514-2014	Park, Su-Hyung/0000-0001-6363-7736; Rehermann, Barbara/0000-0001-6832-9951	NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054508, ZIADK054516, ZIADK054509] Funding Source: NIH RePORTER	NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). We thank J. Kim for drawing Figure 1A.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Bukh J, 2008, J VIROL, V82, P8183, DOI 10.1128/JVI.00142-08; Cheng E, 2013, GASTROENTEROLOGY, V144, pS79; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; da Fonseca JCF, 2010, REV SOC BRAS MED TRO, V43, P322, DOI 10.1590/S0037-86822010000300022; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Fuller MJ, 2010, HEPATOLOGY, V51, P378, DOI 10.1002/hep.23319; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Heller T, 2013, J INFECT DIS, V208, P1020, DOI 10.1093/infdis/jit270; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Honegger JR, 2013, NAT MED, V19, P1529, DOI 10.1038/nm.3351; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kroy D. C., 2013, GASTROENTEROLOGY; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lanford RE, 2011, P NATL ACAD SCI USA, V108, P11223, DOI 10.1073/pnas.1101939108; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lohmann V., 2013, J MED CHEM; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Miyagi T, 2010, J HEPATOL, V53, P424, DOI 10.1016/j.jhep.2010.03.018; Mizukoshi E, 2008, J INFECT DIS, V198, P203, DOI 10.1086/589510; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Park S. H., 2012, GASTROENTEROLOGY, V143, pe4; Park SH, 2013, NAT MED, V19, P1638, DOI 10.1038/nm.3408; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Qu L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002169; Qu L, 2010, SEMIN LIVER DIS, V30, P319, DOI 10.1055/s-0030-1267534; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Semmo N, 2005, HEPATOLOGY, V41, P1019, DOI 10.1002/hep.20669; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Shin EC, 2013, J VIROL, V87, P4772, DOI 10.1128/JVI.03122-12; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Taylor JM, 2012, SEMIN LIVER DIS, V32, P195, DOI 10.1055/s-0032-1323623; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Urbani S, 2006, HEPATOLOGY, V44, P126, DOI 10.1002/hep.21242; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wieland S., 2013, HEPATOLOGY; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhou Y, 2012, J EXP MED, V209, P1481, DOI 10.1084/jem.20111906	122	189	192	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					13	24		10.1016/j.immuni.2013.12.010	http://dx.doi.org/10.1016/j.immuni.2013.12.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439265	Green Accepted, Bronze			2022-12-18	WOS:000331476900006
J	Acton, SE; Astarita, JL; Malhotra, D; Lukacs-Kornek, V; Franz, B; Hess, PR; Jakus, Z; Kuligowski, M; Fletcher, AL; Elpek, KG; Bellemare-Pelletier, A; Sceats, L; Reynoso, ED; Gonzalez, SF; Graham, DB; Chang, J; Peters, A; Woodruff, M; Kim, YA; Swat, W; Morita, T; Kuchroo, V; Carroll, MC; Kahn, ML; Wucherpfennig, KW; Turley, SJ				Acton, Sophie E.; Astarita, Jillian L.; Malhotra, Deepali; Lukacs-Kornek, Veronika; Franz, Bettina; Hess, Paul R.; Jakus, Zoltan; Kuligowski, Michael; Fletcher, Anne L.; Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Sceats, Lindsay; Reynoso, Erika D.; Gonzalez, Santiago F.; Graham, Daniel B.; Chang, Jonathan; Peters, Anneli; Woodruff, Matthew; Kim, Young-A.; Swat, Wojciech; Morita, Takashi; Kuchroo, Vijay; Carroll, Michael C.; Kahn, Mark L.; Wucherpfennig, Kai W.; Turley, Shannon J.			Podoplanin-Rich Stromal Networks Induce Dendritic Cell Motility via Activation of the C-type Lectin Receptor CLEC-2	IMMUNITY			English	Article							SECONDARY LYMPHOID ORGANS; IN-VIVO; LYMPHATIC VESSELS; RHO; MIGRATION; RAC; NEUTROPHILS; INVASION; GTPASES; ROLES	To initiate adaptive immunity, dendritic cells (DCs) move from parenchymal tissues to lymphoid organs by migrating along stromal scaffolds that display the glycoprotein podoplanin (PDPN). PDPN is expressed by lymphatic endothelial and fibroblastic reticular cells and promotes blood-lymph separation during development by activating the C-type lectin receptor, CLEC-2, on platelets. Here, we describe a role for CLEC-2 in the morphodynamic behavior and motility of DCs. CLEC-2 deficiency in DCs impaired their entry into lymphatics and trafficking to and within lymph nodes, thereby reducing T cell priming. CLEC-2 engagement of PDPN was necessary for DCs to spread and migrate along stromal surfaces and sufficient to induce membrane protrusions. CLEC-2 activation triggered cell spreading via downregulation of RhoA activity and myosin light-chain phosphorylation and triggered F-actin-rich protrusions via Vav signaling and Rac1 activation. Thus, activation of CLEC-2 by PDPN rearranges the actin cytoskeleton in DCs to promote efficient motility along stromal surfaces.	[Acton, Sophie E.; Astarita, Jillian L.; Malhotra, Deepali; Lukacs-Kornek, Veronika; Franz, Bettina; Fletcher, Anne L.; Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Sceats, Lindsay; Reynoso, Erika D.; Chang, Jonathan; Wucherpfennig, Kai W.; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Acton, Sophie E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Astarita, Jillian L.; Malhotra, Deepali; Chang, Jonathan; Woodruff, Matthew] Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA; [Hess, Paul R.; Jakus, Zoltan; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Hess, Paul R.; Jakus, Zoltan; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Kuligowski, Michael; Gonzalez, Santiago F.; Kim, Young-A.; Carroll, Michael C.] Harvard Univ, Immune Dis Inst, Sch Med, Boston, MA 02115 USA; [Kuligowski, Michael; Gonzalez, Santiago F.; Kim, Young-A.; Carroll, Michael C.] Harvard Univ, Program Cellular & Mol Med, Sch Med, Childrens Hosp,Dept Pediat, Boston, MA 02115 USA; [Kuligowski, Michael; Gonzalez, Santiago F.; Kim, Young-A.; Carroll, Michael C.] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp,Dept Pathol, Boston, MA 02115 USA; [Graham, Daniel B.; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Peters, Anneli; Kuchroo, Vijay] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Kiyose, Tokyo 2048588, Japan; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; University of London; University College London; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Meiji Pharmaceutical University; Harvard University; Harvard Medical School	Turley, SJ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA.	shannon_turley@dfci.harvard.edu	Jakus, Zoltán/O-1762-2015; Acton, Sophie/G-9784-2012	Jakus, Zoltán/0000-0002-6304-2369; Acton, Sophie/0000-0003-2704-716X; Fletcher, Anne/0000-0003-1534-1142; Malhotra, Deepali/0000-0002-8215-7639; F. Gonzalez, Santiago/0000-0003-4166-7664	National Institutes of Health [R01 DK074500, P01 AI045757, R01AI073718, AI061077]; LLS; Wellcome Trust; National Science Foundation; Benacerraf Postdoctoral Fellowship; National Health Medical Research Council; European Union [220044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073718, P01AI045757, R01AI061077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS; Wellcome Trust(Wellcome TrustEuropean Commission); National Science Foundation(National Science Foundation (NSF)); Benacerraf Postdoctoral Fellowship; National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to J. Campbell and B. Vander Lugt for CCR7 knockout mice; to L.-H. Ang, Y. Zheng, and S. Hagen for assistance with microscopy; and to R. Gelman for assistance with statistical analysis. They are also grateful to E. Sahai for critical reading of the manuscript. This work was supported by National Institutes of Health grants R01 DK074500 and P01 AI045757 (to S.J.T.), R01AI073718 and AI061077 (W.S.), and LLS (W.S., D.B.G.); a Wellcome Trust Henry Wellcome Postdoctoral Fellowship (to S.E.A.); a National Science Foundation Graduate Research Fellowship (to J.L.A.); a Benacerraf Postdoctoral Fellowship (to V.L.K.); a National Health Medical Research Council Postdoctoral Biomedical Training Fellowship (to A.L.F.); and a Seventh Framework Programme of the European Union (Marie Curie International Outgoing Fellowship 220044, to S.F.G.).	Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bekiaris V, 2007, J IMMUNOL, V179, P7535, DOI 10.4049/jimmunol.179.11.7535; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Colonna M, 2000, EUR J IMMUNOL, V30, P697; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Graham DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004652; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Pinner S, 2008, J MICROSC-OXFORD, V231, P441, DOI 10.1111/j.1365-2818.2008.02056.x; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	31	189	202	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 24	2012	37	2					276	289		10.1016/j.immuni.2012.05.022	http://dx.doi.org/10.1016/j.immuni.2012.05.022			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22884313	hybrid, Green Published			2022-12-18	WOS:000308261800012
J	Shinohara, ML; Kim, JH; Garcia, VA; Cantor, H				Shinohara, Mari L.; Kim, June-Ho; Garcia, Virgilio A.; Cantor, Harvey			Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; T-HELPER-CELLS; TH1 IMMUNE-RESPONSE; MULTIPLE-SCLEROSIS; IMMUNOLOGICAL-SYNAPSE; MEDIATED-IMMUNITY; CUTTING EDGE; INFLAMMATION; DISTINCT	Mechanisms that prevent inappropriate or excessive interleukin-17-producing T helper (Th17) cell responses after microbial infection may be necessary to avoid autoimmunity. Here, we define a pathway initiated by engagement of type I IFN receptor (IFNAR) expressed by dendritic cells (DC) that culminated in suppression of Th17 cell differentiation. IFNAR-dependent inhibition of an intracellular translational isoform of Osteopontin, termed Opn-i, dere-pressed interleukin-27 (IL-27) secretion and prevented efficient Th17 responses. Moreover, Opn-i expression in DC and microglia. regulated the type and intensity of experimental autoimmune encephalomyelitis (EAE). Mice containing DC deficient in Opn-i produced excessive amounts of IL-27 and developed a delayed disease characterized by an enhanced Th1 response compared with the dominant Th17 response of Opn-sufficient mice. Definition of the IFNAR-Opn-i axis that controls Th17 development provides insight into regulation of Th cell sub-lineage development and the molecular basis of type I interferon therapy for MS and other autoimmune diseases.	[Shinohara, Mari L.; Cantor, Harvey] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shinohara, Mari L.; Kim, June-Ho; Garcia, Virgilio A.; Cantor, Harvey] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu		Shinohara, Mari/0000-0002-6808-9844; Kim, June-Ho/0000-0001-7705-0717	NCI NIH HHS [T32 CA70083, T32 CA070083] Funding Source: Medline; NIAID NIH HHS [R37 AI012184, R01 AI048125-05, AI 48125, R37 AI012184-31, R01 AI048125, AI 12184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA070083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048125, R01AI012184, R37AI012184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Dalpke AH, 2002, J IMMUNOL, V168, P4854, DOI 10.4049/jimmunol.168.10.4854; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Sato T, 2005, GUT, V54, P1254, DOI 10.1136/gut.2004.048298; Shapiro S, 2003, J NEUROIMMUNOL, V144, P116, DOI 10.1016/j.jneuroim.2003.08.002; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Steinman L, 2003, NAT REV IMMUNOL, V3, P483, DOI 10.1038/nri1108; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yu M, 1996, J NEUROIMMUNOL, V64, P91, DOI 10.1016/0165-5728(95)00160-3	48	189	204	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					68	78		10.1016/j.immuni.2008.05.008	http://dx.doi.org/10.1016/j.immuni.2008.05.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18619869	Green Accepted, Bronze			2022-12-18	WOS:000257905400011
J	Varinou, L; Ramsauer, K; Karaghiosoff, M; Kolbe, T; Pfeffer, K; Muller, M; Decker, T				Varinou, L; Ramsauer, K; Karaghiosoff, M; Kolbe, T; Pfeffer, K; Muller, M; Decker, T			Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity	IMMUNITY			English	Article							KINASE-C-DELTA; INTERFERON-GAMMA; SERINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; I INTERFERONS; GENE; ACTIVATION; RESPONSES; MICE	Stat1 is phosphorylated on serine 727 within its transactivating domain (TAD) in response to interferons or other immunological signals. We generated gene-targeted mutant mice expressing a serine727-alanine mutant of Stat1. These animals showed increased mortality upon infection with Listeria monocytogenes and impaired clearance of the bacteria from spleen and liver. The Stat1S727A mice were more resistant to the LPS-induced septic shock syndrome, suggesting that Stat1 serine phosphorylation promotes inflammatory responses. Expression of IFN-gamma-induced genes was strongly reduced in macrophages expressing Stat1(S727A). While mutation of Stat1 at S727 did not reduce its binding to chromatin, association with the coactivator CBP and histone acetylation at the interferon-responsive GBP promoter was strongly reduced, suggesting defective recruitment of histone acetylases as the mechanism underlying IFN-gamma hyporesponsiveness. Our data demonstrate that the increase in transcription factor activity caused by Stat1 serine phosphorylation contributes to macrophage activation and to IFN-gamma-dependent immune responses in vivo.	Univ Vienna, Max F Perutz Labs, Univ Dept Vienna Bioctr, Dept Genet & Microbiol, A-1030 Vienna, Austria; Vet Univ Vienna, Inst Genet & Anim Breeding, A-1210 Vienna, Austria; Inst Agrobiotechnol Tulln, Dept Biotechnol Anim Prod, A-3430 Tulln, Austria; Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; Heinrich Heine University Dusseldorf	Decker, T (corresponding author), Univ Vienna, Max F Perutz Labs, Univ Dept Vienna Bioctr, Dept Genet & Microbiol, Dr Bohr Gasse 9-4, A-1030 Vienna, Austria.	thomas.decker@univie.ac.at		Decker, Thomas/0000-0001-9683-0620; Muller, Mathias/0000-0002-7879-3552; Pfeffer, Klaus/0000-0002-5652-6330				Agrawal S, 2002, MOL CELL BIOL, V22, P1981, DOI 10.1128/MCB.22.7.1981-1992.2002; Anderson SL, 1999, J INTERF CYTOK RES, V19, P487, DOI 10.1089/107999099313938; BACCARINI M, 1985, J IMMUNOL, V134, P2658; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; BRIKEN V, 1995, MOL CELL BIOL, V15, P975; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; KOHLER J, 1993, J IMMUNOL, V151, P916; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; NICOLET CM, 1994, J IMMUNOL, V152, P153; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Pilz A, 2003, EMBO REP, V4, P368, DOI 10.1038/sj.embor.embor802; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SHEN Y, 2003, IN PRESS MOL CELL BI; Stephanou A, 2001, J BIOL CHEM, V276, P28340, DOI 10.1074/jbc.M101177200; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Zakharova N, 2003, J BIOL CHEM, V278, P43067, DOI 10.1074/jbc.M308166200; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	39	189	190	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2003	19	6					793	802		10.1016/S1074-7613(03)00322-4	http://dx.doi.org/10.1016/S1074-7613(03)00322-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670297	Bronze			2022-12-18	WOS:000187230700005
J	Cherukuri, A; Dykstra, M; Pierce, SK				Cherukuri, A; Dykstra, M; Pierce, SK			Floating the raft hypothesis: Lipid rafts play a role in immune cell activation	IMMUNITY			English	Article							RECEPTOR; TCR; MEMBRANES		NIAID, NIH, Immunogenet Lab, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, NIH, Immunogenet Lab, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000898, Z01AI000899, Z01AI000898, ZIAAI000899] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cheng PC, 2001, SEMIN IMMUNOL, V13, P107, DOI 10.1006/smim.2000.0302; Cherukuri A, 2001, IMMUNITY, V14, P169; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sheets ED, 1999, CURR OPIN CHEM BIOL, V3, P95, DOI 10.1016/S1367-5931(99)80017-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443	15	189	195	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2001	14	6					657	660		10.1016/S1074-7613(01)00156-X	http://dx.doi.org/10.1016/S1074-7613(01)00156-X			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420035	Bronze			2022-12-18	WOS:000169495100001
J	Ohtani, T; Ishihara, K; Atsumi, T; Nishida, K; Kaneko, Y; Miyata, T; Itoh, S; Narimatsu, M; Maeda, H; Fukada, T; Itoh, M; Okano, H; Hibi, M; Hirano, T				Ohtani, T; Ishihara, K; Atsumi, T; Nishida, K; Kaneko, Y; Miyata, T; Itoh, S; Narimatsu, M; Maeda, H; Fukada, T; Itoh, M; Okano, H; Hibi, M; Hirano, T			Dissection of signaling cascades through gp130 in vivo: Reciprocal roles for STAT3-and SHP2-mediated signals in immune responses	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; T-CELL; INTERLEUKIN-6-DEFICIENT MICE; ANTIBODY-PRODUCTION; TRANSDUCER GP130; B-CELL; ACTIVATION; RECEPTOR; ASSOCIATION	We generated a series of knockin mouse lines, in which the cytokine receptor gp130-dependent STATS and/or SHP2 signals were disrupted, by replacing the mouse gp130 gene with human gp130 mutant cDNAs. The SHP2 signal-deficient mice (gp130(F759/F759)) were born normal but displayed splenomegaly and lymphadenopathy and an enhanced acute phase reaction. In contrast, the STATS signal-deficient mice (gp130(FXXQ/FXXQ)) died perinatally, like the gp130-deficient mice (gp130(D/D)). The gp130(F759/F759) mice showed prolonged gp130-induced STATS activation, indicating a negative regulatory role for SHP2. Th1-type cytokine production and IgG2a and IgG2b production were increased in the gp130(F759/F759) mice, while they were decreased in the gp130(FXXQ/FXXQ) immune system. These results indicate that the balance of positive and negative signals generated through gp130 regulates the immune responses.	Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Mol Oncol C7, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Neuroanat D12, Osaka 5650871, Japan; Japan Sci & Technol Corp JST, CREST, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Hirano, T (corresponding author), Osaka Univ, Grad Sch Med, Biomed Res Ctr, Div Mol Oncol C7, Osaka 5650871, Japan.	hirano@molono.med.osaka-u.ac.jp	Hirano, Toshio/C-8194-2009; MIYATA, TAKAKI/I-7066-2014; Hibi, Masahiko/I-6215-2014; Okano, Hideyuki/I-7584-2019	Hibi, Masahiko/0000-0002-9142-4444; 				Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; ERNST M, 1994, EMBO J, V13, P1574, DOI 10.1002/j.1460-2075.1994.tb06420.x; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hirano T, 1999, BIOCHEM BIOPH RES CO, V260, P303, DOI 10.1006/bbrc.1999.0609; HIRANO T, 1990, INT REV IMMUNOL, V16, P249; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Ishihara K, 1996, INT IMMUNOL, V8, P1395, DOI 10.1093/intimm/8.9.1395; Itoh M, 1998, J IMMUNOL, V161, P3974; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; KANEKO Y, 1999, IN PRESS DEV NEUROSC; Karras JG, 1997, J EXP MED, V185, P1035, DOI 10.1084/jem.185.6.1035; Kawasaki K, 1997, ENDOCRINOLOGY, V138, P4959, DOI 10.1210/en.138.11.4959; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; Kojima H, 1996, ONCOGENE, V12, P547; Kopf M, 1995, ANN NY ACAD SCI, V762, P308; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Kumanogoh A, 1997, P NATL ACAD SCI USA, V94, P2478, DOI 10.1073/pnas.94.6.2478; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; METCALF D, 1995, HEMATOPOIETIC COLONY, P109; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nakashima K, 1999, J NEUROSCI, V19, P5429; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; WIETZERBIN J, 1989, ANN NY ACAD SCI, V557, P162; Yamanouchi N, 1998, ADDICT BIOL, V3, P15, DOI 10.1080/13556219872317; Yoshida A, 1996, ASSIST REPROD REV, V67, P93	48	189	197	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2000	12	1					95	105		10.1016/S1074-7613(00)80162-4	http://dx.doi.org/10.1016/S1074-7613(00)80162-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661409	Bronze			2022-12-18	WOS:000085011900010
J	He, YW; Deftos, ML; Ojala, EW; Bevan, MJ				He, YW; Deftos, ML; Ojala, EW; Bevan, MJ			ROR gamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells	IMMUNITY			English	Article							CYTOKINE PRODUCTION; NUCLEAR RECEPTORS; INDUCED APOPTOSIS; THYMIC SELECTION; THYMOCYTES; DEATH; ANTIGEN; MATURE; CD95; ACTIVATION	We have identified ROR gamma t, a novel, thymus-specific isoform of the orphan nuclear receptor ROR gamma that is expressed predominantly in CD4(+) CD8(+) double-positive thymocytes. Ectopic expression of ROR gamma t protects T cell hybridomas from activation-induced cell death by inhibiting the upregulation of Pas ligand. Following hybridoma stimulation, ROR gamma t also inhibits IL-2 production but does not affect the induction of Nur-77 and Egr-3 nor the upregulation of sing. Both the ligand-binding and DNA-binding domains of ROR gamma t are required for this effect. We propose that the role of ROR gamma t expression in immature thymocytes is to inhibit Pas ligand expression and cytokine secretion following engagement of their TCR during positive or negative selection.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA092123, R01 CA092123-05] Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-27] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; ANDJELIC S, 1994, INT IMMUNOL, V6, P73, DOI 10.1093/intimm/6.1.73; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CALNAN BJ, 1995, IMMUNITY, V3, P273; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Castillo C, 1996, J MATER PROCESS TECH, V61, P7, DOI 10.1016/0924-0136(96)02458-2; CHEN D, 1993, MOL CELL BIOL, V13, P228, DOI 10.1128/MCB.13.1.228; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Cohen J J, 1992, Semin Immunol, V4, P363; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; FISCHER M, 1991, J IMMUNOL, V146, P3452; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; French LE, 1997, J IMMUNOL, V159, P2196; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GODFREY DI, 1993, J IMMUNOL, V150, P4244; He YW, 1997, J IMMUNOL, V158, P2592; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NISHIMURA Y, 1995, J IMMUNOL, V154, P4395; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Onishi M, 1996, EXP HEMATOL, V24, P324; ORTIZ MA, 1995, MOL ENDOCRINOL, V9, P1679, DOI 10.1210/me.9.12.1679; Puck J M, 1997, Semin Immunol, V9, P77, DOI 10.1006/smim.1996.0056; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rincon M, 1996, MOL CELL BIOL, V16, P1074; ROEHM NW, 1983, J EXP MED, V158, P317, DOI 10.1084/jem.158.2.317; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WHITE J, 1983, J IMMUNOL, V130, P1033; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879; ZLOTNIK A, 1992, J IMMUNOL, V149, P1211	59	189	224	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1998	9	6					797	806		10.1016/S1074-7613(00)80645-7	http://dx.doi.org/10.1016/S1074-7613(00)80645-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881970	Green Accepted, Bronze			2022-12-18	WOS:000077836600005
J	Huang, AYC; Bruce, AT; Pardoll, DM; Levitsky, HI				Huang, AYC; Bruce, AT; Pardoll, DM; Levitsky, HI			In vivo cross-priming of MHC class I - Restricted antigens requires the TAP transporter	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR H-ANTIGENS; T-CELLS; VIRAL-ANTIGEN; MOLECULES; REGION; REACT	Recent in vitro evidence suggests two alternative mechanisms by which bone marrow-derived APCs may process exogenous antigens for presentation to CTL in vivo, a phenomenon termed cross-priming. Although in vitro studies have suggested that both TAP-dependent and TAP-independent pathways exist, we have now demonstrated an absolute requirement for a functional TAP for cross-priming to occur in vivo. Bone marrow chimeras reconstituted with marrow from TAP-defective donors develop functional CD8(+) CTL, but have APCs with disrupted TAP function. In such chimeras, in vivo priming of naive CTL was observed when antigen was targeted to the ER in a TAP-independent fashion, but cross-priming could not be demonstrated. These results support the TAP-dependent mechanism of cross-priming.			Huang, AYC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205, USA.		Huang, Alex Y./ABG-8182-2021	Huang, Alex Y./0000-0002-5701-4521	PHS HHS [1RO1A137273] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BENNINK JR, 1993, J IMMUNOTHER, V14, P202, DOI 10.1097/00002371-199310000-00006; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; BEVAN MJ, 1976, J IMMUNOL, V117, P2233; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; BRUNT LM, 1990, J IMMUNOL, V145, P3540; Campbell P A, 1994, Immunol Ser, V60, P313; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOODING LR, 1980, J IMMUNOL, V124, P1258; HARDING CV, 1994, J IMMUNOL, V153, P4925; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; KOVACSOVICSBANKOWSKI M, 1994, EUR J IMMUNOL, V24, P2421; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; MINEV BR, 1994, CANCER RES, V54, P4155; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; ROCK KL, 1993, J IMMUNOL, V150, P438; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; YEWDELL JW, 1993, SEMIN HEMATOL, V30, P26	36	189	196	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					349	355		10.1016/S1074-7613(00)80248-4	http://dx.doi.org/10.1016/S1074-7613(00)80248-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612129	hybrid			2022-12-18	WOS:A1996UH52200003
J	Christ, A; Lauterbach, M; Latz, E				Christ, Anette; Lauterbach, Mario; Latz, Eicke			Western Diet and the Immune System: An Inflammatory Connection	IMMUNITY			English	Review							C-REACTIVE PROTEIN; CHAIN FATTY-ACIDS; TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CARDIOVASCULAR RISK-FACTORS; FISH-OIL SUPPLEMENTATION; HISTONE DEACETYLASE 3; HEMATOPOIETIC STEM; INSULIN-RESISTANCE	The consumption of Western-type calorically rich diets combined with chronic overnutrition and a sedentary lifestyle in Western societies evokes a state of chronic metabolic inflammation, termed metaflammation. Metaflammation contributes to the development of many prevalent non-communicable diseases (NCDs), and these lifestyle-associated pathologies represent a rising public health problem with global epidemic dimensions. A better understanding of how modern lifestyle and Western diet (WD) activate immune cells is essential for the development of efficient preventive and therapeutic strategies for common NCDs. Here, we review the current mechanistic understanding of how the Western lifestyle can induce metaflammation, and we discuss how this knowledge can be translated to protect the public from the health burden associated with their selected lifestyle.	[Christ, Anette; Lauterbach, Mario; Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Christ, Anette; Latz, Eicke] UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Latz, Eicke] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Latz, E (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany.; Latz, E (corresponding author), UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA.; Latz, E (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.; Latz, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany.	eicke.latz@uni-bonn.de	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666	Deutsche Forschungsgemeinschaft (DFG) [SFB 645, SFB 670, SFB 1123, TRR 83, TRR 57]; NIH [1R01HL112661]; ERC Consolidator grant (InflammAct); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Consolidator grant (InflammAct); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	E.L. is co-founder and scientific consultant of IFM Therapeutics. Funding was provided by grants from the Deutsche Forschungsgemeinschaft (DFG SFBs 645, 670, 1123; TRRs 83, 57), a grant from NIH (1R01HL112661), and an ERC Consolidator grant (InflammAct). E.L. is a member of ImmunoSensation (EXC2151 - 390873048).	Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540; Aleixandre A, 2016, FOOD FUNCT, V7, P1864, DOI [10.1039/c5fo00950b, 10.1039/C5FO00950B]; Aliasgharzadeh A, 2015, BRIT J NUTR, V113, P321, DOI 10.1017/S0007114514003675; Ambrosi TH, 2017, J MOL MED, V95, P1291, DOI 10.1007/s00109-017-1604-7; Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015; Bedja D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28663-9; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/s2213-8587(18)30288-2, 10.1016/S2213-8587(18)30288-2]; Bhupathiraju SN, 2014, AM J CLIN NUTR, V100, P218, DOI 10.3945/ajcn.113.079533; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Blesso CN, 2013, J CLIN LIPIDOL, V7, P463, DOI 10.1016/j.jacl.2013.03.008; Blundell J, 2010, NAT REV ENDOCRINOL, V6, P53, DOI 10.1038/nrendo.2009.224; Brial F, 2018, CELL MOL LIFE SCI, V75, P3977, DOI 10.1007/s00018-018-2901-1; Buc M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/963748; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Camargo A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-253; Canevari L, 2007, NEUROCHEM RES, V32, P739, DOI 10.1007/s11064-006-9200-1; Canfora EE, 2017, GASTROENTEROLOGY, V153, P87, DOI 10.1053/j.gastro.2017.03.051; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Cao Q, 2014, ARTERIOSCL THROM VAS, V34, P1871, DOI 10.1161/ATVBAHA.114.303393; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4; Clemmensen C, 2017, CELL, V168, P758, DOI 10.1016/j.cell.2017.01.025; Cohen JS, 2006, NEW ENGL J MED, V355, P2368; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Dangardt F, 2010, ATHEROSCLEROSIS, V212, P580, DOI 10.1016/j.atherosclerosis.2010.06.046; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Dehghan P, 2014, INT J FOOD SCI NUTR, V65, P117, DOI 10.3109/09637486.2013.836738; Ding YL, 2012, ARTERIOSCL THROM VAS, V32, P1596, DOI 10.1161/ATVBAHA.112.249847; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ebrahimi M, 2009, ACTA CARDIOL, V64, P321, DOI 10.2143/AC.64.3.2038016; Edrisi F, 2018, EUR J NUTR, V57, P833, DOI 10.1007/s00394-017-1555-3; El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Faintuch J, 2007, OBES SURG, V17, P341, DOI 10.1007/s11695-007-9062-x; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Fletcher J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051019; Fuster JJ, 2018, CIRC RES, V122, P523, DOI 10.1161/CIRCRESAHA.117.312115; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gogebakan O, 2011, CIRCULATION, V124, P2829, DOI 10.1161/CIRCULATIONAHA.111.033274; Gourbal B, 2018, IMMUNOL REV, V283, P21, DOI 10.1111/imr.12647; Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guillemot-Legris O, 2017, TRENDS NEUROSCI, V40, P237, DOI 10.1016/j.tins.2017.02.005; Gurav A, 2015, BIOCHEM J, V469, P267, DOI 10.1042/BJ20150242; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Henkel J, 2017, MOL MED, V23, P70, DOI 10.2119/molmed.2016.00203; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirschberg S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123109; Hoeksema MA, 2014, EMBO MOL MED, V6, P1124, DOI 10.15252/emmm.201404170; Hosseini B, 2016, COMPLEMENT THER CLIN, V22, P44, DOI 10.1016/j.ctcp.2015.12.003; Hosseini Z, 2016, NUTR RES REV, V29, P152, DOI 10.1017/S095442241600007X; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2017, NEW ENGL J MED, V377, P1401, DOI 10.1056/NEJMc1710381; Kelley DS, 2009, J NUTR, V139, P495, DOI 10.3945/jn.108.100354; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kien CL, 2015, J NUTR BIOCHEM, V26, P1599, DOI 10.1016/j.jnutbio.2015.07.014; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Koeth RA, 2019, J CLIN INVEST, V129, P373, DOI 10.1172/JCI94601; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Konstantinidou V, 2010, FASEB J, V24, P2546, DOI 10.1096/fj.09-148452; Kosaraju R, 2017, J IMMUNOL, V198, P4738, DOI 10.4049/jimmunol.1601031; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; de la Vega-Monroy MLL, 2013, J NUTR BIOCHEM, V24, P169, DOI 10.1016/j.jnutbio.2012.03.020; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Li RR, 2018, ASIA PAC J CLIN NUTR, V27, P1344, DOI 10.6133/apjcn.201811_27(6).0022; Li YP, 2018, CIRCULATION, V138, P345, DOI [10.1161/CIRCULATIONAHA.117.032047, 10.1161/circulationaha.117.032047]; Limdi JK, 2018, INDIAN J GASTROENTER, V37, P284, DOI 10.1007/s12664-018-0890-5; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Lopez-Moreno J, 2017, J AGR FOOD CHEM, V65, P7756, DOI 10.1021/acs.jafc.7b01909; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lu XP, 2012, AM J PHYSIOL-GASTR L, V303, pG367, DOI 10.1152/ajpgi.00541.2011; Lyte JM, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0357-6; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Madsen T, 2003, BRIT J NUTR, V89, P517, DOI 10.1079/BJN2002815; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142; Martin CR, 2018, CELL MOL GASTROENTER, V6, P133, DOI 10.1016/j.jcmgh.2018.04.003; Mazaherioun M, 2017, MED PRIN PRACT, V26, P535, DOI 10.1159/000484089; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Moghadam AM, 2012, SINGAP MED J, V53, P615; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Muldoon MF, 2016, J INTERN MED, V279, P98, DOI 10.1111/joim.12442; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orru H, 2017, Curr Environ Health Rep, V4, P504, DOI 10.1007/s40572-017-0168-6; Panagiotakos DB, 2007, J AM DIET ASSOC, V107, P979, DOI 10.1016/j.jada.2007.03.006; Parillo M, 2004, BRIT J NUTR, V92, P7, DOI 10.1079/BJN20041117; Parnell JA, 2017, OBESITY, V25, P510, DOI 10.1002/oby.21763; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Petrides F, 2013, CURR OPIN LIPIDOL, V24, P307, DOI 10.1097/MOL.0b013e328361f62d; Poppitt SD, 2008, NUTRITION, V24, P322, DOI 10.1016/j.nut.2007.12.012; Pot GK, 2009, EUR J CLIN NUTR, V63, P1353, DOI 10.1038/ejcn.2009.63; Raatz SK, 2015, J NUTR, V145, P2265, DOI 10.3945/jn.115.218016; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rallidis LS, 2003, ATHEROSCLEROSIS, V167, P237, DOI 10.1016/S0021-9150(02)00427-6; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rivera Chantal A., 2010, BMC Physiology, V10, P20, DOI 10.1186/1472-6793-10-20; Rodriguez-Monforte M, 2015, BRIT J NUTR, V114, P1341, DOI 10.1017/S0007114515003177; Rutkowsky JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191909; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731; Sarfert KS, 2019, NUTR NEUROSCI, V22, P344, DOI 10.1080/1028415X.2017.1388557; Schmitz J, 2016, MOL METAB, V5, P328, DOI 10.1016/j.molmet.2015.12.001; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Schwingshackl L, 2014, NUTR METAB CARDIOVAS, V24, P929, DOI 10.1016/j.numecd.2014.03.003; Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071; Schwingshackl L, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-154; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Sen T, 2017, PHYSIOL BEHAV, V173, P305, DOI 10.1016/j.physbeh.2017.02.027; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shapiro MD, 2016, CIRC RES, V118, P732, DOI 10.1161/CIRCRESAHA.115.306471; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Silbernagel G, 2014, EUR J CLIN NUTR, V68, P97, DOI 10.1038/ejcn.2013.228; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; Statovci D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00838; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Szic KSV, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0068-2; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tannock LR, 2005, CIRCULATION, V111, P3058, DOI 10.1161/CIRCULATIONAHA.104.506188; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49; Teague H, 2013, IMMUNOLOGY, V139, P386, DOI 10.1111/imm.12088; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Torres N, 2015, ARCH MED RES, V46, P408, DOI 10.1016/j.arcmed.2015.05.010; Torres-Fuentes C, 2017, LANCET GASTROENTEROL, V2, P747, DOI 10.1016/S2468-1253(17)30147-4; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van der Made SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118393; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; van Kampen E, 2014, J LEUKOCYTE BIOL, V96, P833, DOI 10.1189/jlb.1A0114-017R; Vasamsetti SB, 2018, IMMUNITY, V49, P93, DOI 10.1016/j.immuni.2018.05.004; Voon PT, 2011, AM J CLIN NUTR, V94, P1451, DOI 10.3945/ajcn.111.020107; Vors C, 2018, J NUTR, V148, P379, DOI 10.1093/jn/nxx072; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wright GP, 2011, EXPERT REV CLIN IMMU, V7, P213, DOI [10.1586/eci.10.96, 10.1586/ECI.10.96]; Yahfoufi N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111618; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	189	188	190	15	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					794	811		10.1016/j.immuni.2019.09.020	http://dx.doi.org/10.1016/j.immuni.2019.09.020			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747581	Bronze			2022-12-18	WOS:000497811300006
J	Colonna, M				Colonna, Marco			Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity	IMMUNITY			English	Review							ARYL-HYDROCARBON RECEPTOR; CD4(+) T-CELLS; NK CELLS; TRANSCRIPTION FACTOR; TISSUE RESIDENCY; GROWTH-FACTOR; INFECTION; GENETICS; MEMORY; BET	Type 1, 2, and 3 innate lymphoid cells (ILCs) have emerged as tissue-resident innate correlates of T helper 1 (Th1), Th2, and Th17 cells. Recent studies suggest that ILCs are more diverse than originally proposed; this might reflect truly distinct lineages or adaptation of ILCs to disparate tissue microenvironments, known as plasticity. Given that ILCs strikingly resemble T cells, are they redundant? While the regulation, timing, and magnitude of ILC and primary T cell responses differ, tissue-resident memory T cells may render ILCs redundant during secondary responses. The unique impact of ILCs in immunity is probably embodied in the extensive array of surface and intracellular receptors that endow these cells with the ability to distinguish between normal and pathogenic components, interact with other cells, and calibrate their cytokine secretion accordingly. Here I review recent advances in elucidating the diversity of ILCs and discuss their unique and redundant functions.	[Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@wustl.edu			US National Institutes of Health [UO1 AI095542, RO1 DE025884, R01 AI134236, RO1 DK103039]; Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI134236, U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I would like to thank Jennifer Bando, Marina Cella, Victor Cortez, Susan Gilfillan, Gene Oltz, Santosh Panda, and Michelle Robinette for helpful suggestions. This work is supported by the US National Institutes of Health (UO1 AI095542, RO1 DE025884, R01 AI134236, and RO1 DK103039) and Pfizer.	Abdul-Aziz MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01611; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Bando JK, 2018, IMMUNITY, V48, P1208, DOI 10.1016/j.immuni.2018.04.012; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bank U, 2016, J IMMUNOL, V196, P3532, DOI 10.4049/jimmunol.1501643; Bar-Ephraim YE, 2016, IMMUNOL REV, V271, P185, DOI 10.1111/imr.12407; Barrow AD, 2018, CELL, V172, P534, DOI 10.1016/j.cell.2017.11.037; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Cai T, 2019, J ALLERGY CLIN IMMUN, V143, P229, DOI 10.1016/j.jaci.2018.03.007; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cooper MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029512; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Dadi S, 2016, CELL, V164, P365, DOI 10.1016/j.cell.2016.01.002; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; DuPage M, 2016, NAT REV IMMUNOL, V16, P149, DOI 10.1038/nri.2015.18; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Ellinghaus D, 2015, SCAND J GASTROENTERO, V50, P13, DOI 10.3109/00365521.2014.990507; Emgard J, 2018, IMMUNITY, V48, P120, DOI 10.1016/j.immuni.2017.11.020; Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Holmes TD, 2016, SEMIN IMMUNOL, V28, P368, DOI 10.1016/j.smim.2016.05.008; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Huntington ND, 2016, CURR OPIN IMMUNOL, V38, P86, DOI 10.1016/j.coi.2015.11.008; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Ishigaki K, 2018, CLIN IMMUNOL, V186, P9, DOI 10.1016/j.clim.2017.08.017; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Johnson JL, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028779; Jonkers IH, 2017, HUM MOL GENET, V26, pR185, DOI 10.1093/hmg/ddx254; Kamili QUA, 2014, J ALLERGY CLIN IMMUN, V134, P1451, DOI 10.1016/j.jaci.2014.07.009; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Koyasu S, 2010, ADV IMMUNOL, V108, P21, DOI 10.1016/S0065-2776(10)08002_8; Langlais D, 2017, ANNU REV IMMUNOL, V35, P1, DOI 10.1146/annurev-immunol-051116-052442; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Lee YJ, 2016, J IMMUNOL, V197, P1460, DOI 10.4049/jimmunol.1600643; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li SY, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01909; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Liu TC, 2016, ANNU REV PATHOL-MECH, V11, P127, DOI 10.1146/annurev-pathol-012615-044152; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Mace EM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00545; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Maric J, 2018, J ALLERGY CLIN IMMUN, V141, P1761, DOI 10.1016/j.jaci.2017.09.050; Martin CE, 2017, IMMUNITY, V47, P171, DOI 10.1016/j.immuni.2017.07.005; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Mikami Y, 2018, EUR J IMMUNOL, DOI [10.1002, DOI 10.1002.]; Milner JJ, 2018, CURR OPIN IMMUNOL, V51, P162, DOI 10.1016/j.coi.2018.03.017; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Narni-Mancinelli E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9628; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Post M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00535; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Robinette ML, 2018, MUCOSAL IMMUNOL, V11, P50, DOI 10.1038/mi.2017.38; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shin JH, 2013, P NATL ACAD SCI USA, V110, P12391, DOI 10.1073/pnas.1302856110; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Wang Y, 2018, BIORXIV, DOI [10.1101/221010, DOI 10.1101/221010.]; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yu YQ, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/7936258; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang KN, 2017, J IMMUNOL, V198, P1798, DOI 10.4049/jimmunol.1601421; Zook EC, 2016, J EXP MED, V213, P687, DOI 10.1084/jem.20150851	132	188	194	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1104	1117		10.1016/j.immuni.2018.05.013	http://dx.doi.org/10.1016/j.immuni.2018.05.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924976	Green Accepted, Bronze			2022-12-18	WOS:000436456900011
J	Knipper, JA; Willenborg, S; Brinckmann, J; Bloch, W; Maass, T; Wagener, R; Krieg, T; Sutherland, T; Munitz, A; Rothenberg, ME; Niehoff, A; Richardson, R; Hammerschmidt, M; Allen, JE; Eming, SA				Knipper, Johanna A.; Willenborg, Sebastian; Brinckmann, Juergen; Bloch, Wilhelm; Maass, Tobias; Wagener, Raimund; Krieg, Thomas; Sutherland, Tara; Munitz, Ariel; Rothenberg, Marc E.; Niehoff, Anja; Richardson, Rebecca; Hammerschmidt, Matthias; Allen, Judith E.; Eming, Sabine A.			Interleukin-4 Receptor alpha Signaling in Myeloid Cells Controls Collagen Fibril Assembly in Skin Repair	IMMUNITY			English	Article							TELOPEPTIDE LYSYL HYDROXYLASE; PYRIDINOLINE CROSS-LINKS; RESISTIN-LIKE MOLECULE; EXPRESSION; FIBROSIS; IMMUNITY; DISEASE; PATTERN; MATRIX	Activation of the immune response during injury is a critical early event that determines whether the outcome of tissue restoration is regeneration or replacement of the damaged tissue with a scar. The mechanisms by which immune signals control these fundamentally different regenerative pathways are largely unknown. We have demonstrated that, during skin repair in mice, interleukin-4 receptor alpha (IL-4R alpha)-dependent macrophage activation controlled collagen fibril assembly and that this process was important for effective repair while having adverse pro-fibrotic effects. We identified Relm-alpha as one important player in the pathway from IL-4R alpha signaling in macrophages to the induction of lysyl hydroxylase 2 (LH2), an enzyme that directs persistent pro-fibrotic collagen cross-links, in fibroblasts. Notably, Relm-beta induced LH2 in human fibroblasts, and expression of both factors was increased in lipodermatosclerosis, a condition of excessive human skin fibrosis. Collectively, our findings provide mechanistic insights into the link between type 2 immunity and initiation of pro-fibrotic pathways.	[Knipper, Johanna A.; Willenborg, Sebastian; Krieg, Thomas; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Brinckmann, Juergen] Med Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany; [Brinckmann, Juergen] Med Univ Lubeck, Inst Virol & Cell Biol, D-23562 Lubeck, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany; [Maass, Tobias; Wagener, Raimund] Univ Cologne, Dept Biochem, D-50937 Cologne, Germany; [Krieg, Thomas; Hammerschmidt, Matthias; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Krieg, Thomas; Hammerschmidt, Matthias; Eming, Sabine A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Sutherland, Tara; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland; [Munitz, Ariel] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Ramat Aviv, Israel; [Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthoped, D-50933 Cologne, Germany; [Niehoff, Anja] Univ Cologne, Cologne Ctr Musculoskeletal Biomech, D-50931 Cologne, Germany; [Richardson, Rebecca; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany	University of Cologne; University of Lubeck; University of Lubeck; German Sport University Cologne; University of Cologne; University of Cologne; University of Cologne; University of Edinburgh; Tel Aviv University; Sackler Faculty of Medicine; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; German Sport University Cologne; University of Cologne; University of Cologne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany.	sabine.eming@uni-koeln.de	Richardson, Rebecca/L-5198-2019; Sutherland, Tara/S-1427-2019; Allen, Judith E/C-9198-2011; Niehoff, Anja/K-6626-2015	Richardson, Rebecca/0000-0002-4701-8713; Sutherland, Tara/0000-0001-9334-8206; Allen, Judith E/0000-0002-3829-066X; Knipper, Johanna/0000-0002-9038-0566; Niehoff, Anja/0000-0002-4165-0929	Deutsche Forschungsgemeinschaft [SFB829]; Medical Research Council [MR/J001929/1]; NIH [R37 AI045898]; MRC [MR/J001929/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI045898] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Michael Piekarek, Sebastian Wust, Christoph Gottlinger, and Gunter Rappl (Central Cell Sorting Facility, Center for Molecular Medicine Cologne, University of Cologne) for excellent technical assistance. The authors are grateful to Dr. Brombacher for providing Il4ra<SUP>fl/fl</SUP> mice and Dr. Irmgard Forster for providing Lyz2-cre mice, Regeneron Pharmaceuticals for providing the Retnla<SUP>-/-</SUP> mice, Dr. Peter Bruckner and Dr. Uwe Hansen for advice in ECM analysis, and Dr. David Artis and Dr. Meera Nair for providing the plasmid of murine Relm-alpha. The main funding source for this manuscript was the Deutsche Forschungsgemeinschaft (SFB829 to S.A.E., T.K., R.W., and M.H.). J.E.A. and T.S. were supported by the Medical Research Council (MR/J001929/1) and M.E.R. by NIH R37 AI045898.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Angelini DJ, 2009, AM J RESP CELL MOL, V41, P553, DOI 10.1165/rcmb.2008-0271OC; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; Brinckmann J, 2001, J INVEST DERMATOL, V117, P269, DOI 10.1046/j.0022-202x.2001.01414.x; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DOILLON CJ, 1988, J BIOMECH ENG-T ASME, V110, P352, DOI 10.1115/1.3108453; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Fang CL, 2015, CLIN EXP ALLERGY, V45, P940, DOI 10.1111/cea.12481; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hyry M., 2012, THESIS U OULU OULU; Kushiyama A, 2013, ARTERIOSCL THROM VAS, V33, P1986, DOI 10.1161/ATVBAHA.113.301546; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Malan D, 2013, DEVELOPMENT, V140, P987, DOI 10.1242/dev.091298; Malan D, 2010, DEVELOPMENT, V137, P993, DOI 10.1242/dev.045377; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	38	188	193	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					803	816		10.1016/j.immuni.2015.09.005	http://dx.doi.org/10.1016/j.immuni.2015.09.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26474656	Bronze, Green Accepted			2022-12-18	WOS:000363478700021
J	Tumes, DJ; Onodera, A; Suzuki, A; Shinoda, K; Endo, Y; Iwamura, C; Hosokawa, H; Koseki, H; Tokoyoda, K; Suzuki, Y; Motohashi, S; Nakayama, T				Tumes, Damon J.; Onodera, Atsushi; Suzuki, Akane; Shinoda, Kenta; Endo, Yusuke; Iwamura, Chiaki; Hosokawa, Hiroyuki; Koseki, Haruhiko; Tokoyoda, Koji; Suzuki, Yutaka; Motohashi, Shinichiro; Nakayama, Toshinori			The Polycomb Protein Ezh2 Regulates Differentiation and Plasticity of CD4(+) T Helper Type 1 and Type 2 Cells	IMMUNITY			English	Article							IFN-GAMMA PRODUCTION; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; GENE-EXPRESSION; TH1; BET; METHYLATION; GATA-3; MAINTENANCE; REPRESSION	After antigen encounter by CD4(+) T cells, polarizing cytokines induce the expression of master regulators that control differentiation. Inactivation of the histone methyltransferase Ezh2 was found to specifically enhance T helper 1 (Th1) and Th2 cell differentiation and plasticity. Ezh2 directly bound and facilitated correct expression of Tbx21 and Gata3 in differentiating Th1 and Th2 cells, accompanied by substantial trimethylation at lysine 27 of histone 3 (H3K27me3). In addition, Ezh2 deficiency resulted in spontaneous generation of discrete IFN-gamma and Th2 cytokine-producing populations in nonpolarizing cultures, and under these conditions IFN-gamma expression was largely dependent on enhanced expression of the transcription factor Eomesodermin. In vivo, loss of Ezh2 caused increased pathology in a model of allergic asthma and resulted in progressive accumulation of memory phenotype Th2 cells. This study establishes a functional link between Ezh2 and transcriptional regulation of lineage-specifying genes in terminally differentiated CD4(+) T cells.	[Tumes, Damon J.; Onodera, Atsushi; Suzuki, Akane; Shinoda, Kenta; Endo, Yusuke; Iwamura, Chiaki; Hosokawa, Hiroyuki; Tokoyoda, Koji; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Dev Genet, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Motohashi, Shinichiro] Chiba Univ, Grad Sch Med, Dept Med Immunol, Chuo Ku, Chiba 2608670, Japan; [Nakayama, Toshinori] JST, CREST, Chuo Ku, Chiba 2608670, Japan	Chiba University; RIKEN; University of Tokyo; Chiba University; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp	Tumes, Damon J/B-9917-2009; Onodera, Atsushi/E-3136-2017; Koseki, Haruhiko/I-3825-2014; Nakayama, Toshinori/E-1067-2017	Tumes, Damon J/0000-0001-5709-857X; Koseki, Haruhiko/0000-0001-8424-5854; Nakayama, Toshinori/0000-0002-1434-2007; Hosokawa, Hiroyuki/0000-0002-9592-2889; Tokoyoda, Koji/0000-0001-6101-4826	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment); Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [21390147, 24592083, 22790452, 23790522, 24790460, 24790461, 25860351, 25860352, 221S0002]; Ministry of Health, Labour and Welfare; Uehara Memorial Foundation; Princes Takamatsu Cancer Research Fund; Takeda Science Foundation; Japanese Society for the Promotion of Science [2109747]; Grants-in-Aid for Scientific Research [24790461] Funding Source: KAKEN	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Princes Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Sugaya, H. Asou, M. Kato, and T. Ito for excellent technical assistance. We also thank J. O'Shea for active discussion and comments on the manuscript. This work was supported by the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment) and by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) (Grants-in-Aid: for Scientific Research (B) #21390147, (C) #24592083, Young Scientists (B) #22790452, #23790522, #24790460, #24790461, #25860351, and #25860352, and MEXT KAKENHI Grant Number 221S0002), the Ministry of Health, Labour and Welfare, The Uehara Memorial Foundation, Princes Takamatsu Cancer Research Fund, and Takeda Science Foundation. D. J. T. was supported by a Japanese Society for the Promotion of Science postdoctoral fellowship (#2109747).	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Di Meglio T, 2013, SCIENCE, V339, P204, DOI 10.1126/science.1229326; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; He S, 2012, BLOOD, V119, P1274, DOI 10.1182/blood-2011-06-364422; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Kanai A, 2011, DNA RES, V18, P379, DOI 10.1093/dnares/dsr025; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Suzuki A, 2010, J IMMUNOL, V184, P4510, DOI 10.4049/jimmunol.0903426; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thomas RM, 2012, J BIOL CHEM, V287, P22900, DOI 10.1074/jbc.M111.312785; Tofukuji S, 2012, J IMMUNOL, V188, P4846, DOI 10.4049/jimmunol.1103799; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Yu Q, 2012, P NATL ACAD SCI USA, V109, P541, DOI 10.1073/pnas.1103803109; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	188	195	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					819	832		10.1016/j.immuni.2013.09.012	http://dx.doi.org/10.1016/j.immuni.2013.09.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238339	Bronze			2022-12-18	WOS:000330950600006
J	Lee, SK; Silva, DG; Martin, JL; Pratama, A; Hu, X; Chang, PP; Walters, G; Vinuesa, CG				Lee, Sau K.; Silva, Diego G.; Martin, Jaime L.; Pratama, Alvin; Hu, Xin; Chang, Pheh-Ping; Walters, Giles; Vinuesa, Carola G.			Interferon-gamma Excess Leads to Pathogenic Accumulation of Follicular Helper T Cells and Germinal Centers	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IFN-GAMMA; GENE-EXPRESSION; DENDRITIC CELLS; UP-REGULATION; MURINE LUPUS; AUTOIMMUNITY; INDUCTION; BCL6; CYTOKINE	Overactivity of the germinal center (GC) pathway resulting from accumulation of follicular helper T (Tfh) cells causes autoimmunity, underscoring the need to understand the factors that control Tfh cell homeostasis. Here we have identifed posttranscriptional repression of interferon-gamma (Ifng) mRNA as a mechanism to limit Tfh cell formation. By using the sanroque lupus model, we have shown that decreased Ifng mRNA decay caused excessive IFN-gamma signaling in T cells and led to accumulation of Tfh cells, spontaneous GC, autoantibody formation, and nephritis. Unlike ICOS and T-bet deficiency that failed to rescue several autoimmune manifestations, interferon-gamma receptor (IFN-gamma R) deficiency prevented lupus development. IFN-gamma blockade reduced Tfh cells and autoantibodies, demonstrating that IFN-gamma overproduction was required to sustain lupus-associated pathology. Increased IFN-gamma R signaling caused Bcl-6 overexpression in Tfh cells and their precursors. This link between IFN-gamma and aberrant Tfh cell formation provides a rationale for IFN-gamma blockade in lupus patients with an overactive Tfh cell-associated pathway.	[Lee, Sau K.; Silva, Diego G.; Martin, Jaime L.; Pratama, Alvin; Hu, Xin; Chang, Pheh-Ping; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Acton, ACT 2601, Australia; [Walters, Giles] Canberra Hosp, Dept Renal Med, Canberra, ACT 2605, Australia; [Walters, Giles] Australian Natl Univ, Sch Med, Canberra, ACT 2605, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital; Australian National University	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Acton, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Silva, Diego/GRF-5446-2022; Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298; Martin, Jaime/0000-0003-2415-0719; Chang, Pheh Ping/0000-0002-3395-4746; Walters, Giles/0000-0003-4854-9353	Elizabeth Blackburn NHMRC fellowship; NHMRC	Elizabeth Blackburn NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. Gillespie for help in the preparation of electron microscopy slides, A. Prins for H&E staining, and S. Nagata for his kind gift of C57BL/6.Fas<SUP>-/-</SUP> mice. We also thank S. Rao and J. Li for the experiments that are not included in this manuscript. C.G.V. is supported by an Elizabeth Blackburn NHMRC fellowship. This work was funded by NHMRC program and project grants to C.G.V.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Aoki N, 2011, GASTROENTEROLOGY, V140, P1322, DOI 10.1053/j.gastro.2011.01.002; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Bratke K, 2011, ALLERGY, V66, P386, DOI 10.1111/j.1398-9995.2010.02497.x; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chen L, 2007, J IMMUNOL, V178, P2730, DOI 10.4049/jimmunol.178.5.2730; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Haas C, 1998, J IMMUNOL, V160, P3713; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jacob N, 2011, J IMMUNOL, V186, P4984, DOI 10.4049/jimmunol.1000466; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Komori H, 2006, J IMMUNOL, V176, P395, DOI 10.4049/jimmunol.176.1.395; Lawson BR, 2000, J CLIN INVEST, V106, P207, DOI 10.1172/JCI10167; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Li XH, 2007, EUR J DERMATOL, V17, P392, DOI 10.1684/ejd.2007.0236; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu Z, 2011, TRENDS IMMUNOL, V32, P388, DOI 10.1016/j.it.2011.06.004; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; OZMEN L, 1995, EUR J IMMUNOL, V25, P6, DOI 10.1002/eji.1830250103; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Scapini P, 2010, J EXP MED, V207, P1757, DOI 10.1084/jem.20100086; Schwarting A, 1998, J IMMUNOL, V161, P494; Shah D, 2010, IMMUNOL LETT, V129, P7, DOI 10.1016/j.imlet.2010.01.005; Shi ZOQ, 2002, J IMMUNOL, V168, P4764; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; WARREN RW, 1984, CLIN IMMUNOL IMMUNOP, V31, P65, DOI 10.1016/0090-1229(84)90190-9; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008	58	188	196	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					880	892		10.1016/j.immuni.2012.10.010	http://dx.doi.org/10.1016/j.immuni.2012.10.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159227	Bronze			2022-12-18	WOS:000311460000014
J	Strasser, D; Neumann, K; Bergmann, H; Marakalala, MJ; Guler, R; Rojowska, A; Hopfner, KP; Brombacher, F; Urlaub, H; Baier, G; Brown, GD; Leitges, M; Ruland, J				Strasser, Dominikus; Neumann, Konstantin; Bergmann, Hanna; Marakalala, Mohlopheni J.; Guler, Reto; Rojowska, Anna; Hopfner, Karl-Peter; Brombacher, Frank; Urlaub, Henning; Baier, Gottfried; Brown, Gordon D.; Leitges, Michael; Ruland, Juergen			Syk Kinase-Coupled C-type Lectin Receptors Engage Protein Kinase C-delta to Elicit Card9 Adaptor-Mediated Innate Immunity	IMMUNITY			English	Article							PATTERN-RECOGNITION RECEPTOR; FUNGAL-INFECTIONS; CANDIDA-ALBICANS; TYROSINE KINASE; T-LYMPHOCYTES; HOST-DEFENSE; CELLS; ACTIVATION; DECTIN-2; RESPONSES	C-type lectin receptors (CLRs) that couple with the kinase Syk are major pattern recognition receptors for the activation of innate immunity and host defense. CLRs recognize fungi and other forms of microbial or sterile danger, and they induce inflammatory responses through the adaptor protein Card9. The mechanisms relaying CLR proximal signals to the core Card9 module are unknown. Here we demonstrated that protein kinase C-delta (PKC delta) was activated upon Dectin-1-Syk signaling, mediated phosphorylation of Card9 at Thr231, and was responsible for Card9-Bcl10 complex assembly and canonical NF-kappa B control. Prkcd(-/-) dendritic cells, but not those lacking PKC alpha, PKC beta, or PKC theta, were defective in innate responses to Dectin-1, Dectin-2, or Mincle stimulation. Moreover, Candida albicans-induced cytokine production was blocked in Prkcd(-/-) cells, and Prkcd(-/-) mice were highly susceptible to fungal infection. Thus, PKC delta is an essential link between Syk activation and Card9 signaling for CLR-mediated innate immunity and host protection.	[Strasser, Dominikus; Bergmann, Hanna; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany; [Neumann, Konstantin; Ruland, Juergen] Helmholtz Zentrum Munchen German Res Ctr Environm, Lab Signaling Immune Syst, D-85764 Neuherberg, Germany; [Marakalala, Mohlopheni J.; Guler, Reto; Brombacher, Frank; Brown, Gordon D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa; [Guler, Reto; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, ZA-7925 Cape Town, South Africa; [Rojowska, Anna; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Rojowska, Anna; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Baier, Gottfried] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Sect Immunol & Infect, Aberdeen Fungal Grp, Aberdeen AB25 2ZD, Scotland; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cape Town; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Munich; University of Munich; Max Planck Society; University of Gottingen; Medical University of Innsbruck; University of Aberdeen; University of Oslo	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany.	jruland@lrz.tum.de	Leitges, Michael/AAN-1953-2021; Guler, Reto/A-4013-2011; Hopfner, Karl-Peter/B-6864-2014; Baier, Gottfried/E-8755-2012; Neumann, Konstantin/AAD-5056-2019; Ruland, Jürgen/Q-6680-2018; brown, gordon/B-4249-2012	Hopfner, Karl-Peter/0000-0002-4528-8357; Neumann, Konstantin/0000-0002-5527-2834; Ruland, Jürgen/0000-0002-8381-3597; brown, gordon/0000-0002-0287-5383; Leitges, Michael/0000-0003-4203-6995; MARAKALALA, MOHLOPHENI/0000-0001-7476-1652; Baier, Gottfried/0000-0002-2085-8325	Wellcome Trust; NIH; Deutsche Forschungsgemeinschaft	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Hannesschlager and J. Lehne for excellent technical assistance, K. Lammens for discussions and help with protein purification, and S. Kuhn for help with in vitro kinase assays. D.S. is a member of the Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen. This work was supported by grants from the Wellcome Trust to G.D.B., grants from the NIH to K.-PH., and SFB grants from Deutsche Forschungsgemeinschaft to K.-P.H. and J.R.	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Leitges M, 2001, J CLIN INVEST, V108, P1505; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pointon JJ, 2010, GENES IMMUN, V11, P490, DOI 10.1038/gene.2010.17; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	42	188	191	5	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 27	2012	36	1					32	42		10.1016/j.immuni.2011.11.015	http://dx.doi.org/10.1016/j.immuni.2011.11.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22265677	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000299766000008
J	Paredes, JC; Welchman, DP; Poidevin, M; Lemaitre, B				Paredes, Juan C.; Welchman, David P.; Poidevin, Mickael; Lemaitre, Bruno			Negative Regulation by Amidase PGRPs Shapes the Drosophila Antibacterial Response and Protects the Fly from Innocuous Infection	IMMUNITY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; INNATE IMMUNE RECOGNITION; L-ALANINE AMIDASE; HOST-DEFENSE; BACTERIAL; HOMEOSTASIS; EXPRESSION; FAMILY	Peptidoglycan recognition proteins (PGRPs) are key regulators of insect immune responses. In addition to recognition PGRPs, which activate the Toll and Imd pathways, the Drosophila genome encodes six catalytic PGRPs with the capacity to scavenge peptidoglycan. We have performed a systematic analysis of catalytic PGRP function using deletions, separately and in combination. Our findings support the role of PGRP-LB as a negative regulator of the Imd pathway and brought to light a synergy of PGRP-SCs with PGRP-LB in the systemic response. Flies lacking all six catalytic PGRPs were still viable but exhibited deleterious immune responses to innocuous gut infections. Together with recent studies on mammalian PGRPs, our study uncovers a conserved role for PGRPs in gut homeostasis. Analysis of the immune phenotype of flies lacking all catalytic PGRPs and the Imd regulator Pirk reveals that the hid-mediated immune response is highly constrained by the existence of multiple negative feedbacks.	[Paredes, Juan C.; Welchman, David P.; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Poidevin, Mickael] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.	bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Paredes, Juan C./0000-0002-0974-8109	Bettencourt-Scheller Foundation; ERC; Swiss National Fund [3100A0-12079/1]	Bettencourt-Scheller Foundation; ERC(European Research Council (ERC)European Commission); Swiss National Fund(Swiss National Science Foundation (SNSF))	We thank our colleagues M. Frochaux, L. Mury, D. Brandalise, and J.P. Boquete for technical support; M. Gendrin for stimulating discussions; C. Neyen and Nichole Broderick for comments on the manuscript; D. Mengin-Lecreulx for peptidoglycan samples; and the Bloomington stock centre and National Institute of Genetics (NIG) for fly stocks. This work was funded by the Betten-court-Scheller Foundation, the ERC Advanced Grant and the Swiss National Fund (3100A0-12079/1).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Li X, 2007, IMMUNITY, V27, P518, DOI 10.1016/j.immuni.2007.07.020; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Mengel B, 2010, CURR OPIN GENET DEV, V20, P656, DOI 10.1016/j.gde.2010.08.008; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yu Y, 2010, J BIOL CHEM, V285, P32937, DOI 10.1074/jbc.M110.144014; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	36	188	198	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					770	779		10.1016/j.immuni.2011.09.018	http://dx.doi.org/10.1016/j.immuni.2011.09.018			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118526	Green Submitted, Bronze			2022-12-18	WOS:000297390800016
J	Siegel, AM; Heimall, J; Freeman, AF; Hsu, AP; Brittain, E; Brenchley, JM; Douek, DC; Fahle, GH; Cohen, JI; Holland, SM; Milner, JD				Siegel, Andrea M.; Heimall, Jennifer; Freeman, Alexandra F.; Hsu, Amy P.; Brittain, Erica; Brenchley, Jason M.; Douek, Daniel C.; Fahle, Gary H.; Cohen, Jeffrey I.; Holland, Steven M.; Milner, Joshua D.			A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory	IMMUNITY			English	Article							HYPER-IGE SYNDROME; CHRONIC VIRAL-INFECTION; X-LINKED AGAMMAGLOBULINEMIA; FOLLICULAR-HELPER-CELLS; EPSTEIN-BARR-VIRUS; TH17 CELLS; FUNGAL-INFECTIONS; HERPES-ZOSTER; GENERATION; RECEPTOR	STAT3 transcription factor signaling in specific T helper cell differentiation has been well described, although the broader roles for STAT3 in lymphocyte memory are less clear. Patients with autosomal-dominant hyper-IgE syndrome (AD-HIES) carry dominant-negative STAT3 mutations and are susceptible to a variety of bacterial and fungal infections. We found that AD-HIES patients have a cell-intrinsic defect in the number of central memory CD4(+) and CD8(+) T cells compared to healthy controls. Naive T cells from AD-HIES patients had lower expression of memory-related transcription factors BCL6 and SOCS3, a primary proliferation defect, and they failed to acquire central memory-like surface phenotypes in vitro. AD-HIES patients showed a decreased ability to control varicella zoster virus (VZV) and Epstein-Barr virus (EBV) latency, and T cell memory to both of these viruses was compromised. These data point to a specific role for STAT3 in human central memory T cell formation and in control of certain chronic viruses.	[Siegel, Andrea M.; Milner, Joshua D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Heimall, Jennifer; Freeman, Alexandra F.; Hsu, Amy P.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Brittain, Erica] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Cohen, Jeffrey I.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Fahle, Gary H.] NIH, Microbiol Serv, Div Lab Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Milner, JD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jdmilner@niaid.nih.gov	Brenchley, Jason/AAC-5085-2019	Brenchley, Jason/0000-0001-8357-2984	NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001029, ZIAAI001098, ZIAAI000646, ZIAAI000913] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank all of the members of the J.D.M. laboratory for their helpful discussions. We would like to thank the Flow Cytometry Core for all of their sorting assistance. We thank all of the patients and clinical staff whose dedication to human research was invaluable. This work was supported by the intramural research program of the NIAID. A.M.S., J.H., A.P.H., J.M.B., G.H.F., and J.D.M. performed experiments and analyzed data. J.H., A.F.F., S.M.H., and J.D.M. evaluated patients and obtained samples. E.B. performed statistical analysis. J.I.C. and D.C.D. provided sample material and analysis. A.M.S., J.H., and J.D.M. conceived the study, designed experiments, and interpreted data. A.M.S. and J.D.M. wrote the manuscript.	Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BUCKLEY R H, 1991, Journal of Allergy and Clinical Immunology, V87, P313, DOI 10.1016/0091-6749(91)91978-3; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cohen JI, 2010, J MED VIROL, V82, P996, DOI 10.1002/jmv.21751; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; Feng WH, 2004, JNCI-J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Freeman AF, 2010, DIS MARKERS, V29, P123, DOI [10.1155/2010/580197, 10.3233/DMA-2010-0734]; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Heimall J, 2011, CLIN IMMUNOL, V139, P75, DOI 10.1016/j.clim.2011.01.001; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu H, 2011, J INTERF CYTOK RES, V31, P459, DOI 10.1089/jir.2010.0115; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; RYSTEDT I, 1986, BRIT J DERMATOL, V114, P575, DOI 10.1111/j.1365-2133.1986.tb04064.x; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Speckmann C, 2008, CLIN IMMUNOL, V129, P448, DOI 10.1016/j.clim.2008.08.002; Steininger C, 2007, CLIN MICROBIOL INFEC, V13, P953, DOI 10.1111/j.1469-0691.2007.01781.x; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Young TY, 2007, ANN ALLERG ASTHMA IM, V98, P389, DOI 10.1016/S1081-1206(10)60887-3; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	63	188	194	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					806	818		10.1016/j.immuni.2011.09.016	http://dx.doi.org/10.1016/j.immuni.2011.09.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118528	Green Accepted, Bronze			2022-12-18	WOS:000297390800019
J	Johnston, JB; Barrett, JW; Nazarian, SH; Goodwin, M; Ricuttio, D; Wang, G; McFadden, G				Johnston, JB; Barrett, JW; Nazarian, SH; Goodwin, M; Ricuttio, D; Wang, G; McFadden, G			A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection	IMMUNITY			English	Article							MEDITERRANEAN FEVER PROTEIN; FACTOR-KAPPA-B; MYXOMA-VIRUS; NEW-GENERATION; DISEASE VIRUS; SEQUENCE; GENOME; FAMILY; CELLS; INTERLEUKIN-18	Proinflammatory caspases play an essential role in innate immune responses to infection by regulating the cleavage and activation of proinflammatory cytokines. Activation of these enzymes requires the assembly of an intracellular molecular platform, termed the inflammasome, which is comprised of members of the pyrin domain (PYD)-containing superfamily of apoptosis and inflammation-regulatory proteins. We report here the identification and characterization of a poxvirus-encoded PYD-containing protein that interacts with the ASC-1 component of the inflammasome and inhibits caspase-1 activation and the processing of IL-1 beta and IL-18 induced by diverse stimuli. Knockout viruses that do not express this protein are unable to productively infect monocytes and lymphocytes due to an abortive phenotype and are markedly attenuated in susceptible hosts due to decreased virus dissemination and enhanced inflammatory responses at sites of infection. Thus, modulation of inflammasome function constitutes an important immumomodulatory strategy employed by poxviruses to circumvent host antiviral responses.	Robarts Res Inst, BioTherapeut Res Grp, London, ON N6G 2V4, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	McFadden, G (corresponding author), Robarts Res Inst, BioTherapeut Res Grp, 1400 Western Rd, London, ON N6G 2V4, Canada.	mcfadden@robarts.ca		McFadden, Grant/0000-0002-2556-3526				Afonso CL, 2002, J VIROL, V76, P783, DOI 10.1128/JVI.76.2.783-790.2002; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Barrett JW, 2001, SEMIN IMMUNOL, V13, P73, DOI 10.1006/smim.2000.0298; Barry M, 1997, PARASITOLOGY, V115, pS89, DOI 10.1017/S0031182097001820; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Calderara S, 2001, VIROLOGY, V279, P22, DOI 10.1006/viro.2000.0689; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; Chen XG, 2000, P SOC EXP BIOL MED, V224, P32, DOI 10.1046/j.1525-1373.2000.22362.x; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fenner F., 1965, MYXOMATOSIS; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Gumucio DL, 2002, CLIN EXP RHEUMATOL, V20, pS45; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Johnston J, 1999, J VIROL, V73, P2491, DOI 10.1128/JVI.73.3.2491-2498.1999; Johnston JB, 2005, VIROLOGY, V332, P235, DOI 10.1016/j.virol.2004.11.030; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Lee HJ, 2001, VIROLOGY, V281, P170, DOI 10.1006/viro.2000.0761; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, J HISTOCHEM CYTOCHEM, V49, P1269, DOI 10.1177/002215540104901009; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Messud-Petit F, 1998, J VIROL, V72, P7830, DOI 10.1128/JVI.72.10.7830-7839.1998; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; Reed JC, 2003, GENOME RES, V13, P1376, DOI 10.1101/gr.1053803; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tulman ER, 2002, J VIROL, V76, P6054, DOI 10.1128/JVI.76.12.6054-6061.2002; Tulman ER, 2001, J VIROL, V75, P7122, DOI 10.1128/JVI.75.15.7122-7130.2001; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; YU JW, 2005, IN PRESS CELL DEATH	47	188	202	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2005	23	6					587	598		10.1016/j.immuni.2005.10.003	http://dx.doi.org/10.1016/j.immuni.2005.10.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16356857	Green Published, Bronze			2022-12-18	WOS:000234316900006
J	Rooke, R; Waltzinger, C; Benoist, C; Mathis, D				Rooke, R; Waltzinger, C; Benoist, C; Mathis, D			Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL DEVELOPMENT; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; POSITIVE SELECTION; THYMIC EMIGRATION; LIFE-SPANS; EXPRESSION; THYMOCYTES; MEMORY	De novo differentiation of CD4(+) T cells was provoked in mice lacking major histocompatibility complex (MHC) class II molecules by intrathymic injection of adenovirus vectors carrying class II genes. This permits a new approach to questions concerning the dynamics of CD4(+) T cell compartments in the thymus and peripheral lymphoid organs. Here two issues are explored. First, we show that mature CD4(+)CD8(-) cells reside in the thymus for a protracted period before emigrating to the periphery, highlighting the potential importance of, and our ignorance of, the postselection maturation period. Second, we demonstrate that the survival of CD4(+) cells in peripheral lymphoid organs is markedly curtailed when class II molecules are absent and is not further reduced in the absence of both class II and class I molecules, raising the possibility that MHC-mediated selection may continue in the periphery.	UNIV LOUIS PASTEUR,INST GENET & BIOL MOL & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; ALI M, 1994, GENE THER, V1, P367; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Boismenu R, 1996, SCIENCE, V271, P198, DOI 10.1126/science.271.5246.198; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; COSGROVE D, 1992, J EXP MED, V176, P629, DOI 10.1084/jem.176.2.629; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; LANDAIS D, 1986, J IMMUNOL, V137, P3002; LUCAS B, 1993, J IMMUNOL, V151, P4574; LUCAS B, 1994, J IMMUNOL, V153, P53; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; NIKOLICZUGIC J, 1990, INT IMMUNOL, V2, P135, DOI 10.1093/intimm/2.2.135; OZATO K, 1981, J IMMUNOL, V126, P317; RAJEWSKY K, 1993, IMMUNOL TODAY, V14, P40, DOI 10.1016/0167-5699(93)90324-E; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; ROBEY E, 1991, P NATL ACAD SCI USA, V88, P608, DOI 10.1073/pnas.88.2.608; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; SAMBROOK J, 1989, MOLCLONING; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; SURH CD, 1993, J EXP MED, V177, P379, DOI 10.1084/jem.177.2.379; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; TANCHOT C, 1995, EUR J IMMUNOL, V25, P2127, DOI 10.1002/eji.1830250802; TOUGH DF, 1995, IMMUNOL TODAY, V16, P273, DOI 10.1016/0167-5699(95)80180-4; TOUGH DF, 1995, STEM CELLS, V13, P242, DOI 10.1002/stem.5530130305; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; VANVLIET E, 1984, EUR J IMMUNOL, V14, P524, DOI 10.1002/eji.1830140608; VERNACHIO J, 1989, J IMMUNOL, V142, P48; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	54	188	193	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					123	134		10.1016/S1074-7613(00)80515-4	http://dx.doi.org/10.1016/S1074-7613(00)80515-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252125	Bronze			2022-12-18	WOS:A1997XN69300011
J	Balmer, ML; Ma, EH; Bantug, GR; Grahlert, J; Pfister, S; Glatter, T; Jauch, A; Dimeloe, S; Slack, E; Dehio, P; Krzyzaniak, MA; King, CG; Burgener, AV; Fischer, M; Develioglu, L; Belle, R; Recher, M; Bonilla, WV; Macpherson, AJ; Hapfelmeier, S; Jones, RG; Hess, C				Balmer, Maria L.; Ma, Eric H.; Bantug, Glenn R.; Grahlert, Jasmin; Pfister, Simona; Glatter, Timo; Jauch, Annaise; Dimeloe, Sarah; Slack, Emma; Dehio, Philippe; Krzyzaniak, Magdalena A.; King, Carolyn G.; Burgener, Anne-Valerie; Fischer, Marco; Develioglu, Leyla; Belle, Reka; Recher, Mike; Bonilla, Weldy V.; Macpherson, Andrew J.; Hapfelmeier, Siegfried; Jones, Russell G.; Hess, Christoph			Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function	IMMUNITY			English	Article							ACETYL-COA; GUT MICROBIOTA; EFFECTOR FUNCTION; RESPONSES; PHOSPHOTRANSACETYLASE; TRANSCRIPTION; ADAPTATION; ACTIVATION; ANTIGEN; GROWTH	How systemic metabolic alterations during acute infections impact immune cell function remains poorly understood. We found that acetate accumulates in the serum within hours of systemic bacterial infections and that these increased acetate concentrations are required for optimal memory CD8(+) T cell function in vitro and in vivo. Mechanistically, upon uptake by memory CD8(+) T cells, stress levels of acetate expanded the cellular acetyl-coenzyme A pool via ATP citrate lyase and promoted acetylation of the enzyme GAPDH. This context-dependent post-translational modification enhanced GAPDH activity, catalyzing glycolysis and thus boosting rapid memory CD8(+) T cell responses. Accordingly, in a murine Listeria monocytogenes model, transfer of acetate-augmented memory CD8(+) T cells exerted superior immune control compared to control cells. Our results demonstrate that increased systemic acetate concentrations are functionally integrated by CD8(+) T cells and translate into increased glycolytic and functional capacity. The immune system thus directly relates systemic metabolism with immune alertness.	[Balmer, Maria L.; Bantug, Glenn R.; Grahlert, Jasmin; Dimeloe, Sarah; Dehio, Philippe; Burgener, Anne-Valerie; Fischer, Marco; Develioglu, Leyla; Belle, Reka; Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland; [Ma, Eric H.; Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Ma, Eric H.; Jones, Russell G.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada; [Pfister, Simona; Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, CH-3010 Bern, Switzerland; [Glatter, Timo] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland; [Jauch, Annaise; Recher, Mike] Univ Basel, Dept Biomed, Immunodeficiency, CH-4031 Basel, Switzerland; [Slack, Emma] Swiss Fed Inst Technol Zurich, Inst Microbiol, CH-8093 Zurich, Switzerland; [Krzyzaniak, Magdalena A.; Bonilla, Weldy V.] Univ Basel, Div Expt Virol, Dept Biomed, CH-4009 Basel, Switzerland; [King, Carolyn G.] Univ Basel, Dept Biomed, Transplantat Immunol, CH-4031 Basel, Switzerland; [Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs DKF, Univ Klin Viszerale Chirurg & Med, Inselspital, CH-3010 Bern, Switzerland	University of Basel; McGill University; McGill University; University of Bern; University of Basel; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Basel; University of Bern; University Hospital of Bern	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland.	chess@uhbs.ch	Balmer, Maria L/A-8546-2013; Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022; Slack, Emma/AAD-5837-2019; Hapfelmeier, Siegfried/B-6005-2011; Balmer, Maria Luisa/AAB-8993-2021	Jones, Russell Graham/0000-0003-2250-4675; Slack, Emma/0000-0002-2473-1145; Hapfelmeier, Siegfried/0000-0002-6913-7932; Balmer, Maria Luisa/0000-0003-0356-6352; Dimeloe, Sarah/0000-0002-4598-6518; Glatter, Timo/0000-0001-8716-8516; King, Carolyn G./0000-0001-6059-323X; Bantug, Glenn Robert/0000-0003-2253-6028; Fischer, Marco/0000-0002-2704-7912; Recher, Mike/0000-0002-9121-6936	Basel University Young Investigator grants; McGill Integrated Cancer Research Training Program (MICRTP); Fonds de recherche du Quebec - Sante (FRQS); Canadian Institutes of Health Research [MOP-142259]; SNSF Ambizione [PZ00P3_136742]; European Research Council under the European Union's Seventh Framework Programme (FP), ERC Grant [281904 (ERC-2013-StG-281904), SNSF 310030_138452]; Genaxen Foundation; Inselspital; University of Bern;  [SNSF 310030-153059];  [CRSII3_160766];  [SNSF 323530-139181];  [SNSF PP00P3_144863];  [SNSF 310030_140700];  [CRS113_154414]	Basel University Young Investigator grants; McGill Integrated Cancer Research Training Program (MICRTP); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); SNSF Ambizione; European Research Council under the European Union's Seventh Framework Programme (FP), ERC Grant(European Research Council (ERC)); Genaxen Foundation; Inselspital; University of Bern; ; ; ; ; ; 	We thank C.T. Berger, M.Y. Donath, E. Palmer, and D.D. Pinschewer for helpful comments, G. Hoenger for technical help, E. Traunecker, T. Krebs, and D. Labes for cell sorting, and G.J.W. van der Windt and E.L. Pearce for help with the in vitro memory differentiation protocol. Funding: C.H., SNSF 310030-153059 and CRSII3_160766; M.F., SNSF 323530-139181; M.R., SNSF PP00P3_144863; M.L.B. and S.D., Basel University Young Investigator grants; E.H.M., Fellowships from the McGill Integrated Cancer Research Training Program (MICRTP) and Fonds de recherche du Quebec - Sante (FRQS); R.G.J., Grant from the Canadian Institutes of Health Research (MOP-142259); E.S., SNSF Ambizione PZ00P3_136742. S.H., European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013), ERC Grant Agreement n. 281904 (ERC-2013-StG-281904) and SNSF 310030_138452; the Clean Mouse Facility is supported by the Genaxen Foundation, Inselspital and the University of Bern. A.J.M., SNSF 310030_140700 and CRS113_154414.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; BALLARD FJ, 1972, AM J CLIN NUTR, V25, P773; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen AM, 2005, J VIROL, V79, P4700, DOI 10.1128/JVI.79.8.4700-4708.2005; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Hanninen A, 2011, EUR J IMMUNOL, V41, P634, DOI 10.1002/eji.201040760; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Kim YR, 2006, INFECT IMMUN, V74, P2498, DOI 10.1128/IAI.74.4.2498-2502.2006; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Lee SJ, 2012, IMMUNOL LETT, V148, P138, DOI 10.1016/j.imlet.2012.10.009; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; LUNDQUIST F, 1962, NATURE, V193, P579, DOI 10.1038/193579b0; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moschen I, 2012, NEUROCHEM RES, V37, P2562, DOI 10.1007/s11064-012-0857-3; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Wisniewski JR, 2015, J PROTEOME RES, V14, P3263, DOI 10.1021/acs.jproteome.5b00276; Yamashita H, 2001, BBA-MOL CELL BIOL L, V1532, P79, DOI 10.1016/S1388-1981(01)00117-2; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	47	187	194	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1312	1324		10.1016/j.immuni.2016.03.016	http://dx.doi.org/10.1016/j.immuni.2016.03.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27212436	Bronze			2022-12-18	WOS:000378341200011
J	Pao, LI; Lam, KP; Henderson, JM; Kutok, JL; Alimzhanov, M; Nitschke, L; Thomas, ML; Neel, BG; Rajewsky, K				Pao, Lily I.; Lam, Kong-Peng; Henderson, Joel M.; Kutok, Jeffery L.; Alimzhanov, Marat; Nitschke, Lars; Thomas, Matthew L.; Neel, Benjamin G.; Rajewsky, Klaus			B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity	IMMUNITY			English	Article							VIABLE MOTH-EATEN; BONE-MARROW-CELLS; MICE REVEAL; RECEPTOR; CD22; RESPONSES; IDENTIFICATION; THRESHOLDS; EXPRESSION; MUTATIONS	Spontaneous loss-of-function mutations in the protein-tyrosine phosphatase Shp1 cause the motheaten phenotype, characterized by widespread inflammation and autoimmunity. Because Shp1 is expressed in all hematopoietic cells, it has been unclear which aspects of the motheaten phenotypes are primary effects of Shp1 deficiency. We generated mice (Ptpn6(f/f), CD19-cre) that delete Shpl specifically in B cells. Analysis of these mice indicates that the increase in B-1a cells in motheaten mice is a cell-autonomous consequence of Shpl deficiency. Shp1-deficient B-1a cells could be derived from adult bone marrow and had N-nucleotide additions, consistent with an adult origin. Shpl1 deficiency altered calcium response evoked by B cell antigen receptors and impaired CD40-evoked proliferation. Young Ptpn6(f/f),-CD19-cre mice exhibited elevated serum immunoglobulins and impaired antibody responses to immunization, whereas older Ptpn6(f/f)-CD19-cre mice developed systemic autoimmunity, characterized by DNA antibodies and immune complex glomerulonephritis. Thus, Shpl deficiency in B cells alone perturbs B cell development and causes autoimmune disease.	Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA; Agcy Sci Technol & Res, Inst Biomed Sci, Lab Mol & Cellular Immunol, Singapore 138673, Singapore; Singapore Immunol Network, Singapore 138673, Singapore; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Germany; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Erlangen Nuremberg; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Pao, LI (corresponding author), Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA.	lpao@bidmc.harvard.edu; rajewsky@cbr.med.harvard.edu	Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333; Rajewsky, Klaus/0000-0002-6633-6370	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050693, P01DK050654] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054636] Funding Source: Medline; NIDDK NIH HHS [P01-DK50654, R01-DK50693] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Gommerman JL, 2000, J IMMUNOL, V165, P6915, DOI 10.4049/jimmunol.165.12.6915; GU H, 1992, ANN NY ACAD SCI, V651, P304; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HAUGHTON G, 1993, IMMUNOL TODAY, V14, P84, DOI 10.1016/0167-5699(93)90064-R; HAYASHI SI, 1988, J IMMUNOL, V140, P2139; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lajaunias F, 2002, J IMMUNOL, V168, P6078, DOI 10.4049/jimmunol.168.12.6078; Martin A, 1999, J BIOL CHEM, V274, P21725, DOI 10.1074/jbc.274.31.21725; MEDLOCK ES, 1987, J IMMUNOL, V138, P3590; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Sato S, 1996, J IMMUNOL, V157, P4371; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	42	187	187	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					35	48		10.1016/j.immuni.2007.04.016	http://dx.doi.org/10.1016/j.immuni.2007.04.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17600736	Bronze			2022-12-18	WOS:000248398100007
J	Chen, C; Prak, EL; Weigert, M				Chen, C; Prak, EL; Weigert, M			Editing disease-associated autoantibodies	IMMUNITY			English	Article							ANTI-DNA ANTIBODIES; B-CELLS; ESCAPE TOLERANCE; GENE-EXPRESSION; AUTOIMMUNE MICE; CHAIN; REARRANGEMENT; MECHANISM; DELETION	We have generated site-directed transgenic mice whose transgenes code for anti-DNA antibodies. These antibodies are representative of the lupus-associated anti-DNAs seen in mouse models of autoimmunity and human SLE, and have the usual characteristics of pathogenic autoantibodies. As conventional transgenics in nonautoimmune mice, anti-DNA B cells have been shown to be deleted or inactivated. Autoreactive B cells can also escape negative regulation by a process called receptor editing. Here we describe two combined immunoglobulin H and L chain site-directed transgenic mouse models and characterize their editing phenotypes. One model, 3H9R/V kappa 4R, has a deletion-prone phenotype and undergoes editing, primarily by inactivation of the light chain by leap-frogging events. In the other model, 3H9R/V kappa 8R, B cells are susceptible to anergy and maintain most of their HR and LR chains. These studies clarify the relationship between editing and other mechanisms of tolerance.			Chen, C (corresponding author), PRINCETON UNIV,DEPT MOL BIOL,PRINCETON,NJ 08544, USA.							Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; CHEN C, 1994, J IMMUNOL, V152, P1970; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; COLECLOUGH C, 1992, RES IMMUNOL, V143, P832; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; KOFLER R, 1989, IMMUNOGENETICS, V29, P65, DOI 10.1007/BF00395853; Nemazee D, 1995, ANN NY ACAD SCI, V764, P397; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009	22	187	189	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					97	105		10.1016/S1074-7613(00)80673-1	http://dx.doi.org/10.1016/S1074-7613(00)80673-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052841	Bronze			2022-12-18	WOS:A1997XB16100010
J	Atyeo, C; Fischinger, S; Zohar, T; Slein, MD; Burke, J; Loos, C; McCulloch, DJ; Newman, KL; Wolf, C; Yu, JY; Shuey, K; Feldman, J; Hauser, BM; Caradonna, T; Schmidt, AG; Suscovich, TJ; Linde, C; Cai, YF; Barouch, D; Ryan, ET; Charles, RC; Lauffenburger, D; Chu, H; Alter, G				Atyeo, Caroline; Fischinger, Stephanie; Zohar, Tomer; Slein, Matthew D.; Burke, John; Loos, Carolin; McCulloch, Denise J.; Newman, Kira L.; Wolf, Caitlin; Yu, Jingyou; Shuey, Kiel; Feldman, Jared; Hauser, Blake Marie; Caradonna, Tim; Schmidt, Aaron G.; Suscovich, Todd J.; Linde, Caitlyn; Cai, Yongfei; Barouch, Dan; Ryan, Edward T.; Charles, Richelle C.; Lauffenburger, Douglas; Chu, Helen; Alter, Galit			Distinct Early Serological Signatures Track with SARS-CoV-2 Survival	IMMUNITY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; PASSIVE IMMUNOTHERAPY; ANTIBODY-RESPONSES; INFECTION; PROTEIN	As SARS-CoV-2 infections and death counts continue to rise, it remains unclear why some individuals recover from infection, whereas others rapidly progress and die. Although the immunological mechanisms that underlie different clinical trajectories remain poorly defined, pathogen-specific antibodies often point to immunological mechanisms of protection. Here, we profiled SARS-CoV-2-specific humoral responses in a cohort of 22 hospitalized individuals. Despite inter-individual heterogeneity, distinct antibody signatures resolved individuals with different outcomes. Although no differences in SARS-CoV-2-specific IgG levels were observed, spike-specific humoral responses were enriched among convalescent individuals, whereas functional antibody responses to the nucleocapsid were elevated in deceased individuals. Furthermore, this enriched immunodominant spike-specific antibody profile in convalescents was confirmed in a larger validation cohort. These results demonstrate that early antigen-specific and qualitative features of SARS-CoV-2-specific antibodies point to differences in disease trajectory, highlighting the potential importance of functional antigen-specific humoral immunity to guide patient care and vaccine development.	[Atyeo, Caroline; Fischinger, Stephanie; Zohar, Tomer; Slein, Matthew D.; Burke, John; Loos, Carolin; Feldman, Jared; Hauser, Blake Marie; Caradonna, Tim; Schmidt, Aaron G.; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Atyeo, Caroline] Harvard Univ, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA; [Fischinger, Stephanie] Univ Duisburg Essen, PhD Program Immunol & Virol, Essen, Germany; [Zohar, Tomer; Loos, Carolin; Lauffenburger, Douglas] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Newman, Kira L.; Shuey, Kiel; Chu, Helen] Univ Washington, Dept Med, Seattle, WA 98195 USA; [McCulloch, Denise J.; Wolf, Caitlin; Yu, Jingyou; Barouch, Dan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Ryan, Edward T.; Charles, Richelle C.] Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02114 USA; [Suscovich, Todd J.; Linde, Caitlyn] SeromYx Syst, Cambridge, MA USA; [Cai, Yongfei] Harvard Med Sch, Boston Childrens Hosp, Div Mol Med, Boston, MA 02115 USA; [Cai, Yongfei] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; University of Duisburg Essen; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Alter, G (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Chu, H (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	helenchu@uw.edu; galter@partners.org	Cai, Yongfei/ABI-7748-2020	Cai, Yongfei/0000-0002-3628-3802; Newman, Kira/0000-0002-8279-1111; Slein, Matthew/0000-0001-8288-787X; Caradonna, Timothy/0000-0001-7138-4441; Hauser, Blake/0000-0002-0100-1684; Zohar, Tomer/0000-0001-9965-2559; Yu, Jingyou/0000-0002-0775-6623; McCulloch, Denise/0000-0001-8755-6105	Ragon Institute of MGH, MIT and Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); Bill and Melinda Gates Foundation [235730]; NIAID [U19 AI135995]; Centers for Disease Control and Prevention [CK000490]	Ragon Institute of MGH, MIT and Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We thank Bruce Walker, Nancy Zimmerman, Mark and Lisa Schwartz, an anonymous donor, and Terry and Susan Ragon for support. We would also like to thank Bing Chen for protein production efforts. We acknowledge support from the Ragon Institute of MGH, MIT and Harvard, the Massachusetts Consortium on Pathogen Readiness (MassCPR), the Bill and Melinda Gates Foundation (235730), the NIAID (U19 AI135995) and the Centers for Disease Control and Prevention (CK000490).	Ackerman ME, 2018, NAT MED, V24, P1590, DOI 10.1038/s41591-018-0161-0; Althaus C.L., 2020, ESTIMATION SARS COV, DOI 10.1101/2020.03.04.20031104; Altomare A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050367; [Anonymous], 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.1101/2020.04.10.036418]; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Boudreau CM, 2020, J CLIN INVEST, V130, P662, DOI 10.1172/JCI129520; Brown EP, 2017, J IMMUNOL METHODS, V443, P33, DOI 10.1016/j.jim.2017.01.010; Buchholz UJ, 2004, P NATL ACAD SCI USA, V101, P9804, DOI 10.1073/pnas.0403492101; Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776; Chang SC, 2005, CLIN DIAGN LAB IMMUN, V12, P1455, DOI 10.1128/CDLI.12.12.1455-1457.2005; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Cong JJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01416; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Elisseeff A., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Gunn BM, 2016, TRENDS MOL MED, V22, P969, DOI 10.1016/j.molmed.2016.09.002; He YX, 2006, BIOCHEM BIOPH RES CO, V344, P106, DOI 10.1016/j.bbrc.2006.03.139; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Jegaskanda S, 2016, J INFECT DIS, V214, P945, DOI 10.1093/infdis/jiw262; Kong P, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01904-6; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li TS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000024; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pittala S, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188747; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Shi YL, 2004, J CLIN VIROL, V31, P66, DOI 10.1016/j.jcv.2004.05.006; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Timani KA, 2004, J CLIN VIROL, V30, P309, DOI 10.1016/j.jcv.2004.01.001; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; van Erp EA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00548; Wang XL, 2020, CLIN INFECT DIS, V71, P2688, DOI 10.1093/cid/ciaa721; World Health Organization, 2020, 122 WHO; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Yasui F, 2014, VIROLOGY, V454, P157, DOI 10.1016/j.virol.2014.02.005; Zhao JC, 2015, J VIROL, V89, P6117, DOI 10.1128/JVI.00446-15; Zhao YK, 2017, ANTIVIR RES, V137, P125, DOI 10.1016/j.antiviral.2016.11.016; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	44	186	188	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					524	+		10.1016/j.immuni.2020.07.020	http://dx.doi.org/10.1016/j.immuni.2020.07.020			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32783920	hybrid, Green Published			2022-12-18	WOS:000569806100011
J	Ray, JP; Staron, MM; Shyer, JA; Ho, PC; Marshall, HD; Gray, SM; Laidlaw, BJ; Araki, K; Ahmed, R; Kaech, SM; Craft, J				Ray, John P.; Staron, Matthew M.; Shyer, Justin A.; Ho, Ping-Chih; Marshall, Heather D.; Gray, Simon M.; Laidlaw, Brian J.; Araki, Koichi; Ahmed, Rafi; Kaech, Susan M.; Craft, Joe			The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXO1; NF-KAPPA-B; REG CELLS; IMMUNE-RESPONSES; VIRAL-INFECTION; GENE-EXPRESSION; MEMORY; ACTIVATION; EFFECTOR; FH	The differentiation of CD4(+) helper T cell subsets with diverse effector functions is accompanied by changes in metabolism required to meet their bioenergetic demands. We find that follicular B helper T (Tfh) cells exhibited less proliferation, glycolysis, and mitochondrial respiration, accompanied by reduced mTOR kinase activity compared to T helper 1 (Th1) cells in response to acute viral infection. IL-2-mediated activation of the Akt kinase and mTORc1 signaling was both necessary and sufficient to shift differentiation away from Tfh cells, instead promoting that of Th1 cells. These findings were not the result of generalized signaling attenuation in Tfh cells, because they retained the ability to flux calcium and activate NFAT-transcription-factor-dependent cytokine production. These data identify the interleukin-2 (IL-2)-mTORc1 axis as a critical orchestrator of the reciprocal balance between Tfh and Th1 cell fates and their respective metabolic activities after acute viral infection.	[Ray, John P.; Staron, Matthew M.; Shyer, Justin A.; Ho, Ping-Chih; Marshall, Heather D.; Gray, Simon M.; Laidlaw, Brian J.; Kaech, Susan M.; Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Araki, Koichi; Ahmed, Rafi] Yale Univ, Sch Med, Dept Med Rheumatol, New Haven, CT 06520 USA; [Craft, Joe] Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Craft, Joe] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Yale University; Howard Hughes Medical Institute; Yale University; Emory University; Emory University	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu; joseph.craft@yale.edu	; Ray, John/F-3187-2015	Ho, Ping-Chih/0000-0003-3078-3774; Araki, Koichi/0000-0003-3478-6315; Ray, John/0000-0001-7294-4260	National Science Foundation Graduate Research Fellowship Program [2012099695]; NIH [F32AI094791, AR40072, AR062842, AI075157, AR053495, AR063942]; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI094791, R01AI066232, R01AI075157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063942, P30AR053495, R21AR068662, R37AR040072, R21AR062842, R01AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Leslie Berg for the CD25 silencing plasmid, Shane Crotty for the LMP shRNA vector, and Christophe Benoit for the Myr-Akt plasmid. We thank members of the S.M.K. and J.C. laboratories for their suggestions and review. This work was supported by the National Science Foundation Graduate Research Fellowship Program under grant 2012099695 (J.P.R.), NIH grants F32AI094791 (H.D.M.), AR40072, AR062842, AI075157, AR053495, AR063942, and the Alliance for Lupus Research.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Hatzi K., 2015, J EXP MED, V212, P539; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Marshall HD, 2015, ELIFE, V4, DOI 10.7554/eLife.04851; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756	58	186	189	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					690	702		10.1016/j.immuni.2015.08.017	http://dx.doi.org/10.1016/j.immuni.2015.08.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26410627	Green Accepted, Bronze			2022-12-18	WOS:000363478700012
J	Hirahara, K; Ghoreschi, K; Yang, XP; Takahashi, H; Laurence, A; Vahedi, G; Sciume, G; Hall, AO; Dupont, CD; Francisco, LM; Chen, Q; Tanaka, M; Kanno, Y; Sun, HW; Sharpe, AH; Hunter, CA; O'Shea, JJ				Hirahara, Kiyoshi; Ghoreschi, Kamran; Yang, Xiang-Ping; Takahashi, Hayato; Laurence, Arian; Vahedi, Golnaz; Sciume, Giuseppe; Hall, Aisling O'Hara; Dupont, Christopher D.; Francisco, Loise M.; Chen, Qian; Tanaka, Masao; Kanno, Yuka; Sun, Hong-Wei; Sharpe, Arlene H.; Hunter, Christopher A.; O'Shea, John J.			Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY CYTOKINE PRODUCTION; TH1 DIFFERENTIATION; GRAVES-DISEASE; CUTTING EDGE; C-MAF; IL-27; EXPRESSION; RECEPTOR; INFLAMMATION	Interleukin-27 (IL-27) is a key immunosuppressive cytokine that counters T helper 17 (Th17) cell-mediated pathology. To identify mechanisms by which IL-27 might exert its immunosuppressive effect, we analyzed genes in T cells rapidly induced by IL-27. We found that IL-27 priming of naive T cells upregulated expression of programmed death ligand 1 (PD-L1) in a signal transducer and activator of transcription 1 (STAT1)-dependent manner. When cocultured with naive CD4(+) T cells, IL-27-primed T cells inhibited the differentiation of Th17 cells in trans through a PD-1-PD-L1 interaction. In vivo, coadministration of naive TCR transgenic T cells (2D2 T cells) with IL-27-primed T cells expressing PD-L1 inhibited the development of Th17 cells and protected from severe autoimmune encephalomyelitis. Thus, these data identify a suppressive activity of IL-27, by which CD4(+) T cells can restrict differentiation of Th17 cells in trans.	[Hirahara, Kiyoshi; Ghoreschi, Kamran; Yang, Xiang-Ping; Takahashi, Hayato; Laurence, Arian; Vahedi, Golnaz; Sciume, Giuseppe; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Chen, Qian] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Tanaka, Masao] NIAMSD, Translat Immunol Sect, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Hall, Aisling O'Hara; Dupont, Christopher D.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Francisco, Loise M.; Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Pennsylvania; Harvard University; Harvard Medical School	Hirahara, K (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	hiraharak@mail.nih.gov; osheajo@mail.nih.gov	Laurence, Arian/A-8770-2009; Hirahara, Kiyoshi/E-2460-2017; Sciume, Giuseppe/K-8985-2016; Kanno, Yuka/B-5802-2013; Takahashi, Hayato/AAV-7707-2021	Laurence, Arian/0000-0003-0942-8292; Hirahara, Kiyoshi/0000-0002-9128-9449; Sciume, Giuseppe/0000-0003-0131-512X; Kanno, Yuka/0000-0001-5668-9319; Takahashi, Hayato/0000-0001-6768-8821; Yang, Xiang-Ping/0000-0001-9003-1772; Hall, Aisling/0000-0001-8198-3245; Ghoreschi, Kamran/0000-0002-5526-7517	NIAMS; JSPS at NIH; Istituto Pasteur-Fondazione Cenci-Bolognetti; NIH [R01 AI 42334, R01 AI 40614, R37 AI 38310]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040614, T32AI007532, R37AI038310, R01AI042334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); JSPS at NIH; Istituto Pasteur-Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Pelletier (Autoimmunity Branch, NIAMS), J. Simone, J. Lay (Flow Cytometry Section, NIAMS), and the NIAMS LACU staff for their excellent technical support. We thank A. Villarino for critically reading this manuscript and providing helpful suggestions. This work was supported by the Intramural Research Programs of NIAMS, NIAID, the JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH (K.H. and H.T.), Istituto Pasteur-Fondazione Cenci-Bolognetti (G.S.), NIH R01 AI 42334 (C.A.H.), NIH R01 AI 40614 (A.H.S.), and NIH R37 AI 38310 (A.H.S.). K.H. and K.G. designed, performed, analyzed, and interpreted all the experiments and wrote the manuscript. X.-P.Y., H.T., A.L., G.S., A.O'H.H., C.D.D., L.M.F., Q.C., and M.T. helped with performing experiments. H.-W.S. and G.V. interpreted the microarray experiments and ChIP-seq data. Y.K., A.H.S., and C.A.H. contributed to the experimental design and data interpretation and made helpful suggestions. J.J.O'S. contributed to experiment design, analyzed and interpreted all acquired data, and helped to write the manuscript.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hamel KM, 2010, EUR J IMMUNOL, V40, P3117, DOI 10.1002/eji.201040690; Hayashi M, 2008, EUR J ENDOCRINOL, V158, P817, DOI 10.1530/EJE-07-0649; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Mitchell AL, 2009, J CLIN ENDOCR METAB, V94, P5139, DOI 10.1210/jc.2009-1404; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Ouaked N, 2009, J IMMUNOL, V182, P1041, DOI 10.4049/jimmunol.182.2.1041; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	51	186	198	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					1017	1030		10.1016/j.immuni.2012.03.024	http://dx.doi.org/10.1016/j.immuni.2012.03.024			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22726954	Bronze, Green Accepted			2022-12-18	WOS:000306097100018
J	Lu, KT; Kanno, Y; Cannons, JL; Handon, R; Bible, P; Elkahloun, AG; Anderson, SM; Wei, L; Sun, HW; O'Shea, JJ; Schwartzberg, PL				Lu, Kristina T.; Kanno, Yuka; Cannons, Jennifer L.; Handon, Robin; Bible, Paul; Elkahloun, Abdel G.; Anderson, Stacie M.; Wei, Lai; Sun, Hongwei; O'Shea, John J.; Schwartzberg, Pamela L.			Functional and Epigenetic Studies Reveal Multistep Differentiation and Plasticity of In Vitro-Generated and In Vivo-Derived Follicular T Helper Cells	IMMUNITY			English	Article							CENTER B-CELL; MECHANISM DISTINCT; PROVIDE HELP; EXPRESSION; RECEPTOR; IL-21; LINEAGE; ICOS; BCL6; SAP	Follicular T helper (Tfh) cells provide critical help to B cells for germinal center (GC) formation. Mutations affecting SLAM-associated protein (SAP) prevent GC formation because of defective T cell-B cell interactions, yet effects on Tfh cell differentiation remain unclear. We describe the in vitro differentiation of functionally competent "Tfh-like" cells that expressed interleukin-21, Tfh cell markers, and Bcl6 and rescued GC formation in SAP-deficient hosts better than other T helper (Th) cells. SAP-deficient Tfh-like cells appeared virtually indistinguishable from wild-type, yet failed to support GCs in vivo. Interestingly, both Tfh-like and in vivo-derived Tfh cells could produce effector cytokines in response to polarizing conditions. Moreover, Th1, Th2, and Th17 cells could be reprogrammed to obtain Tfh cell characteristics. ChIP-Seq analyses revealed positive epigenetic markings on Tbx21, Gata3, and Rorc in Tfh-like and ex vivo Tfh cells and on Bcl6 in non-Tfh cells, supporting the concept of plasticity between Tfh and other Th cell populations.	[Lu, Kristina T.; Cannons, Jennifer L.; Handon, Robin; Elkahloun, Abdel G.; Anderson, Stacie M.; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Kanno, Yuka; Bible, Paul; Wei, Lai; Sun, Hongwei; O'Shea, John J.] NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	pams@mail.nih.gov	Kanno, Yuka/B-5802-2013; Wei, Lai/D-1088-2014	Kanno, Yuka/0000-0001-5668-9319; 	NHGRI; NIAMS (NIH); NIGMS (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200350, ZICHG200365, ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Gomez-Rodriguez, J. Zhu, and K. Zhao for helpful advice and J. Reilley and A. Venegas for technical assistance. This work was funded in part by the intramural research programs of the NHGRI and NIAMS (NIH). K.T.L. was supported by a PRAT Fellowship from the NIGMS (NIH).	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kamperschroer C, 2008, J IMMUNOL, V181, P3994, DOI 10.4049/jimmunol.181.6.3994; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; WEBB SR, 1985, EUR J IMMUNOL, V15, P92, DOI 10.1002/eji.1830150118; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	56	186	195	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					622	632		10.1016/j.immuni.2011.07.015	http://dx.doi.org/10.1016/j.immuni.2011.07.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22018472	Green Accepted, Bronze			2022-12-18	WOS:000296657700020
J	Gutcher, I; Donkor, MK; Ma, QA; Rudensky, AY; Flavell, RA; Li, MO				Gutcher, Ilona; Donkor, Moses K.; Ma, Qian; Rudensky, Alexander Y.; Flavell, Richard A.; Li, Ming O.			Autocrine Transforming Growth Factor-beta 1 Promotes In Vivo Th17 Cell Differentiation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TGF-BETA; MULTIPLE-SCLEROSIS; INFLAMMATION; LINEAGE; MICE; EXPRESSION; DISEASE	TGF-beta 1 is a regulatory cytokine that has an important role in controlling T cell differentiation. T cell-produced TGF-beta 1 acts on T cells to promote Th17 cell differentiation and the development of experimental autoimmune encephalomyelitis (EAE). However, the exact TGF-beta 1-producing T cell subset required for Th17 cell generation and its cellular mechanism of action remain unknown. Here we showed that deletion of the Tgfb1 gene from activated T cells and Treg cells, but not Treg cells alone, abrogated Th17 cell differentiation, resulting in almost complete protection from EAE. Furthermore, differentiation of T cells both in vitro and in vivo demonstrated that TGF-beta 1 was highly expressed by Th17 cells and acted in a predominantly autocrine manner to maintain Th17 cells in vivo. These findings reveal an essential role for activated T cell-produced TGF-beta 1 in promoting the differentiation of Th17 cells and controlling inflammatory diseases.	[Gutcher, Ilona; Donkor, Moses K.; Ma, Qian; Rudensky, Alexander Y.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rudensky, Alexander Y.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Memorial Sloan Kettering Cancer Center; Yale University; Howard Hughes Medical Institute; Yale University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org		li, ming/0000-0002-1383-0535	Rita Allen Foundation; National Institute of Arthritis, Musculoskeletal, and Skin Diseases [KO1 AR053595, RO1 AR060723]; Arthritis Foundation; National Research Fund, Luxembourg; European Commission; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723, K01AR053595] Funding Source: NIH RePORTER	Rita Allen Foundation; National Institute of Arthritis, Musculoskeletal, and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; National Research Fund, Luxembourg(Luxembourg National Research Fund); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Evangelisti, C. Hughes, and J. Stein for their help in creating the TGF-beta 1-GFP mutant mice and N. Killeen for providing the Tnfrsf4-cre mouse strain. The projects described were supported by grants from the Rita Allen Foundation (M.O.L.), the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (KO1 AR053595 and RO1 AR060723 to M.O.L.), the Arthritis Foundation (M.O.L.), the National Research Fund, Luxembourg, and the Marie Curie actions of the European Commission (FP7-COFUND to I.G.).	Acharya M, 2010, J CLIN INVEST, V120, P4445, DOI 10.1172/JCI43796; BENDING D, J CLIN INVE IN PRESS; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Veldhoen M, 2009, CURR OPIN IMMUNOL, V21, P606, DOI 10.1016/j.coi.2009.07.009; Vokaer B, 2010, J IMMUNOL, V185, P3417, DOI 10.4049/jimmunol.0903961; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	49	186	195	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					396	408		10.1016/j.immuni.2011.03.005	http://dx.doi.org/10.1016/j.immuni.2011.03.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435587	Green Accepted, Bronze			2022-12-18	WOS:000289014500015
J	Hughes, PD; Belz, GT; Fortner, KA; Budd, RC; Strasser, A; Bouillet, P				Hughes, Peter D.; Belz, Gabrielle T.; Fortner, Karen A.; Budd, Ralph C.; Strasser, Andreas; Bouillet, Philippe			Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity	IMMUNITY			English	Article							FAMILY-MEMBER BIM; T-CELL RESPONSES; BH3-ONLY PROTEINS; BCL-2; DEATH; DELETION; PUMA; MICE; SELF; EXPRESSION	Apoptotic death of T lymphocytes is critical for shutdown of immune responses and hemopoietic cell homeostasis. Both death receptor (Fas) activation and mitochondrial apoptosis triggered by the BH3-only protein Bim have been implicated in the killing of antigen-stimulated T cells. We examined mice lacking the gene encoding Bim (Bcl2l11) and with the inactivating lpr mutation in the gene encoding Fas (Fas), designated Bcl2l11(-/-)Fas(lpr/lpr) mice. Shutdown of an acute T cell response to herpes simplex virus involved only Bim with no contribution by Fas, whereas both pathways synergized in killing antigen-stimulated T cells in chronic infection with murine gamma-herpesvirus. Bcl2l11(-/-)Fas(lpr/lpr) mice developed remarkably enhanced and accelerated fatal lymphadenopathy and autoimmunity compared to mice lacking only one of these apoptosis inducers. These results identify critical overlapping roles for Fas and Bim in T cell death in immune response shutdown and prevention of immunopathology and thereby resolve a long-standing controversy.	[Hughes, Peter D.; Belz, Gabrielle T.; Strasser, Andreas; Bouillet, Philippe] Walter & Eliza Hall Inst Med Res, Mol Genet Canc, Melbourne, Vic 3050, Australia; [Hughes, Peter D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Fortner, Karen A.; Budd, Ralph C.] Univ Vermont, Coll Med, Program Immunol, Burlington, MA USA	Walter & Eliza Hall Institute; University of Melbourne; University of Vermont	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au; bouillet@wehi.edu.au	Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013; Belz, Gabrielle T/C-9350-2013	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058; Belz, Gabrielle T/0000-0002-9660-9587	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA 43540, R01 CA043540, R01 CA043540-22, CA 80188, R01 CA080188] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust)		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rajcani J., 2005, Acta Microbiologica et Immunologica Hungarica, V52, P41, DOI 10.1556/AMicr.52.2005.1.2; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Vabulas R, 1996, INFECT IMMUN, V64, P4567, DOI 10.1128/IAI.64.11.4567-4573.1996; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wallach D, 1998, CURR OPIN IMMUNOL, V10, P279, DOI 10.1016/S0952-7915(98)80166-0; Wang XD, 2001, GENE DEV, V15, P2922; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0	42	186	191	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					197	205		10.1016/j.immuni.2007.12.017	http://dx.doi.org/10.1016/j.immuni.2007.12.017			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275830	Green Published, hybrid			2022-12-18	WOS:000253275000010
J	Mckee, AS; Munks, MW; Marrack, P				Mckee, Amy S.; Munks, Michael W.; Marrack, Philippa			How do adjuvants work? Important considerations for new generation adjuvants	IMMUNITY			English	Article							ANTIBODY-PRODUCTION; IMMUNE-RESPONSES; T-CELLS; ALUM; ANTIGEN; VACCINE; INDUCE; DIFFERENTIATION; COMPLEMENT; ACTIVATE	In this Commentary, McKee et al. highlight the properties of extrinsic vaccine adjuvants that must be considered to achieve the most protective immune response, as occurs naturally with many intrinsic pathogen-derived adjuvants.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol,HHMI, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Dept Immunol,HHMI, Denver, CO 80262 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687				Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Coley WB, 1893, POSTGRADUATE, V8, P278; Glenny A, 1926, J PATHOL BACTERIOL, V29, P38; Holt L.B., 1950, DEV DIPHTHERIA PROPH; Iyer S, 2003, VACCINE, V21, P1219, DOI 10.1016/S0264-410X(02)00556-X; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Ott G, 1995, Pharm Biotechnol, V6, P277; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Pollock KGJ, 2003, IMMUNOLOGY, V108, P137, DOI 10.1046/j.1365-2567.2003.01581.x; Ramon G., 1925, B SOC CENTR MED VET, V101, P227; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Stetson DB, 2004, ADV IMMUNOL, V83, P163; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Wong CP, 1999, J IMMUNOL, V162, P2251; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048	25	186	208	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					687	690		10.1016/j.immuni.2007.11.003	http://dx.doi.org/10.1016/j.immuni.2007.11.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031690	Bronze			2022-12-18	WOS:000251269000001
J	Salazar-Gonzalez, RM; Niess, JH; Zammit, DJ; Ravindran, R; Srinivasan, A; Maxwell, JR; Stoklasek, T; Yadav, R; Williams, IR; Gu, XB; McCormick, BA; Pazos, MA; Vella, AT; Lefrancois, L; Reinecker, HC; McSorley, SJ				Salazar-Gonzalez, Rosa Maria; Niess, Jan H.; Zammit, David J.; Ravindran, Rajesh; Srinivasan, Aparna; Maxwell, Joseph R.; Stoklasek, Thomas; Yadav, Rajwardhan; Williams, Ifor R.; Gu, Xiubin; McCormick, Beth A.; Pazos, Michael A.; Vella, Anthony T.; Lefrancois, Leo; Reinecker, Hans-Christian; McSorley, Stephen J.			CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches	IMMUNITY			English	Article							EPITHELIAL-CELLS; SALMONELLA; ANTIGEN; HOMEOSTASIS; TOLERANCE; MIGRATION; TRACKING; IMMUNITY; SUBSETS; DOME	T cell activation by dendritic cells (DCs) is critical to the initiation of adaptive immune responses and protection against pathogens. Here, we demonstrate that a specialized DC subset in Peyer's patches (PPs) mediates the rapid activation of pathogen specific T cells. This DC subset is characterized by the expression of the chemokine receptor CCR6 and is found only in PPs. CCR6(+) DCs were recruited into the dome regions of PPs upon invasion of the follicle associated epithelium (FAE) by an enteric pathogen and were responsible for the rapid local activation of pathogen-specific T cells. CCR6-deficient DCs were unable to respond to bacterial invasion of PPs and failed to initiate T cell activation, resulting in reduced defense against oral infection. Thus, CCR6-dependent regulation of DCs is responsible for localized T cell dependent defense against entero-invasive pathogens.	Univ Minnesota, Sch Med, Mcguire Translat Facil, GI Div,Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Mcguire Translat Facil, Ctr Infect Dis & Microbiol Translat Res Facil, Minneapolis, MN 55455 USA; Univ Connecticut, Ctr Hlth, Div Immunol, Dept Med, Farmington, CT 06030 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Connecticut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Emory University	McSorley, SJ (corresponding author), Univ Minnesota, Sch Med, Mcguire Translat Facil, GI Div,Dept Med, TRF DC 2873,2001 6th St SE, Minneapolis, MN 55455 USA.	mcsor002@umn.edu	Niess, Jan/E-8361-2017; Williams, Ifor R/D-3648-2011	Niess, Jan/0000-0001-6902-5650; Williams, Ifor R/0000-0002-8810-2911; McSorley, Stephen/0000-0002-6363-3222	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055743, P01AI056172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, P30DK043351, R01DK064730, R01DK068181] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI056172-05, AI055743, AI142858, AI056172, P01 AI056172, R01 AI055743] Funding Source: Medline; NIDDK NIH HHS [DK068181, DK33506, DK64730, P01 DK033506, R01 DK068181, R01 DK064730, P30 DK043351, DK43351] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Fleeton M, 2004, ANN NY ACAD SCI, V1029, P60, DOI 10.1196/annals.1309.008; Fleeton MN, 2004, J EXP MED, V200, P235, DOI 10.1084/jem.20041132; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Iwasaki A, 1999, AM J PHYSIOL-GASTR L, V276, pG1074, DOI 10.1152/ajpgi.1999.276.5.G1074; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kelsall BL, 1996, J EXP MED, V183, P237, DOI 10.1084/jem.183.1.237; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Kunkel D, 2003, EUR J IMMUNOL, V33, P1292, DOI 10.1002/eji.200323383; LIU LM, 1993, J EXP MED, V177, P1299, DOI 10.1084/jem.177.5.1299; Lugering A, 2005, AM J PATHOL, V166, P1647, DOI 10.1016/S0002-9440(10)62475-3; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; McSorley SJ, 1997, INFECT IMMUN, V65, P171, DOI 10.1128/IAI.65.1.171-178.1997; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Niess JH, 2005, CURR OPIN GASTROEN, V21, P687, DOI 10.1097/01.mog.0000181710.96904.58; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Pabst O, 2004, CURR OPIN IMMUNOL, V16, P394, DOI 10.1016/j.coi.2004.05.014; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, VACCINE, V23, P1793, DOI 10.1016/j.vaccine.2004.11.007; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Srinivasan A, 2004, J IMMUNOL, V173, P4091, DOI 10.4049/jimmunol.173.6.4091; Srinivasan A, 2004, J IMMUNOL, V172, P6884, DOI 10.4049/jimmunol.172.11.6884; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Vazquez-Torres A, 2000, CURR OPIN MICROBIOL, V3, P54, DOI 10.1016/S1369-5274(99)00051-X; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	36	186	194	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					623	632		10.1016/j.immuni.2006.02.015	http://dx.doi.org/10.1016/j.immuni.2006.02.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713979	Green Accepted, Bronze			2022-12-18	WOS:000237970100018
J	Song, JX; So, T; Cheng, M; Tang, XH; Croft, M				Song, JX; So, T; Cheng, M; Tang, XH; Croft, M			Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion	IMMUNITY			English	Article							PROTEIN-KINASE-B; IN-VIVO; ANTIGENIC-STIMULATION; CD28 COSTIMULATION; APOPTOSIS PROTEIN; BCL-2 EXPRESSION; ACTIVATION; DEATH; PHOSPHORYLATION; EFFECTOR	Sustained signaling from the T cell receptor (TCR) and costimulatory molecules is thought necessary for generating high numbers of effector T cells. Here, we show that Survivin is controlled in peripheral T cells by OX40 cosignaling via sustained PI3k and PKB activation. Survivin is induced by OX40 independent of mitotic progression in late G1, and blocking Survivin suppresses S-phase transition and division of T cells and leads to apoptosis. Moreover, Survivin expression alone is sufficient to restore proliferation and to antagonize apoptosis in costimulation-deficient T cells and can rescue T cell expansion in vivo. Survivin allows effector T cells to accumulate in large numbers, but Bcl-2 family proteins are required for T cell survival after the phase of active division. Thus, sustained Survivin expression from costimulatory signaling maintains T cell division over time and regulates the extent of clonal expansion.	La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA; Third Mil Med Univ, Inst Immunol PLA, Chongqing 400038, Peoples R China	La Jolla Institute for Immunology; Army Medical University	Croft, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA.	mick@liai.org	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049453] Funding Source: NIH RePORTER; NCI NIH HHS [CA 91827] Funding Source: Medline; NIAID NIH HHS [AI49453] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Altieri DC, 2003, ADV CANCER RES, V88, P31, DOI 10.1016/S0065-230X(03)88303-3; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dahl AM, 2000, J EXP MED, V191, P2031, DOI 10.1084/jem.191.12.2031; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; Harrison Stephen A, 2002, Semin Gastrointest Dis, V13, P3; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Radvanyi LG, 1996, J IMMUNOL, V156, P1788; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shon HK, 2003, MOL CELLS, V16, P147; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tamm I, 1998, CANCER RES, V58, P5315; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wall NR, 2003, CANCER RES, V63, P230; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588	51	186	194	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					621	631		10.1016/j.immuni.2005.03.012	http://dx.doi.org/10.1016/j.immuni.2005.03.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894279	Bronze			2022-12-18	WOS:000229447200011
J	Hitoshi, Y; Lorens, J; Kitada, SI; Fisher, J; LaBarge, M; Ring, HZ; Francke, U; Reed, JC; Kinoshita, S; Nolan, GP				Hitoshi, Y; Lorens, J; Kitada, SI; Fisher, J; LaBarge, M; Ring, HZ; Francke, U; Reed, JC; Kinoshita, S; Nolan, GP			Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells	IMMUNITY			English	Article							TUMOR NECROSIS FACTOR; DEATH DOMAIN; LEUKEMIA; PROTEIN; INVOLVEMENT; ANTIGEN; RECEPTOR; MAPS; CYTOTOXICITY; INTERACTS	Fas is a surface receptor that can transmit signals for apoptosis. Using retroviral cDNA library-based functional cloning we identified a gene, toso, that blocks Pas-mediated apoptosis. Toso expression was confined to lymphoid cells and was enhanced after cell-specific activation processes in T cells. Toso appeared limited to inhibition of apoptosis mediated by members of the TNF receptor family and was capable of inhibiting T cell self-killing induced by TCR activation processes that up-regulate Pas ligand. We mapped the effect of Toso to inhibition of caspase-8 processing, the most upstream caspase activity in Fas-mediated signaling, potentially through activation of cFLIP. Toso therefore serves as a novel regulator of Fas-mediated apoptosis and may act as a regulator of cell fate in T cells and other hematopoietic lineages.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol & Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Tokyo, Inst Med Sci, Tokyo 108, Japan; Rigel Inc, Sunnyvale, CA 94086 USA; Burnham Inst, La Jolla, CA 92037 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Tokyo; Sanford Burnham Prebys Medical Discovery Institute	Nolan, GP (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.	gnolan@cmgm.stanford.edu	Lorens, James/B-9737-2017; LaBarge, Mark A/E-2621-2013; Nolan, Garry/AAE-7903-2019	Lorens, James/0000-0002-6782-3349; Nolan, Garry/0000-0002-8862-9043; LaBarge, Mark/0000-0003-2405-4719	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035304, P01AI039646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008404] Funding Source: NIH RePORTER; NIAID NIH HHS [AI39646, AI35304] Funding Source: Medline; NIGMS NIH HHS [T32 GM08404] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARASE H, 1995, J EXP MED, V181, P1235, DOI 10.1084/jem.181.3.1235; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; CLOT J, 1975, IMMUNOLOGY, V29, P445; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FRANCKE U, 1996, COLD SPRING HARB SYM, V2, P855; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; Geley S, 1997, FEBS LETT, V400, P15, DOI 10.1016/S0014-5793(96)01284-7; GHOSE T, 1990, CANCER RES, V50, P3737; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; HOFMANN K, 1992, COMPUT APPL BIOSCI, V8, P331; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; JINNAI I, 1990, AM J HEMATOL, V35, P118, DOI 10.1002/ajh.2830350211; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; MACGAHON AJ, 1995, METHOD CELL BIOL, P172; Mertens F, 1997, CANCER RES, V57, P2765; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; MONTEL AH, 1995, CELL IMMUNOL, V166, P236, DOI 10.1006/cimm.1995.9974; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T; OYAIZU N, 1995, BIOCHEM BIOPH RES CO, V213, P994, DOI 10.1006/bbrc.1995.2227; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RICHARDSON BC, 1994, EUR J IMMUNOL, V24, P2640, DOI 10.1002/eji.1830241111; SCHMID E, 1984, CANCER GENET CYTOGEN, V11, P121, DOI 10.1016/0165-4608(84)90105-5; SHAH NK, 1992, CANCER GENET CYTOGEN, V61, P183, DOI 10.1016/0165-4608(92)90084-L; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; TAGAWA M, 1986, P NATL ACAD SCI USA, V83, P3422, DOI 10.1073/pnas.83.10.3422; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; WAGHRAY M, 1986, CANCER GENET CYTOGEN, V23, P225, DOI 10.1016/0165-4608(86)90182-2; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YIP MY, 1991, CANCER GENET CYTOGEN, V51, P235, DOI 10.1016/0165-4608(91)90136-I; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	51	186	200	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1998	8	4					461	471		10.1016/S1074-7613(00)80551-8	http://dx.doi.org/10.1016/S1074-7613(00)80551-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586636	Bronze			2022-12-18	WOS:000073348000008
J	Sonnenberg, GF; Artis, D				Sonnenberg, Gregory F.; Artis, David			Innate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease	IMMUNITY			English	Review							NATURAL-KILLER-CELLS; ROR-GAMMA-T; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR GATA3; TISSUE-INDUCER CELLS; BACTERIAL TRANSLOCATION; NK CELLS; ATHEROSCLEROTIC LESIONS; COMMENSAL MICROFLORA; DENDRITIC CELLS	The mammalian intestine harbors trillions of beneficial commensal bacteria that are essential for the development of the immune system and for maintenance of physiologic processes in multiple organs. However, numerous chronic infectious, inflammatory, and metabolic diseases in humans have been associated with alterations in the composition or localization of commensal bacteria that result in dysregulated host-commensal bacteria relationships. The mammalian immune system plays an essential role in regulating the acquisition, composition, and localization of commensal bacteria in the intestine. Emerging research has implicated innate lymphoid cells (ILCs) as a critical immune cell population that orchestrates some of these host-commensal bacteria relationships that can impact immunity, inflammation, and tissue homeo-stasis in the intestine. This review will discuss reciprocal interactions between intestinal commensal bacteria and ILCs in the context of health and disease.	[Sonnenberg, Gregory F.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Sonnenberg, GF (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	gfield@mail.med.upenn.edu; dartis@mail.med.upenn.edu		Artis, David/0000-0002-1753-4100	National Institutes of Health [AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI097333, T32-AI055428, DP5OD012116]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097333, R01AI061570, R01AI102942, U01AI095608, R01AI074878, R21AI087990, T32AI055428, R01AI095466, R21AI083480] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Artis laboratory for discussions and critical reading of the manuscript. This work is supported by the National Institutes of Health (AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, and AI097333 to D.A.; T32-AI055428 and DP5OD012116 to G.F.S.) and the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (D.A.).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Chin KF, 2007, DIS COLON RECTUM, V50, P323, DOI 10.1007/s10350-006-0827-4; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Clark E, 2005, GASTROENTEROLOGY, V128, P1258, DOI 10.1053/j.gastro.2005.01.046; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Ding CG, 2008, CURR OPIN INVEST DR, V9, P515; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klatt N.R., 2012, MUCOSAL IMMUNOL; Koizumi S, 2008, IMMUNOL LETT, V120, P14, DOI 10.1016/j.imlet.2008.06.003; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; LESCUT D, 1990, GASTROEN CLIN BIOL, V14, P811; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manta C., 2012, MUCOSAL IMMUNOL, V3; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MULLIN JM, 1990, CANCER RES, V50, P2172; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; PERDEW GH, 1991, NUTR CANCER, V16, P209, DOI 10.1080/01635589109514159; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Renko J, 2008, ATHEROSCLEROSIS, V201, P192, DOI 10.1016/j.atherosclerosis.2008.01.006; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Veldhoen M, 2010, SCIENCE, V330, P594, DOI 10.1126/science.1198298; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu H., 2012, MUCOSAL IMMUNOL; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu QS, 2006, J IMMUNOL, V176, P6180, DOI 10.4049/jimmunol.176.10.6180; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720	115	185	192	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 19	2012	37	4					601	610		10.1016/j.immuni.2012.10.003	http://dx.doi.org/10.1016/j.immuni.2012.10.003			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084357	Green Accepted, Bronze			2022-12-18	WOS:000310185400006
J	Haks, MC; Lefebvre, JM; Lauritsen, JPH; Carleton, M; Rhodes, M; Miyazaki, T; Kappes, DJ; Wiest, DL				Haks, MC; Lefebvre, JM; Lauritsen, JPH; Carleton, M; Rhodes, M; Miyazaki, T; Kappes, DJ; Wiest, DL			Attenuation of gamma delta TCR signaling efficiently diverts thymocytes to the alpha beta lineage	IMMUNITY			English	Article							T-CELL-RECEPTOR; BETA-2-MICROGLOBULIN DEFICIENT MICE; LYMPHOCYTE DEVELOPMENT; PRE-TCR; TRANSCRIPTION FACTORS; POSITIVE SELECTION; CD4(+)CD8(+) STAGE; THYMIC DEVELOPMENT; BETA/GAMMA-DELTA; TRANSGENIC MICE	The role of the T cell antigen receptor complex (TCR) in alpha beta-gamma delta lineage commitment remains controversial, in particular whether different TCR isoforms intrinsically favor adoption of a certain lineage. Here, we demonstrate that impairing the signaling capacity of a gamma delta TCR complex enables it to efficiently direct thymocytes to the up lineage. In the presence of a ligand, a transgenic gamma delta TCR mediates almost exclusive adoption of the gamma delta lineage, while in the absence of ligand, the same gamma delta TCR promotes alpha beta lineage development with efficiency comparable to the pre-TCR. Importantly, attenuating gamma delta TCR signaling through Lck deficiency causes reduced ERK1/2 activation and Egr expression and diverts thymocytes to the up lineage even in the presence of ligand. Conversely, ectopic Egr overexpression favors gamma delta T cell development. Our data support a model whereby gamma delta versus alpha beta lineage commitment is controlled by TCR signal strength, which depends critically on the ERK MAPK-Egr pathway.	Fox Chase Canc Ctr, Div Basic Sci, Immunobiol Working Grp, Philadelphia, PA 19111 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	Fox Chase Cancer Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wiest, DL (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, Immunobiol Working Grp, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dl_wiest@fccc.edu		Wiest, David/0000-0002-0792-3188; Miyazaki, Toru/0000-0003-3842-4362	NATIONAL CANCER INSTITUTE [R01CA087047, R29CA073656, R01CA100144] Funding Source: NIH RePORTER; NCI NIH HHS [CA 087047, CA 100144, CA 73656, P01 CA 06927] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Carleton M, 1999, J IMMUNOL, V163, P2576; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DILLON SR, 1995, INT IMMUNOL, V7, P1363, DOI 10.1093/intimm/7.8.1363; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Erman B, 2002, NAT IMMUNOL, V3, P564, DOI 10.1038/ni800; Fehling H J, 1999, Adv Immunol, V71, P1; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Garcia-Peydro M, 2003, BLOOD, V102, P2444, DOI 10.1182/blood-2002-10-3261; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; Hayday AC, 1999, SEMIN IMMUNOL, V11, P239, DOI 10.1006/smim.1999.0180; Hayes SM, 2003, IMMUNOL REV, V191, P28, DOI 10.1034/j.1600-065X.2003.00011.x; Hernandez-Hoyos G, 2003, SEMIN CELL DEV BIOL, V14, P121, DOI 10.1016/S1084-9521(02)00180-5; ISHIDA I, 1990, P NATL ACAD SCI USA, V87, P3067, DOI 10.1073/pnas.87.8.3067; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345; KERSH GJ, 1995, J IMMUNOL, V154, P5706; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Leduc I, 2000, J IMMUNOL, V165, P1364, DOI 10.4049/jimmunol.165.3.1364; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; MacDonald HR, 1998, IMMUNOL REV, V165, P87, DOI 10.1111/j.1600-065X.1998.tb01232.x; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; PEREIRA P, 1992, EMBO J, V11, P25, DOI 10.1002/j.1460-2075.1992.tb05023.x; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Robey E, 1998, CURR OPIN IMMUNOL, V10, P181, DOI 10.1016/S0952-7915(98)80247-1; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Shin SY, 2001, J BIOL CHEM, V276, P7797, DOI 10.1074/jbc.M009465200; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Steele CR, 2000, CURR BIOL, V10, pR282, DOI 10.1016/S0960-9822(00)00408-5; TAKAYAMA K, 1994, J BIOL CHEM, V269, P2241; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WELLS FB, 1991, SCIENCE, V253, P903, DOI 10.1126/science.1831565; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	61	185	186	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2005	22	5					595	606		10.1016/j.immuni.2005.04.003	http://dx.doi.org/10.1016/j.immuni.2005.04.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894277	Bronze			2022-12-18	WOS:000229447200009
J	Guo, BC; Kato, RM; Garcia-Lloret, M; Wahl, MI; Rawlings, DJ				Guo, BC; Kato, RM; Garcia-Lloret, M; Wahl, MI; Rawlings, DJ			Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex	IMMUNITY			English	Article							TYROSINE KINASE; ANTIGEN RECEPTOR; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3-KINASE; ALLELIC EXCLUSION; MEMBRANE DOMAINS; LIGHT-CHAIN; T-CELLS; IG-BETA; ACTIVATION	Pre-B cell receptor (pre-BCR) expression is critical for B lineage development. The signaling events initiated by the pre-BCR, however, remain poorly defined. We demonstrate that lipid rafts are the major functional compartment for human pre-B cell activation. A fraction of pre-BCR was constitutively raft associated, and receptor engagement enhanced this association. These events promoted Lyn activation and Ig beta phosphorylation and led to the generation of a raft-associated signaling module composed of tyrosine phosphorylated Lyn, Syk, BLNK, PI3K, Btk, VAV, and PLC gamma P. Formation of this module was essential for pre-BCR calcium signaling. Together, these observations directly link the previously identified genetic requirement for the components of this module in B lineage development with their functional role(s) in human pre-BCR signaling.	Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rawlings, DJ (corresponding author), Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA.				NCI NIH HHS [CA81140] Funding Source: Medline; NICHD NIH HHS [HHD37091] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA081140] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOSSY D, 1993, INT IMMUNOL, V5, P467, DOI 10.1093/intimm/5.5.467; Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T; Caplan S, 2000, IMMUNOL TODAY, V21, P223, DOI 10.1016/S0167-5699(00)01604-2; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Conley ME, 1998, CURR OPIN IMMUNOL, V10, P399, DOI 10.1016/S0952-7915(98)80112-X; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Fluckiger AC, 1998, BLOOD, V92, P4509; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Krop I, 1996, J IMMUNOL, V157, P48; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Kuwahara K, 1996, INT IMMUNOL, V8, P1273, DOI 10.1093/intimm/8.8.1273; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; MATSUO T, 1993, J IMMUNOL, V150, P3766; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Nakamura T, 1996, IMMUNOLOGY, V88, P593, DOI 10.1046/j.1365-2567.1996.d01-681.x; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; PAPAVASILIOU F, 1995, J EXP MED, V182, P1389, DOI 10.1084/jem.182.5.1389; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; RAWLINGS DJ, 1995, P NATL ACAD SCI USA, V92, P1570, DOI 10.1073/pnas.92.5.1570; Shan XC, 1999, J BIOL CHEM, V274, P29323, DOI 10.1074/jbc.274.41.29323; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003	48	185	189	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					243	253		10.1016/S1074-7613(00)00024-8	http://dx.doi.org/10.1016/S1074-7613(00)00024-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981967	Bronze			2022-12-18	WOS:000089132100009
J	Degano, M; Garcia, KC; Apostolopoulos, V; Rudolph, MG; Teyton, L; Wilson, IA				Degano, M; Garcia, KC; Apostolopoulos, V; Rudolph, MG; Teyton, L; Wilson, IA			A functional hot spot for antigen recognition in a superagonist TCR/MHC complex	IMMUNITY			English	Article							T-CELL RECEPTOR; PEPTIDE-MHC COMPLEXES; MYELIN BASIC-PROTEIN; MOLECULAR MIMICRY; STRUCTURAL BASIS; SPECIFICITY; HORMONE; CLONES; SYSTEM; COMPLEMENTARITY	A longstanding question in T cell receptor signaling is how structurally similar ligands, with similar affinities, can have substantially different biological activity. The crystal structure of the 2C TCR complex of H-2K(b) with superagonist peptide SIYR at 2.8 Angstrom elucidates a structural basis for TCR discrimination of altered peptide ligands. The difference in antigen potency is modulated by two cavities in the TCR combining site, formed mainly by CDRs 3 alpha, 3 beta, and 1 beta, that complement centrally located peptide residues. This "functional hot spot" allows the TCR to finely discriminate amongst energetically similar interactions within different ligands for those in which the peptide appropriately stabilizes the TCR/pMHC complex and provides a new structural perspective for understanding differential signaling resulting from T cell cross-reactivity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu	Apostolopoulos, Vasso/Q-4525-2019; Degano, Massimo/K-4669-2018	Degano, Massimo/0000-0002-0787-1883; Apostolopoulos, Vasso/0000-0001-6788-2771; Rudolph, Markus/0000-0003-0447-1101	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI142267, R01AI042267, R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA-58896] Funding Source: Medline; NIAID NIH HHS [AI-42267, AI-42266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ausubel LJ, 1996, P NATL ACAD SCI USA, V93, P15317, DOI 10.1073/pnas.93.26.15317; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Delaney JR, 1998, P NATL ACAD SCI USA, V95, P5235, DOI 10.1073/pnas.95.9.5235; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GARCIA KC, 1997, SCIENCE, V285, P221; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JEFFREY PD, 1995, J MOL BIOL, V248, P344, DOI 10.1016/S0022-2836(95)80055-7; JEFFREY PD, 1993, P NATL ACAD SCI USA, V90, P10310, DOI 10.1073/pnas.90.21.10310; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASTOR MI, 1995, IMMUNOL TODAY, V16, P159, DOI 10.1016/0167-5699(95)80134-0; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; Udaka K, 1996, J IMMUNOL, V157, P670; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wilson IA, 1999, CURR OPIN STRUC BIOL, V9, P696, DOI 10.1016/S0959-440X(99)00032-9; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	61	185	187	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2000	12	3					251	261		10.1016/S1074-7613(00)80178-8	http://dx.doi.org/10.1016/S1074-7613(00)80178-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755612	Bronze			2022-12-18	WOS:000086292100003
J	Ikemizu, S; Gilbert, RJC; Fennelly, JA; Collins, AV; Harlos, K; Jones, EY; Stuart, DI; Davis, SJ				Ikemizu, S; Gilbert, RJC; Fennelly, JA; Collins, AV; Harlos, K; Jones, EY; Stuart, DI; Davis, SJ			Structure and dimerization of a soluble form of B7-1	IMMUNITY			English	Article							PROTEIN-PROTEIN RECOGNITION; CTLA-4 COUNTER-RECEPTOR; ADHESION MOLECULE CD2; T-CELL ACTIVATION; CRYSTAL-STRUCTURE; LOW-AFFINITY; IMMUNOGLOBULIN SUPERFAMILY; ANTITUMOR IMMUNITY; LYMPHOCYTES-T; COSTIMULATION	B7-1 (CD80) and B7-2 (CD86) are glycoproteins expressed on antigen-presenting cells. The binding of these molecules to the T cell homodimers CD28 and CTLA-4 (CD152) generates costimulatory and inhibitory signals in T cells, respectively. The crystal structure of the extracellular region of B7-1 (sB7-1), solved to 3 Angstrom resolution, consists of a novel combination of two Ig-like domains, one characteristic of adhesion molecules and the other previously seen only in antigen receptors. In the crystal lattice, sB7-1 unexpectedly forms parallel, 2-fold rotationally symmetric homodimers. Analytical ultracentrifugation reveals that sB7-1 also dimerizes in solution. The structural data suggest a mechanism whereby the avidity-enhanced binding of B7-1 and CTLA-4 homodimers, along with the relatively high affinity of these interactions, favors the formation of very stable inhibitory signaling complexes.	Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, New Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QT, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Stuart, DI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	stuart@strubi.ox.ac.uk; sdavis@molbiol.ox.ac.uk	Jones, Yvonne/J-2293-2016; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Gilbert, Robert/0000-0001-9336-5604; Stuart, David/0000-0002-3426-4210				ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJORATH J, 1994, PROTEIN SCI, V3, P2148, DOI 10.1002/pro.5560031128; Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BUTTERS TD, 1999, PROTEINS, V8, P1707; CANN JR, 1986, METHOD ENZYMOL, V130, P19; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Henry J, 1997, IMMUNOGENETICS, V46, P383, DOI 10.1007/s002510050292; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAUE TM, 1992, TECHNICAL INFORMATIO; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LEE KM, 1999, MOL BASIS T CELL INA, V282, P2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; LINSLEY PS, 1994, PROTEIN SCI, V3, P1341, DOI 10.1002/pro.5560030820; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MARTIN PJ, 1986, J IMMUNOL, V136, P3282; May AP, 1997, PROTEIN SCI, V6, P717; McAdam AJ, 1998, IMMUNOL REV, V165, P231; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Regan MN, 1999, IMMUNOGENETICS, V49, P68, DOI 10.1007/s002510050464; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Slavik JM, 1999, J BIOL CHEM, V274, P3116, DOI 10.1074/jbc.274.5.3116; SPRINGER TA, 1991, NATURE, V353, P704, DOI 10.1038/353704a0; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Tuma R, 1996, J MOL BIOL, V257, P87, DOI 10.1006/jmbi.1996.0149; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEISS A, 1986, J IMMUNOL, V137, P819; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	80	185	214	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2000	12	1					51	60		10.1016/S1074-7613(00)80158-2	http://dx.doi.org/10.1016/S1074-7613(00)80158-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661405	Bronze			2022-12-18	WOS:000085011900006
J	Gutgemann, I; Fahrer, AM; Altman, JD; Davis, MM; Chien, YH				Gutgemann, I; Fahrer, AM; Altman, JD; Davis, MM; Chien, YH			Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen	IMMUNITY			English	Article							IN-VIVO; ESCHERICHIA-COLI; RECEPTOR; OVALBUMIN; ANERGY; IMMUNIZATION; AUTOANTIGENS; MECHANISMS; COMPLEXES; CHAIN	To understand how orally introduced antigen regulates peripheral immune responses, we fed cytochrome c protein to mice transgenic for the beta chain of a cytochrome c-specific TCR and followed the antigen-specific T cell responses with a cyt c/I-E-k tetramer staining reagent. We find that within 6 hr of cytochrome c administration, antigen-specific systemic T cell activation is induced, and spleen cells gain the ability to stimulate cytochrome c-specific T cell responses. Feeding multiple low doses of cytochrome c down-regulates the systemic immune response, which can be correlated with a reduction of antigen-specific T cells and not with immune deviation. These results suggest that systemic distribution of antigen contributes significantly to oral tolerance induction.	Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Chien, YH (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	chien@leland.stanford.edu	Gütgemann, Ines/ABH-6426-2020; Fahrer, Aude M/C-9318-2009	Fahrer, Aude/0000-0001-8556-0223; Davis, Mark/0000-0001-6868-657X				ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Blanas E, 1996, SCIENCE, V274, P1707, DOI 10.1126/science.274.5293.1707; BRUCE MG, 1986, IMMUNOLOGY, V57, P627; CHASE MW, 1946, P SOC EXP BIOL MED, V61, P257; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1997, CELL IMMUNOL, V178, P62, DOI 10.1006/cimm.1997.1119; Chen YH, 1996, P NATL ACAD SCI USA, V93, P388, DOI 10.1073/pnas.93.1.388; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Croft M, 1997, J IMMUNOL, V159, P3257; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; DAVIS MM, 1993, CURR OPIN IMMUNOL, V5, P45, DOI 10.1016/0952-7915(93)90079-8; FAZEKASDESTGROTH B, 1992, MOL MECH IMMUNOLOGIC, P123; HEDRICK SM, 1988, SCIENCE, V239, P1541, DOI 10.1126/science.2832942; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Lanoue A, 1997, J EXP MED, V185, P405, DOI 10.1084/jem.185.3.405; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; Marth T, 1996, J IMMUNOL, V157, P2348; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x; Pearson CI, 1997, J EXP MED, V185, P583, DOI 10.1084/jem.185.4.583; PENG HJ, 1990, CLIN EXP IMMUNOL, V81, P510; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; ROCKEN M, 1992, NATURE, V359, P79, DOI 10.1038/359079a0; ROCKEN M, 1994, J EXP MED, V179, P1885, DOI 10.1084/jem.179.6.1885; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SWARBRICK ET, 1979, GUT, V20, P121, DOI 10.1136/gut.20.2.121; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; VanHouten N, 1996, J IMMUNOL, V157, P1337; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Wells HG, 1911, J INFECT DIS, V9, P147, DOI 10.1093/infdis/9.2.147; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; Whitacre CC, 1996, CLIN IMMUNOL IMMUNOP, V80, pS31, DOI 10.1006/clin.1996.0139; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673	43	185	194	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1998	8	6					667	673		10.1016/S1074-7613(00)80571-3	http://dx.doi.org/10.1016/S1074-7613(00)80571-3			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZW301	9655480	Bronze			2022-12-18	WOS:000074396300002
J	Grubin, CE; Kovats, S; deRoos, P; Rudensky, AY				Grubin, CE; Kovats, S; deRoos, P; Rudensky, AY			Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides	IMMUNITY			English	Article							INVARIANT CHAIN PEPTIDES; ANTIGEN-PROCESSING MUTANT; HLA-DR MOLECULES; TRANSGENIC MICE; MONOCLONAL-ANTIBODY; CLONAL DELETION; LACKING; DM; SPECIFICITY; EXPRESSION	The role of self-peptides in positive selection of CD4(+) T cells has been controversial. We show that some self-peptides are presented by the MHC class II molecule I-A(b) in mice lacking ii or H-2M but not in mice expressing a transgene-encoded peptide fused to I-A(b). In experiments using specific antibodies to block selection, these low-abundance self-peptides were implicated in the positive selection of some CD4(+) T cells in H-2M(-/-) mice. However, all three mutant backgrounds failed to positively select two class II-restricted transgenic T cell receptors. Our findings suggest that minor components of the self-peptide repertoire can contribute to positive selection of a significant number of CD4(+) T cells. In addition, the data suggest that T ce!ll receptor repertoires selected in wild-type mice and in mice displaying limited spectra of self-peptides are distinct.	UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Grubin, CE (corresponding author), UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195, USA.			Kovats, Susan/0000-0001-5479-9952	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206, R29AI034206] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34206, AI08903] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; COSGROVE D, 1992, INT IMMUNOL, V4, P707, DOI 10.1093/intimm/4.6.707; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Farr A, 1996, EUR J IMMUNOL, V26, P3185, DOI 10.1002/eji.1830261252; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LEMEUR M, 1985, NATURE, V316, P38, DOI 10.1038/316038a0; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MONJI T, 1994, J IMMUNOL, V153, P4468; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Nakano N, 1997, SCIENCE, V275, P678, DOI 10.1126/science.275.5300.678; NAUJOKAS MF, 1995, IMMUNITY, V3, P359, DOI 10.1016/1074-7613(95)90120-5; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SYMINGTON FW, 1982, IMMUNOGENETICS, V16, P381, DOI 10.1007/BF00372098; Tourne S, 1997, IMMUNITY, V7, P187, DOI 10.1016/S1074-7613(00)80522-1; TOURNE S, 1995, EUR J IMMUNOL, V25, P1851, DOI 10.1002/eji.1830250709; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; Wong P, 1996, J IMMUNOL, V156, P2133; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83	48	185	184	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1997	7	2					197	208		10.1016/S1074-7613(00)80523-3	http://dx.doi.org/10.1016/S1074-7613(00)80523-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285405	Bronze			2022-12-18	WOS:A1997XT49200004
J	Hudson, WH; Gensheimer, J; Hashimoto, M; Wieland, A; Valanparambil, RM; Li, P; Lin, JX; Konieczny, BT; Im, SJ; Freeman, GJ; Leonard, WJ; Kissick, HT; Ahmed, R				Hudson, William H.; Gensheimer, Julia; Hashimoto, Masao; Wieland, Andreas; Valanparambil, Rajesh M.; Li, Peng; Lin, Jian-Xin; Konieczny, Bogumila T.; Im, Se Jin; Freeman, Gordon J.; Leonard, Warren J.; Kissick, Haydn T.; Ahmed, Rafi			Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1(+) Stem-like CD8(+) T Cells during Chronic Infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; EXPRESSION; GENE; DIFFERENTIATION; SUBSETS; CD101; IDENTIFICATION; PERSISTENCE; EXHAUSTION; COOPERATE	T cell dysfunction is a characteristic feature of chronic viral infection and cancer. Recent studies in chronic lymphocytic choriomeningitis virus (LCMV) infection have defined a PD-1(+) Tcf-1(+) CD8(+) T cell subset capable of self-renewal and differentiation into more terminally differentiated cells that downregulate Tcf-1 and express additional inhibitory molecules such as Tim3. Here, we demonstrated that expression of the glycoprotein CD101 divides this terminally differentiated population into two subsets. Stem-like Tcf-1(+) CD8(+) T cells initially differentiated into a transitory population of CD101 Tim3(+) cells that later converted into CD101(+) Tim3+ cells. Recently generated CD101 Tim3(+) cells proliferated in vivo, contributed to viral control, and were marked by an effector-like transcriptional signature including expression of the chemokine receptor CX3CR1, pro-inflammatory cytokines, and granzyme B. PD-1 pathway blockade increased the numbers of CD101 Tim3(+) CD8(+) T cells, suggesting that these newly generated transitional cells play a critical role in PD-1-based immunotherapy.	[Hudson, William H.; Gensheimer, Julia; Hashimoto, Masao; Wieland, Andreas; Valanparambil, Rajesh M.; Konieczny, Bogumila T.; Im, Se Jin; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30033 USA; [Hudson, William H.; Gensheimer, Julia; Hashimoto, Masao; Wieland, Andreas; Valanparambil, Rajesh M.; Konieczny, Bogumila T.; Im, Se Jin; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30033 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Immunol Ctr, NIH, Bethesda, MD 20892 USA; [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30033 USA; [Freeman, Gordon J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; Harvard University; Dana-Farber Cancer Institute	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30033 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30033 USA.	rahmed@emory.edu	Leonard, Warren/AAA-1397-2022; Hashimoto, Masao/AAC-9225-2020; Leonard, Warren J/ABD-9251-2020; Kissick, Haydn/AAS-6292-2021	Hashimoto, Masao/0000-0002-7120-1390; Kissick, Haydn/0000-0001-7624-5598; Gensheimer, Julia/0000-0001-6579-9579	Cancer Research Institute; National Cancer Institute of the National Institutes of Health (NIH) [K99CA197804]; National Institute of Allergy and Infectious Diseases of the NIH [R01AI030048, P01AI056299]; ORIP/OD [P51OD011132]; NATIONAL CANCER INSTITUTE [K99CA197804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, P01AI056299, U19AI057266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Cancer Research Institute; National Cancer Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ORIP/OD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Alice Kamphorst, Koichi Araki, Timothy Hoang, and Robert Karaffa and Kametha Fife of the Emory University School of Medicine Flow Cytometry Core. W.H.H. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. H.T.K. is supported by grant K99CA197804 from the National Cancer Institute of the National Institutes of Health (NIH). R.A. is supported by grants R01AI030048 and P01AI056299 from the National Institute of Allergy and Infectious Diseases of the NIH. The Yerkes Nonhuman Primate Genomics Core is supported in part by ORIP/OD P51OD011132. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cook CE, 2016, NUCLEIC ACIDS RES, V44, pD20, DOI 10.1093/nar/gkv1352; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Gettinger SN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05032-8; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hosking MP, 2013, J IMMUNOL, V191, P4211, DOI 10.4049/jimmunol.1300920; Hudson WH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07956-7; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jiang H, 2017, DNA CELL BIOL, V36, P321, DOI 10.1089/dna.2016.3571; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Mohammed JP, 2011, J IMMUNOL, V187, P337, DOI 10.4049/jimmunol.1003525; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murter B, 2019, CANCER IMMUNOL RES, V7, P244, DOI 10.1158/2326-6066.CIR-18-0460; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Rainbow DB, 2011, J IMMUNOL, V187, P325, DOI 10.4049/jimmunol.1003523; Rosenblum MD, 2005, J INVEST DERMATOL, V125, P1130, DOI 10.1111/j.0022-202X.2005.23948.x; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schey R, 2016, MUCOSAL IMMUNOL, V9, P1205, DOI 10.1038/mi.2015.139; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Soares LRB, 1998, J IMMUNOL, V161, P209; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ullah U, 2018, CELL REP, V22, P2094, DOI 10.1016/j.celrep.2018.01.070; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Whelan S, 2019, CANCER IMMUNOL RES, V7, P257, DOI 10.1158/2326-6066.CIR-18-0442; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4_9, DOI 10.1007/978-3-319-24277-4]; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yan YY, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97828; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200; Zhu YW, 2016, J EXP MED, V213, P167, DOI 10.1084/jem.20150785	74	184	185	7	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1043	+		10.1016/j.immuni.2019.11.002	http://dx.doi.org/10.1016/j.immuni.2019.11.002			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31810882	Green Accepted, Bronze			2022-12-18	WOS:000503162900011
J	O'Sullivan, TE; Johnson, LR; Kang, HH; Sun, JC				O'Sullivan, Timothy E.; Johnson, Lexus R.; Kang, Helen H.; Sun, Joseph C.			BNIP3-and BNIP3L-Mediated Mitophagy Promotes the Generation of Natural Killer Cell Memory	IMMUNITY			English	Article							CD8(+) T-CELLS; IN-VIVO; HUMAN CYTOMEGALOVIRUS; NK CELLS; FUNCTIONAL-HETEROGENEITY; MITOCHONDRIAL CLEARANCE; LIPID-METABOLISM; AUTOPHAGY; INFECTION; VIRUS	Natural killer (NK) cells are innate lymphocytes that possess traits of adaptive immunity, such as clonal expansion, contraction, and generation of long-lived "memory'' cells, processes poorly understood at the molecular level. Here, we found that as proliferating NK cells accumulated dysfunctional mitochondria during viral infection, a protective mitophagy pathway was induced during the contraction phase to promote their survival in a reactive oxygen species (ROS)-dependent manner. Inhibition of mechanistic target of rapamycin (mTOR) or activation of AMP-activated protein kinase (AMPK) during the contraction-to-memory phase transition of the antiviral response increased autophagic activity and enhanced memory NK cell numbers through an Atg3-dependent mechanism. Furthermore, we demonstrated a temporally regulated role for mitophagy- inducing proteins BCL2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3) and BNIP3-like (BNIP3L) in the generation of robust NK cell memory. Thus, our study reveals the functional importance of mitophagy during the dynamic response of these cytolytic innate lymphocytes.	[O'Sullivan, Timothy E.; Johnson, Lexus R.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Kang, Helen H.; Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	sunj@mskcc.org	O'Sullivan, Timothy/D-3422-2018	O'Sullivan, Timothy/0000-0003-1435-8188	American Cancer Society; Searle Scholars Program; Cancer Research Institute; NIH [AI085034, AI100874]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI085034, R01AI100874] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Searle Scholars Program; Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the J.C.S. lab for technical support and experimental assistance and Sasha Rudensky, Cole Haynes, Michael Overholtzer, Xuejun Jiang, and Aimee Beaulieu for insightful comments and helpful discussions. Gerald Dorn, You-Wen He, Eric Vivier, Liang Deng, and Zhenyu Yu provided mice, reagents, and expertise critical to this study. T.E.O. was supported by a fellowship from the American Cancer Society. J.C.S. was supported by the Searle Scholars Program, the Cancer Research Institute, and NIH grants AI085034 and AI100874.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hendricks DW, 2014, J IMMUNOL, V192, P4492, DOI 10.4049/jimmunol.1303211; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurtulus S, 2010, IMMUNOL REV, V236, P54, DOI 10.1111/j.1600-065X.2010.00920.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Min-Oo G, 2014, J EXP MED, V211, P1289, DOI 10.1084/jem.20132459; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	54	184	194	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					331	342		10.1016/j.immuni.2015.07.012	http://dx.doi.org/10.1016/j.immuni.2015.07.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26253785	Bronze, Green Accepted			2022-12-18	WOS:000360101200015
J	Yang, Q; Monticelli, LA; Saenz, SA; Chi, AWS; Sonnenberg, GF; Tang, JB; De Obaldia, ME; Bailis, W; Bryson, JL; Toscano, K; Huang, J; Haczku, A; Pear, WS; Artis, D; Bhandoola, A				Yang, Qi; Monticelli, Laurel A.; Saenz, Steven A.; Chi, Anthony Wei-Shine; Sonnenberg, Gregory F.; Tang, Jiangbo; De Obaldia, Maria Elena; Bailis, Will; Bryson, Jerrod L.; Toscano, Kristin; Huang, Jian; Haczku, Angela; Pear, Warren S.; Artis, David; Bhandoola, Avinash			T Cell Factor 1 Is Required for Group 2 Innate Lymphoid Cell Generation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR GATA-3; NATURAL HELPER-CELLS; BETA-CATENIN; RECEPTOR; LEF-1; GENE; EXPRESSION; ALPHA; TCF-1; FATE	Group 2 innate lymphoid cells (ILC2) are innate lymphocytes that confer protective type 2 immunity during helminth infection and are also involved in allergic airway inflammation. Here we report that ILC2 development required T cell factor 1 (TCF-1, the product of the Tcf7 gene), a transcription factor also implicated in T cell lineage specification. Tcf7(-/-) mice lack ILC2, and were unable to mount ILC2-mediated innate type 2 immune responses. Forced expression of TCF-1 in bone marrow progenitors partially bypassed the requirement for Notch signaling in the generation of ILC2 in vivo. TCF-1 acted through both GATA-3-dependent and GATA-3-independent pathways to promote the generation of ILC2. These results are reminiscent of the critical roles of TCF-1 in early T cell development. Hence, transcription factors that underlie early steps of T cell development are also implicated in the development of innate lymphoid cells.	[Yang, Qi; De Obaldia, Maria Elena; Bailis, Will; Bryson, Jerrod L.; Toscano, Kristin; Pear, Warren S.; Bhandoola, Avinash] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Monticelli, Laurel A.; Saenz, Steven A.; Chi, Anthony Wei-Shine; Sonnenberg, Gregory F.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Tang, Jiangbo] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Huang, Jian; Haczku, Angela] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Bhandoola, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	HACZKU, ANGELA/A-8486-2013	HACZKU, ANGELA/0000-0002-1301-4941; De Obaldia, Maria/0000-0003-2488-3672; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI059621, AI098428, 5T32CA009140-38, T32CA-009140, DP5OD012116, R01AI047833, T32HD007516, 1F31CA165813, AI095466, AI095608, AI097333, T32-AI007532]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009140, F31CA165813] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098428, R01AI102942, R01AI047833, R01AI095466, U01AI095608, R01AI074878, T32AI007532, R01AI072197, P01AI106697, R01AI097333, R01AI059621, R56AI059621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I.-C. Ho for permission to use GATA-3<SUP>f/f</SUP> mice and S. Zhang and C. Harly for critical comments. This work was supported by National Institutes of Health Grants AI059621 and AI098428 (A. B.), 5T32CA009140-38 (J. L. B.), T32CA-009140 (M. E. O), DP5OD012116 (G. F. S.), R01AI047833 (W. S. P.), T32HD007516 and 1F31CA165813 (W. B.), AI095466, AI095608, and AI097333 (D. A.), and T32-AI007532 (L.A.M.).	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Brault V, 2001, DEVELOPMENT, V128, P1253; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Dyer KD, 2011, J IMMUNOL METHODS, V369, P91, DOI 10.1016/j.jim.2011.04.009; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Held W, 2003, EUR J IMMUNOL, V33, P1393, DOI 10.1002/eji.200323840; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Lee HC, 2005, J IMMUNOL, V174, P7800, DOI 10.4049/jimmunol.174.12.7800; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ribeiro VSG, 2010, J IMMUNOL, V185, P4993, DOI 10.4049/jimmunol.1002273; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	43	184	191	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					694	704		10.1016/j.immuni.2012.12.003	http://dx.doi.org/10.1016/j.immuni.2012.12.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601684	Green Accepted, Bronze			2022-12-18	WOS:000330942100012
J	Soudja, SM; Ruiz, AL; Marie, JC; Lauvau, G				Soudja, Saidi M'Homa; Ruiz, Anne L.; Marie, Julien C.; Lauvau, Gregoire			Inflammatory Monocytes Activate Memory CD8(+) T and Innate NK Lymphocytes Independent of Cognate Antigen during Microbial Pathogen Invasion	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; IN-VIVO DEPLETION; LISTERIA-MONOCYTOGENES; CUTTING EDGE; BONE-MARROW; IL-15; INFECTION; RESPONSES; EXPRESSION; IL-15R-ALPHA	Memory CD8(+) T cells induced upon immunization exhibit improved functional features that contribute to protection of immunized hosts. Although both cognate antigen recognition and inflammation are important for memory CD8(+) T cell reactivation, the relative contribution of these factors and the cell types providing these signals in vivo are poorly defined. Here, we show that Ly6C(+)CCR2(+) inflammatory monocytes, a subset of monocytes, largely orchestrate memory CD8(+) T and NK lymphocytes activation by differentiating into interleukin-18 (IL-18)- and IL-15-producing cells in an inflammasome and type I interferon-IRF3-dependent manner. Memory CD8(+) T cells became potent effector cells by sensing inflammation from monocytes independently of their cognate antigen. Like NK cells, they underwent rapid mobilization, upregulated intense and sustained effector functions during bacterial, viral, and parasitic infections, and contributed to innate responses and protection in vivo. Thus, inflammatory monocyte-derived IL-18 and IL-15 are critical to initiate memory CD8(+) T and NK lymphocytes differentiation into antimicrobial effector cells.	[Soudja, Saidi M'Homa; Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Ruiz, Anne L.; Marie, Julien C.] Univ Lyon 1, Labex DEVweCAN, Canc Res Ctr Lyon, INSERM,Helmholtz Assoc INSERM,CNRS,U1052,UMR5286, F-69000 Lyon, France; [Ruiz, Anne L.; Marie, Julien C.] Ctr Leon Berard, F-69000 Lyon, France	Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard	Lauvau, G (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	gregoire.lauvau@einstein.yu.edu	Marie, Julien/I-5084-2016	Marie, Julien/0000-0001-6713-7923	Albert Einstein College of Medicine of Yeshiva University; National Institute of Health [R21AI095835]; Agence Nationale pour la Recherche [ANR-10-LABX-61]; InCa Atip/Avenir; fundation Bettencourt-Schueller; Albert Einstein Cancer Center (NCI) [2P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095835, R01AI103338] Funding Source: NIH RePORTER	Albert Einstein College of Medicine of Yeshiva University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche(French National Research Agency (ANR)); InCa Atip/Avenir; fundation Bettencourt-Schueller; Albert Einstein Cancer Center (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H2-K<SUP>d</SUP>/LLO<INF>91-99</INF> tetramers came from the NIH Tetramer Facility. We are grateful to W. Jacobs, Jr. for privileged access to the HHMI Aria II and thank L. Tesfa (FACS Core). We thank F. Sutterwala (University of Iowa) and R. Flavell (Yale University) for providing Casp1<SUP>-/-</SUP> bone-marrow cells and mice; ID. Woodland and J. Kohlmeier (Trudeau Institute) for providing Ifnar1<SUP>-/-</SUP> bone marrow cells; T. Moran (Mount Sinai School of Medecine) for Irf3<SUP>-/-</SUP> mice; and E. Pamer (Memorial Sloan-Kettering Cancer Center) for CCR2-DTR and WP20 mice. We thank C. Biron (Brown University) for providing stocks of MCMV. We thank M. Bajenoff (CIML, France), S. Porcelli (AECOM, L. Chorro, C. Chandrabos, and E. Spaulding for helpful discussions. This work was supported by Institutional Funds of the Albert Einstein College of Medicine of Yeshiva University (G.L.), the National Institute of Health (R21AI095835, G.L.), the Agence Nationale pour la Recherche (ANR-10-LABX-61, J.M.), InCa Atip/Avenir (J.M.), and the fundation Bettencourt-Schueller (J.M.). Core flow cytometry were supported by the Albert Einstein Cancer Center (NCI Grant 2P30CA013330). S.M.S. designed the study, performed experiments, and analyzed data. A.R. and J.M. performed and analyzed the LCMV experiments and commented on the manuscript. G.L. designed the study, analyzed the data, and wrote the paper.	Bajenoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011524; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Yajima T, 2005, J IMMUNOL, V174, P3590, DOI 10.4049/jimmunol.174.6.3590; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	44	184	186	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					549	562		10.1016/j.immuni.2012.05.029	http://dx.doi.org/10.1016/j.immuni.2012.05.029			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22940097	Green Accepted, Bronze			2022-12-18	WOS:000309199000018
J	Hardy, RR; Kincade, PW; Dorshkind, K				Hardy, Richard R.; Kincade, Paul W.; Dorshkind, Kenneth			The protean nature of cells in the B lymphocyte lineage	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; MOUSE BONE-MARROW; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; ANTIGEN RECEPTOR SPECIFICITY; ALTERNATIVELY SPLICED EXONS; TOLL-LIKE RECEPTORS; MARGINAL-ZONE; POSITIVE SELECTION; T-CELL; DEVELOPMENTAL SWITCH	The subdivision of bone marrow (BM) with surface markers and reporter systems and the use of multiple culture and transplantation assays to assess differentiation potential have led to extraordinary progress in defining stages of B lymphopoiesis between the hematopoietic stem cell and B cell receptor (BCR)-expressing lymphocytes. Despite the lack of standard nomenclature and a series of technical issues that still need to be resolved, there seems to be a general consensus regarding the major route to becoming a B cell. Nevertheless, evidence that additional, minor pathways through which B lineage cells are generated exists, and a new appreciation that lymphoid progenitors are protean and able to alter their differentiation potential during embryogenesis and after birth in response to infections suggests that a full understanding of B cell development and how it is regulated has not yet been attained.	Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Fox Chase Cancer Center; Oklahoma Medical Research Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hardy, RR (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	rr_hardy@fccc.edu			NIAID NIH HHS [AI 058162, AI 20069, AI 21256, AI 26782, R01 AI020069, AI 40946] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020069, R01AI026782, R01AI021256, R01AI040946, R37AI021256, R37AI020069, R01AI058162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Borrello M A, 2001, Int Rev Immunol, V20, P137, DOI 10.3109/08830180109056727; BORRELLO MA, 1995, J IMMUNOL, V155, P4155; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; Chen XJ, 1997, INT IMMUNOL, V9, P27, DOI 10.1093/intimm/9.1.27; Chumley MJ, 2000, J IMMUNOL, V164, P4586, DOI 10.4049/jimmunol.164.9.4586; CONG YZ, 1991, INT IMMUNOL, V3, P467; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; DAUPHINEE M, 1988, ARTHRITIS RHEUM, V31, P642, DOI 10.1002/art.1780310509; Dorshkind K, 2007, NAT REV IMMUNOL, V7, P213, DOI 10.1038/nri2019; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Godin I, 2005, INT J DEV BIOL, V49, P251, DOI 10.1387/ijdb.041945ig; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hardy RR, 2006, J IMMUNOL, V177, P2749, DOI 10.4049/jimmunol.177.5.2749; HARDY RR, 1989, J IMMUNOL, V142, P3643; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HAYAKAWA K, 1994, J IMMUNOL, V152, P4801; HAYAKAWA K, 1990, J EXP MED, V172, P869, DOI 10.1084/jem.172.3.869; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1988, ANNU REV IMMUNOL, V6, P197, DOI 10.1146/annurev.iy.06.040188.001213; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; JOHNSON P, 1989, J EXP MED, V169, P1179, DOI 10.1084/jem.169.3.1179; JOHNSON P, 1997, J EXP MED, V2; JYONOUCHI H, 1981, J IMMUNOL, V127, P2502; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim JM, 2005, INT IMMUNOL, V17, P1525, DOI 10.1093/intimm/dxh345; Kincade PW, 2002, IMMUNOL REV, V187, P116, DOI 10.1034/j.1600-065X.2002.18710.x; King LB, 2000, IMMUNOL REV, V176, P86; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Krueger A, 2007, IMMUNITY, V26, P105, DOI 10.1016/j.immuni.2006.12.004; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; LALOR PA, 1991, AUTOIMMUNITY, V10, P71, DOI 10.3109/08916939108997150; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LUQMAN M, 1991, EUR J IMMUNOL, V21, P17, DOI 10.1002/eji.1830210104; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Marshall AJ, 1998, J IMMUNOL, V161, P6657; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2002, SEMIN IMMUNOL, V14, P371, DOI 10.1016/S1044532302000714; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Payne KJ, 2007, IMMUNITY, V26, P674, DOI 10.1016/j.immuni.2007.05.011; Perry SS, 2006, J IMMUNOL, V177, P2880, DOI 10.4049/jimmunol.177.5.2880; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Petrie HT, 2007, IMMUNITY, V26, P7, DOI 10.1016/j.immuni.2007.01.003; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Sioud M, 2006, J MOL BIOL, V364, P945, DOI 10.1016/j.jmb.2006.09.054; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; UCHIDA N, 1994, BLOOD, V83, P3758; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101; Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259; Welner RS, 2007, BLOOD, V109, P4825, DOI 10.1182/blood-2006-08-043810; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Ye M, 2005, J EXP MED, V202, P1411, DOI 10.1084/jem.20051089; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136	144	184	188	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					703	714		10.1016/j.immuni.2007.05.013	http://dx.doi.org/10.1016/j.immuni.2007.05.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582343	Bronze			2022-12-18	WOS:000247646900005
J	Yu, JH; Wei, M; Becknell, B; Trotta, R; Liu, SJ; Boyd, Z; Jaung, MS; Blaser, BW; Sun, J; Benson, DM; Mao, HY; Yokohama, A; Bhatt, D; Shen, L; Davuluri, R; Weinstein, M; Marcucci, G; Caligiuri, MA				Yu, Jianhua; Wei, Min; Becknell, Brian; Trotta, Rossana; Liu, Shujun; Boyd, Zachary; Jaung, Michael S.; Blaser, Bradley W.; Sun, Jin; Benson, Don M., Jr.; Mao, Hsiaoyin; Yokohama, Akihiko; Bhatt, Darshna; Shen, Lei; Davuluri, Ramana; Weinstein, Michael; Marcucci, Guido; Caligiuri, Michael A.			Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; INNATE IMMUNE-RESPONSE; CD4(+) T-CELLS; TGF-BETA; IFN-GAMMA; NK CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LINEAGE COMMITMENT; DENDRITIC CELLS	Activated monocytes produce proinflammatory cytokines (monokines) such as interleukin (IL)-12, IL-15, and IL-18 for induction of interferon-gamma (IFN-gamma) by natural killer (NK) cells. NK cells provide the antiinflammatory cytokine transforming growth factor (TGF)-beta, an autocrine/negative regulator of IFN-gamma. The ability of one signaling pathway to prevail over the other is likely important in controlling IFN-gamma for the purposes of infection and autoimmunity, but the molecular mechanism(s) of how this counterregulation occurs is unknown. Here we show that in isolated human NK cells, proinflammatory monokines antagonize antiinflammatory TGF-beta signaling by downregulating the expression of the TGF-beta type 11 receptor, and its signaling intermediates SMAD2 and SMAD3. In contrast, TGF-beta utilizes SMAD2, SMAD3, and SMAD4 to suppress IFN-gamma and T-BET, a positive regulator of IFN-y. Indeed, activated NK cells from Smad3(-/-) mice produce more IFN-gamma in vivo than NK cells from wild-type mice. Collectively, our data suggest that pro- and antiinflammatory cytokine signaling reciprocally antagonize each other in an effort to prevail in the regulation of NK cell IFN-gamma production.	Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Med Scientist Program, Integrated Biomed Grad Program, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Hematol Oncol, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Epidemiol & Biostat, Columbus, OH 43210 USA; Ohio State Univ, Sch Publ Hlth, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Caligiuri, MA (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu	Wei, Min/GSI-8510-2022	Blaser, Bradley/0000-0002-3168-5423; Trotta, Rossana/0000-0003-4546-2615	NCI NIH HHS [CA68458, CA95426] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095426, R37CA068458, R01CA068458] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Akahoshi M, 2005, HUM GENET, V117, P16, DOI 10.1007/s00439-005-1285-0; Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Antonelli M, 1999, J CHEMOTHERAPY, V11, P536, DOI 10.1179/joc.1999.11.6.536; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Becknell B, 2005, J IMMUNOL METHODS, V296, P115, DOI 10.1016/j.jim.2004.11.012; BELLONE G, 1995, J IMMUNOL, V155, P1066; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bright JJ, 1998, J IMMUNOL, V161, P1772; Bright JJ, 1997, J IMMUNOL, V159, P175; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; CHUA AO, 1994, J IMMUNOL, V153, P128; Cooper GJS, 2001, AUST J DAIRY TECHNOL, V56, P97; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Di Noto R, 2001, LEUKEMIA, V15, P1641; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; ESPEVIK T, 1987, J EXP MED, V166, P571, DOI 10.1084/jem.166.2.571; Fehniger TA, 2000, J IMMUNOL, V164, P1643, DOI 10.4049/jimmunol.164.4.1643; Fehniger TA, 1999, J IMMUNOL, V162, P4511; GONG JH, 1994, LEUKEMIA, V8, P652; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gray JD, 1998, J IMMUNOL, V160, P2248; Grignani F, 1998, CANCER RES, V58, P14; Han HS, 1997, J AUTOIMMUN, V10, P299, DOI 10.1006/jaut.1997.0137; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hayes MP, 1998, BLOOD, V91, P4645, DOI 10.1182/blood.V91.12.4645.412k36_4645_4651; HEREMANS H, 1989, LYMPHOKINE RES, V8, P329; Hill N, 2002, CURR OPIN IMMUNOL, V14, P791, DOI 10.1016/S0952-7915(02)00403-X; Horwitz DA, 1997, IMMUNOL TODAY, V18, P538, DOI 10.1016/S0167-5699(97)01149-3; Horwitz DA, 1999, MICROBES INFECT, V1, P1305, DOI 10.1016/S1286-4579(99)00253-1; Ishida Y, 2004, J IMMUNOL, V172, P1848, DOI 10.4049/jimmunol.172.3.1848; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Pardoux C, 1999, BLOOD, V93, P1448, DOI 10.1182/blood.V93.5.1448.403k36_1448_1455; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Reed SG, 1999, MICROBES INFECT, V1, P1313, DOI 10.1016/S1286-4579(99)00252-X; Ross ME, 1997, BLOOD, V89, P910, DOI 10.1182/blood.V89.3.910; Sareneva T, 2000, J IMMUNOL, V165, P1933, DOI 10.4049/jimmunol.165.4.1933; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Sudarshan C, 1999, J IMMUNOL, V162, P2974; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Trinchieri G, 1995, Semin Immunol, V7, P83, DOI 10.1006/smim.1995.0012; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang SM, 2000, J IMMUNOL, V165, P1374, DOI 10.4049/jimmunol.165.3.1374; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhang ZJ, 1998, RNA, V4, P394	89	184	192	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					575	590		10.1016/j.immuni.2006.03.016	http://dx.doi.org/10.1016/j.immuni.2006.03.016			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713975	Bronze			2022-12-18	WOS:000237970100014
J	Ueno, T; Hara, K; Willis, MS; Malin, MA; Hopken, UE; Gray, DHD; Matsushima, K; Lipp, M; Springer, TA; Boyd, RL; Yoshie, O; Takahama, Y				Ueno, T; Hara, K; Willis, MS; Malin, MA; Hopken, UE; Gray, DHD; Matsushima, K; Lipp, M; Springer, TA; Boyd, RL; Yoshie, O; Takahama, Y			Role for CCR7 Ligands in the emigration of newly generated T lymphocytes from the neonatal thymus	IMMUNITY			English	Article							LYMPHOID-TISSUE CHEMOKINE; HIGH ENDOTHELIAL VENULES; CHEMOTACTIC AGENT 4; EBI1-LIGAND CHEMOKINE; MOLECULAR-CLONING; FUNCTIONAL LIGAND; EPITHELIAL-CELLS; DENDRITIC CELLS; BETA-CHEMOKINE; STROMAL CELLS	Most T lymphocytes are generated within the thymus. It is unclear, however, how newly generated T cells relocate out of the thymus to the circulation. The present study shows that a CC chemokine CCL19 attracts mature T cells out of the fetal thymus organ culture. Another CC chemokine CCL21, which shares CCR7 with CCL19 but has a unique C-terminal extension containing positively charged amino acids, failed to show involvement in thymic emigration. Neonatal appearance of circulating T cells was defective in CCL19-neutralized mice as well as in CCR7-deficient mice but not in CCL21-neutralized mice. In the thymus, CCL19 is predominantly localized in the medulla including endothelial venules. These results indicate a CCL19- and CCR7-dependent pathway of thymic emigration, which represents a major pathway of neonatal T cell export.	Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immune Syst Dev, Tokushima 7708503, Japan; Kinki Univ, Sch Med, Dept Microbiol, Osaka 5890014, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; Max Delbruck Ctr Mol Med, Dept Mol Tumorgenet & Immunogenet, Berlin, Germany; Monash Univ, Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Tokushima University; RIKEN; Kindai University (Kinki University); University of Tokyo; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Monash University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Takahama, Y (corresponding author), Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan.	takahama@genome.tokushima-u.ac.jp	Gray, Daniel HD/A-3293-2013; Takahama, Yousuke/A-5863-2010; Willis, Monte S/J-9994-2015; Lipp, Martin/G-2235-2010	Gray, Daniel HD/0000-0002-8457-8242; Takahama, Yousuke/0000-0002-4992-9174; Willis, Monte S/0000-0002-0769-5816; Yoshie, Osamu/0000-0003-4353-5809; Lipp, Martin/0000-0002-0087-2672				Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Campbell JJ, 1999, J IMMUNOL, V163, P2353; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; DUNON D, 1993, BLOOD, V81, P1; FONTAINEPERUS JC, 1981, J IMMUNOL, V126, P2310; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GODFREY DI, 1990, IMMUNOLOGY, V70, P66; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hedrick JA, 1997, J IMMUNOL, V159, P1589; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; KOTANI M, 1966, BLOOD-J HEMATOL, V27, P511, DOI 10.1182/blood.V27.4.511.511; Lu B, 1999, EUR J IMMUNOL, V29, P3804, DOI 10.1002/(SICI)1521-4141(199911)29:11<3804::AID-IMMU3804>3.0.CO;2-9; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; MIYASAKA M, 1990, THYMUS, V16, P29; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518; Nelson AJ, 1996, EUR J IMMUNOL, V26, P401, DOI 10.1002/eji.1830260220; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Norment AM, 2000, J IMMUNOL, V164, P639, DOI 10.4049/jimmunol.164.2.639; Picker L.J., 1999, FUNDAMENTAL IMMUNOLO, P479; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rossi DL, 1997, J IMMUNOL, V158, P1033; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; SCOLLAY R, 1986, IMMUNOL REV, V91, P129, DOI 10.1111/j.1600-065X.1986.tb01487.x; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Soto H, 1998, P NATL ACAD SCI USA, V95, P8205, DOI 10.1073/pnas.95.14.8205; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Suzuki G, 1998, INT IMMUNOL, V10, P1049, DOI 10.1093/intimm/10.8.1049; Takahama Y, 2000, METH MOL B, V134, P37; Tanabe S, 1997, J IMMUNOL, V159, P5671; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; TUCEK CL, 1992, INT IMMUNOL, V4, P1021, DOI 10.1093/intimm/4.9.1021; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; Wilkinson B, 1999, J IMMUNOL, V162, P3873; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803	51	184	189	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2002	16	2					205	218		10.1016/S1074-7613(02)00267-4	http://dx.doi.org/10.1016/S1074-7613(02)00267-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869682	Bronze			2022-12-18	WOS:000174039600005
J	Jayawardena-Wolf, J; Benlagha, K; Chiu, YH; Mehr, R; Bendelac, A				Jayawardena-Wolf, J; Benlagha, K; Chiu, YH; Mehr, R; Bendelac, A			CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-PRESENTING MOLECULES; CLASS-II MOLECULES; T-CELLS; ENDOCYTIC COMPARTMENTS; MHC MOLECULES; CYTOPLASMIC TAIL; DENDRITIC CELLS; TRANSPORT; RECOGNITION	Endosomal trafficking is an essential component of the CD1 pathway of lipid antigen presentation to T cells. We demonstrate that CD1d access to endosomal compartments is under dual regulation by an intrinsic tyrosine-based motif, which governs intense recycling between the plasma membrane and the endosome, and by the invariant chain, with which CD1d associates in the endoplasmic reticulum. Both pathways independently enhance antigen presentation to V alpha 14(+) NKT cells, the main subset of CD1d-restricted T cells. These results reveal the complexity of CD1d trafficking and suggest that the invariant chain was a component of ancestral antigen presentation pathways prior to the evolution of MHC and CD1.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Princeton University; Bar Ilan University	Bendelac, A (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	abendelac@molbio.princeton.edu	Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022	benlagha, kamel/0000-0002-3251-9195; Mehr, Ramit/0000-0002-4303-6834				ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cole DN, 2000, US FOR SERV RMRS-P, V1, P1; Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; GORVEL JP, 1995, J BIOL CHEM, V270, P2741, DOI 10.1074/jbc.270.6.2741; Huttinger R, 1999, INT IMMUNOL, V11, P1615, DOI 10.1093/intimm/11.10.1615; Jayawardena-Wolf J, 2001, CURR OPIN IMMUNOL, V13, P109, DOI 10.1016/S0952-7915(00)00190-4; JONES B, 1986, J IMMUNOL, V136, P348; Kasahara M, 1997, HEREDITAS, V127, P59, DOI 10.1111/j.1601-5223.1997.t01-1-00059.x; KNOWLES BB, 1979, J IMMUNOL, V122, P1798; KULCZYCKI A, 1974, J EXP MED, V139, P600, DOI 10.1084/jem.139.3.600; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LINDSTEDT R, 1995, IMMUNITY, V3, P561, DOI 10.1016/1074-7613(95)90127-2; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Park SH, 2000, NATURE, V406, P788, DOI 10.1038/35021233; Park SH, 1998, J IMMUNOL, V160, P3128; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Roark JH, 1998, J IMMUNOL, V160, P3121; Rodionov DG, 1999, J IMMUNOL, V162, P1488; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Thery C, 1998, J IMMUNOL, V161, P2106; Turvy DN, 1998, J IMMUNOL METHODS, V212, P9, DOI 10.1016/S0022-1759(97)00206-8; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	46	184	187	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					897	908		10.1016/S1074-7613(01)00240-0	http://dx.doi.org/10.1016/S1074-7613(01)00240-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754812	Bronze			2022-12-18	WOS:000172961400005
J	Sonoda, E; PewznerJung, Y; Schwers, S; Taki, S; Jung, S; Eilat, D; Rajewsky, K				Sonoda, E; PewznerJung, Y; Schwers, S; Taki, S; Jung, S; Eilat, D; Rajewsky, K			B cell development under the condition of allelic inclusion	IMMUNITY			English	Article							HEAVY-CHAIN GENE; VARIABLE REGION GENE; IMMUNOGLOBULIN HEAVY; BONE-MARROW; SWITCH RECOMBINATION; MONOCLONAL-ANTIBODY; DEFICIENT MICE; NP ANTIBODIES; EXPRESSION; MOUSE	Mice whose IgH alleles are engineered to encode two distinct antibody heavy (H) chains generate a normal-sized B cell compartment in which most cells stably express the two heavy chains. This demonstrates that ''toxicity'' of bi-allelic H chain expression and cell-autonomous mechanisms of silencing in-frame IgH gene rearrangements do not significantly contribute to allelic exclusion at the IgH locus. Notwithstanding, the stability of the various engineered IgH loci during B cell development in the bone marrow differed substantially from each other.	UNIV COLOGNE, INST GENET, D-50931 COLOGNE, GERMANY; HADASSAH UNIV HOSP, DIV MED, IL-91120 JERUSALEM, ISRAEL	University of Cologne; Hebrew University of Jerusalem			Jung, Steffen/K-1409-2012; Pewzner, Faivish/I-6225-2017	Jung, Steffen/0000-0003-4290-5716; Pewzner, Faivish/0000-0002-7490-8121; Rajewsky, Klaus/0000-0002-6633-6370; Taki, Shinsuke/0000-0001-5143-3496				ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CHOU CL, 1993, J IMMUNOL, V150, P5350; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; DESAYMARD C, 1984, MOL IMMUNOL, V21, P961, DOI 10.1016/0161-5890(84)90154-8; DILDROP R, 1987, EUR J IMMUNOL, V17, P731, DOI 10.1002/eji.1830170525; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; EILAT D, 1988, J IMMUNOL, V141, P1745; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Grutzmann R., 1981, THESIS U COLOGNE COL; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; GULLEY ML, 1988, J IMMUNOL, V140, P3751; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; IMANISHIKARI T, 1993, J IMMUNOL, V150, P3311; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kabat EA, 1991, SEQUENCES PROTEINS I; KANTOR AB, 1997, IN PRESS HDB EXPT IM; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; KUMAGAI K, 1975, J IMMUNOL, V115, P982; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Loffert D, 1996, IMMUNITY, V4, P133, DOI 10.1016/S1074-7613(00)80678-0; LOZANO F, 1993, NATURE, V363, P271, DOI 10.1038/363271a0; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976; PewznerJung Y, 1996, J IMMUNOL, V156, P3065; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RETH M, 1978, EUR J IMMUNOL, V8, P393, DOI 10.1002/eji.1830080605; RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SANCHEZ P, 1987, J EXP MED, V166, P265, DOI 10.1084/jem.166.1.265; SANCHEZ P, 1991, EUR J IMMUNOL, V21, P907, DOI 10.1002/eji.1830210408; SANDER B, 1991, IMMUNOL REV, V119, P65, DOI 10.1111/j.1600-065X.1991.tb00578.x; SCHUPPEL R, 1987, EUR J IMMUNOL, V17, P739, DOI 10.1002/eji.1830170527; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SIMON T, 1988, NUCLEIC ACIDS RES, V16, P354, DOI 10.1093/nar/16.1.354; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; TAKI S, 1993, SCIENCE, V262, P1268, DOI 10.1126/science.8235657; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; WABL M, 1982, P NATL ACAD SCI-BIOL, V79, P6976, DOI 10.1073/pnas.79.22.6976; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	52	184	198	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1997	6	3					225	233		10.1016/S1074-7613(00)80325-8	http://dx.doi.org/10.1016/S1074-7613(00)80325-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075923	Bronze			2022-12-18	WOS:A1997XC61800002
J	Phillips, JH; Chang, CW; Mattson, J; Gumperz, JE; Parham, P; Lanier, LL				Phillips, JH; Chang, CW; Mattson, J; Gumperz, JE; Parham, P; Lanier, LL			CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes	IMMUNITY			English	Article							NATURAL-KILLER-CELL; ANTI-KP43 MONOCLONAL-ANTIBODY; LY-49 MULTIGENE FAMILY; CLASS-I MOLECULES; LYMPHOCYTES-T; MEMBRANE-PROTEINS; SURFACE-ANTIGEN; EXPRESSION; CLONING; CLONES	Whereas the human killer cell inhibitory receptors (KIRs) for HLA class I are immunoglobulin-like monomeric type I glycoproteins, the murine Ly49 receptors for H-2 are type II homodimers of the C-type lectin superfamily. Here, we demonstrate that human NK cells also express C-type lectin receptors that influence recognition of polymorphic HLA-A, HLA-B, and HLA-C molecules. These receptors are heterodimers composed of CD94 chains covalently associated with novel tyrosine-phosphorylated glycoproteins (94AP). Some NK clones recognize a common HLA-C ligand using both KIRs and CD94-94AP receptors. These findings suggest the existence of human inhibitory MHC class I receptors of the immunoglobulin and C-type lectin superfamilies and indicate overlap in ligand specificity.	DNAX RES INST MOL & CELLULAR BIOL INC,DEPT MOL BIOL,PALO ALTO,CA 94304; STANFORD UNIV,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOL STRUCT,STANFORD,CA 94305	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Stanford University; Stanford University	Phillips, JH (corresponding author), DNAX RES INST MOL & CELLULAR BIOL INC,DEPT HUMAN IMMUNOL,901 CALIF AVE,PALO ALTO,CA 94304, USA.		Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NIAID NIH HHS [AI22039] Funding Source: Medline; NIGMS NIH HHS [GM07276] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022039] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAMBURU J, 1991, J IMMUNOL, V147, P714; ARAMBURU J, 1990, J IMMUNOL, V144, P3238; BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; DANDREA A, 1995, J IMMUNOL, V155, P2306; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; Dohring C, 1996, J IMMUNOL, V156, P3098; FRY A, 1996, IN PRESS J EXP MED; GIORDA R, 1992, J IMMUNOL, V149, P1957; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; GUMPERZ JE, 1995, J EXP MED, V181, P133; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; LANIER LL, 1995, J IMMUNOL, V154, P3320; LANIER LL, 1988, J EXP MED, V167, P1572, DOI 10.1084/jem.167.5.1572; Lanier LL, 1996, IMMUNOL TODAY, V17, P86, DOI 10.1016/0167-5699(96)80585-8; LANIER LL, 1994, J IMMUNOL, V153, P2417; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; LITWIN V, 1993, J EXP MED, V178, P1321, DOI 10.1084/jem.178.4.1321; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOPEZBOTET M, 1995, LEUCOCYTE TYPING, V5, P1437; MASON LH, 1995, J EXP MED, V182, P293, DOI 10.1084/jem.182.2.293; MELERO I, 1994, J IMMUNOL, V152, P1662; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; RYAN JC, 1992, J IMMUNOL, V149, P1631; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SMITH HRC, 1994, J IMMUNOL, V153, P1068; STONEMAN ER, 1995, J EXP MED, V182, P305, DOI 10.1084/jem.182.2.305; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; WONG S, 1991, J IMMUNOL, V147, P1417; YOKOYAMA WM, 1990, J IMMUNOL, V145, P2353; YOKOYAMA WM, 1995, CURR OPIN IMMUNOL, V7, P110, DOI 10.1016/0952-7915(95)80036-0; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	45	184	193	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					163	172		10.1016/S1074-7613(00)80492-6	http://dx.doi.org/10.1016/S1074-7613(00)80492-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769479	Bronze			2022-12-18	WOS:A1996VE58900006
J	Duong, BH; Onizawa, M; Oses-Prieto, JA; Advincula, R; Burlingame, A; Malynn, BA; Ma, A				Duong, Bao H.; Onizawa, Michio; Oses-Prieto, Juan A.; Advincula, Rommel; Burlingame, Alma; Malynn, Barbara A.; Ma, Averil			A20 Restricts Ubiquitination of Pro-Interleukin-1 beta Protein Complexes and Suppresses NLRP3 Inflammasome Activity	IMMUNITY			English	Article							NF-KAPPA-B; TLR4-INDUCED AUTOPHAGY; POLYUBIQUITIN CHAINS; ACTIVATION; CASPASE-8; RECEPTOR; KINASE; IL-1-BETA; NECROSIS; CELL	Inappropriate inflammasome activation contributes to multiple human diseases, but the mechanisms by which inflammasomes are suppressed are poorly understood. The NF-kappa B inhibitor A20 is a ubiquitin-modifying enzyme that might be critical in preventing human inflammatory diseases. Here, we report that A20-deficient macrophages, unlike normal cells, exhibit spontaneous NLRP3 inflammasome activity to LPS alone. The kinase RIPK3, but not the adaptor MyD88, is required for this response. In normal cells, A20 constitutively associates with caspase-1 and pro-IL-1 beta, and NLRP3 activation further promotes A20 recruitment to the inflammasome. Pro-IL-1 beta also co-immunoprecipitates with RIPK1, RIPK3, caspase-1, and caspase-8 in a complex that is modified with K63-linked and unanchored polyubiquitin. In A20-deficient macrophages, this pro-IL-1 beta-associated ubiquitination is markedly increased in a RIPK3-dependent manner. Mass spectrometric and mutational analyses reveal that K133 of pro-IL-1 beta is a physiological ubiquitination site that supports processing. Our study reveals a mechanism by which A20 prevents inflammatory diseases.	[Duong, Bao H.; Onizawa, Michio; Advincula, Rommel; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Oses-Prieto, Juan A.; Burlingame, Alma] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu		Oses-Prieto, Juan/0000-0003-4759-2341	NIH; UCSF Liver Center; CCFA Research Fellowship Award; Howard Hughes Medical Institute; Biomedical Technology Research Resources Program at the National Institute of General Medical Sciences [8P41GM103481];  [T32 AI007334];  [T32 DK007007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, T32DK007007, R01DK095693, R01DK071939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center; CCFA Research Fellowship Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biomedical Technology Research Resources Program at the National Institute of General Medical Sciences; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. V. Dixit, S. Akira, R. Medzhitov, X. Wang, R. Vance, and A. Winoto for generously sharing mice. This work was supported by the NIH and the UCSF Liver Center. B. H. D. was partially supported by T32 AI007334, T32 DK007007, and a CCFA Research Fellowship Award. The Bio-Organic Biomedical Mass Spectrometry Resource at UCSF (A. B., Director) is supported by the Howard Hughes Medical Institute and the Biomedical Technology Research Resources Program (8P41GM103481) at the National Institute of General Medical Sciences.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Corn JE, 2014, NAT STRUCT MOL BIOL, V21, P297, DOI 10.1038/nsmb.2808; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Heger K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001762; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Humphries F., 2014, CELL DEATH DIFFER; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247	59	183	191	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					55	67		10.1016/j.immuni.2014.12.031	http://dx.doi.org/10.1016/j.immuni.2014.12.031			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607459	Green Accepted, Bronze			2022-12-18	WOS:000348197500011
J	Sharma, S; DeOliveira, RB; Kalantari, P; Parroche, P; Goutagny, N; Jiang, ZZ; Chan, JN; Bartholomeu, DLC; Lauw, F; Hall, JP; Barber, GN; Gazzinelli, RT; Fitzgerald, KA; Golenbock, DT				Sharma, Shruti; DeOliveira, Rosane B.; Kalantari, Parisa; Parroche, Peggy; Goutagny, Nadege; Jiang, Zhaozhao; Chan, Jennie; Bartholomeu, Daniella C.; Lauw, Fanny; Hall, J. Perry; Barber, Glen N.; Gazzinelli, Ricardo T.; Fitzgerald, Katherine A.; Golenbock, Douglas T.			Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium falciparum Genome	IMMUNITY			English	Article							INDUCIBLE GENE-I; HEPATITIS-C VIRUS; CEREBRAL MALARIA; RIG-I; NALP3 INFLAMMASOME; DENDRITIC CELLS; CYTOSOLIC DNA; LISTERIA-MONOCYTOGENES; INTERFERON INDUCTION; SIGNALING PATHWAY	Although Toll-like receptor 9 (TLR9) has been implicated in cytokine and type I interferon (IFN) production during malaria in humans and mice, the high AT content of the Plasmodium falciparum genome prompted us to examine the possibility that malarial DNA triggered TLR9-independent pathways. Over 6000 ATTTTTAC ("AT-rich") motifs are present in the genome of P. falciparum, which we show here potently induce type I IFNs. Parasite DNA, parasitized erythrocytes and oligonucleotides containing the AT-rich motif induce type I IFNs via a pathway that did not involve the previously described sensors TLR9, DAI, RNA polymerase-Ill or IFI16/p204. Rather, AT-rich DNA sensing involved an unknown receptor that coupled to the STING, TBK1 and IRF3-IRF7 signaling pathway. Mice lacking IRF3, IRF7, the kinase TBK1 or the type I IFN receptor were resistant to otherwise lethal cerebral malaria. Collectively, these observations implicate AT-rich DNA sensing via STING, TBK1 and IRF3-IRF7 in P. falciparum malaria.	[Sharma, Shruti; DeOliveira, Rosane B.; Kalantari, Parisa; Parroche, Peggy; Goutagny, Nadege; Jiang, Zhaozhao; Chan, Jennie; Lauw, Fanny; Gazzinelli, Ricardo T.; Fitzgerald, Katherine A.; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Bartholomeu, Daniella C.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, BR-31270 Belo Horizonte, MG, Brazil; [Bartholomeu, Daniella C.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, BR-31270 Belo Horizonte, MG, Brazil; [Hall, J. Perry] Pfizer, Dept Inflammat & Remodeling, Cambridge, MA 02140 USA; [Barber, Glen N.] Univ Miami, Sch Med, Div Hematol & Oncol, Dept Med, Miami, FL 33136 USA; [Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Rene Rachou Inst, Immunopathol Lab, BR-30190 Belo Horizonte, MG, Brazil	University of Massachusetts System; University of Massachusetts Worcester; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Pfizer; University of Miami; Fundacao Oswaldo Cruz	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu; douglas.golenbock@umassmed.edu	Bartholomeu, Daniella C./J-4714-2015; Barbosa de Oliveira, Rosane/E-4399-2012; Fitzgerald, Katherine/ABE-6317-2020	Bartholomeu, Daniella C./0000-0003-0974-7357; Gazzinelli, Ricardo/0000-0003-2427-7699; Fitzgerald, Kate/0000-0003-3175-609X	NIH [AI067497, AI079293, R21AI80907]; FAPEMIG/CNPq/INCTV from FIOCRUZ, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R37AI067497, R01AI067497, R01AI079293, R21AI080907, R01AI083713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPEMIG/CNPq/INCTV from FIOCRUZ, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank A. Cerny for animal husbandry and genotyping and O. Mulhern for her help with affinity purification assays. This work is supported by NIH grants AI067497 (to K.A.F), by AI079293 (to K.A.F and D.T.G), by R21AI80907 (to R.T.G) and FAPEMIG/CNPq/INCTV from FIOCRUZ, Brazil (to D.T.G). K.A.F and D.T.G oversaw the whole project with R.T.G and S.S. S.S. designed and conducted the experiments with help from Z.J., R.O., P.P., P.K., F.L., and N.G. D.C.B quantified the AT-rich and CpG motif frequency, R.O. and J.C. conducted the in vivo mouse models, and H.B. performed microarray analysis. G.B. made STING-deficient mice and J.P.H made the TBK1-hypomorphic mice. S.S., K.A.F., and D.T.G. wrote the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chessler ADC, 2008, J IMMUNOL, V181, P7917, DOI 10.4049/jimmunol.181.11.7917; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Cooper RA, 2005, MOL BIOCHEM PARASIT, V144, P167, DOI 10.1016/j.molbiopara.2005.07.009; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazzinelli RT, 2004, IMMUNOL REV, V201, P9, DOI 10.1111/j.0105-2896.2004.00174.x; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hanscheid T, 2007, LANCET INFECT DIS, V7, P675, DOI 10.1016/S1473-3099(07)70238-4; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Marchlik E, 2010, J LEUKOCYTE BIOL, V88, P1171, DOI 10.1189/jlb.0210071; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Naka I, 2009, INFECT GENET EVOL, V9, P1406, DOI 10.1016/j.meegid.2009.08.004; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Shimosato T, 2006, CELL MICROBIOL, V8, P485, DOI 10.1111/j.1462-5822.2005.00640.x; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	61	183	202	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					194	207		10.1016/j.immuni.2011.05.016	http://dx.doi.org/10.1016/j.immuni.2011.05.016			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21820332	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000294387900010
J	Rao, DS; O'Connell, RM; Chaudhuri, AA; Garcia-Flores, Y; Geiger, TL; Baltimore, D				Rao, Dinesh S.; O'Connell, Ryan M.; Chaudhuri, Aadel A.; Garcia-Flores, Yvette; Geiger, Theresa L.; Baltimore, David			MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1	IMMUNITY			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-DEVELOPMENT; MONOCYTE DIFFERENTIATION; EXPRESSION; MIR-34A; ACTIVATION; MIR-150; GENES	MicroRNAs (miRNAs) can influence lineage choice or affect critical developmental checkpoints during hematopoiesis. We examined the role of the p53-induced microRNA miR-34a in hematopoiesis by gain-of-function analysis in murine bone marrow. Constitutive expression of miR-34a led to a block in B cell development at the pro-B-cell-to-pre-B-cell transition, leading to a reduction in mature B cells. This block appeared to be mediated primarily by inhibited expression of the transcription factor Foxp1 Foxp1 was a direct target of miR-34a in a 3'-untranslated region (UTR)-dependent fashion. Knockdown of Foxp1 by siRNA recapitulated the B cell developmental phenotype induced by miR-34a, whereas cotransduction of Foxp1 lacking its 3' UTR with miR-34a rescued B cell maturation. Knockdown of miR-34a resulted in increased amounts of Foxp1 and mature B cells. These findings identify a role for miR-34a in connecting the p53 network with suppression of Foxp1, a known B cell oncogene.	[Rao, Dinesh S.; O'Connell, Ryan M.; Chaudhuri, Aadel A.; Garcia-Flores, Yvette; Geiger, Theresa L.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/ABG-1257-2021; Rao, Dinesh/AAE-9625-2019	Rao, Dinesh/0000-0002-0794-9337; Hunter, Theresa/0000-0002-6494-1294	National Cancer Institute [1K08CA133521]; California Institute of Regenerative Medicine/Eli and Edythe Broad Center for Regenerative Medicine and Stem cell Research at UCLA; Cancer Research Institute; National Heart, Lung and Blood Institute [K99HL102228]; National Science Foundation; National Institutes of Health [1R01AI079243-01]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079243] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute of Regenerative Medicine/Eli and Edythe Broad Center for Regenerative Medicine and Stem cell Research at UCLA(California Institute for Regenerative Medicine); Cancer Research Institute; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank members of the Baltimore laboratory, K. Dorshkind, and E. Rothenberg for helpful discussions. This work was supported by career development award 1K08CA133521 from the National Cancer Institute and a clinical fellowship training grant from the California Institute of Regenerative Medicine/Eli and Edythe Broad Center for Regenerative Medicine and Stem cell Research at UCLA (D.S.R.), the Irvington Institute Fellowship Program of the Cancer Research Institute and award number K99HL102228 from the National Heart, Lung and Blood Institute (R.M.O.), the graduate research fellowship program of the National Science Foundation (A.A.C.), and National Institutes of Health (1R01AI079243-01; D.B.). D.B. is a member of the scientific advisory board for Regulus Therapeutics, a company developing therapeutics based on microRNA function.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen L., 2008, BLOOD, V112, P3155; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu LW, 2000, IMMUNOL REV, V175, P158, DOI 10.1034/j.1600-065X.2000.017506.x; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pedersen IM, 2008, BLOOD, V112, P226; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	40	183	195	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					48	59		10.1016/j.immuni.2010.06.013	http://dx.doi.org/10.1016/j.immuni.2010.06.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20598588	Bronze, Green Accepted			2022-12-18	WOS:000280418100009
J	Hanada, T; Yoshida, H; Kato, S; Tanaka, K; Masutani, K; Tsukada, J; Nomura, Y; Mimata, H; Kubo, M; Yoshimura, A				Hanada, T; Yoshida, H; Kato, S; Tanaka, K; Masutani, K; Tsukada, J; Nomura, Y; Mimata, H; Kubo, M; Yoshimura, A			Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity	IMMUNITY			English	Article							LUPUS-ERYTHEMATOSUS; INTERFERON-GAMMA; IFN-GAMMA; B-CELLS; NEGATIVE REGULATOR; JAK/STAT PATHWAY; TRANSGENIC MICE; MURINE LUPUS; T-CELLS; INDUCTION	Suppressor of cytokine signaling-1 (SOCS1/JAB) negatively regulates not only the cytokine-signaling pathway but also lipopolysaccharide (LPS)-induced macrophage activation. We found that SOCS1-deficient dendritic cells (DCs) were also hyperresponsive to interferon-gamma and interieukin-4. To define the role of SOCS1-deficient DCs in vivo, we generated mice in which the SOCS1 expression was restored in T and B cells on a SOCS1(-/-) background. In these mice, DCs were accumulated in the thymus and spleen and produced high levels of BAFF/BLyS and APRIL, resulting in the aberrant expansion of B cells and autoreactive antibody production. SOCS1-deficient DCs efficiently stimulated B cell proliferation in vitro and autoantibody production in vivo. These results indicate that SOCS1 plays an essential role in the normal DC functions and suppression of systemic autoimmunity.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Oita Med Univ, Dept Urol, Oita 8795593, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Kurume Univ, Dept Pathol, Kurume, Fukuoka 8300011, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; Sci Univ Tokyo, Res Inst Biol Sci, Dept Immunobiol, Noda, Chiba 2780022, Japan	Kyushu University; Oita University; Japan Science & Technology Agency (JST); Kurume University; Kyushu University; Tokyo University of Science	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.		Yoshimura, Akihiko/K-5515-2013	Tanaka, Kentaro/0000-0003-4602-4465				Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Christensson B, 1988, Ann N Y Acad Sci, V540, P293, DOI 10.1111/j.1749-6632.1988.tb27079.x; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GRANINGER WB, 1991, J RHEUMATOL, V18, P1621; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Haas C, 1998, J IMMUNOL, V160, P3713; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Ishikawa S, 2001, J EXP MED, V193, P1393, DOI 10.1084/jem.193.12.1393; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mackenzie IS, 2002, CLIN MED, V2, P465, DOI 10.7861/clinmedicine.2-5-465; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nagai H, 2002, CANCER LETT, V186, P59, DOI 10.1016/S0304-3835(02)00244-6; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Palucka AK, 2002, IMMUNOL CELL BIOL, V80, P484, DOI 10.1046/j.1440-1711.2002.01112.x; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Schwarting A, 1998, J IMMUNOL, V161, P494; Seery JP, 1997, J EXP MED, V186, P1451, DOI 10.1084/jem.186.9.1451; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Usui T, 1996, BIOTECH HISTOCHEM, V71, P182, DOI 10.3109/10520299609117157; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225	45	183	201	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					437	450		10.1016/S1074-7613(03)00240-1	http://dx.doi.org/10.1016/S1074-7613(03)00240-1			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499118	Bronze			2022-12-18	WOS:000185499800014
J	Labrecque, N; Whitfield, LS; Obst, R; Waltzinger, C; Benoist, C; Mathis, D				Labrecque, N; Whitfield, LS; Obst, R; Waltzinger, C; Benoist, C; Mathis, D			How much TCR does a T cell need?	IMMUNITY			English	Article							MHC CLASS-II; POSITIVE SELECTION; ANTIGEN RECEPTOR; PEPTIDE LIGANDS; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; SURVIVAL; CD4(+); NAIVE	Kinetic features of TCR:MHC/peptide interactions dictate their outcome in vitro, some important parameters of which include the number of molecules engaged and the duration of engagement. We explored the in vivo significance of these findings in transgenic mice expressing TCRs in a quantitatively and temporally controlled manner. As anticipated, reduced TCR levels resulted in attenuated reactivity, but response thresholds were substantially lower than expected-at as low as 1/20(th), the normal TCR numbers and with no indication of phenotypic skewing at suboptimal levels. We also studied survival of T lymphocytes stripped of their TCRs. Unlike B cells, T cells lacking antigen receptors did not die precipitously; instead, populations decayed gradually, just as previously reported in the absence of MHC molecules.	CNRS, INSERM, ULP, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Benoist, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Joslin Diabet Ctr,Sect Immunol & Innunogenet, Boston, MA 02215 USA.			Obst, Reinhard/0000-0002-4839-207X				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Blichfeldt E, 1996, EUR J IMMUNOL, V26, P2876, DOI 10.1002/eji.1830261211; Boursalian TE, 1999, J IMMUNOL, V162, P3795; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Correia-Neves M, 1999, J IMMUNOL, V163, P5471; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Davis KA, 1998, CYTOMETRY, V33, P197, DOI 10.1002/(SICI)1097-0320(19981001)33:2<197::AID-CYTO14>3.0.CO;2-P; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Ferreira C, 2000, J IMMUNOL, V165, P3689, DOI 10.4049/jimmunol.165.7.3689; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GERMAIN RN, 1997, CURR BIOL, V7, P640; GILFILLAN S, 1994, INT IMMUNOL, V6, P1681, DOI 10.1093/intimm/6.11.1681; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; KELLY BD, 1993, BIOTECHNOLOGY, V3, P23; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Mertsching E, 1997, EUR J IMMUNOL, V27, P389, DOI 10.1002/eji.1830270208; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nesic D, 1998, J IMMUNOL, V160, P3705; Niedergang F, 1997, J IMMUNOL, V159, P1703; Oehen S, 1999, EUR J IMMUNOL, V29, P608, DOI 10.1002/(SICI)1521-4141(199902)29:02<608::AID-IMMU608>3.0.CO;2-A; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Rogers PR, 1999, J IMMUNOL, V163, P1205; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Sohn SJ, 1998, J IMMUNOL, V160, P2130; SOUDAIS C, 1993, NAT GENET, V3, P77, DOI 10.1038/ng0193-77; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TAO W, 1997, J IMMUNOL, V159, P97; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	63	183	188	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					71	82		10.1016/S1074-7613(01)00170-4	http://dx.doi.org/10.1016/S1074-7613(01)00170-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485739	Bronze			2022-12-18	WOS:000170153300008
J	Yoshida, T; Ikuta, K; Sugaya, H; Maki, K; Takagi, M; Kanazawa, H; Sunaga, S; Kinashi, T; Yoshimura, K; Miyazaki, J; Takaki, S; Takatsu, K				Yoshida, T; Ikuta, K; Sugaya, H; Maki, K; Takagi, M; Kanazawa, H; Sunaga, S; Kinashi, T; Yoshimura, K; Miyazaki, J; Takaki, S; Takatsu, K			Defective B-l cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; MURINE INTERLEUKIN-5 RECEPTOR; HIGH-AFFINITY RECEPTORS; GROWTH FACTOR-II; MONOCLONAL-ANTIBODY; REPLACING FACTOR; TRANSGENIC MICE; GM-CSF; TRICHINELLA-SPIRALIS; MOLECULAR-CLONING	We generated interleukin-5 receptor alpha chain (IL-5R alpha)-deficient (IL-5R alpha(-/-)) mice by gene targeting. The IL-5R alpha(-/-) mice showed decreased numbers of B-l cells concomitant with low serum concentrations of IgM and IgG3. They showed no IL-5-induced enhancement of B cell responses to T-independent antigens. The number of alpha beta T cell receptor-positive thymocytes tended to decrease in 3-week-old IL-5R alpha(-/-) mice, returning to normal by 6 weeks of age. The IL-5R alpha(-/-) mice produced basal levels of eosinophils, while their bone marrow cells failed to form eosinophilic colonies in response to IL-5. Impaired eosinophilopoiesis in IL-5R alpha(-/-) mice enhanced the survival of Angiostrongylus cantonensis. These results indicate that IL-5-induced eosinophils serve as potent effector cells in the killing of Angiostrongylus cantonensis in mice.	UNIV TOKYO, FAC MED, DEPT STEM CELL REGULAT, INST MED SCI, TOKYO 108, JAPAN; UNIV TOKYO, FAC MED, DEPT DIS RELATED GENE REGULAT RES SANDOZ, MINATO KU, TOKYO 108, JAPAN; AKITA UNIV, SCH MED, DEPT PARASITOL, AKITA 010, JAPAN	University of Tokyo; Novartis; Sandoz; University of Tokyo; Akita University	Yoshida, T (corresponding author), UNIV TOKYO, FAC MED, DEPT IMMUNOL, MINATO KU, 4-6-1 SHIROKANEDAI, TOKYO 108, JAPAN.		Yoshida, Toshimi/GSN-8717-2022; Miyazaki, Jun-ichi/N-1976-2015	Yoshida, Toshimi/0000-0001-7080-6913; Miyazaki, Jun-ichi/0000-0003-2475-589X; Ikuta, Koichi/0000-0003-1319-1021				BRUCE J, 1981, J IMMUNOL, V127, P2496; COFFMAN RL, 1989, SCIENCE, V245, P308, DOI 10.1126/science.2787531; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; GOYAL PK, 1993, PARASITOLOGY, V106, P371, DOI 10.1017/S0031182000067111; GREENE BM, 1981, J IMMUNOL, V127, P1611; HAGAN P, 1985, PARASITE IMMUNOL, V7, P625, DOI 10.1111/j.1365-3024.1985.tb00106.x; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HARADA N, 1987, P NATL ACAD SCI USA, V84, P4581, DOI 10.1073/pnas.84.13.4581; HARDY RR, 1994, ADV IMMUNOL, V55, P297; HAYASHI SI, 1986, J IMMUNOL, V136, P2069; HERNDON FJ, 1992, J IMMUNOL, V149, P3642; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HITOSHI Y, 1993, INT IMMUNOL, V5, P1183, DOI 10.1093/intimm/5.9.1183; HITOSHI Y, 1991, INT IMMUNOL, V3, P135, DOI 10.1093/intimm/3.2.135; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; IMAMURA F, 1994, DNA CELL BIOL, V13, P283, DOI 10.1089/dna.1994.13.283; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; KANTOR AB, 1991, IMMUNOL TODAY, V12, P389, DOI 10.1016/0167-5699(91)90136-H; KATOH S, 1993, DNA CELL BIOL, V12, P481, DOI 10.1089/dna.1993.12.481; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; KOIKE M, 1995, INT IMMUNOL, V7, P21, DOI 10.1093/intimm/7.1.21; KORENAGA M, 1994, INT J PARASITOL, V24, P951, DOI 10.1016/0020-7519(94)90159-7; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; MAHANTY S, 1992, J IMMUNOL, V148, P3567; MANDLER R, 1993, J EXP MED, V178, P1577, DOI 10.1084/jem.178.5.1577; MATSUMOTO R, 1989, IMMUNOLOGY, V66, P32; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311; MIYAJIMA A, 1993, BLOOD, V82, P1960; MOND JJ, 1982, IMMUNOL REV, V64, P99, DOI 10.1111/j.1600-065X.1982.tb00420.x; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RENNICK DM, 1990, BLOOD, V76, P312; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SASAKI O, 1993, PARASITE IMMUNOL, V15, P349, DOI 10.1111/j.1365-3024.1993.tb00619.x; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; SCHER I, 1982, IMMUNOL REV, V64, P117, DOI 10.1111/j.1600-065X.1982.tb00421.x; SHER A, 1990, P NATL ACAD SCI USA, V87, P61, DOI 10.1073/pnas.87.1.61; SHSHINIAN A, 1993, SCIENCE, V261, P609; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; SONODA Y, 1989, LEUKEMIA, V3, P14; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; SUGAYA H, 1988, PARASITE IMMUNOL, V10, P127, DOI 10.1111/j.1365-3024.1988.tb00209.x; TAKAGI M, 1995, J EXP MED, V181, P889, DOI 10.1084/jem.181.3.889; TAKAHASHI T, 1990, MOL IMMUNOL, V27, P911, DOI 10.1016/0161-5890(90)90158-V; TAKAKI S, 1990, EMBO J, V9, P4367, DOI 10.1002/j.1460-2075.1990.tb07886.x; TAKAKI S, 1991, EMBO J, V10, P2833, DOI 10.1002/j.1460-2075.1991.tb07832.x; TAKAKI S, 1994, MOL CELL BIOL, V14, P7404, DOI 10.1128/MCB.14.11.7404; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAKATSU K, 1994, ADV IMMUNOL, V57, P145, DOI 10.1016/S0065-2776(08)60673-2; TAKATSU K, 1992, CURR OPIN IMMUNOL, V4, P299, DOI 10.1016/0952-7915(92)90080-X; Takatsu Kiyoshi, 1995, Methods (Orlando), V8, P45, DOI 10.1006/meth.1995.1043; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; Tominaga A, 1989, GROWTH FACTORS, V1, P135, DOI 10.3109/08977198909029123; UEHARA S, 1994, INT IMMUNOL, V6, P1937, DOI 10.1093/intimm/6.12.1937; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; YAMAGUCHI N, 1990, INT IMMUNOL, V2, P181, DOI 10.1093/intimm/2.2.181; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; YAMASHITA Y, 1995, IMMUNOLOGY, V85, P248; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388; YOSHIMURA K, 1988, PARASITE IMMUNOL, V10, P411, DOI 10.1111/j.1365-3024.1988.tb00231.x; YOSHIMURA K, 1994, PARASITOL TODAY, V10, P231, DOI 10.1016/0169-4758(94)90124-4; YOSHIMURA K, 1979, INT J PARASITOL, V9, P97; YOSHIMURA K, 1976, AM J TROP MED HYG, V25, P99, DOI 10.4269/ajtmh.1976.25.99; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	82	183	186	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1996	4	5					483	494		10.1016/S1074-7613(00)80414-8	http://dx.doi.org/10.1016/S1074-7613(00)80414-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UM678	8630733	Bronze			2022-12-18	WOS:A1996UM67800007
J	Ritter, AT; Asano, Y; Stinchcombe, JC; Dieckmann, NMG; Chen, BC; Gawden-Bone, C; van Engelenburg, S; Legant, W; Gao, L; Davidson, MW; Betzig, E; Lippincott-Schwartz, J; Griffiths, GM				Ritter, Alex T.; Asano, Yukako; Stinchcombe, Jane C.; Dieckmann, N. M. G.; Chen, Bi-Chang; Gawden-Bone, C.; van Engelenburg, Schuyler; Legant, Wesley; Gao, Liang; Davidson, Michael W.; Betzig, Eric; Lippincott-Schwartz, Jennifer; Griffiths, Gillian M.			Actin Depletion Initiates Events Leading to Granule Secretion at the Immunological Synapse	IMMUNITY			English	Article							T-CELL-RECEPTOR; RETROGRADE FLOW; F-ACTIN; ACTIVATION; MICROCLUSTERS; ADHESION; DOMAIN; POLYMERIZATION; REORIENTATION; ACCUMULATION	Cytotoxic T lymphocytes (CTLs) use polarized secretion to rapidly destroy virally infected and tumor cells. To understand the temporal relationships between key events leading to secretion, we used high-resolution 4D imaging. CTLs approached targets with actin-rich projections at the leading edge, creating an initially actin-enriched contact with rearward-flowing actin. Within 1 min, cortical actin reduced across the synapse, T cell receptors (TCRs) clustered centrally to form the central supramolecular activation cluster (cSMAC), and centrosome polarization began. Granules clustered around the moving centrosome within 2.5 min and reached the synapse after 6 min. TCR-bearing intracellular vesicles were delivered to the cSMAC as the centrosome docked. We found that the centrosome and granules were delivered to an area of membrane with reduced cortical actin density and phospholipid PIP2. These data resolve the temporal order of events during synapse maturation in 4D and reveal a critical role for actin depletion in regulating secretion.	[Ritter, Alex T.; Asano, Yukako; Stinchcombe, Jane C.; Dieckmann, N. M. G.; Gawden-Bone, C.; Griffiths, Gillian M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Ritter, Alex T.; van Engelenburg, Schuyler; Lippincott-Schwartz, Jennifer] NICHD, NIH, Bethesda, MD 20892 USA; [Chen, Bi-Chang; Legant, Wesley; Gao, Liang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32304 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32304 USA	University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Lippincott-Schwartz, J (corresponding author), NICHD, NIH, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov; gg305@cam.ac.uk	Chen, Bi-Chang/F-3480-2014	Chen, Bi-Chang/0000-0002-1876-7432; Gawden-Bone, Christian/0000-0003-0413-3727; Dieckmann, Nele/0000-0003-0785-1708; stinchcombe, jane/0000-0003-1459-9299; Griffiths, Gillian/0000-0003-0434-5842	Wellcome Trust [075880, 103930]; Eunice Shriver National Institute of Child Health and Human Development;  [100140]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Eunice Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by the Wellcome Trust through Principal Research Fellowships (075880 and 103930) to G.M.G. and a Strategic Award (100140) to the Cambridge Institute for Medical Research (CIMR). A.T.R. is an NIH-OxCam scholar supported by funding to J.L.-S. from the Eunice Shriver National Institute of Child Health and Human Development. At the NIH, we thank Senta Kapnick and Pam Schwartzberg for assistance with CTL culture and helpful discussion, P. Sengupta for Farnesyl-EGFP, and Erin Fincher for assistance with the graphic illustration. At the CIMR, we thank Matthew Gratian and Mark Bowen for support with imaging and Alison Schuldt and John James for critical reading of the manuscript. The light-sheet technology used herein is covered by US patent 7,894,136 (issued to E.B. and assigned to Lattice Light LLC of Ashburn, VA), US patent 8,711,211 (issued to E.B. and assigned to the Howard Hughes Medical Institute [HHMI]), and US patent application 13/844,405 (filed by E.B. and assigned to the HHMI).	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Babich A, 2011, IMMUNITY, V34, P825, DOI 10.1016/j.immuni.2011.06.004; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; Blott EJ, 2001, J CELL SCI, V114, P2405; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gillingham AK, 2000, EMBO REP, V1, P524; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Huse M, 2013, IMMUNOL REV, V256, P95, DOI 10.1111/imr.12116; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jenkins MR, 2014, ELIFE, V3, DOI 10.7554/eLife.01310; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Poenie M, 2004, CURR OPIN IMMUNOL, V16, P428, DOI 10.1016/j.coi.2004.05.016; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; YANNELLI JR, 1986, J IMMUNOL, V136, P377; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108	42	182	182	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					864	876		10.1016/j.immuni.2015.04.013	http://dx.doi.org/10.1016/j.immuni.2015.04.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992860	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000354827400013
J	Williams, CJ; Naito, T; Arco, PGD; Seavitt, JR; Cashman, SM; De Souza, B; Qi, XQ; Keables, P; Von Andrian, UH; Georgopoulos, K				Williams, CJ; Naito, T; Arco, PGD; Seavitt, JR; Cashman, SM; De Souza, B; Qi, XQ; Keables, P; Von Andrian, UH; Georgopoulos, K			The chromatin remodeler Mi-2 beta is required for CD4 expression and T cell development	IMMUNITY			English	Article							RNA-POLYMERASE-II; POSITIVE SELECTION; GENE-EXPRESSION; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; HISTONE DEACETYLASE; IKAROS GENE; ALPHA-BETA; PROTEINS; COMPLEX	Changes in chromatin structure underlie the activation or silencing of genes during development. The chromatin remodeler Mi-2beta is highly expressed in thymocytes and is presumed to be a transcriptional repressor because of its presence in the nucleosome remodeling deacetylase (NuRD) complex. Using conditional inactivation, we show that Mi-2beta is required at several steps during T cell development: for differentiation of P selected immature thymocytes, for developmental expression of CD4, and for cell divisions in mature T cells. We further show that Mi-2beta plays a direct role in promoting CD4 gene expression. Mi-2beta associates with the CD4 enhancer as well as the E box binding protein HEB and the histone acetyltransferase (HAT) p300, enabling their recruitment to the CD4 enhancer and causing histone H3-hyperacetylation to this regulatory region. These findings provide important insights into the regulation of CD4 expression during T cell development and define a role for Mi-2beta in gene activation.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Georgopoulos, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Gomez-del Arco, Pablo/L-2728-2013; Arco, Pablo Gomez-del/ABG-3417-2020; von Andrian, Ulrich H/A-5775-2008	Gomez-del Arco, Pablo/0000-0001-6748-7157; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038342] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI038342, R01-AI1380342-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adlam M, 1997, INT IMMUNOL, V9, P877, DOI 10.1093/intimm/9.6.877; Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Barndt R, 1999, J IMMUNOL, V163, P3331; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hirose F, 2002, MOL CELL BIOL, V22, P5182, DOI 10.1128/MCB.22.14.5182-5193.2002; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Manjunath N, 1999, P NATL ACAD SCI USA, V96, P13932, DOI 10.1073/pnas.96.24.13932; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Schilham MW, 1998, J IMMUNOL, V161, P3984; Shimono Y, 2003, J BIOL CHEM, V278, P51638, DOI 10.1074/jbc.M309198200; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; von Boehmer H, 1998, IMMUNOL REV, V165, P111; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	39	182	184	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					719	733		10.1016/j.immuni.2004.05.005	http://dx.doi.org/10.1016/j.immuni.2004.05.005			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189737	Bronze			2022-12-18	WOS:000222205300008
J	Groves, T; Smiley, P; Cooke, MP; Forbush, K; Perlmutter, RM; Guidos, CJ				Groves, T; Smiley, P; Cooke, MP; Forbush, K; Perlmutter, RM; Guidos, CJ			Fyn can partially substitute for Lck in T lymphocyte development	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; IMMATURE CD4+CD8+ THYMOCYTES; CELL RECEPTOR EXPRESSION; POSITIVE SELECTION; MICE LACKING; SIGNAL-TRANSDUCTION; DEFICIENT MICE; MUTANT MICE; NEGATIVE SELECTION; THYMIC SELECTION	Lck, a Src family tyrosine kinase, transduces signals important for the development of alpha beta and gamma delta T cells. However, T cell development is only partially compromised in Lck-deficient mice, suggesting that other kinases may also transduce pre-TCR or TCR signals. One candidate is Fyn, a Src kinase coexpressed with Lck in immature and mature T cells. Here we show that T cell development is completely compromised in lck(-/-)fyn(-/-) mice. In addition, we demonstrate that expression of a gain-of-function mutant fyn(T) transgene completely restores production of immature CD4/CD8 double positive thymocytes and gamma delta T cells and improves the representation of CD4 or CD8 single positive thymocytes. These observations reveal that Fyn can subserve some Lck-like functions in T cell development.	HOSP SICK CHILDREN,RES INST,DIV IMMUNOL & CANC,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON M5S 1A8,CANADA; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle								ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; ANDERSON SJ, 1995, IMMUNOL TODAY, V16, P99, DOI 10.1016/0167-5699(95)80096-4; ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; CARRERA AC, 1992, J IMMUNOL, V149, P3142; CARRERA AC, 1992, EUR J IMMUNOL, V22, P2289, DOI 10.1002/eji.1830220917; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; CORREA I, 1992, P NATL ACAD SCI USA, V89, P653, DOI 10.1073/pnas.89.2.653; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GILLILAND LK, 1991, J IMMUNOL, V146, P1759; GROVES T, 1995, J IMMUNOL, V154, P5011; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; GUIDOS CJ, 1993, MOL MECHANISMS IMMUN, P137; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LEVELT CN, 1995, IMMUNITY, V3, P215, DOI 10.1016/1074-7613(95)90091-8; LEVELT CN, 1993, P NATL ACAD SCI USA, V90, P11401, DOI 10.1073/pnas.90.23.11401; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; NAKAYAMA T, 1991, P NATL ACAD SCI USA, V88, P9949, DOI 10.1073/pnas.88.22.9949; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OHNO H, 1993, EMBO J, V12, P4357, DOI 10.1002/j.1460-2075.1993.tb06120.x; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; Poussier P, 1995, Semin Immunol, V7, P321, DOI 10.1016/1044-5323(95)90013-6; REYNOLDS PJ, 1990, MOL CELL BIOL, V10, P4266, DOI 10.1128/MCB.10.8.4266; SECKINGER P, 1994, J IMMUNOL, V153, P97; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; SHORES EW, 1993, J IMMUNOL, V150, P1263; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEH HS, 1991, NATURE, V349, P241, DOI 10.1038/349241a0; TURKA LA, 1991, J IMMUNOL, V146, P1428; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VANOERS NSC, 1992, EUR J IMMUNOL, V22, P735, DOI 10.1002/eji.1830220317; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WALLACE VA, 1995, EUR J IMMUNOL, V25, P1312, DOI 10.1002/eji.1830250527; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WELLS FB, 1991, SCIENCE, V253, P903, DOI 10.1126/science.1831565; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383; Wu G, 1996, INT IMMUNOL, V8, P1159, DOI 10.1093/intimm/8.7.1159	74	182	183	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					417	428		10.1016/S1074-7613(00)80498-7	http://dx.doi.org/10.1016/S1074-7613(00)80498-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934569	Bronze			2022-12-18	WOS:A1996VV65800003
J	Nakamoto, M; Moy, RH; Xu, J; Bambina, S; Yasunaga, A; Shelly, SS; Gold, B; Cherry, S				Nakamoto, Margaret; Moy, Ryan H.; Xu, Jie; Bambina, Shelly; Yasunaga, An; Shelly, Spencer S.; Gold, Beth; Cherry, Sara			Virus Recognition by Toll-7 Activates Antiviral Autophagy in Drosophila	IMMUNITY			English	Article							VESICULAR STOMATITIS-VIRUS; INNATE IMMUNE RECOGNITION; HOST-DEFENSE; VIRAL RECOGNITION; RECEPTORS; PATHWAY; GENE; MELANOGASTER; RHABDOVIRUS; INFECTION	Innate immunity is highly conserved and relies on pattern recognition receptors (PRRs) such as Toll-like receptors (identified through their homology to Drosophila Toll) for pathogen recognition. Although Drosophila Toll is vital for immune recognition and defense, roles for the other eight Drosophila Tolls in immunity have remained elusive. Here we have shown that Toll-7 is a PRR both in vitro and in adult flies; loss of Toll-7 led to increased vesicular stomatitis virus (VSV) replication and mortality. Toll-7, along with additional uncharacterized Drosophila Tolls, was transcriptionally induced by VSV infection. Furthermore, Toll-7 interacted with VSV at the plasma membrane and induced antiviral autophagy independently of the canonical Toll signaling pathway. These data uncover an evolutionarily conserved role for a second Drosophila Toll receptor that links viral recognition to autophagy and defense and suggest that other Drosophila Tolls may restrict specific as yet untested pathogens, perhaps via non-canonical signaling pathways.	[Nakamoto, Margaret; Moy, Ryan H.; Xu, Jie; Bambina, Shelly; Yasunaga, An; Shelly, Spencer S.; Gold, Beth; Cherry, Sara] Univ Penn, Dept Microbiol, Penn Genome Frontiers Inst, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Penn Genome Frontiers Inst, Sch Med, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu		cherry, sara/0000-0003-3956-6610; Moy, Ryan/0000-0002-0507-8590	NIH [T32AI007324, R01AI074951, U54AI057168]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074951, R56AI074951, U54AI057168, T32AI007324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ross, R. Doms, and M. Tudor for critical reading of the manuscript; the VDRC for Toll snapback transgenic flies; the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks; Y. Yagi for Toll-7 mutants; The Bloomington Stock center for other fly stocks; J. Rose for VSV-GFP; and R. Doms for VSV-G (11) antibody. This work was supported by NIH grants T32AI007324 to R.H.M. and R01AI074951 and U54AI057168 to S.C. S.C. is a recipient of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arsham AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006068; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Bilak H, 2003, BIOCHEM SOC T, V31, P648, DOI 10.1042/bst0310648; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chang S, 2007, J LEUKOCYTE BIOL, V82, P479, DOI 10.1189/jlb.0207128; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; CONTAMINE D, 1989, GENETICS, V123, P525; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; DRU P, 1993, GENETICS, V133, P943; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Fleuriet A., 1988, EVOLUTIONARY BIOL; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Ligoxygakis P, 2002, EMBO REP, V3, P666, DOI 10.1093/embo-reports/kvf130; Longdon B, 2010, P ROY SOC B-BIOL SCI, V277, P35, DOI 10.1098/rspb.2009.1472; Luo C, 2001, INSECT MOL BIOL, V10, P457, DOI 10.1046/j.0962-1075.2001.00284.x; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Mead DG, 2004, VECTOR-BORNE ZOONOT, V4, P351, DOI 10.1089/vbz.2004.4.351; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Narbonne-Reveau K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017470; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Siren J, 2005, J IMMUNOL, V174, P1932, DOI 10.4049/jimmunol.174.4.1932; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Xu Yi, 2010, Proc Am Thorac Soc, V7, P22, DOI 10.1513/pats.200909-103JS; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	63	181	191	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					658	667		10.1016/j.immuni.2012.03.003	http://dx.doi.org/10.1016/j.immuni.2012.03.003			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22464169	Green Accepted, Bronze			2022-12-18	WOS:000303223900017
J	Oschatz, C; Maas, C; Lecher, B; Jansen, T; Bjorkqvist, J; Tradler, T; Sedlmeier, R; Burfeind, P; Cichon, S; Hammerschmidt, S; Muller-Esterl, W; Wuillemin, WA; Nilsson, G; Renne, T				Oschatz, Chris; Maas, Coen; Lecher, Bernd; Jansen, Thomas; Bjorkqvist, Jenny; Tradler, Thomas; Sedlmeier, Reinhard; Burfeind, Peter; Cichon, Sven; Hammerschmidt, Sven; Mueller-Esterl, Werner; Wuillemin, Walter A.; Nilsson, Gunnar; Renne, Thomas			Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo	IMMUNITY			English	Article							FACTOR-XII; HEREDITARY ANGIOEDEMA; CHONDROITIN SULFATE; CONTACT SYSTEM; ACTIVATION; MECHANISMS; GENE; KALLIKREIN; GENERATION; DEFICIENT	Activated mast cells trigger edema in allergic and inflammatory disease. We report a paracrine mechanism by which mast cell-released heparin increases vascular permeability in vivo. Heparin activated the protease factor XII, which initiates bradykinin formation in plasma. Targeting factor XII or kinin B2 receptors abolished heparin-triggered leukocyte-endothelium adhesion and interfered with a mast cell-driven drop in blood pressure in rodents. Intravital laser scanning microscopy and tracer measurements showed heparin-driven fluid extravasation in mouse skin microvessels. Ablation of factor XII or kinin B2 receptors abolished heparin-induced skin edema and protected mice from allergen-activated mast cell-driven leakage. In contrast, heparin and activated mast cells induced excessive edema in mice deficient in the major inhibitor of factor XII, Cl esterase inhibitor. Allergen exposure triggered edema attacks in hereditary angioedema patients, lacking Cl esterase inhibitor. The data indicate that heparin-initiated bradykinin formation plays a fundamental role in mast cell-mediated diseases.	[Oschatz, Chris; Maas, Coen; Jansen, Thomas; Bjorkqvist, Jenny; Renne, Thomas] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Oschatz, Chris; Maas, Coen; Jansen, Thomas; Bjorkqvist, Jenny; Renne, Thomas] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Nilsson, Gunnar] Karolinska Inst, Dept Med, Allergy & Clin Immunol Unit, S-17176 Stockholm, Sweden; [Lecher, Bernd] Mfd Diagnost GmbH, D-55234 Wendelsheim, Germany; [Jansen, Thomas] Univ Med Ctr Mainz, Dept Med 2, D-55131 Mainz, Germany; [Tradler, Thomas] Scil Prot GmbH, D-06120 Halle, Germany; [Sedlmeier, Reinhard] Ingenium Pharmaceut GmbH, D-82152 Martinsried, Germany; [Burfeind, Peter] Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53105 Bonn, Germany; [Cichon, Sven] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Cichon, Sven] Res Ctr Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Mueller-Esterl, Werner] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Wuillemin, Walter A.] Luzerner Kantonsspital, Div Hematol, CH-6000 Luzern, Switzerland; [Wuillemin, Walter A.] Luzerner Kantonsspital, Cent Hematol Lab, CH-6000 Luzern, Switzerland; [Wuillemin, Walter A.] Univ Bern, CH-3010 Bern, Switzerland	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Johannes Gutenberg University of Mainz; University of Gottingen; University of Bonn; University of Bonn; Helmholtz Association; Research Center Julich; Ernst Moritz Arndt Universitat Greifswald; Goethe University Frankfurt; Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Bern	Renne, T (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	thomas@renne.net	Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014; Hammerschmidt, Sven/G-2598-2010	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Hammerschmidt, Sven/0000-0002-6382-6681; Renne, Thomas/0000-0003-4594-5975; Bjorkqvist, Jenny/0000-0003-1256-1908; Nilsson, Gunnar/0000-0001-6795-5512; Maas, Coen/0000-0003-4593-0976	Vetenskapsradet [K2010-64X-21462-01-3]; Hjart Lungfonden [20090642]; Stockholms lans landsting (ALF) [20090540]; Stiftung fur Pathobiochemie und Molekulare Diagnostik of the DGKL,; Cancerfonden [100615]; Federal Ministry of Education and Research (BMBF); Rubicon fellowship [825-10-012]; Netherlands Organisation for Scientific Research (NWO); Margarete Waitz-foundation, Mainz	Vetenskapsradet(Swedish Research Council); Hjart Lungfonden; Stockholms lans landsting (ALF); Stiftung fur Pathobiochemie und Molekulare Diagnostik of the DGKL,; Cancerfonden(Swedish Cancer Society); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Rubicon fellowship; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Margarete Waitz-foundation, Mainz	This work was supported in part by grants from Vetenskapsradet (K2010-64X-21462-01-3), Hjart Lungfonden (20090642), Stockholms lans landsting (ALF, 20090540), Stiftung fur Pathobiochemie und Molekulare Diagnostik of the DGKL, Cancerfonden (100615), and the Federal Ministry of Education and Research (BMBF)-funded ERARE program to T.R. C.M. is supported by a Rubicon fellowship (825-10-012), provided by the Netherlands Organisation for Scientific Research (NWO). T.J. holds a scholarship of the Margarete Waitz-foundation, Mainz. Part of the work of T.T. was performed at Jerini AG, Berlin. We thank L. Kjellen (Uppsala University, Uppsala, Sweden) for providing Ndst2<SUP>-/-</SUP> mice.	Akcali C, 2008, J EUR ACAD DERMATOL, V22, P83, DOI 10.1111/j.1468-3083.2007.02353.x; BELTRAMI E, 1995, P NATL ACAD SCI USA, V92, P8744, DOI 10.1073/pnas.92.19.8744; Bork K, 2009, J ALLERGY CLIN IMMUN, V124, P129, DOI 10.1016/j.jaci.2009.03.038; Brunnee T, 1997, CLIN EXP ALLERGY, V27, P653; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cichon S, 2006, AM J HUM GENET, V79, P1098, DOI 10.1086/509899; COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8; Davis AE, 2008, ANN ALLERG ASTHMA IM, V100, pS7, DOI 10.1016/S1081-1206(10)60580-7; Dlamini Z, 2005, J CLIN PATHOL, V58, P915, DOI 10.1136/jcp.2004.021444; Donelan J, 2006, P NATL ACAD SCI USA, V103, P7759, DOI 10.1073/pnas.0602210103; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; FAREED J, 1989, SEMIN THROMB HEMOST, V15, P440, DOI 10.1055/s-2007-1002744; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Greenhawt M, 2007, CURR OPIN ALLERGY CL, V7, P387, DOI 10.1097/ACI.0b013e3282a6443e; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; HOJIMA Y, 1984, BLOOD, V63, P1453; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; ISHIZAKA T, 1985, J IMMUNOL, V134, P1880; Johne J, 2006, BIOL CHEM, V387, P173, DOI 10.1515/BC.2006.023; Jorpes E, 1935, Biochem J, V29, P1817; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LINKER A, 1972, BIOCHEMISTRY-US, V11, P563, DOI 10.1021/bi00754a013; LOMBARDINI C, 2009, AM J EMERG MED, V27, pE1171; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; MacLaughlin EJ, 2002, PHARMACOTHERAPY, V22, P1511, DOI 10.1592/phco.22.16.1511.33688; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MASS C, 2011, SEMIN THROM IN PRESS; MAZZI G, 1994, HAEMATOLOGICA, V79, P283; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Noga O, 1999, INT ARCH ALLERGY IMM, V120, P310, DOI 10.1159/000024284; Nzeako UC, 2001, ARCH INTERN MED, V161, P2417, DOI 10.1001/archinte.161.20.2417; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; PROUD D, 1988, ANNU REV IMMUNOL, V6, P49, DOI 10.1146/annurev.iy.06.040188.000405; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; SIEBECK M, 1994, J APPL PHYSIOL, V77, P2675, DOI 10.1152/jappl.1994.77.6.2675; Siebenhaar F, 2008, J ALLERGY CLIN IMMUN, V121, P955, DOI 10.1016/j.jaci.2007.11.013; STEVENS RL, 1988, P NATL ACAD SCI USA, V85, P2284, DOI 10.1073/pnas.85.7.2284; Summers CW, 2008, J ALLERGY CLIN IMMUN, V121, P632, DOI 10.1016/j.jaci.2007.12.003; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Ullrich Melanie, 2009, Methods Mol Biol, V561, P145, DOI 10.1007/978-1-60327-019-9_10; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]; WIRTH K, 1991, BRIT J PHARMACOL, V102, P774, DOI 10.1111/j.1476-5381.1991.tb12249.x; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	53	181	187	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					258	268		10.1016/j.immuni.2011.02.008	http://dx.doi.org/10.1016/j.immuni.2011.02.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349432	Bronze			2022-12-18	WOS:000287989500015
J	Hu, XY; Chung, AY; Wu, I; Foldi, J; Chen, J; Ji, JD; Tateya, T; Kang, YJ; Han, JH; Gessler, M; Kageyama, R; Ivashkiv, LB				Hu, Xiaoyu; Chung, Allen Y.; Wu, Indira; Foldi, Julia; Chen, Janice; Ji, Jong Dae; Tateya, Tomoko; Kang, Young Jun; Han, Jiahuai; Gessler, Manfred; Kageyama, Ryoichiro; Ivashkiv, Lionel B.			Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-gamma Pathways	IMMUNITY			English	Article							T-CELL-ACTIVATION; MACROPHAGE ACTIVATION; GENE-EXPRESSION; DENDRITIC CELLS; INFLAMMATORY RESPONSE; NEGATIVE REGULATION; GATA3 EXPRESSION; UP-REGULATION; TARGET GENES; JAK-STAT	Toll-like receptor (TLR) responses are regulated to avoid toxicity and achieve coordinated responses appropriate for the cell environment. We found that Notch and TLR pathways cooperated to activate canonical Notch target genes, including transcriptional repressors Hes1 and Hey1, and to increase production of canonical TLR-induced cytokines TNF, IL-6,and IL-12. Cooperation by these pathways to increase target gene expression was mediated by the Notch-pathway component and transcription factor RBP-J, which also contributed to lethality after endotoxin injection. TLR- and Notch-induced Hes1 and Hey1 attenuated IL-6 and IL-12 production. This Hes1-and Hey1-mediated feedback inhibitory loop was abrogated by interferon-gamma (IFN-gamma), which blocked TLR-induced activation of canonical Notch target genes by inhibiting Notch2 signaling and downstream transcription. These findings identify new immune functions for RBP-J, Hes, and Hey proteins and provide insights into mechanisms by which Notch, TLR, and IFN-gamma signals are integrated to modulate specific effector functions in macrophages.	[Hu, Xiaoyu; Chung, Allen Y.; Wu, Indira; Ji, Jong Dae; Ivashkiv, Lionel B.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Foldi, Julia; Chen, Janice; Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Ji, Jong Dae] Korea Univ, Coll Med, Div Rheumatol, Seoul 136705, South Korea; [Tateya, Tomoko; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Kang, Young Jun; Han, Jiahuai] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97074 Wurzburg, Germany	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Korea University; Korea University Medicine (KU Medicine); Kyoto University; Scripps Research Institute; University of Wurzburg	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	ivashkivl@hss.edu	Han, J/G-4671-2010; æè°·, æå/AAG-3748-2020; Hu, Xiaoyu/D-5403-2017; Tateya, Tomoko/ABF-1420-2021	Hu, Xiaoyu/0000-0002-4289-6998; Kang, Young Jun/0000-0001-9778-1963; Gessler, Manfred/0000-0002-7915-6045	Arthritis Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712, R01AI044938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713] Funding Source: NIH RePORTER	Arthritis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Kopan for the Hes1 reporter and NICD1 expression plasmids, A. Beg for the IL-6-reporler construct, T. Honjo for permission to use Rbpj floxed mice, and E. Fuchs for transfer of Rbpj floxed mice. We also thank C. Shi for some of the RBPJ RNAi experiments, K.-H. Park-Min for critical review of the manuscript and 1. Rogatsky for helpful discussions. This work was supported by grants from the Arthritis Foundation (X.H.) and the National Institutes of Health (L.B.I.).	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hu XY, 2005, J IMMUNOL, V175, P131, DOI 10.4049/jimmunol.175.1.131; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Johansen LM, 2003, J VIROL, V77, P6029, DOI 10.1128/JVI.77.10.6029-6040.2003; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104	55	181	188	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					691	703		10.1016/j.immuni.2008.08.016	http://dx.doi.org/10.1016/j.immuni.2008.08.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18976936	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000261036000008
J	Dion, ML; Poulin, JF; Bordi, R; Sylvestre, M; Corsini, R; Kettaf, N; Dalloul, A; Boulassel, MR; Debre, P; Routy, JP; Grossman, Z; Sekaly, RP; Cheynier, R				Dion, ML; Poulin, JF; Bordi, R; Sylvestre, M; Corsini, R; Kettaf, N; Dalloul, A; Boulassel, MR; Debre, P; Routy, JP; Grossman, Z; Sekaly, RP; Cheynier, R			HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation	IMMUNITY			English	Article							T-CELL-RECEPTOR; RECENT THYMIC EMIGRANTS; EXCISION CIRCLE CONTENT; ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; TELOMERE LENGTH; OUTPUT; HOMEOSTASIS; TURNOVER; DISEASE	The supply of naive T cells by the thymus normally requires precursor T cell proliferation within the thymus and would be particularly important in the setting of HIV infection when both naive and memory T cells are progressively depleted. As a robust, quantitative index of intrathymic proliferation, the ratio of different	Hop Hotel Dieu, CHUM, Immunol Lab, Ctr Rech, Montreal, PQ H2X 1P1, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H2X 1P1, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H2X 1P1, Canada; McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H2X 1P1, Canada; Univ Montreal, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H2X 1P1, Canada; Grp Hosp Pitie Salpetriere, INSERM, U543, F-75651 Paris 13, France; McGill Univ, Ctr Hlth, Royal Victoria Hosp, Immunodeficiency Serv, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Hematol, Montreal, PQ H3A 1A1, Canada; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	Universite de Montreal; McGill University; McGill University; McGill University; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sekaly, RP (corresponding author), Hop Hotel Dieu, CHUM, Immunol Lab, Ctr Rech, Montreal, PQ H2X 1P1, Canada.	rafick-pierre.sekaly@umontreal.ca	Grossman, Zvi/A-9643-2008; Cheynier, Remi/E-9921-2010	Cheynier, Remi/0000-0003-1146-660X				Aladdin H, 2003, SCAND J IMMUNOL, V57, P485, DOI 10.1046/j.1365-3083.2003.01258.x; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Douek Daniel C., 2003, AIDS Reviews, V5, P172; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Grossman Z, 2000, NAT MED, V6, P976, DOI 10.1038/79667; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Livak F, 1996, MOL CELL BIOL, V16, P609; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; Nobile M, 2004, BLOOD, V104, P470, DOI 10.1182/blood-2003-12-4265; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Ometto L, 2002, AIDS, V16, P839, DOI 10.1097/00002030-200204120-00003; Poulin JF, 2003, BLOOD, V102, P4600, DOI 10.1182/blood-2003-05-1428; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; Richardson MW, 2000, BIOMED PHARMACOTHER, V54, P21, DOI 10.1016/S0753-3322(00)88637-0; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Silvestri G, 2003, J CLIN INVEST, V112, P821, DOI 10.1172/JCI200319799; Steffens CM, 2001, AIDS, V15, P1757, DOI 10.1097/00002030-200109280-00003; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; Tanchot C, 1997, J EXP MED, V186, P1099, DOI 10.1084/jem.186.7.1099; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7	39	181	190	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2004	21	6					757	768		10.1016/j.immuni.2004.10.013	http://dx.doi.org/10.1016/j.immuni.2004.10.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589165	Bronze			2022-12-18	WOS:000225901600004
J	Schakel, K; Kannagi, R; Kniep, B; Goto, Y; Mitsuoka, C; Zwirner, J; Soruri, A; von Kietzell, M; Rieber, EP				Schakel, K; Kannagi, R; Kniep, B; Goto, Y; Mitsuoka, C; Zwirner, J; Soruri, A; von Kietzell, M; Rieber, EP			6-sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells	IMMUNITY			English	Article							MONOCLONAL-ANTIBODY; HUMAN BLOOD; PERIPHERAL-BLOOD; SELECTIN LIGAND; LYMPH-NODES; T-CELLS; ANTIGEN; EXPRESSION; SUBSETS; EPITOPE	The monoclonal antibody M-DC8 defines a major subset of human blood dendritic cells (DCs). Here we identify the M-DC8 structure as 6-sulfo LacNAc, a novel carbohydrate modification of the P selectin glycoprotein ligand 1 (PSGL-1). In contrast to previously described blood DCs, M-DC8(+) DCs lack the cutaneous lymphocyte antigen (CLA) on PSGL-1 and fail to bind P and E selectin. Yet they express anaphylatoxin receptors (C5aR and C3aR) and the Fcgamma receptor III (CD16), which recruit cells to inflammatory sites. While sharing with DC1 the expression of myeloid markers and a potent capacity to prime T cells in vitro, M-DC8(+) DCs produce far more TNF-alpha in response to the bacterial endotoxin lipopolysaccharide (LPS). Thus, 6-sulfo LacNAc-expressing DCs appear as a novel proinflammatory DC subset.	Tech Univ Dresden, Inst Immunol, D-8027 Dresden, Germany; Tech Univ Dresden, Fac Med, Dept Dermatol, D-8027 Dresden, Germany; Aichi Canc Ctr, Program Expt Pathol, Nagoya, Aichi 464, Japan; Univ Gottingen, Dept Immunol, D-3400 Gottingen, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Aichi Cancer Center; University of Gottingen	Rieber, EP (corresponding author), Tech Univ Dresden, Inst Immunol, D-8027 Dresden, Germany.	rieber@rcs.urz.tu-dresden.de	Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921				Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BRANDLEY BK, 1993, GLYCOBIOLOGY, V3, P633, DOI 10.1093/glycob/3.6.633; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Cummings RD, 1999, BRAZ J MED BIOL RES, V32, P519, DOI 10.1590/S0100-879X1999000500004; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Fabbi M, 1999, J IMMUNOL, V163, P5964; FINGERLE G, 1993, BLOOD, V82, P3170; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; Ikemoto T, 1997, NEOPLASMA, V44, P289; Ito T, 1999, J IMMUNOL, V163, P1409; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KAMEYAMA A, 1991, CARBOHYD RES, V209, pC1, DOI 10.1016/0008-6215(91)80171-I; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kohrgruber N, 1999, J IMMUNOL, V163, P3250; Komba S, 1996, CARBOHYD RES, V285, pC1, DOI 10.1016/S0008-6215(96)90188-3; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413; PICKER LJ, 1990, AM J PATHOL, V136, P1053; RIEBER P, 1981, HYBRIDOMA, V1, P59, DOI 10.1089/hyb.1.1981.1.59; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; Rothermel E, 1997, BBA-GENE STRUCT EXPR, V1351, P9, DOI 10.1016/S0167-4781(97)00006-7; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Siedlar M, 2000, IMMUNOBIOLOGY, V202, P11, DOI 10.1016/S0171-2985(00)80047-9; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Ulloa F, 2000, J BIOL CHEM, V275, P18785, DOI 10.1074/jbc.M000510200; Vallin H, 1999, J IMMUNOL, V163, P6306; WERFEL T, 1992, BLOOD, V79, P152, DOI 10.1182/blood.V79.1.152.bloodjournal791152; WILHELM M, 1986, J IMMUNOL METHODS, V90, P89, DOI 10.1016/0022-1759(86)90388-1; Zwirner J, 1999, IMMUNOLOGY, V97, P166	43	181	188	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					289	301		10.1016/S1074-7613(02)00393-X	http://dx.doi.org/10.1016/S1074-7613(02)00393-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354382	Bronze			2022-12-18	WOS:000178163100006
J	Lee, CK; Raz, R; Gimeno, R; Gertner, R; Wistinghausen, B; Takeshita, K; DePinho, RA; Levy, DE				Lee, CK; Raz, R; Gimeno, R; Gertner, R; Wistinghausen, B; Takeshita, K; DePinho, RA; Levy, DE			STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; EMBRYONIC STEM-CELLS; FACTOR-RECEPTOR; TARGETED DISRUPTION; MYELOID DIFFERENTIATION; SIGNAL-TRANSDUCTION; CHRONIC NEUTROPENIA; DEFICIENT MICE; GRANULOCYTE; ACTIVATION	STAT3 has been described as an essential component of G-CSF-driven cell proliferation and granulopoiesis. This notion was tested by conditional gene ablation in transgenic mice. Contrary to expectation, granulocytes developed from STAT3 null bone marrow progenitors, and STAT3 null neutrophils displayed mature effector functions. Rather than a deficit in granulopoiesis, mice lacking STAT3 in their hematopoietic progenitors developed neutrophilia, and bone marrow cells were hyperresponsive to G-CSF stimulation. These studies provide direct evidence for STAT3-independent granulopoiesis and suggest that STAT3 directs a negative feedback loop necessary for controlling neutrophil numbers, possibly through induced expression of the signaling inhibitor, SOCS3.	NYU, Sch Med, Dept Pathol, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	New York University; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Levy, DE (corresponding author), NYU, Sch Med, Dept Pathol, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA.		Levy, David/AAG-6202-2019; Lee, Chien-Kuo/AAZ-1039-2020; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; Lee, Chien-Kuo/0000-0001-8189-6045; DePinho, Ronald/0000-0002-5625-577X				Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Basu S, 2000, BLOOD, V95, P3725; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hermans MHA, 1998, BLOOD, V92, P32, DOI 10.1182/blood.V92.1.32.413k42_32_39; Hibi M, 2000, LEUKEMIA LYMPHOMA, V37, P299, DOI 10.3109/10428190009089430; Ihle JN, 1996, BIOESSAYS, V18, P95, DOI 10.1002/bies.950180204; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; Schmitz J, 2000, J IMMUNOL, V164, P848, DOI 10.4049/jimmunol.164.2.848; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tidow N, 1997, Curr Opin Hematol, V4, P171; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; ZOU YR, 1994, CURR BIOL, V4, P1099, DOI 10.1016/S0960-9822(00)00248-7	45	181	187	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					63	72		10.1016/S1074-7613(02)00336-9	http://dx.doi.org/10.1016/S1074-7613(02)00336-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150892	Green Published, Bronze			2022-12-18	WOS:000177187500007
J	Seo, SJ; Fields, ML; Buckler, JL; Reed, AJ; Mandik-Nayak, L; Nish, SA; Noelle, RJ; Turka, LA; Finkelman, FD; Caton, AJ; Erikson, J				Seo, SJ; Fields, ML; Buckler, JL; Reed, AJ; Mandik-Nayak, L; Nish, SA; Noelle, RJ; Turka, LA; Finkelman, FD; Caton, AJ; Erikson, J			The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells	IMMUNITY			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; MRL-LPR/LPR MICE; MRL/LPR MICE; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; AUTOANTIBODY PRODUCTION; DEVELOPMENTAL ARREST; FOLLICULAR EXCLUSION; TRANSGENIC MICE; LYMPHOCYTES-B	Autoreactive B cells that appear to be inactivated can be found in healthy individuals. In this study, we examined the potential of these anergic cells to become activated. We show that anergy of anti-double-stranded DNA (dsDNA) B cells in BALB/c mice is readily reversed, requiring only the provision of T cell help. We further show that spontaneous loss of anergy among anti-dsDNA B cells in autoimmune Ipr/Ipr mice occurs in two phases: an abortive initial response to T help followed by full loss of tolerance. Strikingly, the abortive response can be reproduced in nonautoimmune mice when CD4(+)CD25(+) T regulatory cells are administered in conjunction with CD4(+) T helper cells, suggesting that loss of B cell tolerance may require both the production of T cell help and the overcoming of T suppression.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Dartmouth Coll Sch Med, Dept Microbiol, Lebanon, NH 03756 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA	The Wistar Institute; Dartmouth College; University of Pennsylvania; University System of Ohio; University of Cincinnati	Erikson, J (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	jan@wistar.upenn.edu			NIAID NIH HHS [AI 32137, AI 24541] Funding Source: Medline; NIAMS NIH HHS [AR 49713] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024541, R01AI032137, R29AI032137, R56AI024541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049713] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AARDEN LA, 1975, ANN NY ACAD SCI, V254, P505, DOI 10.1111/j.1749-6632.1975.tb29197.x; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CERASOLI DM, 1995, INT IMMUNOL, V7, P935, DOI 10.1093/intimm/7.6.935; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; Chesnutt MS, 1998, CLIN IMMUNOL IMMUNOP, V87, P23, DOI 10.1006/clin.1997.4492; Cook MC, 1997, J EXP MED, V186, P631, DOI 10.1084/jem.186.5.631; Cook MC, 1998, EUR J IMMUNOL, V28, P2549, DOI 10.1002/(SICI)1521-4141(199808)28:08<2549::AID-IMMU2549>3.0.CO;2-O; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cyster JG, 1999, CURR TOP MICROBIOL, V246, P87; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Fields ML, 2001, J IMMUNOL, V167, P2370, DOI 10.4049/jimmunol.167.4.2370; Filaci G, 2001, J IMMUNOL, V166, P6452, DOI 10.4049/jimmunol.166.10.6452; Foote LC, 1998, J EXP MED, V187, P847, DOI 10.1084/jem.187.6.847; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GIESE T, 1992, J IMMUNOL, V149, P3097; GLEICHMANN E, 1984, IMMUNOL TODAY, V5, P324, DOI 10.1016/0167-5699(84)90126-9; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; JABS DA, 1992, CELL IMMUNOL, V141, P496, DOI 10.1016/0008-8749(92)90166-M; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kinoshita K, 2000, J IMMUNOL, V164, P6046, DOI 10.4049/jimmunol.164.11.6046; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KOH DR, 1995, EUR J IMMUNOL, V25, P2558, DOI 10.1002/eji.1830250923; Liang BL, 1999, J IMMUNOL, V163, P2322; Liang BL, 2000, J IMMUNOL, V165, P3436, DOI 10.4049/jimmunol.165.6.3436; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Ma J, 1996, J IMMUNOL, V157, P417; Mandik-Nayak L, 2000, J IMMUNOL, V164, P1161, DOI 10.4049/jimmunol.164.3.1161; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Matsue H, 1999, J IMMUNOL, V162, P5287; MERINO R, 1993, J IMMUNOL, V151, P6509; MORRIS SC, 1990, J EXP MED, V171, P503, DOI 10.1084/jem.171.2.503; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; RADIC MZ, 1991, J IMMUNOL, V146, P176; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Reed AJ, 2000, J EXP MED, V192, P1763, DOI 10.1084/jem.192.12.1763; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; RUMORE PM, 1990, J CLIN INVEST, V86, P69, DOI 10.1172/JCI114716; Russell JQ, 1998, J IMMUNOL, V161, P729; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SANTORO TJ, 1988, J EXP MED, V167, P1713, DOI 10.1084/jem.167.5.1713; Seo SJ, 2001, J IMMUNOL, V166, P3710, DOI 10.4049/jimmunol.166.6.3710; Shih FF, 1997, INT IMMUNOL, V9, P249, DOI 10.1093/intimm/9.2.249; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tada Y, 1999, J IMMUNOL, V163, P3153; Takiguchi M, 1999, LAB INVEST, V79, P317; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	67	181	197	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					535	546		10.1016/S1074-7613(02)00298-4	http://dx.doi.org/10.1016/S1074-7613(02)00298-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970877	Bronze			2022-12-18	WOS:000175109600005
J	Zan, H; Komori, A; Li, ZD; Cerutti, A; Schaffer, A; Flajnik, MF; Diaz, M; Casali, P				Zan, H; Komori, A; Li, ZD; Cerutti, A; Schaffer, A; Flajnik, MF; Diaz, M; Casali, P			The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation	IMMUNITY			English	Article							HUMAN B-CELLS; HUMAN-ANTIBODY RESPONSE; DAMAGE-INDUCED MUTAGENESIS; CYTIDINE DEAMINASE AID; THYMINE-THYMINE DIMER; BASE-EXCISION-REPAIR; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; IMMUNOGLOBULIN GENES; GERMINAL CENTER	Ig somatic mutations would be introduced by a polymerase (pol) while repairing DNA outside main DNA replication. We show that human B cells constitutively express the translesion pol zeta, which effectively extends DNA past mismatched bases (mispair extender), and pol eta, which bypasses DNA lesions in an error-free fashion. Upon B cell receptor (BCR) engagement and coculture with activated CD4(+) T cells, these lymphocytes upregulated pol zeta, downregulated pol eta, and mutated the Ig and bcl-6 genes. Inhibition of the pol zeta REV3 catalytic subunit by specific phosphorothioate-modified oligonucleotides impaired Ig and bcl-6 hypermutation and UV damage-induced DNA mutagenesis, without affecting cell cycle or viability. Thus, pol zeta plays a critical role in Ig and bcl-6 hypermutation, perhaps facilitated by the downregulation of pol eta.	Cornell Univ, Weill Med Coll, Div Mol Immunol, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Cornell University; Cornell University; Cornell University; University System of Maryland; University of Maryland Baltimore; Scripps Research Institute	Casali, P (corresponding author), Cornell Univ, Weill Med Coll, Div Mol Immunol, Dept Pathol, New York, NY 10021 USA.	pcasali@med.cornell.edu	Casali, Paolo/F-6579-2010	Cerutti, Andrea/0000-0003-3026-4704; Diaz, Marilyn/0000-0002-3046-2746; Flajnik, Martin Francis/0000-0002-2792-5084	NIAID NIH HHS [AI 45011, R01 AI045011, R56 AI045011] Funding Source: Medline; NIAMS NIH HHS [R01 AR040908, AR 40908] Funding Source: Medline; NIA NIH HHS [AG 13910] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R01AI045011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013910] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; BACHL J, 1995, NATURE, V375, P285, DOI 10.1038/375285c0; Bebenek K, 2001, J BIOL CHEM, V276, P2317, DOI 10.1074/jbc.C000690200; Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Bertocci B, 1998, IMMUNITY, V9, P257, DOI 10.1016/S1074-7613(00)80608-1; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300; Catapano CV, 2000, BIOCHEMISTRY-US, V39, P5126, DOI 10.1021/bi992185w; Cerutti A, 1998, IMMUNITY, V9, P247, DOI 10.1016/S1074-7613(00)80607-X; Cerutti A, 1998, J IMMUNOL, V160, P2145; Cerutti A, 2000, J IMMUNOL, V165, P786, DOI 10.4049/jimmunol.165.2.786; Chan PP, 1997, J MOL MED, V75, P267, DOI 10.1007/s001090050112; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Esposito G, 2000, P NATL ACAD SCI USA, V97, P1166, DOI 10.1073/pnas.97.3.1166; Faria M, 2000, P NATL ACAD SCI USA, V97, P3862, DOI 10.1073/pnas.97.8.3862; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; Gibbs PEM, 2000, P NATL ACAD SCI USA, V97, P4186, DOI 10.1073/pnas.97.8.4186; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Holbeck SL, 1997, GENETICS, V147, P1017; IKEMATSU H, 1993, J IMMUNOL, V150, P1325; Ikematsu W, 1998, J IMMUNOL, V161, P2895; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Lawrence CW, 1996, CANCER SURV, V28, P21; Lewis JG, 1996, P NATL ACAD SCI USA, V93, P3176, DOI 10.1073/pnas.93.8.3176; Lin WS, 1999, MUTAT RES-DNA REPAIR, V433, P89, DOI 10.1016/S0921-8777(98)00065-2; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; NOGUCHI PD, 1992, CURRENT PROTOCOLS IM; Ohashi E, 2000, GENE DEV, V14, P1589; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; POLLORATSKY V, 2000, J EXP MED, V192, P27; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Praseuth D, 1999, BBA-GENE STRUCT EXPR, V1489, P181, DOI 10.1016/S0167-4781(99)00149-9; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Schaffer A, 1999, J IMMUNOL, V162, P5327; SEIDMAN MM, 1996, TECHNOLOGIES DETECTI, P373; Shannon M, 1998, SCIENCE, V279, P1159, DOI 10.1126/science.279.5354.1159; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Smith DS, 1996, J IMMUNOL, V156, P2642; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Storb U, 1998, J EXP MED, V188, P689, DOI 10.1084/jem.188.4.689; Storb U, 1998, CURR TOP MICROBIOL, V229, P11; STRATHERN JN, 1995, GENETICS, V140, P965; Tissier A, 2000, GENE DEV, V14, P1642; UEKI Y, 1990, J EXP MED, V171, P19, DOI 10.1084/jem.171.1.19; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WEISSBACH A, 1979, ARCH BIOCHEM BIOPHYS, V198, P386, DOI 10.1016/0003-9861(79)90511-3; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Yamada A, 2000, NUCLEIC ACIDS RES, V28, P2473, DOI 10.1093/nar/28.13.2473; Zan H, 2000, FASEB J, V14, pA1043; Zan H, 2000, J IMMUNOL, V165, P830, DOI 10.4049/jimmunol.165.2.830; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 1998, J IMMUNOL, V161, P5217	76	181	183	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					643	653		10.1016/S1074-7613(01)00142-X	http://dx.doi.org/10.1016/S1074-7613(01)00142-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371365	Green Accepted, Bronze			2022-12-18	WOS:000168880900015
J	Beresford, PJ; Xia, ZN; Greenberg, AH; Lieberman, J				Beresford, PJ; Xia, ZN; Greenberg, AH; Lieberman, J			Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation	IMMUNITY			English	Article							TOXIC LYMPHOCYTE-T; CELL-MEDIATED CYTOTOXICITY; CYTOKINE RESPONSE MODIFIER; NATURAL-KILLER-CELLS; TARGET-CELLS; SERINE PROTEASES; BCR-ABL; INDUCED APOPTOSIS; MYELOID-LEUKEMIA; DEFICIENT MICE	Cytotoxic lymphocytes trigger apoptosis by releasing perforin and granzymes (Grn). GrnB activates the caspase apoptotic pathway, but little is known about GrnA-induced cell death. Perforin was used to load recombinant GrnA and GrnB and enzymatically inactive variants into target cells. GrnA induces single-strand DNA breaks that can be labeled with Klenow polymerase and visualized on alkaline gels. GrnA-induced DNA damage but not cytolysis requires GrnA proteolysis. GrnA-induced membrane perturbation, nuclear condensation, and DNA damage are unimpaired by caspase blockade. GrnA fails to induce cleavage of caspase-3, lamin B, rho-GTPase, or PARP. GrnA-induced cytotoxicity and cleavage of PHAP II, a previously identified GrnA substrate, are unimpaired in Jurkat cells that overexpress bcl-2. Therefore, GrnA activates a novel apoptotic pathway.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Manitoba	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015					Abdelhaleem MM, 1996, J IMMUNOL, V156, P2026; ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Anel A, 1997, J IMMUNOL, V158, P1999; BEDI A, 1994, BLOOD, V83, P2038; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; Beresford PJ, 1998, J IMMUNOL, V161, P161; BLEACKLEY RC, 1988, IMMUNOL REV, V103, P5, DOI 10.1111/j.1600-065X.1988.tb00746.x; Boise L H, 1995, Curr Top Microbiol Immunol, V200, P107; CHIU VK, 1995, J IMMUNOL, V154, P2023; COLLIER NC, 1988, J CELL BIOL, V106, P1131, DOI 10.1083/jcb.106.4.1131; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; DUPUIS M, 1993, J EXP MED, V177, P1, DOI 10.1084/jem.177.1.1; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GARCIASANZ JA, 1990, J IMMUNOL, V145, P3111; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; HAYES MP, 1989, J EXP MED, V170, P933, DOI 10.1084/jem.170.3.933; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; HUDIG D, 1987, BIOCHEM BIOPH RES CO, V149, P882, DOI 10.1016/0006-291X(87)90490-6; ITOH N, 1993, J IMMUNOL, V151, P621; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; KOKILEVA L, 1994, INT ARCH ALLERGY IMM, V105, P339, DOI 10.1159/000236779; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; MASSON D, 1985, J BIOL CHEM, V260, P9069; MASSON D, 1986, FEBS LETT, V208, P84, DOI 10.1016/0014-5793(86)81537-X; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; NAKAJIMA H, 1994, J IMMUNOL, V152, P1057; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; POE M, 1991, ARCH BIOCHEM BIOPHYS, V284, P215, DOI 10.1016/0003-9861(91)90286-R; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; REDELMAN D, 1983, CELL IMMUNOL, V81, P9, DOI 10.1016/0008-8749(83)90206-X; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Roger R, 1996, BLOOD, V87, P1113, DOI 10.1182/blood.V87.3.1113.bloodjournal8731113; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; Sarin A, 1998, J IMMUNOL, V161, P2810; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Schroter M, 1995, EUR J IMMUNOL, V25, P3509, DOI 10.1002/eji.1830251245; SELLINS KS, 1991, J IMMUNOL, V147, P795; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shi LF, 1997, J EXP MED, V185, P855, DOI 10.1084/jem.185.5.855; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; SHRESTA S, 1995, IMMUNOL REV, V146, P211, DOI 10.1111/j.1600-065X.1995.tb00690.x; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Sutton VR, 1997, J IMMUNOL, V158, P5783; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; TORIGOE T, 1994, CANCER RES, V54, P4851; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Xia ZN, 1998, BIOCHEM BIOPH RES CO, V243, P384, DOI 10.1006/bbrc.1998.8102; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	74	181	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1999	10	5					585	594		10.1016/S1074-7613(00)80058-8	http://dx.doi.org/10.1016/S1074-7613(00)80058-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367904	Bronze			2022-12-18	WOS:000080709400010
J	Lin, X; Cunningham, ET; Mu, YJ; Geleziunas, R; Greene, WC				Lin, X; Cunningham, ET; Mu, YJ; Geleziunas, R; Greene, WC			The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappa B acting through the NF-kappa B-inducing kinase and I kappa B kinases	IMMUNITY			English	Article							CD28 RESPONSE ELEMENT; T-CELL RESPONSES; INTERLEUKIN-2 PROMOTER; TERMINAL SEQUENCES; ALPHA PROTEOLYSIS; IL-2 PROMOTER; MICE LACKING; C-REL; ACTIVATION; TPL-2	The proto-oncogene Cot/Tpl-2 encodes a MAP3K-related serine-threonine kinase. Expression of wild type Cot activates the I kappa B kinases (IKK) leading to induction of NF-kappa B. Conversely, expression of kinase-deficient Cot inhibits CD3/CD28 but not TNF alpha induction of NF-kappa B. These findings suggest the selective involvement of Cot/Tpl-2 or a closely related kinase in the CD3/CD28 costimulatory pathway leading to induced nuclear expression of NF-kappa B. In contrast, a kinase-deficient mutant of the NF-kappa B-inducing kinase (NIK) inhibits both CD3/CD28 and TNF alpha signaling, indicating that these pathways converge at or prior to the action of NIK. Consistent with such a sequential function of these two kinases, Cot physically assembles with and phosphorylates NIK in vivo.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.				NEI NIH HHS [K08-EY00352] Funding Source: Medline; PHS HHS [P30A127763] Funding Source: Medline; NATIONAL EYE INSTITUTE [K08EY000352] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Ballester A, 1997, J IMMUNOL, V159, P1613; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Harhaj EW, 1998, J BIOL CHEM, V273, P25185, DOI 10.1074/jbc.273.39.25185; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Maggirwar SB, 1997, MOL CELL BIOL, V17, P2605, DOI 10.1128/MCB.17.5.2605; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McGuire KL, 1997, J IMMUNOL, V159, P1319; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Rudd CE, 1996, IMMUNITY, V4, P527, DOI 10.1016/S1074-7613(00)80479-3; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sun SC, 1996, MOL CELL BIOL, V16, P1058; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; VAN AD, 1996, SCIENCE, V274, P787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	57	181	187	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					271	280		10.1016/S1074-7613(00)80027-8	http://dx.doi.org/10.1016/S1074-7613(00)80027-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072079	Bronze			2022-12-18	WOS:000078972200014
J	Wojno, EDT; Hunter, CA; Stumhofer, JS				Wojno, Elia D. Tait; Hunter, Christopher A.; Stumhofer, Jason S.			The Immunobiology of the Interleukin-12 Family: Room for Discovery	IMMUNITY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA PRODUCTION; IL-12 P40 HOMODIMER; ACTIVE RHEUMATOID-ARTHRITIS; STIMULATORY FACTOR NKSF; REGULATORY T-CELLS; INDUCED GENE 3; CUTTING EDGE; SIGNAL TRANSDUCER	The discovery of interleukin (IL)-6 and its receptor subunits provided a foundation degrees understand the biology of a group of related cytokines: IL-12, IL-23, and IL-27. These family members utilize shared receptors and cytokine subunits and influence the outcome of cancer, infection, and inflammatory diseases. Consequently, many facets of their biology are being therapeutically targeted. Here, we review the landmark discoveries in this field, the combinatorial biology inherent to this family, and how patient datasets have underscored the critical role of these pathways in human disease. We present significant knowledge gaps, including how similar signals from these cytokines can mediate distinct outcomes, and discuss how a better understanding of the biology of the IL-12 family provides new therapeutic opportunities.	[Wojno, Elia D. Tait] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, 235 Hungerford Hill Rd, Ithaca, NY 14853 USA; [Wojno, Elia D. Tait] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, 235 Hungerford Hill Rd, Ithaca, NY 14853 USA; [Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, 380 South Univ Ave, Philadelphia, PA 19104 USA; [Stumhofer, Jason S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, 4301 West Markham St, Little Rock, AR 72205 USA	Cornell University; Cornell University; University of Pennsylvania; University of Arkansas System; University of Arkansas Medical Sciences	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 380 South Univ Ave, Philadelphia, PA 19104 USA.; Stumhofer, JS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, 4301 West Markham St, Little Rock, AR 72205 USA.	chunter@vet.upenn.edu; jstumhofer@uams.edu		Tait Wojno, Elia/0000-0003-2822-296X	US National Institutes of Health [R01 AI32708, AI130379, R01 AI126899, R01 AI116653]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110201, R01AI132708, R01AI130379, R01AI116653, R01AI041158, R01AI126899] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the US National Institutes of Health (R01 AI32708 and AI130379) to E.T.W., (R01 AI126899) to C.A.H., and (R01 AI116653) to J.S.S.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x; Allocca M, 2018, BEST PRACT RES CL GA, V32-33, P1, DOI 10.1016/j.bpg.2018.07.001; Altare F, 1998, CURR OPIN IMMUNOL, V10, P413, DOI 10.1016/S0952-7915(98)80114-3; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Arinuma Y, 2015, INTERNAL MED, V54, P1125, DOI 10.2169/internalmedicine.54.3103; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; BAZAN JF, 1993, CURR BIOL, V3, P603, DOI 10.1016/0960-9822(93)90009-D; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; BECK JT, 1994, NEW ENGL J MED, V330, P602, DOI 10.1056/NEJM199403033300904; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Betz UAK, 1998, INT IMMUNOL, V10, P1175, DOI 10.1093/intimm/10.8.1175; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Boisson-Dupuis S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau8714; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Bosmann M, 2014, J IMMUNOL, V193, P5668, DOI 10.4049/jimmunol.1302280; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Duarte ALBP, 2013, MOL BIOL REP, V40, P4889, DOI 10.1007/s11033-013-2588-1; Briso EM, 2008, J IMMUNOL, V180, P7102, DOI 10.4049/jimmunol.180.11.7102; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Cai XY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004989; Cai XY, 2015, INT J CLIN EXP PATHO, V8, P14757; Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Casella G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16702-w; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chackerian AA, 2006, INFECT IMMUN, V74, P6092, DOI 10.1128/IAI.00621-06; Chan IH, 2014, MUCOSAL IMMUNOL, V7, P842, DOI 10.1038/mi.2013.101; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chehboun S, 2017, J BIOL CHEM, V292, P6644, DOI 10.1074/jbc.M116.762021; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Chong WP, 2014, J AUTOIMMUN, V50, P12, DOI 10.1016/j.jaut.2013.08.003; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CHUA AO, 1994, J IMMUNOL, V153, P128; Cocco C, 2012, LEUKEMIA, V26, P1365, DOI 10.1038/leu.2011.363; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; de Jong R, 1998, SCIENCE, V280, P1435; de Kruif MD, 2012, CLIN EXP RHEUMATOL, V30, P951; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; DeLong Jonathan H, 2019, Immunohorizons, V3, P13, DOI 10.4049/immunohorizons.1800083; DeLong JH, 2018, J IMMUNOL, V200, P1761, DOI 10.4049/jimmunol.1701154; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dietrich C, 2014, J IMMUNOL, V192, P5382, DOI 10.4049/jimmunol.1303435; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Do JS, 2016, MUCOSAL IMMUNOL, V9, P137, DOI 10.1038/mi.2015.45; Do JS, 2017, P NATL ACAD SCI USA, V114, P10190, DOI 10.1073/pnas.1703100114; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; El-Behi M, 2014, EUR J IMMUNOL, V44, P3003, DOI 10.1002/eji.201344360; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Feagan BG, 2017, LANCET, V389, P1699, DOI 10.1016/S0140-6736(17)30570-6; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2013, J IMMUNOL, V190, P3225, DOI 10.4049/jimmunol.1200141; Floss DM, 2016, MOL BIOL CELL, V27, P2301, DOI 10.1091/mbc.E14-12-1645; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Goldberg R, 2004, J IMMUNOL, V173, P6465, DOI 10.4049/jimmunol.173.10.6465; Gordon KB, 2018, LANCET, V392, P650, DOI 10.1016/S0140-6736(18)31713-6; Gordon KB, 2015, NEW ENGL J MED, V373, P136, DOI 10.1056/NEJMoa1501646; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Ha SJ, 1999, J IMMUNOL, V163, P2902; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hall AO, 2012, ADV IMMUNOL, V115, P1, DOI 10.1016/B978-0-12-394299-9.00001-1; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hanson ML, 2014, GASTROENTEROLOGY, V146, P210, DOI 10.1053/j.gastro.2013.09.060; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HIRANO T, 1994, STEM CELLS, V12, P262, DOI 10.1002/stem.5530120303; Ho CCM, 2017, CELL, V168, P1041, DOI 10.1016/j.cell.2017.02.011; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Hu P, 2009, MOL IMMUNOL, V46, P1654, DOI 10.1016/j.molimm.2009.02.025; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Igawa T, 2009, MOD RHEUMATOL, V19, P33, DOI 10.1007/s10165-008-0117-1; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jones BE, 2018, CURR OPIN IMMUNOL, V55, P9, DOI 10.1016/j.coi.2018.09.002; Jones GW, 2015, J EXP MED, V212, P1793, DOI 10.1084/jem.20132307; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kelly-Welch Ann, 2005, Sci STKE, V2005, pcm9, DOI 10.1126/stke.2932005cm9; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kilgore Augustus M, 2018, Immunohorizons, V2, P1, DOI 10.4049/immunohorizons.1700054; Kim G, 2013, J IMMUNOL, V190, P1510, DOI 10.4049/jimmunol.1201017; Kimball Alexa Boer, 2012, J Am Acad Dermatol, V66, pe67, DOI 10.1016/j.jaad.2010.10.020; Kishimoto T., 2005, ANN REV IMMUNOLOGY A; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Kurtz SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109898; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li CS, 2009, J GASTROEN HEPATOL, V24, P1692, DOI 10.1111/j.1440-1746.2009.05901.x; Li TT, 2010, J INVEST MED, V58, P737, DOI 10.231/JIM.0b013e3181d88f7b; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; LING P, 1995, J IMMUNOL, V154, P116; Liu JQ, 2012, J IMMUNOL, V188, P3099, DOI 10.4049/jimmunol.1100106; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Liu X, 2013, BIOCHEM BIOPH RES CO, V435, P306, DOI 10.1016/j.bbrc.2013.03.136; Lokau J, 2016, CELL REP, V14, P1761, DOI 10.1016/j.celrep.2016.01.053; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Ma QY, 2017, EXP CELL RES, V360, P358, DOI 10.1016/j.yexcr.2017.09.026; Mackiewicz A, 1995, ANN NY ACAD SCI, V762, P361; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Matsui M, 2004, J VIROL, V78, P9093, DOI 10.1128/JVI.78.17.9093-9104.2004; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; McLean MH, 2017, INFLAMM BOWEL DIS, V23, P1983, DOI 10.1097/MIB.0000000000001274; MITCHELL BG, 1968, P NATL ACAD SCI USA, V59, P296, DOI 10.1073/pnas.59.1.296; Moschen AR, 2019, NAT REV GASTRO HEPAT, V16, P185, DOI 10.1038/s41575-018-0084-8; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Muller SI, 2019, P NATL ACAD SCI USA, V116, P1585, DOI 10.1073/pnas.1816698116; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nakahara H, 2011, MOD RHEUMATOL, V21, P655, DOI 10.1007/s10165-011-0448-1; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Narazaki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113528; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Owaki T, 2005, J IMMUNOL, V175, P2191, DOI 10.4049/jimmunol.175.4.2191; Papp KA, 2017, NEW ENGL J MED, V376, P1551, DOI 10.1056/NEJMoa1607017; Paradowska-Gorycka A, 2016, SCAND J IMMUNOL, V84, P49, DOI 10.1111/sji.12439; Paradowska-Gorycka A, 2014, SCAND J IMMUNOL, V80, P298, DOI 10.1111/sji.12209; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Park YJ, 2019, P NATL ACAD SCI USA, V116, P3106, DOI 10.1073/pnas.1810254116; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; Paustian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054804; Pennock ND, 2014, P NATL ACAD SCI USA, V111, P16472, DOI 10.1073/pnas.1407393111; Perona-Wright G, 2012, P NATL ACAD SCI USA, V109, P18535, DOI 10.1073/pnas.1119133109; Pfeil A, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03129; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2289, DOI 10.1002/art.30324; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sasaoka T, 2011, AM J PHYSIOL-GASTR L, V300, pG568, DOI 10.1152/ajpgi.00329.2010; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shao JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048127; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shimizu S, 2005, J IMMUNOL, V175, P7185, DOI 10.4049/jimmunol.175.11.7185; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Shimozato O, 2009, IMMUNOLOGY, V128, pe816, DOI 10.1111/j.1365-2567.2009.03088.x; Shinozaki Y, 2009, INT J CANCER, V124, P1372, DOI 10.1002/ijc.24107; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209831; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; Sockolosky JT, 2018, SCIENCE, V359, P1037, DOI 10.1126/science.aar3246; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; SYPEK JP, 1993, J EXP MED, V177, P1797, DOI 10.1084/jem.177.6.1797; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Tausend W, 2014, J CUTAN MED SURG, V18, P156, DOI 10.2310/7750.2013.13125; Teague TK, 2000, J EXP MED, V191, P915, DOI 10.1084/jem.191.6.915; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Nguyen TH, 2018, J IMMUNOL, V200, P237, DOI 10.4049/jimmunol.1601950; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; TRIPP CS, 1994, J IMMUNOL, V152, P1883; Tsai YC, 2017, THER ADV MUSCULOSKEL, V9, P277, DOI 10.1177/1759720X17735756; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verstockt B, 2018, J GASTROENTEROL, V53, P585, DOI 10.1007/s00535-018-1449-z; Vijayan D, 2016, J IMMUNOL, V197, P3008, DOI 10.4049/jimmunol.1600652; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2008, INT IMMUNOL, V20, P739, DOI 10.1093/intimm/dxn032; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Visvanathan S, 2018, J CROHNS COLITIS, V12, P1170, DOI 10.1093/ecco-jcc/jjy099; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Wang X, 1999, EUR J IMMUNOL, V29, P2007, DOI 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0; Wang XY, 2016, IEEE INT SYMP NANO, P23, DOI 10.1145/2950067.2950082; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wirtz S, 2011, GASTROENTEROLOGY, V141, P1875, DOI 10.1053/j.gastro.2011.07.040; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Wu CY, 1997, EUR J IMMUNOL, V27, P147, DOI 10.1002/eji.1830270122; Xia LP, 2015, SCAND J RHEUMATOL, V44, P200, DOI 10.3109/03009742.2014.962080; Xia SY, 2014, J LEUKOCYTE BIOL, V95, P733, DOI 10.1189/jlb.0713371; Yan J, 2015, INT J CLIN EXP MED, V8, P6262; Yan JM, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028530; Yap G, 2000, J IMMUNOL, V165, P628, DOI 10.4049/jimmunol.165.2.628; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Young A, 2012, J IMMUNOL, V189, P2079, DOI 10.4049/jimmunol.1200131; Zhang GX, 2003, J IMMUNOL, V171, P4485, DOI 10.4049/jimmunol.171.9.4485; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhao HF, 2013, AUTOIMMUNITY, V46, P509, DOI 10.3109/08916934.2013.822072; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072; Zhu J., 2018, JCI INSIGHT, V3, P3128; Zhu SG, 2010, J IMMUNOL, V184, P2348, DOI 10.4049/jimmunol.0902371; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zolochevska O, 2011, HUM GENE THER, V22, P1537, DOI 10.1089/hum.2011.076	293	180	184	11	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					851	870		10.1016/j.immuni.2019.03.011	http://dx.doi.org/10.1016/j.immuni.2019.03.011			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995503	Green Accepted, Bronze			2022-12-18	WOS:000464660800007
J	DuPage, M; Chopra, G; Quiros, J; Rosenthal, WL; Morar, MM; Holohan, D; Zhang, R; Turka, L; Marson, A; Bluestone, JA				DuPage, Michel; Chopra, Gaurav; Quiros, Jason; Rosenthal, Wendy L.; Morar, Malika M.; Holohan, Dan; Zhang, Ruan; Turka, Laurence; Marson, Alexander; Bluestone, Jeffrey A.			The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; EPIGENETIC CHANGES; CYTOKINE GENES; EXPRESSION; DIFFERENTIATION; HOMEOSTASIS; PLASTICITY; COSTIMULATION; INFLAMMATION; METHYLATION	Regulatory T cells (Treg cells) are required for immune homeostasis. Chromatin remodeling is essential for establishing diverse cellular identities, but how the epigenetic program in Treg cells is maintained throughout the dynamic activation process remains unclear. Here we have shown that CD28 co-stimulation, an extracellular cue intrinsically required for Treg cell maintenance, induced the chromatin-modifying enzyme, Ezh2. Treg-specific ablation of Ezh2 resulted in spontaneous autoimmunity with reduced Foxp3(+) cells in non-lymphoid tissues and impaired resolution of experimental autoimmune encephalomyelitis. Utilizing a model designed to selectively deplete wild-type Treg cells in adult mice co-populated with Ezh2-deficient Treg cells, Ezh2-deficient cells were destabilized and failed to prevent autoimmunity. After activation, the transcriptome of Ezh2-deficient Treg cells was disrupted, with altered expression of Treg cell lineage genes in a pattern similar to Foxp3-deficient Treg cells. These studies reveal a critical role for Ezh2 in the maintenance of Treg cell identity during cellular activation.	[DuPage, Michel; Chopra, Gaurav; Quiros, Jason; Rosenthal, Wendy L.; Morar, Malika M.; Holohan, Dan; Marson, Alexander; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [DuPage, Michel; Chopra, Gaurav; Quiros, Jason; Rosenthal, Wendy L.; Morar, Malika M.; Holohan, Dan; Marson, Alexander; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif Berkeley, IGI, Berkeley, CA 94720 USA; [Zhang, Ruan; Turka, Laurence] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02129 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jeff.bluestone@ucsf.edu	Chopra, Gaurav/M-2327-2018	Chopra, Gaurav/0000-0003-0942-7898	NIH [R01 AI046643, UM1 AI-12-059, A1007334-23A1]; JDRF; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046643, T32AI007334, U19AI056388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418, P30DK063720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Erle, A. Barczak, R. Barbeau, and J. Pollack of the UCSF Sandler Center Functional Genomics Core for assistance with RNAseq data; M. Lee, V. Nguyen, N. Lescano, and J. Paw for assisting with flow cytometry; K. Fasano for preparation of tissues for histological analyses; N. Ali and M. Rosenblumfor assistance with harvesting cells from mouse skin; and A. Abbas, M. S. Anderson, F. van Gool, S.A. Villalta, and A.G. DuPage for critical reading of this manuscript. This work was supported by NIH grants R01 AI046643 and UM1 AI-12-059. G.C. was supported by a JDRF fellowship. M.D. was supported by the Helen Hay Whitney Foundation and NIH T32 grant to UCSF (A1007334-23A1). J.A.B. is the A.W. and Mary Margaret Clausen Distinguished Professor in Metabolism and Endocrinology.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martinez-Llordella M, 2013, J EXP MED, V210, P1603, DOI 10.1084/jem.20122387; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhang YX, 2014, BLOOD, V124, P737, DOI 10.1182/blood-2013-12-544106; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	47	180	185	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					227	238		10.1016/j.immuni.2015.01.007	http://dx.doi.org/10.1016/j.immuni.2015.01.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25680271	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000349916400008
J	Zhang, L; Mo, JY; Swanson, KV; Wen, HT; Petrucelli, A; Gregory, SM; Zhang, ZG; Schneider, M; Jiang, Y; Fitzgerald, KA; Ouyang, SY; Liu, ZJ; Damania, B; Shu, HB; Duncan, JA; Ting, JPY				Zhang, Lu; Mo, Jinyao; Swanson, Karen V.; Wen, Haitao; Petrucelli, Alex; Gregory, Sean M.; Zhang, Zhigang; Schneider, Monika; Jiang, Yan; Fitzgerald, Katherine A.; Ouyang, Songying; Liu, Zhi-Jie; Damania, Blossom; Shu, Hong-Bing; Duncan, Joseph A.; Ting, Jenny P. -Y.			NLRC3, a Member of the NLR Family of Proteins, Is a Negative Regulator of Innate Immune Signaling Induced by the DNA Sensor STING	IMMUNITY			English	Article							NF-KAPPA-B; CYCLIC DI-GMP; CYTOSOLIC DNA; COLON INFLAMMATION; ADAPTER; RECOGNITION; ACTIVATION; RESPONSES; VIRUS; TRAF6	Stimulator of interferon genes (STING, also named MITA, MYPS, or ERIS) is an intracellular DNA sensor that induces type I interferon through its interaction with TANK-binding kinase 1 (TBK1). Here we found that the nucleotide-binding, leucine-rich-repeat-containing protein, NLRC3, reduced STING-dependent innate immune activation in response to cytosolic DNA, cyclic di-GMP (c-di-GMP), and DNA viruses. NLRC3 associated with both STING and TBK1 and impeded STING-TBK1 interaction and downstream type I interferon production. By using purified recombinant proteins, we found NLRC3 to interact directly with STING. Furthermore, NLRC3 prevented proper trafficking of STING to perinuclear and punctated region, known to be important for its activation. In animals, herpes simplex virus 1 (HSV-1)-infected Nlrc3(-/-) mice exhibited enhanced innate immunity and reduced morbidity and viral load. This demonstrates the intersection of two key pathways of innate immune regulation, NLR and STING, to fine tune host response to intracellular DNA, DNA virus, and c-di-GMP.	[Zhang, Lu; Swanson, Karen V.; Wen, Haitao; Petrucelli, Alex; Gregory, Sean M.; Zhang, Zhigang; Damania, Blossom; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Lu] Univ N Carolina, Dept Oral Biol, Sch Dent, Chapel Hill, NC 27599 USA; [Mo, Jinyao; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Schneider, Monika; Damania, Blossom; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Ctr Translat Immunol, Chapel Hill, NC 27599 USA; [Jiang, Yan; Ouyang, Songying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Liu, Zhi-Jie] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Massachusetts System; University of Massachusetts Worcester; ShanghaiTech University; Wuhan University	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Liu, Zhi-Jie/A-3946-2012; Fitzgerald, Katherine/ABE-6317-2020; Wen, Haitao/AAJ-7621-2020; Zhang, Lu/P-6929-2015	Liu, Zhi-Jie/0000-0001-7279-2893; Fitzgerald, Kate/0000-0003-3175-609X; Swanson, Karen V/0000-0003-3105-0599	NIH [CA156330, P01DK094779, R37-AI029564, AI088255, AI107810, DE 018281, U19 AI1099665]; Burroughs Wellcome Fund Career Award for Medical Scientists; MOST [2014CB910400, 2013CB911103]; NSFC [31200559, 31330019]; NATIONAL CANCER INSTITUTE [T32CA009156, R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965, U19AI107810, R01AI088255, R37AI029564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK094779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); MOST; NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants CA156330, P01DK094779, and R37-AI029564, (J.P.-Y.T.); AI088255 (J.A.D.); AI107810 (B. D.); and DE 018281 and U19 AI1099665 (B. D. and J.P.-Y.T.); Burroughs Wellcome Fund Career Award for Medical Scientists (J.A.D.); and MOST grants 2014CB910400 and 2013CB911103 and NSFC grants 31200559 and 31330019 (S.O. and Z.-J.L.). We thank T. W. Mak for sharing Traf6<SUP>+/+</SUP>, Traf6<SUP>+/-</SUP>, and Traf6<SUP>-/-</SUP> cells, A. Baldwin and L. Su for materials, E. Miao for Burkholderia thaildensis, and R. Chen for support and discussion.	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shaw PJ, 2010, EUR J IMMUNOL, V40, P624, DOI 10.1002/eji.200940211; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	50	180	186	0	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					329	341		10.1016/j.immuni.2014.01.010	http://dx.doi.org/10.1016/j.immuni.2014.01.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24560620	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000333422300007
J	Hunter, CA; Kastelein, R				Hunter, Christopher A.; Kastelein, Rob			Interleukin-27: Balancing Protective and Pathological Immunity	IMMUNITY			English	Review							CD4(+) T-CELLS; CUTTING EDGE; IL-27 RECEPTOR; C-MAF; HELPER-CELLS; AUTOIMMUNE INFLAMMATION; COMPLETE REGRESSION; IL-10 EXPRESSION; MRL/LPR MICE; TH17 CELLS	It has been more than 15 years since the identification of individual interleukin-27 (IL-27) and IL-27 receptor components. The last decade has seen the description of the signaling pathways engaged by IL-27, and an appreciation has emerged that this cytokine can modulate the intensity and duration of many classes of T cell responses. Here we provide an overview of the immunobiology of IL-27 and review advances in understanding the functions of individual IL-27 and IL-27 receptor subunits and the role of IL-27 in dictating the balance between protective and pathological immunity. Additionally, this cytokine has been proposed as a therapy to modify inflammatory conditions or to promote antitumor responses, and situations where experimental and clinical data sets implicate IL-27 in the outcome of disease are highlighted.	[Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kastelein, Rob] Merck Palo Alto CA, Palo Alto, CA 94304 USA	University of Pennsylvania	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Room 313,Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334, P01AI043620] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI043620, R01 AI042334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Anderson CF, 2009, J IMMUNOL, V183, P4619, DOI 10.4049/jimmunol.0804024; Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Ayimba E, 2011, CLIN EXP IMMUNOL, V166, P218, DOI 10.1111/j.1365-2249.2011.04474.x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Chae SC, 2007, J HUM GENET, V52, P355, DOI 10.1007/s10038-007-0123-8; Charlot-Rabiega P, 2011, J BIOL CHEM, V286, P27350, DOI 10.1074/jbc.M111.221010; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Dibra D, 2012, HEPATOLOGY, V55, P1204, DOI 10.1002/hep.24814; Dibra D, 2009, CANCER RES, V69, P5505, DOI 10.1158/0008-5472.CAN-08-4311; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Huang N, 2008, DNA CELL BIOL, V27, P527, DOI 10.1089/dna.2007.0715; Huang ZQ, 2012, CLIN BIOCHEM, V45, P54, DOI 10.1016/j.clinbiochem.2011.10.004; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Hunter CA, 1997, J IMMUNOL, V158, P3311; Igawa T, 2009, MOD RHEUMATOL, V19, P33, DOI 10.1007/s10165-008-0117-1; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kido M, 2011, BRIT J DERMATOL, V164, P1214, DOI 10.1111/j.1365-2133.2011.10244.x; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Li CS, 2009, J GASTROEN HEPATOL, V24, P1692, DOI 10.1111/j.1440-1746.2009.05901.x; Li TT, 2010, J INVEST MED, V58, P737, DOI 10.231/JIM.0b013e3181d88f7b; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; Miyazaki Y, 2005, J IMMUNOL, V175, P2401, DOI 10.4049/jimmunol.175.4.2401; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Perona-Wright G, 2012, P NATL ACAD SCI USA, V109, P18535, DOI 10.1073/pnas.1119133109; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P2289, DOI 10.1002/art.30324; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rousseau F, 2010, P NATL ACAD SCI USA, V107, P19420, DOI 10.1073/pnas.1005793107; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Sasaoka T, 2011, AM J PHYSIOL-GASTR L, V300, pG568, DOI 10.1152/ajpgi.00329.2010; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Shimizu S, 2005, J IMMUNOL, V175, P7185, DOI 10.4049/jimmunol.175.11.7185; Shimozato O, 2009, IMMUNOLOGY, V128, pe816, DOI 10.1111/j.1365-2567.2009.03088.x; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Sugiyama N, 2008, ANN RHEUM DIS, V67, P1461, DOI 10.1136/ard.2007.077537; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tanida S, 2011, CYTOKINE, V55, P237, DOI 10.1016/j.cyto.2011.04.020; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wang H, 2011, IMMUNOL LETT, V136, P21, DOI 10.1016/j.imlet.2010.11.007; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415; Zorzoli A, 2012, CLIN CANCER RES, V18, P1630, DOI 10.1158/1078-0432.CCR-11-2432	113	180	192	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					960	969		10.1016/j.immuni.2012.11.003	http://dx.doi.org/10.1016/j.immuni.2012.11.003			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244718	Bronze, Green Accepted			2022-12-18	WOS:000312575000006
J	Adams, JJ; Narayanan, S; Liu, BY; Birnbaum, ME; Kruse, AC; Bowerman, NA; Chen, W; Levin, AM; Connolly, JM; Zhu, C; Kranz, DM; Garcia, KC				Adams, Jarrett J.; Narayanan, Samanthi; Liu, Baoyu; Birnbaum, Michael E.; Kruse, Andrew C.; Bowerman, Natalie A.; Chen, Wei; Levin, Aron M.; Connolly, Janet M.; Zhu, Cheng; Kranz, David M.; Garcia, K. Christopher			T Cell Receptor Signaling Is Limited by Docking Geometry to Peptide-Major Histocompatibility Complex	IMMUNITY			English	Article							MHC CLASS-I; YEAST SURFACE DISPLAY; CROSS-REACTIVITY; POSITIVE SELECTION; MOLECULAR FLEXIBILITY; THYMIC SELECTION; STRUCTURAL BASIS; TCR RECOGNITION; HIGH-AFFINITY; AMINO-ACIDS	T cell receptor (TCR) engagement of peptide-major histocompatibility complex (pMHC) is essential to adaptive immunity, but it is unknown whether TCR signaling responses are influenced by the binding topology of the TCR-peptide-MHC complex. We developed yeast-displayed pMHC libraries that enabled us to identify new peptide sequences reactive with a single TCR. Structural analysis showed that four peptides bound to the TCR with distinct 3D and 2D affinities using entirely different binding chemistries. Three of the peptides that shared a common docking mode, where key TCR-MHC germline interactions are preserved, induced TCR signaling. The fourth peptide failed to induce signaling and was recognized in a substantially different TCR-MHC binding mode that apparently exceeded geometric tolerances compatible with signaling. We suggest that the stereotypical TCR-MHC docking paradigm evolved from productive signaling geometries and that TCR signaling can be modulated by peptides that are recognized in alternative TCR-pMHC binding orientations.	[Adams, Jarrett J.; Birnbaum, Michael E.; Kruse, Andrew C.; Levin, Aron M.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Adams, Jarrett J.; Birnbaum, Michael E.; Kruse, Andrew C.; Levin, Aron M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Adams, Jarrett J.; Birnbaum, Michael E.; Kruse, Andrew C.; Levin, Aron M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Narayanan, Samanthi; Bowerman, Natalie A.; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Liu, Baoyu; Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Connolly, Janet M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; Georgia Institute of Technology; Washington University (WUSTL)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Liu, Baoyu/C-4911-2009; Chen, Wei/C-4823-2009	Liu, Baoyu/0000-0002-0798-6314; Birnbaum, Michael/0000-0002-2281-3518; Zhu, Cheng/0000-0002-1718-565X; Chen, Wei/0000-0001-5366-7253	Canadian Institutes of Health Research; National Science Foundation; National Institutes of Health [AI48540, GM55767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048540, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Natasha Goriatcheva, Engin Ozkan, Dane Wittrup, Evan Newell, and Mark Davis for helpful discussions. We also gratefully acknowledge the staff and resources of the Stanford Synchrotron Radiation Laboratory and the UC-Berkeley Advanced Light Source. J.J.A. was supported by a Canadian Institutes of Health Research postdoctoral fellowship, M.E.B. is supported by a National Science Foundation and Stanford Graduate predoctoral fellowship and is a member of the Stanford program in Immunology. This work was supported by National Institutes of Health grants AI48540 (K.C.G.) and GM55767 (D.M.K.). K.C.G. is an Investigator of the Howard Hughes Medical Institute.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Felix NJ, 2006, NAT IMMUNOL, V7, P1127, DOI 10.1038/ni1106-1127; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Hornell TMC, 1999, J IMMUNOL, V163, P3217; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mazza C, 2007, SEMIN IMMUNOL, V19, P225, DOI 10.1016/j.smim.2007.03.003; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rubtsova K, 2009, P NATL ACAD SCI USA, V106, P7951, DOI 10.1073/pnas.0902728106; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Stone JD, 2011, J IMMUNOL, V186, P5193, DOI 10.4049/jimmunol.1003755; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Udaka K, 2000, IMMUNOGENETICS, V51, P816, DOI 10.1007/s002510000217; van der Merwe PA, 2011, IMMUNITY, V34, P1, DOI 10.1016/j.immuni.2011.01.001; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wilson IA, 2005, NAT IMMUNOL, V6, P434, DOI 10.1038/ni0505-434; Wucherpfennig KW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005140; Wucherpfennig KW, 2009, CURR OPIN IMMUNOL, V21, P590, DOI 10.1016/j.coi.2009.07.008; Yin YY, 2009, IMMUNITY, V31, P849, DOI 10.1016/j.immuni.2009.12.002; YOON ST, 1994, IMMUNITY, V1, P563	67	180	184	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					681	693		10.1016/j.immuni.2011.09.013	http://dx.doi.org/10.1016/j.immuni.2011.09.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22101157	Green Accepted, Bronze			2022-12-18	WOS:000297390800009
J	Tinoco, R; Alcalde, V; Yang, YT; Sauer, K; Zuniga, EI				Tinoco, Roberto; Alcalde, Victor; Yang, Yating; Sauer, Karsten; Zuniga, Elina I.			Cell-Intrinsic Transforming Growth Factor-beta Signaling Mediates Virus-Specific CD8(+) T Cell Deletion and Viral Persistence In Vivo	IMMUNITY			English	Article							HEPATITIS-C-VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMACYTOID DENDRITIC CELLS; NATURAL-KILLER-CELL; TGF-BETA; INTERLEUKIN-10 RECEPTOR; IMMUNE-RESPONSES; PD-1 EXPRESSION; B-VIRUS	Although deficient CD8(+) T cell responses have long been associated with chronic viral infections, the underlying mechanisms are still unclear. Here we report that sustained transforming growth factor-beta (TGF-beta) expression and phosphorylation of its signaling mediator, Smad-2, Were distinctive features of virus-specific CD8(+) T cells during chronic versus acute viral infections in vivo. The result was TGF-beta-dependent apoptosis of virus-specific CD8(+) T cells that related to upregulation of the proapoptotic protein Bim during chronic infection. Moreover, selective attenuation of TGF-beta signaling in T cells increased the numbers and multiple functions of antiviral CD8(+) T cells and enabled rapid eradication of the persistence-prone virus and memory generation. Finally, we found that cell-intrinsic TGF-beta signaling was responsible for virus-specific-CD8(+) T cell apoptosis and decreased numbers but was not necessary for their functional exhaustion. Our findings reveal persisting TGF-beta-Smad signaling as a hallmark and key regulator of CD8(+) T cell responses during chronic viral infections in vivo.	[Tinoco, Roberto; Alcalde, Victor; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Yang, Yating; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu		Tinoco, Roberto/0000-0001-5420-9692	University of California San Diego [Srce06-07]; Hellman Faculty Award; National Institutes of Health [AI072752, AI081923, AI070845, AI09484, AI45927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072752, R01AI045927, R37AI009484, R01AI009484, R01AI081923, R01AI070845] Funding Source: NIH RePORTER	University of California San Diego(University of California System); Hellman Faculty Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Goldrath and C. Rothlin for critically reading the manuscript. We express gratitude to M. Poling, E. Lee, and L. Mack for technical help. This work was mostly supported by grants from the University of California San Diego Srce06-07 (E.I.Z.), Hellman Faculty Award (E.I.Z.), and the National Institutes of Health (AI072752 and AI081923; E.I.Z.) and partly supported by AI070845 (K.S.), AI09484, and AI45927.	AHMED R, 1988, J VIROL, V62, P2102, DOI 10.1128/JVI.62.6.2102-2106.1988; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Landay AL, 1996, J INFECT DIS, V173, P1085, DOI 10.1093/infdis/173.5.1085; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Longenecker G, 2002, CYTOKINE, V18, P43, DOI 10.1006/cyto.2002.1025; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; McGeachy MJ, 2007, IMMUNITY, V26, P547, DOI 10.1016/j.immuni.2007.05.003; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SU HC, 1991, J IMMUNOL, V147, P2717; SU HC, 1993, J IMMUNOL, V151, P4874; Topper JN, 2000, TRENDS CARDIOVAS MED, V10, P132, DOI 10.1016/S1050-1738(00)00061-X; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zuniga EI, 2004, NAT IMMUNOL, V5, P1227, DOI 10.1038/ni1136; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	65	180	187	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					145	157		10.1016/j.immuni.2009.06.015	http://dx.doi.org/10.1016/j.immuni.2009.06.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604493	Green Accepted, Bronze			2022-12-18	WOS:000268219900019
J	Kohlmeier, JE; Miller, SC; Smith, J; Lu, B; Gerard, C; Cookenham, T; Roberts, AD; Woodland, DL				Kohlmeier, Jacob E.; Miller, Shannon C.; Smith, Joanna; Lu, Bao; Gerard, Craig; Cookenham, Tres; Roberts, Alan D.; Woodland, David L.			The chemokine receptor CCR5 plays a key role in the early memory CD8(+) T cell response to respiratory virus infections	IMMUNITY			English	Article							INFLUENZA-A VIRUS; OBSTRUCTIVE PULMONARY-DISEASE; LUNG AIRWAYS; CUTTING EDGE; RECALL RESPONSES; DENDRITIC CELLS; IFN-GAMMA; ANTIVIRAL IMMUNITY; DELAYED CLEARANCE; VIRAL-INFECTION	Innate recognition of invading pathogens in peripheral tissues results in the recruitment of circulating memory CD8(+) T cells to sites of localized inflammation during the early phase of a recall response. However, the mechanisms that control the rapid recruitment of these cells to peripheral sites are poorly understood, particularly in relation to influenza and parainfluenza. infections of the respiratory tract. In this study, we demonstrate a crucial role for C-C chemokine receptor 5 (CCR5) in the accelerated recruitment of memory CD8(+) T cells to the lung airways during virus challenge. Most importantly, CCR5 deficiency resulted in decreased recruitment of memory T cells expressing key effector molecules and impaired control of virus replication during the initial stages of a secondary response. These data highlight the critical importance of early memory T cell recruitment for the efficacy of cellular immunity in the lung.	[Kohlmeier, Jacob E.; Miller, Shannon C.; Smith, Joanna; Cookenham, Tres; Roberts, Alan D.; Woodland, David L.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Lu, Bao; Gerard, Craig] Harvard Univ, Sch Med, Div Pulm, Childrens Hosp, Boston, MA 02115 USA	Trudeau Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Woodland, DL (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	dwoodland@trudeauinstitute.org			NIAID NIH HHS [AI39759, F32 AI071478, T32 AI049823-06, R01 AI067967, R01 AI076499-01, AI076499, T32 AI049823-07, R01 AI067967-02, T32 AI049823-03, R01 AI067967-03, T32 AI049823-01, T32 AI049823-02, R01 AI067967-01A1, T32 AI049823, T32 AI049823-04, AI067967, T32 AI049823-08, T32 AI49823, T32 AI049823-05, F32 AI071478-01A1, R01 AI076499] Funding Source: Medline; NIA NIH HHS [P01 AG021600-01A10003, P01 AG021600-030003, P01 AG021600-050003, P01 AG021600, P01 AG021600-040003, P01 AG021600-020003, AG021600] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049823, R01AI067967, R01AI076499, F32AI071478, R01AI039759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021600] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Chvatchko Y, 2003, J IMMUNOL, V171, P5498, DOI 10.4049/jimmunol.171.10.5498; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Crowe SR, 2005, J IMMUNOL, V174, P696, DOI 10.4049/jimmunol.174.2.696; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; DALY K, 1995, J VIROL, V69, P7416, DOI 10.1128/JVI.69.12.7416-7422.1995; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Denton AE, 2007, EUR J IMMUNOL, V37, P368, DOI 10.1002/eji.200636766; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gasser O, 2005, BLOOD, V106, P3718, DOI 10.1182/blood-2005-04-1366; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Hoji A, 2005, IMMUNOLOGY, V115, P239, DOI 10.1111/j.1365-2567.2005.02135.x; HOU S, 1992, J IMMUNOL, V149, P1319; Iwasaki M, 2001, J IMMUNOL, V167, P6877, DOI 10.4049/jimmunol.167.12.6877; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Kohlmeier JE, 2006, CURR OPIN IMMUNOL, V18, P357, DOI 10.1016/j.coi.2006.03.012; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; LIANG SH, 1994, J IMMUNOL, V152, P1653; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Ma B, 2006, J IMMUNOL, V176, P4968, DOI 10.4049/jimmunol.176.8.4968; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Marsland BJ, 2004, P NATL ACAD SCI USA, V101, P6116, DOI 10.1073/pnas.0401582101; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; Medoff BD, 2005, ANN NY ACAD SCI, V1062, P220, DOI 10.1196/annals.1358.026; Mukai T, 2001, J LEUKOCYTE BIOL, V70, P422; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Roberts AD, 2004, J IMMUNOL, V172, P6533, DOI 10.4049/jimmunol.172.11.6533; Sato N, 1999, J IMMUNOL, V163, P5519; Schaller MA, 2005, EUR J IMMUNOL, V35, P2061, DOI 10.1002/eji.200425715; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Sun SQ, 1998, J EXP MED, V188, P2335, DOI 10.1084/jem.188.12.2335; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Turner SJ, 2001, J IMMUNOL, V167, P2753, DOI 10.4049/jimmunol.167.5.2753; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2004, SEMIN IMMUNOL, V16, P163, DOI 10.1016/j.smim.2004.02.003; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	62	180	183	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					101	113		10.1016/j.immuni.2008.05.011	http://dx.doi.org/10.1016/j.immuni.2008.05.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18617426	Bronze, Green Accepted			2022-12-18	WOS:000257905400014
J	Mohrs, K; Wakil, AE; Killeen, N; Locksley, RM; Mohrs, M				Mohrs, K; Wakil, AE; Killeen, N; Locksley, RM; Mohrs, M			A two-step process for cytokine production revealed by IL-4 dual-reporter mice	IMMUNITY			English	Article							CD4 T-CELLS; IMMUNITY IN-VIVO; HELIGMOSOMOIDES-POLYGYRUS; TRANSLATION INITIATION; PROTECTIVE IMMUNITY; EXPRESSION; BASOPHILS; GENE; INFECTION; ANTIGEN	To monitor IL-4 expression at the single-cell level, we generated mice with insertions of different reporter genes into both copies of the 114 gene that permitted the simultaneous analysis of IL-4 transcripts via GFP and IL-4 protein secretion by use of huCD2. Innate and adaptive cells competent for IL-4 production were marked by GFP, while cells that presently or recently secreted IL-4 additionally displayed huCD2. After challenge with the strictly enteric helminth, Heligmosomoides polygyrus, GFP-positive innate and adaptive cells disseminated widely, but IL-4 secretion was predominantly mediated by CD4(+) T cells in the intestines and draining lymphoid organs. IL-4-competent cells persisted in cured animals, and memory responses reflected rapid cytokine production at the site of rechallenge. These data reveal a two-step process for cytokine production: the first generating poised cells that disseminate systemically and the second inducing the rapid production of the cytokine in response to local stimulation.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; Univ Calif San Francisco, Dept Microbiol Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Trudeau Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mohrs, M (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	mmohrs@trudeauinstitute.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045666, R01AI030663, P01AI046530, R01AI026918] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI026918, AI046530, R01 AI030663-15, R01 AI030663, P01 AI046530, P01 AI045666, AI45666] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Corbin GA, 2005, J IMMUNOL, V174, P718, DOI 10.4049/jimmunol.174.2.718; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; HAMANN A, 1994, J IMMUNOL, V152, P3282; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Ho IC, 1999, INT IMMUNOL, V11, P243, DOI 10.1093/intimm/11.2.243; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; Kinet JP, 2002, CURR OPIN IMMUNOL, V14, P685, DOI 10.1016/S0952-7915(02)00411-9; Laky K, 1997, J IMMUNOL, V158, P1417; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 1999, J IMMUNOL, V162, P7302; Mohrs M, 2003, J IMMUNOL, V170, P1870, DOI 10.4049/jimmunol.170.4.1870; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; MONROY GF, 1985, AUST J EXP BIOL ME 4, V63, P423; Morimoto M, 2004, J IMMUNOL, V172, P2424, DOI 10.4049/jimmunol.172.4.2424; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; ROBINSON M, 1989, PARASITOLOGY, V98, P115, DOI 10.1017/S0031182000059758; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stockton BM, 1998, IMMUNITY, V8, P373, DOI 10.1016/S1074-7613(00)80542-7; SVETIC A, 1993, J IMMUNOL, V150, P3434; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; URBAN JF, 1991, EXP PARASITOL, V73, P500, DOI 10.1016/0014-4894(91)90074-7; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	52	180	181	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					419	429		10.1016/j.immuni.2005.09.006	http://dx.doi.org/10.1016/j.immuni.2005.09.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226507	Bronze, Green Accepted			2022-12-18	WOS:000232995800010
J	Calzascia, T; Masson, F; Di Berardino-Besson, W; Contassot, E; Wilmotte, R; Aurrand-Lions, M; Ruegg, C; Dietrich, PY; Walker, PR				Calzascia, T; Masson, F; Di Berardino-Besson, W; Contassot, E; Wilmotte, R; Aurrand-Lions, M; Ruegg, C; Dietrich, PY; Walker, PR			Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; CROSS-PRESENTATION; MEDIATED-IMMUNITY; LYMPHOID-TISSUES; CUTTING EDGE; IN-VIVO; ANTIGEN; CNS; BRAIN	Expression of tissue-specific homing molecules directs antigen-experienced T cells to particular peripheral tissues. In studies using soluble antigens that focused on skin and gut, antigen-presenting cells (APCs) within regional lymphoid tissues were proposed to be responsible for imprinting homing phenotypes. Whether this occurs in other sites and after physiologic antigen processing and presentation is unknown. We define in vivo imprinting of distinct homing phenotypes on monospecific T cells responding to antigens expressed by tumors in intracerebral, subcutaneous, and intraperitoneal sites with efficient brain-tropism of CD8 T cells crossprimed in the cervical lymph nodes (LNs). Multiple imprinting programs could occur simultaneously in the same LN when tumors were present in more than one site. Thus, the identity of the LN is not paramount in determining the homing phenotype; this critical functional parameter is dictated upstream at the site of antigen capture by crosspresenting APCs.	Univ Hosp Geneva, Div Oncol, Lab Tumour Immunol, CH-1211 Geneva 14, Switzerland; Univ Geneva, Ctr Med, Louis Jeantet Skin Canc Lab, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; Univ Lausanne, Swiss Inst Expt Canc Res, Lab Ctr Pluridisciplinaire Oncol, CH-1066 Epalinges, Switzerland	University of Geneva; University of Geneva; University of Geneva; Swiss Institute Experimental Cancer Research; University of Lausanne	Walker, PR (corresponding author), Univ Hosp Geneva, Div Oncol, Lab Tumour Immunol, Rue Micheli du Crest 24, CH-1211 Geneva 14, Switzerland.	paul.walker@hcuge.ch	Belz, Gabrielle T/C-9350-2013; Aurrand-Lions, Michel/O-9953-2016	Belz, Gabrielle T/0000-0002-9660-9587; Aurrand-Lions, Michel/0000-0002-8361-3034; Masson, Frederic/0000-0001-9909-2985; Calzascia, Thomas/0000-0001-8225-6744; Contassot, Emmanuel/0000-0002-3060-4644				Alon R, 2001, J CLIN INVEST, V108, P517; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Calzascia T, 2003, J IMMUNOL, V171, P2187, DOI 10.4049/jimmunol.171.5.2187; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; ENGELHARDT B, 1995, INT IMMUNOL, V7, P481, DOI 10.1093/intimm/7.3.481; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Engelhardt B, 1998, J NEUROIMMUNOL, V84, P92, DOI 10.1016/S0165-5728(97)00237-3; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; Irani DN, 1996, J IMMUNOL, V156, P3850; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Okada H, 2004, CANCER RES, V64, P5830, DOI 10.1158/0008-5472.CAN-04-0130; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Roffe E, 2003, J NEUROIMMUNOL, V142, P17, DOI 10.1016/S0165-5728(03)00254-6; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; Spiotto MT, 2002, IMMUNITY, V17, P737, DOI 10.1016/S1074-7613(02)00480-6; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Walker PR, 2003, BRAIN RES REV, V42, P97, DOI 10.1016/S0165-0173(03)00141-3; Walker PR, 2000, J IMMUNOL, V165, P3128, DOI 10.4049/jimmunol.165.6.3128; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yu P, 2003, J EXP MED, V197, P985, DOI 10.1084/jem.20021804	42	180	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					175	184		10.1016/j.immuni.2004.12.008	http://dx.doi.org/10.1016/j.immuni.2004.12.008			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723806	Bronze			2022-12-18	WOS:000227509600004
J	Shibuya, K; Lanier, LL; Phillips, JH; Ochs, HD; Shimizu, K; Nakayama, E; Nakauchi, H; Shibuya, A				Shibuya, K; Lanier, LL; Phillips, JH; Ochs, HD; Shimizu, K; Nakayama, E; Nakauchi, H; Shibuya, A			Physical and functional association of LFA-1 with DNAM-1 adhesion molecule	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; PROTEIN-KINASE-C; T-CELL; TYROSINE KINASE; LYMPHOCYTES-T; PHOSPHOLIPASE C-GAMMA-1; P150,95 GLYCOPROTEINS; CROSS-LINKING; IMMUNE-SYSTEM; B-CELLS	Whereas ligation of the DNAM-1 adhesion molecule triggers cytotoxicity mediated by normal NK and T cells, this function was defective in NK cell clones from leukocyte adhesion deficiency syndrome. However, genetic reconstitution of cell surface expression of LFA-1 restored the ability of DNAM-1 to initiate anti-DNAM-1 mAb-induced cytotoxicity, indicating a functional relationship between DNAM-1 and LFA-1. Further studies demonstrated that LFA-1 physically associates with DNAM-1 in NK cells and anti-CD3 mAb stimulated T cells, for which serine phosphorylation of DNAM-1 plays a critical role. In addition, crosslinking of LFA-1 induces tyrosine phosphorylation of DNAM-1, for which the Fyn protein tyrosine kinase is responsible. These results indicate that DNAM-1 is involved in the LFA-1-mediated intracellular signals.	Univ Tsukuba, Ctr TARA, Inst Basic Med Sci, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; JST, CREST, Tsukuba, Ibaraki 3058575, Japan; Okayama Univ, Sch Med, Inst Mol & Cellular Biol, Dept Mol Genet, Okayama 700, Japan; Okayama Univ, Sch Med, Dept Parasitol & Immunol, Okayama 700, Japan; DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	University of Tsukuba; Japan Science & Technology Agency (JST); Okayama University; Okayama University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of Washington; University of Washington Seattle	Nakauchi, H (corresponding author), Univ Tsukuba, Ctr TARA, Inst Basic Med Sci, Dept Immunol, 1-1-1 Tennodai,Tsukuba Sci City, Tsukuba, Ibaraki 3058575, Japan.	nakauchi@md.tsukuba.ac.jp; ashibuya@md.tsukuba.ac.jp	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; ARROYO AG, 1994, J CELL BIOL, V126, P1277, DOI 10.1083/jcb.126.5.1277; AZUMA M, 1992, J EXP MED, V175, P353, DOI 10.1084/jem.175.2.353; Bauer TR, 1998, BLOOD, V91, P1520, DOI 10.1182/blood.V91.5.1520.1520_1520_1526; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; HIBBS ML, 1990, J CLIN INVEST, V85, P674, DOI 10.1172/JCI114491; HOGG N, 1993, CURR OPIN IMMUNOL, V5, P383, DOI 10.1016/0952-7915(93)90057-Y; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kanner SB, 1996, CELL IMMUNOL, V171, P164, DOI 10.1006/cimm.1996.0188; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; KRENSKY AM, 1985, J IMMUNOL, V135, P3102; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; LANIER LL, 1983, J IMMUNOL, V131, P1789; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; MOY VT, 1992, J EXP MED, V175, P1, DOI 10.1084/jem.175.1.1; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Onishi M, 1996, EXP HEMATOL, V24, P324; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; SCHMIDT RE, 1985, J IMMUNOL, V135, P672; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya A, 1998, J IMMUNOL, V161, P1671; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; SUGIE K, 1995, J IMMUNOL, V154, P1691; TAKEUCHI M, 1993, J BIOL CHEM, V268, P27413; TIMONEN T, 1988, J IMMUNOL, V141, P1041; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Volkov Y, 1998, J IMMUNOL, V161, P6487; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; ZHOU MJ, 1993, J IMMUNOL, V150, P3030	52	180	197	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1999	11	5					615	623		10.1016/S1074-7613(00)80136-3	http://dx.doi.org/10.1016/S1074-7613(00)80136-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591186	Bronze, Green Submitted			2022-12-18	WOS:000083952200013
J	Dombrowicz, D; Lin, SQ; Flamand, V; Brini, AT; Koller, BH; Kinet, JP				Dombrowicz, D; Lin, SQ; Flamand, V; Brini, AT; Koller, BH; Kinet, JP			Allergy-associated FcR beta is a molecular amplifier of IgE- and lgG-mediated in vivo responses	IMMUNITY			English	Article							IMMUNOGLOBULIN-E RECEPTOR; EPIDERMAL LANGERHANS CELLS; HIGH-AFFINITY RECEPTOR; EPSILON-RI; MAST-CELLS; TRANSFECTED CELLS; GAMMA-RIII; MONOCLONAL-ANTIBODY; TYROSINE KINASES; SUBUNIT	A role for the Fc receptor beta chain (FcR beta) in the pathogenesis of allergy has been suggested by genetic studies. FcR beta is a subunit common to the high-affinity IgE (Fc epsilon RI) and low-affinity IgG (Fc gamma RIII) receptors, both of which contribute to the initiation of allergic reactions. Current in vitro data suggest that FcR beta can function as either a positive or negative regulator, leaving a mechanistic explanation for its association with the development of atopy unclear. To address this controversy, we have generated novel mouse models relevant to human Fc receptor function. Analysis of Fc epsilon RI- and Fc gamma RIII-dependent responses in these mice provides unequivocal genetic evidence that FcR beta functions as an amplifier of early and late mast cell responses and, remarkably, in vivo anaphylactic responses.	Beth Israel Deaconess Med Ctr, Lab Allergy & Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; Univ N Carolina, Chapel Hill, NC 27514 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Lab Allergy & Immunol, Boston, MA 02215 USA.	jkinet@mercury.bidmc.harvard.edu	Dombrowicz, David/F-7044-2013; Brini, Anna Teresa/C-2610-2017	Dombrowicz, David/0000-0002-0485-8923; Brini, Anna Teresa/0000-0002-7848-8099; Flamand, Veronique/0000-0002-8906-3758				ALBER G, 1992, J IMMUNOL, V149, P2428; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; COLLEE JM, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91988-X; COOKSON WOCM, 1989, LANCET, V1, P1292; Costa JJ, 1997, JAMA-J AM MED ASSOC, V278, P1815, DOI 10.1001/jama.278.22.1815; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; ELBE A, 1989, J IMMUNOL, V143, P2431; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; HILL MR, 1995, BRIT MED J, V311, P776, DOI 10.1136/bmj.311.7008.776; HIRASAWA N, 1995, J BIOL CHEM, V270, P10960, DOI 10.1074/jbc.270.18.10960; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kimura T, 1997, J IMMUNOL, V159, P4426; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; KUROSAKI T, 1992, J EXP MED, V175, P447, DOI 10.1084/jem.175.2.447; KUSTER H, 1992, J BIOL CHEM, V267, P12782; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; RA C, 1989, J BIOL CHEM, V264, P15323; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; SCHWARZBAUM S, 1989, EUR J IMMUNOL, V19, P1015, DOI 10.1002/eji.1830190610; SHIRAKAWA T, 1994, CLIN GENET, V46, P228; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; WILLIAMS ME, 1993, EUR J IMMUNOL, V23, P1910, DOI 10.1002/eji.1830230827; ZHANG Y, 1992, SCIENCE, V258, P1957, DOI 10.1126/science.1470922	48	180	187	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1998	8	4					517	529		10.1016/S1074-7613(00)80556-7	http://dx.doi.org/10.1016/S1074-7613(00)80556-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586641	Bronze, Green Published			2022-12-18	WOS:000073348000013
J	CASTELLINO, F; GERMAIN, RN				CASTELLINO, F; GERMAIN, RN			EXTENSIVE TRAFFICKING OF MHC CLASS II-INVARIANT CHAIN COMPLEXES IN THE ENDOCYTIC PATHWAY AND APPEARANCE OF PEPTIDE-LOADED CLASS-II IN MULTIPLE COMPARTMENTS	IMMUNITY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; RECEPTOR-MEDIATED ENDOCYTOSIS; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; PLASMA-MEMBRANE; HLA ANTIGENS; CELL-SURFACE; MOLECULES; BINDING; IDENTIFICATION	Major histocompatibility complex class II molecules bind and present to T cells fragments of protein antigens entering the endocytic pathway. Using normal B lymphoblasts, we have combined metabolic pulse-chase labeling, high resolution organelle fractionation, and immunoprecipitation to examine class II trafficking and antigen loading in a physiological model system. Most newly synthesized class II-invariant chain complexes first entered early endosomes, then accessed multiple discrete endocytic subcompartments cofractionating with late endosomes and immature lysosomes. Invariant chain was removed and peptide-loaded class II molecules appeared in each of these latter distinct organelles. These findings suggest that class II molecules traffic through much of the endocytic pathway, permitting capture of distinct determinants made available under differing conditions of pH and proteolytic activity.			CASTELLINO, F (corresponding author), NIAID,LYMPHOCYTE BIOL SECT,IMMUNOL LAB,BETHESDA,MD 20892, USA.		Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020					AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ARMSTRONG J, 1990, EMBO J, V9, P3497; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BLUM JS, 1991, ADV EXP MED BIOL, V306, P281; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; CASTEN LA, 1988, J EXP MED, V168, P171, DOI 10.1084/jem.168.1.171; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; COLLINS DS, 1991, J IMMUNOL, V147, P4054; COURTOY PJ, 1984, J CELL BIOL, V98, P870, DOI 10.1083/jcb.98.3.870; CRESSWELL P, 1985, P NATL ACAD SCI USA, V82, P8188, DOI 10.1073/pnas.82.23.8188; CRESSWELL P, 1990, IMMUNOL RES, V9, P190, DOI 10.1007/BF02918178; CRESSWELL P, 1987, CRIT REV IMMUNOL, V7, P31; CRISTAU B, 1994, J IMMUNOL, V152, P1546; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; GRUENBERG J, 1992, Current Opinion in Cell Biology, V4, P593, DOI 10.1016/0955-0674(92)90077-P; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HARDING CV, 1993, J IMMUNOL, V151, P3988; HARDING CV, 1990, CELL REGUL, V1, P499, DOI 10.1091/mbc.1.7.499; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JAHRAUS A, 1994, J CELL SCI, V107, P145; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LIPPINCOTTSCHWA.J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; LOSS GE, 1993, J IMMUNOL, V150, P3187; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; MANE SM, 1990, BIOCHEM BIOPH RES CO, V170, P1067; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; Mellman I, 1990, Semin Immunol, V2, P229; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; MULLER WA, 1983, J CELL BIOL, V96, P29, DOI 10.1083/jcb.96.1.29; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; NIEBLING WL, 1993, J IMMUNOL, V150, P2687; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; ROBBINS AR, 1987, METHOD ENZYMOL, V138, P458; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; RUDENSKY AY, 1994, IMMUNITY, V1, P585, DOI 10.1016/1074-7613(94)90048-5; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SCHMID SL, 1994, NATURE, V369, P103, DOI 10.1038/369103a0; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; SNIDER DP, 1987, J IMMUNOL, V139, P1609; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VASILETS LA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P201, DOI 10.1016/0304-4157(93)90012-D; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	84	180	181	0	3	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					73	88		10.1016/1074-7613(95)90080-2	http://dx.doi.org/10.1016/1074-7613(95)90080-2			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600303	Bronze			2022-12-18	WOS:A1995QC59300007
J	BERNAD, A; KOPF, M; KULBACKI, R; WEICH, N; KOEHLER, G; GUTIERREZRAMOS, JC				BERNAD, A; KOPF, M; KULBACKI, R; WEICH, N; KOEHLER, G; GUTIERREZRAMOS, JC			INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM	IMMUNITY			English	Article							RECOMBINANT HUMAN INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; 5-FLUOROURACIL TREATMENT; MEGAKARYOCYTES INVITRO; CFU-S; MURINE; MARROW; MICE; INVIVO; SPLEEN	The development of blood cells from hematopoietic stem cells is controlled by multiple cytokines. These growth factors influence survival, cell cycle status, differentiation into lineage-committed progenitors, final maturation into blood cells, and perhaps self-renewal of stem cells. The specific contribution of IL-6 to these processes in vivo was evaluated in mice with a targeted disruption of the IL-6 gene. Decreases in the absolute numbers of CFU-Sd12 and preCFU-S, as well as in the functionality of LTRSC in these mutant mice, suggests a role for IL-6 in the survival, self-renewal, or both of hematopoietic stem cells and early progenitors. In addition, as a result of the IL-6 deficiency, the control between proliferation and differentiation of the progenitor cells of the granulocytic-monocytic, megakaryocytic, and erythroid lineages into mature blood cells is altered, leading to abnormal levels of committed progenitors of these lineages and to a slow recovery from hematopoietic ablation.	MAX PLANCK INST IMMUNOBIOL, W-7800 FREIBURG, GERMANY; GENET INST INC, CAMBRIDGE, MA 02140 USA	Max Planck Society	BERNAD, A (corresponding author), HARVARD UNIV, SCH MED, CTR BLOOD RES INC, DEPT GENET, BOSTON, MA 02115 USA.		Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Bernad, Antonio/0000-0003-0620-9668	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NHLBI NIH HHS [1PO1HL 48675-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASANO S, 1990, BLOOD, V75, P1602; BERNAD A, 1994, BRIT J HAEMATOL, V87, P6, DOI 10.1111/j.1365-2141.1994.tb04863.x; BODINE DM, 1989, P NATL ACAD SCI USA, V86, P8897, DOI 10.1073/pnas.86.22.8897; BURSTEIN SA, 1992, J CELL PHYSIOL, V153, P305, DOI 10.1002/jcp.1041530210; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HARRISON DE, 1991, BLOOD, V78, P1237; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; HERODIN F, 1992, BLOOD, V80, P688; HILL RJ, 1991, BLOOD, V77, P42; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; INOUE T, 1985, ANN NY ACAD SCI, V459, P162, DOI 10.1111/j.1749-6632.1985.tb20824.x; ISHIBASHI T, 1989, P NATL ACAD SCI USA, V86, P5953, DOI 10.1073/pnas.86.15.5953; ISHIBASHI T, 1989, BLOOD, V74, P1241; KATAYAMA N, 1993, BLOOD, V81, P610; KERST JM, 1993, EXP HEMATOL, V21, P1550; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KLEIN B, 1991, BLOOD, V78, P1198; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KRANTZ SB, 1991, BLOOD, V77, P419; KYOLZUMI S, 1993, BLOOD, V81, P1479; LATERVEER L, 1993, EXP HEMATOL, V21, P1621; LERNER C, 1990, EXP HEMATOL, V18, P114; MATTSSON R, 1984, DEV COMP IMMUNOL, V8, P169, DOI 10.1016/0145-305X(84)90020-X; MEANS RT, 1992, BLOOD, V80, P1639; MIYAURA C, 1988, FEBS LETT, V234, P17, DOI 10.1016/0014-5793(88)81293-6; MULDER AH, 1985, EXP HEMATOL, V13, P768; OKADA S, 1992, EXP HEMATOL, V20, P546; OKANO A, 1989, TRANSPLANTATION, V48, P495, DOI 10.1097/00007890-198909000-00028; PATCHEN ML, 1991, BLOOD, V77, P472; POJDA Z, 1990, EXP HEMATOL, V18, P1034; RENCRICCA N J, 1970, Blood, V36, P764; SCHIMPL A, 1972, NATURE-NEW BIOL, V237, P15, DOI 10.1038/newbio237015a0; SHABO Y, 1988, BLOOD, V72, P2070; SUZUKI C, 1989, BIOCHEM BIOPH RES CO, V159, P933, DOI 10.1016/0006-291X(89)92198-0; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; SZILVASSY SJ, 1993, BLOOD, V81, P2310; TAKATSUKI F, 1990, CANCER RES, V50, P2885; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; WILLIAMS N, 1982, CELL TISSUE KINET, V15, P483, DOI 10.1111/j.1365-2184.1982.tb01571.x	45	180	183	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1994	1	9					725	731		10.1016/S1074-7613(94)80014-6	http://dx.doi.org/10.1016/S1074-7613(94)80014-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895162				2022-12-18	WOS:A1994PX64800002
J	Yockey, LJ; Iwasaki, A				Yockey, Laura J.; Iwasaki, Akiko			Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDUCED PRETERM BIRTH; NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; ZIKA VIRUS; MATERNAL OBESITY; T-CELLS; INFLAMMATORY RESPONSE; COMPLEMENT ACTIVATION; EMBRYO IMPLANTATION	Successful pregnancy requires carefully-coordinated communications between the mother and fetus. Immune cells and cytokine signaling pathways participate as mediators of these communications to promote healthy pregnancy. At the same time, certain infections or inflammatory conditions in pregnant mothers cause severe disease and have detrimental impacts on the developing fetus. In this review, we examine evidence for the role of maternal and fetal immune responses affecting pregnancy and fetal development, both under homeostasis and following infection. We discuss immune responses that are necessary to promote healthy pregnancy and those that lead to congenital disorders and pregnancy complications, with a particular emphasis on the role of interferons and cytokines. Understanding the contributions of the immune system in pregnancy and fetal development provides important insights into the pathogenesis underlying maternal and fetal diseases and sheds insights on possible targets for therapy.	[Yockey, Laura J.; Iwasaki, Akiko] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIH [AI054359, R01EB000487, R01AI127429, R21AI131284];  [T32GM007205];  [F30 HD094717]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F30HD094717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131284, R01AI054359, R01AI127429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors received funding from the NIH AI054359, R01EB000487, R01AI127429, and R21AI131284 (to A.I.). A.I. is an Investigator of the Howard Hughes Medical Institute. L.J.Y. was supported in part by T32GM007205 and F30 HD094717. BioRender was used to make Figures 1 and 2. Due to space constraint, we regret our inability to cite all relevant studies.	Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Ahn J, 2015, BIOCHEM BIOPH RES CO, V466, P52, DOI 10.1016/j.bbrc.2015.08.104; Albertsson AM, 2018, AM J PATHOL, V188, P757, DOI 10.1016/j.ajpath.2017.11.012; Altmae S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169223; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ambrosi A, 2014, EXP CELL RES, V325, P2, DOI 10.1016/j.yexcr.2014.01.003; Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029; Aplin JD, 2017, J CELL SCI, V130, P15, DOI 10.1242/jcs.175943; Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Aye ILMH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116186; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Barboza R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08299-x; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Boyle AK, 2017, J REPROD IMMUNOL, V119, P62, DOI 10.1016/j.jri.2016.11.008; Brito-Zeron P, 2015, NAT REV RHEUMATOL, V11, P301, DOI 10.1038/nrrheum.2015.29; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Bundhun PK, 2017, J AUTOIMMUN, V79, P17, DOI 10.1016/j.jaut.2017.02.009; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288; Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR; Care AS, 2013, J CLIN INVEST, V123, P3472, DOI 10.1172/JCI60561; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042; Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578; Chavan AR, 2016, PLACENTA, V40, P40, DOI 10.1016/j.placenta.2016.02.012; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Cohen D, 2011, J PATHOL, V225, P502, DOI 10.1002/path.2893; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Cross SN, 2017, J IMMUNOL, V199, P2885, DOI 10.4049/jimmunol.1700870; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Devakumar D., 2017, LANCET INFECT DIS, V18, P1; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Dosch NC, 2016, J PEDIATR-US, V172, P20, DOI 10.1016/j.jpeds.2016.02.023; Ealy AD, 2001, ENDOCRINOLOGY, V142, P2906, DOI 10.1210/en.142.7.2906; Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Feyaerts D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03191-0; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Fried M, 2017, CLIN INFECT DIS, V65, P1729, DOI 10.1093/cid/cix623; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.15585/mmwr.ss6904a1, 10.1016/j.immuni.2017.11.018]; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gonzalez JM, 2013, J REPROD IMMUNOL, V97, P112, DOI 10.1016/j.jri.2012.07.008; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Green MP, 2005, BIOL REPROD, V73, P1087, DOI 10.1095/biolreprod.105.043406; Griffith OW, 2017, P NATL ACAD SCI USA, V114, pE6566, DOI 10.1073/pnas.1701129114; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hogmalm A, 2014, AM J PHYSIOL-LUNG C, V306, pL23, DOI 10.1152/ajplung.00154.2013; Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Huppertz B, 2014, PROG BIOPHYS MOL BIO, V114, P33, DOI 10.1016/j.pbiomolbio.2013.11.007; Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012; Jennewein MF, 2017, SEMIN IMMUNOPATHOL, V39, P605, DOI 10.1007/s00281-017-0653-x; KALLIALA I, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4511; Kim MY, 2018, ANN RHEUM DIS, V77, P549, DOI 10.1136/annrheumdis-2017-212224; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Kroener L, 2016, SEMIN REPROD MED, V34, P27, DOI 10.1055/s-0035-1570029; Lee AJ, 2013, J LEUKOCYTE BIOL, V93, P905, DOI 10.1189/jlb.0912442; Lei J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12798; Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu S, 2017, J REPROD IMMUNOL, V124, P44, DOI 10.1016/j.jri.2017.10.045; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Mahany EB, 2018, ENDOCRINOLOGY, V159, P1718, DOI 10.1210/en.2017-03053; Mccoy AM, 2017, AM J PATHOL, V187, P2635, DOI 10.1016/j.ajpath.2017.08.013; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Moore K.L., 2017, DEV HUMAN, P457; Moore KA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0877-6; Moser G, 2017, PLACENTA, V56, P19, DOI 10.1016/j.placenta.2017.02.007; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Niikura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185392; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Oger S, 2002, J CLIN ENDOCR METAB, V87, P5524, DOI 10.1210/jc.2002-020575; Ostensen M, 2013, CURR OPIN RHEUMATOL, V25, P591, DOI 10.1097/BOR.0b013e328363ebf7; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK SUSP CONF CAS RE; Park HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138114; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Pazos M, 2012, IMMUNOL RES, V54, P254, DOI 10.1007/s12026-012-8303-9; Pendeloski KPT, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12674; Perdu S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85560; Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019; Persson M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2563; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824; Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rinaldi SF, 2017, MOL HUM REPROD, V23, P708, DOI 10.1093/molehr/gax038; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010; Robertson SA, 2018, J REPROD IMMUNOL, V125, P80, DOI 10.1016/j.jri.2017.12.003; Robertson SA, 2010, ENDOCRINOLOGY, V151, P3996, DOI 10.1210/en.2010-0063; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rozner AE, 2016, AM J REPROD IMMUNOL, V76, P364, DOI 10.1111/aji.12564; Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y; Saccone G, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.026; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Santos TD, 2017, J REPROD IMMUNOL, V123, P78, DOI 10.1016/j.jri.2017.09.007; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Senegas A, 2009, INT J PARASITOL, V39, P481, DOI 10.1016/j.ijpara.2008.08.009; Siewiera J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003257; Simoes R., 1992, REV ASSOC MED BRAS, V62, P106; Simon A, 2012, J ASSIST REPROD GEN, V29, P1227, DOI 10.1007/s10815-012-9861-4; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sullivan KD, 2016, ELIFE, V5, DOI 10.7554/eLife.16220; Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; TAUBENECK MW, 1995, J NUTR, V125, P908; Tessier DR, 2015, AM J REPROD IMMUNOL, V74, P1, DOI 10.1111/aji.12345; Thaxton JE, 2013, J IMMUNOL, V190, P3639, DOI 10.4049/jimmunol.1203488; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Tong M, 2015, HUM REPROD UPDATE, V21, P97, DOI 10.1093/humupd/dmu049; Tribe RM, 2003, BIOL REPROD, V68, P1842, DOI 10.1095/biolreprod.102.011403; van der Zwan A, 2018, P NATL ACAD SCI USA, V115, P385, DOI 10.1073/pnas.1713957115; van Egmond A, 2016, J REPROD IMMUNOL, V113, P1, DOI 10.1016/j.jri.2015.09.073; Vinet E, 2015, ARTHRITIS RHEUMATOL, V67, P3201, DOI 10.1002/art.39320; Vinet E, 2015, CIRCULATION, V131, P149, DOI 10.1161/CIRCULATIONAHA.114.010027; Wahid HH, 2015, ENDOCRINOLOGY, V156, P3828, DOI [10.1210/en.2015-1089, 10.1210/EN.2015-1089]; Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilson RM, 2015, PEDIAT ALLERG IMM-UK, V26, P344, DOI 10.1111/pai.12387; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909; Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821; Zenclussen AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00321; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082713	168	179	183	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					397	412		10.1016/j.immuni.2018.07.017	http://dx.doi.org/10.1016/j.immuni.2018.07.017			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231982	Bronze, Green Accepted			2022-12-18	WOS:000444909600009
J	Phan, AT; Goldrath, AW; Glass, CK				Phan, Anthony T.; Goldrath, Ananda W.; Glass, Christopher K.			Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity	IMMUNITY			English	Review							GLYCOLYTIC METABOLISM; TRANSCRIPTION FACTORS; GENE-EXPRESSION; FUNCTIONAL POLARIZATION; S-ADENOSYLMETHIONINE; DEACETYLASE ACTIVITY; EFFECTOR RESPONSES; DENDRITIC CELLS; CUTTING EDGE; MEMORY	Recognition of pathogens by innate and adaptive immune cells instructs rapid alterations of cellular processes to promote effective resolution of infection. To accommodate increased bioenergetic and biosynthetic demands, metabolic pathways are harnessed to maximize proliferation and effector molecule production. In parallel, activation initiates context-specific gene-expression programs that drive effector functions and cell fates that correlate with changes in epigenetic landscapes. Many chromatin-and DNA-modifying enzymes make use of substrates and cofactors that are intermediates of metabolic pathways, providing potential cross talk between metabolism and epigenetic regulation of gene expression. In this review, we discuss recent studies of T cells and macrophages supporting a role for metabolic activity in integrating environmental signals with activation-induced gene-expression programs through modulation of the epigenome and speculate as to how this may influence context-specific macrophage and T cell responses to infection.	[Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Phan, Anthony T.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	agoldrath@ucsd.edu; cglass@ucsd.edu	Braga, Tarcio T/E-4827-2014; Glass, Christopher/AAI-3933-2021	Braga, Tarcio T/0000-0002-2989-1076; Glass, Christopher/0000-0003-4344-3592; Phan, Anthony/0000-0003-2935-6070; Goldrath, Ananda/0000-0002-5900-508X	NIH [AI072117, AI067545, DK091183, NS096170]; Leducq Transatlantic Network Grant; Ben and Wanda Hildyard Chair in Hereditary Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096852, R01AI067545, R01AI072117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Transatlantic Network Grant; Ben and Wanda Hildyard Chair in Hereditary Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding of this work provided by the NIH (AI072117 and AI067545 for A.W.G. and DK091183 and NS096170 for C.K.G.). C.K.G. was also supported by a Leducq Transatlantic Network Grant and the Ben and Wanda Hildyard Chair in Hereditary Diseases. We thank Nathan Spann and Kyla Omilusik for critical reading of the manuscript.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Ananieva EA, 2014, J BIOL CHEM, V289, P18793, DOI 10.1074/jbc.M114.554113; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arts RJW, 2016, SEMIN IMMUNOL, V28, P425, DOI 10.1016/j.smim.2016.09.002; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Baardman J, 2015, EPIGENOMICS-UK, V7, P1155, DOI 10.2217/epi.15.71; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Blattler A, 2013, J BIOL CHEM, V288, P34287, DOI 10.1074/jbc.R113.512517; Bonelli M., 2014, TRANSCRIPTIONAL CONT; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cao Y., 2014, PLOS ONE, V9; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chaoul N, 2015, CANCER RES, V75, P3279, DOI 10.1158/0008-5472.CAN-15-0454; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang H, 2015, CHEM REV, V115, P2376, DOI 10.1021/cr500491u; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jones RG, 2017, IMMUNITY, V46, P730, DOI 10.1016/j.immuni.2017.04.028; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Link VM, 2015, COLD SH Q B, V80, P213, DOI 10.1101/sqb.2015.80.027367; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Northrop JK, 2008, J IMMUNOL, V181, P865, DOI 10.4049/jimmunol.181.2.865; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; SAKATA SF, 1993, J BIOL CHEM, V268, P13978; Scharer CD, 2017, J IMMUNOL, V198, P2238, DOI 10.4049/jimmunol.1602086; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shrestha S, 2014, P NATL ACAD SCI USA, V111, P14858, DOI 10.1073/pnas.1404264111; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Tripathi SK, 2014, IMMUNOL REV, V261, P62, DOI 10.1111/imr.12204; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vahedi G, 2013, IMMUNOLOGY, V139, P294, DOI 10.1111/imm.12113; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang JY, 2016, TRENDS GENET, V32, P284, DOI 10.1016/j.tig.2016.02.005; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wiles ET, 2017, CURR OPIN GENET DEV, V43, P31, DOI 10.1016/j.gde.2016.11.001; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	147	179	182	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					714	729		10.1016/j.immuni.2017.04.016	http://dx.doi.org/10.1016/j.immuni.2017.04.016			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514673	Bronze, Green Accepted			2022-12-18	WOS:000401316300002
J	Kumar, P; Monin, L; Castillo, P; Elsegeiny, W; Horne, W; Eddens, T; Vikram, A; Good, M; Schoenborn, AA; Bibby, K; Montelaro, RC; Metzger, DW; Gulati, AS; Kolls, JK				Kumar, Pawan; Monin, Leticia; Castillo, Patricia; Elsegeiny, Waleed; Horne, William; Eddens, Taylor; Vikram, Amit; Good, Misty; Schoenborn, Alexi A.; Bibby, Kyle; Montelaro, Ronald C.; Metzger, Dennis W.; Gulati, Ajay S.; Kolls, Jay K.			Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation	IMMUNITY			English	Article							SEGMENTED FILAMENTOUS BACTERIA; COLONY-STIMULATING FACTOR; CYTOKINE GM-CSF; T-HELPER-CELLS; T(H)17 CELLS; TH17 CELLS; IL-17 RECEPTOR; HOST-DEFENSE; DIFFERENTIATION; IMMUNITY	Interleukin-17 (IL-17) and IL-17 receptor (IL-17R) signaling are essential for regulating mucosal host defense against many invading pathogens. Commensal bacteria, especially segmented filamentous bacteria (SFB), are a crucial factor that drives T helper 17 (Th17) cell development in the gastrointestinal tract. In this study, we demonstrate that Th17 cells controlled SFB burden. Disruption of IL-17R signaling in the enteric epithelium resulted in SFB dysbiosis due to reduced expression of alpha-defensins, Pigr, and Nox1. When subjected to experimental autoimmune encephalomyelitis, IL-17R-signaling-deficient mice demonstrated earlier disease onset and worsened severity that was associated with increased intestinal Csf2 expression and elevated systemic GM-CSF cytokine concentrations. Conditional deletion of IL-17R in the enteric epithelium demonstrated that there was a reciprocal relationship between the gut microbiota and enteric IL-17R signaling that controlled dysbiosis, constrained Th17 cell development, and regulated the susceptibility to autoimmune inflammation.	[Kumar, Pawan; Monin, Leticia; Castillo, Patricia; Elsegeiny, Waleed; Horne, William; Eddens, Taylor; Good, Misty; Kolls, Jay K.] Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15224 USA; [Vikram, Amit; Bibby, Kyle] Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA 15261 USA; [Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Schoenborn, Alexi A.; Gulati, Ajay S.] Univ N Carolina, Div Pediat Gastroenterol, Chapel Hill, NC 27599 USA; [Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Albany Medical College	Kolls, JK (corresponding author), Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15224 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019; Vikram, Amit/G-5816-2010; Good, Misty/AAI-6192-2020; Kumar, Pawan/GXF-7072-2022; Bibby, Kyle J/C-6189-2018	Kolls, Jay/0000-0001-5151-6304; Vikram, Amit/0000-0002-1207-9292; Good, Misty/0000-0002-0264-5721; Bibby, Kyle J/0000-0003-3142-6090; Monin Aldama, Leticia/0000-0002-4951-8105	Children's Hospital of Pittsburgh Research Advisory Committee from Children's Hospital of Pittsburgh of the UPMC Health System; NIH [T32GM008208, F30AI114146]; PHS [P50HL084932, 5R01HL061271, R37HL079142];  [K08DK101608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062052, P50HL084932, R01HL061271, R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089443, F30AI114146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK104005, K08DK101608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008208] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh Research Advisory Committee from Children's Hospital of Pittsburgh of the UPMC Health System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ozgene for the generation of our floxed mice. We thank Dr. Donna Beer Stolz and Jonathan Franks for SEM imaging. We thank Dr. Mark Jenkins for providing SFB tetramer. We thank Dr. Dan Littman for providing control and SFB tetramer and also for critically reading the manuscript. We thank Drs. Timothy Sanders and Anuradha Ray for critically reading manuscript. We thank Dr. Mandy McGeachy for advice on EAE experiments. We thank Dr. Avijit Ray (Blood Center of Wisconsin) for advice on EAE experiments. P.K. and L.M. are supported from Children's Hospital of Pittsburgh Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the UPMC Health System. P.C. is supported by NIH grant T32GM008208. T.E. is supported by NIH grant F30AI114146. M.G. is supported by K08DK101608. The authors would like to acknowledge support from the following PHS grants: P50HL084932, 5R01HL061271, and R37HL079142 to J.K.K.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Moon C, 2014, MUCOSAL IMMUNOL, V7, P818, DOI 10.1038/mi.2013.98; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Rumble JM, 2015, J EXP MED, V212, P23, DOI 10.1084/jem.20141015; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	35	179	185	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					659	671		10.1016/j.immuni.2016.02.007	http://dx.doi.org/10.1016/j.immuni.2016.02.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26982366	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000372784200022
J	Pellicci, DG; Patel, O; Kjer-Nielsen, L; Pang, SS; Sullivan, LC; Kyparissoudis, K; Brooks, AG; Reid, HH; Gras, S; Lucet, IS; Koh, R; Smyth, MJ; Mallevaey, T; Matsuda, JL; Gapin, L; McCluskey, J; Godfrey, DI; Rossjohn, J				Pellicci, Daniel G.; Patel, Onisha; Kjer-Nielsen, Lars; Pang, Siew Siew; Sullivan, Lucy C.; Kyparissoudis, Konstantinos; Brooks, Andrew G.; Reid, Hugh H.; Gras, Stephanie; Lucet, Isabelle S.; Koh, Ruide; Smyth, Mark J.; Mallevaey, Thierry; Matsuda, Jennifer L.; Gapin, Laurent; McCluskey, James; Godfrey, Dale I.; Rossjohn, Jamie			Differential Recognition of CD1d-alpha-Galactosyl Ceramide by the V beta 8.2 and V beta 7 Semi-invariant NKT T Cell Receptors	IMMUNITY			English	Article							V-BETA DOMAIN; ALPHA-GALACTOSYLCERAMIDE; STRUCTURAL BASIS; CUTTING EDGE; HUMAN CD1D; ANTIGEN; SELECTION; GLYCOLIPIDS; BINDING; PEPTIDE	The semi-invariant natural killer T cell receptor (NKT TCR) recognizes CD1d-lipid antigens. Although the TCR alpha chain is typically invariant, the beta chain expression is more diverse, where three V beta chains are commonly expressed in mice. We report the structures of V alpha 14-V beta 8.2 and V alpha 14-V beta 7 NKT TCRs in complex with CD1d-alpha-galactosylceramide (alpha-GalCer) and the 2.5 angstrom structure of the human NKT TCR-CD1d-alpha-GalCer complex. Both V beta 8.2 and V beta 7 NKT TCRs and the human NKT TCR ligated CD1d-alpha-GalCer in a similar manner, highlighting the evolutionarily conserved interaction. However, differences within the V beta domains of the V beta 8.2 and V beta 7 NKT TCR-CD1d complexes resulted in altered TCR beta-CD1d-mediated contacts and modulated recognition mediated by the invariant a chain. Mutagenesis studies revealed the differing contributions of V beta 8.2 and V beta 7 residues within the CDR2 beta loop in mediating contacts with CD1d. Collectively we provide a structural basis for the differential NKT TCR V beta usage in NKT cells.	[Pellicci, Daniel G.; Kjer-Nielsen, Lars; Sullivan, Lucy C.; Kyparissoudis, Konstantinos; Brooks, Andrew G.; McCluskey, James; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Patel, Onisha; Pang, Siew Siew; Reid, Hugh H.; Gras, Stephanie; Lucet, Isabelle S.; Koh, Ruide; Rossjohn, Jamie] Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Sch Biomed Sci,Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Smyth, Mark J.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Mallevaey, Thierry; Matsuda, Jennifer L.; Gapin, Laurent] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA; [Mallevaey, Thierry; Matsuda, Jennifer L.; Gapin, Laurent] Natl Jewish Hlth, Denver, CO 80206 USA	University of Melbourne; Monash University; Peter Maccallum Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Godfrey, DI (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	godfrey@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Pellicci, Daniel/AAX-8539-2020; Smyth, Mark J/H-8709-2014; gras, stephanie/C-8307-2013; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Mallevaey, Thierry/AAH-4499-2020	Smyth, Mark J/0000-0001-7098-7240; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Sullivan, Lucy/0000-0003-2907-4989; gras, stephanie/0000-0001-7416-038X; Patel, Onisha/0000-0001-6701-7139; Godfrey, Dale/0000-0002-3009-5472; Brooks, Andrew/0000-0002-4085-9683; Pellicci, Daniel/0000-0001-5305-2398	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); NIH [AI057485]; ARC Federation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076463, R01AI057485, R56AI078246] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Federation Fellowship(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff at the Australian synchrotron and the Advance Photon Source (Chicago, IQ for assistance with data collection. The Australian Research Council (ARC), the National Health and Medical Research Council of Australia (NHMRC), and the Cancer Council of Victoria supported this research. L.G. was supported by an NIH grant (AI057485). D.I.G. and M.J.S. are supported by NHMRC Research Fellowships. J.R. is supported by an ARC Federation Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Burdin N, 1998, J IMMUNOL, V161, P3271; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DeLano W. L, 2002, PYMOL MOL GENETICS G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2008, CHEM BIOL, V15, P654, DOI 10.1016/j.chembiol.2008.05.012; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Mallevaey T, 2009, IMMUNITY, V31, P60, DOI 10.1016/j.immuni.2009.05.010; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2006, J IMMUNOL, V176, P2064, DOI 10.4049/jimmunol.176.4.2064; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Wei DG, 2006, J EXP MED, V203, P1197, DOI 10.1084/jem.20060418; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	179	199	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					47	59		10.1016/j.immuni.2009.04.018	http://dx.doi.org/10.1016/j.immuni.2009.04.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592275	Green Accepted, Bronze			2022-12-18	WOS:000268219900011
J	Kumar, A; Hurnphreys, TD; Kremer, KN; Bramati, PS; Bradfield, L; Edgar, CE; Hedin, KE				Kumar, Ashok; Hurnphreys, Troy D.; Kremer, Kimberly N.; Bramati, Patricia S.; Bradfield, Lavone; Edgar, Contessa E.; Hedin, Karen E.			CXCR4 physically associates with the T cell receptor to signal in T cells	IMMUNITY			English	Article							ANTIGEN RECEPTOR; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-CHEMOKINE; ENERGY-TRANSFER; PROTEIN-KINASE; CUTTING EDGE; ZAP-70; ACTIVATION; TCR	SDF-1 alpha (CXCL12) signaling via its receptor, CXCR4, stimulates T cell chemotaxis and gene expression. The ZAP-70 tyrosine kinase critically mediates SDF-1 alpha-dependent migration and prolonged ERK mitogen-activated protein (MAP) kinase activation in T cells. However, the molecular mechanism by which CXCR4 or other G protein-coupled receptors activate ZAP-70 has not been characterized. Here we show that SDF-1 alpha stimulates the physical association of CXCR4 and the T cell receptor (TCR) and utilizes the ZAP-70 binding ITAM domains of the TCR for signal transduction. This pathway is responsible for several of the effects of SDF-1 alpha on T cells, including prolonged ERK MAP kinase activity, increased intracellular calcium ion concentrations, robust AP-1 transcriptional activity, and SDF-1 alpha costimulation of cytokine secretion. These results suggest new paradigms for understanding the effects of SDF-1 alpha and other chemokines on immunity.	Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Hedin, KE (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	hedin.karen@mayo.edu		Hedin, Karen/0000-0003-1010-923X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252, R01GM059763] Funding Source: NIH RePORTER; NIAID NIH HHS [AI074525] Funding Source: Medline; NIGMS NIH HHS [R01 GM59763, GM55252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALARCON B, 1988, J BIOL CHEM, V263, P2953; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Batard P, 2002, CYTOMETRY, V48, P97, DOI 10.1002/cyto.10106; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Forster R, 1998, J IMMUNOL, V160, P1522; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hedin KE, 1997, J IMMUNOL, V159, P5431; Hernandez-Lopez C, 2002, BLOOD, V99, P546, DOI 10.1182/blood.V99.2.546; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Sawada S, 1998, J EXP MED, V187, P1439, DOI 10.1084/jem.187.9.1439; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; Sotsios Y, 1999, J IMMUNOL, V163, P5954; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Ticchioni M, 2002, BLOOD, V99, P3111, DOI 10.1182/blood.V99.9.3111; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Wang ZY, 2005, J IMMUNOL, V174, P2098, DOI 10.4049/jimmunol.174.4.2098; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	179	185	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					213	224		10.1016/j.immuni.2006.06.015	http://dx.doi.org/10.1016/j.immuni.2006.06.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16919488	Bronze			2022-12-18	WOS:000240047500008
J	Grech, AP; Amesbury, M; Chan, T; Gardam, S; Basten, A; Brink, R				Grech, AP; Amesbury, M; Chan, T; Gardam, S; Basten, A; Brink, R			TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappa B activation in mature B cells	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B2 P100; TNF RECEPTOR; BAFF-R; KINASE; ROLES; DEGRADATION; INDUCTION; SURVIVAL; REQUIRES	To examine the role of the TNF-R superfamily signaling protein TRAF2 in mature B cell development and NF-kappaB activation, conditionally TRAF2-deficient mice were produced. B cells lacking TRAF2 expression in these mice possessed a selective survival advantage, accumulated in the lymph nodes and splenic marginal zone, were larger in size, and expressed increased levels of CD21/35. These TRAF2-deficient B cells could not proliferate or activate the canonical NF-kappaB pathway in response to CD40 ligation. By contrast, noncanonical NF-kappaB activation was constitutively hyperactive, with TRAF2-deficient B cells exhibiting close to maximal processing of NF-kappaB2 from p100 to p52 and high levels of constitutive p52 and RelB DNA binding activity. These findings establish TRAF2 as a multifunctional regulator of NF-kappaB activation that mediates activation of the canonical pathway but acts as a negative regulator of the noncanonical pathway. This dual functionality explains the contrasting roles of TRAF2 in B cell maturation and activation.	Centenary Inst Canc Med & Cell Biol, Newtown, Tas NSW 2042, Australia	University of Sydney; Centenary Institute	Brink, R (corresponding author), Centenary Inst Canc Med & Cell Biol, Locked Bag No 6, Newtown, Tas NSW 2042, Australia.	r.brink@centenary.usyd.edu.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655; Chan, Tyani/0000-0001-9276-8479				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Brown KD, 2002, J BIOL CHEM, V277, P19433, DOI 10.1074/jbc.M111522200; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Wajant H, 2001, INT J BIOCHEM CELL B, V33, P19, DOI 10.1016/S1357-2725(00)00064-9; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	39	179	188	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2004	21	5					629	642		10.1016/j.immuni.2004.09.011	http://dx.doi.org/10.1016/j.immuni.2004.09.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539150	Bronze			2022-12-18	WOS:000225365000005
J	Todd, JA; Wicker, LS				Todd, JA; Wicker, LS			Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models	IMMUNITY			English	Review							ALTERED PEPTIDE LIGAND; SUSCEPTIBILITY LOCUS; AUTOIMMUNE-THYROIDITIS; T-CELLS; MULTIPLE-SCLEROSIS; SJOGRENS-SYNDROME; MOLECULAR-BASIS; GRAVES-DISEASE; INSULIN GENE; HUMAN THYMUS	Populations of humans and mice contain alleles at many loci that protect from immune-mediated diseases. Identification of these alleles, some which are likely to function in immune recognition, tolerance, and regulation, will facilitate the development of diagnostics as well as therapeutics that alter disease progression.	Univ Cambridge, Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 2XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk; linda.wicker@cimr.cam.ac.uk	Wicker, Linda S/F-7384-2010; Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148				Ahmed S, 2001, RHEUMATOLOGY, V40, P662, DOI 10.1093/rheumatology/40.6.662; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bonifacio E, 1999, J IMMUNOL, V163, P525; Brayer J, 2000, J RHEUMATOL, V27, P1896; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cordell HJ, 2001, GENETICS, V158, P357; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; CUCCA F, 2001, IN PRESS HUM MOL GEN; Delemarre FGA, 1996, EXP CLIN ENDOCR DIAB, V104, P10, DOI 10.1055/s-0029-1211670; Delepine M, 1997, AM J HUM GENET, V60, P174; Diez J, 2001, DIABETES, V50, P895, DOI 10.2337/diabetes.50.4.895; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; Esposito L, 1998, DIABETES, V47, P1797, DOI 10.2337/diabetes.47.11.1797; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Harrison L C, 2001, Pediatr Diabetes, V2, P71, DOI 10.1034/j.1399-5448.2001.002002071.x; Hattori M, 1999, J IMMUNOL, V163, P1721; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Hutchings PR, 1999, CELL IMMUNOL, V192, P113, DOI 10.1006/cimm.1998.1446; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; IKEGAMI H, 2001, ANIMAL MODELS DIABET, P43; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Luhder F, 1998, J EXP MED, V187, P379, DOI 10.1084/jem.187.3.379; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Lyons P A, 1999, Curr Dir Autoimmun, V1, P208; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Merriman TR, 2001, DIABETES, V50, P184, DOI 10.2337/diabetes.50.1.184; Mordes JP, 1996, DIABETES METAB REV, V12, P103, DOI 10.1002/(SICI)1099-0895(199607)12:2<103::AID-DMR161>3.0.CO;2-2; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; PIPELEERS D, 1992, DIABETES METAB REV, V8, P209, DOI 10.1002/dmr.5610080303; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; Podolin PL, 1997, J IMMUNOL, V159, P1835; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Rasooly L, 1996, CLIN IMMUNOL IMMUNOP, V81, P287, DOI 10.1006/clin.1996.0191; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Robles DT, 2001, J AUTOIMMUN, V16, P355, DOI 10.1006/jaut.2000.0483; Rose NR, 1997, CRIT REV IMMUNOL, V17, P511; Schmidt D, 1997, J EXP MED, V186, P1059, DOI 10.1084/jem.186.7.1059; Serreze DV, 1998, J IMMUNOL, V160, P1472; SERREZE DV, 2001, IN PRESS MOL PATHOLO; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Tomer Y, 2001, J CLIN ENDOCR METAB, V86, P1687, DOI 10.1210/jc.86.4.1687; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Verge CF, 1998, J CLIN INVEST, V102, P1569, DOI 10.1172/JCI3379; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wicker LS, 1997, J EXP MED, V186, P973, DOI 10.1084/jem.186.7.973; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jcem.80.1.7829637; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	75	179	187	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2001	15	3			SI		387	395		10.1016/S1074-7613(01)00202-3	http://dx.doi.org/10.1016/S1074-7613(01)00202-3			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567629	Bronze			2022-12-18	WOS:000171211800006
J	Alam, SM; Davies, GM; Lin, CM; Zal, T; Nasholds, W; Jameson, SC; Hogquist, KA; Gascoigne, NRJ; Travers, PJ				Alam, SM; Davies, GM; Lin, CM; Zal, T; Nasholds, W; Jameson, SC; Hogquist, KA; Gascoigne, NRJ; Travers, PJ			Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands	IMMUNITY			English	Article							POSITIVE SELECTION; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; VIRAL PEPTIDE; MHC COMPLEX; ALPHA-BETA; AFFINITY; TCR; KINETICS; ACTIVATION	The kinetics of interaction between TCR and MHC-peptide show a general relationship between affinity and the biological response, but the reported kinetic differences between antigenic and antagonistic peptides are very small. Here, we show a remarkable difference in the kinetics of TCR interactions with strong agonist ligands at 37 degrees C compared to 25 degrees C. This difference is not seen with antagonist/positive selecting ligands. The interaction at 37 degrees C shows biphasic binding kinetics best described by a model of TCR dimerization. The altered kinetics greatly increase the stability of complexes with agonist ligands, accounting for the large differences in biological response compared to other ligands. Thus, there may be an allosteric, as well as a kinetic, component to the discrimination between agonists and antagonists.	Royal Free Hosp, Sch Med, Anthony Nolan Bone Marrow Trust, London NW3 2QG, England; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Scripps Research Institute; University of London; Birkbeck University London; University of Minnesota System; University of Minnesota Twin Cities	Gascoigne, NRJ (corresponding author), Royal Free Hosp, Sch Med, Anthony Nolan Bone Marrow Trust, London NW3 2QG, England.		Alam, S. Munir/AAC-6711-2019; Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Zal, Tomasz/0000-0002-3469-4261; Hogquist, Kristin/0000-0001-9963-5687	NIGMS NIH HHS [R01 GM39476] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039476] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Basson MA, 1998, J EXP MED, V187, P1249; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; Fisher Robert J., 1994, Current Opinion in Biotechnology, V5, P389, DOI 10.1016/0958-1669(94)90047-7; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Girao C, 1997, J IMMUNOL, V159, P4205; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jose ES, 1998, EUR J IMMUNOL, V28, P12; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Mariathasan S, 1998, J IMMUNOL, V161, P6030; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Oddie GW, 1997, ANAL BIOCHEM, V244, P301, DOI 10.1006/abio.1996.9912; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; POSNER RG, 1992, BIOCHEMISTRY-US, V31, P5350, DOI 10.1021/bi00138a015; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Schuck P, 1996, BIOPHYS J, V70, P1230, DOI 10.1016/S0006-3495(96)79681-9; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	44	179	183	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					227	237		10.1016/S1074-7613(00)80023-0	http://dx.doi.org/10.1016/S1074-7613(00)80023-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072075	Bronze			2022-12-18	WOS:000078972200010
J	Martin, BK; Chin, KC; Olsen, JC; Skinner, CA; Dey, A; Ozato, K; Ting, JPY				Martin, BK; Chin, KC; Olsen, JC; Skinner, CA; Dey, A; Ozato, K; Ting, JPY			Induction of MHC class I expression by the MHC class II transactivator CIITA	IMMUNITY			English	Article							BARE LYMPHOCYTE SYNDROME; DR-ALPHA GENE; NF-KAPPA-B; INTERFERON-GAMMA; HLA-DM; CONSENSUS SEQUENCE; REGULATORY ELEMENT; TAP-1 EXPRESSION; CARCINOMA-CELLS; COMPLEX	Major histocompatibility complex (MHC) class I-deficient cell lines were used to demonstrate that the MHC class II transactivator (CIITA) can induce surface expression of MHC class I molecules. CIITA induces the promoter of MHC class I heavy chain genes. The site alpha DNA element is the target for CIITA-induced transactivation of class I. In addition, interferon-gamma (IFN gamma)-induced MHC class I expression also requires an intact site alpha. The G3A cell line, which is defective in CIITA induction, does not induce MHC class I antigen and promoter in response to IFN gamma. Trans-dominant-negative forms of CIITA reduce class I MHC promoter function and surface antigen expression. Collectively, these data argue that CIITA has a role in class I MHC gene induction.	UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT MED,CHAPEL HILL,NC 27599; NICHHD,LAB MOL GROWTH REGULAT,NIH,BETHESDA,MD 20892	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Martin, BK (corresponding author), UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599, USA.			Martin, Brian/0000-0002-4873-5351	NCI NIH HHS [F32 CA67480-02] Funding Source: Medline; NIAID NIH HHS [AI29564] Funding Source: Medline; NCPDCID CDC HHS [NCI48185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA067480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029564] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUSEBEL FM, 1987, CURRENT PROTOCOLS MO; Burke P A, 1989, Year Immunol, V4, P23; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; CROMME FV, 1994, BRIT J CANCER, V69, P1176, DOI 10.1038/bjc.1994.231; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOLO V, 1995, CLIN EXP METASTAS, V13, P277, DOI 10.1007/BF00133483; DRIGGERS PH, 1992, NUCLEIC ACIDS RES, V20, P2533, DOI 10.1093/nar/20.10.2533; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GIULIANI C, 1995, J BIOL CHEM, V270, P11453, DOI 10.1074/jbc.270.19.11453; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; MACH B, 1995, NEW ENGL J MED, V332, P120, DOI 10.1056/NEJM199501123320211; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MAGUIRE JE, 1992, MOL CELL BIOL, V12, P3078, DOI 10.1128/MCB.12.7.3078; MAO C, 1993, P NATL ACAD SCI USA, V90, P2880, DOI 10.1073/pnas.90.7.2880; MARTIN BK, 1993, J IMMUNOL, V151, P857; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; OLSEN JC, 1995, HUM GENE THER, V6, P1195, DOI 10.1089/hum.1995.6.9-1195; OSTRANDROSENBERG S, 1990, J IMMUNOL, V144, P4068; PULASKI BA, 1993, CANCER RES, V53, P2112; RAMIREZ R, 1992, CELL IMMUNOL, V140, P248, DOI 10.1016/0008-8749(92)90191-Q; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; SAJI M, 1992, P NATL ACAD SCI USA, V89, P1944, DOI 10.1073/pnas.89.5.1944; SEGARS JH, 1993, MOL CELL BIOL, V13, P6157, DOI 10.1128/MCB.13.10.6157; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SHERMAN PA, 1989, P NATL ACAD SCI USA, V86, P6739, DOI 10.1073/pnas.86.17.6739; SHERMAN PA, 1987, P NATL ACAD SCI USA, V84, P4254, DOI 10.1073/pnas.84.12.4254; SHIRAYOSHI Y, 1987, MOL CELL BIOL, V7, P4542, DOI 10.1128/MCB.7.12.4542; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; SUGITA K, 1987, MOL CELL BIOL, V7, P2625, DOI 10.1128/MCB.7.7.2625; TATAKE RJ, 1993, P SOC EXP BIOL MED, V203, P405; TING JPY, 1993, CURR OPIN IMMUNOL, V5, P8, DOI 10.1016/0952-7915(93)90074-3; VALLEJO AN, 1995, IMMUNOL REV, V143, P249, DOI 10.1111/j.1600-065X.1995.tb00678.x; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	54	179	183	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					591	600		10.1016/S1074-7613(00)80347-7	http://dx.doi.org/10.1016/S1074-7613(00)80347-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175837	Green Published, Bronze			2022-12-18	WOS:A1997XB81900010
J	BASSUK, AG; LEIDEN, JM				BASSUK, AG; LEIDEN, JM			A DIRECT PHYSICAL ASSOCIATION BETWEEN ETS AND AP-1 TRANSCRIPTION FACTORS IN NORMAL HUMAN T-CELLS	IMMUNITY			English	Review							TISSUE-SPECIFIC EXPRESSION; SEQUENCE-SPECIFIC BINDING; LEUCINE ZIPPER DOMAIN; SERUM GROWTH-FACTORS; FOS-JUN INTERACTION; DNA-BINDING; C-JUN; NUCLEAR FACTOR; GENE FAMILY; FUNCTIONAL-ANALYSIS	The Ets and AP-1 families of transcription factors bind distinct DNA elements and subserve diverse functions in multiple lymphoid and nonlymphoid cell types. Functionally im portent Ets and AP-1 binding sites have been identified in a large number of enhancer elements, suggesting important cooperative interactions between these two families of transcription factors. In this report, we have demonstrated a direct physical interaction between Ets and AP-1 proteins both in vitro and in activated human T cells. This interaction is mediated by the binding of the basic domain of Jun to the Ets domain of Ets proteins. Jun, in association with Ets, is capable of interacting with Fos family members to form a trimolecular protein complex. The physical association between Ets-1 and AP-1 proteins is required for the transcriptional activity of enhancer elements containing adjacent Ets and AP-1 binding sites. We conclude that direct physical interactions between Ets and AP-1 transcription factors play an important role in regulating mammalian gene expression.	UNIV CHICAGO, DEPT PATHOL, CHICAGO, IL 60637 USA	University of Chicago	BASSUK, AG (corresponding author), UNIV CHICAGO, DEPT MED, 5841 S MARYLAND AVE, CHICAGO, IL 60637 USA.			Bassuk, Alexander/0000-0002-4067-2157	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029673, R37AI029673] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-29673] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARONOW BJ, 1992, MOL CELL BIOL, V12, P4170, DOI 10.1128/MCB.12.9.4170; BEN DY, 1991, GENE DEV, V5, P908; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BERGELSON S, 1994, BIOCHEM BIOPH RES CO, V200, P290, DOI 10.1006/bbrc.1994.1447; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; CARVALHO M, 1993, J VIROL, V67, P2064, DOI 10.1128/JVI.67.4.2064-2074.1993; CARVALHO M, 1993, J VIROL, V67, P3885, DOI 10.1128/JVI.67.7.3885-3890.1993; DONALDSON LW, 1994, BIOCHEMISTRY-US, V33, P13509, DOI 10.1021/bi00250a001; FISHER RJ, 1992, J BIOL CHEM, V267, P17957; FLEISCHMAN LF, 1993, ONCOGENE, V8, P771; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GOLDBERG Y, 1994, J BIOL CHEM, V269, P16566; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, J IMMUNOL, V151, P837; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; JOHN S, 1995, MOL CELL BIOL, V15, P1786; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KHACHIGIAN LM, 1994, J BIOL CHEM, V269, P22647; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAUDET V, 1993, BIOCHEM BIOPH RES CO, V190, P8, DOI 10.1006/bbrc.1993.1002; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEIDEN JM, 1992, J VIROL, V66, P5890, DOI 10.1128/JVI.66.10.5890-5897.1992; LIANG H, 1994, P NATL ACAD SCI USA, V91, P11655, DOI 10.1073/pnas.91.24.11655; LIANG H, 1994, STRUCT BIOL, V1, P871; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; MAVROTHALASSITIS GJ, 1991, CELL GROWTH DIFFER, V2, P215; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MESSIER H, 1992, J IMMUNOL, V149, P1980; METZ R, 1994, EMBO J, V13, P3832, DOI 10.1002/j.1460-2075.1994.tb06694.x; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; MULLER R, 1987, ONCOGENE RES, V2, P19; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NERLOV C, 1991, ONCOGENE, V6, P1583; NEUBERG M, 1989, NATURE, V341, P243, DOI 10.1038/341243a0; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NOTHIAS JY, 1993, J VIROL, V67, P3036, DOI 10.1128/JVI.67.6.3036-3047.1993; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; OKA T, 1991, ONCOGENE, V6, P2077; PANKOV R, 1994, MOL CELL BIOL, V14, P7744, DOI 10.1128/MCB.14.12.7744; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; PAPAS TS, 1989, CURR TOP MICROBIOL, V149, P143; PETERLIN BM, 1991, RES IMMUNOL, V142, P393, DOI 10.1016/0923-2494(91)90037-J; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; RANSONE LJ, 1990, MOL CELL BIOL, V10, P4565, DOI 10.1128/MCB.10.9.4565; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; REDDY MA, 1992, MOL ENDOCRINOL, V6, P1051, DOI 10.1210/me.6.7.1051; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; TSUCHIYA H, 1993, J VIROL, V67, P7001, DOI 10.1128/JVI.67.12.7001-7007.1993; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; WANG CY, 1993, SCIENCE, V260, P1330, DOI 10.1126/science.8493578; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; WANG CY, 1992, J EXP MED, V178, P1133; WASYLYK B, 1993, EUR J BIOCHEM, V215, P907; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; YASEEN NR, 1994, MOL CELL BIOL, V14, P6886, DOI 10.1128/MCB.14.10.6886; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; ZHANG LQ, 1993, ONCOGENE, V8, P1621	101	179	180	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG	1995	3	2					223	237		10.1016/1074-7613(95)90092-6	http://dx.doi.org/10.1016/1074-7613(95)90092-6			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RR339	7648395	Bronze			2022-12-18	WOS:A1995RR33900008
J	Cillo, AR; Kurten, CHL; Tabib, T; Qi, ZB; Onkar, S; Wang, T; Liu, AG; Duvvuri, U; Kim, S; Soose, RJ; Oesterreich, S; Chen, W; Lafyatis, R; Bruno, TC; Ferris, RL; Vignali, DAA				Cillo, Anthony R.; Kuerten, Cornelius H. L.; Tabib, Tracy; Qi, Zengbiao; Onkar, Sayali; Wang, Ting; Liu, Angen; Duvvuri, Umamaheswar; Kim, Seungwon; Soose, Ryan J.; Oesterreich, Steffi; Chen, Wei; Lafyatis, Robert; Bruno, Tullia C.; Ferris, Robert L.; Vignali, Dario A. A.			Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer	IMMUNITY			English	Article							SQUAMOUS-CELL CARCINOMA; REGULATORY T-CELLS; UNITED-STATES; HUMAN-PAPILLOMAVIRUS; TRANSCRIPTION FACTOR; INCIDENCE TRENDS; DENDRITIC CELLS; ORAL-CAVITY; SURVIVAL; NIVOLUMAB	Head and neck squamous cell carcinoma (HNSCC) arises through exposure to environmental carcinogens or malignant transformation by human papillomavirus (HPV). Here, we assessed the transcriptional profiles of 131,224 single cells from peripheral and intra-tumoral immune populations from patients with HPV- and HPV+ HNSCC and healthy donors. Immune cells within tumors of HPV- and HPV+ HNSCC displayed a spectrum of transcriptional signatures, with helper CD4(+) T cells and B cells being relatively divergent and CD8+ T cells and CD4+ regulatory T cells being relatively similar. Transcriptional results were contextualized through multispectral immuno-fluorescence analyses and evaluating putative cell-cell communication based on spatial proximity. These analyses defined a gene expression signature associated with CD4(+) T follicular helper cells that is associated with longer progression-free survival in HNSCC patients. The datasets and analytical approaches herein provide a resource for the further study of the impact of immune cells on viral- and carcinogen-induced cancers.	[Cillo, Anthony R.; Onkar, Sayali; Bruno, Tullia C.; Ferris, Robert L.; Vignali, Dario A. A.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Cillo, Anthony R.; Kuerten, Cornelius H. L.; Onkar, Sayali; Bruno, Tullia C.; Ferris, Robert L.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Kuerten, Cornelius H. L.; Duvvuri, Umamaheswar; Kim, Seungwon; Soose, Ryan J.; Ferris, Robert L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Kuerten, Cornelius H. L.] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany; [Tabib, Tracy; Qi, Zengbiao; Lafyatis, Robert] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Sch Med, Pittsburgh, PA 15261 USA; [Wang, Ting; Chen, Wei] UPMC, Dept Pediat, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Liu, Angen] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Oesterreich, Steffi] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Oesterreich, Steffi] Univ Pittsburgh, Womens Canc Res Ctr, Magee Womens Res Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Bruno, TC; Ferris, RL; Vignali, DAA (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15261 USA.; Bruno, TC; Ferris, RL; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Ferris, RL (corresponding author), Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA.	tbruno@pitt.edu; ferrrl@upmc.edu; dvignali@pitt.edu	Duvvuri, Umamaheswar/AAN-7973-2020	Duvvuri, Umamaheswar/0000-0003-1968-3756	University of Pittsburgh Cancer Immunology Training Program [T32 CA082084]; Hillman Postdoctoral Fellowship for Innovative Cancer Research; Programm zur Internen Forschungsforderung Essen (IFORES); NIH [P50 HNSCC SPORE CA097190]; NCI Comprehensive Cancer Center support CORE grant [CA047904]	University of Pittsburgh Cancer Immunology Training Program; Hillman Postdoctoral Fellowship for Innovative Cancer Research; Programm zur Internen Forschungsforderung Essen (IFORES); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center support CORE grant	We thank Amy Cuda, Merida Serrano, Tina Harrison, and Denise Kroll for clinical assistance and procurement of patient samples; Aditi Kulkarni, Subinoy Biswas, and Feng Shan for computational input; the Hillman Cancer Center Flow Cytometry Core (Bratislav Janjic and Ernest Meyer) for cell sorting; the Health Science Core Research Facilities Genomics Research Core (William Horne) for next-generation sequencing; the University of Pittsburgh Center for Research Computing for computational resources; the University of Colorado Denver Human Immune Monitoring Shared Resource (Kimberly Jordan and Angela Minic); the Immunologic Monitoring and Cellular Products Laboratory at Hillman Cancer Center (Jason Devlin); the National Surgical Adjuvant Breast and Bowel Project (Marion Joy) for assistance with immunofluorescence imaging; and all members of the Vignali lab for helpful discussions. This work was supported by the University of Pittsburgh Cancer Immunology Training Program (T32 CA082084 to A.R.C.), a Hillman Postdoctoral Fellowship for Innovative Cancer Research (to A.R.C.), the Programm zur Internen Forschungsforderung Essen (IFORES) (stipend to C.H.L.K.), the NIH (P50 HNSCC SPORE CA097190 to D.A.A.V. and R.L.F.), and NCI Comprehensive Cancer Center support CORE grant CA047904 (to D.A.A.V. and R.L.F.).	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baglama J, 2005, SIAM J SCI COMPUT, V27, P19, DOI 10.1137/04060593X; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brown LM, 2012, J ONCOL, V2012, DOI 10.1155/2012/649498; Brown LM, 2011, CANCER CAUSE CONTROL, V22, P753, DOI 10.1007/s10552-011-9748-1; Bruno TC, 2017, CANCER IMMUNOL RES, V5, P898, DOI 10.1158/2326-6066.CIR-17-0075; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell JD, 2018, CELL REP, V23, P194, DOI 10.1016/j.celrep.2018.03.063; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Colevas AD, 2014, HEAD NECK-J SCI SPEC, V36, P34, DOI 10.1002/hed.23253; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fakhry C, 2013, ORAL ONCOL, V49, P863, DOI 10.1016/j.oraloncology.2013.06.002; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Ferris RL, 2018, ORAL ONCOL, V81, P45, DOI 10.1016/j.oraloncology.2018.04.008; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Guo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36107; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Jayaram SC, 2016, HEAD NECK-J SCI SPEC, V38, P1855, DOI 10.1002/hed.24531; Kansy BA, 2017, CANCER RES, V77, P6353, DOI 10.1158/0008-5472.CAN-16-3167; Kobayashi K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090241; Koneva LA, 2018, MOL CANCER RES, V16, P90, DOI 10.1158/1541-7786.MCR-17-0153; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhn M, 2022, CLASSIFICATION REGRE; Kumar MP, 2018, CELL REP, V25, P1458, DOI 10.1016/j.celrep.2018.10.047; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; LeHew CW, 2017, EPIDEMIOL REV, V39, P132, DOI 10.1093/epirev/mxw001; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Linderman GC, 2019, NAT METHODS, V16, P243, DOI 10.1038/s41592-018-0308-4; Linterman Michelle A, 2016, F1000Res, V5, DOI 10.12688/f1000research.7388.1; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nedergaard BS, 2008, GYNECOL ONCOL, V108, P106, DOI 10.1016/j.ygyno.2007.08.089; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; PAK AS, 1995, CLIN CANCER RES, V1, P95; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rose K, 1998, P IEEE, V86, P2210, DOI 10.1109/5.726788; ROSE K, 1990, PATTERN RECOGN LETT, V11, P589, DOI 10.1016/0167-8655(90)90010-Y; ROSE K, 1990, PHYS REV LETT, V65, P945, DOI 10.1103/PhysRevLett.65.945; Russell Sm, 2013, Head Neck Oncol, V5, P24; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Shi JY, 2013, CLIN CANCER RES, V19, P5994, DOI 10.1158/1078-0432.CCR-12-3497; Shimabukuro-Vornhagen A, 2014, ONCOTARGET, V5, P4651, DOI 10.18632/oncotarget.1701; Son M, 2012, P NATL ACAD SCI USA, V109, pE3160, DOI 10.1073/pnas.1212753109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorsson V, 2018, IMMUNITY, V48, P812, DOI 10.1016/j.immuni.2018.03.023; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vasanthakumar A, 2017, CELL REP, V20, P2906, DOI 10.1016/j.celrep.2017.08.068; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Victora Gabriel D, 2014, Cell, V159, P700, DOI 10.1016/j.cell.2014.10.012; Weatherspoon DJ, 2015, CANCER EPIDEMIOL, V39, P497, DOI 10.1016/j.canep.2015.04.007; Weed DT, 2015, CLIN CANCER RES, V21, P39, DOI 10.1158/1078-0432.CCR-14-1711; Wirsing AM, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-38; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Woo JR, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-30; Wood O, 2016, ONCOTARGET, V7, P56781, DOI 10.18632/oncotarget.10788; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Zappia L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1305-0; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	94	178	183	3	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					183	+		10.1016/j.immuni.2019.11.014	http://dx.doi.org/10.1016/j.immuni.2019.11.014			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31924475	Green Accepted, Bronze			2022-12-18	WOS:000507384600017
J	Funabiki, M; Kato, H; Miyachi, Y; Toki, H; Motegi, H; Inoue, M; Minowa, O; Yoshida, A; Deguchi, K; Sato, H; Ito, S; Shiroishi, T; Takeyasu, K; Noda, T; Fujita, T				Funabiki, Masahide; Kato, Hiroki; Miyachi, Yoshiki; Toki, Hideaki; Motegi, Hiromi; Inoue, Maki; Minowa, Osamu; Yoshida, Aiko; Deguchi, Katashi; Sato, Hiroshi; Ito, Sadayoshi; Shiroishi, Toshihiko; Takeyasu, Kunio; Noda, Tetsuo; Fujita, Takashi			Autoimmune Disorders Associated with Gain of Function of the Intracellular Sensor MDA5	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RIG-I HELICASE; ANTIVIRAL RESPONSES; CROHNS-DISEASE; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; ADAPTER PROTEIN; STRANDED-RNA; RECOGNITION; INTERFERON	MDA5 is an essential intracellular sensor for several viruses, including picornaviruses, and elicits antiviral interferon (IFN) responses by recognizing viral dsRNAs. MDA5 has been implicated in autoimmunity. However, the mechanisms of how MDA5 contributes to autoimmunity remain unclear. Here we provide direct evidence that dysregulation of MDA5 caused autoimmune disorders. We established a mutant mouse line bearing MDA5 mutation by ENU mutagenesis, which spontaneously developed lupus-like autoimmune symptoms without viral infection. Inflammation was dependent on an adaptor molecule, MAVS indicating the importance of MDA5-signaling. In addition, intercrossing the mutant mice with type I IFN receptor-deficient mice ameliorated clinical manifestations. This MDA5 mutant could activate signaling in the absence of its ligand but was paradoxically defective for ligand- and virus-induced signaling, suggesting that the mutation induces a conformational change in MDA5. These findings provide insight into the association between disorders of the innate immune system and autoimmunity.	[Funabiki, Masahide; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Mol Genet Lab, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Funabiki, Masahide; Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan; [Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Mol Cell Biol Lab, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068507, Japan; [Kato, Hiroki] Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Toki, Hideaki; Motegi, Hiromi; Inoue, Maki; Minowa, Osamu; Noda, Tetsuo] Riken BioResource Ctr BRC, Team Adv Dev & Evaluat Human Dis Models, Tsukuba, Ibaraki 3050074, Japan; [Yoshida, Aiko; Deguchi, Katashi; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Sendai, Miyagi 9808578, Japan; [Sato, Hiroshi] Fac Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Shiroishi, Toshihiko] Natl Inst Genet, Div Mammalian Genet Lab, Mishima, Shizuoka 4118540, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Koto Ku, Tokyo 1358550, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Kyoto University; Tohoku University; Tohoku University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japanese Foundation for Cancer Research	Fujita, T (corresponding author), Kyoto Univ, Mol Genet Lab, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Noda, Tetsuo/B-1667-2016; Minowa, Osamu/AAM-1238-2020; Ito, Sadayoshi/A-3933-2015	Ito, Sadayoshi/0000-0002-5092-3626	Japan Science and Technology Agency (PRESTO); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24115004, 23249023]; Daiichi Sankyo Foundation of Life Science; Takeda Science Foundation	Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi Sankyo Foundation of Life Science; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by independent grants from Japan Science and Technology Agency (PRESTO), from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (innovative areas, infection competency, no. 24115004 and scientific research A, no. 23249023), from Daiichi Sankyo Foundation of Life Science, and from the Takeda Science Foundation.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bihl T, 2005, ANN RHEUM DIS, V64, P1380, DOI 10.1136/ard.2004.031179; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Dinarello CA, 2004, IMMUNITY, V20, P243, DOI 10.1016/S1074-7613(04)00055-X; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Kageyama M, 2011, BIOCHEM BIOPH RES CO, V415, P75, DOI 10.1016/j.bbrc.2011.10.015; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Toki H, 2013, CANCER SCI, V104, P937, DOI 10.1111/cas.12161; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	46	178	183	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					199	212		10.1016/j.immuni.2013.12.014	http://dx.doi.org/10.1016/j.immuni.2013.12.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24530055	Bronze, Green Submitted			2022-12-18	WOS:000331637600008
J	Rangel-Moreno, J; Moyron-Quiroz, JE; Carragher, DM; Kusser, K; Hartson, L; Moquin, A; Randall, TD				Rangel-Moreno, Javier; Moyron-Quiroz, Juan E.; Carragher, Damian M.; Kusser, Kim; Hartson, Louise; Moquin, Amy; Randall, Troy D.			Omental Milky Spots Develop in the Absence of Lymphoid Tissue-Inducer Cells and Support B and T Cell Responses to Peritoneal Antigens	IMMUNITY			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; FOLLICULAR DENDRITIC CELLS; ALPHA-DEFICIENT MICE; GREATER OMENTUM; GERMINAL-CENTERS; AFFINITY MATURATION; ANTIBODY-PRODUCTION; ORGAN DEVELOPMENT; IMMUNE-RESPONSE; STROMAL CELLS	The omentum is a site of B1 cell lymphopoiesis and immune responsiveness to T cell-independent antigens. However, it is unknown whether it supports immune responses independently of conventional lymphoid organs. We showed that the omentum collected antigens and cells from the peritoneal cavity and supported T cell-dependent B cell responses, including isotype switching, somatic hypermutation, and limited affinity maturation, despite the lack of identifiable follicular dendritic cells. The omentum also supported CD4(+) and CD8(+) T cell responses to peritoneal antigens and recruited effector T cells primed in other locations. Unlike conventional lymphoid organs, milky spots in the omentum developed in the absence of lymphoid tissue-inducer cells, but required the chemokine CXCL13. Although the lymphoid architecture of milky spots was disrupted in lymphotoxin-deficient mice, normal architecture was restored by reconstitution with lymphotoxin-sufficient hematopoietic cells. These results indicate that the milky spots of the omentum function as unique secondary lymphoid organs that promote immunity to peritoneal antigens.	[Rangel-Moreno, Javier; Kusser, Kim; Hartson, Louise; Randall, Troy D.] Univ Rochester, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Moyron-Quiroz, Juan E.; Carragher, Damian M.; Moquin, Amy] Trudeau Inst Inc, Saranac Lake, NY 12983 USA	University of Rochester; Trudeau Institute	Randall, TD (corresponding author), Univ Rochester, Div Allergy Immunol & Rheumatol, 601 Elmwood Ave, Rochester, NY 14642 USA.	troy_randall@urmc.rochester.edu	Carragher, Damian/E-6673-2016; Carragher, Damian/O-4183-2019	Carragher, Damian/0000-0003-4341-4943; Carragher, Damian/0000-0003-4341-4943; Rangel-Moreno, Javier/0000-0002-9738-1182	Trudeau Institute; NIH [HL69409, A1072689, A1061511]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072689, R01AI061511] Funding Source: NIH RePORTER	Trudeau Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank F. Lund for helpful discussions during the course of this work and M. Tighe for help with histology and microscopy. This work was supported by the Trudeau Institute and NIH grants HL69409, A1072689, and A1061511.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; BANKS TA, 1995, J IMMUNOL, V155, P1685; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P585; Beelen RHJ, 2005, PERITON DIALYSIS INT, V25, P30; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cui L, 2002, CELL TISSUE RES, V310, P321, DOI 10.1007/s00441-002-0636-6; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; DAS SK, 1976, BRIT J PLAST SURG, V29, P170, DOI 10.1016/0007-1226(76)90045-X; DE TP, 1994, SCIENCE, V264, P703; Di Paolo N, 2005, PERITON DIALYSIS INT, V25, P48; DUX K, 1977, CELL IMMUNOL, V32, P97, DOI 10.1016/0008-8749(77)90185-X; DUX K, 1986, EUR J IMMUNOL, V16, P1029; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; FEDORKO ME, 1971, EXP CELL RES, V69, P313, DOI 10.1016/0014-4827(71)90230-8; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; GOLDSMITH HS, 1984, JAMA-J AM MED ASSOC, V252, P2034, DOI 10.1001/jama.252.15.2034; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; HAJDU I, 1972, EXP CELL RES, V75, P219, DOI 10.1016/0014-4827(72)90539-3; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; HODEL C, 1970, EUR SURG RES, V2, P435, DOI 10.1159/000127543; Koni PA, 1999, J EXP MED, V189, P855, DOI 10.1084/jem.189.5.855; KRIST LFG, 1995, ANAT REC, V241, P163, DOI 10.1002/ar.1092410204; Krist LFG, 1998, CANCER IMMUNOL IMMUN, V47, P205, DOI 10.1007/s002620050522; KRIST LFG, 1995, J IMMUNOL METHODS, V184, P253, DOI 10.1016/0022-1759(95)00096-S; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morrison R., 1906, BMJ-BRIT MED J, V1, P76; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Portis B, 1924, J INFECT DIS, V34, P159, DOI 10.1093/infdis/34.2.159; Rangel-Moreno J, 2005, J IMMUNOL, V175, P4904, DOI 10.4049/jimmunol.175.8.4904; ROBERTS KB, 1955, BRIT J EXP PATHOL, V36, P357; SOLVASON N, 1992, J EXP MED, V175, P397, DOI 10.1084/jem.175.2.397; SOLVASON N, 1992, ANN NY ACAD SCI, V651, P10; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SZANIAWSKA B, 1975, Archivum Immunologiae et Therapiae Experimentalis, V23, P19; SZANIWSKA B, 1974, Archivum Immunologiae et Therapiae Experimentalis, V22, P585; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; Vakil M, 1991, Dev Immunol, V1, P203, DOI 10.1155/1991/45352; vanVugt E, 1996, ANAT REC, V244, P235; WALKER FC, 1961, BRIT J EXP PATHOL, V42, P222; Williams R, 1986, Curr Probl Surg, V23, P789; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	56	178	183	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 22	2009	30	5					731	743		10.1016/j.immuni.2009.03.014	http://dx.doi.org/10.1016/j.immuni.2009.03.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19427241	Green Accepted, Bronze			2022-12-18	WOS:000266356900015
J	Omori, SA; Cato, MH; Anzelon-Mills, A; Puri, KD; Shapiro-Shelef, M; Calame, K; Rickert, RC				Omori, Sidne A.; Cato, Matthew H.; Anzelon-Mills, Amy; Puri, Kamal D.; Shapiro-Shelef, Miriam; Calame, Kathryn; Rickert, Robert C.			Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling	IMMUNITY			English	Article							ACTIVATION-INDUCED DEAMINASE; INDUCED CYTIDINE DEAMINASE; FOXO TRANSCRIPTION FACTORS; MEMORY B-CELLS; SOMATIC HYPERMUTATION; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; LYMPHOCYTE DIFFERENTIATION; CD40 LIGAND; AID	Class-switch recombination (CSR) is essential for humoral immunity. However, the regulation of CSR is not completely understood. Here we demonstrate that phosphaticlylinositol 3-kinase (PI3K) actively suppressed the onset and frequency of CSR in primary B cells. Consistently, mice lacking the lipid phosphatase, PTEN, in B cells exhibited a hyper-IgM condition due to impaired CSR, which could be restored in vitro by specific inhibition of PI3K delta. Inhibition of CSR by PI3K was partially dependent on the transcription factor, BLIMP1, linking plasma cell commitment and cessation of CSR. PI3K-dependent activation of the serine-threonine kinase, Akt, suppressed CSR, in part, through the inactivation of the Forkhead Box family (Foxo)of transcription factors. Reduced PI3K signaling enhanced the expression of AID (activation-induced cytidine deaminase) and accelerated CSR. However, ectopic expression of AID could not fully overcome inhibition of CSR by PI3K, suggesting that PI3K regulates both the expression and function of AID.	Burham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, Ctr Canc, La Jolla, CA 92037 USA; Burham Inst Med Res, Program Signal Transduct, Ctr Canc, La Jolla, CA 92037 USA; ICOS Corp, Bothell, WA 98021 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Dept Microbiol, New York, NY 10032 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Icos Corporation; Columbia University	Rickert, RC (corresponding author), Burham Inst Med Res, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, Ctr Canc, La Jolla, CA 92037 USA.	robert@burnham.org		Shelef, Miriam/0000-0002-8842-0303	NIAID NIH HHS [AI059447, AI041649] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041649, R01AI059447] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Durandy A, 2005, IMMUNOL REV, V203, P67, DOI 10.1111/j.0105-2896.2005.00222.x; Escobedo J, 2003, BIOTECHNIQUES, V35, P936, DOI 10.2144/03355bm06; Etzioni A, 2004, PEDIATR RES, V56, P519, DOI 10.1203/01.PDR.0000139318.65842.4A; Forssell J, 1999, SCAND J IMMUNOL, V49, P155; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hasbold J, 2004, NAT IMMUNOL, V5, P55, DOI 10.1038/ni1016; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Niu HF, 2002, HEMATOL ONCOL, V20, P155, DOI 10.1002/hon.689; Okazaki I, 2003, ANN NY ACAD SCI, V987, P1, DOI 10.1111/j.1749-6632.2003.tb06027.x; Okkenhaug K, 2002, SCIENCE, V297, P1031; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Peakman MC, 1998, J IMMUNOL, V161, P4008; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Rush JS, 2002, J IMMUNOL, V168, P2676, DOI 10.4049/jimmunol.168.6.2676; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Sciammas R, 2004, J IMMUNOL, V172, P5427, DOI 10.4049/jimmunol.172.9.5427; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	49	178	182	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					545	557		10.1016/j.immuni.2006.08.015	http://dx.doi.org/10.1016/j.immuni.2006.08.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17000121	Bronze			2022-12-18	WOS:000241481500007
J	Maillard, I; Adler, SH; Pear, WS				Maillard, I; Adler, SH; Pear, WS			Notch and the immune system	IMMUNITY			English	Review							HEMATOPOIETIC STEM-CELLS; COMMON LYMPHOID PROGENITORS; CD4(+) T-CELLS; ZONE B-CELLS; MARGINAL ZONE; SIGNALING PATHWAY; LINEAGE DECISION; IN-VIVO; BONE-MARROW; KAPPA-B		Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Pear, WS (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.			Maillard, Ivan/0000-0003-1312-6748	PHS HHS [K08-59366] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson G, 2001, EUR J IMMUNOL, V31, P3349, DOI 10.1002/1521-4141(200111)31:11<3349::AID-IMMU3349>3.0.CO;2-S; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Bertrand FE, 2000, LEUKEMIA, V14, P2095, DOI 10.1038/sj.leu.2401942; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; De Smedt M, 2002, J IMMUNOL, V169, P3021, DOI 10.4049/jimmunol.169.6.3021; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garcia-Peydro M, 2003, BLOOD, V102, P2444, DOI 10.1182/blood-2002-10-3261; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Harman BC, 2003, J IMMUNOL, V170, P1299, DOI 10.4049/jimmunol.170.3.1299; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hoyne GF, 2000, INT IMMUNOL, V12, P177, DOI 10.1093/intimm/12.2.177; Hozumi K, 2003, J IMMUNOL, V170, P4973, DOI 10.4049/jimmunol.170.10.4973; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lancrin C, 2002, J EXP MED, V195, P919, DOI 10.1084/jem.20011475; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Li T, 2003, J NEUROSCI, V23, P3272; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Martinez-Cruz B, 2002, MOL ECOL NOTES, V2, P323, DOI 10.1046/j.1471-8286.2002.00231.x; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; OKAJIMA T, 2003, J BIOL CHEM; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 2002, IMMUNOL REV, V187, P65, DOI 10.1034/j.1600-065X.2002.18706.x; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singh N, 2000, EXP HEMATOL, V28, P527, DOI 10.1016/S0301-472X(00)00146-6; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Tsai S, 2000, BLOOD, V96, P950, DOI 10.1182/blood.V96.3.950.015k43_950_957; VAMUMFINNEY B, 2003, BLOOD, V101, P1784; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Vinuesa CG, 2003, EUR J IMMUNOL, V33, P297, DOI 10.1002/immu.200310003; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Walker L, 2001, STEM CELLS, V19, P543, DOI 10.1634/stemcells.19-6-543; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wilson A, 2000, J IMMUNOL, V165, P5397, DOI 10.4049/jimmunol.165.10.5397; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Yvon ES, 2003, BLOOD, V102, P3815, DOI 10.1182/blood-2002-12-3826; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	96	178	192	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					781	791		10.1016/S1074-7613(03)00325-X	http://dx.doi.org/10.1016/S1074-7613(03)00325-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670296	Bronze			2022-12-18	WOS:000187230700004
J	Dequiedt, F; Kasler, H; Fischle, W; Kiermer, V; Weinstein, M; Herndier, BG; Verdin, E				Dequiedt, F; Kasler, H; Fischle, W; Kiermer, V; Weinstein, M; Herndier, BG; Verdin, E			HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis	IMMUNITY			English	Article							MYOCYTE ENHANCER FACTOR-2; ORPHAN STEROID-RECEPTOR; T-CELL APOPTOSIS; MUSCLE DIFFERENTIATION; PROTEIN-KINASE; NUCLEAR EXPORT; IN-VIVO; MEF2; GENE; EXPRESSION	We report that HDAC7, a class II histone deacetylase, is highly expressed in CD4(+)CD8(+) double-positive thymocytes. HDAC7 inhibits the expression of Nur77, an orphan receptor involved in apoptosis and negative selection, via the transcription factor MEF2D. HDAC7 is exported from the nucleus during T cell receptor activation, leading to Nur77 expression. A triple HDAC7 mutant (S155A, S318A, S448A) is not exported from the nucleus in response to TCR activation and suppresses TCR-mediated apoptosis. Conversely, a fusion of HDAC7 to the transcriptional activator VP16 activates Nur77 expression. Inhibition of HDAC7 expression by RNA interference causes increased apoptosis in response to TCR activation. These observations define HDAC7 as a regulator of Nur77 and apoptosis in developing thymocytes.	Univ Calif San Francisco, Dept Pathol, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verdin, E (corresponding author), Univ Calif San Francisco, Dept Pathol, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.		Verdin, Eric/AAB-7999-2019	Dequiedt, Franck/0000-0003-1234-7477; Verdin, Eric/0000-0003-3703-3183; Kiermer, Veronique/0000-0001-8771-7239	NIGMS NIH HHS [GM51671] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CALNAN BJ, 1995, IMMUNITY, V3, P273; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Esau C, 2001, J EXP MED, V194, P1449, DOI 10.1084/jem.194.10.1449; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HAWLEY RG, 1994, GENE THER, V1, P136; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANNHEIM B, 1996, NONRADIOACTIVE IN SI; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Sambrook J, 1989, MOL CLONING LAB MANU; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	36	178	181	2	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					687	698		10.1016/S1074-7613(03)00109-2	http://dx.doi.org/10.1016/S1074-7613(03)00109-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753745	Green Published, Bronze			2022-12-18	WOS:000182962200013
J	Toyama, H; Okada, S; Hatano, M; Takahashi, Y; Takeda, N; Ichii, H; Takemori, T; Kuroda, Y; Tokuhisa, T				Toyama, H; Okada, S; Hatano, M; Takahashi, Y; Takeda, N; Ichii, H; Takemori, T; Kuroda, Y; Tokuhisa, T			Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; PRIMARY IMMUNE-RESPONSE; CYTIDINE DEAMINASE AID; ALPHA-DEFICIENT MICE; FINGER ENCODING GENE; T-DEPENDENT ANTIGEN; AFFINITY MATURATION; TRANSCRIPTIONAL REPRESSION; CD40-DEFICIENT MICE; ANTIBODY MUTANTS	After immunization with T cell-dependent antigens, the high-affinity B cells selected in germinal centers differentiate into memory B cells or long-lived antibody-forming cells. However, a role for germinal centers in development of these B lineage cells is still controversial. We show here that Bcl6-deficient B cells, which cannot develop germinal centers, differentiated into IgM and IgG1 memory B cells in the spleen but barely differentiated into long-lived IgG1 anti body-forming cells in the bone marrow. Mutation in the V-heavy gene was null in these memory B cells. Therefore, Bcl6 and germinal center formation are essential for somatic hypermutation, and generation of memory B cells can occur independently of germinal center formation, somatic hypermutation, and Ig class switching.	Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chiba 2608670, Japan; Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; Kobe Univ, Grad Sch Med, Dept Surg 1, Kobe, Hyogo 6500017, Japan	Chiba University; National Institute of Infectious Diseases (NIID); Kobe University	Tokuhisa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chiba 2608670, Japan.		Ichii, Hirohito/AAV-8256-2021; Takemori, Toshitada/A-5909-2016; Okada, Seiji/F-5785-2013	Takahashi, Yoshimasa/0000-0001-6342-4087; Ichii, Hirohito/0000-0002-3635-5773				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; BANKS TA, 1995, J IMMUNOL, V155, P1685; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Bothwell AL, 1982, CELL, V24, P625, DOI 10.1016/0092-8674 (81)90089-1; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; CLAFLIN JL, 1987, J IMMUNOL, V138, P3060; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; DELL CL, 1989, J IMMUNOL, V143, P3364; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 2000, J IMMUNOL, V164, P2508, DOI 10.4049/jimmunol.164.5.2508; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; FUKUDA T, 1995, ONCOGENE, V11, P1657; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; GRAY D, 1994, J EXP MED, V180, P141, DOI 10.1084/jem.180.1.141; HANNA MG, 1964, LAB INVEST, V13, P95; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kato J, 1998, J IMMUNOL, V160, P4788; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; MIKI T, 1994, BLOOD, V83, P26; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pulendran B, 1997, IMMUNOL TODAY, V18, P27, DOI 10.1016/S0167-5699(97)80011-4; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ridderstad A, 1998, J IMMUNOL, V160, P4688; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SHAKIMAN A, 1993, SCIENCE, V261, P609; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; Wang Y, 2000, EUR J IMMUNOL, V30, P2226, DOI 10.1002/1521-4141(2000)30:8<2226::AID-IMMU2226>3.0.CO;2-5; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; White H, 2000, J EXP MED, V191, P2209, DOI 10.1084/jem.191.12.2209; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoshida T, 1999, CARDIOVASC RES, V42, P670, DOI 10.1016/S0008-6363(99)00007-3	66	178	195	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					329	339		10.1016/S1074-7613(02)00387-4	http://dx.doi.org/10.1016/S1074-7613(02)00387-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354385	Bronze			2022-12-18	WOS:000178163100009
J	Rivera, RR; Johns, CP; Quan, J; Johnson, RS; Murre, C				Rivera, RR; Johns, CP; Quan, J; Johnson, RS; Murre, C			Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3	IMMUNITY			English	Article							DNA-BINDING PROTEINS; T-CELL DEVELOPMENT; POSITIVE SELECTION; NEGATIVE SELECTION; EXPRESSION PATTERN; THYMIC SELECTION; ANTIGEN RECEPTOR; GENE-EXPRESSION; TRANSGENIC MICE; E2A	E2A, HEB, E2-2, and daughterless are basic helix-loop-helix (bHLH) proteins that play key roles in multiple developmental pathways. The DNA binding activity of E2A, HEB, and E2-2 is regulated by a distinct class of inhibitor HLH proteins, the Id gene products. Here, we show that Id3 is required for major histocompatability (MHC) class I- and class II-restricted thymocyte positive selection. Additionally, H-Y TCR-mediated negative selection is severely perturbed in Id3 null mutant mice. Finally, we show that E2A and Id3 interact genetically to regulate thymocyte development. These observations identify the HLH inhibitory protein Id3 as an essential component required for proper thymocyte maturation.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Dept Biol, 0366, La Jolla, CA 92093 USA.		Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639				Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Arsov I, 1999, J IMMUNOL, V162, P2008; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; Chen BB, 1997, J BIOL CHEM, V272, P2459, DOI 10.1074/jbc.272.4.2459; Chen BB, 1997, NUCLEIC ACIDS RES, V25, P423, DOI 10.1093/nar/25.2.423; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Deed RW, 1998, J BIOL CHEM, V273, P8278, DOI 10.1074/jbc.273.14.8278; DEED RW, 1993, ONCOGENE, V8, P599; Deed RW, 1997, MOL CELL BIOL, V17, P6815, DOI 10.1128/MCB.17.12.6815; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Loveys DA, 1996, NUCLEIC ACIDS RES, V24, P2813, DOI 10.1093/nar/24.14.2813; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAKEDA J, 1990, MOL CELL BIOL, V10, P5027, DOI 10.1128/MCB.10.10.5027; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898	38	178	179	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2000	12	1					17	26		10.1016/S1074-7613(00)80155-7	http://dx.doi.org/10.1016/S1074-7613(00)80155-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	278WL	10661402	Bronze			2022-12-18	WOS:000085011900003
J	Snapper, CM; Marcu, KB; Zelazowski, P				Snapper, CM; Marcu, KB; Zelazowski, P			The immunoglobulin class switch: Beyond ''accessibility''	IMMUNITY			English	Article							HEAVY-CHAIN SWITCH; MURINE B-CELLS; ANTI-IGD ANTIBODIES; GERMLINE TRANSCRIPTS; EPSILON-TRANSCRIPTS; INTERFERON-GAMMA; CIRCULAR DNA; RECOMBINATION BREAKPOINTS; REGION RECOMBINATION; CONSTANT-REGION		SUNY STONY BROOK, DEPT BIOCHEM & CELL BIOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Snapper, CM (corresponding author), UNIFORMED SERV UNIV HLTH SCI, DEPT PATHOL, 4301 JONES BRIDGE RD, BETHESDA, MD 20814 USA.							Baar J, 1996, J IMMUNOL, V157, P3430; Bachl J, 1996, EUR J IMMUNOL, V26, P870, DOI 10.1002/eji.1830260422; Ballantyne J, 1995, Curr Top Microbiol Immunol, V194, P439; BALLANTYNE J, 1997, IN PRESS INT IMMUNOL; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; BRUNSWICK M, 1988, J IMMUNOL, V140, P3364; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; COLLINS JT, 1993, INT IMMUNOL, V5, P885, DOI 10.1093/intimm/5.8.885; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; DANIELS GA, 1995, P NATL ACAD SCI USA, V92, P5625, DOI 10.1073/pnas.92.12.5625; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; DUNNICK W, 1989, MOL CELL BIOL, V9, P1850, DOI 10.1128/MCB.9.5.1850; DUNNICK W, 1990, MOL CELL BIOL, V10, P397, DOI 10.1128/MCB.10.1.397; Fujieda S, 1996, J IMMUNOL, V157, P3450; GAFF C, 1990, INT IMMUNOL, V2, P1143, DOI 10.1093/intimm/2.12.1143; GERONDAKIS S, 1991, IMMUNOGENETICS, V34, P392, DOI 10.1007/BF01787490; GERONDAKIS S, 1990, P NATL ACAD SCI USA, V87, P1581, DOI 10.1073/pnas.87.4.1581; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JUMPER MD, 1994, J IMMUNOL, V152, P438; KENTER AL, 1987, J IMMUNOL METHODS, V97, P111, DOI 10.1016/0022-1759(87)90112-8; KENTER AL, 1993, J IMMUNOL, V151, P4718; LEBMAN DA, 1994, INT IMMUNOL, V6, P113, DOI 10.1093/intimm/6.1.113; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; LEPSE CL, 1994, DNA CELL BIOL, V13, P1151, DOI 10.1089/dna.1994.13.1151; LEUNG H, 1994, MOL CELL BIOL, V14, P1450, DOI 10.1128/MCB.14.2.1450; LEUNG H, 1992, P NATL ACAD SCI USA, V89, P4154, DOI 10.1073/pnas.89.9.4154; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Lin SC, 1996, MOL CELL BIOL, V16, P4591; LOH RKS, 1994, J EXP MED, V180, P663, DOI 10.1084/jem.180.2.663; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; LORENZ M, 1996, CYTOKINE REGULATION, P109; LUNDGREN M, 1995, EUR J IMMUNOL, V25, P2042, DOI 10.1002/eji.1830250736; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Malisan F, 1996, J EXP MED, V183, P937, DOI 10.1084/jem.183.3.937; MANDLER R, 1993, J IMMUNOL, V150, P407; MANDLER R, 1993, J EXP MED, V178, P1577, DOI 10.1084/jem.178.5.1577; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; Michaelson JS, 1996, J IMMUNOL, V156, P2828; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; MILLS FC, 1995, J IMMUNOL, V155, P3021; MILLS FC, 1992, J IMMUNOL, V149, P1075; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Ott D E, 1989, Int Immunol, V1, P582, DOI 10.1093/intimm/1.6.582; OTT DE, 1987, EMBO J, V6, P577, DOI 10.1002/j.1460-2075.1987.tb04793.x; PECANHA LMT, 1993, J IMMUNOL, V150, P2160; PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973; RADCLIFFE G, 1990, MOL CELL BIOL, V10, P382, DOI 10.1128/MCB.10.1.382; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672, DOI 10.1128/MCB.10.4.1672; ROTHMAN P, 1991, MOL CELL BIOL, V11, P5551, DOI 10.1128/MCB.11.11.5551; SEVERINSON E, 1982, IMMUNOL REV, V67, P73, DOI 10.1111/j.1600-065X.1982.tb01056.x; SEVERINSON E, 1990, EUR J IMMUNOL, V20, P1079, DOI 10.1002/eji.1830200520; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHOCKETT P, 1991, J IMMUNOL, V147, P4374; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SIEBENKOTTEN G, 1992, EUR J IMMUNOL, V22, P1827, DOI 10.1002/eji.1830220723; Snapper Clifford M., 1993, P837; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Snapper CM, 1996, J IMMUNOL, V156, P183; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WUERFFEL R, 1992, J EXP MED, V176, P339, DOI 10.1084/jem.176.2.339; WUERFFEL RA, 1990, MOL CELL BIOL, V10, P1714, DOI 10.1128/MCB.10.4.1714; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; ZELAZOWSKI P, 1995, J IMMUNOL, V154, P1223	85	178	179	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1997	6	3					217	223		10.1016/S1074-7613(00)80324-6	http://dx.doi.org/10.1016/S1074-7613(00)80324-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075922	Bronze			2022-12-18	WOS:A1997XC61800001
J	AVVA, RR; CRESSWELL, P				AVVA, RR; CRESSWELL, P			IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES	IMMUNITY			English	Article							MHC CLASS-II; ANTIGEN-PROCESSING MUTANT; ALPHA-BETA-DIMERS; B-CELL LINE; INFLUENZA-VIRUS; MOLECULES; BINDING; TRANSPORT; HLA-DR1; PH	HLA-DR molecules associated with class II-associated invariant chain peptides (CLIP) are generated in vivo as an intermediate in class II maturation. Such complexes can be produced in vitro by proteolytic digestion of DR alpha beta I complexes, suggesting that CLIP is a residual fragment that remains associated with class II molecules following I chain degradation. In vitro, CLIP dissociation from DR alpha beta dimers occurs at different rates depending on the allele, and is facilitated by low pH and by detergents containing 8-10 carbon unbranched hydrocarbons, or by primary aliphatic amines or carboxylic acids. The accumulation of DR alpha beta CLIP complexes in HLA-DM-negative antigen-processing mutant cells argues that a functionally similar mechanism, dependent on HLA-DM expression, catalyzes in vivo CLIP dissociation and generation of normal class II-peptide complexes.			AVVA, RR (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023081, R37AI023081] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 23081] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; AVVA RR, 1994, THESIS DUKE U DURHAM; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHERVONSKY AV, 1994, INT IMMUNOL, V6, P973, DOI 10.1093/intimm/6.7.973; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GORGA JC, 1987, J BIOL CHEM, V262, P16087; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HARDING CV, 1991, P NATL ACAD SCI USA, V88, P2740, DOI 10.1073/pnas.88.7.2740; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMB CA, 1992, J IMMUNOL, V148, P3478; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MAX H, 1993, HUM IMMUNOL, V38, P193, DOI 10.1016/0198-8859(93)90540-H; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; RIBERDY JM, 1994, J CELL BIOL, V125, P1225, DOI 10.1083/jcb.125.6.1225; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; RIBERDY JM, 1992, THESIS DUKE U DURHAM; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCHE PA, 1991, NATURE, V345, P615; ROOF RW, 1990, P NATL ACAD SCI USA, V87, P1735, DOI 10.1073/pnas.87.5.1735; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0	48	178	179	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1994	1	9					763	774		10.1016/S1074-7613(94)80018-9	http://dx.doi.org/10.1016/S1074-7613(94)80018-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX648	7895165				2022-12-18	WOS:A1994PX64800006
J	Dupaul-Chicoine, J; Arabzadeh, A; Dagenais, M; Douglas, T; Champagne, C; Morizot, A; Rodrigue-Gervais, IG; Breton, V; Colpitts, SL; Beauchemin, N; Saleh, M				Dupaul-Chicoine, Jeremy; Arabzadeh, Azadeh; Dagenais, Maryse; Douglas, Todd; Champagne, Claudia; Morizot, Alexandre; Rodrigue-Gervais, Ian Gael; Breton, Valerie; Colpitts, Sara L.; Beauchemin, Nicole; Saleh, Maya			The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity	IMMUNITY			English	Article							KUPFFER CELLS; ACTIVATION; RECEPTOR; CASPASE-1; APOPTOSIS; CYTOKINE; IMMUNOSUPPRESSION; INTERLEUKIN-18; IMMUNOTHERAPY; DEATH	The crosstalk between inflammation and tumorigenesis is now clearly established. However, how inflammation is elicited in the metastatic environment and the corresponding contribution of innate immunity pathways in suppressing tumor growth at secondary sites are poorly understood. Here, we show that mice deficient in Nlrp3 inflammasome components had exacerbated liver colorectal cancer metastatic growth, which was mediated by impaired inteleukin- 18 (IL-18) signaling. Control of tumor growth was independent of differential cancer cell colonization or proliferation, intestinal microbiota effects, or tumoricidal activity by the adaptive immune system. Instead, the inflammasome-IL-18 pathway impacted maturation of hepatic NK cells, surface expression of the death ligand FasL, and capacity to kill FasL-sensitive tumors. Our results define a regulatory signaling circuit within the innate immune system linking inflammasome activation to effective NK-cell-mediated tumor attack required to suppress colorectal cancer growth in the liver.	[Dupaul-Chicoine, Jeremy; Dagenais, Maryse; Beauchemin, Nicole; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Arabzadeh, Azadeh; Breton, Valerie; Beauchemin, Nicole; Saleh, Maya] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Douglas, Todd; Saleh, Maya] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Champagne, Claudia; Morizot, Alexandre; Rodrigue-Gervais, Ian Gael; Beauchemin, Nicole; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Colpitts, Sara L.] UConn Hlth, Ctr Integrated Immunol & Vaccine Res, Dept Immunol, Farmington, CT 06030 USA	McGill University; McGill University; McGill University; McGill University	Saleh, M (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	maya.saleh@mcgill.ca	Brass, Sara Colpitts/ABC-3860-2020	Douglas, Todd/0000-0002-6053-9345; Saleh, Maya/0000-0003-1538-9146	Canadian Institutes for Health Research (CIHR-MOP) [82801, 86582]; Burroughs Wellcome Fund; CIHR; FRSQ; Strauss Foundation; CIHR/CAG/Abbott fellowship; American Cancer Society [PF-11-152-01-LIB]	Canadian Institutes for Health Research (CIHR-MOP)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Strauss Foundation; CIHR/CAG/Abbott fellowship; American Cancer Society(American Cancer Society)	We thank Dr. V. Dixit and Genentech for providing Nlrc4<SUP>-/-</SUP> Nlrp3<SUP>-/-</SUP> and Aim2<SUP>-/-</SUP> mice; Dr. Shoshana Yakar for MC38 cells; and J. Rinz and G. Perrault for animal husbandry. This work was supported by grants from the Canadian Institutes for Health Research (CIHR-MOP 82801 to M.S. and 86582 to N.B.) and the Burroughs Wellcome Fund to M.S., who is also a Fonds de Recherche du Quebec en Sante (FRQS) Senior Investigator and a McGill University William Dawson Scholar. J. D.-C. and M.D. are supported by doctoral studentships from the CIHR. A. A. is supported by a postdoctoral fellowship from the FRSQ. I.G.R.-G. is supported by postdoctoral fellowships from the FRSQ, CIHR, and by the Strauss Foundation. A. M. was supported by a CIHR/CAG/Abbott fellowship. S.L.C. was supported by a postdoctoral fellowship from the American Cancer Society (Grant PF-11-152-01-LIB).	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bongfen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031012; Carrascal MT, 2003, CANCER RES, V63, P491; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Crende O, 2013, AM J PATHOL, V183, P69, DOI 10.1016/j.ajpath.2013.03.026; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Eichhorst ST, 2004, NAT MED, V10, P602, DOI 10.1038/nm1049; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; He JS, 2010, J IMMUNOL, V184, P555, DOI 10.4049/jimmunol.0902465; Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim HY, 2015, FEBS J, V282, P259, DOI 10.1111/febs.13123; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LeBlanc PM, 2014, J BIOL CHEM, V289, P7777, DOI 10.1074/jbc.M113.541474; Li HC, 2009, GASTROENTEROLOGY, V137, P934, DOI 10.1053/j.gastro.2009.06.004; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Qin Y, 2011, MOL CANCER RES, V9, P1537, DOI 10.1158/1541-7786.MCR-11-0279; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Tsikitis VL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-336; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Valcarcell M, 2014, J INVEST DERMATOL, V134, P470, DOI 10.1038/jid.2013.342; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wallin RPA, 2003, EUR J IMMUNOL, V33, P2727, DOI 10.1002/eji.200324070; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046; Zheng HX, 2013, ONCOGENE, V32, P1183, DOI 10.1038/onc.2012.126	53	177	189	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					751	763		10.1016/j.immuni.2015.08.013	http://dx.doi.org/10.1016/j.immuni.2015.08.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26384545	Bronze			2022-12-18	WOS:000363478700017
J	Sun, J; Furio, L; Mecheri, R; van der Does, AM; Lundeberg, E; Saveanu, L; Chen, YQ; van Endert, P; Agerberth, B; Diana, J				Sun, Jia; Furio, Laetitia; Mecheri, Ramine; van der Does, Anne M.; Lundeberg, Erik; Saveanu, Loredana; Chen, Yongquan; van Endert, Peter; Agerberth, Birgitta; Diana, Julien			Pancreatic beta-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; REGULATORY T-CELLS; CHAIN FATTY-ACIDS; CATHELICIDIN LL-37; SIGNALING PATHWAYS; GENE-EXPRESSION; IN-VIVO; DEFENSE; INFLAMMATION; TYPE-1	Antimicrobial peptides (AMPs) expressed by epithelial and immune cells are largely described for the defense against invading microorganisms. Recently, their immunomodulatory functions have been highlighted in various contexts. However how AMPs expressed by non-immune cells might influence autoimmune responses in peripheral tissues, such as the pancreas, is unknown. Here, we found that insulin-secreting beta-cells produced the cathelicidin related antimicrobial peptide (CRAMP) and that this production was defective in non-obese diabetic (NOD) mice. CRAMP administrated to prediabetic NOD mice induced regulatory immune cells in the pancreatic islets, dampening the incidence of autoimmune diabetes. Additional investigation revealed that the production of CRAMP by beta-cells was controlled by short-chain fatty acids produced by the gut microbiota. Accordingly, gut microbiota manipulations in NOD mice modulated CRAMP production and inflammation in the pancreatic islets, revealing that the gut microbiota directly shape the pancreatic immune environment and autoimmune diabetes development.	[Sun, Jia; Chen, Yongquan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Sun, Jia; Chen, Yongquan] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Furio, Laetitia] INSERM, U1163, Inst Imagine, F-75015 Paris, France; [Furio, Laetitia; Mecheri, Ramine; Saveanu, Loredana; van Endert, Peter; Diana, Julien] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [van der Does, Anne M.; Lundeberg, Erik] Karolinska Inst, Dept Physiol & Pharmacol, SE-14186 Stockholm, Sweden; [Saveanu, Loredana; van Endert, Peter; Diana, Julien] CNRS, INSERM, INEM, U1151,Unite 8253, F-75015 Paris, France; [Agerberth, Birgitta] Karolinska Inst, Karolinska Univ Hosp, Clin Microbiol, Med Microbial Pathogenesis Dept Lab Med, SE-14186 Stockholm, Sweden	Jiangnan University; Jiangnan University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Diana, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, 12 Rue Ecole Med, F-75006 Paris, France.	julien.diana@inserm.fr	van Endert, Peter/R-4606-2017; SAVEANU, Loredana/Q-1241-2019; Chen, Yong Q/AAI-9864-2021; DIANA, Julien/A-2873-2014; Saveanu, Loredana/K-6821-2017; van der Does, Anne M./AAA-2247-2022	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; Chen, Yong Q/0000-0003-4747-4708; DIANA, Julien/0000-0001-7542-042X; van der Does, Anne M./0000-0002-1613-106X	Natural Science Foundation of Jiangsu [BK20130133]; National Natural Science Foundation of China [31400779]; la Fondation pour la Recherche Medicale (FRM); Swedish Research Council [K2014-67X-11217-20-3]; Swedish Foundation for Strategic Research [RBd08-0014]; Juvenile Diabetes Research Foundation (JDRF)-Helmsley [47-2013-524]; European Foundation for the Study of Diabetes (EFSD)-Lilly	Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); la Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Juvenile Diabetes Research Foundation (JDRF)-Helmsley(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes (EFSD)-Lilly(Eli Lilly)	The authors greatly acknowledge Meriem Garfa-Traore and Nicolas Goudin of the Necker Imaging Facility and Qin Yang of GC-MS facility, Jiangnan University. This work was supported by funds from: the Natural Science Foundation of Jiangsu (BK20130133) and the National Natural Science Foundation of China (31400779) to J.S.; la Fondation pour la Recherche Medicale (FRM) to P.v.E.; the Swedish Research Council (K2014-67X-11217-20-3) and the Swedish Foundation for Strategic Research (RBd08-0014) to B.A.; and the Juvenile Diabetes Research Foundation (JDRF)-Helmsley (47-2013-524) and the European Foundation for the Study of Diabetes (EFSD)-Lilly to J.D.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bach JF, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007799; Brauner H, 2014, CLIN EXP IMMUNOL, V177, P478, DOI 10.1111/cei.12316; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508; Calderon B, 2008, J IMMUNOL, V181, P6964, DOI 10.4049/jimmunol.181.10.6964; da Silva FP, 2009, IMMUNOL CELL BIOL, V87, P496, DOI 10.1038/icb.2009.19; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Jann NJ, 2009, J LEUKOCYTE BIOL, V86, P1159, DOI 10.1189/jlb.0209053; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Kilsgard O, 2012, AM J RESP CELL MOL, V46, P240, DOI 10.1165/rcmb.2010-0500OC; Koziel J, 2014, J IMMUNOL, V192, P5363, DOI 10.4049/jimmunol.1303062; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mathis D, 2012, IMMUNOL REV, V245, P239, DOI 10.1111/j.1600-065X.2011.01084.x; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Pinegin B, 2015, AUTOIMMUN REV, V14, P633, DOI 10.1016/j.autrev.2015.03.002; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	50	177	188	4	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					304	317		10.1016/j.immuni.2015.07.013	http://dx.doi.org/10.1016/j.immuni.2015.07.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26253786	Bronze			2022-12-18	WOS:000360101200013
J	Yu, W; Jiang, N; Ebert, PJR; Kidd, BA; Muller, S; Lund, PJ; Juang, J; Adachi, K; Tse, T; Birnbaum, ME; Newell, EW; Wilson, DM; Grotenbreg, GM; Valitutti, S; Quake, SR; Davis, MM				Yu, Wong; Jiang, Ning; Ebert, Peter J. R.; Kidd, Brian A.; Mueller, Sabina; Lund, Peder J.; Juang, Jeremy; Adachi, Keishi; Tse, Tiffany; Birnbaum, Michael E.; Newell, Evan W.; Wilson, Darrell M.; Grotenbreg, Gijsbert M.; Valitutti, Salvatore; Quake, Stephen R.; Davis, Mark M.			Clonal Deletion Prunes but Does Not Eliminate Self-Specific alpha beta CD8(+) T Lymphocytes	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; NEGATIVE SELECTION; CELL REPERTOIRE; ANTIGEN RECEPTOR; THYMIC SELECTION; TOLERANCE; PHENOTYPE; EXPRESSION; DIVERSITY; FREQUENCY	It has long been thought that clonal deletion efficiently removes almost all self-specific T cells from the peripheral repertoire. We found that self-peptide MHC-specific CD8(+) T cells in the blood of healthy humans were present in frequencies similar to those specific for non-self antigens. For the Y chromosome-encoded SMCY antigen, self-specific T cells exhibited only a 3-fold lower average frequency in males versus females and were anergic with respect to peptide activation, although this inhibition could be overcome by a stronger stimulus. We conclude that clonal deletion prunes but does not eliminate self-specific T cells and suggest that to do so would create holes in the repertoire that pathogens could readily exploit. In support of this hypothesis, we detected T cells specific for all 20 amino acid variants at the p5 position of a hepatitis C virus epitope in a random group of blood donors.	[Yu, Wong; Ebert, Peter J. R.; Kidd, Brian A.; Lund, Peder J.; Juang, Jeremy; Adachi, Keishi; Tse, Tiffany; Birnbaum, Michael E.; Newell, Evan W.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Yu, Wong] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Jiang, Ning; Quake, Stephen R.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Mueller, Sabina; Valitutti, Salvatore] INSERM, Ctr Physiopathol Toulouse Purpan, UMR1043, Toulouse, France; [Mueller, Sabina; Valitutti, Salvatore] Univ Toulouse III Paul Sabatier, F-31024 Toulouse, France; [Wilson, Darrell M.] Stanford Univ, Sch Med, Dept Pediat Endocrinol, Stanford, CA 94305 USA; [Grotenbreg, Gijsbert M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Quake, Stephen R.; Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Valitutti, Salvatore/M-2999-2014; Newell, Evan W/F-9711-2012; Jiang, Ning/M-5448-2017; adachi, keishi/AAT-7471-2020	Valitutti, Salvatore/0000-0002-6432-4421; Newell, Evan W/0000-0002-2889-243X; Jiang, Ning/0000-0003-1103-5922; Muller, Sabina/0000-0002-4580-2758; Birnbaum, Michael/0000-0002-2281-3518; Davis, Mark/0000-0001-6868-657X; Kidd, Brian/0000-0003-2110-1145	Damon Runyon Cancer Research Foundation [DRR-32-15]; NIH [U19-AI090019, U19-AI57229, 1K08DK093709-01, R00AG040149]; Cancer Prevention and Research Institute of Texas [R1120]; Fondation ARC pour la Recherche sur le Cancer [EML2012090493]; Institut National du Cancer [INCa 2012-054]; Agence Nationale de la Recherche; George D. Smith Stanford Graduate Fellowship; NSF Graduate Research Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG040149] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); George D. Smith Stanford Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Peter Lee, Hongxiang Yu, Tor Stuge, Alexandre Johannsen, Alasdair Leslie, Tao Dong, and Carol Clayberger for help and advice with cell culture; Jeffrey Glenn and Menashe Elazar for the HCV NS3 plasmid; Karin Kealoha, Linda Enomoto, and Cynthia Evora from the Stanford Blood Bank for their assistance in obtaining blood samples; Christina Meyer and Xun Zeng from the Yueh-Hsiu Chien laboratory for help generating JY cells expressing HCV NS3; Olivia M. Martinez and Olivia Hatton for the OH cell line; Marty Bigos, Catherine Crumpton, Ometa Herman, Tim Knaak, David Parks, and Jonathan van Dyke for assistance at the flow cytometry facility; Tandy Aye, Leo Hansmann, and Ileana Rau for helpful suggestions; and Barbara Whyte and Rick Cuevas for administrative assistance. This work was supported by the Damon Runyon Cancer Research Foundation (W.Y., Postdoctoral Fellowship; N.J., Damon Runyon-Rachleff Innovator, DRR-32-15), the NIH (M.M.D., U19-AI090019 and U19-AI57229; W.Y., 1K08DK093709-01; N.J., R00AG040149), the Cancer Prevention and Research Institute of Texas (N.J., R1120), the Fondation ARC pour la Recherche sur le Cancer (S.V., EML2012090493), the Institut National du Cancer (S.V., INCa 2012-054), the Agence Nationale de la Recherche (Laboratoire d'Excellence Toulouse Cancer, S.V.), the George D. Smith Stanford Graduate Fellowship (P.J.L.), the NSF Graduate Research Fellowship (P.J.L), and the Howard Hughes Medical Institute to W.Y. and M.M.D.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Barnea E, 2002, EUR J IMMUNOL, V32, P213, DOI 10.1002/1521-4141(200201)32:1<213::AID-IMMU213>3.0.CO;2-8; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Delluc S, 2010, BLOOD, V116, P4542, DOI 10.1182/blood-2010-04-280875; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Legoux F, 2010, J IMMUNOL, V184, P6731, DOI 10.4049/jimmunol.1000295; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McGuire HM, 2009, P NATL ACAD SCI USA, V106, P19438, DOI 10.1073/pnas.0903561106; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schmidt J, 2011, J VIROL, V85, P5232, DOI 10.1128/JVI.00093-11; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Stuge TB, 2004, PLOS MED, V1, P149, DOI 10.1371/journal.pmed.0010028; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; van den Beemd R, 2000, CYTOMETRY, V40, P336, DOI 10.1002/1097-0320(20000801)40:4<336::AID-CYTO9>3.0.CO;2-0; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; VILLAR HO, 1994, FEBS LETT, V349, P125, DOI 10.1016/0014-5793(94)00648-2; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weinschenk T, 2002, CANCER RES, V62, P5818; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wolfl M, 2008, J IMMUNOL, V181, P6435, DOI 10.4049/jimmunol.181.9.6435; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	67	177	178	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					929	941		10.1016/j.immuni.2015.05.001	http://dx.doi.org/10.1016/j.immuni.2015.05.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992863	Bronze, Green Accepted			2022-12-18	WOS:000354827400018
J	Visvikis, O; Ihuegbu, N; Labed, SA; Luhachack, LG; Alves, AMF; Wollenberg, AC; Stuart, LM; Stormo, GD; Irazoqui, JE				Visvikis, Orane; Ihuegbu, Nnamdi; Labed, Sid A.; Luhachack, Lyly G.; Alves, Anna-Maria F.; Wollenberg, Amanda C.; Stuart, Lynda M.; Stormo, Gary D.; Irazoqui, Javier E.			Innate Host Defense Requires TFEB-Mediated Transcription of Cytoprotective and Antimicrobial Genes	IMMUNITY			English	Article							CAENORHABDITIS-ELEGANS; STAPHYLOCOCCUS-AUREUS; AUTOPHAGY GENES; C. ELEGANS; LYSOSOMAL BIOGENESIS; REGULATES AUTOPHAGY; LIFE-SPAN; INFECTION; PROTEINS; RECOGNITION	Animal host defense against infection requires the expression of defense genes at the right place and the right time. Understanding such tight control of host defense requires the elucidation of the transcription factors involved. By using an unbiased approach in the model Caenorhabditis elegans, we discovered that HLH-30 (known as TFEB in mammals) is a key transcription factor for host defense. HLH-30 was activated shortly after Staphylococcus aureus infection, and drove the expression of close to 80% of the host response, including antimicrobial and autophagy genes that were essential for host tolerance of infection. TFEB was also rapidly activated in murine macrophages upon S. aureus infection and was required for proper transcriptional induction of several proinflammatory cytokines and chemokines. Thus, our data suggest that TFEB is a previously unappreciated, evolutionarily ancient transcription factor in the host response to infection.	[Visvikis, Orane; Labed, Sid A.; Luhachack, Lyly G.; Alves, Anna-Maria F.; Wollenberg, Amanda C.; Irazoqui, Javier E.] Harvard Univ, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Lab Comparat Immunol,Sch Med, Boston, MA 02114 USA; [Ihuegbu, Nnamdi; Stormo, Gary D.] Washington Univ, Sch Med, Ctr Genome Sci, Dept Genet, St Louis, MO 63118 USA; [Stuart, Lynda M.] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Washington University (WUSTL); Bill & Melinda Gates Foundation	Irazoqui, JE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Lab Comparat Immunol,Sch Med, Boston, MA 02114 USA.	jirazoqui@mgh.harvard.edu	VISVIKIS, ORANE/N-1818-2016	VISVIKIS, ORANE/0000-0001-7719-5836; Irazoqui, Javier/0000-0001-6553-1329	NIH Office of Research Infrastructure Programs [P40-OD010440]; National Institute of General Medical Sciences of the National Institutes of Health from NHGRI [P30-GM092431, R01-GM101056, R01-GM101056-S1, R01-HG000249]; Massachusetts General Hospital; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM092431, R01GM101056, R01GM102482] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health from NHGRI; Massachusetts General Hospital(General Electric); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Lacy-Hulbert for helpful discussions, S. Margolis for critical reading of the manuscript, A. Sokolovska and A. Tanne for assistance with macrophage experiments, L.R.Lapierre and M. Hansen for sharing unpublished data, M. Ferron and G. Karsenty for their generous gift of TFEB-3xFLAG RAW264.7 cells, and V. Ambros for the hlh-30(tm1978) strain. We thank the Genome Access Technology Center at Washington University Medical School for their sequencing assistance, especially N. Rockweiler for helpful discussions. Some C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40-OD010440). This study was funded in part by the National Institute of General Medical Sciences of the National Institutes of Health, under awards numbers P30-GM092431, R01-GM101056, and R01-GM101056-S1 (to J.E.I.) and R01-HG000249 from the NHGRI (to G.D.S.). O.V. was funded by a Fund for Medical Discovery postdoctoral fellowship from the Massachusetts General Hospital.	Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Boehnisch C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024619; BRENNER S, 1974, GENETICS, V77, P71; Carralot JP, 2009, J BIOMOL SCREEN, V14, P151, DOI 10.1177/1087057108328762; Cuervo AM, 2013, NAT CELL BIOL, V15, P565, DOI 10.1038/ncb2778; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hoeckendorf A, 2012, BIOCHEM J, V445, P205, DOI 10.1042/BJ20112102; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ihuegbu NE, 2012, J COMPUT BIOL, V19, P139, DOI 10.1089/cmb.2011.0249; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Lapierre LR, 2013, AUTOPHAGY, V9, P278, DOI 10.4161/auto.22930; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Medzhitov R, 2009, P NATL ACAD SCI USA, V106, P15525, DOI 10.1073/pnas.0908451106; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; Pastore N, 2013, EMBO MOL MED, V5, P397, DOI 10.1002/emmm.201202046; Patel KK, 2013, ANNU REV PHYSIOL, V75, P241, DOI 10.1146/annurev-physiol-030212-183658; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Simonsen KT, 2011, VIRULENCE, V2, P120, DOI 10.4161/viru.2.2.15270; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Tarr DEK, 2012, DEV COMP IMMUNOL, V36, P502, DOI 10.1016/j.dci.2011.09.007; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183	64	177	183	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					896	909		10.1016/j.immuni.2014.05.002	http://dx.doi.org/10.1016/j.immuni.2014.05.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24882217	Bronze, Green Accepted			2022-12-18	WOS:000341440200012
J	Egawa, M; Mukai, K; Yoshikawa, S; Iki, M; Mukaida, N; Kawano, Y; Minegishi, Y; Karasuyama, H				Egawa, Mayumi; Mukai, Kaori; Yoshikawa, Soichiro; Iki, Misako; Mukaida, Naofumi; Kawano, Yohei; Minegishi, Yoshiyuki; Karasuyama, Hajime			Inflammatory Monocytes Recruited to Allergic Skin Acquire an Anti-inflammatory M2 Phenotype via Basophil-Derived Interleukin-4	IMMUNITY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; BONE-MARROW; PRODUCE INTERLEUKIN-4; DENDRITIC CELLS; IL-4 PRODUCTION; MICE DEFICIENT; FC-EPSILON; T-CELLS; INFECTION; BLOOD	Monocytes and macrophages are important effectors and regulators of inflammation, and both can be divided into distinct subsets based on their phenotypes. The developmental and functional relationship between individual subsets of monocytes and those of macrophages has not been fully elucidated, although Ly6C(+)CCR2(+) inflammatory and Ly6C(-)CCR2(-) resident monocytes are generally thought to differentiate into M1 (classically activated) and M2 (alternatively activated) macrophages, respectively. Here we show that inflammatory monocytes recruited to allergic skin acquired an M2-like phenotype in response to basophil-derived interleukin-4 (IL-4) and exerted an anti-inflammatory function. CCR2-deficient mice unexpectedly displayed an exacerbation rather than alleviation of allergic inflammation, in spite of impaired recruitment of inflammatory monocytes to skin lesions. Adoptive transfer of inflammatory monocytes from wild-type but not IL-4 receptor-deficient mice dampened the exacerbated inflammation in CCR2-deficient mice. Thus, inflammatory monocytes can be converted from being proinflammatory to anti-inflammatory under the influence of basophils in allergic reactions.	[Egawa, Mayumi; Mukai, Kaori; Yoshikawa, Soichiro; Iki, Misako; Kawano, Yohei; Minegishi, Yoshiyuki; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138519, Japan; [Minegishi, Yoshiyuki; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, CREST, JST, Tokyo 1138519, Japan; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9201192, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Kanazawa University	Karasuyama, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138519, Japan.	karasuyama.mbch@tmd.ac.jp	Mukaida, Naofumi/D-7623-2011; Kawano, Yohei/V-1335-2018; Karasuyama, Hajime/A-7966-2011	Mukaida, Naofumi/0000-0002-4193-1851; Karasuyama, Hajime/0000-0003-0689-0836; Kawano, Yohei/0000-0001-7181-2282	JST, CREST; Grants-in-Aid for Scientific Research [25293232] Funding Source: KAKEN	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. A. Kuziel (External Scientific Affairs, Daiichi Sankyo Group, Edison, NJ) for providing Ccr2<SUP>-/-</SUP> mice, D. Yamanaka and R. Matsunaga for technical support, and M. Miki for secretary assistance. This work was supported by a research grant from JST, CREST (to H.K.).	Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Denney L, 2012, J IMMUNOL, V189, P551, DOI 10.4049/jimmunol.1103608; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Karasuyama H, 2011, TRENDS IMMUNOL, V32, P125, DOI 10.1016/j.it.2010.11.006; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim Y, 2001, J IMMUNOL, V166, P5183, DOI 10.4049/jimmunol.166.8.5183; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melgert BN, 2010, AM J RESP CELL MOL, V42, P595, DOI 10.1165/rcmb.2009-0016OC; Min B, 2012, IMMUNOLOGY, V135, P192, DOI 10.1111/j.1365-2567.2011.03530.x; Montaner LJ, 1999, J IMMUNOL, V162, P4606; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Noben-Trauth N, 1999, J IMMUNOL, V162, P6132; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; PICCINNI MP, 1991, P NATL ACAD SCI USA, V88, P8656, DOI 10.1073/pnas.88.19.8656; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Semnani RT, 2011, INFECT IMMUN, V79, P3957, DOI 10.1128/IAI.05191-11; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Sun Y, 2008, LUNG, V186, P375, DOI 10.1007/s00408-008-9099-1; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Voehringer D, 2011, CURR OPIN IMMUNOL, V23, P789, DOI 10.1016/j.coi.2011.09.005; Voehringer D, 2009, TRENDS PARASITOL, V25, P551, DOI 10.1016/j.pt.2009.09.004; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	62	177	179	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					570	580		10.1016/j.immuni.2012.11.014	http://dx.doi.org/10.1016/j.immuni.2012.11.014			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23434060	Bronze			2022-12-18	WOS:000330941500020
J	Kohlmeier, JE; Cookenham, T; Roberts, AD; Miller, SC; Woodland, DL				Kohlmeier, Jacob E.; Cookenham, Tres; Roberts, Alan D.; Miller, Shannon C.; Woodland, David L.			Type I Interferons Regulate Cytolytic Activity of Memory CD8(+) T Cells in the Lung Airways during Respiratory Virus Challenge	IMMUNITY			English	Article							HERPES-SIMPLEX-VIRUS; INFLUENZA-VIRUS; CUTTING EDGE; A VIRUS; GRANZYME-B; ALPHA/BETA INTERFERON; TARGETED DISRUPTION; ADAPTIVE IMMUNITY; NS1 PROTEIN; INFECTIONS	Memory CD8(+) T cells in the lung airways provide protection from secondary respiratory virus challenge by limiting early viral replication. Here, we demonstrate that although airway-resident memory CD8(+) T cells were poorly cytolytic, memory CD8(+) T cells recruited to the airways early during a recall response showed markedly enhanced cytolytic ability. This enhanced lytic activity did not require cognate antigen stimulation, but rather was dependent on STAT1 transcription factor signaling through the interferon-alpha receptor (Ifnar1), resulting in the antigen-independent expression of granzyme B protein in both murine and human virus-specific T cells. Signaling through Ifnar1 was required for the enhanced lytic activity and control of early viral replication by memory CD8(+) T cells in the lung airways. These findings demonstrate that innate inflammatory signals act directly on memory T cells, enabling them to rapidly destroy infected host cells once they enter infected tissues.	[Kohlmeier, Jacob E.; Cookenham, Tres; Roberts, Alan D.; Miller, Shannon C.; Woodland, David L.] Trudeau Inst, Saranac Lake, NY 12983 USA	Trudeau Institute	Kohlmeier, JE (corresponding author), Trudeau Inst, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.	jkohlmeier@trudeauinstitute.org; dwoodland@trudeauinstitute.org			NIH [AI83610, AI67967, AI76499, T32 AI49823]; Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071478, R21AI083610, R01AI076499, T32AI049823, R01AI067967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trudeau Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Trudeau Institute Molecular Biology Core for the production of class I tetramers, M. Blackman, E. Brincks, G. Perona-Wright, and M. Mohrs for critical review of the manuscript, and B. Sells for cell sorting. This work was supported by NIH grants AI83610 (J.E.K.), AI67967, AI76499, and T32 AI49823 (D.L.W.), and funds from the Trudeau Institute.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heidema J, 2008, J IMMUNOL, V181, P5551, DOI 10.4049/jimmunol.181.8.5551; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; HOU S, 1992, J IMMUNOL, V149, P1319; Jenkins MR, 2008, VIRAL IMMUNOL, V21, P341, DOI 10.1089/vim.2008.0036; Jenkins MR, 2007, J IMMUNOL, V179, P64, DOI 10.4049/jimmunol.179.1.64; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Juelich T, 2009, J IMMUNOL, V183, P7063, DOI 10.4049/jimmunol.0901522; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; LIANG SH, 1994, J IMMUNOL, V152, P1653; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mintern JD, 2007, J IMMUNOL, V179, P7220, DOI 10.4049/jimmunol.179.11.7220; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Reading PC, 2007, J IMMUNOL, V179, P3214, DOI 10.4049/jimmunol.179.5.3214; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Topham DJ, 1997, J IMMUNOL, V159, P5197; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Touvrey C, 2009, J IMMUNOL, V182, P6718, DOI 10.4049/jimmunol.0803095; Turner SJ, 2003, IMMUNITY, V18, P549, DOI 10.1016/S1074-7613(03)00087-6; Vallbracht S, 2006, EUR J IMMUNOL, V36, P1434, DOI 10.1002/eji.200535642; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	44	177	178	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 23	2010	33	1					96	105		10.1016/j.immuni.2010.06.016	http://dx.doi.org/10.1016/j.immuni.2010.06.016			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20637658	Green Accepted, Bronze			2022-12-18	WOS:000280418100013
J	Feuerer, M; Shen, YL; Littman, DR; Benoist, C; Mathis, D				Feuerer, Markus; Shen, Yuelei; Littman, Dan R.; Benoist, Christophe; Mathis, Diane			How Punctual Ablation of Regulatory T Cells Unleashes an Autoimmune Lesion within the Pancreatic Islets	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; NATURAL-KILLER-CELLS; NOD MICE; IFN-GAMMA; LYMPH-NODES; CROSS-TALK; ANTIGEN; FOXP3; COSTIMULATION; ENTEROPATHY	CD4(+)Foxp3(+) regulatory T cells (Treg cells) are known to control the progression of autoimmune diabetes, but when, where, and how they exert their influence in this context are questions still under vigorous debate. Exploiting a transgene encoding the human diphtheria toxin receptor, we punctually and specifically ablated Foxp3(+) cells in the BCD2.5/NOD mouse model of autoimmune diabetes. Strikingly, overt disease developed within 3 days. The earliest detectable event was the activation of natural killer (NK) cells directly within the insulitic lesion, particularly the induction of Ifng gene expression within 7 hours of Treg cell ablation. Interferon-gamma had a strong impact on the gene-expression program of the local CD4(+) T effector cell population, unleashing it to aggressively attack the islets, which was required for the development of diabetes. Thus, Treg cells regulate pancreatic autoimmunity in situ through control of a central innate immune system player, NK cells.	[Feuerer, Markus; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Feuerer, Markus; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02115 USA; [Mathis, Diane] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Shen, Yuelei; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Shen, Yuelei; Littman, Dan R.] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Shen, Yuelei; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; New York University; New York University; Howard Hughes Medical Institute; New York University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu			Juvenile Diabetes Research Foundation [4-2007-1057]; NIH [R01 DK59658]; Asthma Research and the National Multiple Sclerosis Society; NIDDK-funded Diabetes and Endocrinology Research Center; German Research Foundation [FE 801/1-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059658] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asthma Research and the National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIDDK-funded Diabetes and Endocrinology Research Center; German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Stockton for producing the DTR transgenics; J. LaVecchio and G. Buruzala for flow cytometry; J. Hill, J. Perez, and K. Leatherbee for help with the microarray analyses; and H.-J. Wu for the IFN-gamma signature. This work was supported by grants from the Juvenile Diabetes Research Foundation (4-2007-1057) and the NIH (R01 DK59658) to D.M. and C.B.; by grants from the Sandler Program in Asthma Research and the National Multiple Sclerosis Society to D.R.L.; and by the core facilities of Joslin Diabetes Center's NIDDK-funded Diabetes and Endocrinology Research Center. M.F. was supported by postdoctoral fellowships from the German Research Foundation (Emmy-Noether Fellowship, FE 801/1-1) and the Charles A. King Trust.	Alba A, 2008, CLIN EXP IMMUNOL, V151, P467, DOI 10.1111/j.1365-2249.2007.03580.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Carnaud C, 2001, J IMMUNOL, V166, P2404, DOI 10.4049/jimmunol.166.4.2404; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; DEBRAYSACHS M, 1991, J AUTOIMMUN, V4, P237, DOI 10.1016/0896-8411(91)90021-4; Esensten JH, 2009, J IMMUNOL, V183, P75, DOI 10.4049/jimmunol.0804154; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Terme M, 2008, J IMMUNOL, V180, P4679, DOI 10.4049/jimmunol.180.7.4679; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	44	177	182	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					654	664		10.1016/j.immuni.2009.08.023	http://dx.doi.org/10.1016/j.immuni.2009.08.023			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818653	Green Accepted, Bronze			2022-12-18	WOS:000271403900016
J	Huse, M; Klein, LO; Girvin, AT; Faraj, JM; Li, QJ; Kuhns, MS; Davis, MM				Huse, Morgan; Klein, Lawrence O.; Girvin, Andrew T.; Faraj, Joycelyn M.; Li, Qi-Jing; Kuhns, Michael S.; Davis, Mark M.			Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist	IMMUNITY			English	Article							MICROTUBULE-ORGANIZING CENTER; PROTEIN-KINASE-C; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; LIGAND RECOGNITION; FEEDBACK-CONTROL; CAGED COMPOUNDS; TARGET-CELLS; ACTIVATION; CD4	The precise timing of signals downstream of the T cell receptor (TCR) is poorly understood. To address this problem, we prepared major histocompatibility complexes containing an antigenic peptide that is biologically inert until exposed to ultraviolet (LIV) light. LIV irradiation of these complexes in contact with cognate T cells enabled the high-resolution temporal analysis of signaling. Phosphorylation of the LAT adaptor molecule was observed in 4 s, and diacylglycerol production and calcium flux was observed in 6-7 s. TCR activation also induced cytoskeletal polarization within 2 min. Antibody blockade of CD4 reduced the intensity of LAT phosphorylation and the speed of calcium flux. Furthermore, strong desensitization of diacylglycerol production, but not LAT phosphorylation, occurred shortly after TCR activation, suggesting that different molecular events play distinct signal-processing roles. These results establish the speed and localization of early signaling steps, and have important implications regarding the overall structure of the network.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Biophys, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu		Girvin, Andrew/0000-0002-2031-9209; Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Balamuth F, 2004, J IMMUNOL, V172, P5887, DOI 10.4049/jimmunol.172.10.5887; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chan C, 2004, P ROY SOC B-BIOL SCI, V271, P931, DOI 10.1098/rspb.2003.2587; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Delon J, 1998, EUR J IMMUNOL, V28, P716, DOI 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E; DeMond AL, 2006, J AM CHEM SOC, V128, P15354, DOI 10.1021/ja065304l; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Harrison Stephen A, 2002, Semin Gastrointest Dis, V13, P3; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; KUPFER A, 1984, J IMMUNOL, V133, P2762; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lin J, 2001, J CELL SCI, V114, P243; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Patrick SM, 2000, J IMMUNOL METHODS, V241, P97, DOI 10.1016/S0022-1759(00)00216-7; Pellois JP, 2005, ANGEW CHEM INT EDIT, V44, P5713, DOI 10.1002/anie.200501244; RANDRIAMAMPITA C, 1989, FEBS LETT, V249, P199, DOI 10.1016/0014-5793(89)80624-6; REAY PA, 1994, J IMMUNOL, V152, P3946; Roy P, 2001, J CELL BIOL, V153, P1035, DOI 10.1083/jcb.153.5.1035; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Vidal K, 1999, J IMMUNOL, V163, P4811; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Wang XD, 2000, J IMMUNOL, V164, P1934, DOI 10.4049/jimmunol.164.4.1934; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	64	177	180	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2007	27	1					76	88		10.1016/j.immuni.2007.05.017	http://dx.doi.org/10.1016/j.immuni.2007.05.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17629516	Bronze			2022-12-18	WOS:000248398100010
J	Urzainqui, A; Serrador, JM; Viedma, F; Yanez-Mo, M; Rodriguez, A; Corbi, AL; Alonso-Lebrero, JL; Luque, A; Deckert, M; Vazquez, J; Sanchez-Madrid, F				Urzainqui, A; Serrador, JM; Viedma, F; Yanez-Mo, M; Rodriguez, A; Corbi, AL; Alonso-Lebrero, JL; Luque, A; Deckert, M; Vazquez, J; Sanchez-Madrid, F			ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1	IMMUNITY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; P-SELECTIN; T-LYMPHOCYTES; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; PHORBOL-ESTER; CELL-ADHESION; EZRIN; MOESIN; CD43	P-selectin glycoprotein ligand 1 (PSGL-1) is a leukocyte adhesion molecule involved in cell tether and rolling on activated endothelium. Our work shows that PSGL-1 associates with Syk. This association is mediated by the actin-linking proteins moesin and ezrin, which directly interact with Syk in an ITAM-dependent manner. PSGL-1 engagement induces tyrosine phosphorylation of Syk and SRE-dependent transcriptional activity. Treatment of cells with the Syk inhibitor piceatannol and overexpression of either a Syk dead kinase mutant or an ITAM-mutated moesin abrogated PSGL-1 -induced transcriptional activation. These data unveil a new functional role for the ERMs (ezrin/radixin/moesin) as adaptor molecules in the interactions of adhesion receptors and intracellular tyrosine kinases and show that PSGL-1 is a signaling molecule in leukocytes.	Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid, Spain; CSIC, Ctr Nacl Invest Cardiovasc, Madrid, Spain; CSIC, Ctr Invest Biol, Madrid, Spain; Hosp Archet, INSERM, U343, Nice, France; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sanchez-Madrid, F (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid, Spain.	fsanchez@hlpr.insalud.es	Luque, Alfonso/C-5846-2018; Vazquez, Jesus/B-7697-2015; Deckert, Marcel/M-4998-2016; Sanchez-Madrid, Francisco/M-7889-2016; Corbi, Angel/B-7194-2011; Urzainqui, Ana/AAB-4466-2020; Yáñez-Mó, María/K-8577-2014; Urzainqui, Ana/HDN-9549-2022; Serrador, Juan M/K-2718-2014; YÃÃez-MÃ, Maria/AAI-4544-2020; Deckert, Marcel/T-3566-2019; Marquez, Antonio A. Rodriguez/L-2422-2013; Corbí, Angel L./ABC-8146-2020	Vazquez, Jesus/0000-0003-1461-5092; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Corbi, Angel/0000-0003-1980-5733; Urzainqui, Ana/0000-0001-9326-6112; Yáñez-Mó, María/0000-0001-7484-2866; Urzainqui, Ana/0000-0001-9326-6112; Serrador, Juan M/0000-0003-4710-3077; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Deckert, Marcel/0000-0003-2094-559X; Marquez, Antonio A. Rodriguez/0000-0003-2455-6583; Corbí, Angel L./0000-0003-1980-5733				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; DAMLE NK, 1992, EUR J IMMUNOL, V22, P1789, DOI 10.1002/eji.1830220718; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; delPozo MA, 1997, J CELL BIOL, V137, P493; Fluhmann B, 1998, MOL CELL ENDOCRINOL, V139, P89, DOI 10.1016/S0303-7207(98)00070-7; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; Guyer DA, 1996, BLOOD, V88, P2415, DOI 10.1182/blood.V88.7.2415.bloodjournal8872415; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; McEver RP, 1997, J CLIN INVEST, V100, pS97; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Meyer T, 1998, J THROMB THROMBOLYS, V6, P117, DOI 10.1023/A:1008845421381; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Montoya MC, 1999, J CLIN INVEST, V103, P1317, DOI 10.1172/JCI4705; Norman KE, 2000, BLOOD, V96, P3585; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Rainger GE, 1998, THROMB HAEMOSTASIS, V79, P1177; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Rozsnyay Z, 1996, IMMUNOL LETT, V54, P163, DOI 10.1016/S0165-2478(96)02667-3; RUBIO MA, 1995, BLOOD, V86, P3715, DOI 10.1182/blood.V86.10.3715.bloodjournal86103715; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Santana MA, 2000, J BIOL CHEM, V275, P31460, DOI 10.1074/jbc.M005231200; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, J BIOL CHEM, V277, P10400, DOI 10.1074/jbc.M110694200; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	54	177	188	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2002	17	4					401	412		10.1016/S1074-7613(02)00420-X	http://dx.doi.org/10.1016/S1074-7613(02)00420-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387735	Bronze			2022-12-18	WOS:000178667100002
J	Fackler, OT; Baur, AS				Fackler, OT; Baur, AS			Live and let die: Nef functions beyond HIV replication	IMMUNITY			English	Review							T-CELL-ACTIVATION; DENDRITIC CELLS; SURFACE CD4; DC-SIGN; APOPTOSIS; PHOSPHORYLATION; INFECTIVITY; INHIBITION; MODULATION; EXPRESSION	The viral Nef protein is important for the progression of the human and simian immunodeficiency virus (HIV/ SIV) infection. So far, experimental evidence has suggested that Nef enhances viral replication and infectivity through a combination of different effects. Recent insights, however, indicate that its functions are more complex than previously anticipated. By targeting the T cell receptor, Nef may not only prime viral replication but, more importantly, ensure viral survival through distinct mechanisms of immune evasion and antiapoptosis.	Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany; Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg	Baur, AS (corresponding author), Univ Erlangen Nurnberg, Dept Dermatol, Hartmannstr 14, D-91052 Erlangen, Germany.	andreas.baur@derma.imed.uni-erlangen.de		Fackler, Oliver Till/0000-0003-2982-4209				Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Combadiere B, 1996, J EXP MED, V183, P2109, DOI 10.1084/jem.183.5.2109; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Fackler OT, 2001, CURR BIOL, V11, P1294, DOI 10.1016/S0960-9822(01)00373-6; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Ross TM, 2001, LEUKEMIA, V15, P332, DOI 10.1038/sj.leu.2402028; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Steinman RM, 2000, CELL, V100, P491, DOI 10.1016/S0092-8674(00)80684-4; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 2001, IMMUNITY, V15, P867, DOI 10.1016/S1074-7613(01)00255-2; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8	33	177	180	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2002	16	4					493	497		10.1016/S1074-7613(02)00307-2	http://dx.doi.org/10.1016/S1074-7613(02)00307-2			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543PD	11970873	Bronze			2022-12-18	WOS:000175109600001
J	Pearse, RN; Kawabe, T; Bolland, S; Guinamard, R; Kurosaki, T; Ravetch, JV				Pearse, RN; Kawabe, T; Bolland, S; Guinamard, R; Kurosaki, T; Ravetch, JV			SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis	IMMUNITY			English	Article							INOSITOL PHOSPHATASE SHIP; GERMINAL-CENTERS; IMMUNE-RESPONSE; SURFACE-IMMUNOGLOBULIN; CYTOPLASMIC DOMAIN; ANTIGEN RECEPTORS; DISTINCT PATHWAYS; TYROSINE KINASES; LYMPHOCYTES-B; ACTIVATION	Fc gamma RIIB is an inhibitory receptor that terminates activation signals initiated by antigen cross-linking of the BCR through the recruitment of SHIP. Fc gamma RIIB can also signal independently of BCR coligation to directly mediate an apoptotic response, requiring only an intact transmembrane domain. Failure to recruit SHIP, either by deletion of SHIP or mutation of Fc gamma RIIB, results in enhanced Fc gamma RIIB-triggered apoptosis. Thus, in the germinal center, where ICs are retained by FDCs, Fc gamma RIIB may be an active determinant in the negative selection of B cells whose BCRs have reduced affinity for antigen as a result of somatic hypermutation. Selection of B cells may represent the sum of opposing signals generated by the interaction of ICs with the BCR and Fc gamma RIIB through pathways modulated by SHIP.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, Nagoya, Aichi 466, Japan; Kansai Med Univ, Dept Mol Genet, Moriguchi, Osaka 570, Japan	Rockefeller University; Nagoya University; Kansai Medical University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.		Kurosaki, Tomohiro/D-1306-2009; Ravetch, Jeffrey/Z-1596-2019; Kawabe, Tsutomu/I-6277-2014; Guinamard, Rodolphe/P-9804-2016	Kurosaki, Tomohiro/0000-0002-6352-304X; Ravetch, Jeffrey/0000-0003-2024-9041; Kawabe, Tsutomu/0000-0002-9319-9930; Guinamard, Rodolphe/0000-0002-7400-582X				Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Ashman RF, 1996, J IMMUNOL, V157, P5; BEREK C, 1985, NATURE, V316, P412, DOI 10.1038/316412a0; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BIJSTERBOSCH MK, 1985, J EXP MED, V162, P1825, DOI 10.1084/jem.162.6.1825; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHAN PL, 1971, IMMUNOLOGY, V21, P967; CHEN CLH, 1982, J IMMUNOL, V129, P2580; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Goodman PA, 1998, J BIOL CHEM, V273, P17742, DOI 10.1074/jbc.273.28.17742; GRAHAM IL, 1993, J CELL BIOL, V120, P1509, DOI 10.1083/jcb.120.6.1509; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JERNE N K, 1951, Acta Pathol Microbiol Scand Suppl, V87, P1; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Kiener PA, 1997, J BIOL CHEM, V272, P3838, DOI 10.1074/jbc.272.6.3838; Kim JT, 1999, J IMMUNOL, V162, P4253; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Liu YJ, 1996, INT REV CYTOL, V166, P139, DOI 10.1016/S0074-7696(08)62508-5; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NOSSAL GJV, 1964, AUST J EXP BIOL MED, V42, P311, DOI 10.1038/icb.1964.32; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Okada H, 1998, J IMMUNOL, V161, P5129; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; PHILLIPS NE, 1984, J IMMUNOL, V132, P627; PHILLIPS NE, 1983, J IMMUNOL, V130, P602; Qin SF, 1997, J BIOL CHEM, V272, P2098; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tridandapani S, 1997, MOL CELL BIOL, V17, P4305, DOI 10.1128/MCB.17.8.4305; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Yamashita Y, 1996, J EXP MED, V184, P113, DOI 10.1084/jem.184.1.113; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	61	177	180	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					753	760		10.1016/S1074-7613(00)80074-6	http://dx.doi.org/10.1016/S1074-7613(00)80074-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403650	Bronze			2022-12-18	WOS:000081209600013
J	Dutertre, CA; Becht, E; Irac, SE; Khalilnezhad, A; Narang, V; Khalilnezhad, S; Ng, PY; van den Hoogen, LL; Leong, JY; Lee, B; Chevrier, M; Zhang, XM; Yong, PJA; Koh, G; Lum, J; Howland, SW; Mok, E; Chen, JM; Larbi, A; Tan, HKK; Lim, TKH; Karagianni, P; Tzioufas, AG; Malleret, B; Brody, J; Albani, S; van Roon, J; Radstake, T; Newell, EW; Ginhoux, F				Dutertre, Charles-Antoine; Becht, Etienne; Irac, Sergio Erdal; Khalilnezhad, Ahad; Narang, Vipin; Khalilnezhad, Shabnam; Ng, Pei Y.; van den Hoogen, Lucas L.; Leong, Jing Yao; Lee, Bernett; Chevrier, Marion; Zhang, Xiao Meng; Yong, Pearly Jean Ai; Koh, Geraldine; Lum, Josephine; Howland, Shanshan Wu; Mok, Esther; Chen, Jinmiao; Larbi, Anis; Tan, Henry Kun Kiaang; Lim, Tony Kiat Hon; Karagianni, Panagiota; Tzioufas, Athanasios G.; Malleret, Benoit; Brody, Joshua; Albani, Salvatore; van Roon, Joel; Radstake, Timothy; Newell, Evan W.; Ginhoux, Florent			Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HIGH-DIMENSIONAL ANALYSIS; EXPRESSION; MACROPHAGES; POPULATIONS; MONOCYTES; CYTOMETRY; ONTOGENY; ANTIBODY; TISSUES	Human mononuclear phagocytes comprise phenotypically and functionally overlapping subsets of dendritic cells (DCs) and monocytes, but the extent of their heterogeneity and distinct markers for subset identification remains elusive. By integrating high-dimensional single-cell protein and RNA expression data, we identified distinct markers to delineate monocytes from conventional DC2 (cDC2s). Using CD88 and CD89 for monocytes and HLA-DQ and Fc epsilon RI alpha for cDC2s allowed for their specific identification in blood and tissues. We also showed that cDC2s could be subdivided into phenotypically and functionally distinct subsets based on CD5, CD163, and CD14 expression, including a distinct subset of circulating inflammatory CD5(-)CD163(+)CD14(+) cells related to previously defined DC3s. These inflammatory DC3s were expanded in systemic lupus erythematosus patients and correlated with disease activity. These findings further unravel the heterogeneity of DC subpopulations in health and disease and may pave the way for the identification of specific DC subset-targeting therapies.	[Dutertre, Charles-Antoine; Becht, Etienne; Irac, Sergio Erdal; Khalilnezhad, Ahad; Narang, Vipin; Khalilnezhad, Shabnam; Ng, Pei Y.; Lee, Bernett; Chevrier, Marion; Zhang, Xiao Meng; Koh, Geraldine; Lum, Josephine; Howland, Shanshan Wu; Mok, Esther; Chen, Jinmiao; Larbi, Anis; Malleret, Benoit; Newell, Evan W.; Ginhoux, Florent] ASTAR, Singapore Immunol Network, 8A Biomed Grove,Immunos Bldg, Singapore 138648, Singapore; [Dutertre, Charles-Antoine; Irac, Sergio Erdal] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore; [Khalilnezhad, Ahad; Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore; [van den Hoogen, Lucas L.; van Roon, Joel; Radstake, Timothy] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3584 CX Utrecht, Netherlands; [van den Hoogen, Lucas L.; van Roon, Joel; Radstake, Timothy] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, NL-3584 CX Utrecht, Netherlands; [Leong, Jing Yao; Albani, Salvatore; Ginhoux, Florent] Singhlth Duke NUS Acad Med Ctr, Translat Immunol Inst, 20 Coll Rd,Discovery Tower Level 8, Singapore 169856, Singapore; [Yong, Pearly Jean Ai] Singapore Hlth Serv Flow Cytometry Core Platform, 20 Coll Rd,Discovery Tower Level 10, Singapore 169856, Singapore; [Tan, Henry Kun Kiaang] KK Womens & Childrens Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Lim, Tony Kiat Hon] Singapore Gen Hosp, Dept Pathol, 20 Coll Rd, Singapore 169856, Singapore; [Karagianni, Panagiota; Tzioufas, Athanasios G.] Univ Athens, Sch Med, Dept Pathophysiol, 75 M Asias St, GR-11527 Athens, Greece; [Brody, Joshua] Icahn Sch Med Mt Sinai, Hess Ctr Sci & Med, New York, NY 10029 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; KK Women's & Children's Hospital; Singapore General Hospital; Athens Medical School; National & Kapodistrian University of Athens; Icahn School of Medicine at Mount Sinai	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network, 8A Biomed Grove,Immunos Bldg, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), Singhlth Duke NUS Acad Med Ctr, Translat Immunol Inst, 20 Coll Rd,Discovery Tower Level 8, Singapore 169856, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Larbi, Anis/ABE-5868-2020; TZIOUFAS, ATHANASIOS G/A-1690-2008; Malleret, Benoit/E-9159-2011; Howland, Shanshan W/I-2245-2014; Irac, Sergio Erdal/G-6690-2014; Chen, Jinmiao/ABE-5601-2021; Newell, Evan W/F-9711-2012	Malleret, Benoit/0000-0001-9658-7528; Howland, Shanshan W/0000-0003-4794-1564; Irac, Sergio Erdal/0000-0001-5622-1409; Newell, Evan W/0000-0002-2889-243X; Leong, Jing Yao/0000-0002-8651-9801; Tzioufas, Athanasios/0000-0001-6666-8642; Narang, Vipin/0000-0001-8669-9964; Becht, Etienne/0000-0003-1859-9202; Dutertre, Charles-Antoine/0000-0001-7950-3652	Singapore Immunology Network (SIgN); Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; BMRC [IAF 311006]; BMRC transition funds [H16/99/b0/011]	Singapore Immunology Network (SIgN)(Agency for Science Technology & Research (A*STAR)); Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore); BMRC(Agency for Science Technology & Research (A*STAR)); BMRC transition funds(Agency for Science Technology & Research (A*STAR))	We thank L. Robinson of Insight Editing London for critical review and editing of the manuscript and M.L. Ng, S.H. Tan, and T.B. Lu from the Electron Microscope Unit of NUS for their assistance. F. G. is an EMBO YIP awardee and is supported by Singapore Immunology Network (SIgN) core funding, as well as a Singapore National Research Foundation Senior Investigatorship (NRFI) NRF2016NRF-NRFI001-02. The CyTOF, bioinformatics, and immunogenomics platforms are part of the SIgN Immunomonitoring platform (supported by a BMRC IAF 311006 grant and BMRC transition funds #H16/99/b0/011).	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Becht E, 2019, BIOINFORMATICS, V35, P301, DOI 10.1093/bioinformatics/bty491; Brynjolfsson SF, 2016, INFLAMM BOWEL DIS, V22, P1803, DOI 10.1097/MIB.0000000000000822; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calzetti F, 2018, J ALLERGY CLIN IMMUN, V141, P2276, DOI 10.1016/j.jaci.2017.12.988; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; DiGiuseppe JA, 2018, CYTOM PART B-CLIN CY, V94, P588, DOI 10.1002/cyto.b.21588; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Dutertre CA, 2014, CELL IMMUNOL, V291, P3, DOI 10.1016/j.cellimm.2014.08.006; Dutertre CA, 2012, BLOOD, V120, P2259, DOI 10.1182/blood-2012-03-418681; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gunther P, 2019, BIORXIV, DOI [10.1101/658179, DOI 10.1101/658179]; Hamers AAJ, 2019, ARTERIOSCL THROM VAS, V39, P25, DOI 10.1161/ATVBAHA.118.311022; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Klarquist J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5045248; Kuryliszyn-Moskal A, 2007, ARCH IMMUNOL THER EX, V55, P179, DOI 10.1007/s00005-007-0017-7; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li HH, 2008, CLIN IMMUNOL, V129, P277, DOI 10.1016/j.clim.2008.07.006; Liao XF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6012715; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McInnes L., 2018, ARXIV180203426; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nguyen-Lefebvre AT, 2018, J CLIN INVEST, V128, P4870, DOI 10.1172/JCI98156; Nielepkowicz-Gozdzinska A, 2014, ARCH IMMUNOL THER EX, V62, P231, DOI 10.1007/s00005-014-0270-5; Parks CG, 2004, ANN RHEUM DIS, V63, P91, DOI 10.1136/ard.2003.007336; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Samy E, 2017, INT REV IMMUNOL, V36, P3, DOI 10.1080/08830185.2016.1276903; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Sun F, 2018, EXP THER MED, V15, P2611, DOI 10.3892/etm.2018.5711; Tan-Garcia A, 2017, J HEPATOL, V67, P490, DOI 10.1016/j.jhep.2017.04.023; Tang-Huau TL, 2019, SEMIN CELL DEV BIOL, V86, P44, DOI 10.1016/j.semcdb.2018.02.018; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573	59	176	178	7	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					573	+		10.1016/j.immuni.2019.08.008	http://dx.doi.org/10.1016/j.immuni.2019.08.008			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31474513	Bronze			2022-12-18	WOS:000486184600018
J	Nakaya, HI; Hagan, T; Duraisingham, SS; Lee, EK; Kwissa, M; Rouphael, N; Frasca, D; Gersten, M; Mehta, AK; Gaujoux, R; Li, GM; Gupta, S; Ahmed, R; Mulligan, MJ; Shen-Orr, S; Blomberg, BB; Subramaniam, S; Pulendran, B				Nakaya, Helder I.; Hagan, Thomas; Duraisingham, Sai S.; Lee, Eva K.; Kwissa, Marcin; Rouphael, Nadine; Frasca, Daniela; Gersten, Merril; Mehta, Aneesh K.; Gaujoux, Renaud; Li, Gui-Mei; Gupta, Shakti; Ahmed, Rafi; Mulligan, Mark J.; Shen-Orr, Shai; Blomberg, Bonnie B.; Subramaniam, Shankar; Pulendran, Bali			Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures	IMMUNITY			English	Article							YELLOW-FEVER VACCINE; T-CELL RESPONSES; HUMAN NK-CELLS; SEASONAL INFLUENZA; ANTIBODY-RESPONSES; DENDRITIC CELLS; ACTIVATION; HUMANS; DECONVOLUTION; MICRORNAS	Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar across multiple seasons and in diverse populations is unknown. We applied systems approaches to study immune responses in young, elderly, and diabetic subjects vaccinated with the seasonal influenza vaccine across five consecutive seasons. Signatures of innate immunity and plasmablasts correlated with and predicted influenza antibody titers at 1 month after vaccination with >80% accuracy across multiple seasons but were not associated with the longevity of the response. Baseline signatures of lymphocyte and monocyte inflammation were positively and negatively correlated, respectively, with antibody responses at 1 month. Finally, integrative analysis of microRNAs and transcriptomic profiling revealed potential regulators of vaccine immunity. These results identify shared vaccine-induced signatures across multiple seasons and in diverse populations and might help guide the development of next-generation vaccines that provide persistent immunity against influenza.	[Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30307 USA; [Hagan, Thomas; Gersten, Merril; Gupta, Shakti; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Duraisingham, Sai S.] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Immunol, Oxford OX3 7J, England; [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA; [Kwissa, Marcin] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Rouphael, Nadine; Mulligan, Mark J.] Emory Univ, Hope Clin, Atlanta, GA 30030 USA; [Frasca, Daniela; Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Mehta, Aneesh K.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30307 USA; [Gaujoux, Renaud; Shen-Orr, Shai] Technion Israel Inst Technol, Fac Med, Dept Immunol, IL-3109601 Haifa, Israel; [Li, Gui-Mei; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Li, Gui-Mei; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	Universidade de Sao Paulo; Emory University; University of California System; University of California San Diego; Oxford University Hospitals NHS Foundation Trust; University System of Georgia; Georgia Institute of Technology; University of Chicago; Emory University; University of Miami; Emory University; Technion Israel Institute of Technology; Emory University; Emory University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr MC 0412, La Jolla, CA 92093 USA.	shankar@ucsd.edu; bpulend@emory.edu	Mehta, Aneesh/B-8054-2012; Nakaya, Helder I/A-1397-2010; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder/AAF-1738-2020; Mulligan, Mark/V-9275-2019	Mehta, Aneesh/0000-0002-6552-9162; Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Shen-Orr, Shai/0000-0002-6991-7736; Pulendran, Bali/0000-0001-6517-4333; Rouphael, Nadine/0000-0002-2512-7919	NIH [U19AI090023, U19AI057266, HHSN272201400004C, U54AI057157, R37AI48638, R37DK057665]; NSF [STC-0939370]; CNPq (Brazilian Research Council) research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R37AI048638, U19AI090023, U54AI057157, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023717] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CNPq (Brazilian Research Council) research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Mary Bower, Srilatha Edugupanti, and the Hope Clinic Staff who assisted with the clinical work. We also thank Emory Immunology/Flow Cytometry Core for technical assistance. H.I.N. receives a CNPq (Brazilian Research Council) research fellowship. This work was supported by NIH grants U19AI090023 (B.P.), U19AI057266 (R.A. and B.P.), HHSN272201400004C (B.P.), U54AI057157 (B.P.), R37AI48638 (B.P.), and R37DK057665 (B.P.) and NSF Grant STC-0939370 (S.S.).	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Almeida-Oliveira A, 2011, HUM IMMUNOL, V72, P319, DOI 10.1016/j.humimm.2011.01.009; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Brooks JP, 2010, ANN OPER RES, V174, P147, DOI 10.1007/s10479-008-0424-0; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Cao RG, 2014, J INFECT DIS, V210, P224, DOI 10.1093/infdis/jiu079; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Frasca D, 2014, EXP GERONTOL, V54, P116, DOI 10.1016/j.exger.2014.01.004; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Seidman JC, 2012, INFLUENZA OTHER RESP, V6, P52, DOI 10.1111/j.1750-2659.2011.00268.x; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Solana R, 2014, CURR OPIN IMMUNOL, V29, P56, DOI 10.1016/j.coi.2014.04.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan SJ, 2010, EXPERT REV VACCINES, V9, P1127, DOI [10.1586/erv.10.117, 10.1586/ERV.10.117]; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023698; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491	52	176	176	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1186	1198		10.1016/j.immuni.2015.11.012	http://dx.doi.org/10.1016/j.immuni.2015.11.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682988	Green Accepted, Bronze			2022-12-18	WOS:000366846600021
J	Qiao, Y; Giannopoulou, EG; Chan, CH; Park, SH; Gong, SC; Chen, J; Hu, XY; Elemento, O; Ivashkiv, LB				Qiao, Yu; Giannopoulou, Eugenia G.; Chan, Chun Hin; Park, Sung-ho; Gong, Shiaoching; Chen, Janice; Hu, Xiaoyu; Elemento, Olivier; Ivashkiv, Lionel B.			Synergistic Activation of Inflammatory Cytokine Genes by Interferon-gamma-Induced Chromatin Remodeling and Toll-like Receptor Signaling	IMMUNITY			English	Article							IFN-GAMMA; TRANSCRIPTION FACTORS; JAK-STAT; MACROPHAGE; PATHWAYS; LANDSCAPE; ENHANCERS; INTEGRATION; INHIBITION; MECHANISMS	Synergistic activation of inflammatory cytokine genes by interferon-gamma (IFN-gamma) and Toll-like receptor (TLR) signaling is important for innate immunity and inflammatory disease pathogenesis. Enhancement of TLR signaling, a previously proposed mechanism, is insufficient to explain strong synergistic activation of cytokine production in human macrophages. Rather, we found that IFN-gamma induced sustained occupancy of transcription factors STAT1, IRF-1, and associated histone acetylation at promoters and enhancers at the TNF, IL6, and IL12B loci. This priming of chromatin did not activate transcription but greatly increased and prolonged recruitment of TLR4-induced transcription factors and RNA polymerase II to gene promoters and enhancers. Priming sensitized cytokine transcription to suppression by Jak inhibitors. Genome-wide analysis revealed pervasive priming of regulatory elements by IFN-gamma and linked coordinate priming of promoters and enhancers with synergistic induction of transcription. Our results provide a synergy mechanism whereby IFN-gamma creates a primed chromatin environment to augment TLR-induced gene transcription.	[Qiao, Yu; Chan, Chun Hin; Park, Sung-ho; Gong, Shiaoching; Chen, Janice; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA; [Qiao, Yu; Chan, Chun Hin; Park, Sung-ho; Gong, Shiaoching; Chen, Janice; Hu, Xiaoyu; Ivashkiv, Lionel B.] Hosp Special Surg, Genom Ctr, New York, NY 10021 USA; [Giannopoulou, Eugenia G.; Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Giannopoulou, Eugenia G.; Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Hu, Xiaoyu; Ivashkiv, Lionel B.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Hosp Special Surg, Arthritis & Tissue Degenerat Program, New York, NY 10021 USA.	ivashkivl@hss.edu	Hu, Xiaoyu/D-5403-2017; Giannopoulou, Evgenia/K-9576-2019	Hu, Xiaoyu/0000-0002-4289-6998; 	NIH; Arthritis Foundation; Leonard Tow Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044938, R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR050401, R01AR056729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Leonard Tow Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Weill Cornell Medical College Epigenomics Core and A. Melnick laboratory for advice about ChIP-seq, A. Pernis and I. Rogatsky for review of the manuscript, and R. Prinjha of GlaxoSmithKline for providing I-BET. This work was supported by grants from the NIH (L. B. I.), Arthritis Foundation (Y.Q.) and the Leonard Tow Foundation to the HSS Genomics Center.	ADAMS DO, 1987, IMMUNOL REV, V97, P5, DOI 10.1111/j.1600-065X.1987.tb00514.x; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pattison MJ, 2012, J IMMUNOL, V189, P2784, DOI 10.4049/jimmunol.1200310; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Smale ST, 2012, CURR OPIN IMMUNOL, V24, P51, DOI 10.1016/j.coi.2011.12.008; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; St Clair EW, 2009, CURR OPIN IMMUNOL, V21, P648, DOI 10.1016/j.coi.2009.09.008; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168	43	176	181	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					454	469		10.1016/j.immuni.2013.08.009	http://dx.doi.org/10.1016/j.immuni.2013.08.009			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24012417	Green Accepted, Bronze			2022-12-18	WOS:000330949600010
J	Chang, SH; Reynolds, JM; Pappu, BP; Chen, G; Martinez, GJ; Dong, C				Chang, Seon Hee; Reynolds, Joseph M.; Pappu, Bhanu P.; Chen, Guangjie; Martinez, Gustavo J.; Dong, Chen			Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E	IMMUNITY			English	Article							T-CELLS; NUCLEAR RECEPTORS; FAMILY CYTOKINES; ADAPTER PROTEIN; HELPER-CELLS; ROR-GAMMA; DIFFERENTIATION; INFLAMMATION; GENERATION; T(H)17	Although several interleukin-17 (IL-17) family members and their receptors have been recently appreciated as important regulators in inflammatory diseases, the function of other IL-17 cytokines and IL-17 receptor-like molecules is unclear. Here we show that an IL-17 cytokine family member, IL-17C, was induced in a Th17 cell-dependent autoimmune disease and was required for its pathogenesis. IL-17C bound to IL-17RE, a member of IL-17 receptor family whose full-length isoform was selectively expressed in Th17 cells and signaled via an IL-17RA-RE receptor complex and the downstream adaptor Act1 IL-17C-IL-17RE induced the expression of a nuclear IkappaB family member, I kappa B zeta, in Th17 cells to potentiate the Th17 cell response. Thus, our work has identified a cytokine-receptor pair with important function in regulating proinflammatory responses. This pathway may be targeted to treat autoimmune diseases.	[Chang, Seon Hee; Reynolds, Joseph M.; Pappu, Bhanu P.; Chen, Guangjie; Martinez, Gustavo J.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Chang, Seon Hee; Reynolds, Joseph M.; Pappu, Bhanu P.; Chen, Guangjie; Martinez, Gustavo J.; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009; Chang, Seon Hee/AAQ-9521-2020	dong, chen/0000-0002-0084-9130; Chang, Seon Hee/0000-0002-9389-508X; Reynolds, Joseph/0000-0003-3490-0544; Martinez, Gustavo/0000-0003-0178-3329	NIH; NCI; Research Trust; Olga and Harry Wiess Distinguished University Chair in Cancer Research of the University of Texas MD Anderson Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Trust; Olga and Harry Wiess Distinguished University Chair in Cancer Research of the University of Texas MD Anderson Cancer Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank MD Anderson Genetic Engineering Mouse Facility for their assistance in generation of Il17c gene-targeted animals, K. Murphy for RV-GFP vector, D. Littman for the CD4 minigene construct, and the C.D. lab members for their help. The work is supported by research grants from NIH (to C.D.). J.M.R. receives an NCI training grant and C.D. receives a Research Trust Fellowship, is Olga and Harry Wiess Distinguished University Chair in Cancer Research of the University of Texas MD Anderson Cancer Center, and is a Leukemia and Lymphoma Society Scholar.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li TS, 2006, CELL SIGNAL, V18, P1287, DOI 10.1016/j.cellsig.2005.10.010; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pappu BP, 2008, PHARMACOL THERAPEUT, V117, P374, DOI 10.1016/j.pharmthera.2007.12.003; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	40	176	195	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					611	621		10.1016/j.immuni.2011.09.010	http://dx.doi.org/10.1016/j.immuni.2011.09.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	21982598	Bronze, Green Accepted			2022-12-18	WOS:000296657700019
J	Ng, SYM; Yoshida, T; Zhang, JW; Georgopoulos, K				Ng, Samuel Yao-Ming; Yoshida, Toshimi; Zhang, Jiangwen; Georgopoulos, Katia			Genome-wide Lineage-Specific Transcriptional Networks Underscore Ikaros-Dependent Lymphoid Priming in Hematopoietic Stem Cells	IMMUNITY			English	Article							CHROMATIN REMODELER MI-2-BETA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW; PROGENITOR CELLS; MULTIPOTENT PROGENITORS; GENE-EXPRESSION; SELF-RENEWAL; COMMITMENT; RECEPTOR; PROTEINS	The mechanisms regulating lineage potential during early hematopoiesis were investigated. First, a cascade of lineage-affiliated gene expression signatures, primed in hematopoietic stem cells (HSCs) and differentially propagated in lineage-restricted progenitors, was identified. Lymphoid transcripts were primed as early as the HSC, together with myeloid and erythroid transcripts. Although this multilineage priming was resolved upon subsequent lineage restrictions, an unexpected cosegregation of lymphoid and myeloid gene expression and potential past a nominal myeloid restriction point was identified. Finally, we demonstrated that whereas the zinc finger DNA-binding factor Ikaros was required for induction of lymphoid lineage priming in the HSC, it was also necessary for repression of genetic programs compatible with self-renewal and multipotency downstream of the HSC. Taken together, our studies provide new insight into the priming and restriction of lineage potentials during early hematopoiesis and identify Ikaros as a key bivalent regulator of this process.	[Ng, Samuel Yao-Ming; Yoshida, Toshimi; Georgopoulos, Katia] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Zhang, Jiangwen] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Georgopoulos, K (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	katia.georgopoulos@cbrc2.mgh.harvard.edu	Yoshida, Toshimi/GSN-8717-2022; Zhang, Jiangwen/A-7654-2013	Yoshida, Toshimi/0000-0001-7080-6913; Zhang, Jiangwen/0000-0002-2911-8446	National Institutes of Health [NIH-R37-AI33062-16, NIH-R01-AI42254-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042254, R37AI033062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants NIH-R37-AI33062-16 and NIH-R01-AI42254-11 to K.G. We thank Bob Czyzewski for mouse husbandry, and we thank the K.G. lab and Bruce Morgan for a critical review of the manuscript.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Alvarez JD, 2000, GENE DEV, V14, P521; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Georgopoulos K, 2009, NEW ENGL J MED, V360, P524, DOI 10.1056/NEJMe0809819; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kioussis D, 2007, SCIENCE, V317, P620, DOI 10.1126/science.1143777; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kumar P, 2002, BIOCHEM J, V362, P533, DOI 10.1042/0264-6021:3620533; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	56	176	179	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					493	507		10.1016/j.immuni.2009.01.014	http://dx.doi.org/10.1016/j.immuni.2009.01.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19345118	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000265319000007
J	Birnberg, T; Bar-On, L; Sapoznikov, A; Caton, ML; Cervantes-Barragan, L; Makia, D; Krauthgamer, R; Brenner, O; Ludewig, B; Brockschnieder, D; Riethmacher, D; Reizis, B; Jung, S				Birnberg, Tal; Bar-On, Liat; Sapoznikov, Anita; Caton, Michele L.; Cervantes-Barragan, Luisa; Makia, Divine; Krauthgamer, Rita; Brenner, Ori; Ludewig, Burkhard; Brockschnieder, Damian; Riethmacher, Dieter; Reizis, Boris; Jung, Steffen			Lack of Conventional Dendritic Cells Is Compatible with Normal Development and T Cell Homeostasis, but Causes Myeloid Proliferative Syndrome	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELLS; IN-VIVO; BONE-MARROW; FLT3 LIGAND; ANTIGEN PRESENTATION; CENTRAL TOLERANCE; MYELOPROLIFERATIVE DISORDER; POSITIVE SELECTION	Dendritic cells are critically involved in the promotion and regulation of T cell responses. Here, we report a mouse strain that lacks conventional CD11c(hi) dendritic cells (cDCs) because of constitutive cell-type specific expression of a suicide gene. As expected, cDC-less mice failed to mount effective T cell responses resulting in impaired viral clearance. In contrast, neither thymic negative selection nor T regulatory cell generation or T cell homeostasis were markedly affected. Unexpectedly, cDC-less mice developed a progressive myeloproliferative disorder characterized by prominent extramedullary hematopoiesis and increased serum amounts of the cytokine Flt3 ligand. Our data identify a critical role of cDCs in the control of steady-state hematopoiesis, revealing a feedback loop that links peripheral cDCs to myelogenesis through soluble growth factors, such as Flt3 ligand.	[Caton, Michele L.; Reizis, Boris] Columbia Univ, Dept Microbiol, Med Ctr, New York, NY 10032 USA; [Birnberg, Tal; Bar-On, Liat; Sapoznikov, Anita; Krauthgamer, Rita; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Brockschnieder, Damian] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Brenner, Ori] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Riethmacher, Dieter] Univ Southampton, SGH, Div Human Genet, Southampton SO16 6YD, Hants, England; [Cervantes-Barragan, Luisa; Makia, Divine; Ludewig, Burkhard] Kantonal Hosp St Gallen, Res Dept, CH-9007 St Gallen, Switzerland	Columbia University; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of Southampton; Kantonsspital St. Gallen	Reizis, B (corresponding author), Columbia Univ, Dept Microbiol, Med Ctr, New York, NY 10032 USA.	bvr2101@columbia.edu; s.jung@weizmann.ac.il	Riethmacher, Dieter/AAB-8690-2022; Jung, Steffen/K-1409-2012; Riethmacher, Dieter/AAP-2227-2021; Riethmacher, Dieter/A-6242-2010	Jung, Steffen/0000-0003-4290-5716; Riethmacher, Dieter/0000-0002-4206-5529; Sapoznikov, Anita/0000-0002-2543-7837; Reizis, Boris/0000-0003-1140-7853	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067804, T32AI007525] Funding Source: NIH RePORTER; NIAID NIH HHS [AI067804, AI007525] Funding Source: Medline; NICHD NIH HHS [HD055165] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Brasel K, 1996, BLOOD, V88, P2004, DOI 10.1182/blood.V88.6.2004.bloodjournal8862004; Brocker T, 1999, J LEUKOCYTE BIOL, V66, P331, DOI 10.1002/jlb.66.2.331; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Cong YZ, 2005, J IMMUNOL, V174, P2787, DOI 10.4049/jimmunol.174.5.2787; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gruber A, 2005, J IMMUNOL, V175, P201, DOI 10.4049/jimmunol.175.1.201; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Li L, 2008, BLOOD, V111, P3849, DOI 10.1182/blood-2007-08-109942; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Maraskovsky E, 1997, ADV EXP MED BIOL, V417, P33; Mattei F, 2006, BLOOD, V108, P609, DOI 10.1182/blood-2005-11-4490; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Probst HC, 2005, J IMMUNOL, V174, P3920, DOI 10.4049/jimmunol.174.7.3920; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Sapoznikov A, 2008, IMMUNOL CELL BIOL, V86, P409, DOI 10.1038/icb.2008.23; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; SPRENT J, 1992, BONE MARROW TRANSPL, V10, P5; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428	70	176	182	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					986	997		10.1016/j.immuni.2008.10.012	http://dx.doi.org/10.1016/j.immuni.2008.10.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19062318	Bronze			2022-12-18	WOS:000262012400017
J	Dorner, T; Radbruch, A				Doerner, Thomas; Radbruch, Andreas			Antibodies and B cell memory in viral immunity	IMMUNITY			English	Review							LIVED PLASMA-CELLS; CD8 T-CELLS; FOLLICULAR DENDRITIC CELLS; VACCINIA VIRUS; IMMUNOLOGICAL MEMORY; SMALLPOX VACCINATION; PROTECTIVE IMMUNITY; HUMORAL IMMUNITY; DEFICIENT MICE; BONE-MARROW	Humoral immunity, in particular secreted neutralizing antibodies, is of central importance to protect the body against acutely cytopathic viruses, whereas noncytopathic viruses have found ways of balanced coexistence with the immune system to avoid antibody-mediated elimination. There is evidence that polyspecific "natural" antibodies provide early protection, independent of T cell help. If that line of defense is crossed, T cell-dependent immune responses then generate a humoral memory provided by long-lived plasma cells secreting specific antibodies of adapted avidity and function, i.e., isotype, even in the absence of virus. Secreted protective antibodies of humoral memory provide an efficient line of defense against reinfection and are backed up by specific B and T memory cells of reactive memory. Whereas humoral memory has developed effective antiviral protection, some viruses (i.e., HIV) have managed to develop specific evasion strategies to escape it. Thus, coevolution provides us with some insight into just how substantial antiviral antibodies and memory B cell are in protecting the host from virus infection.	Charite Univ Med Berlin, D-10117 Berlin, Germany; Deutsch Rheumaforsch Zentrum Berlin, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Radbruch, A (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.	radbruch@drfz.de		Radbruch, Andreas/0000-0001-5753-0000				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Anderson SM, 2006, J IMMUNOL, V176, P4515, DOI 10.4049/jimmunol.176.8.4515; Bachmann MF, 2004, EUR J IMMUNOL, V34, P317, DOI 10.1002/eji.200324717; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bartlett JG, 2003, CLIN INFECT DIS, V36, P468, DOI 10.1086/368093; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Beckett S, 2002, CALL CENT MAG, V15, P8; Behring E, 1900, DEUT MED WOCHENSCHR, V26, P29, DOI 10.1055/s-0029-1203658; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; COULIE PG, 1985, EUR J IMMUNOL, V15, P638, DOI 10.1002/eji.1830150620; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Durandy A, 2004, ADV IMMUNOL, V82, P295, DOI 10.1016/S0065-2776(04)82007-8; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gray D, 1996, IMMUNOL REV, V150, P45, DOI 10.1111/j.1600-065X.1996.tb00695.x; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hammarlund E, 2005, NAT MED, V11, P1005, DOI 10.1038/nm1273; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hebeis BJ, 2004, J EXP MED, V199, P593, DOI 10.1084/jem.20030091; Hofer T, 2006, IMMUNOL REV, V211, P295, DOI 10.1111/j.0105-2896.2006.00380.x; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Jones-Trower A, 2005, VIROLOGY, V343, P128, DOI 10.1016/j.virol.2005.08.008; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; MACK TM, 1972, AM J TROP MED HYG, V21, P214, DOI 10.4269/ajtmh.1972.21.214; MAKELA O, 1962, J EXP MED, V115, P231, DOI 10.1084/jem.115.1.231; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mascola JR, 2003, NAT MED, V9, P393, DOI 10.1038/nm0403-393; MILLER JJ, 1964, J IMMUNOL, V92, P673; Mohamadzadeh M, 2006, VIRAL IMMUNOL, V19, P602, DOI 10.1089/vim.2006.19.602; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Naniche D, 2004, J INFECT DIS, V190, P1387, DOI 10.1086/424571; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; PEIRCE ER, 1958, LANCET, V2, P635; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Raftery MJ, 2006, J IMMUNOL, V177, P6207, DOI 10.4049/jimmunol.177.9.6207; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rock MT, 2005, J IMMUNOL, V174, P3757, DOI 10.4049/jimmunol.174.6.3757; SCHITTEK B, 1992, J EXP MED, V176, P427, DOI 10.1084/jem.176.2.427; Slifka MK, 1996, ANN NY ACAD SCI, V797, P166, DOI 10.1111/j.1749-6632.1996.tb52958.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slifka MK, 2004, CURR OPIN IMMUNOL, V16, P443, DOI 10.1016/j.coi.2004.05.013; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Terajima M, 2003, J EXP MED, V197, P927, DOI 10.1084/jem.20022222; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whitmire JK, 1996, J VIROL, V70, P8375, DOI 10.1128/JVI.70.12.8375-8381.1996; WOFSY D, 1985, J IMMUNOL, V135, P1698; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265; ZAGURY D, 1991, LANCET, V338, P694, DOI 10.1016/0140-6736(91)91269-Z; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	90	176	184	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2007	27	3					384	392		10.1016/j.immuni.2007.09.002	http://dx.doi.org/10.1016/j.immuni.2007.09.002			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892847	Bronze			2022-12-18	WOS:000249843400004
J	HOLLANDER, GA; SIMPSON, SJ; MIZOGUCHI, E; NICHOGIANNOPOULOU, A; SHE, JA; GUTIERREZRAMOS, JC; BHAN, AK; BURAKOFF, SJ; WANG, BP; TERHORST, C				HOLLANDER, GA; SIMPSON, SJ; MIZOGUCHI, E; NICHOGIANNOPOULOU, A; SHE, JA; GUTIERREZRAMOS, JC; BHAN, AK; BURAKOFF, SJ; WANG, BP; TERHORST, C			SEVERE COLITIS IN MICE WITH ABERRANT THYMIC SELECTION	IMMUNITY			English	Article							INFLAMMATORY BOWEL-DISEASE; CD4+ T-CELLS; INDUCE WASTING DISEASE; INTRAEPITHELIAL LYMPHOCYTES; INTESTINAL EPITHELIUM; NEGATIVE SELECTION; SELF-TOLERANCE; RECEPTOR; GUT; EXPRESSION	Tg epsilon 26 mice display an arrest very early in T cell development that has a profound effect on the architecture of thymic stromal cells. We have recently demonstrated that transplantation of wild-type bone marrow cells restores the thymic microenvironment of fetal but not adult Tg epsilon 26 mice. Here, we report that T cell-reconstituted adult Tg epsilon 26 mice develop a spontaneous wasting syndrome characterized by extensive inflammation of the colon, resembling human ulcerative colitis. Colitis in these animals was marked by substantial infiltration of the colon by activated thymus-derived CD4(+) T cells. Importantly, bone marrow-transplanted Tg epsilon 26 mice previously engrafted with a fetal Tg epsilon 26 thymus did not develop colitis. These results suggest that T cells selected in an aberrant thymic microenvironment contain a population of cells able to induce severe colitis that can be prevented by T cells that have undergone normal thymic development.	BETH ISRAEL HOSP, DIV IMMUNOL, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, CTR BLOOD RES, BOSTON, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	HOLLANDER, GA (corresponding author), BETH ISRAEL HOSP, DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA.			Hollander, Georg/0000-0002-8790-0874	NATIONAL CANCER INSTITUTE [P01CA039542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047677, P30DK043351] Funding Source: NIH RePORTER; NCI NIH HHS [5 PO1 CA39542-09] Funding Source: Medline; NIDDK NIH HHS [P30 DK43351, R01 DK47677-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT TA, 1992, J EXP MED, V175, P65, DOI 10.1084/jem.175.1.65; BARRETT TA, 1993, MUCOSAL IMMUNOLOGY I, P115; BIRKELAND ML, 1988, J MOL CELL IMMUNOL, V4, P71; BLAND P, 1988, IMMUNOL TODAY, V9, P174, DOI 10.1016/0167-5699(88)91293-5; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; BRADLEY LM, 1992, J IMMUNOL, V148, P324; BRYNSKOV J, 1992, SCAND J GASTROENTERO, V27, P897, DOI 10.3109/00365529209000160; CERFBENSUSSAN N, 1984, J IMMUNOL, V132, P2244; CERFBENSUSSAN N, 1983, J IMMUNOL, V130, P2615; CROITORU K, 1992, FASEB J, V6, pA1707; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; KLEIN JR, 1993, MUCOSAL IMMUNOLOGY I, P33; KROEMER G, 1992, IMMUNOL TODAY, V13, P401, DOI 10.1016/0167-5699(92)90090-T; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LEE WT, 1990, J IMMUNOL, V144, P3288; LEFRANCOIS L, 1994, CURRENT PROTOCOLS IM; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; PFEFFER K, 1994, ANNU REV IMMUNOL, V12, P367, DOI 10.1146/annurev.immunol.12.1.367; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; POUSSIER P, 1993, J EXP MED, V178, P1947, DOI 10.1084/jem.178.6.1947; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; POWRIE F, 1990, CURR TOP MICROBIOL, V159, P79; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; SARTOR RB, 1990, CAN J GASTROENTEROL, V4, P271; SPARSHOTT SM, 1991, EUR J IMMUNOL, V21, P993, DOI 10.1002/eji.1830210420; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WANG BP, 1995, INT IMMUNOL, V7, P435, DOI 10.1093/intimm/7.3.435; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; WU M, 1991, J EXP MED, V174, P213, DOI 10.1084/jem.174.1.213	46	176	179	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1995	3	1					27	38		10.1016/1074-7613(95)90156-6	http://dx.doi.org/10.1016/1074-7613(95)90156-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RK868	7621076	Bronze			2022-12-18	WOS:A1995RK86800005
J	Herndler-Brandstetter, D; Ishigame, H; Shinnakasu, R; Plajer, V; Stecher, C; Zhao, J; Lietzenmayer, M; Kroehling, L; Takumi, A; Kometani, K; Inoue, T; Kluger, Y; Kaech, SM; Kurosaki, T; Okada, T; Flavell, RA				Herndler-Brandstetter, Dietmar; Ishigame, Harumichi; Shinnakasu, Ryo; Plajer, Valerie; Stecher, Carmen; Zhao, Jun; Lietzenmayer, Melanie; Kroehling, Lina; Takumi, Akiko; Kometani, Kohei; Inoue, Takeshi; Kluger, Yuval; Kaech, Susan M.; Kurosaki, Tomohiro; Okada, Takaharu; Flavell, Richard A.			KLRG1(+) Effector CD8(+) T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity	IMMUNITY			English	Article							TRANSCRIPTION FACTORS; TERMINAL DIFFERENTIATION; LYMPHOID ORGANS; SUBSETS; EXPRESSION; CHROMATIN; ANTIGEN; REPRESSION; POPULATION; INDUCTION	Protective immunity against pathogens depends on the efficient generation of functionally diverse effector and memory T lymphocytes. However, whether plasticity during effector-to-memory CD8(+) T cell differentiation affects memory lineage specification and functional versatility remains unclear. Using genetic fate mapping analysis of highly cytotoxic KLRG1(+) effector CD8(+) T cells, we demonstrated that KLRG1(+) cells receiving intermediate amounts of activating and inflammatory signals downregulated KLRG1 during the contraction phase in a Bach2-dependent manner and differentiated into all memory T cell linages, including CX(3)CR1(int) peripheral memory cells and tissue-resident memory cells. "ExKLRG1" memory cells retained high cytotoxic and proliferative capacity distinct from other populations, which contributed to effective anti-influenza and anti-tumor immunity. Our work demonstrates that developmental plasticity of KLRG1(+) effector CD8(+) T cells is important in promoting functionally versatile memory cells and long-term protective immunity.	[Herndler-Brandstetter, Dietmar; Ishigame, Harumichi; Plajer, Valerie; Stecher, Carmen; Zhao, Jun; Lietzenmayer, Melanie; Kroehling, Lina; Kaech, Susan M.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Ishigame, Harumichi; Takumi, Akiko; Okada, Takaharu] RIKEN Ctr Integrat Med Sci, Lab Tissue Dynam, Yokohama, Kanagawa 2300045, Japan; [Shinnakasu, Ryo; Kometani, Kohei; Kurosaki, Tomohiro] RIKEN Ctr Integrat Med Sci, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan; [Shinnakasu, Ryo; Inoue, Takeshi; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Suita, Osaka 5650871, Japan; [Zhao, Jun; Kluger, Yuval] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06511 USA; [Zhao, Jun; Kluger, Yuval] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Kluger, Yuval] Yale Univ, Appl Math Program, New Haven, CT 06511 USA; [Okada, Takaharu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Okada, Takaharu] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Kometani, Kohei; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Herndler-Brandstetter, Dietmar] Med Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria	Yale University; RIKEN; RIKEN; Osaka University; Yale University; Yale University; Yale University; Japan Science & Technology Agency (JST); Yokohama City University; Howard Hughes Medical Institute; Yale University; Medical University of Vienna	Ishigame, H; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Ishigame, H; Okada, T (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Tissue Dynam, Yokohama, Kanagawa 2300045, Japan.; Okada, T (corresponding author), Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan.; Okada, T (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	harumichi.ishigame@riken.jp; takaharu.okada@riken.jp; richard.flavell@yale.edu	Zhao, Jun/AAT-2086-2021	Stecher, Carmen/0000-0002-1308-4544; Kometani, Kohei/0000-0003-4281-4371	Erwin Schrodinger Fellowship (Austrian Science Fund) [J3220-B19]; Ministry of Education, Culture, Sports, Science, and Technology [16K19166, 22113006, 26221306, 21229007]; Austrian Marshall Plan Foundation Fellowship; University of Vienna KWA Scholarship; NIH [1R01HG008383-01A1]; Japan Science and Technology Agency [CREST J098501018]; Japan Science and Technology Agency (PRESTO); Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066232] Funding Source: NIH RePORTER	Erwin Schrodinger Fellowship (Austrian Science Fund); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Austrian Marshall Plan Foundation Fellowship; University of Vienna KWA Scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Science and Technology Agency (PRESTO)(Japan Science & Technology Agency (JST)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Alderman, C. Lieber, E. Hughes-Picard, and P. Musco for administrative assistance, J. Stein, L. Evangelisti, and C. Hughes for generating Klrg1<SUP>Cre</SUP> mice, Y. Harada and L. Yun-Cai for providing Foxo1-CA cDNA, S. Fujii for providing B16-OVA, P. Ranney, G. Lyon, Z. Tobiasova, and L. Borelli for technical assistance, and members of the Flavell and Okada lab for helpful discussions. This work was supported by an Erwin Schrodinger Fellowship (Austrian Science Fund; J3220-B19 to D.H.-B.), the Ministry of Education, Culture, Sports, Science, and Technology (16K19166 to H.I., 22113006 to T.O., and 26221306 and 21229007 to T.K.), an Austrian Marshall Plan Foundation Fellowship (V.P.), a University of Vienna KWA Scholarship (C.S.), NIH grant 1R01HG008383-01A1 (Y.K.), Japan Science and Technology Agency (CREST J098501018 to T.K. and PRESTO to T.O.), and the Howard Hughes Medical Institute (R.A.F.).	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Endrizzi BT, 2003, INT IMMUNOL, V15, P1341, DOI 10.1093/intimm/dxg133; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SK, 1999, J IMMUNOL, V163, P4125; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuwahara M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12596; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Mackay LK, 2017, TRENDS IMMUNOL, V38, P94, DOI 10.1016/j.it.2016.11.004; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Martin M., 2011, EMBNET J, V17, P5, DOI 10.14806/ej.17.1.200; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926; Plumlee CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12264; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Xin A, 2016, NAT IMMUNOL, V17, P422, DOI 10.1038/ni.3410; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	175	176	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					716	+		10.1016/j.immuni.2018.03.015	http://dx.doi.org/10.1016/j.immuni.2018.03.015			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29625895	Bronze, Green Accepted			2022-12-18	WOS:000430198900018
J	Ouyang, WM; Beckett, O; Ma, Q; Li, MO				Ouyang, Weiming; Beckett, Omar; Ma, Qian; Li, Ming O.			Transforming Growth Factor-beta Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development	IMMUNITY			English	Article							TGF-BETA; CENTRAL TOLERANCE; IN-VIVO; FOXP3 EXPRESSION; SELF-PEPTIDE; APOPTOSIS; ANTIGEN; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION	Thymus-derived naturally occurring regulatory T (nTreg) cells are necessary for immunological self-tolerance. nTreg cell development is instructed by the T cell receptor and can be induced by agonist antigens that trigger T cell-negative selection. How T cell deletion is regulated so that nTreg cells are generated is unclear. Here we showed that transforming growth factor-beta (TGF-beta) signaling protected nTreg cells and antigen-stimulated conventional T cells from apoptosis. Enhanced apoptosis of TGF-beta receptor-deficient nTreg cells was associated with high expression of proapoptotic proteins Bim, Box, and Bak and low expression of the antiapoptotic protein Bcl-2. Ablation of Bim in mice corrected the nTreg cell development and homeostasis defects. Our results suggest that nTreg cell commitment is independent of TGF-beta signaling. Instead, TGF-beta promotes nTreg cell survival by antagonizing T cell negative selection. These findings reveal a critical function for TGF-beta in control of autoreactive T cell fates with important implications for understanding T cell self-tolerance mechanisms.	[Ouyang, Weiming; Beckett, Omar; Ma, Qian; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org		li, ming/0000-0002-1383-0535	NIAMS [KO1 AR053595]; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053595, R01AR060723] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell, W. Heath, and A. Singer for providing critical mouse strains and A. Rudensky, E. Pamer, D. Sant'Angelo, M. Huse, Y. Zheng, and R. Jacobson for discussions. The projects described were supported by KO1 AR053595 from NIAMS (M.O.L.) and an Arthritis Foundation Investigator Award (M.O.L.). M.O.L. is a Rita Allen Foundation Scholar.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DiPaolo RJ, 2009, EUR J IMMUNOL, V39, P234, DOI 10.1002/eji.200838772; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Ludwinski MW, 2009, J CLIN INVEST, V119, P1706, DOI 10.1172/JCI37619; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanjabi S, 2009, IMMUNITY, V31, P131, DOI 10.1016/j.immuni.2009.04.020; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	50	175	181	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					642	653		10.1016/j.immuni.2010.04.012	http://dx.doi.org/10.1016/j.immuni.2010.04.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20471291	Bronze, Green Accepted			2022-12-18	WOS:000278280500010
J	Barrett, NA; Austen, KF				Barrett, Nora A.; Austen, K. Frank			Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation	IMMUNITY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; KILLER T-CELLS; HUMAN MAST-CELLS; FC-EPSILON-RI; CHRONIC ALLERGIC INFLAMMATION; ANTIGEN-PRESENTING CELLS; HUMAN EPITHELIAL-CELLS; RESPONSES IN-VIVO; DENDRITIC CELLS; HUMAN BASOPHILS	Activated mast cells, eosinophils, and basophils infiltrate the airways of asthmatics as a result of an overexuberant T helper 2 (Th2) cell immune response that drives the production of IgE, primes mast cells and basophils, and promotes tissue eosinophilia and mast cell hyperplasia. Recent evidence demonstrates that these innate effectors can be activated outside of this classical Th2 cell paradigm and that they have additional roles in promoting the development of innate and adaptive pulmonary inflammation. There is also an appreciation for the role of airway epithelial cells in orchestrating allergic pulmonary inflammation. Emerging data from basic research highlight the involvement of many unique pathways in the inflammation triggered by complex native allergens and microbes at the airway mucosal surface. Here, we review the role of effector cells and airway epithelial cells in augmenting and, at times, bypassing traditional Th2 cell-mediated allergic inflammation.	[Barrett, Nora A.; Austen, K. Frank] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barrett, Nora A.; Austen, K. Frank] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Barrett, NA (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	nbarrett@partners.org; fausten@rics.bwh.harvard.edu			National Institutes of Health [HL-36110]; American Academy of Allergy, Asthma, and Immunology/Altana; Joycelyn C. Austen Fund for the Career Development of Women Physician-Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI080948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Allergy, Asthma, and Immunology/Altana; Joycelyn C. Austen Fund for the Career Development of Women Physician-Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank H. Katz for his critical reading of the manuscript. This work was supported by the National Institutes of Health grant HL-36110, by the American Academy of Allergy, Asthma, and Immunology/Altana grant for advanced fellows-in-training, and by the Joycelyn C. Austen Fund for the Career Development of Women Physician-Scientists.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bradding P, 2003, CURR OPIN ALLERGY CL, V3, P45, DOI 10.1097/01.all.0000053267.39029.fd; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Celestin J, 2001, J IMMUNOL, V167, P6097, DOI 10.4049/jimmunol.167.11.6097; Cheung PFY, 2006, ALLERGY, V61, P878, DOI 10.1111/j.1398-9995.2006.01102.x; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Das J, 2006, NAT MED, V12, P1345, DOI 10.1038/nm1206-1345; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Gratchev A, 2004, SCAND J IMMUNOL, V60, P233, DOI 10.1111/j.0300-9475.2004.01443.x; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; He R, 2008, P NATL ACAD SCI USA, V105, P11875, DOI 10.1073/pnas.0801532105; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Kambayashi T, 2008, BLOOD, V111, P1489, DOI 10.1182/blood-2007-07-102111; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kay AB, 1997, CIBA F SYMP, V206, P56; Kepley CL, 2001, AM J RESP CRIT CARE, V164, P1053, DOI 10.1164/ajrccm.164.6.2102025; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Koh YI, 2008, J IMMUNOL, V181, P4560, DOI 10.4049/jimmunol.181.7.4560; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Letuve S, 2006, J ALLERGY CLIN IMMUN, V117, P590, DOI 10.1016/j.jaci.2005.10.025; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Macfarlane AJ, 2000, J ALLERGY CLIN IMMUN, V105, P99, DOI 10.1016/S0091-6749(00)90184-2; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oh K, 2007, BLOOD, V109, P2921, DOI 10.1182/blood-2006-07-037739; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Petsky HL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub2; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schroeder JT, 2001, J ALLERGY CLIN IMMUN, V107, P265, DOI 10.1067/mai.2001.112846; SCHROEDER JT, 2009, ADV IMMUNOL, P123; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Skokos D, 2003, J IMMUNOL, V170, P3037, DOI 10.4049/jimmunol.170.6.3037; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Takeda K, 1997, J EXP MED, V186, P449, DOI 10.1084/jem.186.3.449; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Wang HB, 2008, J LEUKOCYTE BIOL, V83, P817, DOI 10.1189/jlb.0607392; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wong CK, 2005, AM J RESP CELL MOL, V33, P186, DOI 10.1165/rcmb.2005-0034OC; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Yoshimura C, 2002, J ALLERGY CLIN IMMUN, V109, P817, DOI 10.1067/mai.2002.123532; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhang Y, 1996, J EXP MED, V184, P1507, DOI 10.1084/jem.184.4.1507; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	126	175	185	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					425	437		10.1016/j.immuni.2009.08.014	http://dx.doi.org/10.1016/j.immuni.2009.08.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766085	Green Accepted, Bronze			2022-12-18	WOS:000270525900008
J	Watanabe, T; Kitani, A; Murray, PJ; Wakatsuki, Y; Fuss, IJ; Strober, W				Watanabe, Tomohiro; Kitani, Atsushi; Murray, Peter J.; Wakatsuki, Yoshio; Fuss, Ivan J.; Strober, Warren			Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; T-CELLS; MEDIATED-IMMUNITY; ESCHERICHIA-COLI; LEISHMANIA-MAJOR; KAPPA-B; NOD2; MICE	In this study, we determined conditions leading to the development of colitis in mice with nucleotide binding oligomerization domain 2 (NOD2) deficiency, a susceptibility factor in Crohn's disease. We found that NOD2-deficient antigen-presenting cells (APCs) produced increased amounts of interleukin (IL)-12 in the presence of ovalbumin (OVA) peptide and peptidoglycan or recombinant E. coli that express OVA peptide (ECOVA). Furthermore, these APCs elicited heightened interferon-gamma (IFN-gamma) responses from cocultured OVA-specific CD4(+) T cells. We then demonstrated that NOD2-deficient mice adoptively transferred OVA-specific CD4(+) T cells and that administered intrarectal ECOVA developed colitis associated with the expansion of OVA-specific CD4(+) T cells producing IFN-gamma. Importantly, this colitis was highly dependent on Toll-like receptor 2 (TLR2) function since it was suppressed in NOD2 and TLR2 double-deficient mice. Thus, NOD2-deficient mice become susceptible to colitis as a result of increased TLR2 responses when they have the capacity to respond to an antigen expressed by mucosal bacteria.	NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA; St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Kyoto Univ, Grad Sch Med, Dept Clin Bioregulatory Sci, Sakyo Ku, Kyoto 6068507, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital; Kyoto University	Strober, W (corresponding author), NIAID, Mucosal Immun Sect, Host Def Lab, NIH, Bldg 10-CRC,Room 5W3940,10 Ctr Dr, Bethesda, MD 20892 USA.	wstrober@niaid.nih.gov	Murray, Peter J/K-4725-2018; Watanabe, Tomohiro/ABA-4712-2021	Murray, Peter J/0000-0001-6329-9802; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000354, ZIAAI000354] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Boirivant M, 1999, GASTROENTEROLOGY, V116, P557, DOI 10.1016/S0016-5085(99)70177-0; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bouma G, 2002, GASTROENTEROLOGY, V123, P554, DOI 10.1053/gast.2002.34752; Campbell KA, 1996, IMMUNITY, V4, P283, DOI 10.1016/S1074-7613(00)80436-7; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Parronchi P, 1997, AM J PATHOL, V150, P823; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; Watanabe T, 2005, INFLAMM BOWEL DIS, V11, P541, DOI 10.1097/01.MIB.0000163696.26969.e4; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2002, J IMMUNOL, V168, P2188, DOI 10.4049/jimmunol.168.5.2188; Watanabe Yuichiro, 2003, Nucl Recept, V1, P1, DOI 10.1186/1478-1336-1-1; Yoshida M, 2002, GASTROENTEROLOGY, V123, P1949, DOI 10.1053/gast.2002.37049; Yoshida M, 2001, INT IMMUNOL, V13, P1561, DOI 10.1093/intimm/13.12.1561	38	175	179	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					473	485		10.1016/j.immuni.2006.06.018	http://dx.doi.org/10.1016/j.immuni.2006.06.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16949315	Bronze			2022-12-18	WOS:000240862200015
J	Lazarski, CA; Chaves, FA; Jenks, SA; Wu, SH; Richards, KA; Weaver, JM; Sant, AJ				Lazarski, CA; Chaves, FA; Jenks, SA; Wu, SH; Richards, KA; Weaver, JM; Sant, AJ			The kinetic stability of MHC class II: Peptide complexes is a key parameter that dictates immunodominance	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; CD4 T-CELLS; IN-VIVO; ANTIGEN PRESENTATION; LEISHMANIA-MAJOR; CUTTING EDGE; HLA-DM; BINDING; MOLECULE	T cell priming to exogenous antigens reflects regulated antigen processing in dendritic cells, subsequent homing to lymph nodes, sustained interactions between T cells and antigen-bearing dendritic cells, and, ultimately, selective T cell activation and differentiation. In this study, we test the hypothesis that an intrinsic property of the class II:peptide complex is a key determinant that dictates the specificity of an emerging CD4 T cell response. We found that immunodominant peptides possess extremely long half-lives with class II molecules (t(1/2) > 150 hr), whereas cryptic peptides displayed half-lives of less than 10 hr. Furthermore, and most importantly, by using a peptide shuttle vector and four independent antigens, we demonstrate a direct, causative relationship between the half-life of peptide epitopes and their immunogenicity in vivo. Taken collectively, our results suggest the half-life of class II:peptide complexes is the primary parameter that dictates the ultimate hierarchy of the elicited T cell response.	Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Chicago, Div Biol Sci, Comm Immunol, Chicago, IL 60637 USA	University of Rochester; University of Chicago	Sant, AJ (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	andrea_sant@urmc.rochester.edu			NIAID NIH HHS [AI51542, AI34359, AI57998] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051542, R21AI057998, R01AI034359] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; BEESON C, 1995, J AM CHEM SOC, V117, P10429, DOI 10.1021/ja00147a003; BEESON C, 1994, P NATL ACAD SCI USA, V91, P8842, DOI 10.1073/pnas.91.19.8842; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Blum JS, 1997, CRIT REV IMMUNOL, V17, P411; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; BUUS S, 1987, IMMUNOL REV, V98, P115, DOI 10.1111/j.1600-065X.1987.tb00522.x; Chaves FA, 2005, J IMMUNOL METHODS, V300, P74, DOI 10.1016/j.jim.2005.02.013; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; Harrington CJ, 1998, IMMUNITY, V8, P571, DOI 10.1016/S1074-7613(00)80562-2; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jensen PE, 1999, IMMUNOL RES, V20, P195, DOI 10.1007/BF02790403; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; Lanzavecchia A, 2001, NAT IMMUNOL, V2, P487, DOI 10.1038/88678; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; MARTINEAU P, 1992, GENE, V118, P151, DOI 10.1016/0378-1119(92)90266-R; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Medd PG, 2000, SEMIN CELL DEV BIOL, V11, P203, DOI 10.1006/scdb.2000.0162; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MILON G, 1986, J IMMUNOL, V136, P1467; Mirshahidi S, 2004, J IMMUNOL, V172, P5346, DOI 10.4049/jimmunol.172.9.5346; Moudgil KD, 1997, J IMMUNOL, V159, P2574; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Peterson M, 1998, J IMMUNOL, V161, P2961; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Reiner SL, 1998, J IMMUNOL, V160, P884; REINER SL, 1993, SCIENCE, V259, P1457, DOI 10.1126/science.8451641; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Ryan KR, 2004, CELL IMMUNOL, V227, P70, DOI 10.1016/j.cellimm.2004.01.003; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SANT AJ, 2005, IN PRESS IMMUNOL REV; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SETTE A, 1988, J IMMUNOL, V141, P45; SETTE A, 1989, J IMMUNOL, V142, P35; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; Targoni OS, 1998, J EXP MED, V187, P2055, DOI 10.1084/jem.187.12.2055; Vogt AB, 1999, SEMIN IMMUNOL, V11, P391, DOI 10.1006/smim.1999.0197; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wong DC, 2001, KIDNEY INT, V60, P1777, DOI 10.1046/j.1523-1755.2001.00014.x	55	175	180	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					29	40		10.1016/j.immuni.2005.05.009	http://dx.doi.org/10.1016/j.immuni.2005.05.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039577	Bronze			2022-12-18	WOS:000231024800006
J	Stoddart, A; Dykstra, ML; Brown, BK; Song, WX; Pierce, SK; Brodsky, FM				Stoddart, A; Dykstra, ML; Brown, BK; Song, WX; Pierce, SK; Brodsky, FM			Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; IMMATURE B-CELLS; ENDOCYTIC PATHWAY; COATED VESICLES; CUTTING EDGE; MEMBRANE; PROTEIN; ACTIVATION; COMPLEX; PHOSPHORYLATION	A major function of the B cell is the internalization of antigen through the BCR for processing and presentation to T cells. While there is evidence suggesting that lipid raft signaling may regulate internalization, the molecular machinery coordinating these two processes remains to be defined. Here we present a link between the B cell signaling and internalization machinery and show that Src-family kinase activity is required for inducible clathrin heavy chain phosphorylation, BCR colocalization with clathrin, and regulated internalization. An analysis of different B cell lines shows that BCR uptake occurs only when clathrin is associated with rafts and is tyrosine phosphorylated following BCR crosslinking. We therefore propose that lipid rafts spatially organize signaling cascades with clathrin to regulate BCR internalization.	Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; NIAID, NIH, Immunogenet Lab, Rockville, MD 20852 USA; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland College Park	Brodsky, FM (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA.	fmarbro@itsa.ucsf.edu		Brodsky, Frances/0000-0002-1334-9258	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045865, R29AI042093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45865, AI42093] Funding Source: Medline; NIGMS NIH HHS [GM38093] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Chung JB, 2001, J IMMUNOL, V166, P736, DOI 10.4049/jimmunol.166.2.736; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; DEMARS R, 1983, HUM IMMUNOL, V8, P123, DOI 10.1016/0198-8859(83)90008-3; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dustin ML, 2001, NAT IMMUNOL, V2, P480, DOI 10.1038/88666; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fruehling S, 1998, J VIROL, V72, P7796, DOI 10.1128/JVI.72.10.7796-7806.1998; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; JELACHICH ML, 1984, P NATL ACAD SCI-BIOL, V81, P5537, DOI 10.1073/pnas.81.17.5537; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oved S, 2002, NATURE, V416, P133, DOI 10.1038/416133a; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SALISBURY JL, 1980, J CELL BIOL, V87, P132, DOI 10.1083/jcb.87.1.132; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Santini F, 1996, J CELL BIOL, V132, P1025, DOI 10.1083/jcb.132.6.1025; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Sproul TW, 2000, J IMMUNOL, V165, P6020, DOI 10.4049/jimmunol.165.11.6020; Wagle NM, 2000, CURR TOP MICROBIOL, V245, P101; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	49	175	176	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2002	17	4					451	462		10.1016/S1074-7613(02)00416-8	http://dx.doi.org/10.1016/S1074-7613(02)00416-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387739	Bronze			2022-12-18	WOS:000178667100006
J	Hanissian, SH; Geha, RS				Hanissian, SH; Geha, RS			Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ANTI-CD40 MONOCLONAL-ANTIBODY; X-LINKED IMMUNODEFICIENCY; REGULATORY FACTOR-I; HYPER-IGM SYNDROME; ACTIVATED T-CELLS; NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; DEFECTIVE EXPRESSION; CD40-DEFICIENT MICE	CD40 is a receptor that is critical for the survival, growth, differentiation, and isotype switching of B lymphocytes. Although CD40 lacks intrinsic tyrosine kinase activity, its ligation induces protein tyrosine phosphorylation, which is necessary for several CD40-mediated events. We show that engagement of CD40 induces tyrosine phosphorylation and activation of Jak3 as well as of STAT3. Jak3 is constitutively associated with CD40, and this interaction requires a proline-rich sequence in the membrane-proximal region of CD40. Deletion of this sequence abolishes the capacity of CD40 to induce expression of CD23, ICAM-1, and lymphotoxin-alpha genes in 8 cells. These results indicate that signaling through Jak3 is activated by CD40 and plays an important role in CD40-mediated functions.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV IMMUNOL,BOSTON,MA 02115; HARVARD UNIV,DEPT PEDIAT,SCH MED,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School					NIAID NIH HHS [AI-31136, AI-35714] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031136, P01AI035714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BARRETT TB, 1991, J IMMUNOL, V146, P1722; CALDENHOVEN E, 1994, J BIOL CHEM, V269, P21146; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; HU HM, 1994, J BIOL CHEM, V269, P30063; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; IVASHKIV LB, 1995, IMMUNITY, V3, P1, DOI 10.1016/1074-7613(95)90152-3; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; KANSAS GS, 1991, J IMMUNOL, V147, P4094; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; LEDERMAN S, 1993, CURR OPIN IMMUNOL, V5, P439, DOI 10.1016/0952-7915(93)90066-2; LOH RKS, 1995, IMMUNOL LETT, V45, P99, DOI 10.1016/0165-2478(94)00233-H; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MIYAZAKI T, 1994, SCIENCE, V266, P1046; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; RICHARDS ML, 1994, J IMMUNOL, V152, P3453; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; UCKUN FM, 1990, BLOOD, V76, P2449; VORABERGER G, 1991, J IMMUNOL, V147, P2777; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883; WORM M, 1995, EUR J IMMUNOL, V25, P2438, DOI 10.1002/eji.1830250905; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; YULEE LY, 1990, MOL CELL BIOL, V10, P3087, DOI 10.1128/MCB.10.6.3087; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	53	175	183	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					379	387		10.1016/S1074-7613(00)80281-2	http://dx.doi.org/10.1016/S1074-7613(00)80281-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133417	Bronze			2022-12-18	WOS:A1997XC61900003
J	Tan, HY; Yang, K; Li, YX; Shaw, TI; Wang, YY; Blanco, DB; Wang, XS; Cho, JH; Wang, H; Rankin, S; Guy, C; Peng, JM; Chi, HB				Tan, Haiyan; Yang, Kai; Li, Yuxin; Shaw, Timothy I.; Wang, Yanyan; Blanco, Daniel Bastardo; Wang, Xusheng; Cho, Ji-Hoon; Wang, Hong; Rankin, Sherri; Guy, Cliff; Peng, Junmin; Chi, Hongbo			Integrative Proteomics and Phosphoproteomics Profiling Reveals Dynamic Signaling Networks and Bioenergetics Pathways Underlying T Cell Activation	IMMUNITY			English	Article							MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; HUMAN BRAIN; INHIBITION; QUIESCENCE; DIFFERENTIATION; HOMEOSTASIS; METABOLISM; PROTEINS; PROMOTES	The molecular circuits by which antigens activate quiescent T cells remain poorly understood. We combined temporal profiling of the whole proteome and phosphoproteome via multiplexed isobaric labeling proteomics technology, computational pipelines for integrating multi-omics datasets, and functional perturbation to systemically reconstruct regulatory networks underlying T cell activation. T cell receptors activated the T cell proteome and phosphoproteome with discrete kinetics, marked by early dynamics of phosphorylation and delayed ribosome biogenesis and mitochondrial activation. Systems biology analyses identified multiple functional modules, active kinases, transcription factors and connectivity between them, and mitochondrial pathways including mitoribosomes and complex IV. Genetic perturbation revealed physiological roles for mitochondrial enzyme COX10-mediated oxidative phosphorylation in T cell quiescence exit. Our multi-layer proteomics profiling, integrative network analysis, and functional studies define landscapes of the T cell proteome and phosphoproteome and reveal signaling and bioenergetics pathways that mediate lymphocyte exit from quiescence.	[Tan, Haiyan; Li, Yuxin; Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Wang, Hong; Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Tan, Haiyan; Li, Yuxin; Wang, Xusheng; Cho, Ji-Hoon; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yang, Kai; Wang, Yanyan; Blanco, Daniel Bastardo; Rankin, Sherri; Guy, Cliff; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Shaw, Timothy I.] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Blanco, Daniel Bastardo; Wang, Hong] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Peng, JM (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.; Peng, JM (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Peng, JM (corresponding author), St Jude Childrens Res Hosp, St Jude Prote Facil, 332 N Lauderdale St, Memphis, TN 38105 USA.; Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	junmin.peng@stjude.org; hongbo.chi@stjude.org	li, Yu/HCI-9086-2022; Li, yuxin/GSD-1668-2022; Wang, Hong/AAE-2340-2019; Shaw, Timothy I/AAE-8523-2019; Peng, Junmin/N-2614-2018; Chi, Hongbo/M-9397-2018; li, yu/HGL-9518-2022	Wang, Hong/0000-0002-6215-6348; Shaw, Timothy I/0000-0002-9316-1924; Peng, Junmin/0000-0003-0472-7648; Chi, Hongbo/0000-0002-9997-2496; Bastardo Blanco, Daniel/0000-0001-8232-7522	NIH [AG047928, GM114260, AI101407, CA176624, AI105887, NS064599, P30CA021765]; American Asthma Foundation; ALSAC (American Lebanese Syrian Associated Charities); NATIONAL CANCER INSTITUTE [R01CA176624, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI105887, R01AI105887, R01AI101407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG053987, R01AG047928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; ALSAC (American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank for all other members in the Peng and Chi labs and in St. Jude Proteomics Facility for insightful discussion, and Anil KC and Melissa Hendren for technical assistance. This work was partially supported by NIH grants AG047928 (J.P.), GM114260 (J.P.), AI101407 (H.C.), CA176624 (H.C.), AI105887 (H.C.), and NS064599 (H.C.), American Asthma Foundation, and ALSAC (American Lebanese Syrian Associated Charities). The MS analysis was performed in the St. Jude Proteomics Facility, partially supported by NIH P30CA021765.	Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Hamilton SE, 2012, TRENDS IMMUNOL, V33, P224, DOI 10.1016/j.it.2012.01.007; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hukelmann JL, 2016, NAT IMMUNOL, V17, P104, DOI 10.1038/ni.3314; Jansen R., 2002, NAT IMMUNOL, V12, P37; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li JJ, 2015, SCIENCE, V347, P1066, DOI 10.1126/science.aaa8332; Li YX, 2016, J PROTEOME RES, V15, P2309, DOI 10.1021/acs.jproteome.6b00344; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mischnik M, 2016, BIOINFORMATICS, V32, P424, DOI 10.1093/bioinformatics/btv699; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shrestha S, 2014, P NATL ACAD SCI USA, V111, P14858, DOI 10.1073/pnas.1404264111; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tan HY, 2015, PROTEOMICS, V15, P500, DOI 10.1002/pmic.201400171; Thornton TM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10553; Wang H, 2015, J PROTEOME RES, V14, P829, DOI 10.1021/pr500882h; Wang XS, 2014, MOL CELL PROTEOMICS, V13, P3663, DOI 10.1074/mcp.O114.039586; Wu RH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009654; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang ZF, 2014, MOL CELL BIOL, V34, P3194, DOI 10.1128/MCB.00492-12; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	38	174	175	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					488	503		10.1016/j.immuni.2017.02.010	http://dx.doi.org/10.1016/j.immuni.2017.02.010			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28285833	Green Accepted, Bronze			2022-12-18	WOS:000396818100019
J	Dorrestein, PC; Mazmanian, SK; Knight, R				Dorrestein, Pieter C.; Mazmanian, Sarkis K.; Knight, Rob			Finding the Missing Links among Metabolites, Microbes, and the Host	IMMUNITY			English	Review							GUT MICROBIOTA; INTESTINAL MICROBIOTA; RECEPTOR; RECOGNITION; DIVERSITY; MICROORGANISMS; IDENTIFICATION; COMMUNITIES; LIPIDOMICS; BACTERIUM	The unexpected diversity of the human microbiome and metabolome far exceeds the complexity of the human genome. Although we now understand microbial taxonomic and genetic repertoires in some populations, we are just beginning to assemble the necessary computational and experimental tools to understand the metabolome in comparable detail. However, even with the limited current state of knowledge, individual connections between microbes and metabolites, between microbes and immune function, and between metabolites and immune function are being established. Here, we provide our perspective on these connections and outline a systematic research program that could turn these individual links into a broader network that allows us to understand how these components interact. This program will enable us to exploit connections among the microbiome, metabolome, and host immune system to maintain health and perhaps help us understand how to reverse the processes that lead to a wide range of immune and other diseases.	[Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Knight, Rob] BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California Institute of Technology; Howard Hughes Medical Institute	Knight, R (corresponding author), BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA.	rob.knight@colorado.edu	Dorrestein, Pieter/ABF-2930-2020; Knight, Rob/D-1299-2010	Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [U01 HG004866, R01 HG004872] Funding Source: Medline; NIDDK NIH HHS [P01 DK078669, R01 DK078938] Funding Source: Medline; NIMH NIH HHS [R01 MH100556] Funding Source: Medline; NINDS NIH HHS [R01 NS085910] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872, U01HG004866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Fuchs O, 2013, LANCET RESP MED, V1, P743, DOI 10.1016/S2213-2600(13)70145-0; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Moroboshi T., 2005, MICROBES ENVIRON, V4, P264; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath CM, 2012, ANAL CHEM, V84, P9259, DOI 10.1021/ac302039u; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Swearingen MC, 2013, J BACTERIOL, V195, P173, DOI 10.1128/JB.01341-12; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tinh NTN, 2007, FEMS MICROBIOL ECOL, V62, P45, DOI 10.1111/j.1574-6941.2007.00378.x; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang H, 2006, J MED MICROBIOL, V55, P1751, DOI 10.1099/jmm.0.46756-0; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	72	174	182	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					824	832		10.1016/j.immuni.2014.05.015	http://dx.doi.org/10.1016/j.immuni.2014.05.015			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950202	Green Accepted, Bronze			2022-12-18	WOS:000341440200002
J	Chung, EY; Liu, JG; Homma, Y; Zhang, YH; Brendolan, A; Saggese, M; Han, JH; Silverstein, R; Selleri, L; Ma, XJ				Chung, Elaine Y.; Liu, Jianguo; Homma, Yoichiro; Zhang, Yunhua; Brendolan, Andrea; Saggese, Matilde; Han, Jilhong; Silverstein, Roy; Selleri, Licia; Ma, Xiaojing			Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1	IMMUNITY			English	Article							MONOCYTE-DERIVED MACROPHAGES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IL-10 GENE-EXPRESSION; VITRONECTIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSLOCATION PROTEIN; CYTOKINE SYNTHESIS; TRANSGENIC MICE; ENDOTOXIC-SHOCK; TH1 CLONES	Production of interleukin (IL)-10, a major immunoregulatory cytokine, by phagocytes during clearance of apoptotic cells is critical to ensuring cellular homeostasis and suppression of autoimmunity. Little is known about the regulatory mechanisms in this fundamental process. We report that IL-10 production stimulated by apoptotic cells was regulated at the point of transcription in a manner dependent on p38 mitogen-activated protein kinase, partially on the scavenger receptor CD36, and required cell-cell contact but not phagocytosis. By using a reporter assay, we mapped the apoptotic-cell-response element (ACRE) in the human IL10 promoter and provide biochemical and physiological evidence that ACRE mediates the transcriptional activation of IL10 by pre-B cell leukemia transcription factor-1b and another Hox cofactor Pbx-regulating protein 1 in response to apoptotic cells. This study establishes a role of two developmentally critical factors (Pbx1 and Prep-1) in the regulation of homeostasis in the immune system.	[Chung, Elaine Y.; Liu, Jianguo; Homma, Yoichiro; Zhang, Yunhua; Ma, Xiaojing] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Brendolan, Andrea; Saggese, Matilde; Selleri, Licia] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Han, Jilhong] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chung, Elaine Y.; Ma, Xiaojing] Cornell Univ, Weill Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10021 USA; [Silverstein, Roy] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cleveland Clinic Foundation	Ma, XJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	xim2002@med.cornell.edu	Andrea, Brendolan/ABG-3387-2020	Brendolan, Andrea/0000-0003-0109-6879	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045899] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045899-07, AI45899, R01 AI045899-10, R01 AI045899, R01 AI045899-08, R01 AI045899-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brightbill HD, 2000, J IMMUNOL, V164, P1940, DOI 10.4049/jimmunol.164.4.1940; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Cao SJ, 2002, J IMMUNOL, V169, P5715, DOI 10.4049/jimmunol.169.10.5715; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Fadok VA, 1998, J IMMUNOL, V161, P6250; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Foey AD, 1998, J IMMUNOL, V160, P920; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HSU DH, 1992, INT IMMUNOL, V4, P563, DOI 10.1093/intimm/4.5.563; Huh HY, 1996, BLOOD, V87, P2020; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1991, J EXP MED, V174, P915; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Somersan S, 2001, J CELL BIOL, V155, P501, DOI 10.1083/jcb.200110066; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Voll RE, 1997, ARTHRITIS RHEUM-US, V40, P2162, DOI 10.1002/art.1780401210; WALPORT M J, 1990, Current Opinion in Rheumatology, V2, P661; YSSEL H, 1992, J IMMUNOL, V149, P2378	55	174	181	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					952	964		10.1016/j.immuni.2007.11.014	http://dx.doi.org/10.1016/j.immuni.2007.11.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093541	Green Accepted, Bronze			2022-12-18	WOS:000251907300014
J	Ciofani, M; Knowles, GC; Wiest, DL; von Boehmer, H; Zuniga-Pflucker, JC				Ciofani, Maria; Knowles, Gisele C.; Wiest, David L.; von Boehmer, Harald; Zuniga-Pflucker, Juan Carlos			Stage-specific and differential notch dependency at the alpha beta and gamma delta T lineage bifurcation	IMMUNITY			English	Article							CELL-DEVELOPMENT; PRE-TCR; THYMOCYTE DIFFERENTIATION; THYMIC DEVELOPMENT; BETA/GAMMA-DELTA; FATE; EXPRESSION; MICE; SELECTION; REARRANGEMENT	Signals transduced by Notch receptors are indispensable for T cell specification and differentiation of up T lineage cells. However, the role of Notch signals during alpha beta versus gamma delta T lineage decision remains controversial. Here, we addressed this question by employing a clonal analysis of CD4(-)CD8(-) (DN) progenitor potential to position the divergence of alpha beta and gamma delta T cell lineages to the late DN2 to DN3 developmental stages. Accordingly, alpha beta and gamma delta precursor frequencies within these T cell progenitor subsets were determined, both in the presence and absence of Notch signaling through Delta-like 1. Notch signals were found to be critical for the DN to CD4(+)CD8(+) (DP) transition, irrespective of the identity (pT alpha beta or gamma delta) of the inducing T cell receptor complex, whereas gamma delta T cells developed from gamma delta TCR-expressing T cell progenitors in the absence of further Notch ligand interaction. Collectively, our findings demonstrate a differential, stage-specific requirement for Notch receptor-ligand interactions in the differentiation of up and gamma delta T cells from T cell progenitors.	Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; Fox Chase Canc Ctr, Div Basic Sci, Immunobiol Working Grp, Philadelphia, PA 19111 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fox Chase Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Sunnybrook Res Inst, Dept Immunol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jczp@sri.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Ciofani, Maria/0000-0001-6472-5260; Wiest, David/0000-0002-0792-3188				ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Capone M, 1998, P NATL ACAD SCI USA, V95, P12522, DOI 10.1073/pnas.95.21.12522; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; De Smedt M, 2002, J IMMUNOL, V169, P3021, DOI 10.4049/jimmunol.169.6.3021; DESTFAZEKAS G, 1982, J IMMUNOL METHODS, V49, pR11; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Garcia-Peydro M, 2003, BLOOD, V102, P2444, DOI 10.1182/blood-2002-10-3261; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayday AC, 1999, SEMIN IMMUNOL, V11, P239, DOI 10.1006/smim.1999.0180; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kang J, 1998, IMMUNITY, V8, P427, DOI 10.1016/S1074-7613(00)80548-8; KERSH GJ, 1995, J IMMUNOL, V154, P5706; Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257; Livak F, 1999, J IMMUNOL, V162, P2575; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pennington DJ, 2005, CURR OPIN IMMUNOL, V17, P108, DOI 10.1016/j.coi.2005.01.009; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PEREIRA P, 1992, EMBO J, V11, P25, DOI 10.1002/j.1460-2075.1992.tb05023.x; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Shen HQ, 2003, J IMMUNOL, V171, P3401, DOI 10.4049/jimmunol.171.7.3401; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Talora C, 2003, EMBO REP, V4, P1067, DOI 10.1038/sj.embor.7400013; Tanaka Y, 1995, IMMUNOL REV, V148, P171, DOI 10.1111/j.1600-065X.1995.tb00098.x; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weber-Arden J, 2000, J IMMUNOL, V164, P1002, DOI 10.4049/jimmunol.164.2.1002; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; YOKOYAMA WM, 1995, CURRENT PROTOCOLS IM	50	174	177	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					105	116		10.1016/j.immuni.2006.05.010	http://dx.doi.org/10.1016/j.immuni.2006.05.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16814577	Bronze			2022-12-18	WOS:000239713000014
J	Hawiger, D; Masilamani, RF; Bettelli, E; Kuchroo, VK; Nussenzweig, MC				Hawiger, D; Masilamani, RF; Bettelli, E; Kuchroo, VK; Nussenzweig, MC			Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dentritic cells in vivo	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR TRANSGENIC MICE; DENDRITIC CELLS; ANTIGEN PRESENTATION; SIGNAL-TRANSDUCTION; SELF-ANTIGENS; CLONAL ELIMINATION; CROSS-PRESENTATION; MOLECULAR-CLONING	In the steady state, interaction between T cells and antigen-presenting dendritic cells (DCs) leads to T cell tolerance. To examine the role of DC regulated peripheral tolerance in a model autoimmune disease, we delivered an encephalitogenic oligodendrocyte glycoprotein (MOG) peptide to DCs in vivo. We found that targeting MOG peptide to DCs resulted in a novel form of peripheral T cell tolerance that was sufficiently profound to prevent autoimmune experimental acute encephalomyelitis (EAE). The tolerized T cells were severely impaired in specific secondary responses to antigen in vivo but they were not intrinsically anergic since they remained highly responsive to T cell receptor (TCR) stimulation in vitro. The mechanism that mediates this dynamic antigen-specific T cell unresponsiveness differs from previously described forms of tolerance in that it requires that DCs induce CD5 expression on activated T cells.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Rockefeller University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019					Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barthlott T, 2003, J EXP MED, V197, P451, DOI 10.1084/jem.20021387; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brossard U, 2003, J IMMUNOL, V170, P4623, DOI 10.4049/jimmunol.170.9.4623; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dhodapkar MV, 2002, BLOOD, V100, P174, DOI 10.1182/blood.V100.1.174; Finkelman FD, 1996, J IMMUNOL, V157, P1406; FRIEDMAN A, 1994, P NATL ACAD SCI USA, V91, P6688, DOI 10.1073/pnas.91.14.6688; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; GROSS JA, 1990, J IMMUNOL, V144, P3201; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Grossman Z, 2001, CURR OPIN IMMUNOL, V13, P687, DOI 10.1016/S0952-7915(01)00280-1; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HUANG HJS, 1987, P NATL ACAD SCI USA, V84, P204, DOI 10.1073/pnas.84.1.204; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Joliat MJ, 2002, J AUTOIMMUN, V18, P105, DOI 10.1006/jaut.2001.0570; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Miller SD, 1995, IMMUNITY, V3, P739, DOI 10.1016/1074-7613(95)90063-2; Morgan DJ, 1999, J IMMUNOL, V163, P723; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; O'Garra A, 2003, IMMUNOL LETT, V85, P135, DOI 10.1016/S0165-2478(02)00239-0; Pape KA, 1998, J IMMUNOL, V160, P4719; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Smilek D E, 1992, Int Rev Immunol, V9, P223, DOI 10.3109/08830189209061792; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; SPERTINI F, 1991, J IMMUNOL, V146, P47; Stamou P, 2003, J IMMUNOL, V171, P1278, DOI 10.4049/jimmunol.171.3.1278; SUN DM, 1992, CELL IMMUNOL, V145, P263, DOI 10.1016/0008-8749(92)90330-R; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; VERWILGHEN J, 1992, ARTHRITIS RHEUM, V35, P1445, DOI 10.1002/art.1780351207; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179	74	174	179	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					695	705		10.1016/j.immuni.2004.05.002	http://dx.doi.org/10.1016/j.immuni.2004.05.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189735	Bronze			2022-12-18	WOS:000222205300006
J	Sleckman, BP; Bardon, CG; Ferrini, R; Davidson, L; Alt, FW				Sleckman, BP; Bardon, CG; Ferrini, R; Davidson, L; Alt, FW			Function of the TCR alpha enhancer in alpha beta and gamma delta T cells	IMMUNITY			English	Article							RECEPTOR ALPHA/DELTA-LOCUS; CHAIN GENE REARRANGEMENT; V(D)J RECOMBINATION; TRANSCRIPTIONAL ENHANCER; THYMOCYTE DEVELOPMENT; TARGETED DELETION; INTRON ENHANCER; 3' END; GENOMIC ORGANIZATION; ATTACHMENT REGION	We have used gene targeted mutational approaches to assess the role of the T cell receptor alpha (TCR alpha) enhancer (E alpha) in the control of TCR alpha. and TCR delta gene rearrangement and expression. We show that E alpha functions in cis to promote V alpha to J alpha rearrangement across the entire J alpha locus, a distance of greater than 70 kb. We also show that E alpha is required for normal alpha beta T cell development; in this lineage, E alpha is required for germline J alpha expression, for normal expression levels of rearranged V alpha J alpha genes, and for expression of a diverse V alpha repertoire. In gamma delta T cells, E alpha is not required for V delta DJ delta rearrangement, but, surprisingly, is required for normal expression levels of mature V delta DJ delta transcripts and for expression of germline J alpha transcripts. Our findings imply that E alpha function is not limited to the TCR alpha components of the TCR alpha/delta locus or to the alpha beta lineage; rather, E alpha function is important in both alpha beta and gamma delta lineage T cells.	CHILDRENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; CTR BLOOD RES, BOSTON, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001297, R37AI020047, R01AI020047] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-01297-01, AI-20047] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1987, IMMUNOL TODAY, V8, P293, DOI 10.1016/0167-5699(87)90014-4; Arden Bernhard, 1995, Immunogenetics, V42, P501; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bories JC, 1996, P NATL ACAD SCI USA, V93, P7871, DOI 10.1073/pnas.93.15.7871; BORIES JC, 1990, J EXP MED, V171, P75, DOI 10.1084/jem.171.1.75; Bouvier G, 1996, P NATL ACAD SCI USA, V93, P7877, DOI 10.1073/pnas.93.15.7877; Burtrum DB, 1996, J IMMUNOL, V157, P4293; CAPONE M, 1993, EMBO J, V12, P4335, DOI 10.1002/j.1460-2075.1993.tb06118.x; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Coligan JE., 1994, CURRENT PROTOCOLS IM; DECHASSEVAL R, 1993, EUR J IMMUNOL, V23, P1294, DOI 10.1002/eji.1830230616; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; ELLIOTT JF, 1988, NATURE, V331, P627; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; GILL LL, 1991, EUR J IMMUNOL, V21, P807, DOI 10.1002/eji.1830210339; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GOLD DP, 1987, P NATL ACAD SCI USA, V84, P7649, DOI 10.1073/pnas.84.21.7649; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAUZURICA P, 1994, J EXP MED, V179, P43, DOI 10.1084/jem.179.1.43; LAUZURICA P, 1994, J EXP MED, V179, P1913, DOI 10.1084/jem.179.6.1913; Livak F, 1996, MOL CELL BIOL, V16, P609; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MALYNN BA, 1987, CURR TOP MICROBIOL, V135, P75; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NAKAJIMA PB, 1995, IMMUNITY, V3, P609, DOI 10.1016/1074-7613(95)90132-9; Okada A, 1994, Semin Immunol, V6, P185, DOI 10.1006/smim.1994.1024; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PIRCHER H, 1992, EUR J IMMUNOL, V22, P399, DOI 10.1002/eji.1830220217; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; Roberts JL, 1997, J EXP MED, V185, P131, DOI 10.1084/jem.185.1.131; SATYANARAYANA K, 1988, P NATL ACAD SCI USA, V85, P8166, DOI 10.1073/pnas.85.21.8166; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHIMIZU T, 1993, INT IMMUNOL, V5, P155, DOI 10.1093/intimm/5.2.155; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; TOMOYUKI T, 1992, GROWTH DIFFER, V34, P561; VANELP J, 1993, P NATL ACAD SCI USA, V90, P9664, DOI 10.1073/pnas.90.20.9664; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Villey I, 1997, EUR J IMMUNOL, V27, P1619, DOI 10.1002/eji.1830270705; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WANG K, 1994, GENOMICS, V20, P419, DOI 10.1006/geno.1994.1196; WHITE J, 1989, J IMMUNOL, V143, P1822; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; Wilson A, 1996, IMMUNITY, V4, P37, DOI 10.1016/S1074-7613(00)80296-4; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219	72	174	175	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1997	7	4					505	515		10.1016/S1074-7613(00)80372-6	http://dx.doi.org/10.1016/S1074-7613(00)80372-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354471	Bronze			2022-12-18	WOS:A1997YD59300007
J	Carr, MW; Alon, R; Springer, TA				Carr, MW; Alon, R; Springer, TA			The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes	IMMUNITY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; CELL-ADHESION; TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; CYTOKINE; LEUKOCYTES; MIP-1-BETA; MONOCYTES; RECEPTOR; ICAM-1	The ability of chemokines, particularly MCP-1, to induce integrin-dependent binding of T lymphocytes to endothelial adhesion molecules or extracellular matrix (ECM) components was examined. MCP-1 induced significant adhesion to fibronectin (FN) and to endothelial-secreted ECM but not to purified ICAM-1 or VCAM-1, or to activated endothelium. The MCP-1-induced binding of T lymphocytes to FN was rapid, dose dependent, and resulted from activation of both VLA-4 and VLA-5. Like MCP-1, the chemokines RANTES and MIP-1 beta induced T lymphocyte binding to FN, but not to ICAM-1. We suggest, therefore, that these T lymphocyte chemokines may be most important, not in initiating integrin-dependent firm adhesion of T lymphocytes to the vascular wall, but rather, in subsequent adhesive interactions during migration into tissue.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	Carr, MW (corresponding author), HARVARD UNIV,CTR BLOOD RES,BOSTON,MA 02115, USA.		ALON, RONEN/GRX-6987-2022	Alon, Ronen/0000-0001-9161-6369	NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NCI NIH HHS [CA31798] Funding Source: Medline; NHLBI NIH HHS [HL48675] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BREARD J, 1980, J IMMUNOL, V124, P1943; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; FERGUSON TA, 1991, P NATL ACAD SCI USA, V88, P8072, DOI 10.1073/pnas.88.18.8072; FLEIT HB, 1989, LEUKOCYTE TYPING, V4, P579; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GILAT D, 1994, J IMMUNOL, V153, P4899; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; JAKUBOWSKI A, 1995, CELL ADHES COMMUN, V3, P131, DOI 10.3109/15419069509081282; JONES DA, 1994, J CLIN INVEST, V94, P2443, DOI 10.1172/JCI117612; KAVANAUGH AF, 1991, J IMMUNOL, V146, P4149; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; LUSCINSKAS FW, 1995, J EXP MED, V181, P1179, DOI 10.1084/jem.181.3.1179; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NAPOLITANO M, 1990, J EXP MED, V172, P285, DOI 10.1084/jem.172.1.285; OPPENHEIMERMARKS N, 1990, J IMMUNOL, V145, P140; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; PEPINSKY B, 1992, J BIOL CHEM, V267, P17820; ROTH SJ, 1995, J IMMUNOL METHODS, V100, P97; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; STASHENKO P, 1980, J IMMUNOL, V125, P1678; TANAKA J, 1993, INT ARCH ALLERGY IMM, V100, P201, DOI 10.1159/000236412; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; VANKOOYK Y, J CELL BIOL, V92, P69	45	174	176	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1996	4	2					179	187		10.1016/S1074-7613(00)80682-2	http://dx.doi.org/10.1016/S1074-7613(00)80682-2			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624808	Bronze			2022-12-18	WOS:A1996TX22500008
J	RILEY, JL; WESTERHEIDE, SD; PRICE, JA; BROWN, JA; BOSS, JM				RILEY, JL; WESTERHEIDE, SD; PRICE, JA; BROWN, JA; BOSS, JM			ACTIVATION OF CLASS-II MHC GENES REQUIRES BOTH THE X-BOX REGION AND THE CLASS-II TRANSACTIVATOR (CIITA)	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY GENES; BARE LYMPHOCYTE SYNDROME; B-CELL LINES; DRA PROMOTER; WILD-TYPE; EXPRESSION; BINDING; TRANSCRIPTION; INTERFERON; CLONING	CIITA, a gene that can complement a transcriptional mutation of the major histocompatibility complex (MHC) class II genes, was tested for its ability to function as a coactivator. CIITA cDNA clones isolated showed alternative RNA splicing, but only one splice site combination was able to restore class II MHC gene expression. DNA-mediated transfection experiments showed that CIITA directs its activity through the X box element; the presence of CIITA leads to the formation of a higher order complex at the X box region; and CIITA contains a potent activation domain. These findings support the hypothesis that CIITA directly interacts with the MHC class II-specific transcription factors and is required for expression.			RILEY, JL (corresponding author), EMORY UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,ATLANTA,GA 30322, USA.			Riley, James/0000-0002-1057-576X	NIAID NIH HHS [AI34000] Funding Source: Medline; NIGMS NIH HHS [GM47310, GM849002] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034000, R21AI034000, R56AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BASTA PV, 1987, J IMMUNOL, V138, P1275; BASTA PV, 1988, P NATL ACAD SCI USA, V85, P8618, DOI 10.1073/pnas.85.22.8618; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BOSS JM, 1986, P NATL ACAD SCI USA, V83, P9139, DOI 10.1073/pnas.83.23.9139; BREEDEN L, 1985, REGULATION YEAST HO, P643; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; COGSWELL JP, 1991, J IMMUNOL, V146, P1361; DEPREVAL C, 1985, NATURE, V18, P291; DURAND B, 1994, MOL CELL BIOL, V14, P6839, DOI 10.1128/MCB.14.10.6839; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; GORDON HM, 1992, J IMMUNOL, V148, P4021; Griscelli C, 1989, Immunodefic Rev, V1, P135; GUARDIOLA J, 1993, CRIT REV IMMUNOL, V13, P247; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; NOELLE RJ, 1986, J IMMUNOL, V137, P1718; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; POBER JS, 1983, NATURE, V305, P726, DOI 10.1038/305726a0; REIGH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; RIGAUD G, 1994, EUR J IMMUNOL, V24, P2415, DOI 10.1002/eji.1830241023; RILEY JL, 1993, J IMMUNOL, V151, P6942; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SAMBROOK J, 1989, MOLC LONING LABORATO; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SEIDL C, 1992, J IMMUNOL, V148, P1576; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; SKEEN MJ, 1993, J EXP MED, V178, P971, DOI 10.1084/jem.178.3.971; SLOAN JH, 1988, P NATL ACAD SCI USA, V85, P8186, DOI 10.1073/pnas.85.21.8186; SLOAN JH, 1992, J IMMUNOL, V148, P2591; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; SUGAWARA M, 1991, P NATL ACAD SCI USA, V88, P10347, DOI 10.1073/pnas.88.22.10347; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; TSANG SY, 1988, P NATL ACAD SCI USA, V85, P8598, DOI 10.1073/pnas.85.22.8598; UNANUE ER, 1989, COLD SH Q B, V54, P383; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VILEN BJ, 1991, MOL CELL BIOL, V11, P2406, DOI 10.1128/MCB.11.5.2406; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; YOON K, 1988, GENE, V66, P11, DOI 10.1016/0378-1119(88)90220-X	54	174	182	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1995	2	5					533	543		10.1016/1074-7613(95)90033-0	http://dx.doi.org/10.1016/1074-7613(95)90033-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7749984	Bronze			2022-12-18	WOS:A1995QZ43000010
J	ANDROLEWICZ, MJ; CRESSWELL, P				ANDROLEWICZ, MJ; CRESSWELL, P			HUMAN TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING POSSESS A PROMISCUOUS PEPTIDE-BINDING SITE	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II REGION; ENDOPLASMIC-RETICULUM; HLA-DR; LYMPHOCYTES-T; MHC; MOLECULES; HLA-DR1; IDENTIFICATION; TRANSLOCATION	The peptide selectivity of the human transporters associated with antigen processing (TAP) was investigated using a panel of peptides of varying length and sequence. Peptides were assayed for their ability to compete for the translocation of a labeled reporter peptide containing an N-linked glycosylation acceptor site in Streptolysin O (SLO)-permeabilized cells. We find that human TAP is very promiscuous for peptides in the 8-12 amino acid range, while showing increased selectivity and lower translocation efficiency for peptides in the 13-30 amino acid range. The minimum peptide length appears to be 8 amino acids, while the maximum length appears to be similar to 25 amino acids. Furthermore, a photoactive peptide analogue was synthesized that can photolabel TAP molecules. Using this analogue, we showed that an ATP-independent peptide-binding site exists on TAP, and that competition for translocation reflects competition for peptide binding.			ANDROLEWICZ, MJ (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510, USA.							ALLEN PM, 1984, P NATL ACAD SCI-BIOL, V81, P2489, DOI 10.1073/pnas.81.8.2489; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; ANDERSON KS, 1993, J IMMUNOL, V151, P3407; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; DECKHUT AM, 1992, J VIROL, V66, P440, DOI 10.1128/JVI.66.1.440-447.1992; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; GOULD KG, 1991, J VIROL, V65, P5401, DOI 10.1128/JVI.65.10.5401-5409.1991; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; KOENIG S, 1990, J IMMUNOL, V145, P127; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANBLEEK GM, 1990, NATURE, V348, P213; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; 1990, IMMUNOGENETICS, V31, P131	41	174	174	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1994	1	1					7	14		10.1016/1074-7613(94)90004-3	http://dx.doi.org/10.1016/1074-7613(94)90004-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK154	7889401				2022-12-18	WOS:A1994PK15400002
J	Wang, CG; Guan, YK; Lv, MZ; Zhang, R; Guo, ZY; Wei, XM; Du, XX; Yang, J; Li, T; Wan, Y; Su, XD; Huang, XJ; Jiang, ZF				Wang, Chenguang; Guan, Yukun; Lv, Mengze; Zhang, Rui; Guo, Zhaoying; Wei, Xiaoming; Du, Xiaoxia; Yang, Jing; Li, Tong; Wan, Yi; Su, Xiaodong; Huang, Xiaojun; Jiang, Zhengfan			Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses	IMMUNITY			English	Article							CYCLIC GMP-AMP; VITAMIN-D; CELLS; 2ND-MESSENGER; MITOCHONDRIA; ADAPTER; DINUCLEOTIDE; RECOGNITION; TRANSITION; TRANSPORT	Manganese (Mn) is essential for many physiological processes, but its functions in innate immunity remain undefined. Here, we found that Mn2+ was required for the host defense against DNA viruses by increasing the sensitivity of the DNA sensor cGAS and its downstream adaptor protein STING. Mn2+ was released from membrane-enclosed organelles upon viral infection and accumulated in the cytosol where it bound directly to cGAS. Mn2+ enhanced the sensitivity of cGAS to double-stranded DNA (dsDNA) and its enzymatic activity, enabling cGAS to produce secondary messenger cGAMP in the presence of low concentrations of dsDNA that would otherwise be non-stimulatory. Mn2+ also enhanced STING activity by augmenting cGAMP-STING binding affinity. Mn-deficient mice showed diminished cytokine production and were more vulnerable to DNA viruses, and Mn-deficient STING-deficient mice showed no increased susceptibility. These findings indicate that Mn is critically involved and required for the host defense against DNA viruses.	[Wang, Chenguang; Guan, Yukun; Lv, Mengze; Zhang, Rui; Guo, Zhaoying; Wei, Xiaoming; Yang, Jing; Jiang, Zhengfan] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Wang, Chenguang; Guan, Yukun; Lv, Mengze; Zhang, Rui; Guo, Zhaoying; Wei, Xiaoming; Du, Xiaoxia; Yang, Jing; Su, Xiaodong; Jiang, Zhengfan] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Wang, Chenguang; Guan, Yukun; Lv, Mengze; Zhang, Rui; Guo, Zhaoying; Wei, Xiaoming; Yang, Jing; Huang, Xiaojun; Jiang, Zhengfan] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Tong; Wan, Yi] Peking Univ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Su, Xiaodong] Peking Univ, Peoples Hosp, Inst Hematol,Collaborat Innovat Ctr Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100044, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.; Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Jiang, ZF (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Lyu, Mengze/GXV-3779-2022; Yang, Jing/GLU-3905-2022	Guan, Yukun/0000-0001-9312-0164; Yang, Jing/0000-0001-5414-2141; Lyu, Mengze/0000-0002-8509-7969	National Natural Science Foundation of China [31230023, 91129000, 81621001]; Chinese Ministry of Science and Technology [2015CB943203, 2014CB542600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank Ms. Liying Du, Drs. Hongxia Lv, Yingchun Hu, Hui Li, Guilan Li, and Cheng Li from Core Facilities and Bioinformatics Core Facility, School of Life Sciences, Peking University for assistance with FACS, ITC, protein purification, and statistical tests. We thank Drs. Zhijian Chen for Mavs<SUP>-/-</SUP> mice and cGAS plasmids, Tadatsugu Taniguchi for Irf3<SUP>-/-</SUP> and Irf3<SUP>-/-</SUP>Irf7<SUP>-/-</SUP> mice, Kevin Ryan for Bax<SUP>-/-</SUP>Bak<SUP>-/-</SUP> MEF, and George Stark for HT1080 and its derived mutants. We thank Drs. Rongbin Zhou, Chen Wang, Congyi Zheng, Min Fang, Meilin Jin, Hongbing Shu, and Bernard Roizman for viruses. We are also grateful to Dr. Xiang Zhou for critical reading of the manuscript. This work was supported by National Natural Science Foundation of China (31230023, 91129000 and 81621001) and the Chinese Ministry of Science and Technology (2015CB943203 and 2014CB542600).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Bowman AB, 2014, NEUROTOXICOLOGY, V41, P141, DOI 10.1016/j.neuro.2014.01.010; BRAGADIN M, 1983, EUR J BIOCHEM, V134, P385, DOI 10.1111/j.1432-1033.1983.tb07579.x; Brophy MB, 2015, ACS CHEM BIOL, V10, P641, DOI 10.1021/cb500792b; Carmona A, 2014, METALLOMICS, V6, P822, DOI 10.1039/c4mt00012a; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Clark HL, 2016, J IMMUNOL, V196, P336, DOI 10.4049/jimmunol.1502037; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dai PH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003989; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; FORADORI AC, 1967, J GEN PHYSIOL, V50, P2255, DOI 10.1085/jgp.50.9.2255; Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; GAVIN CE, 1990, BIOCHEM J, V266, P329, DOI 10.1042/bj2660329; GUNTER TE, 1978, BIOCHEMISTRY-US, V17, P339, DOI 10.1021/bi00595a023; Gunter TE, 2013, NEUROTOXICOLOGY, V34, P118, DOI 10.1016/j.neuro.2012.10.018; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Izzo V, 2016, TRENDS CELL BIOL, V26, P655, DOI 10.1016/j.tcb.2016.04.006; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kwakye GF, 2015, INT J ENV RES PUB HE, V12, P7519, DOI 10.3390/ijerph120707519; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; dos Santos APM, 2008, BRAIN RES, V1236, P200, DOI 10.1016/j.brainres.2008.07.125; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; Mizoi Y, 1997, Rinsho Shinkeigaku, V37, P54; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022; Pavelin J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003820; RABIN O, 1993, J NEUROCHEM, V61, P509; Radin JN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006040; Roembke BT, 2014, MOL BIOSYST, V10, P1568, DOI 10.1039/c3mb70518h; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Sarasombath P., 2002, HAWAII MED J, V61, P57; SMIALOWICZ RJ, 1988, IMMUNOPHARM IMMUNOT, V10, P93, DOI 10.3109/08923978809014404; Stacy A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006084; Stelitano V, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt028; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; SUZUKI S, 1987, J BIOL CHEM, V262, P3199; THOLEY G, 1988, NEUROCHEM RES, V13, P45, DOI 10.1007/BF00971853; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Wedler F C, 1993, Prog Med Chem, V30, P89, DOI 10.1016/S0079-6468(08)70376-X; WENTE SR, 1990, P NATL ACAD SCI USA, V87, P2805, DOI 10.1073/pnas.87.7.2805; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	62	173	188	62	303	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					675	+		10.1016/j.immuni.2018.03.017	http://dx.doi.org/10.1016/j.immuni.2018.03.017			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29653696	Bronze			2022-12-18	WOS:000430198900015
J	Heesters, BA; Chatterjee, P; Kim, YA; Gonzalez, SF; Kuligowski, MP; Kirchhausen, T; Carroll, MC				Heesters, Balthasar A.; Chatterjee, Priyadarshini; Kim, Young-A.; Gonzalez, Santiago F.; Kuligowski, Michael P.; Kirchhausen, Tomas; Carroll, Michael C.			Endocytosis and Recycling of Immune Complexes by Follicular Dendritic Cells Enhances B Cell Antigen Binding and Activation	IMMUNITY			English	Article							ALPHA-DEFICIENT MICE; GERMINAL-CENTERS; AFFINITY MATURATION; LYMPHOTOXIN BETA; HUMORAL IMMUNITY; CYTOCHALASIN-D; STROMAL CELLS; IGG RESPONSES; FOLLICLES; RECEPTOR	Stromal-derived follicular dendritic cells (FDCs) are a major reservoir for antigen that are essential for formation of germinal centers, the site where memory and effector B cells differentiate. A long-standing question is how FDCs retain antigen in its native form for extended periods and how they display it to specific B cells. Here we found that FDCs acquired complement-coated immune complexes (ICs) from noncognate B cells via complement receptors 1 and 2 (CD35 and CD21, respectively) and rapidly internalized them by an actin-dependent pathway. ICs were retained intact within a nondegradative cycling compartment and were displayed periodically on the cell surface where they were accessible to antigen-specific B cells. This would explain how antigens are protected from damage and retained over long periods of time, while remaining accessible for B cells.	[Heesters, Balthasar A.; Chatterjee, Priyadarshini; Kim, Young-A.; Gonzalez, Santiago F.; Kuligowski, Michael P.; Kirchhausen, Tomas; Carroll, Michael C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Carroll, Michael C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Heesters, Balthasar A.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center	Carroll, MC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	michael.carroll@childrens.harvard.edu	Heesters, Balthasar/ABA-7594-2021	Heesters, Balthasar/0000-0002-2909-8481; F. Gonzalez, Santiago/0000-0003-4166-7664	National Institutes of Health [RO1 AI039246-16, R37 AI054636, PO1 AI078897-04]; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases [GM-075252, U54 AI057159]; Glaxo-Smith Kline [GSK-P-11-02]; Marie Curie International Outgoing Fellowship for Career Development [220044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI039246, P01AI078897, R37AI054636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; Glaxo-Smith Kline(GlaxoSmithKline); Marie Curie International Outgoing Fellowship for Career Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank all members of the M.C.C. lab and P. Reeves of the T.K. lab for suggestions and help with experiments. We acknowledge the valuable technical assistance with live cell and confocal imaging from E. Marino and H. Leung, respectively, and help by M. Coughlin for preparation of EM sections. Supported by the National Institutes of Health (RO1 AI039246-16, R37 AI054636, and PO1 AI078897-04 to M.C.C.), New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases (GM-075252 and U54 AI057159 to T.K.), Glaxo-Smith Kline (GSK-P-11-02 to M.C.C. and GSK postdoctoral fellowship to P.C.), and Marie Curie International Outgoing Fellowship for Career Development (220044 to S.F.G.).	Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Bajenoff M, 2009, BLOOD, V114, P4989, DOI 10.1182/blood-2009-06-229567; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; BURTON GF, 1991, IMMUNOLOGY, V73, P271; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Cyster JG, 2000, IMMUNOL REV, V176, P181; El Shikh ME, 2006, EUR J IMMUNOL, V36, P2715, DOI 10.1002/eji.200636122; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Fang YF, 1998, J IMMUNOL, V160, P5273; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gommerman JL, 2002, J CLIN INVEST, V110, P1359, DOI 10.1172/JCI200215975; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; HANNA MG, 1968, J IMMUNOL, V101, P949; Kinoshita T., 1991, EXPRESSION COMPLEMEN, V2; Kosco M H, 1988, Adv Exp Med Biol, V237, P883; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; May JA, 1998, PLATELETS, V9, P227, DOI 10.1080/09537109876744; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SZAKAL AK, 1988, J IMMUNOL, V140, P341; Taylor PR, 2002, EUR J IMMUNOL, V32, P1888; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041	39	173	173	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1164	1175		10.1016/j.immuni.2013.02.023	http://dx.doi.org/10.1016/j.immuni.2013.02.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23770227	Green Accepted, Bronze			2022-12-18	WOS:000330947500012
J	Suzuki, K; Maruya, M; Kawamoto, S; Sitnik, K; Kitamura, H; Agace, WW; Fagarasan, S				Suzuki, Keiichiro; Maruya, Mikako; Kawamoto, Shimpei; Sitnik, Katarzyna; Kitamura, Hiroshi; Agace, William W.; Fagarasan, Sidonia			The Sensing of Environmental Stimuli by Follicular Dendritic Cells Promotes Immunoglobulin A Generation in the Gut	IMMUNITY			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; MUCOSAL IGA RESPONSES; APRIL-DEFICIENT MICE; TOLL-LIKE RECEPTORS; RETINOIC ACID; LAMINA PROPRIA; LYMPH-NODE; T-CELLS; CUTTING EDGE	In the Peyer's patches (PPs), germinal centers (GCs) are chronically induced by bacteria and are the major sites for generation of gut immunoglobulin A (IgA) immune responses. Whether follicular dendritic cells (FDCs) within the GCs directly contribute to the IgA production in PPs is unknown. We showed here that direct stimulation of FDCs by bacterial products and retinoic acid synergistically enhanced the expression of the chemokine CXCL13, the survival factor BAFF, and molecules that facilitate the secretion and activation of the cytokine TGF-beta 1. A reduced production of these molecules by PP FDCs associated with deficiencies in the Toll-like receptor pathway or vitamin A resulted in decreased numbers of GC B cells and defective generation of IgA(+) B cells within PP GCs. Our data indicate that PP FDCs are conditioned by environmental stimuli to express key factors for B cell migration, survival, and preferential generation of IgA in gut.	[Suzuki, Keiichiro; Maruya, Mikako; Kawamoto, Shimpei; Fagarasan, Sidonia] RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Kitamura, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Immunogenom, Yokohama, Kanagawa 2300045, Japan; [Kawamoto, Shimpei] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan; [Sitnik, Katarzyna; Agace, William W.] Lund Univ, Immunol Sect, S-22184 Lund, Sweden	RIKEN; RIKEN; Kyoto University; Lund University	Fagarasan, S (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Mucosal Immun, Yokohama 1-7-22, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402; Sitnik, Katarzyna/0000-0002-6965-0322; Agace, william/0000-0003-3823-5772	strategic research program; Naito Foundation	strategic research program; Naito Foundation(Naito Memorial Foundation)	We thank Y. Doi, A. Yagisawa, and Y. Tsutsui for technical assistance; R. Blomhoff, M. Iwata, and H. Ohmori for sharing reagents with us; and T. Honjo, M. Hikida, T. Katakai, and O. Kanagawa for helpful discussion and for comments on the manuscript. This work is supported in part by a strategic research program grant for R&D to S.F. and by a grant from The Naito Foundation to K. Suzuki.	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BATOVA A, 1992, CELL GROWTH DIFFER, V3, P763; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; El Shikh MEM, 2007, J IMMUNOL, V179, P4444, DOI 10.4049/jimmunol.179.7.4444; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; FALK LA, 1991, BLOOD, V77, P1248; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; GROUARD G, 1995, J IMMUNOL, V155, P3345; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; McCarthy DD, 2006, CELL IMMUNOL, V241, P85, DOI 10.1016/j.cellimm.2006.08.002; Mebius RE, 1998, J IMMUNOL, V161, P3836; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nishikawa Y, 2006, J IMMUNOL, V177, P5204, DOI 10.4049/jimmunol.177.8.5204; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Sukumar S, 2006, J IMMUNOL METHODS, V313, P81, DOI 10.1016/j.jim.2006.03.018; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Svensson M, 2008, MUCOSAL IMMUNOL, V1, P38, DOI 10.1038/mi.2007.4; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Teraishi F, 2003, INT J CANCER, V103, P833, DOI 10.1002/ijc.10892; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Wu YZ, 2008, J IMMUNOL, V180, P281, DOI 10.4049/jimmunol.180.1.281; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	52	173	179	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					71	83		10.1016/j.immuni.2010.07.003	http://dx.doi.org/10.1016/j.immuni.2010.07.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643338	Bronze			2022-12-18	WOS:000280418100011
J	Kitoh, A; Ono, M; Naoe, Y; Ohkura, N; Yamaguchi, T; Yaguchi, H; Kitabayashi, I; Tsukada, T; Nomura, T; Miyachi, Y; Taniuchi, I; Sakaguchi, S				Kitoh, Akihiko; Ono, Masahiro; Naoe, Yoshinori; Ohkura, Naganari; Yamaguchi, Tomoyuki; Yaguchi, Hiroko; Kitabayashi, Issay; Tsukada, Toshihiko; Nomura, Takashi; Miyachi, Yoshiki; Taniuchi, Ichiro; Sakaguchi, Shimon			Indispensable Role of the Runx1-Cbf beta Transcription Complex for In Vivo-Suppressive Function of FoxP3(+) Regulatory T Cells	IMMUNITY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; HELPER TYPE-1 CELLS; RUNX1 BINDING-SITE; MEDIATED SUPPRESSION; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; GENE-EXPRESSION; CUTTING EDGE; GRANZYME-B; REPRESSION	Naturally arising regulatory T (Treg) cells express the transcription factor FoxP3, which critically controls the development and function of Treg cells. FoxP3 interacts with another transcription factor Runx1 (also known as AML1). Here, we showed that Treg cell-specific deficiency of Cbf beta, a cofactor for all Runx proteins, or that of Runx1, but not Runx3, induced lymphoproliferation, autoimmune disease, and hyperproduction of IgE. Cbfb-deleted Treg cells exhibited impaired suppressive function in vitro and in vivo, with altered gene expression profiles including attenuated expression of FoxP3 and high expression of interleukin-4. The Runx complex bound to more than 3000 gene loci in Treg cells, including the Foxp3 regulatory regions and the Il4 silencer. In addition, knockdown of RUNX1 showed that RUNX1 is required for the optimal regulation of FoxP3 expression in human T cells. Taken together, our results indicate that the Runx1-Cbf beta heterodimer is indispensable for in vivo Treg cell function, in particular, suppressive activity and optimal expression of FoxP3.	[Kitoh, Akihiko; Ono, Masahiro; Ohkura, Naganari; Yamaguchi, Tomoyuki; Yaguchi, Hiroko; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; [Kitoh, Akihiko; Ono, Masahiro; Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Ono, Masahiro; Ohkura, Naganari; Yaguchi, Hiroko; Sakaguchi, Shimon] Osaka Univ, WPI Immunol Frontier Res Ctr, Expt Immunol Lab, Suita, Osaka 5650871, Japan; [Ohkura, Naganari; Yaguchi, Hiroko; Tsukada, Toshihiko] Natl Canc Ctr, Res Inst, Tumor Endocrinol Project, Tokyo 1040045, Japan; [Kitabayashi, Issay] Natl Canc Ctr, Res Inst, Div Mol Oncol, Tokyo 1040045, Japan	Kyoto University; Kyoto University; Osaka University; National Cancer Center - Japan; National Cancer Center - Japan	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Kitabayashi, Issay/G-2204-2017; Taniuchi, Ichiro/N-6399-2015; Sakaguchi, Shimon/C-9535-2009; Ono, Masahiro/H-2378-2011	Taniuchi, Ichiro/0000-0002-9853-9068; Ono, Masahiro/0000-0002-9284-7326; Yamaguchi, Tomoyuki/0000-0002-4159-5448; Kitabayashi, Issay/0000-0002-8409-0407	Grants-in-Aid for Scientific Research [21791073] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alarcon-Riquelme ME, 2004, ARTHRITIS RES THER, V6, P169, DOI 10.1186/ar1203; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pace L, 2006, J IMMUNOL, V176, P3900, DOI 10.4049/jimmunol.176.7.3900; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Speck NA, 2001, CURR OPIN HEMATOL, V8, P192, DOI 10.1097/00062752-200107000-00002; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yoshida H, 2008, INT J HEMATOL, V87, P19, DOI 10.1007/s12185-007-0004-0; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	45	173	180	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					609	620		10.1016/j.immuni.2009.09.003	http://dx.doi.org/10.1016/j.immuni.2009.09.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19800266	Bronze			2022-12-18	WOS:000271403900012
J	Diao, HY; Kon, S; Iwabuchi, K; Kimura, C; Morimoto, J; Ito, D; Segawa, T; Maeda, M; Hamuro, J; Nakayama, T; Taniguchi, M; Yagita, H; Van Kaer, L; Onoe, K; Denhardt, D; Rittling, S; Uede, T				Diao, HY; Kon, S; Iwabuchi, K; Kimura, C; Morimoto, J; Ito, D; Segawa, T; Maeda, M; Hamuro, J; Nakayama, T; Taniguchi, M; Yagita, H; Van Kaer, L; Onoe, K; Denhardt, D; Rittling, S; Uede, T			Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases	IMMUNITY			English	Article							A-INDUCED HEPATITIS; CONCANAVALIN-A; ALPHA-GALACTOSYLCERAMIDE; IMMUNOHISTOCHEMICAL DETECTION; ALPHA(4)BETA(1) INTEGRIN; GRANULOMA-FORMATION; MULTIPLE-SCLEROSIS; BLOOD-COAGULATION; INDUCED ARTHRITIS; MURINE MODEL	Both osteopontin (OPN) and natural killer T (NKT) cells play a role in the development of immunological disorders. We examined a functional link between OPN and NKT cells. Concanavalin A (Con A)-induced hepatitis is a well-characterized murine model of T cell-mediated liver diseases. Here, we show that NKT cells secrete OPN, which augments NKT cell activation and triggers neutrophil infiltration and activation. Thus, OPN- and NKT cell-deficient mice were refractory to Con A-induced hepatitis. In addition, a neutralizing antibody specific for a cryptic epitope of OPN, exposed by thrombin cleavage, ameliorated hepatitis. These findings identify NKT cell-derived OPN as a novel target for the treatment of inflammatory liver diseases.	Hokkaido Univ, Div Mol Immunol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Inst Med Genet, Div Immunobiol, Sapporo, Hokkaido 0600815, Japan; Immunobiol Labs Co Ltd, Gunma 3750005, Japan; Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki, Kanagawa 2108613, Japan; Chiba Univ, Grad Sch Med, Dept Immunol, Chiba 2608670, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Immune Regulat, Yokohama, Kanagawa 2300045, Japan; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Hokkaido University; Hokkaido University; Immuno-Biological Laboratories Co. Ltd.; Ajinomoto Co Inc; Chiba University; RIKEN; Juntendo University; Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Uede, T (corresponding author), Hokkaido Univ, Div Mol Immunol, Sapporo, Hokkaido 0600815, Japan.	toshi@igm.hokudai.ac.jp	uede, toshimitsu/A-4273-2012; Ito, Daisuke/C-7593-2014; Nakayama, Toshinori/E-1067-2017; Van Kaer, Luc/H-1033-2015	Ito, Daisuke/0000-0003-1350-637X; Nakayama, Toshinori/0000-0002-1434-2007; Van Kaer, Luc/0000-0001-5275-2309				Arai M, 1996, TRANSPLANTATION, V62, P1398, DOI 10.1097/00007890-199611270-00004; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BAJT MK, 2001, LIVER PHYSL, V281, pG1188; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45; Brown KE, 2001, AM J PATHOL, V159, P2081, DOI 10.1016/S0002-9440(10)63059-3; Burdin N, 1998, J IMMUNOL, V161, P3271; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Copple BL, 2003, J PHARMACOL EXP THER, V305, P417, DOI 10.1124/jpet.102.046391; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; ESMON CT, 1993, ANNU REV CELL BIOL, V9, P1; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; FENG LL, 1995, J CLIN INVEST, V95, P1009, DOI 10.1172/JCI117745; Grone HJ, 2002, LAB INVEST, V82, P5, DOI 10.1038/labinvest.3780390; Iwabuchi K, 2001, BLOOD, V97, P1765, DOI 10.1182/blood.V97.6.1765; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kon S, 2002, J CELL BIOCHEM, V84, P420, DOI 10.1002/jcb.10039; LEIRISALOREPO M, 1994, PHARMACOL TOXICOL, V75, P1, DOI 10.1111/j.1600-0773.1994.tb01988.x; Louis H, 1997, HEPATOLOGY, V25, P1382, DOI 10.1002/hep.510250614; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; McFarlane IG, 1999, BIOMED PHARMACOTHER, V53, P255, DOI 10.1016/S0753-3322(99)80096-1; Miyazawa Y, 1998, HEPATOLOGY, V27, P497, DOI 10.1002/hep.510270225; Morimoto J, 2004, INT IMMUNOL, V16, P477, DOI 10.1093/intimm/dxh044; Moriyama H, 1997, AM J PATHOL, V150, P2047; Nakamura K, 2002, J HEPATOL, V36, P766, DOI 10.1016/S0168-8278(02)00059-4; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Ramsaransing G, 2003, J NEUROL NEUROSUR PS, V74, P953, DOI 10.1136/jnnp.74.7.953; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Singh N, 1999, J IMMUNOL, V163, P2373; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Steinman L, 2003, NAT REV IMMUNOL, V3, P483, DOI 10.1038/nri1108; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Tanaka K, 2004, AM J PATHOL, V164, P567, DOI 10.1016/S0002-9440(10)63146-X; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; YASUDA M, 1995, INT IMMUNOL, V7, P251, DOI 10.1093/intimm/7.2.251; Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599	57	173	191	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					539	550		10.1016/j.immuni.2004.08.012	http://dx.doi.org/10.1016/j.immuni.2004.08.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485631	Bronze			2022-12-18	WOS:000224744400010
J	Shigematsu, H; Reizis, B; Iwasaki, H; Mizuno, S; Hu, D; Traver, D; Leder, P; Sakaguchi, N; Akashi, K				Shigematsu, H; Reizis, B; Iwasaki, H; Mizuno, S; Hu, D; Traver, D; Leder, P; Sakaguchi, N; Akashi, K			Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin	IMMUNITY			English	Article							RECEPTOR-ALPHA-GENE; COMMON PRECURSOR POPULATION; HEMATOPOIETIC STEM-CELLS; MOUSE BONE-MARROW; T-CELLS; MYELOID PROGENITOR; FLT3 LIGAND; COMMITTED PROGENITORS; ARTIFICIAL CHROMOSOME; DEFICIENT MICE	The developmental origin of type I interferon (IFN)-producing plasmacytoid dendritic cells (PDCs) is controversial. In particular, the rearrangement of immunoglobulin heavy chain (IgH) genes in murine PDCs and the expression of pre-T cell receptor alpha (pTalpha) gene by human PDCs were proposed as evidence for their "lymphoid" origin. Here we demonstrate that PDCs capable of IFN production develop efficiently from both myeloid- and lymphoid-committed progenitors. Rearranged IgH genes as well as RAG transcripts were found in both myeloid- and lymphoid-derived PDCs. The human pTalpha transgenic reporter was activated in both myeloid- and lymphoid-derived PDCs at a level comparable to pre-T cells. PDCs were the only cell population that activated murine RAG1 knockin and human pTalpha transgenic reporters outside the lymphoid lineage. These results highlight a unique developmental program of PDCs that distinguishes them from other cell types including conventional dendritic cells.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Dept Hematol Oncol, Boston, MA 02115 USA; Kumamoto Univ, Grad Sch Med Sci, Dept Immunol, Kumamoto 8608556, Japan; Kyushu Univ Hosp, Ctr Cellular & Mol Med, Higashi Ku, Fukuoka 8128582, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Kumamoto University	Akashi, K (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	koichi_akashi@dfci.harvard.edu		Reizis, Boris/0000-0003-1140-7853	NCI NIH HHS [CA072009] Funding Source: Medline; NIDDK NIH HHS [DK061320, DK050654] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061320, P01DK050654] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bendriss-Vermare N, 2001, J CLIN INVEST, V107, P835, DOI 10.1172/JCI11734; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Gilliet M, 2002, J EXP MED, V195, P695, DOI 10.1084/jem.20011603; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Igarashi H, 2001, BLOOD, V97, P2680, DOI 10.1182/blood.V97.9.2680; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Izon D, 2001, J IMMUNOL, V167, P1387, DOI 10.4049/jimmunol.167.3.1387; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kuwata N, 1999, J IMMUNOL, V163, P6355; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Okada T, 2003, EUR J IMMUNOL, V33, P1012, DOI 10.1002/eji.200323616; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; Olweus J, 1996, BLOOD, V88, P3741, DOI 10.1182/blood.V88.10.3741.bloodjournal88103741; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; Reizis B, 1999, J EXP MED, V189, P1669, DOI 10.1084/jem.189.10.1669; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Res PCM, 1999, BLOOD, V94, P2647, DOI 10.1182/blood.V94.8.2647.420k06_2647_2657; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376	60	173	180	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2004	21	1					43	53		10.1016/j.immuni.2004.06.011	http://dx.doi.org/10.1016/j.immuni.2004.06.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345219	Bronze			2022-12-18	WOS:000222975500007
J	Souabni, A; Cobaleda, C; Schebesta, M; Busslinger, M				Souabni, A; Cobaleda, C; Schebesta, M; Busslinger, M			PaX5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1	IMMUNITY			English	Article							HELIX INHIBITOR ID2; TRANSCRIPTION FACTOR; LYMPHOID LINEAGE; STEM-CELLS; IKAROS; MICE; EXPRESSION; DIFFERENTIATION; PROGENITORS; GENE	The B lineage commitment factor Pax5 (BSAP) is exclusively expressed in B lymphocytes of the blood system. To study the effect of Pax5 on the development of other hematopoietic lineages, we generated a heterozygous knockin mouse carrying a Pax5 minigene under the control of the Ikaros locus. Conditional and constitutive activation of the Ik(Pax5) allele demonstrated that precocious Pax5 expression in hematopoietic stem cells and progenitors failed to interfere with myeloid development and only weakly affected erythroblast formation. Instead, pan-hematopoietic Pax5 expression strongly promoted B cell development at the expense of T lymphopoiesis. Pax5 thereby interfered with T lineage commitment and early thymocyte development by repressing the transcription of the T cell specification gene Notch1.	Res Inst Mol Pathol, Vienna Bioctr, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Busslinger, M (corresponding author), Res Inst Mol Pathol, Vienna Bioctr, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Busslinger, Meinrad J./J-1249-2016; Cobaleda, Cesar/D-4668-2011; Schebesta, Michael/B-5891-2008	Busslinger, Meinrad J./0000-0002-9111-9351; Cobaleda, Cesar/0000-0003-3807-9204; 				Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Izon DJ, 2002, CURR OPIN IMMUNOL, V14, P192, DOI 10.1016/S0952-7915(02)00321-7; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lin Q, 1998, J EXP MED, V187, P79, DOI 10.1084/jem.187.1.79; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; ROLINK A, 1993, BLOOD, V81, P2290; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; von Boehmer H, 1999, CURR OPIN IMMUNOL, V11, P135, DOI 10.1016/S0952-7915(99)80024-7; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	35	173	180	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					781	793		10.1016/S1074-7613(02)00472-7	http://dx.doi.org/10.1016/S1074-7613(02)00472-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479824	Bronze			2022-12-18	WOS:000179985500010
J	Thomas, DA; Du, CY; Xu, M; Wang, XD; Ley, TJ				Thomas, DA; Du, CY; Xu, M; Wang, XD; Ley, TJ			DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis	IMMUNITY			English	Article							CASPASE-ACTIVATED DNASE; CYTOTOXIC LYMPHOCYTES; CELL-DEATH; CHROMATIN CONDENSATION; MEDIATED APOPTOSIS; FAMILY PROTEASES; RAPID INDUCTION; TARGET-CELLS; FRAGMENTATION; CLEAVAGE	Granzyme B (GzmB) is a component of cytotoxic lymphocyte granules that can rapidly initiate apoptosis in target cells. While several procaspases are cleaved and activated by GzmB, the absolute requirement of caspase activation for GzmB-induced apoptosis is controversial. In this report, we demonstrate that GzmB can initiate apoptosis in the absence of caspase-3 activity by directly cleaving DFF45/ICAD to liberate activated DFF40/CAD. DFF45/ICAD cleavage occurs less efficiently in cells that lack caspase-3 activity, suggesting that the caspases normally amplify the GzmB death signal. DFF45/ICAD-deficient mouse embryo fibroblasts are partially resistant to GzmB-induced death, demonstrating the biological importance of DFF45/ICAD for GzmB-mediated apoptosis.	Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, Div Oncol, St Louis, MO 63110 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	timley@im.wustl.edu		Wang, Xiaodong/0000-0001-9885-356X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049786] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07088] Funding Source: Medline; NIDDK NIH HHS [DK49786] Funding Source: Medline; NIGMS NIH HHS [GMR01-55942] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrade F, 1998, IMMUNITY, V8, P451, DOI 10.1016/S1074-7613(00)80550-6; Atkinson EA, 1998, J BIOL CHEM, V273, P21261, DOI 10.1074/jbc.273.33.21261; CAPUTO A, 1994, NAT STRUCT BIOL, V1, P364, DOI 10.1038/nsb0694-364; Chinnaiyan AM, 1996, CURR BIOL, V6, P897, DOI 10.1016/S0960-9822(02)00614-0; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; Heibein JA, 1999, J IMMUNOL, V163, P4683; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Macen JL, 1996, P NATL ACAD SCI USA, V93, P9108, DOI 10.1073/pnas.93.17.9108; Maclvor DM, 1999, BLOOD, V93, P963, DOI 10.1182/blood.V93.3.963.403k18_963_973; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Pham CTN, 1998, J BIOL CHEM, V273, P1629, DOI 10.1074/jbc.273.3.1629; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sarin A, 1998, J IMMUNOL, V161, P2810; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Shi LF, 1996, P NATL ACAD SCI USA, V93, P11002, DOI 10.1073/pnas.93.20.11002; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Trapani JA, 1998, J BIOL CHEM, V273, P27934, DOI 10.1074/jbc.273.43.27934; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Zhang JH, 1999, J BIOL CHEM, V274, P37450, DOI 10.1074/jbc.274.52.37450; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	43	173	177	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					621	632		10.1016/S1074-7613(00)80213-7	http://dx.doi.org/10.1016/S1074-7613(00)80213-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894162	Bronze			2022-12-18	WOS:000087937300004
J	Garcia, S; DiSanto, J; Stockinger, B				Garcia, S; DiSanto, J; Stockinger, B			Following the development of a CD4 T cell response in vivo: From activation to memory formation	IMMUNITY			English	Article							IN-VIVO; TOLERANCE INDUCTION; VIRAL-INFECTION; DENDRITIC CELLS; SELF-ANTIGEN; MONOCLONAL-ANTIBODIES; CLONAL ELIMINATION; MOUSE MACROPHAGE; SURVIVAL; BCL-2	The in vivo differentiation of CD4 T cells from naive to memory cells was followed after their adoptive transfer together with syngeneic dendritic cells into MHC mismatched adoptive hosts lacking lymphocytes and NK cells. Functional and molecular changes were measured as the antigenic stimulus, provided by the cotransferred dendritic cells, disappeared. Memory cells as opposed to effector cells show an inversion in the relative expression of Bcl-2 family members in favor of antiapoptotic molecules, and compared with naive cells they have an increased ratio of bcl-x(L) to bcl-2. They differ qualitatively from naive T cells, suggesting that accelerated CD4 memory responses can occur without the need for increased frequencies of specific T cells.	Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; Hop Necker Enfants Malad, INSERM, U429, F-75743 Paris, France	MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stockinger, B (corresponding author), Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	b-stocki@nimr.mrc.ac.uk	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862; Stockinger, Brigitta/0000-0001-8781-336X; Garcia, Sylvie/0000-0002-7655-8911				AKBAR AN, 1993, IMMUNOL TODAY, V14, P526, DOI 10.1016/0167-5699(93)90181-J; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Barthlott T, 1998, J IMMUNOL, V161, P3992; BREEL M, 1987, EUR J IMMUNOL, V17, P1555, DOI 10.1002/eji.1830171105; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; De Smedt T, 1998, J IMMUNOL, V161, P4476; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; Farber DL, 1998, J IMMUNOL, V160, P535; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Gray D, 1996, IMMUNOL REV, V150, P45, DOI 10.1111/j.1600-065X.1996.tb00695.x; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lecoeur H, 1997, J IMMUNOL METHODS, V209, P111, DOI 10.1016/S0022-1759(97)00138-5; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; MOSKOPHIDIS D, 1993, EUR J IMMUNOL, V23, P3306, DOI 10.1002/eji.1830231237; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NUNEZ G, 1991, NATURE, V353, P71, DOI 10.1038/353071a0; Oehen S, 1998, J IMMUNOL, V161, P5338; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; STOCKINGER B, 1994, INT IMMUNOL, V6, P247, DOI 10.1093/intimm/6.2.247; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; SWAIN SL, 1994, IMMUNITY, V1, P543, DOI 10.1016/1074-7613(94)90044-2; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; TANCHOT C, 1995, EUR J IMMUNOL, V25, P2127, DOI 10.1002/eji.1830250802; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Tanchot C, 1998, IMMUNOL TODAY, V19, P575, DOI 10.1016/S0167-5699(98)01344-9; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Varga SM, 1998, J IMMUNOL, V161, P367; Volkmann A, 1997, J IMMUNOL, V158, P693; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	60	173	176	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1999	11	2					163	171		10.1016/S1074-7613(00)80091-6	http://dx.doi.org/10.1016/S1074-7613(00)80091-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485651	Bronze			2022-12-18	WOS:000082383400005
J	Kwong, PD; Mascola, JR				Kwong, Peter D.; Mascola, John R.			HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure	IMMUNITY			English	Review							BROADLY NEUTRALIZING ANTIBODIES; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; IG KNOCKIN MICE; RESPIRATORY SYNCYTIAL VIRUS; FUSION-GLYCOPROTEIN VACCINE; INFLUENZA-A VIRUSES; CRYO-EM STRUCTURE; CD4 BINDING-SITE; ENVELOPE TRIMER	HIV-1 vaccine development has been stymied by an inability to induce broadly reactive neutralizing antibodies to the envelope (Env) trimer, the sole viral antigen on the virion surface. Antibodies isolated from HIV-1-infected donors, however, have been shown to recognize all major exposed regions of the prefusion-closed Env trimer, and an emerging understanding of the immunological and structural characteristics of these antibodies and the epitopes they recognize is enabling new approaches to vaccine design. Antibody lineage-based design creates immunogens that activate the naive ancestor-B cell of a target antibody lineage and that mature intermediate-B cells toward effective neutralization, with proof of principle achieved with select HIV-1-neutralizing antibody lineages in human-gene knock-in mouse models. Epitope-based vaccine design involves the engineering of sites of Env vulnerability as defined by the recognition of broadly neutralizing antibodies, with cross-reactive neutralizing antibodies elicited in animal models. Both epitope-based and antibody lineage-based HIV-1 vaccine approaches are being readied for human clinical trials.	[Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwong, PD; Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov	Mascola, John/AAI-7193-2021		Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005112, ZIAAI005024, ZICAI005113, ZICAI005114, ZICAI005111] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G.-Y. Chuang, J. Gorman, C.-H. Shen, T. Zhou, and J. Stuckey for assistance with figures and the Structural Bioinformatics Core and the Humoral Immunology Section, Vaccine Research Center, for discussions and comments on the manuscript. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health. This work was also supported in part by the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Agrawal-Gamse C, 2011, J VIROL, V85, P470, DOI 10.1128/JVI.01349-10; Alam SM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7521; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boyington JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159709; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Briney BS, 2012, IMMUNOLOGY, V137, P56, DOI 10.1111/j.1365-2567.2012.03605.x; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chuang G-Y, 2018, BIORXIV, DOI [10.1101/312579, DOI 10.1101/312579]; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crowe JE, 2016, CELL, V166, P1360, DOI 10.1016/j.cell.2016.08.039; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Dingens A. S., 2018, BIORXIV, DOI [10.1101/307587, DOI 10.1101/307587]; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Farzan M, 1998, J VIROL, V72, P7620, DOI 10.1128/JVI.72.9.7620-7625.1998; Freund NT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2144; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Georgiev IS, 2018, ACS INFECT DIS, V4, P788, DOI 10.1021/acsinfecdis.7b00192; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gilbert Peter B, 2017, Stat Commun Infect Dis, V9, DOI 10.1515/scid-2016-0001; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Guenaga J, 2017, IMMUNITY, V46, P792, DOI 10.1016/j.immuni.2017.04.014; Halper-Stromberg A, 2016, J CLIN INVEST, V126, P415, DOI 10.1172/JCI80561; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Ingale J, 2014, J VIROL, V88, P14002, DOI 10.1128/JVI.02614-14; Irimia A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006212; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joyce MG, 2017, CELL REP, V21, P2992, DOI 10.1016/j.celrep.2017.11.016; Joyce MG, 2016, NAT STRUCT MOL BIOL, V23, P811, DOI 10.1038/nsmb.3267; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kwon YD, 2018, CELL REP, V22, P1798, DOI 10.1016/j.celrep.2018.01.023; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2017, IMMUNOL REV, V275, P108, DOI 10.1111/imr.12480; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Luallen RJ, 2008, J VIROL, V82, P6447, DOI 10.1128/JVI.00412-08; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mayer KH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002435; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; Moore PL, 2017, IMMUNOL REV, V275, P217, DOI 10.1111/imr.12501; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Rujas E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38177; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Rutten L, 2018, CELL REP, V23, P584, DOI 10.1016/j.celrep.2018.03.061; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Saunders KO, 2017, CELL REP, V18, P2175, DOI 10.1016/j.celrep.2017.02.003; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shivatare VS, 2018, J AM CHEM SOC, V140, P5202, DOI 10.1021/jacs.8b00896; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Stamatatos L, 2017, IMMUNOL REV, V275, P203, DOI 10.1111/imr.12483; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; UNAIDS, 2021, CONFR IN LESS PAND R; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Verkoczy L, 2017, IMMUNOL REV, V275, P89, DOI 10.1111/imr.12505; Voss JE, 2018, CELL REP, V22, P1103, DOI 10.1016/j.celrep.2017.10.089; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Williams WB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01336-3; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Xu K., 2018, BIORXIV, DOI [10.1101/306282, DOI 10.1101/306282]; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zhang H, 2015, VACCINE, V33, P5140, DOI 10.1016/j.vaccine.2015.08.012; Zhang RJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0618; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2018, IMMUNITY, V48, P500, DOI 10.1016/j.immuni.2018.02.013; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099881; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	199	172	177	6	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					855	871		10.1016/j.immuni.2018.04.029	http://dx.doi.org/10.1016/j.immuni.2018.04.029			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768174	Bronze			2022-12-18	WOS:000432488600009
J	Ahrends, T; Spanjaard, A; Pilzecker, B; Babala, N; Bovens, A; Xiao, YL; Jacobs, H; Borst, J				Ahrends, Tomasz; Spanjaard, Aldo; Pilzecker, Bas; Babala, Nikolina; Bovens, Astrid; Xiao, Yanling; Jacobs, Heinz; Borst, Jannie			CD4(+) T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness	IMMUNITY			English	Article							CD27-CD70 INTERACTIONS; DIFFERENTIATION; TUMORS; LYMPHOCYTES; EXPRESSION; RESPONSES; CD27; TRAFFICKING; SURVIVAL; SIGNALS	CD4(+) T cells optimize the cytotoxic T cell (CTL) response in magnitude and quality, by unknown molecular mechanisms. We here present the transcriptomic changes in CTLs resulting from CD4(+) T cell help after anti-cancer vaccination or virus infection. The gene expression signatures revealed that CD4(+) T cell help during priming optimized CTLs in expression of cytotoxic effector molecules and many other functions that ensured efficacy of CTLs throughout their life cycle. Key features included downregulation of PD-1 and other coinhibitory receptors that impede CTL activity, and increased motility and migration capacities. "Helped'' CTLs acquired chemokine receptors that helped them reach their tumor target tissue and metalloprotease activity that enabled them to invade into tumor tissue. A very large part of the "help'' program was instilled in CD8(+) T cells via CD27 costimulation. The help program thus enhances specific CTL effector functions in response to vaccination or a virus infection.	[Ahrends, Tomasz; Spanjaard, Aldo; Pilzecker, Bas; Babala, Nikolina; Bovens, Astrid; Xiao, Yanling; Jacobs, Heinz; Borst, Jannie] Netherlands Canc Inst Antoni van Leeuwenhoek, Div Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Borst, J (corresponding author), Netherlands Canc Inst Antoni van Leeuwenhoek, Div Tumor Biol & Immunol, NL-1066 CX Amsterdam, Netherlands.	j.borst@nki.nl		Borst, Jannie/0000-0002-8043-5009; Ahrends, Tomasz/0000-0002-1424-1230; Pilzecker, Bas/0000-0002-3407-9197; Xiao, Yanling/0000-0003-1755-1709	Dutch Cancer Society [NKI 2012-5397]; KWF [NKI 2012-5243]; Netherlands Organization for Scientific Research; ZonMW Top grant [91213018]	Dutch Cancer Society(KWF Kankerbestrijding); KWF; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMW Top grant	This research was supported by grant NKI 2012-5397 of the Dutch Cancer Society to J.B. and KWF grant NKI 2012-5243 and the Netherlands Organization for Scientific Research and ZonMW Top grant 91213018 to H.J. J.B. is inventor on a patent regarding CD27 agonist antibodies.	Ahrends T, 2016, CANCER RES, V76, P2921, DOI 10.1158/0008-5472.CAN-15-3130; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Dunussi-Joannopoulos K, 2002, BLOOD, V100, P1551, DOI 10.1182/blood.V100.5.1551.h81702001551_1551_1558; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Feau S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1948; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Greyer M, 2016, CELL REP, V14, P586, DOI 10.1016/j.celrep.2015.12.058; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Karlstrom S, 2013, J MED CHEM, V56, P3177, DOI 10.1021/jm3012273; Lin KY, 1996, CANCER RES, V56, P21; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Nolz JC, 2011, IMMUNOTHERAPY-UK, V3, P1223, DOI [10.2217/IMT.11.100, 10.2217/imt.11.100]; Oshima H, 1998, INT IMMUNOL, V10, P517, DOI 10.1093/intimm/10.4.517; Owen JL, 2003, J IMMUNOL, V171, P4340, DOI 10.4049/jimmunol.171.8.4340; Peperzak V, 2010, J IMMUNOL, V185, P6670, DOI 10.4049/jimmunol.1000159; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Sakanishi T, 2010, BIOCHEM BIOPH RES CO, V393, P829, DOI 10.1016/j.bbrc.2010.02.092; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Siddiqui I, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0125-1; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Osterk MF, 2007, INT IMMUNOL, V19, P713, DOI 10.1093/intimm/dxm033; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007	39	172	176	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					848	+		10.1016/j.immuni.2017.10.009	http://dx.doi.org/10.1016/j.immuni.2017.10.009			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29126798	Bronze			2022-12-18	WOS:000416483700010
J	Lee, YJ; Wang, HG; Starrett, GJ; Phuong, V; Jameson, SC; Hogquist, KA				Lee, You Jeong; Wang, Haiguang; Starrett, Gabriel J.; Phuong, Vanessa; Jameson, Stephen C.; Hogquist, Kristin A.			Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response	IMMUNITY			English	Article							INVARIANT NKT CELLS; KILLER T-CELLS; ALPHA-GALACTOSYLCERAMIDE; ORPHAN RECEPTOR; CUTTING EDGE; ACTIVATION; IDENTIFICATION; HOMEOSTASIS; EXPRESSION; PROGRAM	Three subsets of invariant natural killer T (iNKT) cells have been identified, NKT1, NKT2, and NKT17, which produce distinct cytokines when stimulated, but little is known about their localization. Here, we have defined the anatomic localization and systemic distribution of these subsets and measured their cytokine production. Thymic NKT2 cells that produced interleukin-4 (IL-4) at steady state were located in the medulla and conditioned medullary thymocytes. NKT2 cells were abundant in the mesenteric lymph node (LN) of BALB/c mice and produced IL-4 in the T cell zone that conditioned other lymphocytes. Intravenous injection of alpha-galactosylceramide activated NKT1 cells with vascular access, but not LN or thymic NKT cells, resulting in systemic interferon-gamma and IL-4 production, while oral alpha-galactosylceramide activated NKT2 cells in the mesenteric LN, resulting in local IL-4 release. These findings indicate that the localization of iNKT cells governs their cytokine response both at steady state and upon activation.	[Lee, You Jeong; Wang, Haiguang; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; [Starrett, Gabriel J.] Univ Minnesota, Biochem Mol Biol & Biophys Dept, Minneapolis, MN 55455 USA; [Phuong, Vanessa] Johns Hopkins Univ, Publ Hlth Studies & Biol, Baltimore, MD 21218 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu	Jameson, Stephen C/D-9892-2013; Lee, You Jeong/T-6086-2019	Jameson, Stephen C/0000-0001-9137-1146; Wang, Haiguang/0000-0001-5403-9179; Starrett, Gabriel/0000-0001-5871-5306	NIH [R37-AI39560, RO1-AI075168, K99-AI114884]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI114884, R01AI075168, R37AI039560, R01AI039560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Michael Y. Gerner (NIH) for technical comments. This research was supported by NIH grants R37-AI39560 (to K.A.H.), RO1-AI075168 (to S.C.J.), and K99-AI114884 (to Y.J.L).	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Carreno LJ, 2014, IMMUNOTHERAPY-UK, V6, P309, DOI 10.2217/imt.13.175; Castillo EF, 2010, BLOOD, V116, P2494, DOI 10.1182/blood-2010-03-277103; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Drennan MB, 2009, J IMMUNOL, V183, P2213, DOI 10.4049/jimmunol.0901213; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Engel I, 2014, CURR TOP MICROBIOL, V381, P51, DOI 10.1007/82_2014_375; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gray EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038258; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Holzapfel KL, 2014, J IMMUNOL, V192, P5490, DOI 10.4049/jimmunol.1400722; Irla M, 2013, J IMMUNOL, V190, P586, DOI 10.4049/jimmunol.1200119; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; King IL, 2013, J IMMUNOL, V191, P572, DOI 10.4049/jimmunol.1300299; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Loh L, 2014, MUCOSAL IMMUNOL, V7, P1233, DOI 10.1038/mi.2014.13; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pellicci DG, 2003, EUR J IMMUNOL, V33, P1816, DOI 10.1002/eji.200323894; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Singh M, 2014, BRIT J CANCER, V111, P1945, DOI 10.1038/bjc.2014.486; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Venkataswamy MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108383; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; White AJ, 2014, J IMMUNOL, V192, P2659, DOI 10.4049/jimmunol.1303057; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017	51	172	173	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					566	578		10.1016/j.immuni.2015.06.025	http://dx.doi.org/10.1016/j.immuni.2015.06.025			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26362265	Bronze, Green Accepted			2022-12-18	WOS:000361575300009
J	Ramanan, D; Tang, MS; Bowcutt, R; Loke, P; Cadwell, K				Ramanan, Deepshika; Tang, Mei San; Bowcutt, Rowann; Loke, P'ng; Cadwell, Ken			Bacterial Sensor Nod2 Prevents Inflammation of the Small Intestine by Restricting the Expansion of the Commensal Bacteroides vulgatus	IMMUNITY			English	Article							AUTOPHAGY GENE ATG16L1; CROHNS-DISEASE; BOWEL-DISEASE; MURAMYL DIPEPTIDE; PANETH CELLS; GUT MICROBIOTA; HOST; COLITIS; MOUSE; MICE	Nod2 has been extensively characterized as a bacterial sensor that induces an antimicrobial and inflammatory gene expression program. Therefore, it is unclear why Nod2 mutations that disrupt bacterial recognition are paradoxically among the highest risk factors for Crohn's disease, which involves an exaggerated immune response directed at intestinal bacteria. Here, we identified several abnormalities in the small-intestinal epithelium of Nod2(-/-) mice including inflammatory gene expression and goblet cell dysfunction, which were associated with excess interferon-gamma production by intraepithelial lymphocytes and Myd88 activity. Remarkably, these abnormalities were dependent on the expansion of a common member of the intestinal microbiota Bacteroides vulgatus, which also mediated exacerbated inflammation in Nod2(-/-) mice upon small-intestinal injury. These results indicate that Nod2 prevents inflammatory pathologies by controlling the microbiota and support a multihit disease model involving specific gene-microbe interactions.	[Ramanan, Deepshika; Cadwell, Ken] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ramanan, Deepshika] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; [Tang, Mei San; Bowcutt, Rowann; Loke, P'ng; Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University; New York University	Cadwell, K (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu	Loke, Png/X-2278-2019	Cadwell, Ken/0000-0002-5860-0661	Cancer Center Support [P30CA016087]; NCRR [S10 RR023704-01A1]; NIH [R01 DK093668, AI093811]; Broad Medical Research Program; Kevin and Marsha Keating Family Foundation; NIH/NCATS [UL1 TR000038]; Crohn's & Colitis Foundation of America Genetics Pilot Award; New York University Whitehead Fellowship; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093668] Funding Source: NIH RePORTER	Cancer Center Support; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Program; Kevin and Marsha Keating Family Foundation; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Crohn's & Colitis Foundation of America Genetics Pilot Award; New York University Whitehead Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank D. Littman and S. Schwab for providing reagents, Y. Deng for assistance with confocal microscopy (NCRR S10 RR023704-01A1), J. Zavadil for assistance with microarray analysis, NYULMC OCS microscopy core for their assistance with transmission electron microscopy, and genome technology center, flow cytometry, and histopathology cores (Cancer Center Support Grant, P30CA016087) for assistance with sample preparation and analyses. This research was supported by NIH grants R01 DK093668 (D.R. and K.C.) and AI093811 (P.L.); The Broad Medical Research Program (P.L.); Kevin and Marsha Keating Family Foundation (P.L.); NIH/NCATS UL1 TR000038 (K.C. and P.L.); Crohn's & Colitis Foundation of America Genetics Pilot Award (K.C.); and New York University Whitehead Fellowship (K.C.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Asquith MJ, 2010, GASTROENTEROLOGY, V139, P519, DOI 10.1053/j.gastro.2010.04.045; Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Billmann-Born S, 2011, J IMMUNOL, V186, P4027, DOI 10.4049/jimmunol.1000085; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kim YG, 2011, J IMMUNOL, V187, P2849, DOI 10.4049/jimmunol.1001854; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Mondot S, 2012, GUT, V61, P634, DOI 10.1136/gutjnl-2011-300478; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Shanahan MT, 2014, GUT, V63, P903, DOI 10.1136/gutjnl-2012-304190; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JCI33145, 10.1172/JC133145]; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07	46	172	178	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					311	324		10.1016/j.immuni.2014.06.015	http://dx.doi.org/10.1016/j.immuni.2014.06.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25088769	Green Accepted, Bronze			2022-12-18	WOS:000341455300017
J	Babon, JJ; Kershaw, NJ; Murphy, JM; Varghese, LN; Laktyushin, A; Young, SN; Lucet, IS; Norton, RS; Nicola, NA				Babon, Jeffrey J.; Kershaw, Nadia J.; Murphy, James M.; Varghese, Leila N.; Laktyushin, Artem; Young, Samuel N.; Lucet, Isabelle S.; Norton, Raymond S.; Nicola, Nicos A.			Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity	IMMUNITY			English	Article							JANUS TYROSINE KINASE; SH2 DOMAIN; PSEUDOKINASE DOMAIN; IN-VIVO; UNSTRUCTURED INSERTION; POLYCYTHEMIA-VERA; UBIQUITIN LIGASE; JAK2; BOX; PROTEIN	Janus kinases (JAKs) are key effectors in controlling immune responses and maintaining hematopoiesis. SOCS3 (suppressor of cytokine signaling-3) is a major regulator of JAK signaling and here we investigate the molecular basis of its mechanism of action. We found that SOCS3 bound and directly inhibited the catalytic domains of JAK1, JAK2, and TYK2 but not JAK3 via an evolutionarily conserved motif unique to JAKs. Mutation of this motif led to the formation of an active kinase that could not be inhibited by SOCS3. Surprisingly, we found that SOCS3 simultaneously bound JAK and the cytokine receptor to which it is attached, revealing how specificity is generated in SOCS action and explaining why SOCS3 inhibits only a subset of cytokines. Importantly, SOCS3 inhibited JAKs via a noncompetitive mechanism, making it a template for the development of specific and effective inhibitors to treat JAK-based immune and proliferative diseases.	[Babon, Jeffrey J.; Kershaw, Nadia J.; Murphy, James M.; Varghese, Leila N.; Laktyushin, Artem; Young, Samuel N.; Norton, Raymond S.; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Babon, Jeffrey J.; Murphy, James M.; Varghese, Leila N.; Norton, Raymond S.; Nicola, Nicos A.] Univ Melbourne, Parkville, Vic 3050, Australia; [Kershaw, Nadia J.] Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Lucet, Isabelle S.] Monash Univ, Clayton, Vic 3800, Australia	Walter & Eliza Hall Institute; University of Melbourne; Ludwig Institute for Cancer Research; Monash University	Babon, JJ (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Pde, Parkville, Vic 3052, Australia.	babon@wehi.edu.au; nicola@wehi.edu.au	Kershaw, Nadia/G-5770-2014; babon, jeffrey j/B-9170-2013; Nicola, Nicos/D-2989-2011; Murphy, James/B-4863-2017	babon, jeffrey j/0000-0002-5408-6239; Nicola, Nicos/0000-0003-1054-7889; Murphy, James/0000-0003-0195-3949; Varghese, Leila/0000-0003-2476-0306; Norton, Raymond/0000-0001-8893-0584; Kershaw, Nadia/0000-0002-3554-2622	National Health and Medical Research Council of Australia [461219, 487922, 1011804]; U.S. National Institutes of Health [CA22556]; Victorian State Government; NHMRC [361646]; National Health and Medical Research Council; Australian Research Council; Leukaemia Foundation of Australia and the Australian Stem Cell Centre; NATIONAL CANCER INSTITUTE [R01CA022556, R37CA022556] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian State Government; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Leukaemia Foundation of Australia and the Australian Stem Cell Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Yao for assistance with NMR, A. Bullock for plasmids, J.-G. Zhang for recombinant IL-6, and the ACRF Biomolecular Resource Facility for sequencing. We are grateful to P. Hertzog for the gift of U4A cells. This work was supported in part by the National Health and Medical Research Council of Australia (program grant nos. 461219 and 487922 and project grant no. 1011804), the U.S. National Institutes of Health (grant no. CA22556), the Victorian State Government Operational Infrastructure Support Grant, and the NHMRC Independent Research Institutes Infrastructure Support Scheme (361646). J.J.B., R.S.N., and N.A.N. acknowledge fellowship support from the National Health and Medical Research Council, and J.M.M. from the Australian Research Council. L.N.V. acknowledges scholarship support from the Leukaemia Foundation of Australia and the Australian Stem Cell Centre. N.A.N. is a founder and member of the scientific advisory board of MuriGen Pty Ltd.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Babon JJ, 2005, FEBS J, V272, P6120, DOI 10.1111/j.1742-4658.2005.05010.x; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Boyle K, 2007, BLOOD, V110, P1466, DOI 10.1182/blood-2007-03-079178; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; Cozza G, 2009, ANTI-CANCER AGENT ME, V9, P778, DOI 10.2174/187152009789056930; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haan C, 2009, J IMMUNOL, V182, P2969, DOI 10.4049/jimmunol.0800572; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jenkins BJ, 2005, BLOOD, V105, P3512, DOI 10.1182/blood-2004-09-3751; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Starr R, 2009, J IMMUNOL, V183, P4537, DOI 10.4049/jimmunol.0901010; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; WILKS AF, 1994, BIOESSAYS, V16, P313, DOI 10.1002/bies.950160505; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhao LQ, 2010, BIOCHEM J, V426, P91, DOI 10.1042/BJ20090615	49	172	182	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 24	2012	36	2					239	250		10.1016/j.immuni.2011.12.015	http://dx.doi.org/10.1016/j.immuni.2011.12.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22342841	Green Accepted, Bronze			2022-12-18	WOS:000300812400012
J	Lu, LR; Ikizawa, K; Hu, D; Werneck, MBF; Wucherpfennig, KW; Cantor, H				Lu, Linrong; Ikizawa, Koichi; Hu, Dan; Werneck, Miriam B. F.; Wucherpfennig, Kai W.; Cantor, Harvey			Regulation of activated CD4(+) T cells by NK cells via the Qa-1-NKG2A inhibitory pathway	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CLASS IB MOLECULES; IFN-GAMMA; RECEPTOR CD94/NKG2A; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; SELF-TOLERANCE; IN-VIVO	The ability of natural-killer cells to regulate adaptive immunity is not well understood. Here we define an interaction between the class Ib major histocompatibility complex (MHC) molecule Qa-1-Qdm on activated T cells responsible for adaptive immunity and CD94-NKG2A inhibitory receptors expressed by natural-killer cells by using Qa-1-deficient and Qa-1 knockin mice containing a point mutation that selectively abolishes Qa-1-Qdm binding to CD94-NKG2A receptors. The Qa-1-NKG2A interaction protected activated CD4(+) T cells from lysis by a subset of NKG2A(+) NK cells and was essential for T cell expansion and development of immunologic memory. Antibody-dependent blockade of this Qa-1-NKG2A interaction resulted in potent NK-dependent elimination of activated autoreactive T cells and amelioration of experimental autoimmune encephalomyelitis. These findings extend the functional reach of the NK system to include regulation of adaptive T cell responses and suggest a new clinical strategy for elimination of antigen-activated T cells in the context of autoimmune disease and transplantation.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cantor, H (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	harvey_cantor@dfci.harvard.edu	Lu, Linrong/A-1429-2013; Werneck, Miriam B.F./H-5802-2012	Werneck, Miriam/0000-0003-1287-8526; Lu, Linrong/0000-0002-0171-4115	NIAID NIH HHS [R01 AI037562, AI 37562] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH CJ, 1992, J IMMUNOL, V149, P3773; Bach JF, 2006, CR BIOL, V329, P260, DOI 10.1016/j.crvi.2005.12.007; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brooks CR, 2006, J IMMUNOL, V176, P1141, DOI 10.4049/jimmunol.176.2.1141; Chatenoud L, 2004, CURR OPIN PHARMACOL, V4, P403, DOI 10.1016/j.coph.2004.03.012; Durelli L, 1995, Mult Scler, V1 Suppl 1, pS32; EDWARDS BS, 1985, J CLIN INVEST, V75, P1908, DOI 10.1172/JCI111905; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; Lo WF, 1999, J IMMUNOL, V162, P5398; Lu LR, 2006, IMMUNOL REV, V212, P51, DOI 10.1111/j.0105-2896.2006.00418.x; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; SOLOSKI MJ, 1995, IMMUNOL REV, V147, P67, DOI 10.1111/j.1600-065X.1995.tb00088.x; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Sullivan BA, 2002, IMMUNITY, V17, P95, DOI 10.1016/S1074-7613(02)00343-6; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; TRANSY C, 1987, J EXP MED, V166, P341, DOI 10.1084/jem.166.2.341; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang MD, 1998, J IMMUNOL, V160, P1098; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu W, 2005, J NEUROIMMUNOL, V163, P24, DOI 10.1016/j.jneuroim.2005.02.011; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	41	172	184	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					593	604		10.1016/j.immuni.2007.03.017	http://dx.doi.org/10.1016/j.immuni.2007.03.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17509909	Green Accepted, Bronze			2022-12-18	WOS:000246895900012
J	Minguet, S; Swamy, M; Alarcon, B; Luescher, IF; Schamel, WWA				Minguet, Susana; Swamy, Mahima; Alarcon, Balbino; Luescher, Immanuel F.; Schamel, Wolfgang W. A.			Full activation of the T cell receptor requires both clustering and conformational changes at CD3	IMMUNITY			English	Article							CLASS-I MOLECULES; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; PEPTIDE-MHC; MULTIVALENT ENGAGEMENT; COMPLEX; LIGANDS; BINDING; TCRS; FRAGMENT	T cell receptor (TCR-CD3) triggering involves both receptor clustering and conformational changes at the cytoplasmic tails of the CD3 subunits. The mechanism by which TCR alpha beta ligand binding confers conformational changes to CD3 is unknown. By using well-defined ligands, we showed that induction of the conformational change requires both multivalent engagement and the mobility restriction of the TCR-CD3 imposed by the plasma membrane. The conformational change is elicited by cooperative rearrangements of two TCR-CD3 complexes and does not require accompanying changes in the structure of the TCR alpha beta ectodomains. This conformational change at CD3 reverts upon ligand dissociation and is required for T cell activation. Thus, our permissive geometry model provides a molecular mechanism that rationalizes how the information of ligand binding to TCR alpha beta is transmitted to the CD3 subunits and to the intracellular signaling machinery.	Univ Freiburg, Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Freiburg, Fac Biol, D-79108 Freiburg, Germany; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland	Max Planck Society; University of Freiburg; University of Freiburg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Ludwig Institute for Cancer Research	Schamel, WWA (corresponding author), Univ Freiburg, Max Planck Inst Immunbiol, Stubeweg 51, D-79108 Freiburg, Germany.	schamel@immunbio.mpg.de	Swamy, Mahima/J-7046-2019; Alarcon, Balbino/N-9648-2016	Swamy, Mahima/0000-0003-3977-3425; Alarcon, Balbino/0000-0001-7820-1070; Minguet, Susana/0000-0001-8211-5538				ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; Arcaro A, 2001, J EXP MED, V194, P1485, DOI 10.1084/jem.194.10.1485; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Bankovich AJ, 2003, IMMUNITY, V18, P7, DOI 10.1016/S1074-7613(02)00517-4; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Cebecauer M, 2005, J BIOL CHEM, V280, P23820, DOI 10.1074/jbc.M500654200; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; Coombs D, 2002, NAT IMMUNOL, V3, P926, DOI 10.1038/ni838; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Doucey MA, 2003, J BIOL CHEM, V278, P3257, DOI 10.1074/jbc.M208119200; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Gregoire C, 1996, P NATL ACAD SCI USA, V93, P7184, DOI 10.1073/pnas.93.14.7184; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jose ES, 1998, EUR J IMMUNOL, V28, P12; Kalergis AM, 2000, J IMMUNOL METHODS, V234, P61, DOI 10.1016/S0022-1759(99)00215-X; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KRISHNA S, 1992, NATURE, V357, P164, DOI 10.1038/357164a0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1991, NATURE, V351, P72, DOI 10.1038/351072a0; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; ROJO JM, 1988, J IMMUNOL, V140, P1081; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Sigalov A, 2005, SEMIN IMMUNOL, V17, P51, DOI 10.1016/j.smim.2004.09.003; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	51	172	181	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					43	54		10.1016/j.immuni.2006.10.019	http://dx.doi.org/10.1016/j.immuni.2006.10.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17188005	Green Submitted, Bronze			2022-12-18	WOS:000243959000008
J	Moyron-Quiroz, JE; Rangel-Moreno, J; Hartson, L; Kusser, K; Tighe, MP; Klonowski, KD; Lefrancois, L; Cauley, LS; Harmsen, AG; Lund, FE; Randall, TD				Moyron-Quiroz, Juan E.; Rangel-Moreno, Javier; Hartson, Louise; Kusser, Kim; Tighe, Michael P.; Klonowski, Kimberly D.; Lefrancois, Leo; Cauley, Linda S.; Harmsen, Allen G.; Lund, Frances E.; Randall, Troy D.			Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs	IMMUNITY			English	Article							CD8(+) T-CELLS; RESPIRATORY VIRUS-INFECTIONS; ANTIBODY-SECRETING CELLS; BONE-MARROW; LUNG AIRWAYS; PROTECTIVE IMMUNITY; PERIPHERAL-TISSUES; DENDRITIC CELLS; DEFICIENT MICE; MESSENGER-RNA	Secondary lymphoid organs (SLOs) promote primary immune responses by recruiting naive lymphocytes and activated APCs. However, their role in the persistence or responsiveness of memory lymphocytes is unclear. We tested whether memory cells were maintained and could respond to challenge in the absence of SLOs. We found that influenza-specific CD8 cells in the lung acquired a memory phenotype, underwent homeostatic proliferation, recirculated through non-lymphoid tissues, and responded to and cleared a challenge infection in the complete absence of SLOs. Similarly, influenza-specific virus-neutralizing antibody was generated and maintained in the absence of SLOs. Inducible bronchus-associated lymphoid tissue (iBALT) was also formed in the lungs of previously infected mice and may provide a niche for the maintenance of memory cells at the local level. These data show that SLOs are dispensable for the maintenance of immunologic memory and directly demonstrate the utility of local tissues, such as iBALT, in secondary immune responses.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06032 USA; Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Trudeau Institute; University of Connecticut; Montana State University System; Montana State University Bozeman	Randall, TD (corresponding author), Trudeau Inst Inc, POB 59, Saranac Lake, NY 12983 USA.	trandall@trudeauinstitute.org	Connor, Toni R/C-6964-2012	Rangel-Moreno, Javier/0000-0002-9738-1182	NHLBI NIH HHS [HL63925, HL69409] Funding Source: Medline; NIAID NIH HHS [AI068056] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068056] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Chalasani G, 2002, P NATL ACAD SCI USA, V99, P6175, DOI 10.1073/pnas.092596999; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Doherty TM, 1996, J IMMUNOL, V156, P735; Ely KH, 2003, J IMMUNOL, V171, P3338, DOI 10.4049/jimmunol.171.7.3338; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; GIMBLE JM, 1989, BLOOD, V74, P303; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hogan RJ, 2002, J IMMUNOL, V169, P4976, DOI 10.4049/jimmunol.169.9.4976; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; JOHANSSON BE, 1990, J INFECT DIS, V162, P800, DOI 10.1093/infdis/162.4.800; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; JONES PD, 1987, VACCINE, V5, P244, DOI 10.1016/0264-410X(87)90109-5; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Jonuleit H, 1997, J IMMUNOL, V158, P2610; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lund FE, 2002, J IMMUNOL, V169, P5236, DOI 10.4049/jimmunol.169.9.5236; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; van Panhuys N, 2005, TRENDS IMMUNOL, V26, P242, DOI 10.1016/j.it.2005.03.005; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Woodland DL, 2004, SEMIN IMMUNOL, V16, P163, DOI 10.1016/j.smim.2004.02.003; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	40	172	174	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					643	654		10.1016/j.immuni.2006.08.022	http://dx.doi.org/10.1016/j.immuni.2006.08.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045819	Bronze			2022-12-18	WOS:000241481500015
J	Khoury, SJ; Sayegh, MH				Khoury, SJ; Sayegh, MH			The roles of the new negative T cell costimulatory pathways in regulating autoimmunity	IMMUNITY			English	Review							DEATH-1 PD-1 PATHWAY; B7 FAMILY; MOLECULE ICOS; DILATED CARDIOMYOPATHY; GENOMIC ORGANIZATION; CO-STIMULATION; SOLUBLE FORM; CTLA-4; EXPRESSION; B7-H1	The B7 family of T cell costimulatory molecules has recently acquired several new members. Some of these are activating while others are inhibitory. In this review, we will focus on the novel inhibitory pathways with particular emphasis on the PD-1:PD-L pathway. Understanding the mechanisms of these pathways has implications for development of novel treatment strategies for autoimmune disease, transplantation, tumor immunotherapy, and vaccine development.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Khoury, SJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	skhoury@rics.bwh.harvard.edu; msayegh@rics.bwh.harvard.edu		Sayegh, Mohamed/0000-0002-2847-588X; khoury, samia/0000-0003-3198-6063				Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Ariyan C, 2003, J IMMUNOL, V171, P5673, DOI 10.4049/jimmunol.171.11.5673; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baroja ML, 2003, AM J TRANSPLANT, V3, P919, DOI 10.1034/j.1600-6143.2003.00182.x; Bluestone JA, 1997, J IMMUNOL, V158, P1989; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chitnis T, 2001, J CLIN INVEST, V107, P575, DOI 10.1172/JCI11220; Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gao WD, 2003, TRANSPLANTATION, V76, P994, DOI 10.1097/01.TP.0000085010.39567.FB; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Griffin MD, 2001, J IMMUNOL METHODS, V248, P77, DOI 10.1016/S0022-1759(00)00344-6; Harada H, 2003, J CLIN INVEST, V112, P234, DOI 10.1172/JCI200317008; Hatachi S, 2003, J RHEUMATOL, V30, P1410; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kanai T, 2003, J IMMUNOL, V171, P4156, DOI 10.4049/jimmunol.171.8.4156; Kantarci OH, 2003, J NEUROIMMUNOL, V134, P133, DOI 10.1016/S0165-5728(02)00395-8; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lechner O, 2001, CURR BIOL, V11, P587, DOI 10.1016/S0960-9822(01)00160-9; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.3.CO;2-P; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rietz C, 2004, AM J TRANSPLANT, V4, P8, DOI 10.1046/j.1600-6143.2003.00303.x; Rodriguez MR, 2002, HUM IMMUNOL, V63, P76, DOI 10.1016/S0198-8859(01)00358-5; Rothstein DM, 2003, IMMUNOL REV, V196, P85, DOI 10.1046/j.1600-065X.2003.00088.x; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Subudhi SK, 2004, J CLIN INVEST, V113, P694, DOI 10.1172/JCI200419210; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Tamura H, 2003, INT J HEMATOL, V78, P321, DOI 10.1007/BF02983556; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Van Parijs L, 1998, SCIENCE, V280, P243; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang SD, 2000, BLOOD, V96, P2808; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2	84	172	185	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					529	538		10.1016/S1074-7613(04)00116-5	http://dx.doi.org/10.1016/S1074-7613(04)00116-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142522	Bronze			2022-12-18	WOS:000221631900004
J	Martin, F; Chan, AC				Martin, F; Chan, AC			Pathogenic roles of B cells in human autoimmunity: Insights from the clinic	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNE THROMBOCYTOPENIC PURPURA; ANTI-CD20 MONOCLONAL-ANTIBODY; LYMPHOCYTE DEPLETION THERAPY; LIVED PLASMA-CELLS; RHEUMATOID-ARTHRITIS; MYASTHENIA-GRAVIS; IN-VIVO; INTRAVENOUS IMMUNOGLOBULIN; PEMPHIGUS-VULGARIS	The pathogenic roles of B cells in human autoimmune diseases involve a multitude of mechanistic pathways and include the well-established contributions of autoantibodies and immune complexes that induce local inflammatory reactions and tissue destruction. Recent results using several novel B cell-directed therapies have provided new insights into additional roles of B cells in human autoimmunity. In this review, we will highlight some of these studies and discuss how clinical insights parallel murine models of normal immunity and autoimmunity.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Martin, F (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way,MS-34, San Francisco, CA 94080 USA.	flavius@gene.com; acc@gene.com						ANASETTI C, 1992, TRANSPLANTATION, V54, P844, DOI 10.1097/00007890-199211000-00015; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Anolik JH, 2003, ARTHRITIS RHEUM, V48, P455, DOI 10.1002/art.10764; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Arce S, 2002, IMMUNOBIOLOGY, V206, P558, DOI 10.1078/0171-2985-00204; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Beardsley DS, 2002, BLOOD REV, V16, P13, DOI 10.1054/blre.2001.0173; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Binstadt BA, 2003, J ALLERGY CLIN IMMUN, V111, P697, DOI 10.1067/mai.2003.1380; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brucato A, 2002, CLIN REV ALLERG IMMU, V23, P279, DOI 10.1385/CRIAI:23:3:279; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Buyon JP, 2003, AUTOIMMUNITY, V36, P41, DOI 10.1080/0891693031000067340; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cersosimo RJ, 2003, AM J HEALTH-SYST PH, V60, P1631, DOI 10.1093/ajhp/60.16.1631; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chan OTM, 2000, J IMMUNOL, V164, P1658, DOI 10.4049/jimmunol.164.4.1658; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Cohen S, 2002, ARTHRITIS RHEUM, V46, P614, DOI 10.1002/art.10141; COOPER MD, 1980, IMMUNOL REV, V52, P29, DOI 10.1111/j.1600-065X.1980.tb00329.x; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Cooper N, 2004, BRIT J HAEMATOL, V125, P232, DOI 10.1111/j.1365-2141.2004.04889.x; COUSER WG, 1995, J AM SOC NEPHROL, V5, P1888; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; De Vita S, 2002, ARTHRITIS RHEUM, V46, P2029, DOI 10.1002/art.10467; Dupuy A, 2004, ARCH DERMATOL, V140, P91, DOI 10.1001/archderm.140.1.91; EDWARDS JC, 2004, IN PRESS N ENGL J ME; Edwards JCW, 2002, BIOCHEM SOC T, V30, P824, DOI 10.1042/bst0300824; Eisenberg R, 2003, IMMUNOL RES, V27, P203, DOI 10.1385/IR:27:2-3:203; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Goebeler M, 2003, BRIT J DERMATOL, V149, P899, DOI 10.1046/j.1365-2133.2003.05580.x; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gottlieb AB, 2003, LUPUS, V12, P190, DOI 10.1191/0961203303lu354xx; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haskell BD, 2002, LAB INVEST, V82, P833, DOI 10.1097/01.LAB.0000018915.53257.00; Hauser AE, 2003, ANN NY ACAD SCI, V987, P266, DOI 10.1111/j.1749-6632.2003.tb06059.x; Holers VM, 2003, CLIN IMMUNOL, V107, P140, DOI 10.1016/S1521-6616(03)00034-2; Huang H, 2002, IEEE COMMUN MAG, V40, P46, DOI 10.1109/MCOM.2002.1046992; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Ichikawa HT, 2002, J IMMUNOL, V169, P2781, DOI 10.4049/jimmunol.169.5.2781; Juweid M, 2003, CURR OPIN MOL THER, V5, P192; Kalled SL, 2001, LUPUS, V10, P9, DOI 10.1191/096120301668384751; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Keystone EC, 2003, CLIN EXP RHEUMATOL, V21, pS198; Keystone EC, 2003, CURR OPIN RHEUMATOL, V15, P253, DOI 10.1097/00002281-200305000-00012; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Levine TD, 1999, NEUROLOGY, V52, P1701, DOI 10.1212/WNL.52.8.1701; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; McCarthy H, 2003, BRIT J HAEMATOL, V123, P770, DOI 10.1046/j.1365-2141.2003.04698.x; McMillan R, 2003, J PEDIAT HEMATOL ONC, V25, pS57, DOI 10.1097/00043426-200312001-00013; McMillan R, 2001, BLOOD, V97, P2171, DOI 10.1182/blood.V97.7.2171; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Nguyen C, 2002, ARTHRITIS RES THER, V4, pS255, DOI 10.1186/ar583; Pascual M, 1997, SEMIN HEMATOL, V34, P40; Pestronk A, 2003, J NEUROL NEUROSUR PS, V74, P485, DOI 10.1136/jnnp.74.4.485; Pisetsky DS, 2000, NEW ENGL J MED, V342, P810, DOI 10.1056/NEJM200003163421110; Pisetsky DS, 2000, CURR OPIN RHEUMATOL, V12, P364, DOI 10.1097/00002281-200009000-00002; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; REFF ME, 1994, BLOOD, V83, P435; Reichlin M, 2003, LUPUS, V12, P916, DOI 10.1191/0961203303lu502oa; Richman DP, 2003, NEUROLOGY, V61, P1652, DOI 10.1212/01.WNL.0000098887.24618.A0; Robak T, 2004, EUR J HAEMATOL, V72, P79, DOI 10.1046/j.0902-4441.2003.00196.x; Rojas-Garcia R, 2003, NEUROLOGY, V61, P1814, DOI 10.1212/01.WNL.0000098996.02934.86; Rouziere AS, 2003, ARTHRITIS RHEUM, V48, pS138; Ruiz-Irastorza Guillermo, 2002, Autoimmunity Reviews, V1, P43, DOI 10.1016/S1568-9972(01)00005-2; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Saleh MN, 2000, SEMIN ONCOL, V27, P99; Salopek TG, 2002, J AM ACAD DERMATOL, V47, P785, DOI 10.1067/mjd.2002.126273; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Saydain G, 2002, CRIT CARE CLIN, V18, P957, DOI 10.1016/S0749-0704(02)00028-3; Schroder C, 2003, TRANSPL IMMUNOL, V12, P19, DOI 10.1016/S0966-3274(03)00059-5; Shanahan JC, 2003, CURR OPIN RHEUMATOL, V15, P226, DOI 10.1097/00002281-200305000-00009; Shaw T, 2003, ANN RHEUM DIS, V62, P55, DOI 10.1136/ard.62.suppl_2.ii55; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SILBERSTEIN LE, 1994, ADV EXP MED BIOL, V347, P193; Silverman GJ, 2003, ARTHRITIS RHEUM-US, V48, P1484, DOI 10.1002/art.10947; Stasi R, 2001, BLOOD, V98, P952, DOI 10.1182/blood.V98.4.952; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Tesser J, 2001, ARTHRITIS RHEUM, V44, pS274; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Trendelenburg M, 2003, CLIN EXP IMMUNOL, V133, P153, DOI 10.1046/j.1365-2249.2003.02198.x; Treon SP, 2000, SEMIN ONCOL, V27, P79, DOI 10.1053/sonc.2000.20425; Tuscano JM, 2002, ARTHRITIS RHEUM, V46, P3420; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Vugmeyster Y, 2003, INT IMMUNOPHARMACOL, V3, P1477, DOI 10.1016/S1567-5769(03)00147-4; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang XB, 2003, ARTHRITIS RHEUM, V48, P495, DOI 10.1002/art.10929; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; Ward J H, 2001, Curr Treat Options Oncol, V2, P253, DOI 10.1007/s11864-001-0039-z; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wellmann U, 2001, INT IMMUNOL, V13, P1461, DOI 10.1093/intimm/13.12.1461; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Wiestner A, 2002, BLOOD, V100, P3426, DOI 10.1182/blood-2002-03-0765; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wylam ME, 2003, J PEDIATR-US, V143, P674, DOI 10.1067/S0022-3476(03)00300-7; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Zaja F, 2003, HAEMATOLOGICA, V88, P538; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	121	172	191	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					517	527		10.1016/S1074-7613(04)00112-8	http://dx.doi.org/10.1016/S1074-7613(04)00112-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142521	Bronze			2022-12-18	WOS:000221631900003
J	Vijayakrishnan, L; Slavik, JM; Illes, Z; Greenwald, RJ; Rainbow, D; Greve, B; Peterson, LB; Hafler, DA; Freeman, GJ; Sharpe, AH; Wicker, LS; Kuchroo, VK				Vijayakrishnan, L; Slavik, JM; Illes, Z; Greenwald, RJ; Rainbow, D; Greve, B; Peterson, LB; Hafler, DA; Freeman, GJ; Sharpe, AH; Wicker, LS; Kuchroo, VK			An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells	IMMUNITY			English	Article							ANTIGEN 4 CTLA-4; REGULATORY CELLS; ACTIVATION; SUSCEPTIBILITY; GENE; LYMPHOCYTES; ENGAGEMENT; EXPRESSION; MICE; LOCI	Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) plays a critical role in downregulating T cell responses. A number of autoimmune diseases have shown genetic linkage to the CTLA-4 locus. We have cloned and expressed an alternatively spliced form of CTLA-4 that has genetic linkage with type I diabetes in the NOD mice. This splice variant of CTLA-4, named ligand-independent CTLA-4 (liCTLA-4), lacks exon2 including the MYPPPY motif essential for binding to the costimulatory ligands B7-1 and B7-2. Here we show that liCTLA-4 is expressed as a protein in primary T cells and strongly inhibits T cell responses by binding and dephosphorylating the TcRzeta chain. Expression of liCTLA-4, but not full-length CTLA-4 (fICTLA-4), was higher in memory/regulatory T cells from diabetes-resistant NOD congenic mice compared to susceptible NOD mice. These data suggest that increased expression and negative signaling delivered by the liCTLA-4 may regulate development of T cell-mediated autoimmune diseases.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Cambridge, Cambridge Inst Med Res, Diabet & Inflammat Lab, Juvenille Diabet Res Fdn,Wellcome Trust, Cambridge CB2 2XY, England; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cambridge; Wellcome Trust Sanger Institute; Merck & Company; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.	wicker@cimr.cam.ac.uk; vkuchroo@rics.bwh.harvard.edu	Wicker, Linda S/F-7384-2010; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Illes, Zsolt/0000-0001-9655-0450	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035685] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI 39671, R01 AI4480] Funding Source: Medline; NINDS NIH HHS [NS35685] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alegre ML, 1996, J IMMUNOL, V157, P4762; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Brunner MC, 1999, J IMMUNOL, V162, P5813; Carreno BM, 2000, J IMMUNOL, V165, P1352, DOI 10.4049/jimmunol.165.3.1352; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Greenwald RJ, 2002, CURR OPIN IMMUNOL, V14, P391, DOI 10.1016/S0952-7915(02)00341-2; Hanawa H, 2002, BLOOD, V99, P2138, DOI 10.1182/blood.V99.6.2138; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kouki T, 2002, J ENDOCRINOL INVEST, V25, P208, DOI 10.1007/BF03343992; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Lamhamedi-Cherradi SE, 2001, DIABETES, V50, P2874, DOI 10.2337/diabetes.50.12.2874; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; LINDSTEN T, 1993, J IMMUNOL, V151, P3489; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Mandelbrot DA, 1999, J EXP MED, V189, P435, DOI 10.1084/jem.189.2.435; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Metz DP, 1998, J IMMUNOL, V161, P5855; Nakaseko C, 1999, J EXP MED, V190, P765, DOI 10.1084/jem.190.6.765; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X	32	172	185	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					563	575		10.1016/S1074-7613(04)00110-4	http://dx.doi.org/10.1016/S1074-7613(04)00110-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142525	Bronze			2022-12-18	WOS:000221631900007
J	Schmidt-Supprian, M; Courtois, G; Tian, J; Coyle, AJ; Israel, A; Rajewsky, K; Pasparakis, M				Schmidt-Supprian, M; Courtois, G; Tian, J; Coyle, AJ; Israel, A; Rajewsky, K; Pasparakis, M			Mature T cells depend on signaling through the IKK complex	IMMUNITY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; TRANSGENIC MICE; DEFICIENT MICE; KINASE-ALPHA; CYTOKINE PRODUCTION; LIVER DEGENERATION; GENE-EXPRESSION; NEMO/IKK-GAMMA; ACTIVATION	The transcription factor NF-kappaB is implicated in various aspects of T cell development and function. The IkappaB kinase (IKK) complex, consisting of two kinases, IKK1/alpha and IKK2/beta, and the NEMO/IKKgamma regulatory subunit, mediates NF-kappaB activation by most known stimuli. Adoptive transfer experiments had demonstrated that IKK1 and IKK2 are dispensable for T cell development. We show here that T lineage-specific deletion of IKK2 allows survival of naive peripheral T cells but interferes with the generation of regulatory and memory T cells. T cell-specific ablation of NEMO or replacement of IKK2 with a kinase-dead mutant prevent development of peripheral T cells altogether. Thus, IKK-induced NF-kappaB activation, mediated by either IKK1 or IKK2, is essential for the generation and survival of mature T cells, and IKK2 has an additional role in regulatory and memory T cell development.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Inst Pasteur, CNRS, URA 2582, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Italy	University of Cologne; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; European Molecular Biology Laboratory (EMBL)	Rajewsky, K (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.	rajewsky@cbr.med.harvard.edu; pasparakis@embl-monterotondo.it	Pasparakis, Manolis/N-4350-2019; Schmidt-Supprian, Marc/F-5893-2011; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Schmidt-Supprian, Marc/0000-0002-8543-6166; Pasparakis, Manolis/0000-0002-9870-0966; Rajewsky, Klaus/0000-0002-6633-6370; COURTOIS, Gilles/0000-0003-3117-9595				Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Attar RM, 1998, MOL CELL BIOL, V18, P477, DOI 10.1128/MCB.18.1.477; Aune TM, 1999, J IMMUNOL, V162, P5805; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Denk A, 2000, CYTOKINE GROWTH F R, V11, P303, DOI 10.1016/S1359-6101(00)00009-5; Dorfman JR, 2002, MICROBES INFECT, V4, P547, DOI 10.1016/S1286-4579(02)01571-X; Esslinger CW, 1997, J IMMUNOL, V158, P5075; Esslinger CW, 1998, MOL IMMUNOL, V35, P847, DOI 10.1016/S0161-5890(98)00071-6; Ferreira V, 1999, J IMMUNOL, V162, P6442; Fischer C, 1999, J BIOL CHEM, V274, P24625, DOI 10.1074/jbc.274.35.24625; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldrath AW, 2002, MICROBES INFECT, V4, P539, DOI 10.1016/S1286-4579(02)01570-8; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Mackenzie IS, 2002, CLIN MED, V2, P465, DOI 10.7861/clinmedicine.2-5-465; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Read S, 2001, CURR OPIN IMMUNOL, V13, P644, DOI 10.1016/S0952-7915(01)00273-4; Ren H, 2002, J IMMUNOL, V168, P3721, DOI 10.4049/jimmunol.168.8.3721; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; SHORTMAN K, 1988, CELL IMMUNOL, V113, P462, DOI 10.1016/0008-8749(88)90042-1; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tian T, 2001, INT IMMUNOL, V13, P313, DOI 10.1093/intimm/13.3.313; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	49	172	179	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					377	389		10.1016/S1074-7613(03)00237-1	http://dx.doi.org/10.1016/S1074-7613(03)00237-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499113	Bronze			2022-12-18	WOS:000185499800009
J	Reiser, JB; Gregoire, C; Darnault, C; Mosser, T; Guimezanes, A; Schmitt-Verhulst, AM; Fontecilla-Camps, JC; Mazza, G; Malissen, B; Housset, D				Reiser, JB; Gregoire, C; Darnault, C; Mosser, T; Guimezanes, A; Schmitt-Verhulst, AM; Fontecilla-Camps, JC; Mazza, G; Malissen, B; Housset, D			A T cell receptor CDR3 beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex	IMMUNITY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURES; HYPERVARIABLE REGIONS; ANTIBODY; ANTIGEN; MHC; FAB; RECOGNITION; THERMODYNAMICS	The elongated complementary-determining region (CDR) 3beta found in the unliganded KB5-C20 TCR protrudes from the antigen binding site and prevents its docking onto the peptide/MHC (pMHC) surface according to a canonical diagonal orientation. We now present the crystal structure of a complex involving the KB5-C20 TCR and an octapeptide bound to the allogeneic H-2K(b) MHC class I molecule. This structure reveals how a tremendously large CDR3beta conformational change allows the KB5-C20 TCR to adapt to the rather constrained pMHC surface and achieve a diagonal docking mode. This extreme case of induced fit also shows that TCR plasticity is primarily restricted to CDR3 loops and does not propagate away from the antigen binding site.	Univ Mediterranee, INSERM, Ctr Immunol Marseille Luminy, CNRS, F-13288 Marseille 9, France; UJF, CNRS, Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Prot,CEA, F-38027 Grenoble 1, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Housset, D (corresponding author), Univ Mediterranee, INSERM, Ctr Immunol Marseille Luminy, CNRS, Parc Sci Luminy,Case 906, F-13288 Marseille 9, France.	bernardm@ciml.univ-mrs.fr	Mazza, Giuseppe/A-2833-2013; Reiser, Jean-Baptiste/W-7683-2019; Malissen, Bernard/AAK-4659-2020	Reiser, Jean-Baptiste/0000-0001-6926-9137; Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739; Malissen, Bernard/0000-0003-1340-9342; HOUSSET, Dominique/0000-0003-1732-0193				Al-Lazikani B, 2000, J MOL BIOL, V295, P979, DOI 10.1006/jmbi.1999.3358; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; CHARBONNIER JB, 1995, P NATL ACAD SCI USA, V92, P11721, DOI 10.1073/pnas.92.25.11721; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Gregoire C, 1996, EUR J IMMUNOL, V26, P2410, DOI 10.1002/eji.1830261022; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; HAWKINS RE, 1993, J MOL BIOL, V234, P958, DOI 10.1006/jmbi.1993.1650; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; Huang MD, 1998, J MOL BIOL, V275, P873, DOI 10.1006/jmbi.1997.1512; Hubbard SJ, 1993, NACCESS COMPUTER PRO; HUE I, 1990, J IMMUNOL, V144, P4410; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat EA, 1991, SEQUENCES PROTEINS I; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Li YL, 2000, BIOCHEMISTRY-US, V39, P6296, DOI 10.1021/bi000054l; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Mazza G, 1999, J MOL BIOL, V287, P773, DOI 10.1006/jmbi.1999.2645; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4; Mylvaganam SE, 1998, J MOL BIOL, V281, P301, DOI 10.1006/jmbi.1998.1942; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHONRICH G, 1993, J IMMUNOL, V151, P4098; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; Sindelar CV, 1998, PROTEIN SCI, V7, P1898, DOI 10.1002/pro.5560070906; SOUZA SC, 1995, P NATL ACAD SCI USA, V92, P959, DOI 10.1073/pnas.92.4.959; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	60	172	175	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					345	354		10.1016/S1074-7613(02)00288-1	http://dx.doi.org/10.1016/S1074-7613(02)00288-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911820	Bronze			2022-12-18	WOS:000174572800004
J	Grandea, AG; Golovina, TN; Hamilton, SE; Sriram, V; Spies, T; Brutkiewicz, RR; Harty, JT; Eisenlohr, LC; Van Kaer, L				Grandea, AG; Golovina, TN; Hamilton, SE; Sriram, V; Spies, T; Brutkiewicz, RR; Harty, JT; Eisenlohr, LC; Van Kaer, L			Impaired assembly yet normal trafficking of MHC class I molecules in tapasin mutant mice	IMMUNITY			English	Article							ANTIGEN PRESENTATION TAP; CELL-LINE .220; T-CELLS; ALPHA-3 DOMAIN; PEPTIDE; TRANSPORTER; HEAVY; EXPRESSION; ASSOCIATION; RESPONSES	Loading of peptides onto major histocompatibility complex class I molecules involves a multifactorial complex that includes tapasin (TPN), a membrane protein that tethers empty class I glycoproteins to the transporter associated with antigen processing. To evaluate the in vivo role of TPN, we have generated Tpn mutant mice. In these animals, most class I molecules exit the endoplasmic reticulum (ER) in the absence of stably bound peptides. Consequently, mutant animals have defects in class I cell surface expression, antigen presentation, CD8(+) T cell development, and immune responses. These findings reveal a critical role of TPN for ER retention of empty class I molecules. Tpn mutant animals should prove useful for studies on alternative antigen-processing pathways that involve post-ER peptide loading.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Howard Hughes Medical Institute; Vanderbilt University; Jefferson University; Jefferson University; University of Iowa; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Fred Hutchinson Cancer Center	Grandea, AG (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Nashville, TN 37232 USA.		Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Brutkiewicz, Randy/0000-0002-7396-480X; Sriram, Venkataraman/0000-0003-3433-5258; Harty, John/0000-0001-7266-2802	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030581, R56AI046455, R37AI030581, R01AI039501, R01AI046455] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46455, AI39501, AI30581] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUTKIEWICZ RR, 1992, NAT IMMUN, V11, P203; CONNOLLY JM, 1990, P NATL ACAD SCI USA, V87, P2137, DOI 10.1073/pnas.87.6.2137; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grandea AG, 1998, IMMUNOGENETICS, V48, P260, DOI 10.1007/s002510050430; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; JORG R, 1999, IMMUNOL REV, V172, P131; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kulig K, 1998, J EXP MED, V187, P865, DOI 10.1084/jem.187.6.865; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Liu TM, 1997, J IMMUNOL, V159, P5364; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MACHOLD RP, 1995, J EXP MED, V181, P1111, DOI 10.1084/jem.181.3.1111; NOSSNER E, 1995, J EXP MED, V181, P327, DOI 10.1084/jem.181.1.327; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RELTS EA, 2000, NATURE, V404, P774; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SANDERSON S, 1994, INT IMMUNOL, V6, P369, DOI 10.1093/intimm/6.3.369; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Song R, 1996, J IMMUNOL, V156, P4182; Suh WK, 1999, J IMMUNOL, V162, P1530; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vogt AB, 1999, TRENDS BIOCHEM SCI, V24, P150, DOI 10.1016/S0968-0004(99)01364-X; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; YellenShaw AJ, 1997, J EXP MED, V186, P1655, DOI 10.1084/jem.186.10.1655; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	43	172	181	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2000	13	2					213	222		10.1016/S1074-7613(00)00021-2	http://dx.doi.org/10.1016/S1074-7613(00)00021-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	350ZT	10981964	Bronze			2022-12-18	WOS:000089132100006
J	Sugita, M; Grant, EP; van Donselaar, E; Hsu, VW; Rogers, RA; Peters, PJ; Brenner, MB				Sugita, M; Grant, EP; van Donselaar, E; Hsu, VW; Rogers, RA; Peters, PJ; Brenner, MB			Separate pathways for antigen presentation by CD1 molecules	IMMUNITY			English	Article							HUMAN LANGERHANS CELLS; CLASS-II MOLECULES; PHAGOSOME-LYSOSOME FUSION; T-CELLS; LIPOGLYCAN ANTIGENS; STRUCTURAL REQUIREMENTS; LISTERIA-MONOCYTOGENES; BIRBECK GRANULES; CYTOPLASMIC TAIL; LYMPHOCYTES-T	The ability to sample relevant intracellular compartments is necessary for effective antigen presentation. To detect peptide antigens, MHC class I and II molecules differentially sample cytosolic and endosomal compartments. CD1 constitutes another lineage of lipid antigen-presenting molecules. We show that CD1b traffics deeply into late endosomal compartments, while CD1a is excluded from these compartments and instead traffics independently in the recycling pathway of the early endocytic system. Further, CD1b but not CD1a antigen presentation is dependent upon vesicular acidification. Since lipids and various bacteria are known to traffic differentially, either penetrating deeply into the endocytic system or following the route of recycling endosomes, these findings elucidate efficient monitoring of distinct components of the endocytic compartment by CD1 lipid antigen-presenting molecules.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Netherlands Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Brenner, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Grant, Ethan/GQP-2720-2022	Sugita, Masahiko/0000-0001-5511-1304				Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; BALK SP, 1989, P NATL ACAD SCI USA, V86, P252, DOI 10.1073/pnas.86.1.252; BARTOSIK J, 1992, J INVEST DERMATOL, V99, P53, DOI 10.1111/1523-1747.ep12611845; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; BOUWER HGA, 1992, J EXP MED, V175, P1467, DOI 10.1084/jem.175.6.1467; Brossay L, 1998, J IMMUNOL, V160, P3681; Brossay L, 1998, J IMMUNOL, V161, P5124; BRUNT LM, 1990, J IMMUNOL, V145, P3540; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Crawford J M, 1989, Reg Immunol, V2, P91; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; HANAU D, 1987, J INVEST DERMATOL, V89, P172, DOI 10.1111/1523-1747.ep12470555; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; KASHIHARA M, 1986, J INVEST DERMATOL, V87, P602, DOI 10.1111/1523-1747.ep12455849; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Mazzaccaro RJ, 1998, ADV EXP MED BIOL, V452, P85; MILLER CJ, 1992, LAB INVEST, V67, P628; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; PETERS PJ, 1995, J EXP MED, V182, P325, DOI 10.1084/jem.182.2.325; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; RAY A, 1989, J INVEST DERMATOL, V92, P217, DOI 10.1111/1523-1747.ep12276745; Rodionov DG, 1999, J IMMUNOL, V162, P1488; ROGERS RA, 1993, J CELL SCI, V106, P485; Rosat JP, 1999, J IMMUNOL, V162, P366; Russell GJ, 1996, J IMMUNOL, V157, P3366; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SHCOFIELD L, 1999, SCIENCE, V283, P225; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; STREILEIN JW, 1990, IMMUNOL REV, V117, P159, DOI 10.1111/j.1600-065X.1990.tb00572.x; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; TAZI A, 1993, J CLIN INVEST, V91, P566, DOI 10.1172/JCI116236; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; XU SM, 1994, J IMMUNOL, V153, P2568; Yoshida A, 1997, BRIT J OPHTHALMOL, V81, P402, DOI 10.1136/bjo.81.5.402	63	172	175	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1999	11	6					743	752		10.1016/S1074-7613(00)80148-X	http://dx.doi.org/10.1016/S1074-7613(00)80148-X			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626896	Bronze			2022-12-18	WOS:000084612900010
J	Wu, L; Nichogiannopoulou, A; Shortman, K; Georgopoulos, K				Wu, L; Nichogiannopoulou, A; Shortman, K; Georgopoulos, K			Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; PRECURSOR CELLS; MOUSE THYMUS; TRANSCRIPTION FACTOR; CD8 EXPRESSION; TNF-ALPHA; T-CELLS; GENE; COMMITMENT; LIGAND	The transcription factor Ikaros is a major determinant of lymphocyte differentiation. Mice homozygous for an Ikaros dominat-negative (DN-/-) mutation lack all cells of lymphoid origin, including T, B, and natural killer (NK) cells. Mice homozygous for an Ikaros null allele lack B and NK cells but display specific defects in T lymphocytes. Nonetheless, both Ikaros mutant lines make an excess of monocytes and macrophages. Here we report that the production of subsets of antigen-presenting dendritic cells (DCs) is also defective. By constructing bone marrow chimeras, we demonstrate that the Ikaros-mediated defect in lymphocytes and DCs is intrinsic to their precursors and is not environment dependent. The selective defects in DCs manifested with the Ikaros null mutation suggest a tight linkage between development of T cells and CD8 alpha(+) DCs. The complete lack of DCs in the lymphoid organs of Ikaros DN-/- micke points to an essential role for the Ikaros gene family in the development of all DCs.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CUTANEOUS BIOL RES CTR,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital	Wu, L (corresponding author), WALTER & ELIZA HALL INST MED RES,MELBOURNE,VIC 3050,AUSTRALIA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033062] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI33062-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CAUX C, 1996, IN PRESS BLOOD CELL, V7; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ismaili J, 1996, EUR J IMMUNOL, V26, P731, DOI 10.1002/eji.1830260402; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; MATSUZAKI Y, 1993, J EXP MED, V178, P1283, DOI 10.1084/jem.178.4.1283; Molnar A, 1996, J IMMUNOL, V156, P585; MOORE TA, 1995, BLOOD, V86, P1850, DOI 10.1182/blood.V86.5.1850.bloodjournal8651850; MORGAN B, 1997, IN PRESS EMBO J; Saunders D, 1996, J EXP MED, V184, P2185, DOI 10.1084/jem.184.6.2185; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; VREMEC D, 1997, IN PRESS J IMMUNOL; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; WU L, 1995, EUR J IMMUNOL, V25, P418, DOI 10.1002/eji.1830250217; YOUNG JW, 1995, J EXP MED, V182, P1111, DOI 10.1084/jem.182.4.1111; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	28	172	176	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1997	7	4					483	492		10.1016/S1074-7613(00)80370-2	http://dx.doi.org/10.1016/S1074-7613(00)80370-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YD593	9354469	Bronze			2022-12-18	WOS:A1997YD59300005
J	CORREA, I; RAULET, DH				CORREA, I; RAULET, DH			BINDING OF DIVERSE PEPTIDES TO MHC CLASS-I MOLECULES INHIBITS TARGET-CELL LYSIS BY ACTIVATED NATURAL-KILLER-CELLS	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; VIRUS-INFECTED CELLS; RMA-S CELLS; MONOCLONAL-ANTIBODIES; NK CELLS; HEMATOPOIETIC-CELLS; HEAVY-CHAINS; BONE-MARROW; T-CELLS; RECOGNITION	Class I MHC expression by target cells inhibits lysis mediated by natural killer (NK) cells, often in an allele-specific fashion. It has been proposed that NK cell inhibitory receptors recognize complexes of class I molecules with specific cellular peptides that define self, displacement of which would render cells NK sensitive. By loading the mostly empty D-d class I molecules of cell lines deficient in peptide transporter molecules with synthetic or natural D-d-bound peptides, we have demonstrated specific dose-dependent inhibition of the Ly49(+) subset of activated NK cells by class I-peptide complexes. Inhibition occurred with most if not all Dd-binding peptides, suggesting that Ly49(+) NK cells recognize class I-peptide complexes largely independently of peptide composition. The results suggest a primary role of NK cells in the destruction of cells that have down-regulated or extinguished cell surface expression of some or all class I molecules.	UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	CORREA, I (corresponding author), UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA.			Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035021] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI35021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; BLUESTONE JA, 1993, J IMMUNOL, V151, P3943; CARBONE E, 1993, EUR J IMMUNOL, V23, P1752, DOI 10.1002/eji.1830230803; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; CHADWICK BS, 1992, J IMMUNOL, V148, P2307; CHADWICK BS, 1992, J IMMUNOL, V149, P3150; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; CONNOLLY JM, 1988, J EXP MED, V168, P325, DOI 10.1084/jem.168.1.325; CORR M, 1993, J EXP MED, V178, P1877, DOI 10.1084/jem.178.6.1877; CORREA I, 1994, EUR J IMMUNOL, V24, P1323, DOI 10.1002/eji.1830240613; DANIELS BF, 1994, J EXP MED, V180, P687, DOI 10.1084/jem.180.2.687; EVANS GA, 1982, NATURE, V300, P755, DOI 10.1038/300755a0; FRANKSSON L, 1993, J EXP MED, V177, P201, DOI 10.1084/jem.177.1.201; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; KANE KP, 1994, J EXP MED, V179, P1011, DOI 10.1084/jem.179.3.1011; KAUFMAN DS, 1992, P NATL ACAD SCI USA, V89, P8337, DOI 10.1073/pnas.89.17.8337; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; LJUNGGREN HG, 1994, P NATL ACAD SCI USA, V91, P6520, DOI 10.1073/pnas.91.14.6520; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MALNATI MS, 1993, J EXP MED, V178, P961, DOI 10.1084/jem.178.3.961; MAUDSLEY DJ, 1991, IMMUNOL TODAY, V12, P429, DOI 10.1016/0167-5699(91)90013-J; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; MORETTA A, 1994, J EXP MED, V180, P545, DOI 10.1084/jem.180.2.545; NAGASAWA R, 1987, J IMMUNOL, V138, P815; OTTEN GR, 1992, J IMMUNOL, V148, P3723; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROCK KL, 1991, P NATL ACAD SCI USA, V88, P4200, DOI 10.1073/pnas.88.10.4200; SENTMAN CL, 1989, J EXP MED, V170, P191, DOI 10.1084/jem.170.1.191; SHIRAI M, 1992, J IMMUNOL, V148, P1657; SMITH HRC, 1994, J IMMUNOL, V153, P1068; STORKUS WJ, 1991, CRIT REV IMMUNOL, V10, P393; STORKUS WJ, 1989, J IMMUNOL, V143, P3853; STORKUS WJ, 1991, P NATL ACAD SCI USA, V88, P5989, DOI 10.1073/pnas.88.14.5989; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; STORKUS WJ, 1992, J IMMUNOL, V149, P1185; SYKES M, 1993, J EXP MED, V178, P223, DOI 10.1084/jem.178.1.223; SZIKORA JP, 1990, EMBO J, V9, P1041, DOI 10.1002/j.1460-2075.1990.tb08208.x; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; YANG Y, 1992, J BIOL CHEM, V267, P11669; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; YU YYL, 1992, ANNU REV IMMUNOL, V10, P189, DOI 10.1146/annurev.iy.10.040192.001201	53	172	175	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1995	2	1					61	71		10.1016/1074-7613(95)90079-9	http://dx.doi.org/10.1016/1074-7613(95)90079-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7541307	Bronze			2022-12-18	WOS:A1995QC59300006
J	GUERDER, S; MEYERHOFF, J; FLAVELL, R				GUERDER, S; MEYERHOFF, J; FLAVELL, R			THE ROLE OF THE T-CELL COSTIMULATOR B7-1 IN AUTOIMMUNITY AND THE INDUCTION AND MAINTENANCE OF TOLERANCE TO PERIPHERAL ANTIGEN	IMMUNITY			English	Article							PANCREATIC BETA-CELLS; GLUTAMIC-ACID DECARBOXYLASE; RECEPTOR TRANSGENIC MICE; II I-E; CLONAL DELETION; HISTOCOMPATIBILITY MOLECULES; ACTIVATION ANTIGEN-B7; EXTRATHYMIC TOLERANCE; VIRUS-INFECTION; IMMUNE-RESPONSE	T cell tolerance to peripheral antigens is believed to result mainly from the inability of parenchymal cells to present antigens in an immunogenic form due to the lack of expression of T cell costimulator. We found, however, that transgenic expression of the T cell costimulator B7-1 on the islets of Langerhans is not sufficient to abolish the in vivo tolerance to islets antigen. Here, we present evidence indicating that the level of major histocompatibility complex (MHC) antigen expressed by islet cells plays a critical role. Mice coexpressing the B7-1 transgene and high levels of the class II MHC antigen I-E on the islets develop an autoimmune destruction of the beta cells of the pancreas. By contrast, expression of the I-E molecule by islets, in the absence of T cell costimulator, leads to specific tolerance of these autoreactive T cells that cannot be reversed by costimulation with B7-1.			GUERDER, S (corresponding author), YALE UNIV, SCH MED, HOWARD HUGHES MED INST, IMMUNOBIOL SECT, 333 CEDAR ST, NEW HAVEN, CT 06520 USA.		Guerder, sylvie/L-6548-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK043078] Funding Source: NIH RePORTER; NIDDK NIH HHS [5P01-DK43078] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; AUPHAN N, 1992, INT IMMUNOL, V4, P541, DOI 10.1093/intimm/4.4.541; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BAEKKESKOV S, 1981, P NATL ACAD SCI-BIOL, V78, P6456, DOI 10.1073/pnas.78.10.6456; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURKLY LC, 1990, SCIENCE, V248, P1364, DOI 10.1126/science.1694042; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; CAMPBELL IL, 1985, DIABETES, V34, P1205, DOI 10.2337/diabetes.34.11.1205; CARLOW DA, 1992, INT IMMUNOL, V4, P599, DOI 10.1093/intimm/4.5.599; CHANG CH, 1992, J EXP MED, V176, P1465, DOI 10.1084/jem.176.5.1465; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; FABER OK, 1977, DIABETES, V26, P605, DOI 10.2337/diabetes.26.7.605; FIELDS LE, 1992, P NATL ACAD SCI USA, V89, P5730, DOI 10.1073/pnas.89.13.5730; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; GUERDER S, 1994, IN PRESS P NATL ACAD; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; Hogan B., 1986, MANIPULATING MOUSE E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; LEVIN D, 1993, J IMMUNOL, V151, P6742; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MANDEL TE, 1979, TRANSPLANT P, V11, P1505; MARKMANN J, 1988, NATURE, V336, P476, DOI 10.1038/336476a0; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NICKOLOFF BJ, 1993, AM J PATHOL, V142, P1029; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; REISER H, 1992, P NATL ACAD SCI USA, V89, P271, DOI 10.1073/pnas.89.1.271; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0; YOKOCHI T, 1982, J IMMUNOL, V128, P823	48	172	174	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1994	1	2					155	166						12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7534199				2022-12-18	WOS:A1994PK16200008
J	Yanez, A; Coetzee, SG; Olsson, A; Muench, DE; Berman, BP; Hazelett, DJ; Salomonis, N; Grimes, HL; Goodridge, HS				Yanez, Alberto; Coetzee, Simon G.; Olsson, Andre; Muench, David E.; Berman, Benjamin P.; Hazelett, Dennis J.; Salomonis, Nathan; Grimes, H. Leighton; Goodridge, Helen S.			Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; EMERGENCY GRANULOPOIESIS; CLONOGENIC PROGENITOR; COMMITTED PROGENITOR; MYELOID PROGENITOR; LINEAGE; DIFFERENTIATION; MACROPHAGES; EXPRESSION; IDENTIFICATION	Granulocyte-monocyte progenitors (GMPs) and monocyte-dendritic cell progenitors (MDPs) produce monocytes during homeostasis and in response to increased demand during infection. Both progenitor populations are thought to derive from common myeloid progenitors (CMPs), and a hierarchical relationship (CMP-GMP-MDP-monocyte) is presumed to underlie monocyte differentiation. Here, however, we demonstrate that mouse MDPs arose from CMPs independently of GMPs, and that GMPs and MDPs produced monocytes via similar but distinct monocyte-committed progenitors. GMPs and MDPs yielded classical (Ly6C hi) monocytes with gene expression signatures that were defined by their origins and impacted their function. GMPs produced a subset of "neutrophil-like'' monocytes, whereas MDPs gave rise to a subset of monocytes that yielded monocyte-derived dendritic cells. GMPs and MDPs were also independentlymobilized to produce specific combinations of myeloid cell types following the injection of microbial components. Thus, the balance of GMP and MDP differentiation shapes the myeloid cell repertoire during homeostasis and following infection.	[Yanez, Alberto; Berman, Benjamin P.; Goodridge, Helen S.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Yanez, Alberto; Coetzee, Simon G.; Berman, Benjamin P.; Hazelett, Dennis J.; Goodridge, Helen S.] Cedars Sinai Med Ctr, Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Coetzee, Simon G.; Berman, Benjamin P.; Hazelett, Dennis J.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Olsson, Andre; Muench, David E.; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Olsson, Andre; Muench, David E.; Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Ctr Syst Immunol, Cincinnati, OH 45229 USA; [Salomonis, Nathan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Goodridge, HS (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.; Goodridge, HS (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	helen.goodridge@csmc.edu	Boyer, Alberto Yáñez/R-1587-2018; BERMAN, BENJAMIN/AAT-3720-2021; Coetzee, Simon Gert/C-1218-2014	Boyer, Alberto Yáñez/0000-0002-7719-1963; BERMAN, BENJAMIN/0000-0002-2099-9005; Coetzee, Simon Gert/0000-0003-4267-5930; Muench, David E./0000-0002-8723-3389	Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center; Cedars-Sinai Medical Center; National Institutes of Health [R01HL122661]; American Association of Immunologists; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122661] Funding Source: NIH RePORTER	Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center; Cedars-Sinai Medical Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Immunologists; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funds from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center (to H.S.G.), development funds from Cedars-Sinai Medical Center (to S.C., D.H., and B.B.), a grant from the National Institutes of Health (R01HL122661 to H.L.G.), a Careers in Immunology fellowship from the American Association of Immunologists (to A.Y. and H.S.G.), and a Scholar Award from the American Society of Hematology (to A.Y.). We thank Dr. Ritchie Ho for helpful discussions.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Basu S, 2000, BLOOD, V95, P3725; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2015, SEMIN IMMUNOL, V27, P353, DOI 10.1016/j.smim.2016.03.016; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Kawamura S, 2017, IMMUNITY, V46, P835, DOI 10.1016/j.immuni.2017.04.019; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Marteijn JAF, 2007, BLOOD, V109, P100, DOI 10.1182/blood-2006-02-003590; McGrath KE, 2015, SEMIN IMMUNOL, V27, P379, DOI 10.1016/j.smim.2016.03.013; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Thambyrajah R, 2016, NAT CELL BIOL, V18, P21, DOI 10.1038/ncb3276; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang HS, 2014, J IMMUNOL, V193, P1766, DOI 10.4049/jimmunol.1301939; Yanez A, 2016, CURR OPIN HEMATOL, V23, P11, DOI 10.1097/MOH.0000000000000196; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833; Yanez A, 2013, EUR J IMMUNOL, V43, P2526, DOI 10.1002/eji.201343833; Yanez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024761; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhu YFP, 2016, ARTERIOSCL THROM VAS, V36, P1722, DOI 10.1161/ATVBAHA.116.304054	46	171	172	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					890	+		10.1016/j.immuni.2017.10.021	http://dx.doi.org/10.1016/j.immuni.2017.10.021			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166589	Green Accepted, Bronze			2022-12-18	WOS:000416483700013
J	Ray, JP; Marshall, HD; Laidlaw, BJ; Staron, MM; Kaech, SM; Craft, J				Ray, John P.; Marshall, Heather D.; Laidlaw, Brian J.; Staron, Matthew M.; Kaech, Susan M.; Craft, Joe			Transcription Factor STAT3 and Type I Interferons Are Corepressive Insulators for Differentiation of Follicular Helper and T Helper 1 Cells	IMMUNITY			English	Article							CD4 T-CELLS; CENTER B-CELL; CUTTING EDGE; BCL6; EFFECTOR; IL-21; GENERATION; EXPRESSION; MUTATIONS; INDUCTION	Follicular helper T (Tfh) cells are required for the establishment of T-dependent B cell memory and high affinity antibody-secreting cells. We have revealed herein opposing roles for signal transducer and activator of transcription 3 (STAT3) and type I interferon (IFN) signaling in the differentiation of Tfh cells following viral infection. STAT3-deficient CD4(+) T cells had a profound defect in Tfh cell differentiation, accompanied by decreased germinal center (GC) B cells and antigen-specific antibody production during acute infection with lymphocytic choriomeningitis virus. STAT3-deficient Tfh cells had strikingly increased expression of a number of IFN-inducible genes, in addition to enhanced T-bet synthesis, thus adopting a T helper 1 (Th1) cell-like effector phenotype. Conversely, IFN-alpha beta receptor blockade restored Tfh and GC B cell phenotypes in mice containing STAT3-deficient CD4(+) T cells. These data suggest mutually repressive roles for STAT3 and type I IFN signaling pathways in the differentiation of Tfh cells following viral infection.	[Ray, John P.; Marshall, Heather D.; Laidlaw, Brian J.; Staron, Matthew M.; Kaech, Susan M.; Craft, Joe] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Med Rheumatol, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.craft@yale.edu	Ray, John/F-3187-2015	Ray, John/0000-0001-7294-4260	National Science Foundation Graduate Research Fellowship Program [2012099695]; National Institute of Health [F32AI094791, AR40072, AR062842, AI075157, AR053495, AR063942]; Abbvie-Yale Collaboration in Immunobiology; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI075157, F32AI094791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044076, R01AR040072, R21AR063942, R37AR040072, P30AR053495, R21AR062842] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbvie-Yale Collaboration in Immunobiology; Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Shane Crotty for the STAT1 silencing vector. We also thank Steve Reilly for help with RNA-seq analysis and members of the Kaech and Craft laboratories for critical review of the manuscript. This work was supported by the National Science Foundation Graduate Research Fellowship Program under grant 2012099695 (J.P.R.), National Institute of Health grants F32AI094791 (H. D. M), AR40072, AR062842, AI075157, AR053495, AR063942, the Abbvie-Yale Collaboration in Immunobiology, and the Alliance for Lupus Research.	ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Malmgaard L, 2002, J VIROL, V76, P4520, DOI 10.1128/JVI.76.9.4520-4525.2002; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	50	171	178	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					367	377		10.1016/j.immuni.2014.02.005	http://dx.doi.org/10.1016/j.immuni.2014.02.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24631156	Bronze, Green Accepted			2022-12-18	WOS:000333422300010
J	Olson, JA; McDonald-Hyman, C; Jameson, SC; Hamilton, SE				Olson, Janelle A.; McDonald-Hyman, Cameron; Jameson, Stephen C.; Hamilton, Sara E.			Effector-like CD8(+) T Cells in the Memory Population Mediate Potent Protective Immunity	IMMUNITY			English	Article							CUTTING EDGE; LISTERIA-MONOCYTOGENES; LINEAGE RELATIONSHIP; RESIDENT MEMORY; SUBSETS; GENERATION; PHENOTYPE; DIFFERENTIATION; EXPRESSION; HISTORY	The CD8(+) memory T cell population is heterogeneous, and it is unclear which subset(s) optimally mediate the central goal of the immune system-protection against infection. Here we investigate the protective capacities of CD8(+) T cell subsets present at the memory stage of the immune response. We show that a population of CD8(+) T cells bearing markers associated with effector cells (KLRG1(hi), CD27 lo, T-bet hi, Eomes lo) persisted to the memory phase and provided optimal control of Listeria monocytogenes and vaccinia virus, despite weak recall proliferative responses. After antigen-specific boosting, this population formed the predominant secondary memory subset and maintained superior pathogen control. The effector-like memory subset displayed a distinct pattern of tissue distribution and localization within the spleen, and their enhanced capacity to eliminate Listeria involved specialized utilization of cytolysis. Together, these data suggest that long-lived effector CD8(+) T cells are optimal for protective immunity against certain pathogens.	[Olson, Janelle A.; McDonald-Hyman, Cameron; Jameson, Stephen C.; Hamilton, Sara E.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA.	james024@umn.edu; hamil062@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146	National Institutes of Health [R01AI75168, R37AI38903]; Cancer Biology Postdoctoral Training [5T32CA009138-38]; Leukemia and Lymphoma Career Development Award; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038903, R01AI075168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Postdoctoral Training; Leukemia and Lymphoma Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Masopust laboratory (especially Kristin Anderson) for help establishing splenic localization assays and timely provision of aged memory P14 CD8<SUP>+</SUP> T cells, Josiah Zacharias for valuable experimental input, and the University of Minnesota Flow Core personnel for cell sorting. We are grateful to Kris Hogquist, Matt Mescher, Dave Masopust, Dietmar Zehn, Stephen McSorley, and members of the Jamequist laboratory for mouse and bacterial strains and helpful discussions. This work was supported by the National Institutes of Health (grants R01AI75168 and R37AI38903 to S.C.J., and Cancer Biology Postdoctoral Training Grant 5T32CA009138-38 to J.A.O) and a Leukemia and Lymphoma Career Development Award (to S.E.H.).	Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Aoshi T, 2009, EUR J IMMUNOL, V39, P417, DOI 10.1002/eji.200838718; Baars PA, 2005, EUR J IMMUNOL, V35, P3131, DOI 10.1002/eji.200425770; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Bajenoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011524; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Edwards LE, 2013, IMMUNOL RES, V55, P135, DOI 10.1007/s12026-012-8356-9; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heffner M, 2007, P NATL ACAD SCI USA, V104, P13414, DOI 10.1073/pnas.0706040104; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huster KM, 2009, J IMMUNOL, V183, P6898, DOI 10.4049/jimmunol.0902454; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kambayashi T, 2003, J IMMUNOL, V170, P2399, DOI 10.4049/jimmunol.170.5.2399; KARUPIAH G, 1990, IMMUNOL CELL BIOL, V68, P325, DOI 10.1038/icb.1990.44; Laouar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004089; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2007, EUR J IMMUNOL, V37, pS103, DOI 10.1002/eji.200737584; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Messingham KAN, 2003, J IMMUNOL, V171, P4254, DOI 10.4049/jimmunol.171.8.4254; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Pham NLL, 2010, P NATL ACAD SCI USA, V107, P12198, DOI 10.1073/pnas.1004661107; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Prlic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032576; Rutishauser RL, 2010, IMMUNOL REV, V235, P219, DOI 10.1111/j.0105-2896.2010.00901.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sandau MM, 2010, J IMMUNOL, V184, P35, DOI 10.4049/jimmunol.0803355; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wirth TC, 2010, EUR J IMMUNOL, V40, P1916, DOI 10.1002/eji.201040310; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	60	171	173	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1250	1260		10.1016/j.immuni.2013.05.009	http://dx.doi.org/10.1016/j.immuni.2013.05.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23746652	Bronze, Green Accepted			2022-12-18	WOS:000330947500019
J	Isnardi, I; Ng, YS; Srdanovic, I; Motaghedi, R; Rudchenko, S; von Bernuth, H; Zhang, SY; Puel, A; Jouanguy, E; Picard, C; Garty, BZ; Camcioglu, Y; Doffinger, R; Kumararatne, D; Davies, G; Gallin, JI; Haraguchi, S; Day, NK; Casanova, JL; Meffre, E				Isnardi, Isabelle; Ng, Yen-Shing; Srdanovic, Iva; Motaghedi, Roja; Rudchenko, Sergei; von Bernuth, Horst; Zhang, Shen-Ying; Puel, Anne; Jouanguy, Emmanuelle; Picard, Capucine; Garty, Ben-Zion; Camcioglu, Yildiz; Doffinger, Rainer; Kumararatne, Dinakantha; Davies, Graham; Gallin, John I.; Haraguchi, Soichi; Day, Noorbibi K.; Casanova, Jean-Laurent; Meffre, Eric			IRAK-4-and MyD88-Dependent Pathways Are Essential for the Removal of Developing Autoreactive B Cells in Humans	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; RECURRENT BACTERIAL-INFECTIONS; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; MYD88-DEFICIENT MICE; ANTIGEN RECEPTOR; TOLERANCE; DEFICIENCY; IMMUNITY	Most autoreactive B cells are normally counterselected during early B cell development. To determine whether Toll-like receptors (TLRs) regulate the removal of autoreactive B lymphocytes, we tested the reactivity of recombinant antibodies from single B cells isolated from patients deficient for interleukin-1 receptor-associated kinase 4 (IRAK-4), myeloid differentiation factor 88 (MyD88), and UNC-93B. Indeed, all TLRs except TLR3 require IRAK-4 and MyD88 to signal, and UNC-93B-deficient cells are unresponsive to TLR3, TLR7, TLR8, and TLR9. All patients suffered from defective central and peripheral B cell tolerance checkpoints, resulting in the accumulation of large numbers of autoreactive mature naive B cells in their blood. Hence, TLR7, TLR8, and TLR9 may prevent the recruitment of developing autoreactive B cells in healthy donors. Paradoxically, IRAK-4-, MyD88-, and UNC-93B-deficient patients did not display autoreactive antibodies in their serum or develop autoimmune diseases, suggesting that IRAK-4, MyD88, and UNC-93B pathway blockade may thwart autoimmunity in humans.	[Isnardi, Isabelle; Ng, Yen-Shing; Srdanovic, Iva; Meffre, Eric] Hosp Special Surg, Lab Biochem & Mol Immunol, New York, NY 10021 USA; [Motaghedi, Roja] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Rudchenko, Sergei] Hosp Special Surg, Flow Cytometry Facil, New York, NY 10021 USA; [von Bernuth, Horst; Zhang, Shen-Ying; Puel, Anne; Jouanguy, Emmanuelle; Picard, Capucine; Casanova, Jean-Laurent] Univ Paris 05, Lab Genet Humaine Malad Infect, INSERM, Fac Med Necker,U550, F-75015 Paris, France; [Garty, Ben-Zion] Schneider Childrens Med Ctr Israel, Dept Pediat, IL-49202 Petah Tigva, Israel; [Camcioglu, Yildiz] Univ Istanbul, Cerrahpasa Med Sch, Dept Pediat, TR-3403 Istanbul, Turkey; [Doffinger, Rainer; Kumararatne, Dinakantha] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge CB2 0QQ, England; [Davies, Graham] Great Ormond St Hosp Sick Children, Dept Immunol, London WC1N 3JH, England; [Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Haraguchi, Soichi; Day, Noorbibi K.] Univ S Florida, Div Allergy & Immunol, Dept Pediat, St Petersburg, FL 33701 USA; [Haraguchi, Soichi; Day, Noorbibi K.] All Childrens Hosp, St Petersburg, FL 33701 USA	Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Istanbul University; Istanbul University - Cerrahpasa; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University System of Florida; University of South Florida	Meffre, E (corresponding author), Hosp Special Surg, Lab Biochem & Mol Immunol, 535 E 70th St, New York, NY 10021 USA.	meffree@hss.edu	Puel, Anne/H-7305-2017; Picard, Capucine/H-3914-2017; von Bernuth, Horst/AAQ-9797-2021; Zhang, Shen-Ying/I-2685-2017; Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017	Puel, Anne/0000-0003-2603-0323; Picard, Capucine/0000-0001-8788-5056; von Bernuth, Horst/0000-0002-5812-7675; Zhang, Shen-Ying/0000-0002-9449-3672; Jouanguy, Emmanuelle/0000-0002-7358-9157; Casanova, Jean-Laurent/0000-0002-7782-4169	National Institutes of Health [C06-RR12538-01]; National Institutes of Health-National Institute of Allergy and Infectious Diseases [A1061093, A1071087]; Fondation pour la Recherche Medicale; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095848, R01AI071087, P01AI061093, ZIAAI000521, ZIAAI000155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Charvin for help with microscopy analysis; N. Tangsinmankong for information on IRAK-4-deficient patient 2; M.C. Nussenzweig, S. Yurasov, and M. Tsuiji for sharing recombinant antibodies; C.-A. Reynaud, M. Herv6, L. IV16nard, and D. Saadoun for helpful discussions; and L. Abel, M. Tardieu, F. Rozenberg, V. Sancho-Shimizu, L. Lazaro, M. Chrabeh, and C.L. Ku for various support. We are very much indebted to the patients and their families. This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program grant number C06-RR12538-01 from the National Center for Research Resources, National Institutes of Health. This publication was made possible by grant number A1061093 and A1071087 from the National Institutes of Health-National Institute of Allergy and Infectious Diseases (to E.M.) and a grant from Fondation pour la Recherche Medicale (to I.I.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Day N, 2004, J PEDIATR-US, V144, P524, DOI 10.1016/j.jpeds.2003.11.025; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Haraguchi S, 1998, P NATL ACAD SCI USA, V95, P13125, DOI 10.1073/pnas.95.22.13125; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kuhns DB, 1997, J IMMUNOL, V158, P3959; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Meffre E, 1998, J EXP MED, V188, P765, DOI 10.1084/jem.188.4.765; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; Nemazee D, 2000, CURR TOP MICROBIOL, V245, P57; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Radic MZ, 1995, ANN NY ACAD SCI, V764, P384; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; Samuels J, 2005, ANN NY ACAD SCI, V1062, P116, DOI 10.1196/annals.1358.014; Samuels J, 2005, J EXP MED, V201, P1659, DOI 10.1084/jem.20042321; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wardemann H, 2004, J EXP MED, V200, P191, DOI 10.1084/jem.20040818; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	53	171	175	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					746	757		10.1016/j.immuni.2008.09.015	http://dx.doi.org/10.1016/j.immuni.2008.09.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006693	Green Accepted, Bronze			2022-12-18	WOS:000261036000012
J	Raftery, MJ; Schwab, M; Eibert, SM; Samstag, Y; Walczak, H; Schonrich, G				Raftery, MJ; Schwab, M; Eibert, SM; Samstag, Y; Walczak, H; Schonrich, G			Targeting the function of mature dendritic cells by human cytomegalovirus: A multilayered viral defense strategy	IMMUNITY			English	Article							APOPTOSIS-INDUCING LIGAND; MEASLES-VIRUS; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; T-CELLS; RECEPTOR; IMMUNOLOGY; INDUCTION; INFECTION; COMPLEX	Human cytomegalovirus (HCMV) can suppress and evade the immune system. We have identified as a mechanism the ability of HCMV to infect dendritic cells (DC), which initiate the antiviral immune response. HCMV-infected DC show enhanced expression of costimulatory molecules. In contrast, MHC molecules are partially downregulated, leading to a reduced antigen-presenting capacity. Moreover, the apoptosis-inducing ligands CD95L (FasL) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) are upregulated, thereby enabling HCMV-infected DC to delete activated T lymphocytes. This additional layer of viral defense is complemented by nondeletional mechanisms, which suppress surviving T cells. Thus, infection of DC allows the virus to blunt the antiviral T cell response by a multilayered defense strategy and could play a pivotal role in HCMV-triggered immuno-suppression.	Humboldt Univ, Inst Virol, Charite Med Sch, D-10117 Berlin, Germany; Heidelberg Univ, Inst Hyg, Dept Med Virol, D-69120 Heidelberg, Germany; Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, German Canc Res Ctr, Dept Apoptosis Regulat, Tumor Immunol Program, D-69120 Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Schonrich, G (corresponding author), Humboldt Univ, Inst Virol, Charite Med Sch, D-10117 Berlin, Germany.	guenther.schoenrich@charite.de	Walczak, Henning/AAV-2214-2020	Walczak, Henning/0000-0002-6312-4591; Schonrich, Gunther/0000-0002-5346-5704				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; Bertho N, 2000, J IMMUNOL, V164, P2379, DOI 10.4049/jimmunol.164.5.2379; Bhardwaj N, 1997, J EXP MED, V186, P795, DOI 10.1084/jem.186.6.795; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; BHARDWAJ N, 1993, J EXP MED, V178, P633, DOI 10.1084/jem.178.2.633; BLAUVELT A, 1995, J IMMUNOL, V154, P3506; Britt W J, 1996, VIROLOGY, V3, P2493; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Dengler TJ, 2000, TRANSPLANTATION, V69, P1160, DOI 10.1097/00007890-200003270-00022; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Green DR, 1997, P NATL ACAD SCI USA, V94, P5986, DOI 10.1073/pnas.94.12.5986; Greenberg PD, 1999, SCIENCE, V285, P546, DOI 10.1126/science.285.5427.546; GRIFFITHS PD, 1987, BIOCHEM J, V241, P313, DOI 10.1042/bj2410313; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jeremias I, 1998, EUR J IMMUNOL, V28, P143, DOI 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kalia R, 1999, COMPUT SCI ENG, V1, P2; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MACATONIA SE, 1992, IMMUNOLOGY, V75, P576; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Raftery MJ, 1999, J EXP MED, V190, P1103, DOI 10.1084/jem.190.8.1103; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; Schnorr JJ, 1997, P NATL ACAD SCI USA, V94, P5326, DOI 10.1073/pnas.94.10.5326; Sedger LM, 1999, J IMMUNOL, V163, P920; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Simon AK, 2001, P NATL ACAD SCI USA, V98, P5158, DOI 10.1073/pnas.091100398; SISSONS JGP, 1986, J ROY COLL PHYS LOND, V20, P40; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; SOUTHERN P, 1986, NEW ENGL J MED, V314, P359, DOI 10.1056/NEJM198602063140606; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tomazin R, 1999, NAT MED, V5, P1039, DOI 10.1038/12478; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Ward PL, 1998, INFEC AGENT, P1; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	56	171	179	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					997	1009		10.1016/S1074-7613(01)00239-4	http://dx.doi.org/10.1016/S1074-7613(01)00239-4			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754820	Bronze			2022-12-18	WOS:000172961400013
J	Koch, U; Lacombe, TA; Holland, D; Bowman, JL; Cohen, BL; Egan, SE; Guidos, CJ				Koch, U; Lacombe, TA; Holland, D; Bowman, JL; Cohen, BL; Egan, SE; Guidos, CJ			Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of notch-1	IMMUNITY			English	Article							T-CELL FATE; THYMOCYTE DEVELOPMENT; DROSOPHILA EYE; ALPHA-BETA; STEM-CELLS; B-CELL; EXPRESSION; GLYCOSYLTRANSFERASE; BOUNDARY; CHOICE	Notch-1 signaling is essential for lymphoid progenitors to undergo T cell commitment, but the mechanism has not been defined. Here we show that thymocytes ectopically expressing Lunatic Fringe, a modifier of Notch-1 signaling, induce lymphoid progenitors to develop into B cells in the thymus. This cell fate switch resulted from Lunatic Fringe-mediated inhibition of Notch-1 function, as revealed by experiments utilizing lymphoid progenitors in which Notch-1 activity was genetically manipulated. These data identify Lunatic Fringe as a potent regulator of Notch-1 during the T/B lineage decision and show that an important function of Notch-1 in T cell commitment is to suppress B cell development in the thymus.	Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Guidos, CJ (corresponding author), Hosp Sick Children, Res Inst, Program Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	guidos@sickkids.on.ca		Koch, Ute/0000-0001-7914-7061				Akashi K, 2000, CURR OPIN IMMUNOL, V12, P144, DOI 10.1016/S0952-7915(99)00064-3; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Busslinger M, 2000, CURR OPIN IMMUNOL, V12, P151, DOI 10.1016/S0952-7915(99)00065-5; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; GUIDOS CJ, 1989, J IMMUNOL, V142, P3773; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Lian ZX, 1997, STEM CELLS, V15, P430, DOI 10.1002/stem.150430; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mori S, 1997, J IMMUNOL, V158, P4193; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105; Singh N, 2000, EXP HEMATOL, V28, P527, DOI 10.1016/S0301-472X(00)00146-6; Tokoro Y, 1998, J IMMUNOL, V161, P4591; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	48	171	175	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2001	15	2					225	236		10.1016/S1074-7613(01)00189-3	http://dx.doi.org/10.1016/S1074-7613(01)00189-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520458	Bronze			2022-12-18	WOS:000170717200005
J	Olson, MC; Scott, EW; Hack, AA; Su, GH; Tenen, DG; Singh, H; Simon, MC				Olson, MC; Scott, EW; Hack, AA; Su, GH; Tenen, DG; Singh, H; Simon, MC			PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; CD34+ MARROW-CELLS; YOLK-SAC; FACTOR RECEPTOR; ETS ONCOGENE; FC-RECEPTOR; STEM-CELLS; MOUSE; MACROPHAGE; SEQUENCE	We have previously shown using gene targeting that PU.1 is essential for the development of lymphoid and myeloid lineages during fetal liver hematopoiesis. We now show that PU.1 is required for the maturation of yolk sac-derived myeloid progenitors and for the differentiation of ES cells into macrophages. The role of PU.1 in regulating target genes, thought to be critical in the development of monocytes and granulocytes, has been analyzed. Early genes such as GM-CSFR, G-CSFR, and myeloperoxidase are expressed in PU.1(-/-) embryos and differentiated PU.1(-/-) ES cells. However, the expression of genes associated with terminal myeloid differentiation (CD11b, CD64, and M-CSFR) is eliminated in differentiated PU.1(-/-) ES cells. Development of macrophages is restored with the introduction of a PU.1 cDNA regulated by its own promoter. The PU.1(-/-) ES cells represent an important model for analyzing myeloid cell development.	BETH ISRAEL HOSP, GWEN KNAPP CTR LUPUS & IMMUNOL RES, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, COMM IMMUNOL, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, DEPT MOLEC GENET & CELL BIOL, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Olson, MC (corresponding author), UNIV CHICAGO, HOWARD HUGHES MED INST, 5841 S MARYLAND AVE, CHICAGO, IL 60637 USA.		Simon, Celeste/AAG-3941-2021	Su, Gloria/0000-0002-5158-6019; Tenen, Daniel/0000-0002-6423-3888	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008933] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52094] Funding Source: Medline; NIAID NIH HHS [F32 AI08933] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; BERENSON RJ, 1991, BLOOD, V77, P1717; BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175; CARE A, 1994, ONCOGENE, V9, P739; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLINE MJ, 1972, BLOOD-J HEMATOL, V39, P842, DOI 10.1182/blood.V39.6.842.842; DEMETRI GD, 1991, BLOOD, V78, P2791; DIPERSIO J, 1988, J BIOL CHEM, V263, P1834; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FUKUNAGA R, 1990, CELL, V61, P341, DOI 10.1016/0092-8674(90)90814-U; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; HOHAUS S, 1995, IN PRESS MOL CELL BI; HROMAS R, 1993, BLOOD, V82, P2998; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KONECKI DS, 1982, NUCLEIC ACIDS RES, V10, P6763, DOI 10.1093/nar/10.21.6763; KONKEL DA, 1978, CELL, V15, P1125, DOI 10.1016/0092-8674(78)90040-5; KRAUSE DS, 1994, BLOOD, V84, P691; LEWIS VA, 1986, NATURE, V324, P372, DOI 10.1038/324372a0; LUBBERT M, 1991, BLOOD, V77, P909; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAGATA S, 1990, HDB EXPT PHARM, V95, P699; NAITO M, 1993, ARCH HISTOL CYTOL, V56, P331, DOI 10.1679/aohc.56.331; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PAHL HL, 1993, J BIOL CHEM, V268, P5014; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PARK LS, 1986, J EXP MED, V164, P251, DOI 10.1084/jem.164.1.251; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; PEREZ C, 1993, MOL CELL BIOL, V13, P2182, DOI 10.1128/MCB.13.4.2182; PERKINS AC, 1995, NATURE, V375, P318; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; REGENSTREIF LJ, 1989, DEV BIOL, V133, P284, DOI 10.1016/0012-1606(89)90319-9; ROSMARIN AG, 1989, BLOOD, V73, P131; ROSMARIN AG, 1995, P NATL ACAD SCI USA, V92, P801, DOI 10.1073/pnas.92.3.801; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SMITH LT, 1994, BLOOD, V84, pA372; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; TOBLER A, 1988, J CELL PHYSIOL, V136, P215, DOI 10.1002/jcp.1041360203; TSUJI K, 1992, BLOOD, V79, P2855; UZUMAKI H, 1989, P NATL ACAD SCI USA, V86, P9323, DOI 10.1073/pnas.86.23.9323; VENTURELLI D, 1989, NUCLEIC ACIDS RES, V17, P7987, DOI 10.1093/nar/17.19.7987; WILKS AF, 1988, ONCOGENE, V3, P289; WILSON RW, 1989, NUCLEIC ACIDS RES, V17, P5397, DOI 10.1093/nar/17.13.5397; WOGNUM AW, 1994, BLOOD, V84, P764; YU G, 1988, MOL PHARMACOL, V33, P384; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	54	171	171	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1995	3	6					703	714		10.1016/1074-7613(95)90060-8	http://dx.doi.org/10.1016/1074-7613(95)90060-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TM023	8777716	Bronze			2022-12-18	WOS:A1995TM02300005
J	MONACH, PA; MEREDITH, SC; SIEGEL, CT; SCHREIBER, H				MONACH, PA; MEREDITH, SC; SIEGEL, CT; SCHREIBER, H			A UNIQUE TUMOR-ANTIGEN PRODUCED BY A SINGLE AMINO-ACID SUBSTITUTION	IMMUNITY			English	Article							DISSEMINATED MURINE LEUKEMIA; T-CELL STIMULATION; CLASS-II MOLECULES; MONOCLONAL-ANTIBODIES; LYMPHOCYTES-T; TRANSPLANTATION ANTIGENS; RECOMBINANT PROTEINS; ULTRAVIOLET-LIGHT; INVARIANT CHAIN; GENE	Mice immunized against a cancer recognize antigens unique to that cancer, but the molecular structures of such antigens are unknown. We isolated CD4(+) T cell clones recognizing an antigen uniquely expressed on the UV-induced tumor 6132A; some clones inhibited the growth of tumors bearing the specific antigen. A T cell hybridoma was used to purify this antigen from nuclear extracts by RP-HPLC and SDS-PAGE using T cell immunoblot assays. A partial amino acid sequence was nearly identical to a sequence in ribosomal protein L9. The cDNA sequence of L9 from 6132A PRO cells differed from the normal sequence at one nucleotide; this mutation encoded histidine instead of leucine at position 47. A synthetic peptide containing this mutation was over 1000-fold more stimulatory of T cells than was the wild-type peptide. These results indicate that this unique tumor antigen is derived from a single amino acid substitution in a cellular protein.			MONACH, PA (corresponding author), UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637, USA.			Monach, Paul/0000-0003-4937-0515	NATIONAL CANCER INSTITUTE [R01CA037156, P01CA019266, R37CA022677, R01CA022677] Funding Source: NIH RePORTER; NCI NIH HHS [CA19266, CA22677, CA37156] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN PM, 1984, J IMMUNOL, V132, P1077; BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; BASOMBRIO MA, 1970, CANCER RES, V30, P2458; BRASH DE, 1982, NATURE, V298, P189, DOI 10.1038/298189a0; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; BUELOW R, 1992, J IMMUNOL, V148, P1; BURNET FM, 1970, NATURE, V226, P123, DOI 10.1038/226123a0; CARBONE G, 1991, INT J CANCER, V47, P619, DOI 10.1002/ijc.2910470423; CHAN YL, 1994, J BIOL CHEM, V269, P5589; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CHOU TK, 1987, J IMMUNOL, V139, P2103; COHEN PA, 1994, CANCER RES, V54, P1055; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DEKRUYFF RH, 1986, J IMMUNOL, V137, P1109; FENTON RG, 1993, JNCI-J NATL CANCER I, V85, P1294, DOI 10.1093/jnci/85.16.1294; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FUJIWARA H, 1984, J IMMUNOL, V133, P1671; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GAVIN MA, 1993, J IMMUNOL, V151, P3971; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GOLDSBY RA, 1977, NATURE, V267, P707, DOI 10.1038/267707a0; GREENBERG PD, 1981, J EXP MED, V154, P952, DOI 10.1084/jem.154.3.952; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; HICKLING JK, 1992, EUR J IMMUNOL, V22, P1983, DOI 10.1002/eji.1830220805; HORI N, 1993, NUCLEIC ACIDS RES, V21, P4395, DOI 10.1093/nar/21.18.4395; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JOYCE S, 1994, J EXP MED, V179, P579, DOI 10.1084/jem.179.2.579; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; KOEPPEN H, 1993, EUR J IMMUNOL, V23, P2770, DOI 10.1002/eji.1830231108; KOEPPEN HKW, 1993, TRANSPLANTATION, V55, P1349; KRIPKE ML, 1974, J NATL CANCER I, V53, P1333, DOI 10.1093/jnci/53.5.1333; KUHNLEIN U, 1976, P NATL ACAD SCI USA, V73, P1169, DOI 10.1073/pnas.73.4.1169; KUNDIG TM, 1993, J IMMUNOL, V150, P4450; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBKOWSKI JS, 1985, P NATL ACAD SCI USA, V82, P8606, DOI 10.1073/pnas.82.24.8606; LEE DR, 1988, J EXP MED, V168, P1719, DOI 10.1084/jem.168.5.1719; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NAPARSTEK Y, 1993, ANNU REV IMMUNOL, V11, P79, DOI 10.1146/annurev.iy.11.040193.000455; NOGUCHI Y, 1994, P NATL ACAD SCI USA, V91, P3171, DOI 10.1073/pnas.91.8.3171; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; ORTEGA G, 1984, J IMMUNOL, V133, P1970; OZATO K, 1980, J IMMUNOL, V124, P533; OZAWA H, 1987, J IMMUNOL, V139, P3896; PASTERNAK G, 1964, Acta Biol Med Ger, V13, P276; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; PHILIPPS C, 1985, P NATL ACAD SCI USA, V82, P5140, DOI 10.1073/pnas.82.15.5140; PREHN RT, 1957, J NATL CANCER I, V18, P769; ROHRER JW, 1994, J IMMUNOL, V152, P754; ROSENSTEIN M, 1984, J IMMUNOL, V132, P2117; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SALLUSTIO S, 1990, J BIOL CHEM, V265, P582; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; SIBILLE C, 1990, J EXP MED, V172, P35, DOI 10.1084/jem.172.1.35; SRIVASTAVA PK, 1988, IMMUNOL TODAY, V9, P78, DOI 10.1016/0167-5699(88)91269-8; STEWART MJ, 1993, MOL CELL BIOL, V13, P2524, DOI 10.1128/MCB.13.4.2524; SUZUKI K, 1990, GENE, V93, P297, DOI 10.1016/0378-1119(90)90239-N; TENG MN, 1991, P NATL ACAD SCI USA, V88, P3535, DOI 10.1073/pnas.88.9.3535; TOPALIAN SL, 1994, INT J CANCER, V58, P69, DOI 10.1002/ijc.2910580113; UDONO H, 1989, JPN J CANCER RES, V80, P649, DOI 10.1111/j.1349-7006.1989.tb01692.x; URBAN JL, 1982, J EXP MED, V155, P557, DOI 10.1084/jem.155.2.557; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; WARD PL, 1990, CANCER RES, V50, P3851; WEISBURGER JH, 1981, SCIENCE, V214, P401, DOI 10.1126/science.7291981; WILDE DB, 1984, J IMMUNOL, V132, P1632; YOUNG DB, 1986, IMMUNOLOGY, V59, P167; ZIEMIECKI A, 1990, EMBO J, V9, P191, DOI 10.1002/j.1460-2075.1990.tb08095.x	81	171	187	0	8	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					45	59		10.1016/1074-7613(95)90078-0	http://dx.doi.org/10.1016/1074-7613(95)90078-0			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600302	Bronze			2022-12-18	WOS:A1995QC59300005
J	Brewitz, A; Eickhoff, S; Dahling, S; Quast, T; Bedoui, S; Kroczek, RA; Kurts, C; Garbi, N; Barchet, W; Iannacone, M; Klauschen, F; Kolanus, W; Kaisho, T; Colonna, M; Germain, RN; Kastenmuller, W				Brewitz, Anna; Eickhoff, Sarah; Daehling, Sabrina; Quast, Thomas; Bedoui, Sammy; Kroczek, Richard A.; Kurts, Christian; Garbi, Natalio; Barchet, Winfried; Iannacone, Matteo; Klauschen, Frederick; Kolanus, Waldemar; Kaisho, Tsuneyasu; Colonna, Marco; Germain, Ronald N.; Kastenmueller, Wolfgang			CD8(+) T Cells Orchestrate pDC-XCR1(+) Dendritic Cell Spatial and Functional Cooperativity to Optimize Priming	IMMUNITY			English	Article							LYMPH-NODES; ANTIVIRAL IMMUNITY; CROSS-PRESENTATION; VIRAL-INFECTION; VIRUS-INFECTION; IFN-GAMMA; IN-VIVO; ACTIVATION; ANTIGEN; CD4(+)	Adaptive cellular immunity is initiated by antigenspecific interactions between T lymphocytes and dendritic cells (DCs). Plasmacytoid DCs (pDCs) support antiviral immunity by linking innate and adaptive immune responses. Here we examined pDC spatiotemporal dynamics during viral infection to uncover when, where, and how they exert their functions. We found that pDCs accumulated at sites of CD8(+) T cell antigen-driven activation in a CCR5-dependent fashion. Furthermore, activated CD8(+) T cells orchestrated the local recruitment of lymph node-resident XCR1 chemokine receptor-expressing DCs via secretion of the XCL1 chemokine. Functionally, this CD8+ T cell-mediated reorganization of the local DC network allowed for the interaction and cooperation of pDCs and XCR1(+) DCs, thereby optimizing XCR1(+) DC maturation and cross-presentation. These data support a model in which CD8(+) T cells upon activation create their own optimal priming microenvironment by recruiting additional DC subsets to the site of initial antigen recognition.	[Brewitz, Anna; Eickhoff, Sarah; Daehling, Sabrina; Kurts, Christian; Garbi, Natalio; Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, D-53127 Bonn, Germany; [Quast, Thomas; Kolanus, Waldemar] Univ Bonn, Mol Immunol & Cell Biol Life & Med Sci Inst, D-53115 Bonn, Germany; [Bedoui, Sammy] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Kroczek, Richard A.] Robert Koch Inst, Mol Immunol, D-13353 Berlin, Germany; [Barchet, Winfried] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Iannacone, Matteo] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Via Olgettina 58, I-20132 Milan, Italy; [Iannacone, Matteo] Univ Vita Salute San Raffaele, Expt Imaging Ctr, IRCCS San Raffaele Sci Inst, Via Olgettina 58, I-20132 Milan, Italy; [Klauschen, Frederick] Charite, Inst Pathol, CharitePlatz 1, D-10117 Berlin, Germany; [Klauschen, Frederick] Einstein Fdn Berlin, D-10117 Berlin, Germany; [Kaisho, Tsuneyasu] Wakayama Med Univ, Inst Adv Med, Dept Immunol, Wakayama 6418509, Japan; [Kaisho, Tsuneyasu] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Inflammatory Regulat, Yokohama, Kanagawa 2300045, Japan; [Kaisho, Tsuneyasu] Osaka Univ, World Premier Int Res Ctr Initiat, Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Germain, Ronald N.] Natl Inst Allergy & Infect Dis, Lab Syst Biol, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA; [Brewitz, Anna; Eickhoff, Sarah; Daehling, Sabrina; Kurts, Christian; Garbi, Natalio; Kastenmueller, Wolfgang] Univ Hosp, Inst Expt Immunol, D-53127 Bonn, Germany; [Barchet, Winfried; Kastenmueller, Wolfgang] Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany	University of Bonn; University of Bonn; University of Melbourne; Robert Koch Institute; University of Bonn; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wakayama Medical University; RIKEN; Osaka University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bonn; University of Bonn	Kastenmuller, W (corresponding author), Univ Bonn, Inst Expt Immunol, D-53127 Bonn, Germany.; Kastenmuller, W (corresponding author), Univ Hosp, Inst Expt Immunol, D-53127 Bonn, Germany.; Kastenmuller, W (corresponding author), Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	wkastenm@uni-bonn.de	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Iannacone, Matteo/I-8507-2018; Klauschen, Frederick/C-5637-2015	Iannacone, Matteo/0000-0002-9370-2671; Klauschen, Frederick/0000-0002-9131-2389; Barchet, Winfried/0000-0002-6745-6606; BEDOUI, SAMMY/0000-0002-7443-0543	NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia; Kishimoto Foundation; Japan Society for the Promotion of Science (JSPS) [26293106]; Einstein Foundation Berlin; Intramural Research Program, NIAID, NIH; DFG Graduate program [2168/1];  [SFB704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, ZIAAI000545] Funding Source: NIH RePORTER	NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia; Kishimoto Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Einstein Foundation Berlin; Intramural Research Program, NIAID, NIH; DFG Graduate program; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S. Ebbinghaus and S. Rathmann for technical assistance and D.H. Busch for kindly providing MHCI multimers. This research was supported by the Intramural Research Program, NIAID, NIH. W. Kastenmuller, N.G., C.K., and W. Kolanus are members of the DFG Excellence Cluster ImmunoSensation in Bonn, Germany, and are supported by grant SFB704. S.D., S.B., and W. Kastenmuller are supported by the DFG Graduate program 2168/1 (Bo&MeRang). W. Kastenmuller is supported by NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia. T.K. was supported by the Kishimoto Foundation and a Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS, 26293106). F.K. is supported by the Einstein Foundation Berlin (JF-Klauschen-2014).	Ang DKY, 2010, J IMMUNOL, V184, P5429, DOI 10.4049/jimmunol.1000128; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bachem A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00214; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Haeryfar SMM, 2005, TRENDS IMMUNOL, V26, P311, DOI 10.1016/j.it.2005.04.002; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jusforgues-Saklani H, 2008, J IMMUNOL, V181, P3067, DOI 10.4049/jimmunol.181.5.3067; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kitano M, 2016, P NATL ACAD SCI USA, V113, P1044, DOI 10.1073/pnas.1513607113; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Xu RH, 2015, IMMUNITY, V43, P1148, DOI 10.1016/j.immuni.2015.11.015; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	47	170	173	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					205	219		10.1016/j.immuni.2017.01.003	http://dx.doi.org/10.1016/j.immuni.2017.01.003			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28190711	Green Accepted, Bronze			2022-12-18	WOS:000396410900010
J	Hor, JL; Whitney, PG; Zaid, A; Brooks, AG; Heath, WR; Mueller, SN				Hor, Jyh Liang; Whitney, Paul G.; Zaid, Ali; Brooks, Andrew G.; Heath, William R.; Mueller, Scott N.			Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4(+) and CD8(+) T Cell Activation to Localized Viral Infection	IMMUNITY			English	Article							HERPES-SIMPLEX-VIRUS; LYMPH-NODE; ANTIGEN PRESENTATION; CUTTING EDGE; CROSS-PRESENTATION; SUBCAPSULAR SINUS; LANGERHANS CELLS; IN-VIVO; B-CELLS; RESPONSES	The dynamics of when and where CD4(+) T cells provide help for CD8(+) T cell priming and which dendritic cells (DCs) activate CD4(+) T cells in vivo after localized infection are poorly understood. By using a cutaneous herpes simplex virus infection model combined with intravital 2-photon imaging of the draining lymph node (LN) to concurrently visualize pathogen-specific CD4(+) and CD8(+) T cells, we found that early priming of CD4(+) T cells involved clustering with migratory skin DCs. CD8(+) T cells did not interact with migratory DCs and their activation was delayed, requiring later clustering interactions with LN-resident XCR1(+) DCs. CD4(+) T cells interacted with these late CD8(+) T cell clusters on resident XCR1(+) DCs. Together, these data reveal asynchronous T cell activation by distinct DC subsets and highlight the key role of XCR1(+) DCs as the central platform for cytotoxic T lymphocyte activation and the delivery of CD4(+) T cell help.	[Hor, Jyh Liang; Whitney, Paul G.; Zaid, Ali; Brooks, Andrew G.; Heath, William R.; Mueller, Scott N.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Hor, Jyh Liang; Zaid, Ali; Heath, William R.; Mueller, Scott N.] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Mueller, SN (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.	smue@unimelb.edu.au	; Mueller, Scott/B-1918-2012	Heath, William/0000-0001-9670-259X; Whitney, Paul/0000-0003-3836-7601; Brooks, Andrew/0000-0002-4085-9683; Mueller, Scott/0000-0002-3838-3989; Zaid, Ali/0000-0002-2528-2783	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank S. Bedoui for discussions and C. Jones, G. Davey, and M. Damtsis for technical assistance. Supported by the National Health and Medical Research Council of Australia (P.G.W., A.G.B., W.R.H., and S.N.M.) and the Australian Research Council (W.R.H. and S.N.M.).	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Eidsmo L, 2012, J PATHOL, V226, P806, DOI 10.1002/path.3975; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Singh-Jasuja H, 2013, IMMUNOBIOLOGY, V218, P28, DOI 10.1016/j.imbio.2012.01.021; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stock AT, 2004, J IMMUNOL, V173, P2241, DOI 10.4049/jimmunol.173.4.2241; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Weeks BS, 2000, ARCH VIROL, V145, P385, DOI 10.1007/s007050050030; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	45	170	172	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					554	565		10.1016/j.immuni.2015.07.020	http://dx.doi.org/10.1016/j.immuni.2015.07.020			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE9NY	26297566	Bronze			2022-12-18	WOS:000370965900007
J	Van Dyken, SJ; Mohapatra, A; Nussbaum, JC; Molofsky, AB; Thornton, EE; Ziegler, SF; McKenzie, ANJ; Krummel, MF; Liang, HE; Locksley, RM				Van Dyken, Steven J.; Mohapatra, Alexander; Nussbaum, Jesse C.; Molofsky, Ari B.; Thornton, Emily E.; Ziegler, Steven F.; McKenzie, Andrew N. J.; Krummel, Matthew F.; Liang, Hong-Erh; Locksley, Richard M.			Chitin Activates Parallel Immune Modules that Direct Distinct Inflammatory Responses via Innate Lymphoid Type 2 and gamma delta T Cells	IMMUNITY			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE PRODUCTION; PERITROPHIC MATRIX; INTERLEUKIN 33; RECEPTOR; TISSUE; IL-4; HOMEOSTASIS; IDENTIFICATION; EOSINOPHILS	Chitin, a polysaccharide constituent of many allergens and parasites, initiates innate type 2 lung inflammation through incompletely defined pathways. We show that inhaled chitin induced expression of three epithelial cytokines, interleukin-25 (IL-25), IL-33, and thymic stromal lymphopoietin (TSLP), which nonredundantly activated resident innate lymphoid type 2 cells (ILC2s) to express IL-5 and IL-13 necessary for accumulation of eosinophils and alternatively activated macrophages (AAMs). In the absence of all three epithelial cytokines, ILC2s normally populated the lung but failed to increase IL-5 and IL-13. Although eosinophils and AAMs were attenuated, neutrophil influx remained normal without these epithelial cytokines. Genetic ablation of ILC2s, however, enhanced IL-1 beta, TNF alpha, and IL-23 expression, increased activation of IL-17A-producing gamma delta T cells, and prolonged neutrophil influx. Thus, chitin elicited patterns of innate cytokines that targeted distinct populations of resident lymphoid cells, revealing divergent but interacting pathways underlying the tissue accumulation of specific types of inflammatory myeloid cells.	[Van Dyken, Steven J.; Mohapatra, Alexander; Nussbaum, Jesse C.; Molofsky, Ari B.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Van Dyken, Steven J.; Mohapatra, Alexander; Nussbaum, Jesse C.; Molofsky, Ari B.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Van Dyken, Steven J.; Mohapatra, Alexander; Nussbaum, Jesse C.; Molofsky, Ari B.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Van Dyken, Steven J.; Mohapatra, Alexander; Nussbaum, Jesse C.; Molofsky, Ari B.; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Thornton, Emily E.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [McKenzie, Andrew N. J.] Med Res Council Lab Mol Biol, Cambridge CB2 0QH, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Benaroya Research Institute; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Molofsky, Ari/0000-0003-0764-3175; Van Dyken, Steven/0000-0002-9787-0883; Thornton, Emily/0000-0002-0068-2502	National Institutes of Health [AI026918, AI030663, HL107202]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California, San Francisco; Medical Research Council [MC_U105178805] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R01AI030663, R37AI026918, T32AI007334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California, San Francisco(University of California System); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Akira (Osaka University), J. Ihle (St. Jude), and M. Steinhoff (UCSF) for mice, D. Sheppard, C. Lowell, and D. Erle for helpful comments on the manuscript, and Z. Wang, N. Flores, and M. Consengco for expert technical assistance. This work was supported by National Institutes of Health grants AI026918, AI030663, and HL107202, Howard Hughes Medical Institute, and the Sandler Asthma Basic Research Center at the University of California, San Francisco.	Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Doherty TA, 2012, AM J PHYSIOL-LUNG C, V303, pL577, DOI 10.1152/ajplung.00174.2012; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Roy RM, 2012, J IMMUNOL, V189, P2545, DOI 10.4049/jimmunol.1200689; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	52	170	171	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					414	424		10.1016/j.immuni.2014.02.003	http://dx.doi.org/10.1016/j.immuni.2014.02.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24631157	Green Accepted, Bronze			2022-12-18	WOS:000333422300014
J	Kataru, RP; Kim, H; Jang, C; Choi, DK; Koh, BI; Kim, M; Gollamudi, S; Kim, YK; Lee, SH; Koh, GY				Kataru, Raghu P.; Kim, Honsoul; Jang, Cholsoon; Choi, Dong Kyu; Koh, Bong Ihn; Kim, Minah; Gollamudi, Sudheer; Kim, Yun-Keun; Lee, Seung-Hyo; Koh, Gou Young			T Lymphocytes Negatively Regulate Lymph Node Lymphatic Vessel Formation	IMMUNITY			English	Article							IFN-GAMMA; INTERFERON-GAMMA; INDUCED LYMPHANGIOGENESIS; ANTIGEN PRESENTATION; ENDOTHELIAL-CELLS; INFLAMMATION; MECHANISMS; SYSTEM; VEGF; VASCULATURE	Lymph node lymphatic vessels (LNLVs) serve as a conduit to drain antigens from peripheral tissues to within the lymph nodes. LNLV density is known to be positively regulated by vascular endothelial growth factors secreted by B cells, macrophages, and dendritic cells (DCs). Here, we show that LNLV formation was negatively regulated by T cells. In both steady and inflammatory states, the density of LNLVs was increased in the absence of T cells but decreased when T cells were restored. Interferon-gamma secretion by T cells suppressed lymphatic-specific genes in lymphatic endothelial cells and consequently caused marked reduction in LNLV formation. When T cells were depleted, recruitment of antigen-carrying DCs to LNs was augmented, reflecting a compensatory mechanism for antigen presentation to T cells through increased LNLVs. Thus, T cells maintain the homeostatic balance of LNLV density through a negative paracrine action of interferon-gamma.	[Kataru, Raghu P.; Kim, Honsoul; Koh, Bong Ihn; Lee, Seung-Hyo; Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Kataru, Raghu P.; Kim, Honsoul; Jang, Cholsoon; Choi, Dong Kyu; Koh, Bong Ihn; Kim, Minah; Gollamudi, Sudheer; Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Jang, Cholsoon; Choi, Dong Kyu; Kim, Minah; Gollamudi, Sudheer; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea; [Kim, Yun-Keun] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Kim, Yun-Keun] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea.	seung-hyo.lee@kaist.ac.kr; gykoh@kaist.ac.kr	Kataru, Raghu P/AAB-9990-2022; Koh, Gou Young/C-1615-2011; Kataru, Raghu/K-8896-2019; Lee, Seung-Hyo/B-9922-2015	Kataru, Raghu/0000-0003-1315-7982; Lee, Seung-Hyo/0000-0003-0010-4072; Jang, Cholsoon/0000-0001-6651-4213	Korea Science and Engineering Foundation (KOSEF) [R2009-0079390]; MEST, Korea [R31-2009-000-10071-0]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank J.S. Hong and E.S. Lee for their technical assistance. This work was supported by the grant (R2009-0079390, G.Y.K.) of Korea Science and Engineering Foundation (KOSEF) and the WCU grant (R31-2009-000-10071-0) funded by the MEST, Korea. R.P.K., H.K., C.J., D.K.C., B.I.K, Y.-K.K., S.-H.L., and G.Y.K. designed, organized, and performed the experiments, analyzed the data, generated the figures, and wrote the manuscript. M.K. and S.G. performed flow cytometry and MACS sorting.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cohen JN, 2010, J EXP MED, V207, P681, DOI 10.1084/jem.20092465; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; GATELY MK, 1994, INT IMMUNOL, V6, P157, DOI 10.1093/intimm/6.1.157; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Ibe S, 2001, J EXP MED, V194, P1549, DOI 10.1084/jem.194.11.1549; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kim KE, 2009, AM J PATHOL, V175, P1733, DOI 10.2353/ajpath.2009.090133; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ohtani O, 2008, ARCH HISTOL CYTOL, V71, P69, DOI 10.1679/aohc.71.69; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rodriguez-Palmero M, 1999, INFLAMMATION, V23, P153, DOI 10.1023/A:1020293012793; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shao XJ, 2006, J INTERF CYTOK RES, V26, P568, DOI 10.1089/jir.2006.26.568; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tedeschi E, 2002, ANN NY ACAD SCI, V973, P435, DOI 10.1111/j.1749-6632.2002.tb04678.x; Tewari K, 2007, J IMMUNOL, V179, P2115, DOI 10.4049/jimmunol.179.4.2115; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1	40	170	173	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					96	107		10.1016/j.immuni.2010.12.016	http://dx.doi.org/10.1016/j.immuni.2010.12.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21256057	Bronze			2022-12-18	WOS:000287336600013
J	Kim, HS; Han, MS; Chung, KW; Kim, S; Kim, E; Kim, MJ; Jang, E; Lee, HA; Youn, J; Akira, S; Lee, MS				Kim, Hun Sik; Han, Myoung Sook; Chung, Kun Wook; Kim, Sunshin; Kim, Eunshil; Kim, Myoung Joo; Jang, Eunkyeong; Lee, Hyun Ah; Youn, Jeehee; Akira, Shizuo; Lee, Myung-Shik			Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes	IMMUNITY			English	Article							APOPTOTIC CELLS; GENE-EXPRESSION; DENDRITIC CELLS; STRANDED-RNA; T-CELLS; KAPPA-B; TOLL-LIKE-RECEPTOR-7; RECOGNITION; DISRUPTION; ACTIVATION	Although it is established that defective clearance and, hence, increased accumulation of apoptotic cells can lead to autoimmunity, the mechanism by which this occurs remains elusive. Here, we observed that apoptotic cells undergoing secondary necrosis but not intact apoptotic cells provoked substantial immune responses, which were mediated through the toll-like receptor 2 (TLR2) pathway. The development of autoimmune diabetes was markedly inhibited in Tlr2(-/-) mice but not in Tlr4(-/-) mice, showing that TLR2 plays an important role in the initiation of the disease. Apoptotic P-cell injury could stimulate the priming of diabetogenic T cells through a TLR2-dependent, but TLR4-independent, activation of antigen-presenting cells. These findings suggest that beta-cell death and its sensing via TLR2 may be an initial event for the stimulation of antigen-presenting cells and development of autoimmune diabetes.	Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Canc Res Ctr, Seoul 135710, South Korea; Hanyang Univ, Coll Med, Dept Anat & Cell Biol, Seoul 133791, South Korea; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Osaka University	Lee, MS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea.	msiee@smc.samsung.co.kr	Akira, Shizuo/C-3134-2009; Lee, Myung Shik/C-9606-2011	Han, Myoung Sook/0000-0002-7226-2590				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Bratton DL, 2005, NAT MED, V11, P26, DOI 10.1038/nm0105-26; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; ELIAS D, 1994, DIABETES, V43, P992, DOI 10.2337/diabetes.43.8.992; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2983, DOI 10.1073/pnas.052714199; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Ip WK, 2004, J IMMUNOL, V173, P189, DOI 10.4049/jimmunol.173.1.189; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Mora C, 1999, J IMMUNOL, V162, P4576; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Park EW, 2004, ANN FAM MED, V2, P170, DOI 10.1370/afm.64; Rovere P, 1998, J IMMUNOL, V161, P4467; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Szanya V, 2002, J IMMUNOL, V169, P2461, DOI 10.4049/jimmunol.169.5.2461; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; VANCE JE, 1991, J BIOL CHEM, V266, P89; WELCH WJ, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0593-56; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	42	170	182	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					321	333		10.1016/j.immuni.2007.06.010	http://dx.doi.org/10.1016/j.immuni.2007.06.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17707128	Bronze			2022-12-18	WOS:000249056300017
J	Li, SL; Wilkinson, MF				Li, SL; Wilkinson, MF			Nonsense surveillance in lymphocytes?	IMMUNITY			English	Article							NUCLEAR MESSENGER-RNA; HUMAN TRIOSEPHOSPHATE ISOMERASE; ADENINE PHOSPHORIBOSYLTRANSFERASE; FRAMESHIFT MUTATIONS; REGULATORY MECHANISM; PROTEIN-SYNTHESIS; PREMESSENGER RNA; BETA-THALASSEMIA; CIS EFFECTORS; READING FRAME		Univ Texas, MD Anderson Cancer Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wilkinson, MF (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Dept Immunol, Houston, TX 77030 USA.	mwilkins@notes.mdacc.tmc.edu	Li, Shulin/D-6478-2011					AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Arking DE, 1997, AM J HUM GENET, V61, pA25; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; BLENCOWE BJ, 1995, RNA, V1, P852; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CONNOR A, 1994, J BIOL CHEM, V269, P25178; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; HALL GW, 1994, BLOOD, V83, P2031; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JACK HM, 1989, EUR J IMMUNOL, V19, P843, DOI 10.1002/eji.1830190510; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; Kessler O, 1996, MOL CELL BIOL, V16, P4426; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; LEE BS, 1995, P NATL ACAD SCI USA, V92, P10354, DOI 10.1073/pnas.92.22.10354; Li SL, 1997, J EXP MED, V185, P985, DOI 10.1084/jem.185.6.985; Long RM, 1995, RNA, V1, P1071; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Maquat LE, 1996, AM J HUM GENET, V59, P279; MAQUAT LE, 1995, RNA, V1, P453; MENON KP, 1994, CELL MOL BIOL, V40, P999; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; QIAN L, 1993, J IMMUNOL, V151, P6801; QIAN LA, 1993, MOL CELL BIOL, V13, P1686, DOI 10.1128/MCB.13.3.1686; SIMPSON SB, 1994, MOL CELL BIOL, V14, P1835, DOI 10.1128/MCB.14.3.1835; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; Zhang J, 1996, RNA, V2, P235	45	170	180	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1998	8	2					135	141		10.1016/S1074-7613(00)80466-5	http://dx.doi.org/10.1016/S1074-7613(00)80466-5			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9491995	Bronze			2022-12-18	WOS:000072201800001
J	Kropshofer, H; Arndt, SO; Moldenhauer, G; Hammerling, GJ; Vogt, AB				Kropshofer, H; Arndt, SO; Moldenhauer, G; Hammerling, GJ; Vogt, AB			HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH	IMMUNITY			English	Article							COMPLEX CLASS-II; CHAIN-DERIVED PEPTIDES; INVARIANT-CHAIN; ANTIGEN PRESENTATION; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; HLA-DR1 MOLECULES; PRESENTING CELLS; MICE LACKING; MHC	HLA-DM (DM) is a nonclassical MHC class II molecule that interacts with classical MHC II molecules in acidic compartments. During this association DM is supposed to catalyze the release of invariant chain (li)derived CLIP peptides, as well as other peptides bound with low kinetic stability. Here we provide evidence that in lysosomal compartments of B cells a considerable fraction of DM is stably associated with empty DR alpha beta dimers, thereby preventing their functional inactivation and aggregation. Upon encounter with cognate peptide, the DM-associated DR molecules can be rapidly loaded and no longer bind to DM. Thus, DM seems to act as a dedicated class Ii-specific chaperone. In view of the suggested shortage of DM-resistant self-peptides in the loading compartment, empty class II molecules that are chaperoned by DM may enable the antigen-processing system to respond promptly to the challenge by newly entering antigens.	GERMAN CANC RES CTR,DEPT MOL IMMUNOL,D-69120 HEIDELBERG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)				Arndt, Sven Oliver/0000-0002-1861-7573				ADAMS TE, 1983, IMMUNOLOGY, V50, P613; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BROOKS AG, 1994, J IMMUNOL, V153, P5382; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CHO SG, 1991, NATURE, V353, P573, DOI 10.1038/353573a0; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DEVAUX B, 1995, J IMMUNOL, V155, P1921; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; GELUK A, 1992, J IMMUNOL, V149, P2864; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; KOMFELD S, 1992, ANNU REV BIOCHEM, V61, P307; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; KROPSHOFER H, 1995, P NATL ACAD SCI USA, V92, P8313, DOI 10.1073/pnas.92.18.8313; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; KROPSHOFER H, 1991, BIOCHEMISTRY-US, V30, P9177, DOI 10.1021/bi00102a008; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LINDSTEDT R, 1995, IMMUNITY, V3, P561, DOI 10.1016/1074-7613(95)90127-2; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; MAX H, 1993, HUM IMMUNOL, V38, P193, DOI 10.1016/0198-8859(93)90540-H; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Ramachandra L, 1996, J IMMUNOL, V156, P2196; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; Schafer PH, 1996, J IMMUNOL, V157, P5487; SCHAIFF WT, 1992, J EXP MED, V176, P657, DOI 10.1084/jem.176.3.657; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stebbins CC, 1996, J IMMUNOL, V157, P4892; STEM LJ, 1992, CELL, V68, P465; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; URBAN RG, 1994, J EXP MED, V180, P751, DOI 10.1084/jem.180.2.751; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Verreck FAW, 1996, INT IMMUNOL, V8, P397, DOI 10.1093/intimm/8.3.397; VIVILLE S, 1993, CELL, V72, P635, DOI 10.1016/0092-8674(93)90081-Z; VOGT AB, 1994, J IMMUNOL, V153, P1665; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; VOGT AB, 1995, J IMMUNOL, V155, P4757; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	64	170	172	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					293	302		10.1016/S1074-7613(00)80332-5	http://dx.doi.org/10.1016/S1074-7613(00)80332-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075930	Bronze			2022-12-18	WOS:A1997XC61800009
J	SantAngelo, DB; Waterbury, G; PrestonHurlburt, P; Yoon, ST; Medzhitov, R; Hong, SC; Janeway, CA				SantAngelo, DB; Waterbury, G; PrestonHurlburt, P; Yoon, ST; Medzhitov, R; Hong, SC; Janeway, CA			The specificity and orientation of a TCR to its Peptide - MHC class II Ligands	IMMUNITY			English	Article							T-CELL RECEPTOR; ANTIGEN RECEPTOR; CHAIN; EXPRESSION; GENES; RECOGNITION; COMPLEXES; REGION	A T cell-mediated immune response is mainly determined by the 3-5 aa residues that protrude upwards from a peptide bound to an MHC molecule. Alterations of these peptide residues can diminish, eliminate or radically alter the signal that the T cell receives through its T cell receptor (TCR). We have used peptide immunizations of normal mice and mice carrying alpha or beta chain TCR transgenes to identify three distinct peptide contact points. One, near the carboxyl terminus of the peptide, involves the beta chain CDR3 region; the second was centrally located and interacted with both the alpha and beta chain CDR3 loops; the third was near the amino terminus of the peptide, and affected V alpha gene usage, but not the structure of CDR3 of either TCR chain. Based on these results, we propose an orientation for the TCR of this cloned line and argue for its generality.			SantAngelo, DB (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.				NIAID NIH HHS [AI-14579] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014579, R37AI014579] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1993, IMMUNOL TODAY, V14, P405, DOI 10.1016/0167-5699(93)90144-A; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BOTH GW, 1990, MOL CELL BIOL, V10, P5187, DOI 10.1128/MCB.10.10.5187; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CLAVERIE JM, 1989, IMMUNOL TODAY, V10, P10, DOI 10.1016/0167-5699(89)90058-3; DANSKA JS, 1990, J EXP MED, V172, P27, DOI 10.1084/jem.172.1.27; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; GEIGER T, 1993, J IMMUNOL, V151, P7030; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HONG SC, 1992, CELL, V69, P1; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; KATAYAMA CD, 1995, EMBO J, V14, P927, DOI 10.1002/j.1460-2075.1995.tb07074.x; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; NAKAGAWA TY, 1991, EUR J IMMUNOL, V21, P2851, DOI 10.1002/eji.1830211129; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PERCUS JK, 1993, P NATL ACAD SCI USA, V90, P1691, DOI 10.1073/pnas.90.5.1691; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; REICH EP, 1994, J IMMUNOL, V152, P2279; ROTZSCHKE O, 1994, CURR OPIN IMMUNOL, V6, P45, DOI 10.1016/0952-7915(94)90032-9; SAITO T, 1987, NATURE, V329, P256, DOI 10.1038/329256a0; SCHILHAM MW, 1986, J IMMUNOL, V137, P2748; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; SUN R, 1995, IMMUNITY, V3, P573, DOI 10.1016/1074-7613(95)90128-0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; YELAMOS J, 1995, NATURE, V376, P225; YOON ST, 1994, IMMUNITY, V1, P563; YOON ST, 1994, THESIS YALE U SCH ME	54	170	171	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1996	4	4					367	376		10.1016/S1074-7613(00)80250-2	http://dx.doi.org/10.1016/S1074-7613(00)80250-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UH522	8612131	Bronze			2022-12-18	WOS:A1996UH52200005
J	KING, LB; VACCHIO, MS; DIXON, K; HUNZIKER, R; MARGULIES, DH; ASHWELL, JD				KING, LB; VACCHIO, MS; DIXON, K; HUNZIKER, R; MARGULIES, DH; ASHWELL, JD			A TARGETED GLUCOCORTICOID RECEPTOR ANTISENSE TRANSGENE INCREASES THYMOCYTE APOPTOSIS AND ALTERS THYMOCYTE DEVELOPMENT	IMMUNITY			English	Article							T-CELLS; MESSENGER-RNA; BETA-CHAIN; GENE-EXPRESSION; WILD-TYPE; MICE; ACTIVATION; IMMATURE; INDUCTION; DEATH	The exquisite sensitivity of thymocytes to steroid-induced apoptosis, the steroidogenic potential of thymic epithelial cells, and the ability of steroid synthesis inhibitors to enhance antigen-specific deletion of thymocytes in fetal thymic organ cultures suggest a role for glucocorticoids in thymocyte development. To address this further, transgenic mice that express antisense transcripts to the glucocorticoid receptor (GR) specifically in immature thymocytes were generated. The consequent hyporesponsiveness of thymocytes to glucocorticoids was accompanied by a reduction in thymic size, primarily owing to a decrease in the number of CD4(+)CD8(+) cells. While an enhanced susceptibility to T cell receptor (TCR)-mediated apoptosis appeared to be partially responsible for this reduction, thymocyte loss could also be detected before thymocytes progressed to the CD4(+)CD8(+) TCR alpha beta-expressing stage, These results suggest that glucocorticoids are necessary for survival and maturation of thymocytes, and are consistent with a role for steroids in both the transition from CD4(-)CD8(-) to CD4(+)CD8(+) cells and the survival of CD4(+)CD8(+) cells stimulated via the TCR.	NIAID, IMMUNOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	KING, LB (corresponding author), NCI, IMMUNE CELL BIOL LAB, BETHESDA, MD 20892 USA.			Margulies, David/0000-0001-8530-7375	NCI NIH HHS [CA09162] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA009162] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIRD F, 1993, P NATL ACAD SCI USA, V90, P7104, DOI 10.1073/pnas.90.15.7104; ANDJELIC S, 1993, EUR J IMMUNOL, V23, P2109, DOI 10.1002/eji.1830230910; BALLARD PL, 1979, GLUCOCORTICOID HORMO, P493; BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R; BAUGHMAN G, 1991, MOL ENDOCRINOL, V5, P637, DOI 10.1210/mend-5-5-637; BAUGHMAN G, 1992, J IMMUNOL, V149, P1488; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENDROR I, 1993, P NATL ACAD SCI USA, V90, P1117, DOI 10.1073/pnas.90.3.1117; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cohen J J, 1992, Semin Immunol, V4, P363; COHEN JJ, 1984, J IMMUNOL, V132, P38; COLE TJ, 1993, J STEROID BIOCHEM, V47, P49, DOI 10.1016/0960-0760(93)90056-3; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DEFRANCO D, 1991, P NATL ACAD SCI USA, V88, P5607, DOI 10.1073/pnas.88.13.5607; DIEKEN ES, 1992, MOL CELL BIOL, V12, P589, DOI 10.1128/MCB.12.2.589; DOUGHERTY TF, 1952, PHYSIOL REV, V32, P379, DOI 10.1152/physrev.1952.32.4.379; DUVAL D, 1976, BIOCHIM BIOPHYS ACTA, V451, P82, DOI 10.1016/0304-4165(76)90259-2; ERICKSON RP, 1968, P NATL ACAD SCI USA, V59, P437, DOI 10.1073/pnas.59.2.437; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; GOLD R, 1993, J HISTOCHEM CYTOCHEM, V41, P1023, DOI 10.1177/41.7.8515045; GROETTRUP M, 1993, EUR J IMMUNOL, V23, P1393, DOI 10.1002/eji.1830230633; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GRUBER J, 1994, EUR J IMMUNOL, V24, P1115, DOI 10.1002/eji.1830240516; HADDEN JW, 1992, INT J IMMUNOPHARMACO, V14, P345, DOI 10.1016/0192-0561(92)90163-F; HANUKOGLU I, 1990, J BIOL CHEM, V265, P20602, DOI 10.1016/S0021-9258(17)30545-8; HUETMINKOWSKI M, 1982, DRUG HORMONE RESISTA, P79; Hunziker R, 1991, Biotechnology, V16, P175; IWATA M, 1991, EUR J IMMUNOL, V21, P643, DOI 10.1002/eji.1830210316; Jaffe HL, 1924, J EXP MED, V40, P325, DOI 10.1084/jem.40.3.325; LEVELT CN, 1993, J EXP MED, V177, P707, DOI 10.1084/jem.177.3.707; LEVELT CN, 1993, J EXP MED, V178, P1867, DOI 10.1084/jem.178.6.1867; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MIESFELD R, 1984, NATURE, V312, P779, DOI 10.1038/312779a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; NOVAK TJ, 1992, MOL CELL BIOL, V12, P1515, DOI 10.1128/MCB.12.4.1515; PEPIN MC, 1992, NATURE, V355, P725, DOI 10.1038/355725a0; PLAUT M, 1987, ANNU REV IMMUNOL, V5, P621, DOI 10.1146/annurev.iy.05.040187.003201; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Selye H, 1936, BRIT J EXP PATHOL, V17, P234; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SPRENT J, 1988, IMMUNOL REV, V101, P172; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; ZACHARCHUK CM, 1991, ANN NY ACAD SCI, V636, P52, DOI 10.1111/j.1749-6632.1991.tb33438.x; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; ZHANG HY, 1993, P NATL ACAD SCI USA, V90, P3880, DOI 10.1073/pnas.90.9.3880; ZHOU T, 1993, J IMMUNOL, V150, P3651	56	170	175	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	1995	3	5					647	656		10.1016/1074-7613(95)90135-3	http://dx.doi.org/10.1016/1074-7613(95)90135-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TG281	7584154	Bronze			2022-12-18	WOS:A1995TG28100012
J	Martinez-Gonzalez, I; Matha, L; Steer, CA; Ghaedi, M; Poon, GFT; Takei, F				Martinez-Gonzalez, Itziar; Matha, Laura; Steer, Catherine A.; Ghaedi, Maryam; Poon, Grace F. T.; Takei, Fumio			Allergen-Experienced Group 2 Innate Lymphoid Cells Acquire Memory-like Properties and Enhance Allergic Lung Inflammation	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; AIRWAY INFLAMMATION; T-CELLS; VIRAL-INFECTION; ASTHMA; PROTECTION; CYTOKINES; IMMUNITY; TYPE-2; IL-33	Group 2 innate lymphoid cells (ILC2s) in the lung are stimulated by inhaled allergens. ILC2s do not directly recognize allergens but they are stimulated by cytokines including interleukin (IL)-33 released by damaged epithelium. In response to allergens, lung ILC2s produce T helper 2 cell type cytokines inducing T cell-independent allergic lung inflammation. Here we examined the fate of lung ILC2s upon allergen challenges. ILC2s proliferated and secreted cytokines upon initial stimulation with allergen or IL-33, and this phase was followed by a contraction phase as cytokine production ceased. Some ILC2s persisted long after the resolution of the inflammation as allergen-experienced ILC2s and responded to unrelated allergens more potently than naive ILC2s, mediating severe allergic inflammation. The allergen-experienced ILC2s exhibited a gene expression profile similar to that of memory T cells. The memory-like properties of allergen-experienced ILC2s may explain why asthma patients are often sensitized to multiple allergens.	[Martinez-Gonzalez, Itziar; Ghaedi, Maryam; Poon, Grace F. T.; Takei, Fumio] Univ British Columbia, Department Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Martinez-Gonzalez, Itziar; Matha, Laura; Steer, Catherine A.; Ghaedi, Maryam; Poon, Grace F. T.; Takei, Fumio] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Matha, Laura; Steer, Catherine A.] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Takei, F (corresponding author), Univ British Columbia, Department Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.; Takei, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	ftakei@bccrc.ca		Martinez Gonzalez, Itziar/0000-0002-1695-5691; Takei, Fumio/0000-0002-3620-5046; Matha, Laura/0000-0002-4399-6851	Canadian Institute of Health Research; MITACS; Michael Smith Foundation for Health Research (MSFHR); Canadian Institute of Health Research (CIHR); UBC 4YF studentship; CIHR	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); MITACS; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); UBC 4YF studentship; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institute of Health Research (F.T.). I.M.-G. was supported by MITACS, Michael Smith Foundation for Health Research (MSFHR), and Canadian Institute of Health Research (CIHR) post-doctoral fellowships. C.A.S. was supported by a UBC 4YF studentship and a CIHR studentship. We thank Dr. Sergio Martinez-Hoyer for his help in microarray data analyses.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Calderon MA, 2012, J ALLERGY CLIN IMMUN, V129, P929, DOI 10.1016/j.jaci.2011.11.019; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; DeKruyff RH, 2014, IMMUNOL REV, V260, P235, DOI 10.1111/imr.12187; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamelmann E, 2001, IMMUNOL REV, V179, P182, DOI 10.1034/j.1600-065X.2001.790118.x; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Martinez-Gonzalez I, 2015, TRENDS IMMUNOL, V36, P189, DOI 10.1016/j.it.2015.01.005; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Remakus S, 2013, ADV EXP MED BIOL, V785, P77, DOI 10.1007/978-1-4614-6217-0_9; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salmond RJ, 2012, J ALLERGY CLIN IMMUN, V130, P1159, DOI 10.1016/j.jaci.2012.05.018; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	33	169	174	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					198	208		10.1016/j.immuni.2016.06.017	http://dx.doi.org/10.1016/j.immuni.2016.06.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27421705	Bronze			2022-12-18	WOS:000380749000021
J	Perry, JSA; Lio, CWJ; Kau, AL; Nutsch, K; Yang, Z; Gordon, JI; Murphy, KM; Hsieh, CS				Perry, Justin S. A.; Lio, Chan-Wang J.; Kau, Andrew L.; Nutsch, Katherine; Yang, Zhuo; Gordon, Jeffrey I.; Murphy, Kenneth M.; Hsieh, Chyi-Song			Distinct Contributions of Aire and Antigen-Presenting-Cell Subsets to the Generation of Self-Tolerance in the Thymus	IMMUNITY			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; NEGATIVE SELECTION; EPITHELIAL-CELLS; CLONAL DELETION; CLASS-II; REPERTOIRE; MICROENVIRONMENT; DIFFERENTIATION; AUTOIMMUNITY	The contribution of thymic antigen-presenting-cell (APC) subsets in selecting a self-tolerant T cell population remains unclear. We show that bone marrow (BM) APCs and medullary thymic epithelial cells (mTECs) played nonoverlapping roles in shaping the T cell receptor (TCR) repertoire by deletion and regulatory T (Treg) cell selection of distinct TCRs. Aire, which induces tissue-specific antigen expression in mTECs, affected the TCR repertoire in a manner distinct from mTEC presentation. Approximately half of Aire-dependent deletion or Treg cell selection utilized a pathway dependent on antigen presentation by BM APCs. Batf3-dependent CD8 alpha(+) dendritic cells (DCs) were the crucial BM APCs for Treg cell selection via this pathway, showing enhanced ability to present antigens from stromal cells. These results demonstrate the division of function between thymic APCs in shaping the selftolerant TCR repertoire and reveal an unappreciated cooperation between mTECs and CD8 alpha(+) DCs for presentation of Aire-induced self-antigens to developing thymocytes.	[Perry, Justin S. A.; Lio, Chan-Wang J.; Nutsch, Katherine; Yang, Zhuo; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA; [Kau, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA.	chsieh@wustl.edu	Kau, Andrew/AGX-9881-2022	Hsieh, Chyi-Song/0000-0001-5976-9250; Lio, Jerry/0000-0003-3876-6741; Kau, Andrew/0000-0002-9386-3766	NIH NIAID [AI079187]; Burroughs Wellcome Fund; NIH NRSA postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091044] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Luo (Division of Biostatistics, WUSTL) for consultation regarding statistical analysis; T. Egawa and E. Unanue (both WUSTL) for critical reading of the manuscript and advice; and L. Klein (LMU Munich), A. Rudensky (MSK), and M. Colonna (WUSTL) for gifts of reagents and mice. C.-S.H. is supported by NIH NIAID AI079187 and the Burroughs Wellcome Fund and J.S.A.P. is the recipient of an R01 Research Supplement to Promote Diversity in Health-Related Research (NIH NIAID AI079187-06S1). A.L.K. is the recipient of an NIH NRSA postdoctoral fellowship.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Daniely D, 2010, J IMMUNOL, V184, P6865, DOI 10.4049/jimmunol.0903609; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Hubert FX, 2009, J IMMUNOL, V182, P3902, DOI 10.4049/jimmunol.0802124; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Lio CWJ, 2010, J IMMUNOL, V184, P6007, DOI 10.4049/jimmunol.1000019; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Roman E, 2010, J IMMUNOL, V185, P3819, DOI 10.4049/jimmunol.0900665; RUDENSKY AY, 1991, NATURE, V353, P660, DOI 10.1038/353660a0; Sawicka M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00019; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252	51	169	169	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					414	426		10.1016/j.immuni.2014.08.007	http://dx.doi.org/10.1016/j.immuni.2014.08.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25220213	Bronze, Green Accepted			2022-12-18	WOS:000342626500012
J	Koch, MA; Thomas, KR; Perdue, NR; Smigiel, KS; Srivastava, S; Campbell, DJ				Koch, Meghan A.; Thomas, Kerri R.; Perdue, Nikole R.; Smigiel, Kate S.; Srivastava, Shivani; Campbell, Daniel J.			T-bet(+) Treg Cells Undergo Abortive Th1 Cell Differentiation due to Impaired Expression of IL-12 Receptor beta 2	IMMUNITY			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; AUTOIMMUNE ENCEPHALOMYELITIS; LISTERIA-MONOCYTOGENES; FATE DETERMINATION; TARGET GENES; IFN-GAMMA; INFLAMMATION; INTERLEUKIN-12	Foxp3(+) regulatory T (Treg) cells limit inflammatory responses and maintain immune homeostasis. Although comprised of several phenotypically and functionally distinct subsets, the differentiation of specialized Treg cell populations within the periphery is poorly characterized. We demonstrate that the development of T-bet(+) Treg cells that potently inhibit T helper 1 (Th1) cell responses was dependent on the transcription factor STAT1 and occurred directly in response to interferon-gamma produced by effector T cells. Additionally, delayed induction of the IL-12R beta 2 receptor component after STAT1 activation helped ensure that Treg cells do not readily complete STAT4-dependent Th1 cell development and lose their ability to suppress effector T cell proliferation. Thus, we define a pathway of abortive Th1 cell development that results in the specialization of peripheral Treg cells and demonstrate that impaired expression of a single cytokine receptor helps maintain Treg cell-suppressive function in the context of inflammatory Th1 cell responses.	[Koch, Meghan A.; Thomas, Kerri R.; Perdue, Nikole R.; Smigiel, Kate S.; Srivastava, Shivani; Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Koch, Meghan A.; Smigiel, Kate S.; Srivastava, Shivani; Campbell, Daniel J.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle	Campbell, DJ (corresponding author), Benaroya Res Inst, Seattle, WA 98101 USA.	campbell@benaroyaresearch.org		Srivastava, Shivani/0000-0002-1626-8402	NIH [AR055695, HL098067, AI067750, AI085130]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085130, R56AI067750, R01AI067750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank K. Aru for flow cytometry assistance, J. Hamerman for helpful discussions, and M. Warren for administrative assistance. This work was supported by grants from the NIH (AR055695, HL098067, AI067750, and AI085130) to D.J.C.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Way SS, 2007, J IMMUNOL, V178, P4498, DOI 10.4049/jimmunol.178.7.4498; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	40	169	171	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					501	510		10.1016/j.immuni.2012.05.031	http://dx.doi.org/10.1016/j.immuni.2012.05.031			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22960221	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000309199000014
J	Herlands, RA; Christensen, SR; Sweet, RA; Hershberg, U; Shlomchik, MJ				Herlands, Robin A.; Christensen, Sean R.; Sweet, Rebecca A.; Hershberg, Uri; Shlomchik, Mark J.			T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells	IMMUNITY			English	Article							SINGLE-STRANDED RNA; MURINE LUPUS; AUTOANTIBODY PRODUCTION; SOMATIC HYPERMUTATION; MONOCLONAL-ANTIBODY; RESPONSES; MICE; AUTOIMMUNITY; RECOGNITION; HELPER	On the lupus-prone MRL-lpr/lpr (MRL-lpr) background, AM14 rheumatoid factor (RF) B cells are activated, differentiate into plasmablasts, and undergo somatic hypermutation outside of follicles. Using multiple strategies to impair T cells, we found that such AM14 B cell activation did not require T cells but could be modulated by them. In vitro, the signaling adaptor MyD88 is required for IgG anti-chromatin to stimulate AM14 B cell proliferation when T cells are absent. However, the roles of Toll-like receptors (TLRs) in AM14 B cell activation in vivo have not been investigated. We found that activation, expansion, and differentiation of AM14 B cells depended on MyD88; however, mice lacking either TLR7 or TLR9 displayed partial defects, indicating complex roles for these receptors. T cell-independent activation of certain autoreactive B cells, which gain stimuli via endogenous TLR ligands instead of T cells, may be the initial step in the generation of canonical autoantibodies.	[Herlands, Robin A.; Christensen, Sean R.; Sweet, Rebecca A.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Hershberg, Uri; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA	Yale University; Yale University	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Box 208035, New Haven, CT 06520 USA.	mark.shlomchik@yale.edu	Hershberg, Uri/AAQ-6255-2020; Shlomchik, Mark J./AAN-6189-2020	Hershberg, Uri/0000-0002-6425-5980; Shlomchik, Mark J./0000-0002-2152-0959; Sweet, Rebecca/0000-0002-4104-1648	NIH [P01-AI36529, P01-AR050256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061090, P01AI036529, R01AI073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Craft and Z. Yin for generously providing the Tcrb<SUP>-/-</SUP> mice and UC-7 Ab. We thank M. Horniak, T. Hunt, M. Baez, and D. Kent for outstanding animal husbandry. We thank the members of the Shlomchilk lab autoimmunity group for many useful discussions and A. Rothstein and J. Craft for critical comments on the manuscript. The research was supported by NIH grants P01-AI36529 and P01-AR050256.	ADAMS S, 1991, P NATL ACAD SCI USA, V88, P11271, DOI 10.1073/pnas.88.24.11271; ANDO DG, 1987, J IMMUNOL, V138, P3185; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; CARTERON NL, 1989, J IMMUNOL, V142, P1470; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; CONNOLLY K, 1992, J IMMUNOL, V149, P3083; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; Fields ML, 2005, J IMMUNOL, V175, P4255, DOI 10.4049/jimmunol.175.7.4255; Fields ML, 2005, J IMMUNOL, V175, P104, DOI 10.4049/jimmunol.175.1.104; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; HOULDEN BA, 1989, COLD SH Q B, V54, P45; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kleinstein SH, 2003, J IMMUNOL, V171, P4639, DOI 10.4049/jimmunol.171.9.4639; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LIN RH, 1991, J EXP MED, V173, P1433, DOI 10.1084/jem.173.6.1433; LOSMAN MJ, 1993, INT IMMUNOL, V5, P513, DOI 10.1093/intimm/5.5.513; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MAMULA MJ, 1994, J IMMUNOL, V152, P1453; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peng SL, 1998, CLIN EXP IMMUNOL, V111, P107; Peng SL, 1996, J IMMUNOL, V156, P4041; Peng SL, 1996, J IMMUNOL, V157, P5689; Rossbacher J, 2003, J EXP MED, V198, P591, DOI 10.1084/jem.20022042; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; Shlomchik MJ, 2001, NAT REV IMMUNOL, V1, P147, DOI 10.1038/35100573; Singh RR, 1998, IMMUNOL REV, V164, P201, DOI 10.1111/j.1600-065X.1998.tb01221.x; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; Weisel F, 2007, EUR J IMMUNOL, V37, P3330, DOI 10.1002/eji.200737971; William J, 2006, J IMMUNOL, V176, P2142, DOI 10.4049/jimmunol.176.4.2142; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; William J, 2005, J IMMUNOL, V174, P6872, DOI 10.4049/jimmunol.174.11.6872; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; WOFSY D, 1987, J IMMUNOL, V138, P3247; Wofsy D, 1993, Immunol Ser, V59, P221; Zelenika D, 2001, IMMUNOL REV, V182, P164, DOI 10.1034/j.1600-065X.2001.1820113.x	54	169	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2008	29	2					249	260		10.1016/j.immuni.2008.06.009	http://dx.doi.org/10.1016/j.immuni.2008.06.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18691914	Green Accepted, Bronze			2022-12-18	WOS:000258610800013
J	Berland, R; Fernandez, L; Kari, E; Han, JH; Lomakin, I; Akira, S; Wortis, HH; Kearney, JF; Ucci, AA; Imanishi-Kari, T				Berland, Robert; Fernandez, Luis; Kari, Elina; Han, Jin-Hwan; Lomakin, Ina; Akira, Shizuo; Wortis, Henry H.; Kearney, John F.; Ucci, Angelo A.; Imanishi-Kari, Thereza			Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice	IMMUNITY			English	Article							ANTI-DNA ANTIBODIES; X SWR MODEL; T-BET; LUPUS NEPHRITIS; MURINE LUPUS; AUTOIMMUNITY; DIFFERENTIATION; RECOMBINATION; RECOGNITION; REPERTOIRE	Systemic lupus erythematosus (SLE) is characterized by the production of autoantibodies that are frequently directed against nucleic acid-associated antigens. To better understand how B cells reactive with such antigens are regulated, we generated a model system in which heavy and light chain genes encoding 564 immunoglobulin have been targeted to the heavy and light chain loci of the nonautoimmune C57BL/6 mouse strain. This antibody recognizes RNA, single-stranded DNA, and nucleosomes. We show that B cells expressing this immunoglobulin were activated, producing class-switched autoantibody in vivo despite the apparently normal induction of anergy. This autoantibody production was largely dependent on Toll-like receptor 7 (TLR7). We further show that production of these autoantibodies was sufficient to cause kidney pathology in these mice. These results demonstrate that the particular threat of nucleic acid-containing autoantigens lies in their ability to bind both antigen receptor and TLR7.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Immunol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; Tufts NEMCH, Dept Pathol, Boston, MA 02111 USA; Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	Tufts University; Tufts University; Osaka University; University of Alabama System; University of Alabama Birmingham	Imanishi-Kari, T (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	thereza.imanishi-kari@tufts.edu	Kearney, John/GOV-3123-2022; Akira, Shizuo/C-3134-2009		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043535, R21AI014782, R01AI014782, R01AI045104] Funding Source: NIH RePORTER; NIAID NIH HHS [AI014782-27, AI043535, AI45104-5, R01 AI014782] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; FERNANDEZ LPJ, 2001, THESIS TUFTS U SOMER; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GAVALCHIN J, 1987, J IMMUNOL, V138, P138; GAVALCHIN J, 1987, J IMMUNOL, V138, P128; Gerth AJ, 2003, INT IMMUNOL, V15, P937, DOI 10.1093/intimm/dxg093; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li YJ, 2002, J EXP MED, V196, P1543, DOI 10.1084/jem.20021560; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Liu S, 2005, J IMMUNOL, V175, P5067, DOI 10.4049/jimmunol.175.8.5067; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; MURAKAMI M, 1992, NATURE, V357, P77, DOI 10.1038/357077a0; Oliver AM, 1999, J IMMUNOL, V162, P7198; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Qian Y, 2001, J IMMUNOL, V166, P2412, DOI 10.4049/jimmunol.166.4.2412; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Rui LX, 2003, NAT IMMUNOL, V4, P594, DOI 10.1038/ni924; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; VLAHAKOS DV, 1992, KIDNEY INT, V41, P1690, DOI 10.1038/ki.1992.242; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; Yachimovich N, 2002, EUR J IMMUNOL, V32, P1164, DOI 10.1002/1521-4141(200204)32:4<1164::AID-IMMU1164>3.0.CO;2-1	49	169	188	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2006	25	3					429	440		10.1016/j.immuni.2006.07.014	http://dx.doi.org/10.1016/j.immuni.2006.07.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16973388	Bronze			2022-12-18	WOS:000240862200012
J	Fukuyama, S; Hiroi, T; Yokota, Y; Rennert, PD; Yanagita, M; Kinoshita, N; Terawaki, S; Shikina, T; Yamamoto, M; Kurono, Y; Kiyono, H				Fukuyama, S; Hiroi, T; Yokota, Y; Rennert, PD; Yanagita, M; Kinoshita, N; Terawaki, S; Shikina, T; Yamamoto, M; Kurono, Y; Kiyono, H			Initiation of NALT organogenesis is independent of the IL-7R, LT beta R, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells	IMMUNITY			English	Article							PERIPHERAL LYMPHOID ORGANS; NF-KAPPA-B; DEFICIENT MICE; T-CELLS; NASAL IMMUNIZATION; PEYERS-PATCHES; IMMUNE-SYSTEM; IGA RESPONSES; NODE GENESIS; TISSUE NALT	Initiation of nasopharyngeal-associated lymphoid tissue (NALT) development is independent of the programmed cytokine cascade necessary for the formation of Peyer's patches (PP) and peripheral lymph nodes (PLN), a cytokine cascade which consists of IL-7R, LTalpha1beta2/LTbetaR, and NIK. However, the subsequent organization of NALT seems to be controlled by these cytokine signaling cascades since the maturation of NALT structure is generally incomplete in those cytokine cascade-deficient mice. NALT as well as PP and PLN are completely absent in Id2(-/-) mice. NALT organogenesis is initiated following the adoptive transfer of CD3(-)CD4(+)CD45(+) cells into Id2(-/-) mice, constituting direct evidence that CD3-CD4+CD45+ inducer cells can provide an IL-7R-, LTalpha1beta2/LTbetaR-, and NIK-independent tissue organogenesis pathway for secondary lymphoid tissue development.	Osaka Univ, Dept Mucosal Immunol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; Fukui Med Univ, Dept Biochem 1, Matsuoka, Fukui 9101193, Japan; Biogen Inc, Cambridge, MA 02142 USA; Nihon Univ, Sch Dent, Dept Oral Med, Matsudo, Chiba 2718587, Japan; Kagoshima Univ, Fac Med, Dept Otolaryngol, Kagoshima 8908520, Japan; Univ Alabama, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan	Osaka University; University of Fukui; Biogen; Nihon University; Kagoshima University; University of Alabama System; University of Alabama Birmingham; University of Tokyo	Kiyono, H (corresponding author), Osaka Univ, Dept Mucosal Immunol, Res Inst Microbial Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Kiyono, Hiroshi/AAC-6735-2022	TERAWAKI, Seigo/0000-0001-6019-1628				Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; ASANUMA H, 1995, J IMMUNOL METHODS, V187, P41, DOI 10.1016/0022-1759(95)00165-7; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Csencsits KL, 1999, J IMMUNOL, V163, P1382; Cuff CA, 1999, J IMMUNOL, V162, P5965; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; HIROI T, 1995, EUR J IMMUNOL, V25, P2743, DOI 10.1002/eji.1830251005; HIROI T, 1994, EUR J IMMUNOL, V24, P2653, DOI 10.1002/eji.1830241113; Hiroi T, 1998, EUR J IMMUNOL, V28, P3346, DOI 10.1002/(SICI)1521-4141(199810)28:10<3346::AID-IMMU3346>3.0.CO;2-P; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Imaoka K, 1998, J IMMUNOL, V161, P5952; Jeong KI, 2000, J ANAT, V196, P443, DOI 10.1046/j.1469-7580.2000.19630443.x; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KUPER CF, 1992, IMMUNOL TODAY, V13, P219; KUPER CF, 1990, CELL TISSUE RES, V259, P371, DOI 10.1007/BF00318460; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rennert PD, 1997, INT IMMUNOL, V9, P1627, DOI 10.1093/intimm/9.11.1627; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Shimoda M, 2001, J EXP MED, V194, P1597, DOI 10.1084/jem.194.11.1597; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yanagita M, 1999, J IMMUNOL, V162, P3559; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	40	169	171	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2002	17	1					31	40		10.1016/S1074-7613(02)00339-4	http://dx.doi.org/10.1016/S1074-7613(02)00339-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150889	Bronze			2022-12-18	WOS:000177187500004
J	Krawczyk, C; Bachmaier, K; Sasaki, T; Jones, RG; Snapper, SB; Bouchard, D; Kozieradzki, I; Ohashi, PS; Alt, FW; Penninger, JM				Krawczyk, C; Bachmaier, K; Sasaki, T; Jones, RG; Snapper, SB; Bouchard, D; Kozieradzki, I; Ohashi, PS; Alt, FW; Penninger, JM			Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells	IMMUNITY			English	Article							DEFICIENT MICE; CYTOSKELETAL REORGANIZATION; SIGNAL-TRANSDUCTION; C-CBL; ACTIVATION; PROTEIN; COSTIMULATION; VAV; REQUIREMENT; LYMPHOCYTES	Stimulation of T cells via the antigen and costimulatory receptors leads to the organization of a supramolecular activation cluster called the immune synapse. We report that loss of the molecular adaptor Cbl-b in T cells frees antigen receptor-triggered receptor clustering, lipid raft aggregation, and sustained tyrosine phosphorylation from the requirement for CD28 costimulation. Introduction of the cbl-b mutation into a vav1(-/-) background relieved the functional defects of vav1(-/-) T cells and caused spontaneous autoimmunity. Wiscott Aldrich Syndrome protein (WASP) was found to be essential for deregulated proliferation and membrane receptor reorganization of cbl-b mutant T cells. Antigen receptor-triggered Ca2+ mobilization, cytokine production, and receptor clustering can be genetically uncoupled in cbl-b mutant T cells. Thus, Cbl-b functions as a negative regulator of receptor clustering and raft aggregation in T cells.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Dept Immunol, Toronto, ON M5G 2M9, Canada; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jpenning@amgen.com	Jones, Russell Graham/ABD-5261-2021; Bachmaier, Kurt/AHC-5491-2022; Penninger, Josef M/I-6860-2013; Jones, Russell/AAC-2861-2022; Bachmaier, Kurt/B-6331-2014	Jones, Russell Graham/0000-0003-2250-4675; Bachmaier, Kurt/0000-0002-0299-2707; Penninger, Josef M/0000-0002-8194-3777; Bachmaier, Kurt/0000-0002-0299-2707; Sasaki, Takehiko/0000-0003-1837-3748; Ohashi, Pamela S./0000-0003-2915-9317				Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; ZINKERNAGEL RM, 1985, J EXP MED, V162, P2125, DOI 10.1084/jem.162.6.2125	30	169	184	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					463	473		10.1016/S1074-7613(00)00046-7	http://dx.doi.org/10.1016/S1074-7613(00)00046-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070165	Bronze			2022-12-18	WOS:000090079100006
J	Green, EA; Eynon, EE; Flavell, RA				Green, EA; Eynon, EE; Flavell, RA			Local expression of TNF alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; PANCREATIC BETA-CELLS; T-CELL; DENDRITIC CELLS; TRANSGENIC MICE; THYMIC MEDULLA; NITRIC-OXIDE; SCID MOUSE; INSULITIS; TOLERANCE	The relationship of inflammation to autoimmunity has been long observed, but the underlying mechanisms are unclear. Here, we demonstrate that islet-specific expression of TNF alpha in neonatal nonobese diabetic mice accelerated diabetes. In neonatal transgenic mice, disease was preceded by apoptosis of some beta cells, upregulation of MHC class I molecules on residual islet cells, and influx and activation of both antigen-presenting cells bearing MHC-islet peptide complexes and T cells. Infiltrating dendritic cells/macrophages, but not B cells, from neonatal islets activated islet-specific T cells in vitro. Thus, inflammation can trigger autoimmunity by recruiting and activating dendritic cells/macrophages to present self-antigens to autoreactive T cells.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 310 Cedar St, New Haven, CT 06520 USA.	richard.flavell@qm.yale.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051665] Funding Source: NIH RePORTER; NIDDK NIH HHS [R0I DK51665] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chakrabarti D, 1996, J IMMUNOL, V157, P522; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; CLEVELAND JL, 1995, CELL, V81, P479, DOI 10.1016/0092-8674(95)90068-3; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Corcione A, 1997, BLOOD, V90, P4493; Dahlen E, 1998, J IMMUNOL, V160, P3585; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; ETTINGER R, 1998, FFASEB J, V12, pA6354; Gonzalez A, 1997, IMMUNITY, V7, P873, DOI 10.1016/S1074-7613(00)80405-7; Grewal IS, 1996, J EXP MED, V184, P1963, DOI 10.1084/jem.184.5.1963; GUERDER S, 1994, IMMUNITY, V1, P155; Guerder S, 1998, J IMMUNOL, V161, P2128; HARLAN DM, 1994, P NATL ACAD SCI USA, V91, P3137, DOI 10.1073/pnas.91.8.3137; HELD W, 1990, P NATL ACAD SCI USA, V87, P2239, DOI 10.1073/pnas.87.6.2239; Henseleit U, 1995, Exp Dermatol, V4, P249; Herold KC, 1997, J IMMUNOL, V158, P984; Itoh N, 1997, J EXP MED, V186, P613, DOI 10.1084/jem.186.4.613; JANSEN A, 1993, AUTOIMMUNITY, V15, P31, DOI 10.3109/08916939309004836; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kay TWH, 1996, J IMMUNOL, V157, P3688; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; McSorley SJ, 1997, IMMUNITY, V7, P401, DOI 10.1016/S1074-7613(00)80361-1; MILLER BJ, 1988, J IMMUNOL, V140, P52; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; OBrien BA, 1997, DIABETES, V46, P750, DOI 10.2337/diabetes.46.5.750; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; PICARELLA DE, 1993, J IMMUNOL, V150, P4136; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; REID CDL, 1992, J IMMUNOL, V149, P2681; REINER SL, 1993, J IMMUNOL METHODS, V165, P37, DOI 10.1016/0022-1759(93)90104-F; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Rosmalen JGM, 1997, ADV EXP MED BIOL, V417, P291; Sarukhan A, 1998, EMBO J, V17, P71, DOI 10.1093/emboj/17.1.71; Serreze DV, 1997, J IMMUNOL, V158, P3978; SHIMIZU J, 1995, J IMMUNOL, V155, P4095; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Stassi G, 1997, J EXP MED, V186, P1193, DOI 10.1084/jem.186.8.1193; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Wang B, 1997, P NATL ACAD SCI USA, V94, P13844, DOI 10.1073/pnas.94.25.13844; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; WONG S, 1995, DIABETES, V44, P326, DOI 10.2337/diabetes.44.3.326; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	60	169	172	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1998	9	5					733	743		10.1016/S1074-7613(00)80670-6	http://dx.doi.org/10.1016/S1074-7613(00)80670-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846494	Bronze			2022-12-18	WOS:000077298300015
J	RODEWALD, HR; KRETZSCHMAR, K; SWAT, W; TAKEDA, S				RODEWALD, HR; KRETZSCHMAR, K; SWAT, W; TAKEDA, S			INTRATHYMICALLY EXPRESSED C-KIT LIGAND (STEM-CELL FACTOR) IS A MAJOR FACTOR DRIVING EXPANSION OF VERY IMMATURE THYMOCYTES IN-VIVO	IMMUNITY			English	Article							TYROSINE KINASE RECEPTOR; GROWTH-FACTOR; W-LOCUS; THYMUS DEVELOPMENT; PRECURSOR CELLS; TRANSGENIC MICE; PROTO-ONCOGENE; GENE-PRODUCT; MOUSE THYMUS; SI-LOCUS	To investigate the role of the receptor-type tyrosine kinase, c-kit and its ligand, stem cell factor (SCF) in T cell development, we analyzed c-kit (W/M) and SCF (SCF) deficient mice. We also engrafted wild-type or SCF-deficient fetal thymi onto wild-type recipient mice and analyzed the rate of proliferation by in vivo bromodeoxyuridine labeling. The results show that the most immature thymocyte compartment defined as CD3(-)CD4(-)CD8(-) is significantly reduced in SI/SI grafts and W/W thymi compared with wild-type counterparts. Also, the expansion rate of these immature thymocytes in SI/SI graft is reduced by similar to 50%. These experiments provide direct evidence for an important role for c-kit-SCF interactions in expansion of very early thymocytes.			RODEWALD, HR (corresponding author), BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND.							ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ANTICA M, 1993, J IMMUNOL, V151, P5887; ASAMOTO H, 1981, LAB INVEST, V45, P418; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GODFREY DI, 1992, J IMMUNOL, V149, P2281; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HOGAN B, 1986, MANIPULATING MOUSE E, P271; HOZUMI K, 1994, EUR J IMMUNOL, V24, P1339, DOI 10.1002/eji.1830240615; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; MATSUZAKI Y, 1993, J EXP MED, V4178, P1283; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MOLL J, 1992, EUR J IMMUNOL, V22, P1587, DOI 10.1002/eji.1830220636; MOORE NC, 1993, EUR J IMMUNOL, V23, P922, DOI 10.1002/eji.1830230424; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; RODEWALD HR, 1994, EMBO J, V13, P4299; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sambrook J., 1989, MOL CLONING LAB MANU; SCOLLAY R, 1988, IMMUNOL REV, V104, P81, DOI 10.1111/j.1600-065X.1988.tb00760.x; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TROWBRIDGE IS, 1985, NATURE, V315, P666, DOI 10.1038/315666a0; WILES MV, 1992, EUR J IMMUNOL, V22, P1037, DOI 10.1002/eji.1830220424; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V3, P71; ZLOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206, DOI 10.1016/0952-7915(95)80005-0; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	43	169	169	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1995	3	3					313	319		10.1016/1074-7613(95)90116-7	http://dx.doi.org/10.1016/1074-7613(95)90116-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX645	7552996	Bronze			2022-12-18	WOS:A1995RX64500006
J	Wu, DJ; Sanin, DE; Everts, B; Chen, QY; Qiu, J; Buck, MD; Patterson, A; Smith, AM; Chang, CH; Liu, ZP; Artyomov, MN; Pearce, EL; Cella, M; Pearce, EJ				Wu, Duojiao; Sanin, David E.; Everts, Bart; Chen, Qiongyu; Qiu, Jing; Buck, Michael D.; Patterson, Annette; Smith, Amber M.; Chang, Chih-Hao; Liu, Zhiping; Artyomov, Maxim N.; Pearce, Erika L.; Cella, Marina; Pearce, Edward J.			Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; I INTERFERONS; LIPID-METABOLISM; VIRAL-INFECTION; T-CELLS; ACTIVATION; FLUX; INTEGRATION; LIPOLYSIS; DATABASE	Greater understanding of the complex host responses induced by type 1 interferon (IFN) cytokines could allow new therapeutic approaches for diseases in which these cytokines are implicated. We found that in response to the Toll-like receptor-9 agonist CpGA, plasmacytoid dendritic cells (pDC) produced type 1 IFNs, which, through an autocrine type 1 IFN receptor-dependent pathway, induced changes in cellular metabolism characterized by increased fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS). Direct inhibition of FAO and of pathways that support this process, such as fatty acid synthesis, prevented full pDC activation. Type 1 IFNs also induced increased FAO and OXPHOS in non-hematopoietic cells and were found to be responsible for increased FAO and OXPHOS in virus-infected cells. Increased FAO and OXPHOS in response to type 1 IFNs was regulated by PPAR alpha. Our findings reveal FAO, OXPHOS and PPARa as potential targets to therapeutically modulate downstream effects of type 1 IFNs.	[Wu, Duojiao; Sanin, David E.; Everts, Bart; Chen, Qiongyu; Qiu, Jing; Buck, Michael D.; Smith, Amber M.; Chang, Chih-Hao; Artyomov, Maxim N.; Pearce, Erika L.; Cella, Marina; Pearce, Edward J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Wu, Duojiao] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Sanin, David E.; Qiu, Jing; Buck, Michael D.; Patterson, Annette; Pearce, Erika L.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany; [Everts, Bart] Leiden Univ, Med Ctr, Dept Parasitol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Liu, Zhiping] Shandong Univ, Dept Biomed Engn, Jinan 250061, Shandong, Peoples R China; [Pearce, Edward J.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	Washington University (WUSTL); Fudan University; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shandong University; University of Freiburg	Pearce, EJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.; Pearce, EJ (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.	pearceed@ie-freiburg.mpg.de	Liu, Zhi-Ping/C-9846-2010; Sanin, David E/CAA-0373-2022; Everts, Bart/H-6986-2016; Cella, Marina/ABA-8564-2020; Sanin, David E/CAA-0391-2022	Liu, Zhi-Ping/0000-0001-7742-9161; Sanin, David E/0000-0003-0188-7267; Everts, Bart/0000-0002-3764-5131; Sanin, David E/0000-0003-0188-7267; Cella, Marina/0000-0003-1230-1313; Buck, Michael/0000-0002-9611-1199; CHANG, CHIH-HAO/0000-0002-0139-7439	NIH [CA164062, AI110481, AI091965, CA158823]; Max Planck Society, a National Multiple Sclerosis Society grant [RG4687A1]; Shanghai Rising-Star Program grant [13QA1400800]; NSF Graduate Research Fellowship; Netherlands Organisation for Scientific Research; European Union; NATIONAL CANCER INSTITUTE [R21CA158823, R01CA164062, R01CA181125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965, R01AI110481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society, a National Multiple Sclerosis Society grant; Shanghai Rising-Star Program grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Alexey Sergushichev, Wei Yang, Skip Virgin, Joel Schilling, Stanley Huang, David O'Sullivan, Ramon Klein Geltink, Michael Diamond, Kathy Sheehan, Robert Schreiber, and the Genome Technology Access Center at Washington University for their generous help and advice. Supported by NIH grants to E. J. P. (CA164062, AI110481) and E. L. P (AI091965, CA158823), The Max Planck Society, a National Multiple Sclerosis Society grant to M. C. (RG4687A1), a Shanghai Rising-Star Program grant to D. W. (13QA1400800), an NSF Graduate Research Fellowship to M. D. B., and a VENI grant from the Netherlands Organisation for Scientific Research and Marie Curie CIG from European Union to B. E.	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow Mary K, 2010, Arthritis Res Ther, V12 Suppl 1, pS5, DOI 10.1186/ar2886; Dai PH, 2011, J VIROL, V85, P10814, DOI 10.1128/JVI.00104-11; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Faul EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001016; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Greseth MD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004021; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pearce EL, 2004, J IMMUNOL, V173, P2494, DOI 10.4049/jimmunol.173.4.2494; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wang YM, 2011, IMMUNOL REV, V243, P74, DOI 10.1111/j.1600-065X.2011.01049.x; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yim HY, 2012, BIOCHEM BIOPH RES CO, V423, P436, DOI 10.1016/j.bbrc.2012.05.154; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	48	168	176	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1325	1336		10.1016/j.immuni.2016.06.006	http://dx.doi.org/10.1016/j.immuni.2016.06.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332732	Green Accepted, Bronze			2022-12-18	WOS:000378341200012
J	Mukherjee, S; Hooper, LV				Mukherjee, Sohini; Hooper, Lora V.			Antimicrobial Defense of the Intestine	IMMUNITY			English	Review							LECTIN REGIII-GAMMA; ALPHA-DEFENSINS; PEPTIDE LL-37; PANETH CELLS; BACTERICIDAL ACTIVITY; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; GENETIC-VARIANTS; INNATE IMMUNITY; MOLECULAR-BASIS	The mammalian gastrointestinal tract is home to a dense community of resident bacteria and is also exposed to microorganisms from the external environment. The epithelial surface of the intestine plays a critical role in host protection by producing a diverse repertoire of antimicrobial proteins that directly kill or hinder the growth of microorganisms. Here we discuss the general principles that govern the mechanisms of action of epithelial antimicrobial proteins, regulation of antimicrobial protein expression and activity, and in vivo functions of intestinal antimicrobial proteins. We also consider how altered antimicrobial protein expression and function can contribute to disease and how these endogenous antibiotics might be harnessed for the benefit of human health.	[Mukherjee, Sohini; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chairatana P, 2014, J AM CHEM SOC, V136, P13267, DOI 10.1021/ja5057906; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P3806, DOI 10.1128/JCM.41.8.3806-3815.2003; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ERS.13.24, 10.1586/ers.13.24]; Duplantier AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00143; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hood JL, 2013, ANTIVIR THER, V18, P95, DOI 10.3851/IMP2346; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hornef MW, 2004, NAT IMMUNOL, V5, P836, DOI 10.1038/ni1094; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Koslowski MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002523; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Larrick JW, 1996, FEBS LETT, V398, P74, DOI 10.1016/S0014-5793(96)01199-4; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mendez-Samperio P, 2014, INFECT DRUG RESIST, V7, P229, DOI 10.2147/IDR.S49229; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Nyberg P, 2004, J BIOL CHEM, V279, P52820, DOI 10.1074/jbc.C400485200; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Ramanan D, 2014, IMMUNITY, V41, P311, DOI 10.1016/j.immuni.2014.06.015; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schroeder BO, 2015, MUCOSAL IMMUNOL, V8, P661, DOI 10.1038/mi.2014.100; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shanahan MT, 2014, GUT, V63, P903, DOI 10.1136/gutjnl-2012-304190; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	119	168	175	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					28	39		10.1016/j.immuni.2014.12.028	http://dx.doi.org/10.1016/j.immuni.2014.12.028			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607457	Bronze			2022-12-18	WOS:000348197500009
J	Yonekawa, A; Saijo, S; Hoshino, Y; Miyake, Y; Ishikawa, E; Suzukawa, M; Inoue, H; Tanaka, M; Yoneyama, M; Oh-hora, M; Akashi, K; Yamasaki, S				Yonekawa, Akiko; Saijo, Shinobu; Hoshino, Yoshihiko; Miyake, Yasunobu; Ishikawa, Eri; Suzukawa, Maho; Inoue, Hiromasa; Tanaka, Masato; Yoneyama, Mitsutoshi; Oh-hora, Masatsugu; Akashi, Koichi; Yamasaki, Sho			Dectin-2 Is a Direct Receptor for Mannose-Capped Lipoarabinomannan of Mycobacteria	IMMUNITY			English	Article							C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; DC-SIGN; DENDRITIC CELLS; PATHOGENIC FUNGUS; INNATE IMMUNITY; HOST-DEFENSE; TUBERCULOSIS; MINCLE; MACROPHAGE	Mycobacteria possess various immunomodulatory molecules on the cell wall. Mannose-capped lipoarabinomannan (Man-LAM), amajor lipoglycan of Mycobacterium tuberculosis, has long been known to have both inhibitory and stimulatory effects on host immunity. However, the direct Man-LAM receptor that explains its pleiotropic activities has not been clearly identified. Here, we report that a C-type lectin receptor Dectin-2 (gene symbol Clec4n) is a direct receptor for Man-LAM. Man-LAM activated bonemarrow- derived dendritic cells (BMDCs) to produce pro-and anti-inflammatory cytokines, whereas it was completely abrogated in Clec4n(-/-) BMDCs. Man-LAM promoted antigen-specific T cell responses through Dectin-2 on DCs. Furthermore, Man-LAM induced experimental autoimmune encephalitis (EAE) as an adjuvant in mice, whereas Clec4n(-/-) mice were resistant. Upon mycobacterial infection, Clec4n(-/-) mice showed augmented lung pathology. These results demonstrate that Dectin-2 contributes to host immunity against mycobacterial infection through the recognition of Man-LAM.	[Yonekawa, Akiko; Miyake, Yasunobu; Ishikawa, Eri; Oh-hora, Masatsugu; Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Yonekawa, Akiko; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Saijo, Shinobu; Yoneyama, Mitsutoshi; Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan; [Saijo, Shinobu; Oh-hora, Masatsugu] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hoshino, Yoshihiko] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo 1890002, Japan; [Suzukawa, Maho] Tokyo Natl Hosp, Natl Hosp Org, Ctr Pulm Dis, Tokyo 2048585, Japan; [Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 8908544, Japan; [Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Immune Regulat, Tokyo 1920392, Japan	Kyushu University; Kyushu University; Chiba University; Japan Science & Technology Agency (JST); National Institute of Infectious Diseases (NIID); Kagoshima University; Tokyo University of Pharmacy & Life Sciences	Yamasaki, S (corresponding author), Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp	Hoshino, Yoshihiko/B-5159-2019; Yoneyama, Mitsutoshi/D-8244-2017	Hoshino, Yoshihiko/0000-0002-3132-0715; Yoneyama, Mitsutoshi/0000-0001-9512-0408; Suzukawa, Maho/0000-0002-2265-1950; Yamasaki, Sho/0000-0002-5184-6917	Medical Institute of Bioregulation, Kyushu University; Funding Program for Next Generation World-Leading Researcher (NEXT Program); Coordination, Support and Training Program for Translational Research; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [25461178, 25293192] Funding Source: KAKEN	Medical Institute of Bioregulation, Kyushu University; Funding Program for Next Generation World-Leading Researcher (NEXT Program); Coordination, Support and Training Program for Translational Research; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank I. Yano, Y. Morita, K. Kawakami, D. Mori, and K. Toyonaga for discussion; S. Akira and T. Saito for providing mice; K. Machida, K. Wakamatsu, and Y. Koreeda for providing NTM strains; T. Kamichi for technical support; Y. Sanui for secretarial assistance; and Laboratory for Technical Support, Medical Institute of Bioregulation, Kyushu University for support. This work was partly performed in the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University and Medical Mycology Research Center, Chiba University. This work was supported by Funding Program for Next Generation World-Leading Researcher (NEXT Program) and Coordination, Support and Training Program for Translational Research and Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Afonso-Barroso A, 2013, CELL MICROBIOL, V15, P660, DOI 10.1111/cmi.12065; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Feng CG, 2002, INFECT IMMUN, V70, P6672, DOI 10.1128/IAI.70.12.6672-6679.2002; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Heitmann L, 2013, IMMUNOBIOLOGY, V218, P506, DOI 10.1016/j.imbio.2012.06.005; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Jonsson B, 2012, MICROBES INFECT, V14, P1186, DOI 10.1016/j.micinf.2012.07.021; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LEOPOLD K, 1993, ANAL BIOCHEM, V208, P57, DOI 10.1006/abio.1993.1008; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Nagaoka K, 2010, J LEUKOCYTE BIOL, V88, P913, DOI 10.1189/jlb.0510251; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Pitarque S, 2005, BIOCHEM J, V392, P615, DOI 10.1042/BJ20050709; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Richmond JM, 2012, J IMMUNOL, V189, P5886, DOI 10.4049/jimmunol.1103092; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamashita Y, 2013, JPN J INFECT DIS, V66, P207, DOI 10.7883/yoken.66.207; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	48	168	172	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					402	413		10.1016/j.immuni.2014.08.005	http://dx.doi.org/10.1016/j.immuni.2014.08.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25176311	Green Published, Bronze			2022-12-18	WOS:000342626500011
J	Bannard, O; Horton, RM; Allen, CDC; An, JP; Nagasawa, T; Cyster, JG				Bannard, Oliver; Horton, Robert M.; Allen, Christopher D. C.; An, Jinping; Nagasawa, Takashi; Cyster, Jason G.			Germinal Center Centroblasts Transition to a Centrocyte Phenotype According to a Timed Program and Depend on the Dark Zone for Effective Selection	IMMUNITY			English	Article							MEMORY B-CELLS; RECEPTOR CXCR4; BONE-MARROW; IN-VIVO; HYPERMUTATION; EXPRESSION; PHOSPHORYLATION; PROLIFERATION; ORGANIZATION; DEAMINASE	Germinal center (GC) B cells cycle between the dark zone (DZ) and light zone (LZ) during antibody affinity maturation. Whether this movement is necessary for GC function has not been tested. Here we show that CXCR4-deficient GC B cells, which are restricted to the LZ, are gradually outcompeted by WT cells indicating an essential role for DZ access. Remarkably, the transition between DZ centroblast and LZ centrocyte phenotypes occurred independently of positioning. However, CXCR4-deficient cells carried fewer mutations and were overrepresented in the CD73(+) memory compartment. These findings are consistent with a model where GC B cells change from DZ to LZ phenotype according to a timed cellular program but suggest that spatial separation of DZ cells facilitates more effective rounds of mutation and selection. Finally, we identify a network of DZ CXCL12-expressing reticular cells that likely support DZ functions.	[Bannard, Oliver; Horton, Robert M.; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Bannard, Oliver; Horton, Robert M.; Allen, Christopher D. C.; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Allen, Christopher D. C.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto 6068507, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kyoto University	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Nagasawa, Takashi/0000-0002-1085-0960; Allen, Christopher/0000-0002-1879-9047	Wellcome Trust; HHMI; National Institutes of Health [AI45073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); HHMI(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Xu for technical help, C. Ludka and G. Hardiman (UCSD) for Pac-bio sequencing, and D. Fearon and R. Cornell for support to O.B. This work was supported by The Wellcome Trust (O.B.), HHMI (J.G.C.), and grant AI45073 from The National Institutes of Health (J.G.C.).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Imai Y, 1996, PATHOL INT, V46, P807, DOI 10.1111/j.1440-1827.1996.tb03555.x; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; Rohlich K., 1930, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V20, P287; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Yasuda M, 1998, COMP IMMUNOL MICROB, V21, P179, DOI 10.1016/S0147-9571(98)00007-1; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	33	168	169	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					912	924		10.1016/j.immuni.2013.08.038	http://dx.doi.org/10.1016/j.immuni.2013.08.038			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24184055	hybrid, Green Published			2022-12-18	WOS:000330950600013
J	Chai, Q; Onder, L; Scandella, E; Gil-Cruz, C; Perez-Shibayama, C; Cupovic, J; Danuser, R; Sparwasser, T; Luther, SA; Thiel, V; Rulicke, T; Stein, JV; Hehlgans, T; Ludewig, B				Chai, Qian; Onder, Lucas; Scandella, Elke; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Cupovic, Jovana; Danuser, Renzo; Sparwasser, Tim; Luther, Sanjiv A.; Thiel, Volker; Ruelicke, Thomas; Stein, Jens V.; Hehlgans, Thomas; Ludewig, Burkhard			Maturation of Lymph Node Fibroblastic Reticular Cells from Myofibroblastic Precursors Is Critical for Antiviral Immunity	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELL; DENDRITIC CELLS; KEY REGULATOR; SECONDARY; HOMEOSTASIS; DEFICIENT; ORGANOGENESIS; DIFFERENTIATE; ORGANIZATION	The stromal scaffold of the lymph node (LN) paracortex is built by fibroblastic reticular cells (FRCs). Conditional ablation of lymphotoxin-beta receptor (LT beta R) expression in LN FRCs and their mesenchymal progenitors in developing LNs revealed that LT beta R-signaling in these cells was not essential for the formation of LNs. Although T cell zone reticular cells had lost podoplanin expression, they still formed a functional conduit system and showed enhanced expression of myofibroblastic markers. However, essential immune functions of FRCs, including homeostatic chemokine and interleukin-7 expression, were impaired. These changes in T cell zone reticular cell function were associated with increased susceptibility to viral infection. Thus, myofibroblasic FRC precursors are able to generate the basic T cell zone infrastructure, whereas LT beta R-dependent-maturation of FRCs guarantees full immunocompetence and hence optimal LN function during infection.	[Chai, Qian; Onder, Lucas; Scandella, Elke; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Cupovic, Jovana; Thiel, Volker; Ludewig, Burkhard] Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Danuser, Renzo; Stein, Jens V.] Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Sparwasser, Tim] Hannover Med Sch, TWINCORE, Inst Infect Immunol, D-30625 Hannover, Germany; [Luther, Sanjiv A.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Thiel, Volker] Univ Zurich, VetSuisse Fac, CH-8006 Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci & Biomodels Austria, A-1210 Vienna, Austria; [Hehlgans, Thomas] Univ Regensburg, D-93042 Regensburg, Germany	Kantonsspital St. Gallen; University of Bern; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; University of Veterinary Medicine Vienna; University of Regensburg	Ludewig, B (corresponding author), Kantonal Hosp St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland.	burkhard.ludewig@kssg.ch	Luther, Sanjiv A/B-4380-2016; Sparwasser, Tim D/AAA-4306-2022; Thiel, Volker/AAI-2391-2019; Luther, Sanjiv/AAP-6525-2020; Sparwasser, Tim/AAF-7085-2019; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; Sparwasser, Tim/0000-0001-5645-902X; , Sanjiv/0000-0002-0614-561X; Gil Cruz, Cristina/0000-0001-5285-6503; Thiel, Volker/0000-0002-5783-0887; Stein, Jens V/0000-0002-8199-9586	Swiss National Science Foundation [Sinergia 125447/1]; Wilhelm Sander Stiftung; Austrian Genome Research Programme GEN-AU II and III	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wilhelm Sander Stiftung; Austrian Genome Research Programme GEN-AU II and III	We would like to thank Rita DeGiuli for technical support and Alexander Link for help with designing the cloning strategy. This study received financial support from the Swiss National Science Foundation (Sinergia 125447/1 to J.V.S. and B. L.), the Wilhelm Sander Stiftung (to B. L.), and from the Austrian Genome Research Programme GEN-AU II and III (to T. R.). B. L. designed the study and wrote the paper; L.O. performed research and wrote the paper; E. S., J.V.S., V. T., T. S., and T. H. analyzed and discussed data; R. D., T. R., C.G.-C., C.P.-S., J.C., and Q. C. performed research and discussed data.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Cervantes-Barragan L, 2012, J IMMUNOL, V188, P3678, DOI 10.4049/jimmunol.1102422; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Cervantes-Barragan L, 2009, J IMMUNOL, V182, P1099, DOI 10.4049/jimmunol.182.2.1099; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Vega F, 2006, PATHOBIOLOGY, V73, P71, DOI 10.1159/000094491; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; White A, 2007, BLOOD, V110, P1950, DOI 10.1182/blood-2007-01-070003; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	48	168	170	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1013	1024		10.1016/j.immuni.2013.03.012	http://dx.doi.org/10.1016/j.immuni.2013.03.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23623380	Bronze, Green Published			2022-12-18	WOS:000330942500018
J	Trost, M; English, L; Lemieux, S; Courcelles, M; Desjardins, M; Thibault, P				Trost, Matthias; English, Luc; Lemieux, Sebastien; Courcelles, Mathieu; Desjardins, Michel; Thibault, Pierre			The Phagosomal Proteome in Interferon-gamma-Activated Macrophages	IMMUNITY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; HIGHLY SELECTIVE ENRICHMENT; ACTIN CYTOSKELETON; PHOSPHORYLATED PEPTIDES; CROSS-PRESENTATION; ENA/VASP PROTEINS; TITANIUM-DIOXIDE; DENDRITIC CELLS; F-ACTIN; KINASE	The ability of macrophages to clear pathogens and elicit a sustained immune response is regulated by various cytokines, including interferon-gamma (IFN-gamma). To investigate the molecular mechanisms by which IFN-gamma modulates phagosome functions, we profiled the changes in composition, abundance, and phosphorylation of phagosome proteins in resting and activated macrophages by using quantitative proteomics and bioinformatics approaches. We identified 2415 phagosome proteins together with 2975 unique phosphorylation sites with a high level of sensitivity. Using network analyses, we determined that IFN-gamma delays phagosomal acquisition of lysosomal hydrolases and peptidases for the gain of antigen presentation. Furthermore, this gain in antigen presentation is dependent on phagosomal networks of the actin cytoskeleton and vesicle-trafficking proteins, as well as Src kinases and calpain proteases. Major histocompatibility complex class I antigen-presentation assays validated the molecular participation of these networks in the enhanced capacity of IFN-gamma-activated macrophages to crosspresent exogenous antigens to CD8(+) T cells.	[Trost, Matthias; English, Luc; Desjardins, Michel] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Trost, Matthias; Lemieux, Sebastien; Courcelles, Mathieu; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Desjardins, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Desjardins, Michel] Capr Proteom, Montreal, PQ H4S 2C8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Desjardins, M (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, POB 6128,Ctr Ville, Montreal, PQ H3C 3J7, Canada.	michel.desjardins@umontreal.ca; pierre.thibault@umontreal.ca	Trost, Matthias/A-9999-2009	Trost, Matthias/0000-0002-5732-700X; Thibault, Pierre/0000-0001-5993-0331; Desjardins, Michel/0000-0002-5684-5980	Deutsche Forschungsgemeinschaft (DFG); Fonds de la Recherche en Sante du Quebec (FRSC); Canadian Institutes for Health Research (CIHR); National Science and Engineering Research Council (NSERC); Canada Research Chair program; CIHR	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds de la Recherche en Sante du Quebec (FRSC)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR))	We would like to thank T. Stradal for the kind gift of antibodies, P. Desai for GFP-tagged HSV, K. Eng for bioinformatic support, E. Bonneil for help with mass-spectrometric analyses, and C. Perreault for critical review of the manuscript. M.T. acknowledges the Deutsche Forschungsgemeinschaft (DFG) for a fellowship. The Institute for Research in Immunology and Cancer receives infrastructure support funds from the Fonds de la Recherche en Sante du Quebec (FRSC) and from a Canadian Institutes for Health Research (CIHR) multiresource grant. This work was carried out with the financial support of operating grants from the National Science and Engineering Research Council (NSERC), the Canada Research Chair program, and the CIHR.	ANGIOLILLO A, 1993, MOL CELL BIOCHEM, V125, P65, DOI 10.1007/BF00926836; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BURDEN AC, 1978, IMMUNOLOGY, V34, P217; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Holm A, 2001, CELL MICROBIOL, V3, P439, DOI 10.1046/j.1462-5822.2001.00127.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Ikewaki N, 2000, J CLIN IMMUNOL, V20, P424, DOI 10.1023/A:1026403615037; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lerm M, 2007, J IMMUNOL, V178, P7357, DOI 10.4049/jimmunol.178.11.7357; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Machida K, 2003, MOL CELL PROTEOMICS, V2, P215, DOI 10.1074/mcp.R300002-MCP200; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcantonio M, 2008, MOL CELL PROTEOMICS, V7, P645, DOI 10.1074/mcp.M700383-MCP200; Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x; Myers JT, 2002, J LEUKOCYTE BIOL, V72, P677; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sirianni R, 2001, J MOL ENDOCRINOL, V26, P207, DOI 10.1677/jme.0.0260207; Stockinger W, 2006, MOL BIOL CELL, V17, P1697, DOI 10.1091/mbc.E05-12-1140; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Via LE, 1998, J CELL SCI, V111, P897; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Watts C, 2001, SEMIN IMMUNOL, V13, P373; WONG GHW, 1982, P NATL ACAD SCI-BIOL, V79, P6989, DOI 10.1073/pnas.79.22.6989; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	59	168	1016	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					143	154		10.1016/j.immuni.2008.11.006	http://dx.doi.org/10.1016/j.immuni.2008.11.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144319	Bronze			2022-12-18	WOS:000262769900017
J	Erazo, A; Kutchukhidze, N; Leung, M; Christ, APG; Urban, JF; de Lafaille, MAC; Lafaille, JJ				Erazo, Agustin; Kutchukhidze, Nino; Leung, Monica; Christ, Ana P. Guarnieri; Urban, Joseph F., Jr.; de Lafaille, Maria A. Curotto; Lafaille, Juan J.			Unique maturation program of the IgE response in vivo	IMMUNITY			English	Article							GERMINAL-CENTER FORMATION; CD4(+) T-CELLS; NIPPOSTRONGYLUS-BRASILIENSIS; B-CELLS; ANTIBODY-RESPONSES; EPSILON TRANSCRIPTION; LYMPHOID-CELLS; GENE DELETION; IMMUNOGLOBULIN; EXPRESSION	A key event in the pathogenesis of asthma and allergies is the production of IgE antibodies. We show here that IgE(+) cells were exceptional because they were largely found outside germinal centers and expressed, from very early on, a genetic program of plasma cells. In spite of their extragerminal center localization, IgE(+) cells showed signs of somatic hypermutation and affinity maturation. We demonstrated that high-affinity IgE(+) cells could be generated through a unique differentiation program that involved two phases: a pre-IgE phase in which somatic hypermutation and affinity maturation take place in IgG1(+) cells, and a post-IgE-switching phase in which IgE cells differentiate swiftly into plasma cells. Our results have implications for the understanding of IgE memory responses in allergy.	NYU, Sch Med, Program Mol Pathogenesis, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Univ Sao Paulo, Dept Immunol, BR-05508900 Sao Paulo, Brazil; USDA ARS, Beltsville Human Nutr Res Ctr, Nutrient Requirements & Funct Lab, Beltsville, MD 20705 USA	New York University; New York University; New York University; Universidade de Sao Paulo; United States Department of Agriculture (USDA)	de Lafaille, MAC (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, Skirball Inst Biomol Med, New York, NY 10016 USA.	curotto@saturn.med.nyu.edu; lafaille@saturn.med.nyu.edu		Urban, Joseph/0000-0002-1590-8869; Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777	NIAID NIH HHS [R01 AI045654] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045654] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; FINKELMAN FD, 1989, J IMMUNOL, V142, P403; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Johnson K, 2003, CURR OPIN GENET DEV, V13, P522, DOI 10.1016/j.gde.2003.08.004; JUNG S, 1994, J EXP MED, V179, P2023, DOI 10.1084/jem.179.6.2023; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KATONA IM, 1985, P NATL ACAD SCI USA, V82, P511, DOI 10.1073/pnas.82.2.511; KATONA IM, 1988, J IMMUNOL, V140, P3206; KATONA IM, 1983, J IMMUNOL, V130, P350; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Manser T, 2002, NAT IMMUNOL, V3, P114, DOI 10.1038/ni0202-114; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oettgen HC, 2001, J ALLERGY CLIN IMMUN, V107, P429, DOI 10.1067/mai.2001.113759; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; PINILLA C, 1993, MOL IMMUNOL, V30, P577, DOI 10.1016/0161-5890(93)90032-7; Przylepa J, 1998, CURR TOP MICROBIOL, V229, P85; RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; Suto A, 2002, BLOOD, V100, P4565, DOI 10.1182/blood-2002-04-1115; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YOSHIDA K, 1990, P NATL ACAD SCI USA, V87, P7829, DOI 10.1073/pnas.87.20.7829; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811	47	168	169	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					191	203		10.1016/j.immuni.2006.12.006	http://dx.doi.org/10.1016/j.immuni.2006.12.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17292640	Bronze, Green Accepted			2022-12-18	WOS:000244628600010
J	Bobardt, MD; Saphire, ACS; Hung, HC; Yu, XC; Van der Schueren, B; Zhang, Z; David, G; Gallay, PA				Bobardt, MD; Saphire, ACS; Hung, HC; Yu, XC; Van der Schueren, B; Zhang, Z; David, G; Gallay, PA			Syndecan captures, protects, and transmits HIV to T lymphocytes	IMMUNITY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN INTERACTIONS; HEPARAN-SULFATE; ENDOTHELIAL-CELLS; BINDING-PROPERTIES; INFECTION; TYPE-1; ATTACHMENT; MEDIATE; ENTRY	This study demonstrates that syndecan functions as an in trans HIV receptor. We show that syndecan, when expressed in nonpermissive cells, becomes the major mediator for HIV adsorption. This adsorption is mediated by the binding of gp120 to the heparan sulfate chains of syndecan. Although syndecan does not substitute for HIV entry receptors, it enhances the in trans infectivity of a broad range of primate lentiviruses including primary viruses produced from PBMCs. Furthermore, syndecan preserves virus infectivity for a week, whereas unbound virus loses its infectivity in less than a day. Moreover, we obtain evidence suggesting that the vast syndecan-rich endothelial lining of the vasculature can provide a microenvironment which boosts HIV replication in T cells.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, La Jolla, CA 92037 USA	Scripps Research Institute; KU Leuven	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046958, R21AI046958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 46958] Funding Source: Medline; NIMH NIH HHS [MH 62261] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; Callebaut C, 2001, VIROLOGY, V281, P248, DOI 10.1006/viro.2000.0767; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Saphire ACS, 2002, J VIROL, V76, P4671, DOI 10.1128/JVI.76.9.4671-4677.2002; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; SCHOLS D, 1989, J ACQ IMMUN DEF SYND, V2, P10; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	28	168	172	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2003	18	1					27	39		10.1016/S1074-7613(02)00504-6	http://dx.doi.org/10.1016/S1074-7613(02)00504-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530973	Bronze			2022-12-18	WOS:000180860600004
J	Boname, JM; Stevenson, PG				Boname, JM; Stevenson, PG			MHC class I ubiquitination by a viral PHD/LAP finger protein	IMMUNITY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CD8(+) T-CELLS; ENDOPLASMIC-RETICULUM; GAMMA-HERPESVIRUS; HEAVY-CHAINS; MURINE GAMMAHERPESVIRUS-68; CD4-DEFICIENT MICE; MEMBRANE-PROTEINS; DOWN-REGULATION; DEGRADATION	The murine gamma -herpesvirus-68 K3 (MK3) is a PHD/LAP finger protein that downregulates major histocompatibility complex (MHC) class I expression. In transfected cell lines, MK3 was expressed in the endoplasmic reticulum (ER) membrane, where it bound the cytoplasmic tail of newly synthesized H-2D(b) glycoproteins and targeted them for degradation. Proteasome inhibitors blocked the degradation and led to an accumulation of ubiquitinated H-2D(b). Because this retained its native conformation, ubiquitination preceded any denaturation or dislocation to the cytosol. The PHD/LAP finger of MK3 was not required for H-2D(b) binding but was essential for its ubiquitination and degradation. Thus, gamma -herpesviruses have adapted the cellular PHD/LAP motif to immune evasion, apparently for the catalysis of MHC class I ubiquitination.	Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Tennis Court Rd, Cambridge CB2 1QP, England.		Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Boname, Jessica/0000-0002-5149-5934				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; BIEDERER T, 1997, SCIENCE, V278, P1728; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; EHTISHAM S, 1993, J VIROL, V67, P5147; Everett RD, 1999, TRENDS BIOCHEM SCI, V24, P293, DOI 10.1016/S0968-0004(99)01433-4; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Haque M, 2000, J VIROL, V74, P2867, DOI 10.1128/JVI.74.6.2867-2875.2000; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lyngso C, 2000, J BIOL CHEM, V275, P26144, DOI 10.1074/jbc.M003405200; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Nicholas J, 1997, J VIROL, V71, P1963, DOI 10.1128/JVI.71.3.1963-1974.1997; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Reusch U, 1999, EMBO J, V18, P1081, DOI 10.1093/emboj/18.4.1081; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 1999, J GEN VIROL, V80, P477, DOI 10.1099/0022-1317-80-2-477; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stevenson PG, 1998, P NATL ACAD SCI USA, V95, P15565, DOI 10.1073/pnas.95.26.15565; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tomazin R, 1999, NAT MED, V5, P1039, DOI 10.1038/12478; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	168	175	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					627	636		10.1016/S1074-7613(01)00213-8	http://dx.doi.org/10.1016/S1074-7613(01)00213-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672544	Bronze			2022-12-18	WOS:000171757800013
J	Josephson, K; Logsdon, NJ; Walter, MR				Josephson, K; Logsdon, NJ; Walter, MR			Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site	IMMUNITY			English	Article							X-RAY-DIFFRACTION; HUMAN INTERLEUKIN-10; FUNCTIONAL-CHARACTERIZATION; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; INDUCIBLE FACTOR; IL-10 HOMOLOG; INTERFERON; IDENTIFICATION; HORMONE	Interleukin 10 (IL-10) is a dimeric cytokine that plays a central role in suppressing inflammatory responses. These activities are dependent on the interaction of IL-10 with its high-affinity receptor (IL-10R1). This intermediate complex must subsequently recruit the low-affinity IL-10R2 chain before cell signaling can occur. Here we report the 2.9 Angstrom crystal structure of IL-10 bound to a soluble form of IL-10R1 (sIL-10R1). The complex consists of two IL-10s and four sIL-10R1 molecules. Several residues in the IL-10/sIL-10R1 interface are conserved in all IL-10 homologs and their receptors. The data suggests that formation of the active IL-10 signaling complex occurs by a novel molecular recognition paradigm where IL-10R1 and IL-10R2 both recognize the same binding site on IL-10.	Univ Alabama Birmingham, Ctr Macromol Crystallog, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Walter, MR (corresponding author), Univ Alabama Birmingham, Ctr Macromol Crystallog, Birmingham, AL 35294 USA.	walter@uab.edu			NCI NIH HHS [CA36871] Funding Source: Medline; NIAID NIH HHS [AI47300] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; LANGER JA, 1994, P NATL ACAD SCI USA, V91, P5818, DOI 10.1073/pnas.91.13.5818; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 1997, J IMMUNOL, V158, P604; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramakrishnan V, 1997, METHOD ENZYMOL, V276, P538, DOI 10.1016/S0076-6879(97)76077-4; Randal M, 2001, STRUCTURE, V9, P155, DOI 10.1016/S0969-2126(01)00567-6; Reineke U, 1998, PROTEIN SCI, V7, P951; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RODE HJ, 1994, VIRUS GENES, V9, P61, DOI 10.1007/BF01703436; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; Thiel DJ, 2000, STRUCTURE, V8, P927, DOI 10.1016/S0969-2126(00)00184-2; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zdanov A, 1997, J MOL BIOL, V268, P460, DOI 10.1006/jmbi.1997.0990; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	49	168	185	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2001	15	1					35	46		10.1016/S1074-7613(01)00169-8	http://dx.doi.org/10.1016/S1074-7613(01)00169-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485736	Bronze			2022-12-18	WOS:000170153300005
J	Pallard, C; Stegmann, APA; van Kleffens, T; Smart, F; Venkitaraman, A; Spits, H				Pallard, C; Stegmann, APA; van Kleffens, T; Smart, F; Venkitaraman, A; Spits, H			Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors	IMMUNITY			English	Article							RECEPTOR-DEFICIENT MICE; SEVERE COMBINED IMMUNODEFICIENCY; RESCUES T-LYMPHOPOIESIS; PROTEIN-KINASE-B; INTERLEUKIN-7 RECEPTOR; GAMMA-CHAIN; NATURAL-KILLER; LYMPHOID DEVELOPMENT; CELL-DEVELOPMENT; HEMATOPOIETIC-CELLS	Here, we define the IL-7R-activated signal that promotes survival and proliferation of T cell progenitors and demonstrate that it is distinct from the signals that induce differentiation. We show that IL-7 activates PKB and STAT5 in human thymocytes. Into T cell precursors we introduced chimeric receptors with a cytoplasmic domain of the IL-7R that is no longer able to activate PI-3K/PKB and STAT5 and tested the transduced cells in a fetal thymic organ culture. We also examined the T cell precursor activity of progenitors expressing dominant-negative forms of PI-3K or STAT5B. These experiments revealed that PI-3K/PKB activation is essential for the survival and proliferation of T cell precursors and suggest that STAT5 activated by IL-7 mediates T cell differentiation.	Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; Univ Cambridge, Med Res Council Lab Mol Biol, Sch Clin Med, Dept Oncol, Cambridge CB2 2XY, England	Netherlands Cancer Institute; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Spits, H (corresponding author), Netherlands Canc Inst, Div Immunol, Antoni Leeuwenhoekhuis,Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	hergen@nki.nl	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Stegmann, Alexander/0000-0002-9736-7137				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Blom B, 1999, BLOOD, V93, P3033; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; DADI HK, 1993, J CLIN INVEST, V92, P1559, DOI 10.1172/JCI116736; delPeso L, 1997, SCIENCE, V278, P687; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; HORI T, 1991, J IMMUNOL, V146, P4078; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; LAI CF, 1995, J BIOL CHEM, V270, P23254, DOI 10.1074/jbc.270.40.23254; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MARQUEZ C, 1995, J EXP MED, V181, P475, DOI 10.1084/jem.181.2.475; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Nakamura S, 1997, MRS INTERNET J N S R, V2; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; PANDRAUGARCIA D, 1994, BLOOD, V83, P3613; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Plum J, 1996, BLOOD, V88, P4239; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Res P, 1996, BLOOD, V87, P5196, DOI 10.1182/blood.V87.12.5196.bloodjournal87125196; Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; VENKITARAMAN AR, 1994, EUR J IMMUNOL, V24, P2168, DOI 10.1002/eji.1830240935; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang DM, 1996, MOL CELL BIOL, V16, P6141; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	52	168	170	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1999	10	5					525	535		10.1016/S1074-7613(00)80052-7	http://dx.doi.org/10.1016/S1074-7613(00)80052-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367898	Bronze			2022-12-18	WOS:000080709400004
J	Wyer, JR; Willcox, BE; Gao, GF; Gerth, UC; Davis, SJ; Bell, JI; van der Merwe, PA; Jakobsen, BK				Wyer, JR; Willcox, BE; Gao, GF; Gerth, UC; Davis, SJ; Bell, JI; van der Merwe, PA; Jakobsen, BK			T cell receptor and coreceptor CD8 alpha alpha bind peptide-MHC independently and with distinct kinetics	IMMUNITY			English	Article							CLASS-I MOLECULES; ANTAGONIST LIGANDS; LOW-AFFINITY; INFLUENZA-A; ADHESION; COMPLEX; ACTIVATION; CD8; HLA-A2; CHAIN	The T cell surface glycoprotein CD8 enhances T cell antigen recognition by binding to MHC class I molecules. We show that human CD8 alpha alpha binds to the MHC class I molecule HLA-A2 with an extremely low affinity (Kd similar to 0.2 mM at 37 degrees C) and with kinetics that are between 2 and 3 orders of magnitude faster than reported for T cell receptor/peptide-MHC interactions. Furthermore, CD8 alpha alpha had no detectable effect on a T cell receptor (TCR) binding to the same peptide-MHC class I complex. These binding properties provide an explanation as to why the CD8/MHC class I interaction is unable to initiate cell-cell adhesion and how it can enhance TCR recognition without interfering with its specificity.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; John Radcliffe Hosp, Inst Mol Med, Nuffield Dept Clin Med, MRC,Human Immunol Unit, Oxford OX3 9DS, England; John Radcliffe Hosp, Inst Mol Med, Nuffield Dept Clin Med, Mol Sci Div, Oxford OX3 9DS, England	University of Oxford; University of Oxford; University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		van der Merwe, P. Anton/F-8539-2011; Gao, George Fu/ABD-5229-2021					Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Gao GF, 1998, PROTEIN SCI, V7, P1245, DOI 10.1002/pro.5560070520; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GIBLIN PA, 1994, P NATL ACAD SCI USA, V91, P1716, DOI 10.1073/pnas.91.5.1716; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MASON DW, 1986, HDB EXPT IMMUNOLOGY; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; OROURKE AM, 1992, NATURE, V358, P253, DOI 10.1038/358253a0; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Thome M, 1996, EUR J IMMUNOL, V26, P2093, DOI 10.1002/eji.1830260920; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; VANDERMERWE PA, 1994, BIOCHEMISTRY-US, V33, P10149, DOI 10.1021/bi00199a043; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Vessey SJR, 1997, EUR J IMMUNOL, V27, P879; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	38	168	171	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					219	225		10.1016/S1074-7613(00)80022-9	http://dx.doi.org/10.1016/S1074-7613(00)80022-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072074	Bronze			2022-12-18	WOS:000078972200009
J	Ossendorp, F; Eggers, M; Neisig, A; Ruppert, T; Groettrup, M; Sijts, A; Mengede, E; Kloetzel, PM; Neefjes, J; Koszinowski, U; Melief, C				Ossendorp, F; Eggers, M; Neisig, A; Ruppert, T; Groettrup, M; Sijts, A; Mengede, E; Kloetzel, PM; Neefjes, J; Koszinowski, U; Melief, C			A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation	IMMUNITY			English	Article							MURINE LEUKEMIA-VIRUS; T-LYMPHOCYTE EPITOPE; CLASS-I MOLECULES; ENDOPLASMIC-RETICULUM; CELL RECOGNITION; PEPTIDES; COMPLEX; MOUSE; MICE; TRANSLOCATION	CTL epitope (KSPWFTTL) encoded by AKV/MCF type of murine leukemia virus (MuLV) differs from the sequence in Friend/Moloney/Rauscher (FMR) type in one residue (RSPWFTTL). CTL experiments indicated defective processing of the FMR peptide in tumor cells. Proteasome-mediated digestion of AKV/MCF-type 26-mer peptides resulted in the early generation and higher levels of epitope-containing fragments than digestion of FWR-type peptides, explained by prominent cleavage next to R in the FMR sequence. The fragments were identified as 10- and Il-mer peptides and were efficiently translocated by TAP. The naturally presented AKV/MCF peptide is the 8-mer, indicating ER peptide trimming. In conclusion, a single residue exchange can cause CTL epitope destruction by specific proteasomal cleavage.	ACAD HOSP LEIDEN,BLOOD BANK,NL-2300 RC LEIDEN,NETHERLANDS; NETHERLANDS CANC INST,DEPT CELLULAR BIOCHEM,NL-1066 CX AMSTERDAM,NETHERLANDS; UNIV HEIDELBERG,DEPT VIROL,D-69120 HEIDELBERG,GERMANY; HUMBOLDT UNIV BERLIN,FAC MED CHARITE,INST BIOCHEM,D-10115 BERLIN,GERMANY	Leiden University; Leiden University Medical Center (LUMC); Netherlands Cancer Institute; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ossendorp, F (corresponding author), ACAD HOSP LEIDEN,DEPT IMMUNOHAEMATOL,RIJNSBURGERWEG 10,NL-2300 RC LEIDEN,NETHERLANDS.		Ruppert, Thomas/AAC-2467-2021; Neefjes, Jacques J.C./H-8780-2017	Ruppert, Thomas/0000-0001-9152-2266; Neefjes, Jacques J.C./0000-0001-6763-2211; Eggers, Maren/0000-0001-8485-9485; Sijts, Alice/0000-0003-3815-4788				ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DECAMPOSLIMA PO, 1994, J EXP MED, V179, P1297, DOI 10.1084/jem.179.4.1297; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; DICK LR, 1994, J IMMUNOL, V152, P3884; EGGERS M, 1995, IN PRESS J EXP MED; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GAUSEPOHL H, 1990, PEPTIDES CHEM STRUCT, P1003; GOLDBERG AL, 1992, NATURE, V357, P9; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; HAWES GE, 1993, J IMMUNOL, V150, P2033; HOWARD JC, 1993, NATURE, V365, P211, DOI 10.1038/365211a0; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MELLEF CJM, 1992, ADV CANCER RES, V58, P143; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEISIG A, 1995, J IMMUNOL, V154, P1273; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; OZATO K, 1981, J IMMUNOL, V126, P317; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PLATA F, 1979, J EXP MED, V150, P1174, DOI 10.1084/jem.150.5.1174; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SHINNICK TM, 1981, NATURE, V293, P534; SIJTS AJAM, 1994, J IMMUNOL, V152, P106; SIJTS AJAM, 1994, J VIROL, V68, P6038, DOI 10.1128/JVI.68.9.6038-6046.1994; SIJTS EJAM, 1994, VIRUS RES, V34, P339, DOI 10.1016/0168-1702(94)90133-3; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; VANBINNENDIJK RS, 1992, J EXP MED, V176, P119, DOI 10.1084/jem.176.1.119; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VASMEL WLE, 1988, J VIROL, V62, P3156, DOI 10.1128/JVI.62.9.3156-3166.1988; WHITE HD, 1994, J VIROL, V68, P897, DOI 10.1128/JVI.68.2.897-904.1994; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; ZIJLSTRA M, 1983, VIROLOGY, V125, P47, DOI 10.1016/0042-6822(83)90062-4; ZIJLSTRA M, 1986, BIOCHIM BIOPHYS ACTA, V865, P197, DOI 10.1016/0304-419X(86)90028-4	46	168	170	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					115	124		10.1016/S1074-7613(00)80488-4	http://dx.doi.org/10.1016/S1074-7613(00)80488-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769475	Bronze			2022-12-18	WOS:A1996VE58900002
J	Adrover, JM; del Fresno, C; Crainiciuc, G; Cuartero, MI; Casanova-Acebes, M; Weiss, LA; Huerga-Encabo, H; Silvestre-Roig, C; Rossaint, J; Cossio, I; Lechuga-Vieco, AV; Garcia-Prieto, J; Gomez-Parrizas, M; Quintana, JA; Ballesteros, I; Martin-Salamanca, S; Aroca-Crevillen, A; Chong, SZ; Evrard, M; Balabanian, K; Lopez, J; Bidzhekov, K; Bachelerie, F; Abad-Santos, F; Munoz-Calleja, C; Zarbock, A; Soehnlein, O; Weber, C; Ng, LG; Lopez-Rodriguez, C; Sancho, D; Moro, MA; Ibanez, B; Hidalgo, A				Adrover, Jose M.; del Fresno, Carlos; Crainiciuc, Georgiana; Isabel Cuartero, Maria; Casanova-Acebes, Maria; Weiss, Linnea A.; Huerga-Encabo, Hector; Silvestre-Roig, Carlos; Rossaint, Jan; Cossio, Itziar; Lechuga-Vieco, Ana V.; Garcia-Prieto, Jaime; Gomez-Parrizas, Monica; Quintana, Juan A.; Ballesteros, Ivan; Martin-Salamanca, Sandra; Aroca-Crevillen, Alejandra; Chong, Shu Zhen; Evrard, Maximilien; Balabanian, Karl; Lopez, Jorge; Bidzhekov, Kiril; Bachelerie, Frangoise; Abad-Santos, Francisco; Munoz-Calleja, Cecilia; Zarbock, Alexander; Soehnlein, Oliver; Weber, Christian; Ng, Lai Guan; Lopez-Rodriguez, Cristina; Sancho, David; Moro, Maria A.; Ibanez, Borja; Hidalgo, Andres			A Neutrophil Timer Coordinates Immune Defense and Vascular Protection	IMMUNITY			English	Article							FLUORESCENT PROTEIN; LEUKOCYTE ADHESION; BONE-MARROW; CXCR4; SELECTIN; INFLAMMATION; MODULATION; OSCILLATIONS; EXPRESSION; RELEASE	Neutrophils eliminate pathogens efficiently but can inflict severe damage to the host if they over-activate within blood vessels. It is unclear how immunity solves the dilemma of mounting an efficient anti-microbial defense while preserving vascular health. Here, we identify a neutrophil-intrinsic program that enabled both. The gene Bmal1 regulated expression of the chemokine CXCL2 to induce chemokine receptor CXCR2-dependent diurnal changes in the transcriptional and migratory properties of circulating neutrophils. These diurnal alterations, referred to as neutrophil aging, were antagonized by CXCR4 (C-X-C chemokine receptor type 4) and regulated the outer topology of neutrophils to favor homeostatic egress from blood vessels at night, resulting in boosted anti-microbial activity in tissues. Mice engineered for constitutive neutrophil aging became resistant to infection, but the persistence of intravascular aged neutrophils predisposed them to thrombo-inflammation and death. Thus, diurnal compartmentalization of neutrophils, driven by an internal timer, coordinates immune defense and vascular protection.	[Adrover, Jose M.; Crainiciuc, Georgiana; Casanova-Acebes, Maria; Weiss, Linnea A.; Cossio, Itziar; Quintana, Juan A.; Ballesteros, Ivan; Martin-Salamanca, Sandra; Aroca-Crevillen, Alejandra; Hidalgo, Andres] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Dev & Cell Biol, Madrid, Spain; [del Fresno, Carlos; Lechuga-Vieco, Ana V.; Garcia-Prieto, Jaime; Gomez-Parrizas, Monica; Sancho, David; Ibanez, Borja] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Myocardial Pathophysiol, Madrid, Spain; [Isabel Cuartero, Maria; Moro, Maria A.] Univ Complutense, Fac Med, Dept Pharmacol, Unidad Invest Neurovasc, Madrid, Spain; [Isabel Cuartero, Maria; Moro, Maria A.] Inst Invest Hosp 12 Octubre I 12, Madrid, Spain; [Huerga-Encabo, Hector; Lopez-Rodriguez, Cristina] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Immunol Unit, Barcelona, Spain; [Silvestre-Roig, Carlos; Bidzhekov, Kiril; Soehnlein, Oliver; Weber, Christian; Hidalgo, Andres] Ludwig Maximillians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Silvestre-Roig, Carlos; Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Rossaint, Jan; Zarbock, Alexander] Univ Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Chong, Shu Zhen; Evrard, Maximilien; Ng, Lai Guan] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Balabanian, Karl; Bachelerie, Frangoise] Univ Paris Sud, Lab Excellence Res Medicat & Innovat Therapeut, Inserm Unite Mixte Rech UMR S996, Clamart, France; [Lopez, Jorge; Munoz-Calleja, Cecilia] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Dept Immunol, Madrid, Spain; [Abad-Santos, Francisco] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Inst Teofilo Hernando, Dept Clin Pharmacol, Madrid, Spain; [Weber, Christian] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands; [Ibanez, Borja] GIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain; [Ibanez, Borja] Fdn Jimenez Diaz, IIS, Dept Cardiol, Madrid, Spain; [Casanova-Acebes, Maria] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Weiss, Linnea A.] Ctr Nacl Biotecnol, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; Hospital Universitario 12 de Octubre; Pompeu Fabra University; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munster; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); UDICE-French Research Universities; Universite Paris Saclay; Hospital de La Princesa; Hospital de La Princesa; Maastricht University; Fundacion Jimenez Diaz; Icahn School of Medicine at Mount Sinai; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Hidalgo, A (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Area Dev & Cell Biol, Madrid, Spain.; Hidalgo, A (corresponding author), Ludwig Maximillians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany.	ahidalgo@cnic.es	Ibáñez, Borja/J-6993-2014; Del Fresno Sánchez, CArlos/AAY-1525-2021; Cuartero, Maria Isabel/E-8103-2012; Ng, Lai Guan/N-6980-2019; Abad-Santos, Francisco/J-7115-2013; Acebes, Maria Casanova/AAH-1929-2019; Ng, Lai Guan/E-5673-2011; Del Fresno, Carlos/ABD-7766-2020; Hidalgo, Andrés/L-5643-2014; Balabanian, Karl/S-6250-2019; Evrard, Maximilien/L-3886-2019; Sancho, David/D-3433-2009; Weiss, Linnea A/AFV-8680-2022; Weiss, Linnea A/K-8062-2014; Muñoz, Cecilia/M-1945-2018; Weber, Christian/AAW-2153-2020; BACHELERIE, FRANCOISE/F-8823-2013; Silvestre-Roig, Carlos/ABF-9769-2020; Adrover, Jose M/G-9741-2017; Balabanian, Karl/I-2990-2016; Ballesteros, Iván/AAA-6745-2020; Moro, María Ángeles/K-6396-2014; Lopez Rodriguez, Cristina/G-4482-2014	Ibáñez, Borja/0000-0002-5036-254X; Cuartero, Maria Isabel/0000-0003-4728-068X; Ng, Lai Guan/0000-0003-1905-3586; Abad-Santos, Francisco/0000-0002-6519-8885; Acebes, Maria Casanova/0000-0002-5790-1163; Ng, Lai Guan/0000-0003-1905-3586; Del Fresno, Carlos/0000-0003-1771-7254; Hidalgo, Andrés/0000-0001-5513-555X; Balabanian, Karl/0000-0002-0534-3198; Evrard, Maximilien/0000-0002-2105-1160; Sancho, David/0000-0003-2890-3984; Weber, Christian/0000-0003-4610-8714; BACHELERIE, FRANCOISE/0000-0002-0399-3277; Silvestre-Roig, Carlos/0000-0003-1169-7475; Adrover, Jose M/0000-0002-1395-5477; Balabanian, Karl/0000-0002-0534-3198; Moro, María Ángeles/0000-0003-1010-8237; Lechuga-Vieco, Ana Victoria/0000-0001-5546-9752; Ballesteros, Ivan/0000-0002-6246-2353; Chong, Shu Zhen/0000-0002-2682-912X; Lopez Rodriguez, Cristina/0000-0002-2311-2406; Huerga Encabo, Hector/0000-0002-3723-8624; , Linnea/0000-0002-7593-7821	A* STAR; MEIC [SAF2014-61993-EXP, SAF2015-68632-R, SAF-2013-42920R, SAF2016-79040R, SAF2015-65607-R, SAF2013-49662-EXP, PCIN-2014-103]; European Commission [635122-PROCROP H2020]; European Research Council (ERC) [ERC CoG 725091]; ERC [ERC AdG 692511 PROVASC]; Deutsche Forschungsgemeinschaft [SFB1123-A1]; German Center for Cardiovascular Research (DZHK) [MHA VD1.2/81Z1600212]; Fondo de Investigaciones Sanitarias (FIS) [PI12/00494]; Cardiovascular Network grant [RD 12/0042/0054, PI13/01979]; CIBERCV; Fondo Europeo de Desarrollo Regional (FEDER); Pro CNIC Foundation [SEV-2015-0505]; Severo Ochoa Center of Excellence (MEIC) [PI13/01979]; Ministerio de Economia, Industria y Competitividad; MEIC [BES-2013-065550, BES-2010-032828, JCI-2012-14147];  [SFB1123-A6];  [SFB914-B08];  [INST 211/604-2];  [ZA 428/12-1];  [ZA 428/13-1]	A* STAR(Agency for Science Technology & Research (A*STAR)); MEIC; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Center for Cardiovascular Research (DZHK); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Cardiovascular Network grant; CIBERCV; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Pro CNIC Foundation; Severo Ochoa Center of Excellence (MEIC); Ministerio de Economia, Industria y Competitividad; MEIC; ; ; ; ; 	We thank all members of the Hidalgo Lab for discussion and insightful comments; J.M. Ligos, R. Nieto, and M. Viton for help with sorting and cytometric analyses; I. Ortega and E. Santos for animal husbandry; D. Rico, M.J. Gomez, C. Torroja, and F. Sanchez-Cabo for insightful comments and help with transcriptomic analyses; V. Labrador, E. Arza, A.M. Santos, and the Microscopy Unit of the CNIC for help with microscopy; S. Aznar-Benitah, U. Albrecht, Q.-J. Meng, B. Staels, and H. Duez for the generous gift of mice; J.A. Enriquez and J. Avila for scientific insights; and J.M. Garcia and A. Diez de la Cortina for art. This study was supported by Intramural grants from A* STAR to L.G.N., BES-2013-065550 to J.M.A., BES-2010-032828 to M.C.-A, and JCI-2012-14147 to L.A.W (all from Ministerio de Economia, Industria y Competitividad; MEIC). Additional MEIC grants were SAF2014-61993-EXP to C.L.-R.; SAF2015-68632-R to M.A.M. and SAF-2013-42920R and SAF2016-79040Rto D.S. D.S. also received 635122-PROCROP H2020 from the European Commission and ERC CoG 725091 from the European Research Council (ERC). ERC AdG 692511 PROVASC from the ERC and SFB1123-A1 from the Deutsche Forschungsgemeinschaft were given to C.W.; MHA VD1.2/81Z1600212 from the German Center for Cardiovascular Research (DZHK) was given to C.W. and O.S.; SFB1123-A6 was given to O.S.; SFB914-B08 was given to O.S. and C.W.; and INST 211/604-2, ZA 428/12-1, and ZA 428/13-1 were given to A.Z. This study was also supported by PI12/00494 from Fondo de Investigaciones Sanitarias (FIS) to C.M.; PI13/01979, Cardiovascular Network grant RD 12/0042/0054, and CIBERCV to B.I.; SAF2015-65607-R, SAF2013-49662-EXP, and PCIN-2014-103 from MEIC; and co-funding by Fondo Europeo de Desarrollo Regional (FEDER) to A.H. The CNIC is supported by the MEIC and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; del Fresno C, 2018, SCIENCE, V362, P351, DOI 10.1126/science.aan8423; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Faust N, 2000, BLOOD, V96, P719; Finger EB, 1996, J IMMUNOL, V157, P5085; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Garcia-Prieto J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14780; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Man K, 2016, SCIENCE, V354, P999, DOI 10.1126/science.aah4966; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schageman J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/253957; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schloss MJ, 2016, EMBO MOL MED, V8, P937, DOI 10.15252/emmm.201506083; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Simon SI, 2007, ANN BIOMED ENG, V35, P595, DOI 10.1007/s10439-007-9260-7; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tanji-Matsuba K, 1998, CIRCULATION, V97, P91, DOI 10.1161/01.CIR.97.1.91; Tognini P, 2017, CELL HOST MICROBE, V22, P185, DOI 10.1016/j.chom.2017.07.007; Uhl B, 2016, BLOOD, V128, P2327, DOI 10.1182/blood-2016-05-718999; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	53	167	168	8	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					390	+		10.1016/j.immuni.2019.01.002	http://dx.doi.org/10.1016/j.immuni.2019.01.002			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30709741	Bronze, Green Accepted			2022-12-18	WOS:000459006700014
J	Rodewald, HR; Feyerabend, TB				Rodewald, Hans-Reimer; Feyerabend, Thorsten B.			Widespread Immunological Functions of Mast Cells: Fact or Fiction?	IMMUNITY			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; C-KIT; TRICHINELLA-SPIRALIS; GROWTH-FACTOR; W-SH; HYPERSENSITIVITY REACTIONS; PROMOTE ATHEROSCLEROSIS; DELAYED EXPULSION; TRYPTASE MMCP-6; PROTECTIVE ROLE	Immunological functions of mast cells are currently considered to be much broader than the original role of mast cells in IgE-driven allergic disease. The spectrum of proposed mast cell functions includes areas as diverse as the regulation of innate and adaptive immune responses, protective immunity against viral, microbial, and parasitic pathogens, autoimmunity, tolerance to graft rejection, promotion of or protection from cancer, wound healing, angiogenesis, cardiovascular diseases, diabetes, obesity, and others. The vast majority of in vivo mast cell data have been based on mast cell-deficient Kit mutant mice. However, work in new mouse mutants with unperturbed Kit function, which have a surprisingly normal immune system, has failed to corroborate some key immunological aspects, formerly attributed to mast cells. Here, we consider the implications of these recent developments for the state of the field as well as for future work, aiming at deciphering the physiological functions of mast cells.	[Rodewald, Hans-Reimer; Feyerabend, Thorsten B.] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de			ERC [233074]; SFB 938-project L.	ERC(European Research Council (ERC)European Commission); SFB 938-project L.	We thank H.J. Fehling, A. Roers, and A. Weiser for insightful discussions, S. Stocker for kindly proving literature from P. Ehrlich, and members of the Rodewald laboratory for years of work on mast cell mutants. H.R.R. was supported by ERC Advanced Grant Nr. 233074 and SFB 938-project L.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Berrozpe G, 2006, MOL CELL BIOL, V26, P5850, DOI 10.1128/MCB.01854-05; BESMER P, 1993, DEVELOPMENT, P125; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Brown MA, 2012, IMMUNITY, V36, P891, DOI 10.1016/j.immuni.2012.05.004; Chan CY, 2012, CURR OPIN MICROBIOL, V15, P78, DOI 10.1016/j.mib.2011.10.007; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; de Vries VC, 2010, TRANSPL P, V42, P2759, DOI 10.1016/j.transproceed.2010.05.168; de Vries VC, 2010, CURR OPIN IMMUNOL, V22, P643, DOI 10.1016/j.coi.2010.08.015; Ebmeyer J, 2010, OTOL NEUROTOL, V31, P42, DOI 10.1097/MAO.0b013e3181b4e3e3; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ehrlich P, 1877, ARCH MIKROSK ANAT, V13, P263; Ehrlich P., 1901, DEUT MED WOCHENSCHR, V27, P915; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; GALLI SJ, 1987, AM J PATHOL, V127, P191; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Geoffrey R, 2006, J IMMUNOL, V177, P7275, DOI 10.4049/jimmunol.177.10.7275; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; GORDON JR, 1990, BLOOD, V75, P1637; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; HA TY, 1983, INFECT IMMUN, V41, P445, DOI 10.1128/IAI.41.1.445-447.1983; Haidl G, 2011, EXPERT REV CLIN IMMU, V7, P627, DOI [10.1586/eci.11.57, 10.1586/ECI.11.57]; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Heikkila HM, 2010, J CELL BIOCHEM, V109, P615, DOI 10.1002/jcb.22443; Hubner MP, 2011, CLIN IMMUNOL, V141, P205, DOI 10.1016/j.clim.2011.08.004; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; ISHIZAKA K, 1966, J ALLERGY, V37, P169, DOI 10.1016/0021-8707(66)90091-8; JACOBY W, 1984, J INVEST DERMATOL, V83, P302, DOI 10.1111/1523-1747.ep12340431; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kawakami T, 2009, J IMMUNOL, V183, P6861, DOI 10.4049/jimmunol.0990101; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Maes T., 2012, AM J RESP CELL  0603; Magnol L, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-81; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Matsushima H, 2004, EUR J IMMUNOL, V34, P1910, DOI 10.1002/eji.200424912; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Menzies FM, 2011, HUM REPROD UPDATE, V17, P383, DOI 10.1093/humupd/dmq053; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Milenkovic N, 2007, NEURON, V56, P893, DOI 10.1016/j.neuron.2007.10.040; MOTA I, 1956, NATURE, V177, P427, DOI 10.1038/177427a0; Musch W, 2008, GENESIS, V46, P163, DOI 10.1002/dvg.20378; NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Piconese S, 2011, LAB INVEST, V91, P627, DOI 10.1038/labinvest.2011.3; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Pirquet Clemens von, 1906, MUNCHEN MED WOCHEN, V30, P1457; Portier P, 1902, CR SEANC SOC BIOL, V54, P170; PUDDINGTON L, 1994, IMMUNITY, V1, P733, DOI 10.1016/S1074-7613(94)80015-4; Rodewald HR, 2012, IMMUNITY, V36, P893, DOI 10.1016/j.immuni.2012.06.004; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Sergeant GP, 2002, PHYSIOL GENOMICS, V11, P1, DOI 10.1152/physiolgenomics.00052.2002; Shi MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00007; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Wang ZP, 2012, J IMMUNOL, V188, P345, DOI 10.4049/jimmunol.1101703; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Waskow C, 2007, BLOOD, V109, P5363, DOI 10.1182/blood-2006-08-039131; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803; YUNG YP, 1982, J IMMUNOL, V129, P1256; Zhang J, 2011, CIRC RES, V108, P1316, DOI 10.1161/CIRCRESAHA.111.243758; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	114	167	174	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 27	2012	37	1					13	24		10.1016/j.immuni.2012.07.007	http://dx.doi.org/10.1016/j.immuni.2012.07.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840840	Bronze			2022-12-18	WOS:000307133200006
J	Kim, YG; Kamada, N; Shaw, MH; Warner, N; Chen, GY; Franchi, L; Nunez, G				Kim, Yun-Gi; Kamada, Nobuhiko; Shaw, Michael H.; Warner, Neil; Chen, Grace Y.; Franchi, Luigi; Nunez, Gabriel			The Nod2 Sensor Promotes Intestinal Pathogen Eradication via the Chemokine CCL2-Dependent Recruitment of Inflammatory Monocytes	IMMUNITY			English	Article							CITROBACTER-RODENTIUM INFECTION; INNATE IMMUNE-RESPONSES; TOXOPLASMA-GONDII; MUCOSAL INFECTION; EFFACING PATHOGEN; DENDRITIC CELLS; CROHNS-DISEASE; HOST-DEFENSE; T-CELLS; MACROPHAGES	The intracellular sensor Nod2 is activated in response to bacteria, and the impairment of this response is linked to Crohn's disease. However, the function of Nod2 in host defense remains poorly understood. We found that Nod2(-/-) mice exhibited impaired intestinal clearance of Citrobacter rodentium, an enteric bacterium that models human infection by pathogenic Escherichia coli. The increased bacterial burden was preceded by reduced CCL2 chemokine production, inflammatory monocyte recruitment, and Th1 cell responses in the intestine. Colonic stromal cells, but not epithelial cells or resident CD11b(+) phagocytic cells, produced CCL2 in response to C. rodentium in a Nod2-dependent manner. Unlike resident phagocytic cells, inflammatory monocytes produced IL-12, a cytokine that induces adaptive immunity required for pathogen clearance. Adoptive transfer of Ly6C(hi) monocytes restored the clearance of the pathogen in infected Ccr2(-/-) mice. Thus, Nod2 mediates CCL2-CCR2-dependent recruitment of inflammatory monocytes, which is important in promoting bacterial eradication in the intestine.	[Kim, Yun-Gi; Kamada, Nobuhiko; Shaw, Michael H.; Warner, Neil; Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chen, Grace Y.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chen, Grace Y.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Kamada, Nobuhiko/AAW-3299-2020; Warner, Neil/ABE-7329-2020; Nuñez, Gabriel/A-7160-2014	Kamada, Nobuhiko/0000-0002-1980-4178; Warner, Neil/0000-0002-9207-5979; 	NIH [R01 DK61707, 2T32 HL007517]; University of Michigan's Cancer Center [5 P30 CA46592]; University of Michigan Comprehensive Cancer Center; Uehara Memorial Foundation; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); University of Michigan Comprehensive Cancer Center; Uehara Memorial Foundation(Uehara Memorial Foundation); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Flavell, T. Mak, and K. Pienta for generous supply of mutant mice and D. Schauer for bacterial strains. S. Koonse for excellent animal husbandry, and J. Whitfield for ELISA assays. This work was supported by NIH grant R01 DK61707 and funds to the Michigan Comprehensive Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant (5 P30 CA46592). Y.-G. Kim was supported by training funds from the University of Michigan Comprehensive Cancer Center, N.K. by a Fellowship from the Uehara Memorial Foundation, L.F. by a Career Development Award from the Crohn's and Colitis Foundation of America, and M.H.S. by training grant 2T32 HL007517 from the NIH.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; COLOTTA F, 1992, J IMMUNOL, V148, P760; Cruickshank SM, 2008, WORLD J GASTROENTERO, V14, P5834, DOI 10.3748/wjg.14.5834; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Moreira LO, 2008, VACCINE, V26, P5808, DOI 10.1016/j.vaccine.2008.08.038; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Peters W, 2004, J IMMUNOL, V172, P7647, DOI 10.4049/jimmunol.172.12.7647; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Smith RS, 1997, AM J PATHOL, V151, P317; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Struyf S, 1998, J LEUKOCYTE BIOL, V63, P364; Takada Y, 2010, J IMMUNOL, V184, P2671, DOI 10.4049/jimmunol.0804012; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018	48	167	172	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 27	2011	34	5					769	780		10.1016/j.immuni.2011.04.013	http://dx.doi.org/10.1016/j.immuni.2011.04.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21565531	Green Accepted, Bronze			2022-12-18	WOS:000291456500015
J	Desvignes, L; Ernst, JD				Desvignes, Ludovic; Ernst, Joel D.			Interferon-gamma-Responsive Nonhematopoietic Cells Regulate the Immune Response to Mycobacterium tuberculosis	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; LUNG EPITHELIAL-CELLS; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN-METABOLITES; MACROPHAGE RESPONSES; TOXOPLASMA-GONDII; ENDOTHELIAL-CELLS; HUMAN-FIBROBLASTS; DENDRITIC CELLS	Immunity to Mycobacterium tuberculosis in humans and in mice requires interferon gamma (IFN-gamma). Whereas IFN-gamma has been studied extensively for its effects on macrophages in tuberculosis, we determined that protective immunity to tuberculosis also requires IFN-gamma-responsive nonhematopoietic cells. Bone marrow chimeric mice with IFN-gamma-unresponsive lung epithelial and endothelial cells exhibited earlier mortality and higher bacterial burdens than control mice, underexpressed indoleamine-2,3-dioxygenase (idol) in lung endothelium and epithelium, and over-expressed interleukin-17 (IL-17) with massive neutrophilic inflammation in the lungs. We also found that the products of IDO catabolism of tryptophan selectively inhibit IL-17 production by Th17 cells, by inhibiting the action of IL-23. These results reveal a previously unsuspected role for IFN-gamma responsiveness in nonhematopoietic cells in regulation of immunity to M. tuberculosis and illustrate the role of IDO in the inhibition of Th17 cell responses.	[Desvignes, Ludovic; Ernst, Joel D.] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University; New York University	Ernst, JD (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis, 550 1st Ave,Smilow 901, New York, NY 10016 USA.		Desvignes, Ludovic/AAP-5888-2020	Desvignes, Ludovic/0000-0001-6246-0828; Ernst, Joel/0000-0001-9951-6207	NIH [R03 A1053074, R01 A1059667]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI053074, R01AI059667] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J LaFaille for invaluable assistance in making these studies possible and for helpful comments on the manuscript We also thank E Allen, E Hayes, and S Stukes for expert technical assistance This work was supported by NIH grants R03 A1053074 and R01 A1059667.	Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brandacher G, 2008, CURR OPIN ORGAN TRAN, V13, P10, DOI 10.1097/MOT.0b013e3282f3df26; CARLIN JM, 1989, EXPERIENTIA, V45, P535, DOI 10.1007/BF01990503; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; EVANS SE, 2009, AM J RESP C IN PRESS, DOI DOI 10.1165/RCMB2008-0260OC; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Happel KI, 2005, INFECT IMMUN, V73, P5782, DOI 10.1128/IAI.73.9.5782-5788.2005; Heseler K, 2008, FEMS IMMUNOL MED MIC, V52, P273, DOI 10.1111/j.1574-695X.2007.00374.x; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kotton DN, 2005, AM J RESP CELL MOL, V33, P328, DOI 10.1165/rcmb.2005-0175RC; Le AV, 2006, CURR ALLERGY ASTHM R, V6, P27, DOI 10.1007/s11882-006-0006-7; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mehta PK, 2006, MICROB PATHOGENESIS, V41, P119, DOI 10.1016/j.micpath.2006.05.002; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Narui K, 2009, BIOL PHARM BULL, V32, P41, DOI 10.1248/bpb.32.41; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; PFEFFERKORN ER, 1986, J INTERFERON RES, V6, P267, DOI 10.1089/jir.1986.6.267; RAPOZA PA, 1991, INVEST OPHTH VIS SCI, V32, P2919; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V198, P835, DOI 10.1006/bbrc.1994.1119; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Sauty A, 1999, J IMMUNOL, V162, P3549; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Teitelbaum R, 1999, IMMUNITY, V10, P641, DOI 10.1016/S1074-7613(00)80063-1; Ting LM, 1999, J IMMUNOL, V163, P3898; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	58	167	174	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					974	985		10.1016/j.immuni.2009.10.007	http://dx.doi.org/10.1016/j.immuni.2009.10.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064452	Green Accepted, Bronze			2022-12-18	WOS:000273616400017
J	Redmond, WL; Sherman, LA				Redmond, WL; Sherman, LA			Peripheral tolerance of CD8 T lymphocytes	IMMUNITY			English	Review							RECEPTOR DOWN-REGULATION; CROSS-PRESENTATION; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; NAIVE CD8(+); NEGATIVE SELECTION; SELF-ANTIGEN; VIRUS-INFECTION; MEMORY; DELETION	Whereas high-avidity recognition of peptide-MHC complexes by developing T cells in the thymus results in deletion and promotes self-tolerance, such recognition by mature T cells in the periphery results in activation and clonal expansion. This dichotomy represents the basis of a dilemma that has stumped immunologists for many years, how are self-specific T cells tolerized in the periphery? There appear to be two important criteria used to achieve this goal. The first is that in the absence of inflammatory pathogens, tolerance is promoted when T cells recognize antigen presented by quiescent dendritic cells (DCs) expressing low levels of costimulatory molecules. A second critical factor that defines "self" and drives tolerance through deletion, anergy, or suppression is the persistence of antigen.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sherman, LA (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lsherman@scripps.edu		Redmond, William/0000-0002-2572-1731; Sherman, Linda/0000-0001-6422-7069	NCI NIH HHS [CA57855] Funding Source: Medline; NIAID NIH HHS [T32 AI07606] Funding Source: Medline; NIDDK NIH HHS [DK50824] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050824] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Davey GM, 2002, J EXP MED, V196, P947, DOI 10.1084/jem.20020827; Deeths MJ, 1999, J IMMUNOL, V163, P102; Denis GV, 2003, J BIOL CHEM, V278, P5775, DOI 10.1074/jbc.M210202200; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dubois PM, 1998, J IMMUNOL, V161, P5260; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Frauwirth KA, 2001, J IMMUNOL, V167, P4936, DOI 10.4049/jimmunol.167.9.4936; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Guillaume S, 2003, EUR J IMMUNOL, V33, P2551, DOI 10.1002/eji.200324196; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kreuwel HTC, 2002, IMMUNITY, V17, P73, DOI 10.1016/S1074-7613(02)00337-0; Kundig TM, 1996, IMMUNITY, V5, P41, DOI 10.1016/S1074-7613(00)80308-8; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Lefrancois L, 2000, J IMMUNOL, V164, P725, DOI 10.4049/jimmunol.164.2.725; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; Madakamutil LT, 2004, SCIENCE, V304, P590, DOI 10.1126/science.1092316; MAMALAKI C, 1993, INT IMMUNOL, V5, P1285, DOI 10.1093/intimm/5.10.1285; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Morgan DJ, 1998, J IMMUNOL, V160, P643; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Redmond WL, 2003, J IMMUNOL, V171, P6349, DOI 10.4049/jimmunol.171.12.6349; Redmond WL, 2005, J IMMUNOL, V174, P2046, DOI 10.4049/jimmunol.174.4.2046; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; Ruedl C, 1999, J EXP MED, V189, P1875, DOI 10.1084/jem.189.12.1875; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmidt CS, 1999, J IMMUNOL, V163, P2561; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Schuler T, 2002, J MOL MED-JMM, V80, P533, DOI 10.1007/s00109-002-0360-4; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Stamou P, 2003, J IMMUNOL, V171, P1278, DOI 10.4049/jimmunol.171.3.1278; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tanchot C, 1998, IMMUNITY, V8, P581, DOI 10.1016/S1074-7613(00)80563-4; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; Wang B, 2001, J IMMUNOL, V167, P1283, DOI 10.4049/jimmunol.167.3.1283; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101; Zinkernagel RM, 2000, SEMIN IMMUNOL, V12, P163, DOI 10.1006/smim.2000.0253	101	167	171	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					275	284		10.1016/j.immuni.2005.01.010	http://dx.doi.org/10.1016/j.immuni.2005.01.010			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780985	Bronze			2022-12-18	WOS:000228105700003
J	Van Parijs, L; Peterson, DA; Abbas, AK				Van Parijs, L; Peterson, DA; Abbas, AK			RETRACTED: The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens (Retracted article. See vol. 30, pg. 611, 2009)	IMMUNITY			English	Article; Retracted Publication							RECEPTOR TRANSGENIC MICE; IN-VIVO; LYMPHOPROLIFERATIVE SYNDROME; PERIPHERAL TOLERANCE; NEGATIVE SELECTION; FAS ANTIGEN; B-CELLS; APOPTOSIS; DEATH; COSTIMULATION	We have examined the role of Fas and Bcl-2 in T cell survival and responses to antigen in vivo using T cells that express a transgenic antigen receptor specific for hen egg lysozyme (HEL) and that either lack functional Fas or Fas ligand (FasL) or overexpress Bcl-2 as a transgene. HEL-specific, Bcl-2-transgenic T cells showed prolonged responses to immunization with cognate peptide but were eliminated rapidly when exposed to HEL expressed systemically as a self antigen. In contrast, Fas- and FasL-defective T cells did not display exaggerated responses to immunization with HEL peptide, but did show increased expansion and survival in response to systemic self antigen and were able to activate anti-HEL (self) antibody-forming cells. Thus, Bcl-2 and Fas play different roles in the regulation of T cell responses to antigen in vivo and in self tolerance.	Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL)	Abbas, AK (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, 75 Francis St, Boston, MA 02115 USA.	aabbas@bustoff.bwh.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297, R01AI022033] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32531, AI35297, AI22033] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kondo M, 1997, IMMUNITY, V7, P155, DOI 10.1016/S1074-7613(00)80518-X; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; Moreno MB, 1996, J IMMUNOL, V157, P3845; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NUNEZ G, 1991, NATURE, V353, P71, DOI 10.1038/353071a0; PEREZ VL, 1995, INT IMMUNOL, V7, P869, DOI 10.1093/intimm/7.5.869; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SINGER GG, 1994, CURR OPIN IMMUNOL, V6, P913, DOI 10.1016/0952-7915(94)90013-2; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1995, CURR OPIN IMMUNOL, V7, P228, DOI 10.1016/0952-7915(95)80007-7; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tivol EA, 1996, CURR OPIN IMMUNOL, V8, P822, DOI 10.1016/S0952-7915(96)80011-2; Van Parijs Luk, 1997, Journal of Experimental Medicine, V186, P1119; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; VanParijs L, 1997, J IMMUNOL, V158, P3738; VANPARIJS L, 1998, IN PRESS J IMMUNOL; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weintraub JP, 1997, J IMMUNOL, V159, P4117	43	167	169	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					265	274		10.1016/S1074-7613(00)80478-1	http://dx.doi.org/10.1016/S1074-7613(00)80478-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492007	Bronze			2022-12-18	WOS:000072201800013
J	Sichien, D; Scott, CL; Martens, L; Vanderkerken, M; Van Gassen, S; Plantinga, M; Joeris, T; De Prijck, S; Vanhoutte, L; Vanheerswynghels, M; Van Isterdael, G; Toussaint, W; Madeira, FB; Vergote, K; Agace, WW; Clausen, BE; Hammad, H; Dalod, M; Saeys, Y; Lambrecht, BN; Guilliams, M				Sichien, Dorine; Scott, Charlotte L.; Martens, Liesbet; Vanderkerken, Matthias; Van Gassen, Sofie; Plantinga, Maud; Joeris, Thorsten; De Prijck, Sofie; Vanhoutte, Leen; Vanheerswynghels, Manon; Van Isterdael, Gert; Toussaint, Wendy; Madeira, Filipe Branco; Vergote, Karl; Agace, William W.; Clausen, Bjoern E.; Hammad, Hamida; Dalod, Marc; Saeys, Yvan; Lambrecht, Bart N.; Guilliams, Martin			IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively	IMMUNITY			English	Article							LEUKEMIA-LIKE SYNDROME; CLONOGENIC PROGENITOR; STEADY-STATE; BONE-MARROW; FACTOR E2-2; IN-VIVO; MOUSE; LINEAGE; MACROPHAGES; HOMEOSTASIS	Interferon regulatory factor-8 (IRF8) has been proposed to be essential for development of monocytes, plasmacytoid dendritic cells (pDCs) and type 1 conventional dendritic cells (cDC1s) and remains highly expressed in differentiated DCs. Transcription factors that are required to maintain the identity of terminally differentiated cells are designated '' terminal selectors.'' Using BM chimeras, conditional Irf8(fl/fl) mice and various promotors to target Cre recombinase to different stages of monocyte and DC development, we have identified IRF8 as a terminal selector of the cDC1 lineage controlling survival. In monocytes, IRF8 was necessary during early but not late development. Complete or late deletion of IRF8 had no effect on pDC development or survival but altered their phenotype and gene-expression profile leading to increased T cell stimulatory function but decreased type 1 interferon production. Thus, IRF8 differentially controls the survival and function of terminally differentiated monocytes, cDC1s, and pDCs.	[Sichien, Dorine; Scott, Charlotte L.; Vanderkerken, Matthias; Van Gassen, Sofie; Plantinga, Maud; De Prijck, Sofie; Vanhoutte, Leen; Vanheerswynghels, Manon; Van Isterdael, Gert; Toussaint, Wendy; Madeira, Filipe Branco; Vergote, Karl; Hammad, Hamida; Saeys, Yvan; Lambrecht, Bart N.; Guilliams, Martin] Univ Ghent, Immunoregulat Lab, VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Sichien, Dorine; Scott, Charlotte L.; De Prijck, Sofie; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Martens, Liesbet; Vanderkerken, Matthias; Plantinga, Maud; Vanheerswynghels, Manon; Van Isterdael, Gert; Toussaint, Wendy; Madeira, Filipe Branco; Vergote, Karl; Hammad, Hamida; Saeys, Yvan; Lambrecht, Bart N.] Univ Hosp Ghent, Dept Resp Med, B-9000 Ghent, Belgium; [Martens, Liesbet; Van Gassen, Sofie; Saeys, Yvan] Univ Ghent, Data Min & Modelling Biomed Grp, VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Van Gassen, Sofie] Univ Ghent, Dept Informat Technol, IMinds, Ghent, Belgium; [Joeris, Thorsten; Agace, William W.] Danish Tech Univ, Vet Inst, Sect Immunol & Vaccinol, DK-1870 Copenhagen, Denmark; [Vanhoutte, Leen] Univ Hosp Ghent, Dept Med Genet, B-9000 Ghent, Belgium; [Agace, William W.] Lund Univ, Immunol Sect, Dept Expt Med Sci, S-22100 Lund, Sweden; [Clausen, Bjoern E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany; [Dalod, Marc] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UNIV UM2, Parc Sci & Technol Luminy, F-13288 Marseille, France; [Dalod, Marc] INSERM, U1104, F-13288 Marseille, France; [Dalod, Marc] CNRS, UMR7280, F-13288 Marseille, France; [Lambrecht, Bart N.] Erasmus MC, Univ Med Ctr, Dept Pulm Med, NL-3015 Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; IMEC; Technical University of Denmark; Ghent University; Ghent University Hospital; Lund University; Johannes Gutenberg University of Mainz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN; Guilliams, M (corresponding author), Univ Ghent, Immunoregulat Lab, VIB Inflammat Res Ctr, B-9052 Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium.; Lambrecht, BN (corresponding author), Univ Hosp Ghent, Dept Resp Med, B-9000 Ghent, Belgium.; Lambrecht, BN (corresponding author), Erasmus MC, Univ Med Ctr, Dept Pulm Med, NL-3015 Rotterdam, Netherlands.	bart.lambrecht@irc.vib-ugent.be; martin.guilliams@irc.vib-ugent.be	Saeys, Yvan/C-1311-2009; Guilliams, Martin/N-7803-2013; Hammad, Hamida/J-9391-2015; Dalod, Marc/AAK-6163-2020; Lambrecht, Bart N/K-2484-2014; CLAUSEN, Björn Erik/A-8229-2010; Scott, Charlotte/K-3563-2014	Saeys, Yvan/0000-0002-0415-1506; Guilliams, Martin/0000-0003-3525-7570; Hammad, Hamida/0000-0003-3762-8603; Dalod, Marc/0000-0002-6436-7966; Lambrecht, Bart N/0000-0003-4376-6834; CLAUSEN, Björn Erik/0000-0002-2484-7842; Van Gassen, Sofie/0000-0002-7119-5330; Scott, Charlotte/0000-0003-4914-6580; Martens, Liesbet/0000-0001-9180-7456; Agace, william/0000-0003-3823-5772; Sichien, Dorine/0000-0002-7298-3005; Van Isterdael, Gert/0000-0001-6626-1316	FWO; Flanders Agency for Innovation by Science and Technology (IWT); Lundbeckfonden [R155-2014-4184]; Danish research council; Swedish Medical Research council; University of Gent MRP program "Group-ID''; European Research Council consolidator grant; Interuniversity Attraction Pole grant; several FWO grants; Marie Curie Intra-European Fellowship (IEF) as part of Horizon; Marie Curie Reintegration grant of the Flanders Government; Odysseus grant of the Flanders Government; several FWO grants of the Flanders Government	FWO(FWO); Flanders Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Lundbeckfonden(Lundbeckfonden); Danish research council(Det Frie Forskningsrad (DFF)); Swedish Medical Research council(Swedish Medical Research Council (SMRC)); University of Gent MRP program "Group-ID''; European Research Council consolidator grant(European Research Council (ERC)); Interuniversity Attraction Pole grant; several FWO grants; Marie Curie Intra-European Fellowship (IEF) as part of Horizon; Marie Curie Reintegration grant of the Flanders Government; Odysseus grant of the Flanders Government; several FWO grants of the Flanders Government	We would like to thank Dr. M. Kool (Erasmus MC Rotterdam) for providing OTII mice. D.S. and M. Vanheerswynghels are supported by a fellowship grant of FWO. S.V.G. is funded by the Flanders Agency for Innovation by Science and Technology (IWT). W.W.A. is supported by grants from the Lundbeckfonden (R155-2014-4184), a Sapere Aude III grant from the Danish research council, and the Swedish Medical Research council. Y.S. is an ISAC Marylou Ingram Scholar. G.V.I. is an ISAC SRL Emerging Leader. B.E.C. is a member of the Research Center for Immunotherapy (FZI) Mainz. B.N.L. is supported by the University of Gent MRP program "Group-ID,'' a European Research Council consolidator grant, an Interuniversity Attraction Pole grant, and several FWO grants. C.L.S. is supported by a Marie Curie Intra-European Fellowship (IEF) as part of Horizon 2020. M.G. is supported by a Marie Curie Reintegration grant, an Odysseus grant, and several FWO grants of the Flanders Government.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kool M, 2011, J LEUKOCYTE BIOL, V90, P1177, DOI 10.1189/jlb.0610342; Kurotaki D, 2016, J INTERF CYTOK RES, V36, P433, DOI 10.1089/jir.2015.0138; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Lin Q, 2015, NUCLEIC ACIDS RES, V43, P9680, DOI 10.1093/nar/gkv1056; Luda KM, 2016, IMMUNITY, V44, P860, DOI 10.1016/j.immuni.2016.02.008; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy T.L., 2015, ANNU REV IMMUNOL, V20, P93; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880	47	166	170	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					626	640		10.1016/j.immuni.2016.08.013	http://dx.doi.org/10.1016/j.immuni.2016.08.013			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27637148	Bronze			2022-12-18	WOS:000388454300018
J	Crouse, J; Bedenikovic, G; Wiesel, M; Ibberson, M; Xenarios, I; Von Laer, D; Kalinke, U; Vivier, E; Jonjic, S; Oxenius, A				Crouse, Josh; Bedenikovic, Gregor; Wiesel, Melanie; Ibberson, Mark; Xenarios, Ioannis; Von Laer, Dorothee; Kalinke, Ulrich; Vivier, Eric; Jonjic, Stipan; Oxenius, Annette			Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; CUTTING EDGE; CLONAL EXPANSION; SURFACE EXPRESSION; CYTOLYTIC FUNCTION; DENDRITIC CELLS; NKP46; RECOGNITION; INFECTION; LIGANDS	Direct type I interferon (IFN) signaling on T cells is necessary for the proper expansion, differentiation, and survival of responding T cells following infection with viruses prominently inducing type I IFN. The reasons for the abortive response of T cells lacking the type I IFN receptor (Ifnar1(-/-)) remain unclear. We report here that Ifnar1(-/-) T cells were highly susceptible to natural killer (NK) cell-mediated killing in a perforin-dependent manner. Depletion of NK cells prior to lymphocytic choriomeningitis virus (LCMV) infection completely restored the early expansion of Ifnar1(-/-) T cells. Ifnar1(-/-) T cells had elevated expression of natural cytotoxicity triggering receptor 1 (NCR1) ligands upon infection, rendering them targets for NCR1 mediated NK cell attack. Thus, direct sensing of type I IFNs by T cells protects them from NK cell killing by regulating the expression of NCR1 ligands, thereby revealing a mechanism by which T cells can evade the potent cytotoxic activity of NK cells.	[Crouse, Josh; Bedenikovic, Gregor; Wiesel, Melanie; Oxenius, Annette] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Ibberson, Mark; Xenarios, Ioannis] Univ Lausanne, CHUV, Vital IT, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Von Laer, Dorothee] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, Ctr Expt & Clin Infect Res, TWINCORE, Inst Expt Infect Res, Braunschweig, Germany; [Kalinke, Ulrich] Hannover Med Sch, D-30625 Hannover, Germany; [Vivier, Eric] Ctr Immunol Marseille Luminy, Inst Natl St & Rech Med, U1104, Marseille, France; [Jonjic, Stipan] Fac Med, Dept Histol & Embryol, Rijeka 51000, Croatia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Rijeka	Oxenius, A (corresponding author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	oxenius@micro.biol.ethz.ch	Jonjic, Stipan/C-5657-2016; Xenarios, Ioannis/ABD-5045-2021; Vivier, Eric/F-8939-2010; Oxenius, Annette/G-7794-2015	Jonjic, Stipan/0000-0001-5003-3108; Xenarios, Ioannis/0000-0002-3413-6841; Vivier, Eric/0000-0001-7022-8287; Ibberson, Mark/0000-0003-3152-5670; von Laer, Dorothee/0000-0001-5825-7237; Kalinke, Ulrich/0000-0003-0503-9564	ETH; Swiss National Science Foundation [310030-113947, 310030_146140]	ETH(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank P. Aichele (University of Freiburg) for providing the P14 Ifnar1<SUP>-/-</SUP> mice and B. Polic for providing klrk1<SUP>-/-</SUP> mice. We thank O. Mandelboim for providing the NCR1-IgG fusion protein producing cell line, N. Oetiker for excellent assistance in cell sorting, and F. Wagen for mouse genotyping. We are grateful to the members of the Oxenius and LeibundGut groups for helpful discussions and critical reading of the manuscript. This work was supported by the ETH and the Swiss National Science Foundation (Grant No. 310030-113947 and 310030_146140 to A.O.).	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BIRON CA, 1984, J LEUKOCYTE BIOL, V35, P31, DOI 10.1002/jlb.35.1.31; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Keppler SJ, 2011, EUR J IMMUNOL, V41, P3176, DOI 10.1002/eji.201141537; Keppler SJ, 2009, EUR J IMMUNOL, V39, P1774, DOI 10.1002/eji.200839093; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Waggoner SN, 2014, J VIROL, V88, P1953, DOI 10.1128/JVI.03002-13; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081	42	166	169	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					961	973		10.1016/j.immuni.2014.05.003	http://dx.doi.org/10.1016/j.immuni.2014.05.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24909889	Bronze			2022-12-18	WOS:000341440200017
J	Guo, XH; Qiu, J; Tu, T; Yang, XM; Deng, LF; Anders, RA; Zhou, L; Fu, YX				Guo, Xiaohuan; Qiu, Ju; Tu, Tony; Yang, Xuanming; Deng, Liufu; Anders, Robert A.; Zhou, Liang; Fu, Yang-Xin			Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection	IMMUNITY			English	Article							ROR-GAMMA-T; CITROBACTER-RODENTIUM; FACTOR GATA3; MUCOSAL INFECTION; NKP46(+) CELLS; HOST-DEFENSE; DIFFERENTIATION; GENERATION; TISSUE; IL-22	Inhibitors of the transcription factor STAT3 target STAT3-dependent tumorigenesis but patients often develop diarrhea from unknown mechanisms. Here we showed that STAT3 deficiency increased morbidity and mortality after Citrobacter rodentium infection with decreased secretion of cytokines including IL-17 and IL-22 associated with the transcription factor ROR gamma t. Administration of the cytokine IL-22 was sufficient to rescue STAT3-deficient mice from lethal infection. Although STAT3 was required for IL-22 production in both innate and adaptive arms, by using conditional gene-deficient mice, we observed that STAT3 expression in ROR gamma t(+) innate lymphoid cells (ILC3s), but not T cells, was essential for the protection. However, STAT3 was required for ROR gamma t expression in T helper cells, but not in ILC3s. Activated STAT3 could directly bind to the Il22 locus. Thus, cancer therapies that utilize STAT3 inhibitors increase the risk for pathogen-mediated diarrhea through direct suppression of IL-22 from gut ILCs.	[Guo, Xiaohuan; Tu, Tony; Yang, Xuanming; Deng, Liufu; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Guo, Xiaohuan; Tu, Tony; Yang, Xuanming; Deng, Liufu; Fu, Yang-Xin] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Qiu, Ju; Zhou, Liang] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Qiu, Ju; Zhou, Liang] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Anders, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA	University of Chicago; University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University	Zhou, L (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	l-zhou@northwestern.edu; yfu@uchicago.edu	Guo, Xiaohuan/I-3710-2017; Deng, Liufu/I-4443-2013; Deng, Liufu/AAG-7244-2021; Qiu, Ju/AAW-7301-2021	Guo, Xiaohuan/0000-0001-5152-3010; Deng, Liufu/0000-0002-1164-6777; Yang, Xuanming/0000-0002-3261-8206; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [AI 089954, AI 091962, DK080736, CA141975]; Pew Scholarship; Cancer Research Institute Investigator Award; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA134563, R01CA141975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089954, R21AI091962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080736, R01DK105562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholarship; Cancer Research Institute Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to H. Yu (Beckman Research Institute of City of Hope, CA) for Stat3-floxed mice and Sunitinib (SU11248; SUTENT); D. Littman and I. Ivanov (New York University, NY) for Rorc-cre mice; W. Ouyang (Genentech, CA) for IL-22-expressing plasmid, IL-22-Ig and anti-IL-22 antibody; C. Dong (MD Anderson Cancer Center, TX) for IL-17 plasmid; V. Krishnamoorthy (University of Chicago, IL) for ChIP protocol; and S. Kron and J. Cunningham (University of Chicago, IL) for sharing sonicator. The work was supported by the National Institutes of Health grants (AI 089954 and AI 091962 to L.Z., DK080736 and CA141975 to Y.X.F.), by a Pew Scholarship and by a Cancer Research Institute Investigator Award (to L.Z). L.Z. is a BWF Investigator in the Pathogenesis of Infectious Disease.	Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schwandt A, 2009, ONCOTARGETS THER, V2, P51; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1998, J IMMUNOL, V161, P4652; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2012, IMMUNITY, V37, P589, DOI 10.1016/j.immuni.2012.10.002	51	166	176	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					25	39		10.1016/j.immuni.2013.10.021	http://dx.doi.org/10.1016/j.immuni.2013.10.021			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24412612	Green Accepted, Bronze			2022-12-18	WOS:000331476900007
J	Luoma, AM; Castro, CD; Mayassi, T; Bembinster, LA; Bai, L; Picard, D; Anderson, B; Scharf, L; Kung, JE; Sibener, LV; Savage, PB; Jabri, B; Bendelac, A; Adams, EJ				Luoma, Adrienne M.; Castro, Caitlin D.; Mayassi, Toufic; Bembinster, Leslie A.; Bai, Li; Picard, Damien; Anderson, Brian; Scharf, Louise; Kung, Jennifer E.; Sibener, Leah V.; Savage, Paul B.; Jabri, Bana; Bendelac, Albert; Adams, Erin J.			Crystal Structure of V delta 1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human gamma delta T Cells	IMMUNITY			English	Article							CLASS-I MOLECULES; ANTIGEN RECEPTOR; MULTIPLE-SCLEROSIS; EPITHELIAL-CELLS; SMALL-INTESTINE; CELIAC-DISEASE; NKT CELLS; LYMPHOCYTES; TCR; EXPRESSION	The nature of the antigens recognized by gamma delta T cells and their potential recognition of major histocompatibility complex (MHC)-like molecules has remained unclear. Members of the CD1 family of lipid-presenting molecules are suggested ligands for V delta 1 TCR-expressing gamma delta T cells, the major gamma delta lymphocyte population in epithelial tissues. We crystallized a V delta 1 TCR in complex with CD1d and the self-lipid sulfatide, revealing the unusual recognition of CD1d by germline V delta 1 residues spanning all complementarity-determining region (CDR) loops, as well as sulfatide recognition separately encoded by non-germline CDR3d residues. Binding and functional analysis showed that CD1d presenting self-lipids, including sulfatide, was widely recognized by gut V delta 1+ gamma delta T cells. These findings provide structural demonstration of MHC-like recognition of a self-lipid by gamma delta T cells and reveal the prevalence of lipid recognition by innate-like T cell populations.	[Luoma, Adrienne M.; Mayassi, Toufic; Jabri, Bana; Bendelac, Albert; Adams, Erin J.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Luoma, Adrienne M.; Castro, Caitlin D.; Bembinster, Leslie A.; Scharf, Louise; Kung, Jennifer E.; Sibener, Leah V.; Adams, Erin J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Mayassi, Toufic; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bai, Li] Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230027, Peoples R China; [Bai, Li; Picard, Damien; Bendelac, Albert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bai, Li; Picard, Damien; Bendelac, Albert] Brigham Young Univ, Howard Hughes Med Inst, Provo, UT 84602 USA; [Anderson, Brian; Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	University of Chicago; University of Chicago; University of Chicago; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Chicago; Brigham Young University; Howard Hughes Medical Institute; Brigham Young University	Adams, EJ (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	ejadams@uchicago.edu	Savage, Paul B/HGB-3414-2022; Savage, Paul B/E-1448-2011	Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; Kung, Jennifer/0000-0002-6784-7076	National Institutes of Health [R56_AI097386, R01_AI073922, R01_DK67180, RO1 AI038339, PO1 AI053725, P30_DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339, R56AI097386, P01AI053725, T32AI007090, R01AI073922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067180, P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff of the Advanced Proton Source at GM/CA-CAT (23-ID) and LS-CAT (21-ID) for their use and assistance with X-ray beamlines and Ruslan Sanishvili and Craig Ogata in particular for help and advice during data collection. We thank Mike Kuhns for the gift of the P2-pMSCV vector. This work was supported by National Institutes of Health grants R56_AI097386 and R01_AI073922 to E.J.A., R01_DK67180 to B.J., RO1 AI038339 and PO1 AI053725 to A. B., and P30_DK42086 to the DDRCC (University of Chicago Digestive Diseases Research Core Center).	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Adams EJ, 2008, NAT IMMUNOL, V9, P777, DOI 10.1038/ni.1620; Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Bai L, 2012, EUR J IMMUNOL, V42, P2505, DOI 10.1002/eji.201242531; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BONNEVILLE M, 1989, P NATL ACAD SCI USA, V86, P5928, DOI 10.1073/pnas.86.15.5928; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Born WK, 2013, CELL MOL IMMUNOL, V10, P13, DOI 10.1038/cmi.2012.45; Breimer ME, 2012, GLYCOBIOLOGY, V22, P1721, DOI 10.1093/glycob/cws115; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; CHOWERS Y, 1994, J EXP MED, V180, P183, DOI 10.1084/jem.180.1.183; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEUSCH K, 1991, EUR J IMMUNOL, V21, P1053, DOI 10.1002/eji.1830210429; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Haig NA, 2011, J BIOL CHEM, V286, P37692, DOI 10.1074/jbc.M111.267948; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Lopez-Sagaseta J, 2013, P NATL ACAD SCI USA, V110, pE1771, DOI 10.1073/pnas.1222678110; Mangan BA, 2013, J IMMUNOL, V191, P30, DOI 10.4049/jimmunol.1300121; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McVay LD, 1999, CRIT REV IMMUNOL, V19, P431; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Perera L, 2007, INFLAMM BOWEL DIS, V13, P298, DOI 10.1002/ibd.20026; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Russano AM, 2007, J IMMUNOL, V178, P3620, DOI 10.4049/jimmunol.178.6.3620; Russano AM, 2006, J ALLERGY CLIN IMMUN, V117, P1178, DOI 10.1016/j.jaci.2006.01.001; Sandstrom A, 2012, J BIOL CHEM, V287, P6035, DOI 10.1074/jbc.M111.333153; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Smith PM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00111; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011	60	166	170	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1032	1042		10.1016/j.immuni.2013.11.001	http://dx.doi.org/10.1016/j.immuni.2013.11.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24239091	Bronze, Green Accepted			2022-12-18	WOS:000330951000010
J	Uderhardt, S; Herrmann, M; Oskolkova, OV; Aschermann, S; Bicker, W; Ipseiz, N; Sarter, K; Frey, B; Rothe, T; Voll, R; Nimmerjahn, F; Bochkov, VN; Schett, G; Kronke, G				Uderhardt, Stefan; Herrmann, Martin; Oskolkova, Olga V.; Aschermann, Susanne; Bicker, Wolfgang; Ipseiz, Natacha; Sarter, Kerstin; Frey, Benjamin; Rothe, Tobias; Voll, Reinhard; Nimmerjahn, Falk; Bochkov, Valery N.; Schett, Georg; Kroenke, Gerhard			12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GLOBULE-EGF FACTOR-8; E-DEFICIENT MICE; DENDRITIC CELLS; PHOSPHATIDYLSERINE RECEPTOR; OXIDIZED PHOSPHOLIPIDS; PHAGOSOME MATURATION; ANTIGEN PRESENTATION; LIPID MEDIATORS; TISSUE-DAMAGE	Noninflammatory clearance of apoptotic cells (ACs) is crucial to maintain self-tolerance. Here, we have reported a role for the enzyme 12/15-lipoxygenase (12/15-LO) as a central factor governing the sorting of ACs into differentially activated monocyte subpopulations. During inflammation, uptake of ACs was confined to a population of 12/15-LO-expressing, alternatively activated resident macrophages (resM Phi), which blocked uptake of ACs into freshly recruited inflammatory Ly6C(hi) monocytes in a 12/15-LO-dependent manner. ResM Phi. exposed 12/15-LO-derived oxidation products of phosphatidylethanolamine (oxPE) on their plasma membranes and thereby generated a sink for distinct soluble receptors for ACs such as milk fat globule-EGF factor 8, which were essential for the uptake of ACs into inflammatory monocytes. Loss of 12/15-LO activity, in turn, resulted in an aberrant phagocytosis of ACs by inflammatory monocytes, subsequent antigen presentation of AC-derived antigens, and a lupus-like autoimmune disease. Our data reveal an unexpected key role for enzymatic lipid oxidation during the maintenance of self-tolerance.	[Uderhardt, Stefan; Herrmann, Martin; Ipseiz, Natacha; Sarter, Kerstin; Rothe, Tobias; Voll, Reinhard; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Uderhardt, Stefan; Herrmann, Martin; Ipseiz, Natacha; Sarter, Kerstin; Rothe, Tobias; Voll, Reinhard; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany; [Uderhardt, Stefan; Ipseiz, Natacha; Rothe, Tobias; Kroenke, Gerhard] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Univ Hosp Erlangen, D-91054 Erlangen, Germany; [Frey, Benjamin] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Oskolkova, Olga V.; Bochkov, Valery N.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Aschermann, Susanne; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Inst Genet, Dept Biol, D-91058 Erlangen, Germany; [Bicker, Wolfgang] FTC Forens Toxicol Lab Ltd, A-1090 Vienna, Austria	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Medical University of Vienna; University of Erlangen Nuremberg	Kronke, G (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany.	gerhard.kroenke@uk-erlangen.de	Uderhardt, Stefan/AAA-5224-2022; herrmann, martin/AAT-9836-2020; Herrmann, Martin/A-9597-2013; Ipseiz, Natacha/AAG-6390-2019; Frey, Benjamin/D-9565-2017; Kronke, Gerhard/C-6615-2014	Uderhardt, Stefan/0000-0002-2489-2109; Herrmann, Martin/0000-0002-0258-2484; Ipseiz, Natacha/0000-0001-5008-8889; Frey, Benjamin/0000-0001-6743-3351; Nimmerjahn, Falk/0000-0002-5418-316X; Kronke, Gerhard/0000-0002-7566-4325; Oskolkova, Olga/0000-0001-9443-8705	Deutsche Forschungsgemeinschaft [SCHE1583, KR3523, FG 661, SFB643, SPP1468-IMMUNOBONE]; ELAN of the University of Erlangen-Nuremberg; MASTERSWITCH of the European Union; IMI; Interdisciplinary Centre for Clinical Research; osterreichische Forschungsforderungsgesellschaft [815445]; Fonds zur Forderung wissenschaftlicher Forschung [P20801-B11, P22267-B11]; Austrian Science Fund (FWF) [P 22267] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ELAN of the University of Erlangen-Nuremberg; MASTERSWITCH of the European Union; IMI; Interdisciplinary Centre for Clinical Research; osterreichische Forschungsforderungsgesellschaft; Fonds zur Forderung wissenschaftlicher Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Steffen, C. Stoll, and I. Schmidt for technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (SCHE1583, KR3523, FG 661, SFB643, and SPP1468-IMMUNOBONE to G.K. and G.S.), the ELAN-Program of the University of Erlangen-Nuremberg (to G.K.), the MASTERSWITCH project of the European Union and the IMI-funded project BTCure, the Interdisciplinary Centre for Clinical Research, and by grants of the osterreichische Forschungsforderungsgesellschaft (project 815445 to V.N.B.) and Fonds zur Forderung wissenschaftlicher Forschung (P20801-B11 to V.N.B. and P22267-B11 to O.V.O.). Author contributions are as follows: S.U., G.K., and K.S. performed phagocytosis assays; S.A. performed microscopy; W.B. and V.N.B. performed MS analysis; O.V.O. and V.N.B. performed lipid synthesis; B.F. and T.R. collected data; B.F. provided the mice; R.V. and F.N. were involved in study design; and S.U., M.H., G.S., V.N.B., and G.K. designed the study, analyzed data, and wrote the paper. All authors discussed the results and commented on the manuscript.	Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Brys L, 2005, J IMMUNOL, V174, P6095, DOI 10.4049/jimmunol.174.10.6095; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Van Etten RA, 2007, J EXP MED, V204, P461, DOI 10.1084/jem.20062335; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yamaguchi H, 2010, EUR J IMMUNOL, V40, P1778, DOI 10.1002/eji.200940096	55	166	178	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					834	846		10.1016/j.immuni.2012.03.010	http://dx.doi.org/10.1016/j.immuni.2012.03.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22503541	Bronze			2022-12-18	WOS:000304976000016
J	Vinuesa, CG; Cyster, JG				Vinuesa, Carola G.; Cyster, Jason G.			How T Cells Earn the Follicular Rite of Passage	IMMUNITY			English	Review							CENTER B-CELL; FACTOR BATF CONTROLS; HELPER-CELL; DENDRITIC CELLS; ANTIBODY-RESPONSES; BCL-6 EXPRESSION; DIFFERENTIATION; GENERATION; ANTIGEN; IL-21	The discovery that Bcl-6 was the transcriptional regulator of follicular helper T (Tfh) cells completed the recognition of this population as an effector subset specialized in the provision of help to B cells. Improved reagents and recent models that allow tracking of Bcl-6-expressing T cells have revealed that the decision to become a Tfh cell occurs soon after T cells are primed by dendritic cells and start dividing, before interaction with B cells. The latter are important for sustaining Bcl-6 expression. Bcl-6 coordinates a signaling program that changes expression or function of multiple guidance receptors, leading to Tfh cell localization within germinal centers. This program is not unique to CD4(+) helper T cells; FoxP3(+) regulatory T cells and NKT cells co-opt the follicular differentiation pathway to enter the follicle and become specialized follicular cells. This review will focus on recent insights into the early events that determine Tfh cell differentiation.	[Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia; [Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Australian National University; John Curtin School of Medical Research; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298				Alexander CM, 2011, IMMUNOLOGY, V133, P452, DOI 10.1111/j.1365-2567.2011.03456.x; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; Awasthi A, 2009, SCIENCE, V325, P953, DOI 10.1126/science.1178752; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fields ML, 2005, J IMMUNOL, V175, P4255, DOI 10.4049/jimmunol.175.7.4255; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Han XB, 2006, J IMMUNOL, V176, P5232, DOI 10.4049/jimmunol.176.9.5232; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ichii H, 2004, J IMMUNOL, V173, P883, DOI 10.4049/jimmunol.173.2.883; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Kelly LM, 2011, J IMMUNOL, V187, P3026, DOI 10.4049/jimmunol.1101262; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Polo JM, 2008, BLOOD, V112, P644, DOI 10.1182/blood-2008-01-131813; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Reiner SL, 2008, IMMUNOL RES, V42, P160, DOI 10.1007/s12026-008-8054-9; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Russell SM, 2008, IMMUNOL CELL BIOL, V86, P423, DOI 10.1038/icb.2008.24; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhang TT, 2010, J IMMUNOL, V184, P164, DOI 10.4049/jimmunol.0902505; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	100	166	173	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					671	680		10.1016/j.immuni.2011.11.001	http://dx.doi.org/10.1016/j.immuni.2011.11.001			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118524	Bronze			2022-12-18	WOS:000297390800008
J	Siddiqui, KRR; Laffont, S; Powrie, F				Siddiqui, Karima R. R.; Laffont, Sophie; Powrie, Fiona			E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated Colitis	IMMUNITY			English	Article							LANGERHANS CELLS; BLOOD MONOCYTES; LAMINA PROPRIA; BONE-MARROW; ADHESION; GENERATION; MIGRATION; RESPONSES; PATHWAY; INNATE	Dendritic cells (DCs) play a pivotal role in controlling the balance between tolerance and immunity in the intestine. Gut conditioned CD103(+) DCs promote regulatory T (Treg) cell responses; however, little is known about DCs that drive inflammation in the intestine. Here, we show that monocyte-derived inflammatory DCs that express E-cadherin, the receptor for CD103, promote intestinal inflammation. E-cadherin(+) DCs accumulated in the inflamed mesenteric lymph nodes and colon, had high expression of toll-like receptors, and produced colitogenic cytokines, such as IL-6 and IL-23, after activation. Importantly, adoptive transfer of E-cadherin+ DCs into T cell-restored immunodeficient hosts increased Th17 cell responses in the intestine and led to exacerbation of colitis. These results identify a monocyte-derived inflammatory DC subset that is associated with the pathogenesis of intestinal inflammation, providing a therapeutic target for the treatment of inflammatory bowel disease.	[Siddiqui, Karima R. R.; Laffont, Sophie; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Laffont, Sophie; Powrie, Fiona] John Radcliffe Hosp, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.			Laffont, Sophie/0000-0003-2319-0217	MRC; Wellcome Trust	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We would like to thank N Rust for cell sorting and C Arancibia for critical reading of the manuscript KRRS is supported by the MRC, and S L and F P are supported by the Wellcome Trust	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Guilliams M, 2009, J IMMUNOL, V182, P1107, DOI 10.4049/jimmunol.182.2.1107; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Jakob T, 1998, J IMMUNOL, V160, P4067; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Malmstrom V, 2001, J IMMUNOL, V166, P6972, DOI 10.4049/jimmunol.166.11.6972; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Riedl E, 2000, BLOOD, V96, P4276; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	42	166	172	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					557	567		10.1016/j.immuni.2010.03.017	http://dx.doi.org/10.1016/j.immuni.2010.03.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20399121	Green Published, hybrid			2022-12-18	WOS:000277171900014
J	Meylan, F; Davidson, TS; Kahle, E; Kinder, M; Acharya, K; Jankovic, D; Bundoc, V; Hodges, M; Shevach, EM; Keane-Myers, A; Wang, ECY; Siegel, RM				Meylan, Francoise; Davidson, Todd S.; Kahle, Erin; Kinder, Michelle; Acharya, Krishika; Jankovic, Dragana; Bundoc, Virgilio; Hodges, Marcus; Shevach, Ethan M.; Keane-Myers, Andrea; Wang, Eddie C. Y.; Siegel, Richard M.			The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALLERGIC INFLAMMATION; TOXOPLASMA-GONDII; RHEUMATOID-ARTHRITIS; LUNG INFLAMMATION; DENDRITIC CELLS; TL1A; LIGAND; CYTOKINE; PROTEIN	DR3 (TRAMP, LARD, WSL-1, TNFRSF25) is a death-domain-containing tumor necrosis factor (TNF)family receptor primarily expressed on T cells. TL1A, the TNF-family ligand for DR3, can costimulate T cells, but the physiological function of TL1A-DR3 interactions in immune responses is not known. Using DR3-deficient mice, we identified DR3 as the receptor responsible for TL1A-induced T cell costimulation and dendritic cells as the likely source for TL1A during T cell activation. Despite its role in costimulation, DR3 was not required for in vivo T cell priming, for polarization into T helper 1 (Th1), Th2, or Th17 effector cell subtypes, or for effective control of infection with Toxoplasma gondii. Instead, DR3 expression was required on T cells for immunopathology, local T cell accumulation, and cytokine production in Experimental Autoimmune Encephalomyelitis (EAE) and allergic lung inflammation, disease models that depend on distinct effector T cell subsets. DR3 could be an attractive therapeutic target for T cell-mediated autoimmune and allergic diseases.	[Meylan, Francoise; Kahle, Erin; Kinder, Michelle; Acharya, Krishika; Siegel, Richard M.] NIAMSD, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Jankovic, Dragana] NIAID, Immunol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Bundoc, Virgilio; Hodges, Marcus; Keane-Myers, Andrea] NIAID, Allerg Inflammat Sect, Lab Allerg Dis, Bethesda, MD 20892 USA; [Davidson, Todd S.; Shevach, Ethan M.] NIAID, Cellular Immunol Sect, Immunol Lab, Bethesda, MD 20892 USA; [Wang, Eddie C. Y.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, Wales	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cardiff University	Siegel, RM (corresponding author), NIAMSD, Immunoregulat Unit, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893; Wang, Eddie/0000-0002-2243-4964	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041174] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AR041174-01] Funding Source: Medline; Medical Research Council [G0300180, G0500617, G0500617(74644), G0300180(65735)] Funding Source: Medline; MRC [G0300180, G0500617] Funding Source: UKRI	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arestides RSS, 2002, EUR J IMMUNOL, V32, P2874, DOI 10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; BAMIAS G, 2006, ROLE TL1A ITS RECEPT; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Kim S, 2005, J IMMUNOL METHODS, V298, P1, DOI 10.1016/j.jim.2004.12.019; McConchie BW, 2006, INFECT IMMUN, V74, P6632, DOI 10.1128/IAI.00720-06; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Nakajima A, 2000, J NEUROIMMUNOL, V109, P188, DOI 10.1016/S0165-5728(00)00324-6; Nohara C, 2001, J IMMUNOL, V166, P2108, DOI 10.4049/jimmunol.166.3.2108; Norris HH, 2007, J LEUKOCYTE BIOL, V82, P1531, DOI 10.1189/jlb.1106667; Osawa K, 2004, GENES IMMUN, V5, P439, DOI 10.1038/sj.gene.6364097; Papadakis KA, 2004, J IMMUNOL, V172, P7002, DOI 10.4049/jimmunol.172.11.7002; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; PARKER SJ, 1991, CLIN EXP IMMUNOL, V84, P207, DOI 10.1111/j.1365-2249.1991.tb08150.x; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Scorza T, 2003, INFECT IMMUN, V71, P309, DOI 10.1128/IAI.71.1.309-316.2003; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Soroosh P, 2006, J IMMUNOL, V176, P5975, DOI 10.4049/jimmunol.176.10.5975; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tao X, 1997, J IMMUNOL, V159, P5956; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	32	166	188	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					79	89		10.1016/j.immuni.2008.04.021	http://dx.doi.org/10.1016/j.immuni.2008.04.021			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18571443	Bronze, Green Accepted			2022-12-18	WOS:000257905400012
J	Santiago, C; Ballesteros, A; Martinez-Munoz, L; Mellado, M; Kaplan, GG; Freeman, GJ; Casasnovas, JM				Santiago, Cesar; Ballesteros, Angela; Martinez-Munoz, Laura; Mellado, Mario; Kaplan, Gerardo G.; Freeman, Gordon J.; Casasnovas, Jose M.			Structures of T cell immunoglobulin mucin protein 4 show a metal-ion-dependent ligand binding site where phosphatidylserine binds	IMMUNITY			English	Article							IMMUNE-RESPONSES; RECEPTOR; RECOGNITION; MECHANISM; TIM-3; IDENTIFICATION; ACTIVATION; REVEALS; FAMILY; KIDNEY	The T cell immunoglobulin and mucin domain (TIM) proteins are important regulators of T cell responses. Crystal structures of the murine TIM-4 identified a metal-ion-dependent ligand binding site (MILIBS) in the immunoglobulin (Ig) domain of the TIM family. The characteristic CC' loop of the TIM domain and the hydrophobic FG loop shaped a narrow cavity where acidic compounds penetrate and coordinate to a metal ion bound to conserved residues in the TIM proteins. The structure of phosphatidylserine bound to the Ig domain showed that the hydrophilic head penetrates into the MILIBS and coordinates with the metal ion, whereas the aromatic residues on the tip of the FG loop interacted with the fatty acid chains and could insert into the lipid bilayer. Our results also revealed an important role of the MILIBS in the trafficking of TIM-1 to the cell surface.	[Santiago, Cesar; Ballesteros, Angela; Martinez-Munoz, Laura; Mellado, Mario; Casasnovas, Jose M.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Kaplan, Gerardo G.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); US Food & Drug Administration (FDA); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Casasnovas, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma, Madrid 28049, Spain.	jcasasnovas@cnb.uam.es	Freeman, Gordon/AAC-5380-2019; Martínez-Muñoz, Laura/C-2719-2017; Santiago, César/K-4240-2014; Casasnovas, Jose M/L-6299-2014; Mellado, Mario/M-9893-2014	Freeman, Gordon/0000-0002-7210-5616; Martínez-Muñoz, Laura/0000-0003-3098-279X; Santiago, César/0000-0002-5149-1722; Casasnovas, Jose M/0000-0002-2873-6410; Mellado, Mario/0000-0001-6325-1630; Ballesteros Morcillo, Angela/0000-0001-5796-6875; kaplan, gerardo/0000-0003-3303-7259	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456] Funding Source: NIH RePORTER; NIAID NIH HHS [AI054456, P01 AI054456, P01 AI054456-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Feigelstock D, 1998, J VIROL, V72, P6621, DOI 10.1128/JVI.72.8.6621-6628.1998; Han Won K, 2004, Curr Opin Crit Care, V10, P476, DOI 10.1097/01.ccx.0000145095.90327.f2; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kuchroo VK, 2006, ADV IMMUNOL, V91, P227, DOI 10.1016/S0065-2776(06)91006-2; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Silberstein E, 2003, J VIROL, V77, P8765, DOI 10.1128/JVI.77.16.8765-8774.2003; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vila MR, 2004, KIDNEY INT, V65, P1761, DOI 10.1111/j.1523-1755.2004.00601.x; Wilker PR, 2007, INT IMMUNOL, V19, P763, DOI 10.1093/intimm/dxm044; WILLIAMSON P, 1992, BIOCHEMISTRY-US, V31, P6355, DOI 10.1021/bi00142a027; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	36	166	180	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					941	951		10.1016/j.immuni.2007.11.008	http://dx.doi.org/10.1016/j.immuni.2007.11.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18083575	Green Accepted, Bronze			2022-12-18	WOS:000251907300013
J	Olivera, A; Mizugishi, K; Tikhonova, A; Ciaccia, L; Odom, S; Proia, RL; Rivera, J				Olivera, Ana; Mizugishi, Kiyomi; Tikhonova, Anastassia; Ciaccia, Laura; Odom, Sandra; Proia, Richard L.; Rivera, Juan			The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis	IMMUNITY			English	Article							FC-EPSILON-RI; PROTEIN-KINASE-C; KAPPA-B ACTIVATION; CYTOKINE PRODUCTION; CALCIUM MOBILIZATION; GENE-EXPRESSION; MICE DEFICIENT; RBL-2H3 CELLS; FYN KINASE; 1-PHOSPHATE	Sphingosine-1-phosphate,a key mediator in immune cell trafficking, is elevated in the lungs of asthmatic patients and regulates pulmonary epithelium permeability. Stimulation of mast cells by allergens induces two mammalian sphingosine kinases (Sphk1 and Sphk2) to produce sphingosine-1-phosphate (S1P). Little is known about the individual role of these kinases in regulating immune cell function. Here we show that in mast cells, Sphk2 is required for production of S1P, for calcium influx, for activation of protein kinase C, and for cytokine production and degranulation. However, susceptibility to in vivo anaphylaxis is determined both by S1P within the mast cell compartment and by circulating S1P generated by Sphk1 predominantly from a non-mast cell source(s). Thus, sphingosine kinases are determinants of mast cell responsiveness, demonstrating a previously unrecognized relationship with anaphylaxis.	NIAMS, Mol Immunol & Inflammat Branch, Mol Inflammat Sect, NIH, Bethesda, MD 20892 USA; NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rivera, J (corresponding author), NIAMS, Mol Immunol & Inflammat Branch, Mol Inflammat Sect, NIH, Bethesda, MD 20892 USA.	riveraj@mail.nih.gov	Proia, Richard L/A-7908-2012; Tikhonova, Anastasia/F-1186-2015	Proia, Richard/0000-0003-0456-1270	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041155, ZIAAR041155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056015, ZIADK056015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Birchwood CJ, 2001, J BIOL CHEM, V276, P11712, DOI 10.1074/jbc.M010221200; Blom T, 2005, CELL SIGNAL, V17, P827, DOI 10.1016/j.cellsig.2004.11.022; Choi OH, 1996, NATURE, V380, P634; Condrescu M, 2002, ANN NY ACAD SCI, V976, P214; Edsall L, 2000, METHOD ENZYMOL, V312, P9; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Lee HS, 2005, CELL CALCIUM, V38, P581, DOI 10.1016/j.ceca.2005.08.002; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Mathes C, 1998, J BIOL CHEM, V273, P25020, DOI 10.1074/jbc.273.39.25020; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Melendez AJ, 2002, J BIOL CHEM, V277, P17255, DOI 10.1074/jbc.M110944200; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Michell RH, 1992, CIBA FDN S, V164, P2; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Olivera A, 2005, J IMMUNOL, V174, P1153, DOI 10.4049/jimmunol.174.3.1153; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Prieschl EE, 1999, J EXP MED, V190, P1, DOI 10.1084/jem.190.1.1; Pumphrey R, 2004, CURR OPIN ALLERGY CL, V4, P285, DOI 10.1097/01.all.0000136762.89313.0b; Rivera J, 2006, TRENDS IMMUNOL, V27, P251, DOI 10.1016/j.it.2006.04.001; Rivera J, 2006, NAT MED, V12, P999, DOI 10.1038/nm0906-999; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Saito H, 2005, CHEM IMMUNOL ALLERGY, V87, P198, DOI 10.1159/000087645; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Titievsky A, 1998, J BIOL CHEM, V273, P242, DOI 10.1074/jbc.273.1.242; Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	56	166	171	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					287	297		10.1016/j.immuni.2007.02.008	http://dx.doi.org/10.1016/j.immuni.2007.02.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17346996	Bronze			2022-12-18	WOS:000245228100006
J	Van Molle, W; Wielockx, B; Mahieu, T; Takada, M; Taniguchi, T; Sekikawa, K; Libert, C				Van Molle, W; Wielockx, B; Mahieu, T; Takada, M; Taniguchi, T; Sekikawa, K; Libert, C			HSP70 protects against TNF-induced lethal inflammatory shock	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; WHOLE-BODY HYPERTHERMIA; ISOLATED LIMB PERFUSION; FACTOR-ALPHA; ALPHA(1)-ACID GLYCOPROTEIN; MOLECULAR CHAPERONES; APAF-1 APOPTOSOME; RECOMBINANT HUMAN; IN-VIVO; HEAT	The heat shock (HS) response is a universal response activated after exposure to various stimuli. The major HS protein (HSP) is the 72 kDa HSP70 with strong homology in different eukaryotic species. We demonstrate that HS treatment of mice leads to a strong induction of HSP70 in several organs and confers significant protection against lethality induced by tumor necrosis factor (TNF). HS prevents high production of interleukin-6 and nitric oxide and reduces severe damage and apoptosis of the enterocytes in the bowel. Mice deficient in the inducible hsp70.1 gene were no longer protected by HS treatment. We show that HS can be applied successfully in an antitumor protocol based on TNF and interferon-gamma, leading to a significant inhibition of lethality but not to a reduction of antitumoral capacity.	Flanders Interuniv Inst Biotechnol, Dept Biol Mol, Unit Mouse Mol Genet, B-9000 Ghent, Belgium; Univ Ghent, B-9000 Ghent, Belgium; Natl Inst Agrobiol Sci, Dept Mol Biol & Immunol, Tsukuba, Ibaraki 3058602, Japan	Ghent University; National Institute of Agrobiological Sciences - Japan	Libert, C (corresponding author), Flanders Interuniv Inst Biotechnol, Dept Biol Mol, Unit Mouse Mol Genet, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	claude.libert@dmb.rug.ac.be	Libert, Claude/A-6504-2010; Wielockx, Ben/AAC-6854-2020	Wielockx, Ben/0000-0002-4923-2596				Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; ALEXANDROVA M, 1992, J STEROID BIOCHEM, V42, P493, DOI 10.1016/0960-0760(92)90261-G; ALLEN RL, 1988, MOL CELL BIOL, V8, P828, DOI 10.1128/MCB.8.2.828; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BROUCKAERT PGG, 1986, INT J CANCER, V38, P763, DOI 10.1002/ijc.2910380521; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; COVERT JB, 1977, NATURE, V267, P43, DOI 10.1038/267043a0; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; CREECH O, 1958, ANN SURG, V148, P616, DOI 10.1097/00000658-195810000-00009; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; DOMANICO SZ, 1993, MOL CELL BIOL, V13, P3598, DOI 10.1128/MCB.13.6.3598; Eggermont AMM, 1998, ANTICANCER RES, V18, P3899; Emery P, 2001, HOSP MED, V62, P150, DOI 10.12968/hosp.2001.62.3.1534; Fox ES, 1996, SHOCK, V5, P429, DOI 10.1097/00024382-199606000-00007; FUJIO N, 1987, J BIOCHEM-TOKYO, V101, P181, DOI 10.1093/oxfordjournals.jbchem.a121889; GIEBEL LB, 1988, DEV BIOL, V125, P200, DOI 10.1016/0012-1606(88)90073-5; GRIESS P, 1879, BER DTSCH CHEM GES, V1, P426; HOTCHKISS R, 1993, AM J PHYSIOL, V265, pR1447, DOI 10.1152/ajpregu.1993.265.6.R1447; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Hunger RE, 1997, EUR J IMMUNOL, V27, P255, DOI 10.1002/eji.1830270138; HUNT CR, 1993, GENOMICS, V16, P193, DOI 10.1006/geno.1993.1158; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; JAATTELA M, 1989, EUR J IMMUNOL, V19, P1413, DOI 10.1002/eji.1830190810; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; KOZUTSUMI Y, 1989, J CELL SCI, P115; Kume M, 1996, J LAB CLIN MED, V128, P251, DOI 10.1016/S0022-2143(96)90026-8; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LIBERT C, 1990, EUR J IMMUNOL, V20, P691, DOI 10.1002/eji.1830200333; LIBERT C, 1991, J IMMUNOTHER, V10, P227, DOI 10.1097/00002371-199108000-00001; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Libert C, 1996, J IMMUNOL, V157, P5126; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lorenz H M, 2000, Curr Opin Investig Drugs, V1, P188; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MARGULIS BA, 1991, DIABETES, V40, P1418, DOI 10.2337/diabetes.40.11.1418; MATSUMOTO M, 1990, BIOCHEM BIOPH RES CO, V166, P43, DOI 10.1016/0006-291X(90)91909-C; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mestril R, 1996, J MOL CELL CARDIOL, V28, P2351, DOI 10.1006/jmcc.1996.0228; MINOR DR, 1985, CANCER, V55, P2638, DOI 10.1002/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; NEILSON IR, 1989, SURGERY, V106, P439; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; Olieman AFT, 1999, ARCH SURG-CHICAGO, V134, P303, DOI 10.1001/archsurg.134.3.303; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; ROBINS HI, 1989, CANCER RES, V49, P1609; RYAN AJ, 1992, J APPL PHYSIOL, V73, P1517, DOI 10.1152/jappl.1992.73.4.1517; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Salgame P, 1997, NUCLEIC ACIDS RES, V25, P680, DOI 10.1093/nar/25.3.680; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Trost SU, 1998, J CLIN INVEST, V101, P855, DOI 10.1172/JCI265; Van Molle W, 1999, J IMMUNOL, V163, P5235; VanMolle W, 1997, J IMMUNOL, V159, P3555; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Watkins PE, 1997, GUT, V40, P628, DOI 10.1136/gut.40.5.628; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943	61	166	174	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2002	16	5					685	695		10.1016/S1074-7613(02)00310-2	http://dx.doi.org/10.1016/S1074-7613(02)00310-2			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049720	Bronze			2022-12-18	WOS:000175820400007
J	Fruman, DA; Satterthwaite, AB; Witte, ON				Fruman, DA; Satterthwaite, AB; Witte, ON			Xid-like phenotypes: A B cell signalosome takes shape	IMMUNITY			English	Review							PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASE; DEFICIENT MICE; IMMUNODEFICIENCY; P85-ALPHA; BLNK		Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Harold C Simmons Arthrit Res Ctr, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Witte, ON (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.							Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	19	166	217	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					1	3		10.1016/S1074-7613(00)00002-9	http://dx.doi.org/10.1016/S1074-7613(00)00002-9			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933389	Bronze			2022-12-18	WOS:000088463600001
J	Latek, RR; Suri, A; Petzold, SJ; Nelson, CA; Kanagawa, O; Unanue, ER; Fremont, DH				Latek, RR; Suri, A; Petzold, SJ; Nelson, CA; Kanagawa, O; Unanue, ER; Fremont, DH			Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice	IMMUNITY			English	Article							A-BETA-CHAIN; BOUND SINGLE PEPTIDES; T-CELL RECEPTOR; CRYSTAL-STRUCTURE; AUTOIMMUNE-DISEASE; PROTEIN HLA-DR1; SIDE-CHAINS; COMPLEX; I-A(G7); MELLITUS	We have determined the crystal structure of I-A(g7), an integral component in murine type I diabetes development. Several features distinguish I-A(g7) from other non-autoimmune-associated MHC class II molecules, including novel peptide and heterodimer pairing interactions. The binding groove of I-A(g7) is unusual at both terminal ends, with a potentially solvent-exposed channel at the base of the P1 pocket and a widened entrance to the P9 pocket. Peptide binding studies with variants of the hen egg lysozyme I-A(g7) epitope HEL(11-25) support a comprehensive structure-based I-A(g7) binding motif. Residues critical for T cell recognition were investigated with a panel of HEL(11-25)-restricted clones, which uncovered P1 anchor-dependent structural variations. These results establish a framework for future experiments directed at understanding the role of I-A(g7) in autoimmunity.	Washington Univ, Sch Med, Mol Biophys Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Fremont, DH (corresponding author), Washington Univ, Sch Med, Mol Biophys Program, 660 S euclid Ave,Box 8118, St Louis, MO 63110 USA.	fremont@immunology.wustl.edu		Fremont, Daved/0000-0002-8544-2689				ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; Amor S, 1996, J IMMUNOL, V156, P3000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOEHNCKE WH, 1993, J IMMUNOL, V150, P331; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Carrasco-Marin E, 1999, P NATL ACAD SCI USA, V96, P8621, DOI 10.1073/pnas.96.15.8621; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; CARSON M, 1987, J MOL GRAPHICS, V5, P139; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; CHOI E, 1983, SCIENCE, V221, P283, DOI 10.1126/science.6407114; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; DENG HK, 1993, J EXP MED, V178, P1675, DOI 10.1084/jem.178.5.1675; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Harrison LC, 1997, J EXP MED, V185, P1013, DOI 10.1084/jem.185.6.1013; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nelson C A, 1999, Rev Immunogenet, V1, P47; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; NICHOLS A, 1991, PROTEINS, V11, P14; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; QUARTEYPAPAFIO R, 1995, J IMMUNOL, V154, P5567; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; REICH EP, 1994, J IMMUNOL, V152, P2279; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reizis B, 1997, INT IMMUNOL, V9, P43, DOI 10.1093/intimm/9.1.43; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SHIBATA K, 1992, P NATL ACAD SCI USA, V89, P3135, DOI 10.1073/pnas.89.7.3135; Singer SM, 1998, DIABETES, V47, P1570, DOI 10.2337/diabetes.47.10.1570; Smith A, 1998, PHARM SCI TECHNOL TO, V1, P188, DOI 10.1016/S1461-5347(98)00057-1; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Wong FS, 1999, CURR OPIN IMMUNOL, V11, P643, DOI 10.1016/S0952-7915(99)00031-X; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878	50	166	168	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2000	12	6					699	710		10.1016/S1074-7613(00)80220-4	http://dx.doi.org/10.1016/S1074-7613(00)80220-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329ZA	10894169	Bronze			2022-12-18	WOS:000087937300011
J	Villadangos, JA; Ploegh, HL				Villadangos, JA; Ploegh, HL			Proteolysis in MHC class II antigen presentation: Who's in charge?	IMMUNITY			English	Review							COMPLEX-CLASS-II; INVARIANT CHAIN FRAGMENT; HLA-DR MOLECULES; DENDRITIC CELLS; MICE LACKING; CATHEPSIN-L; PEPTIDE; DM; P41; DEGRADATION		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Walter & Eliza Hall Inst Med Res, Dept Immunol, Melbourne, Vic 3050, Australia	Harvard University; Harvard Medical School; Walter & Eliza Hall Institute	Ploegh, HL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.		Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891				ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; Bogyo M, 1998, NATURE, V396, P625, DOI 10.1038/25238; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; Castellino F, 1998, J IMMUNOL, V161, P4048; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COLLINS DS, 1991, J IMMUNOL, V147, P4054; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENG HK, 1993, J EXP MED, V178, P1675, DOI 10.1084/jem.178.5.1675; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Fineschi B, 1996, J IMMUNOL, V157, P3211; FINESCHI B, 1995, P NATL ACAD SCI USA, V92, P10257, DOI 10.1073/pnas.92.22.10257; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Geuze HJ, 1998, IMMUNOL TODAY, V19, P282, DOI 10.1016/S0167-5699(98)01269-9; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MALCHEREK G, 1995, J EXP MED, V181, P527, DOI 10.1084/jem.181.2.527; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moudgil KD, 1997, J IMMUNOL, V159, P2574; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; OGRINC T, 1993, FEBS LETT, V336, P555, DOI 10.1016/0014-5793(93)80875-U; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; SHI GP, 2000, IN PRESS J EXP MED; Stebbins CC, 1996, J IMMUNOL, V157, P4892; STEBBINS CC, 1995, J EXP MED, V181, P223, DOI 10.1084/jem.181.1.223; TAKAESU NT, 1995, IMMUNITY, V3, P385, DOI 10.1016/1074-7613(95)90122-1; Tan LJ, 1997, EUR J IMMUNOL, V27, P1479, DOI 10.1002/eji.1830270626; Villadangos JA, 2000, EMBO J, V19, P882, DOI 10.1093/emboj/19.5.882; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WERDELIN O, 1986, SCAND J IMMUNOL, V24, P625, DOI 10.1111/j.1365-3083.1986.tb02181.x; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	60	166	178	3	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					233	239		10.1016/S1074-7613(00)80176-4	http://dx.doi.org/10.1016/S1074-7613(00)80176-4			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755610	Bronze			2022-12-18	WOS:000086292100001
J	Bain, G; Maandag, ECR; Riele, HPJT; Feeney, AJ; Sheehy, A; Schlissel, M; Shinton, SA; Hardy, RR; Murre, C				Bain, G; Maandag, ECR; Riele, HPJT; Feeney, AJ; Sheehy, A; Schlissel, M; Shinton, SA; Hardy, RR; Murre, C			Both E12 and E47 allow commitment to the B cell lineage	IMMUNITY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; LOOP-HELIX PROTEINS; DNA-BINDING; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; DIFFERENTIATION; EXPRESSION; ENHANCER; MICE; E2A	The E2A gene products, E12 and E47, are required for proper B cell development. Mice lacking the E2A gene products generate only a very small number of 8220(+) cells, which lack immunoglobulin DJ(H) rearrangements. We have now generated mice expressing either E12 or E47. B cell development in mice expressing E12 but lacking E47 is perturbed at the pro-B cell stage, and these mice lack IgM(+)B220(+) B cells in both bone marrow and spleen. IgM(+)B220(+) B cells can be detected, albeit at significantly reduced levels, in the bone marrow and spleen of mice lacking E12. Ectopic expression of both E12 and E47 in a null mutant background shows that E12 and E47 act in concert to promote B lineage development. Taken together, the data indicate that both E12 and E47 allow commitment to the B cell lineage and act synergistically to promote B lymphocyte maturation.	NETHERLANDS CANC INST, DEPT MOL GENET, NL-1066 CX AMSTERDAM, NETHERLANDS; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; FOX CHASE CANC CTR, INST CANC RES, PHILADELPHIA, PA 19111 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MOL BIOL & GENET, BALTIMORE, MD 21205 USA	Netherlands Cancer Institute; Scripps Research Institute; Fox Chase Cancer Center; Johns Hopkins University; Johns Hopkins University	Bain, G (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.			Bain, Gretchen/0000-0001-7513-9486	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI126782, R01AI026782] Funding Source: NIH RePORTER; NIAID NIH HHS [AI26782] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FEENEY AJ, 1991, J IMMUNOL, V147, P4343; FEENEY AJ, 1992, J IMMUNOL, V149, P222; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; JACOBS Y, 1993, MOL CELL BIOL, V13, P7321, DOI 10.1128/MCB.13.12.7321; Kee BL, 1996, CURR BIOL, V6, P1159, DOI 10.1016/S0960-9822(02)70683-0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Massari ME, 1996, MOL CELL BIOL, V16, P121; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; XIN XQ, 1994, J IMMUNOL, V152, P16351; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	43	166	167	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1997	6	2					145	154		10.1016/S1074-7613(00)80421-5	http://dx.doi.org/10.1016/S1074-7613(00)80421-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC616	9047236	hybrid			2022-12-18	WOS:A1997XC61600004
J	Lucas, B; Germain, RN				Lucas, B; Germain, RN			Unexpectedly complex regulation of CD4/CD8 coreceptor expression supports a revised model for CD4(+)CD8(+) thymocyte differentiation	IMMUNITY			English	Article							T-CELL RECEPTOR; POSITIVE SELECTION; LINEAGE COMMITMENT; CD8 LINEAGE; NEGATIVE SELECTION; INTERMEDIATE STEPS; INSTRUCTIVE MODEL; THYMIC SELECTION; CLONAL DELETION; DEFICIENT MICE	CD4(+)CD8(+)TCR(lo) thymocytes are the precursors of CD4(+) and CD8(+) mature T cells, whose receptors show specific recognition of peptide-MHC class II and MHC class I complexes, respectively. How T cells emerge from the intrathymic differentiation process with selective expression of either CD8 molecule or CD4 molecule coordinated with the MHC class specificity of the TCR has been the subject of intense examination. Many previous studies of this question have been based on the assumption that extinction of CD4 or CD8 expression by the precursor thymocytes was a steady, uninterrupted process. Here we show that this is an incorrect assumption, with CD4 and CD8 expression undergoing an unexpectedly complex series of expression changes involving down-modulation, kinetically asymmetric up-regulation, and then selective loss. Based on these data, we propose a model for the differentiation pathway of alpha beta TCR thymocytes that explains previous, apparently contradictory findings and establishes useful parameters for future studies at the cellular and gene level.			Lucas, B (corresponding author), NIAID,LYMPHOCYTE BIOL SECT,IMMUNOL LAB,NIH,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	LUCAS, Bruno/0000-0002-0322-3977				BARON A, 1994, EUR J IMMUNOL, V24, P1933, DOI 10.1002/eji.1830240834; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHAN SH, 1993, IMMUNOL REV, V135, P119, DOI 10.1111/j.1600-065X.1993.tb00646.x; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Davis CB, 1995, INT IMMUNOL, V7, P1977, DOI 10.1093/intimm/7.12.1977; DAVIS CB, 1994, CURR OPIN IMMUNOL, V6, P266, DOI 10.1016/0952-7915(94)90100-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FOWLKES BJ, 1985, J EXP MED, V162, P802, DOI 10.1084/jem.162.3.802; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KERSH GJ, 1995, J IMMUNOL, V154, P1057; KISHIMOTO H, 1995, J EXP MED, V181, P649, DOI 10.1084/jem.181.2.649; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KYDD R, 1995, J IMMUNOL, V155, P3806; LUCAS B, 1995, J EXP MED, V181, P1623, DOI 10.1084/jem.181.5.1623; Lucas B, 1996, J IMMUNOL, V156, P1743; LUCAS B, 1993, J IMMUNOL, V151, P4574; LUCAS B, 1994, J IMMUNOL, V153, P53; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; LUNDBERG K, 1994, J EXP MED, V179, P1475, DOI 10.1084/jem.179.5.1475; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; MANNIE MD, 1995, J IMMUNOL, V154, P2642; MARODON G, 1994, EUR J IMMUNOL, V24, P196, DOI 10.1002/eji.1830240131; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; NAKAYAMA T, 1993, P NATL ACAD SCI USA, V90, P10534, DOI 10.1073/pnas.90.22.10534; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OHAKA Y, 1996, INT IMMUNOL, V8, P297; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; PAGE DM, 1994, P NATL ACAD SCI USA, V91, P4057, DOI 10.1073/pnas.91.9.4057; PENIT C, 1995, J IMMUNOL, V154, P5103; PENIT C, 1989, J IMMUNOL, V142, P3369; PENIT C, 1986, J IMMUNOL, V137, P2115; PETRIE HT, 1993, J IMMUNOL, V151, P1273; RAVICHANDRAN KS, 1994, J EXP MED, V179, P727, DOI 10.1084/jem.179.2.727; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SCOLLAY R, 1995, TODAY, V16, P268; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SPAIN LM, 1994, J IMMUNOL, V152, P1709; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; van Meerwijk J P, 1994, Semin Immunol, V6, P231, DOI 10.1006/smim.1994.1030; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VANMEERWIJK JPM, 1995, J IMMUNOL, V154, P6314; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; VONBOEHMER H, 1988, IMMUNOL REV, V101, P21; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZUNIGAPFLUCKER JC, 1989, NATURE, V338, P76, DOI 10.1038/338076a0; ZUNIGAPFLUCKER JC, 1990, J EXP MED, V171, P427, DOI 10.1084/jem.171.2.427	67	166	167	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1996	5	5					461	477		10.1016/S1074-7613(00)80502-6	http://dx.doi.org/10.1016/S1074-7613(00)80502-6			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VV658	8934573	Bronze			2022-12-18	WOS:A1996VV65800007
J	Maizels, RM; Smits, HH; McSorley, HJ				Maizels, Rick M.; Smits, Hermelijn H.; McSorley, Henry J.			Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules	IMMUNITY			English	Review							MIGRATION INHIBITORY FACTOR; GROWTH-FACTOR-BETA; ALLERGIC AIRWAY INFLAMMATION; CYSTEINE PROTEASE INHIBITOR; MANSONI EGG ANTIGENS; MUCIN-LIKE PEPTIDE; SCHISTOSOMA-MANSONI; INTESTINAL INFLAMMATION; DENDRITIC CELLS; PRODUCT ES-62	Helminths are extraordinarily successful parasites due to their ability to modulate the host immune response. They have evolved a spectrum of immunomodulatory molecules that are now beginning to be defined, heralding a molecular revolution in parasite immunology. These discoveries have the potential both to transform our understanding of parasite adaptation to the host and to develop possible therapies for immune-mediated disease. In this review we will summarize the current state of the art in parasite immunomodulation and discuss perspectives on future areas for research and discovery.	[Maizels, Rick M.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Smits, Hermelijn H.] Leiden Univ, Med Ctr, Leiden, Netherlands; [McSorley, Henry J.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh	Maizels, RM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland.; Smits, HH (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.; McSorley, HJ (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	rick.maizels@glasgow.ac.uk; h.h.smits@lumc.nl; henry.mcsorley@ed.ac.uk	Smits, Hermelijn/V-4216-2018	Smits, Hermelijn/0000-0001-9279-2890; McSorley, Henry/0000-0003-1300-7407	Wellcome Trust [106122]; Kenneth Rainin Foundation [2016-3067]; Wellcome Centre for Molecular Parasitology [104111]; ZonMW-VIDI grant from the Netherlands Organisation for Scientific Research [91714352]; Netherlands Lung Foundation [5115015]; Netherlands Lung Foundation Accelerate Programme [12017001]	Wellcome Trust(Wellcome TrustEuropean Commission); Kenneth Rainin Foundation; Wellcome Centre for Molecular Parasitology; ZonMW-VIDI grant from the Netherlands Organisation for Scientific Research; Netherlands Lung Foundation; Netherlands Lung Foundation Accelerate Programme	R.M.M. is supported by the Wellcome Trust through an Investigator Award (106122), by the Kenneth Rainin Foundation (2016-3067), and by core funding to the Wellcome Centre for Molecular Parasitology (104111). H.H.S. is supported by a ZonMW-VIDI grant (91714352) from the Netherlands Organisation for Scientific Research and a Consortium Grant (5115015) from the Netherlands Lung Foundation. R.M.M., H.H.S., and H.J.M. are supported by a Consortium grant (12017001) from the Netherlands Lung Foundation Accelerate Programme.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Al-Riyami L, 2013, J MED CHEM, V56, P9982, DOI 10.1021/jm401251p; Alvarado R, 2017, FASEB J, V31, P85, DOI 10.1096/fj.201500093R; Ambadapadi S, 2016, J BIOL CHEM, V291, P2874, DOI 10.1074/jbc.M115.704841; Anbu KA, 2008, PARASITE IMMUNOL, V30, P23, DOI 10.1111/j.1365-3024.2007.00995.x; Antunes MFP, 2015, J HELMINTHOL, V89, P367, DOI 10.1017/S0022149X14000200; Araujo CA, 2008, CYTOKINE, V44, P335, DOI 10.1016/j.cyto.2008.09.005; Ball DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22716-9; Baska P, 2013, EXP PARASITOL, V133, P472, DOI 10.1016/j.exppara.2013.01.006; Beall MJ, 2001, J BIOL CHEM, V276, P31613, DOI 10.1074/jbc.M104685200; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; Chhabra S, 2014, FASEB J, V28, P3952, DOI 10.1096/fj.14-251967; Cho MK, 2015, PARASITE IMMUNOL, V37, P180, DOI 10.1111/pim.12172; Coakley G, 2017, CELL REP, V19, P1545, DOI 10.1016/j.celrep.2017.05.001; Coghlan A, 2019, NAT GENET, V51, P163, DOI 10.1038/s41588-018-0262-1; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Coronado S, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12425; Crowe J, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12410; Cuellar C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000439; Culley FJ, 2000, J IMMUNOL, V165, P6447, DOI 10.4049/jimmunol.165.11.6447; Da'dara AA, 2014, PEERJ, V2, DOI 10.7717/peerj.316; Dainichi T, 2001, INFECT IMMUN, V69, P7380, DOI 10.1128/IAI.69.12.7380-7386.2001; Danilowicz-Luebert E, 2013, INT J PARASITOL, V43, P201, DOI 10.1016/j.ijpara.2012.10.014; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Deehan MR, 2001, J IMMUNOL, V166, P7462, DOI 10.4049/jimmunol.166.12.7462; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Doonan J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01016; Driss V, 2016, MUCOSAL IMMUNOL, V9, P322, DOI 10.1038/mi.2015.62; Eichenberger RM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00850; Elzoheiry M, 2018, THROMB HAEMOSTASIS, V118, P979, DOI 10.1055/s-0038-1641715; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Falcon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114505; Faveeuw C, 2003, EUR J IMMUNOL, V33, P1271, DOI 10.1002/eji.200323717; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Ferreira IB, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.42; Fleming J, 2019, MULT SCLER J, V25, P81, DOI 10.1177/1352458517736377; Franchini GR, 2015, PROSTAG LEUKOTR ESS, V93, P31, DOI 10.1016/j.plefa.2014.08.003; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Gomez-Escobar N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-8; Goodridge HS, 2007, PARASITE IMMUNOL, V29, P127, DOI 10.1111/j.1365-3024.2006.00926.x; Gounaris K, 2004, MOL BIOCHEM PARASIT, V136, P257, DOI 10.1016/j.molbiopara.2004.04.008; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Haeberlein S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006539; Hagen J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6375; Hams E, 2016, FASEB J, V30, P824, DOI 10.1096/fj.15-277822; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; Hartmann W, 2015, EUR J IMMUNOL, V45, P2568, DOI 10.1002/eji.201545503; Hewitson JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003492; Hokke CH, 2017, MOL BIOCHEM PARASIT, V215, P47, DOI 10.1016/j.molbiopara.2016.12.001; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; Jang SW, 2011, KOREAN J PARASITOL, V49, P245, DOI 10.3347/kjp.2011.49.3.245; Johnston CJC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01886-6; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Kaiser MMM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005504; Kaur I, 2011, INFECT IMMUN, V79, P1779, DOI 10.1128/IAI.01048-10; Ke XD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1962-y; Kemmer A, 2015, EXP DERMATOL, V24, P872, DOI 10.1111/exd.12804; Kim JY, 2010, MOL BIOCHEM PARASIT, V174, P53, DOI 10.1016/j.molbiopara.2010.06.014; Kron MA, 2013, CLIN VACCINE IMMUNOL, V20, P276, DOI 10.1128/CVI.00594-12; Laan LC, 2017, FASEB J, V31, P719, DOI 10.1096/fj.201600841R; Leontovyc A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006446; LIU LX, 1992, AM J TROP MED HYG, V46, P520, DOI 10.4269/ajtmh.1992.46.520; Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002; Makou E, 2015, BIOCHEM SOC T, V43, P812, DOI 10.1042/BST20150074; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Maric J, 2018, J ALLERGY CLIN IMMUN, V141, P1761, DOI 10.1016/j.jaci.2017.09.050; Martin I, 2015, J IMMUNOL, V194, P3924, DOI 10.4049/jimmunol.1401182; Martinez-Colon GJ, 2018, PHARMACOL THERAPEUT, V185, P135, DOI 10.1016/j.pharmthera.2017.12.008; Martinez-Sernandez V, 2017, J BIOL CHEM, V292, P8667, DOI 10.1074/jbc.M116.771675; Mbanefo EC, 2018, FASEB J, V32, P4408, DOI 10.1096/fj.201701415R; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Mebius MM, 2018, MOL BIOCHEM PARASIT, V221, P10, DOI 10.1016/j.molbiopara.2018.02.001; Mebius MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003781; Meenan NAG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001040; Meevissen MHJ, 2012, EXP PARASITOL, V132, P14, DOI 10.1016/j.exppara.2011.05.005; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Navarro S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8807; Nono JK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002632; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; Noya V, 2016, PARASITOL RES, V115, P1053, DOI 10.1007/s00436-015-4834-z; Noya V, 2017, SCI REP-UK, V7, DOI 10.1038/srep40615; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Okano M, 1999, J IMMUNOL, V163, P6712; Osbourn M, 2017, IMMUNITY, V47, P739, DOI 10.1016/j.immuni.2017.09.015; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; Pennington LF, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00301-17; Pfaff AW, 2002, INT J PARASITOL, V32, P171, DOI 10.1016/S0020-7519(01)00350-2; Pineda MA, 2014, MOL BIOCHEM PARASIT, V194, P1, DOI 10.1016/j.molbiopara.2014.03.003; Prieto-Lafuente L, 2009, J LEUKOCYTE BIOL, V85, P844, DOI 10.1189/jlb.0808459; Ramos-Benitez MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05735-w; Ranasinghe SL, 2017, TRENDS PARASITOL, V33, P400, DOI 10.1016/j.pt.2016.12.013; Ranasinghe SL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1022-z; Retra K, 2015, INT J PARASITOL, V45, P629, DOI 10.1016/j.ijpara.2015.03.011; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Robb CT, 2018, J ALLERGY CLIN IMMUN, V141, P152, DOI 10.1016/j.jaci.2017.04.045; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Rodriguez E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00264; Rzepecka J, 2014, INT J PARASITOL, V44, P669, DOI 10.1016/j.ijpara.2014.05.001; Scholmerich J, 2017, J CROHNS COLITIS, V11, P390, DOI 10.1093/ecco-jcc/jjw184; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; Sikri N, 2007, TEX HEART I J, V34, P318; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Smout MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005209; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; Smyth DJ, 2018, INT J PARASITOL, V48, P379, DOI 10.1016/j.ijpara.2017.12.004; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Suckling CJ, 2018, ACTA TROP, V185, P212, DOI 10.1016/j.actatropica.2018.05.015; Sulaiman AA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005991; Sun X, 2016, PARASITOL RES, V115, P4559, DOI 10.1007/s00436-016-5247-3; Sun YX, 2013, IMMUNOLOGY, V138, P370, DOI 10.1111/imm.12049; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Terrazas LI, 2001, J IMMUNOL, V167, P5294, DOI 10.4049/jimmunol.167.9.5294; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Tribolet L, 2015, J INFECT DIS, V211, P416, DOI 10.1093/infdis/jiu451; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vaux R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005998; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Vermeire JJ, 2008, TRENDS PARASITOL, V24, P355, DOI 10.1016/j.pt.2008.04.007; Wang LF, 2015, PARASITOL RES, V114, P1865, DOI 10.1007/s00436-015-4373-7; Wang Q, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2704-0; Wang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13141-5; Wang SS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1288-1; Wangchuk P., 2018, BIORXIV, DOI [10.1101/316885, DOI 10.1101/316885]; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Wilbers RHP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007300; Wilbers RHP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45910; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Zaccone P, 2011, EUR J IMMUNOL, V41, P2709, DOI 10.1002/eji.201141429; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zang XX, 2002, J BIOL CHEM, V277, P44261, DOI 10.1074/jbc.M204655200; Zarowiecki M, 2015, PARASITOLOGY, V142, pS85, DOI 10.1017/S0031182014001449; Zavala-Gongora R, 2006, MOL BIOCHEM PARASIT, V146, P265, DOI 10.1016/j.molbiopara.2005.12.011; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407; Ziegler T, 2015, J IMMUNOL, V194, P1555, DOI 10.4049/jimmunol.1401217	149	165	166	4	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					801	818		10.1016/j.immuni.2018.10.016	http://dx.doi.org/10.1016/j.immuni.2018.10.016			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462997	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000450752200008
J	Metidji, A; Omenetti, S; Crotta, S; Li, Y; Nye, E; Ross, E; Li, V; Maradana, MR; Schiering, C; Stockinger, B				Metidji, Amina; Omenetti, Sara; Crotta, Stefania; Li, Ying; Nye, Emma; Ross, Ellie; Li, Vivian; Maradana, Muralidhara R.; Schiering, Chris; Stockinger, Brigitta			The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; COLORECTAL-CANCER; DIOXIN RECEPTOR; LIGANDS; INDOLE-3-CARBINOL; SUSCEPTIBILITY; ACTIVATION; TRYPTOPHAN; NUTRITION; PATHWAYS	The epithelium and immune compartment in the intestine are constantly exposed to a fluctuating external environment. Defective communication between these compartments at this barrier surface underlies susceptibility to infections and chronic inflammation. Environmental factors play a significant, but mechanistically poorly understood, role in intestinal homeostasis. We found that regeneration of intestinal epithelial cells (IECs) upon injury through infection or chemical insults was profoundly influenced by the environmental sensor aryl hydrocarbon receptor (AHR). IEC-specific deletion of Ahr resulted in failure to control C. rodentium infection due to unrestricted intestinal stem cell (ISC) proliferation and impaired differentiation, culminating in malignant transformation. AHR activation by dietary ligands restored barrier homeostasis, protected the stem cell niche, and prevented tumorigenesis via transcriptional regulation of of Rnf43 and Znrf3, E3 ubiquitin ligases that inhibit Wnt-beta-catenin signaling and restrict ISC proliferation. Thus, activation of the AHR pathway in IECs guards the stem cell niche to maintain intestinal barrier integrity.	[Metidji, Amina; Omenetti, Sara; Crotta, Stefania; Li, Ying; Nye, Emma; Li, Vivian; Maradana, Muralidhara R.; Schiering, Chris; Stockinger, Brigitta] Francis Crick Inst, London NW1 1AT, England; [Ross, Ellie] Univ London, Royal Vet Coll, London, England; [Schiering, Chris] Imperial Coll, Hammersmith Hosp, Med Res Council London Inst Med Sci, London W12 0NN, England	Francis Crick Institute; University of London; University of London Royal Veterinary College; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Schiering, C; Stockinger, B (corresponding author), Francis Crick Inst, London NW1 1AT, England.; Schiering, C (corresponding author), Imperial Coll, Hammersmith Hosp, Med Res Council London Inst Med Sci, London W12 0NN, England.	c.schiering@lms.mrc.ac.uk; brigitta.stockinger@crick.ac.uk		Crotta, Stefania/0000-0003-4676-8616; Schiering, Chris/0000-0001-7902-6024; Metidji, Amina/0000-0003-2785-7023; Li, Vivian/0000-0003-2041-0085; Stockinger, Brigitta/0000-0001-8781-336X; Omenetti, Sara/0000-0002-2443-3631	Francis Crick Institute - Cancer Research UK [FC001159, FC001105]; UK Medical Research Council [FC001159, FC001105]; Wellcome Trust [FC001159, FC001105]; Wellcome Advanced Investigator Grant [100910/Z/13/Z]; CRUK cancer immunology project grant [19691]; Sir Henry Wellcome Fellowship [103156/B/13/Z]; Fondation Acteria award; MRC [MC_U117597139] Funding Source: UKRI	Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Advanced Investigator Grant; CRUK cancer immunology project grant; Sir Henry Wellcome Fellowship; Fondation Acteria award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001159 and FC001105), The UK Medical Research Council (FC001159 and FC001105), and the Wellcome Trust (FC001159 and FC001105). We would like to acknowledge the Biological Research Facility at the Francis Crick Institute for expert breeding and maintenance of our mouse strains, the Histopathology Facility for help with sections and staining, and the Flow Cytometry Facility and Cell Services for provision of organoid culture supernatants. We are grateful to Dr. Gad Frankel for rabbit antiserum against Citrobacter rodentium and for Citrobacter strain ICC169. The study was supported by a Wellcome Advanced Investigator Grant (100910/Z/13/Z) and a CRUK cancer immunology project grant (19691) to B.S. and a Sir Henry Wellcome Fellowship (103156/B/13/Z) and a Fondation Acteria award to C.S.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; [Anonymous], NATURE, V459, P262; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Borten MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18815-8; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Diaz-Diaz CJ, 2016, ANN SURG, V264, P429, DOI 10.1097/SLA.0000000000001874; Furumatsu K, 2011, DIGEST DIS SCI, V56, P2532, DOI 10.1007/s10620-011-1643-9; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jiang RQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-59; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kim YS, 2005, J NUTR BIOCHEM, V16, P65, DOI 10.1016/j.jnutbio.2004.10.007; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KLEMAN MI, 1994, J BIOL CHEM, V269, P5137; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Luecke-Johansson S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00630-16; Mayne ST, 2016, NAT REV CLIN ONCOL, V13, P504, DOI 10.1038/nrclinonc.2016.24; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mitchell KA, 2009, BIOCHEM PHARMACOL, V77, P947, DOI 10.1016/j.bcp.2008.10.028; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Potter JD, 1996, IARC SCI PUBL, P61; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Tsukiyama T, 2015, MOL CELL BIOL, V35, P2007, DOI 10.1128/MCB.00159-15; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754	44	165	169	11	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					353	+		10.1016/j.immuni.2018.07.010	http://dx.doi.org/10.1016/j.immuni.2018.07.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30119997	Green Published, hybrid			2022-12-18	WOS:000442354500019
J	Abbott, RK; Lee, JH; Menis, S; Skog, P; Rossi, M; Ota, T; Kulp, DW; Bhullar, D; Kalyuzhniy, O; Havenar-Daughton, C; Schief, WR; Nemazee, D; Crotty, S				Abbott, Robert K.; Lee, Jeong Hyun; Menis, Sergey; Skog, Patrick; Rossi, Meghan; Ota, Takayuki; Kulp, Daniel W.; Bhullar, Deepika; Kalyuzhniy, Oleksandr; Havenar-Daughton, Colin; Schief, William R.; Nemazee, David; Crotty, Shane			Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens	IMMUNITY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; IG KNOCKIN MICE; MATURATION PATHWAY; STRUCTURAL BASIS; IMMUNE-RESPONSE; MEMORY B; ANTIGEN; DESIGN; IMMUNODOMINANCE; IMMUNIZATION	How precursor frequencies and antigen affinities impact interclonal B cell competition is a particularly relevant issue for candidate germline-targeting HIV vaccine designs because of the in vivo rarity of naive B cells that recognize broadly neutralizing epitopes. Knowing the frequencies and affinities of HIV-specific VRC01-class naive human B cells, we transferred B cells with germline VRC01 B cell receptors into congenic recipients to elucidate the roles of precursor frequency, antigen affinity, and avidity on B cell responses following immunization. All three factors were interdependently limiting for competitive success of VRC01-class B cells. In physiological high-affinity conditions using a multivalent immunogen, rare VRC01-class B cells successfully competed in germinal centers (GC), underwent extensive somatic hypermutation, and differentiated into memory B cells. The data reveal dominant influences of precursor frequency, affinity, and avidity for interclonal GC competition and indicate that germline-targeting immunogens can overcome these challenges with high-affinity multimeric designs.	[Abbott, Robert K.; Lee, Jeong Hyun; Rossi, Meghan; Havenar-Daughton, Colin; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Abbott, Robert K.; Lee, Jeong Hyun; Menis, Sergey; Rossi, Meghan; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Havenar-Daughton, Colin; Schief, William R.; Crotty, Shane] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Menis, Sergey; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Menis, Sergey; Kulp, Daniel W.; Kalyuzhniy, Oleksandr; Schief, William R.] Scripps Res Inst, CAVD, La Jolla, CA 92037 USA; [Skog, Patrick; Ota, Takayuki; Bhullar, Deepika; Schief, William R.; Nemazee, David] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Kulp, Daniel W.] Wistar Inst Anat & Biol, Vaccine & Immune Therapy Ctr, Philadelphia, PA 19104 USA; [Schief, William R.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Schief, William R.] Harvard Univ, Cambridge, MA 02139 USA; [Crotty, Shane] Univ Calif San Diego, Div Infect Dis, Dept Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; The Wistar Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; University of California System; University of California San Diego	Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Schief, WR; Crotty, S (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, CAVD, La Jolla, CA 92037 USA.; Schief, WR; Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA.; Schief, WR (corresponding author), Harvard Univ, Cambridge, MA 02139 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Div Infect Dis, Dept Med, La Jolla, CA 92037 USA.	schief@scripps.edu; nemazee@scripps.edu; shane@lji.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Schief, William/ABF-3645-2020	Crotty, Shane/0000-0002-6484-6262; Schief, William/0000-0002-1120-0150; Abbott, Robert/0000-0003-0335-1175; Rossi, Meghan/0000-0002-2151-3230; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Lee, Jeong Hyun/0000-0001-7371-845X	NIH NIAID grants [R01 AI124796, CHAVI-ID UM1 AI100663, R01 AI073148, R01AI12883]; LJI T32 training grant [AI125179]; IAVI; USAID; Netherlands MFA; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI128836, T32AI125179, R01AI124796, UM1AI100663, R01AI073148] Funding Source: NIH RePORTER	NIH NIAID grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LJI T32 training grant; IAVI; USAID(United States Agency for International Development (USAID)); Netherlands MFA; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the members of the FACS and microscopy facilities at LJI (C. Kim, D. Hinz, L. Nosworthy, R. Simmons, Z. Mikulski, S. McArdle, and A. Lamberth) for outstanding expertise. This work was funded by NIH NIAID grants R01 AI124796 (S. C.), CHAVI-ID UM1 AI100663 (S. C., W.R.S.), R01 AI073148 (D.N., W.R.S.), and R01AI12883 (D.N.). RKA was funded by LJI T32 training grant (AI125179). This work was also funded by IAVI with support from USAID, Netherlands MFA, and Bill & Melinda Gates Foundation; a full list of IAVI donors is available at www.iavi.org (W.R.S).	Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Aoki-Ota M, 2012, J IMMUNOL, V188, P2305, DOI 10.4049/jimmunol.1103484; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Gotelli Nicholas J., 2011, P39; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; SIGAL NH, 1977, J IMMUNOL, V119, P1129; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	42	165	169	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					133	+		10.1016/j.immuni.2017.11.023	http://dx.doi.org/10.1016/j.immuni.2017.11.023			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29287996	Bronze, Green Accepted			2022-12-18	WOS:000422751600016
J	Teng, F; Klinger, CN; Felix, KM; Bradley, CP; Wu, E; Tran, NL; Umesaki, Y; Wu, HJJ				Teng, Fei; Klinger, Christina N.; Felix, Krysta M.; Bradley, C. Pierce; Wu, Eric; Tran, Nhan L.; Umesaki, Yoshinori; Wu, Hsin-Jung Joyce			Gut Microbiota Drive Autoimmune Arthritis by Promoting Differentiation and Migration of Peyer's Patch T Follicular Helper Cells	IMMUNITY			English	Article							T(H)17 CELLS; BACTERIA; RESPONSES; IGA; INTERLEUKIN-2; SPECIFICITY	Gut microbiota profoundly affect gut and systemic diseases, but the mechanism whereby microbiota affect systemic diseases is unclear. It is not known whether specific microbiota regulate T follicular helper (Tfh) cells, whose excessive responses can inflict antibody-mediated autoimmunity. Using the K/BxN autoimmune arthritis model, we demonstrated that Peyer's patch (PP) Tfh cells were essential for gut commensal segmented filamentous bacteria (SFB)-induced systemic arthritis despite the production of auto-antibodies predominantly occurring in systemic lymphoid tissues, not PPs. We determined that SFB, by driving differentiation and egress of PP Tfh cells into systemic sites, boosted systemic Tfh cell and auto-antibody responses that exacerbated arthritis. SFB induced PP Tfh cell differentiation by limiting the access of interleukin 2 to CD4(+) T cells, thereby enhancing Tfh cell master regulator Bcl-6 in a dendritic cell-dependent manner. These findings showed that gut microbiota remotely regulated a systemic disease by driving the induction and egress of gut Tfh cells.	[Teng, Fei; Klinger, Christina N.; Felix, Krysta M.; Bradley, C. Pierce; Wu, Eric; Tran, Nhan L.; Wu, Hsin-Jung Joyce] Univ Arizona, Dept Immunobiol, Tucson, AZ 85719 USA; [Wu, Hsin-Jung Joyce] Univ Arizona, Coll Med, Arizona Arthrit Ctr, Tucson, AZ 85719 USA; [Umesaki, Yoshinori] Yakult Cent Inst, Izumi 5-11, Tokyo, Japan	University of Arizona; University of Arizona; Yakult Honsha Company, Limited	Wu, HJJ (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85719 USA.; Wu, HJJ (corresponding author), Univ Arizona, Coll Med, Arizona Arthrit Ctr, Tucson, AZ 85719 USA.	joycewu@email.arizona.edu		Klinger, Christina/0000-0003-2547-1426	NIH [R56AI107117, R01AI107117]; Southwest Clinic and Research Institute Fund; Microbial Pathogenesis Program at the University of Arizona; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107117, R01AI107117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwest Clinic and Research Institute Fund; Microbial Pathogenesis Program at the University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Haochu Huang for the initial supply of rGPI. We thank Drs. Dominik Schenten, Vesna Pulko, and Taras Kreslavsky for comments about the manuscript and Ms. Kelly O'Callaghan for editing. This work was supported by grants from the NIH (R56AI107117 and R01AI107117) and by the Southwest Clinic and Research Institute Fund to H.-J.J.W. This work was also supported by funds from the Microbial Pathogenesis Program at the University of Arizona to H.-J.J.W.	Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chervonsky AV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007294; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; TANNOCK GW, 1984, APPL ENVIRON MICROB, V47, P441, DOI 10.1128/AEM.47.2.441-442.1984; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Urich E, 2006, P NATL ACAD SCI USA, V103, P18697, DOI 10.1073/pnas.0607283103; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	41	165	175	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					875	888		10.1016/j.immuni.2016.03.013	http://dx.doi.org/10.1016/j.immuni.2016.03.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096318	Green Accepted, Bronze			2022-12-18	WOS:000374444300018
J	Chittezhath, M; Dhillon, MK; Lim, JY; Laoui, D; Shalova, IN; Teo, YL; Chen, JM; Kamaraj, R; Raman, L; Lum, J; Thamboo, TP; Chiong, E; Zolezzi, F; Yang, H; Van Ginderachter, JA; Poidinger, M; Wong, ASC; Biswas, SK				Chittezhath, Manesh; Dhillon, Manprit Kaur; Lim, Jyue Yuan; Laoui, Damya; Shalova, Irina N.; Teo, Yi Ling; Chen, Jinmiao; Kamaraj, Revathy; Raman, Lata; Lum, Josephine; Thamboo, Thomas Paulraj; Chiong, Edmund; Zolezzi, Francesca; Yang, Henry; Van Ginderachter, Jo A.; Poidinger, Michael; Wong, Alvin S. C.; Biswas, Subhra K.			Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression	IMMUNITY			English	Article							NECROSIS-FACTOR-ALPHA; RENAL-CELL CARCINOMA; NF-KAPPA-B; ANGIOGENIC SWITCH; SUPPRESSOR-CELLS; MYELOID CELLS; INFLAMMATION; INTERLEUKIN-1-BETA; MOUSE; POLARIZATION	Monocytes and macrophages are major components of the tumor microenvironment, but their contributions to human cancer are poorly understood. We used molecular profiling combined with functional assays to investigate the role of these cells in human renal cell carcinoma (RCC). Blood monocytes from RCC patients displayed a tumor-promoting transcriptional profile that supported functions like angiogenesis and invasion. Induction of this protumor phenotype required an interleukin-1 receptor (IL-1R)-dependent mechanism. Indeed, targeting of IL-1-IL-1R axis in a human RCC xenograft model abrogated the protumor phenotype of tumor-associated macrophages (TAMs) and reduced tumor growth in vivo. Supporting this, meta-analysis of gene expression from human RCC tumors showed IL1B expression to correlate with myelomonocytic markers, protumor genes, and tumor staging. Analyzing RCC patient tumors confirmed the protumor phenotype of TAMs. These data provide direct evidence for a tumor-promoting role of monocytes and macrophages in human cancer and indicate IL-1-IL-1R as a possible therapeutic target.	[Chittezhath, Manesh; Dhillon, Manprit Kaur; Lim, Jyue Yuan; Shalova, Irina N.; Teo, Yi Ling; Chen, Jinmiao; Lum, Josephine; Zolezzi, Francesca; Yang, Henry; Poidinger, Michael; Biswas, Subhra K.] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Laoui, Damya; Van Ginderachter, Jo A.] VIB, Lab Myeloid Cell Immunol, B-1050 Brussels, Belgium; [Laoui, Damya; Van Ginderachter, Jo A.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [Kamaraj, Revathy; Raman, Lata; Chiong, Edmund] Natl Univ Hlth Syst, Dept Urol, Singapore 119074, Singapore; [Thamboo, Thomas Paulraj] Natl Univ Hlth Syst, Dept Pathol, Singapore 119074, Singapore; [Wong, Alvin S. C.] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore 119074, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; National University of Singapore; National University of Singapore; National University of Singapore	Biswas, SK (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	subhra_biswas@immunol.a-star.edu.sg	Van Ginderachter, Jo A/H-5473-2013; Chiong, Edmund/B-5775-2011; Chen, Jinmiao/ABE-5601-2021	Van Ginderachter, Jo A/0000-0002-4442-7474; Chiong, Edmund/0000-0002-5241-5000; Laoui, Damya/0000-0002-3373-1403; Poidinger, Michael/0000-0002-1047-2277	Singapore Immunology Network, A*STAR, Singapore; Venerable Yen Pei-National Kidney Foundation Research Fund, Singapore [NKFRC/2008/04]	Singapore Immunology Network, A*STAR, Singapore; Venerable Yen Pei-National Kidney Foundation Research Fund, Singapore	This work was supported by core funding from Singapore Immunology Network, A*STAR, Singapore (to S.K.B.) and the Venerable Yen Pei-National Kidney Foundation Research Fund, Singapore (to A.S.C.W., NKFRC/2008/04). We are grateful to the Health Sciences Authority, Singapore for their kind support with the blood supply; Mouse core, Flow Cytometry and Immunomonitoring platforms (SIgN), Biopolis Shared Facility (Imaging and Histopathology Units), and Biological Resource Center (A*STAR) for their kind support and service. We thank Alessandra Nardin for her helpful comments. We are grateful to M. Celeste Simon (Abramson Family Cancer Research Institute, University of Pennsylvania, US) for the generous gift of RCC4 cell line. Rajeev Singh and the Tissue Repository, Department of Pathology, NUHS, for their kind help. Neil McCarthy of Insight Editing London edited the manuscript.	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, J LEUKOCYTE BIOL, V88, P877, DOI 10.1189/jlb.0310153; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Caso R, 2010, INT J ONCOL, V37, P891, DOI 10.3892/ijo_00000740; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Cavnar MJ, 2013, J EXP MED, V210, P2873, DOI 10.1084/jem.20130875; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Chuang MJ, 2008, CANCER SCI, V99, P905, DOI 10.1111/j.1349-7006.2008.00756.x; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DOSQUET C, 1994, EUR J CANCER, V30A, P162, DOI 10.1016/0959-8049(94)90079-5; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GRANOWITZ EV, 1992, BLOOD, V79, P2356; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howlader N., 2000, SEER CANC STAT REV 1; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; KOO AS, 1992, CANCER IMMUNOL IMMUN, V35, P97, DOI 10.1007/BF01741856; Koul H, 2011, AM J CANCER RES, V1, P240; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Motzer RJ, 2007, J CLIN ONCOL, V25, P3958, DOI 10.1200/JCO.2006.10.5916; Motzer RJ, 2007, J UROLOGY, V178, P1883, DOI 10.1016/j.juro.2007.07.030; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; van Rossum AP, 2009, NETH J MED, V67, P191; Yang XMJ, 2005, CANCER RES, V65, P5628, DOI 10.1158/0008-5472.CAN-05-0533; Yoshida N, 2002, BRIT J CANCER, V86, P1396, DOI 10.1038/sj.bjc.6600257; Zhang QL, 2012, LECT NOTES CONTR INF, V421, P7	51	165	169	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					815	829		10.1016/j.immuni.2014.09.014	http://dx.doi.org/10.1016/j.immuni.2014.09.014			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25453823	Bronze			2022-12-18	WOS:000345504900017
J	Wu, C; Thalhamer, T; Franca, RF; Xiao, S; Wang, C; Hotta, C; Zhu, C; Hirashima, M; Anderson, AC; Kuchroo, VK				Wu, Chuan; Thalhamer, Theresa; Franca, Rafael F.; Xiao, Sheng; Wang, Chao; Hotta, Chie; Zhu, Chen; Hirashima, Mitsuomi; Anderson, Ana C.; Kuchroo, Vijay K.			Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; FOXP3 EXPRESSION; REG-CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; RETINOIC-ACID; IFN-GAMMA; INFLAMMATION	The beta-galactoside-binding protein galectin-9 is critical in regulating the immune response, but the mechanism by which it functions remains unclear. We have demonstrated that galectin-9 is highly expressed by induced regulatory T cells (iTreg) and was crucial for the generation and function of iTreg cells, but not natural regulatory T (nTreg) cells. Galectin-9 expression within iTreg cells was driven by the transcription factor Smad3, forming a feed-forward loop, which further promoted Foxp3 expression. Galectin-9 increased iTreg cell stability and function by directly binding to its receptor CD44, which formed a complex with transforming growth factor-beta (TGF-beta) receptor I (TGF-beta RI), and activated Smad3. Galectin-9 signaling was further found to regulate iTreg cell induction by dominantly acting through the CNS1 region of the Foxp3 locus. Our data suggest that exogenous galectin-9, in addition to being an effector molecule for Treg cells, acts synergistically with TGF-beta to enforce iTreg cell differentiation and maintenance.	[Wu, Chuan; Thalhamer, Theresa; Franca, Rafael F.; Xiao, Sheng; Wang, Chao; Hotta, Chie; Zhu, Chen; Anderson, Ana C.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Kagawa 7610793, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kagawa University	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Wang, Chao/GYD-5103-2022; Anderson, Ana C/ABD-6829-2021; Freitas de Oliveira Franca, Rafael/ABB-2376-2021; Wu, Chuan/H-6379-2013	Wang, Chao/0000-0003-3084-6093; Anderson, Ana C/0000-0002-0877-2932; Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Wu, Chuan/0000-0003-2288-353X	National Multiple Sclerosis Society [FG2046]; Austrian Science Fund (FWF) [J 3091-B12]; US National Institutes of Health [K01DK090105, P01AI073748, P01AI056299, P01AI039671, R01NS045937]; Sao Paulo Research Foundation FAPESP [2012/14924-7]; American Cancer Society [RSG-11-057-01-LIB]; Slomo and Cindy Silvian Foundation; Tempero Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, P01AI039671, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045937, R01NS030843] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); American Cancer Society(American Cancer Society); Slomo and Cindy Silvian Foundation; Tempero Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz for cell sorting. A. Rudensky provided the CNS1-deficient mice. C.W. was supported by a Postdoctoral Fellowship from the National Multiple Sclerosis Society (FG2046). T.T. was supported by the Austrian Science Fund (FWF, J 3091-B12). S.X. was supported by the US National Institutes of Health (K01DK090105). R.F.F. was supported by Sao Paulo Research Foundation FAPESP (2012/14924-7). A.C.A was supported by the American Cancer Society (RSG-11-057-01-LIB) and the Slomo and Cindy Silvian Foundation. V.K.K. was supported by the US National Institutes of Health (P01AI073748, P01AI056299, P01AI039671, and R01NS045937). V.K.K. is a founder of, and has financial interest in, Tempero Pharmaceuticals. The company has interests in research and therapy development in areas related to this research. V.K.K.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their conflict of interest policies.	Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Arikawa T, 2010, EUR J IMMUNOL, V40, P548, DOI 10.1002/eji.200939886; Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ferber IA, 1996, J IMMUNOL, V156, P5; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Kim HP, 2005, J BIOL CHEM, V280, P34042, DOI 10.1074/jbc.M505833200; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; PENDER MP, 1992, J AUTOIMMUN, V5, P401, DOI 10.1016/0896-8411(92)90001-7; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Reddy PBJ, 2011, J IMMUNOL, V187, P5745, DOI 10.4049/jimmunol.1102105; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Su EW, 2011, GLYCOBIOLOGY, V21, P1258, DOI 10.1093/glycob/cwq214; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Toker A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001783; Toms C, 2008, IMMUNOLOGY, V125, P302, DOI 10.1111/j.1365-2567.2008.02857.x; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	68	165	171	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					270	282		10.1016/j.immuni.2014.06.011	http://dx.doi.org/10.1016/j.immuni.2014.06.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25065622	Green Accepted, Bronze			2022-12-18	WOS:000341455300014
J	Hou, BD; Saudan, P; Ott, G; Wheeler, ML; Ji, M; Kuzmich, L; Lee, LM; Coffman, RL; Bachmann, MF; DeFranco, AL				Hou, Baidong; Saudan, Philippe; Ott, Gary; Wheeler, Matthew L.; Ji, Ming; Kuzmich, Lili; Lee, Linda M.; Coffman, Robert L.; Bachmann, Martin F.; DeFranco, Anthony L.			Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response	IMMUNITY			English	Article							VIRUS-LIKE PARTICLES; DENDRITIC CELLS; ANTIBODY-RESPONSES; HUMORAL IMMUNITY; ANTIGEN RECEPTOR; IMMUNOGENICITY; MECHANISMS; ADJUVANT; VACCINES; INNATE	The contribution of Toll-like receptor (TLR) signaling to T cell-dependent (TD) antibody responses was assessed by using mice lacking the TLR signaling adaptor MyD88 in individual cell types. When a soluble TLR9 ligand was used as adjuvant for a protein antigen, MyD88 was required in dendritic cells but not in B cells to enhance the TO antibody response, regardless of the inherent immunogenicity of the antigen. In contrast, a TLR9 ligand contained within a virus-like particle substantially augmented the TD germinal center IgG antibody response, and this augmentation required B cell MyD88. The ability of B cells to discriminate between antigens based on the physical form of a TLR ligand probably reflects an adaptation to facilitate strong antiviral antibody responses.	[Saudan, Philippe; Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Zurich, Postfach, Switzerland; [Ott, Gary; Coffman, Robert L.] Dynavax Technol, Berkeley, CA 94710 USA; [Hou, Baidong; Wheeler, Matthew L.; Ji, Ming; Kuzmich, Lili; Lee, Linda M.; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hou, BD (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.	baidong_hou@ibp.ac.cn; anthony.defranco@ucsf.edu		Hou, Baidong/0000-0002-0892-0181	NIH [R01 AI072058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D.K. Hong (Stanford University) for providing protocols for inactivating influenza virus; S. Jiang (UCSF) for assistance with cell purification by flow cytometry; and S. Anderson (UCSF) for advice. This research was supported by NIH R01 AI072058 (A.L.D.). P.S. and M.F.B. (Cytos Biotechnology, AG) and G.O. and R.L.C. (Dynavax Technologies) are employed by companies that are in the business of developing new vaccines.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chaplin DD, 2002, ADV EXP MED BIOL, V512, P49; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Cline AM, 2004, CLIN IMMUNOL, V112, P175, DOI 10.1016/j.clim.2004.02.017; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Gatto D, 2004, J IMMUNOL, V173, P4308, DOI 10.4049/jimmunol.173.7.4308; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Halperin SA, 2006, VACCINE, V24, P20, DOI 10.1016/j.vaccine.2005.08.095; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199; Senti G, 2009, CLIN EXP ALLERGY, V39, P562, DOI 10.1111/j.1365-2222.2008.03191.x; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Zinkernagel RM, 2001, ADV IMMUNOL, V79, P1, DOI 10.1016/S0065-2776(01)79001-3	39	165	172	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 25	2011	34	3					375	384		10.1016/j.immuni.2011.01.011	http://dx.doi.org/10.1016/j.immuni.2011.01.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21353603	Green Accepted, Bronze			2022-12-18	WOS:000289014500013
J	Liu, MA				Liu, Margaret A.			Immunologic Basis of Vaccine Vectors	IMMUNITY			English	Review							CYTOTOXIC T-LYMPHOCYTES; GENE-BASED VACCINES; DEFECTIVE ADENOVIRUS VECTORS; HEMATOPOIETIC NECROSIS VIRUS; ANTIGEN-PRESENTING CELLS; HIGHLY CONSERVED REGION; DNA VACCINE; HIV-1 VACCINE; IMMUNE-RESPONSES; MESSENGER-RNA	Efforts to make vaccines against infectious diseases as well as immunotherapies for cancer, autoimmune diseases and allergy have utilized a variety of heterologous expression systems, including viral and bacterial vectors, as well as DNA and RNA constructs This review explores the immunologic rationale and provides an update of insights obtained from preclinical and clinical studies of such vaccines	[Liu, Margaret A.] ProTherImmune, Lafayette, CA 94549 USA; [Liu, Margaret A.] Karolinska Inst, Dept Microbiol & Tumor Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Liu, MA (corresponding author), ProTherImmune, 3656 Happy Valley Rd, Lafayette, CA 94549 USA.							Acosta F, 2006, FISH SHELLFISH IMMUN, V21, P272, DOI 10.1016/j.fsi.2005.12.006; ALIZON M, 1987, ANN NY ACAD SCI, V511, P376, DOI 10.1111/j.1749-6632.1987.tb36266.x; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Babiuk S, 2004, IMMUNOLOGY, V113, P114, DOI 10.1111/j.1365-2567.2004.01938.x; Barouch DH, 2006, J PATHOL, V208, P283, DOI 10.1002/path.1874; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; Bergmann-Leitner ES, 2009, VACCINE, V27, P5700, DOI 10.1016/j.vaccine.2009.06.059; Boudreau JE, 2009, MOL THER, V17, P1465, DOI 10.1038/mt.2009.95; Brave A, 2005, MOL THER, V12, P1197, DOI 10.1016/j.ymthe.2005.06.473; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Chattergoon MA, 2000, NAT BIOTECHNOL, V18, P974, DOI 10.1038/79470; Chiarella P, 2010, CURR GENE THER, V10, P281, DOI 10.2174/156652310791823506; Chin'ombe N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-87; Chua KY, 2009, CURR OPIN ALLERGY CL, V9, P50, DOI 10.1097/ACI.0b013e3283207ad8; Corbeil S, 2000, FISH SHELLFISH IMMUN, V10, P711, DOI 10.1006/fsim.2000.0286; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; de Mare A, 2008, GENE THER, V15, P393, DOI 10.1038/sj.gt.3303060; DeLong RK, 2009, BIOMATERIALS, V30, P6451, DOI 10.1016/j.biomaterials.2009.07.067; DENIS MKS, 2000, GENE THER, V7, P2105; DENIS MKS, 2003, CELL IMMUNOL, V225, P12; Dharmapuri S, 2009, HUM GENE THER, V20, P589, DOI 10.1089/hum.2008.210; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; Einfeld DA, 2001, J VIROL, V75, P11284, DOI 10.1128/JVI.75.23.11284-11291.2001; Fennelly GJ, 1999, J IMMUNOL, V162, P1603; Ferrari G, 2000, AIDS RES HUM RETROV, V16, P1433, DOI 10.1089/08892220050140982; FOUTS TR, 1995, VACCINE, V13, P561, DOI 10.1016/0264-410X(94)00016-G; Fouts TR, 1995, VACCINE, V13, P1697, DOI 10.1016/0264-410X(95)00106-B; Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683; Gabitzsch ES, 2009, VACCINE, V27, P6394, DOI 10.1016/j.vaccine.2009.06.028; Gahan ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006062; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GOMEZ RVR, 2006, VACCINE, V24, P5064; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; HAMMOND SA, 1991, J IMMUNOL, V146, P1470; Hanke T, 2002, VACCINE, V21, P108, DOI 10.1016/S0264-410X(02)00403-6; Hanke T, 2002, VACCINE, V20, P1995, DOI 10.1016/S0264-410X(02)00085-3; Harrer T, 1996, J IMMUNOL, V156, P2616; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Hartikka J, 2009, VACCINE, V27, P6399, DOI 10.1016/j.vaccine.2009.06.014; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Huang H, 2009, J MED MICROBIOL, V58, P1236, DOI 10.1099/jmm.0.011767-0; HUANG JM, 2010, VACCINE IN PRESS, DOI DOI 10.1016/J.VACCINE.2010.09.001; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; JOHNSON RP, 1991, J IMMUNOL, V147, P1512; JOHNSON RP, 1994, J VIROL, V68, P3145, DOI 10.1128/JVI.68.5.3145-3153.1994; Karlsson Gunilla B, 2004, Methods Mol Biol, V246, P543; Kim TW, 2004, J BIOMED SCI, V11, P493, DOI 10.1159/000077899; Klinman DM, 1997, J IMMUNOL, V158, P3635; Kojima Y, 2007, VACCINE, V25, P438, DOI 10.1016/j.vaccine.2006.08.007; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Kurath G, 2005, DEV BIOLOGICALS, V121, P201; KUWANO K, 1989, J EXP MED, V169, P1361, DOI 10.1084/jem.169.4.1361; Leitner WW, 2004, VACCINE, V22, P1537, DOI 10.1016/j.vaccine.2003.10.013; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Liao Jack C F, 2006, Cancer Immun, V6, P8; Liu MA, 2006, HUM GENE THER, V17, P1051, DOI 10.1089/hum.2006.17.1051; Liu MA, 2010, CURR OPIN MOL THER, V12, P86; Liu X, 2009, VACCINE, V27, P2760, DOI 10.1016/j.vaccine.2009.03.003; Mackowiak M, 1999, ADV VETER MED AP, V41, P571; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Mastrangelo MJ, 2000, J CLIN INVEST, V105, P1031, DOI 10.1172/JCI9819; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nabel GJ, 2010, NEW GENERATION VACCI, P386; NISHINO Y, 1994, VACCINE, V12, P485, DOI 10.1016/0264-410X(94)90304-2; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; Oh YK, 1997, VACCINE, V15, P511, DOI 10.1016/S0264-410X(97)00221-1; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Pan CH, 2010, J VIROL, V84, P3798, DOI 10.1128/JVI.01566-09; Parsania M, 2010, IMMUNOL LETT, V128, P137, DOI 10.1016/j.imlet.2009.12.014; Pascolo Steve, 2006, V127, P23; Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]; PEETERS M, 1991, AIDS, V5, pS29; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; RERKS NS, 2009, NEW ENGL J MED, V361, P2209; ROBERT GM, 2007, CURR OPIN BIOTECH, V18, P546; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rosenberg ES, 1998, AIDS RES HUM RETROV, V14, pS143; Rottinghaus ST, 2003, VACCINE, V21, P4604, DOI 10.1016/S0264-410X(03)00447-X; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656; Schirmbeck R, 1998, EUR J IMMUNOL, V28, P4149, DOI 10.1002/(SICI)1521-4141(199812)28:12<4149::AID-IMMU4149>3.0.CO;2-D; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Schweiger B, 2002, MED MICROBIOL IMMUN, V191, P133, DOI 10.1007/s00430-002-0132-3; Sedegah M, 2010, VACCINE, V28, P3055, DOI 10.1016/j.vaccine.2009.10.044; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Stevenson FK, 2004, IMMUNOL REV, V199, P5, DOI 10.1111/j.0105-2896.2004.00146.x; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI 10.1586/ERV.09.29; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Turell MJ, 2003, EMERG INFECT DIS, V9, P1077, DOI 10.3201/eid0909.030025; Ulmer J B, 2000, Dev Biol (Basel), V104, P9; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Vilalta A, 2007, HUM GENE THER, V18, P763, DOI 10.1089/hum.2007.009; Wang SX, 2006, VACCINE, V24, P4531, DOI 10.1016/j.vaccine.2005.08.023; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059; Wee EGT, 2002, J GEN VIROL, V83, P75, DOI 10.1099/0022-1317-83-1-75; Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068; WEISS R, 2010, CURR OPIN A IN PRESS, DOI DOI 10.1016/J.VACCINE.2010.09.001; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Xiang SD, 2010, WIRES NANOMED NANOBI, V2, P205, DOI 10.1002/wnan.88; Xu XY, 1996, VIROLOGY, V224, P175, DOI 10.1006/viro.1996.0519; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Zhang XL, 2008, CELL MOL IMMUNOL, V5, P91, DOI 10.1038/cmi.2008.11; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	126	165	178	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					504	515		10.1016/j.immuni.2010.10.004	http://dx.doi.org/10.1016/j.immuni.2010.10.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	21029961	Bronze			2022-12-18	WOS:000284300200007
J	Bucala, R; Donnelly, SC				Bucala, Richard; Donnelly, Seamas C.			Macrophage migration inhibitory factor: A probable link between inflammation and cancer	IMMUNITY			English	Article							ACTIVATED PROTEIN-KINASE; INNATE IMMUNE-RESPONSES; FACTOR MIF; DISEASE SEVERITY; REGULATORY ROLE; CELL-GROWTH; HYPOXIA; EXPRESSION; CYTOKINE; CD44	hThe pleiotropic effects of macrophage migration inhibitory factor (MIF) place it in a central position in the immunopathogenesis of many diseases. Here we discuss the current understanding of MIF's role and highlight it as a potential link between inflammatory activation and malignant progression.	Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Univ Coll Dublin, Sch Med & Med Sci, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	Yale University; Yale University; University College Dublin	Bucala, R (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA.	richard.bucala@yale.edu; seamas.donnelly@ucd.ie		Donnelly, Seamas/0000-0001-7145-1843				Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Bando H, 2003, BIOMED PHARMACOTHER, V57, P333, DOI 10.1016/S0753-3322(03)00098-2; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Daun JM, 2000, AM J PHYSIOL-REG I, V279, pR1043, DOI 10.1152/ajpregu.2000.279.3.R1043; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koong AC, 2000, CANCER RES, V60, P883; Leech M, 2000, ARTHRITIS RHEUM, V43, P827, DOI 10.1002/1529-0131(200004)43:4<827::AID-ANR13>3.0.CO;2-K; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Talos F, 2005, CELL DEATH DIFFER, V12, P1319, DOI 10.1038/sj.cdd.4401653; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	39	165	173	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					281	285		10.1016/j.immuni.2007.03.005	http://dx.doi.org/10.1016/j.immuni.2007.03.005			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17376392	Bronze			2022-12-18	WOS:000245228100005
J	Partida-Sanchez, S; Goodrich, S; Kusser, K; Oppenheimer, N; Randall, TD; Lund, FE				Partida-Sanchez, S; Goodrich, S; Kusser, K; Oppenheimer, N; Randall, TD; Lund, FE			Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: Impact on the development of humoral immunity	IMMUNITY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CALCIUM-RELEASE; T-LYMPHOCYTES; MOUSE; ACTIVATION; EXPRESSION; RECEPTORS; MIGRATION; INFLUX; GLYCOHYDROLASE	Mice lacking CD38, an ectoenzyme that generates the calcium-mobilizing metabolite cADPR, make reduced T cell-dependent antibody responses. Despite the predicted role for CD38 in B cell activation, we find that CD38 regulates the migration of dendritic cell (DC) precursors from the blood to peripheral sites and controls the migration of mature DCs from sites of inflammation to lymph nodes. Thus, T cells are inefficiently primed in Cd38(-/-) mice, leading to poor humoral immune responses. We also show that CD38 and cADPR modulate calcium mobilization in chemokine-stimulated DCs and are required for the chemotaxis of immature and mature DCs to CCL2, CCL19, CCL21, and CXCL12. Therefore, CD38 regulates adaptive immunity by controlling chemokine receptor signaling in DCs.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Trudeau Institute; University of California System; University of California San Francisco	Lund, FE (corresponding author), Trudeau Inst Inc, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.	flund@trudeauinstitute.org	Partida-Sanchez, Santiago/B-7523-2008	Partida-Sanchez, Santiago/0000-0003-2996-9440	NIAID NIH HHS [R01-AI43629, R01-AI43589] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043629, R01AI043589] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABDALLAH MA, 1975, EUR J BIOCHEM, V50, P475, DOI 10.1111/j.1432-1033.1975.tb09885.x; BAMDEN MJ, 1998, IMMUNOL CELL BIOL, V76, P34; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; Barone F, 2002, FASEB J, V16, DOI 10.1096/fj.01-0749com; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; BEAN AGD, 1995, INT IMMUNOL, V7, P213, DOI 10.1093/intimm/7.2.213; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; DEAGLIO S, 2002, MOD ASP IMMUNOBIOL, V2, P121; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ge ZD, 2003, J VASC RES, V40, P28, DOI 10.1159/000068936; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2003, CELL CALCIUM, V33, P533, DOI 10.1016/S0143-4160(03)00058-7; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; KIM UH, 1993, ARCH BIOCHEM BIOPHYS, V305, P147, DOI 10.1006/abbi.1993.1404; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Koch F, 2001, METH MOLEC MED, V64, P43, DOI 10.1385/1-59259-150-7:43; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LUND FE, 1995, EUR J IMMUNOL, V25, P1338, DOI 10.1002/eji.1830250531; Lund FE, 1996, J IMMUNOL, V157, P1455; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; MALAVASI F, 1992, INT J CLIN LAB RES, V22, P73, DOI 10.1007/BF02591400; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Okamoto S, 1998, J IMMUNOL, V160, P4190; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SANTOSARGUMEDO L, 1993, J IMMUNOL, V151, P3119; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; SOZZANI S, 1993, J IMMUNOL, V150, P1544; SOZZANI S, 1991, J IMMUNOL, V147, P2215; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; WALSETH TF, 2002, CYCLIC ADP RIBOSE NA, P121; Yasue T, 1999, INT IMMUNOL, V11, P915, DOI 10.1093/intimm/11.6.915	49	165	174	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					279	291		10.1016/S1074-7613(04)00048-2	http://dx.doi.org/10.1016/S1074-7613(04)00048-2			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030772	Bronze			2022-12-18	WOS:000221442600006
J	Saito, K; Tolias, KF; Saci, A; Koon, HB; Humphries, LA; Scharenberg, A; Rawlings, DJ; Kinet, JP; Carpenter, CL				Saito, K; Tolias, KF; Saci, A; Koon, HB; Humphries, LA; Scharenberg, A; Rawlings, DJ; Kinet, JP; Carpenter, CL			BTK regulates Ptdlns-4,5-P-2 synthesis: Importance for calcium signaling and PI3K activity	IMMUNITY			English	Article							BRUTONS TYROSINE KINASE; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; RECEPTOR-MEDIATED ACTIVATION; 4-PHOSPHATE 5-KINASE; PH DOMAIN; FAMILY; RHO; PROTEIN; MEMBERS; CELLS	Intracellular signaling by most cell surface receptors requires the generation of two major second messengers, phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P-3) and inositol-1,4,5-trisphosphate (IP3) The enzymes that produce these second messengers phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC), utilize a common substrate, phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P-2). Until now, it has not been clear whether de novo PtdIns-4,5-P2 synthesis is necessary for PtdIns-3,4,5-P3 and IP3 production. Here we show that BTK, a member of the Tec family of cytoplasmic protein tyrosine kinases, associates with phosphatidylinositol-4-phosphate 5-kinases (PIP5Ks), the enzymes that synthesize PtdIns-4,5-P-2. Upon B cell receptor activation, BTK brings PIP5K to the plasma membrane as a means of generating local PtdIns-4,5-P2 synthesis. This enzyme-enzyme interaction provides a shuttling mechanism that allows BTK to stimulate the production of the substrate required by both its upstream activator, PI3K, and its downstream target, PLC-gamma2.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.			Tolias, Kimberley/0000-0002-2092-920X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA081140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033617, R01AI038348] Funding Source: NIH RePORTER; NCI NIH HHS [CA81140] Funding Source: Medline; NIAID NIH HHS [AI38348, AI33617] Funding Source: Medline; NICHD NIH HHS [HD37091] Funding Source: Medline; NIGMS NIH HHS [GM54389, GM53590] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BILLAH MM, 1982, J BIOL CHEM, V257, P2705; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; WEISS SJ, 1982, BIOCHEM J, V206, P555, DOI 10.1042/bj2060555; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	34	165	170	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					669	678		10.1016/S1074-7613(03)00297-8	http://dx.doi.org/10.1016/S1074-7613(03)00297-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614854	Bronze			2022-12-18	WOS:000186672200007
J	Li, Z; Dordai, DI; Lee, JH; Desiderio, S				Li, Z; Dordai, DI; Lee, JH; Desiderio, S			A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND-BREAK-REPAIR; KAPPA-B-ALPHA; UBIQUITIN-PROTEASOME PATHWAY; DNA-REPAIR; CATALYTIC SUBUNIT; DEFICIENT MUTANT; GENE-EXPRESSION; TRANSGENIC MICE; PHOSPHORYLATION	The proteins RAG-1 and RAG-2 are essential for initiation of V(D)J recombination. In dividing cells, RAG-2 accumulates during G1 and is undetectable during the S and G2/M cell cycle phases. A conserved degradation signal, including an essential CDK phosphorylation site at Thr-490, regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Mutations within this signal abolish periodic degradation of RAG-2 protein in dividing cells. In mice expressing endogenous or wild-type transgenic RAG-2, V(D)J recombination intermediates accumulate preferentially in G0/G1 thymocytes; this restriction is relieved by mutation of Thr-490 to alanine (T490A). Thus, periodic destruction of RAG-2 protein couples V(D)J recombination to cell cycle phase. Using transgenic mice expressing the T490A RAG-2 mutant and a functional T cell receptor beta chain, we demonstrate that coupling of V(D)J recombination to the cell cycle is not essential for enforcement of allelic exclusion.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	Li, Z (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205, USA.							ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOUBNOV NV, 1995, MOL CELL BIOL, V15, P5700; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; GETTS RC, 1994, J BIOL CHEM, V269, P15981; GIACCIA A, 1985, SOMAT CELL MOLEC GEN, V11, P485, DOI 10.1007/BF01534842; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; JONES DH, 1992, BIOTECHNIQUES, V12, P528; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LEE SE, 1995, MUTAT RES-DNA REPAIR, V336, P279, DOI 10.1016/0921-8777(95)00002-2; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MURRAY A, 1995, CELL, V81, P149, DOI 10.1016/0092-8674(95)90322-4; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PERGOLA F, 1993, MOL CELL BIOL, V13, P3464, DOI 10.1128/MCB.13.6.3464; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; REYNOLDS PJ, 1990, MOL CELL BIOL, V10, P4266, DOI 10.1128/MCB.10.8.4266; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; WAYNE J, 1994, IMMUNITY, V1, P95, DOI 10.1016/1074-7613(94)90103-1; WAYNE J, 1994, J IMMUNOL, V153, P5491; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Xu Y, 1996, P NATL ACAD SCI USA, V93, P2169, DOI 10.1073/pnas.93.5.2169; ZDZIENICKA MZ, 1995, MUTAT RES-DNA REPAIR, V336, P203, DOI 10.1016/0921-8777(95)00003-3	48	165	169	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					575	589		10.1016/S1074-7613(00)80272-1	http://dx.doi.org/10.1016/S1074-7613(00)80272-1			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986717	Bronze			2022-12-18	WOS:A1996WA65100008
J	Goudot, C; Coillard, A; Villani, AC; Gueguen, P; Cros, A; Sarkizova, S; Tang-Huau, TL; Bohec, M; Baulande, S; Hacohen, N; Amigorena, S; Segura, E				Goudot, Christel; Coillard, Alice; Villani, Alexandra-Chloe; Gueguen, Paul; Cros, Adeline; Sarkizova, Siranush; Tang-Huau, Tsing-Lee; Bohec, Mylene; Baulande, Sylvain; Hacohen, Nir; Amigorena, Sebastian; Segura, Elodie			Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages	IMMUNITY			English	Article							TISSUE-RESIDENT; LY6C(HI) MONOCYTES; EXPRESSION; REVEALS; GENE; MOUSE; IDENTIFICATION; POPULATION; PROGRAMS; BALANCE	After entering tissues, monocytes differentiate into cells that share functional features with either macrophages or dendritic cells (DCs). How monocyte fate is directed toward monocyte-derived macrophages (mo-Macs) or monocyte-derived DCs (mo-DCs) and which transcription factors control these differentiation pathways remains unknown. Using an in vitro culture model yielding human mo-DCs and moMacs closely resembling those found in vivo in ascites, we show that IRF4 and MAFB were critical regulators of monocyte differentiation into mo-DCs and mo-Macs, respectively. Activation of the aryl hydrocarbon receptor (AHR) promoted mo-DC differentiation through the induction of BLIMP-1, while impairing differentiation into mo-Macs. AhR deficiency also impaired the in vivo differentiation of mousemo-DCs. Finally, AHR activation correlated with mo-DC infiltration in leprosy lesions. These results establish that mo-DCs and mo-Macs are controlled by distinct transcription factors and show that AHR acts as a molecular switch for monocyte fate specification in response to micro-environmental factors.	[Goudot, Christel; Coillard, Alice; Gueguen, Paul; Cros, Adeline; Tang-Huau, Tsing-Lee; Amigorena, Sebastian; Segura, Elodie] PSL Res Univ, INSERM, U932, Inst Curie, 26 Rue Ulm, F-75005 Paris, France; [Villani, Alexandra-Chloe; Hacohen, Nir] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Villani, Alexandra-Chloe; Hacohen, Nir] MIT, Cambridge, MA 02142 USA; [Villani, Alexandra-Chloe; Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Ctr Canc Res, Charlestown, MA 02129 USA; [Sarkizova, Siranush] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02142 USA; [Tang-Huau, Tsing-Lee] Sanofi, Breakthrough Lab, 1 Impasse Ateliers, F-94400 Vitry Sur Seine, France; [Bohec, Mylene; Baulande, Sylvain] PSL Res Univ, Inst Curie, NGS Platform, 26 Rue Ulm, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Segura, E (corresponding author), PSL Res Univ, INSERM, U932, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	elodie.segura@curie.fr	Segura, Elodie/K-7614-2017	Segura, Elodie/0000-0003-1795-1921; BAULANDE, Sylvain/0000-0003-3104-1684; Coillard, Alice/0000-0001-6309-5754; Gueguen, Paul/0000-0003-2930-6073; Amigorena, Sebastian/0000-0001-8583-8416; CROS, Adeline/0000-0002-2100-7290; Bohec, Mylene/0000-0002-6530-596X	INSERM; Agence Nationale de la Recherche [ANR-10-LABX-0043, ANR-CHIN-0002, ANR-10-IDEX-0001-02 PSL]; Institut Curie [CIC IGR-Curie 1428]; European Research Council [340046 DCBIOX]; La Ligue Nationale contre le Cancer [EL2014.LNCC/SA]; Fondation Bristol-Myers Squibb pour la Recherche en Immuno-Oncologie; National Human Genome Research Institute Centers of Excellence in Genomics Science [P50 HG006193]; National Human Genome Research Institute [NIH T32 HG002295]; Banting Postdoctoral Fellowship; Universite Paris Descartes; Equipex [ANR-10-EQPX-03]; France Genomique Consortium [ANR-10-INBS-09-08]; Canceropole Ile-de-France; SESAME program from Region Ile-de-France; SiRIC-Curie program (SiRIC) [INCa-DGOS-4654]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, P50HG006193] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Curie; European Research Council(European Research Council (ERC)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation Bristol-Myers Squibb pour la Recherche en Immuno-Oncologie; National Human Genome Research Institute Centers of Excellence in Genomics Science; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Banting Postdoctoral Fellowship; Universite Paris Descartes; Equipex; France Genomique Consortium; Canceropole Ile-de-France(Region Ile-de-France); SESAME program from Region Ile-de-France; SiRIC-Curie program (SiRIC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by INSERM, Agence Nationale de la Recherche (ANR-10-LABX-0043, ANR-CHIN-0002, and ANR-10-IDEX-0001-02 PSL), Institut Curie (CIC IGR-Curie 1428), the European Research Council (2013-AdG No 340046 DCBIOX) (S.A.), La Ligue Nationale contre le Cancer (EL2014.LNCC/SA) (S.A.), Fondation Bristol-Myers Squibb pour la Recherche en Immuno-Oncologie (E.S.), the National Human Genome Research Institute Centers of Excellence in Genomics Science P50 HG006193 (N.H.), the National Human Genome Research Institute NIH T32 HG002295 (S.S.), and the Banting Postdoctoral Fellowship (A.-C.V.). T.-L. T.-H. is supported by an industry-funded PhD fellowship at Universite Paris Descartes. High-throughput sequencing performed by the ICGex NGS platform of the Institut Curie was supported by grants ANR-10-EQPX-03 (Equipex) and ANR-10-INBS-09-08 (France Genomique Consortium), by Canceropole Ile-de-France, by SESAME program from Region Ile-de-France, and by SiRIC-Curie program (SiRIC Grant INCa-DGOS-4654).	Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Breton G, 2016, J EXP MED, V213, P2861, DOI 10.1084/jem.20161135; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Carpentier S, 2016, J IMMUNOL METHODS, V432, P35, DOI 10.1016/j.jim.2016.02.023; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chessel D., 2004, R NEWS; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; De Abrew KN, 2010, TOXICOL SCI, V118, P454, DOI 10.1093/toxsci/kfq265; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Eguiluz-Gracia I, 2016, J ALLERGY CLIN IMMUN, V137, P1872, DOI 10.1016/j.jaci.2015.11.025; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Ikuta T, 2010, J DERMATOL SCI, V58, P211, DOI 10.1016/j.jdermsci.2010.04.003; Jenner W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089375; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schreiber HA, 2010, IMMUNOL LETT, V130, P26, DOI 10.1016/j.imlet.2009.12.009; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Sieling PA, 1999, J IMMUNOL, V162, P1851; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	62	164	171	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					582	+		10.1016/j.immuni.2017.08.016	http://dx.doi.org/10.1016/j.immuni.2017.08.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930664	Green Submitted, Bronze			2022-12-18	WOS:000411128200020
J	Scott-Browne, JP; Lopez-Moyado, IF; Trifari, S; Wong, V; Chavez, L; Rao, A; Pereira, RM				Scott-Browne, James P.; Lopez-Moyado, Isaac F.; Trifari, Sara; Wong, Victor; Chavez, Lukas; Rao, Anjana; Pereira, Renata M.			Dynamic Changes in Chromatin Accessibility Occur in CD8(+) T Cells Responding to Viral Infection	IMMUNITY			English	Article							EXHAUSTION; DIFFERENTIATION; EFFECTOR; BET; EXPRESSION; RECEPTORS; INSIGHTS; FATE; PD-1	In response to acute infection, naive CD8(+) T cells expand, differentiate into effector cells, and then contract to a long-lived pool of memory cells after pathogen clearance. During chronic infections or in tumors, CD8(+) T cells acquire an "exhausted'' phenotype. Here we present genome-wide comparisons of chromatin accessibility and gene expression from endogenous CD8(+) T cells responding to acute and chronic viral infection using ATAC-seq and RNA-seq techniques. Acquisition of effector, memory, or exhausted phenotypes was associated with stable changes in chromatin accessibility away from the naive T cell state. Regions differentially accessible between functional subsets in vivo were enriched for binding sites of transcription factors known to regulate these subsets, including E2A, BATF, IRF4, T-bet, and TCF1. Exhaustion-specific accessible regions were enriched for consensus binding sites for NFAT and Nr4a family members, indicating that chronic stimulation confers a unique accessibility profile on exhausted cells.	[Scott-Browne, James P.; Lopez-Moyado, Isaac F.; Trifari, Sara; Wong, Victor; Chavez, Lukas; Rao, Anjana; Pereira, Renata M.] La Jolla Inst, Div Signaling & Gene Express, 9420 Athena Circle, San Diego, CA 92037 USA; [Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Rao, Anjana] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Rao, Anjana] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92037 USA; [Chavez, Lukas] German Canc Res Ctr, Div Pediat Neurooncol, Computat Oncoepigen Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Pereira, Renata M.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941900 Rio De Janeiro, RJ, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Federal do Rio de Janeiro	Rao, A (corresponding author), La Jolla Inst, Div Signaling & Gene Express, 9420 Athena Circle, San Diego, CA 92037 USA.; Rao, A (corresponding author), Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA.; Rao, A (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92037 USA.	arao@lji.org	Pereira, Renata/V-6194-2019	Lopez-Moyado, Isaac/0000-0002-3720-0722; Pereira, Renata/0000-0002-7719-8356; Chavez, Lukas/0000-0002-8718-8848; Rao, Anjana/0000-0002-1870-1775	NIH grants [R01 AI109842, AI40127]; Pew Latin American Fellows Program in the Biomedical Sciences; UC MEXUS-CONACYT fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI109842] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016262] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Latin American Fellows Program in the Biomedical Sciences; UC MEXUS-CONACYT fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Kim, K. Gunst, and L. Nosworthy for cell sorting, J. Greenbaum, Z. Fu, and J. Day for next-generation sequencing, S. Crotty for LCMV virus (all at La Jolla Institute), the NIH Tetramer Facility for tetramers, and L. Gapin (University of Colorado), P. Marrack (National Jewish Health), and M. Prlic (FHCRC) for providing critical comments. This work was funded by NIH grants R01 AI109842 and AI40127 (to A.R.). J.P.S.-B. was the Fraternal Order of Eagles Fellow of the Damon Runyon Cancer Research Foundation, DRG-2069-11. R.M.P. was supported by a fellowship from the Pew Latin American Fellows Program in the Biomedical Sciences. I.F.L.-M. was supported by a UC MEXUS-CONACYT fellowship.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	40	164	167	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1327	1340		10.1016/j.immuni.2016.10.028	http://dx.doi.org/10.1016/j.immuni.2016.10.028			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27939672	Green Accepted, Bronze			2022-12-18	WOS:000392918100017
J	Hondowicz, BD; An, D; Schenkel, JM; Kim, KS; Steach, HR; Krishnamurty, AT; Keitany, GJ; Garza, EN; Fraser, KA; Moon, JJ; Altemeier, WA; Masopust, D; Pepper, M				Hondowicz, Brian D.; An, Dowon; Schenkel, Jason M.; Kim, Karen S.; Steach, Holly R.; Krishnamurty, Akshay T.; Keitany, Gladys J.; Garza, Esteban N.; Fraser, Kathryn A.; Moon, James J.; Altemeier, William A.; Masopust, David; Pepper, Marion			Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma	IMMUNITY			English	Article							DUST MITE ALLERGEN; FOLLICULAR HELPER-CELL; CD4(+) T-CELLS; TRANSCRIPTION FACTOR; LYMPHOCYTE EGRESS; TH2 CELLS; INFECTION; RESPONSES; PATTERNS; DIFFERENTIATION	Exposure to inhaled allergens generates T helper 2 (Th2) CD4(+) T cells that contribute to episodes of inflammation associated with asthma. Little is known about allergen-specific Th2 memory cells and their contribution to airway inflammation. We generated reagents to understand how endogenous CD4(+) T cells specific for a house dust mite (HDM) allergen form and function. After allergen exposure, HDM-specific memory cells persisted as central memory cells in the lymphoid organs and tissue-resident memory cells in the lung. Experimental blockade of lymphocyte migration demonstrated that lung-resident cells were sufficient to induce airway hyper-responsiveness, which depended upon CD4(+) T cells. Investigation into the differentiation of pathogenic Trm cells revealed that interleukin-2 (IL-2) signaling was required for residency and directed a program of tissue homing migrational cues. These studies thus identify IL-2-dependent resident Th2 memory cells as drivers of lung allergic responses.	[Hondowicz, Brian D.; Kim, Karen S.; Steach, Holly R.; Krishnamurty, Akshay T.; Keitany, Gladys J.; Garza, Esteban N.; Pepper, Marion] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [An, Dowon; Altemeier, William A.] Univ Washington, Sch Med, Ctr Lung Biol, Seattle, WA 98109 USA; [Schenkel, Jason M.; Fraser, Kathryn A.; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Moon, James J.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Charlestown, MA 02129 USA; [Moon, James J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Pepper, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.	mpepper@uw.edu	Moon, James/AAA-9905-2020; masopust, david/B-5027-2008; Moon, James C/F-1031-2014; Schenkel, Jason/AAV-8184-2020	Moon, James/0000-0001-8071-1491; Moon, James C/0000-0001-8071-1491; Schenkel, Jason/0000-0003-4641-6872; Krishnamurty, Akshay/0000-0001-5382-1417; Altemeier, William/0000-0001-8860-405X; Steach, Holly/0000-0003-0018-3129	NCI NIH HHS [P30 CA077598] Funding Source: Medline; NIAID NIH HHS [U19 AI095261, R01 AI084913, R01 AI108626, T32 AI007313, T32 AI106677] Funding Source: Medline; NIDDK NIH HHS [P30 DK043351] Funding Source: Medline; NIGMS NIH HHS [T32 GM007270] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI107020, R01AI108626, T32AI106677, R01AI084913, T32AI007313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agache I, 2012, ALLERGY, V67, P835, DOI 10.1111/j.1398-9995.2012.02832.x; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; CORRIS PA, 1993, LANCET, V341, P1369, DOI 10.1016/0140-6736(93)90941-9; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Endo Y, 2014, TRENDS IMMUNOL, V35, P69, DOI 10.1016/j.it.2013.11.003; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Glennie ND, 2015, J EXP MED, V212, P1405, DOI 10.1084/jem.20142101; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hall G, 2003, VACCINE, V21, P549, DOI 10.1016/S0264-410X(02)00394-8; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; HOYNE GF, 1993, J EXP MED, V178, P1783, DOI 10.1084/jem.178.5.1783; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; LANZAVECCHIA A, 1983, CLIN EXP IMMUNOL, V52, P21; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Lee SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002499; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schober SL, 1999, J IMMUNOL, V163, P3662; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; YSSEL H, 1992, J IMMUNOL, V148, P738; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zheng LJ, 2007, J IMMUNOL, V179, P8035, DOI 10.4049/jimmunol.179.12.8035; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	58	164	173	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					155	166		10.1016/j.immuni.2015.11.004	http://dx.doi.org/10.1016/j.immuni.2015.11.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26750312	Green Accepted, Bronze			2022-12-18	WOS:000368347000020
J	Xie, P; Stunz, LL; Larison, KD; Yang, B; Bishop, GA				Xie, Ping; Stunz, Laura L.; Larison, Karen D.; Yang, Baoli; Bishop, Gail A.			Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs	IMMUNITY			English	Article							NF-KAPPA-B; TNF-RECEPTOR; AUTOIMMUNE-DISEASE; BCL-2 FAMILY; BAFF; MICE; SURVIVAL; KINASE; TRAF3; EXPRESSION	Tumor necrosis factor receptor-associated factor 3 (TRAF3) is an adaptor protein that directly binds to a number of receptors of the tumor necrosis factor receptor (TNF-R) superfamily. Despite in vitro evidence that TRAF3 plays diverse roles in different cell types, little is known about the in vivo functions of TRAF3. To address this gap in knowledge and to circumvent the early lethal effect of TRAF3 null mutations, we generated conditional TRAF3-deficient mice. B-cell-specific Traf3(-/-) mice displayed severe peripheral B cell hyperplasia, which culminated in hyperimmunoglobulinemia. and increased T-independent antibody responses, splenomegaly and lymphadenopathy. Resting splenic B cells from these mice exhibited remarkably prolonged survival ex vivo independent of B cell activating factor and showed increased amounts of active nuclear factor-kappa B2 but decreased amounts of nuclear protein kinase C delta. Furthermore, these mice developed autoimmune manifestations as they aged. These findings indicate that TRAF3 is a critical regulator of peripheral B cell homeostasis and may be implicated in the regulation of peripheral self-tolerance induction.	Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	NCI NIH HHS [CA099997, R01 CA099997, R01 CA099997-05] Funding Source: Medline; NIAID NIH HHS [R56 AI049993, R01 AI049993, R56 AI028847, AI49993, R01 AI028847, R01 AI028847-15, R01 AI028847-16A1, R01 AI049993-07, AI28847] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI028847, R56AI028847, R01AI028847, R01AI049993, R56AI049993] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Catlett IM, 2001, J IMMUNOL, V166, P6019, DOI 10.4049/jimmunol.166.10.6019; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gauld SB, 2006, CURR OPIN IMMUNOL, V18, P292, DOI 10.1016/j.coi.2006.03.015; Grammer A C, 2000, Adv Immunol, V76, P61; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; Miller JP, 2006, J IMMUNOL, V176, P6405, DOI 10.4049/jimmunol.176.11.6405; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Packham G, 2005, IMMUNOLOGY, V114, P441, DOI 10.1111/j.1365-2567.2005.02117.x; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Stunz LL, 2004, IMMUNITY, V21, P255, DOI 10.1016/j.immuni.2004.07.008; TEXIDO G, 1994, J IMMUNOL, V153, P3028; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	49	164	166	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2007	27	2					253	267		10.1016/j.immuni.2007.07.012	http://dx.doi.org/10.1016/j.immuni.2007.07.012			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723217	Green Accepted, Bronze			2022-12-18	WOS:000249056300012
J	Colgan, J; Asmal, M; Neagu, M; Yu, B; Schneidkraut, J; Lee, Y; Sokolskaja, E; Andreotti, A; Luban, J				Colgan, J; Asmal, M; Neagu, M; Yu, B; Schneidkraut, J; Lee, Y; Sokolskaja, E; Andreotti, A; Luban, J			Cyclophilin A regulates TCR signal strength in CD4(+) T cells via a proline-directed conformational switch in Itk	IMMUNITY			English	Article							NONRECEPTOR TYROSINE KINASE; TEC FAMILY KINASE; CYCLOSPORINE-A; CIS/TRANS ISOMERIZATION; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; ALLOGRAFT-REJECTION; GENE-TRANSCRIPTION; BINDING-PROTEIN; ALLERGIC-ASTHMA	Cyclophilin A (CypA/Ppia) is a peptidyl-prolyl isomerase (PPlase) that binds the immunosuppressive drug cyclosporine. The resulting complex blocks T cell function by inhibiting the calcium-dependent phosphatase calcineurin. To identify the native function of CypA, long suspected of regulating signal transduction, we generated mice lacking the Ppia gene. These animals develop allergic disease, with elevated IgE and tissue infiltration by mast cells and eosinophils, that is driven by CD4(+) T helper type II (Th2) cytokines. Ppia(-/-) Th2 cells were hypersensitive to TCR stimulation, a phenotype consistent with increased activity of Itk, a Tec family tyrosine kinase crucial for Th2 responses. CypA bound Itk via the PPlase active site. Mutation of a conformationally heterogeneous proline in the SH2 domain of Itk disrupted interaction with CypA and specifically increased Th2 cytokine production from wild-type CD4(+) T cells. Thus, CypA inhibits CD4(+) T cell signal transduction in the absence of cyclosporine via a regulatory proline residue in Itk.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Iowa State University; Columbia University	Luban, J (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	jl45@columbia.edu		Colgan, John/0000-0001-9273-2644; Luban, Jeremy/0000-0001-5650-4054	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036199] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 36199, R01 AI036199] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansari H, 2002, MOL CELL BIOL, V22, P6993, DOI 10.1128/MCB.22.20.6993-7003.2002; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Braaten D, 1996, J VIROL, V70, P4220, DOI 10.1128/JVI.70.7.4220-4227.1996; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Breheny PJ, 2003, J AM CHEM SOC, V125, P15706, DOI 10.1021/ja0375380; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Colgan J, 2000, GENOMICS, V68, P167, DOI 10.1006/geno.2000.6295; ERB KJ, 1994, EUR J IMMUNOL, V24, P1143, DOI 10.1002/eji.1830240520; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; Huang TM, 2002, J BIOL CHEM, V277, P37798, DOI 10.1074/jbc.M204786200; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Kashiwakura J, 1999, J EXP MED, V190, P1147, DOI 10.1084/jem.190.8.1147; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; Miller AT, 2002, CURR OPIN IMMUNOL, V14, P331, DOI 10.1016/S0952-7915(02)00345-X; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Newell KA, 1999, J IMMUNOL, V163, P2358; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RYFFEL B, 1991, IMMUNOLOGY, V72, P399; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; Sommers CL, 1999, J EXP MED, V190, P1427, DOI 10.1084/jem.190.10.1427; Takeba Y, 2002, J IMMUNOL, V168, P2365, DOI 10.4049/jimmunol.168.5.2365; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WALDSCHMIDT TJ, 1989, J IMMUNOL, V143, P2820; Wang H, 2003, J IMMUNOL, V171, P3823, DOI 10.4049/jimmunol.171.7.3823; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	69	164	174	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2004	21	2					189	201		10.1016/j.immuni.2004.07.005	http://dx.doi.org/10.1016/j.immuni.2004.07.005			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308100	Bronze			2022-12-18	WOS:000223441900008
J	Kurth, J; Spieker, T; Wustrow, J; Strickler, JG; Hansmann, ML; Rajewsky, K; Kuppers, R				Kurth, J; Spieker, T; Wustrow, J; Strickler, JG; Hansmann, ML; Rajewsky, K; Kuppers, R			EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency	IMMUNITY			English	Article							EPSTEIN-BARR-VIRUS; MEMBRANE-PROTEIN LMP1; REED-STERNBERG CELLS; CD8(+) T-CELLS; HODGKINS-DISEASE; IN-VIVO; LYMPHOCYTES-B; MOLECULAR ANALYSIS; GERMINAL-CENTERS; ACTIVATED CD40	Infection of humans with Epstein-Barr virus (EBV) may cause infectious mononucleosis (IM). Analysis of single EBV-infected cells from tonsils of IM patients for rearranged immunoglobulin genes revealed two strategies of EBV for rapid and massive spread in the B cell compartment: the direct infection of many naive as well as memory and/or germinal center B cells and the expansion of the latter cells to large clones. In IM, the generation of virus-harboring memory B cells from naive B cells passing through a germinal center reaction likely plays no role. Members of clones can show distinct morphologies and likely also EBV gene expression patterns, and this ability implies a mechanism by which EBV-harboring cells can evade immune surveillance and establish a pool of persisting EBV-infected B cells.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; Goethe Univ Frankfurt, Dept Pathol, D-60590 Frankfurt, Germany; St Elizabeth Hosp, D-50935 Cologne, Germany; Allina Labs, Minneapolis, MN 55407 USA	University of Cologne; University of Cologne; Goethe University Frankfurt	Kurth, J (corresponding author), Univ Cologne, Inst Genet, D-50931 Cologne, Germany.	jkurth@mac.genetik.uni-koeln.de		Kuppers, Ralf/0000-0002-6691-7191; Rajewsky, Klaus/0000-0002-6633-6370				ALFIERI C, 1991, VIROLOGY, V181, P595, DOI 10.1016/0042-6822(91)90893-G; ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; Araujo I, 1999, J PATHOL, V187, P326, DOI 10.1002/(SICI)1096-9896(199902)187:3&lt;326::AID-PATH242&gt;3.0.CO;2-N; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Braeuninger A, 1997, P NATL ACAD SCI USA, V94, P9337, DOI 10.1073/pnas.94.17.9337; Brauninger A, 1999, BLOOD, V93, P2679, DOI 10.1182/blood.V93.8.2679.408k05_2679_2687; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Callan MFC, 1996, NAT MED, V2, P906, DOI 10.1038/nm0896-906; CASALI P, 1989, ANNU REV IMMUNOL, V7, P513, DOI 10.1146/annurev.immunol.7.1.513; CHENG ADY, 1995, GRAVITATION COSMOLOG, V1, P1; DIEHL V, 1969, IN VITRO, V4, P92; Ehlin-Henriksson B, 1999, INT J CANCER, V83, P50, DOI 10.1002/(SICI)1097-0215(19990924)83:1<50::AID-IJC10>3.0.CO;2-1; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; HENLE G, 1968, P NATL ACAD SCI USA, V59, P94, DOI 10.1073/pnas.59.1.94; ISAACSON PG, 1992, J PATHOL, V167, P267, DOI 10.1002/path.1711670302; Kanzler H, 2000, BLOOD, V95, P1023, DOI 10.1182/blood.V95.3.1023.003k07_1023_1031; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Kieff E., 1996, FIELDS VIROLOGY, P2343; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klein U, 1998, IMMUNOL REV, V162, P261; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Kuppers R, 1997, WEIRS HDB EXPT IMMUN, P2061; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; MUNOZ N, 1978, INT J CANCER, V22, P10, DOI 10.1002/ijc.2910220104; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; NIEDOBITEK G, 1992, BLOOD, V79, P2520; NIEDOBITEK G, 1991, J GEN VIROL, V72, P3035, DOI 10.1099/0022-1317-72-12-3035; Niedobitek G, 1997, BLOOD, V90, P1664, DOI 10.1182/blood.V90.4.1664.1664_1664_1672; QU LR, 1992, J VIROL, V66, P3715, DOI 10.1128/JVI.66.6.3715-3724.1992; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; REYNOLDS DJ, 1995, AM J PATHOL, V146, P379; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; ROCCHI G, 1977, NEW ENGL J MED, V296, P132, DOI 10.1056/NEJM197701202960302; ROSDAHL N, 1974, BMJ-BRIT MED J, V2, P253, DOI 10.1136/bmj.2.5913.253; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Szeles A, 1999, J VIROL, V73, P5064, DOI 10.1128/JVI.73.6.5064-5069.1999; ThorleyLawson DA, 1996, TRENDS MICROBIOL, V4, P204, DOI 10.1016/S0966-842X(96)90020-7; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; TOKUNAGA M, 1993, ACTA PATHOL JAPON, V43, P146; TOSATO G, 1984, J CLIN INVEST, V73, P1789, DOI 10.1172/JCI111388; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; WAGNER HJ, 1992, J CLIN MICROBIOL, V30, P2826, DOI 10.1128/JCM.30.11.2826-2829.1992; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZimberStrobl U, 1996, EMBO J, V15, P7070, DOI 10.1002/j.1460-2075.1996.tb01098.x	52	164	172	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					485	495		10.1016/S1074-7613(00)00048-0	http://dx.doi.org/10.1016/S1074-7613(00)00048-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070167	Bronze			2022-12-18	WOS:000090079100008
J	Ernst, WA; Maher, J; Cho, SG; Niazi, KR; Chatterjee, D; Moody, DB; Besra, GS; Watanabe, Y; Jensen, PE; Porcelli, SA; Kronenberg, M; Modlin, RL				Ernst, WA; Maher, J; Cho, SG; Niazi, KR; Chatterjee, D; Moody, DB; Besra, GS; Watanabe, Y; Jensen, PE; Porcelli, SA; Kronenberg, M; Modlin, RL			Molecular interaction of CD1b with lipoglycan antigens	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER CELLS; MYCOBACTERIUM-TUBERCULOSIS; PEPTIDE BINDING; ACIDIC PH; LIPOARABINOMANNAN; RECEPTOR; KINETICS; EMPTY; SPECIFICITY; LIPOMANNAN	The ability of human CD1b molecules to present nonpeptide antigens is suggested by the T cell recognition of microbial lipids and lipoglycans in the presence of CD1b-expressing antigen-presenting cells. We demonstrate the high-affinity interaction of CD1b molecules with the acyl side chains of known T cell antigens, lipoarabinomannan, phosphatidylinositol mannoside, and glucose monomycolate. Furthermore, CD1b-antigen binding was optimal at acidic pH, consistent with the known requirement for endosomal acidification in CD1b-restricted antigen presentation. The mechanism for CD1b-ligand interaction involves the partial unfolding of the alpha helices of CD1b at acidic pH, revealing a hydrophobic binding site that could accommodate lipid. These data provide direct evidence that the CD1b molecule has evolved unique biochemical properties that enable the binding of lipid-containing antigens from intracellular pathogens.	Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Immunol & Microbiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; Ehime Univ, Dept Appl Chem, Matsuyama, Ehime 790, Japan; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Lymphocyte Biol Sect, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; La Jolla Institute for Immunology; Colorado State University; Ehime University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Emory University	Modlin, RL (corresponding author), Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA 90095 USA.	modlin@medicine.medsch.ucla.edu	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Besra, Gurdyal/0000-0002-5605-0395	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022553, R01AI036069, R22AI022553] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07126-19, AI36069, AI22553] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARUFFO A, 1989, J IMMUNOL, V143, P1723; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BONIFACE JJ, 1993, BIOCHEMISTRY-US, V32, P11761, DOI 10.1021/bi00095a003; CALABI F, 1991, TISSUE ANTIGENS, V37, P1, DOI 10.1111/j.1399-0039.1991.tb01836.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; DATTA AK, 1991, CARBOHYD RES, V218, P95, DOI 10.1016/0008-6215(91)84089-W; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; GUERCIO M, 1995, J IMMUNOL, V154, P685; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; KAPPLER J, 1994, P NATL ACAD SCI USA, V91, P8462, DOI 10.1073/pnas.91.18.8462; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; LEE JM, 1992, INT IMMUNOL, V4, P889, DOI 10.1093/intimm/4.8.889; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; PARKER KC, 1985, BIOCHEMISTRY-US, V24, P5543, DOI 10.1021/bi00341a039; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; Schuck P, 1996, BIOPHYS J, V70, P1230, DOI 10.1016/S0006-3495(96)79681-9; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Watanabe Y, 1997, TETRAHEDRON, V53, P903, DOI 10.1016/S0040-4020(96)01038-1; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	36	164	167	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					331	340		10.1016/S1074-7613(00)80538-5	http://dx.doi.org/10.1016/S1074-7613(00)80538-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529150	Bronze			2022-12-18	WOS:000072705300006
J	Doolan, DL; Hoffman, SL; Southwood, S; Wentworth, PA; Sidney, J; Chesnut, RW; Keogh, E; Appella, E; Nutman, TB; Lal, AA; Gordon, DM; Oloo, A; Sette, A				Doolan, DL; Hoffman, SL; Southwood, S; Wentworth, PA; Sidney, J; Chesnut, RW; Keogh, E; Appella, E; Nutman, TB; Lal, AA; Gordon, DM; Oloo, A; Sette, A			Degenerate cytotoxic T cell epitopes from P-falciparum restricted by multiple HLA-A and HLA-B supertype alleles	IMMUNITY			English	Article							SPOROZOITE SURFACE PROTEIN-2; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; GAMMA-INTERFERON; LYMPHOCYTES-T; INFECTED HEPATOCYTES; VACCINE DEVELOPMENT; PEPTIDE-BINDING; SEVERE MALARIA; RESPONSES	We recently described human leukocyte antigen (HLA) A2, A3 and B7 supertypes, characterized by largely overlapping peptide-binding specificities and represented in a high percentage of different populations. Here, we identified 17 Plasmodium falciparum peptides capable of binding these supertypes and assessed antigenicity in both vaccinated and naturally exposed populations. Positive cytotoxic T lymphocyte recall and cytokine (interferon-gamma and tumor necrosis factor alpha) responses were detected for all peptides; all were recognized in the context of more than one HLA class I molecule; and at least 12 of the 17 were recognized in the context of all HLA alleles studied. These data validate the concept of HLA supertypes at the biological level, show that highly degenerate peptides are almost always recognized as epitopes, and demonstrate the feasibility of developing a universally effective vaccine by focusing on a limited number of peptide specificities.	CYTEL CORP,SAN DIEGO,CA 92121; NCI,NIH,BETHESDA,MD 20892; NIAID,PARASIT DIS LAB,NIH,BETHESDA,MD 20892; CTR DIS CONTROL & PREVENT,DIV PARASIT DIS,ATLANTA,GA 30333; WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DEPT IMMUNOL,WASHINGTON,DC 20307; KENYA GOVT MED RES CTR,KISSIAN,KENYA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed National Military Medical Center; Kenya Medical Research Institute	Doolan, DL (corresponding author), USN,MED RES INST,MALARIA PROGRAM,BETHESDA,MD 20889, USA.		Sette, Alessandro/AFO-8916-2022; Oloo, James Aggrey/CAF-3948-2022; Doolan, Denise L/F-1969-2015	Oloo, James Aggrey/0000-0001-7495-1827; Doolan, Denise/0000-0001-7354-8817	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045241] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-45241] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AIDOO M, 1995, LANCET, V345, P1003, DOI 10.1016/S0140-6736(95)90754-8; BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; CHICZ RM, 1994, IMMUNOL TODAY, V15, P155, DOI 10.1016/0167-5699(94)90311-5; DELGUERCIO MF, 1995, J IMMUNOL, V154, P685; Doolan DL, 1996, IMMUNOL RES, V15, P280, DOI 10.1007/BF02935313; DOOLAN DL, 1993, INT IMMUNOL, V5, P37, DOI 10.1093/intimm/5.1.37; DOOLAN DL, 1992, INFECT IMMUN, V60, P675, DOI 10.1128/IAI.60.2.675-682.1992; DOOLAN DL, 1991, INT IMMUNOL, V3, P511, DOI 10.1093/intimm/3.6.511; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Doolan DL, 1997, PARASITOL TODAY, V13, P171, DOI 10.1016/S0169-4758(97)01040-5; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; FRANCO A, 1994, CLIN IMMUNOL IMMUNOP, V71, P75, DOI 10.1006/clin.1994.1054; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOFFMAN SL, 1990, IMMUNOL LETT, V25, P33, DOI 10.1016/0165-2478(90)90087-7; Hoffman Stephen L., 1996, P35; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; KUBO RT, 1994, J IMMUNOL, V152, P3913; Lalvani A, 1996, EUR J IMMUNOL, V26, P773, DOI 10.1002/eji.1830260408; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; MCCUTCHAN TF, 1990, IMMUNOL LETT, V25, P23, DOI 10.1016/0165-2478(90)90085-5; MCELROY PD, 1994, AM J TROP MED HYG, V51, P523, DOI 10.4269/ajtmh.1994.51.523; MELLOUK S, 1991, J IMMUNOL, V146, P3971; MELLOUK S, 1987, J IMMUNOL, V139, P4192; NUSSLER A, 1991, INT IMMUNOL, V3, P317, DOI 10.1093/intimm/3.4.317; OOBA T, 1989, IMMUNOGENETICS, V30, P76, DOI 10.1007/BF02421534; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; RAJAHDYAKSHA M, 1995, P NATL ACA SCI US, V62, P1575; REBAI N, 1983, TISSUE ANTIGENS, V22, P107; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; SCHOFIELD L, 1987, FASEB J, V46, P760; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SEDEGAH M, 1992, J IMMUNOL, V149, P966; SETTE A, 1994, J IMMUNOL, V153, P5586; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; SIDNEY J, 1995, J IMMUNOL, V154, P247; Sidney J, 1996, J IMMUNOL, V157, P3480; STEEL C, 1984, J INFECT DIS, V170, P962; STORKUS WJ, 1993, J IMMUNOL, V151, P3719; SUHRBIER A, 1991, J IMMUNOL, V147, P2507; vanderMost RG, 1996, J IMMUNOL, V157, P5543; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VITIELLO A, 1995, J CLIN INVEST, V95, P341, DOI 10.1172/JCI117662; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Wentworth PA, 1996, EUR J IMMUNOL, V26, P97, DOI 10.1002/eji.1830260115; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P309; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435; WIZEL B, 1995, J IMMUNOL, V155, P766	59	164	179	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					97	112		10.1016/S1074-7613(00)80513-0	http://dx.doi.org/10.1016/S1074-7613(00)80513-0			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252123	Bronze			2022-12-18	WOS:A1997XN69300009
J	Hogquist, KA; Tomlinson, AJ; Kieper, WC; McGargill, MA; Hart, MC; Naylor, S; Jameson, SC				Hogquist, KA; Tomlinson, AJ; Kieper, WC; McGargill, MA; Hart, MC; Naylor, S; Jameson, SC			Identification of a naturally occurring ligand for thymic positive selection	IMMUNITY			English	Article							T-CELL RECEPTOR; COMPLEX CLASS-I; MHC CLASS-I; MASS-SPECTROMETRY; CLONAL DELETION; TRANSGENIC MICE; SIDE-CHAINS; PEPTIDES; THYMOCYTES; SPECIFICITY	In the thymus, positive and negative selection shape the T cell repertoire. it has previously been shown that positive selection, like negative selection, is the result of the interaction of the TCR with self-peptides bound to MHC. However, lime is known about the number or nature of the self-peptide ligands that mediate positive selection in vivo. We devised a novel assay with enhanced sensitivity for low affinity TCR ligands to identify self-peptides that may be biologically relevant. At least eight K-b-bound serf-peptides were detected by this assay using thymocytes bearing the OT-I TCR (specific for OVAp/K-b). The sequence of one of these peptides was determined using the recently developed technique of membrane preconcentration-capillary electrophoresis-tandem mass spectrometry. This peptide, CP alpha 1, has limited sequence similarity to OVAp, yet was found to induce positive selection of OT-I thymocytes in fetal thymic organ culture.	UNIV MINNESOTA,CTR IMMUNOL,MINNEAPOLIS,MN 55455; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOL BIOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,BIOMED MASS SPECTROMETRY FACIL,ROCHESTER,MN 55905; WASHINGTON UNIV,DEPT CELL BIOL,ST LOUIS,MO 63110	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Washington University (WUSTL)	Hogquist, KA (corresponding author), UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455, USA.		McGargill, Maureen/N-8131-2018; Jameson, Stephen C/D-9892-2013	McGargill, Maureen/0000-0002-0916-0372; Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687	NIGMS NIH HHS [GM38542] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALEXANDERMILLER MA, 1993, J IMMUNOL, V151, P1; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BARNDEN MJ, 1994, EUR J IMMUNOL, V24, P2452, DOI 10.1002/eji.1830241029; BEVAN MJ, 1994, SCIENCE, V264, P796, DOI 10.1126/science.8171333; CHEN W, 1993, J EXP MED, V177, P869, DOI 10.1084/jem.177.3.869; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Falk K, 1993, Semin Immunol, V5, P81, DOI 10.1006/smim.1993.1012; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; HOGQUIST KA, 1993, EUR J IMMUNOL, V23, P3028, DOI 10.1002/eji.1830231145; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Margulies DH, 1996, NATURE, V381, P558, DOI 10.1038/381558a0; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MARTIN WD, 1996, CELL, V84, P542; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; NANDA NK, 1995, J EXP MED, V182, P531, DOI 10.1084/jem.182.2.531; PAGE DM, 1993, J IMMUNOL, V151, P1868; Pawlowski TJ, 1996, EUR J IMMUNOL, V26, P851, DOI 10.1002/eji.1830260419; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHUMACHER TNM, 1994, IMMUNITY, V1, P721, DOI 10.1016/S1074-7613(94)80013-8; Sebzda E, 1996, J EXP MED, V183, P1093, DOI 10.1084/jem.183.3.1093; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHIBATA K, 1992, P NATL ACAD SCI USA, V89, P3135, DOI 10.1073/pnas.89.7.3135; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; TOMLINSON AJ, 1995, J LIQ CHROMATOGR, V18, P3591, DOI 10.1080/10826079508014613; Tomlinson AJ, 1995, J CAPILLARY ELECTROP, V2, P225; Tomlinson AJ, 1996, J CHROMATOGR A, V744, P273, DOI 10.1016/0021-9673(96)00333-0; TOMLINSON AJ, 1994, HRC-J HIGH RES CHROM, V17, P729; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANSANTEN HM, 1995, J EXP MED, V181, P787, DOI 10.1084/jem.181.2.787; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; ZUGIC JN, 1990, NATURE, V344, P65	58	164	164	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					389	399		10.1016/S1074-7613(00)80282-4	http://dx.doi.org/10.1016/S1074-7613(00)80282-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133418	Bronze			2022-12-18	WOS:A1997XC61900004
J	Price, AE; Shamardani, K; Lugo, KA; Deguine, J; Roberts, AW; Lee, BL; Barton, GM				Price, April E.; Shamardani, Kiarash; Lugo, Kyler A.; Deguine, Jacques; Roberts, Allison W.; Lee, Bettina L.; Barton, Gregory M.			A Map of Toll-like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial, Cell Type-Specific, and Temporal Patterns	IMMUNITY			English	Article							INFLAMMATORY BOWEL DISEASES; BACTERIAL FLAGELLIN; PANETH CELLS; CROHNS-DISEASE; HOMEOSTASIS; MICROBIOTA; COLITIS; POLYMORPHISMS; RECOGNITION; CHEMOKINES	Signaling by Toll-like receptors (TLRs) on intestinal epithelial cells (IECs) is critical for intestinal homeostasis. To visualize epithelial expression of individual TLRs in vivo, we generated five strains of reporter mice. These mice revealed that TLR expression varied dramatically along the length of the intestine. Indeed, small intestine (SI) IECs expressed low levels of multiple TLRs that were highly expressed by colonic IECs. TLR5 expression was restricted to Paneth cells in the SI epithelium. Intestinal organoid experiments revealed that TLR signaling in Paneth cells or colonic IECs induced a core set of host defense genes, but this set did not include antimicrobial peptides, which instead were induced indirectly by inflammatory cytokines. This comprehensive blueprint of TLR expression and function in IECs reveals unexpected diversity in the responsiveness of IECs to microbial stimuli, and together with the associated reporter strains, provides a resource for further study of innate immunity.	[Price, April E.; Shamardani, Kiarash; Lugo, Kyler A.; Deguine, Jacques; Roberts, Allison W.; Lee, Bettina L.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Lugo, Kyler A.] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Deguine, Jacques] Cell Press, 50 Hampshire St, Cambridge, MA 02139 USA; [Lee, Bettina L.] Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California Berkeley; Stanford University; Roche Holding; Genentech	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.	barton@berkeley.edu	Shamardani, Kiarash/AAV-4494-2021	Shamardani, Kiarash/0000-0002-2548-705X; Lugo, Kyler/0000-0001-9050-6993; Deguine, Jacques/0000-0001-9218-3040	Kenneth Rainin Foundation; NIH [AI072429, AI063302]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award; Irvington Postdoctoral Fellowship from the Cancer Research Institute; NIH S10 program [1S10RR026866-01]; NIH Instrumentation Grant [S10 OD018174]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, P01AI063302, R01AI072429] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018174] Funding Source: NIH RePORTER	Kenneth Rainin Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Irvington Postdoctoral Fellowship from the Cancer Research Institute; NIH S10 program; NIH Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Nolla and A. Valeros (UC Berkeley Cancer Research Laboratory Flow Cytometry Facility) for assistance with cell sorting, J. Valencia and J. Xie for assistance cutting tissue sections, and E. Wu, K. Ching, and B. Russell for technical assistance. We thank J. Price and members of the Barton and Vance labs for critical reading of the manuscript and helpful discussions and K. Pestal for help with the graphical abstract. This work was supported by an Innovator Award from the Kenneth Rainin Foundation, NIH grants AI072429 and AI063302 to G.M.B., and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award to G.M.B. A.E.P. was supported by an Irvington Postdoctoral Fellowship from the Cancer Research Institute. Microscopy was completed at the Biological Imaging Facility at UC Berkeley, supported in part by the NIH S10 program under award number 1S10RR026866-01. Sequencing was performed by the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 OD018174 Instrumentation Grant.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Dheer R, 2016, INFECT IMMUN, V84, P798, DOI 10.1128/IAI.01374-15; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Ogier-Denis E, 2008, SEMIN IMMUNOPATHOL, V30, P291, DOI 10.1007/s00281-008-0120-9; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2015, P NATL ACAD SCI USA, V112, P1929, DOI 10.1073/pnas.1424886112; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sivick KE, 2014, CELL HOST MICROBE, V15, P203, DOI 10.1016/j.chom.2014.01.013; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yu SY, 2015, CELL MOL LIFE SCI, V72, P3343, DOI 10.1007/s00018-015-1931-1; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	43	163	168	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					560	+		10.1016/j.immuni.2018.07.016	http://dx.doi.org/10.1016/j.immuni.2018.07.016			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30170812	Bronze, Green Accepted			2022-12-18	WOS:000444909600021
J	Tolar, P; Hanna, J; Krueger, PD; Pierce, SK				Tolar, Pavel; Hanna, Joseph; Krueger, Peter D.; Pierce, Susan K.			The Constant Region of the Membrane Immunoglobulin Mediates B Cell-Receptor Clustering and Signaling in Response to Membrane Antigens	IMMUNITY			English	Article							SUBCAPSULAR SINUS; STRUCTURAL BASIS; LIVING CELLS; MICROCLUSTERS; ACTIVATION; REVEALS; INITIATION; COMPLEX; TRANSMEMBRANE; MUTANTS	B cells are activated in vivo after the B cell receptors (BCRs) bind to antigens captured on the surfaces of antigen-presenting cells. Antigen binding results in BCR microclustering and signaling; however, the molecular nature of the signaling-active BCR clusters is not well understood. Using single-molecule imaging techniques, we provide evidence that within microclusters, the binding of monovalent membrane antigens results in the assembly of immobile signaling-active BCR oligomers. The oligomerization depends on interactions between the membrane-proximal C mu 4 domains of the membrane immunoglobulin that are both necessary and sufficient for assembly. Antigen-bound BCRs that lacked the C mu 4 domain failed to cluster and signal, and conversely, C mu 4 domains alone clustered spontaneously and activated B cells. These results support a unique mechanism for the initiation of BCR signaling in which antigen binding induces a conformational change in the Fc portion of the BCR, revealing an interface that promotes BCR clustering.	[Tolar, Pavel; Hanna, Joseph; Krueger, Peter D.; Pierce, Susan K.] NIAID, Immunogenet Lab, Natl Inst Hlth, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, Natl Inst Hlth, Rockville, MD 20852 USA.	spierce@niaid.nih.gov		Tolar, Pavel/0000-0003-4693-7299	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000898, ZIAAI000899, Z01AI000899] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Davis and J. Huppa for advice on bilayer preparation, T. Meckel for advice on single-molecule data analysis, C.-Y. Huang for advice on statistical analysis, and J. Brzostowski for help with imaging and comments on the manuscript. This work has been supported by the Intramural Research program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.	Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; CORCOS D, 1995, CURR BIOL, V5, P1140, DOI 10.1016/S0960-9822(95)00230-2; CORCOS D, 1991, EUR J IMMUNOL, V21, P2711, DOI 10.1002/eji.1830211110; Corcos D, 2007, ARCH IMMUNOL THER EX, V55, P77, DOI 10.1007/s00005-007-0010-1; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Metzger H, 1974, Adv Immunol, V18, P169, DOI 10.1016/S0065-2776(08)60310-7; METZGER H, 1992, J IMMUNOL, V149, P1477; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pracht C, 2002, EUR J IMMUNOL, V32, P1614, DOI 10.1002/1521-4141(200206)32:6<1614::AID-IMMU1614>3.0.CO;2-A; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 2000, IMMUNOL REV, V176, P10; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shaffer AL, 1997, J IMMUNOL, V159, P1265; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	46	163	166	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					44	55		10.1016/j.immuni.2008.11.007	http://dx.doi.org/10.1016/j.immuni.2008.11.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19135393	Green Accepted, Bronze			2022-12-18	WOS:000262769900009
J	Matheu, MP; Beeton, C; Garcia, A; Chi, V; Rangaraju, S; Safrina, O; Monaghan, K; Uemura, MI; Li, D; Pal, S; de la Maza, LM; Monuki, E; Flugel, A; Pennington, MW; Parker, I; Chandy, KG; Cahalan, MD				Matheu, Melanie P.; Beeton, Christine; Garcia, Adriana; Chi, Victor; Rangaraju, Srikant; Safrina, Olga; Monaghan, Kevin; Uemura, Marc I.; Li, Dan; Pal, Sukumar; de la Maza, Luis M.; Monuki, Edwin; Fluegel, Alexander; Pennington, Michael W.; Parker, Ian; Chandy, K. George; Cahalan, Michael D.			Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block	IMMUNITY			English	Article							COLLAGEN-BINDING INTEGRINS; MULTIPLE-SCLEROSIS; POTASSIUM CHANNELS; AUTOIMMUNE-DISEASES; LYMPHOCYTE MOTILITY; IMMUNE-RESPONSES; K+ CHANNELS; IN-VIVO; EXPRESSION; ACTIVATION	Effector memory T (Tem) cells are essential mediators of autoimmune disease and delayed-type hypersensitivity (DTH), a convenient model for two-photon imaging of Tern cell participation in an inflammatory response. Shortly (3 hr) after entry into antigen-primed ear tissue, Tem cells stably attached to antigen-bearing antigen-presenting cells (APCs). After 24 hr, enlarged Tern cells were highly motile along collagen fibers and continued to migrate rapidly for 18 hr. Tern cells rely on voltagegated Kv1.3 potassium channels to regulate calcium signaling. ShK-186, a specific Kv1.3 blocker, inhibited DTH and suppressed Tem cell enlargement and motility in inflamed tissue but had no effect on homing to or motility in lymph nodes of naive and central memory T (Tcm) cells. ShK-186 effectively treated disease in a rat model of multiple sclerosis. These results demonstrate a requirement for Kv1.3 channels in Tem cells during an inflammatory immune response in peripheral tissues. Targeting Kv1.3 allows for effector memory responses to be suppressed while central memory responses remain intact.	[Matheu, Melanie P.; Beeton, Christine; Garcia, Adriana; Chi, Victor; Rangaraju, Srikant; Safrina, Olga; Monaghan, Kevin; Uemura, Marc I.; Parker, Ian; Chandy, K. George; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Matheu, Melanie P.; Beeton, Christine; Garcia, Adriana; Chi, Victor; Rangaraju, Srikant; Safrina, Olga; Monaghan, Kevin; Uemura, Marc I.; Parker, Ian; Chandy, K. George; Cahalan, Michael D.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA; [Li, Dan; Pal, Sukumar; de la Maza, Luis M.; Monuki, Edwin] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Fluegel, Alexander] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Pennington, Michael W.] Bachem Biosci Inc, King Of Prussia, PA 19406 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Max Planck Society	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu	Rangaraju, S/Q-1924-2018	Rangaraju, S/0000-0003-2765-1500; Beeton, Christine/0000-0002-2500-5874; Pal, Sukumar/0000-0001-5170-5121; Monuki, Edwin/0000-0001-5130-781X; Uemura, Marc/0000-0002-6628-8356; pennington, michael/0000-0001-5446-3447	NIH [Al-64128, GM-41514, NS-48252, GM-48071, AI-32248]; American Heart Association Western States Affiliates [0665009Y]; AIRMID Inc; Hertie Foundation [1.01.1/04/010]; Deutsche Forschungsgemeinschaft [SFB455]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI064128, R01AI032248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R37GM048071, R01GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western States Affiliates(American Heart Association); AIRMID Inc; Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank R. Paquette for assistance with reagent preparation and D. Sen for advice on movie compression. We also thank B. Andersen and S. Griffey for helpful discussions and advice. M.P.M. was supported by a NIH Ruth L. Kirchstein predoctoral fellowship Al-64128. A.G. was supported by a NIH Minority Supplement. M.U. was supported by a 2006-2007 Medical Student Research Grant from the American Heart Association Western States Affiliates. AIRMID Inc. supported the good laboratory practices (GLP) studies at the Burleson Research Technologies to examine the effect of Kv1.3 blockers on rat-adapted influenza virus in rats. Additional support was provided by the Hertie Foundation (#1.01.1/04/010) and the Deutsche Forschungsgemeinschaft (SFB455) (A.F.); the American Heart Association Western States Affiliates (0665009Y) (C.B.); and NIH grants GM-41514 (M.D.C.), NS-48252 (K.G.C.), GM-48071 (I.P.), and AI-32248 (L.M.W.M.).	Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton Christine, 2007, J Vis Exp, DOI 10.3791/325; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; FERGUSON TA, 1991, P NATL ACAD SCI USA, V88, P8072, DOI 10.1073/pnas.88.18.8072; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; GAGA M, 1991, J IMMUNOL, V147, P816; Goffe B, 2005, CLIN THER, V27, P1912, DOI 10.1016/j.clinthera.2005.12.007; Gomez M, 1997, EUR J IMMUNOL, V27, P8, DOI 10.1002/eji.1830270103; Gottlieb AB, 2003, J AM ACAD DERMATOL, V49, P816, DOI 10.1016/S0190-9622(03)01836-X; Haegele KF, 2007, J NEUROIMMUNOL, V183, P168, DOI 10.1016/j.jneuroim.2006.09.008; HANCOCK WW, 1994, AM J PATHOL, V144, P1149; Heydtmann M, 2006, J IMMUNOL, V177, P729, DOI 10.4049/jimmunol.177.1.729; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Li YYY, 2006, EXPERT OPIN THER TAR, V10, P489, DOI 10.1517/14728222.10.4.489; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; Matheu MP, 2007, J IMMUNOL, V179, P2261, DOI 10.4049/jimmunol.179.4.2261; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Panyi G, 2004, P NATL ACAD SCI USA, V101, P1285, DOI 10.1073/pnas.0307421100; Pereira LE, 2007, EXP BIOL MED, V232, P1338, DOI 10.3181/0705-RM-148; PICKER LJ, 1990, J IMMUNOL, V145, P3247; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Rowin ME, 1998, J CELL PHYSIOL, V175, P193, DOI 10.1002/(SICI)1097-4652(199805)175:2<193::AID-JCP9>3.0.CO;2-J; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640	49	163	174	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					602	614		10.1016/j.immuni.2008.07.015	http://dx.doi.org/10.1016/j.immuni.2008.07.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18835197	Bronze, Green Accepted			2022-12-18	WOS:000260316700013
J	Manz, MG				Manz, Markus G.			Human-hemato-lymphoid-system mice: Opportunities and challenges	IMMUNITY			English	Article							HUMAN IMMUNE-SYSTEM; T-CELLS; STEM-CELLS; MARROW; BLOOD; MOUSE; MODEL; RECONSTITUTION; MATURATION; SELECTION	With the recent advances in human-hemato-lymphoid-system mice, this commentary discusses the utility of these mice and further improvements required to generate an accessible system that allows predictive in vivo human hematology and immunology research.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Osped San Giovanni Bellinzona, Oncol Inst So Switzerland IOSI, Dept Hematol, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni	Manz, MG (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	manz@irb.unisi.ch	Manz, Markus G/C-7588-2011	Manz, Markus/0000-0002-4676-7931				Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Grewal SS, 2003, BLOOD, V101, P4233, DOI 10.1182/blood-2002-08-2510; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kerre TCC, 2002, BLOOD, V99, P1620, DOI 10.1182/blood.V99.5.1620; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Legrand N, 2006, BLOOD, V108, P238, DOI 10.1182/blood-2006-01-0190; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Zinkernagel RM, 1999, P NATL ACAD SCI USA, V96, P8092, DOI 10.1073/pnas.96.14.8092	26	163	176	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					537	541		10.1016/j.immuni.2007.05.001	http://dx.doi.org/10.1016/j.immuni.2007.05.001			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521579	Bronze			2022-12-18	WOS:000246895900003
J	Robinson, DS; O'Garra, A				Robinson, DS; O'Garra, A			Further checkpoints in Th1 development	IMMUNITY			English	Review							HELPER CELL SUBSETS; IFN-GAMMA; T(H)1 CELLS; T-CELLS; CYTOKINE; INTERLEUKIN-12; TRANSCRIPTION; EXPRESSION; RESPONSES; IMMUNITY	Tight control of Th1 immunity is essential to prevent immunopathology. Central to control of the IFN-gamma gene is the transcription factor T-bet, whose induction is Stat-1 dependent. IL-12 is dominant in directing Th1 development, while synergizing with IL-18 for IFNgamma production from differentiated Th1 cells. In this issue of Immunity, IL-27 is described, which acts in synergy with IL-12 early in Th1 development from naive T cells via the receptor TCCR/WSX-1. We review the coordination of these checkpoints in Th1 development and function.	Natl Inst Med Res, Immunoregulat Lab, London NW7 1AA, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AK, England	MRC National Institute for Medical Research; Imperial College London	O'Garra, A (corresponding author), Natl Inst Med Res, Immunoregulat Lab, The Ridgeway,Mill Hill, London NW7 1AA, England.			O'Garra, Anne/0000-0001-9845-6134				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Heath VL, 2000, J IMMUNOL, V164, P2861, DOI 10.4049/jimmunol.164.6.2861; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Neighbors M, 2001, J EXP MED, V194, P343, DOI 10.1084/jem.194.3.343; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	31	163	170	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2002	16	6					755	758		10.1016/S1074-7613(02)00331-X	http://dx.doi.org/10.1016/S1074-7613(02)00331-X			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121657	Bronze			2022-12-18	WOS:000176534000001
J	Pinaud, E; Khamlichi, AA; Le Morvan, C; Drouet, M; Nalesso, V; Le Bert, M; Cogne, M				Pinaud, E; Khamlichi, AA; Le Morvan, C; Drouet, M; Nalesso, V; Le Bert, M; Cogne, M			Localization of the 3 ' IgH locus elements that effect long-distance regulation of class switch recombination	IMMUNITY			English	Article							HEAVY-CHAIN LOCUS; BETA-GLOBIN LOCUS; B-CELL DEVELOPMENT; CONTROL REGION; GERMLINE TRANSCRIPTION; CONSTANT-REGION; CUTTING EDGE; ENHANCER; GENE; EXPRESSION	Four transcriptional enhancers lie downstream of the immunoglobulin heavy chain locus: C alpha3'/hs3a, hs1,2, hs3b, and hs4. Although individually weak, these elements have strong transcriptional synergies when combined and they altogether behave as a locus control region. Previous knockout experiments in the 3' region have shown that both hs3a and hs1,2 are dispensable for normal expression and rearrangement of the IgH locus but that their replacement with a transcribed neo gene severely affects class switch recombination. Here we show that even in the absence of a neo gene, joint deletion of the last two 3' enhancers, hs3b and hs4, severely impairs germline transcription and class switching to most isotypes and may in addition affect mu gene expression in resting B cells.	Fac Med Limoges, CNRS, UMR6101, Immunol Lab, F-87025 Limoges, France; CNRS, UPS 44, Ctr Dev Tech Avancees Expt Anim, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Cogne, M (corresponding author), Fac Med Limoges, CNRS, UMR6101, Immunol Lab, 2 Rue Dr Marcland, F-87025 Limoges, France.		cogné, michel/D-7370-2015; Le Bert, Marc/AAR-4577-2021; PINAUD, Eric/O-8443-2016	cogné, michel/0000-0002-8519-4427; Le Bert, Marc/0000-0002-5945-3800; PINAUD, Eric/0000-0001-7405-9273; Khamlichi, Ahmed Amine/0000-0002-6523-2035				Adams K, 2000, INT IMMUNOL, V12, P1705, DOI 10.1093/intimm/12.12.1705; ARULAMPALAM V, 1994, EUR J IMMUNOL, V24, P1671, DOI 10.1002/eji.1830240732; Aupetit C, 2000, KIDNEY INT, V58, P966, DOI 10.1046/j.1523-1755.2000.00253.x; Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Chauveau C, 1999, J IMMUNOL, V163, P4637; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.3.CO;2-M; Chen CQ, 1997, J IMMUNOL, V159, P1310; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Collins JT, 1999, J IMMUNOL, V163, P5758; Cunningham K, 1998, INT IMMUNOL, V10, P1027, DOI 10.1093/intimm/10.8.1027; Cunningham K, 1998, INT IMMUNOL, V10, P527, DOI 10.1093/intimm/10.4.527; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Denizot Y, 2001, IMMUNOLOGY, V103, P35, DOI 10.1046/j.1365-2567.2001.01217.x; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; FLERING S, 1995, GENE DEV, V9, P2203; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; GRANT PA, 1995, EMBO J, V14, P4501, DOI 10.1002/j.1460-2075.1995.tb00129.x; Grant PA, 1996, EMBO J, V15, P6691, DOI 10.1002/j.1460-2075.1996.tb01059.x; GREGOR PD, 1986, MOL CELL BIOL, V6, P1903, DOI 10.1128/MCB.6.6.1903; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; Michaelson JS, 1996, J IMMUNOL, V156, P2828; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Mills FC, 1997, J EXP MED, V186, P845, DOI 10.1084/jem.186.6.845; MOCIKAT R, 1995, EUR J IMMUNOL, V25, P3195, DOI 10.1002/eji.1830251132; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Ong J, 1998, J IMMUNOL, V160, P4896; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; Pinaud E, 1997, EUR J IMMUNOL, V27, P2981, DOI 10.1002/eji.1830271134; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Saleque S, 1999, J IMMUNOL, V162, P2791; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Snapper CM, 1996, J IMMUNOL, V156, P183; TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; WAGNER SD, 1994, EUR J IMMUNOL, V24, P2672, DOI 10.1002/eji.1830241116; Wagner SD, 1996, GENOMICS, V35, P405, DOI 10.1006/geno.1996.0379; XU MZ, 1992, EMBO J, V11, P145, DOI 10.1002/j.1460-2075.1992.tb05037.x	53	163	168	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					187	199		10.1016/S1074-7613(01)00181-9	http://dx.doi.org/10.1016/S1074-7613(01)00181-9			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520455	Bronze			2022-12-18	WOS:000170717200002
J	Arroyo, AG; Yang, JT; Rayburn, H; Hynes, RO				Arroyo, AG; Yang, JT; Rayburn, H; Hynes, RO			alpha 4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo	IMMUNITY			English	Article							LATE ACTIVATION ANTIGEN-4; T-CELL DEVELOPMENT; BONE-MARROW; IN-VIVO; STEM-CELLS; STROMAL CELLS; C-MYB; ADHESION; FIBRONECTIN; DIFFERENTIATION	We investigated roles of alpha 4 integrins during hematopoiesis using mutant and chimeric mice. Yolk sac erythropoiesis and migration of hematopoietic progenitors to fetal liver, spleen, and bone marrow can occur without a4 integrins. Although terminal differentiation of these progenitors is possible without alpha 4 integrins, these receptors are essential to maintain normal hematopoiesis in fetal liver, spleen, and bone marrow microenvironments. Moreover, alpha 4-deficient erythroid progenitors and pre-B cells neither transmigrate beneath the stroma nor expand properly in vitro. In contrast, alpha 4-null cells migrate and differentiate efficiently into T lymphocytes within the thymus. In summary, alpha 4 integrins are essential for normal development of ail hematopoietic lineages in fetal liver, bone marrow, and spleen, likely by regulating the proliferation/differentiation balance of hematopoietic progenitors.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hynes, RO (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.		Arroyo, Alicia G./L-2796-2014	Arroyo, Alicia G./0000-0002-1536-3846	NHLBI NIH HHS [P01 HL41484] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiuti A, 1998, EXP HEMATOL, V26, P143; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655; Crisa L, 1996, J EXP MED, V184, P215, DOI 10.1084/jem.184.1.215; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P11; Friedrich C, 1996, EUR J IMMUNOL, V26, P2773, DOI 10.1002/eji.1830261133; Friedrich C, 1996, BLOOD, V87, P4596, DOI 10.1182/blood.V87.11.4596.bloodjournal87114596; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Goltry KL, 1997, BLOOD, V90, P138; Grayson MH, 1998, J EXP MED, V188, P2187, DOI 10.1084/jem.188.11.2187; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; Hanspal M, 1997, Curr Opin Hematol, V4, P142; Hemler M E, 1995, Curr Opin Hematol, V2, P61; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Imai K, 1999, BLOOD, V93, P149, DOI 10.1182/blood.V93.1.149.401a02_149_156; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Levesque JP, 1996, BLOOD, V88, P1168, DOI 10.1182/blood.V88.4.1168.bloodjournal8841168; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OGAWA M, 1993, BLOOD, V81, P2844; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; RYAN DH, 1992, J IMMUNOL, V149, P3759; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Schofield KP, 1998, BLOOD, V91, P3230, DOI 10.1182/blood.V91.9.3230.3230_3230_3238; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Wagner N, 1998, CURR TOP MICROBIOL, V231, P23; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; WHITNEY JB, 1978, BIOCHEM GENET, V16, P667, DOI 10.1007/BF00484723; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; YANAI N, 1994, BLOOD, V83, P2844, DOI 10.1182/blood.V83.10.2844.2844; Yang JT, 1996, J CELL BIOL, V135, P829, DOI 10.1083/jcb.135.3.829; YANG JT, 1995, DEVELOPMENT, V121, P549; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272	54	163	170	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					555	566		10.1016/S1074-7613(00)80131-4	http://dx.doi.org/10.1016/S1074-7613(00)80131-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591181	Bronze			2022-12-18	WOS:000083952200008
J	Harrington, CJ; Paez, A; Hunkapiller, T; Mannikko, V; Brabb, T; Ahearn, ME; Beeson, C; Goverman, J				Harrington, CJ; Paez, A; Hunkapiller, T; Mannikko, V; Brabb, T; Ahearn, ME; Beeson, C; Goverman, J			Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein	IMMUNITY			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CLASS-II MHC; AUTOIMMUNE ENCEPHALOMYELITIS; ENCEPHALITOGENIC EPITOPES; MOUSE; DETERMINANT; PEPTIDES; ANTIGEN; IMMUNE	Experimental allergic encephalomyelitis (EAE) is induced by T cell-mediated immunity to central nervous system antigens. In H-2(U) mice, EAE is mediated primarily by T cells specific for residues 1-11 of myelin basic protein (MBP). We demonstrate that differential tolerance to MBP1-11 versus epitopes in MBP121-150 is induced by expression of endogenous MBP, reflecting extreme differences in stability of peptide/MHC complexes. The diverse MBP121-150-specific TCR repertoire can be divided into three fine specificity groups. Two groups were identified in wild-type mice despite extensive tolerance, but the third group was not detected. Activated MBP121-150-specific T cells induce EAE in wild-type mice. Thus, encephalitogenic T cells that escape tolerance either recognize short-lived peptide/MHC complexes or express TCRs with unique specificities for stable complexes.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Goverman, J (corresponding author), Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA.	goverman@u.washington.edu		Goverman, Joan/0000-0002-7361-9424	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM016642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035126] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM16642-02] Funding Source: Medline; NINDS NIH HHS [R01 NS35126] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER CF, 1977, ADV IMMUNOL, V25, P1; BHARDWAJ V, 1994, J IMMUNOL, V152, P3711; CABANIOLS JP, 1994, EUR J IMMUNOL, V24, P1743, DOI 10.1002/eji.1830240804; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; DUPOUEY P, 1979, NEUROSCI LETT, V12, P113, DOI 10.1016/0304-3940(79)91490-3; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; FRITZ RB, 1989, CHEM IMMUNOL, V46, P101; FRITZ RB, 1983, J IMMUNOL, V130, P191; FRITZ RB, 1985, J IMMUNOL, V134, P2328; Fritz RB, 1996, J IMMUNOL, V157, P5249; GAMMON G, 1989, NATURE, V342, P183, DOI 10.1038/342183a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Greer JM, 1996, J IMMUNOL, V156, P371; GUERY JC, 1995, J IMMUNOL, V154, P545; Kim DT, 1996, J IMMUNOL, V156, P2737; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MASON K, 1995, BIOCHEMISTRY-US, V34, P14874, DOI 10.1021/bi00045a031; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; MILLER SD, 1995, IMMUNOL REV, V144, P225, DOI 10.1111/j.1600-065X.1995.tb00071.x; Muraro PA, 1997, J CLIN INVEST, V100, P339, DOI 10.1172/JCI119539; NANDA NK, 1995, J EXP MED, V182, P531, DOI 10.1084/jem.182.2.531; NELSON CA, 1994, NATURE, V371, P250, DOI 10.1038/371250a0; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; ORBEA HA, 1988, CELL, V54, P263; PATERSON PY, 1976, TXB IMMUNOPATHOLOGY, P179; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; QUARATINO S, 1995, P NATL ACAD SCI USA, V92, P10398, DOI 10.1073/pnas.92.22.10398; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROTHBARD JB, 1991, ANNU REV IMMUNOL, V9, P527, DOI 10.1146/annurev.iy.09.040191.002523; SAKAI K, 1989, P NATL ACAD SCI USA, V86, P9470, DOI 10.1073/pnas.86.23.9470; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VINER NJ, 1995, P NATL ACAD SCI USA, V92, P2214, DOI 10.1073/pnas.92.6.2214; Viner NJ, 1996, J IMMUNOL, V156, P2365; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Williams KC, 1995, CURR TOP MICROBIOL, V202, P221; Zaller DM, 1996, CURR TOP MICROBIOL, V206, P15; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; ZAMVIL SS, 1987, J IMMUNOL, V139, P1075; ZAMVIL SS, 1988, J EXP MED, V168, P1181, DOI 10.1084/jem.168.3.1181	46	163	166	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1998	8	5					571	580		10.1016/S1074-7613(00)80562-2	http://dx.doi.org/10.1016/S1074-7613(00)80562-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620678	Bronze			2022-12-18	WOS:000073885400005
J	Tyagi, AM; Yu, MC; Darby, TM; Vaccaro, C; Li, JY; Owens, JA; Hsu, E; Adams, J; Weitzmann, MN; Jones, RM; Pacifici, R				Tyagi, Abdul Malik; Yu, Mingcan; Darby, Trevor M.; Vaccaro, Chiara; Li, Jau-Yi; Owens, Joshua A.; Hsu, Emory; Adams, Jonathan; Weitzmann, M. Neale; Jones, Rheinallt M.; Pacifici, Roberto			The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression	IMMUNITY			English	Article							CHAIN FATTY-ACIDS; ANABOLIC ACTIVITY; PARATHYROID-HORMONE; PTH; BACTERIA; OSTEOBLAST; DIVERSITY; DEPLETION; DIFFERENTIATION; PROLIFERATION	Nutritional supplementation with probiotics can prevent pathologic bone loss. Here we examined the impact of supplementation with Lactobacillus rhamnosus GG (LGG) on bone homeostasis in eugonadic young mice. Micro-computed tomography revealed that LGG increased trabecular bone volume in mice, which was due to increased bone formation. Butyrate produced in the gut following LGG ingestion, or butyrate fed directly to germ-free mice, induced the expansion of intestinal and bone marrow (BM) regulatory T (Treg) cells. Interaction of BM CD8(+) T cells with Treg cells resulted in increased secretion of Wnt10b, a bone anabolic Wnt ligand. Mechanistically, Treg cells promoted the assembly of a NFAT1-SMAD3 transcription complex in CD8(+) cells, which drove expression of Wnt10b. Reducing Treg cell numbers, or reconstitution of TCRb-/- mice with CD8(+) T cells from Wnt10b(-/-) mice, prevented butyrate-induced bone formation and bone mass acquisition. Thus, butyrate concentrations regulate bone anabolism via Treg cell-mediated regulation of CD8(+) T cell Wnt10b production.	[Tyagi, Abdul Malik; Yu, Mingcan; Vaccaro, Chiara; Li, Jau-Yi; Hsu, Emory; Adams, Jonathan; Weitzmann, M. Neale; Pacifici, Roberto] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA; [Darby, Trevor M.; Owens, Joshua A.; Jones, Rheinallt M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Weitzmann, M. Neale] Atlanta VA Med Ctr, Decatur, GA USA; [Pacifici, Roberto] Emory Univ, Immunol & Mol Pathogenesis Program, Atlanta, GA 30322 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University	Pacifici, R (corresponding author), Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA.; Pacifici, R (corresponding author), Emory Univ, Immunol & Mol Pathogenesis Program, Atlanta, GA 30322 USA.	roberto.pacifici@emory.edu	Malik, Abdul/AAX-5715-2020	Malik, Abdul/0000-0001-9012-5779; Owens, Joshua/0000-0001-7315-2898; Jones, Rheinallt/0000-0002-0415-9487; Darby, Trevor/0000-0002-7379-3836	National Institutes of Health [DK112946, DK108842, RR028009, DK108735, DK098391, AR070091, AR068157, AG062334]; Crohn's and Colitis Foundation of America (CCFA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [5I01BX000105]; Georgia Clinical & Translational Science Alliance; Emory University School of Medicine; Emory Neuroscience NINDS Core Facilities; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112946, R01DK108842, R01DK098391, T32DK108735, R01DK119229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U54AG062334] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; Georgia Clinical & Translational Science Alliance; Emory University School of Medicine; Emory Neuroscience NINDS Core Facilities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the National Institutes of Health (DK112946, DK108842, and RR028009 to R.P.; DK108735 to E.H.; DK098391 to R.M.J.; AR070091, AR068157, and AG062334 to M.N.W.). T.M.D. is a recipient of the Research Fellowship award from the Crohn's and Colitis Foundation of America (CCFA). M.N.W. was also supported by a grant from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (5I01BX000105). The Emory Gnotobiotic Animal Core is supported by the Georgia Clinical & Translational Science Alliance and the Emory University School of Medicine. The Emory Integrated Core Facilities are supported by the Emory Neuroscience NINDS Core Facilities, the Georgia Clinical & Translational Science Alliance, and the Emory University School of Medicine.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bedi B, 2012, P NATL ACAD SCI USA, V109, pE725, DOI 10.1073/pnas.1120735109; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen TH, 2007, BIOCHEM BIOPH RES CO, V355, P913, DOI 10.1016/j.bbrc.2007.02.057; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258; Fehr T, 2010, BLOOD, V115, P1280, DOI 10.1182/blood-2009-07-230680; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Gao Y, 2008, CELL METAB, V8, P132, DOI 10.1016/j.cmet.2008.07.001; Hippe B, 2011, FEMS MICROBIOL LETT, V316, P130, DOI 10.1111/j.1574-6968.2010.02197.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jafarnejad S, 2017, J AM COLL NUTR, V36, P497, DOI 10.1080/07315724.2017.1318724; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Kim YG, 2007, BIOCHEM BIOPH RES CO, V357, P1046, DOI 10.1016/j.bbrc.2007.04.042; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Knudsen KEB, 2015, ADV NUTR, V6, P206, DOI 10.3945/an.114.007450; Komatsu N, 2012, ADV IMMUNOL, V115, P45, DOI 10.1016/B978-0-12-394299-9.00002-3; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184; Li JY, 2016, J CLIN INVEST, V126, P2049, DOI 10.1172/JCI86062; Li JY, 2015, CELL METAB, V22, P799, DOI 10.1016/j.cmet.2015.09.012; Li JY, 2014, J BONE MINER RES, V29, P43, DOI 10.1002/jbmr.2044; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Messora MR, 2013, J PERIODONTOL, V84, P1818, DOI 10.1902/jop.2013.120644; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Najafian N, 2000, EXPERT OPIN INV DRUG, V9, P2147, DOI 10.1517/13543784.9.9.2147; Nilsson AG, 2018, J INTERN MED, V284, P307, DOI 10.1111/joim.12805; Ohlsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092368; Robinson JW, 2015, J BONE MINER RES, V30, P695, DOI 10.1002/jbmr.2394; Roser-Page S, 2014, ARTHRITIS RHEUMATOL, V66, P990, DOI 10.1002/art.38319; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yu MC, 2018, EMBO REP, V19, P156, DOI 10.15252/embr.201744421; Zhang J, 2015, ENDOCRINOLOGY, V156, P3169, DOI 10.1210/EN.2015-1308	62	162	183	16	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1116	+		10.1016/j.immuni.2018.10.013	http://dx.doi.org/10.1016/j.immuni.2018.10.013			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30446387	Green Accepted, hybrid			2022-12-18	WOS:000453556500016
J	Mondanelli, G; Bianchi, R; Pallotta, MT; Orabona, C; Albini, E; Iacono, A; Belladonna, ML; Vacca, C; Fallarino, F; Macchiarulo, A; Ugel, S; Bronte, V; Gevi, F; Zolla, L; Verhaar, A; Peppelenbosch, M; Mazza, EMC; Bicciato, S; Laouar, Y; Santambrogio, L; Puccetti, P; Volpi, C; Grohmann, U				Mondanelli, Giada; Bianchi, Roberta; Pallotta, Maria Teresa; Orabona, Ciriana; Albini, Elisa; Iacono, Alberta; Belladonna, Maria Laura; Vacca, Carmine; Fallarino, Francesca; Macchiarulo, Antonio; Ugel, Stefano; Bronte, Vincenzo; Gevi, Federica; Zolla, Lello; Verhaar, Auke; Peppelenbosch, Maikel; Mazza, Emilia Maria Cristina; Bicciato, Silvio; Laouar, Yasmina; Santambrogio, Laura; Puccetti, Paolo; Volpi, Claudia; Grohmann, Ursula			A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; SUPPRESSOR-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; TGF-BETA; IMMUNE-RESPONSE; CROSS-TALK; IDO; TOLERANCE; CANCER	Arginase 1 (Arg1) and indoleamine 2,3-dioxygenase 1 (IDO1) are immunoregulatory enzymes catalyzing the degradation of L-arginine and L-tryptophan, respectively, resulting in local amino acid deprivation. In addition, unlike Arg1, IDO1 is also endowed with non-enzymatic signaling activity in dendritic cells (DCs). Despite considerable knowledge of their individual biology, no integrated functions of Arg1 and IDO1 have been reported yet. We found that IDO1 phosphorylation and consequent activation of IDO1 signaling in DCs was strictly dependent on prior expression of Arg1 and Arg1-dependent production of polyamines. Polyamines, either produced by DCs or released by bystander Arg1(+) myeloid-derived suppressor cells, conditioned DCs toward an IDO1-dependent, immunosuppressive phenotype via activation of the Src kinase, which has IDO1-phosphorylating activity. Thus our data indicate that Arg1 and IDO1 are linked by an entwined pathway in immuno-metabolism and that their joint modulation could represent an important target for effective immunotherapy in several disease settings.	[Mondanelli, Giada; Bianchi, Roberta; Pallotta, Maria Teresa; Orabona, Ciriana; Albini, Elisa; Iacono, Alberta; Belladonna, Maria Laura; Vacca, Carmine; Fallarino, Francesca; Puccetti, Paolo; Volpi, Claudia; Grohmann, Ursula] Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Pharmaceut Sci, I-06132 Perugia, Italy; [Ugel, Stefano; Bronte, Vincenzo] Verona Univ Hosp, Dept Med, I-37134 Verona, Italy; [Gevi, Federica; Zolla, Lello] Univ Tuscia, Dept Ecol & Biol Sci, I-01100 Viterbo, Italy; [Verhaar, Auke; Peppelenbosch, Maikel] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Mazza, Emilia Maria Cristina; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Laouar, Yasmina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY 10461 USA	University of Perugia; University of Perugia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Tuscia University; Erasmus University Rotterdam; Erasmus MC; Universita di Modena e Reggio Emilia; University of Michigan System; University of Michigan; Yeshiva University	Volpi, C; Grohmann, U (corresponding author), Univ Perugia, Dept Expt Med, I-06132 Perugia, Italy.	claudia.volpi@unipg.it; ursula.grohmann@unipg.it	Bronte, Vincenzo/K-7902-2016; Bicciato, Silvio/C-9825-2009; Mondanelli, Giada/H-7899-2018; Vacca, Carmine/AAE-7046-2019; Grohmann, Ursula/T-6545-2019; Gevi, Federica/AAB-2524-2022; Macchiarulo, Antonio/L-2846-2017; Gevi, Federica/AAO-4485-2020; Pallotta, Maria Teresa/K-7021-2016; Peppelenbosch, Maikel P./U-5304-2019; Ugel, Stefano/J-5535-2016; Fallarino, Francesca/O-3358-2013	Bronte, Vincenzo/0000-0002-3741-5141; Bicciato, Silvio/0000-0002-1944-7078; Mondanelli, Giada/0000-0002-0798-0465; Vacca, Carmine/0000-0002-3799-8164; Gevi, Federica/0000-0001-6208-8130; Macchiarulo, Antonio/0000-0001-9535-4183; Pallotta, Maria Teresa/0000-0002-0417-1638; Ugel, Stefano/0000-0002-6639-7608; Albini, Elisa/0000-0002-2351-8422; Iacono, Alberta/0000-0002-2650-072X; Fallarino, Francesca/0000-0002-8501-2136; Mazza, Emilia Maria Cristina/0000-0003-2424-3640; Peppelenbosch, Maikel/0000-0001-9112-6028	European Research Council [338954-DIDO]; Ministero dell'Istruzione, Universita e Ricerca, Italy [FIRB RBAP11T3WB]	European Research Council(European Research Council (ERC)European Commission); Ministero dell'Istruzione, Universita e Ricerca, Italy(Ministry of Education, Universities and Research (MIUR))	We thank Ioana M. Iamandii for statistical analyses. This work was supported by the European Research Council (338954-DIDO; to U.G. and A. M.) and in part by Ministero dell'Istruzione, Universita e Ricerca, Italy (FIRB RBAP11T3WB; to U.G., V.B., and S.B.).	Anderson DP, 2016, ELIFE, V5, DOI 10.7554/eLife.10147; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belladonna ML, 2008, J IMMUNOL, V181, P5194, DOI 10.4049/jimmunol.181.8.5194; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Billaud M, 2011, CANCER RES, V71, P6572, DOI 10.1158/0008-5472.CAN-11-2158; BOUTARD V, 1995, J IMMUNOL, V155, P2077; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Buque A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1149674; Cervelli M, 2014, AMINO ACIDS, V46, P521, DOI 10.1007/s00726-013-1572-3; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; de St Groth BF, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; Espinosa-Cantu A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00227; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goldszmid RS, 2014, CELL HOST MICROBE, V15, P295, DOI 10.1016/j.chom.2014.02.003; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Grohmann U, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00058; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; Guo YJ, 2005, CANCER RES, V65, P1146, DOI 10.1158/0008-5472.CAN-04-3244; Hayes CS, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27360; HOLTTA E, 1993, J CELL BIOL, V122, P903, DOI 10.1083/jcb.122.4.903; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; MUSSO T, 1994, BLOOD, V83, P1408; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Orabona C, 2012, MOL MED, V18, P834, DOI 10.2119/molmed.2012.00029; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pallotta MT, 2014, J CELL MOL MED, V18, P2082, DOI 10.1111/jcmm.12360; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; PUCCETTI P, 1994, EUR J IMMUNOL, V24, P1446, DOI 10.1002/eji.1830240631; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Ray RM, 2012, CELL SIGNAL, V24, P931, DOI 10.1016/j.cellsig.2011.12.016; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tu E, 2014, CYTOKINE GROWTH F R, V25, P423, DOI 10.1016/j.cytogfr.2014.07.014; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; Volpi C, 2016, NEUROPHARMACOLOGY, V102, P59, DOI 10.1016/j.neuropharm.2015.10.036; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang Q, 2015, MOL CELL BIOL, V35, P63, DOI 10.1128/MCB.00805-14; Ye C, 2016, J IMMUNOL, V196, P915, DOI 10.4049/jimmunol.1500729; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yuasa HJ, 2007, J MOL EVOL, V65, P705, DOI 10.1007/s00239-007-9049-1; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759	64	162	168	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					233	244		10.1016/j.immuni.2017.01.005	http://dx.doi.org/10.1016/j.immuni.2017.01.005			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28214225	Green Published, hybrid			2022-12-18	WOS:000396410900012
J	Najjar, M; Saleh, D; Zelic, M; Nogusa, S; Shah, S; Tai, A; Finger, JN; Polykratis, A; Gough, PJ; Bertin, J; Whalen, MJ; Pasparakis, M; Balachandran, S; Kelliher, M; Poltorak, A; Degterev, A				Najjar, Malek; Saleh, Danish; Zelic, Matija; Nogusa, Shoko; Shah, Saumil; Tai, Albert; Finger, Joshua N.; Polykratis, Apostolos; Gough, Peter J.; Bertin, John; Whalen, Michael J.; Pasparakis, Manolis; Balachandran, Siddharth; Kelliher, Michelle; Poltorak, Alexander; Degterev, Alexei			RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4	IMMUNITY			English	Article							KAPPA-B ACTIVATION; PROGRAMMED NECROSIS; TRANSFORMING ACTIVITY; TNF-ALPHA; C-FOS; NECROPTOSIS; APOPTOSIS; PHOSPHORYLATION; TRIF; INHIBITOR	Macrophages are a crucial component of the innate immune system in sensing pathogens and promoting local and systemic inflammation. RIPK1 and RIPK3 are homologous kinases, previously linked to activation of necroptotic death. In this study, we have described roles for these kinases as master regulators of pro-inflammatory gene expression induced by lipopolysaccharide, independent of their well-documented cell death functions. In primary macrophages, this regulation was elicited in the absence of caspase-8 activity, required the adaptor molecule TRIF, and proceeded in a cell autonomous manner. RIPK1 and RIPK3 kinases promoted sustained activation of Erk, cFos, and NF-kappa B, which were required for inflammatory changes. Utilizing genetic and pharmacologic tools, we showed that RIPK1 and RIPK3 account for acute inflammatory responses induced by lipopolysaccharide in vivo; notably, this regulation did not require exogenous manipulation of caspases. These findings identified a new pharmacologically accessible pathway that may be relevant to inflammatory pathologies.	[Najjar, Malek; Degterev, Alexei] Tufts Univ, Sackler Grad Sch, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Saleh, Danish] Tufts Univ, Sackler Grad Sch, Med Scientist Training Program, Boston, MA 02111 USA; [Saleh, Danish] Tufts Univ, Sackler Grad Sch, Program Neurosci, Boston, MA 02111 USA; [Zelic, Matija; Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Nogusa, Shoko; Balachandran, Siddharth] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, Philadelphia, PA 19111 USA; [Shah, Saumil; Degterev, Alexei] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Tai, Albert; Poltorak, Alexander] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Finger, Joshua N.; Gough, Peter J.; Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA; [Polykratis, Apostolos; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med, Inst Genet, D-50674 Cologne, Germany; [Polykratis, Apostolos; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Whalen, Michael J.] Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA 02129 USA; [Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA; [Whalen, Michael J.] Harvard Med Sch, Charlestown, MA 02129 USA	Tufts University; Tufts University; Tufts University; University of Massachusetts System; University of Massachusetts Worcester; Fox Chase Cancer Center; Tufts University; Tufts University; GlaxoSmithKline; University of Cologne; University of Cologne; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Degterev, A (corresponding author), Tufts Univ, Sackler Grad Sch, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA.; Degterev, A (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	alexei.degterev@tufts.edu	Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Polykratis, Apostolos/0000-0001-6720-3302	NIH [R01GM080356, R01GM084205, R01CA190542, R01AI07118, R01NS047447]; NATIONAL CANCER INSTITUTE [R01CA190542, R01CA168621, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213, R01AI075118, R01AI056234, R01AI007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080356, R01GM084205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NIH to A.D. (R01GM080356 and R01GM084205), to S.B. and A.D. (R01CA190542), to M.K. (R01AI07118), and to M.J.W. (R01NS047447). We thank Drs. Vishva Dixit, Francis K.M. Chan, Stan Krajewski, Katherine Fitzgerald, and Sergei Nedospasov for providing the reagents. P.J.G., J.B., and J.N.F. are employees of GlaxoSmithKline. A.D. is a consultant for Denali Therapeutics.	Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Chen RH, 1996, ONCOGENE, V12, P1493; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Cuda CM, 2014, J IMMUNOL, V192, P5548, DOI 10.4049/jimmunol.1400122; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kearney CJ, 2015, CELL DEATH DIFFER, V22, P1313, DOI 10.1038/cdd.2014.222; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; McNamara CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056576; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schworer SA, 2014, J BIOL CHEM, V289, P14422, DOI 10.1074/jbc.M114.547547; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; van Lieshout MHP, 2015, J INNATE IMMUN, V7, P637, DOI 10.1159/000430913; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	57	162	167	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					46	59		10.1016/j.immuni.2016.06.007	http://dx.doi.org/10.1016/j.immuni.2016.06.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27396959	Bronze, Green Accepted			2022-12-18	WOS:000380749000009
J	Zhang, QX; Vignali, DAA				Zhang, Qianxia; Vignali, Dario A. A.			Co-stimulatory and Co-inhibitory Pathways in Autoimmunity	IMMUNITY			English	Review							REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; WHITE)F-1 MICE PROMOTES; NONOBESE DIABETIC MICE; B7 FAMILY-MEMBER; MONOCLONAL-ANTIBODY; PROGRAMMED DEATH-1; FOLLICULAR HELPER; RHEUMATOID-ARTHRITIS	The immune system is guided by a series of checks and balances, a major component of which is a large array of co-stimulatory and co-inhibitory pathways that modulate the host response. Although co-stimulation is essential for boosting and shaping the initial response following signaling through the antigen receptor, inhibitory pathways are also critical for modulating the immune response. Excessive co-stimulation and/or insufficient co-inhibition can lead to a breakdown of self-tolerance and thus to autoimmunity. In this review, we will focus on the role of co-stimulatory and co-inhibitory pathways in two systemic (systemic lupus erythematosus and rheumatoid arthritis) and two organ-specific (multiple sclerosis and type 1 diabetes) emblematic autoimmune diseases. We will also discuss how mechanistic analysis of these pathways has led to the identification of potential therapeutic targets and initiation of clinical trials for autoimmune diseases, as well as outline some of the challenges that lie ahead.	[Zhang, Qianxia; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Vignali, Dario A. A.] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.; Vignali, DAA (corresponding author), Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	Zhang, Qianxia/D-7689-2011	Zhang, Qianxia/0000-0002-2885-2147	NIH [AI108545, AI091977, DK089125]; National Cancer Institute Comprehensive Cancer Center [CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI108545, R01AI091977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank the D.A.A.V. lab for helpful discussions. This work was supported by the NIH (grants AI108545, AI091977, and DK089125 to D.A.A.V), and the National Cancer Institute Comprehensive Cancer Center (Support Grant CA047904 to D.A.A.V.). D.A.A.V. has submitted LAG3 patents that are pending or granted and is entitled to a share in net income generated from licensing of these patent rights for commercial development.	Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Araki M, 2009, J IMMUNOL, V183, P5146, DOI 10.4049/jimmunol.0802610; Askanase AD, 2014, ARTHRITIS RHEUMATOL, V66, P3096, DOI 10.1002/art.38790; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Baker RL, 2008, J AUTOIMMUN, V31, P385, DOI 10.1016/j.jaut.2008.09.001; Balasa B, 1997, J IMMUNOL, V159, P4620; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Bodhankar S., 2013, J CLIN CELL IMMUNOL, V4, P143, DOI [10.4172/2155-9899.1000143,04, DOI 10.4172/2155-9899.1000143]; Boon L, 2002, TOXICOLOGY, V174, P53, DOI 10.1016/S0300-483X(02)00057-4; Boon L, 2001, J IMMUNOL, V167, P2942, DOI 10.4049/jimmunol.167.5.2942; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Brown DR, 2011, J IMMUNOL, V187, P21, DOI 10.4049/jimmunol.1100510; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Cannons JL, 2005, J AUTOIMMUN, V25, P13, DOI 10.1016/j.jaut.2005.04.007; Carboni S, 2003, J NEUROIMMUNOL, V145, P1, DOI 10.1016/j.jneuroim.2003.07.001; Carter LL, 2007, J NEUROIMMUNOL, V182, P124, DOI 10.1016/j.jneuroim.2006.10.006; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Chitnis T, 2001, J CLIN INVEST, V107, P575, DOI 10.1172/JCI11220; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Crampton SP, 2014, DIS MODEL MECH, V7, P1033, DOI 10.1242/dmm.016451; Cribbs AP, 2014, ARTHRITIS RHEUMATOL, V66, P2344, DOI 10.1002/art.38715; Cross AH, 1999, EUR J IMMUNOL, V29, P3140, DOI 10.1002/(SICI)1521-4141(199910)29:10<3140::AID-IMMU3140>3.3.CO;2-N; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cuzzocrea S, 2005, FASEB J, V19, P1253, DOI 10.1096/fj.04-3556com; Dahlen E, 2000, J IMMUNOL, V164, P2444, DOI 10.4049/jimmunol.164.5.2444; Daikh DI, 1997, J IMMUNOL, V159, P3104; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong HD, 2003, J CLIN INVEST, V111, P363, DOI 10.1172/JCI200316015; Early GS, 1996, J IMMUNOL, V157, P3159; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; Findlay EG, 2014, P NATL ACAD SCI USA, V111, P2289, DOI 10.1073/pnas.1321071111; Foell J, 2003, J CLIN INVEST, V111, P1505, DOI 10.1172/JCI200317662; Ford ML, 2014, NAT REV NEPHROL, V10, P14, DOI 10.1038/nrneph.2013.183; Furie R, 2014, ARTHRITIS RHEUMATOL, V66, P379, DOI 10.1002/art.38260; Galicia G, 2009, J CLIN IMMUNOL, V29, P426, DOI 10.1007/s10875-009-9287-7; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gomez JMM, 2012, J NEUROSCI, V32, P18246, DOI 10.1523/JNEUROSCI.2473-12.2012; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Green EA, 2000, J EXP MED, V191, P225, DOI 10.1084/jem.191.2.225; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Haanstra KG, 2015, J IMMUNOL, V194, P1454, DOI 10.4049/jimmunol.1402563; Hawiger D, 2008, J IMMUNOL, V180, P3140, DOI 10.4049/jimmunol.180.5.3140; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; Howard LM, 1999, J CLIN INVEST, V103, P281, DOI 10.1172/JCI5388; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Hurwitz AA, 1997, J NEUROIMMUNOL, V73, P57, DOI 10.1016/S0165-5728(96)00168-3; Hurwitz AA, 2002, P NATL ACAD SCI USA, V99, P3013, DOI 10.1073/pnas.042684699; Ichinose K, 2013, ARTHRITIS RHEUM-US, V65, P764, DOI 10.1002/art.37790; Irie J, 2007, DIABETES, V56, P186, DOI 10.2337/db06-0793; Iwai H, 2002, J IMMUNOL, V169, P4332, DOI 10.4049/jimmunol.169.8.4332; Jabs C, 2002, EUR J IMMUNOL, V32, P2687, DOI 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kachapati K, 2013, J AUTOIMMUN, V47, P94, DOI 10.1016/j.jaut.2013.09.002; Kachapati K, 2012, J IMMUNOL, V189, P5001, DOI 10.4049/jimmunol.1101013; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kalunian KC, 2002, ARTHRITIS RHEUM, V46, P3251, DOI 10.1002/art.10681; Karandikar NJ, 2000, J NEUROIMMUNOL, V109, P173, DOI 10.1016/S0165-5728(00)00322-2; Karandikar NJ, 1998, J IMMUNOL, V161, P192; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Kasagi S, 2010, J IMMUNOL, V184, P2337, DOI 10.4049/jimmunol.0901652; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Khalaf AT, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/167395; KHOURY SJ, 1995, J IMMUNOL, V155, P4521; Kim YH, 2011, J IMMUNOL, V187, P1120, DOI 10.4049/jimmunol.1002681; KNOERZER DB, 1995, J CLIN INVEST, V96, P987, DOI 10.1172/JCI118146; Ko HJ, 2010, J AUTOIMMUN, V34, P111, DOI 10.1016/j.jaut.2009.07.006; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Koh AE, 2011, J AUTOIMMUN, V37, P48, DOI 10.1016/j.jaut.2011.03.004; Kornete M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126311; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Kotani M, 2006, ARTHRITIS RHEUM-US, V54, P473, DOI 10.1002/art.21769; Kyburz D, 1999, J IMMUNOL, V163, P3116; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Laman JD, 2002, EUR J IMMUNOL, V32, P2218, DOI 10.1002/1521-4141(200208)32:8<2218::AID-IMMU2218>3.0.CO;2-0; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Liang BL, 1999, J IMMUNOL, V163, P2322; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Luhder F, 1998, J EXP MED, V187, P427, DOI 10.1084/jem.187.3.427; Luo LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130126; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Ma J, 1996, J IMMUNOL, V157, P417; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Magnus T, 2005, J NEUROSCI, V25, P2537, DOI 10.1523/JNEUROSCI.4794-04.2005; Manku H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003554; Martin-Orozco N, 2003, J IMMUNOL, V171, P6954, DOI 10.4049/jimmunol.171.12.6954; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Mihara M, 2000, J CLIN INVEST, V106, P91, DOI 10.1172/JCI9244; Miller SD, 1995, IMMUNITY, V3, P739, DOI 10.1016/1074-7613(95)90063-2; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Nakajima A, 2000, J NEUROIMMUNOL, V109, P188, DOI 10.1016/S0165-5728(00)00324-6; Ndhlovu LC, 2001, J IMMUNOL, V167, P2991, DOI 10.4049/jimmunol.167.5.2991; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Nohara C, 2001, J IMMUNOL, V166, P2108, DOI 10.4049/jimmunol.166.3.2108; O'Neill SK, 2007, J IMMUNOL, V179, P5109, DOI 10.4049/jimmunol.179.8.5109; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Oflazoglu E, 2009, J IMMUNOL, V183, P3770, DOI 10.4049/jimmunol.0901637; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Oliveira EML, 2003, J AUTOIMMUN, V20, P71, DOI 10.1016/S0896-8411(02)00106-3; Oliveira-dos-Santos AJ, 1999, J IMMUNOL, V162, P4490; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Oya Y, 2011, INT IMMUNOL, V23, P335, DOI 10.1093/intimm/dxr017; Pakala SV, 2004, EUR J IMMUNOL, V34, P3039, DOI 10.1002/eji.200425141; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Perrin PJ, 1996, J NEUROIMMUNOL, V65, P31, DOI 10.1016/0165-5728(95)00172-7; Pierer M, 2009, J IMMUNOL, V182, P3139, DOI 10.4049/jimmunol.0713715; Podojil JR, 2013, J AUTOIMMUN, V44, P71, DOI 10.1016/j.jaut.2013.04.001; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Prasad DVR, 2003, IMMUNITY, V18, P863, DOI 10.1016/S1074-7613(03)00147-X; Quattrocchi E, 2000, ARTHRITIS RHEUM, V43, P1688, DOI 10.1002/1529-0131(200008)43:8<1688::AID-ANR4>3.0.CO;2-C; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; Raptopoulou AP, 2010, ARTHRITIS RHEUM-US, V62, P1870, DOI 10.1002/art.27500; Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Saverino D, 2010, AUTOIMMUN HIGHLIGHTS, V1, P73, DOI 10.1007/s13317-010-0011-7; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Scholz C, 1998, J IMMUNOL, V160, P1532; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Sporici RA, 2001, CLIN IMMUNOL, V100, P277, DOI 10.1006/clim.2001.5074; Stumpf M, 2013, J IMMUNOL, V190, P961, DOI 10.4049/jimmunol.1201362; Subudhi SK, 2004, J CLIN INVEST, V113, P694, DOI 10.1172/JCI200419210; Sun YL, 2002, J IMMUNOL, V168, P1457, DOI 10.4049/jimmunol.168.3.1457; Sun YL, 2002, NAT MED, V8, P1405, DOI 10.1038/nm796; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Sytwu HK, 2003, J AUTOIMMUN, V21, P247, DOI 10.1016/S0896-8411(03)00112-4; Tada Y, 1999, J IMMUNOL, V163, P3153; Tada Y, 1999, J IMMUNOL, V162, P203; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Tellander AC, 2000, J AUTOIMMUN, V14, P295, DOI 10.1006/jaut.2000.0374; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran CN, 2008, J IMMUNOL, V180, P2989, DOI 10.4049/jimmunol.180.5.2989; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van den Berg WB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2803; Verhagen J, 2013, P NATL ACAD SCI USA, V110, pE221, DOI 10.1073/pnas.1208573110; Verhagen J, 2009, P NATL ACAD SCI USA, V106, P3306, DOI 10.1073/pnas.0803186106; Viglietta V, 2008, NEUROLOGY, V71, P917, DOI 10.1212/01.wnl.0000325915.00112.61; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Vinay DS, 2007, IMMUNOLOGY, V122, P394, DOI 10.1111/j.1365-2567.2007.02653.x; Vogel I, 2015, EUR J IMMUNOL, V45, P1832, DOI 10.1002/eji.201445190; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wang CJ, 2008, DIABETES, V57, P1861, DOI 10.2337/db07-1260; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang XB, 2003, ARTHRITIS RHEUM, V48, P495, DOI 10.1002/art.10929; Wang XJ, 2011, DIABETES, V60, P3246, DOI 10.2337/db11-0375; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Weinberg AD, 1996, NAT MED, V2, P183, DOI 10.1038/nm0296-183; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Westhovens R, 2014, CLIN EXP RHEUMATOL, V32, P553; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wong MD, 2013, J IMMUNOL, V190, P5402, DOI 10.4049/jimmunol.1202382; Wong M, 2010, J IMMUNOL, V185, P6563, DOI 10.4049/jimmunol.0903401; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; Yoshioka T, 2000, EUR J IMMUNOL, V30, P2815, DOI 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#; Zhu B, 2006, J IMMUNOL, V176, P3480, DOI 10.4049/jimmunol.176.6.3480; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	191	162	169	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1034	1051		10.1016/j.immuni.2016.04.017	http://dx.doi.org/10.1016/j.immuni.2016.04.017			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192568	Green Accepted, Bronze			2022-12-18	WOS:000376478500006
J	Xu, HC; Grusdat, M; Pandyra, AA; Polz, R; Huang, J; Sharma, P; Deenen, R; Kohrer, K; Rahbar, R; Diefenbach, A; Gibbert, K; Lohning, M; Hocker, L; Waibler, Z; Haussinger, D; Mak, TW; Ohashi, PS; Lang, KS; Lang, PA				Xu, Haifeng C.; Grusdat, Melanie; Pandyra, Aleksandra A.; Polz, Robin; Huang, Jun; Sharma, Piyush; Deenen, Rene; Koehrer, Karl; Rahbar, Ramtin; Diefenbach, Andreas; Gibbert, Kathrin; Loehning, Max; Hoecker, Lena; Waibler, Zoe; Haeussinger, Dieter; Mak, Tak W.; Ohashi, Pamela S.; Lang, Karl S.; Lang, Philipp A.			Type I Interferon Protects Antiviral CD8(+) T Cells from NK Cell Cytotoxicity	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; PLASMACYTOID DENDRITIC CELLS; CHRONIC HEPATITIS-C; IMMUNE-RESPONSES; TRANSGENIC MICE; RECEPTOR; VIRUS; EFFECTOR; THERAPY; INNATE	Despite development of new antiviral drugs, viral infections are still a major health problem. The most potent antiviral defense mechanism is the innate production of type I interferon (IFN-I), which not only limits virus replication but also promotes antiviral T cell immunity through mechanisms, which remain insufficiently studied. Using the murine lymphocytic choriomeningitis virus model system, we show here that IFN-I signaling on T cells prevented their rapid elimination in vivo. Microarray analyses uncovered that IFN-I triggered the expression of selected inhibitory NK-cell-receptor ligands. Consequently, T cell immunity of IFN-I receptor (IFNAR)-deficient T cells could be restored by NK cell depletion or in NK-cell-deficient hosts (Nfil3(-/-)).The elimination of Ifnar1(-/-) T cells was dependent on NK-cell-mediated perforin expression. In summary, we identified IFN-I as a key player regulating the protection of T cells against regulatory NK cell function.	[Xu, Haifeng C.; Grusdat, Melanie; Polz, Robin; Huang, Jun; Haeussinger, Dieter; Lang, Philipp A.] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Xu, Haifeng C.; Pandyra, Aleksandra A.; Sharma, Piyush; Lang, Karl S.] Univ Duisburg Essen, Fac Med, Inst Immunol, D-45147 Essen, Germany; [Deenen, Rene; Koehrer, Karl] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, Biol & Med Res Ctr BMFZ, D-40225 Dusseldorf, Germany; [Rahbar, Ramtin; Mak, Tak W.; Ohashi, Pamela S.] Univ Hlth Network UHN, Princess Margaret Canc Ctr, Campell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Gibbert, Kathrin] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45147 Essen, Germany; [Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Loehning, Max] German Rheumatism Res Ctr DRFZ, Leibniz Inst, D-10117 Berlin, Germany; [Hoecker, Lena; Waibler, Zoe] Paul Ehrlich Inst, D-63225 Langen, Germany	Heinrich Heine University Dusseldorf; University of Duisburg Essen; Heinrich Heine University Dusseldorf; University of Cologne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Johannes Gutenberg University of Mainz; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Paul Ehrlich Institute	Lang, PA (corresponding author), Univ Dusseldorf, Dept Gastroenterol Hepatol & Infect Dis, Univ Str 1, D-40225 Dusseldorf, Germany.	philipp.lang@med.uni-duesseldorf.de	Diefenbach, Andreas/T-2589-2018; Sutter, Kathrin/AAE-9019-2020; Sutter, Kathrin/AAY-9167-2020; Löhning, Max/AAL-2967-2021; Sharma, Piyush/K-8927-2019; Lang, Karl S/R-2505-2016	Diefenbach, Andreas/0000-0002-9176-9530; Sutter, Kathrin/0000-0001-6397-6551; Löhning, Max/0000-0001-6382-7281; Sharma, Piyush/0000-0003-1185-9534; Lang, Karl/0000-0001-9783-7605; Ohashi, Pamela S./0000-0003-2915-9317; Grusdat, Melanie/0000-0003-0708-0077	Alexander von Humboldt Foundation [SKA2008, SKA2010]; German Research Council [SFB974, LA2558/3-1, LA2558/5-1, TRR60, LA1419/5-1, RTG1949]; NIH Tetramer Facility; Strategic Research Fund; Forschungskomission of the Heinrich Heine University	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Council(German Research Foundation (DFG)); NIH Tetramer Facility; Strategic Research Fund; Forschungskomission of the Heinrich Heine University	The authors are grateful for the technical assistance of Eugen Backer and Anne Trenkel. This study was supported by the Alexander von Humboldt Foundation (SKA2008 and SKA2010), the German Research Council (SFB974, LA2558/3-1, LA2558/5-1, TRR60, LA1419/5-1, RTG1949), and the NIH Tetramer Facility. Further support came from the Strategic Research Fund and the Forschungskomission of the Heinrich Heine University.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Biron CA, 2002, CURR TOP MICROBIOL, V263, P7; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lang PA, 2010, HEPATOLOGY, V52, P25, DOI 10.1002/hep.23640; Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Marshall HD, 2010, J IMMUNOL, V185, P1419, DOI 10.4049/jimmunol.1001140; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Oliviero B, 2013, J HEPATOL, V59, P38, DOI 10.1016/j.jhep.2013.03.003; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Paladino N, 2007, TISSUE ANTIGENS, V69, P109, DOI 10.1111/j.1399-0039.2006.762_7.x; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Su HC, 2001, EUR J IMMUNOL, V31, P3048, DOI 10.1002/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waggoner SN, 2014, J VIROL, V88, P1953, DOI 10.1128/JVI.03002-13; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	58	162	166	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					949	960		10.1016/j.immuni.2014.05.004	http://dx.doi.org/10.1016/j.immuni.2014.05.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24909887	Bronze			2022-12-18	WOS:000341440200016
J	Aleksic, M; Dushek, O; Zhang, H; Shenderov, E; Chen, JL; Cerundolo, V; Coombs, D; van der Merwe, PA				Aleksic, Milos; Dushek, Omer; Zhang, Hao; Shenderov, Eugene; Chen, Ji-Li; Cerundolo, Vincenzo; Coombs, Daniel; van der Merwe, P. Anton			Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LIGAND INTERACTIONS; BINDING-KINETICS; TCR-BINDING; ACTIVATION; AFFINITY; FLEXIBILITY; VACCINES; DESIGN; IMMUNOGENICITY	T cell receptor (TCR) binding to diverse peptide-major histocompatibility complex (pMHC) ligands results in various degrees of T cell activation. Here we analyze which binding properties of the TCR-pMHC interaction are responsible for this variation in pMHC activation potency. We have analyzed activation of the 1G4 cytotoxic T lymphocyte clone by cognate pMHC variants and performed thorough correlation analysis of T cell activation with 1134 TCR-pMHC binding properties measured in solution. We found that both the on rate (k(on)) and off rate (k(off)) contribute to activation potency. Based on our results, we propose a model in which rapid TCR rebinding to the same pMHC after chemical dissociation increases the effective half-life or "confinement time" of a TCR-pMHC interaction. This confinement time model clarifies the role of k(on) in T cell activation and reconciles apparently contradictory repo on the role of TCR-pMHC binding kinetics and affinity in T cell activation.	[Aleksic, Milos; Dushek, Omer; Zhang, Hao; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Dushek, Omer] Univ Oxford, Ctr Math Biol, Oxford OX1 3LB, England; [Shenderov, Eugene; Chen, Ji-Li; Cerundolo, Vincenzo] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Shenderov, Eugene] NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; [Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; [Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V6T 1Z2, Canada	University of Oxford; University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of British Columbia; University of British Columbia	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Shenderov, Eugene/AAF-4842-2019	Shenderov, Eugene/0000-0001-9886-8542; Cerundolo, Vincenzo/0000-0003-0040-3793; Coombs, Daniel/0000-0002-8038-6278	Cancer Research UK, the Medical Research Council (UK); National Sciences and Engineering Research Council (Canada); Mathematics of Information Technology and Complex Systems National Centre of Excellence (Canada); MRC [MC_U137884181, G9722488] Funding Source: UKRI; Cancer Research UK [11331] Funding Source: researchfish; Medical Research Council [G9722488, MC_U137884181] Funding Source: researchfish	Cancer Research UK, the Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); National Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems National Centre of Excellence (Canada); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Shepherd for the supply of the 1G4 TCR expression plasmid and J. Byrne for the help with protein expression. We would also like to thank the reviewers for their constructive criticism. This work was supported by Cancer Research UK, the Medical Research Council (UK), the National Sciences and Engineering Research Council (Canada), and the Mathematics of Information Technology and Complex Systems National Centre of Excellence (Canada).	ALRAMADI BK, 1995, J IMMUNOL, V155, P662; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Apostolopoulos V, 2000, CURR OPIN MOL THER, V2, P29; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Bell G I, 1979, Cell Biophys, V1, P133, DOI 10.1007/BF02781347; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Burroughs NJ, 2007, IMMUNOL REV, V216, P69; Carreno LJ, 2007, IMMUNOLOGY, V121, P227, DOI 10.1111/j.1365-2567.2007.02561.x; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Choudhuri K, 2005, CURR BIOL, V15, pR382, DOI 10.1016/j.cub.2005.05.001; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Dushek O, 2008, BIOPHYS J, V94, P3447, DOI 10.1529/biophysj.107.116897; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hudrisier D, 1998, J IMMUNOL, V161, P553; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lauffenburger DA., 1993, RECEPTORS MODELS BIN; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Luxembourg AT, 1998, J IMMUNOL, V161, P5226; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Segura JM, 2008, J BIOL CHEM, V283, P24254, DOI 10.1074/jbc.M803549200; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Tolentino TP, 2008, BIOPHYS J, V95, P920, DOI 10.1529/biophysj.107.114447; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219	44	162	163	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					163	174		10.1016/j.immuni.2009.11.013	http://dx.doi.org/10.1016/j.immuni.2009.11.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20137987	Green Published, hybrid			2022-12-18	WOS:000275346000007
J	Esashi, E; Wang, YH; Perng, O; Qin, XF; Liu, YJ; Watowich, SS				Esashi, Eiji; Wang, Yui-Hsi; Perng, Olivia; Qin, Xiao-Feng; Liu, Yong-Jun; Watowich, Stephanie S.			The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; INTERFERON-PRODUCING CELLS; FLT3 LIGAND; COMMITTED PROGENITORS; REGULATORY FACTOR-4; LYMPH-NODES; IN-VIVO; MOUSE; GENERATION; IDENTIFICATION	The development of distinct dendritic cell (DC) subsets is regulated by cytokines. The ligand for the FMS-like tyrosine kinase 3 receptor (Flt3L) is necessary for plasmacytoid DC (pDC) and conventional DC (cDC) maturation. The cytokine GM-CSF inhibits Flt3L-driven pDC production while promoting cDC growth. We show that GM-CSF selectively utilized its signal transducer STAT5 to block Flt3L-dependent pDC development from the lineage-negative, Flt3(+) (lin(-) Flt3(+)) bone-marrow subset. The signaling molecule STAT3, by contrast, was necessary for expansion of DC progenitors but not pDC maturation. In vivo, STAT5 suppressed pDC formation during repopulation of the DC compartment after bone-marrow ablation. GM-CSF-dependent STAT5 signaling rapidly extinguished pDC-related gene expression in lin- Flt3+ progenitors. Inspection of the Irf8 promoter revealed that STAT5 was recruited during GM-CSF-mediated suppression, indicating that STAT5 directly inhibited transcription of this critical pDC gene. Our results therefore show that GM-CSF controls the production of pDCs by employing STAT5 to suppress IRF8 and the pDC transcriptional network in lin(-) Flt3(+) progenitors.	[Esashi, Eiji; Wang, Yui-Hsi; Perng, Olivia; Qin, Xiao-Feng; Liu, Yong-Jun; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Esashi, Eiji; Wang, Yui-Hsi; Perng, Olivia; Qin, Xiao-Feng; Liu, Yong-Jun; Watowich, Stephanie S.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Qin, Xiao-Feng; Liu, Yong-Jun; Watowich, Stephanie S.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Liu, YJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	yjliu@mdanderson.org; swatowic@mdanderson.org		Watowich, Stephanie/0000-0003-1969-659X; QIN, FRANK XIAOFENG/0000-0002-5395-0304	NIAID NIH HHS [R01 AI059718-04, R01 AI059718-01A1, R21 AI073587-01, R01 AI059718-03, R01 AI059718-02, R21 AI073587, R01 AI059718] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073587, R01AI059718] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; GRANUCCI F, 1994, EUR J IMMUNOL, V24, P2522, DOI 10.1002/eji.1830241039; GUENRIERO A, 2000, BLOOD, V95, P879; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki-Arai J, 2003, J EXP MED, V197, P1311, DOI 10.1084/jem.20021843; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mach N, 2000, CANCER RES, V60, P3239; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Pulendran B, 2000, J IMMUNOL, V165, P566, DOI 10.4049/jimmunol.165.1.566; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	45	162	163	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2008	28	4					509	520		10.1016/j.immuni.2008.02.013	http://dx.doi.org/10.1016/j.immuni.2008.02.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18342552	Green Accepted, Bronze			2022-12-18	WOS:000254939400012
J	Frolet, C; Thoma, M; Blandin, S; Hoffmann, JA; Levashina, EA				Frolet, Cecile; Thoma, Martine; Blandin, Stephanie; Hoffmann, Jules A.; Levashina, Elena A.			Boosting NF-kappa B-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei	IMMUNITY			English	Article							COMPLEMENT-LIKE PROTEIN; MOSQUITO AEDES-AEGYPTI; MALARIA VECTOR; DROSOPHILA; INFECTION; RESPONSES; GENES; BACTERIAL; PATHWAY	Anopheles gambiae, the major vector for the protozoan malaria parasite Plasmodium falciparum, mounts powerful antiparasitic responses that cause marked parasite loss during midgut invasion. Here, we showed that these antiparasitic defenses were composed of pre- and postinvasion phases and that the preinvasion phase was predominantly regulated by Rel1 and Rel2 members of the NF-kappa B transcription factors. Concurrent silencing of Rel1 and Rel2 decreased the basal expression of the major antiparasitic genes TEP1 and LRIM1 and abolished resistance of Anopheles to the rodent malaria parasite P. berghel. Conversely, depletion of a negative regulator of Rel1, Cactus, prior to infection, enhanced the basal expression of TEP1 and of other immune factors and completely prevented parasite development. Our findings uncover the crucial role of the preinvasion defense in the elimination of parasites, which is at least in part based on circulating blood molecules.	CNRS, Inst Biol Mol & Cellulaire, UPR9022, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Levashina, EA (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR9022, 15 Rue R Descartes, F-67084 Strasbourg, France.	e.levashina@ibmc.u-strasbg.fr	Blandin, Stephanie/ABH-2267-2021; Blandin, Stephanie/I-2786-2016	Blandin, Stephanie/0000-0003-4566-1200; Blandin, Stephanie/0000-0003-4566-1200; Levashina, Elena/0000-0003-4605-906X	NIAID NIH HHS [2P01AI044220-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; BarillasMury C, 1996, EMBO J, V15, P4691, DOI 10.1002/j.1460-2075.1996.tb00846.x; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, CURR OPIN IMMUNOL, V16, P16, DOI 10.1016/j.coi.2003.11.010; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296	20	162	169	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					677	685		10.1016/j.immuni.2006.08.019	http://dx.doi.org/10.1016/j.immuni.2006.08.019			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045818	Bronze			2022-12-18	WOS:000241481500018
J	Neilson, JR; Winslow, MM; Hur, EM; Crabtree, GR				Neilson, JR; Winslow, MM; Hur, EM; Crabtree, GR			Calcineurin B1 is essential for positive but not negative selection during thymocyte development	IMMUNITY			English	Article							T-CELL-RECEPTOR; DETERMINE IMMUNE RESPONSIVENESS; XENOPUS EGG EXTRACTS; CYCLOSPORINE-A; THYMIC SELECTION; ALPHA-BETA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; IN-VIVO; NF-ATC	During development, discrete cell fates often result from variation in the intensity of a particular signal. The mechanisms underlying these seemingly analog-to-digital switches are not understood. In developing T lymphocytes, low-intensity signals through the antigen receptor result in positive selection while more intense signals give rise to negative selection. By deleting the genetic locus encoding the regulatory B1 subunit of calcineurin specifically in thymocytes, we found an absolute requirement for calcineurin in positive selection. In contrast, calcineurin activity was dispensable in several models of negative selection. Unexpectedly, we found that removal of calcineurin activity from thymocytes results in inefficient ERK activation at the double-positive stage of thymocyte development, when selection occurs. These studies clarify the mechanism by which graded signals are converted to discrete outcomes in T cell development and further indicate that the developmental roles of calcineurin likely contribute to immunosuppression by calcineurin inhibitors.	Howard Hughes Med Inst, Dept Dev Biol & Pathol, Beckman Ctr, Stanford, CA 94305 USA; Howard Hughes Med Inst, Dept Microbiol & Immunol, Beckman Ctr, Stanford, CA 94305 USA; Howard Hughes Med Inst, Program Immunol, Beckman Ctr, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Crabtree, GR (corresponding author), Howard Hughes Med Inst, Dept Dev Biol & Pathol, Beckman Ctr, Room B211, Stanford, CA 94305 USA.	crabtree@cmgm.stanford.edu		Neilson, Joel R./0000-0002-3408-608X	NATIONAL CANCER INSTITUTE [R37CA039612, R01CA039612] Funding Source: NIH RePORTER; NCI NIH HHS [CA-39612] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; BESCHORNER WE, 1987, AM J PATHOL, V126, P487; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DESTGROTH BF, 1993, MOL MECH IMMUNOLOGIC, P123; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Fischer A, 1998, SCIENCE, V280, P237, DOI 10.1126/science.280.5361.237; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; GAO EK, 1988, NATURE, V336, P176, DOI 10.1038/336176a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hayden-Martinez K, 2000, J IMMUNOL, V165, P3713, DOI 10.4049/jimmunol.165.7.3713; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HOLLANDER GA, 1994, TRANSPLANTATION, V58, P1037, DOI 10.1097/00007890-199411150-00011; JENKINS MK, 1988, SCIENCE, V241, P1655, DOI 10.1126/science.3262237; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kane LP, 1996, J IMMUNOL, V156, P4594; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; MCCAFFREY PG, 1994, NUCLEIC ACIDS RES, V22, P2134, DOI 10.1093/nar/22.11.2134; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Paget WJ, 1999, SOZ PRAVENTIV MED, V44, P1, DOI 10.1007/BF01624804; PUGHHUMPHREYS RGP, 1990, IMMUNOLOGY, V70, P398; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Zhang W, 1996, J EXP MED, V183, P413, DOI 10.1084/jem.183.2.413; ZINKERNAGEL RM, 1978, J EXP MED, V148, P805, DOI 10.1084/jem.148.3.805	61	162	163	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2004	20	3					255	266		10.1016/S1074-7613(04)00052-4	http://dx.doi.org/10.1016/S1074-7613(04)00052-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EJ	15030770	Bronze			2022-12-18	WOS:000221442600004
J	Leishman, AJ; Gapin, L; Capone, M; Palmer, E; MacDonald, HR; Kronenberg, M; Cheroutre, H				Leishman, AJ; Gapin, L; Capone, M; Palmer, E; MacDonald, HR; Kronenberg, M; Cheroutre, H			Precursors of functional MHC class I- or class II-restricted CD8 alpha alpha(+) T cells are positively selected in the thymus by agonist self-peptides	IMMUNITY			English	Article							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; CD8 BETA-CHAIN; ANTIGEN RECEPTOR; NEGATIVE SELECTION; GUT CRYPTOPATCHES; GAMMA-DELTA; MICE; DIFFERENTIATION; SPECIFICITY	The origin and specificity of alphabeta TCR+ T cells that express CD8alphaalpha have been controversial issues. Here we provide direct evidence that precursors of functional CD8alphaalpha T cells are positively selected in the thymus in the presence of agonist self-peptides. Like conventional positive selection, this agonist selection process requires functional TCR alpha-CPM, whereas it is independent of CD8beta expression. Furthermore, CD8alphaalpha expression on mature, agonist-selected T cells does not imply selection by MHC class I, and CD8alphaalpha(+) T cells can be either class I or class II restricted. Our data define a distinct agonist-dependent, positive selection process in the thymus, and they suggest a function for CD8alphaalpha distinct from the conventional TOR coreceptor function of CD8alphabeta or CD4.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Basel Inst Immunol, CH-40053 Basel, Switzerland	La Jolla Institute for Immunology; Ludwig Institute for Cancer Research; University of Lausanne	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.				NIDDK NIH HHS [DK 46763, DK 54451] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK054451, R01DK054451, P01DK046763] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; BADINER G, 1993, INT IMMUNOL, V5, P223, DOI 10.1093/intimm/5.2.223; BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43; Barnden MJ, 1997, CELL IMMUNOL, V175, P111, DOI 10.1006/cimm.1996.1054; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Capone M, 2001, EUR J IMMUNOL, V31, P1867, DOI 10.1002/1521-4141(200106)31:6<1867::AID-IMMU1867>3.0.CO;2-B; CROOKS MEC, 1994, IMMUNITY, V1, P277; Cruz D, 1998, J EXP MED, V188, P255, DOI 10.1084/jem.188.2.255; Das G, 1999, J EXP MED, V190, P881, DOI 10.1084/jem.190.6.881; DIGIUSTO DL, 1994, MOL IMMUNOL, V31, P693, DOI 10.1016/0161-5890(94)90179-1; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; Gapin L, 1999, J IMMUNOL, V163, P4100; Guehler SR, 1996, J EXP MED, V184, P493, DOI 10.1084/jem.184.2.493; Guy-Grand D, 2001, EUR J IMMUNOL, V31, P2593, DOI 10.1002/1521-4141(200109)31:9<2593::AID-IMMU2593>3.0.CO;2-X; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; GUYGRAND D, 1991, J EXP MED, V173, P1549, DOI 10.1084/jem.173.6.1549; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAYE J, 1992, J IMMUNOL, V148, P3342; Kuo S, 2001, PEDIATR RES, V49, P543, DOI 10.1203/00006450-200104000-00017; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; LEFRANCOIS L, 1994, J IMMUNOL, V153, P987; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Levelt CN, 1999, P NATL ACAD SCI USA, V96, P5628, DOI 10.1073/pnas.96.10.5628; LIN T, 1993, EUR J IMMUNOL, V23, P1968, DOI 10.1002/eji.1830230836; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; OHTEKI T, 1993, EUR J IMMUNOL, V23, P1251, DOI 10.1002/eji.1830230609; Oida T, 2000, J IMMUNOL, V164, P3616, DOI 10.4049/jimmunol.164.7.3616; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; ROCHA B, 1992, IMMUNOL TODAY, V13, P449, DOI 10.1016/0167-5699(92)90074-H; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Suzuki K, 2000, IMMUNITY, V13, P691, DOI 10.1016/S1074-7613(00)00068-6; Sydora BC, 1996, J IMMUNOL, V156, P4209; SYDORA BC, 1993, J IMMUNOL, V150, P2179; Yelon D, 1997, J IMMUNOL, V158, P5219	43	162	165	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2002	16	3					355	364		10.1016/S1074-7613(02)00284-4	http://dx.doi.org/10.1016/S1074-7613(02)00284-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911821	Bronze			2022-12-18	WOS:000174572800005
J	Coxon, A; Cullere, X; Knight, S; Sethi, S; Wakelin, MW; Stavrakis, G; Luscinskas, FW; Mayadas, TN				Coxon, A; Cullere, X; Knight, S; Sethi, S; Wakelin, MW; Stavrakis, G; Luscinskas, FW; Mayadas, TN			Fc gamma RIII mediates neutrophil recruitment to immune complexes: A mechanism for neutrophil accumulation in immune-mediated inflammation	IMMUNITY			English	Article							LEUKOCYTE ADHESION; P-SELECTIN; ARTHUS REACTION; IN-VITRO; RECEPTOR; CELLS; MAC-1; CD11B/CD18; EXPRESSION; FLOW	Neutrophil accumulation is a hallmark of immune complex-mediated inflammatory disorders. Current models of neutrophil recruitment envision the capture of circulating neutrophils by activated endothelial cells. We now demonstrate that immobilized immune complexes alone support the rapid attachment of neutrophils, under physiologic flow conditions. Initial cell tethering requires the low-affinity Fc gamma receptor IIIB (Fc gamma RIIIB), and the beta (2) integrins are additionally required for the subsequent shear-resistant adhesion. The attachment function of Fc gamma RIIIB may be facilitated by its observed presentation on neutrophil microvilli. In vivo, in a model of acute antiglomerular basement membrane nephritis in which immune complexes are accessible to circulating neutrophils, Fc gamma RIII-deficient mice had a significant reduction in neutrophil recruitment. Thus, the interaction of immune complexes with Fc gamma RIII may mediate early neutrophil recruitment in immune complex-mediated inflammation.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mayadas, TN (corresponding author), Brigham & Womens Hosp, Dept Pathol, 221 Longwood Ave, Boston, MA 02115 USA.	tmayadas@rics.bwh.harvard.edu			NHLBI NIH HHS [HL36028, T32 HL07627, HL65095, HL65090, HL56985, HL53993] Funding Source: Medline; NIDDK NIH HHS [DK51643] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053993, P01HL036028, P50HL056985, T32HL007627, R01HL065090, R01HL065095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051643] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBAS AK, 1997, CELLULAR MOL IMMUNOL, P423; ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; BREUHL RE, 1997, J LEUKOCYTE BIOL, V61, P489; BUCKLE AM, 1989, J IMMUNOL, V143, P2295; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CARLOS TM, 1994, BLOOD, V84, P2068; Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377; COCHRANE CG, 1968, J EXP MED, V127, P137, DOI 10.1084/jem.127.1.137; COCHRANE CG, 1959, J EXP MED, V110, P481, DOI 10.1084/jem.110.3.481; COUSER WG, 1993, KIDNEY INT, V44, pS19; COUSER WG, 1985, KIDNEY INT, V28, P569, DOI 10.1038/ki.1985.167; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; CREAM JJ, 1971, BRIT J DERMATOL, V84, P106, DOI 10.1111/j.1365-2133.1971.tb06851.x; DARRIGO C, 1995, CLIN EXP IMMUNOL, V100, P173; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; FEINTZEIG ID, 1986, KIDNEY INT, V29, P649, DOI 10.1038/ki.1986.48; FRIES JWU, 1988, KIDNEY INT, V34, P333, DOI 10.1038/ki.1988.186; Fujigaki Y, 1997, VIRCHOWS ARCH, V431, P53, DOI 10.1007/s004280050069; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Goetz DJ, 1996, AM J PATHOL, V149, P1661; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; GRAHAM IL, 1993, J CELL BIOL, V120, P1509, DOI 10.1083/jcb.120.6.1509; Groger M, 1999, J INVEST DERMATOL, V113, P56, DOI 10.1046/j.1523-1747.1999.00620.x; Groger M, 1996, J IMMUNOL, V156, P1549; HAAKENSTAD AO, 1982, IMMUNOLOGY, V47, P407; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Heisig N., 1968, ADV MICROCIRCULAT, V1, P89; Hoffmeyer F, 1997, IMMUNOLOGY, V92, P544, DOI 10.1046/j.1365-2567.1997.00381.x; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Johnston B, 1999, IMMUNOL TODAY, V20, P545, DOI 10.1016/S0167-5699(99)01544-3; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; JONES SL, 1996, HUMAN IGG FC RECEPTO, P149; JOSELOW SA, 1985, J INVEST DERMATOL, V85, P559, DOI 10.1111/1523-1747.ep12277404; JOSELOW SA, 1984, J INVEST DERMATOL, V82, P335, DOI 10.1111/1523-1747.ep12260644; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; LAMOUR A, 1993, EUR J CLIN INVEST, V23, P97, DOI 10.1111/j.1365-2362.1993.tb00747.x; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Luscinskas FW, 1996, J IMMUNOL, V157, P326; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Luscinskas FW, 1996, ANNU REV MED, V47, P413, DOI 10.1146/annurev.med.47.1.413; Mayadas TN, 1999, CURR OPIN NEPHROL HY, V8, P293, DOI 10.1097/00041552-199905000-00004; Mayadas TN, 1996, KIDNEY INT, V49, P1342, DOI 10.1038/ki.1996.190; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pan LF, 1998, CLIN EXP IMMUNOL, V112, P533; RADEKE HH, 1994, J IMMUNOL, V153, P1281; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Rennke H G, 1981, Contrib Nephrol, V24, P30; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; SALANT DJ, 1985, KIDNEY INT, V27, P938, DOI 10.1038/ki.1985.102; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; SCHERZER H, 1978, J IMMUNOL, V121, P947; SCHRIJVER G, 1990, KIDNEY INT, V38, P86, DOI 10.1038/ki.1990.171; SPERTINI O, 1991, J IMMUNOL, V147, P942; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; TOSI MF, 1992, J CLIN INVEST, V90, P462, DOI 10.1172/JCI115882; Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; VOSSEBELD PJM, 1995, J BIOL CHEM, V270, P10671, DOI 10.1074/jbc.270.18.10671; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	69	162	170	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2001	14	6					693	704		10.1016/S1074-7613(01)00150-9	http://dx.doi.org/10.1016/S1074-7613(01)00150-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	446CJ	11420040	Bronze			2022-12-18	WOS:000169495100006
J	Senftleben, U; Li, ZW; Baud, V; Karin, M				Senftleben, U; Li, ZW; Baud, V; Karin, M			IKK beta is essential for protecting T cells from TNF alpha-induced apoptosis	IMMUNITY			English	Article							NF-KAPPA-B; MOUSE BONE-MARROW; IMMUNE-RESPONSES; DEFICIENT MICE; INCONTINENTIA PIGMENTI; EMBRYONIC LETHALITY; LIVER DEGENERATION; KINASE COMPLEX; ACTIVATION; EXPRESSION	Transcription factor NF-KB, whose activation depends on the IKK beta catalytic subunit of the I kappaB kinase, was assigned with both anti- and proapoptotic functions in T lymphocytes. To critically evaluate these functions, we transferred Ikk beta (-/-) or wild-type (wt) fetal liver (FL) stem cells into lethally irradiated mice. Ikk beta (-/-) radiation chimeras show thymic rudiments, aberrant lymphoid organs, and absence of T cells. T lymphopoiesis is rescued when Ikk beta (-/-) stem cells are cotransferred with wt bone marrow, suggesting that IKK beta may mediate its lymphopoietic function via extrinsic factors. However, almost normal development of Ikk beta (-/-) T cells is observed upon removal of type 1 TNF alpha receptor, indicating that TNF alpha signaling accounts for the absence of Ikk beta (-/-) T cells. Indeed, Ikk beta (-/-) radiation chimeras exibit elevated circulating TNF alpha, and Ikk beta (-/-) thymocytes display increased TNF alpha sensitivity.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Munich, Klinikum Grosshadern, Anesthesiol Clin, D-81377 Munich, Germany	University of California System; University of California San Diego; University of Munich	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.		Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X	NIAID NIH HHS [R01AI43477-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Carsetti R, 2000, J EXP MED, V191, P5, DOI 10.1084/jem.191.1.5; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Eckmann L, 1996, J IMMUNOL, V156, P2894; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MOORE NC, 1995, J IMMUNOL, V155, P4653; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; ROTHWARF DM, NF KB PATHWAY PARADI; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; VAN AD, 1996, SCIENCE, V274, P787; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	43	162	173	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2001	14	3					217	230		10.1016/S1074-7613(01)00104-2	http://dx.doi.org/10.1016/S1074-7613(01)00104-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290332	Bronze			2022-12-18	WOS:000167959500002
J	McLemore, ML; Grewal, S; Liu, FL; Archambault, A; Poursine-Laurent, J; Haug, J; Link, DC				McLemore, ML; Grewal, S; Liu, FL; Archambault, A; Poursine-Laurent, J; Haug, J; Link, DC			STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; DISTINCT CYTOPLASMIC REGIONS; FACTOR-RECEPTOR; LINEAGE COMMITMENT; MEDIATED TRANSFER; MICE LACKING; IN-VIVO; GENE; GRANULOPOIESIS	To investigate the role of signal transducer and activator of transcription (STAT) proteins in granulocyte colony-stimulating factor (G-CSF)-regulated biological responses, we generated transgenic mice with a targeted mutation of their G-CSF receptor (termed d715F) that abolishes G-CSF-dependent STAT-3 activation and attenuates STAT-5 activation. Homozygous mutant mice are severely neutropenic with an accumulation of immature myeloid precursors in their bone marrow. G-CSF-induced proliferation and granulocytic differentiation of hematopoietic progenitors is severely impaired. Expression of a constitutively active form of STAT-3 in d715F progenitors nearly completely rescued these defects. Conversely, expression of a dominant-negative form of STAT-3 in wild-type progenitors results in impaired G-CSF-induced proliferation and differentiation. These data suggest that STAT-3 activation by the G-CSFR is critical for the transduction of normal proliferative signals and contributes to differentiative signals.	Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA.	dlink@im.wustl.edu			NHLBI NIH HHS [R01 HL60772-01A1, T32 HL 07088-23] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060772, T32HL007088] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avalos BR, 1997, EXP HEMATOL, V25, P160; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; BOBER LA, 1995, IMMUNOPHARMACOLOGY, V29, P111, DOI 10.1016/0162-3109(94)00050-P; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Carulli G, 1997, HAEMATOLOGICA, V82, P606; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chakraborty A, 1998, LEUKEMIA LYMPHOMA, V30, P433, DOI 10.3109/10428199809057555; Chakraborty A, 1999, BLOOD, V93, P15, DOI 10.1182/blood.V93.1.15.401a46_15_24; Chakraborty A, 1996, BLOOD, V88, P2442, DOI 10.1182/blood.V88.7.2442.bloodjournal8872442; de Koning JP, 2000, ONCOGENE, V19, P3290, DOI 10.1038/sj.onc.1203627; DEHAAS M, 1994, BLOOD, V84, P3885, DOI 10.1182/blood.V84.11.3885.bloodjournal84113885; deKoning JP, 1996, BLOOD, V87, P1335, DOI 10.1182/blood.V87.4.1335.bloodjournal8741335; Dong F, 1998, J IMMUNOL, V161, P6503; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Faust N, 2000, BLOOD, V96, P719; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Gouilleux-Gruart V, 1997, LEUKEMIA LYMPHOMA, V28, P83, DOI 10.3109/10428199709058334; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hermans MHA, 1998, BLOOD, V92, P32, DOI 10.1182/blood.V92.1.32.413k42_32_39; Hoglund M, 1997, EUR J HAEMATOL, V58, P195; Hug BA, 1996, MOL CELL BIOL, V16, P2906; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; Lutz PG, 2000, P NATL ACAD SCI USA, V97, P1601, DOI 10.1073/pnas.97.4.1601; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; METCALF D, 1984, HEMATOPOITIC COLONY; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Persons DA, 1998, NAT MED, V4, P1201, DOI 10.1038/2704; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Semerad CL, 1999, IMMUNITY, V11, P153, DOI 10.1016/S1074-7613(00)80090-4; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; TIAN SS, 1994, BLOOD, V84, P1760; Ward AC, 2000, BLOOD, V95, P19; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; WATANABE M, 1991, ANAL BIOCHEM, V195, P38, DOI 10.1016/0003-2697(91)90291-Z; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	50	162	169	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2001	14	2					193	204		10.1016/S1074-7613(01)00101-7	http://dx.doi.org/10.1016/S1074-7613(01)00101-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239451	Bronze			2022-12-18	WOS:000167092500009
J	Hernandez-Hoyos, G; Sohn, SJ; Rothenberg, EV; Alberola-Ila, J				Hernandez-Hoyos, G; Sohn, SJ; Rothenberg, EV; Alberola-Ila, J			Lck activity controls CD4/CD8 T cell lineage commitment	IMMUNITY			English	Article							TYROSINE-PROTEIN-KINASE; POSITIVE SELECTION; CD8 LINEAGE; THYMOCYTE DEVELOPMENT; THYMIC SELECTION; TRANSGENIC MICE; ANTIGEN RECEPTOR; CYTOPLASMIC TAIL; ACTIVATED LCK; CROSS-LINKING	Thymocytes carrying MHC class I-restricted TCRs differentiate into dos T cells, while those recognizing MHC class II become CD4 T cells. The mechanisms underlying how MHC class recognition, coreceptor expression, and effector function are coordinated are not well understood. Since the tyrosine kinase Lck binds with more affinity to CD4 than CD8, it has been proposed as a candidate to mediate this process. By using transgenic mice with altered Lck activity, we show that thymocytes carrying a class Ii-restricted TCR develop into functional CD8 T cells when Lck activity is reduced. Conversely, thymocytes carrying a class I-restricted TCR develop into functional CD4 T cells when Lck activity is increased. these results directly show that quantitative differences in the Lck signal control the CD4/CD8 lineage decision.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	California Institute of Technology; Stowers Institute for Medical Research; University of Washington; University of Washington Seattle	Alberola-Ila, J (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Rothenberg, Ellen/0000-0002-3901-347X; alberola-ila, Jose/0000-0003-2439-553X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045072] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045072-05, AI45072-01A1, R01 AI045072] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Basson MA, 1998, J EXP MED, V187, P1249; Bommhardt U, 1997, EUR J IMMUNOL, V27, P1152, DOI 10.1002/eji.1830270516; Bommhardt U, 1999, J IMMUNOL, V163, P715; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; FOWLKES BJ, 1995, CURR OPIN IMMUNOL, V7, P188, DOI 10.1016/0952-7915(95)80003-4; Goldberg JE, 1999, J IMMUNOL METHODS, V224, P1, DOI 10.1016/S0022-1759(98)00038-6; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; Hare KJ, 1998, J IMMUNOL, V160, P3666; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; HEATH WR, 1993, J EXP MED, V178, P1807, DOI 10.1084/jem.178.5.1807; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KLINKEN SP, 1988, J IMMUNOL, V140, P1123; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; ROY M, 1993, J IMMUNOL, V151, P2497; SEONG RH, 1992, NATURE, V356, P718, DOI 10.1038/356718a0; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Suzuki H, 1998, EUR J IMMUNOL, V28, P3252, DOI 10.1002/(SICI)1521-4141(199810)28:10<3252::AID-IMMU3252>3.0.CO;2-G; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VANDEKERCKHOVE BAE, 1994, J IMMUNOL, V152, P1738; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; Wang H, 1998, INT IMMUNOL, V10, P1623, DOI 10.1093/intimm/10.11.1623; WEIST DL, 1993, J EXP MED, V178, P1701; WILDIN RS, 1995, J IMMUNOL, V155, P1286	57	162	164	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2000	12	3					313	322		10.1016/S1074-7613(00)80184-3	http://dx.doi.org/10.1016/S1074-7613(00)80184-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	301DC	10755618	Bronze			2022-12-18	WOS:000086292100009
J	Bousso, P; Casrouge, A; Altman, JD; Haury, M; Kanellopoulos, J; Abastado, JP; Kourilsky, P				Bousso, P; Casrouge, A; Altman, JD; Haury, M; Kanellopoulos, J; Abastado, JP; Kourilsky, P			Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires	IMMUNITY			English	Article							RECEPTOR REPERTOIRE; ANTIGENIC PEPTIDES; ALLELIC EXCLUSION; BETA-CHAIN; IN-VIVO; SELECTION; GENES; RECOGNITION; DIVERSITY; CLONES	Previous studies have analyzed the diversity of T cell responses upon immunization. Little is known, however, about the individual variability of naive repertoires and its influence on immune responses. In the present study, T cells specific for a Kd-restricted epitope derived from HLA-AS were purified from individual immunized mice using tetramers of MHC-peptide. Their TCR beta chains were sequenced revealing strong biases but large variations in BJ usage and clonal composition. Most importantly, sequence analysis from nonimmunized mice demonstrated the preexistence of a small set of splenic precursors, distinct in each mouse and comprising less than 200 cells. Therefore, differences in precursor pools appear to be the major source of individual variability in antigen-selected repertoires.	INSERM, U277, Unite Biol Mol Gene, F-75015 Paris, France; Inst Pasteur, Dept Immunol, Stn Cytofluometrie, F-75015 Paris, France; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Emory University	Abastado, JP (corresponding author), INSERM, U277, Unite Biol Mol Gene, F-75015 Paris, France.	jpabas@pasteur.fr	BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X; Haury, Matthias/0000-0002-1796-1479				ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; CANDEIAS S, 1991, J EXP MED, V174, P989, DOI 10.1084/jem.174.5.989; CASANOVA JL, 1993, J EXP MED, V177, P811, DOI 10.1084/jem.177.3.811; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; CASANOVA JL, 1992, J EXP MED, V176, P439, DOI 10.1084/jem.176.2.439; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CIBOTTI R, 1994, J EXP MED, V180, P861, DOI 10.1084/jem.180.3.861; Das MRP, 1996, J NEUROIMMUNOL, V71, P3; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; KATO T, 1994, EUR J IMMUNOL, V24, P2410, DOI 10.1002/eji.1830241022; KUIDA K, 1991, INT IMMUNOL, V3, P75, DOI 10.1093/intimm/3.1.75; KUMAR A, 1994, AM J GERIAT PSYCHIAT, V2, P179, DOI 10.1097/00019442-199405000-00016; Levraud JP, 1996, J EXP MED, V183, P439, DOI 10.1084/jem.183.2.439; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; MARTINON F, 1989, J IMMUNOL, V142, P3489; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; MARYANSKI JL, 1986, J IMMUNOL, V136, P4340; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NANDA NK, 1991, P NATL ACAD SCI USA, V88, P9503, DOI 10.1073/pnas.88.21.9503; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PANNETIER C, 1993, NUCLEIC ACIDS RES, V21, P577, DOI 10.1093/nar/21.3.577; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Regnault A, 1996, EUR J IMMUNOL, V26, P914, DOI 10.1002/eji.1830260429; SAITO T, 1989, J IMMUNOL, V143, P3379; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; VANPEL A, 1985, SOMAT CELL MOLEC GEN, V11, P467	35	162	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					169	178		10.1016/S1074-7613(00)80599-3	http://dx.doi.org/10.1016/S1074-7613(00)80599-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729037	Bronze			2022-12-18	WOS:000075610300003
J	Maryanski, JL; Jongeneel, CV; Bucher, P; Casanova, JL; Walker, PR				Maryanski, JL; Jongeneel, CV; Bucher, P; Casanova, JL; Walker, PR			Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: A high magnitude CD8 response is comprised of very few clones	IMMUNITY			English	Article							RECEPTOR DIVERSITY; LYMPHOCYTES-T; REGION GENES; RECOGNITION; PEPTIDES; INVIVO; EXPRESSION; PRODUCTS; SEQUENCE	Taking advantage of a potent MHC class I-restricted response that allows the identification of antigen-selected CD8 T cells directly ex vivo, we characterized the antigen-specific T cell repertoires that develop in individual mice by single-cell PCR analysis. Each of the immune mice displayed distinct yet structurally similar TCR repertoires. The overall repertoire size was estimated to be in the range of 15-20 for most mice. No major differences were observed between primary and secondary responses. Moreover, for a hyperimmunized mouse the antigen-specific TCR repertoire expressed 8 months after the initial immunization was very similar to that found at the peak of the primary response. Our results demonstrate that a high magnitude immune response may be composed of very few clones, and that at least in the system analyzed, the memory response largely reflects the repertoire selected by the peak of the primary response.	SWISS INST EXPTL CANC RES,LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND	Ludwig Institute for Cancer Research; Swiss Institute Experimental Cancer Research			Jongeneel, Cornelis V/B-2135-2012; Maryanski, Janet/G-3161-2013; Casanova, Jean-Laurent/I-3418-2017	Casanova, Jean-Laurent/0000-0002-7782-4169; Jongeneel, Cornelis Victor/0000-0002-3922-1906				BEHLKE MA, 1985, SCIENCE, V229, P566, DOI 10.1126/science.3875151; CALLAN MFC, 1995, EUR J IMMUNOL, V25, P1529, DOI 10.1002/eji.1830250609; Casanova J L, 1993, Methods Mol Biol, V23, P191; CASANOVA JL, 1993, J EXP MED, V177, P811, DOI 10.1084/jem.177.3.811; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; CASANOVA JL, 1992, J EXP MED, V176, P439, DOI 10.1084/jem.176.2.439; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; COCHET M, 1992, EUR J IMMUNOL, V22, P2639, DOI 10.1002/eji.1830221025; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FORD JE, 1994, EUR J IMMUNOL, V24, P1816, DOI 10.1002/eji.1830240814; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GASCOIGNE NRJ, 1984, NATURE, V310, P387, DOI 10.1038/310387a0; HINGORANI R, 1993, J IMMUNOL, V151, P5762; HIRAMA T, 1991, EUR J IMMUNOL, V21, P483, DOI 10.1002/eji.1830210234; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; KATO T, 1994, EUR J IMMUNOL, V24, P2410, DOI 10.1002/eji.1830241022; KAVALER J, 1984, NATURE, V310, P421, DOI 10.1038/310421a0; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; MACDONALD HR, 1993, J EXP MED, V177, P1487, DOI 10.1084/jem.177.5.1487; MARYANSKI JL, 1986, J IMMUNOL, V136, P4340; MASUKO K, 1994, INT IMMUNOL, V6, P1959, DOI 10.1093/intimm/6.12.1959; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; NECKER A, 1991, EUR J IMMUNOL, V21, P3035, DOI 10.1002/eji.1830211220; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SIU G, 1984, NATURE, V311, P344, DOI 10.1038/311344a0; STEINLE A, 1995, J EXP MED, V181, P503, DOI 10.1084/jem.181.2.503; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WALKER PR, 1995, J IMMUNOL, V155, P3443; ZHENG B, 1994, NATURE, V372, P556, DOI 10.1038/372556a0	34	162	163	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					47	55		10.1016/S1074-7613(00)80297-6	http://dx.doi.org/10.1016/S1074-7613(00)80297-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574851	Bronze			2022-12-18	WOS:A1996TT31900005
J	Granot, T; Senda, T; Carpenter, DJ; Matsuoka, N; Weiner, J; Gordon, CL; Miron, M; Kumar, BV; Griesemer, A; Ho, SH; Lerner, H; Thome, JJC; Connors, T; Reizis, B; Farber, DL				Granot, Tomer; Senda, Takashi; Carpenter, Dustin J.; Matsuoka, Nobuhide; Weiner, Joshua; Gordon, Claire L.; Miron, Michelle; Kumar, Brahma V.; Griesemer, Adam; Ho, Siu-Hong; Lerner, Harvey; Thome, Joseph J. C.; Connors, Thomas; Reizis, Boris; Farber, Donna L.			Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life	IMMUNITY			English	Article							STEADY-STATE; CROSS-PRESENTATION; SOLUBLE-ANTIGEN; LUNG; COMPARTMENTALIZATION; MACROPHAGES; POPULATION; MIGRATION; IMMUNITY; RESIDENT	Maturation and migration to lymph nodes (LNs) constitutes a central paradigm in conventional dendritic cell (cDC) biology but remains poorly defined in humans. Using our organ donor tissue resource, we analyzed cDC subset distribution, maturation, and migration in mucosal tissues (lungs, intestines), associated lymph nodes (LNs), and other lymphoid sites from 78 individuals ranging from less than 1 year to 93 years of age. The distribution of cDC1 (CD141(hi)CD13(hi)) and cDC2 (Sirp-alpha(+)CD1c(+)) subsets was a function of tissue site and was conserved between donors. We identified cDC2 as the major mature (HLA-DRhi) subset in LNs with the highest frequency in lung-draining LNs. Mature cDC2 in mucosal-draining LNs expressed tissue-specific markers derived from the paired mucosal site, reflecting their tissue-migratory origin. These distribution and maturation patterns were largely maintained throughout life, with site-specific variations. Our findings provide evidence for localized DC tissue surveillance and reveal a lifelong division of labor between DC subsets, with cDC2 functioning as guardians of the mucosa.	[Granot, Tomer; Senda, Takashi; Carpenter, Dustin J.; Matsuoka, Nobuhide; Gordon, Claire L.; Miron, Michelle; Kumar, Brahma V.; Griesemer, Adam; Ho, Siu-Hong; Thome, Joseph J. C.; Connors, Thomas; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Granot, Tomer; Gordon, Claire L.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Senda, Takashi; Carpenter, Dustin J.; Matsuoka, Nobuhide; Weiner, Joshua; Griesemer, Adam; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Miron, Michelle; Ho, Siu-Hong; Thome, Joseph J. C.; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Connors, Thomas] Columbia Univ, Med Ctr, Dept Pediat, Div Crit Care, New York, NY 10032 USA; [Reizis, Boris] NYU, Langone Med Ctr, Dept Pathol, 550 1St Ave, New York, NY 10016 USA; [Lerner, Harvey] LiveOnNY, New York, NY 10001 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York University; NYU Langone Medical Center	Farber, DL (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA.; Farber, DL (corresponding author), Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA.; Farber, DL (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	df2396@cumc.columbia.edu		Gordon, Claire/0000-0001-5172-4728; Weiner, Joshua/0000-0003-3780-1875; Reizis, Boris/0000-0003-1140-7853; Farber, Donna/0000-0001-8236-9183; Connors, Thomas/0000-0002-0199-7733	NIH [AI06697, AI100119]; S10 Shared Instrumentation Grant [1S10RR027050, 5P30DK063608]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571, P01AI106697, U01AI100119, U19AI128949, R01AI100119, T32AI106711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); S10 Shared Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants AI06697 and AI100119 awarded to D.L.F. These studies were performed in the CCTI Flow Cytometry Core, funded in part through an S10 Shared Instrumentation Grant, 1S10RR027050 and 5P30DK063608. We wish to thank Kazuhiro Furuhashi (CCTI) for help with the imaging and Bruce Levin for statistical consultation. We wish to gratefully acknowledge the generosity of the donor families and the outstanding efforts of LiveOnNY transplant coordinators and staff for making this study possible.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Ghosh M, 2012, J IMMUNOL, V188, P5489, DOI 10.4049/jimmunol.1103490; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hammer GE, 2013, ANNU REV IMMUNOL, V31, P743, DOI 10.1146/annurev-immunol-020711-074929; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ruckwardt TJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003934; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Thome JJC, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6506; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Trautwein-Weidner K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005164; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116	46	161	166	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					504	515		10.1016/j.immuni.2017.02.019	http://dx.doi.org/10.1016/j.immuni.2017.02.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329707	Bronze, Green Accepted			2022-12-18	WOS:000396818100020
J	Kuraoka, M; Schmidt, AG; Nojima, T; Feng, F; Watanabe, A; Kitamura, D; Harrison, SC; Kepler, TB; Kelsoe, G				Kuraoka, Masayuki; Schmidt, Aaron G.; Nojima, Takuya; Feng, Feng; Watanabe, Akiko; Kitamura, Daisuke; Harrison, Stephen C.; Kepler, Thomas B.; Kelsoe, Garnett			Complex Antigens Drive Permissive Clonal Selection in Germinal Centers	IMMUNITY			English	Article							PRIMARY IMMUNE-RESPONSE; CENTER B-CELLS; INFLUENZA-VIRUS HEMAGGLUTININ; VARIABLE REGION GENES; AFFINITY MATURATION; IN-SITU; ANTIBODY-RESPONSES; HAPTEN RESPONSE; BINDING SITE; MEMORY B	Germinal center (GC) B cells evolve toward increased affinity by a Darwinian process that has been studied primarily in genetically restricted, hapten-specific responses. We explored the population dynamics of genetically diverse GC responses to two complex antigens-Bacillus anthracis protective antigen and influenza hemagglutinin-in which B cells competed both intra-and interclonally for distinct epitopes. Preferred VH rearrangements among antigen-binding, naive B cells were similarly abundant in early GCs but, unlike responses to haptens, clonal diversity increased in GC B cells as early "winners" were replaced by rarer, high-affinity clones. Despite affinity maturation, inter-and intraclonal avidities varied greatly, and half of GC B cells did not bind the immunogen but nonetheless exhibited biased VH use, V(D) J mutation, and clonal expansion comparable to antigen-binding cells. GC reactions to complex antigens permit a range of specificities and affinities, with potential advantages for broad protection.	[Kuraoka, Masayuki; Nojima, Takuya; Watanabe, Akiko; Kelsoe, Garnett] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [Kelsoe, Garnett] Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA; [Schmidt, Aaron G.; Harrison, Stephen C.] Harvard Univ, Childrens Hosp, Sch Med, Lab Mol Med, Boston, MA 02115 USA; [Feng, Feng; Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Kepler, Thomas B.] Boston Univ, Dept Math & Stat, Boston, MA 02118 USA	Duke University; Duke University; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston University; Tokyo University of Science; Howard Hughes Medical Institute; Boston University	Kelsoe, G (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27710 USA.; Kelsoe, G (corresponding author), Duke Univ, Human Vaccine Inst, Durham, NC 27710 USA.	ghkelsoe@duke.edu			NIH [AI100645, HHSN272201000053C, AI117892, AI089618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, U19AI117892, P01AI089618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Zhang, D. Liao, X. Liang, M. Cunningham, X. Nie, S. Sanders, and A. Miller (Duke University) for assistance. We thank Dr. M.A. Moody (Duke Human Vaccine Institute) for rHA tetramer and Dr. H. Wardemann (Max Planck Institute) for Ig expression vectors. This work was supported in part by NIH awards AI100645 (to G.K.), HHSN272201000053C and AI117892 (to G.K. and T.B.K.), and AI089618 (to S.C.H.).	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Aoki-Ota M, 2012, J IMMUNOL, V188, P2305, DOI 10.4049/jimmunol.1103484; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; Cain DW, 2013, VACCINE, V31, P653, DOI 10.1016/j.vaccine.2012.11.044; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Felsenstein J, 2005, PHYLIP PHYLOGENY INF; George J, 1992, Semin Immunol, V4, P11; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; Kantor AB, 1997, J IMMUNOL, V158, P1175; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; Kuraoka M, 2011, P NATL ACAD SCI USA, V108, P11560, DOI 10.1073/pnas.1102571108; Kuraoka M, 2009, J IMMUNOL, V183, P3237, DOI 10.4049/jimmunol.0901548; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; LOH DY, 1983, CELL, V33, P85, DOI 10.1016/0092-8674(83)90337-9; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MANSER T, 1984, SCIENCE, V226, P1283, DOI 10.1126/science.6334361; McWilliams L, 2013, J LEUKOCYTE BIOL, V94, P991, DOI 10.1189/jlb.0113048; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Rohatgi S, 2008, J IMMUNOL METHODS, V339, P205, DOI 10.1016/j.jim.2008.09.017; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; WHITESCHARF ME, 1981, EUR J IMMUNOL, V11, P897, DOI 10.1002/eji.1830111109; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	39	161	161	2	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 15	2016	44	3					542	552		10.1016/j.immuni.2016.02.010	http://dx.doi.org/10.1016/j.immuni.2016.02.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH4VR	26948373	Bronze, Green Accepted			2022-12-18	WOS:000372784200013
J	Moriwaki, K; Balaji, S; McQuade, T; Malhotra, N; Kang, J; Chan, FKM				Moriwaki, Kenta; Balaji, Sakthi; McQuade, Thomas; Malhotra, Nidhi; Kang, Joonsoo; Chan, Francis Ka-Ming			The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair	IMMUNITY			English	Article							INTESTINAL EPITHELIAL-CELLS; IN-VIVO; INDUCED COLITIS; PROTECTS MICE; APOPTOSIS; KINASE; ACTIVATION; NECROSIS; RECEPTOR; INFLAMMATION	Programmed necrosis or necroptosis is an inflammatory form of cell death that critically requires the receptor-interacting protein kinase 3 (RIPK3). Here we showed that RIPK3 controls a separate, necrosis-independent pathway of inflammation by regulating cytokine expression in dendritic cells (DCs). Ripk3(-/-) bone-marrow-derived dendritic cells (BMDCs) were highly defective in lipopolysaccharide (LPS)-induced expression of inflammatory cytokines. These effects were caused by impaired NFkB subunit ReIB and p50 activation and by impaired caspase 1-mediated processing of interleukin-1 beta (IL-1 beta). This DC-specific function of RIPK3 was critical for injury-induced inflammation and tissue repair in response to dextran sodium sulfate (DSS). Ripk3(-/-) mice exhibited an impaired axis of injury-induced IL-1 beta, IL-23, and IL-22 cytokine cascade, which was partially corrected by adoptive transfer of wildtype DCs, but not Ripk3(-/-) DCs. These results reveal an unexpected function of RIPK3 in NF-kappa B activation, DC biology, innate inflammatory-cytokine expression, and injury-induced tissue repair.	[Moriwaki, Kenta; Balaji, Sakthi; McQuade, Thomas; Malhotra, Nidhi; Kang, Joonsoo; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Immunol & Microbiol Program, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Immunol & Microbiol Program, Worcester, MA 01655 USA.	francis.chan@umassmed.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014	Chan, Francis Ka-Ming/0000-0002-4803-8353; Moriwaki, Kenta/0000-0002-8724-4715; kang, joonsoo/0000-0001-8419-7995	Uehara Memorial Foundation; Japan Society for the Promotion of Science; NIH [AI083497, AI101301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083497, R01AI101301] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Hwa-Jeong and X. Wang (UMMS) for blind histology scoring, the UMass DERC morphology core for immunohistochemistry, V. Kapoor (UMMS) for technical assistance with the BM chimeras, V. Dixit (Genentech) for Ripk3<SUP>-/-</SUP> mice, K Fitzgerald (UMMS) for Ripk3<SUP>-/-</SUP> Casp8<SUP>-/-</SUP> mice, P. Gough (GlaxoSmithKline) for RIPK3 kinase inhibitor, and W. Ouyang (Genentech) for IL-22-Fc. K.M. was supported by a postdoctoral fellowship from the Uehara Memorial Foundation and the Japan Society for the Promotion of Science. This work is supported by NIH grants AI083497 (F.K-M.C) and AI101301 (J.K.). F.K-M.C. and J.K. are members of the UMass DERC (DK32520).	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee Y, 2013, J IMMUNOL, V190, P5296, DOI 10.4049/jimmunol.1201452; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mizoguchi A, 2012, INFLAMM BOWEL DIS, V18, P1777, DOI 10.1002/ibd.22929; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qualls JE, 2009, INFLAMM BOWEL DIS, V15, P236, DOI 10.1002/ibd.20733; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	53	161	171	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					567	578		10.1016/j.immuni.2014.09.016	http://dx.doi.org/10.1016/j.immuni.2014.09.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367573	Green Accepted, Bronze			2022-12-18	WOS:000345504300011
J	Thevenot, PT; Sierra, RA; Raber, PL; Al-Khami, AA; Trillo-Tinoco, J; Zarreii, P; Ochoa, AC; Cui, Y; Del Valle, L; Rodriguez, PC				Thevenot, Paul T.; Sierra, Rosa A.; Raber, Patrick L.; Al-Khami, Amir A.; Trillo-Tinoco, Jimena; Zarreii, Parisa; Ochoa, Augusto C.; Cui, Yan; Del Valle, Luis; Rodriguez, Paulo C.			The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors	IMMUNITY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; HOMOLOGOUS PROTEIN CHOP; ER STRESS; OXIDATIVE STRESS; LUNG-CANCER; T-CELLS; EXPRESSION; INDUCTION; AUTOPHAGY	Adaptation of malignant cells to the hostile milieu present in tumors is an important determinant of their survival and growth. However, the interaction between tumor-linked stress and antitumor immunity remains poorly characterized. Here, we show the critical role of the cellular stress sensor C/EBPhomologous protein (Chop) in the accumulation and immune inhibitory activity of tumor-infiltrating myeloid-derived suppressor cells (MDSCs). MDSCs lacking Chop had decreased immune-regulatory functions and showed the ability to prime T cell function and induce antitumor responses. Chop expression in MDSCs was induced by tumor-linked reactive oxygen and nitrogen species and regulated by the activating-transcription factor-4. Chop-deficient MDSCs displayed reduced signaling through CCAAT/enhancer-binding protein-b, leading to a decreased production of interleukin-6 (IL-6) and low expression of phospho-STAT3. IL-6 overexpression restored immune-suppressive activity of Chop-deficient MDSCs. These findings suggest the role of Chop in tumor-induced tolerance and the therapeutic potential of targeting Chop in MDSCs for cancer immunotherapy.	[Thevenot, Paul T.; Sierra, Rosa A.; Raber, Patrick L.; Al-Khami, Amir A.; Trillo-Tinoco, Jimena; Zarreii, Parisa; Ochoa, Augusto C.; Cui, Yan; Del Valle, Luis; Rodriguez, Paulo C.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Raber, Patrick L.; Cui, Yan; Rodriguez, Paulo C.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [Ochoa, Augusto C.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Rodriguez, PC (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.	prodri1@lsuhsc.edu	Rodríguez, Paulo/HDM-9539-2022; Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206; Trillo-Tinoco, Jimena/0000-0002-1240-9650; Cui, Yan/0000-0002-2800-6039; Rodriguez, Paulo/0000-0001-7480-6566	Immunology Core Laboratories from the Stanley S. Scott Cancer Center (LSU-HSC) [P20GM103501]; Tulane University [P20GM103518]; NIH [P20GM103501, NIH-R21CA162133]; NATIONAL CANCER INSTITUTE [R01CA107974, R21CA162133, R01CA169133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103518, P20GM103501, U54GM104940] Funding Source: NIH RePORTER	Immunology Core Laboratories from the Stanley S. Scott Cancer Center (LSU-HSC); Tulane University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Immunology Core Laboratories from the Stanley S. Scott Cancer Center (LSU-HSC) and Tulane University (funded through P20GM103501 and P20GM103518, respectively) for their help with the flow sorting studies. This work was supported in part by NIH grant P20GM103501 subproject #3 and NIH-R21CA162133, both to P.C.R.	Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025; Condamine T, 2014, J CLIN INVEST, V124, P2626, DOI 10.1172/JCI74056; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dalton LE, 2013, BRIT J CANCER, V108, P1340, DOI 10.1038/bjc.2013.66; De Santo C, 2005, P NATL ACAD SCI USA, V102, P4185, DOI 10.1073/pnas.0409783102; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Dolcetti L., 2010, CURR PROTOC IMMUNOL, V14; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Esposito V, 2013, AM J PHYSIOL-RENAL, V304, pF440, DOI 10.1152/ajprenal.00487.2011; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Grant R, 2014, J BIOL CHEM, V289, P14045, DOI 10.1074/jbc.M113.545921; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Kim KM, 2012, INT J CANCER, V131, pE362, DOI 10.1002/ijc.26463; Liu HY, 2014, MOL CELL BIOL, V34, P428, DOI 10.1128/MCB.00946-13; Loinard C, 2012, CIRCULATION, V125, P1014, DOI 10.1161/CIRCULATIONAHA.111.041830; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Malhi H, 2013, J BIOL CHEM, V288, P18624, DOI 10.1074/jbc.M112.442954; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2007, CLIN CANCER RES, V13, P2537, DOI 10.1158/1078-0432.CCR-06-2126; Sawant A, 2013, CANCER RES, V73, P6609, DOI 10.1158/0008-5472.CAN-13-0987; Scaiewicz V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081065; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Sonda N, 2011, CURR OPIN IMMUNOL, V23, P279, DOI 10.1016/j.coi.2010.12.006; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81	46	161	170	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					389	401		10.1016/j.immuni.2014.08.015	http://dx.doi.org/10.1016/j.immuni.2014.08.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238096	Green Accepted, Bronze			2022-12-18	WOS:000342626500010
J	Zhu, JZ; Zhang, YG; Ghosh, A; Cuevas, RA; Forero, A; Dhar, J; Ibsen, MS; Schmid-Burgk, JL; Schmidt, T; Ganapathiraju, MK; Fujita, T; Hartmann, R; Barik, S; Hornung, V; Coyne, CB; Sarkar, SN				Zhu, Jianzhong; Zhang, Yugen; Ghosh, Arundhati; Cuevas, Rolando A.; Forero, Adriana; Dhar, Jayeeta; Ibsen, Mikkel Soes; Schmid-Burgk, Jonathan Leo; Schmidt, Tobias; Ganapathiraju, Madhavi K.; Fujita, Takashi; Hartmann, Rune; Barik, Sailen; Hornung, Veit; Coyne, Carolyn B.; Sarkar, Saumendra N.			Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor	IMMUNITY			English	Article							STRUCTURAL BASIS; VIRAL-RNA; DSRNA RECOGNITION; UBIQUITIN LIGASE; INNATE IMMUNITY; CYTOSOLIC DNA; INTERFERON; ACTIVATION; GENES; MDA5	Virus infection is sensed in the cytoplasm by retinoic acid-inducible gene I (RIG-I, also known as DDX58), which requires RNA and polyubiquitin binding to induce type I interferon (IFN) and activate cellular innate immunity. We show that the human IFN-inducible oligoadenylate synthetases-like (OASL) protein has antiviral activity and mediates RIG-I activation by mimicking polyubiquitin. Loss of OASL expression reduced RIG-I signaling and enhanced virus replication in human cells. Conversely, OASL expression suppressed replication of a number of viruses in a RIG-I-dependent manner and enhanced RIG-I-mediated IFN induction. OASL interacted and colocalized with RIG-I, and through its C-terminal ubiquitin-like domain specifically enhanced RIG-I signaling. Bone-marrow-derived macrophages from mice deficient for Oasl2 showed that among the two mouse orthologs of human OASL, Oasl2 is functionally similar to human OASL. Our findings show a mechanism by which human OASL contributes to host antiviral responses by enhancing RIG-I activation.	[Zhu, Jianzhong; Zhang, Yugen; Ghosh, Arundhati; Cuevas, Rolando A.; Forero, Adriana; Coyne, Carolyn B.; Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15213 USA; [Zhu, Jianzhong; Zhang, Yugen; Ghosh, Arundhati; Cuevas, Rolando A.; Forero, Adriana; Coyne, Carolyn B.; Sarkar, Saumendra N.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Dhar, Jayeeta; Barik, Sailen] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Dhar, Jayeeta; Barik, Sailen] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Ibsen, Mikkel Soes; Hartmann, Rune] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Schmid-Burgk, Jonathan Leo; Schmidt, Tobias; Hornung, Veit] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Fujita, Takashi] Kyoto Univ, Lab Mol Genet, Kyoto 6068507, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Aarhus University; University of Bonn; Kyoto University	Sarkar, SN (corresponding author), Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15213 USA.	saumen@pitt.edu	Schmid-Burgk, Jonathan/GSN-3512-2022; Hornung, Veit/C-3565-2012; Sarkar, Saumendra N/B-5038-2011; Cuevas, Rolando/AAE-9179-2022	Hornung, Veit/0000-0002-4150-194X; Sarkar, Saumendra N/0000-0002-2850-6121; Hartmann, Rune/0000-0003-1159-066X; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Cuevas, Rolando/0000-0002-3571-5845; Ibsen, Mikkel/0000-0001-5442-3904; Ganapathiraju, Madhavi/0000-0002-3825-0924; Schmidt, Tobias/0000-0003-3102-3515	NIAID/NIH [AI082673]; University of Pittsburgh Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082673] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Pittsburgh Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Z.J. Chen for sharing crucial reagents and expert advice. We thank P. Desai, A. Pattnaik, K. Fitzgerald, and T. Cathomen for reagents. This work was supported in part by AI082673 from NIAID/NIH (S.N.S.) and University of Pittsburgh Cancer Institute Startup funds (S.N.S.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Goswami R, 2013, CELL RES, V23, P1025, DOI 10.1038/cr.2013.98; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang QX, 2012, EMBO REP, V13, P7, DOI 10.1038/embor.2011.239; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li Y, 2008, HEPATOL RES, V38, P85, DOI 10.1111/j.1872-034X.2007.00207.x; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Melchjorsen J, 2009, J INTERF CYTOK RES, V29, P199, DOI 10.1089/jir.2008.0050; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2012, J BIOCHEM, V151, P5, DOI 10.1093/jb/mvr111; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Rebouillat D, 1998, EUR J BIOCHEM, V257, P319, DOI 10.1046/j.1432-1327.1998.2570319.x; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351	42	161	169	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					936	948		10.1016/j.immuni.2014.05.007	http://dx.doi.org/10.1016/j.immuni.2014.05.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24931123	Bronze, Green Accepted			2022-12-18	WOS:000341440200015
J	Dias, S; Mansson, R; Gurbuxani, S; Sigvardsson, M; Kee, BL				Dias, Sheila; Mansson, Robert; Gurbuxani, Sandeep; Sigvardsson, Mikael; Kee, Barbara L.			E2A proteins promote development of lymphoid-primed multipotent progenitors	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MOUSE BONE-MARROW; LINEAGE COMMITMENT; SELF-RENEWAL; GENE-EXPRESSION; UP-REGULATION; FACTOR EBF; LONG-TERM; B-CELLS; TRANSCRIPTION	The first lymphoid-restricted progeny of hematopoietic stem cells (HSCs) are lymphoid-primed multipotent progenitors (LMPPs), which have little erythromyeloid potential but retain lymphoid, granulocyte, and macrophage differentiation capacity. Despite recent advances in the identification of LMPPs, the transcription factors essential for their generation remain to be identified. Here, we demonstrated that the E2A transcription factors were required for proper development of LMPPs. Within HSCs and LMPPs, E2A proteins primed expression of a subset of lymphoid-associated genes and prevented expression of genes that are not normally prevalent in these cells, including HSC-associated and nonlymphoid genes. E2A proteins also restricted proliferation of HSCs, MPPs, and LMPPs and antagonized differentiation of LMPPs toward the myeloid fate. Our results reveal that E2A proteins play a critical role in supporting lymphoid specification from HSCs and that the reduced generation of LMPPs underlies the severe lymphocyte deficiencies observed in E2A-deficient mice.	[Dias, Sheila; Gurbuxani, Sandeep; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Dias, Sheila; Kee, Barbara L.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Mansson, Robert; Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, SE-58183 Linkoping, Sweden	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Linkoping University	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu	Mansson, Robert/D-4372-2014	Mansson, Robert/0000-0003-0738-0328; Sigvardsson, Mikael/0000-0001-8527-7276	NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER; NCI NIH HHS [CA99978, R01 CA099978, R01 CA099978-05, R01 CA099978-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhalla S, 2008, J IMMUNOL, V180, P1694, DOI 10.4049/jimmunol.180.3.1694; Borghesi L, 2005, J EXP MED, V202, P1669, DOI 10.1084/jem.20051190; Cau E, 2002, DEVELOPMENT, V129, P1871; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Dubchak Inna, 2006, V338, P69; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2005, J IMMUNOL, V175, P4518, DOI 10.4049/jimmunol.175.7.4518; Kee BL, 2002, EMBO J, V21, P103, DOI 10.1093/emboj/21.1.103; Kee BL, 2001, CURR OPIN IMMUNOL, V13, P180, DOI 10.1016/S0952-7915(00)00202-8; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Manaia A, 2000, DEVELOPMENT, V127, P643; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; Scimone ML, 2006, P NATL ACAD SCI USA, V103, P7006, DOI 10.1073/pnas.0602024103; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340; Zhuang YA, 2004, MOL IMMUNOL, V40, P1165, DOI 10.1016/j.molimm.2003.11.031	58	161	163	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					217	227		10.1016/j.immuni.2008.05.015	http://dx.doi.org/10.1016/j.immuni.2008.05.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18674933	Bronze, Green Accepted			2022-12-18	WOS:000258610800010
J	Hutcheson, J; Scatizzi, JC; Siddiqui, AM; Haines, GK; Wu, T; Li, QZ; Davis, LS; Mohan, C; Perlman, H				Hutcheson, Jack; Scatizzi, John C.; Siddiqui, Akbar M.; Haines, G. Kenneth, III; Wu, Tianfu; Li, Quan-Zhen; Davis, Laurie S.; Mohan, Chandra; Perlman, Harris			Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity	IMMUNITY			English	Article							LUPUS-ERYTHEMATOSUS; B-CELL; NEGATIVE SELECTION; MURINE LUPUS; T-CELLS; APOPTOSIS; LPR; THYMOCYTES; DISEASE; PROTEIN	Alterations in the stoichiometric balance between members of Bcl-2 and Fas apoptotic pathway could lead to the pathogenesis of systemic lupus erythematosus (SLE). We showed that patients with SLE displayed increased expression in antiapoptotic members of the Bcl-2 and Fas apoptotic pathways in isolated mononuclear cells. Further, mice (Bcl2l11(-/-) Fas(lpr/lpr) lacking the Bcl-2 pro-apoptotic member, Bim (Bcl2l11(-/-)) and and with an lpr mutation in the gene encoding Fas (Fas(lpr/lpr)) developed severe SLE-like disease by 16 weeks of age unlike Bcl2l11(-/-) or Fas(lpr/lpr) mice. Bcl2l11(-/-)Fas(lpr/lpr) antigen-presenting cells (APCs) were markedly activated, and their numbers were increased in lymphoid tissues and in kidneys, yet numerous TUNEL-positive cells were observed in glomeruli of Bcl2l11(-/-)Fas(lpr/lpr) mice. These data demonstrate that dysreaulation of the Bcl-2 or Fas pathways can alter the function of APCs, thereby leading to SLE pathogenesis.	[Hutcheson, Jack; Scatizzi, John C.; Siddiqui, Akbar M.; Perlman, Harris] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Hutcheson, Jack; Wu, Tianfu; Li, Quan-Zhen; Davis, Laurie S.; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Ctr Immunol, Dept Rheumatol & Internal Med, Dallas, TX 75390 USA; [Scatizzi, John C.] Univ Calif San Diego, Sch Med, Dept Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA; [Haines, G. Kenneth, III] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Saint Louis University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Yale University	Perlman, H (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	perlmanh@slu.edu	Mohan, Chandra/GPX-8233-2022; Wu, Tianfu/G-6672-2019; Wu, Tianfu/F-7071-2012	Hutcheson, Jack/0000-0002-6317-2788; Wu, Tianfu/0000-0003-4406-1449; Wu, Tianfu/0000-0001-8235-5929	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067590, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050250, R01AR045293] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI 057160, AI 067590] Funding Source: Medline; NIAMS NIH HHS [AR 050250, AR 45293] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brown NJ, 2004, J IMMUNOL, V173, P7584, DOI 10.4049/jimmunol.173.12.7584; Bunin A, 2005, J IMMUNOL, V175, P1532, DOI 10.4049/jimmunol.175.3.1532; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cohen PL, 2006, SPRINGER SEMIN IMMUN, V28, P145, DOI 10.1007/s00281-006-0038-z; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Han BK, 2005, LUPUS, V14, P598, DOI 10.1191/0961203305lu2171oa; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; Hsu WT, 2006, CLIN EXP IMMUNOL, V145, P513, DOI 10.1111/j.1365-2249.2006.03173.x; Hughes J, 2004, RHEUM DIS CLIN N AM, V30, P655, DOI 10.1016/j.rdc.2004.04.004; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Hutcheson J, 2005, J EXP MED, V201, P1949, DOI 10.1084/jem.20041484; Hutcheson J, 2007, IMMUNOBIOLOGY, V212, P629, DOI 10.1016/j.imbio.2007.05.003; King LB, 2000, IMMUNOL REV, V176, P86; Laouar Y, 2000, EUR J IMMUNOL, V30, P1402; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Liu K, 2006, CLIN IMMUNOL, V119, P123, DOI 10.1016/j.clim.2006.01.014; Mohan C, 2001, CURR OPIN RHEUMATOL, V13, P352, DOI 10.1097/00002281-200109000-00003; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Oliver PM, 2006, J EXP MED, V203, P731, DOI 10.1084/jem.20051407; Pasqualetto V, 2005, J LEUKOCYTE BIOL, V78, P1106, DOI 10.1189/jlb.0105047; REAP EA, 1995, J IMMUNOL, V155, P5455; Roy V, 2005, J IMMUNOL, V175, P7363, DOI 10.4049/jimmunol.175.11.7363; Scatizzi JC, 2006, ARTHRITIS RHEUM, V54, P3182, DOI 10.1002/art.22133; Sheriff A, 2004, RHEUM DIS CLIN N AM, V30, P505, DOI 10.1016/j.rdc.2004.04.006; SOBEL ES, 1991, J EXP MED, V173, P1441, DOI 10.1084/jem.173.6.1441; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587; Zhu J, 2007, ADV EXP MED BIOL, V601, P85	41	161	165	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2008	28	2					206	217		10.1016/j.immuni.2007.12.015	http://dx.doi.org/10.1016/j.immuni.2007.12.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275831	Bronze			2022-12-18	WOS:000253275000011
J	Broussard, C; Fleischecker, C; Horai, R; Chetana, M; Venegas, AM; Sharp, LL; Hedrick, SM; Fowlkes, BJ; Schwartzberg, PL				Broussard, Christine; Fleischecker, Christine; Horai, Reiko; Chetana, Madeva; Venegas, Ana M.; Sharp, Leslie L.; Hedrick, Stephen M.; Fowlkes, B. J.; Schwartzberg, Pamela L.			Altered development of CD8(+) T cell lineages in mice deficient for the Tec kinases Itk and Rlk	IMMUNITY			English	Article							DOUBLE-POSITIVE THYMOCYTES; CLASS-I MOLECULES; CUTTING EDGE; HISTOCOMPATIBILITY ANTIGEN; HEMATOPOIETIC-CELLS; NEGATIVE SELECTION; FAMILY KINASES; COMMITMENT; RECEPTOR; PROTEIN	Mutations affecting the Tec kinases Itk and Rlk decrease T cell receptor-induced Ca2+ mobilization and Erk kinase activation and impair both positive and negative thymic selection. Itk(-/-) and Rlk(-/-) Itk(-/-) mice also have decreased CD4:8 T cell ratios, suggestive of altered CD4:8 lineage commitment. Nonetheless, we find that CD8 single-positive (SP) thymocytes and peripheral CD8(+) T cells in these mice do not resemble conventional CD8(+) T cells. Instead, these cells express memory markers, rapidly produce interferon-gamma, and can be selected on hematopoietically derived cells, similar to MHC class Ib-restricted "innate-type" lymphocytes. Itk deficiency also greatly increases the number of cells selected by MHC class Ib. Expression of a hypersensitive Erk2 mutant partially corrects the CD8(+) T cell phenotypes in Itk(-/-) mice, arguing that altered signaling permits development of this innate-type CD8(+) cell population. Our results suggest that Tec kinases differentially regulate development of conventional versus nonconventional lymphocytes.	NHGRI, NIH, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	pams@nhgri.nih.gov	Hedrick, Stephen M/E-9171-2010	Broussard, Christine/0000-0001-6202-8154; Hedrick, Stephen/0000-0002-6345-8751	Intramural NIH HHS Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000486, Z01AI000486] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; Bommhardt U, 1999, J IMMUNOL, V163, P715; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Coligan J, 1995, CURRENT PROTOCOLS IM; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Eberl G, 1999, J IMMUNOL, V163, P4091; Finkelstein LD, 2005, J IMMUNOL, V175, P5923, DOI 10.4049/jimmunol.175.9.5923; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gangadharan D, 2004, CURR OPIN IMMUNOL, V16, P264, DOI 10.1016/j.coi.2004.03.015; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kennedy P, 2000, LAT TRADE, V8, P15; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Singer A, 2004, ADV IMMUNOL, V83, P91; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125	57	161	162	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					93	104		10.1016/j.immuni.2006.05.011	http://dx.doi.org/10.1016/j.immuni.2006.05.011			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860760	Bronze			2022-12-18	WOS:000239713000013
J	Gomez, TS; McCarney, SD; Carrizosa, E; Labno, CM; Comiskey, EO; Nolz, JC; Zhu, PM; Freedman, BD; Clark, MR; Rawlings, DJ; Billadeau, DD; Burkhardt, JK				Gomez, Timothy S.; McCarney, Sean D.; Carrizosa, Esteban; Labno, Christine M.; Comiskey, Erin O.; Nolz, Jeffrey C.; Zhu, Peimin; Freedman, Bruce D.; Clark, Marcus R.; Rawlings, David J.; Billadeau, Daniel D.; Burkhardt, Janis K.			HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse	IMMUNITY			English	Article							ALDRICH-SYNDROME PROTEIN; T-CELL LINE; MEDIATED TYROSINE PHOSPHORYLATION; FILAMENT NETWORK FORMATION; APC CONTACT SITE; NF-KAPPA-B; IMMUNOLOGICAL SYNAPSE; ARP2/3 COMPLEX; SEQUENTIAL PHOSPHORYLATION; LOCALIZED ACTIVATION	HS1, the leukocyte-specific homolog of cortactin, regulates F-actin in vitro and is phosphorylated in response to TCR ligation, but its role in lymphocyte activation has not been addressed. We demonstrate that HS1-deficient T cells fail to accumulate F-actin at the immune synapse (IS) and, upon TCR ligation, form actin-rich structures that are disordered and unstable. Early TCR activation events are intact in these cells, but Ca2+ influx and IL-2 gene transcription are defective. Importantly, HS1 tyrosine phosphorylation is required for its targeting to the IS and for its function in regulating actin dynamics and IL-2 promoter activity. Phosphorylation also links HS1 to multiple signaling proteins, including Lck, PLC gamma 1, and Vav1, and is essential for the stable recruitment of Vav1 to the IS. Taken together, our studies show that HS1 is indispensable for signaling events leading to actin assembly and IL-2 production during T cell activation.	Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Chicago; University of Chicago; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Billadeau, DD (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu; jburkhar@mail.med.upenn.edu	Rawlings, David/CAI-4751-2022	Burkhardt, Janis/0000-0002-8176-1375	NIAID NIH HHS [R01 AI065474, F31 AI068624, R01 AI060921, R01-AI44835, R01-AI065474, R01 AI044835, F31-AI068624] Funding Source: Medline; NICHD NIH HHS [HD37091, R01 HD037091] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044835, R01AI065474, F31AI068624, R01AI060921] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Badour K, 2004, SEMIN IMMUNOL, V16, P395, DOI 10.1016/j.smim.2004.08.019; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brunati AM, 1999, J BIOL CHEM, V274, P7557, DOI 10.1074/jbc.274.11.7557; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Hao JJ, 2005, J BIOL CHEM, V280, P37988, DOI 10.1074/jbc.M504552200; Hao JJ, 2004, J BIOL CHEM, V279, P33413, DOI 10.1074/jbc.M313564200; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Hutchcroft JE, 1998, J IMMUNOL, V161, P4506; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Ruzzene M, 1996, BIOCHEMISTRY-US, V35, P5327, DOI 10.1021/bi9528614; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Takemoto Y, 1996, INT IMMUNOL, V8, P1699, DOI 10.1093/intimm/8.11.1699; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; TING AT, 1992, J EXP MED, V176, P1751, DOI 10.1084/jem.176.6.1751; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; Zakaria S, 2004, J EXP MED, V199, P429, DOI 10.1084/jem.20031228; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	46	161	164	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					741	752		10.1016/j.immuni.2006.03.022	http://dx.doi.org/10.1016/j.immuni.2006.03.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782030	Green Accepted, Bronze			2022-12-18	WOS:000238592200012
J	Zhu, JF; Guo, LY; Min, BK; Watson, CJ; Hu-Li, J; Young, HA; Tsichlis, PN; Paul, WE				Zhu, JF; Guo, LY; Min, BK; Watson, CJ; Hu-Li, J; Young, HA; Tsichlis, PN; Paul, WE			Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation	IMMUNITY			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; IN-VIVO; T-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; GATA-3; GFI-1; STAT6; COMMITMENT	IL-4 is important in Th2 differentiation and in cell expansion. Stat6 is necessary and sufficient for both functions. Although Gata3 is critical for Th2 polarization, it is not sufficient to mediate IL-4-driven cell expansion. We report that growth factor independent-1 (Gfi-1), a Stat6-dependent transcriptional repressor, strikingly increases Th2 cell expansion by promoting proliferation and preventing apoptosis. Cells infected with a Gfi-1 retrovirus show striking enhancement of IL-2-induced Stat5 phosphorylation and repression of p27(Kip-1) expression, suggesting a potential mechanism for the Gfi-1 growth effect. The synergy of Gfi-1 and Gata3 provides a mechanism through which IL-4 could selectively promote Th2 cell expansion.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; NCI, Expt Immunol Lab, Frederick, MD 21701 USA; Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jefferson University	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.		Zhu, Jinfang/B-7574-2012; Young, Howard/A-6350-2008	Zhu, Jinfang/0000-0002-0117-4745; Young, Howard/0000-0002-3118-5111	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493, Z01AI000493] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; BELL DW, 1995, CYTOGENET CELL GENET, V70, P263, DOI 10.1159/000134048; Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hoch RV, 1999, INT J CANCER, V84, P122; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1998, MOL CELL BIOL, V18, P1996, DOI 10.1128/MCB.18.4.1996; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Roberts SM, 1997, CURR ORG CHEM, V1, P1; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Sakai I, 2001, INT J HEMATOL, V73, P507, DOI 10.1007/BF02994015; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; SHIGA K, 1993, ANTICANCER RES, V13, P1293; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276; Zornig M, 1996, ONCOGENE, V12, P1789	42	161	166	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					733	744		10.1016/S1074-7613(02)00317-5	http://dx.doi.org/10.1016/S1074-7613(02)00317-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049724	Bronze			2022-12-18	WOS:000175820400011
J	Barnes, N; Gavin, AL; Tan, PS; Mottram, P; Koentgen, F; Hogarth, PM				Barnes, N; Gavin, AL; Tan, PS; Mottram, P; Koentgen, F; Hogarth, PM			Fc-gamma RI-deficient mice show multiple alterations to inflammatory and immune responses	IMMUNITY			English	Article							HIGH-AFFINITY RECEPTOR; ANTIGEN PRESENTATION; NOD MICE; ANTIBODY; MACROPHAGE; EXPRESSION; BINDING; CHAIN; IDENTIFICATION; MATURATION	The inactivation of the mouse high-affinity IgG Fc receptor FcgammaRI resulted in a wide range of defects in antibody Fc-dependent functions. These studies showed the primary importance of FcgammaRI in endocytosis of monomeric IgG, kinetics, and extent of phagocytosis of immune complexes, in macrophage-based ADCC, and in immune complex-dependent antigen presentation to primed T cells. In the absence of FcgammaRI, antibody responses were elevated, implying the removal of a control point by the deletion of FcgammaRI. In addition, FcR-gamma chain-deficient mice were found to express partially functional FcgammaRI. Thus, FcgammaRI is an early participant in Fc-dependent cell activation and in the development of immune responses.	Austin Res Inst, Heidelberg, Vic 3084, Australia; Scripps Res Inst, La Jolla, CA 92037 USA; Ozgene, Canning Vale, WA 6970, Australia	Austin Research Institute; Scripps Research Institute	Hogarth, PM (corresponding author), Austin Res Inst, Kronheimer Bldg,Studley Rd, Heidelberg, Vic 3084, Australia.	pm.hogarth@ari.unimelb.edu.au		Hogarth, Mark/0000-0002-0360-7890				Barnett LD, 2000, METH MOL B, V158, P65; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; FANGER MW, 1989, IMMUNOL TODAY, V10, P92, DOI 10.1016/0167-5699(89)90234-X; Gavin AL, 1996, J BIOL CHEM, V271, P17091, DOI 10.1074/jbc.271.29.17091; Gavin AL, 1998, J IMMUNOL, V160, P20; Gavin AL, 1998, EMBO J, V17, P3850, DOI 10.1093/emboj/17.14.3850; Gavin AL, 2000, IMMUNOGENETICS, V51, P206, DOI 10.1007/s002510050033; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HULETT MD, 1991, J IMMUNOL, V147, P1863; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; IERINO FL, 1993, J EXP MED, V178, P1617, DOI 10.1084/jem.178.5.1617; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; LIEW FY, 1972, CELL IMMUNOL, V5, P520, DOI 10.1016/0008-8749(72)90102-5; Luan JJ, 1996, J IMMUNOL, V157, P4707; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; ROMBALL CG, 1993, J EXP MED, V178, P1637, DOI 10.1084/jem.178.5.1637; SANDERS CC, 1984, ANTIMICROBIC NEWSLET, V1, P27; SEARS DW, 1990, J IMMUNOL, V144, P371; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; Vora KA, 1997, J IMMUNOL, V159, P2116	30	161	176	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					379	389		10.1016/S1074-7613(02)00287-X	http://dx.doi.org/10.1016/S1074-7613(02)00287-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911823	Bronze			2022-12-18	WOS:000174572800007
J	Julia, V; Hessel, EM; Malherbe, L; Glaichenhaus, N; O'Garra, A; Coffman, RL				Julia, V; Hessel, EM; Malherbe, L; Glaichenhaus, N; O'Garra, A; Coffman, RL			A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure	IMMUNITY			English	Article							IN-VIVO; AIRWAY HYPERRESPONSIVENESS; IMMUNOLOGICAL-TOLERANCE; INHALED ANTIGEN; ATOPIC ASTHMA; MURINE MODEL; LYMPH-NODES; EXPRESSION; INDUCTION; LUNG	Mice sensitized for a Th2 response to Leishmania LACK antigen developed allergic airway inflammation upon exposure to LACK aerosol. Using multimers of I-A(d) molecules bound to a LACK peptide as probes, we tracked the migration of LACK-specific Th2 cells to the airways. Elevated numbers of LACK-specific Th2 cells remained in the airways for 5 weeks after the last aerosol. Substantial numbers of DC presenting LACK peptides were found in the airways, but not in other compartments, for up to 8 weeks after antigen exposure. These LACK-presenting airway DC expressed CD11c and CD11b as well as high levels of surface molecules involved in uptake and costimulation. Taken together, our results may explain the chronic Th2 airway inflammation characteristic of allergic asthma.	DNAX Res Inst Mol & Cellular Biol Inc, Res Inst, Dept Immunol, Palo Alto, CA 94304 USA; Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Julia, V (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Res Inst, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.	julia@ipmc.cnrs.fr; rcoffman@dvax.com	Hessel, Edith M/AAB-6002-2021	Hessel, Edith M/0000-0002-2339-4482; O'Garra, Anne/0000-0001-9845-6134				Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Blyth DI, 1998, AM J RESP CELL MOL, V19, P38, DOI 10.1165/ajrcmb.19.1.2930; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; Doherty PC, 1998, CURR OPIN MICROBIOL, V1, P419, DOI 10.1016/S1369-5274(98)80059-3; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gutgemann I, 1998, IMMUNITY, V8, P667, DOI 10.1016/S1074-7613(00)80571-3; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; HOLT PG, 1994, J IMMUNOL, V153, P256; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; Hurst SD, 2001, J IMMUNOL, V166, P4922, DOI 10.4049/jimmunol.166.8.4922; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421; Kim SK, 2000, J IMMUNOL, V165, P7285, DOI 10.4049/jimmunol.165.12.7285; Knight SC, 1998, EUR J IMMUNOL, V28, P1636; Kronin V, 2000, INT IMMUNOL, V12, P731, DOI 10.1093/intimm/12.5.731; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Liu CP, 2000, P NATL ACAD SCI USA, V97, P14596, DOI 10.1073/pnas.250390997; Malhotra V, 2000, J AM SOC ECHOCARDIOG, V13, P771, DOI 10.1067/mje.2000.106078; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McSorley SJ, 1997, IMMUNITY, V7, P401, DOI 10.1016/S1074-7613(00)80361-1; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SEDGWICK JD, 1985, IMMUNOLOGY, V56, P635; Seymour BWP, 1998, J EXP MED, V187, P721, DOI 10.1084/jem.187.5.721; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; TAYLOR FGR, 1985, INT ARCH ALLER A IMM, V76, P243, DOI 10.1159/000233699; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wang J, 2000, BLOOD, V95, P2337, DOI 10.1182/blood.V95.7.2337.007k22_2337_2345; White DW, 1999, J IMMUNOL, V162, P980; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yamaguchi E, 1999, EUR RESPIR J, V13, P814, DOI 10.1034/j.1399-3003.1999.13d20.x	45	161	168	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					271	283		10.1016/S1074-7613(02)00276-5	http://dx.doi.org/10.1016/S1074-7613(02)00276-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869687	Bronze			2022-12-18	WOS:000174039600010
J	Naka, T; Tsutsui, H; Fujimoto, M; Kawazoe, Y; Kohzaki, H; Morita, Y; Nakagawa, R; Narazaki, M; Adachi, K; Yoshimoto, T; Nakanishi, K; Kishimoto, T				Naka, T; Tsutsui, H; Fujimoto, M; Kawazoe, Y; Kohzaki, H; Morita, Y; Nakagawa, R; Narazaki, M; Adachi, K; Yoshimoto, T; Nakanishi, K; Kishimoto, T			SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo	IMMUNITY			English	Article							NK1(+) T-CELLS; INTERFERON-GAMMA; SOCS PROTEINS; NEGATIVE REGULATION; CUTTING EDGE; CYTOKINE; MICE; ACTIVATION; EXPRESSION; GENE	Suppressor of cytokine signaling-1 (SOCS-1), also known as STAT-induced STAT inhibitor-1 (SSI-1), is a negative feedback molecule for cytokine signaling, and its in vivo deletion induces fulminant hepatitis. However, elimination of the STAT1 or STAT6 gene or deletion of NKT cells substantially prevented severe hepatitis in SOCS-1-deficient mice, while administration of IFN-gamma and IL-4 accelerated its development. SOCS-1 deficiency not only sustained IFN-gamma /lL-4 signaling but also eliminated the cross-inhibitory action of IFN-gamma on IL-4 signaling. These results suggest that SOCS-1 deficiency-induced persistent activation of STAT1 and STAT6, which would be inhibited by SOCS-1 under normal conditions, may induce abnormal activation of NKT cells, thus leading to lethal pathological changes in SOCS-1-deficient mice.	Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Microbiol, Suita, Osaka 5650871, Japan; Hyogo Coll Med, Dept Immunol & Med Zool, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Hyogo College of Medicine; Osaka University	Naka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	naka@imed3.med.osaka-u.ac.jp	adachi, keishi/AAT-7471-2020; Kishimoto, Tadamitsu/C-8470-2009; Nakagawa, Reiko/C-4214-2017; Yoshimoto, Tomohiro/E-2224-2014	Nakagawa, Reiko/0000-0002-6178-2945; FUJIMOTO, MINORU/0000-0002-6390-8863; Naka, Tetsuji/0000-0002-1269-3997; narazaki, masashi/0000-0002-5613-4409; Tsutsui, Hiroko/0000-0001-7928-4875				Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Chen HJ, 1997, J IMMUNOL, V159, P2240; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; Fujimoto M, 2000, J IMMUNOL, V165, P1799, DOI 10.4049/jimmunol.165.4.1799; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Helman D, 1998, FEBS LETT, V441, P287, DOI 10.1016/S0014-5793(98)01555-5; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kawamura T, 1998, J IMMUNOL, V160, P16; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Krebs DL, 2000, J CELL SCI, V113, P2813; LEWIS DB, 1991, J EXP MED, V173, P89, DOI 10.1084/jem.173.1.89; LOHR HF, 1994, LIVER, V14, P161; Losman JA, 1999, J IMMUNOL, V162, P3770; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Morita Y, 2000, P NATL ACAD SCI USA, V97, P5405, DOI 10.1073/pnas.090084797; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; NAKA T, 2001, CYTOKINE INHIBITORS, P241; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nicola NA, 2000, EXP HEMATOL, V28, P1105, DOI 10.1016/S0301-472X(00)00525-7; Pezet A, 1999, J BIOL CHEM, V274, P24497, DOI 10.1074/jbc.274.35.24497; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Sonoda KH, 1999, J EXP MED, V190, P1215, DOI 10.1084/jem.190.9.1215; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STARR R, 2001, CYTOKINE INHIBITOR I, P261; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tomic S, 1999, MOL CELL ENDOCRINOL, V158, P45, DOI 10.1016/S0303-7207(99)00180-X; Toyabe S, 1997, J IMMUNOL, V159, P1537; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; TSUTSUI H, 1992, HEPATO-GASTROENTEROL, V39, P553; Venkataraman C, 1999, J IMMUNOL, V162, P4053; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583	50	161	167	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					535	545		10.1016/S1074-7613(01)00132-7	http://dx.doi.org/10.1016/S1074-7613(01)00132-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371356	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000168880900006
J	Bross, L; Fukita, Y; McBlane, F; Demolliere, C; Rajewsky, K; Jacobs, H				Bross, L; Fukita, Y; McBlane, F; Demolliere, C; Rajewsky, K; Jacobs, H			DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation	IMMUNITY			English	Article							MEMORY B-CELLS; ANTIBODY MUTANTS; CLONAL SELECTION; IMMUNE-RESPONSE; SEQUENCES; RECOMBINATION; TRANSCRIPTION; CONSEQUENCES; MATURATION; GENERATION	How rearranged immunoglobulin (Ig) genes are further diversified by somatic hypermutation is unknown. Using VDJ passenger Ig heavy chain (IgH) knockin mouse strains, we now demonstrate a high frequency of DNA double-strand breaks (DSBs) in the targeted VDJ passenger gene of germinal center (GC) B cells. These DSBs parallel the distribution of mutations in the targeted hypermutation domain and are found preferentially at RGYW motifs, the intrinsic hot spots of somatic hypermutation. The introduction of DSBs appears to depend on transcriptional activity. Thus, secondary diversification of rearranged V gene segments relates to an error-prone nonhomologous DSB repair system acting in B cells of the GC.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Cologne, Inst Genet, D-50931 Cologne, Germany	University of Cologne	Jacobs, H (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.	jacobs@bii.ch		Jacobs, Heinz/0000-0001-6227-9850; Rajewsky, Klaus/0000-0002-6633-6370				ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BETZ AG, 1993, P NATL ACAD SCI USA, V90, P2385, DOI 10.1073/pnas.90.6.2385; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Jacobs H, 1999, CURR TOP MICROBIOL, V246, P149; KABAT EA, 1991, J IMMUNOL, V147, P1709; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Longacre A, 2000, CELL, V102, P541, DOI 10.1016/S0092-8674(00)00075-1; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud C A, 1996, Semin Immunol, V8, P125, DOI 10.1006/smim.1996.0016; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; ROTHENFLUH HS, 1993, EUR J IMMUNOL, V23, P2152, DOI 10.1002/eji.1830230916; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; SCHITTEK B, 1992, J EXP MED, V176, P427, DOI 10.1084/jem.176.2.427; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Storb U, 1998, IMMUNOL REV, V162, P5, DOI 10.1111/j.1600-065X.1998.tb01424.x; WEBER JS, 1991, J IMMUNOL, V146, P3652; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Wiesendanger M, 1998, CELL, V94, P415, DOI 10.1016/S0092-8674(00)81581-0; YELAMOS J, 1995, NATURE, V376, P225	41	161	163	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2000	13	5					589	597		10.1016/S1074-7613(00)00059-5	http://dx.doi.org/10.1016/S1074-7613(00)00059-5			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114372	Bronze			2022-12-18	WOS:000165598500002
J	Fujimoto, M; Fujimoto, Y; Poe, JC; Jansen, PJ; Lowell, CA; DeFranco, AL; Tedder, TF				Fujimoto, M; Fujimoto, Y; Poe, JC; Jansen, PJ; Lowell, CA; DeFranco, AL; Tedder, TF			CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification	IMMUNITY			English	Article							SIGNAL-TRANSDUCTION MOLECULE; LYN-DEFICIENT MICE; PHOSPHATIDYLINOSITOL 3-KINASE; GEL-ELECTROPHORESIS; CYTOPLASMIC DOMAIN; ANTIGEN; RECEPTOR; CELLS; PHOSPHORYLATION; COMPLEX	CD19 regulates constitutive and antigen receptor-induced signaling thresholds in B lymphocytes through its unique cytoplasmic domain. Herein, we demonstrate a novel molecular mechanism where interactions between CD19 and Lyn amplify basal and antigen receptor-induced Src family kinase activation. Lyn expression was required for CD19 tyrosine phosphorylation in primary B cells. Experiments with purified proteins demonstrated that CD19-Y-513 was Lyn's initial phosphorylation and binding site. This led to processive phosphorylation of CD19-Y-482, which recruited a second Lyn molecule, allowing for transphosphorylation and amplification of Lyn activation. In vivo, CD19 deficiency impaired, and CD19 overexpression enhanced, Lyn kinase activity. Thus, CD19 functions as a specialized adapter protein for the amplification of Src family kinases that is crucial for intrinsic and antigen receptor-induced signal transduction.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.			Poe, Jonathan/0000-0002-7789-1564; Fujimoto, Manabu/0000-0002-3062-4872	NATIONAL CANCER INSTITUTE [R01CA081776, R01CA054464, R55CA054464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054476] Funding Source: NIH RePORTER; NCI NIH HHS [CA54464, CA81776] Funding Source: Medline; NHLBI NIH HHS [HL54476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; Beckwith M, 1996, BLOOD, V88, P3502, DOI 10.1182/blood.V88.9.3502.bloodjournal8893502; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Brooks SR, 2000, J IMMUNOL, V164, P3123, DOI 10.4049/jimmunol.164.6.3123; Buhl AM, 1999, J IMMUNOL, V162, P4438; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CHALUPNY NJ, 1995, EUR J IMMUNOL, V25, P2978, DOI 10.1002/eji.1830251040; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fujimoto M, 1999, IMMUNITY, V11, P191, DOI 10.1016/S1074-7613(00)80094-1; Fujimoto M, 1999, J IMMUNOL, V162, P7088; Fujimoto M, 1998, SEMIN IMMUNOL, V10, P267, DOI 10.1006/smim.1998.9999; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; Li XL, 1997, J IMMUNOL, V158, P5649; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROIFMAN CM, 1993, BIOCHEM BIOPH RES CO, V194, P222, DOI 10.1006/bbrc.1993.1807; Ruzzene M, 1997, EUR J BIOCHEM, V245, P701, DOI 10.1111/j.1432-1033.1997.t01-1-00701.x; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1997, J IMMUNOL, V159, P3278; Sato S, 1997, P NATL ACAD SCI USA, V94, P13158, DOI 10.1073/pnas.94.24.13158; Sato S, 1997, J IMMUNOL, V158, P4662; Sato S, 1996, J IMMUNOL, V157, P4371; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; SOTIRELLIS N, 1995, J BIOL CHEM, V270, P29773; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; Tedder TF, 1998, SEMIN IMMUNOL, V10, P259, DOI 10.1006/smim.1998.0118; TEDDER TF, 1989, J IMMUNOL, V143, P712; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; UCKUN FM, 1993, J BIOL CHEM, V268, P21172; VANNOESEL CJM, 1993, INT IMMUNOL, V5, P699; WENG WK, 1994, J BIOL CHEM, V269, P32514; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302; ZHOU LJ, 1992, IMMUNOGENETICS, V35, P102, DOI 10.1007/BF00189519; ZHOU LJ, 1991, J IMMUNOL, V147, P1424; ZHOU LJ, 1994, MOL CELL BIOL, V14, P3884, DOI 10.1128/MCB.14.6.3884	44	161	168	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2000	13	1					47	57		10.1016/S1074-7613(00)00007-8	http://dx.doi.org/10.1016/S1074-7613(00)00007-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339EA	10933394	Bronze			2022-12-18	WOS:000088463600006
J	Moreno, CS; Beresford, GW; Louis-Plence, P; Morris, AC; Boss, JM				Moreno, CS; Beresford, GW; Louis-Plence, P; Morris, AC; Boss, JM			CREB regulates MHC class II expression in a CIITA-dependent manner	IMMUNITY			English	Article							BARE-LYMPHOCYTE-SYNDROME; HISTOCOMPATIBILITY COMPLEX GENES; TRANSCRIPTION FACTOR CREB; X-BOX REGION; ELEMENT-BINDING PROTEIN; AMP RESPONSE ELEMENT; CYCLIC-AMP; NUCLEAR-PROTEIN; SOMATOSTATIN PROMOTER; MEDIATED INDUCTION	The X2 box of MHC class II promoters is homologous to TRE/CRE elements and is required for expression of MHC class II genes. The X2 box-specific DNA binding activity, X2BP, was purified to homogeneity, sequenced, and identified as CREB. Transient transactivation experiments showed that CREB can cooperate with CIITA to enhance activation of transcription from MHC class II promoters in a dose-dependent manner. Binding of CREB to the class II promoter in vivo was demonstrated by a chromatin immunoprecipitation assay. Additionally, ICER, a dominant inhibitor of CREB function, was found to repress class II expression. These results demonstrate that CREB binds to the X2 box in vivo and cooperates with CIITA to direct MHC class II expression.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	boss@microbio.emory.edu	Beresford, Guy/C-6548-2016; Moreno, Carlos S/B-3863-2009; Louis-Plence, Pascale/H-1553-2015	Moreno, Carlos S/0000-0002-5582-0028; Louis-Plence, Pascale/0000-0001-7701-5241; Morris, Ann/0000-0003-1489-4431	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09106] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490, GM43710] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON G, 1990, J IMMUNOL, V145, P3456; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; BASTA PV, 1987, J IMMUNOL, V138, P1275; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLIGAN JE, 1991, CURRENT PROTOCOLS IM, V1; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Fontes JD, 1999, MOL CELL BIOL, V19, P941; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; HASEGAWA SL, 1993, J IMMUNOL, V150, P1781; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P1243, DOI 10.1093/nar/19.6.1243; IVASHKIV LB, 1991, J EXP MED, V174, P1583, DOI 10.1084/jem.174.6.1583; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kushida MM, 1997, J IMMUNOL, V159, P4913; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; LouisPlence P, 1997, J IMMUNOL, V159, P3899; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; MARTIN BK, 1997, IMMUNITY, V6, P581; MASSON N, 1992, MOL CELL BIOL, V12, P1096, DOI 10.1128/MCB.12.3.1096; Mayall TP, 1997, GENE DEV, V11, P887, DOI 10.1101/gad.11.7.887; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORENO CS, 1995, J IMMUNOL, V155, P4313; Moreno CS, 1997, J IMMUNOL, V158, P5841; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4304, DOI 10.1073/pnas.88.10.4304; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; ROPER RL, 1994, CELL IMMUNOL, V154, P296, DOI 10.1006/cimm.1994.1079; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; SEIDL C, 1992, J IMMUNOL, V148, P1576; SHORT ML, 1991, NUCLEIC ACIDS RES, V19, P1096; SLOAN JH, 1992, J IMMUNOL, V148, P2591; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; UNANUE ER, 1989, COLD SH Q B, V54, P383; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Westerheide SD, 1997, J IMMUNOL, V158, P4812; Wright KL, 1998, P NATL ACAD SCI USA, V95, P6267, DOI 10.1073/pnas.95.11.6267; Xie HJ, 1996, CELL IMMUNOL, V169, P264, DOI 10.1006/cimm.1996.0117; XIE HJ, 1995, J IMMUNOL, V154, P1717; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	66	161	164	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					143	151		10.1016/S1074-7613(00)80015-1	http://dx.doi.org/10.1016/S1074-7613(00)80015-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173GF	10072067	Bronze			2022-12-18	WOS:000078972200002
J	Di, AK; Xiong, SQ; Ye, ZM; Malireddi, RKS; Kometani, S; Zhong, M; Mittal, M; Hong, ZG; Kanneganti, TD; Rehman, J; Malik, AB				Di, Anke; Xiong, Shiqin; Ye, Zhiming; Malireddi, R. K. Subbarao; Kometani, Satoshi; Zhong, Ming; Mittal, Manish; Hong, Zhigang; Kanneganti, Thirumala-Devi; Rehman, Jalees; Malik, Asrar B.			The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation	IMMUNITY			English	Article							P-2X RECEPTOR; K+ EFFLUX; CASPASE-1 ACTIVATION; P2X(7); MECHANISM; HYPERTENSION; CLONING; ASC	Potassium (K+) efflux across the plasma membrane is thought to be an essential mechanism for ATP-induced NLRP3 inflammasome activation, yet the identity of the efflux channel has remained elusive. Here we identified the two-pore domain K+ channel (K-2P) TWIK2 as the K+ efflux channel triggering NLRP3 inflammasome activation. Deletion of Kcnk6 (encoding TWIK2) prevented NLRP3 activation in macrophages and suppressed sepsis-induced lung inflammation. Adoptive transfer of Kcnk6(-/-) macrophages into mouse airways after macrophage depletion also prevented inflammatory lung injury. The K+ efflux channel TWIK2 in macrophages has a fundamental role in activating the NLRP3 inflammasome and consequently mediates inflammation, pointing to TWIK2 as a potential target for anti-inflammatory therapies.	[Di, Anke; Xiong, Shiqin; Ye, Zhiming; Kometani, Satoshi; Zhong, Ming; Mittal, Manish; Hong, Zhigang; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Di, Anke; Xiong, Shiqin; Ye, Zhiming; Kometani, Satoshi; Zhong, Ming; Mittal, Manish; Hong, Zhigang; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA; [Malireddi, R. K. Subbarao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; St Jude Children's Research Hospital	Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.; Malik, AB (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA.	abmalik@uic.edu	Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013; Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012; Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malik, Asrar/0000-0002-8205-7128	NIH [P01-HL60678, P01-HL077806, T32-HL007829, R01-HL118068, R01-HL90152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL118068, P01HL077806, T32HL007829, R01HL090152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Lulia Koujah, Dr. Saroj Nepal, and Kwong Tai Cheng for technical assistance as well as Drs. Dolly Mehta and Chinnaswamy Tiruppathi for helpful discussions. The work was supported by NIH grants P01-HL60678, P01-HL077806, T32-HL007829, R01-HL118068, and R01-HL90152.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Aidley P.R.S., 1996, ION CHANNELS; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Bobak N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00640-8; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chavez RA, 1999, J BIOL CHEM, V274, P7887, DOI 10.1074/jbc.274.12.7887; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Cuenca Alex G, 2010, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1913s91; de Torre-Minguela C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22586; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; dos Santos G, 2012, AM J PHYSIOL-LUNG C, V303, pL627, DOI 10.1152/ajplung.00225.2012; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Howrylak JA, 2017, ANNU REV PHYSIOL, V79, P471, DOI 10.1146/annurev-physiol-021115-105229; HUME RI, 1988, J PHYSIOL-LONDON, V406, P503, DOI 10.1113/jphysiol.1988.sp017393; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Lloyd EE, 2011, HYPERTENSION, V58, P672, DOI 10.1161/HYPERTENSIONAHA.111.175349; Lloyd EE, 2009, EXP BIOL MED, V234, P1493, DOI 10.3181/0903-RM-110; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Pandit LM, 2014, HYPERTENSION, V64, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03406; Patel AJ, 2000, J BIOL CHEM, V275, P28722, DOI 10.1074/jbc.M003755200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SHELDON R, 1995, CIRCULATION, V92, P2944, DOI 10.1161/01.CIR.92.10.2944; Shieh CC, 2000, PHARMACOL REV, V52, P557; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; THOMAS SA, 1990, J GEN PHYSIOL, V95, P569, DOI 10.1085/jgp.95.4.569; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Wang WY, 2017, J CELL BIOL, V216, P1715, DOI 10.1083/jcb.201612123; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; Weisser SB, 2012, JOVE-J VIS EXP, DOI 10.3791/4105; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	49	160	171	5	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					56	+		10.1016/j.immuni.2018.04.032	http://dx.doi.org/10.1016/j.immuni.2018.04.032			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	29958799	Green Accepted, Bronze			2022-12-18	WOS:000438949100011
J	Takata, K; Kozaki, T; Lee, CZW; Thion, MS; Otsuka, M; Lim, S; Utami, KH; Fidan, K; Park, DS; Malleret, B; Chakarov, S; See, P; Low, D; Low, G; Garcia-Miralles, M; Zeng, RZ; Zhang, JQ; Goh, CC; Gul, A; Hubert, S; Lee, B; Chen, JM; Low, I; Shadan, NB; Lum, J; Wei, TS; Mok, E; Kawanishi, S; Kitamura, Y; Larbi, A; Poidinger, M; Renia, L; Ng, LG; Wolf, Y; Jung, S; Onder, T; Newell, E; Huber, T; Ashihara, E; Garel, S; Pouladi, MA; Ginhoux, F				Takata, Kazuyuki; Kozaki, Tatsuya; Lee, Christopher Zhe Wei; Thion, Morgane Sonia; Otsuka, Masayuki; Lim, Shawn; Utami, Kagistia Hana; Fidan, Kerem; Park, Dong Shin; Malleret, Benoit; Chakarov, Svetoslav; See, Peter; Low, Donovan; Low, Gillian; Garcia-Miralles, Marta; Zeng, Ruizhu; Zhang, Jinqiu; Goh, Chi Ching; Gul, Ahmet; Hubert, Sandra; Lee, Bernett; Chen, Jinmiao; Low, Ivy; Shadan, Nurhidaya Binte; Lum, Josephine; Wei, Tay Seok; Mok, Esther; Kawanishi, Shohei; Kitamura, Yoshihisa; Larbi, Anis; Poidinger, Michael; Renia, Laurent; Ng, Lai Guan; Wolf, Yochai; Jung, Steffen; Onder, Tamer; Newell, Evan; Huber, Tara; Ashihara, Eishi; Garel, Sonia; Pouladi, Mahmoud A.; Ginhoux, Florent			Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function	IMMUNITY			English	Article							DIRECTED DIFFERENTIATION; FETAL MONOCYTES; DENDRITIC CELLS; SERUM-FREE; HUMAN ES; MICROGLIA; MOUSE; WNT; SPECIFICATION; PRECURSORS	Tissue macrophages arise during embryogenesis from yolk-sac (YS) progenitors that give rise to primitive YS macrophages. Until recently, it has been impossible to isolate or derive sufficient numbers of YS-derived macrophages for further study, but data now suggest that induced pluripotent stem cells (iPSCs) can be driven to undergo a process reminiscent of YS-hematopoiesis in vitro. We asked whether iPSC-derived primitive macrophages (iMacs) can terminally differentiate into specialized macrophages with the help of growth factors and organ-specific cues. Co-culturing human or murine iMacs with iPSC-derived neurons promoted differentiation into microglia-like cells in vitro. Furthermore, murine iMacs differentiated in vivo into microglia after injection into the brain and into functional alveolar macrophages after engraftment in the lung. Finally, iPSCs from a patient with familial Mediterranean fever differentiated into iMacs with pro-inflammatory characteristics, mimicking the disease phenotype. Altogether, iMacs constitute a source of tissue-resident macrophage precursors that can be used for biological, pathophysiological, and therapeutic studies.	[Takata, Kazuyuki; Kozaki, Tatsuya; Lee, Christopher Zhe Wei; Otsuka, Masayuki; Lim, Shawn; Park, Dong Shin; Malleret, Benoit; Chakarov, Svetoslav; See, Peter; Low, Donovan; Low, Gillian; Goh, Chi Ching; Hubert, Sandra; Lee, Bernett; Chen, Jinmiao; Low, Ivy; Shadan, Nurhidaya Binte; Lum, Josephine; Wei, Tay Seok; Mok, Esther; Larbi, Anis; Poidinger, Michael; Renia, Laurent; Ng, Lai Guan; Newell, Evan; Ginhoux, Florent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Takata, Kazuyuki; Kawanishi, Shohei; Kitamura, Yoshihisa; Ashihara, Eishi] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Yamashina Ku, Kyoto 6078414, Japan; [Thion, Morgane Sonia; Garel, Sonia] PSL Res Univ, Ecole Normale Super, INSERM, Inst Biol,U1024,CNRS,UMR8197, F-75005 Paris, France; [Utami, Kagistia Hana; Garcia-Miralles, Marta; Zeng, Ruizhu; Zhang, Jinqiu; Pouladi, Mahmoud A.] Agcy Sci Technol & Res, Translat Lab Genet Med, Singapore 138648, Singapore; [Fidan, Kerem; Onder, Tamer] Koc Univ, Sch Med, TR-34450 Istanbul, Turkey; [Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Microbiol & Immunol, Singapore 117545, Singapore; [Gul, Ahmet] Istanbul Univ, Fac Med, TR-34093 Istanbul, Turkey; [Wolf, Yochai; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Huber, Tara] Agcy Sci Technol & Res, Genome Inst Singapore, Stem Cell & Dev Biol Dept, Singapore 138672, Singapore; [Pouladi, Mahmoud A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117597, Singapore; [Kitamura, Yoshihisa] Ritsumeikan Univ, Dept Pharmaceut Sci, Kusatsu 5258577, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Kyoto Pharmaceutical University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Agency for Science Technology & Research (A*STAR); Koc University; National University of Singapore; Istanbul University; Weizmann Institute of Science; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Ritsumeikan University	Ginhoux, F (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012; Gul, Ahmet/AAT-7787-2020; Chakarov, Svetoslav/AAC-9283-2019; Larbi, Anis/ABE-5868-2020; Thion, Morgane Sonia/GRJ-4332-2022; Sander-Effron, Samuel/AAX-2231-2020; Ng, Lai Guan/N-6980-2019; Onder, Tamer/O-3669-2019; Garel, Sonia/P-4538-2017; Onder, Tamer T/H-3330-2013; Renia, Laurent/E-2117-2011; Utami, Kagistia Hana/AAS-2710-2021; Jung, Steffen/K-1409-2012; Resource Center, NINDS Human Genetics/AGF-2474-2022; Malleret, Benoit/E-9159-2011; Chen, Jinmiao/ABE-5601-2021; Ng, Lai Guan/E-5673-2011; Pouladi, Mahmoud/B-8743-2016	Newell, Evan W/0000-0002-2889-243X; Gul, Ahmet/0000-0001-8219-3720; Chakarov, Svetoslav/0000-0002-0665-5417; Ng, Lai Guan/0000-0003-1905-3586; Onder, Tamer/0000-0002-2372-9158; Garel, Sonia/0000-0003-2984-3645; Onder, Tamer T/0000-0002-2372-9158; Renia, Laurent/0000-0003-0349-1557; Jung, Steffen/0000-0003-4290-5716; Malleret, Benoit/0000-0001-9658-7528; Ng, Lai Guan/0000-0003-1905-3586; Wolf, Yochai/0000-0003-0270-2025; Pouladi, Mahmoud/0000-0002-9030-0976; Poidinger, Michael/0000-0002-1047-2277; Garcia Miralles, Marta/0000-0001-7250-5778; Thion, Morgane/0000-0003-2364-8451; Lee, Christopher/0000-0001-9802-4550; See, Peter/0000-0003-4428-7763	Singapore Immunology Network; National Research Foundation Singapore [NRF-NRFI2017-02]; Strategic Positioning Fund for Genetic Orphan Diseases [SPF2012/005]; Joint Council Office Project grant from A<SUP>star</SUP>STAR, Singapore [1431AFG122]; Singapore National Medical Research Council [NMRC/CBRG/0047/2013]; A*STAR Singapore Young Investigator Grant (BMRC YIG grant) [13/1/16/YA/009]; ERC [616080]	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); National Research Foundation Singapore(National Research Foundation, Singapore); Strategic Positioning Fund for Genetic Orphan Diseases; Joint Council Office Project grant from A<SUP>star</SUP>STAR, Singapore; Singapore National Medical Research Council(National Medical Research Council, Singapore); A*STAR Singapore Young Investigator Grant (BMRC YIG grant)(Agency for Science Technology & Research (A*STAR)); ERC(European Research Council (ERC)European Commission)	This work was supported by core grants of the Singapore Immunology Network and National Research Foundation Singapore (NRF-NRFI2017-02) to F.G.; by the Strategic Positioning Fund for Genetic Orphan Diseases (SPF2012/005) and a Joint Council Office Project grant (1431AFG122) from A<SUP>star</SUP>STAR, Singapore to M.A.P.; by the Singapore National Medical Research Council (NMRC/CBRG/0047/2013) and an A*STAR Singapore Young Investigator Grant (BMRC YIG grant number: 13/1/16/YA/009) to B.M; and by an ERC Consolidator Grant "NImO" (grant number: 616080) to S.G.	Ackermann M, 2015, EMBO MOL MED, V7, P1388, DOI 10.15252/emmm.201505301; Aksentijevich I, 1997, CELL, V90, P797; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bernot A, 1997, NAT GENET, V17, P25; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Clanchy FIL, 2013, CYTOKINE, V61, P33, DOI 10.1016/j.cyto.2012.09.005; Etemad S, 2012, J NEUROSCI METH, V209, P79, DOI 10.1016/j.jneumeth.2012.05.025; Fidan K, 2016, METHODS MOL BIOL, V1353, P215, DOI 10.1007/7651_2015_278; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hinze A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-35; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kanke K, 2014, STEM CELL REP, V2, P751, DOI 10.1016/j.stemcr.2014.04.016; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noto D, 2010, EUR J NEUROSCI, V31, P1155, DOI 10.1111/j.1460-9568.2010.07152.x; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stein CK, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0478-3; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI 10.1038/nbt.2915; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	54	160	164	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					183	+		10.1016/j.immuni.2017.06.017	http://dx.doi.org/10.1016/j.immuni.2017.06.017			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723550	Bronze			2022-12-18	WOS:000405712800019
J	Wong, MT; Ong, DEH; Lim, FSH; Teng, KWW; McGovern, N; Narayanan, S; Ho, WQ; Cerny, D; Tan, HKK; Anicete, R; Tan, BK; Lim, TKH; Chan, CY; Cheow, PC; Lee, SY; Takano, A; Tan, EH; Tam, JKC; Tan, EY; Chan, JKY; Fink, K; Bertoletti, A; Ginhoux, F; De Lafaille, MAC; Newell, EW				Wong, Michael Thomas; Ong, David Eng Hui; Lim, Frances Sheau Huei; Teng, Karen Wei Weng; McGovern, Naomi; Narayanan, Sriram; Ho, Wen Qi; Cerny, Daniela; Tan, Henry Kun Kiaang; Anicete, Rosslyn; Tan, Bien Keem; Lim, Tony Kiat Hon; Chan, Chung Yip; Cheow, Peng Chung; Lee, Ser Yee; Takano, Angela; Tan, Eng-Huat; Tam, John Kit Chung; Tan, Ern Yu; Chan, Jerry Kok Yen; Fink, Katja; Bertoletti, Antonio; Ginhoux, Florent; De Lafaille, Maria Alicia Curotto; Newell, Evan William			A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures	IMMUNITY			English	Article							CHEMOKINE RECEPTOR EXPRESSION; MASS CYTOMETRY; INTERLEUKIN 22; TGF-BETA; DIFFERENTIATION; IMMUNITY; DISTINCT; SUBSET; COMPARTMENTALIZATION; LYMPHOCYTES	Depending on the tissue microenvironment, T cells can differentiate into highly diverse subsets expressing unique trafficking receptors and cytokines. Studies of human lymphocytes have primarily focused on a limited number of parameters in blood, representing an incomplete view of the human immune system. Here, we have utilized mass cytometry to simultaneously analyze T cell trafficking and functional markers across eight different human tissues, including blood, lymphoid, and non-lymphoid tissues. These data have revealed that combinatorial expression of trafficking receptors and cytokines better defines tissue specificity. Notably, we identified numerous T helper cell subsets with overlapping cytokine expression, but only specific cytokine combinations are secreted regardless of tissue type. This indicates that T cell lineages defined in mouse models cannot be clearly distinguished in humans. Overall, our data uncover a plethora of tissue immune signatures and provide a systemic map of how T cell phenotypes are altered throughout the human body.	[Wong, Michael Thomas; Teng, Karen Wei Weng; McGovern, Naomi; Narayanan, Sriram; Ho, Wen Qi; Cerny, Daniela; Fink, Katja; Bertoletti, Antonio; Ginhoux, Florent; De Lafaille, Maria Alicia Curotto; Newell, Evan William] Singapore Immunol Network SIgN, A STAR, Singapore 138648, Singapore; [Ong, David Eng Hui] Natl Univ Hlth Syst, Univ Med Cluster, Div Gastroenterol & Hepatol, Singapore 119228, Singapore; [Lim, Frances Sheau Huei] Natl Univ Hlth Syst, Univ Surg Ctr, Div Colorectal Surg, Singapore 119228, Singapore; [Cerny, Daniela] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tan, Henry Kun Kiaang; Anicete, Rosslyn] KK Womens & Childrens Hosp, Dept Otolaryngol, Singapore 229899, Singapore; [Tan, Bien Keem] Singapore Gen Hosp, Dept Plast Reconstruct & Aesthet Surg, Singapore 169608, Singapore; [Lim, Tony Kiat Hon; Takano, Angela] Singapore Gen Hosp, Dept Pathol, Singapore 169856, Singapore; [Chan, Chung Yip; Cheow, Peng Chung; Lee, Ser Yee] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, Singapore 169856, Singapore; [Tan, Eng-Huat] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore; [Tam, John Kit Chung] Natl Univ Singapore, Dept Surg, Singapore 119228, Singapore; [Tan, Ern Yu] Tan Tock Seng Hosp, Dept Gen Surg, Singapore 308433, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Bertoletti, Antonio] Duke NUS Med Sch, Emerging Infect Dis EID Program, Singapore 169857, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; KK Women's & Children's Hospital; Singapore General Hospital; Singapore General Hospital; Singapore General Hospital; National Cancer Centre Singapore (NCCS); National University of Singapore; Tan Tock Seng Hospital; KK Women's & Children's Hospital; National University of Singapore	Wong, MT; Newell, EW (corresponding author), Singapore Immunol Network SIgN, A STAR, Singapore 138648, Singapore.	michael.thomas.wong@merck.com; evan_newell@immunol.a-star.edu.sg	Lim, Frances/B-5168-2011; Newell, Evan W/F-9711-2012; Fink, Katja/AAI-1881-2021; Tam, John/B-6048-2012	Newell, Evan W/0000-0002-2889-243X; Fink, Katja/0000-0002-3571-0390; McGovern, Naomi/0000-0001-5200-2698; Curotto de Lafaille, Maria Alicia/0000-0002-3510-3777	A-STAR/SIgN core funding; A-STAR/SIgN immunomonitoring platform funding; Singapore Translational Research (STaR) Investigator Award [NMRC/STaR/013/2012]	A-STAR/SIgN core funding; A-STAR/SIgN immunomonitoring platform funding; Singapore Translational Research (STaR) Investigator Award	The authors thank the Singapore Immunology Network (SIgN) community and all members of the Newell lab for helpful discussion and technical support. We thank the Clinical Trials Resource Centre (Singapore General Hospital) for providing select skin samples and the National Cancer Center Singapore (NCCS) Translational & Clinical Research (TCR) research coordinators for helping to provide select lung samples. We also thank Paul Klenerman and Laura Mackay for helpful comments. This study was primarily funded by A-STAR/SIgN core funding (E.W.N., F.G., M.A.C.D., and K.F.) and the A-STAR/SIgN immunomonitoring platform funding (E.W.N.) and was partially supported by a Singapore Translational Research (STaR) Investigator Award (NMRC/STaR/013/2012) to A. B.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Duhen T, 2014, J IMMUNOL, V193, P120, DOI 10.4049/jimmunol.1302734; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Fu HM, 2013, FRONT BIOSCI-LANDMRK, V18, P422, DOI 10.2741/4111; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Kattah MG, 2008, ARTHRITIS RHEUM, V58, P1619, DOI 10.1002/art.23497; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	47	160	164	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					442	456		10.1016/j.immuni.2016.07.007	http://dx.doi.org/10.1016/j.immuni.2016.07.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27521270	Bronze			2022-12-18	WOS:000382267300023
J	Schuberth-Wagner, C; Ludwig, J; Bruder, AK; Herzner, AM; Zillinger, T; Goldeck, M; Schmidt, T; Schmid-Burgk, JL; Kerber, R; Wolter, S; Stumpel, JP; Roth, A; Bartok, E; Drosten, C; Coch, C; Hornung, V; Barchet, W; Kummerer, BM; Hartmann, G; Schlee, M				Schuberth-Wagner, Christine; Ludwig, Janos; Bruder, Ann Kristin; Herzner, Anna-Maria; Zillinger, Thomas; Goldeck, Marion; Schmidt, Tobias; Schmid-Burgk, Jonathan L.; Kerber, Romy; Wolter, Steven; Stuempel, Jan-Philip; Roth, Andreas; Bartok, Eva; Drosten, Christian; Coch, Christoph; Hornung, Veit; Barchet, Winfried; Kuemmerer, Beate M.; Hartmann, Gunther; Schlee, Martin			A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N-1-2 ' O-Methylated Self RNA	IMMUNITY			English	Article							5'-TRIPHOSPHATE RNA; STRUCTURAL BASIS; PATTERN-RECOGNITION; STRANDED-RNA; ACTIVATION; MDA5; RESPONSES; INSIGHTS; VIRUS; METHYLTRANSFERASE	The cytosolic helicase retinoic acid-inducible gene-I (RIG-I) initiates immune responses to most RNA viruses by detecting viral 5'-triphosphorylated RNA (pppRNA). Although endogenous mRNA is also 5'-triphosphorylated, backbone modifications and the 5'-ppp-linked methylguanosine ((m7) G) cap prevent immunorecognition. Here we show that the methylation status of endogenous capped mRNA at the 5'-terminal nucleotide (N-1) was crucial to prevent RIG-I activation. Moreover, we identified a single conserved amino acid (H830) in the RIG-I RNA binding pocket as the mediator of steric exclusion of N-1-2'O-methylated RNA. H830A alteration (RIG-I(H830A)) restored binding of N-1-2'O-methylated pppRNA. Consequently, endogenous mRNA activated the RIG-I(H830A) mutant but not wild-type RIG-I. Similarly, knockdown of the endogenous N-1-2'O-methyltransferase led to considerable RIG-I stimulation in the absence of exogenous stimuli. Studies involving yellow-fever-virus-encoded 2'O-methyltransferase and RIG-I(H830A) revealed that viruses exploit this mechanism to escape RIG-I. Our data reveal a new role for cap N-1-2'O-methylation in RIG-I tolerance of self-RNA.	[Schuberth-Wagner, Christine; Ludwig, Janos; Bruder, Ann Kristin; Herzner, Anna-Maria; Zillinger, Thomas; Goldeck, Marion; Wolter, Steven; Stuempel, Jan-Philip; Roth, Andreas; Bartok, Eva; Coch, Christoph; Barchet, Winfried; Hartmann, Gunther; Schlee, Martin] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53105 Bonn, Germany; [Zillinger, Thomas; Barchet, Winfried] Univ Bonn, Univ Hosp, German Ctr Infect Res Cologne Bonn, D-53105 Bonn, Germany; [Schmidt, Tobias; Schmid-Burgk, Jonathan L.; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, D-53105 Bonn, Germany; [Kerber, Romy] Bernhard Nocht Inst Trop Med, Dept Virol, D-20259 Hamburg, Germany; [Drosten, Christian; Kuemmerer, Beate M.] Univ Bonn, Med Ctr, Inst Virol, D-53127 Bonn, Germany	University of Bonn; German Center for Infection Research; University of Bonn; University of Bonn; Bernhard Nocht Institut fur Tropenmedizin; University of Bonn	Schlee, M (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53105 Bonn, Germany.	martin.schlee@uni-bonn.de	Schlee, Martin/AAL-1238-2021; Kümmerer, Beate/HGV-0882-2022; Goldeck, Marion/AAX-5599-2020; Schmid-Burgk, Jonathan/GSN-3512-2022; Hornung, Veit/C-3565-2012; Zillinger, Thomas/AAD-7320-2020; Bartok, Eva/AAM-6274-2020; Ludwig, Janos/I-3544-2013; Coch, Christoph/AAW-5336-2021; Hartmann, Gunther/P-7492-2017	Hornung, Veit/0000-0002-4150-194X; Zillinger, Thomas/0000-0002-0866-4835; Bartok, Eva/0000-0003-0556-1950; Hartmann, Gunther/0000-0003-1021-2018; Goldeck, Marion/0000-0003-1899-4763; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Barchet, Winfried/0000-0002-6745-6606; Schlee, Martin/0000-0003-3671-7639; Schmidt, Tobias/0000-0003-3102-3515	Deutsche Forschungsgemeinschaft [SFB670, DFG SCHL1930/1-1, SFB704, SFB832, KFO177, KU1201/4-1]; University Hospital of Bonn (BONFOR); DFG Excellence Cluster ImmunoSensation; German Center of Infectious Disease (DZIF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Hospital of Bonn (BONFOR); DFG Excellence Cluster ImmunoSensation(German Research Foundation (DFG)); German Center of Infectious Disease (DZIF)	We thank Janett Wieseler for excellent technical assistance and Cristina A. Hagmann and Jasper v.d. Boorn for critically reading the manuscript. We are also thankful to Charles M. Rice for providing pACNR/YF 17D. B.M.K., C.C., G.H., M.S., V.H., and W.B. are supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de; SFB670 to M.S., G.H., V.H., and W.B., DFG SCHL1930/1-1 to M.S., SFB704 to G.H. and W.B., SFB832 and KFO177 to G.H. and C.C., and KU1201/4-1 to B.M.K.). E.B. is supported by the University Hospital of Bonn (BONFOR). A.K.B., E.B., G.H., M.S., V.H., and W.B. are supported by the DFG Excellence Cluster ImmunoSensation. C.D., G.H., V.H., and W.B. are supported by the German Center of Infectious Disease (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.S.-W., G.H., and V.H. are co-founders and shareholders of the Rigontec GmbH.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Belanger F, 2010, J BIOL CHEM, V285, P33037, DOI 10.1074/jbc.M110.155283; Bray M, 2008, ANTIVIR RES, V78, P1, DOI 10.1016/j.antiviral.2007.12.007; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goldeck M, 2014, ANGEW CHEM INT EDIT, V53, P4694, DOI 10.1002/anie.201400672; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	33	160	164	2	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					41	51		10.1016/j.immuni.2015.06.015	http://dx.doi.org/10.1016/j.immuni.2015.06.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26187414	Green Published, Bronze			2022-12-18	WOS:000360101100009
J	Tindemans, I; Serafini, N; Di Santo, JP; Hendriks, RW				Tindemans, Irma; Serafini, Nicolas; Di Santo, James P.; Hendriks, Rudi W.			GATA-3 Function in Innate and Adaptive Immunity	IMMUNITY			English	Review							TRANSCRIPTION FACTOR GATA-3; ROR-GAMMA-T; CYTOKINE GENE-EXPRESSION; DELTA-LIKE 4; LYMPHOID-CELLS; NATURAL-KILLER; ENFORCED EXPRESSION; CUTTING EDGE; NERVOUS-SYSTEM; BINDING FACTOR	The zinc-finger transcription factor GATA-3 has received much attention as a master regulator of T helper 2 (Th2) cell differentiation, during which it controls interleukin-4 (IL-4), IL-5, and IL-13 expression. More recently, GATA-3 was shown to contribute to type 2 immunity through regulation of group 2 innate lymphoid cell (ILC2) development and function. Furthermore, during thymopoiesis, GATA-3 represses B cell potential in early T cell precursors, activates TCR signaling in pre-T cells, and promotes the CD4(+) T cell lineage after positive selection. GATA-3 also functions outside the thymus in hematopoietic stem cells, regulatory T cells, CD8(+) T cells, thymic natural killer cells, and ILC precursors. Here we discuss the varied functions of GATA-3 in innate and adaptive immune cells, with emphasis on its activity in T cells and ILCs, and examine the mechanistic basis for the dose-dependent, developmental-stage-and cell-lineage-specific activity of this transcription factor.	[Tindemans, Irma; Hendriks, Rudi W.] Erasmus MC, Dept Pulm Med, NL-3000 CA Rotterdam, Netherlands; [Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Serafini, Nicolas; Di Santo, James P.] INSERM U668, F-75724 Paris, France	Erasmus University Rotterdam; Erasmus MC; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hendriks, RW (corresponding author), Erasmus MC, Dept Pulm Med, NL-3000 CA Rotterdam, Netherlands.	r.hendriks@erasmusmc.nl	Di Santo, James P/M-4298-2014; SERAFINI, nicolas/S-5675-2019	Di Santo, James P/0000-0002-7146-1862; SERAFINI, nicolas/0000-0002-7440-4353; Hendriks, Rudi/0000-0003-2291-0382	Lung Foundation Netherlands [3.2.12.087]; Institut Pasteur, Inserm, ANR; LNCC	Lung Foundation Netherlands; Institut Pasteur, Inserm, ANR(French National Research Agency (ANR)); LNCC	These studies were partly supported by Lung Foundation Netherlands Grant 3.2.12.087 (R.W.H.) and by the Institut Pasteur, Inserm, ANR, and the LNCC (J.P.D.).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ali A, 2007, HUM MOL GENET, V16, P265, DOI 10.1093/hmg/ddl454; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Banerjee A, 2013, IMMUNITY, V38, P930, DOI 10.1016/j.immuni.2013.01.014; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Chi AW, 2009, CURR OPIN IMMUNOL, V21, P121, DOI 10.1016/j.coi.2009.01.012; Chlon TM, 2012, DEVELOPMENT, V139, P3905, DOI 10.1242/dev.080440; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Di Santo JP, 2006, IMMUNOL REV, V214, P35, DOI 10.1111/j.1600-065X.2006.00461.x; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Fiedler K, 2012, AM J BLOOD RES, V2, P57; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hasegawa SL, 2007, DEV BIOL, V301, P568, DOI 10.1016/j.ydbio.2006.09.030; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Imanishi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4566; Jankovic D, 2000, J IMMUNOL, V164, P3047, DOI 10.4049/jimmunol.164.6.3047; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; KleinJan A, 2014, J IMMUNOL, V192, P1385, DOI 10.4049/jimmunol.1301888; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Ku CJ, 2012, BLOOD, V119, P2242, DOI 10.1182/blood-2011-07-366070; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kwan M, 2005, EUR J IMMUNOL, V35, P1267, DOI 10.1002/eji.200425619; Laky K, 2008, CURR OPIN IMMUNOL, V20, P197, DOI 10.1016/j.coi.2008.03.004; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li BWS, 2013, IMMUNOLOGY, V140, P281, DOI 10.1111/imm.12153; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Ling KW, 2007, EUR J IMMUNOL, V37, P1043, DOI 10.1002/eji.200636485; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; Nawijn MC, 2001, J IMMUNOL, V167, P724, DOI 10.4049/jimmunol.167.2.724; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Rothenberg EV, 2013, BLOOD, V121, P1673, DOI 10.1182/blood-2013-01-477737; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsai FY, 1998, DEV BIOL, V196, P218, DOI 10.1006/dbio.1997.8842; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van Hamburg JP, 2008, MOL IMMUNOL, V45, P3085, DOI 10.1016/j.molimm.2008.03.018; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Vosshenrich CAJ, 2013, CURR OPIN IMMUNOL, V25, P130, DOI 10.1016/j.coi.2013.02.002; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamagata T, 2000, EMBO J, V19, P4676, DOI 10.1093/emboj/19.17.4676; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	168	160	170	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					191	206		10.1016/j.immuni.2014.06.006	http://dx.doi.org/10.1016/j.immuni.2014.06.006			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148023	Bronze			2022-12-18	WOS:000341455300008
J	Lai, YP; Li, DQ; Li, CW; Muehleisen, B; Radek, KA; Park, HJ; Jiang, ZW; Li, ZH; Lei, H; Quan, YC; Zhang, T; Wu, YL; Kotol, P; Morizane, S; Hata, TR; Iwatsuki, K; Tang, C; Gallo, RL				Lai, Yuping; Li, Dongqing; Li, Changwei; Muehleisen, Beda; Radek, Katherine A.; Park, Hyun Jeong; Jiang, Ziwei; Li, Zhiheng; Lei, Hu; Quan, Yanchun; Zhang, Tian; Wu, Yelin; Kotol, Paul; Morizane, Shin; Hata, Tissa R.; Iwatsuki, Keiji; Tang, Ce; Gallo, Richard L.			The Antimicrobial Protein REG3A Regulates Keratinocyte Proliferation and Differentiation after Skin Injury	IMMUNITY			English	Article							GENE-EXPRESSION; CELLS; PSORIASIS; PEPTIDE; MIGRATION; RECEPTOR; IL-17; HOST; INTERLEUKIN-22; INFLAMMATION	Epithelial keratinocyte proliferation is an essential element of wound repair, and abnormal epithelial proliferation is an intrinsic element in the skin disorder psoriasis. The factors that trigger epithelial proliferation in these inflammatory processes are incompletely understood. Here we have shown that regenerating islet-derived protein 3-alpha (REG3A) is highly expressed in keratinocytes during psoriasis and wound repair and in imiquimod-induced psoriatic skin lesions. The expression of REG3A by keratinocytes is induced by interleukin-17 (IL-17) via activation of keratinocyte-encoded IL-17 receptor A (IL-17RA) and feeds back on keratinocytes to inhibit terminal differentiation and increase cell proliferation by binding to exostosin-like 3 (EXTL3) followed by activation of phosphatidylinositol 3 kinase (PI3K) and the kinase AKT. These findings reveal that REG3A, a secreted intestinal antimicrobial protein, can promote skin keratinocyte proliferation and can be induced by IL-17. This observation suggests that REG3A may mediate the epidermal hyperproliferation observed in normal wound repair and in psoriasis.	[Lai, Yuping; Li, Dongqing; Li, Changwei; Jiang, Ziwei; Li, Zhiheng; Lei, Hu; Quan, Yanchun; Zhang, Tian; Wu, Yelin] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Muehleisen, Beda; Kotol, Paul; Hata, Tissa R.; Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Muehleisen, Beda; Kotol, Paul; Hata, Tissa R.; Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, Div Dermatol, La Jolla, CA 92093 USA; [Radek, Katherine A.] Loyola Univ, Burn & Shock Trauma Inst, Dept Surg, Chicago, IL 60153 USA; [Park, Hyun Jeong] Catholic Univ Korea, Coll Med, Dept Dermatol, Seoul 150713, South Korea; [Morizane, Shin; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan; [Tang, Ce] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo 1088639, Japan	East China Normal University; University of California System; University of California San Diego; University of California System; University of California San Diego; Loyola University Chicago; Catholic University of Korea; Okayama University; University of Tokyo	Lai, YP (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.	yplai@bio.ecnu.edu.cn	Gallo, Richard L/A-8931-2009; Li, Dongqing/AAJ-2650-2020	Gallo, Richard L/0000-0002-1401-7861; Li, Dongqing/0000-0003-0588-9390; lei, hu/0000-0003-3288-5205; Lai, Yuping/0000-0001-7445-6738	National Natural Science Foundation of China [31170867, 81072422, 11QA1401900, 12ZZ039, NCET-11-0141]; program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions; NIH [AR052728, AI052453, AI083358]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R56AI083358, R01AI083358, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L.V. Hooper from the University of Texas Southwestern Medical Center at Dallas for kindly providing polyclonal rabbit anti-mouse RegIII gamma antibody and M. Liu from East China Normal University for kindly gift of plasmids pEGFP-C1, pEGFP-N2, pLL3.7, psPAX2, and pMD2.G. This work was supported by National Natural Science Foundation of China grants 31170867 and 81072422, grants 11QA1401900, 12ZZ039, and NCET-11-0141 to Y.L., the program for professor of Special Appointment (Eastern Scholar) at Shanghai Institutions (Y.L.), NIH grants AR052728, AI052453, and AI083358 to R.L.G., and the Science and Technology Commission of Shanghai Municipality grant 11DZ2260300.	Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Choi B, 2007, EXP MOL MED, V39, P796, DOI 10.1038/emm.2007.86; Croyle MJ, 2011, DEVELOPMENT, V138, P1675, DOI 10.1242/dev.060210; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Drognitz O, 2006, TRANSPLANTATION, V81, P1428, DOI 10.1097/01.tp.0000208619.71264.40; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; EPSTEIN B, 1983, CELL TISSUE KINET, V16, P313; Finnerty CC, 2009, CYTOKINE, V45, P20, DOI 10.1016/j.cyto.2008.10.005; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Heo YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3398; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Levetan Claresa S, 2008, Endocr Pract, V14, P1075; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lieu HT, 2005, HEPATOLOGY, V42, P618, DOI 10.1002/hep.20845; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Patel GK, 2006, J INVEST DERMATOL, V126, P497, DOI 10.1038/sj.jid.5700101; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Syder AJ, 2003, P NATL ACAD SCI USA, V100, P3467, DOI 10.1073/pnas.0230380100; Tokura Yoshiki, 2010, Journal of UOEH, V32, P317; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yu XJ, 2009, CELL BIOL INT, V33, P1144, DOI 10.1016/j.cellbi.2009.07.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	44	160	168	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					74	84		10.1016/j.immuni.2012.04.010	http://dx.doi.org/10.1016/j.immuni.2012.04.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22727489	Green Accepted, Bronze			2022-12-18	WOS:000307133200011
J	Stritesky, GL; Muthukrishnan, R; Sehra, S; Goswami, R; Pham, D; Travers, J; Nguyen, ET; Levy, DE; Kaplan, MH				Stritesky, Gretta L.; Muthukrishnan, Rajarajeswari; Sehra, Santa; Goswami, Ritobrata; Pham, Duy; Travers, Jared; Nguyen, Evelyn T.; Levy, David E.; Kaplan, Mark H.			The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development	IMMUNITY			English	Article							HELPER TYPE-2 DIFFERENTIATION; CONSTITUTIVELY ACTIVE STAT6; ALPHA-CHAIN EXPRESSION; REGULATORY T-CELLS; HYPER-IGE SYNDROME; TH2 DIFFERENTIATION; B-CELLS; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; SIGNAL TRANSDUCER	Signal transducer and activator of transcription (STAT) family members direct the differentiation of T helper cells, with specific STAT proteins promoting distinct effector subsets. STAT6 is required for the development of T helper 2 (Th2) cells, whereas STAT3 promotes differentiation of Th17 and follicular helper T cell subsets. We demonstrated that STAT3 was also activated during Th2 cell development and was required for the expression of Th2 cell-associated cytokines and transcription factors. STAT3 bound directly to Th2 cell-associated gene loci and was required for the ability of STAT6 to bind target genes. In vivo, STAT3 deficiency in T cells eliminated the allergic inflammation in mice sensitized and challenged with ovalbumin or transgenic for constitutively active STAT6. Thus, STAT3 cooperates with STAT6 in promoting Th2 cell development. These results demonstrate that differentiating T helper cells integrate multiple STAT protein signals during Th2 cell development.	[Stritesky, Gretta L.; Muthukrishnan, Rajarajeswari; Sehra, Santa; Goswami, Ritobrata; Pham, Duy; Travers, Jared; Nguyen, Evelyn T.; Kaplan, Mark H.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Stritesky, Gretta L.; Goswami, Ritobrata; Pham, Duy; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Levy, David E.] NYU, Sch Med, Dept Pathol & Microbiol, New York, NY 10016 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; New York University	Kaplan, MH (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019; Goswami, Ritobrata/W-9057-2019	Levy, David/0000-0002-7320-7788; Goswami, Ritobrata/0000-0002-4388-7962; Travers, Jared/0000-0003-4786-604X; Kaplan, Mark/0000-0002-2923-8245	 [U19 AI070448];  [T32 AI060519];  [T32 HL07910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519, U19AI070448] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank I.C. Ho and E.J. Taparowsky for providing the c-Maf and Batf plasmids, respectively, B. Zhou for DO11.10 mice, J. Blum, A. Dent, and S. Goenka for review of this paper. This work was supported by U19 AI070448. G.L.S. was supported by T32 AI060519. D.P. was supported by T32 HL07910.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avery DT, 2008, BLOOD, V112, P1784, DOI 10.1182/blood-2008-02-142745; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; BENSASSON SZ, 1990, J IMMUNOL, V145, P1127; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Bruns HA, 2003, J IMMUNOL, V170, P3478, DOI 10.4049/jimmunol.170.7.3478; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kagami S, 2001, BLOOD, V97, P2358, DOI 10.1182/blood.V97.8.2358; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; O'Malley JT, 2009, IMMUNOLOGY, V127, P587, DOI 10.1111/j.1365-2567.2008.03037.x; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rocken M, 1996, IMMUNOL TODAY, V17, P225, DOI 10.1016/0167-5699(96)80556-1; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sehra S, 2008, J IMMUNOL, V180, P3551, DOI 10.4049/jimmunol.180.5.3551; Sehra S, 2010, J IMMUNOL, V184, P3186, DOI 10.4049/jimmunol.0901860; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Takatori H, 2005, J IMMUNOL, V174, P3734, DOI 10.4049/jimmunol.174.6.3734; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Williams KL, 2003, J IMMUNOL, V170, P2417, DOI 10.4049/jimmunol.170.5.2417; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	57	160	163	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					39	49		10.1016/j.immuni.2010.12.013	http://dx.doi.org/10.1016/j.immuni.2010.12.013			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21215659	Bronze, Green Accepted			2022-12-18	WOS:000287336600008
J	Yates, RM; Russell, DG				Yates, RM; Russell, DG			Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4	IMMUNITY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SIGNALING PATHWAYS; H+-ATPASE; ACTIVATION; MACROPHAGES; RESPONSES; DIFFERENTIATION; MYD88; P38; LIPOPOLYSACCHARIDE	Toll-like receptors modulate many aspects of the innate immune response. Recent reports suggest that the maturation of phagosomes following particle uptake is modulated through signaling of Toll-like receptors. In the current study, the kinetics of phagosome maturation was evaluated quantitatively by ratio fluorometry to determine the lumenal pH of the phagosomes and a FRET-based technique to determine the degree of phagosome/lysosome fusion. Profiles generated for phagosomes containing experimental particles with or without the TLR ligands Pam(3)Cys-Ser-(Lys)(4) or LPS failed to reveal a difference in maturation despite activating TLR-signaling pathways. Moreover, while macrophages defective in individual TLRs generated phagosome maturation profiles identical to wild-type macrophages, MyD88-deficient macrophages exhibited a marked depression in phagosome/lysosome fusion that appears independent of short-term TLR-mediated effects. The results demonstrate that the rate of maturation of phagosomes proceeds independently of TLR signaling pathways.	Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Yates, Robin/K-5032-2015; Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Yates, Robin/0000-0003-3122-1845; Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X	NIAID NIH HHS [AI057086] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057086] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; LUKACS GL, 1991, J BIOL CHEM, V266, P24540; Marr KA, 2003, INFECT IMMUN, V71, P5280, DOI 10.1128/IAI.71.9.5280-5286.2003; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; TALAMASROHANA P, 1990, J IMMUNOL, V144, P4817; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x	34	160	169	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2005	23	4					409	417		10.1016/j.immuni.2005.09.007	http://dx.doi.org/10.1016/j.immuni.2005.09.007			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226506	Bronze			2022-12-18	WOS:000232995800009
J	Lacorazza, HD; Miyazaki, Y; Di Cristofano, A; Deblasio, A; Hedvat, C; Zhang, J; Cordon-Cardo, C; Mao, SF; Pandolfi, PP; Nimer, SD				Lacorazza, HD; Miyazaki, Y; Di Cristofano, A; Deblasio, A; Hedvat, C; Zhang, J; Cordon-Cardo, C; Mao, SF; Pandolfi, PP; Nimer, SD			The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells	IMMUNITY			English	Article							RECEPTOR-ALPHA-CHAIN; TRANSCRIPTION FACTOR; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; INTERLEUKIN-2 RECEPTORS; BINDING-SITE; MICE LACKING; SPI-B; ELF-1; ACTIVATION; PROMOTER	We utilized gene targeting by homologous recombination to define the role that MEF, a transcriptional activating member of the ETS family of transcription factors, plays in lymphopoiesis. MEF-/- mice have a profound reduction in the number of NK-T and NK cells. Purified MEF-/- NK cells cannot lyse tumor cell targets and secrete only minimal amounts of IFNgamma. Perforin protein expression is severely impaired in MEF-deficient NK cells, likely accounting for the lack of tumor cell cytotoxicity. Promoter studies and chromatin immunoprecipitation analyses demonstrate that MEF and not ETS-1 directly regulates transcription of the perforin gene in NK cells. Our results uncover a specific role of MEF in the development and function of NK cells and in innate immunity.	Mem Sloan Kettering Canc Ctr, Lab Mol Aspects Hematopoiesis, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol & Dev Biol Lab, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Mol Aspects Hematopoiesis, 1275 York Ave, New York, NY 10021 USA.		di cristofano, antonio/AAJ-3796-2020; Di Cristofano, Antonio/B-4148-2016	di cristofano, antonio/0000-0003-2537-3228; Lacorazza, Daniel/0000-0003-0660-617X; HEDVAT, CYRUS/0000-0003-0045-3491	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052208] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK52208] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DENNERT G, 1980, CELL IMMUNOL, V53, P350, DOI 10.1016/0008-8749(80)90335-4; Fadeel B, 2001, LEUKEMIA LYMPHOMA, V42, P13, DOI 10.3109/10428190109097672; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; Kai H, 1999, J BIOL CHEM, V274, P20098, DOI 10.1074/jbc.274.29.20098; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KOIZUMI H, 1993, MOL CELL BIOL, V13, P6690, DOI 10.1128/MCB.13.11.6690; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LEIDEN JM, 1992, J VIROL, V66, P5890, DOI 10.1128/JVI.66.10.5890-5897.1992; LICHTENHELD MG, 1992, J IMMUNOL, V149, P2619; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Mao SF, 1999, MOL CELL BIOL, V19, P3635; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Miyazaki Y, 1996, ONCOGENE, V13, P1721; Moore TA, 1996, IMMUNOL RES, V15, P151, DOI 10.1007/BF02918504; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NIKOLICZUGIC J, 1991, IMMUNOL TODAY, V12, P65, DOI 10.1016/0167-5699(91)90160-U; Papas Takis S., 1997, Leukemia (Basingstoke), V11, P557; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; RAULET DH, 1985, NATURE, V314, P101, DOI 10.1038/314101a0; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SCOTT GK, 1994, J BIOL CHEM, V269, P19848; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Spain LM, 1999, J IMMUNOL, V163, P2681; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; Walunas TL, 2000, J IMMUNOL, V164, P2857, DOI 10.4049/jimmunol.164.6.2857; WANG CY, 1993, SCIENCE, V260, P1330, DOI 10.1126/science.8493578; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wilson SB, 2001, CURR OPIN IMMUNOL, V13, P555, DOI 10.1016/S0952-7915(00)00258-2; Yu CR, 1999, J IMMUNOL, V162, P2785; Zhang YG, 1997, J IMMUNOL, V158, P1734; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	56	160	168	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2002	17	4					437	449		10.1016/S1074-7613(02)00422-3	http://dx.doi.org/10.1016/S1074-7613(02)00422-3			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	605FQ	12387738	Bronze			2022-12-18	WOS:000178667100005
J	Cherukuri, A; Cheng, PC; Sohn, HW; Pierce, SK				Cherukuri, A; Cheng, PC; Sohn, HW; Pierce, SK			The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts	IMMUNITY			English	Article							T-DEPENDENT ANTIGEN; PHOSPHOLIPASE-C; LYMPHOCYTES-B; TRANSDUCTION MOLECULE; ACQUIRED-IMMUNITY; KINASE ACTIVATION; DOWN-REGULATION; CD19; IMMUNOGLOBULIN; PROTEIN	The CD19/CD21 complex functions to significantly enhance B cell antigen receptor (BCR) signaling in response to complement-tagged antigens. Recent studies showed that following antigen binding the BCR translocates into plasma membrane lipid rafts that serve as platforms for BCR signaling. Here, we show that the binding of complement-tagged antigens stimulates the translocation of both the BCR and the CD19/ CD21 complex into lipid rafts, resulting in prolonged residency in and signaling from the rafts, as compared to BCR cross-linking alone. When coligated to the BCR, the CD19/CD21 complex retards the internalization and degradation of the BCR. The colocalization and stabilization of the BCR and the CD19/CD21 complex in plasma membrane lipid rafts represents a novel mechanism by which a coreceptor enhances BCR signaling.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University	Pierce, SK (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000898, Z01AI000898, Z01AI000899, ZIAAI000899] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Brooks SR, 2000, J IMMUNOL, V164, P3123, DOI 10.4049/jimmunol.164.6.3123; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; CALLARD RE, 1992, J IMMUNOL, V148, P2983; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Carter RH, 1997, J IMMUNOL, V158, P3062; CARTER RH, 1991, J IMMUNOL, V147, P3663; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fehr T, 1998, J EXP MED, V188, P145, DOI 10.1084/jem.188.1.145; Fischer MB, 1996, J IMMUNOL, V157, P549; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Krudewig R, 2000, J NEUROCHEM, V74, P1721, DOI 10.1046/j.1471-4159.2000.0741721.x; Li XL, 1998, J IMMUNOL, V161, P5901; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; PESANDO JM, 1989, J EXP MED, V170, P2159, DOI 10.1084/jem.170.6.2159; Prodinger WM, 1998, J IMMUNOL, V161, P4604; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A; SMITHGILL SJ, 1982, J IMMUNOL, V128, P314; SONG WX, 1995, J IMMUNOL, V155, P4255; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; Verdier F, 2000, J BIOL CHEM, V275, P18375, DOI 10.1074/jbc.275.24.18375; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; WENG WK, 1994, J BIOL CHEM, V269, P32514	37	160	166	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					169	179						11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239449				2022-12-18	WOS:000167092500007
J	Ersching, J; Efeyan, A; Mesin, L; Jacobsen, JT; Pasqual, G; Grabiner, BC; Dominguez-Sola, D; Sabatini, DM; Victora, GD				Ersching, Jonatan; Efeyan, Alejo; Mesin, Luka; Jacobsen, Johanne T.; Pasqual, Giulia; Grabiner, Brian C.; Dominguez-Sola, David; Sabatini, David M.; Victora, Gabriel D.			Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase	IMMUNITY			English	Article							CELL-CYCLE PROGRESSION; ONE-STEP GENERATION; CENTER B-CELLS; TRANSCRIPTION FACTOR; C-MYC; DENDRITIC CELLS; TRANSLATION INITIATION; DARK ZONE; DIFFERENTIATION; GROWTH	During antibody affinity maturation, germinal center (GC) B cells cycle between affinity-driven selection in the light zone (LZ) and proliferation and somatic hypermutation in the dark zone (DZ). Although selection of GC B cells is triggered by antigen-dependent signals delivered in the LZ, DZ proliferation occurs in the absence of such signals. We show that positive selection triggered by T cell help activates the mechanistic target of rapamycin complex 1 (mTORC1), which promotes the anabolic program that supports DZ proliferation. Blocking mTORC1 prior to growth prevented clonal expansion, whereas blockade after cells reached peak size had little to no effect. Conversely, constitutively active mTORC1 led to DZ enrichment but loss of competitiveness and impaired affinity maturation. Thus, mTORC1 activation is required for fueling B cells prior to DZ proliferation rather than for allowing cell-cycle progression itself and must be regulated dynamically during cyclic re-entry to ensure efficient affinity-based selection.	[Ersching, Jonatan; Efeyan, Alejo; Mesin, Luka; Jacobsen, Johanne T.; Pasqual, Giulia; Grabiner, Brian C.; Sabatini, David M.; Victora, Gabriel D.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Jacobsen, Johanne T.] Univ Oslo, Oslo Univ Hosp, Ctr Immune Regulat, N-0372 Oslo, Norway; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Sabatini, David M.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Sabatini, David M.] Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Ersching, Jonatan; Mesin, Luka; Jacobsen, Johanne T.; Pasqual, Giulia; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA; [Efeyan, Alejo] Ctr Nacl Invest Oncol, Madrid 28029, Spain; [Grabiner, Brian C.] Biogen, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oslo; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Rockefeller University; Biogen	Victora, GD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Victora, GD (corresponding author), Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA.	victora@rockefeller.edu	Efeyan, Alejo/J-8197-2016; Pasqual, Giulia/AAD-8378-2022	Efeyan, Alejo/0000-0002-3806-6799; Pasqual, Giulia/0000-0002-1476-2669; Jacobsen, Johanne/0000-0001-9757-1923; Dominguez-Sola, David/0000-0001-9569-8402; Victora, Gabriel/0000-0001-8807-348X	NIH [7DP5OD012146, 1R01AI119006, CA103866, AI47389]; Norwegian Research Council FRIPRO mobility grant; Cancer Research Institute Irvington Postdoctoral Fellowship; NIH/NCI [R00 CA151827]; Louis Sklarow Trust; Howard Hughes Medical Institute; Human Frontier Science Program; Simeon Fortin Charles King Trust; NATIONAL CANCER INSTITUTE [R00CA151827, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI119006, R01AI047389] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Research Council FRIPRO mobility grant; Cancer Research Institute Irvington Postdoctoral Fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louis Sklarow Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); Simeon Fortin Charles King Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Aguila for technical assistance, S. Markoulaki and the Whitehead Institute CRISPR facility for zygote injections, T.Y. Oliveira (Rockefeller University) for help with RNA-seq analysis, M. Reth (Max Planck Institute, Freiburg, Germany) for Mb1-Cre (Cd79a<SUP>cre</SUP>) mice, B. Sleckman (Weill Cornell Medicine) and R. Dalla-Favera and T. Mo (Columbia University) for GFP-Myc mice, and members of the Victora and Sabatini laboratories for helpful discussion. This work was funded by NIH grants 7DP5OD012146 and 1R01AI119006 (G.D.V). J.T.J. is supported by a Norwegian Research Council FRIPRO mobility grant. G.P. is supported by a Cancer Research Institute Irvington Postdoctoral Fellowship. D.D.-S. is supported by an NIH/NCI career development grant (R00 CA151827) and by the Louis Sklarow Trust. D.M.S. and A.E. were funded by the Howard Hughes Medical Institute and by NIH grants CA103866 and AI47389. A.E. was supported by Human Frontier Science Program and Simeon Fortin Charles King Trust postdoctoral fellowships. B.C.G. is an employee of Biogen and has restricted stock units in the company.	AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Ci XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127527; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Jones DD, 2016, J CLIN INVEST, V126, P4250, DOI 10.1172/JCI86504; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Limon JJ, 2014, P NATL ACAD SCI USA, V111, pE5076, DOI 10.1073/pnas.1407104111; Lin WHW, 2015, CELL REP, V13, P2203, DOI 10.1016/j.celrep.2015.10.072; Lucas CL, 2014, J EXP MED, V211, P2537, DOI 10.1084/jem.20141759; MacLennan I. C., 1994, IMMUNITY, V45, P471; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Pasqual G, 2015, METHODS MOL BIOL, V1291, P125, DOI 10.1007/978-1-4939-2498-1_10; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun KM, 2017, MOL CANCER THER, V16, P285, DOI 10.1158/1535-7163.MCT-16-0390; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang J., 2016, ELIFE, V5, P5, DOI DOI 10.1155/2016/1690896; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	69	159	160	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					1045	+		10.1016/j.immuni.2017.06.005	http://dx.doi.org/10.1016/j.immuni.2017.06.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636954	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-18	WOS:000403665900017
J	Garces, F; Lee, JH; de Val, N; de la Pena, AT; Kong, L; Puchades, C; Hua, YZ; Stanfield, RL; Burton, DR; Moore, JP; Sanders, RW; Ward, AB; Wilson, IA				Garces, Fernando; Lee, Jeong Hyun; de Val, Natalia; de la Pena, Alba Torrents; Kong, Leopold; Puchades, Cristina; Hua, Yuanzi; Stanfield, Robyn L.; Burton, Dennis R.; Moore, John P.; Sanders, Rogier W.; Ward, Andrew B.; Wilson, Ian A.			Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans	IMMUNITY			English	Article							NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; RECOGNITION; GENERATION	The high-mannose patch on the HIV-1 envelope (Env) glycoprotein is the epicenter for binding of the potent broadly neutralizing PGT121 family of antibodies, but strategies for generating such antibodies by vaccination have not been defined. We generated structures of inferred antibody intermediates by X-ray crystallography and electron microscopy to elucidate the molecular events that occurred during evolution of this family. Binding analyses revealed that affinity maturation was primarily focused on avoiding, accommodating, or binding the N137 glycan. The overall antibody approach angle to Env was defined very early in the maturation process, yet some variation evolved in the PGT121 family branches that led to differences in glycan specificities in their respective epitopes. Furthermore, we determined a crystal structure of the recombinant BG505 SOSIP. 664 HIV-1 trimer with a PGT121 family member at 3.0 angstrom that, in concert with these antibody intermediate structures, provides insights to advance design of HIV vaccine candidates.	[Garces, Fernando; Lee, Jeong Hyun; de Val, Natalia; Kong, Leopold; Puchades, Cristina; Hua, Yuanzi; Stanfield, Robyn L.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Garces, Fernando; Lee, Jeong Hyun; de Val, Natalia; Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Garces, Fernando; Lee, Jeong Hyun; de Val, Natalia; Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [de la Pena, Alba Torrents; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Burton, Dennis R.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Cornell University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu	Ward, Andrew B/F-9203-2014; de Val, Natalia/AAF-4822-2019; Stanfield, Robyn/AAH-3190-2019; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Puchades, Cristina/0000-0003-3240-4176; Lee, Jeong Hyun/0000-0001-7371-845X; Kong, Leopold/0000-0001-7456-1773	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; HIV Vaccine Research and Design (HIVRAD) program [P01 AI082362, P01 AI110657, R37 AI036082]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [CHAVI-ID UM1 AI00663]; International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD); NIH [RO1 GM046192, 2R56 AI084817]; Joint Center of Structural Genomics (JCSG) - NIH NIGMS, Protein Structure Initiative [U54 GM094586]; Vidi grant from the Netherlands Organization for Scientific Research (NWO); Starting Investigator Grant from the European Research Council [ERC-StG-2011-280829-SHEV]; California HIV/AIDS Research Program Dissertation Award [D12-SRI-353]; IAVI; USAID; Ministry of Foreign Affairs of the Netherlands; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084817, UM1AI100663, P01AI082362, R37AI036082, P01AI110657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046192, U54GM094586] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); HIV Vaccine Research and Design (HIVRAD) program; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center of Structural Genomics (JCSG) - NIH NIGMS, Protein Structure Initiative; Vidi grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Investigator Grant from the European Research Council(European Research Council (ERC)); California HIV/AIDS Research Program Dissertation Award; IAVI; USAID(United States Agency for International Development (USAID)); Ministry of Foreign Affairs of the Netherlands; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to X. Dai for assistance with data processing; M. Elsliger for computer support; and M. Deller and H. Tien for the crystallization screening. X-ray data sets were collected at the ALS and APS. The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The APS is supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. This work was supported by the HIV Vaccine Research and Design (HIVRAD) program (P01 AI082362 and P01 AI110657) (J.P.M., R.W.S., A.B.W., I.A.W.), R37 AI036082 (J.P.M.), by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID UM1 AI00663) and International AIDS Vaccine Initiative Neutralizing Antibody Center and Collaboration for AIDS Vaccine Discovery (CAVD) (A.B.W., D.R.B., I.A.W.), by NIH RO1 GM046192 (I.A.W.), by NIH 2R56 AI084817 (A.B.W., I.A.W.), and by the Joint Center of Structural Genomics (JCSG) funded by the NIH NIGMS, Protein Structure Initiative (U54 GM094586) (I.A.W.). R.W.S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). J.H.L. is supported by the California HIV/AIDS Research Program Dissertation Award D12-SRI-353. This work was also partially funded by IAVI with the generous support of USAID, Ministry of Foreign Affairs of the Netherlands, and the Bill & Melinda Gates Foundation; a full list of IAVI donors is available at http://www.iavi.org. The contents of this manuscript are the responsibility of the authors and do not necessarily reflect the views of USAID or the US Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; GOIDL EA, 1968, J IMMUNOL, V100, P371; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907	34	159	162	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1053	1063		10.1016/j.immuni.2015.11.007	http://dx.doi.org/10.1016/j.immuni.2015.11.007			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682982	Bronze, Green Accepted			2022-12-18	WOS:000366846600010
J	Takagi, H; Fukaya, T; Eizumi, K; Sato, Y; Sato, K; Shibazaki, A; Otsuka, H; Hijikata, A; Watanabe, T; Ohara, O; Kaisho, T; Malissen, B; Sato, K				Takagi, Hideaki; Fukaya, Tomohiro; Eizumi, Kawori; Sato, Yumiko; Sato, Kaori; Shibazaki, Azusa; Otsuka, Haruna; Hijikata, Atsushi; Watanabe, Takashi; Ohara, Osamu; Kaisho, Tsuneyasu; Malissen, Bernard; Sato, Katsuaki			Plasmacytoid Dendritic Cells Are Crucial for the Initiation of Inflammation and T Cell Immunity In Vivo	IMMUNITY			English	Article							ANTIGEN-PRESENTATION; ORAL TOLERANCE; KAPPA-B; AUTOIMMUNITY; ACTIVATION; ENGAGEMENT; INFECTION; RESPONSES; ROLES; TLR	Plasmacytoid dendritic cells (pDCs) are characterized as type I interferon-producing cells that engage endosomal toll-like receptors (TLRs) and exclusively express sialic acid binding Ig-like lectin (Siglec)-H. However, their role in vivo remains unclear. Here we report a critical role for pDCs in the regulation of inflammation and T cell immunity in vivo by using gene-targeted mice with a deficiency of Siglec-H and conditional ablation of pDCs. pDCs were required for inflammation triggered by a TLR ligand as well as by bacterial and viral infections. pDCs controlled homeostasis of effector and regulatory CD4(+) T cells. Upon antigenic stimulation and microbial infection, pDCs suppressed the induction of CD4(+) T cell responses and participated in the initiation of CD8(+) T cell responses. Furthermore, Siglec-H appeared to modulate the function of pDCs in vivo. Thus, our findings highlight previously unidentified roles of pDCs and the regulation of their function for the control of innate and adaptive immunity.	[Takagi, Hideaki; Fukaya, Tomohiro; Eizumi, Kawori; Sato, Yumiko; Sato, Kaori; Shibazaki, Azusa; Otsuka, Haruna; Sato, Katsuaki] RIKEN Res Ctr Allergy & Immunol, Lab Dendrit Cell Immunobiol, Yokohama, Kanagawa 2300045, Japan; [Hijikata, Atsushi; Watanabe, Takashi; Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Lab Immunogen, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kaisho, Tsuneyasu] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Malissen, Bernard] Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, Case 906, Inst Natl Sante & Rech Med U631, F-13288 Marseille 9, France; [Malissen, Bernard] Ctr Natl Rech Sci UMR6102, F-13288 Marseille 9, France; [Sato, Katsuaki] PRESTO, Japan Sci & Technol Agcy, Saitama 3320012, Japan	RIKEN; RIKEN; Osaka University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Japan Science & Technology Agency (JST)	Sato, K (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Dendrit Cell Immunobiol, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	katsuaki@rcai.riken.jp; katsuaki@rcai.riken.jp	Ohara, Osamu/G-5448-2015; Kaisho, Tsuneyasu/B-4130-2012; Ohara, Osamu/A-9119-2012; Malissen, Bernard/AAK-4659-2020	Ohara, Osamu/0000-0002-3328-9571; Hijikata, Atsushi/0000-0003-4297-8368; Malissen, Bernard/0000-0003-1340-9342	Ministry of Education, Science and Culture of Japan; Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO); Grants-in-Aid for Scientific Research [21117003] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Kawaguchi (The Institute of Medical Science, The University of Tokyo) for WT HSV-1 (strain F), all members of the Central Facility at the RIKEN Research Center for Allergy and Immunology for technical help in cell sorting, and S. Haraguchi for secretarial assistance. This work was supported by a Grants-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (C) (K. Sato) and Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (PRESTO) (K. Sato).	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Efron PA, 2004, J IMMUNOL, V173, P3035, DOI 10.4049/jimmunol.173.5.3035; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Fukaya T, 2010, BLOOD, V116, P2266, DOI 10.1182/blood-2009-10-250472; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Shen H, 2006, J CLIN INVEST, V116, P2237, DOI 10.1172/JCI28681; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	36	159	162	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 23	2011	35	6					958	971		10.1016/j.immuni.2011.10.014	http://dx.doi.org/10.1016/j.immuni.2011.10.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22177923	Bronze			2022-12-18	WOS:000298777300014
J	Egen, JG; Rothfuchs, AG; Feng, CG; Horwitz, MA; Sher, A; Germain, RN				Egen, Jackson G.; Rothfuchs, Antonio Gigliotti; Feng, Carl G.; Horwitz, Marcus A.; Sher, Alan; Germain, Ronald N.			Intravital Imaging Reveals Limited Antigen Presentation and T Cell Effector Function in Mycobacterial Granulomas	IMMUNITY			English	Article							DENDRITIC CELLS; LYMPH-NODES; IMMUNE-RESPONSE; IN-VIVO; TUBERCULOSIS; MICE; CD4; ACTIVATION; INFECTION; DYNAMICS	Cell-mediated adaptive immunity is critical for host defense, but little is known about T cell behavior during delivery of effector function. Here we investigate relationships among antigen presentation, T cell motility, and local production of effector cytokines by CD4(+) T cells within hepatic granulomas triggered by Bacille Calmette-Guerin or Mycobacterium tuberculosis. At steady-state, only small fractions of mycobacteria-specific T cells showed antigen-induced migration arrest within granulomas, resulting in low-level, polarized secretion of cytokines. However, exogenous antigen elicited rapid arrest and robust cytokine production by the vast majority of effector T cells. These findings suggest that limited antigen presentation and/or recognition within granulomas evoke a muted T cell response drawing on only a fraction of the host's potential effector capacity. Our results provide new insights into the regulation of host-protective functions, especially how antigen availability influences T cell dynamics and, in turn, effector T cell function during chronic infection.	[Egen, Jackson G.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Rothfuchs, Antonio Gigliotti; Feng, Carl G.; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Program Syst Immunol & Infect Dis Modeling, NIH, Bethesda, MD 20892 USA; [Horwitz, Marcus A.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Rothfuchs, Antonio G/F-5981-2013; Germain, Ronald/ABE-7090-2020	Rothfuchs, Antonio G/0000-0001-6001-7240; feng, carl/0000-0003-4301-4640; Egen, Jackson/0000-0003-2053-0837	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001034, ZIAAI000843] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank W. Kastenmuller, M. Gerner, N. Vrisekoop, and M. Clatworthy for helpful discussions and/or critical reading of the manuscript, O. Schwartz and L. Koo (Research Technology Branch/NIAID) for technical assistance with intravital microscopy under BSL3 conditions, and A. Rinker, I. Ifrim, and S. White for technical support. We are extremely grateful to J. Ernst for providing valuable reagents used in this study, as well as for insightful discussions, sharing of unpublished data, and helpful comments on the manuscript. This work was supported by the Intramural Research Program of the NIAID, NIH.	ABADIE V, 2005, J IMMUNOL, V106, P1344; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Beltman JB, 2007, IMMUNOL CELL BIOL, V85, P306, DOI 10.1038/sj.icb.7100054; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Caruso AM, 1999, J IMMUNOL, V162, P5407; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Faust N, 2000, BLOOD, V96, P719; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; Schreiber HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011453; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Zheng H, 2008, MOL CELL BIOL, V28, P4040, DOI 10.1128/MCB.00136-08	41	159	162	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					807	819		10.1016/j.immuni.2011.03.022	http://dx.doi.org/10.1016/j.immuni.2011.03.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21596592	Green Accepted, Bronze			2022-12-18	WOS:000291456500018
J	Pacholczyk, R; Kern, J; Singh, N; Iwashima, M; Kraj, P; Lgnatowicz, L				Pacholczyk, Rafal; Kern, Joanna; Singh, Nagendra; Iwashima, Makio; Kraj, Piotr; Lgnatowicz, Leszek			Nonself-antigens are the cognate Specificities of Foxp3(+) regulatory T cells	IMMUNITY			English	Article							ALTERED PEPTIDE LIGANDS; THYMIC SELECTION; SELF; REPERTOIRES; AGONIST; RECOGNITION; EXPRESSION; EFFECTOR; ABSENCE; ORIGIN	The majority of regulatory Foxp3(+)CD4(+) T cells naturally arises in the thymus. It has been proposed that T cell receptors (TCRs) on these cells recognize self-MHC class II-peptide complexes with high or higher affinity and that their specificities mirror specificities of autoreactive T cells. Here, we analyzed hundreds of TCRs derived from regulatory or nonregulatory T cells and found little evidence that the former population preferably recognizes self-antigens as agonists. Instead, these cells recognized foreign MHC-peptide complexes as often as nonregulatory T cells. Our results show that high-affinity, autoreactive TCRs are rare on all CD4(+) T cells and suggest that selecting self-peptide is different from the peptide that activates the same regulatory T cells in the periphery.	Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Pacholczyk, R (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	rpacholczyk@3mcg.edu; lignatowicz@mcg.edu			NCI NIH HHS [CA107349-01A1, R01 CA107349] Funding Source: Medline; NIAID NIH HHS [R01 AI041145, AI041145-07A1, R01 AI041145-09] Funding Source: Medline; NIDDK NIH HHS [R01 DK099264] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041145] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; BILL J, 1989, J EXP MED, V170, P739, DOI 10.1084/jem.170.3.739; Buzas EI, 2003, J IMMUNOL, V171, P3025, DOI 10.4049/jimmunol.171.6.3025; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; Caton AJ, 2004, ANN NY ACAD SCI, V1029, P101, DOI 10.1196/annals.1309.028; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gad M, 2005, CURR TOP MICROBIOL, V293, P179, DOI 10.1007/3-540-27702-1_9; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Ge Q, 2001, P NATL ACAD SCI USA, V98, P1728, DOI 10.1073/pnas.98.4.1728; Grakoui A, 1999, J IMMUNOL, V162, P1923; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Larkin J, 2007, EUR J IMMUNOL, V37, P139, DOI 10.1002/eji.200636577; Lerman MA, 2004, J IMMUNOL, V173, P236, DOI 10.4049/jimmunol.173.1.236; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pennington DJ, 2006, NATURE, V444, P1073, DOI 10.1038/nature06051; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Tuovinen H, 2006, BLOOD, V108, P4063, DOI 10.1182/blood-2006-04-016105; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; YANOMA S, 1988, IMMUNOLOGY, V64, P113; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	49	159	162	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					493	504		10.1016/j.immuni.2007.07.019	http://dx.doi.org/10.1016/j.immuni.2007.07.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17869133	Green Accepted, Bronze			2022-12-18	WOS:000249843400015
J	Gelman, AE; LaRosa, DF; Zhang, JD; Walsh, PT; Choi, Y; Sunyer, JO; Turka, LA				Gelman, Andrew E.; LaRosa, David F.; Zhang, Jidong; Walsh, Patrick T.; Choi, Yongwon; Sunyer, J. Oriol; Turka, Laurence A.			The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4(+) T cells and enables CpG oligodeoxynucleotide-mediated costimulation	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; GLYCOGEN-SYNTHASE KINASE-3; KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; IFN-GAMMA; CD28; EXPRESSION; PROLIFERATION; SURVIVAL; IMMUNITY	While T cells respond directly to toll-like receptor (TLR) agonists, TLR-signaling pathways in T cells are poorly characterized. Here we demonstrate in CD4(+) T cells that CpG DNA directly enhances proliferation, prevents anergy, and augments humoral responses to a T cell-dependent antigen by a Myeloid differentiation primary-response protein 88 (MyD88) and Phosphatidylinositol 3-kinase (PI-3 kinase)-dependent pathway. PI-3 kinase activation required a putative Src-homology domain (SH2) binding motif in the MyD88 Toll-Like or IL-1 Receptor (TIR) domain. Reconstitution of MyD88-deficient primary T cells with a MyD88 transgene mutated in this motif abrogated association of PI-3 kinase with MyD88, phosphorylation of protein kinase B (Akt) and Glycogen Synthetase Kinase-3 (GSK-3), and interleukin-2 (IL-2) production. The MyD88 death domain, on the other hand, was required for NF-kB activation and survival. These studies identify a MyD88-dependent PI-3 kinase-signaling pathway in T cells that differentiates CpG DNA-mediated proliferation from survival and is required for an in vivo T cell-dependent immune response.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19010 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19010 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Turka, LA (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19010 USA.	turka@mail.med.upenn.edu	Walsh, Patrick/I-7909-2014	Walsh, Patrick/0000-0002-0130-8766	NIAID NIH HHS [R01 AI062789, AI-41521, AI-62789, P01 AI041521, R01 AI062789-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, R01AI062789] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Exley M, 1997, MOL IMMUNOL, V34, P221, DOI 10.1016/S0161-5890(97)00027-8; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kitamura T, 1998, INT J HEMATOL, V67, P351; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Mannon RB, 2000, CELL IMMUNOL, V201, P14, DOI 10.1006/cimm.2000.1635; Marengere LEM, 1997, J IMMUNOL, V159, P3220; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; UEDA Y, 1995, INT IMMUNOL, V7, P957, DOI 10.1093/intimm/7.6.957; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	42	159	164	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					783	793		10.1016/j.immuni.2006.08.023	http://dx.doi.org/10.1016/j.immuni.2006.08.023			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17055754	Green Accepted, Bronze			2022-12-18	WOS:000242063100011
J	Serbina, NV; Kuziel, W; Flavell, R; Akira, S; Rollins, B; Pamer, EG				Serbina, NV; Kuziel, W; Flavell, R; Akira, S; Rollins, B; Pamer, EG			Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection	IMMUNITY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; LISTERIA-MONOCYTOGENES; MICE DEFICIENT; MACROPHAGE RECRUITMENT; CHEMOKINE RECEPTOR; MURINE LISTERIOSIS; IFN-GAMMA	Microbial infections induce chemokine and cytokine cascades that coordinate innate immune defenses. Infection with the intracellular bacterial pathogen Listeria monocytogenes induces CCR2-dependent monocyte recruitment and activation, an essential response for host survival. Herein we show that invasive L. monocytogenes, but not killed or noninvasive bacteria, induce secretion of MCP-1, the requisite chemokine for monocyte recruitment. Induction of MCP-1, but not TNF or IL-12, following L. monocytogenes infection is MyD88 independent. Consistent with these results, MyD88 deficiency does not impair monocyte recruitment to L. monocytogenes infected spleens, but prevents monocyte activation. Our results indicate that distinct microbial signals activate innate immune responses in an ordered, step-wise fashion, providing a mechanism to specify and modulate antimicrobial effector functions.	Sloan Kettering Inst, Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med,Immunol Program, New York, NY 10021 USA; Univ Texas, Sect Mol Genet & Microbiol, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Osaka Univ, ERATO, Dept Host Def, Res Inst Microbial Dis,Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan; Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Austin; Yale University; Howard Hughes Medical Institute; Japan Science & Technology Agency (JST); Osaka University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Pamer, EG (corresponding author), Sloan Kettering Inst, Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med,Immunol Program, 1275 York Ave, New York, NY 10021 USA.		Akira, Shizuo/C-3134-2009		NCI NIH HHS [CA 09149] Funding Source: Medline; NIAID NIH HHS [R01 AI 42135, AI 39301] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI039301, R01AI042135] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Barsig J, 1998, IMMUNOBIOLOGY, V199, P87, DOI 10.1016/S0171-2985(98)80066-1; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bhardwaj V, 1998, J IMMUNOL, V160, P376; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; BOUWER HGA, 1994, INFECT IMMUN, V62, P1039, DOI 10.1128/IAI.62.3.1039-1045.1994; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Cossart P, 2001, CURR OPIN IMMUNOL, V13, P96, DOI 10.1016/S0952-7915(00)00188-6; Demuth A, 1996, INFECT IMMUN, V64, P3475, DOI 10.1128/IAI.64.9.3475-3483.1996; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Flesch IEA, 1998, INT IMMUNOL, V10, P757, DOI 10.1093/intimm/10.6.757; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; Hauf N, 1997, P NATL ACAD SCI USA, V94, P9394, DOI 10.1073/pnas.94.17.9394; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kumar SN, 2000, MOL IMMUNOL, V37, P623, DOI 10.1016/S0161-5890(00)00097-3; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ping DS, 1999, J IMMUNOL, V162, P727; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROSEN H, 1989, J EXP MED, V170, P27, DOI 10.1084/jem.170.1.27; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sibelius U, 1996, J IMMUNOL, V157, P4055; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tesch GH, 1999, J EXP MED, V190, P1813, DOI 10.1084/jem.190.12.1813; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; Zhou ZHL, 1998, J IMMUNOL, V160, P3908	47	159	162	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2003	19	6					891	901		10.1016/S1074-7613(03)00330-3	http://dx.doi.org/10.1016/S1074-7613(03)00330-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	753KN	14670305	Bronze			2022-12-18	WOS:000187230700013
J	Brooks, DG; Hamer, DH; Arlen, PA; Gao, LY; Bristol, G; Kitchen, CMR; Berger, EA; Zack, JA				Brooks, DG; Hamer, DH; Arlen, PA; Gao, LY; Bristol, G; Kitchen, CMR; Berger, EA; Zack, JA			Molecular characterization, reactivation, and depletion of latent HIV	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; SCID-HU MOUSE; HUMAN HEMATOLYMPHOID DIFFERENTIATION; ANTIRETROVIRAL THERAPY; VIRAL RESERVOIRS; GENE-EXPRESSION; LYMPHOCYTES; MODEL; REPLICATION	Antiretroviral therapy is unable to eliminate HIV infection in a small, long-lived population of latently infected T cells, providing a source for renewed viral replication following cessation of therapy. Analysis of individual latently infected cells generated in the SCID-hu (Thy/Liv) mouse demonstrated no functional viral RNA produced in the latent state. Following reactivation viral expression was dramatically increased, rendering the infected cells susceptible to an anti-HIV immunotoxin. Treatment with the immunotoxin in conjunction with agents that activate virus expression without inducing cell division (IL-7 or the non-tumor-promoting phorbol ester prostratin) depleted the bulk of the latent reservoir and left uninfected cells able to respond to subsequent costimulation. We demonstrate that activation of latent virus is required for targeting by antiviral agents and provide the basis for future therapeutic strategies to eradicate the latent reservoir.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zack, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jzack@ucla.edu	Ramirez, Christina/AAT-5088-2021; Arlen, Philip A/B-6859-2009; Hamer, Dean H/L-1248-2015	Hamer, Dean H/0000-0002-6211-5781; Brooks, David/0000-0001-7763-8764; Arlen, Philip/0000-0001-9663-1824; Ramirez, Christina/0000-0002-8435-0416	NIAID NIH HHS [AI36059, AI36554] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036554, R01AI036059, R37AI036059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Aldrovandi GM, 1996, J VIROL, V70, P1505, DOI 10.1128/JVI.70.3.1505-1511.1996; Bera TK, 1998, MOL MED, V4, P384, DOI 10.1007/BF03401745; Berger EA, 1998, P NATL ACAD SCI USA, V95, P11511, DOI 10.1073/pnas.95.20.11511; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Butera ST, 2000, ANTIVIR RES, V48, P143, DOI 10.1016/S0166-3542(00)00133-9; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Engert A, 1998, CURR TOP MICROBIOL, V234, P13; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Goldstein H, 2000, J INFECT DIS, V181, P921, DOI 10.1086/315351; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Ho DD, 1998, SCIENCE, V280, P1866, DOI 10.1126/science.280.5371.1866; Jamieson BD, 1998, J VIROL, V72, P6520, DOI 10.1128/JVI.72.8.6520-6526.1998; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kreitman RJ, 1998, ADV DRUG DELIVER REV, V31, P53, DOI 10.1016/S0169-409X(97)00094-X; KROWKA JF, 1991, J IMMUNOL, V146, P3751; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCCUNE JM, 1992, BONE MARROW TRANSPL, V9, P74; McCutchen D, 1996, EDUC PSYCHOL REV, V8, P187, DOI 10.1007/BF01464072; McHugh L, 2002, J BIOL CHEM, V277, P34383, DOI 10.1074/jbc.M205456200; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pomerantz RJ, 2002, CLIN INFECT DIS, V34, P91, DOI 10.1086/338256; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; RARNRATNAM B, 2000, NAT MED, V6, P82; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	51	159	164	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2003	19	3					413	423		10.1016/S1074-7613(03)00236-X	http://dx.doi.org/10.1016/S1074-7613(03)00236-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499116	Bronze			2022-12-18	WOS:000185499800012
J	Tumanov, AV; Kuprash, DV; Lagarkova, MA; Grivennikov, SI; Abe, K; Shakhov, AN; Drutskaya, LN; Stewart, CL; Chervonsky, AV; Nedospasov, SA				Tumanov, AV; Kuprash, DV; Lagarkova, MA; Grivennikov, SI; Abe, K; Shakhov, AN; Drutskaya, LN; Stewart, CL; Chervonsky, AV; Nedospasov, SA			Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; T-CELL; BETA-RECEPTOR; DEFICIENT MICE; STROMAL CELLS; MOUSE SPLEEN; ABNORMAL-DEVELOPMENT; AFFINITY MATURATION; GERMINAL-CENTERS	In order to definitively ascertain the functional contribution of lymphotoxin (LT) expressed by B cells, we produced mice with the LTbeta gene deleted from B cells (B-LTbeta KO mice). In contrast to systemic LTbeta deletion, in B-LTbeta KO mice only splenic microarchitecture was affected, while lymph nodes and Peyer's patches (PP) were normal, except for PP's reduced size. Even though B-LTbeta KO spleens retained a small number of follicular dendritic cells (FDC) which appeared to be dependent on LPbeta produced by T cells, IgG responses to sheep red blood cells were markedly reduced. Thus, the organogenic function of B-LTbeta is almost entirely restricted to spleen, where it supports the correct lymphoid architecture that is critical for an effective humoral immune response.	VA Engelhardt Mol Biol Inst, Lab Mol Immunol, Moscow 119991, Russia; Belozersky Inst Physicochem Biol, Moscow 119991, Russia; NCI, Basic Res Program, Sci Applicat Int Corp Frederick, Frederick, MD 21702 USA; NCI, Mol Immunoregulat Lab, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jackson Laboratory	Nedospasov, SA (corresponding author), VA Engelhardt Mol Biol Inst, Lab Mol Immunol, Moscow 119991, Russia.	tumanov@imb.ac.ru; snedos@online.ru	Kuprash, Dmitry/O-4899-2015; Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/Q-7319-2016; Grivennikov, Sergei/AAE-7365-2019; Nedospasov, Sergei/J-5936-2013; Nedospasov, Sergei/L-1990-2015; Tumanov, Alexei/AAR-1607-2021; Lagarkova, Maria/A-3296-2014	Kuprash, Dmitry/0000-0002-1488-4148; Grivennikov, Sergei/0000-0003-2987-0555; Tumanov, Alexei/0000-0001-6042-0152; Chervonsky, Alexander/0000-0001-7547-871X; Lagarkova, Maria/0000-0001-9594-1134	NCI NIH HHS [N01-CO-12400, CA65795] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA065795] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bergmann CC, 2001, J IMMUNOL, V167, P1575, DOI 10.4049/jimmunol.167.3.1575; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; BROWNING JL, 1995, J IMMUNOL, V154, P33; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; Debard N, 2001, GASTROENTEROLOGY, V120, P1173, DOI 10.1053/gast.2001.22476; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Ettinger R, 1998, INT IMMUNOL, V10, P727, DOI 10.1093/intimm/10.6.727; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 2000, J IMMUNOL, V164, P2508, DOI 10.4049/jimmunol.164.5.2508; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Guo Z, 2001, J IMMUNOL, V167, P4796, DOI 10.4049/jimmunol.167.9.4796; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; KAPASI ZF, 1993, J IMMUNOL, V150, P2648; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; KOSCO MH, 1992, J IMMUNOL, V148, P2331; KRAAL G, 1986, IMMUNOLOGY, V58, P665; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; KRAAL G, 1995, AM J PATHOL, V147, P763; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Kuprash DV, 1999, J IMMUNOL, V163, P6575; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Murphy M, 1998, CELL DEATH DIFFER, V5, P497, DOI 10.1038/sj.cdd.4400374; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Shakhov AN, 2000, J LEUKOCYTE BIOL, V68, P151; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; VANVLIET E, 1985, J HISTOCHEM CYTOCHEM, V33, P40, DOI 10.1177/33.1.3880783; Wang Y, 2001, J IMMUNOL, V166, P330, DOI 10.4049/jimmunol.166.1.330; WARE CF, 1992, J IMMUNOL, V149, P3881; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Wu XB, 2000, J IMMUNOL, V165, P3119, DOI 10.4049/jimmunol.165.6.3119; YOSHIDA K, 1993, IMMUNOLOGY, V80, P34	67	159	163	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2002	17	3					239	250		10.1016/S1074-7613(02)00397-7	http://dx.doi.org/10.1016/S1074-7613(02)00397-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354378	Bronze			2022-12-18	WOS:000178163100002
J	Chuvpilo, S; Jankevics, E; Tyrsin, D; Akimzhanov, A; Moroz, D; Jha, MK; Luehrmann, JS; Santner-Nanan, B; Feoktistova, E; Konig, T; Avots, A; Schmitt, E; Berberich-Siebelt, F; Schimpl, A; Serfling, E				Chuvpilo, S; Jankevics, E; Tyrsin, D; Akimzhanov, A; Moroz, D; Jha, MK; Luehrmann, JS; Santner-Nanan, B; Feoktistova, E; Konig, T; Avots, A; Schmitt, E; Berberich-Siebelt, F; Schimpl, A; Serfling, E			Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis	IMMUNITY			English	Article							ATP-DEFICIENT MICE; TRANSCRIPTION FACTOR; NF-ATC; NUCLEAR FACTOR; MAST-CELLS; DNA METHYLATION; BINDING-PROTEIN; ACTIVATION; INDUCTION; PROMOTER	Threshold levels of individual NFAT factors appear to be critical for apoptosis induction in effector T cells. In these cells, the short isoform A of NFATc1 is induced to high levels due to the autoregulation of the NFATc1 promoter P1 by NFATs. P1 is located within a CpG island in front of exon 1, represents a DNase I hypersensitive chromatin site, and harbors several sites for binding of inducible transcription factors, including a tandemly arranged NFAT site. A second promoter, P2, before exon 2, is not controlled by NFATs and directs synthesis of the longer NFATc1/B+C isoforms. Contrary to other NFATs, NFATc1/A is unable to promote apoptosis, suggesting that NFATc1/A enhances effector functions without promoting apoptosis of effector T cells.	Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany; Univ Wurzburg, Inst Virol & Immunobiol, D-97080 Wurzburg, Germany; Johannes Gutenberg Univ Mainz, Inst Immunol, D-55101 Mainz, Germany; Latvian State Univ, Biomed Res & Study Ctr, LV-1067 Riga, Latvia	University of Wurzburg; University of Wurzburg; Johannes Gutenberg University of Mainz; Latvian Biomedical Research & Study Centre; University of Latvia	Serfling, E (corresponding author), Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany.	path015@mail.uni-wuerzburg.de	Chuvpilo, Sergey/AAD-3144-2019; Serfling, Edgar/X-7212-2019	Akimzhanov, Askar/0000-0002-5592-8215				Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; Berberich-Siebelt F, 2000, EUR J IMMUNOL, V30, P2576, DOI 10.1002/1521-4141(200009)30:9<2576::AID-IMMU2576>3.0.CO;2-N; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Cockerill P N, 2000, Methods Mol Biol, V130, P29; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LI X, 1995, CYTOGENET CELL GENET, V68, P185, DOI 10.1159/000133910; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Luo C, 1996, MOL CELL BIOL, V16, P3955; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nan XS, 1998, CIBA F SYMP, V214, P6; NAVEHMANY T, 1981, P NATL ACAD SCI-BIOL, V78, P4246, DOI 10.1073/pnas.78.7.4246; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Pan S, 1997, BIOCHEM BIOPH RES CO, V240, P314, DOI 10.1006/bbrc.1997.7381; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PRIESCHL EE, 1995, J IMMUNOL, V154, P6112; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sherman MA, 1999, J IMMUNOL, V162, P2820; Sorensen AB, 1996, J VIROL, V70, P4063; Stassen M, 2000, J IMMUNOL, V164, P5549, DOI 10.4049/jimmunol.164.11.5549; Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	56	159	160	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2002	16	6					881	895		10.1016/S1074-7613(02)00329-1	http://dx.doi.org/10.1016/S1074-7613(02)00329-1			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	568GL	12121669	Bronze			2022-12-18	WOS:000176534000013
J	Sol-Foulon, N; Moris, A; Nobile, C; Boccaccio, C; Engering, A; Abastado, JP; Heard, JM; van Kooyk, Y; Schwartz, O				Sol-Foulon, N; Moris, A; Nobile, C; Boccaccio, C; Engering, A; Abastado, JP; Heard, JM; van Kooyk, Y; Schwartz, O			HIV-1 nef-induced Upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 DOWN-REGULATION; T-CELLS; MHC-I; PRODUCTIVE INFECTION; CLATHRIN ADAPTER; DILEUCINE MOTIF; REPLICATION; TRANSMISSION; TRAFFICKING	DC-SIGN, a dendritic cell (DC)-specific lectin, mediates clustering of DCs with T lymphocytes, a crucial event in the initiation of immune responses. DC-SIGN also binds HIV envelope glycoproteins, allowing efficient virus capture by DCs. We show here that DC-SIGN surface levels are upregulated in HIV-1-infected DCs. This process is caused by the viral protein Nef, which acts by inhibiting DC-SIGN endocytosis. Upregulation of DC-SIGN at the cell surface dramatically increases clustering of DCs with T lymphocytes and HIV-1 transmission. These results provide new insights into how HIV-1 spreads from DCs to T lymphocytes and manipulates immune responses. They help explain how Nef may act as a virulence factor in vivo.	Inst Pasteur, Unite Retrovirus & Transfert Genet, URA CNRS 1930, F-75724 Paris 15, France; UPMC, Inst Cordeliers, Immunodesigned Molecules Res Lab, F-75006 Paris, France; Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Vrije Universiteit Amsterdam	Schwartz, O (corresponding author), Inst Pasteur, Unite Retrovirus & Transfert Genet, URA CNRS 1930, 28 Rue Dr Roux, F-75724 Paris 15, France.		Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475; Sol-Foulon, Nathalie/0000-0002-2643-0311; Van Kooyk, Yvette/0000-0001-5997-3665; Moris, Arnaud/0000-0002-5052-1678				Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Frankel SS, 1997, AM J PATHOL, V151, P89; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Goxe B, 1998, RES IMMUNOL, V149, P643, DOI 10.1016/S0923-2494(99)80031-5; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Klagge IM, 1999, J GEN VIROL, V80, P823, DOI 10.1099/0022-1317-80-4-823; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lin CL, 2000, J EXP MED, V192, P587, DOI 10.1084/jem.192.4.587; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marechal V, 1998, J VIROL, V72, P2208; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; PETIT C, 2001, IMMUNOL REV, V286, P225; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; PINCHUK LM, 1994, IMMUNITY, V1, P317, DOI 10.1016/1074-7613(94)90083-3; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Reece JC, 1998, J EXP MED, V187, P1623, DOI 10.1084/jem.187.10.1623; Sewell AK, 2001, TRENDS IMMUNOL, V22, P173, DOI 10.1016/S1471-4906(01)01866-X; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Steinman RM, 2000, CELL, V100, P491, DOI 10.1016/S0092-8674(00)80684-4; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Tsunetsugu-Yokota Y, 1997, VIROLOGY, V239, P259, DOI 10.1006/viro.1997.8895; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369	45	159	162	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2002	16	1					145	155		10.1016/S1074-7613(02)00260-1	http://dx.doi.org/10.1016/S1074-7613(02)00260-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516UT	11825573	Bronze, Green Published			2022-12-18	WOS:000173575700014
J	Li, HM; Llera, A; Tsuchiya, D; Leder, L; Ysern, X; Schlievert, PM; Karjalainen, K; Mariuzza, RA				Li, HM; Llera, A; Tsuchiya, D; Leder, L; Ysern, X; Schlievert, PM; Karjalainen, K; Mariuzza, RA			Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B	IMMUNITY			English	Article							REFINED CRYSTAL-STRUCTURE; CLASS-II MOLECULES; BACTERIAL SUPERANTIGEN; ALPHA-CHAIN; YERSINIA-PSEUDOTUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; ANTIGEN RECEPTOR; SPE-C; MHC; RECOGNITION	Superantigens (SAGs) are a class of immunostimulatory proteins of bacterial or viral origin that activate T cells by binding to the V beta domain of the T cell antigen receptor (TCR). The three-dimensional structure of the complex between a TCR beta chain (mouse V beta 8.2) and the SAG staphylococcal enterotoxin B (SEB) at 2.4 Angstrom resolution reveals why SEE recognizes only certain V beta families, as well as why only certain SAGs bind mouse V beta 8.2. Models of the TCR-SEB-peptide/MHC class II complex indicate that V alpha interacts with the MHC beta chain in the TCR-SAG-MHC complex. The extent of the interaction is variable and is largely determined by the geometry of V alpha/V beta domain association. This variability can account for the preferential expression of certain V alpha regions among T cells reactive with SEE.	Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland	US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Twin Cities	Mariuzza, RA (corresponding author), Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	mariuzza@indigo2.carb.nist.gov	Llera, Andrea S/AAW-8116-2021; Karjalainen, Klaus/A-2206-2011		NIAID NIH HHS [AI36900, AI42937] Funding Source: Medline; CSR NIH HHS [RG2747] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036900, R01AI036900] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSR NIH HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Blackman MA, 1996, IMMUNOL RES, V15, P98, DOI 10.1007/BF02918500; BORRERO H, 1995, J IMMUNOL, V154, P4247; BROCKE S, 1993, NATURE, V365, P642, DOI 10.1038/365642a0; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Ciurli C, 1998, J EXP MED, V187, P253, DOI 10.1084/jem.187.2.253; COLE BC, 1993, ARTHRITIS RHEUM-US, V36, P994, DOI 10.1002/art.1780360717; CONRAD B, 1994, NATURE, V371, P351, DOI 10.1038/371351a0; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DALY K, 1995, J IMMUNOL, V155, P27; DAVIES D R, 1992, Current Biology, V2, P254, DOI 10.1016/0960-9822(92)90369-L; DECKHUT AM, 1994, J EXP MED, V180, P1931, DOI 10.1084/jem.180.5.1931; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Donson D, 1997, J IMMUNOL, V158, P5229; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hodtsev AS, 1998, J EXP MED, V187, P319, DOI 10.1084/jem.187.3.319; HOFF SJ, 1994, PROG PEDIATR CARDIOL, V3, P62, DOI 10.1016/1058-9813(94)90026-4; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; IMANISHI K, 1990, J IMMUNOL, V145, P3170; ITO Y, 1995, J IMMUNOL, V154, P5896; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Khandekar SS, 1997, MOL IMMUNOL, V34, P493, DOI 10.1016/S0161-5890(97)00044-8; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LABRECQUE N, 1994, J EXP MED, V180, P1921, DOI 10.1084/jem.180.5.1921; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIYOSHIAKIYAMA T, 1995, J IMMUNOL, V154, P5228; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Papageorgiou AC, 1996, J MOL BIOL, V260, P553, DOI 10.1006/jmbi.1996.0421; Proft T, 1998, J EXP MED, V187, P819, DOI 10.1084/jem.187.6.819; RACKE MK, 1994, J IMMUNOL, V152, P2051; Renno T, 1996, IMMUNOL REV, V154, P175, DOI 10.1111/j.1600-065X.1996.tb00934.x; Roussel A, 1997, NAT STRUCT BIOL, V4, P635, DOI 10.1038/nsb0897-635; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; TATE MW, 1995, J APPL CRYSTALLOGR, V28, P196, DOI 10.1107/S0021889894007867; TULIP WR, 1992, J MOL BIOL, V227, P122, DOI 10.1016/0022-2836(92)90687-F; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; WEBB SR, 1994, CURR OPIN IMMUNOL, V6, P467, DOI 10.1016/0952-7915(94)90129-5; WILSON BA, 1993, NEUROPSYCHOL REHABIL, V3, P1; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; WOODLAND DL, 1993, IMMUNOL TODAY, V14, P208, DOI 10.1016/0167-5699(93)90164-G	66	159	170	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	1998	9	6					807	816		10.1016/S1074-7613(00)80646-9	http://dx.doi.org/10.1016/S1074-7613(00)80646-9			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ	9881971	Bronze			2022-12-18	WOS:000077836600006
J	Ryu, JK; Kim, SJ; Rah, SH; Kang, JI; Jung, HE; Lee, D; Lee, HK; Lee, JO; Park, BS; Yoon, TY; Kim, HM				Ryu, Je-Kyung; Kim, Soo Jin; Rah, Sang-Hyun; Kang, Ji In; Jung, Hi Eun; Lee, Dongsun; Lee, Heung Kyu; Lee, Jie-Oh; Park, Beom Seok; Yoon, Tae-Young; Kim, Ho Min			Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer	IMMUNITY			English	Article							ESTER TRANSFER PROTEIN; LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; CRYSTAL-STRUCTURE; BINDING-PROTEIN; SOLUBLE CD14; CELL ACTIVATION; COMPLEX; ENDOTOXIN; DOMAIN; MD-2	Lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, binds Toll-like receptor 4 (TLR4)-MD2 complex and activates innate immune responses. LPS transfer to TLR4-MD2 is catalyzed by both LPS binding protein (LBP) and CD14. To define the sequential molecular interactions underlying this transfer, we reconstituted in vitro the entire LPS transfer process from LPS micelles to TLR4-MD2. Using electron microscopy and single-molecule approaches, we characterized the dynamic intermediate complexes for LPS transfer: LBP-LPS micelles, CD14-LBP-LPS micelle, and CD14-LPS-TLR4-MD2 complex. A single LBP molecule bound longitudinally to LPS micelles catalyzed multi-rounds of LPS transfer to CD14s that rapidly dissociated from LPB-LPS complex upon LPS transfer via electrostatic interactions. Subsequently, the single LPS molecule bound to CD14 was transferred to TLR4-MD2 in a TLR4-dependent manner. The definition of the structural determinants of the LPS transfer cascade to TLR4 may enable the development of targeted therapeutics for intervention in LPS-induced sepsis.	[Ryu, Je-Kyung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Single Mol Syst Biol, Daejeon 34141, South Korea; [Ryu, Je-Kyung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon 34141, South Korea; [Kim, Soo Jin; Kang, Ji In; Jung, Hi Eun; Lee, Heung Kyu; Kim, Ho Min] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon 34141, South Korea; [Lee, Dongsun; Lee, Heung Kyu; Kim, Ho Min] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon 34141, South Korea; [Park, Beom Seok] Eulji Univ, Dept Biomed Lab Sci, Coll Hlth Sci, Seongnam 461713, South Korea; [Rah, Sang-Hyun; Yoon, Tae-Young] Yonsei Univ, Ctr Nanomed, IBS, Seoul 03722, South Korea; [Rah, Sang-Hyun; Yoon, Tae-Young] Yonsei Univ, Yonsei IBS Inst, Seoul 03722, South Korea; [Ryu, Je-Kyung] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, NL-2629 HZ Delft, Netherlands	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Eulji University; Institute for Basic Science - Korea (IBS); Yonsei University; Institute for Basic Science - Korea (IBS); Yonsei University; Delft University of Technology	Yoon, TY (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Single Mol Syst Biol, Daejeon 34141, South Korea.; Yoon, TY (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Daejeon 34141, South Korea.; Kim, HM (corresponding author), Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon 34141, South Korea.; Kim, HM (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.; Yoon, TY (corresponding author), Yonsei Univ, Ctr Nanomed, IBS, Seoul 03722, South Korea.; Yoon, TY (corresponding author), Yonsei Univ, Yonsei IBS Inst, Seoul 03722, South Korea.	tyyoon@yonsei.ac.kr; hm_kim@kaist.ac.kr	Yoon, Tae-Young/C-1687-2011; Kim, Ho Min/G-2712-2011; Lee, Heung Kyu/C-2073-2011; Lee, Jie-Oh/AAG-4302-2020	Yoon, Tae-Young/0000-0002-5184-7725; Lee, Heung Kyu/0000-0002-3977-1510; Rah, Sang-Hyun/0000-0002-9480-7731; Lee, Jie-Oh/0000-0001-6519-6049; Ryu, Je-Kyung/0000-0002-0545-9502	National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future Planning, Korea [NRF2015R1A2A2A01005533, NRF-2015R1A4A1042416, NRF-2012M3A9B4028274]; NRF (Center for Single-Molecule Systems Biology) [NRF-2011-0018352]; Institute for Basic Science (IBS) [IBS-R0216-D1]	National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future Planning, Korea; NRF (Center for Single-Molecule Systems Biology); Institute for Basic Science (IBS)	This work was supported by grants from the National Research Foundation of Korea (NRF), Ministry of Science, ICT, and Future Planning, Korea (NRF2015R1A2A2A01005533 to H.M.K., NRF-2015R1A4A1042416 to H.M.K. and H.K.L., NRF-2012M3A9B4028274 to H.K.L.). It was also supported by the National Creative Research Initiative Program funded by the NRF (Center for Single-Molecule Systems Biology NRF-2011-0018352 to T.-Y.Y.) and Institute for Basic Science (IBS; IBS-R0216-D1).	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bruce C, 1998, CURR OPIN STRUC BIOL, V8, P426, DOI 10.1016/S0959-440X(98)80118-8; Eckert JK, 2013, IMMUNITY, V39, P647, DOI 10.1016/j.immuni.2013.09.005; Georgel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007803; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; HAN JH, 1994, J BIOL CHEM, V269, P8172; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Lamping N, 1996, J IMMUNOL, V157, P4648; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yu B, 1996, J BIOL CHEM, V271, P4100; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	30	158	171	10	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					38	50		10.1016/j.immuni.2016.11.007	http://dx.doi.org/10.1016/j.immuni.2016.11.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	27986454	Bronze			2022-12-18	WOS:000392918300009
J	Kain, L; Webb, B; Anderson, BL; Deng, SL; Holt, M; Costanzo, A; Zhao, M; Self, K; Teyton, A; Everett, C; Kronenberg, M; Zajonc, DM; Bendelac, A; Savage, PB; Teyton, L				Kain, Lisa; Webb, Bill; Anderson, Brian L.; Deng, Shenglou; Holt, Marie; Costanzo, Anne; Zhao, Meng; Self, Kevin; Teyton, Anais; Everett, Chris; Kronenberg, Mitchell; Zajonc, Dirk M.; Bendelac, Albert; Savage, Paul B.; Teyton, Luc			The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian alpha-Linked Glycosylceramides	IMMUNITY			English	Article							ACID CERAMIDASE; GLUCOSYLCERAMIDE SYNTHASE; DENDRITIC CELLS; NKT CELLS; IN-VIVO; ANTIGENS; RECOGNITION; ABSENCE; LIPIDS	Glycosylceramides in mammalian species are thought to be present in the form of beta-anomers. This conclusion was reinforced by the identification of only one glucosylceramide and one galactosylceramide synthase, both beta-transferases, in mammalian genomes. Thus, the possibility that small amounts of alpha-anomers could be produced by an alternative enzymatic pathway, by an unfaithful enzyme, or spontaneously in unusual cellular compartments has not been examined in detail. We approached the question by taking advantage of the exquisite specificity of T and B lymphocytes and combined it with the specificity of catabolic enzymes of the sphingolipid pathway. Here, we demonstrate that mammalian immune cells produce constitutively very small quantities of alpha-glycosylceramides, which are the major endogenous ligands of natural killer T cells. Catabolic enzymes of the ceramide and glycolipid pathway tightly control the amount of these alpha-glycosylceramides. The exploitation of this pathway to manipulate the immune response will create new therapeutic opportunities.	[Kain, Lisa; Holt, Marie; Costanzo, Anne; Self, Kevin; Teyton, Anais; Everett, Chris; Teyton, Luc] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Webb, Bill] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Anderson, Brian L.; Deng, Shenglou; Savage, Paul B.] Brigham Young Univ, Dept Chem, Provo, UT 84602 USA; [Zhao, Meng; Kronenberg, Mitchell; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	Scripps Research Institute; Scripps Research Institute; Brigham Young University; La Jolla Institute for Immunology; University of Chicago	Teyton, L (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	lteyton@scripps.edu	Teyton, Anais/AAC-4160-2022; Kronenberg, Mitchell/AAT-6078-2021; Savage, Paul B/E-1448-2011; Savage, Paul B/HGB-3414-2022	Teyton, Anais/0000-0001-7154-5540; Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109	NIH [AI053725, AI102892, AI71922]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102892, P01AI053725, R01AI071922, R37AI071922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR064194] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The making of L317 and L363 by Steve Porcelli (Albert Einstein College of Medicine, New York) and his generosity in making these reagents available to us were critical for the present work. Ken Rock (University of Massachusetts-Worcester) provided us with the CD1d-positive dendritic cell line DC3.2. Deborah Wittherton (the Scripps Research Institute) helped us establish fetal thymus organ culture. Ajit Varki (University California, San Diego) gave us critical advice for the radioactive labeling of glycolipids. This work was supported by NIH grants AI053725 (to P.B.S., A.B., and L.T.), AI102892 (to L.T.), and AI71922 (to M.K.). This is manuscript 23088 from the Scripps Research Institute.	Arora P, 2014, IMMUNITY, V40, P105, DOI 10.1016/j.immuni.2013.12.004; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2006, J IMMUNOL, V176, P4059, DOI 10.4049/jimmunol.176.7.4059; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Darmoise A, 2010, IMMUNITY, V33, P216, DOI 10.1016/j.immuni.2010.08.003; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; HAYES LW, 1976, BIOCHEM J, V160, P195, DOI 10.1042/bj1600195; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Khanna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040776; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042558, 10.1371/journal.pone.0043023]; Meisen I, 2011, BBA-MOL CELL BIOL L, V1811, P875, DOI 10.1016/j.bbalip.2011.04.006; Meissner F, 2013, SCIENCE, V340, P475, DOI 10.1126/science.1232578; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Parekh VV, 2004, J IMMUNOL, V173, P3693, DOI 10.4049/jimmunol.173.6.3693; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Park SH, 1998, J IMMUNOL, V160, P3128; Pereira CS, 2013, MOL GENET METAB, V108, P241, DOI 10.1016/j.ymgme.2013.01.018; Realini N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01035; Roark JH, 1998, J IMMUNOL, V160, P3121; Sandhoff K., 2011, COLD SPRING HARB PER, V3, P3; Shen ZH, 1997, J IMMUNOL, V158, P2723; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Tadano-Aritomi K, 2000, J LIPID RES, V41, P1237; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yamashita A, 2005, BIOSCI BIOTECH BIOCH, V69, P1381, DOI 10.1271/bbb.69.1381; Yu ED, 2012, J BIOL CHEM, V287, P1269, DOI 10.1074/jbc.M111.308783; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zigmond E, 2007, GUT, V56, P82, DOI 10.1136/gut.2006.095497	41	158	159	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					543	554		10.1016/j.immuni.2014.08.017	http://dx.doi.org/10.1016/j.immuni.2014.08.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367571	Bronze, Green Accepted			2022-12-18	WOS:000345504300009
J	Yu, YX; Hayward, GS				Yu, Yanxing; Hayward, Gary S.			The Ubiquitin E3 Ligase RAUL Negatively Regulates Type I Interferon through Ubiquitination of the Transcription Factors IRF7 and IRF3	IMMUNITY			English	Article							NF-KAPPA-B; ANTIVIRAL RESPONSE; MEDIATED DEGRADATION; IMMUNE-RESPONSES; VIRUS-INFECTION; ROTAVIRUS NSP1; PATHWAY; PROTEIN; DOMAIN; PHOSPHORYLATION	In the course of combating infectious agents, type I interferon (IFN) needs a timely downregulation mechanism to avoid detrimental overreaction. Here we showed a mechanism for restraining type I IFN responses, which relied on a HECT domain ubiquitin (Ub) E3 ligase, RAUL. RAUL limited type I IFN production by directly catalyzing lysine 48-linked polyubiquitination of both interferon regulatory factor 7 (IRF7) and IRF3 followed by proteasome-dependent degradation. Suppression of RAUL by dominant-negative RAUL or siRNA augmented both basal and virus-induced production of type I IFN, which resulted in reduced viral replication. The Kaposi's sarcoma-associated herpes virus immediate-early lytic cycle trigger protein RTA recruited this mechanism to augment its countermeasures against the host antiviral response. These results unveil a previously unrecognized "brake mechanism" for type I IFN that maintains proper low amounts of type I IFN under physiological conditions and restrains its magnitude when the antiviral response intensifies.	[Yu, Yanxing; Hayward, Gary S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Viral Oncol Program, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Yu, YX (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Canc Immunol Program, 1650 Orleans St,CRB1 4M4, Baltimore, MD 21231 USA.	yyanxin1@jhmi.edu; ghayward@jhmi.edu			National Cancer Institute, National Institute of Health [R01 CA73585]; American Cancer Society [IRG-58-005-43]; NATIONAL CANCER INSTITUTE [R01CA073585] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were funded by National Cancer Institute research grants R01 CA73585 to G.S.H. from the National Institute of Health and American Cancer Society Institutional Research Grant IRG-58-005-43 to Y.Y. We thank D.M. Pardoll, F. Housseau, C.M. Pickart, M. Wang, B. Vogelstein, Y. Zheng, J.D. Powell, K. Watanabe, T. Fuita, Y. Yuan, S. Yamaoka, K. Fitzgerald, A. Ryo, M.E. Hardy, T. Maniatis, R. Everett, J. Hiscott, J.S. Pagano, S.D. Hayward, P. Desai, and S. Jiang for gifts of plasmids or cell lines or technical support.	Barrington RE, 1998, MOL CELL BIOL, V18, P85, DOI 10.1128/MCB.18.1.85; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chomvarin Chariya, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P879; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Graff JW, 2002, J VIROL, V76, P9545, DOI 10.1128/JVI.76.18.9545-9550.2002; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; You JX, 2003, J BIOL CHEM, V278, P23369, DOI 10.1074/jbc.M212887200; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	46	158	169	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					863	877		10.1016/j.immuni.2010.11.027	http://dx.doi.org/10.1016/j.immuni.2010.11.027			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21167755	Green Accepted, Bronze			2022-12-18	WOS:000286293900008
J	Town, T; Bai, FW; Wang, T; Kaplan, AT; Qian, F; Montgomery, RR; Anderson, JF; Flavell, RA; Fikrig, E				Town, Terrence; Bai, Fengwei; Wang, Tian; Kaplan, Amber T.; Qian, Feng; Montgomery, Ruth R.; Anderson, John F.; Flavell, Richard A.; Fikrig, Erol			Toll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and Homing	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; CD8(+) T-CELLS; DOUBLE-STRANDED-RNA; VIRUS-INFECTION; DENDRITIC CELLS; B-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; BACTERIAL-DNA; I INTERFERON; RECOGNITION	West Nile virus (WNV), a mosquito-transmitted single-stranded RNA (ssRNA) flavivirus, causes human disease of variable severity. We investigated Toll-like receptor 7-deficient (TLr7(-/-)) and myeloid differentiation factor 88-deficient (Myd88(-/-)) mice, which both have defective recognition of ssRNA, and found increased viremia. and susceptibility to lethal WNV infection. Despite increased tissue concentrations of most innate cytokines, CD45(+) leukocytes and CD11b(+) macrophages failed to home to WNV-infected cells and infiltrate into target organs of Tlr7(-/-) mice. Tlr7(-/-) mice and macrophages had reduced interleukin-12 (IL-12) and IL-23 responses after WNV infection, and mice deficient in IL-12 p40 and IL-23 p40 (II12b(-/)) or IL-23 p19 (II23a(-/)), but not IL-12 p35 (II12a(-/)), responded similarly to Tlr7(-/) mice, with increased susceptibility to lethal WNV encephalitis. Collectively, these results demonstrate that TLR7 and IL-23-dependent WNV responses represent a vital host defense mechanism that operates by affecting immune cell homing to infected target cells.	[Town, Terrence; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Bai, Fengwei; Wang, Tian; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Qian, Feng; Montgomery, Ruth R.] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Flavell, Richard A.; Fikrig, Erol] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Town, Terrence; Kaplan, Amber T.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Town, Terrence; Kaplan, Amber T.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Wang, Tian] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Town, Terrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90048 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Connecticut Agricultural Experiment Station; Colorado State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Kaplan, Amber/B-4284-2009; Qian, Feng/F-8186-2010	Kaplan, Amber/0000-0003-1917-0512; Montgomery, Ruth/0000-0002-8661-4454	NIH [A1055749, A150031, 5R03AI067409]; Northeast Biodefense Center [1K99AG029726-01, 4R00AG029726-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI067409, U54AI057158, N01AI050031, R01AI055749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029726, K99AG029726] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Ferrandino, D. Beck, X. Liu, and D. Gate for expert technical assistance and F. Manzo for assistance with preparing this manuscript. This work was supported by NIH awards A1055749 and A150031. T.T. is supported by an Alzheimer's Association grant and a National Institutes of Health, National Institute on Aging "Pathway to Independence" award (1K99AG029726-01 and 4R00AG029726-02). F.B. is supported by a Career Development Award from the Northeast Biodefense Center (U54-A1057158Lipkin). T.W. is supported by a grant from the National Institutes of Health (5R03AI067409). R.A.F. and E.F. are Investigators of the Howard Hughes Medical Institute. T.T. isthe inaugural holder of the Ben Winters Endowed Chair in Regenerative Medicine.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bekeredjian-Ding I, 2006, J IMMUNOL, V176, P7438, DOI 10.4049/jimmunol.176.12.7438; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gould LH, 2004, J CLIN INVEST, V113, P1102, DOI [10.1172/JCI200421623, 10.1172/JCI21623]; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Juedes AE, 2001, J IMMUNOL, V166, P5168, DOI 10.4049/jimmunol.166.8.5168; Kattah MG, 2008, ARTHRITIS RHEUM, V58, P1619, DOI 10.1002/art.23497; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; KULKARNI AB, 1991, IMMUNOL CELL BIOL, V69, P71, DOI 10.1038/icb.1991.12; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Qureshi ST, 2003, GENES IMMUN, V4, P87, DOI 10.1038/sj.gene.6363937; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Roeder A, 2004, MED MYCOL, V42, P485, DOI 10.1080/13693780400011112; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVI.01136-07; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Triantafilou K, 2005, EUR J IMMUNOL, V35, P2416, DOI 10.1002/eji.200526149; van de Vosse E, 2003, IMMUNOGENETICS, V54, P817, DOI 10.1007/s00251-002-0534-9; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	64	158	164	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					242	253		10.1016/j.immuni.2008.11.012	http://dx.doi.org/10.1016/j.immuni.2008.11.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19200759	Bronze, Green Accepted			2022-12-18	WOS:000263710500011
J	Sun, CM; Deriaud, E; Leclerc, C; Lo-Man, R				Sun, CM; Deriaud, E; Leclerc, C; Lo-Man, R			Upon TLR9 signaling, CD5(+) B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs	IMMUNITY			English	Article							MHC CLASS-II; DENDRITIC CELLS; T-CELLS; IN-VIVO; ADAPTIVE IMMUNITY; BACTERIAL-DNA; CPG MOTIFS; EARLY-LIFE; B-1 CELLS; MICE	The susceptibility to infections and the strong Th2 bias observed in neonates are thought to be due to the immaturity of the dendritic cell (DC) compartment. We show that neonatal DCs, like their adult counterparts, elicit Th1 responses. We also demonstrate that during potentially harmful systemic inflammation, after Toll-like receptor (TLR) 9 triggering, neonatal B cells produce high concentrations of IL-10, preventing optimal IL-12 secretion by neonatal DCs and, thus, Th1 priming. Although both CD5(+) and CD5(-) B cell subsets respond to CpG ODN stimulation, we found that only CD5(+) B cells produce IL-10. Therefore, these results show the regulatory role of CD5(+) B cells on DC activation in vivo for Th1/Th2 polarization and highlight the paradoxical effects of TLR triggering in vivo.	Inst Pasteur, INSERM E352, Unite Biol Regulat Immunitaires, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lo-Man, R (corresponding author), Inst Pasteur, INSERM E352, Unite Biol Regulat Immunitaires, 25 Rue Dr Roux, F-75724 Paris, France.	rloman@pasteur.fr	Sun, Cheng-Ming/G-6505-2018	Sun, Cheng-Ming/0000-0002-2392-7701				Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 2002, J IMMUNOL, V169, P4998, DOI 10.4049/jimmunol.169.9.4998; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Dakic A, 2004, J IMMUNOL, V172, P1018, DOI 10.4049/jimmunol.172.2.1018; Dubois B, 1998, J IMMUNOL, V161, P2223; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Emmanuilidis K, 2001, J IMMUNOL, V167, P3919, DOI 10.4049/jimmunol.167.7.3919; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; Hardy RR, 2003, CURR OPIN IMMUNOL, V15, P158, DOI 10.1016/S0952-7915(03)00012-8; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Li LQ, 2004, IMMUNITY, V20, P429, DOI 10.1016/S1074-7613(04)00072-X; LU CY, 1979, NATURE, V282, P327, DOI 10.1038/282327a0; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Martinez X, 1997, P NATL ACAD SCI USA, V94, P8726, DOI 10.1073/pnas.94.16.8726; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Muthukkumar S, 2000, J IMMUNOL, V165, P4803, DOI 10.4049/jimmunol.165.9.4803; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RADKA SF, 1982, J IMMUNOL, V128, P2804; Ridge JP, 1996, SCIENCE, V271, P1723, DOI 10.1126/science.271.5256.1723; Sarzotti M, 1996, SCIENCE, V271, P1726, DOI 10.1126/science.271.5256.1726; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Sun CM, 2003, BLOOD, V102, P585, DOI 10.1182/blood-2002-09-2966; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; TAYLOR S, 1985, J IMMUNOL, V134, P1493; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032	44	158	171	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2005	22	4					467	477		10.1016/j.immuni.2005.02.008	http://dx.doi.org/10.1016/j.immuni.2005.02.008			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845451	Bronze			2022-12-18	WOS:000228909600008
J	Giagulli, C; Scarpini, E; Ottoboni, L; Narumiya, S; Butcher, EC; Constantin, G; Laudanna, C				Giagulli, C; Scarpini, E; Ottoboni, L; Narumiya, S; Butcher, EC; Constantin, G; Laudanna, C			RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: Critical role of LFA-1 affinity triggering in lymphocyte in vivo homing	IMMUNITY			English	Article							ACTIN STRESS FIBERS; BINDING PROTEIN RHO; INTEGRIN ACTIVATION; FOCAL ADHESIONS; KINASE; ARREST; RECRUITMENT	Chemokines regulate rapid leukocyte adhesion by triggering a complex modality of integrin activation. We show that the small GTPase RhoA and the atypical zeta PKC differently control lymphocyte LFA-1 high-affinity state and rapid lateral mobility induced by chemokines. Activation of LFA-1 high-affinity state and lateral mobility is controlled by RhoA through the activity of distinct effector regions, demonstrating that RhoA is a central point of diversification of signaling pathways leading to both modalities of LFA-1 triggering. In contrast, PKC controls LFA-1 lateral mobility but not affinity triggering. Blockade of the 23-40 RhoA effector region prevents induction of LFA-1 high-affinity state as well as lymphocyte arrest in Peyer's patch high endothelial venues. Thus, RhoA controls the induction of LFA-1 high-affinity state by chemokines independently of PKC, and this is critical to support chemokine-regulated homing of circulating lymphocytes.	Univ Verona, Fac Med, Dept Pathol, I-37134 Verona, Italy; Univ Milan, Dept Neurol Sci, IRCCS Osped Maggiore, I-20122 Milan, Italy; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Vet Affairs Hlth Care Syst, Ctr Mol Biol & Med, Palo Alto, CA 94304 USA; Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan	University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Kyoto University	Laudanna, C (corresponding author), Univ Verona, Fac Med, Dept Pathol, Strada Grazie 8, I-37134 Verona, Italy.	carlo.laudanna@univr.it	Ottoboni, Linda/AAC-4508-2022; Scarpini, Elio/K-6547-2016	Ottoboni, Linda/0000-0001-5412-7785; Scarpini, Elio/0000-0002-6395-2119; Constantin, Gabriela/0000-0001-8978-3539	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037734, R01GM037734] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fenton M, 1998, J IMMUNOL METHODS, V212, P41, DOI 10.1016/S0022-1759(97)00208-1; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Limatola C, 1997, BIOCHEM J, V321, P497, DOI 10.1042/bj3210497; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; Weber KSC, 2001, CURR BIOL, V11, P1969, DOI 10.1016/S0960-9822(01)00597-8; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074	27	158	164	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2004	20	1					25	35		10.1016/S1074-7613(03)00350-9	http://dx.doi.org/10.1016/S1074-7613(03)00350-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EG	14738762	Bronze			2022-12-18	WOS:000221442200004
J	Sandel, PC; Monroe, JG				Sandel, PC; Monroe, JG			Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter	IMMUNITY			English	Article							V(D)J RECOMBINASE ACTIVITY; HEAT-STABLE ANTIGEN(HI); REACTIVE LYMPHOCYTES-B; MOUSE BONE-MARROW; TOLERANCE-INDUCTION; BCL-2 EXPRESSION; SURFACE-IGM; APOPTOSIS; ACTIVATION; MATURATION	Immature B cells that encounter self-antigen are eliminated from the immune repertoire by negative selection. Negative selection has been proposed to take place by two distinct mechanisms: deletion by apoptosis or alteration of the antigen receptor specificity by receptor editing. While convincing evidence exists for each, the two models are inherently contradictory. In this paper, we propose a resolution to this contradiction by demonstrating that the site of first antigen encounter dictates which mechanism of negative selection is utilized. We demonstrate that the bone marrow microenvironment provides signals that block antigen-induced deletion and promote RAG reinduction. In the periphery, the absence of these signals allows the immature B cell to default to apoptosis as a result of BCR engagement.	Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Monroe, JG (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.				NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032592, P01AI043620] Funding Source: NIH RePORTER; NCI NIH HHS [NIH/NCI-CA09140] Funding Source: Medline; NIAID NIH HHS [R01-AI32592, P01-AI43620] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CHANG TL, 1991, J IMMUNOL, V147, P750; Clayton LK, 1997, EMBO J, V16, P2282, DOI 10.1093/emboj/16.9.2282; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GHIA P, 1995, EUR J IMMUNOL, V25, P3108, DOI 10.1002/eji.1830251118; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; KING LB, 1998, MOL MECHANISMS REGUL; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Mandik L, 1997, ANN NY ACAD SCI, V815, P40, DOI 10.1111/j.1749-6632.1997.tb52043.x; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; Melamed D, 1997, J IMMUNOL, V159, P1233; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; METCALF ES, 1976, J EXP MED, V143, P1327, DOI 10.1084/jem.143.6.1327; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Monroe JG, 1996, J IMMUNOL, V156, P2657; MONROE JG, 1985, J IMMUNOL, V135, P1674; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NORVELL A, 1995, J IMMUNOL, V154, P4404; Norvell A, 1996, J IMMUNOL, V156, P1328; NOSSAL GJV, 1975, J EXP MED, V141, P904; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PIETRANGELI CE, 1988, EUR J IMMUNOL, V18, P863, DOI 10.1002/eji.1830180606; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Sambrook J, 1989, MOL CLONING LAB MANU; Sater RA, 1998, INT IMMUNOL, V10, P1673, DOI 10.1093/intimm/10.11.1673; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; YELLEN AJ, 1991, J IMMUNOL, V146, P1446; YELLENSHAW A, 1992, CELL IMMUNOL, V145, P339, DOI 10.1016/0008-8749(92)90336-N	46	158	160	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					289	299		10.1016/S1074-7613(00)80029-1	http://dx.doi.org/10.1016/S1074-7613(00)80029-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204485	Bronze			2022-12-18	WOS:000079455700002
J	Schwarz, DA; Katayama, CD; Hedrick, SM				Schwarz, DA; Katayama, CD; Hedrick, SM			Schlafen, a new family of growth regulatory genes that affect thymocyte development	IMMUNITY			English	Article							CELL ANTIGEN RECEPTOR; T-CELLS; POSITIVE SELECTION; NEGATIVE SELECTION; MURINE THYMOCYTES; THYMIC SELECTION; TRANSGENIC MICE; PRECURSOR CELLS; IN-VIVO; C-MYC	The Schlafen (Slfn) family of genes are differentially regulated during thymocyte maturation and are preferentially expressed in the lymphoid tissues. Ectopic expression of the prototype member Slfn 1 early in the T lineage profoundly alters cell growth and development. In these mice, the DP thymocytes fail to complete maturation, and, depending on the transgene dosage, the number of thymocytes is reduced to 1%-30% of normal. Furthermore, expression of the Schlafen family members in fibroblasts and thymoma cells either retards or ablates cell growth. The conceptual protein sequences deduced for each of the family members have no similarity to characterized proteins and must therefore participate in a heretofore unknown regulatory mechanism guiding both cell growth and T cell development.	Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751	NATIONAL CANCER INSTITUTE [R01CA076554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI009208] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA76554] Funding Source: Medline; NIAID NIH HHS [F32 AI09208] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Attwood TK, 1998, NUCLEIC ACIDS RES, V26, P304, DOI 10.1093/nar/26.1.304; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BroussardDiehl C, 1996, J IMMUNOL, V156, P3141; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; DOU QP, 1995, P NATL ACAD SCI USA, V92, P9019, DOI 10.1073/pnas.92.20.9019; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; GROSS JA, 1992, J IMMUNOL, V149, P380; HARA T, 1994, BLOOD, V84, P189; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; HOGQUIST KA, 1994, CURR OPIN IMMUNOL, V6, P273, DOI 10.1016/0952-7915(94)90101-5; JENKINSON EJ, 1989, EUR J IMMUNOL, V19, P2175, DOI 10.1002/eji.1830191132; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KERSH GJ, 1995, J IMMUNOL, V154, P1057; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; LUNDBERG K, 1994, CELL, V76, P17; MOMBAERTS P, 1992, NATURE, V360, P491; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Murata Y, 1997, FEBS LETT, V409, P41, DOI 10.1016/S0014-5793(97)00477-8; PENIT C, 1995, J IMMUNOL, V154, P5103; PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rees S, 1996, BIOTECHNIQUES, V20, P108; Rees S, 1996, BIOTECHNIQUES, V20, P106; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; WEISSMAN IL, 1975, FED PROC, V34, P141; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; ZACHARCHUK CM, 1991, J IMMUNOL, V147, P460; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; ZINKERNAGEL RM, 1978, NATURE, V271, P251, DOI 10.1038/271251a0	54	158	173	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					657	668		10.1016/S1074-7613(00)80663-9	http://dx.doi.org/10.1016/S1074-7613(00)80663-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK	9846487	Bronze			2022-12-18	WOS:000077298300008
J	Kern, PS; Teng, MK; Smolyar, A; Liu, JH; Liu, J; Hussey, RE; Spoerl, R; Chang, HC; Reinherz, EL; Wang, JH				Kern, PS; Teng, MK; Smolyar, A; Liu, JH; Liu, J; Hussey, RE; Spoerl, R; Chang, HC; Reinherz, EL; Wang, JH			Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8 alpha alpha ectodomain fragment in complex with H-2K	IMMUNITY			English	Article							T-CELL RECEPTOR; MHC CLASS-I; CYTOTOXIC LYMPHOCYTES-T; ALPHA-3 DOMAIN; BETA-CHAIN; CRYSTAL-STRUCTURE; VIRAL PEPTIDE; RECOGNITION; BINDING; MOLECULE	The crystal structure of the two immunoglobulin variable-like domains of the murine CD8 alpha alpha homodimer complexed to the class I MHC H-2K(b) molecule at 2.8 A resolution shows that CD8 alpha alpha binds to the protruding MHC alpha 3 domain loop in an antibody-like manner. Comparison of mouse CD8 alpha alpha/H-2K(b) and human CD8 alpha alpha/HLA-A2 complexes reveals shared as well as species-specific recognition features. In both species, core-ceptor function apparently involves the participation of CD8 dimer in a bidentate attachment to an MHC class I molecule in conjunction with a T cell receptor without discernable conformational alteration of the peptide or MHC antigen-presenting platform.	Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wang, JH (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA.	Ellis_Reinherz@dfci.harvard.edu; jwang@red.dfci.harvard.edu			NIAID NIH HHS [AI39098, AI19807] Funding Source: Medline; NIGMS NIH HHS [GM56008] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI019807, R37AI019807, R01AI039098, R01AI019807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056008] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRICH CJ, 1991, J IMMUNOL, V146, P3082; Arden B, 1998, CURR OPIN IMMUNOL, V10, P74, DOI 10.1016/S0952-7915(98)80035-6; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CANTOR H, 1975, J EXP MED, V141, P1376, DOI 10.1084/jem.141.6.1376; CASABO LG, 1994, J IMMUNOL, V152, P397; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CLASSON BJ, 1992, INT IMMUNOL, V4, P215, DOI 10.1093/intimm/4.2.215; CONNOLLY JM, 1990, P NATL ACAD SCI USA, V87, P2137, DOI 10.1073/pnas.87.6.2137; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CROOKS MEC, 1994, IMMUNITY, V1, P277; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FUNGLEUNG WP, 1994, J EXP MED, V180, P959, DOI 10.1084/jem.180.3.959; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GIBLIN PA, 1994, P NATL ACAD SCI USA, V91, P1716, DOI 10.1073/pnas.91.5.1716; Irie HY, 1998, J IMMUNOL, V161, P183; ITANO A, 1994, IMMUNITY, V1, P287, DOI 10.1016/1074-7613(94)90080-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALINKE U, 1990, NATURE, V348, P642, DOI 10.1038/348642a0; KARAKI S, 1992, J IMMUNOL, V149, P1613; KIRSZBAUM L, 1989, J IMMUNOL, V142, P3931; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LETOURNEUR F, 1990, P NATL ACAD SCI USA, V87, P2339, DOI 10.1073/pnas.87.6.2339; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; MEUER SC, 1982, P NATL ACAD SCI-BIOL, V79, P4395, DOI 10.1073/pnas.79.14.4395; MOEBIUS U, 1991, EUR J IMMUNOL, V21, P1793, DOI 10.1002/eji.1830210803; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; MOOTS RJ, 1992, EUR J IMMUNOL, V22, P1643, DOI 10.1002/eji.1830220645; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; POUSSIER P, 1994, ANNU REV IMMUNOL, V12, P521, DOI 10.1146/annurev.immunol.12.1.521; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; Renard V, 1996, J EXP MED, V184, P2439, DOI 10.1084/jem.184.6.2439; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SANDERS SK, 1991, J EXP MED, V174, P371, DOI 10.1084/jem.174.2.371; SEKIMATA M, 1993, J IMMUNOL, V150, P4416; SUN JR, 1995, J EXP MED, V182, P1275, DOI 10.1084/jem.182.5.1275; SWAIN M, 1981, J MULTILING MULTICUL, V2, P1; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	58	158	164	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1998	9	4					519	530		10.1016/S1074-7613(00)80635-4	http://dx.doi.org/10.1016/S1074-7613(00)80635-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	133HG	9806638	Bronze			2022-12-18	WOS:000076680700010
J	O'Rourke, LM; Tooze, R; Turner, M; Sandoval, DM; Carter, RH; Tybulewicz, VLJ; Fearon, DT				O'Rourke, LM; Tooze, R; Turner, M; Sandoval, DM; Carter, RH; Tybulewicz, VLJ; Fearon, DT			CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav	IMMUNITY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; SIGNAL-TRANSDUCTION MOLECULE; GTP-BINDING PROTEINS; SWISS 3T3 CELLS; T-CELL; TYROSINE PHOSPHORYLATION; PROTOONCOGENE PRODUCT; ACTIVATION; ANTIGEN; COMPLEX	CD19 is a coreceptor that amplifies signaling by membrane immunoglobulin (mlg) to promote responses of the B lymphocyte to T-dependent antigens. Vav is a guanine nucleotide exchange factor for the Rho, Rac, Cdc42 family of small GTPases. We found that coligating mig and CD19 causes a synergistic increase in the tyrosine phosphorylation of CD19. Phosphorylated tyrosine-391 of CD19 binds Vav to mediate a sustained increase in intracellular Ca2(+) concentration. This response correlates with activation by the CD19-Vav complex of phosphatidylinositol 4-phosphate 5-kinase for the synthesis of phosphatidylinositol 4,5-bisphosphate. Interaction of CD19 with Vav also mediates the synergistic activation of the mitogen-activated protein kinase JNK. Therefore, CD19 is a membrane adaptor protein that recruits Vav for the activation of lipid and protein kinases.	Univ Cambridge, Sch Clin Med, Dept Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England; Univ Alabama, Vet Affairs Med Ctr, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Vet Affairs Med Ctr, Dept Microbiol, Birmingham, AL 35294 USA; Natl Inst Med Res, London NW7 1AA, England	University of Cambridge; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); MRC National Institute for Medical Research	Fearon, DT (corresponding author), Univ Cambridge, Sch Clin Med, Dept Med, Wellcome Trust Immunol Unit, Cambridge CB2 2SP, England.		Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Tybulewicz, Victor/0000-0003-2439-0798; Tooze, Reuben/0000-0003-2915-7119	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; ALEXANDER DR, 1989, BIOCHEM J, V260, P893, DOI 10.1042/bj2600893; BILLIPS LG, 1995, J EXP MED, V182, P973, DOI 10.1084/jem.182.4.973; BRADBURY LE, 1993, J IMMUNOL, V151, P2915; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; BUSTELO XR, 1994, ONCOGENE, V9, P2405; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1991, J IMMUNOL, V147, P3663; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Delibrias CC, 1997, J EXP MED, V186, P1575, DOI 10.1084/jem.186.9.1575; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; GOLD MR, 1987, J IMMUNOL, V139, P3604; HAMETT MM, 1988, J IMMUNOL, V140, P3135; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; Li XL, 1997, J IMMUNOL, V158, P5649; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; PEZZUTTO A, 1987, J IMMUNOL, V138, P2793; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; REIF K, 1994, J BIOL CHEM, V269, P14081; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1997, P NATL ACAD SCI USA, V94, P13158, DOI 10.1073/pnas.94.24.13158; Schuebel KE, 1996, ONCOGENE, V13, P363; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STEPHENS L, 1993, BIOCHEM J, V296, P481, DOI 10.1042/bj2960481; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TEDDER TF, 1989, J IMMUNOL, V143, P712; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; WENG WK, 1994, J BIOL CHEM, V269, P32514; Woscholski R, 1995, J BIOL CHEM, V270, P31001, DOI 10.1074/jbc.270.52.31001; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	52	158	161	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1998	8	5					635	645		10.1016/S1074-7613(00)80568-3	http://dx.doi.org/10.1016/S1074-7613(00)80568-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620684	Bronze			2022-12-18	WOS:000073885400011
J	Liljedahl, M; Winqvist, O; Surh, CD; Wong, P; Ngo, K; Teyton, L; Peterson, PA; Brunmark, A; Rudensky, AY; Fung-Leung, WP; Karlsson, L				Liljedahl, M; Winqvist, O; Surh, CD; Wong, P; Ngo, K; Teyton, L; Peterson, PA; Brunmark, A; Rudensky, AY; Fung-Leung, WP; Karlsson, L			Altered antigen presentation in mice lacking H2-O	IMMUNITY			English	Article							MHC CLASS-II; DROSOPHILA-MELANOGASTER CELLS; HLA-DM; PRESENTING CELLS; T-CELLS; PEPTIDE BINDING; B-LYMPHOCYTES; ACIDIC PH; COMPLEX; MOLECULES	HLA-DM catalyzes the release of MHC class II-associated invariant chain-derived peptides (CLIP) from class II molecules. Recent evidence has suggested that HLA-DO is a negative regulator of HLA-DM in B cells, but the physiological function of HLA-DO remains unclear. Analysis of antigen presentation by B cells from mice lacking H2-O (the mouse equivalent of HLA-DO), together with biochemical analysis using purified HLA-DO and HLA-DM molecules, suggests that HLA-DO/H2-O influences the peptide loading of class II molecules by limiting the pH range in which HLA-DM is active. This effect may serve to decrease the presentation of antigens internalized by fluid-phase endocytosis, thus concentrating the B cell-mediated antigen presentation to antigens internalized by membrane immunoglobulin.	RW Johnson Pharmaceut Res Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Johnson & Johnson; Johnson & Johnson USA; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Karlsson, L (corresponding author), RW Johnson Pharmaceut Res Inst, 3535 Gen Atom Court,Suite 100, San Diego, CA 92121 USA.			winqvist, Ola/0000-0003-0842-4441; Fung-Leung, Wai-Ping/0000-0001-7013-8855				ACCOLLA RS, 1981, P NATL ACAD SCI-BIOL, V78, P2478, DOI 10.1073/pnas.78.4.2478; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; CALAFAT J, 1994, J CELL BIOL, V126, P967, DOI 10.1083/jcb.126.4.967; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; Douek DC, 1997, INT IMMUNOL, V9, P355, DOI 10.1093/intimm/9.3.355; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; GEARHART PJ, 1975, J EXP MED, V141, P56, DOI 10.1084/jem.141.1.56; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JEMMERSON R, 1986, SCIENCE, V232, P1001, DOI 10.1126/science.2422757; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; JONES PP, 1980, SELECTED METHODS CEL, P398; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; KLEIJMEER MJ, 1994, J INVEST DERMATOL, V103, P516, DOI 10.1111/1523-1747.ep12395666; Kropshofer H, 1997, IMMUNOL TODAY, V18, P77, DOI 10.1016/S0167-5699(97)01006-2; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Ozaki ME, 1997, J IMMUNOL, V159, P214; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; SANDERSON F, 1994, SCIENCE, V266, P1566, DOI 10.1126/science.7985027; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SPRENT J, 1995, CURR BIOL, V5, P1095, DOI 10.1016/S0960-9822(95)00219-3; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; STORB U, 1986, J EXP MED, V164, P627, DOI 10.1084/jem.164.2.627; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; SURH CD, 1992, J EXP MED, V176, P495, DOI 10.1084/jem.176.2.495; TONELLE C, 1985, EMBO J, V4, P2839; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VITETTA ES, 1991, ANNU REV IMMUNOL, V9, P193, DOI 10.1146/annurev.iy.09.040191.001205; WAKE CT, 1985, CELL, V42, P623, DOI 10.1016/0092-8674(85)90119-9; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; WEBB SR, 1990, SCIENCE, V248, P1643; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	50	158	159	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1998	8	2					233	243		10.1016/S1074-7613(00)80475-6	http://dx.doi.org/10.1016/S1074-7613(00)80475-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YY926	9492004	Bronze			2022-12-18	WOS:000072201800010
J	Horwitz, BH; Scott, ML; Cherry, SR; Bronson, RT; Baltimore, D				Horwitz, BH; Scott, ML; Cherry, SR; Bronson, RT; Baltimore, D			Failure of lymphopoiesis after adoptive transfer of NF-kappa B-deficient fetal liver cells	IMMUNITY			English	Article							DNA-BINDING SUBUNIT; TARGETED DISRUPTION; GENE TRANSCRIPTION; MICE LACKING; REL; ENHANCER; INDUCIBILITY; INHIBITION; ACTIVATION; EXPRESSION	Mice deficient in the p65 subunit of NF-kappa B die during fetal development. Introduction of p50/p65-deficient fetal liver cells into lethally irradiated hosts resulted in a severe deficit of fetal liver-derived lymphocytes and their immediate precursors but an overabundance of fetal liver-derived granulocytes. Surprisingly, simultaneous transplantation of wild-type bone marrow cells rescued the production of p50/p65-deficient lymphocytes. Expression of immunoglobulin kappa light chains on these rescued NF-kappa B-deficient B lymphocytes was normal. These results suggest that while p50 and p65 do not regulate the maturation of pre-B cells, NF-kappa B mediates the development or survival of an early lymphocyte precursor through regulation of an extracellular factor.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; CHILDRENS HOSP,DIV EMERGENCY MED,BOSTON,MA 02115; TUFTS UNIV,SCH MED & VET MED,DEPT PATHOL,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Tufts University				cherry, sara/0000-0003-3956-6610	NIGMS NIH HHS [5 T32 GM07287] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GRILLI M, 1993, INT REV CYTOL, V143, P1; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KLUG CA, 1994, GENE DEV, V8, P678, DOI 10.1101/gad.8.6.678; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Sachs L, 1996, P NATL ACAD SCI USA, V93, P4742, DOI 10.1073/pnas.93.10.4742; Scherer DC, 1996, IMMUNITY, V5, P563, DOI 10.1016/S1074-7613(00)80271-X; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	35	158	165	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1997	6	6					765	772		10.1016/S1074-7613(00)80451-3	http://dx.doi.org/10.1016/S1074-7613(00)80451-3			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XG579	9208848	Bronze			2022-12-18	WOS:A1997XG57900011
J	Ndhlovu, ZM; Kamya, P; Mewalal, N; Kloverpris, HN; Nkosi, T; Pretorius, K; Laher, F; Ogunshola, F; Chopera, D; Shekhar, K; Ghebremichael, M; Ismail, N; Moodley, A; Malik, A; Leslie, A; Goulder, PJR; Buus, S; Chakraborty, A; Dong, K; Ndung'u, T; Walker, BD				Ndhlovu, Zaza M.; Kamya, Philomena; Mewalal, Nikoshia; Kloverpris, Henrik N.; Nkosi, Thandeka; Pretorius, Karyn; Laher, Faatima; Ogunshola, Funsho; Chopera, Denis; Shekhar, Karthik; Ghebremichael, Musie; Ismail, Nasreen; Moodley, Amber; Malik, Amna; Leslie, Alasdair; Goulder, Philip J. R.; Buus, Soren; Chakraborty, Arup; Dong, Krista; Ndung'u, Thumbi; Walker, Bruce D.			Magnitude and Kinetics of CD8(+) T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point	IMMUNITY			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; VIREMIA; EXPRESSION; EXPANSION; ANTIBODY; ESCAPE; AIDS; SEROCONVERSION	CD8(+) T cells contribute to the control of HIV, but it is not clear whether initial immune responses modulate the viral set point. We screened high-risk uninfected women twice a week for plasma HIV RNA and identified 12 hyperacute infections. Onset of viremia elicited a massive HIV-specific CD8(+) T cell response, with limited bystander activation of non-HIV memory CD8(+) T cells. HIV-specific CD8(+) T cells secreted little interferon-gamma, underwent rapid apoptosis, and failed to upregulate the interleukin-7 receptor, known to be important for T cell survival. The rapidity to peak CD8(+) T cell activation and the absolute magnitude of activation induced by the exponential rise in viremia were inversely correlated with set point viremia. These data indicate that rapid, high magnitude HIV-induced CD8(+) T cell responses are crucial for subsequent immune control of acute infection, which has important implications for HIV vaccine design.	[Ndhlovu, Zaza M.; Kamya, Philomena; Mewalal, Nikoshia; Nkosi, Thandeka; Pretorius, Karyn; Laher, Faatima; Ogunshola, Funsho; Ismail, Nasreen; Moodley, Amber; Goulder, Philip J. R.; Ndung'u, Thumbi; Walker, Bruce D.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4001 Durban, South Africa; [Ndhlovu, Zaza M.; Kamya, Philomena; Ghebremichael, Musie; Moodley, Amber; Leslie, Alasdair; Chakraborty, Arup; Dong, Krista; Ndung'u, Thumbi; Walker, Bruce D.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA; [Kloverpris, Henrik N.; Chopera, Denis; Leslie, Alasdair; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chakraborty, Arup] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Malik, Amna; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Kloverpris, Henrik N.; Buus, Soren] Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen N, Denmark	University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; Max Planck Society; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Oxford; University of Copenhagen	Walker, BD (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4001 Durban, South Africa.	bwalker@mgh.harvard.edu	Perry, George/A-8611-2009; Ndhlovu, Zaza/W-2437-2019; Ogunshola, Funsho/AHA-0602-2022; Smith, Mark A/A-9053-2009	Perry, George/0000-0002-6547-0172; Ndhlovu, Zaza/0000-0002-2708-3315; Ndung'u, Thumbi/0000-0003-2962-3992; leslie, alasdair/0000-0003-2538-6467; Kloverpris, Henrik/0000-0002-2165-3313	Bill and Melinda Gates Foundation; Witten Family Foundation; Mark and Lisa Schwartz Foundation; International AIDS Vaccine Initiative (IAVI) [UKZNRSA1001]; NIAID [R37AI067073]; NIH [P30 AI060354]; NIAID, NIH; NCI, NIH; NICHD, NIH; NHLBI, NIH; NIDA, NIH; NIMH, NIH; NIA, NIH; FIC, NIH; OAR, NIH; Howard Hughes Medical Institute; South African Research Chairs Initiative; Collaboration for AIDS Vaccine Discovery; Lundbeck Foundation [R151-2013-14624] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI046995, R37AI067073] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Witten Family Foundation; Mark and Lisa Schwartz Foundation; International AIDS Vaccine Initiative (IAVI); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OAR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); South African Research Chairs Initiative; Collaboration for AIDS Vaccine Discovery; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the FRESH participants, as well as the FRESH and HIV Pathogenesis Programme (HPP) laboratory staff. This work was supported by the Bill and Melinda Gates Foundation and the Collaboration for AIDS Vaccine Discovery, the Witten Family Foundation, Dan and Marjorie Sullivan, the Mark and Lisa Schwartz Foundation, Ursula Brunner, Gary and Loren Cohen, the International AIDS Vaccine Initiative (IAVI) (UKZNRSA1001), the NIAID (R37AI067073), and an NIH funded Center for AIDS Research (P30 AI060354), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and OAR, and the Howard Hughes Medical Institute. Additional funding was received from the South African Research Chairs Initiative. We would like to thank Drs. Alan S. Perelson and Ruy M. Rubeiro for their expert advice on viral growth kinetics calculations, and Dr. Daniel E. Kaufmann, MD for critical reading of the manuscript.	Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; Dalod M, 1999, J CLIN INVEST, V104, P1431, DOI 10.1172/JCI7162; Delva W, 2014, CURR HIV-AIDS REP, V11, P99, DOI 10.1007/s11904-014-0205-0; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; GERDES J, 1984, J IMMUNOL, V133, P1710; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Kalichman SC, 2006, SOC SCI MED, V62, P1641, DOI 10.1016/j.socscimed.2005.08.021; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kostense S, 2002, BLOOD, V99, P2505, DOI 10.1182/blood.V99.7.2505; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; McMichael A., 2012, PERSPECT MED, V2; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2015, NAT IMMUNOL, V16, P563, DOI 10.1038/ni.3161; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Phillips AN, 2006, CURR OPIN HIV AIDS, V1, P43, DOI 10.1097/01.COH.0000194106.12816.b1; Radebe M, 2015, AIDS, V29, P23, DOI 10.1097/QAD.0000000000000508; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Streeck H, 2014, J VIROL, V88, P12793, DOI 10.1128/JVI.02016-14; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785	50	157	159	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					591	604		10.1016/j.immuni.2015.08.012	http://dx.doi.org/10.1016/j.immuni.2015.08.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26362266	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000361575300011
J	Kuroda, E; Ishii, KJ; Uematsu, S; Ohata, K; Coban, C; Akira, S; Aritake, K; Urade, Y; Morimoto, Y				Kuroda, Etsushi; Ishii, Ken J.; Uematsu, Satoshi; Ohata, Keiichi; Coban, Cevayir; Akira, Shizuo; Aritake, Kosuke; Urade, Yoshihiro; Morimoto, Yasuo			Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms	IMMUNITY			English	Article							NLRP3 INFLAMMASOME; DENDRITIC CELLS; IMMUNE-RESPONSES; INTRATRACHEAL INSTILLATION; E-2 PRODUCTION; B-LYMPHOCYTES; BETA-GLUCAN; BALB/C MICE; ACTIVATION; DIFFERENTIATION	Particulates such as silica crystal (silica) and aluminum salts (alum) activate the inflammasome and induce the secretion of proinflammatory cytokines in macrophages. These particulates also induce the production of immunoglobulin E via a T helper 2 (Th2) cell-associated mechanism. However, the mechanism involved in the induction of type 2 immunity has not been elucidated. Here, we showed that silica and alum induced lipopolysaccharide-primed macrophages to produce the lipid mediator prostaglandin E-2 (PGE(2)) and interleukin-1 beta (IL-1 beta). Macrophages deficient in the inflammasome components caspase 1, NALP3, and ASC revealed that PGE(2) production was independent of the NALP3 inflammasome. PGE(2) expression was markedly reduced in PGE synthase-deficient (Piges(-/-)) macrophages, and Ptges(-/-)mice displayed reduced antigen-specific serum IgE concentrations after immunization with alum or silica. Our results indicate that silica and alum regulate the production of PGE(2) and that the induction of PGE(2) by particulates controls the immune response in vivo.	[Kuroda, Etsushi] Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Fukuoka 8078555, Japan; [Morimoto, Yasuo] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Fukuoka 8078555, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjunt Innovat, Osaka 5670085, Japan; [Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, Suita, Osaka 5650871, Japan; [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, Host Def Lab, Suita, Osaka 5650871, Japan; [Ohata, Keiichi; Coban, Cevayir] Osaka Univ, Lab Malaria Immunol WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; National Institute of Health Sciences - Japan; Osaka University; Osaka University; Osaka University	Kuroda, E (corresponding author), Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Fukuoka 8078555, Japan.	kuroetu@med.uoeh-u.ac.jp	Ishii, Ken J/B-1685-2012; COBAN, Cevayir/P-1928-2019; Akira, Shizuo/C-3134-2009; Coban, Cevayir/B-2129-2012	Ishii, Ken J/0000-0002-6728-3872; COBAN, Cevayir/0000-0002-4467-7799; Ohata, Keiichi/0000-0002-5635-4292	UOEH; Ministry of Education, Science, Sports and Culture of Japan [21890297, 22791094]; Grants-in-Aid for Scientific Research [21689015] Funding Source: KAKEN	UOEH(University of Occupational & Environmental Health - Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Krystal (British Columbia Cancer Research Agency) for helpful discussion. This work was supported in part by a UOEH Research Grant for Promotion of Occupational Health (to E.K.) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (21890297 and 22791094 to E.K.).	Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fabricius D, 2010, J IMMUNOL, V184, P677, DOI 10.4049/jimmunol.0902028; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GARRONE P, 1994, J IMMUNOL, V152, P4282; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; GORDON TP, 1985, CLIN EXP RHEUMATOL, V3, P291; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; He JS, 2002, ANTIOXID REDOX SIGN, V4, P509, DOI 10.1089/15230860260196317; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kuroda E, 2003, J IMMUNOL, V170, P757, DOI 10.4049/jimmunol.170.2.757; Kuroda E, 2007, EUR J IMMUNOL, V37, P2185, DOI 10.1002/eji.200737041; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; MANCINO D, 1983, INT ARCH ALLER A IMM, V71, P279, DOI 10.1159/000233404; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Narumiya S, 2009, J MOL MED, V87, P1015, DOI 10.1007/s00109-009-0500-1; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Nishi K, 2009, INHAL TOXICOL, V21, P1030, DOI 10.1080/08958370802716722; Ogami A, 2009, INHAL TOXICOL, V21, P812, DOI 10.1080/08958370802499022; ROPER RL, 1995, J IMMUNOL, V154, P162; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; VONBEHREN LA, 1983, INFECT IMMUN, V42, P818, DOI 10.1128/IAI.42.2.818-823.1983; Watanabe H, 2008, J IMMUNOL, V180, P5826, DOI 10.4049/jimmunol.180.9.5826; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003	55	157	160	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					514	526		10.1016/j.immuni.2011.03.019	http://dx.doi.org/10.1016/j.immuni.2011.03.019			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21497116	Bronze			2022-12-18	WOS:000290367300011
J	Saitoh, T; Satoh, T; Yamamoto, N; Uematsu, S; Takeuchi, O; Kawai, T; Akira, S				Saitoh, Tatsuya; Satoh, Takashi; Yamamoto, Naoki; Uematsu, Satoshi; Takeuchi, Osamu; Kawai, Taro; Akira, Shizuo			Antiviral Protein Viperin Promotes Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Type I Interferon Production in Plasmacytoid Dendritic Cells	IMMUNITY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; AMPHIPATHIC ALPHA-HELIX; INNATE IMMUNITY; GENE INDUCTION; AUTOPHAGY; ACTIVATION; VIRUS; IDENTIFICATION; RESPONSES	Toll-like receptor 7 (TLR7) and TLR9 sense viral nucleic acids and induce production of type I interferon (IFN) by plasmacytoid dendritic cells (pDCs) to protect the host from virus infection. We showed that the IFN-inducible antiviral protein Viperin promoted TLR7- and TLR9-mediated production of type I IFN by pDCs. Viperin expression was potently induced after TLR7 or TLR9 stimulation and Viperin localized to the cytoplasmic lipid-enriched compartments, lipid bodies, in pDCs. Viperin interacted with the signal mediators IRAK1 and TRAF6 to recruit them to the lipid bodies and facilitated K63-linked ubiquitination of IRAK1 to induce the nuclear translocation of transcription factor IRF7. Loss of Viperin reduced TLR7- and TLR9-mediated production of type I IFN by pDCs. However, Viperin was dispensable for the production of type I IFN induced by intracellular nucleic acids. Thus, Viperin mediates its antiviral function via the regulation of the TLR7 and TLR9-IRAK1 signaling axis in pDCs.	[Saitoh, Tatsuya; Satoh, Takashi; Uematsu, Satoshi; Takeuchi, Osamu; Kawai, Taro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Satoh, Takashi; Uematsu, Satoshi; Takeuchi, Osamu; Kawai, Taro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	Osaka University; Osaka University; National University of Singapore	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Kawai, Taro/0000-0001-7510-4662	Ministry of Education, Culture, Sports, Science, and Technology in Japan; Ministry of Health, Labour and Welfare in Japan; 21st Century Center of Excellence Program of Japan; NIH [AI070167]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); 21st Century Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to J.A. Thomas, J.D. Ashwell, S. Yamaoka, T. Kitamura, T. Yasui, and Y. Kawaguchi for providing invaluable materials. We thank the members of the Laboratory of Host Defense for discussion; K. Yamamoto, M. Kumagai, N. Ishizawa, and Y. Fujiwara for technical assistance; and E. Kamada for secretarial assistance. This work was in part supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan, from the Ministry of Health, Labour and Welfare in Japan, and from the 21st Century Center of Excellence Program of Japan, and from NIH (AI070167) to S.A. This research was also supported by the Japan Society for the Promotion of Science through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" to S.A. T. S. generated Viperin-deficient mice and performed the immunological research. N.Y. contributed the expression vectors. O.T, S.U., T. K., and T.S. contributed the immunological research. S.A. designed overall research and wrote the paper.	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bougneres L, 2009, IMMUNITY, V31, P232, DOI 10.1016/j.immuni.2009.06.022; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	48	157	171	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					352	363		10.1016/j.immuni.2011.03.010	http://dx.doi.org/10.1016/j.immuni.2011.03.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435586	Bronze			2022-12-18	WOS:000289014500011
J	Tezuka, H; Abe, Y; Asano, J; Sato, T; Liu, JJ; Iwata, M; Ohteki, T				Tezuka, Hiroyuki; Abe, Yukiko; Asano, Jumpei; Sato, Taku; Liu, Jiajia; Iwata, Makoto; Ohteki, Toshiaki			Prominent Role for Plasmacytoid Dendritic Cells in Mucosal T Cell-Independent IgA Induction	IMMUNITY			English	Article							I INTERFERONS; EPITHELIAL-CELLS; LAMINA PROPRIA; IMMUNE-SYSTEM; TNF RECEPTOR; LYMPH-NODES; B-CELLS; BAFF-R; BETA; EXPRESSION	Although both conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs) are present in the gut-associated lymphoid tissues (GALT), the roles of pDCs in the gut remain largely unknown. Here we show a critical role for pDCs in T cell-independent (TI) IgA production by B cells in the GALT. When pDCs of the mesenteric lymph nodes (MLNs) and Peyer's patches (PPs) (which are representative GALT) were cultured with naive B cells to induce TI IgA class switch recombination (CSR), IgA production was substantially higher than in cocultures of these cells with cDCs. IgA production was dependent on APRIL and BAFF production by pDCs. Importantly, pDC expression of APRIL and BAFF was dependent on stromal cell-derived type I IFN signaling under steady-state conditions. Our findings provide insight into the molecular basis of pDC conditioning to induce mucosal TI IgA production, which may lead to improvements in vaccination strategies and treatment for mucosal-related disorders.	[Tezuka, Hiroyuki; Asano, Jumpei; Sato, Taku; Liu, Jiajia; Ohteki, Toshiaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1010062, Japan; [Tezuka, Hiroyuki; Asano, Jumpei; Sato, Taku; Iwata, Makoto; Ohteki, Toshiaki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Abe, Yukiko] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 0108543, Japan; [Iwata, Makoto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biodef Res, Kagawa 7692193, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Akita University; Tokushima Bunri University	Ohteki, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biodef Res, Tokyo 1010062, Japan.	ohteki.bre@mri.tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology (CREST); Grants-in-Aid for Scientific Research [23790528] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Kamioka for secretarial support, H. Ishikawa (Keio University) for the B6.Tcrb<SUP>-/-</SUP>Tcrd<SUP>-/-</SUP> mice, T. Seya (Hokkaido University) for the B6.lfnb<SUP>-/-</SUP> mice, and S. Akira and M. Yamamoto (Osaka University) for the B6.Myd88<SUP>-/-</SUP>Trif<SUP>-/-</SUP> mice. This work was supported by a Grant-in-Aid for Young Scientists (B) (H.T.), the Takeda Science Foundation (T.O.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan (T.O.), and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST) (T.O.).	Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fletcher CA, 2006, EUR J IMMUNOL, V36, P2504, DOI 10.1002/eji.200636270; Gao YF, 2009, BLOOD, V114, P2623, DOI 10.1182/blood-2008-10-183301; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hardenberg G, 2007, EUR J IMMUNOL, V37, P2900, DOI 10.1002/eji.200737210; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Munakata K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-192; Musso T, 1999, BLOOD, V93, P3531; Nishiyama Y, 2002, J IMMUNOL, V168, P2626, DOI 10.4049/jimmunol.168.6.2626; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vadiveloo PK, 2000, CYTOKINE, V12, P1639, DOI 10.1006/cyto.2000.0766; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yamamoto M, 2004, J IMMUNOL, V173, P762, DOI 10.4049/jimmunol.173.2.762; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	49	157	163	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					247	257		10.1016/j.immuni.2011.02.002	http://dx.doi.org/10.1016/j.immuni.2011.02.002			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21333555	Bronze			2022-12-18	WOS:000287989500014
J	Hughes, T; Becknell, B; Freud, AG; McClory, S; Briercheck, E; Yu, JH; Mao, C; Giovenzana, C; Nuovo, G; Wei, L; Zhang, XL; Gavrilin, MA; Wewers, MD; Caligiuri, MA				Hughes, Tiffany; Becknell, Brian; Freud, Aharon G.; McClory, Susan; Briercheck, Edward; Yu, Jianhua; Mao, Charlene; Giovenzana, Chiara; Nuovo, Gerard; Wei, Lai; Zhang, Xiaoli; Gavrilin, Mikhail A.; Wewers, Mark D.; Caligiuri, Michael A.			Interleukin-1 beta Selectively Expands and Sustains Interleukin-22(+) Immature Human Natural Killer Cells in Secondary Lymphoid Tissue	IMMUNITY			English	Article							ROR-GAMMA-T; DIFFERENTIATION IN-VIVO; CD56(DIM) NK CELLS; PROINFLAMMATORY IL-17(+); T(H)17 CYTOKINE; INNATE IMMUNITY; NKP46(+) CELLS; INDUCER CELLS; RECEPTOR; CD56(BRIGHT)	Among human natural killer (NK) cell intermediates in secondary lymphoid tissue (SLT), stage 3 CD34(-)CD117(+)CD161(+)CD94(-) immature NK (iNK) cells uniquely express aryl hydrocarbon receptor (AHR) and interleukin-22 (IL-22), supporting a role in mucosal immunity. The mechanisms controlling proliferation and differentiation of these cells are unknown. Here we demonstrate that the IL-1 receptor IL-1R1 was selectively expressed by a subpopulation of iNK cells that localized proximal to IL-1 beta-producing conventional dendritic cells (cDCs) within SLT. IL-1R1(hi) iNK cells required continuous exposure to IL-1 beta to retain AHR and IL-22 expression, and they proliferate in direct response to cDC-derived IL-15 and IL-1 beta. In the absence of IL-1 beta, a substantially greater fraction of IL-1R1(hi) iNK cells differentiated to stage 4 NK cells and acquired the ability to kill and secrete IFN-gamma. Thus, cDC-derived IL-1 beta preserves and expands IL-1R1(hi) IL-22(+)AHR(+) iNK cells, potentially influencing human mucosal innate immunity during infection.	[McClory, Susan; Briercheck, Edward; Caligiuri, Michael A.] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA; [Freud, Aharon G.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94305 USA; [Hughes, Tiffany; McClory, Susan; Briercheck, Edward] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA; [Becknell, Brian] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yu, Jianhua; Mao, Charlene; Giovenzana, Chiara; Caligiuri, Michael A.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nuovo, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Wei, Lai; Zhang, Xiaoli] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Gavrilin, Mikhail A.; Wewers, Mark D.] Ohio State Univ, Dept Internal Med, Div Pulm & Crit Care, Columbus, OH 43210 USA; [Wewers, Mark D.; Caligiuri, Michael A.] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA; [Caligiuri, Michael A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Caligiuri, Michael A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Caligiuri, Michael A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Stanford University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Caligiuri, MA (corresponding author), Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu	Wewers, Mark/AAB-6202-2021	McClory, Susan/0000-0002-4607-5230; Gavrilin, Mikhail/0000-0003-2003-768X	NCI [CA95426, CA68458]; NATIONAL CANCER INSTITUTE [P01CA095426, R37CA068458, R01CA068458, P30CA016058] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grants (CA95426 and CA68458). The authors thank Ventana Medical Systems and K. Sergott for providing reagents for the immunohistochemistry.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arend W P, 1991, Br J Rheumatol, V30 Suppl 2, P49; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Cooper MA, 2001, EUR J IMMUNOL, V31, P792, DOI 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; IKEJIMA T, 1984, J CLIN INVEST, V73, P1312, DOI 10.1172/JCI111334; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Trotta R, 2005, BLOOD, V105, P3011, DOI 10.1182/blood-2004-10-4072; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	43	157	162	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 25	2010	32	6					803	814		10.1016/j.immuni.2010.06.007	http://dx.doi.org/10.1016/j.immuni.2010.06.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620944	Bronze, Green Accepted			2022-12-18	WOS:000279365800011
J	Treiber, T; Mandel, EM; Pott, S; Gyory, I; Firner, S; Liu, ET; Grosschedl, R				Treiber, Thomas; Mandel, Elizabeth M.; Pott, Sebastian; Gyoery, Ildiko; Firner, Sonja; Liu, Edison T.; Grosschedl, Rudolf			Early B Cell Factor 1 Regulates B Cell Gene Networks by Activation, Repression, and Transcription-Independent Poising of Chromatin	IMMUNITY			English	Article							FATE COMMITMENT; FACTOR EBF; EXPRESSION; SPECIFICATION; INTERLEUKIN-7; DIFFERENTIATION; PAX5; E2A; LYMPHOPOIESIS; INDUCTION	The transcription factor early B cell factor-1 (Ebf1) is a key determinant of B lineage specification and differentiation. To gain insight into the molecular basis of Ebf1 function in early-stage B cells, we combined a genome-wide ChIP sequencing analysis with gain- and loss-of-function transcriptome analyses. Among 565 genes that are occupied and transcriptionally regulated by Ebf1, we identified large sets involved in (pre)-B cell receptor and Akt signaling, cell adhesion, and migration. Interestingly, a third of previously described Pax5 targets was found to be occupied by Ebf1. In addition to Ebf1-activated and -repressed genes, we identified targets at which Ebf1 induces chromatin changes that poise the genes for expression at subsequent stages of differentiation. Poised chromatin states on specific targets could also be established by Ebf1 expression in T cells but not in NI H 3T3 cells, suggesting that Ebf1 acts as a "pioneer" factor in a hematopoietic chromatin context.	[Treiber, Thomas; Mandel, Elizabeth M.; Gyoery, Ildiko; Firner, Sonja; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Pott, Sebastian; Liu, Edison T.] Genome Inst Singapore, Singapore 138672, Singapore	Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de	Liu, Edison/C-4141-2008		Max-Planck-Society; German Research Foundation; Agency for Science, Technology and Research (A*STAR), Singapore	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We are grateful to H. Singh and J. Pongubala for providing Ebf1-deficient pre-pro-B cells and advice concerning retroviral transduction of the primary cells. We thank I. Falk for help in cell sorting and members of our lab for discussions. We thank J. Kisielow for the Beko cells. This work was supported by funds of the Max-Planck-Society and German Research Foundation and by the Agency for Science, Technology and Research (A*STAR), Singapore. S.P. is a student of the Department of Microbiology, Tumor and Cell Biology at the Karolinska Institute in Stockholm, Sweden.	Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Murre C, 2009, GENE DEV, V23, P2366, DOI 10.1101/gad.1861709; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Singh H, 2007, ADV EXP MED BIOL, V596, P57; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Wang SS, 1997, J NEUROSCI, V17, P4149; XU H, 2010, BIOINFORMAT IN PRESS; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	57	157	159	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 28	2010	32	5					714	725		10.1016/j.immuni.2010.04.013	http://dx.doi.org/10.1016/j.immuni.2010.04.013			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	604LM	20451411	Bronze			2022-12-18	WOS:000278280500016
J	Celli, S; Lemaitre, F; Bousso, P				Celli, Susanna; Lemaitre, Fabrice; Bousso, Philippe			Real-time manipulation of T cell-dendritic cell interactions in vivo reveals the importance of prolonged contacts for CD4(+) T cell activation	IMMUNITY			English	Article							LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; CLONAL EXPANSION; ANTIGEN; TOLERANCE; DYNAMICS; IMMUNITY; SIGNAL; DETERMINES; INDUCTION	T cells interact with dendritic cells (DCs) for periods lasting from minutes to hours. However, a causal link between the duration of this interaction and the efficiency of T cell activation has not been established in vivo. Employing intravital two-photon imaging, we manipulated T cell-DC interactions in real time and found that the first T cell-DC encounter often resulted in a long-lived interaction. Moreover, the cessation of T cell receptor-major histocompatibility complex signals promoted cellular dissociation, suggesting that antigen availability on DCs regulates contact duration. Finally, at least 6 hr of in vivo T cell-DC interaction were required for naive CD4(+) T cells to undergo clonal expansion. These results establish the importance of prolonged T cell-DC interactions for efficient CD4(+) cell activation in vivo.	Inst Pasteur, F-75015 Paris, France; INSERM, Equipe Avenir, U668, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bousso, P (corresponding author), Inst Pasteur, F-75015 Paris, France.	bousso@pasteur.fr	BOUSSO, Philippe/M-6547-2014; Celli, Susanna/M-7138-2014	BOUSSO, Philippe/0000-0002-6362-561X; 				Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breart B, 2006, CURR OPIN IMMUNOL, V18, P483, DOI 10.1016/j.coi.2006.05.006; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Hofer S, 2006, BLOOD, V107, P1003, DOI 10.1182/blood-2005-01-0425; Hombach A, 2006, J IMMUNOL, V177, P5668, DOI 10.4049/jimmunol.177.8.5668; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; TAKOKORO CE, 2006, J EXP MED, V203, P505; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	34	157	162	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					625	634		10.1016/j.immuni.2007.08.018	http://dx.doi.org/10.1016/j.immuni.2007.08.018			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17950004	Bronze			2022-12-18	WOS:000250490700013
J	Buxade, M; Parra, JL; Rousseau, S; Shpiro, N; Marquez, R; Morrice, N; Bain, J; Espel, E; Proud, CG				Buxade, M; Parra, JL; Rousseau, S; Shpiro, N; Marquez, R; Morrice, N; Bain, J; Espel, E; Proud, CG			The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; AU-RICH ELEMENTS; P38 MAP KINASE; MESSENGER-RNA; IN-VIVO; BINDING PROTEIN; GENE-EXPRESSION; T-LYMPHOCYTES	Posttranscriptional regulatory mechanisms control TNF alpha expression through AU-rich elements in the 3'UTR of its mRNA. This is mediated through Erk and p38 MAP kinase signaling, although the mechanisms involved remain poorly understood. Here, we show that the MAP kinase signal-integrating kinases (Mnks), which are activated by both these pathways, regulate TNFa expression in T cells via the 3'UTR. A selective Mnk inhibitor or siRNA-mediated knockdown of Mnk1 inhibits TNFa production in T cells, whereas Mnk1 overexpression enhances expression of a reporter construct containing the TNFa 3'UTR. We identify ARE binding proteins that are Mnk substrates, such as hnRNP A1, which they phosphorylate at two sites in vitro. hnRNP A1 is phosphorylated in response to T cell activation, and this is blocked by Mnk inhibition. Moreover, Mnk-mediated phosphorylation decreases binding of hnRNP A1 to TNF alpha-ARE in vitro or TNF alpha-mRNA in vivo. Therefore, Mnks are novel players in cytokine regulation and potential new targets for antiinflammatory therapy.	Univ Dundee, Sch Life Sci, Div Signal Transduct Therapy, Dundee DD1 5EH, Scotland; Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Parasitol, Dundee DD1 5EH, Scotland; Univ Barcelona, Dept Fisiol, E-08028 Barcelona, Spain	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Barcelona	Proud, CG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cgpr@interchange.ubc.ca	Buxade, Maria/F-7870-2014; Espel, Enric/ABD-3481-2020; Rousseau, Simon/A-1800-2009; Marquez, Rudi/F-4045-2014	Buxade, Maria/0000-0002-3020-8393; Espel, Enric/0000-0003-1666-3821; Marquez, Rudi/0000-0001-9777-2012; Proud, Christopher/0000-0003-0704-6442; Rousseau, Simon/0000-0002-8773-575X				Ballester A, 1998, J BIOL CHEM, V273, P14099, DOI 10.1074/jbc.273.23.14099; Buxade M, 2001, IMMUNOLOGY, V102, P416, DOI 10.1046/j.1365-2567.2001.01206.x; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hamilton BJN, 1997, J BIOL CHEM, V272, P28732, DOI 10.1074/jbc.272.45.28732; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hoffmeyer A, 1999, J BIOL CHEM, V274, P4319, DOI 10.1074/jbc.274.7.4319; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; KRUYS V, 1992, P NATL ACAD SCI USA, V89, P673, DOI 10.1073/pnas.89.2.673; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; O'Loghlen A, 2004, FEBS LETT, V578, P31, DOI 10.1016/j.febslet.2004.10.063; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Salituro FG, 1999, CURR MED CHEM, V6, P807; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	39	157	170	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					177	189		10.1016/j.immuni.2005.06.009	http://dx.doi.org/10.1016/j.immuni.2005.06.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111636	Bronze			2022-12-18	WOS:000231721700008
J	Hahm, B; Trifilo, MJ; Zuniga, EI; Oldstone, MBA				Hahm, B; Trifilo, MJ; Zuniga, EI; Oldstone, MBA			Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; DENDRITIC CELL MATURATION; DOUBLE-STRANDED-RNA; MEASLES-VIRUS; T-CELLS; VIRAL PERSISTENCE; JAK-STAT; INDUCED IMMUNOSUPPRESSION; TARGETED DISRUPTION	Understanding, treating, and preventing diseases caused by immunosuppression and/or persistent infections remain both a major challenge in biomedical research and an important health goal. For a virus or any infectious agent to persist, it must utilize strategies to suppress or evade the host's immune response. Here, we report that two dissimilar viruses employ a common maneuver to cause a profound immunosuppression. Measles virus (MV) and lymphocytic choriomeningitis virus (LCMV) interfere with dendritic cell (DC) development and expansion in vivo and in vitro. The underlying mechanism for this is through the generation of type I interferon (IFN) that acts via a signal transducer and activator of a transcription (STAT)2-dependent, but STAT1 -independent, pathway. Thus, viruses subvert the known antiviral effect of type I IFN through STAT2-speciflc signaling to benefit their survival. These observations have implications for understanding and developing therapies to treat diseases caused by immunosuppression and/or persistent infections.	Scripps Res Inst, Dept Neuropharmacol, Dept Infectol, Div Virol, La Jolla, CA 92037 USA	Scripps Research Institute	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Neuropharmacol, Dept Infectol, Div Virol, La Jolla, CA 92037 USA.	mbaobo@scripps.edu			NIAID NIH HHS [AI28900, AI45927, AI09484, AI36222] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900, R37AI009484, R01AI009484, R01AI045927, R01AI036222] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Binder D, 1997, J EXP MED, V185, P517, DOI 10.1084/jem.185.3.517; Biron C.A., 2001, FIELDS VIROLOGY, P321; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Colonna M, 2004, J CLIN INVEST, V113, P660, DOI 10.1172/JCI200421166; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dauer M, 2003, IMMUNOLOGY, V110, P38, DOI 10.1046/j.1365-2567.2003.01702.x; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Griffin D., 2001, FIELDS VIROLOGY, P1401; Grosjean I, 1997, J EXP MED, V186, P801, DOI 10.1084/jem.186.6.801; Hahm B, 2004, VIROLOGY, V323, P292, DOI 10.1016/j.virol.2004.03.011; Hahm B, 2003, J VIROL, V77, P3505, DOI 10.1128/JVI.77.6.3505-3515.2003; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ito T, 2001, J IMMUNOL, V166, P2961, DOI 10.4049/jimmunol.166.5.2961; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; JOSEPH BS, 1975, J VIROL, V16, P1638, DOI 10.1128/JVI.16.6.1638-1649.1975; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Klagge IM, 2000, EUR J IMMUNOL, V30, P2741, DOI 10.1002/1521-4141(200010)30:10<2741::AID-IMMU2741>3.0.CO;2-N; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Li LQ, 2002, BLOOD, V99, P3725, DOI 10.1182/blood.V99.10.3725; Luft T, 1998, J IMMUNOL, V161, P1947; Manchester M, 2002, J VIROL, V76, P6636, DOI 10.1128/JVI.76.13.6636-6642.2002; MCCHESNEY MB, 1989, ADV IMMUNOL, V45, P335, DOI 10.1016/S0065-2776(08)60696-3; MCCHESNEY MB, 1987, J VIROL, V61, P3441, DOI 10.1128/JVI.61.11.3441-3447.1987; MCCHESNEY MB, 1988, J IMMUNOL, V140, P1269; McKenna HJ, 2001, CURR OPIN HEMATOL, V8, P149, DOI 10.1097/00062752-200105000-00004; McRae BL, 2000, BLOOD, V96, P210, DOI 10.1182/blood.V96.1.210.013k52_210_217; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naniche D, 1999, J VIROL, V73, P1894, DOI 10.1128/JVI.73.3.1894-1901.1999; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Pawlotsky JM, 2003, CURR OPIN INFECT DIS, V16, P587, DOI 10.1097/00001432-200312000-00012; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Santodonato L, 2003, J IMMUNOL, V170, P5195, DOI 10.4049/jimmunol.170.10.5195; SCHNEIDERSCHAUL.S, 2003, CURR TOP MICROBIOL I, V267, P77; Servet-Delprat C, 2003, CURR TOP MICROBIOL, V276, P103; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Slifka MK, 2003, J CLIN INVEST, V111, P805, DOI 10.1172/JCI200313603; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Sun XM, 1998, VIROLOGY, V246, P24, DOI 10.1006/viro.1998.9186; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; TISHON A, 1993, VIROLOGY, V195, P397, DOI 10.1006/viro.1993.1389; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947	72	157	163	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					247	257		10.1016/j.immuni.2005.01.005	http://dx.doi.org/10.1016/j.immuni.2005.01.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723812	Bronze			2022-12-18	WOS:000227509600010
J	Honjo, T; Muramatsu, M; Fagarasan, S				Honjo, T; Muramatsu, M; Fagarasan, S			AID: How does it aid antibody diversity?	IMMUNITY			English	Review							CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; URACIL-DNA GLYCOSYLASE; B MESSENGER-RNA; DOUBLE-STRAND BREAKS; IMMUNOGLOBULIN GENE CONVERSION; MISMATCH-REPAIR PROTEIN; SOMATIC HYPERMUTATION; CHROMOSOMAL LOCALIZATION; V(D)J RECOMBINATION	Activation-induced cytidine deaminase (AID) is an essential enzyme to regulate class switch recombination (CSR), somatic hypermutation (SHM), and gene conversion (GC). AID is known to be required for DNA cleavage of S regions in CSR. However, its molecular mechanism is a focus of extensive debate. RNA editing hypothesis postulates that AID edits yet unknown mRNA to generate specific endonucleases for CSR and SHM. By contrast, DNA deamination hypothesis assumes that AID deaminates cytosine in DNA, followed by DNA cleavage by base excision repair enzymes. We discuss available evidence for the two proposed models. Recent findings, namely requirement of protein synthesis for DNA breakage and dispensability of U removal activity of uracil DNA glycosylase, force us to reconsider DNA deamination hypothesis.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kyoto University; RIKEN	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402				Arakawa H, 2004, DEV DYNAM, V229, P458, DOI 10.1002/dvdy.10495; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Diaz M, 2003, MOL IMMUNOL, V40, P261, DOI 10.1016/S0161-5890(03)00113-5; Diaz M, 2001, J IMMUNOL, V167, P327, DOI 10.4049/jimmunol.167.1.327; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; MAIZELS N, 2000, GENOME BIOL, V1, P1025; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SEKIGUCHI J, 2004, MOL BIOL B CELLS, P62; SHINKURA R, 2004, IN PRESS NAT IMMUNOL; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; STAVNEZER J, 2004, MOL BIOL B CELLS, P307; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Yavuz S, 2002, J IMMUNOL, V169, P3825, DOI 10.4049/jimmunol.169.7.3825; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	81	157	158	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2004	20	6					659	668		10.1016/j.immuni.2004.05.011	http://dx.doi.org/10.1016/j.immuni.2004.05.011			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189732	Bronze			2022-12-18	WOS:000222205300003
J	Serrador, JM; Cabrero, JR; Sancho, D; Mittelbrunn, M; Urzainqui, A; Sanchez-Madrid, F				Serrador, JM; Cabrero, JR; Sancho, D; Mittelbrunn, M; Urzainqui, A; Sanchez-Madrid, F			HDAC6 deacetylase activity links the tubulin cytoskeleton with immune synapse organization	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; CELL ANTIGEN RECEPTOR; TOXIC LYMPHOCYTES-T; IMMUNOLOGICAL SYNAPSE; ALPHA-TUBULIN; ACTIN CYTOSKELETON; HISTONE DEACETYLASE-6; TARGET-CELLS; ZETA-CHAIN; B-CELLS	We investigated the role of acetylated microtubules in the antigen-specific interaction of T helper and antigen-presenting cells (APCs). In T cells, acetylated microtubules concentrated at contact site with APCs, surrounding clusters of CD3 and LFA-1. TcR engagement induced a transient deacetylation of microtubules at early times and an enhanced acetylation at late times. Confocal videomicroscopy studies revealed that the HDAC6 tubulin deacetylase was translocated and concentrated at the contact site of T cells with APCs. Overexpression of HDAC6 but not a dead deacetylase mutant in T cells disorganized CD3 and LFA-1 at the immune synapse. This effect was reverted by treatment with the deacetylase inhibitor trichostatin A. The antigen-specific translocation of the microtubule organizing center (MTOC) and IL-2 production were also severely impaired by overexpression of HDAC6. Our results underscore the key role for HDAC6 in the organization of the immune synapse and the antigen-specific reorientation of the MTOC.	Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, E-28006 Madrid, Spain; Univ Valencia, Unidad Mixta Ctr Nacl Invest Cardiovasc, E-46010 Valencia, Spain	Autonomous University of Madrid; Hospital de La Princesa; University of Valencia	Sanchez-Madrid, F (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, E-28006 Madrid, Spain.	fsanchez.hlpr@salud.madrid.org	Serrador, Juan M/K-2718-2014; Urzainqui, Ana/HDN-9549-2022; Mittelbrunn, Maria/J-9146-2019; Mittelbrunn, Maria/I-5882-2015; Urzainqui, Ana/AAB-4466-2020; Sancho, David/D-3433-2009; Sanchez-Madrid, Francisco/M-7889-2016	Serrador, Juan M/0000-0003-4710-3077; Urzainqui, Ana/0000-0001-9326-6112; Mittelbrunn, Maria/0000-0003-3487-8762; Mittelbrunn, Maria/0000-0003-3487-8762; Urzainqui, Ana/0000-0001-9326-6112; Sancho, David/0000-0003-2890-3984; Sanchez-Madrid, Francisco/0000-0001-5303-0762				Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CAMPANERO MR, 1993, J CELL BIOL, V123, P1007, DOI 10.1083/jcb.123.4.1007; Caplan S, 2000, IMMUNOL TODAY, V21, P223, DOI 10.1016/S0167-5699(00)01604-2; Caplan S, 1996, J BIOL CHEM, V271, P20705, DOI 10.1074/jbc.271.34.20705; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hollenbeck P, 2001, CURR BIOL, V11, pR820, DOI 10.1016/S0960-9822(01)00494-8; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huby RDJ, 1995, J BIOL CHEM, V270, P30241, DOI 10.1074/jbc.270.51.30241; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KOURZARIDES T, 2000, EMBO J, V19, P1176; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; MarieCardine A, 1995, EUR J IMMUNOL, V25, P3290, DOI 10.1002/eji.1830251214; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Peters JD, 1996, J BIOL CHEM, V271, P4755; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; Rubbi CP, 1996, J IMMUNOL METHODS, V192, P157, DOI 10.1016/0022-1759(96)00046-4; RYSER JE, 1982, J IMMUNOL, V128, P1159; Sancho D, 2002, J IMMUNOL, V169, P292, DOI 10.4049/jimmunol.169.1.292; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Sedwick CE, 1999, J IMMUNOL, V162, P1367; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; THOMPSON WC, 1984, J CELL BIOL, V98, P1017, DOI 10.1083/jcb.98.3.1017; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Zhang WZ, 2002, AM J PHYSIOL-RENAL, V283, pF904, DOI 10.1152/ajprenal.00156.2002; Zhou XM, 2000, J BIOL CHEM, V275, P20217, DOI 10.1074/jbc.M909129199	49	157	178	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					417	428		10.1016/S1074-7613(04)00078-0	http://dx.doi.org/10.1016/S1074-7613(04)00078-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084271	Bronze			2022-12-18	WOS:000221442800008
J	Li, H; Jiang, YF; Prak, EL; Radic, M; Weigert, M				Li, H; Jiang, YF; Prak, EL; Radic, M; Weigert, M			Editors and editing of anti-DNA receptors	IMMUNITY			English	Article							LIGHT-CHAIN; B-CELLS; GENE REARRANGEMENT; SOMATIC MUTATION; ESCAPE TOLERANCE; BINDING; HEAVY; ANTIBODIES; AUTOANTIBODIES; SEQUENCES	Receptor editing is a means by which immature bone marrow B cells can become self-tolerant. Rearrangements of heavy (H) and/or light (L) chain genes are induced by encounter with autoantigens to change the specificity from self to nonself. We have developed site-directed transgenic mice (sd-tg) whose transgenes code for the H chain of antibodies that bind DNA. B cells that express the transgenic H chain associate mainly with four of the 93 functional VK genes of the mouse. Numerous aspartate residues that might inhibit DNA binding by the VH domain distinguish these L chain VK sequences, but engaging these VK editors often requires multiple rearrangements. Among the edited B cells is a subset of multispecific cells that express multiple receptors. One consequence of multispecificity is partial autoreactivity; these multispecific B cells may contribute to autoimmunity.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Tennessee, Ctr Hlth Sci, Dept Microbiol & Immunol, Memphis, TN 38163 USA	Princeton University; University of Pennsylvania; University of Tennessee System; University of Tennessee Health Science Center	Weigert, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	mweigert@molbio.princeton.edu		Radic, Marko/0000-0002-8004-282X				ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Brard F, 1999, J EXP MED, V190, P691, DOI 10.1084/jem.190.5.691; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; CHEN C, 1994, J IMMUNOL, V152, P1970; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; EILAT D, 1988, J IMMUNOL, V141, P1745; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Jang YJ, 1998, MOL IMMUNOL, V35, P1207, DOI 10.1016/S0161-5890(98)00095-9; Jang YJ, 1996, MOL IMMUNOL, V33, P197, DOI 10.1016/0161-5890(95)00094-1; Kabat EA, 1991, SEQUENCES PROTEINS I; KAUSHIK A, 1989, J EXP MED, V169, P1859, DOI 10.1084/jem.169.5.1859; LAWLER AM, 1989, P NATL ACAD SCI USA, V86, P6744, DOI 10.1073/pnas.86.17.6744; Lee JS, 2000, J IMMUNOL, V165, P6322, DOI 10.4049/jimmunol.165.11.6322; LI Y, 2002, IN PRESS J EXP MED; Lin XD, 2000, J IMMUNOL, V165, P7058, DOI 10.4049/jimmunol.165.12.7058; LUNINGPRAK E, 1995, J EXP MED, V182, P541; Mehr R, 1999, J IMMUNOL, V163, P1793; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PAUL E, 1992, J IMMUNOL, V149, P3588; POLYMENIS M, 1995, J IMMUNOL, V154, P2198; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; Ravirajan CT, 1998, EUR J IMMUNOL, V28, P339, DOI 10.1002/(SICI)1521-4141(199801)28:01<339::AID-IMMU339>3.0.CO;2-C; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Roben P, 1996, J CLIN INVEST, V98, P2827, DOI 10.1172/JCI119111; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SESKAK A, 1987, J CLIN INVEST, V80, P138; SHAPIRO MA, 1987, MOL CELL BIOL, V7, P4130, DOI 10.1128/MCB.7.11.4130; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; TAN EM, 1988, PEDIATR INFECT DIS J, V7, pS3; Thiebe R, 1999, EUR J IMMUNOL, V29, P2072, DOI 10.1002/(SICI)1521-4141(199907)29:07&lt;2072::AID-IMMU2072&gt;3.0.CO;2-E; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Xu H, 1998, J EXP MED, V188, P1247, DOI 10.1084/jem.188.7.1247; Yamagami T, 1999, IMMUNITY, V11, P309, DOI 10.1016/S1074-7613(00)80106-5; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	45	157	158	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2001	15	6					947	957		10.1016/S1074-7613(01)00251-5	http://dx.doi.org/10.1016/S1074-7613(01)00251-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754816	Bronze			2022-12-18	WOS:000172961400009
J	Le, LQ; Kabarowski, JHS; Weng, ZG; Satterthwaite, AB; Harvill, ET; Jensen, ER; Miller, JF; Witte, ON				Le, LQ; Kabarowski, JHS; Weng, ZG; Satterthwaite, AB; Harvill, ET; Jensen, ER; Miller, JF; Witte, ON			Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; ACTIVATION; EXHIBIT; IDENTIFICATION; LYMPHOCYTES; DISRUPTION; EXPRESSION; RESPONSES	Mice with a targeted disruption of the gene encoding a lymphoid-expressed orphan G protein-coupled receptor, G2A, demonstrate a normal pattern of T and B lineage differentiation through young adulthood. As G2A-deficient animals age, they develop secondary lymphoid organ enlargement associated with abnormal expansion of both T and B lymphocytes. Older G2A-deficient mice (>1 year) develop a slowly progressive wasting syndrome, characterized by lymphocytic infiltration into various tissues, glomerular immune complex deposition, and anti-nuclear autoantibodies. G2A-deficient T cells are hyperresponsive to TCR stimulation, exhibiting enhanced proliferation and a lower threshold for activation. Our findings demonstrate that G2A plays a critical role in controlling peripheral lymphocyte homeostasis and that its ablation results in the development of a novel, late-onset autoimmune syndrome.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Aventis Pharmaceut, Cambridge, MA 02139 USA; Univ Texas, SW Med Ctr, Harold C Simmons Arthrit Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Sanofi-Aventis; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Witte, ON (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	owenw@microbio.ucla.edu		Weng, Zhigang/0000-0003-1885-5501; Le, Lu/0000-0003-2817-5382; Harvill, Eric/0000-0001-8893-2133	NATIONAL CANCER INSTITUTE [R01CA090576, R01CA076204] Funding Source: NIH RePORTER; NCI NIH HHS [CA76204, T32 CA090576] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Beadling C, 1999, J IMMUNOL, V162, P2677; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Choi JW, 1996, CELL IMMUNOL, V168, P78, DOI 10.1006/cimm.1996.0051; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; Hashimoto Y, 2000, J IMMUNOL, V164, P1569, DOI 10.4049/jimmunol.164.3.1569; Heller M, 2000, ELECTROPHORESIS, V21, P2180, DOI 10.1002/1522-2683(20000601)21:11<2180::AID-ELPS2180>3.0.CO;2-#; Hornquist CE, 1997, J IMMUNOL, V158, P1068; JACOBSON BA, 1995, IMMUNITY, V3, P509, DOI 10.1016/1074-7613(95)90179-5; Jensen ER, 1998, INFECT IMMUN, V66, P4143; Kabarowski JHS, 2000, P NATL ACAD SCI USA, V97, P12109, DOI 10.1073/pnas.97.22.12109; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KRALL WJ, 1992, NEW BIOL, V4, P581; Kyaw H, 1998, DNA CELL BIOL, V17, P493, DOI 10.1089/dna.1998.17.493; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lippert E, 1997, FEBS LETT, V417, P292, DOI 10.1016/S0014-5793(97)01308-2; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; Miyazaki T, 1997, EMBO J, V16, P4217, DOI 10.1093/emboj/16.14.4217; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ohteki T, 1999, EUR J IMMUNOL, V29, P2886, DOI 10.1002/(SICI)1521-4141(199909)29:09<2886::AID-IMMU2886>3.0.CO;2-A; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Peterson EJ, 1999, CLIN EXP RHEUMATOL, V17, P107; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Plas DR, 1998, J MOL MED-JMM, V76, P589, DOI 10.1007/s001090050254; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Satterthwaite AB, 1998, J EXP MED, V188, P833, DOI 10.1084/jem.188.5.833; Sullivan KE, 2000, RHEUM DIS CLIN N AM, V26, P229, DOI 10.1016/S0889-857X(05)70137-X; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Van Parijs L, 1998, SCIENCE, V280, P243; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; WHITLOCK CA, 1987, METHOD ENZYMOL, V150, P275; Zohn IE, 2000, ONCOGENE, V19, P3866, DOI 10.1038/sj.onc.1203731	47	157	165	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					561	571		10.1016/S1074-7613(01)00145-5	http://dx.doi.org/10.1016/S1074-7613(01)00145-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371358	Bronze			2022-12-18	WOS:000168880900008
J	Chan, FKM; Siegel, RM; Lenardo, MJ				Chan, FKM; Siegel, RM; Lenardo, MJ			Signaling by the TNF receptor superfamily and T cell homeostasis	IMMUNITY			English	Review							NECROSIS-FACTOR RECEPTOR; APOPTOSIS; DOMAINS; ACTIVATION; LYMPHOCYTE; MUTATIONS		NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10,Room 11N311, Bethesda, MD 20892 USA.	mlenardo@nih.gov	Chan, Francis/ABB-1895-2021; Siegel, Richard/C-7592-2009; Chan, Francis Ka-Ming/E-9647-2014	Siegel, Richard/0000-0001-5953-9893; Chan, Francis Ka-Ming/0000-0002-4803-8353				BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Schreiber M, 1997, J VIROL, V71, P2171, DOI 10.1128/JVI.71.3.2171-2181.1997; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Tsao DHH, 2000, MOL CELL, V5, P1051, DOI 10.1016/S1097-2765(00)80270-1; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4	18	157	163	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2000	13	4					419	422		10.1016/S1074-7613(00)00041-8	http://dx.doi.org/10.1016/S1074-7613(00)00041-8			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	367UD	11070160	Bronze			2022-12-18	WOS:000090079100001
J	Weinmann, AS; Plevy, SE; Smale, ST				Weinmann, AS; Plevy, SE; Smale, ST			Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription	IMMUNITY			English	Article							NF-KAPPA-B; CHROMATIN STRUCTURE; MMTV PROMOTER; T-CELLS; INTERLEUKIN-12; ACTIVATION; ENHANCER; GENE; EXPRESSION; DISRUPTION	Nucleosomes are important for gene regulation, but comprehensive studies of nucleosome positioning, remodeling, and transcription factor binding at inducible mammalian promoters have not been reported. We have analyzed the IL-12 p40 promoter, which is induced in macrophages by bacterial products. High-resolution micrococcal nuclease analyses revealed that a positioned nucleosome, nucleosome 1, spans the promoter, with three positioned nucleosomes further upstream. Upon activation, nucleosome 1 was rapidly and selectively remodeled in a protein synthesis-dependent manner. In primary macrophages, IFN gamma synergistically enhanced p40 expression, but little effect on remodeling or promoter occupancy was observed. These results suggest that remodeling complexes are selectively targeted to a single, promoter-encompassing nucleosome and that IFN gamma influences an event that is independent or downstream of remodeling.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Smale, ST (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM07185] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; ENVER T, 1985, NATURE, V318, P680, DOI 10.1038/318680a0; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GROVES T, 1995, J IMMUNOL, V154, P501; Herrera RE, 1997, CHROMOSOMA, V106, P284, DOI 10.1007/s004120050249; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; REIK A, 1991, EMBO J, V10, P2569, DOI 10.1002/j.1460-2075.1991.tb07797.x; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; SAGAR AD, 1985, J INTERFERON RES, V5, P597, DOI 10.1089/jir.1985.5.597; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Ward SB, 1998, NUCLEIC ACIDS RES, V26, P2923, DOI 10.1093/nar/26.12.2923; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	35	157	158	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1999	11	6					665	675		10.1016/S1074-7613(00)80141-7	http://dx.doi.org/10.1016/S1074-7613(00)80141-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	271UX	10626889	Bronze			2022-12-18	WOS:000084612900003
J	Huppa, JB; Ploegh, HL				Huppa, JB; Ploegh, HL			The alpha chain of the T cell antigen receptor is degraded in the cytosol	IMMUNITY			English	Article							PRE-GOLGI DEGRADATION; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; PROTEINS; PEPTIDE; COMPLEX; ASSOCIATION; ER; DEGLYCOSYLATION; TRANSLOCATION	To reach the cell surface, the T cell receptor for antigen (TCR)-CD3 complex must assemble in the endoplasmic reticulum (ER), where single subunits are retained and degraded. However, the exact location of breakdown and the mechanism and proteases involved in destruction of free subunits have remained elusive. We show that degradation of the TCR alpha chain is impaired in the presence of lactacystin and carboxybenzyl-leucyl-leucyl-leucinal, two inhibitors for proteasomal proteolysis. We identified breakdown intermediates that were either soluble, cytosolic, and devoid of N-linked glycans, or membrane-associated and partially deglycosylated by cytosolic N-glycanase. Protease protection experiments showed a cytosolic disposition of these membrane-associated intermediates. Combined, these results argue for a cytosolic degradation route of the TCR alpha chain involving dislocation from the ER, followed by cytosolic deglycosylation and proteolysis by the proteasome.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)				Huppa, Johannes/0000-0003-2634-8198	NIAID NIH HHS [1 PO1 AI 37833-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037833] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BNIFACINO JS, 1994, MODERN CELL BIOL CEL, P137; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; FABBI M, 1995, EUR J IMMUNOL, V15, P821; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Machold RP, 1996, J EXP MED, V184, P2251, DOI 10.1084/jem.184.6.2251; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; MOZDZANOWSKI J, 1995, CURRENT PROTOCOL PRO; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; PARHAM P, 1979, J IMMUNOL, V123, P342; PLOEGH HL, 1995, CURRENT PROTOCOL PRO; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403; Scallen T J, 1981, Methods Enzymol, V74 Pt C, P320; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; STAM NJ, 1986, J IMMUNOL, V137, P2299; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Terhorst Cox, 1995, P369; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; WILEMAN T, 1991, J BIOL CHEM, V266, P4500; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973; WILEMAN T, 1993, J CELL BIOL, V122, P67, DOI 10.1083/jcb.122.1.67	56	157	158	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1997	7	1					113	122		10.1016/S1074-7613(00)80514-2	http://dx.doi.org/10.1016/S1074-7613(00)80514-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XN693	9252124	Bronze			2022-12-18	WOS:A1997XN69300010
J	Park, CG; Lee, SY; Kandala, G; Lee, SY; Choi, Y				Park, CG; Lee, SY; Kandala, G; Lee, SY; Choi, Y			A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death	IMMUNITY			English	Article							MATURE T-CELLS; CLONAL ELIMINATION; ANTIGEN; HYBRIDOMAS; THYMOCYTES; PATHWAY; TRANSCRIPTION; INTERFERON; TOLERANCE; APOPTOSIS	Cross-linking the TCR in T cell hybridomas induces cell apoptosis following activation. This activation-induced apoptosis has been used as a model for clonal deletion of thymocytes or peripheral T cells. Anti-TCR-induced apoptosis of T cell hybridomas requires de novo macromolecular synthesis, including up-regulation of Fas and Fast. The Fas-FasL interactiom then activates the apoptosis program. To study apoptosis-specific signaling processes, we generated a mutant T cell hybridoma line defective in induction of apoptosis, but competent to induce activation, upon TCR triggering. Subsequently, we cloned the gene TDAG51, which restored activation-induced apoptosis when transfected into the mutant cell line, and showed that TDAG51 expression was required for Fas expression. Thus, TDAG51 plays an essential role in induction of apoptosis by coupling TCR stimulation to Fas expression.	ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Rockefeller University	Park, CG (corresponding author), HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA.			Park, Chae Gyu/0000-0003-1906-1308				ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; ATWATER JA, 1990, ANNU REV GENET, V24, P519; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CAI JX, 1994, MECH DEVELOP, V47, P139, DOI 10.1016/0925-4773(94)90086-8; CALNAN BJ, 1995, IMMUNITY, V3, P273; COHEN PL, 1992, IMMUNOL TODAY, V13, P427, DOI 10.1016/0167-5699(92)90066-G; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GREEN DR, 1994, IMMUNOL REV, V142, P321, DOI 10.1111/j.1600-065X.1994.tb00895.x; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KUBO RT, 1989, J IMMUNOL, V142, P2736; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; Maniatis T, 1989, MOL CLONING; MCNABB DS, 1992, J VIROL, V66, P7581, DOI 10.1128/JVI.66.12.7581-7584.1992; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PARK CG, 1995, J EXP MED, V181, P1899, DOI 10.1084/jem.181.5.1899; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; UCKER DS, 1989, J IMMUNOL, V143, P3461; UCKER DS, 1994, IMMUNOL REV, V142, P273, DOI 10.1111/j.1600-065X.1994.tb00893.x; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; YAZDANBAKHSH K, 1995, P NATL ACAD SCI USA, V92, P437, DOI 10.1073/pnas.92.2.437; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037	44	157	163	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	1996	4	6					583	591		10.1016/S1074-7613(00)80484-7	http://dx.doi.org/10.1016/S1074-7613(00)80484-7			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UU443	8673705	Bronze			2022-12-18	WOS:A1996UU44300007
J	Zhu, LN; Yang, PH; Zhao, YZ; Zhuang, ZK; Wang, ZF; Son, R; Zhang, J; Liu, CY; Gao, QQ; Xu, QM; Wei, XY; Su, HX; Ye, BW; Wu, YA; Zhang, N; Lei, GL; Yu, LX; Yan, J; Diao, GH; Meng, FP; Bai, CQ; Mao, PY; Yu, YY; Wang, MY; Yuan, Y; Deng, QT; Li, ZY; Huang, YT; Hu, GH; Liu, Y; Wang, XQ; Xu, ZQ; Liu, PP; Bi, YH; Shi, Y; Zhang, SG; Chen, ZH; Wan, J; Xu, X; Wu, GZ; Wang, FS; Gao, GF; Liu, LQ; Liu, WJ				Zhu, Linnan; Yang, Penghui; Zhao, Yingze; Zhuang, Zhenkun; Wang, Zhifeng; Son, Rui; Zhang, Jie; Liu, Chuanyu; Gao, Qianqian; Xu, Qumiao; Wei, Xiaoyu; Su, Hai-Xi; Ye, Beiwei; Wu, Yanan; Zhang, Ning; Lei, Guanglin; Yu, Lingxiang; Yan, Jin; Diao, Guanghao; Meng, Fanping; Bai, Changqing; Mao, Panyong; Yu, Yeya; Wang, Mingyue; Yuan, Yue; Deng, Qiuting; Li, Ziyi; Huang, Yunting; Hu, Guohai; Liu, Yang; Wang, Xiaoqian; Xu, Ziqian; Liu, Peipei; Bi, Yuhai; Shi, Yi; Zhang, Shaogeng; Chen, Zhihai; Wan, Jian; Xu, Xun; Wu, Guizhen; Wang, Fu-Sheng; Gao, George F.; Liu, Longqi; Liu, William J.			Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients	IMMUNITY			English	Article							CORONAVIRUS; APOPTOSIS; OUTBREAK; RECEPTOR; PACKAGE	The coronavirus disease 2019 (COVID-19) pandemic poses a current world-wide public health threat. However, little is known about its hallmarks compared to other infectious diseases. Here, we report the single-cell transcriptional landscape of longitudinally collected peripheral blood mononuclear cells (PBMCs) in both COVID-19- and influenza A virus (IAV)-infected patients. We observed increase of plasma cells in both COVID-19 and IAV patients and XIAP associated factor 1 (XAF1)-, tumor necrosis factor (TNF)-, and FAS-induced T cell apoptosis in COVID-19 patients. Further analyses revealed distinct signaling pathways activated in COVID-19 (STAT1 and IRF3) versus IAV (STAT3 and NF kappa B) patients and substantial differences in the expression of key factors. These factors include relatively increase of interleukin (106R and 1L6ST expression in COVID-19 patients but similarly increased IL-6 concentrations compared to IAV patients, supporting the clinical observations of increased proinflammatory cytokines in COVID-19 patients. Thus, we provide the landscape of PBMCs and unveil distinct immune response pathways in COVID-19 and IAV patients.	[Zhu, Linnan; Zhuang, Zhenkun; Wang, Zhifeng; Liu, Chuanyu; Gao, Qianqian; Xu, Qumiao; Wei, Xiaoyu; Su, Hai-Xi; Yu, Yeya; Wang, Mingyue; Yuan, Yue; Deng, Qiuting; Li, Ziyi; Liu, Yang; Wang, Xiaoqian; Wan, Jian; Xu, Xun; Liu, Longqi] BGI Shenzhen, Shenzhen 518103, Peoples R China; [Zhu, Linnan; Zhuang, Zhenkun; Su, Hai-Xi; Huang, Yunting; Hu, Guohai; Wan, Jian; Xu, Xun; Liu, Longqi] BGI Shenzhen, China Natl GeneBank, Shenzhen 518120, Peoples R China; [Yang, Penghui; Lei, Guanglin; Yu, Lingxiang; Yan, Jin; Diao, Guanghao; Meng, Fanping; Bai, Changqing; Mao, Panyong; Zhang, Shaogeng; Wang, Fu-Sheng] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Beijing 100039, Peoples R China; [Zhao, Yingze; Zhang, Jie; Ye, Beiwei; Wu, Yanan; Xu, Ziqian; Liu, Peipei; Wu, Guizhen; Gao, George F.; Liu, William J.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China; [Son, Rui; Chen, Zhihai] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing 100015, Peoples R China; [Zhuang, Zhenkun] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou 510006, Peoples R China; [Zhang, Ning; Bi, Yuhai; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Wei, Xiaoyu; Yuan, Yue; Deng, Qiuting; Liu, Yang] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China; [Li, Ziyi] Northwest A&F Univ, Yangling 712100, Shanxi, Peoples R China; [Wang, Xiaoqian] BGI Shenzhen, BGI GenoImmune, Wuhan 4300794, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; South China University of Technology; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Beijing Genomics Institute (BGI)	Liu, LQ (corresponding author), BGI Shenzhen, Shenzhen 518103, Peoples R China.; Wang, FS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Med Ctr 5, Beijing 100039, Peoples R China.; Gao, GF; Liu, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 102206, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	fswang302@163.com; gaofu@chinacdc.cn; liulongqi@genomics.cn; liujun@ivdc.chinacdc.cn	Gao, George Fu/ABD-5229-2021	Liu, Chuanyu/0000-0003-2258-0897; Hu, Guohai/0000-0003-2756-8328	CAMS Research Units of Adaptive Evolution and Control of Emerging Viruses [2018RU009]; National Mega-projects for Infectious Diseases [2020ZX10001016-005-001]; Beijing New Star Plan of Science and Technology [Z181100006218080]; Excellent Young Scientist Program of the National Natural Science Foundation of China [81822040]; National Youth Talent Support Program; National Natural Science Foundation of China [81971564]; Science, Technology and Innovation Commission of Shenzhen Municipality [JSGG20180508152912700]; Shenzhen Key Laboratory of Single-Cell Omics [ZDSYS20190902093613831]	CAMS Research Units of Adaptive Evolution and Control of Emerging Viruses; National Mega-projects for Infectious Diseases; Beijing New Star Plan of Science and Technology; Excellent Young Scientist Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Youth Talent Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science, Technology and Innovation Commission of Shenzhen Municipality; Shenzhen Key Laboratory of Single-Cell Omics	We thank Yuxuan Liu (BGI) and Bo Li (BGI) for assisting the scRNA-seq library preparation. We also thank Dr. Andres Keller (Saarland University, Germany) for helpful discussion and evaluation of the DNBelab C4 technology. The study was supported by CAMS Research Units of Adaptive Evolution and Control of Emerging Viruses (2018RU009), National Mega-projects for Infectious Diseases (2020ZX10001016-005-001), and Beijing New Star Plan of Science and Technology (Z181100006218080). W.J.L. is supported by the Excellent Young Scientist Program of the National Natural Science Foundation of China (81822040) and the National Youth Talent Support Program. The study was supported by the National Natural Science Foundation of China (81971564); the Science, Technology and Innovation Commission of Shenzhen Municipality (JSGG20180508152912700); and Shenzhen Key Laboratory of Single-Cell Omics (ZDSYS20190902093613831). Editing support was received from Life Sciences Editors.	Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Desai P, 2018, J IMMUNOL, V200, P2894, DOI 10.4049/jimmunol.1701499; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gan HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17916; Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595; Jeong SI, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0867-4; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu C, 2019, PORTABLE COST EFFEC, DOI [DOI 10.1101/818450, 10.1101/818450]; Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006; Liu YX, 2020, NATL SCI REV, V7, P1003, DOI 10.1093/nsr/nwaa037; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Raju S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007053; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rolfes MA, 2018, INFLUENZA OTHER RESP, V12, P132, DOI 10.1111/irv.12486; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Straszewski-Chavez SL, 2007, J BIOL CHEM, V282, P13059, DOI 10.1074/jbc.M609038200; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xiong Y, 2020, EMERG MICROBES INFEC, V9, P761, DOI 10.1080/22221751.2020.1747363; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-x, 10.1038/s41368-020-0074-X]; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025933; Zhang FQ, 2019, EXP THER MED, V17, P4663, DOI 10.3892/etm.2019.7491; Zhao M, 2017, SCI CHINA LIFE SCI, V60, P1307, DOI 10.1007/s11427-017-9241-3; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zou B, 2012, MOL CARCINOGEN, V51, P422, DOI 10.1002/mc.20807	44	156	162	7	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					685	+		10.1016/j.immuni.2020.07.009	http://dx.doi.org/10.1016/j.immuni.2020.07.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32783921	Green Published, Bronze			2022-12-18	WOS:000569806100021
J	Glodde, N; Bald, T; van den Boorn-Konijnenberg, D; Nakamura, K; O'Donnell, JS; Szczepanski, S; Brandes, M; Eickhoff, S; Das, I; Shridhar, N; Hinze, D; Rogava, M; van der Sluis, TC; Ruotsalainen, JJ; Gaffal, E; Landsberg, J; Ludwig, KU; Wilhelm, C; Riek-Burchardt, M; Muller, AJ; Gebhardt, C; Scolyer, RA; Long, GV; Janzen, V; Teng, MWL; Kastenmuller, W; Mazzone, M; Smyth, MJ; Tuting, T; Hoelzel, M				Glodde, Nicole; Bald, Tobias; van den Boorn-Konijnenberg, Debby; Nakamura, Kyohei; O'Donnell, Jake S.; Szczepanski, Sabrina; Brandes, Maria; Eickhoff, Sarah; Das, Indrajit; Shridhar, Naveen; Hinze, Daniel; Rogava, Meri; van der Sluis, Tetje C.; Ruotsalainen, Janne J.; Gaffal, Evelyn; Landsberg, Jennifer; Ludwig, Kerstin U.; Wilhelm, Christoph; Riek-Burchardt, Monika; Mueller, Andreas J.; Gebhardt, Christoffer; Scolyer, Richard A.; Long, Georgina V.; Janzen, Viktor; Teng, Michele W. L.; Kastenmueller, Wolfgang; Mazzone, Massimiliano; Smyth, Mark J.; Tueting, Thomas; Hoelzel, Michael			Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy	IMMUNITY			English	Article							TUMOR-ASSOCIATED NEUTROPHILS; HEPATOCYTE GROWTH-FACTOR; T-CELL RESPONSES; IMMUNE-RESPONSE; LYMPH-NODES; G-CSF; LUNG; ACTIVATION; INHIBITION; MIGRATION	Inhibitors of the receptor tyrosine kinase c-MET are currently used in the clinic to target oncogenic signaling in tumor cells. We found that concomitant c-MET inhibition promoted adoptive T cell transfer and checkpoint immunotherapies in murine cancer models by increasing effector T cell infiltration in tumors. This therapeutic effect was independent of tumor cell-intrinsic c-MET dependence. Mechanistically, c-MET inhibition impaired the reactive mobilization and recruitment of neutrophils into tumors and draining lymph nodes in response to cytotoxic immunotherapies. In the absence of c-MET inhibition, neutrophils recruited to T cell-inflamed microenvironments rapidly acquired immunosuppressive properties, restraining T cell expansion and effector functions. In cancer patients, high serum levels of the c-MET ligand HGF correlated with increasing neutrophil counts and poor responses to checkpoint blockade therapies. Our findings reveal a role for the HGF/c-MET pathway in neutrophil recruitment and function and suggest that c-MET inhibitor co-treatment may improve responses to cancer immunotherapy in settings beyond c-MET-dependent tumors.	[Glodde, Nicole; Bald, Tobias; Shridhar, Naveen; Rogava, Meri; van der Sluis, Tetje C.; Ruotsalainen, Janne J.; Gaffal, Evelyn; Tueting, Thomas] Univ Magdeburg, Dept Dermatol, Lab Expt Dermatol, D-39120 Magdeburg, Germany; [Glodde, Nicole; Bald, Tobias; Shridhar, Naveen; Rogava, Meri; van der Sluis, Tetje C.; Gaffal, Evelyn; Landsberg, Jennifer] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany; [Glodde, Nicole; van den Boorn-Konijnenberg, Debby] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany; [Nakamura, Kyohei; O'Donnell, Jake S.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [O'Donnell, Jake S.; Teng, Michele W. L.] QIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy Lab, Herston, Qld 4006, Australia; [O'Donnell, Jake S.; Teng, Michele W. L.; Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Szczepanski, Sabrina; Brandes, Maria] Univ Bonn, Dept Internal Med Hematol Oncol Rheumatol 3, D-53105 Bonn, Germany; [Eickhoff, Sarah] Univ Bonn, Inst Expt Immunol, Lab Cellular Interact & Immunimaging, D-53105 Bonn, Germany; [Ludwig, Kerstin U.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Ludwig, Kerstin U.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany; [Wilhelm, Christoph] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit Immunopathol, D-53105 Bonn, Germany; [Riek-Burchardt, Monika; Mueller, Andreas J.] Univ Magdeburg, Inst Mol & Clin Immunol, D-39120 Magdeburg, Germany; [Mueller, Andreas J.] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany; [Gebhardt, Christoffer] Ruprecht Karl Univ Heidelberg, Skin Canc Unit, German Canc Res Ctr, D-69121 Heidelberg, Germany; [Scolyer, Richard A.] Ruprecht Karl Univ Heidelberg, Dept Dermatol Venereol & Allergol, Univ Med Ctr Mannheim, D-69121 Heidelberg, Germany; [Scolyer, Richard A.; Long, Georgina V.] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Sydney, NSW 2050, Australia; [Mazzone, Massimiliano] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia; [Mazzone, Massimiliano] Univ Sydney, Sydney Med Sch, Sydney, NSW 2065, Australia; [Mazzone, Massimiliano; Tueting, Thomas] VIB, Lab Mol Oncol & Angiogenesis, Vesalius Res Ctr, B-B3000 Leuven, Belgium; [Mazzone, Massimiliano; Hoelzel, Michael] Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium	Otto von Guericke University; University of Bonn; University of Bonn; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Sydney; Melanoma Institute Australia; University of Sydney; University of Sydney; Flanders Institute for Biotechnology (VIB); KU Leuven	Bald, T (corresponding author), Univ Magdeburg, Dept Dermatol, Lab Expt Dermatol, D-39120 Magdeburg, Germany.; Bald, T (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany.; Tuting, T (corresponding author), VIB, Lab Mol Oncol & Angiogenesis, Vesalius Res Ctr, B-B3000 Leuven, Belgium.; Hoelzel, M (corresponding author), Katholieke Univ Leuven, Vesalius Res Ctr, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium.	tobias.bald@qimrberghofer.edu.au; thomas.tueting@med.ovgu.de; michael.hoelzel@ukbonn.de	Ludwig, Kerstin U/H-7828-2019; Landsberg, Jennifer/AAF-5113-2019; Teng, Michele WL/S-5055-2016; Scolyer, Richard/AAE-8511-2019; Nakamura, Kyohei/AAH-4823-2019; Landsberg, Jenny/AGI-0216-2022; Tüting, Thomas/AAJ-3610-2021; Wilhelm, Christoph/ABE-7176-2020; Long, Georgina V/C-1771-2013	Ludwig, Kerstin U/0000-0002-8541-2519; Teng, Michele WL/0000-0003-1886-9145; Scolyer, Richard/0000-0002-8991-0013; Nakamura, Kyohei/0000-0002-6631-9028; Landsberg, Jenny/0000-0001-8029-3883; Tüting, Thomas/0000-0001-7146-0934; Wilhelm, Christoph/0000-0002-9839-0291; Long, Georgina V/0000-0001-8894-3545; Gebhardt, Christoffer/0000-0001-7090-9584; Mazzone, Massimiliano/0000-0001-8824-4015; Muller, Andreas/0000-0002-0281-6383; van der Sluis, Tetje/0000-0003-1804-1647; O'Donnell, Jake/0000-0003-2960-7992; Rogava, Meri/0000-0002-0314-5323; Ruotsalainen, Janne/0000-0002-5312-5486; Das, Indrajit/0000-0001-8407-9796	DFG-INST [217/674-1 FUGG]; EMBO long-term Fellowship [ALT945-2015]; National Health and Medical Research Council of Australia (NH&MRC) Early Career Fellowship [1124690]; DFG [1944/3-1, GE 2152/2-1, TU 90/8-1, SFB704, SFB854, HO4281/2-1]; ERC starting grant (OxyMO) [308459]; NH&MRC Research Fellowship [1078671]; NHMRC Project [1098960]; Australian Post-Graduate Award; QIMR Berghofer PhD Top-Up Scholarship; DFG (Z01) [SFB854, MU 3742/2-1]; DFG Cluster of Excellence ImmunoSensation [EXC 1023]; Else-Kroner-Fresenius-Stiftung [EKFS 2013_A297]	DFG-INST(German Research Foundation (DFG)); EMBO long-term Fellowship(European Molecular Biology Organization (EMBO)); National Health and Medical Research Council of Australia (NH&MRC) Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); DFG(German Research Foundation (DFG)); ERC starting grant (OxyMO); NH&MRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Post-Graduate Award(Australian Government); QIMR Berghofer PhD Top-Up Scholarship; DFG (Z01)(German Research Foundation (DFG)); DFG Cluster of Excellence ImmunoSensation(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung	We thank S. Bald, P. Aymans, K. Elder, and L. Town for managing the mouse colonies, K. Keppler and S. Sivalingam for help with NGS, and E. Endel, P. Wurst and An. Dolf for help with FACS sorting. We thank the UKB FACS core facility. We thank the UKB and Mannheim/DKFZ Biobank core facilities. Instruments at the UKB NGS core facility were supported in part by grant DFG-INST 217/674-1 FUGG. T.B. was funded by an EMBO long-term Fellowship (ALT945-2015) and a National Health and Medical Research Council of Australia (NH&MRC) Early Career Fellowship (1124690). K.U.L. was supported by DFG (1944/3-1). M.M. was supported by an ERC starting grant (OxyMO, 308459). M.J.S. was supported by a NH&MRC Research Fellowship (1078671) and M.J.S., K.N, and M.W.L.T. were supported by a NH&MRC Project Grant (1098960). J.S.O'D. was supported by an Australian Post-Graduate Award and QIMR Berghofer PhD Top-Up Scholarship. M.R.-B. and A.J.M. were supported by grants from the DFG (Z01 in the SFB854, MU 3742/2-1). C.G. was supported by a grant from the DFG (GE 2152/2-1). T.T. was funded in part by grants from the DFG (TU 90/8-1, A22 in the SFB704, and A27 in the SFB854). M.H. was funded in part by DFG (HO4281/2-1) and DFG Cluster of Excellence ImmunoSensation (EXC 1023). T.T. and M. H. were funded by Else-Kroner-Fresenius-Stiftung (EKFS 2013_A297). C.W., W.K., T.T., and M. H. are members of the DFG Cluster of Excellence ImmunoSensation (EXC 1023).	Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Blaisdell A, 2015, CANCER CELL, V28, P785, DOI 10.1016/j.ccell.2015.11.005; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Crompton JG, 2015, CANCER RES, V75, P296, DOI 10.1158/0008-5472.CAN-14-2277; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Ferrucci PF, 2015, BRIT J CANCER, V112, P1904, DOI 10.1038/bjc.2015.180; Finisguerra V, 2016, ONCOGENE, V35, P5457, DOI 10.1038/onc.2016.36; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; GERRARD TL, 1981, J NATL CANCER I, V66, P483; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Graveel CR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009209; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Hampton HR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8139; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hattori N, 2004, AM J PATHOL, V164, P1091, DOI 10.1016/S0002-9440(10)63196-3; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Holzel M, 2013, NAT REV CANCER, V13, P365, DOI 10.1038/nrc3498; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jalili A, 2010, STEM CELLS DEV, V19, P1143, DOI 10.1089/scd.2009.0376; Kamenyeva O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004827; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Singhal S, 2016, CANCER CELL, V30, P120, DOI 10.1016/j.ccell.2016.06.001; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289	64	156	158	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					789	+		10.1016/j.immuni.2017.09.012	http://dx.doi.org/10.1016/j.immuni.2017.09.012			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045907	Bronze, Green Published			2022-12-18	WOS:000413091600021
J	Sander, S; Chu, VT; Yasuda, T; Franklin, A; Graf, R; Calado, DP; Li, S; Imami, K; Selbach, M; Di Virgilio, M; Bullinger, L; Rajewsky, K				Sander, Sandrine; Van Trung Chu; Yasuda, Tomoharu; Franklin, Andrew; Graf, Robin; Calado, Dinis Pedro; Li, Shuang; Imami, Koshi; Selbach, Matthias; Di Virgilio, Michela; Bullinger, Lars; Rajewsky, Klaus			PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark Zones	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; TUMOR-SUPPRESSOR; SOMATIC HYPERMUTATION; AID; SELECTION; MYC; PROLIFERATION; INVOLVEMENT; MUTATIONS; REGULATOR	Phosphatidylinositol 3' OH kinase (PI3K) signaling and FOXO transcription factors play opposing roles at several B cell developmental stages. We show here abundant nuclear FOXO1 expression in the proliferative compartment of the germinal center (GC), its dark zone (DZ), and PI3K activity, downregulating FOXO1, in the light zone (LZ), where cells are selected for further differentiation. In the LZ, however, FOXO1 was expressed in a fraction of cells destined for DZ reentry. Upon FOXO1 ablation or induction of PI3K activity, GCs lost their DZ, owing at least partly to downregulation of the chemokine receptor CXCR4. Although this prevented proper cyclic selection of cells in GCs, somatic hypermutation and proliferation were maintained. Class switch recombination was partly lost due to a failure of switch region targeting by activation-induced deaminase (AID).	[Sander, Sandrine; Van Trung Chu; Yasuda, Tomoharu; Franklin, Andrew; Graf, Robin; Calado, Dinis Pedro; Li, Shuang; Rajewsky, Klaus] Max Delbruck Ctr Mol Med, Immune Regulat & Canc, Helmholtz Alliance, D-13125 Berlin, Germany; [Imami, Koshi; Selbach, Matthias] Max Delbruck Ctr Mol Med, Proteome Dynam, Helmholtz Alliance, D-13125 Berlin, Germany; [Di Virgilio, Michela] Max Delbruck Ctr Mol Med, DNA Repair & Maintenance Genome Stabil, Helmholtz Alliance, D-13125 Berlin, Germany; [Bullinger, Lars] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Calado, Dinis Pedro] London Res Inst, Canc Res UK, London WC2A 3LY, England; [Calado, Dinis Pedro] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ulm University; Cancer Research UK; University of London; King's College London	Sander, S (corresponding author), Max Delbruck Ctr Mol Med, Immune Regulat & Canc, Helmholtz Alliance, D-13125 Berlin, Germany.	sandrine.sander@mdc-berlin.de; klaus.rajewsky@mdc-berlin.de	Di Virgilio, Michela/AAE-9298-2022; Bullinger, Lars/AAL-7965-2020; Calado, Dinis/U-8379-2019; Yasuda, Tomoharu/J-5102-2019	Calado, Dinis/0000-0001-8239-7184; Graf, Robin/0000-0002-5400-9938; Di Virgilio, Michela/0000-0001-5189-0793; Chu, Van Trung/0000-0003-1327-8696; Sander, Sandrine/0000-0003-4645-3366; Yasuda, Tomoharu/0000-0001-9997-6852; Imami, Koshi/0000-0002-7451-4982; Rajewsky, Klaus/0000-0002-6633-6370; Bullinger, Lars/0000-0002-5890-5510	Else Kroner-Fresenius-Stiftung [2014-A191]; European Research Council (ERC Advanced Grant) [268921]; Deutsche Forschungsgemeinschaft [BU 1339/3-1]; MRC [MR/J008060/1] Funding Source: UKRI; Cancer Research UK [16857] Funding Source: researchfish; Medical Research Council [MR/J008060/1] Funding Source: researchfish; The Francis Crick Institute [10057] Funding Source: researchfish	Else Kroner-Fresenius-Stiftung; European Research Council (ERC Advanced Grant)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank R.A. DePinho (MD Anderson Cancer Center) for Foxo1<SUP>fl/fl</SUP> mice. We thank C. Grosse, J. Woehlecke, J. Pempe, and K. Petsch for technical assistance; R. Lauhkonen-Seitz for administrative assistance; and the K. R. laboratory members for critical comments and suggestions. We are grateful to R. Dalla-Favera and D. Dominguez-Sola for discussions and the communication of unpublished results. The work was supported by the Else Kroner-Fresenius-Stiftung (2014-A191 to S.S. and K.R.), the European Research Council (ERC Advanced Grant 268921 to K.R.), and the Deutsche Forschungsgemeinschaft (Heisenberg Scholarship BU 1339/3-1 to L.B.). M.D.V. is a Helmholtz Young Investigators Group leader (Helmholtz Association).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Bjorkman A, 2015, P NATL ACAD SCI USA, V112, P2157, DOI 10.1073/pnas.1418947112; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Mori H, 2009, DNA REPAIR, V8, P1328, DOI 10.1016/j.dnarep.2009.08.007; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Obrador-Hevia A, 2012, BRIT J HAEMATOL, V156, P334, DOI 10.1111/j.1365-2141.2011.08951.x; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Oprea M, 1997, J IMMUNOL, V158, P5155; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reth M, 2014, ADV IMMUNOL, V122, P129, DOI 10.1016/B978-0-12-800267-4.00004-3; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Nguyen TV, 2014, J EXP MED, V211, P1011, DOI 10.1084/jem.20131637; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003	51	156	157	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1075	1086		10.1016/j.immuni.2015.10.021	http://dx.doi.org/10.1016/j.immuni.2015.10.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26620760	Bronze, Green Accepted			2022-12-18	WOS:000366846600012
J	Colom, B; Bodkin, JV; Beyrau, M; Woodfin, A; Ody, C; Rourke, C; Chavakis, T; Brohi, K; Imhof, BA; Nourshargh, S				Colom, Bartomeu; Bodkin, Jennifer V.; Beyrau, Martina; Woodfin, Abigail; Ody, Christiane; Rourke, Claire; Chavakis, Triantafyllos; Brohi, Karim; Imhof, Beat A.; Nourshargh, Sussan			Leukotriene B-4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo	IMMUNITY			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; HUMAN-LEUKOCYTE ELASTASE; VENULAR WALLS; VASCULAR-PERMEABILITY; AMMATORY ARTHRITIS; INFLAMMATION; ADHESION; INHIBITOR; MOLECULE	Breaching endothelial cells (ECs) is a decisive step in the migration of leukocytes from the vascular lumen to the extravascular tissue, but fundamental aspects of this response remain largely unknown. We have previously shown that neutrophils can exhibit abluminal-to-luminal migration through EC junctions within mouse cremasteric venules and that this response is elicited following reduced expression and/or functionality of the EC junctional adhesion molecule-C (JAM-C). Here we demonstrate that the lipid chemoattractant leukotriene B-4 (LTB4) was efficacious at causing loss of venular JAM-C and promoting neutrophil reverse transendothelial cell migration (rTEM) in vivo. Local proteolytic cleavage of EC JAM-C by neutrophil elastase (NE) drove this cascade of events as supported by presentation of NE to JAM-C via the neutrophil adhesion molecule Mac-1. The results identify local LTB4-NE axis as a promoter of neutrophil rTEM and provide evidence that this pathway can propagate a local sterile inflammatory response to become systemic.	[Colom, Bartomeu; Bodkin, Jennifer V.; Beyrau, Martina; Woodfin, Abigail; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Ody, Christiane; Imhof, Beat A.] Ctr Med Univ Geneva, CH-1211 Geneva, Switzerland; [Rourke, Claire; Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Trauma Sci, London E1 4NS, England; [Chavakis, Triantafyllos] Univ Dresden, Dept Clin Pathobiochem, D-01307 Dresden, Germany	University of London; Queen Mary University London; University of Geneva; University of London; Queen Mary University London; Technische Universitat Dresden	Nourshargh, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk	Colom, Bartomeu/AAA-7539-2019; Chavakis, Triantafyllos/ABE-8845-2020	Nourshargh, Sussan/0000-0001-5677-1806; Colom, Bartomeu/0000-0001-6256-6462	Wellcome Trust [098291/Z/12/Z]; ERC (ENDHORET); William Harvey Research Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); ERC (ENDHORET); William Harvey Research Foundation	This work was supported by generous funds from the Wellcome Trust (098291/Z/12/Z to S.N.). T.C. was supported by the ERC (ENDHORET). The work was also supported in part by funds from the William Harvey Research Foundation.	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Aikawa N, 2011, PULM PHARMACOL THER, V24, P549, DOI 10.1016/j.pupt.2011.03.001; Auner B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/536156; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; DONNELLY SC, 1995, AM J RESP CRIT CARE, V151, P1428, DOI 10.1164/ajrccm.151.5.7735596; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Fujii M, 2010, INTERACT CARDIOV TH, V10, P859, DOI 10.1510/icvts.2009.225243; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Manetti M, 2013, ARTHRITIS RHEUM-US, V65, P247, DOI 10.1002/art.37712; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Rabquer BJ, 2010, J IMMUNOL, V185, P1777, DOI 10.4049/jimmunol.1000556; Rainger GE, 1998, BLOOD, V92, P4819, DOI 10.1182/blood.V92.12.4819.424k16_4819_4827; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Smith PD, 2012, CIRCULATION, V126, pS110, DOI 10.1161/CIRCULATIONAHA.111.080275; Souza DG, 2000, EUR J PHARMACOL, V403, P121, DOI 10.1016/S0014-2999(00)00574-4; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7; Voisin MB, 2013, J INNATE IMMUN, V5, P336, DOI 10.1159/000346659; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yoo SK, 2011, J LEUKOCYTE BIOL, V89, P661, DOI 10.1189/jlb.1010567; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267	48	156	158	2	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1075	1086		10.1016/j.immuni.2015.05.010	http://dx.doi.org/10.1016/j.immuni.2015.05.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26047922	hybrid, Green Published			2022-12-18	WOS:000356362800013
J	Tai, X; Erman, B; Alag, A; Mu, J; Kimura, M; Katz, G; Guinter, T; McCaughtry, T; Etzensperger, R; Feigenbaum, L; Singer, DS; Singer, A				Tai, Xuguang; Erman, Batu; Alag, Amala; Mu, Jie; Kimura, Motoko; Katz, Gil; Guinter, Terry; McCaughtry, Tom; Etzensperger, Ruth; Feigenbaum, Lionel; Singer, Dinah S.; Singer, Alfred			Foxp3 Transcription Factor Is Proapoptotic and Lethal to Developing Regulatory T Cells unless Counterbalanced by Cytokine Survival Signals	IMMUNITY			English	Article							NEGATIVE SELECTION; LINEAGE FATE; GENE; SPECIFICITY; APOPTOSIS; THYMUS; SELF; BIM; DIFFERENTIATION; AUTOIMMUNITY	Immune tolerance requires regulatory T (Treg) cells to prevent autoimmune disease, with the transcription factor Foxp3 functioning as the critical regulator of Treg cell development and function. We report here that Foxp3 was lethal to developing Treg cells in the thymus because it induced a unique proapoptotic protein signature (Puma(++) p-Bim(++) p-JNK(++) DUSP6(-)) and repressed expression of prosurvival Bcl-2 molecules. However, Foxp3 lethality was prevented by common gamma chain (gc)-dependent cytokine signals that were present in the thymus in limiting amounts sufficient to support only similar to 1 million Treg cells. Consequently, most newly arising Treg cells in the thymus were deprived of this signal and underwent Foxp3-induced death, with Foxp3(+)CD25(-) Treg precursor cells being the most susceptible. Thus, we identify Foxp3 as a proapoptotic protein that requires developing Treg cells to compete with one another for limiting amounts of gamma c-dependent survival signals in the thymus.	[Tai, Xuguang; Alag, Amala; Mu, Jie; Kimura, Motoko; Katz, Gil; Guinter, Terry; McCaughtry, Tom; Etzensperger, Ruth; Singer, Dinah S.; Singer, Alfred] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Erman, Batu] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Feigenbaum, Lionel] SAIC Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sabanci University; Science Applications International Corporation (SAIC); SAIC-Frederick	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	singera@mail.nih.gov	erman, batu/AAE-1963-2020		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC011111, ZIABC011113, ZIABC011114, ZIABC011106, ZIABC011425, ZIABC011111, ZIABC011112, ZIABC009273, ZIABC011117, ZIABC011116] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to P. Henkart for editorial assistance; J. Bluestone, V. Kuchroo, A. Strasser, and M. A. Farrar for mice; and R. Hodes, J.-H. Park, and N. Taylor for reading the manuscript. This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kim GY, 2012, J IMMUNOL, V188, P5859, DOI 10.4049/jimmunol.1102328; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; KRAMER S, 1995, J EXP MED, V182, P1769, DOI 10.1084/jem.182.6.1769; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	44	156	161	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1116	1128		10.1016/j.immuni.2013.02.022	http://dx.doi.org/10.1016/j.immuni.2013.02.022			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23746651	Green Accepted, Bronze			2022-12-18	WOS:000330947500008
J	Miyake, Y; Toyonaga, K; Mori, D; Kakuta, S; Hoshino, Y; Oyamada, A; Yamada, H; Ono, KI; Suyama, M; Iwakura, Y; Yoshikai, Y; Yamasaki, S				Miyake, Yasunobu; Toyonaga, Kenji; Mori, Daiki; Kakuta, Shigeru; Hoshino, Yoshihiko; Oyamada, Akiko; Yamada, Hisakata; Ono, Ken-ichiro; Suyama, Mikita; Iwakura, Yoichiro; Yoshikai, Yasunobu; Yamasaki, Sho			C-type Lectin MCL Is an FcR gamma-Coupled Receptor that Mediates the Adjuvanticity of Mycobacterial Cord Factor	IMMUNITY			English	Article							DENDRITIC CELL-RECEPTOR; ACTIVATING RECEPTOR; CANDIDA-ALBICANS; INNATE IMMUNITY; DAMAGED CELLS; MICE; RECOGNITION; MINCLE; TUBERCULOSIS; MACROPHAGES	Cord factor, also called trehalose-6,6'-dimycolate (TDM), is a potent mycobacterial adjuvant. We herein report that the C-type lectin MCL (also called Clec4d) is a TDM receptor that is likely to arise from gene duplication of Mincle (also called Clec4e). Mincle is known to be an inducible receptor recognizing TDM, whereas MCL was constitutively expressed in myeloid cells. To examine the contribution of MCL in response to TDM adjuvant, we generated MCL-deficient mice. TDM promoted innate immune responses, such as granuloma formation, which was severely impaired in MCL-deficient mice. TDM-induced acquired immune responses, such as experimental autoimmune encephalomyelitis (EAE), was almost completely dependent on MCL, but not Mincle. Furthermore, by generating Clec4e(gfp) reporter mice, we found that MCL was also crucial for driving Mincle induction upon TDM stimulation. These results suggest that MCL is an FcR gamma-coupled activating receptor that mediates the adjuvanticity of TDM.	[Miyake, Yasunobu; Toyonaga, Kenji; Mori, Daiki; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan; [Miyake, Yasunobu; Yamada, Hisakata; Yoshikai, Yasunobu; Yamasaki, Sho] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Oyamada, Akiko; Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Div Host Def, Fukuoka 8128582, Japan; [Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Fukuoka 8128582, Japan; [Kakuta, Shigeru; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Dept Mol Pathogenesis, Tokyo 1088639, Japan; [Hoshino, Yoshihiko] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo 1890002, Japan; [Ono, Ken-ichiro] Med & Biol Labs Corp Ltd, Ina Lab, Dept Res & Dev, Ina, Nagano 3960002, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; University of Tokyo; National Institute of Infectious Diseases (NIID)	Yamasaki, S (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp	Hoshino, Yoshihiko/B-5159-2019; Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018	Hoshino, Yoshihiko/0000-0002-3132-0715; Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Yamasaki, Sho/0000-0002-5184-6917; Suyama, Mikita/0000-0001-9526-3193; MORI, Daiki/0000-0002-3596-0840	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation; Uehara memorial foundation; Institute of Medical Science, the University of Tokyo; Grants-in-Aid for Scientific Research [25461178] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara memorial foundation(Uehara Memorial Foundation); Institute of Medical Science, the University of Tokyo; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Kubo for generating mutant mice; Y. Fukui, E. Ishikawa, M. Nagata, S. Saijo, S. Maenaka, and M. Nakao for discussion; M. Tanaka for cDNA; H. Miyoshi for lentivirus vectors; M. Kurata, M. Shiokawa, Y. Sakakibara, and A. Nakayama for technical assistance; Y. Sanui-Nishi for secretarial assistance; and Laboratory, Medical Institute of Bioregulation, Kyushu University for technical support. This work was supported by Grant-in-Aid for Young Scientists (S), Funding Program for Next Generation World-Leading Researchers (NEXT Program), Takeda Science Foundation, the Uehara memorial foundation (S. Y.), Grant-in-Aid for Young Scientists (B), the Uehara Memorial foundation (Y. M.), and the Grant for Joint Research Project of the Institute of Medical Science, the University of Tokyo.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Balch SG, 1998, J BIOL CHEM, V273, P18656, DOI 10.1074/jbc.273.29.18656; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; BEKIERKUNST A, 1968, J BACTERIOL, V96, P958, DOI 10.1128/JB.96.4.958-961.1968; BLOCH H, 1950, J EXP MED, V91, P197, DOI 10.1084/jem.91.2.197; Cambi A, 2009, CURR BIOL, V19, pR375, DOI 10.1016/j.cub.2009.03.032; Christensen D, 2009, J LIPOSOME RES, V19, P2, DOI 10.1080/08982100902726820; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Edwards MJ, 2012, DEV COMP IMMUNOL, V37, P213, DOI 10.1016/j.dci.2012.03.013; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Masumoto M, 1999, J IMMUNOL, V163, P5039; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; NUMATA F, 1985, CHEM PHARM BULL, V33, P4544; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; SAKURAI T, 1989, VACCINE, V7, P269, DOI 10.1016/0264-410X(89)90242-9; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Watanabe R, 1999, VACCINE, V17, P1484, DOI 10.1016/S0264-410X(98)00367-3; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wines BD, 2006, J BIOL CHEM, V281, P17108, DOI 10.1074/jbc.M601640200; YAMAGUCHI M, 1955, Kekkaku, V30, P521; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	47	156	158	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1050	1062		10.1016/j.immuni.2013.03.010	http://dx.doi.org/10.1016/j.immuni.2013.03.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23602766	Bronze			2022-12-18	WOS:000330942500021
J	Schakel, K; Kietzell, M; Haensel, A; Ebling, A; Schulze, L; Haase, M; Semmler, C; Sarfati, M; Barclay, AN; Randolph, GJ; Meurer, M; Rieber, EP				Schakel, K; Kietzell, M; Haensel, A; Ebling, A; Schulze, L; Haase, M; Semmler, C; Sarfati, M; Barclay, AN; Randolph, GJ; Meurer, M; Rieber, EP			Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes	IMMUNITY			English	Article							RED-BLOOD-CELLS; SIGNAL-REGULATORY PROTEIN; CHIMERIC MONOCLONAL-ANTIBODY; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; T-CELL; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; TNF-ALPHA; ACTIVATION	Early and high-level production of IL-12 is crucial for effective immune responses against pathogens. Up until now, the cells providing this initial IL-12 have remained elusive. Here we show that a subset of human blood dendritic cells (DC) is the principal and primary source of IL-12p70 when blood leukocytes are stimulated with the TILR4-ligand LPS or with CD40-ligand. These so-called slanDC are characterized by the 6-sulfo LacNAc modification of PSGL-1, which is identified by the mAb M-DC8. The IL-12 response of slanDC requires a few hours of in vitro maturation, which is completely blocked in the presence of erythrocytes. This inhibition of maturation depends on the expression of CD47 on erythrocytes and of its ligand SIRP alpha on DC. While strictly controlled in the blood by erythrocytes, the high IL-12- and TNF-alpha-producing capacity of slanDC in tissues may be critical in fighting off pathogens; if uncontrolled, it may lead to adverse inflammatory reactions.	Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany; Tech Univ Dresden, Dept Dermatol, D-01307 Dresden, Germany; Tech Univ Dresden, Fac Med, Inst Pathol, D-01307 Dresden, Germany; CHU Montreal, Notre Dame Hosp, Res Ctr, Montreal, PQ H2L 4M1, Canada; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; CUNY Mt Sinai Sch Med, Icahn Res Inst, Dept Gene & Cell Med, New York, NY 10029 USA	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Universite de Montreal; University of Oxford; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Schakel, K (corresponding author), Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany.	knut.schaekel@tu-dresden.de			MRC [G0400808] Funding Source: UKRI; Medical Research Council [G0400808] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aoshiba K, 1999, BLOOD, V93, P4006, DOI 10.1182/blood.V93.11.4006.411k18_4006_4010; Arosa FA, 2004, CURR PHARM DESIGN, V10, P191, DOI 10.2174/1381612043453432; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; COHEN J, 1995, SCIENCE, V270, P908; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Fonseca AM, 2003, CELL IMMUNOL, V224, P17, DOI 10.1016/S0008-8749(03)00170-9; Fonseca AM, 2001, BLOOD, V97, P3152, DOI 10.1182/blood.V97.10.3152; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Leonard JP, 1997, BLOOD, V90, P2541; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Morita Y, 1998, ARTHRITIS RHEUM, V41, P306, DOI 10.1002/1529-0131(199802)41:2<306::AID-ART15>3.3.CO;2-W; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Portielje JEA, 2003, CANCER IMMUNOL IMMUN, V52, P133, DOI 10.1007/s00262-002-0356-5; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; ROBERTSON MJ, 1992, J EXP MED, V175, P779, DOI 10.1084/jem.175.3.779; Schakel K, 1998, EUR J IMMUNOL, V28, P4084, DOI 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmitz M, 2005, J IMMUNOL, V174, P4127, DOI 10.4049/jimmunol.174.7.4127; Schmitz M, 2002, BLOOD, V100, P1502, DOI 10.1182/blood.V100.4.1502.h81602001502_1502_1504; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Youn HS, 2005, J IMMUNOL, V175, P3339, DOI 10.4049/jimmunol.175.5.3339	39	156	162	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					767	777		10.1016/j.immuni.2006.03.020	http://dx.doi.org/10.1016/j.immuni.2006.03.020			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782032	Bronze			2022-12-18	WOS:000238592200014
J	Kuhns, MS; Davis, MM; Garcia, KC				Kuhns, MS; Davis, MM; Garcia, KC			Deconstructing the form and function of the TCR/CD3 complex	IMMUNITY			English	Review							T-CELL-RECEPTOR; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGE; POSITIVE SELECTION; STRUCTURAL BASIS; CD3 COMPLEX; ALPHA; TCR; CHAIN; CD3-EPSILON-GAMMA	When T cells encounter antigens via the T cell antigen receptor (TCR), information about the quantity and quality of antigen engagement is relayed to the intracellular signal transduction machinery. This process is poorly understood. The TCR itself lacks a significant intracellular domain. Instead, it is associated with CD3 molecules that contain intracellular signaling domains that couple the TCR/CD3 complex to the downstream signaling machinery. The earliest events in TCR signaling must involve the transfer of information from the antigen binding TCR subunit to the CD3 signaling subunits of the TCR/CD3 complex. Elucidating the structural organization of the TCR with the associated CD3 signaling molecules is necessary for understanding the mechanism by which TCR engagement is coupled to activation. Here, we review the current state of our understanding of the structure and organization of the TCR/CD3 complex.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Kuhns, MS (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Davis, Mark/0000-0001-6868-657X				Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Hayes SM, 2002, J EXP MED, V196, P1355, DOI 10.1084/jem.20021196; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Karaivanova V, 1999, HYBRIDOMA, V18, P497; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094	34	156	188	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2006	24	2					133	139		10.1016/j.immuni.2006.01.006	http://dx.doi.org/10.1016/j.immuni.2006.01.006			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473826	Bronze			2022-12-18	WOS:000235479000005
J	Boackle, SA; Holers, VM; Chen, XJ; Szakonyi, G; Karp, DR; Wakeland, EK; Morel, L				Boackle, SA; Holers, VM; Chen, XJ; Szakonyi, G; Karp, DR; Wakeland, EK; Morel, L			Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein	IMMUNITY			English	Article							MOUSE COMPLEMENT RECEPTOR-1; B-CELL HYPERACTIVITY; T-DEPENDENT ANTIGEN; ERYTHEMATOSUS SLE; LIGAND-BINDING; LYMPHOCYTES-B; TYPE-1 CR-1; EXPRESSION; CD21; DISSECTION	The major murine systemic lupus erythematosus (SLE) susceptibility locus, Sle1, corresponds to three loci independently affecting loss of tolerance to chromatin in the NZM2410 mouse. The congenic interval corresponding to Sle1c contains Cr2, which encodes complement receptors 1 and 2 (CR1/CR2, CD35/CD21). NZM2410/NZW Cr2 exhibits a single nucleotide polymorphism that introduces a novel glycosylation site, resulting in higher molecular weight proteins. This polymorphism, located in the Cad binding domain, reduces ligand binding and receptor-mediated cell signaling. Molecular modeling based on the recently solved CR2 structure in complex with Cad reveals that this glycosylation interferes with receptor dimerization. These data demonstrate a functionally significant phenotype for the NZM2410 Cr2 allele and strongly support its role as a lupus susceptibility gene.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Texas, SW Med Ctr, Harold C Simmons Arthritis Res Ctr, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75235 USA; Univ Florida, Dept Med, Gainesville, FL 32608 USA; Univ Florida, Dept Pathol, Gainesville, FL 32608 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Boackle, SA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA.				NATIONAL CANCER INSTITUTE [P30CA046934, R01CA053615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001516, R01AI031105] Funding Source: NIH RePORTER; NCI NIH HHS [R0-1 CA53615, CA46934] Funding Source: Medline; NIAID NIH HHS [K0-8 AI01516, R0-1 AI49901, R0-1 AI31105] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ARVIEUX J, 1988, IMMUNOLOGY, V65, P229; Boackle SA, 1998, J IMMUNOL, V161, P6537; Boackle SA, 1997, EUR J IMMUNOL, V27, P122, DOI 10.1002/eji.1830270119; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1988, J IMMUNOL, V141, P457; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; EASTCOTT JW, 1983, J IMMUNOL, V131, P2232; FINGEROTH JD, 1989, IMMUNOL LETT, V21, P291, DOI 10.1016/0165-2478(89)90022-9; FINGEROTH JD, 1990, J IMMUNOL, V144, P3458; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; HENSON SE, 2001, IN PRESS J IMMUNOL M; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAUS GGB, 1978, IMMUNOLOGY, V34, P643; KOZONO Y, 1995, EUR J IMMUNOL, V25, P1013, DOI 10.1002/eji.1830250423; Kozono Y, 1998, J IMMUNOL, V160, P1565; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LANZAVECCHIA A, 1988, J EXP MED, V167, P345, DOI 10.1084/jem.167.2.345; Leiter E. H., 1993, ILAR News, V35, P4; Leiter E. H., 1998, NOD MICE RELATED STR, P1; LEVY E, 1992, CLIN EXP IMMUNOL, V90, P235; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; Marchbank KJ, 2000, J IMMUNOL, V165, P2354, DOI 10.4049/jimmunol.165.5.2354; MARQUART HV, 1995, CLIN EXP IMMUNOL, V101, P60; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Mohan C, 1999, J IMMUNOL, V162, P6492; Mohan C, 1997, J IMMUNOL, V159, P454; Mohan C, 1998, J CLIN INVEST, V101, P1362; MOLINA H, 1990, J IMMUNOL, V145, P2974; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOLINA H, 1994, J IMMUNOL, V153, P789; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; PAPAMICHAIL M, 1975, SCAND J IMMUNOL, V4, P343, DOI 10.1111/j.1365-3083.1975.tb02635.x; PRAMOONJAGO P, 1993, INT IMMUNOL, V5, P337, DOI 10.1093/intimm/5.4.337; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; RUDOFSKY UH, 1993, LAB INVEST, V68, P419; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Takahashi K, 1997, J IMMUNOL, V159, P1557; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Wakeland EK, 1999, CURR OPIN IMMUNOL, V11, P701, DOI 10.1016/S0952-7915(99)00039-4; WILSON JG, 1986, ARTHRITIS RHEUM, V29, P739, DOI 10.1002/art.1780290606; Wu XB, 2000, J IMMUNOL, V165, P3119, DOI 10.4049/jimmunol.165.6.3119	53	156	159	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2001	15	5					775	785		10.1016/S1074-7613(01)00228-X	http://dx.doi.org/10.1016/S1074-7613(01)00228-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728339	Bronze			2022-12-18	WOS:000172528200010
J	Roumier, A; Olivo-Marin, JC; Arpin, M; Michel, F; Martin, M; Mangeat, P; Acuto, O; Dautry-Varsat, A; Alcover, A				Roumier, A; Olivo-Marin, JC; Arpin, M; Michel, F; Martin, M; Mangeat, P; Acuto, O; Dautry-Varsat, A; Alcover, A			The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation	IMMUNITY			English	Article							AUREUS ENTEROTOXIN-B; F-ACTIN BINDING; SMALL G-PROTEIN; ANTIGEN-RECEPTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CYTOSKELETAL POLARIZATION; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; DOWN-REGULATION; ERM PROTEINS	Dynamic interactions between membrane and cytoskeleton components are crucial for T cell antigen recognition and subsequent cellular activation. We report here that the membrane-microfilament linker ezrin plays an important role in these processes. First, ezrin relocalizes to the contact area between T cells and stimulatory antigen-presenting cells (APCs), accumulating in F-actin-rich membrane protrusions at the periphery of the immunological synapse. Second, T cell receptor (TCR)-mediated intracellular signals are sufficient to induce ezrin relocalization, indicating that this protein is an effector of TCR signaling. Third, overexpression of the membrane binding domain of ezrin perturbs T cell receptor clustering in the T cell-APC contact area and inhibits the activation of nuclear factor for activated T cells (NF-AT).	Inst Pasteur, Unite Biol Interact Cellulaires, CNRS, URA 1960, Paris, France; Inst Pasteur, Lab Anal Images Quantitat, CNRS, URA 1947, Paris, France; Inst Pasteur, Lab Immunol Mol, CNRS, URA 1961, Paris, France; Inst Curie, CNRS, Lab Morphogenese & Signalisat Cellulaires, UMR 144, F-75231 Paris, France; Univ Montpellier 2, CNRS, UMR 5539, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Alcover, A (corresponding author), Inst Pasteur, Unite Biol Interact Cellulaires, CNRS, URA 1960, Paris, France.	aalcover@pasteur.fr	Roumier, Anne/AAG-5878-2021; Olivo-Marin, Jean-Christophe/K-4428-2015	Roumier, Anne/0000-0002-1369-9231; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Michel, Frederique/0000-0002-3524-2232; Alcover, Andres/0000-0002-9507-3450; MARTIN, Marianne/0000-0001-8932-3129				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; ALCOVER A, 1999, REC RES DEV IMMUNOL, V1, P75; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; delPozo MA, 1997, J CELL BIOL, V137, P493; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; EGERTON M, 1992, J IMMUNOL, V149, P1847; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Jose ES, 2000, IMMUNITY, V12, P161, DOI 10.1016/S1074-7613(00)80169-7; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1989, ANNU REV IMMUNOL, V7, P309, DOI 10.1146/annurev.immunol.7.1.309; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIEDERGANG F, 1995, J BIOL CHEM, V270, P12839, DOI 10.1074/jbc.270.21.12839; Niedergang F, 1997, J IMMUNOL, V159, P1703; Niedergang F, 1997, RES IMMUNOL, V148, P231, DOI 10.1016/S0923-2494(97)80865-6; OLIVOMARIN JC, 2001, IN PRESS PATTERN REC; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sperling AI, 1998, J IMMUNOL, V161, P6459; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; THUILLIER L, 1994, CELL IMMUNOL, V156, P322, DOI 10.1006/cimm.1994.1178; TUOSTO L, 1995, EUR J IMMUNOL, V25, P2917, DOI 10.1002/eji.1830251031; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	56	156	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2001	15	5					715	728		10.1016/S1074-7613(01)00225-4	http://dx.doi.org/10.1016/S1074-7613(01)00225-4			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728334	Bronze			2022-12-18	WOS:000172528200005
J	Lee, GR; Fields, PE; Flavell, RA				Lee, GR; Fields, PE; Flavell, RA			Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level	IMMUNITY			English	Article							LOCUS-CONTROL REGION; T-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR GATA-3; HYPERSENSITIVE SITE; TRANSGENIC MICE; ENHANCER; INTERLEUKIN-4; TH1; IDENTIFICATION; SEQUENCE	Using a transgenic approach, we examined distal regulatory elements located in the 1L-4 locus and the role of GATA-3 at these elements. The intergenic DNase I hypersensitive sites (HSS) showed strong enhancement, and the intronic enhancer (IE) and HS5/HS5a sites showed weaker enhancement of the IL-4 promoter. Elements in the 3' region of the IL-4 gene contributed to Th2 specificity. All individual enhancers were T cell activation dependent but not Th2 specific, with the exception of IE. However, when these distal elements were combined into a "minilocus," expression was strongly enhanced and Th2 specific. GATA-9 mediated strong enhancement of IL-4 promoter activity in Th1 cells when the promoter was embedded in the minilocus or linked to HSS and IE, demonstrating that GATA-3 acts through these elements to regulate IL-4 gene expression.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.		Fields, Patrick E/G-4878-2012	Fields, Patrick/0000-0002-6797-4139				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Bagga R, 1998, COLD SPRING HARB SYM, V63, P569, DOI 10.1101/sqb.1998.63.569; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bonifer C, 1996, CRIT REV EUKAR GENE, V6, P285, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.90; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; EMORINE L, 1983, NATURE, V304, P447, DOI 10.1038/304447a0; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Flavell RA, 1999, IMMUNOL RES, V19, P159, DOI 10.1007/BF02786484; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Glimcher LH, 2000, GENE DEV, V14, P1693; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P157; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HENKEL G, 1992, J IMMUNOL, V149, P3239; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Hogan B., 1986, MANIPULATING MOUSE E; HUBER MC, 1995, DNA CELL BIOL, V14, P397, DOI 10.1089/dna.1995.14.397; Hural JA, 2000, J IMMUNOL, V165, P3239, DOI 10.4049/jimmunol.165.6.3239; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; Li-Weber M, 1997, IMMUNOBIOLOGY, V198, P170, DOI 10.1016/S0171-2985(97)80038-1; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; Rincon M, 1997, CURR BIOL, V7, pR729, DOI 10.1016/S0960-9822(06)00368-X; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wenner CA, 1997, J IMMUNOL, V158, P765; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	43	156	158	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					447	459		10.1016/S1074-7613(01)00125-X	http://dx.doi.org/10.1016/S1074-7613(01)00125-X			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB	11336690	Bronze			2022-12-18	WOS:000168246700012
J	Izon, DJ; Punt, JA; Xu, LW; Karnell, FG; Allman, D; Myung, PS; Boerth, NJ; Pui, JC; Koretzky, GA; Pear, WS				Izon, DJ; Punt, JA; Xu, LW; Karnell, FG; Allman, D; Myung, PS; Boerth, NJ; Pui, JC; Koretzky, GA; Pear, WS			Notch1 regulates maturation of CD4(+) and CD8(+) thymocytes by modulating TCR signal strength	IMMUNITY			English	Article							CELL LINEAGE COMMITMENT; DROSOPHILA-MELANOGASTER; POSITIVE SELECTION; T-CELLS; INTRACELLULAR DOMAIN; ANTIGEN RECEPTOR; ANKYRIN REPEAT; NUCLEAR ACCESS; BONE-MARROW; ALPHA-BETA	Notch signaling regulates cell fate decisions in multiple lineages. We demonstrate in this report that retroviral expression of activated Notch1 in mouse thymocytes abrogates differentiation of immature CD4(+)CD8(+) thymocytes into both CD4 and CD8 mature single-positive T cells. The ability of Notch1 to inhibit T cell development was observed in vitro and in vivo with both normal and TCR transgenic thymocytes. Notch1-mediated developmental arrest was dose dependent and was associated with impaired thymocyte responses to TCR stimulation. Notch1 also inhibited TCR-mediated signaling in Jurkat T cells. These data indicate that constitutively active Notch1 abrogates CD4(+) and CD8(+) maturation by interfering with TCR signal strength and provide an explanation for the physiological regulation of Notch expression during thymocyte development.	Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Inst Med & Engn, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Abramson Family Canc Inst, Philadelphia, PA 19104 USA; Haverford Coll, Dept Biol, Haverford, PA 19041 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Haverford College	Pear, WS (corresponding author), Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021					AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Basson MA, 2000, IMMUNOL TODAY, V21, P509, DOI 10.1016/S0167-5699(00)01711-4; Berry LW, 1997, DEVELOPMENT, V124, P925; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bhandoola A, 1999, IMMUNITY, V10, P301, DOI 10.1016/S1074-7613(00)80030-8; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Bommhardt U, 1999, J IMMUNOL, V163, P715; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; DELACONCHA A, 1988, GENETICS, V118, P499; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; Di Santo JP, 2000, CURR OPIN IMMUNOL, V12, P159, DOI 10.1016/S0952-7915(99)00066-7; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jehn BM, 1999, J IMMUNOL, V162, P635; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lin K, 2000, J EXP MED, V191, P703, DOI 10.1084/jem.191.4.703; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; REDDY UR, 1990, MOL BRAIN RES, V8, P137; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; Sawamoto K, 1996, NEUROSCI RES, V26, P205, DOI 10.1016/S0168-0102(96)01110-8; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; Shawber C, 1996, DEVELOPMENT, V122, P3765; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	66	156	160	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					253	264		10.1016/S1074-7613(01)00107-8	http://dx.doi.org/10.1016/S1074-7613(01)00107-8			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290335	Bronze			2022-12-18	WOS:000167959500005
J	King, C; Davies, J; Mueller, R; Lee, MS; Krahl, T; Yeung, B; O'Connor, E; Sarvetnick, N				King, C; Davies, J; Mueller, R; Lee, MS; Krahl, T; Yeung, B; O'Connor, E; Sarvetnick, N			TGF-beta 1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; CD4(+) T-CELLS; GLUTAMIC-ACID DECARBOXYLASE; DIABETIC NOD MICE; B-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; INTERFERON-GAMMA; EXPRESSION; INTERLEUKIN-2; SUPPRESSION	TGF-beta 1, expressed in the pancreatic islets, protects the nonobese diabetic (NOD) mouse from insulin-dependent diabetes mellitus (IDDM). The islet antigen-specific T cell response of ins-TGF-beta 1 mice relied on different antigen-presenting cells (APC) from those used by NOD T cells. T cells from NOD mice utilized B cells to present islet antigen, whereas T cells from ins-TGF-beta 1 mice utilized macrophages. In addition, the islet antigen-specific T cell repertoire of ins-TGF-beta 1 mice was distinct and deviated toward an IL-4-producing Th2 phenotype. When ins-TGF-beta 1 mice were treated with anti-IL-4 antibody, islet antigen-specific IFN gamma-producing Th1 cells were unleashed, and the incidence of diabetes increased to the level of NOD mice. This suggests active suppression of a diabetogenic T cell response. This study describes a novel mechanism in which expression of TGF-beta 1 in the context of self-antigen shifts APC preference, deviating T cell responses to a Th2 phenotype, preventing IDDM.	Scripps Res Inst, Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Sarvetnick, N (corresponding author), Scripps Res Inst, Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	noras@scripps.edu	Lee, Myung Shik/C-9606-2011; King, Cecile/Q-9794-2019	King, Cecile/0000-0003-2193-2563				ATKINSON MA, 1994, J CLIN INVEST, V94, P2125, DOI 10.1172/JCI117567; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Bridoux F, 1997, J EXP MED, V185, P1769, DOI 10.1084/jem.185.10.1769; Bright JJ, 1997, J IMMUNOL, V159, P175; COBBOLD S, 1994, TISSUE ANTIGENS, V43, P137, DOI 10.1111/j.1399-0039.1994.tb02315.x; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; Endl J, 1997, J CLIN INVEST, V99, P2405, DOI 10.1172/JCI119423; FALCONE M, 1998, IN PRESS J IMMUNOL; Fowell D, 1995, CIBA F SYMP, V195, P173; FOWELL D, 1995, CIBA FOUND S, V195, P182; GRAY JD, 1994, J EXP MED, V180, P1937, DOI 10.1084/jem.180.5.1937; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KEHRL JH, 1991, J IMMUNOL, V146, P4016; KEHRL JH, 1986, J EXP MED, V163, P1057; LANZAVECCHIA A, 1995, J EXP MED, V181, P1945, DOI 10.1084/jem.181.6.1945; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; LEE MS, 1995, AM J PATHOL, V147, P42; MAMULA MJ, 1994, J IMMUNOL, V152, P1453; MORIKAWA M, 1993, CYTOKINE, V5, P255, DOI 10.1016/1043-4666(93)90013-U; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; MOUGDIL KD, 1993, CLIN IMMUNOL IMMUNOP, V73, P283; Mueller DL, 1997, CURR BIOL, V7, pR255, DOI 10.1016/S0960-9822(06)00115-1; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; RON Y, 1987, J IMMUNOL, V138, P2848; Roth R, 1997, ANN NY ACAD SCI, V815, P88, DOI 10.1111/j.1749-6632.1997.tb52047.x; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Schneider SC, 1997, HUM IMMUNOL, V54, P148, DOI 10.1016/S0198-8859(97)00079-7; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Sitnicka E, 1996, BLOOD, V88, P82; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; SWAIN SL, 1981, P NATL ACAD SCI-BIOL, V78, P2517, DOI 10.1073/pnas.78.4.2517; Takeuchi M, 1997, EUR J IMMUNOL, V27, P1648, DOI 10.1002/eji.1830270709; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WEBB LMC, 1995, BLOOD, V86, P3479, DOI 10.1182/blood.V86.9.3479.bloodjournal8693479; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; Weiner HL, 1997, ANNU REV MED, V48, P341; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; ZHANG XH, 1995, J EXP MED, V182, P699, DOI 10.1084/jem.182.3.699; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	48	156	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1998	8	5					601	613		10.1016/S1074-7613(00)80565-8	http://dx.doi.org/10.1016/S1074-7613(00)80565-8			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ611	9620681	Bronze			2022-12-18	WOS:000073885400008
J	Sauvageau, G; Thorsteinsdottir, U; Hough, MR; Hugo, P; Lawrence, HJ; Largman, C; Humphries, RK				Sauvageau, G; Thorsteinsdottir, U; Hough, MR; Hugo, P; Lawrence, HJ; Largman, C; Humphries, RK			Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation	IMMUNITY			English	Article							STEM-CELLS; GENE-EXPRESSION; COMPETITIVE REPOPULATION; MONOCLONAL-ANTIBODY; HOMEOBOX GENES; MICE LACKING; ALPHA-BETA; IN-VIVO; MOUSE; DIFFERENTIATION	HOXB3 mRNA levels are high in the earliest CD34(+) lineage(-) bone marrow cells and low to undetectable in later CD34(+)/CD34(-) cells. To gain some insight into the role this gene may play in hematopoiesis, HOXB3 was overexpressed in murine bone marrow cells using retroviral gene transfer. Thymi of HOXB3 marrow recipients were reduced in size compared with control transplant recipients, with a 24-fold decrease in the absolute number of CD4(+)CD8(+) cells and a 3-fold increase in the number of CD4(-)CD8(-) thymocytes that contained a high proportion of gamma delta TCR+ celIs. B cell differentiation was also perturbed in these mice, as indicated by the virtual absence of transduced IL-7-responsive pre-B clonogenic progenitors. Recipients of HOXB3-transduced cells also had elevated numbers of mature granulocyte macrophage colony-forming cells in their bone marrow and spleen. Together these results suggest roles for HOXB3 in proliferation and differentiation processes of both early myeloid and lymphoid developmental pathways.	UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER,BC V5Z 1L3,CANADA; INST RECH CLIN MONTREAL,MONTREAL,PQ H2W 1R7,CANADA; VET AFFAIRS MED CTR,DEPT MED,SAN FRANCISCO,CA 94121; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94121	University of British Columbia; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Sauvageau, G (corresponding author), BRITISH COLUMBIA CANC AGCY,TERRY FOX LAB,601 W 10TH AVE,VANCOUVER,BC V5Z 1L3,CANADA.		Hough, Margaret/AAA-1026-2019	Hough, Margaret/0000-0001-8539-6398; Humphries, Richard/0000-0003-0540-7005; Sauvageau, Guy/0000-0002-4333-7266				ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; ALLEN JD, 1995, J IMMUNOL, V154, P1531; BARBA P, 1993, ADV EXP MED BIOL, V348, P45; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BRADY G, 1990, METHODS MOL CELL BIO, V2, P1; CILLO C, 1992, INT J CANCER, V51, P892, DOI 10.1002/ijc.2910510610; DAVIS L, 1994, BASIC METHODS MOL BI, P277; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; FRIEDMANN Y, 1994, CANCER RES, V54, P6981; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GIAMPAOLO A, 1994, BLOOD, V84, P3637, DOI 10.1182/blood.V84.11.3637.bloodjournal84113637; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Hough MR, 1996, J IMMUNOL, V156, P479; HOUGH MR, 1994, J EXP MED, V179, P177, DOI 10.1084/jem.179.1.177; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUMPHRIES RK, 1981, P NATL ACAD SCI USA, V76, P3629; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; KUBO RT, 1989, J IMMUNOL, V142, P2736; LAWRENCE HJ, 1992, BLOOD, V80, P2445; Lawrence HJ, 1996, STEM CELLS, V14, P281, DOI 10.1002/stem.140281; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PAWLIUK R, 1994, BLOOD, V84, P2868, DOI 10.1182/blood.V84.9.2868.bloodjournal8492868; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; PEVERALI FA, 1990, DIFFERENTIATION, V45, P61, DOI 10.1111/j.1432-0436.1990.tb00458.x; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; SUDA T, 1989, BLOOD, V74, P1936; SUDA T, 1993, J IMMUNOL, V150, P447; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1	45	156	159	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1997	6	1					13	22		10.1016/S1074-7613(00)80238-1	http://dx.doi.org/10.1016/S1074-7613(00)80238-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB161	9052833	Bronze			2022-12-18	WOS:A1997XB16100002
J	Alcantara-Hernandez, M; Leylek, R; Wagar, LE; Engleman, EG; Keler, T; Marinkovich, MP; Davis, MM; Nolan, GP; Idoyaga, J				Alcantara-Hernandez, Marcela; Leylek, Rebecca; Wagar, Lisa E.; Engleman, Edgar G.; Keler, Tibor; Marinkovich, M. Peter; Davis, Mark M.; Nolan, Garry P.; Idoyaga, Juliana			High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization	IMMUNITY			English	Article							TRANSCRIPTION FACTOR E2-2; C-TYPE LECTIN; CANCER VACCINES; IMMUNITY; EXPRESSION; SUBSETS; HETEROGENEITY; DISTINCT; LINEAGE; ANTIGEN	Given the limited efficacy of clinical approaches that rely on ex vivo generated dendritic cells (DCs), it is imperative to design strategies that harness specialized DC subsets in situ. This requires delineating the expression of surfacemarkers by DC subsets among individuals and tissues. Here, we performed a multi-parametric phenotypic characterization and unbiased analysis of human DC subsets in blood, tonsil, spleen, and skin. We uncovered previously unreported phenotypic heterogeneity of human cDC2s among individuals, including variable expression of functional receptors such as CD172a. We found marked differences in DC subsets localized in blood and lymphoid tissues versus skin, and a striking absence of the newly discovered Axl(+) DCs in the skin. Finally, we evaluated the capacity of anti-receptor monoclonal antibodies to deliver vaccine components to skin DC subsets. These results offer a promising path for developing DC subset-specific immunotherapies that cannot be provided by transcriptomic analysis alone.	[Alcantara-Hernandez, Marcela; Leylek, Rebecca; Wagar, Lisa E.; Davis, Mark M.; Nolan, Garry P.; Idoyaga, Juliana] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Alcantara-Hernandez, Marcela; Leylek, Rebecca; Wagar, Lisa E.; Engleman, Edgar G.; Davis, Mark M.; Nolan, Garry P.; Idoyaga, Juliana] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Engleman, Edgar G.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Keler, Tibor] Celldex Therapeut Inc, Hampton, NJ 08827 USA; [Marinkovich, M. Peter] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Marinkovich, M. Peter] Vet Affairs Med Ctr, Dermatol Serv, 3801 Miranda Ave, Palo Alto, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; Stanford University	Idoyaga, J (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Idoyaga, J (corresponding author), Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA.	jidoyaga@stanford.edu	Nolan, Garry/AAE-7903-2019	Alcantara-Hernandez, Marcela/0000-0002-3620-1248; Wagar, Lisa/0000-0001-5980-3586; Davis, Mark/0000-0001-6868-657X; Nolan, Garry/0000-0002-8862-9043	CONACyT (Mexico) [237333]; Stanford Medicine Dean's Office; NSF GRFP fellowship [DGE-1147470]; NIH [1DP2AR069953, R01AI118884, U19AI057229, P30 CA124435]; Baxter Foundation; Freidenrich Foundation;  [S10RR025518];  [S10OD016318]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, T32AI007290, R01AI118884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR069953] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016318] Funding Source: NIH RePORTER	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Stanford Medicine Dean's Office; NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; Freidenrich Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.A.-H. is recipient of a CONACyT (#237333, Mexico) and Stanford Medicine Dean's Office fellowships. R.L. is the recipient of an NSF GRFP fellowship (DGE-1147470). This work was supported by NIH grant 1DP2AR069953 (to J.I.), the Baxter and Freidenrich Foundations (to J.I.), and NIH grants R01AI118884 (to E.G.E.) and U19AI057229 (to M.M.D.). Further support comes from NIH P30 CA124435 utilizing the Shared FACS Facility and Tissue Bank. Cell sorting and CyTOF was performed on instruments funded through S10RR025518 and S10OD016318. We thank the blood and tissue donors for their participation. We also thank the surgical pathology department, the surgeons, and nurses, Drs. Dekker and Capasso, Research Nurse Swope, and Janet Bueno for tonsil, spleen, and skin sample acquisition. We also thank Drs. Maecker, Leipold, Dermadi, and Fragiadakis for helpful discussion about CyTOF and analysis. We thank the Idoyaga Lab members for technical support, and Drs. Gottfried, Carette, and Fernandez Vidal for discussions and critical reading of the manuscript. E.G.E. is a scientific cofounder, shareholder, and member of the board of directors of Medeor Therapeutics and Bolt Biopharmaceutics. T.K. is an employee and shareholder of Celldex Therapeutics. G.P.N. is the inventor of CyTOF.	Adema GJ, 2005, CURR OPIN IMMUNOL, V17, P170, DOI 10.1016/j.coi.2005.01.004; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Balan S, 2014, J IMMUNOL, V193, P1622, DOI 10.4049/jimmunol.1401243; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Cheong C, 2007, J IMMUNOL METHODS, V324, P48, DOI 10.1016/j.jim.2007.05.001; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068; Fossum E, 2015, EUR J IMMUNOL, V45, P624, DOI 10.1002/eji.201445080; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Granot T, 2017, IMMUNITY, V46, P504, DOI 10.1016/j.immuni.2017.02.019; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hanc P, 2016, EMBO J, V35, P2484, DOI 10.15252/embj.201694695; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Heidkamp GF, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7677; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mittag D, 2011, J IMMUNOL, V186, P6207, DOI 10.4049/jimmunol.1002632; Morse MA, 2011, CLIN CANCER RES, V17, P4844, DOI 10.1158/1078-0432.CCR-11-0891; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Sehgal K, 2014, IMMUNOL LETT, V162, P59, DOI 10.1016/j.imlet.2014.07.004; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Tullett KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87102; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Zhang H, 2017, P NATL ACAD SCI USA, V114, P1988, DOI 10.1073/pnas.1610630114	49	155	157	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1037	+		10.1016/j.immuni.2017.11.001	http://dx.doi.org/10.1016/j.immuni.2017.11.001			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29221729	Green Accepted, Bronze			2022-12-18	WOS:000418486500010
J	Menezes, S; Melandri, D; Anselmi, G; Perchet, T; Loschko, J; Dubrot, J; Patel, R; Gautier, EL; Hugues, S; Longhi, MP; Henry, JY; Quezada, SA; Lauvau, G; Lennon-Dumenil, AM; Gutierrez-Martinez, E; Bessis, A; Gomez-Perdiguero, E; Jacome-Galarza, CE; Garner, H; Geissmann, F; Golub, R; Nussenzweig, MC; Guermonprez, P				Menezes, Shinelle; Melandri, Daisy; Anselmi, Giorgio; Perchet, Thibaut; Loschko, Jakob; Dubrot, Juan; Patel, Rajen; Gautier, Emmanuel L.; Hugues, Stephanie; Longhi, M. Paula; Henry, Jake Y.; Quezada, Sergio A.; Lauvau, Gregoire; Lennon-Dumenil, Ana-Maria; Gutierrez-Martinez, Enrique; Bessis, Alain; Gomez-Perdiguero, Elisa; Jacome-Galarza, Christian E.; Garner, Hannah; Geissmann, Frederic; Golub, Rachel; Nussenzweig, Michel C.; Guermonprez, Pierre			The Heterogeneity of Ly6C(hi) Monocytes Controls Their Differentiation into iNOS(+) Macrophages or Monocyte-Derived Dendritic Cells	IMMUNITY			English	Article							TRANSCRIPTION FACTOR PU.1; COLONY-STIMULATING FACTOR; MHC CLASS-II; BONE-MARROW; IN-VIVO; BACTERIAL-INFECTION; HEMATOPOIETIC PROGENITORS; TISSUE MACROPHAGES; FLT3 LIGAND; EXPRESSION	Inflammation triggers the differentiation of Ly6C(hi) monocytes into microbicidal macrophages or monocyte-derived dendritic cells (moDCs). Yet, it is unclear whether environmental inflammatory cues control the polarization of monocytes toward each of these fates or whether specialized monocyte progenitor subsets exist before inflammation. Here, we have shown that naive monocytes are phenotypically heterogeneous and contain an NR4A1- and Flt3L-independent, CCR2-dependent, Flt3(+)CD11c(-)MHCII(+)PU.1(hi) subset. This subset acted as a precursor for Fc gamma RIII+PD-L2(+)CD209a(+), GM-CSF-dependent moDCs but was distal from the DC lineage, as shown by fate-mapping experiments using Zbtb46. By contrast, Flt3(-)CD11c(-)MHCII(-)PU.1(lo) monocytes differentiated into Fc gamma RIII+PD-L2(-)CD209a(-)iNOS(+) macrophages upon microbial stimulation. Importantly, Sfpi1 haploinsufficiency genetically distinguished the precursor activities of monocytes toward moDCs or microbicidal macrophages. Indeed, Sfpi1(+/-) mice had reduced Flt3(+)CD11c(-)MHCII(+) monocytes and GM-CSF-dependent Fc gamma RIII+PD-L2(+)CD209a(+) moDCs but generated iNOS(+) macrophages more efficiently. Therefore, intercellular disparities of PU.1 expression within naive monocytes segregate progenitor activity for inflammatory iNOS(+) macrophages or moDCs.	[Menezes, Shinelle; Melandri, Daisy; Anselmi, Giorgio; Patel, Rajen; Gutierrez-Martinez, Enrique; Guermonprez, Pierre] Kings Coll London, Lab Phagocyte Immunobiol, London SE1 1UL, England; [Menezes, Shinelle; Melandri, Daisy; Anselmi, Giorgio; Patel, Rajen; Gutierrez-Martinez, Enrique; Guermonprez, Pierre] Kings Coll London, Ctr Inflammat Biol & Canc Immunol, London SE1 1UL, England; [Menezes, Shinelle; Melandri, Daisy; Anselmi, Giorgio; Patel, Rajen; Gutierrez-Martinez, Enrique; Guermonprez, Pierre] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Perchet, Thibaut; Gomez-Perdiguero, Elisa; Golub, Rachel] Inst Pasteur, F-75724 Paris, France; [Loschko, Jakob; Nussenzweig, Michel C.] Rockefeller Univ, New York, NY 10065 USA; [Dubrot, Juan; Hugues, Stephanie] Univ Geneva, CH-1211 Geneva, Switzerland; [Gautier, Emmanuel L.] Hop La Pitie Salpetriere, F-75013 Paris, France; [Longhi, M. Paula] Barts & London Queen Marys Sch Med & Dent, London EC1M 6BQ, England; [Henry, Jake Y.; Quezada, Sergio A.] UCL, London WC1E 6BT, England; [Lauvau, Gregoire] Albert Einstein Coll Med, New York, NY 10461 USA; [Lennon-Dumenil, Ana-Maria] Inst Curie, F-75248 Paris, France; [Bessis, Alain] Ecole Normale Super, F-75230 Paris, France; [Jacome-Galarza, Christian E.; Garner, Hannah; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	University of London; King's College London; University of London; King's College London; University of London; King's College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; Queen Mary University London; University of London; University College London; Yeshiva University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Memorial Sloan Kettering Cancer Center	Guermonprez, P (corresponding author), Kings Coll London, Lab Phagocyte Immunobiol, London SE1 1UL, England.; Guermonprez, P (corresponding author), Kings Coll London, Ctr Inflammat Biol & Canc Immunol, London SE1 1UL, England.; Guermonprez, P (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 1UL, England.	pierre.guermonprez@kcl.ac.uk	Quezada, Sergio/ABF-6466-2020; Gautier, Emmanuel L./E-2259-2017; Dubrot, Juan/ABI-1676-2020; Rachel, GOLUB/M-7188-2014; Guermonprez, Pierre/ABE-7718-2020; GOLUB, rachel/X-8717-2019; Perdiguero, Elisa Gomez/U-2120-2018; Gutiérrez-Martínez, Enric/J-5965-2017; Lennon-Dumenil, Ana-Maria/I-6716-2016; Nussenzweig, Michel/AAE-7292-2019	Quezada, Sergio/0000-0002-9763-1700; Gautier, Emmanuel L./0000-0003-2976-7566; Dubrot, Juan/0000-0002-8093-2208; Rachel, GOLUB/0000-0002-2306-5363; Guermonprez, Pierre/0000-0001-5621-2262; GOLUB, rachel/0000-0002-2306-5363; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Gutiérrez-Martínez, Enric/0000-0003-1316-3936; Anselmi, Giorgio/0000-0002-8870-3354; hugues, stephanie/0000-0002-1031-5909; Longhi, Paula/0000-0003-1854-4594; Bessis, Alain/0000-0001-8362-6874; Henry, Jake/0000-0003-0435-3308	King's Overseas Research Studentships; MRC [MR/K01241X/1]; BBSRC [BB/M029735/1]; King's Health Partners; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103338, R01AI130345] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M029735/1, 1168004] Funding Source: researchfish; British Heart Foundation [FS/13/49/30421] Funding Source: researchfish; Medical Research Council [MR/K01241X/1] Funding Source: researchfish	King's Overseas Research Studentships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King's Health Partners; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	P.G. is a CNRS investigator. S.M. is funded by King's Overseas Research Studentships. The research was supported by the MRC (MR/K01241X/1), BBSRC (BB/M029735/1), and King's Health Partners. We thank Dr. Loredana Saveanu, Prof. Caetano Reis e Sousa, and Dr. Julie Helft for reagents and insightful discussions. All flow cytometry work was performed within the NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London; we especially thank Prabhjoat Singh Chana for help at the facility and Nedyalko Petrov for assistance with t-SNE analysis. We would like to thank Matthew Arno and Erick Nasser at the Genomics Centre of King's College London for performing the microarray experiments and providing technical support. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Barthelemy O, 2015, ARCH CARDIOVASC DIS, V108, P428, DOI 10.1016/j.acvd.2015.03.002; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Mach N, 2000, CANCER RES, V60, P3239; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Sathe P, 2014, IMMUNITY, V41, P104, DOI 10.1016/j.immuni.2014.05.020; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	62	155	159	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1205	1218		10.1016/j.immuni.2016.12.001	http://dx.doi.org/10.1016/j.immuni.2016.12.001			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002729	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000392918100008
J	Schonthaler, HB; Guinea-Viniegra, J; Wculek, SK; Ruppen, I; Ximenez-Embun, P; Guio-Carrion, A; Navarro, R; Hogg, N; Ashman, K; Wagner, EF				Schonthaler, Helia B.; Guinea-Viniegra, Juan; Wculek, Stefanie K.; Ruppen, Isabel; Ximenez-Embun, Pilar; Guio-Carrion, Ana; Navarro, Raquel; Hogg, Nancy; Ashman, Keith; Wagner, Erwin F.			S100A8-S100A9 Protein Complex Mediates Psoriasis by Regulating the Expression of Complement Factor C3	IMMUNITY			English	Article							INTRAVENOUS IMMUNOGLOBULIN; CYTOKINE PRODUCTION; SKIN INFLAMMATION; S100A9; DISEASES; CELLS; MODEL; MECHANISMS; IMIQUIMOD; INSIGHTS	Psoriasis is a common heterogeneous inflammatory skin disease with a complex pathophysiology and limited treatment options. Here we performed proteomic analyses of human psoriatic epidermis and found S100A8-S100A9, also called calprotectin, as the most upregulated proteins, followed by the complement component C3. Both S100A8-S100A9 and C3 are specifically expressed in lesional psoriatic skin. S100A9 is shown here to function as a chromatin component modulating C3 expression in mouse and human cells by binding to a region upstream of the C3 start site. When S100A9 was genetically deleted in mouse models of skin inflammation, the psoriasis-like skin disease and inflammation were strongly attenuated, with a mild immune infiltrate and decreased amounts of C3. In addition, inhibition of C3 in the mouse model strongly reduced the inflammatory skin disease. Thus, S100A8-S100A9 can regulate C3 at the nuclear level and present potential new therapeutic targets for psoriasis.	[Schonthaler, Helia B.; Guinea-Viniegra, Juan; Wculek, Stefanie K.; Guio-Carrion, Ana; Wagner, Erwin F.] Spanish Natl Canc Res Ctr CNIO, CNIO Canc Cell Biol Programme, BBVA Fdn, Madrid 29029, Spain; [Ruppen, Isabel; Ximenez-Embun, Pilar; Ashman, Keith] Spanish Natl Canc Res Ctr CNIO, Prote Unit, Madrid 29029, Spain; [Navarro, Raquel] Hosp Univ La Princesa, Dept Dermatol, Madrid 28006, Spain; [Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital de La Princesa; Cancer Research UK	Wagner, EF (corresponding author), Spanish Natl Canc Res Ctr CNIO, CNIO Canc Cell Biol Programme, BBVA Fdn, Madrid 29029, Spain.	ewagner@cnio.es	Schönthaler, Helia/AAG-4767-2021; Wculek, Stefanie K/F-9626-2016	Wculek, Stefanie K/0000-0001-5565-8561; Guio-Carrion, Ana/0000-0002-8963-4389; Wagner, Erwin F/0000-0001-7872-0196; Ximenez-Embun, Pilar/0000-0002-2582-9443	Boehringer Ingelheim; Austrian Science Foundation [NFN S94-SP11]; Banco Bilbao Vizcaya Argentaria (BBVA) Foundation; European Research Council Advanced Grant [ERC FCK/2008/37]	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Foundation(Austrian Science Fund (FWF)); Banco Bilbao Vizcaya Argentaria (BBVA) Foundation; European Research Council Advanced Grant(European Research Council (ERC))	We are very grateful to Peter Angel, Doug Hanahan, Mirna Perez-Moreno, Mercedes Rincon, Ethan Shevach, Maria Sibilia, Erwin Tschachler, Ronald Wolf, and members of the Wagner laboratory for discussions and critically reading the manuscript. We thank Thomas Jenuwein for advice and critical discussions regarding the role of S100 proteins in the nucleus. We would also like to thank Maria Helena Idarraga-Amado and Maria Martin for excellent technical support and Diego Megias from the CNIO Confocal Microscopy unit and the CNIO Proteomics unit for outstanding technical assistance. We are grateful to Esteban Dauden for providing psoriasis tissue samples. The project was initiated at the IMP, which is funded by Boehringer Ingelheim, and was supported by an Austrian Science Foundation grant NFN S94-SP11. E. F. W. is funded by the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation and a European Research Council Advanced Grant (ERC FCK/2008/37).	Abtin A, 2010, J INVEST DERMATOL, V130, P2423, DOI 10.1038/jid.2010.158; ACEVEDO F, 1989, BRIT J DERMATOL, V121, P329, DOI 10.1111/j.1365-2133.1989.tb01426.x; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Baker JR, 2011, DEV DYNAM, V240, P2194, DOI 10.1002/dvdy.22709; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; BASSETSEGUIN N, 1993, J INVEST DERMATOL, V101, P827, DOI 10.1111/1523-1747.ep12371702; Bayry J, 2007, NAT CLIN PRACT RHEUM, V3, P262, DOI 10.1038/ncprheum0481; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Dalakas MC, 2004, JAMA-J AM MED ASSOC, V291, P2367, DOI 10.1001/jama.291.19.2367; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Gurmin V, 2002, BRIT J DERMATOL, V147, P554, DOI 10.1046/j.1365-2133.2002.04753.x; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Javkhlan P, 2011, INFLAMMATION, V34, P668, DOI 10.1007/s10753-010-9277-1; Johansen C, 2004, BRIT J DERMATOL, V151, P600, DOI 10.1111/j.1365-2133.2004.06088.x; Kanada KN, 2011, J INVEST DERMATOL, V131, pS85; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lutz HU, 2004, BLOOD, V103, P465, DOI 10.1182/blood-2003-05-1530; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20; Robinson MJ, 2000, BIOCHEM BIOPH RES CO, V275, P865, DOI 10.1006/bbrc.2000.3407; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Suzuki H, 2000, J INVEST DERMATOL, V114, P135, DOI 10.1046/j.1523-1747.2000.00833.x; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Lent PLEM, 2009, ARTHRITIS RHEUM-US, V60, P2954, DOI 10.1002/art.24908; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Wolf R, 2011, AMINO ACIDS, V41, P789, DOI 10.1007/s00726-010-0666-4; Wolf R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001108; WYATT RJ, 1989, HUM HERED, V39, P327, DOI 10.1159/000153884; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	48	155	158	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					1171	1181		10.1016/j.immuni.2013.11.011	http://dx.doi.org/10.1016/j.immuni.2013.11.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332034	Bronze			2022-12-18	WOS:000330951000021
J	Vignesh, KS; Figueroa, JAL; Porollo, A; Caruso, JA; Deepe, GS				Vignesh, Kavitha Subramanian; Figueroa, Julio A. Landero; Porollo, Aleksey; Caruso, Joseph A.; Deepe, George S., Jr.			Granulocyte Macrophage-Colony Stimulating Factor Induced Zn Sequestration Enhances Macrophage Superoxide and Limits Intracellular Pathogen Survival	IMMUNITY			English	Article							ZINC; METALLOTHIONEIN; CALPROTECTIN; GROWTH; HOMEOSTASIS; ACTIVATION; MECHANISMS; EXPRESSION; PROTEINS; REVEALS	Macrophages possess numerous mechanisms to combat microbial invasion, including sequestration of essential nutrients, like zinc (Zn). The pleiotropic cytokine granulocyte macrophage-colony stimulating factor (GM-CSF) enhances antimicrobial defenses against intracellular pathogens such as Histoplasma capsulatum, but its mode of action remains elusive. We have found that GM-CSF-activated infected macrophages sequestered labile Zn by inducing binding to metallothioneins (MTs) in a STAT3 and STAT5 transcription-factor-dependent manner. GM-CSF upregulated expression of Zn exporters, Slc30a4 and Slc30a7; the metal was shuttled away from phagosomes and into the Golgi apparatus. This distinctive Zn sequestration strategy elevated phagosomal H+ channel function and triggered reactive oxygen species generation by NADPH oxidase. Consequently, H. capsulatum was selectively deprived of Zn, thereby halting replication and fostering fungal clearance. GM-CSF mediated Zn sequestration via MTs in vitro and in vivo in mice and in human macrophages. These findings illuminate a GM-CSF-induced Zn-sequestration network that drives phagocyte antimicrobial effector function.	[Vignesh, Kavitha Subramanian] Univ Cincinnati, Dept Mol Genet Biochem Microbiol & Immunol, Cincinnati, OH 45267 USA; [Vignesh, Kavitha Subramanian; Deepe, George S., Jr.] Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati, OH 45267 USA; [Figueroa, Julio A. Landero; Caruso, Joseph A.] Univ Cincinnati, Agilent Technol Metall Ctr Amer, Dept Chem, Cincinnati, OH 45221 USA; [Porollo, Aleksey] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Deepe, George S., Jr.] Vet Affairs Hosp, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Deepe, GS (corresponding author), Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati, OH 45267 USA.	george.deepe@uc.edu		Landero, Julio/0000-0001-8641-0497; Porollo, Alexey/0000-0002-3202-5099	NIH [AI-094971, AI-106269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106269, R01AI083313, R21AI094971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Agilent Technologies for instrumentation, ICP-MS, and nanoHPLC-ESI-IT-MS and B. Klein, W. Nauseef, and D. Hildeman for their valuable feedback. This work was supported by grants from the NIH, AI-094971, AI-106269, and a Merit Review from Veterans Affairs.	Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Beyersmann D, 2002, MATERIALWISS WERKST, V33, P764, DOI 10.1002/mawe.200290008; Bhattacharya S, 2001, AM J RESP CELL MOL, V24, P312, DOI 10.1165/ajrcmb.24.3.4238; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Deepe GS, 1999, J IMMUNOL, V163, P4985; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Falnoga I, 2012, BIOL TRACE ELEM RES, V149, P331, DOI 10.1007/s12011-012-9431-8; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FRAKER PJ, 1986, FASEB J, V45, P1474; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; HOWARD DH, 1964, J BACTERIOL, V87, P33, DOI 10.1128/JB.87.1.33-38.1964; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lee DK, 1999, BIOCHEM J, V337, P59, DOI 10.1042/0264-6021:3370059; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Muijsers RBR, 2000, BRIT J PHARMACOL, V130, P932, DOI 10.1038/sj.bjp.0703401; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; NEWMAN SL, 1992, INFECT IMMUN, V60, P4593, DOI 10.1128/IAI.60.11.4593-4597.1992; Novak U, 1996, J BIOL CHEM, V271, P18350, DOI 10.1074/jbc.271.31.18350; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Tomat E, 2010, CURR OPIN CHEM BIOL, V14, P225, DOI 10.1016/j.cbpa.2009.12.010; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Winters MS, 2010, J INFECT DIS, V202, P1136, DOI 10.1086/656191; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	42	155	158	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					697	710		10.1016/j.immuni.2013.09.006	http://dx.doi.org/10.1016/j.immuni.2013.09.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138881	Green Accepted, Bronze			2022-12-18	WOS:000330950000011
J	Bancerek, J; Poss, ZC; Steinparzer, I; Sedlyarov, V; Pfaffenwimmer, T; Mikulic, I; Dolken, L; Strobl, B; Muller, M; Taatjes, DJ; Kovarik, P				Bancerek, Joanna; Poss, Zachary C.; Steinparzer, Iris; Sedlyarov, Vitaly; Pfaffenwimmer, Thaddaeus; Mikulic, Ivana; Doelken, Lars; Strobl, Birgit; Mueller, Mathias; Taatjes, Dylan J.; Kovarik, Pavel			CDK8 Kinase Phosphorylates Transcription Factor STAT1 to Selectively Regulate the Interferon Response	IMMUNITY			English	Article							RNA-POLYMERASE-II; IFN-GAMMA; SERINE PHOSPHORYLATION; GENE-EXPRESSION; TRANSACTIVATION DOMAIN; INNATE IMMUNITY; P-TEFB; MEDIATOR; ACTIVATION; PROMOTER	Gene regulation by cytokine-activated transcription factors of the signal transducer and activator of transcription (STAT) family requires serine phosphorylation within the transactivation domain (TAD). STAT1 and STAT3 TAD phosphorylation occurs upon promoter binding by an unknown kinase. Here, we show that the cyclin-dependent kinase 8 (CDK8) module of the Mediator complex phosphorylated regulatory sites within the TADs of STAT1, STAT3, and STAT5, including S727 within the STAT1 TAD in the interferon (IFN) signaling pathway. We also observed a CDK8 requirement for IFN-gamma-inducible antiviral responses. Microarray analyses revealed that CDK8-mediated STAT1 phosphorylation positively or negatively regulated over 40% of IFN-gamma-responsive genes, and RNA polymerase II occupancy correlated with gene expression changes. This divergent regulation occurred despite similar CDK8 occupancy at both S727 phosphorylation-dependent and -independent genes. These data identify CDK8 as a key regulator of STAT1 and antiviral responses and suggest a general role for CDK8 in STAT-mediated transcription. As such, CDK8 represents a promising target for therapeutic manipulation of cytokine responses.	[Bancerek, Joanna; Steinparzer, Iris; Sedlyarov, Vitaly; Pfaffenwimmer, Thaddaeus; Mikulic, Ivana; Kovarik, Pavel] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Poss, Zachary C.; Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Doelken, Lars] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England; [Strobl, Birgit; Mueller, Mathias] Univ Vet Med Vienna, Inst Genet & Anim Breeding, A-1210 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Colorado System; University of Colorado Boulder; University of Cambridge; University of Veterinary Medicine Vienna	Kovarik, P (corresponding author), Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	pavel.kovarik@univie.ac.at	Kovarik, Pavel/D-1184-2014	Kovarik, Pavel/0000-0003-2956-0944; Muller, Mathias/0000-0002-7879-3552; Strobl, Birgit/0000-0001-5716-3212	Austrian Science Fund [W1220-B09 DP, P22806-B11, SFB F28]; University of Vienna [I031-B]; National Cancer Institute [R01 CA127364]; National Institutes of Health [T32 GM08759]; MRC [G1002523] Funding Source: UKRI; Austrian Science Fund (FWF) [P 22806] Funding Source: researchfish; Medical Research Council [G1002523] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA127364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); University of Vienna; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Thomas Decker for providing gene-targeted mice expressing the S727A STAT1 mutant for MEF isolation and Michaela Prchal-Murphy for splenocyte preparation. We thank David Price for expression vectors for CDK9 and cyclin T1 and Richard Moriggl for STAT5a plasmids. Recombinant insect cell expression was completed by the Tissue Culture Shared Resource at the University of Colorado Cancer Center. This work was supported by Austrian Science Fund grants W1220-B09 DP ("Molecular Mechanisms of Cell Signaling") and P22806-B11 to P. K. and SFB F28 to M. M., University of Vienna grant Initiativkolleg I031-B to P. K., and National Cancer Institute grant R01 CA127364 to D.J.T. Z.C.P. was supported in part by a National Institutes of Health Predoctoral Training Grant (T32 GM08759).	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Alessi F, 1998, EXP CELL RES, V245, P8, DOI 10.1006/excr.1998.4216; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; STREHLOW I, 1993, J BIOL CHEM, V268, P16590; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yankulov KY, 1997, EMBO J, V16, P1638, DOI 10.1093/emboj/16.7.1638; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	48	155	163	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					250	262		10.1016/j.immuni.2012.10.017	http://dx.doi.org/10.1016/j.immuni.2012.10.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23352233	Green Published, hybrid			2022-12-18	WOS:000330940800008
J	Choi, JH; Cheong, C; Dandamudi, DB; Park, CG; Rodriguez, A; Mehandru, S; Velinzon, K; Jung, IH; Yoo, JY; Oh, GT; Steinman, RM				Choi, Jae-Hoon; Cheong, Cheolho; Dandamudi, Durga B.; Park, Chae Gyu; Rodriguez, Anthony; Mehandru, Saurabh; Velinzon, Klara; Jung, In-Hyuk; Yoo, Ji-Young; Oh, Goo Taeg; Steinman, Ralph M.			Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis	IMMUNITY			English	Article							REGULATORY T-CELLS; REDUCES ATHEROSCLEROSIS; DECREASES ATHEROSCLEROSIS; ARTERIAL INTIMA; IN-VIVO; MACROPHAGES; MONOCYTES; IMMUNITY; IDENTIFICATION; HOMEOSTASIS	Early events in atherosclerosis occur in the aortic intima and involve monocytes that become macrophages. We looked for these cells in the steady state adult mouse aorta, and surprisingly, we found a dominance of dendritic cells (DCs) in the intima. In contrast to aortic adventitial macrophages, CD11c(+)MHC IIhi DCs were poorly phagocytic but were immune stimulatory. DCs were of two types primarily: classical Flt3-Flt3L signaling-dependent, CD103(+)CD11b(-) DCs and macrophage-colony stimulating factor (M-CSF)-dependent, CD14(+)CD11b(+)DC-SIGN(+) monocyte-derived DCs. Both types expanded during atherosclerosis. By crossing Flt3(-/-) to Ldlr(-/-) atherosclerosis-prone mice, we developed a selective and marked deficiency of classical CD103(+) aortic DCs, and they were associated with exacerbated atherosclerosis without alterations in blood lipids. Concomitantly, the Flt3(-/-) Ldlr(-/-) mice had fewer Foxp3(+) Treg cells and increased inflammatory cytokine mRNAs in the aorta. Therefore, functional DCs are dominant in normal aortic intima and, in contrast to macrophages, CD103(+) classical DCs are associated with atherosclerosis protection.	[Jung, In-Hyuk; Yoo, Ji-Young; Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Choi, Jae-Hoon; Cheong, Cheolho; Dandamudi, Durga B.; Park, Chae Gyu; Rodriguez, Anthony; Mehandru, Saurabh; Steinman, Ralph M.] Rockefeller Univ, Cellular Physiol & Immunol Lab, Chris Browne Ctr Immunol, New York, NY 10065 USA; [Choi, Jae-Hoon] Hanyang Univ, Dept Life Sci, Coll Nat Sci, Seoul 133791, South Korea; [Velinzon, Klara] Rockefeller Univ, Lab Mol Immunol, Howard Hughes Med Inst, New York, NY 10065 USA	Ewha Womans University; Rockefeller University; Hanyang University; Howard Hughes Medical Institute; Rockefeller University	Oh, GT (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	gootaeg@ewha.ac.kr; steinma@mail.rockefeller.edu	Choi, Jae-Hoon/R-6224-2016; Steinman, Ralph/F-7729-2012; Oh, Goo Taeg/AAQ-9995-2021	Choi, Jae-Hoon/0000-0002-5265-3463; Park, Chae Gyu/0000-0003-1906-1308	NIGMS [GM62116]; National Institutes of Health [AI13013, AI051573]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, South Korea [2011-0013669]; National Research Laboratory [R0A-2007-000-20016-0]; National Core Research Center from the Ministry of Education, Science & Technology, South Korea [R15-2006-020]; New York Community Trust; NIH/NCRR [5UL1RR024143-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573, R01AI013013, R37AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Laboratory(Korea Science and Engineering Foundation); National Core Research Center from the Ministry of Education, Science & Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); New York Community Trust; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to the memory of R.M. Steinman. The authors thank J. Adams for help with the figures and E. Shrestha for PCR genotyping Ldlr and Flt3-deficient mice. We also appreciate J. Breslow and J. Rodriguez for their valuable comments and technical help. We thank the Consortium for Functional Glycomics supported by NIGMS (GM62116) for DC-SIGN/Cd209a<SUP>-/-</SUP> mice. This work is supported by grants from National Institutes of Health (AI13013 and AI051573) (R.M.S), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, South Korea (2011-0013669) (J.-H C), the Research Program for the National Research Laboratory (R0A-2007-000-20016-0), and a National Core Research Center grant (R15-2006-020) from the Ministry of Education, Science & Technology, South Korea (G.T.O.), and New York Community Trust's Francis Florio funds for blood diseases and the Rockefeller University clinical and translation science award pilot project from NIH/NCRR (5UL1RR024143-05) (C.C.).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Benagiano M, 2005, J IMMUNOL, V174, P6509, DOI 10.4049/jimmunol.174.10.6509; Cheong C, 2007, J IMMUNOL METHODS, V324, P48, DOI 10.1016/j.jim.2007.05.001; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; GOWN AM, 1986, AM J PATHOL, V125, P191; Habets KLL, 2010, CARDIOVASC RES, V85, P622, DOI 10.1093/cvr/cvp338; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Jeon HJ, 2010, CIRCULATION, V121, P1124, DOI 10.1161/CIRCULATIONAHA.109.882704; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Rajavashisth T, 1998, J CLIN INVEST, V101, P2702, DOI 10.1172/JCI119891; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Sun JS, 2010, CIRCULATION, V122, P808, DOI 10.1161/CIRCULATIONAHA.109.891887; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; VANVOORHIS WC, 1983, J EXP MED, V158, P174, DOI 10.1084/jem.158.1.174; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Weyand CM, 2004, AUTOIMMUN REV, V3, P46, DOI 10.1016/S1568-9972(03)00064-8; Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhou XH, 2000, CIRCULATION, V102, P2919	65	155	160	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 23	2011	35	5					819	831		10.1016/j.immuni.2011.09.014	http://dx.doi.org/10.1016/j.immuni.2011.09.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22078798	Green Submitted, Bronze			2022-12-18	WOS:000297390800020
J	Weinreich, MA; Takada, K; Skon, C; Reiner, SL; Jameson, SC; Hogquist, KA				Weinreich, Michael A.; Takada, Kensuke; Skon, Cara; Reiner, Steven L.; Jameson, Stephen C.; Hogquist, Kristin A.			KLF2 Transcription-Factor Deficiency in T Cells Results in Unrestrained Cytokine Production and Upregulation of Bystander Chemokine Receptors	IMMUNITY			English	Article							LYMPHOCYTE EGRESS; EXPRESSION; BET; TRAFFICKING; MIGRATION; LACKING; S1P(1); LKLF	The transcription factor KLF2 regulates T cell trafficking by promoting expression of the lipid-binding receptor S1P(1) and the selectin CD62L. Recently, it was proposed that KLF2 also represses the expression of chemokine receptors. We confirmed the up-regulation of the chemokine receptor CXCR3 on KLF2-deficient T cells. However, we showed that this was a cell-nonautonomous effect, as revealed by CXCR3 upregulation on wild-type bystander cells in mixed bone-marrow chimeras with KLF2-deficient cells. Furthermore, KLF2-deficient T cells overproduced IL-4, leading to the upregulation of CXCR3 through an IL-4-receptor- and eomesodermin-dependent pathway. Consistent with the increased IL-4 production, we found high concentrations of serum IgE in mice with T cell-specific KLF2 deficiency. Our findings support a model where KLF2 regulates T cell trafficking by direct regulation of S1P(1) and CD62L and restrains spontaneous cytokine production in naive T cells.	[Weinreich, Michael A.; Takada, Kensuke; Skon, Cara; Jameson, Stephen C.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	james024@umn.edu; hogqu001@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Skon-Hegg, Cara/0000-0003-0703-3553; Hogquist, Kristin/0000-0001-9963-5687	NIH [R01-AI39560, R01-AI38903, T32-AI007313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076458, R37AI038903, R01AI042370, R01AI039560, T32AI007313, R01AI038903] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank Caitlin Dejong for preparing and shipping Eomes-deficient bones and Thirumalai Ramalingam and Thomas Wynn for providing IL-13R-deficient bones. Jerry Lingrel provided Klf2<SUP>fl</SUP> mice. Jason Cyster provided reagents and assistance with anti-S1P<INF>1</INF> staining. Xiao Jie Ding and Jason Vevea provided excellent technical support We thank Oludare Odumade and Amy Moran for helpful discussion and critical review of the manuscript. The authors declare no competing financial interests. This research was supported by NIH grants R01-AI39560 (to K.A.H.), R01-AI38903 (to S.C.J.), and T32-AI007313 (to M.A.W.).	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Dang XT, 2009, BBA-GENE REGUL MECH, V1789, P146, DOI 10.1016/j.bbagrm.2008.10.004; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Schnell FJ, 2006, J IMMUNOL, V176, P4740, DOI 10.4049/jimmunol.176.8.4740; Schober SL, 1999, J IMMUNOL, V163, P3662; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Whyatt D, 2002, EMBO REP, V3, P130, DOI 10.1093/embo-reports/kvf033; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	32	155	158	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					122	130		10.1016/j.immuni.2009.05.011	http://dx.doi.org/10.1016/j.immuni.2009.05.011			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19592277	Bronze, Green Accepted			2022-12-18	WOS:000268219900017
J	Lambrecht, BN				Lambrecht, BN			Alveolar macrophage in the driver's seat	IMMUNITY			English	Editorial Material							PULMONARY; INHIBITION	Although alveolar macrophages are normally quiescent to prevent damaging the alveoli, in this issue of Immunity, Takabayshi et al. (2006) demonstrate that alveolar macrophages can self-regulate their function on demand to mount an appropriate immune response.	Erasmus Univ, Med Ctr, Dept Pulm Med, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Erasmus Univ, Med Ctr, Dept Pulm Med, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834				BILYK N, 1993, J EXP MED, V177, P1773, DOI 10.1084/jem.177.6.1773; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; HOLT PG, 1978, AM REV RESPIR DIS, V118, P791, DOI 10.1164/arrd.1978.118.4.791; MacLean JA, 1996, AM J PATHOL, V148, P657; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; THEPEN T, 1989, J EXP MED, V170, P494; Warmington KS, 1999, AM J PATHOL, V154, P1407, DOI 10.1016/S0002-9440(10)65394-1	9	155	166	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2006	24	4					366	368		10.1016/j.immuni.2006.03.008	http://dx.doi.org/10.1016/j.immuni.2006.03.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618595	Bronze			2022-12-18	WOS:000237153000006
J	Finke, D; Acha-Orbea, H; Mattis, A; Lipp, M; Kraehenbuhl, JP				Finke, D; Acha-Orbea, H; Mattis, A; Lipp, M; Kraehenbuhl, JP			CD4(+)CD3(-) cells induce Peyer's patch development: role of alpha 4 beta 1 integrin activation by CXCR5	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; LYMPHOCYTE HOMING RECEPTOR; HEMATOPOIETIC STEM-CELLS; B-CELL; T-CELL; ADHESION MOLECULE-1; CHEMOKINE RECEPTOR; BETA(1) INTEGRINS; ORGAN DEVELOPMENT; LYMPHOTOXIN-BETA	CD4(+)CD3(+) cells are the predominant hematopoietic cells found in mouse fetal intestine. We prove their role as Peyer's patch(PP)-inducing cells by transfer into neonatal PP-deficient mice. To test the requirement of chemokines and adhesion molecules in induction of PIP, we studied mice deficient in CXCR5 and/or alpha4beta1 integrin-mediated adhesion. CXCR5(-/-) mice have CD4(+)CD3 cells, which are inefficient in inducing PIP formation. We show here that CXCR5/CXCL13 signaling activates alpha4beta1 integrin on CD4(+)CD3(+) cells. Blocking of beta1 integrin or VCAM-1, the ligand of alpha4beta1 integrin, inhibits PIP formation. This study demonstrates the link between chemokine receptors and adhesion molecules that regulates stromal/hematopoietic cell interaction leading to PP formation.	Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Max Delbruck Ctr Mol Med, Dept Mol Tumorgenet & Immunogenet, D-13092 Berlin, Germany; Swiss Inst Expt Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland	University of Lausanne; Ludwig Institute for Cancer Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Swiss Institute Experimental Cancer Research	Finke, D (corresponding author), Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland.		Lipp, Martin/G-2235-2010	Lipp, Martin/0000-0002-0087-2672				Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; CHAN BMC, 1992, J BIOL CHEM, V267, P8366; Cuff CA, 1999, J IMMUNOL, V162, P5965; Debard N, 2001, GASTROENTEROLOGY, V120, P1173, DOI 10.1053/gast.2001.22476; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Finke D, 2001, CURR OPIN GENET DEV, V11, P561, DOI 10.1016/S0959-437X(00)00233-1; Finke D, 2001, J IMMUNOL, V166, P6266, DOI 10.4049/jimmunol.166.10.6266; Finke D, 2001, EUR J IMMUNOL, V31, P2603; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Giblin PA, 1997, J IMMUNOL, V159, P3498; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Iizuka T, 2000, J IMMUNOL, V164, P2463, DOI 10.4049/jimmunol.164.5.2463; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Koni PA, 1998, J EXP MED, V187, P1977, DOI 10.1084/jem.187.12.1977; KOVACH NL, 1995, BLOOD, V85, P159, DOI 10.1182/blood.V85.1.159.bloodjournal851159; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Schabath R, 1999, J LEUKOCYTE BIOL, V66, P996, DOI 10.1002/jlb.66.6.996; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; Yokota Y, 2000, CURR TOP MICROBIOL, V251, P35; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	58	155	160	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2002	17	3					363	373		10.1016/S1074-7613(02)00395-3	http://dx.doi.org/10.1016/S1074-7613(02)00395-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	596KB	12354388	Bronze			2022-12-18	WOS:000178163100012
J	Xaus, J; Cardo, M; Valledor, AF; Soler, C; Lloberas, J; Celada, A				Xaus, J; Cardo, M; Valledor, AF; Soler, C; Lloberas, J; Celada, A			Inteferon gamma induces the expression of p21(waf-1) and arrests macrophage cell cycle, preventing induction of apoptosis	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD MONOCYTES; INTERFERON-GAMMA; T-CELLS; GENE-EXPRESSION; GROWTH ARREST; G1 PHASE; IN-VIVO; SURFACE-IMMUNOGLOBULIN; P53-INDUCED APOPTOSIS	Incubation of bone marrow macrophages with lipopolysaccharide (LPS) or interferon gamma (IFN gamma) blacks macrophage proliferation. LPS treatment or M-CSF withdrawal arrests the cell cycle at early G(1) and induces apoptosis. Treatment of macrophages with IFN gamma stops the cell cycle later, at the G(1)/S boundary, induces p21(Waf1), and does not induce apoptosis. Moreover, pretreatment of macrophages with IFN gamma protects from apoptosis induced by several stimuli. Inhibition of p21(Waf1) with antisense oligonucleotides or using KO mice shows that the induction of p21(Waf1) by IFN gamma mediates this protection. Thus, IFN gamma makes macrophages unresponsive to apoptotic stimuli by inducing p21(Waf1) and arresting the cell cycle at the G(1)/S boundary. Therefore, the cells of the innate immune system could only survive while they were functionally active.	Univ Barcelona, Fac Biol, Dept Fisiol Biol Macrofag, E-08028 Barcelona, Spain; Univ Barcelona, Fdn August Pi & Sunyer, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Celada, A (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol Biol Macrofag, Campus Bellvitge,Ave Diagonal 645, E-08028 Barcelona, Spain.	acelada@bio.ub.es	Soler, Concepció/L-1185-2014; Celada, Antonio/I-1714-2016; Lloberas, Jorge/D-4303-2014; Valledor, Annabel/H-5653-2015	Soler, Concepció/0000-0001-6502-5012; Lloberas, Jorge/0000-0001-7075-4201; Valledor, Annabel/0000-0003-4232-2633; Celada, Antonio/0000-0003-3883-2171				ADAMS DO, 1976, AM J PATHOL, V84, P164; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; BACH MK, 1995, INT ARCH ALLERGY IMM, V107, P90, DOI 10.1159/000236940; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; BUSCHLE M, 1993, J EXP MED, V177, P213, DOI 10.1084/jem.177.1.213; CELADA A, 1992, J IMMUNOL, V148, P1102; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; CHEN WH, 1995, ENDOCRINOLOGY, V136, P5240, DOI 10.1210/en.136.11.5240; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Dao T, 1997, J IMMUNOL, V159, P4261; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ETTINGER R, 1995, J IMMUNOL, V154, P4302; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FOX MH, 1987, CYTOMETRY, V8, P315, DOI 10.1002/cyto.990080312; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; GomezManzano C, 1997, J NATL CANCER I, V89, P1036, DOI 10.1093/jnci/89.14.1036; GRAWUNDER U, 1993, EUR J IMMUNOL, V23, P544, DOI 10.1002/eji.1830230237; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1993, CELL, V75, P805; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; KRANENBURG O, 1995, ONCOGENE, V10, P87; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MANGAN DF, 1991, J IMMUNOL, V146, P1541; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Poluha W, 1996, MOL CELL BIOL, V16, P1335; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; SACHS L, 1993, BLOOD, V82, P15, DOI 10.1182/blood.V82.1.15.bloodjournal82115; Sangfelt O, 1996, INT J CANCER, V67, P106, DOI 10.1002/(SICI)1097-0215(19960703)67:1<106::AID-IJC18>3.0.CO;2-C; SCHREIBER RD, 1985, LYMPHOKINES, V11, P87; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sherr Charles J., 1994, Trends in Cell Biology, V4, P15, DOI 10.1016/0962-8924(94)90033-7; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TORCZYNSKI R, 1983, NUCLEIC ACIDS RES, V11, P4879, DOI 10.1093/nar/11.14.4879; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; Vadiveloo PK, 1996, ONCOGENE, V13, P599; VAIRO G, 1995, ONCOGENE, V10, P1969; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723; Xaus J, 1999, J IMMUNOL, V162, P3607; XAUS J, 1999, IN PRESS J IMMUNOL; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494; Zhang W, 1995, CLIN CANCER RES, V1, P1051; ZHU LQ, 1995, J IMMUNOL, V154, P192	67	155	156	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	1999	11	1					103	113		10.1016/S1074-7613(00)80085-0	http://dx.doi.org/10.1016/S1074-7613(00)80085-0			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220ND	10435583	Bronze			2022-12-18	WOS:000081671300010
J	Rodewald, HR; Ogawa, M; Haller, C; Waskow, C; DiSanto, JP				Rodewald, HR; Ogawa, M; Haller, C; Waskow, C; DiSanto, JP			Pro-thymocyte expansion by c-kit and the common cytokine receptor gamma chain is essential for repertoire formation	IMMUNITY			English	Article							STEM-CELL-FACTOR; MICE; REARRANGEMENT; PROLIFERATION; LIGAND; MOUSE; GENE; INTERLEUKIN-2; LYMPHOCYTES; EXPRESSION	Growth factors have been implicated in thymocyte development, but mutants lacking cytokines, or their receptors, have failed to reveal essential roles for growth/differentiation factors in the thymus. Mutations in the receptor tyrosine kinase c-kit and the common cytokine receptor gamma chain (gamma(c)) reduce cellularity, but are permissive for thymocyte development. We now report that thymocyte development is completely abrogated in mice lacking both c-kit and gamma(c) (c-kit(-)gamma(c)(-)). Thymic hypocellularity is so severe that the T cell receptor repertoire fails to form except for monoclonal or oligoclonal beta chain DJ rearrangements. B lymphopoiesis is only mildly reduced in c-kit(-)gamma(c)(-) as compared with c-kit(+)gamma(c)(-) mice, and hematological values are identical comparing c-kit-deficient and c-kit(-)gamma(c)(-) mice. These experiments reveal essential, overlapping, and synergistic functions for two distinct signaling pathways, one utilizing c-kit and the other cytokine receptor gamma(c) complexes coupling to Janus kinases and signal transducers and activators of transcription.	HOP NECKER ENFANTS MALAD,INSERM,U429,F-75743 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rodewald, HR (corresponding author), BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND.		Waskow, Claudia/F-8146-2010; Di Santo, James P/M-4298-2014	Waskow, Claudia/0000-0003-3261-0922; Di Santo, James P/0000-0002-7146-1862				Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; ASAMOTO H, 1981, LAB INVEST, V45, P418; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; DADAMIO L, 1992, J IMMUNOL, V149, P3550; DENNERT G, 1980, EUR J IMMUNOL, V10, P583, DOI 10.1002/eji.1830100803; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GILFILLAN S, 1995, IMMUNOL REV, V148, P202; GODFREY DI, 1992, J IMMUNOL, V149, P2281; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PIERRES A, 1984, J IMMUNOL, V132, P2775; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SADLACK B, 1994, EUR J IMMUNOL, V24, P281, DOI 10.1002/eji.1830240144; Sambrook J, 1989, MOL CLONING LAB MANU; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; ZIOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206	36	155	156	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAR	1997	6	3					265	272		10.1016/S1074-7613(00)80329-5	http://dx.doi.org/10.1016/S1074-7613(00)80329-5			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC618	9075927	Bronze			2022-12-18	WOS:A1997XC61800006
J	Barcik, W; Boutin, RCT; Sokolowska, M; Finlay, BB				Barcik, Weronika; Boutin, Rozlyn C. T.; Sokolowska, Milena; Finlay, B. Brett			The Role of Lung and Gut Microbiota in the Pathology of Asthma	IMMUNITY			English	Review							ALLERGIC AIRWAY DISEASE; RESPIRATORY-TRACT; VIRUS-INFECTION; HAEMOPHILUS-INFLUENZAE; PNEUMOCYSTIS-CARINII; FUNGAL MICROBIOTA; IMMUNE-RESPONSE; INNATE IMMUNITY; BACTERIAL; DYSBIOSIS	Asthma is a common chronic respiratory disease affecting more than 300 million people worldwide. Clinical features of asthma and its immunological and molecular etiology vary significantly among patients. An understanding of the complexities of asthma has evolved to the point where precision medicine approaches, including microbiome analysis, are being increasingly recognized as an important part of disease management. Lung and gut microbiota play several important roles in the development, regulation, and maintenance of healthy immune responses. Dysbiosis and subsequent dysregulation of microbiota-related immunological processes affect the onset of the disease, its clinical characteristics, and responses to treatment. Bacteria and viruses are the most extensively studied microorganisms relating to asthma pathogenesis, but other microbes, including fungi and even archaea, can potently influence airway inflammation. This review focuses on recently discovered connections between lung and gut microbiota, including bacteria, fungi, viruses, and archaea, and their influence on asthma.	[Barcik, Weronika; Boutin, Rozlyn C. T.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Barcik, Weronika; Boutin, Rozlyn C. T.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Sokolowska, Milena] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland; [Sokolowska, Milena] CK CARE, Davos, Switzerland	University of British Columbia; University of British Columbia; University of British Columbia; Swiss Institute of Allergy & Asthma Research; University of Zurich	Finlay, BB (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	bfinlay@interchange.ubc.ca	Boutin, Rozlyn C.T./AAD-3203-2022	Boutin, Rozlyn C.T./0000-0003-1598-0104; Barcik, Weronika/0000-0001-8580-9690; Sokolowska, Milena/0000-0001-9710-6685	Canadian Institutes of Health Research Foundation [FDN-159935]; Vanier Canada Graduate Scholarship; University of British Columbia Four Year Doctoral Fellowship; Vancouver Coastal Health-Canadian Institutes of Health Research (CIHR)-UBC MD/PhD Studentship Award; Swiss National Science Foundation, Switzerland [310030_189334]	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship; University of British Columbia Four Year Doctoral Fellowship; Vancouver Coastal Health-Canadian Institutes of Health Research (CIHR)-UBC MD/PhD Studentship Award; Swiss National Science Foundation, Switzerland(Swiss National Science Foundation (SNSF))	We apologize to members of the community whose studies were not cited herein because of space constraints. The Finlay lab is supported by Canadian Institutes of Health Research Foundation grant no. FDN-159935; R.C.T.B. is supported by Vanier Canada Graduate Scholarship, a University of British Columbia Four Year Doctoral Fellowship, and a Vancouver Coastal Health-Canadian Institutes of Health Research (CIHR)-UBC MD/PhD Studentship Award; M.S. is supported by Swiss National Science Foundation grant no. 310030_189334, Switzerland; and B.B.F. is a University of British Columbia Peter Wall Distinguished Professor.	Aab A, 2017, ALLERGY, V72, P232, DOI 10.1111/all.12931; Abbas AA, 2017, AM J TRANSPLANT, V17, P1313, DOI 10.1111/ajt.14076; Agache I, 2016, ALLERGOL INT, V65, P243, DOI 10.1016/j.alit.2016.04.011; Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Alnahas S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01562; Altan E, 2019, J VIROL, V93, DOI 10.1128/JVI.00681-19; [Anonymous], 2018, MEDICINA LITHUANIA, DOI DOI 10.3390/medicina54050072; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrieta MC, 2018, J ALLERGY CLIN IMMUN, V142, P424, DOI 10.1016/j.jaci.2017.08.041; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Auchtung TA, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00092-18, 10.1128/msphere.00092-18]; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Barcik W, 2019, ALLERGY, V74, P899, DOI 10.1111/all.13709; Barcik Weronika, 2015, Drug Discov Today Dis Models, V17-18, P71, DOI 10.1016/j.ddmod.2016.06.003; Barnett DJM, 2019, J ALLERGY CLIN IMMUN, V143, P2305, DOI 10.1016/j.jaci.2019.02.009; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bhuiyan MU, 2019, THORAX, V74, P261, DOI 10.1136/thoraxjnl-2018-212096; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bomar L, 2016, MBIO, V7, DOI 10.1128/mBio.01725-15; Bosch AATM, 2016, EBIOMEDICINE, V9, P336, DOI 10.1016/j.ebiom.2016.05.031; Boutin RCT, 2017, ANN AM THORAC SOC, V14, pS316, DOI [10.1513/AnnalsATS.201707-534AW, 10.1513/annalsats.201707-534aw]; Bragin A O, 2018, Mol Biol (Mosk), V52, P326, DOI 10.7868/S0026898418020179; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Budden KF, 2019, LANCET RESP MED, V7, P907, DOI 10.1016/S2213-2600(18)30510-1; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Cait A, 2018, MUCOSAL IMMUNOL, V11, P785, DOI 10.1038/mi.2017.75; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Caverly LJ, 2019, CHEST, V156, P376, DOI 10.1016/j.chest.2019.05.011; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Chiang SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216799; Chishimba L, 2012, J ASTHMA, V49, P423, DOI 10.3109/02770903.2012.662568; Christiansen SC, 2019, NEW ENGL J MED, V381, P1046, DOI 10.1056/NEJMra1800345; Chung KF, 2017, J ALLERGY CLIN IMMUN, V139, P1071, DOI 10.1016/j.jaci.2017.02.004; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Corren J, 2020, J ALLER CL IMM-PRACT, V8, P516, DOI 10.1016/j.jaip.2019.08.050; Cosio B.G., 2017, EUR RESPIR J, V49, P49; Coverstone AM, 2019, IMMUNOL ALLERGY CLIN, V39, P391, DOI 10.1016/j.iac.2019.03.007; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Steenhuijsen Piters W.A., 2015, PHILOS T R SOC LON B, V370, DOI [10.1098/rstb.2014.0294, DOI 10.1098/RSTB.2014.0294.]; del Rosal T, 2016, ALLERGOL IMMUNOPATH, V44, P410, DOI 10.1016/j.aller.2015.07.004; Denner DR, 2016, J ALLERGY CLIN IMMUN, V137, P1398, DOI 10.1016/j.jaci.2015.10.017; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Desai M, 2016, ANN ALLERG ASTHMA IM, V116, P394, DOI 10.1016/j.anai.2015.12.024; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055; Eddens T, 2016, AM J RESP CRIT CARE, V194, P807, DOI 10.1164/rccm.201511-2205OC; Elmore SA, 2006, TOXICOL PATHOL, V34, P687, DOI 10.1080/01926230600939989; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Fraczek MG, 2018, J ALLERGY CLIN IMMUN, V142, P407, DOI 10.1016/j.jaci.2017.09.039; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Freer G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00686; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Ghebre MA, 2018, J ALLERGY CLIN IMMUN, V141, P2027, DOI 10.1016/j.jaci.2018.04.013; Goldman DL, 2018, J ALLERGY CLIN IMMUN, V141, P808, DOI 10.1016/j.jaci.2017.09.018; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; He Y, 2017, CRIT REV MICROBIOL, V43, P81, DOI [10.1080/1040841X.2016.1176988, 10.1080/1040841x.2016.1176988]; Heinonen S, 2019, IMMUNOL ALLERGY CLIN, V39, P361, DOI 10.1016/j.iac.2019.03.005; Hilliard KL, 2015, AM J RESP CELL MOL, V53, P378, DOI 10.1165/rcmb.2014-0195OC; Hillman ET, 2017, MICROBES ENVIRON, V32, P300, DOI 10.1264/jsme2.ME17017; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Huang YJ, 2017, J ALLERGY CLIN IMMUN, V139, P1099, DOI 10.1016/j.jaci.2017.02.007; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Huffnagle GB, 2017, MUCOSAL IMMUNOL, V10, P299, DOI 10.1038/mi.2016.108; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2017, J ALLERGY CLIN IMMUN, V140, P895, DOI 10.1016/j.jaci.2017.08.003; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kast JI, 2017, CLIN EXP IMMUNOL, V190, P351, DOI 10.1111/cei.13042; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kim Y.-G., 2014, CELL HOST MICROBE; Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Koskinen K, 2017, MBIO, V8, DOI 10.1128/mBio.00824-17; Kuo Chih-Hsi Scott, 2017, Eur Respir J, V49, DOI 10.1183/13993003.02135-2016; Lecours PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023326; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li X, 2018, CELL HOST MICROBE, V24, P847, DOI 10.1016/j.chom.2018.11.003; Liu HW, 2020, J ASTHMA, V57, P459, DOI 10.1080/02770903.2019.1585870; Loewen K, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.02070-2017; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lynch MDJ, 2015, NAT REV MICROBIOL, V13, P217, DOI 10.1038/nrmicro3400; Mahnic A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209209; Makris Spyridon, 2018, F1000Res, V7, DOI 10.12688/f1000research.15337.1; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; McLoughlin R, 2019, EBIOMEDICINE, V46, P473, DOI 10.1016/j.ebiom.2019.07.048; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Michalovich D., 2019, NATURE COMMUNICATION; Mikhail I, 2019, ANN ALLERG ASTHMA IM, V123, P352, DOI 10.1016/j.anai.2019.06.020; Mitre E, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.0315; Moffatt MF, 2017, CLIN MED, V17, P525, DOI 10.7861/clinmedicine.17-6-525; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; Pammi M, 2019, J PEDIATR-US, V204, P126, DOI 10.1016/j.jpeds.2018.08.042; Pattaroni C, 2018, CELL HOST MICROBE, V24, P857, DOI 10.1016/j.chom.2018.10.019; Pavlidis S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00938-2018; Pereira FC, 2017, ENVIRON MICROBIOL, V19, P1366, DOI 10.1111/1462-2920.13659; Perez Francisco J, 2014, Results Immunol, V4, P58, DOI 10.1016/j.rinim.2014.07.001; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Pineros YSS, 2019, ALLERGY, V74, P1898, DOI 10.1111/all.13802; Piters WAAD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10814-9; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Pugin Benoit, 2017, Microbial Ecology in Health and Disease, V28, P1353881, DOI 10.1080/16512235.2017.1353881; Qin N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14771; Ramratnam SK, 2017, J ALLER CL IMM-PRACT, V5, P889, DOI 10.1016/j.jaip.2017.04.031; Ravanetti L, 2019, J ALLERGY CLIN IMMUN, V143, P1355, DOI 10.1016/j.jaci.2018.08.051; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Ritchie AI, 2015, ANN AM THORAC SOC, V12, pS115, DOI 10.1513/AnnalsATS.201503-151AW; Roduit C, 2019, ALLERGY, V74, P799, DOI 10.1111/all.13660; Rojas DA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39079-4; Rossios C, 2018, J ALLERGY CLIN IMMUN, V141, P560, DOI 10.1016/j.jaci.2017.02.045; Rubner FJ, 2017, J ALLERGY CLIN IMMUN, V139, P501, DOI 10.1016/j.jaci.2016.03.049; Sarna M, 2018, THORAX, V73, P969, DOI 10.1136/thoraxjnl-2017-210233; SAVAGE DC, 1969, J BACTERIOL, V98, P1278, DOI 10.1128/JB.98.3.1278-1283.1969; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shao TY, 2019, CELL HOST MICROBE, V25, P404, DOI 10.1016/j.chom.2019.02.004; Sharma A., 2019, J ALLERGY CLIN IMMUN; Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Sitarik AR, 2018, INDOOR AIR, V28, P539, DOI 10.1111/ina.12456; Skalski JH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007260; Sokolowska Milena, 2018, Asthma Res Pract, V4, P1, DOI 10.1186/s40733-017-0037-y; Sokolowska M, 2017, J ALLERGY CLIN IMMUN, V139, P1379, DOI 10.1016/j.jaci.2016.09.031; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stiemsma LT, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-016-0173-6; Stokholm J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02573-2; Strati F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01227; Sugita K., 2018, IMPLEMENTING PRECISI, P107; Sun HM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3345-9; Sundell N, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00716-18; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111228; Tan HTT, 2019, ALLERGY, V74, P294, DOI 10.1111/all.13619; Taylor SL, 2019, AM J RESP CRIT CARE, V200, P309, DOI 10.1164/rccm.201809-1739OC; Taylor SL, 2018, J ALLERGY CLIN IMMUN, V141, P94, DOI 10.1016/j.jaci.2017.03.044; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Toussaint M, 2017, NAT MED, V23, P681, DOI 10.1038/nm.4332; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; van Woerden HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-69; Vandini S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060521; Vargas SL, 2013, CLIN INFECT DIS, V56, P171, DOI 10.1093/cid/cis870; Vargas SL, 2005, J INFECT DIS, V191, P122, DOI 10.1086/426451; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Wang F, 2011, EUR RESPIR J, V38, P567, DOI 10.1183/09031936.00170110; Wang JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2768; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wolsk HM, 2016, ALLERGY, V71, P820, DOI 10.1111/all.12847; Wos-Oxley ML, 2016, ENVIRON MICROBIOL, V18, P2259, DOI 10.1111/1462-2920.13378; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031; Young RP, 2016, AM J RESP CELL MOL, V54, P161, DOI 10.1165/rcmb.2015-0250PS; Yun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097289; Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724; Zhivaki D, 2017, IMMUNITY, V46, P301, DOI 10.1016/j.immuni.2017.01.010; Zhou YJ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r66	187	154	164	6	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					241	255		10.1016/j.immuni.2020.01.007	http://dx.doi.org/10.1016/j.immuni.2020.01.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075727	Bronze, Green Published			2022-12-18	WOS:000515082000009
J	Cortez, VS; Cervantes-Barragan, L; Robinette, ML; Bando, JK; Wang, YM; Geiger, TL; Gilfillan, S; Fuchs, A; Vivier, E; Sun, JC; Cella, M; Colonna, M				Cortez, Victor S.; Cervantes-Barragan, Luisa; Robinette, Michelle L.; Bando, Jennifer K.; Wang, Yaming; Geiger, Theresa L.; Gilfillan, Susan; Fuchs, Anja; Vivier, Eric; Sun, Joe C.; Cella, Marina; Colonna, Marco			Transforming Growth Factor-beta Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands	IMMUNITY			English	Article							MEMORY T-CELLS; TGF-BETA; TRANSCRIPTIONAL REGULATION; NFIL3; EXPRESSION; INDUCTION; INFECTION; EFFECTOR; ISOFORMS; LIVER	The signals guiding differentiation of innate lymphoid cells (ILCs) within tissues are not well understood. Salivary gland (SG) ILCs as well as liver and intestinal intraepithelial ILC1 have markers that denote tissue residency and transforming growth factor-beta (TGF-beta) imprinting. We deleted Tgfbr2 in cells expressing the ILC and NK marker NKp46 and found that SG ILCs were reduced in number. They lost distinct tissue markers, such as CD49a, and the effector molecules TRAIL and CD73. Expression of the transcription factor Eomes, which promotes NK cell differentiation, was elevated. Conversely, Eomes deletion in NKp46(+) cells enhanced TGF-beta-imprinting of SG ILCs. Thus, TGF-beta induces SG ILC differentiation by suppressing Eomes. TGF-beta acted through a JNK-dependent, Smad4-independent pathway. Transcriptome analysis demonstrated that SG ILCs had characteristic of both NK cells and ILC1. Finally, TGF-beta imprinting of SG ILCs was synchronized with SG development, highlighting the impact of tissue microenvironment on ILC development.	[Cortez, Victor S.; Cervantes-Barragan, Luisa; Robinette, Michelle L.; Bando, Jennifer K.; Wang, Yaming; Gilfillan, Susan; Cella, Marina; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Geiger, Theresa L.; Sun, Joe C.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Fuchs, Anja] Washington Univ, Sch Med, Dept Surg, Sect Acute & Crit Care Surg, St Louis, MO 63108 USA; [Vivier, Eric] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France	Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/ABA-8564-2020; Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287; Hunter, Theresa/0000-0002-6494-1294; Cella, Marina/0000-0003-1230-1313; Bando, Jennifer/0000-0002-1331-7424; Colonna, Marco/0000-0001-5222-4987	NIH [UO1 AI095542, RO1 DE021255, RO1 DK103039, RO1 CA176695, R24AI072073]; NATIONAL CANCER INSTITUTE [R01CA176695, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI072073, U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884, R01DE021255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH awards UO1 AI095542, RO1 DE021255, and RO1 DK103039 (M. Colonna) and RO1 CA176695 (M. Cella). We thank the Hope Center Animal Surgery Core at Washington University School of Medicine for performing parabiosis experiments. The authors thank Steve Reiner and Olga Pikovskaya for helpful discussions and the ImmGen consortium (supported by NIH R24AI072073) for generation of microarray data and helpful discussions.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hu YH, 2015, J IMMUNOL, V194, P2407, DOI 10.4049/jimmunol.1402369; Huser CA, 2010, CELL DEATH DIFFER, V17, P304, DOI 10.1038/cdd.2009.126; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Jaskoll T, 1999, ANAT REC, V256, P252; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Larsen M, 2010, WIRES SYST BIOL MED, V2, P670, DOI 10.1002/wsbm.94; Lourenco SV, 2008, VIRCHOWS ARCH, V452, P427, DOI 10.1007/s00428-007-0552-y; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marcoe JP, 2012, NAT IMMUNOL, V13, P843, DOI 10.1038/ni.2388; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meharra EJ, 2000, CELL IMMUNOL, V201, P1, DOI 10.1006/cimm.2000.1630; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Rijal S, 2015, BLOOD, V125, P2815, DOI 10.1182/blood-2014-09-603555; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Robinson PW, 2001, IMMUNOLOGY, V103, P146, DOI 10.1046/j.1365-2567.2001.01232.x; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	44	154	158	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1127	1139		10.1016/j.immuni.2016.03.007	http://dx.doi.org/10.1016/j.immuni.2016.03.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27156386	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000376478500017
J	van Panhuys, N; Klauschen, F; Germain, RN				van Panhuys, Nicholas; Klauschen, Frederick; Germain, Ronald N.			T-Cell-Receptor-Dependent Signal Intensity Dominantly Controls CD4(+) T Cell Polarization In Vivo	IMMUNITY			English	Article							PROTEIN-KINASE-C; DENDRITIC CELLS; LYMPH-NODES; PKC-THETA; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; ANTIGEN; CYTOKINES; RESPONSES	Polarization of effector CD4(+) T cells can be influenced by both antigen-specific signals and by pathogen- or adjuvant-induced cytokines, with current models attributing a dominant role to the latter. Here we have examined the relationship between these factors in shaping cell-mediated immunity by using intravital imaging of CD4(+) T cell interactions with dendritic cells (DCs) exposed to polarizing adjuvants. These studies revealed a close correspondence between strength of T cell receptor (TCR)-dependent signaling and T helper 1 (Th1) versus Th2 cell fate, with antigen concentration dominating over adjuvant in controlling T cell polarity. Consistent with this finding, at a fixed antigen concentration, adjuvants inducing Th1 cells operated by affecting DC costimulation that amplified TCR signaling. TCR signal strength controlled downstream cytokine receptor expression, linking the two components in a hierarchical fashion. These data reveal how quantitative integration of antigen display and costimulation regulates downstream checkpoints responsible for cytokine-mediated control of effector differentiation.	[van Panhuys, Nicholas; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick] Charite, Inst Pathol, D-10117 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	van Panhuys, N (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	vanpanhuysn@niaid.nih.gov; rgermain@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; van Panhuys, Nicholas/E-1812-2011; van Panhuys, Nick/F-7034-2016; Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015	van Panhuys, Nick/0000-0003-2199-852X; Klauschen, Frederick/0000-0002-9131-2389	Intramural Research Program of the NIAID, NIH; New Zealand FRST; International Human Frontier Science Program [RGY0077/2011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, ZIAAI000545] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New Zealand FRST(New Zealand Foundation for Research, Science and Technology); International Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. E. Paul, J. Zhu, H. Yamane, M. Gerner, R. Gottschalk, Z. Liu, and W. Kastenmueller for their reading and critical discussions of this manuscript. We also thank D. Jankovic for providing reagents. This work was supported by the Intramural Research Program of the NIAID, NIH. N.V.P. was supported by the New Zealand FRST and F.K. was supported by the Grant from the International Human Frontier Science Program (RGY0077/2011).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Boyton RJ, 2002, J IMMUNOL, V168, P1018, DOI 10.4049/jimmunol.168.3.1018; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Corn RA, 2005, J IMMUNOL, V175, P2102, DOI 10.4049/jimmunol.175.4.2102; DING L, 1993, J IMMUNOL, V151, P1224; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Klauschen F, 2009, NAT PROTOC, V4, P1305, DOI 10.1038/nprot.2009.129; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levin D, 2008, EUR J IMMUNOL, V38, P3339, DOI 10.1002/eji.200838584; Lim TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045185; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Medoff BD, 2006, J IMMUNOL, V176, P7272, DOI 10.4049/jimmunol.176.12.7272; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pulecio J, 2010, J EXP MED, V207, P2719, DOI 10.1084/jem.20100007; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; Varga G, 2010, J INVEST DERMATOL, V130, P1005, DOI 10.1038/jid.2009.398; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	51	154	155	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					63	74		10.1016/j.immuni.2014.06.003	http://dx.doi.org/10.1016/j.immuni.2014.06.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	24981853	Green Accepted, Bronze			2022-12-18	WOS:000341444200011
J	Paul, S; Kashyap, AK; Jia, W; He, YW; Schaefer, BC				Paul, Suman; Kashyap, Anuj K.; Jia, Wei; He, You-Wen; Schaefer, Brian C.			Selective Autophagy of the Adaptor Protein BcI10 Modulates T Cell Receptor Activation of NF-kappa B	IMMUNITY			English	Article							UBIQUITIN; BCL10; DEGRADATION; GENE; P62; PHOSPHORYLATION; PROLIFERATION; INFLAMMATION; RECOGNITION; LYSOSOMES	The adaptor protein BcI10 is a critically important mediator of T cell receptor (TCR)-to-NF-kappa B signaling. BcI10 degradation is a poorly understood biological phenomenon suggested to reduce TCR activation of NF-kappa B. Here we have shown that TCR engagement triggers the degradation of BcI10 in primary effector T cells but not in naive T cells. TCR engagement promoted K63 polyubiquitination of BcI10, causing BcI10 association with the autophagy adaptor p62. Paradoxically, p62 binding was required for both BcI10 signaling to NF-kappa B and gradual degradation of BcI10 by autophagy. BcI10 autophagy was highly selective, as shown by the fact that it spared Malt1, a direct BcI10 binding partner. Blockade of BcI10 autophagy enhanced TCR activation of NF-kappa B. Together, these data demonstrate that selective autophagy of BcI10 is a pathway-intrinsic homeostatic mechanism that modulates TCR signaling to NF-kappa B in effector I cells. This homeostatic process may protect T cells from adverse consequences of unrestrained NF-kappa B activation, such as cellular senescence.	[Paul, Suman; Kashyap, Anuj K.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Kashyap, Anuj K.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Jia, Wei; He, You-Wen] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Duke University	Schaefer, BC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	brian.schaefer@usuhs.edu		Paul, Suman/0000-0001-9357-3702; Schaefer, Brian C/0000-0001-8877-3507	National Institutes of Health [AI057481, AI074944, AI073947]; Center for Neuroscience and Regenerative Medicine (CNRM); American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074944, R01AI073947, R01AI057481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Neuroscience and Regenerative Medicine (CNRM)(United States Department of Defense); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank J. Latoche for care of mice, C. Olsen (Uniformed Services University) for consultation regarding statistics, D. McDaniel for microscopy support, R. Tsien for fluorescent protein cDNAs, M. Schell for imaging advice, and C.-Z. Giam, E. Mitre, and A. Snow for critical reading of the manuscript. Supported by grants from the National Institutes of Health (AI057481 to B.C.S. and AI074944 and AI073947 to Y.-W.H.), the Center for Neuroscience and Regenerative Medicine (CNRM) (to B.C.S.), and a predoctoral fellowship (to S.P.) from the American Heart Association.	BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Chaturvedi A, 2009, CURR ALLERGY ASTHM R, V9, P341, DOI 10.1007/s11882-009-0050-1; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Fitch Frank W, 2006, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0313s72; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Jia W, 2011, J IMMUNOL, V186, P5313, DOI 10.4049/jimmunol.1002404; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kingeter LM, 2008, J IMMUNOL, V181, P6244, DOI 10.4049/jimmunol.181.9.6244; Kingeter LM, 2010, J IMMUNOL, V185, P4520, DOI 10.4049/jimmunol.1001051; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Lunemann JD, 2009, CELL DEATH DIFFER, V16, P79, DOI 10.1038/cdd.2008.113; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Martin P, 2006, EMBO J, V25, P3524, DOI 10.1038/sj.emboj.7601250; Moscat J, 2009, CELL DEATH DIFFER, V16, P1426, DOI 10.1038/cdd.2009.119; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Rossman JS, 2006, MOL BIOL CELL, V17, P2166, DOI 10.1091/mbc.E05-10-0985; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; WILCOX D, 1992, BIOCHEM J, V285, P495, DOI 10.1042/bj2850495; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zeng H, 2007, MOL CELL BIOL, V27, P5235, DOI 10.1128/MCB.01645-06; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	43	154	162	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					947	958		10.1016/j.immuni.2012.04.008	http://dx.doi.org/10.1016/j.immuni.2012.04.008			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22658522	Bronze, Green Accepted			2022-12-18	WOS:000306097100013
J	Rajput, A; Kovalenko, A; Bogdanov, K; Yang, SH; Kang, TB; Kim, JC; Du, JF; Wallach, D				Rajput, Akhil; Kovalenko, Andrew; Bogdanov, Konstantin; Yang, Seung-Hoon; Kang, Tae-Bong; Kim, Jin-Chul; Du, Jianfang; Wallach, David			RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is Negatively Regulated by Caspase-8-Mediated Cleavage of the RIP1 Protein	IMMUNITY			English	Article							NF-KAPPA-B; DOMAIN KINASE RIP; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; DEATH; UBIQUITINATION; RECEPTOR; POLYUBIQUITINATION; RECOGNITION; MECHANISM	Excessive responses to pattern-recognition receptors are prevented by regulatory mechanisms that affect the amounts and activities of the downstream signaling proteins. We report that activation of the transcription factor IRF3 by the ribonucleic acid sensor RIG-I was restricted by caspase-8-mediated cleavage of the RIP1 protein, which resulted in conversion of RIP1 from a signaling enhancer to a signaling inhibitor. The proteins RIP1 and caspase-8 were recruited to the RIG-I complex after viral infection and served antagonistic regulatory roles. Conjugation of ubiquitin chains to RIP1 facilitated assembly of the RIG-I complex, resulting in enhanced phosphorylation of IRF3. However, the ubiquitination of RIP1 also rendered it susceptible to caspase-8-mediated cleavage that yielded an inhibitory RIP1 fragment. The dependence of RIP1 cleavage on the same molecular change as that facilitating RIG-I signaling allows for RIG-I signaling to be restricted in its duration without compromising its initial activation.	[Rajput, Akhil; Kovalenko, Andrew; Bogdanov, Konstantin; Yang, Seung-Hoon; Kang, Tae-Bong; Kim, Jin-Chul; Du, Jianfang; Wallach, David] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470; Yang, Seung-Hoon/0000-0002-6880-8861	Ares Trading SA, Switzerland; Flight Attendant Medical Research Institute (FAMRI); Kekst Family Center for Medical Genetics; Shapell Family Center for Genetic Disorders Research at the Weizmann Institute of Science	Ares Trading SA, Switzerland; Flight Attendant Medical Research Institute (FAMRI); Kekst Family Center for Medical Genetics; Shapell Family Center for Genetic Disorders Research at the Weizmann Institute of Science	We thank T. Shalevich, I. Kolesnik, V. Konstantinov, and R. Ischakov for assistance; S. Grossfeld for animal maintenance; R. Eylam and T. Berkutzki for assistance with histology; and T. Goncharov for devoted tutoring. Special thanks to I. Vlodavsky for assistance. This study was supported in part by grants from Ares Trading SA, Switzerland, a Center of Excellence Grant from the Flight Attendant Medical Research Institute (FAMRI), the Kekst Family Center for Medical Genetics, and the Shapell Family Center for Genetic Disorders Research at the Weizmann Institute of Science. D.W. is the incumbent of the Joseph and Bessie Feinberg Professorial Chair at the Weizmann Institute.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, V1; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Ben Moshe T, 2008, CYTOKINE GROWTH F R, V19, P209, DOI 10.1016/j.cytogfr.2008.04.012; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Wallach D, 1997, NATURE, V388, P123, DOI 10.1038/40516; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	31	154	156	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					340	351		10.1016/j.immuni.2010.12.018	http://dx.doi.org/10.1016/j.immuni.2010.12.018			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21419663	Bronze			2022-12-18	WOS:000289014500010
J	He, YK; Zhang, JY; Donahue, C; Falo, LD				He, Yukai; Zhang, Jiying; Donahue, Cara; Falo, Louis D., Jr.			Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization	IMMUNITY			English	Article							EPIDERMAL LANGERHANS CELLS; HERPES-SIMPLEX VIRUS-1; IN-VIVO; CUTTING EDGE; ANTIGEN PRESENTATION; CROSS-PRESENTATION; LYMPH-NODES; ANTITUMOR IMMUNITY; DISTINCT; MOUSE	The skin contains readily accessible dendritic cells (DCs) with potent antigen presentation function and functional plasticity enabling the integration of antigen specificity with environmentally responsive immune control. Recent studies challenge the established paradigm of cutaneous immune function by suggesting that lymph node-resident DCs, rather than skin-derived DCs (sDCs), are responsible for eliciting T cell immunity against cutaneous pathogens including viral vectors. We show that cutaneous delivery of lentivirus results in direct transfection of sDCs and potent and prolonged antigen presentation. Further, sDCs are the predominant antigen-presenting cells for the induction of potent and durable CD8(+) T cell immunity. These results support the classical paradigm of cutaneous immune function and suggest that antigen presentation by sDCs contributes to the high potency of lentivector-mediated genetic immunization.	Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	He, YK (corresponding author), Univ Pittsburgh, Sch Med, Dept Dermatol, Suite 145 Lothrop Hall,190 Lothrop St, Pittsburgh, PA 15213 USA.	ykhe@pitt.edu; lof2@pitt.edu	Falo, Louis/ABD-1499-2020	He, Yukai/0000-0001-7636-5549; Carey, Cara Donahue/0000-0002-3602-099X	NATIONAL CANCER INSTITUTE [R01CA116444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR047576] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA116444-01A2, R01 CA116444] Funding Source: Medline; NIAMS NIH HHS [K01 AR047576, K01 AR047576-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ada Gordon, 2003, Expert Opin Emerg Drugs, V8, P27, DOI 10.1517/14728214.8.1.27; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Anjuere F, 2000, J LEUKOCYTE BIOL, V67, P206, DOI 10.1002/jlb.67.2.206; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Celluzzi CM, 1996, J EXP MED, V183, P283, DOI 10.1084/jem.183.1.283; Celluzzi CM, 1997, J INVEST DERMATOL, V108, P716, DOI 10.1111/1523-1747.ep12292095; Celluzzi CM, 1998, J IMMUNOL, V160, P3081; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Esslinger C, 2002, HUM GENE THER, V13, P1091, DOI 10.1089/104303402753812494; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253; GREEN I, 1980, J INVEST DERMATOL, V75, P44, DOI 10.1111/1523-1747.ep12521102; He YK, 2005, J IMMUNOL, V174, P3808, DOI 10.4049/jimmunol.174.6.3808; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; La Montagne JR, 2004, NEW ENGL J MED, V351, P2330, DOI 10.1056/NEJMe048314; Larregina AT, 2005, J INVEST DERMATOL, V124, P1, DOI 10.1111/j.1523-1747.2004.23554.x; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Liu M, 2004, P NATL ACAD SCI USA, V101, P14567, DOI 10.1073/pnas.0404845101; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Moore AC, 2004, IMMUNOL REV, V199, P126, DOI 10.1111/j.0105-2896.2004.00138.x; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; Nicolo C, 2001, BLOOD, V97, P1803, DOI 10.1182/blood.V97.6.1803; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Palmowski MJ, 2004, J IMMUNOL, V172, P1582, DOI 10.4049/jimmunol.172.3.1582; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Racanelli V, 2004, IMMUNITY, V20, P47, DOI 10.1016/S1074-7613(03)00353-4; Rosenberg SA, 1998, J NATL CANCER I, V90, P1894, DOI 10.1093/jnci/90.24.1894; Sasaki S, 2003, METHODS, V31, P243, DOI 10.1016/S1046-2023(03)00140-3; Serbina NV, 2003, SCIENCE, V301, P1856, DOI 10.1126/science.1090613; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; STINGL G, 1980, IMMUNOL REV, V53, P149, DOI 10.1111/j.1600-065X.1980.tb01043.x; STINGL G, 1977, NATURE, V268, P245, DOI 10.1038/268245a0; STINGL G, 1980, J INVEST DERMATOL, V74, P315, DOI 10.1111/1523-1747.ep12543548; Stock AT, 2004, J IMMUNOL, V173, P2241, DOI 10.4049/jimmunol.173.4.2241; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Young JW, 1996, J EXP MED, V183, P7, DOI 10.1084/jem.183.1.7; Zhang MX, 2004, IMMUNOLOGY, V112, P567, DOI 10.1111/j.1365-2567.2004.01916.x	64	154	158	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2006	24	5					643	656		10.1016/j.immuni.2006.03.014	http://dx.doi.org/10.1016/j.immuni.2006.03.014			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713981	Bronze, Green Accepted			2022-12-18	WOS:000237970100020
J	Nera, KP; Kohonen, P; Narvi, E; Peippo, A; Mustonen, L; Terho, P; Koskela, K; Buerstedde, JM; Lassila, O				Nera, KP; Kohonen, P; Narvi, E; Peippo, A; Mustonen, L; Terho, P; Koskela, K; Buerstedde, JM; Lassila, O			Loss of Pax5 promotes plasma cell differentiation	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BSAP; B-CELL; CHAIN GENE; LYMPHOCYTE DIFFERENTIATION; MESSENGER-RNA; DEAMINASE AID; IN-VIVO; EXPRESSION; BLIMP-1; PROTEIN	Pax5 is indispensable for the commitment of early lymphoid progenitors to the B cell lineage as well as for the development of B cells. To better understand the functional importance of Pax5 at the later stages of B cell differentiation, we established a Pax5-deficient DT40 B cell line. The Pax5(-/-) cells exhibited slower growth, decreased surface IgM expression, and total loss of B cell receptor signaling. Moreover, the expression of the plasma cell-characteristic transcription factors Blimp-1 and XBP-1 were significantly upregulated and the expression of Bcl-6 diminished in the Pax5(-/-) cells, and this alteration was normalized by restored Pax5 expression. The Pax5-deficient cells further manifested substantially elevated secretion of IgM into the supernatant, another characteristic of plasma cells. These results indicate that downregulation of Pax5 function promotes the plasma cell differentiation of B cells.	Turku Univ, Turku Grad Sch Biomed Sci, Turku 20520, Finland; Turku Univ, Dept Med Microbiol, FIN-20520 Turku, Finland; Inst Mol Radiol, D-85764 Neuherberg, Germany	University of Turku; University of Turku	Nera, KP (corresponding author), Turku Univ, Turku Grad Sch Biomed Sci, Kiinamykkynkatu 13, Turku 20520, Finland.	kalle-pekka.nera@utu.fi	Kohonen, Pekka/F-9596-2011; Nera, Kalle-Pekka/F-3221-2010	Kohonen, Pekka/0000-0002-7845-3611; Narvi, Elli/0000-0002-1468-5587				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Arakawa Hiroshi, 2001, BMC Biotechnology, V1, P1; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Borson ND, 2002, BLOOD, V100, P4629, DOI 10.1182/blood.V100.13.4629; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Hsu LY, 2004, J EXP MED, V199, P825, DOI 10.1084/jem.20032249; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neiman PE, 2001, P NATL ACAD SCI USA, V98, P6378, DOI 10.1073/pnas.111144898; Nera KP, 2006, EUR J IMMUNOL, V36, P516, DOI 10.1002/eji.200535418; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; PINK JR, 1983, HYBRIDOMA, V2, P287, DOI 10.1089/hyb.1983.2.287; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rosnet O, 2004, J BIOL CHEM, V279, P10228, DOI 10.1074/jbc.M312169-A200; Sato H, 2004, J IMMUNOL, V172, P4858, DOI 10.4049/jimmunol.172.8.4858; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Tian JY, 1997, EUR J IMMUNOL, V27, P750, DOI 10.1002/eji.1830270325; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Usui T, 1997, J IMMUNOL, V158, P3197; Wallin JJ, 1998, SCIENCE, V279, P1961, DOI 10.1126/science.279.5358.1961; Wallin JJ, 1999, J BIOL CHEM, V274, P15959, DOI 10.1074/jbc.274.22.15959; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	53	154	157	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					283	293		10.1016/j.immuni.2006.02.003	http://dx.doi.org/10.1016/j.immuni.2006.02.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546097	Bronze			2022-12-18	WOS:000236504500009
J	Svensson, M; Maroof, A; Ato, M; Kaye, PM				Svensson, M; Maroof, A; Ato, M; Kaye, PM			Stromal cells direct local differentiation of regulatory dendritic cells	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; CROSS-PRESENTATION; ADHESION RECEPTOR; GM-CSF; FIBROBLASTS; EXPRESSION; MACROPHAGES; SUBSETS; ANTIGEN; CD8(+)	CD11c(hi) dendritic cells (DC) play an essential role during the initiation of cell-mediated immunity. Recently, CD11c(lo)CD45RB(hi) DC with regulatory properties have been described. However, the origins of regulatory DC are poorly understood. Here, we show that spleen-derived stromal cells promote selective development of CD11c(lo)OCD45RB(+) IL-10-producing regulatory DC from lineage-negative c-kit(+) progenitor cells. These DC have the capacity to suppress T cell responses and induce IL-10-producing regulatory T cells in vitro and to induce antigen -specific tolerance in vivo. Furthermore, stromal cells from mice infected with Leishmania donovani more effectively supported differentiation of these highly potent regulatory DC. The ability of tissue stromal cells to direct the development of DC with a regulatory phenotype thus provides a new mechanism for local immune regulation.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Kaye, PM (corresponding author), Univ York, Dept Biol, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England.	pmk2@york.ac.uk	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645; Kaye, Paul/0000-0002-8796-4755; Svensson, Mattias/0000-0003-1695-7934				ALVAREZSILVA M, 1993, J CELL SCI, V104, P477; Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2002, J IMMUNOL, V168, P6066, DOI 10.4049/jimmunol.168.12.6066; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1982, J CELL PHYSIOL, P87; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HASTHORPE S, 1992, EXP HEMATOL, V20, P476; Higgins AD, 2002, J IMMUNOL, V169, P3622, DOI 10.4049/jimmunol.169.7.3622; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jordan JH, 2003, EUR J CLIN INVEST, V33, P611, DOI 10.1046/j.1365-2362.2003.01172.x; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Manickasingham SR, 2003, EUR J IMMUNOL, V33, P101, DOI 10.1002/immu.200390001; MORRIS L, 1991, J CELL SCI, V99, P141; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Schulz O, 2002, J IMMUNOL, V168, P6057, DOI 10.4049/jimmunol.168.12.6057; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Smelt SC, 1997, J IMMUNOL, V158, P3813; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Torok-Storb B, 1999, ANN NY ACAD SCI, V872, P164, DOI 10.1111/j.1749-6632.1999.tb08461.x; Verfaillie CM, 1998, BLOOD, V92, P2609, DOI 10.1182/blood.V92.8.2609; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; WEISS L, 1991, BLOOD, V78, P975, DOI 10.1182/blood.V78.4.975.bloodjournal784975; Wilson ME, 2002, EUR J IMMUNOL, V32, P3556, DOI 10.1002/1521-4141(200212)32:12&lt;3556::AID-IMMU3556&gt;3.0.CO;2-Q; YOUNG AM, 1986, CELL IMMUNOL, V97, P227, DOI 10.1016/0008-8749(86)90393-X; Zhan Y, 2000, IMMUNOL CELL BIOL, V78, P118, DOI 10.1046/j.1440-1711.2000.00891.x; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	48	154	159	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					805	816		10.1016/j.immuni.2004.10.012	http://dx.doi.org/10.1016/j.immuni.2004.10.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589169	Bronze			2022-12-18	WOS:000225901600008
J	Mathis, D; Benoist, C				Mathis, D; Benoist, C			Back to central tolerance	IMMUNITY			English	Review							T-CELL TOLERANCE; THYMIC EPITHELIAL-CELLS; DIABETIC NOD MICE; PROMISCUOUS GENE-EXPRESSION; AUTOIMMUNE REGULATOR AIRE; NEGATIVE SELECTION; TRANSPLANTATION TOLERANCE; PERIPHERAL TOLERANCE; APOPTOSIS RESISTANCE; MULTIPLE-SCLEROSIS	The establishment and maintenance of immunological tolerance entails both central and peripheral mechanisms. The latter have been highlighted in the past several years, mostly because of great interest in the activities of regulatory T cells. However, an important role for central tolerance mechanisms has been reemphasized by recent results on human autoimmune diseases, including APECED and type 1 diabetes.	Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Benoist, C (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med, Joslin Diabet Ctr,Sect Immunol & Immunogenet, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu						Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Adorini L, 2002, TRENDS MOL MED, V8, P31, DOI 10.1016/S1471-4914(01)02193-1; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; ANDERSON M, 2004, DYSREGUALTED T CELL, P45; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; Bach JF, 2001, ANNU REV IMMUNOL, V19, P131, DOI 10.1146/annurev.immunol.19.1.131; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Bergman ML, 2003, DIABETES, V52, P1677, DOI 10.2337/diabetes.52.7.1677; Bergman ML, 2001, J AUTOIMMUN, V16, P105, DOI 10.1006/jaut.2000.0474; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Dubois-Lafforgue D, 2002, DIABETES, V51, pS489, DOI 10.2337/diabetes.51.2007.S489; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GARCHON HJ, 1994, EUR J IMMUNOL, V24, P380, DOI 10.1002/eji.1830240217; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Heino M, 2001, HUM MUTAT, V18, P205, DOI 10.1002/humu.1176; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kanagawa O, 1998, P NATL ACAD SCI USA, V95, P1721, DOI 10.1073/pnas.95.4.1721; Kasai M, 1996, EUR J IMMUNOL, V26, P2101, DOI 10.1002/eji.1830260921; Kasai M, 2000, EUR J IMMUNOL, V30, P3542, DOI 10.1002/1521-4141(200012)30:12<3542::AID-IMMU3542>3.0.CO;2-N; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1996, J EXP MED, V184, P531, DOI 10.1084/jem.184.2.531; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kishimoto H, 1999, J EXP MED, V190, P65, DOI 10.1084/jem.190.1.65; Klein L, 1998, J EXP MED, V188, P5, DOI 10.1084/jem.188.1.5; Kreuwel HTC, 2001, J IMMUNOL, V167, P1112, DOI 10.4049/jimmunol.167.2.1112; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Lamhamedi-Cherradi SE, 1998, DIABETOLOGIA, V41, P178, DOI 10.1007/s001250050887; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; LEIJON K, 1994, INT IMMUNOL, V6, P339, DOI 10.1093/intimm/6.2.339; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; LIBLAU R, 1991, EUR J IMMUNOL, V21, P1391, DOI 10.1002/eji.1830210610; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Makhlouf L, 2002, DIABETES, V51, P3202, DOI 10.2337/diabetes.51.11.3202; Markees TG, 1999, DIABETES, V48, P967, DOI 10.2337/diabetes.48.5.967; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; MIZUOCHI T, 1992, J EXP MED, V175, P1601, DOI 10.1084/jem.175.6.1601; Molano RD, 2001, DIABETES, V50, P270, DOI 10.2337/diabetes.50.2.270; Moriyama H, 2003, P NATL ACAD SCI USA, V100, P10376, DOI 10.1073/pnas.1834450100; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Oukka M, 1996, J IMMUNOL, V156, P968; Oukka M, 1996, IMMUNITY, V4, P545, DOI 10.1016/S1074-7613(00)80481-1; Oukka M, 1997, EUR J IMMUNOL, V27, P855, DOI 10.1002/eji.1830270408; Pearson T, 2003, J IMMUNOL, V171, P185, DOI 10.4049/jimmunol.171.1.185; Pearson T, 2003, DIABETES, V52, P321, DOI 10.2337/diabetes.52.2.321; PENHAGONCALVES C, 1995, GENOMICS, V28, P398, DOI 10.1006/geno.1995.1167; Pugliese A, 2002, DIABETES-METAB RES, V18, P13, DOI 10.1002/dmrr.261; Quinn J, 2001, POETRY REV, V91, P13; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Ridgway WM, 1996, J EXP MED, V183, P1657, DOI 10.1084/jem.183.4.1657; Ridgway WM, 1998, J EXP MED, V188, P2267, DOI 10.1084/jem.188.12.2267; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; SUN JP, 1991, EUR J IMMUNOL, V21, P1461, DOI 10.1002/eji.1830210620; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TOUME S, 1997, IMMUNITY, V7, P187; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Venanzi ES, 2004, CURR OPIN IMMUNOL, V16, P197, DOI 10.1016/j.coi.2004.01.008; VENANZI ES, 2004, AIRE INFLUENCES PERI, P77; Villunger A, 2003, NAT IMMUNOL, V4, P717, DOI 10.1038/ni0803-717; Vogel A, 2002, J MOL MED, V80, P201, DOI 10.1007/s00109-001-0306-2; Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048	87	154	163	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					509	516		10.1016/S1074-7613(04)00111-6	http://dx.doi.org/10.1016/S1074-7613(04)00111-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142520	Bronze			2022-12-18	WOS:000221631900002
J	Salas, A; Shimaoka, M; Kogan, AN; Harwood, C; von Andrian, UH; Springer, TA				Salas, A; Shimaoka, M; Kogan, AN; Harwood, C; von Andrian, UH; Springer, TA			Rolling adhesion through an extended conformation of integrin alpha(L)beta(2) and relation to alpha I and beta I-like domain interaction	IMMUNITY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; SMALL-MOLECULE; L-SELECTIN; EXTRACELLULAR SEGMENT; ACTIVATED PLATELETS; PHYSIOLOGICAL FLOW; CRYSTAL-STRUCTURE; LIGAND-BINDING; DISULFIDE BOND; FIRM ADHESION	In vivo, beta(2) integrins and particularly alpha(L)beta(2) (LFA-1) robustly support firm adhesion of leukocytes, but can also cooperate with other molecules in supporting rolling adhesion. Strikingly, a small molecule alpha/beta I-like allosteric antagonist, XVA143, inhibits LFA-1-dependent firm adhesion, while at the same time it enhances adhesion in shear flow and rolling both in vitro and in vivo. XVA143 appears to induce the extended conformation of integrins as shown by increased activation epitope exposure. Fab to the beta(2) I-like domain converts firm adhesion to rolling adhesion, but does not enhance adhesion. Residue alpha(L)-Glu-310 in the linker following the I domain is critical for communication to the beta(2) I-like domain, rolling, integrin extension, and activation by Mn2+ of firm adhesion. The results demonstrate the importance of integrin extension in rolling, and suggest that rolling and firm adhesion are mediated by extended conformations Of alpha(L)beta(2) that differ in the affinity of the alpha(L) I domain for ICAM-1.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Anesthesia, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Program Biophys, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Salas, Azucena/AAN-7035-2020	Salas, Azucena/0000-0003-4572-2907	NHLBI NIH HHS [HL-48675, HL-54936] Funding Source: Medline; NIAMS NIH HHS [AR-42689] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Bednar RA, 1998, J PHARMACOL EXP THER, V285, P1317; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Diacovo TG, 1998, J EXP MED, V187, P197, DOI 10.1084/jem.187.2.197; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Forlow SB, 2000, J CLIN INVEST, V106, P1457, DOI 10.1172/JCI10555; FOTOUHI N, 1999, Patent No. 0021920; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; Gordon KB, 2003, JAMA-J AM MED ASSOC, V290, P3073, DOI 10.1001/jama.290.23.3073; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; KOUNS WC, 1992, BLOOD, V80, P2539; Last-Barney K, 2001, J AM CHEM SOC, V123, P5643, DOI 10.1021/ja0104249; LAWRENCE MB, 1995, EUR J IMMUNOL, V25, P1025, DOI 10.1002/eji.1830250425; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Liu G, 2001, J MED CHEM, V44, P1202, DOI 10.1021/jm000503f; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2003, J BIOL CHEM, V278, P17185, DOI 10.1074/jbc.M301516200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MARTIN S, 1993, J VIROL, V67, P3561, DOI 10.1128/JVI.67.6.3561-3568.1993; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; PERRY MA, 1991, J CLIN INVEST, V87, P1798, DOI 10.1172/JCI115200; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; ULMER AJ, 1979, J IMMUNOL METHODS, V30, P1, DOI 10.1016/0022-1759(79)90268-0; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yahalom D, 2002, BIOCHEMISTRY-US, V41, P8321, DOI 10.1021/bi025690t; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200	67	154	166	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					393	406		10.1016/S1074-7613(04)00082-2	http://dx.doi.org/10.1016/S1074-7613(04)00082-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084269	Bronze			2022-12-18	WOS:000221442800006
J	Lee, GR; Fields, PE; Griffin, TJ; Flavell, RA				Lee, GR; Fields, PE; Griffin, TJ; Flavell, RA			Regulation of the Th2 cytokine locus by a locus control region	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR GATA-3; COORDINATE REGULATOR; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; PROMOTER OCCLUSION; GENE-TRANSCRIPTION; TRANSGENIC MICE; MOLECULAR-BASIS; IMMUNE-SYSTEM	The Th2 cytokine genes IL4, IL5, and IL13 are clustered and expressed in a cell lineage-specific manner. We investigated the global locus-specific regulation of these genes using BAC transgenic mice containing the murine Th2 cytokine cluster carrying an IL4 promoter-luciferase reporter. IL4 promoter activity in effector CD4 T cells from these transgenic mice was strong, Th2 specific, and copy number dependent, suggesting the presence of an LCR in the locus. The production of IL4 and IL13, but not IL5, by these cells was also copy number dependent. Deletion analysis defined a 25 kb fragment in the RAD50 gene as the region containing the LCR activity. Expression of the IL4 promoter-luciferase reporter was transactivated by GATA-3 irrespective of position in the locus, suggesting the global nature of this regulation. The LCR itself, however, does not respond directly to GATA-3.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.		Fields, Patrick E/G-4878-2012	Fields, Patrick/0000-0002-6797-4139	NHLBI NIH HHS [HL56389] Funding Source: Medline; NIGMS NIH HHS [GM 28407] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056389, P50HL056389] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 1999, J ALLERGY CLIN IMMUN, V103, P990, DOI 10.1016/S0091-6749(99)70168-5; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; BATEMAN E, 1988, CELL, V54, P985, DOI 10.1016/0092-8674(88)90113-4; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Dong C, 2001, CURR OPIN HEMATOL, V8, P47, DOI 10.1097/00062752-200101000-00009; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Flavell RA, 1999, IMMUNOL RES, V19, P159, DOI 10.1007/BF02786484; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Glimcher LH, 2000, GENE DEV, V14, P1693; Griffin TJ, 1999, NUCLEIC ACIDS RES, V27, P3859, DOI 10.1093/nar/27.19.3859; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Hogan B., 1986, MANIPULATING MOUSE E; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Lee CY, 2001, J SCHED, V4, P3, DOI 10.1002/1099-1425(200101/02)4:1<3::AID-JOS57>3.0.CO;2-D; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Leschziner AE, 1998, P NATL ACAD SCI USA, V95, P7345, DOI 10.1073/pnas.95.13.7345; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pasceri P, 1998, BLOOD, V92, P653, DOI 10.1182/blood.V92.2.653.414k10_653_663; PINKERT CA, 1985, EMBO J, V4, P2225, DOI 10.1002/j.1460-2075.1985.tb03918.x; Range LM, 1998, J PERS INTERPERS LOS, V3, P161, DOI 10.1080/10811449808414438; Sabbattini P, 1999, MOL CELL BIOL, V19, P671; Schedl A, 1996, Methods Mol Biol, V54, P293; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Takemoto N, 2002, J IMMUNOL, V169, P4103, DOI 10.4049/jimmunol.169.8.4103; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	44	154	157	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2003	19	1					145	153		10.1016/S1074-7613(03)00179-1	http://dx.doi.org/10.1016/S1074-7613(03)00179-1			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	703BP	12871646	Bronze			2022-12-18	WOS:000184260400015
J	Krawczyk, C; Oliveira-Dos-Santos, A; Sasaki, T; Griffiths, E; Ohashi, PS; Snapper, S; Alt, F; Penninger, JM				Krawczyk, C; Oliveira-Dos-Santos, A; Sasaki, T; Griffiths, E; Ohashi, PS; Snapper, S; Alt, F; Penninger, JM			Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells	IMMUNITY			English	Article							EXCHANGE FACTOR VAV; T-CELL; SIGNAL-TRANSDUCTION; TYROSINE PHOSPHORYLATION; IMMUNOLOGICAL SYNAPSE; RECEPTOR; ACTIVATION; PROTEIN; REGULATOR; LFA-1	Integrin-mediated adhesion is essential for the formation of stable contacts between T cells and antigen-presenting cells (APCs). We show that Vav1 controls integrin-mediated adhesion of thymocytes and T cells to ECM proteins and ICAM1 following TCR stimulation. In a peptide-specific system, Vav1 is required for T cell adhesion to peptide-loaded APCs. Intriguingly, TCR-induced cell adhesion and aggregation of integrins occurs independent of WASP. Whereas LFA-1 and actin caps colocalize in wasp(-/-) T cells in response to TCR stimulation, loss of WASP uncouples TCR caps from actin patches. Our data reveal a novel role for Vav1 and WASP in the regulation of TCR-induced integrin clustering and cell adhesion and show that integrin and TCR clustering are controlled by distinct pathways.	Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, Tokyo 1138613, Japan; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	University of Toronto; University of Toronto; University of Toronto; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Tokyo Metropolitan Institute of Medical Science; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Penninger, JM (corresponding author), Univ Toronto, Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jpenning@amgen.com	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; Ohashi, Pamela S./0000-0003-2915-9317				Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bachmann MF, 1999, J IMMUNOL, V163, P137; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001; CHAN ASH, 1994, EUR J IMMUNOL, V24, P2602, DOI 10.1002/eji.1830241106; Chan ASH, 1997, J IMMUNOL, V159, P934; Chen T, 1999, EUR J IMMUNOL, V29, P809, DOI 10.1002/(SICI)1521-4141(199903)29:03<809::AID-IMMU809>3.3.CO;2-O; Dedhar S, 1999, Curr Opin Hematol, V6, P37, DOI 10.1097/00062752-199901000-00007; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1998, CELL ADHES COMMUN, V6, P255, DOI 10.3109/15419069809004481; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Epler J A, 2000, Dev Immunol, V7, P155; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; QUDDUS J, 1994, IMMUNOLOGY, V82, P301; SanchezMateos P, 1996, SEMIN CANCER BIOL, V7, P99, DOI 10.1006/scbi.1996.0015; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Shimizu Y, 2000, Immunol Today, V21, P597, DOI 10.1016/S0167-5699(00)01783-7; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Tanaka Y, 2000, HISTOL HISTOPATHOL, V15, P1169, DOI 10.14670/HH-15.1169; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; VAN SG, 1990, J IMMUNOL, V144, P4579; VILLAVERDE DMS, 1995, BRAZ J MED BIOL RES, V28, P907; Woods ML, 2001, J LEUKOCYTE BIOL, V69, P874; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329	49	154	157	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2002	16	3					331	343		10.1016/S1074-7613(02)00291-1	http://dx.doi.org/10.1016/S1074-7613(02)00291-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	534EZ	11911819	Bronze			2022-12-18	WOS:000174572800003
J	Cyster, JG; Goodnow, CC				Cyster, JG; Goodnow, CC			Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment	IMMUNITY			English	Review							B-CELL ANTIGEN; TYROSINE-PHOSPHATASE 1C; LYN-DEFICIENT MICE; LYMPHOCYTES-B; ADHESION MOLECULE; T-CELLS; IMMUNOGLOBULIN SUPERFAMILY; NEGATIVE REGULATION; AUTOIMMUNE-DISEASE; SELF-TOLERANCE		STANFORD UNIV, SCH MED, BECKMAN CTR, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Cyster, JG (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT IMMUNOL & MICROBIOL, SAN FRANCISCO, CA 94143 USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Andersson KB, 1996, EUR J IMMUNOL, V26, P3170, DOI 10.1002/eji.1830261250; ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; BRAESCHANDERSEN S, 1994, J BIOL CHEM, V269, P11783; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; CAMPANA D, 1985, J IMMUNOL, V134, P1524; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DORKEN B, 1986, J IMMUNOL, V136, P4470; ENGEL P, 1995, J EXP MED, V181, P1581, DOI 10.1084/jem.181.4.1581; Erickson LD, 1996, INT IMMUNOL, V8, P1121, DOI 10.1093/intimm/8.7.1121; ERIKSTEIN BK, 1992, EUR J IMMUNOL, V22, P1149, DOI 10.1002/eji.1830220507; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOLD MR, 1994, ADV IMMUNOL, V55, P221; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; LAW CL, 1995, J IMMUNOL, V155, P3368; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Leitenberg D, 1996, J EXP MED, V183, P249, DOI 10.1084/jem.183.1.249; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; LOKEN MR, 1987, BLOOD, V70, P1316; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; OTOPOBY KL, 1996, NATURE, V384, P634; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; PEZZUTTO A, 1987, J IMMUNOL, V138, P98; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; SGROI D, 1993, J BIOL CHEM, V268, P7011; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; STAMENKOVIC I, 1990, NATURE, V345, P74, DOI 10.1038/345074a0; STAMENKOVIC I, 1991, CELL, V66, P1133, DOI 10.1016/0092-8674(91)90036-X; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TORRES RM, 1992, J IMMUNOL, V149, P2641; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; VANDERMERWE A, 1996, J BIOL CHEM, V271, P9273; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137; YELLEN AJ, 1991, J IMMUNOL, V146, P1446	73	154	155	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1997	6	5					509	517		10.1016/S1074-7613(00)80339-8	http://dx.doi.org/10.1016/S1074-7613(00)80339-8			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XB819	9175829	Bronze			2022-12-18	WOS:A1997XB81900002
J	MOMBAERTS, P; ANDERSON, SJ; PERLMUTTER, RM; MAK, TW; TONEGAWA, S				MOMBAERTS, P; ANDERSON, SJ; PERLMUTTER, RM; MAK, TW; TONEGAWA, S			AN ACTIVATED LCK TRANSGENE PROMOTES THYMOCYTE DEVELOPMENT IN RAG-1 MUTANT MICE	IMMUNITY			English	Article							T-CELL-RECEPTOR; TCR-BETA-CHAIN; PROTEIN-TYROSINE KINASE; SURFACE EXPRESSION; V(D)J RECOMBINATION; LYMPHOCYTES-T; ALPHA-CHAIN; GENE; P56(LCK); IMMATURE	Expression of the T cell receptor P (TCR beta) chain is necessary for the transition from the CD4(-)CD8(-) stage in the major alpha beta thymocyte lineage. The protein tyrosine kinase p56(lck) has been implicated in the regulation of early thymocyte differentiation and of allelic exclusion at the TCR beta locus. Using mice overexpressing an activated lck transgene and mice with a disruption of the lck gene, we demonstrate that p5(lck) participates in a pathway that regulates the expansion of the pool of CD4(+)CD8(+) thymocytes to wild-type levels. In addition, p56(lck) may be involved in the down-regulation of the putative pre-TCR on CD4(+)CD8(+) thymocytes.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139; MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT MED MED GENET,SEATTLE,WA 98185; UNIV TORONTO,AMGEN INST,ONTARIO CANC INST,DEPT IMMUNOL,TORONTO M4X 1K9,ON,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M4X 1K9,ON,CANADA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto								ABRAHAM KM, 1992, J EXP MED, V175, P1421; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; BERNARD O, 1993, LEUKEMIA, V7, P1645; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; GODFREY DI, 1994, J IMMUNOL, V152, P4783; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GROETTRUP M, 1993, EUR J IMMUNOL, V23, P1393, DOI 10.1002/eji.1830230633; GROETTRUP M, 1992, EMBO J, V11, P2735, DOI 10.1002/j.1460-2075.1992.tb05339.x; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GROETTRUP M, 1993, IMMUNOL TODAY, V14, P610, DOI 10.1016/0167-5699(93)90201-U; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; KISHI H, 1991, EMBO J, V10, P93, DOI 10.1002/j.1460-2075.1991.tb07924.x; KRIMPENFORT P, 1989, NATURE, V341, P742, DOI 10.1038/341742a0; LEVIN SD, 1993, J EXP MED, V178, P245, DOI 10.1084/jem.178.1.245; LEVIN SD, 1993, EMBO J, V12, P1671, DOI 10.1002/j.1460-2075.1993.tb05812.x; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOMBAERTS P, 1994, TARGETED MUTAGENESIS, P15; Mombaerts Peter, 1993, Current Opinion in Biotechnology, V4, P690, DOI 10.1016/0958-1669(93)90051-W; NAKAYAMA T, 1993, P NATL ACAD SCI USA, V90, P10534, DOI 10.1073/pnas.90.22.10534; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OWEN MJ, 1993, CURR BIOL, V3, P780, DOI 10.1016/0960-9822(93)90031-I; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PUNT JA, 1991, J EXP MED, V174, P775, DOI 10.1084/jem.174.4.775; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHILHAM MW, 1993, EUR J IMMUNOL, V23, P1299, DOI 10.1002/eji.1830230617; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P856; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531	42	154	154	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUL	1994	1	4					261	267		10.1016/1074-7613(94)90077-9	http://dx.doi.org/10.1016/1074-7613(94)90077-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK166	7889413				2022-12-18	WOS:A1994PK16600003
J	Odegaard, JI; Chawla, A				Odegaard, Justin I.; Chawla, Ajay			The Immune System as a Sensor of theMetabolic State	IMMUNITY			English	Review							ALTERNATIVELY ACTIVATED MACROPHAGES; INDUCED INSULIN-RESISTANCE; HEPATIC GLUCOSE-PRODUCTION; DIET-INDUCED OBESITY; BETA/NF-KAPPA-B; KILLER T-CELLS; ADIPOSE-TISSUE; ADAPTIVE THERMOGENESIS; IKK-BETA; KUPFFER CELLS	Mammals possess a remarkable ability to maintain and defend a constant internal milieu against diverse environmental threats. Unsurprisingly, the two systems tasked with these duties, metabolism and immunity, have evolved to share a common modular architecture that allows extensive bidirectional communication and coordination. Indeed, recent observations have highlighted numerous functionally critical immune regulatory modules located within diverse metabolic circuits. In this review, we discuss the architectural commonality between immunity and metabolism and highlight how these two primordially disparate systems leverage shared regulatory axes to coordinate metabolic physiology under conditions of normality and chronic overnutrition. Such an integrated perspective both advances our understanding of basic physiology and highlights potential opportunities for therapeutic intervention in metabolic dysfunction.	[Odegaard, Justin I.; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu			NIH [HL076746, DK094641]; Larry L. Hillblom Foundation Network; Diabetes Family Fund (UCSF); AHA Innovative Award [12PILT11840038]; NIH Director's Pioneer Award [DP1AR064158]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Network; Diabetes Family Fund (UCSF); AHA Innovative Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Mukundan for constructive comments on this manuscript. A. C. was supported by grants from the NIH (HL076746, DK094641), Larry L. Hillblom Foundation Network, and Diabetes Family Fund (UCSF) and by an AHA Innovative Award (12PILT11840038) and an NIH Director's Pioneer Award (DP1AR064158).	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Afacan NJ, 2012, MOL ASPECTS MED, V33, P14, DOI 10.1016/j.mam.2011.10.013; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Boehm T, 2012, CURR BIOL, V22, pR722, DOI 10.1016/j.cub.2012.07.003; Brooks-Worrell B, 2012, TRENDS IMMUNOL, V33, P546, DOI 10.1016/j.it.2012.07.002; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard Justin I, 2012, F1000 Biol Rep, V4, P13, DOI 10.3410/B4-13; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Papackova Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-22; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Poggi M, 2011, ARTERIOSCL THROM VAS, V31, P2251, DOI 10.1161/ATVBAHA.111.231357; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	78	153	157	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					644	654		10.1016/j.immuni.2013.04.001	http://dx.doi.org/10.1016/j.immuni.2013.04.001			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601683	Green Accepted, Bronze			2022-12-18	WOS:000330942100008
J	Kitamura, H; Kamon, H; Sawa, SI; Park, SJ; Katunuma, N; Ishihara, K; Murakami, M; Hirano, T				Kitamura, H; Kamon, H; Sawa, SI; Park, SJ; Katunuma, N; Ishihara, K; Murakami, M; Hirano, T			IL-6-STAT3 controls intracellular MHC class II alpha beta dimer level through cathepsin S activity in dendritic cells	IMMUNITY			English	Article							THYMIC EPITHELIAL-CELLS; IN-VIVO; DEVELOPMENTAL REGULATION; ANTIGEN PRESENTATION; CYSTATIN-C; PROTEOLYSIS; PEPTIDE; ROLES; DIFFERENTIATION; EXPRESSION	We found IL-6-STAT3 pathway suppresses MHC class II (MHCII) expression on dendritic cells (DCs) and attenuates T cell activation. Here, we showed that IL-6-STAT3 signaling reduced intracellular MHCII alpha beta dimmer, Ii, and H2-DM levels in DCs. IL-6-mediated STAT3 activation decreased cystatin C level, an endogenous inhibitor of cathepsins, and enhanced cathepsin activities. Importantly, cathepsin S inhibitors blocked reduction of MHCII alpha beta dimer, Ii, and H2-DM in the IL-6-treated DCs. Overexpression of cystatin C suppressed IL-6-STAT3-mediated increase of cathepsin S activity and reduction of MHCII alpha beta dimer, Ii, and H2-DM levels in DCs. Cathepsin S overexpression in DCs decreased intracellular MHCII alpha beta dimer, Ii, and H2-DM levels, LPS-mediated surface expression of MHCII and suppressed CD4(+) T cell activation. IL-6-gp130-STAT3 signaling in vivo decreased cystatin C expression and MHCII alpha beta dimer level in DCs. Thus, IL-6-STAT3-mediated increase of cathepsin S activity reduces the MHCII alpha beta dimer, Ii, and H2-DM levels in DCs, and suppresses CD4(+) T cell-mediated immune responses.	RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Frontier Biosci, Lab Dev Immunol, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Dev Immunol C7, Osaka 5650871, Japan; Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan	RIKEN; Osaka University; Osaka University; Tokushima Bunri University	Hirano, T (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan.	hirano@molonc.med.osaka-u.ac.jp	Ishihara, Katsuhiko/AAL-8175-2021; Kitamura, Hidemitsu/A-8184-2012; Hirano, Toshio/C-8194-2009	, Masaaki/0000-0001-7159-7279				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; BROMME D, 1993, J BIOL CHEM, V268, P4832; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chain BM, 2005, J IMMUNOL, V174, P1791, DOI 10.4049/jimmunol.174.4.1791; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Chow AY, 2005, TRENDS IMMUNOL, V26, P72, DOI 10.1016/j.it.2004.11.008; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Drakesmith H, 1998, P NATL ACAD SCI USA, V95, P14903, DOI 10.1073/pnas.95.25.14903; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; El-Sukkari D, 2003, J IMMUNOL, V171, P5003, DOI 10.4049/jimmunol.171.10.5003; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kasai M, 2000, EUR J IMMUNOL, V30, P3542, DOI 10.1002/1521-4141(200012)30:12<3542::AID-IMMU3542>3.0.CO;2-N; Kasai M, 1998, EUR J IMMUNOL, V28, P1867, DOI 10.1002/(SICI)1521-4141(199806)28:06<1867::AID-IMMU1867>3.0.CO;2-K; Katunuma N, 2003, BIOL CHEM, V384, P883, DOI 10.1515/BC.2003.099; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Katunuma Nobuhiko, 2003, Journal of Medical Investigation, V50, P154; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Martinez-Palacios CA, 1996, AQUACULT NUTR, V2, P11, DOI 10.1111/j.1365-2095.1996.tb00003.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Petanceska S, 1996, J BIOL CHEM, V271, P4403; Pierre P, 2000, J EXP MED, V191, P1057, DOI 10.1084/jem.191.6.1057; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Wolf PR, 1998, EUR J IMMUNOL, V28, P2605, DOI 10.1002/(SICI)1521-4141(199809)28:09<2605::AID-IMMU2605>3.0.CO;2-B; Zavasnik-Bergant T, 2005, J LEUKOCYTE BIOL, V78, P122, DOI 10.1189/jlb.0804451	48	153	163	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2005	23	5					491	502		10.1016/j.immuni.2005.09.010	http://dx.doi.org/10.1016/j.immuni.2005.09.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286017	Bronze			2022-12-18	WOS:000233660700006
J	Bryce, PJ; Miller, ML; Miyajima, I; Tsai, M; Galli, SJ; Oettgen, HC				Bryce, PJ; Miller, ML; Miyajima, I; Tsai, M; Galli, SJ; Oettgen, HC			Immune sensitization in the skin is enhanced by antigen-independent effects of IgE	IMMUNITY			English	Article							MAST-CELL-DEFICIENT; DELAYED-TYPE HYPERSENSITIVITY; TUMOR-NECROSIS-FACTOR; FC-EPSILON-RI; CONTACT SENSITIVITY; LANGERHANS CELLS; T-CELLS; DENDRITIC CELLS; ARTHUS REACTION; TNF-ALPHA	Contact sensitivity responses require both effective immune sensitization following cutaneous exposure to chemical haptens and antigen-specific elicitation of inflammation upon subsequent hapten challenge. We report that antigen-independent effects of IgE antibodies can promote immune sensitization to haptens in the skin. Contact sensitivity was markedly impaired in IgE(-/-) mice but was restored by either transfer of sensitized cells from wild-type mice or administration of hapten-irrelevant IgE before sensitization. Moreover, IgE(-/-) mice exhibited impairment in the reduction of dendritic cell numbers in the epidermis after hapten exposure. Monomeric IgE has been reported to influence mast cell function. We observed diminished contact sensitivity in mice lacking FcepsilonRI or mast cells, and mRNA for several mast cell-associated genes was reduced in IgE(-/-) versus wild-type skin after hapten exposure. We speculate that levels of IgE normally present in mice favor immune sensitization via antigen-independent but FcepsilonRI-dependent effects on mast cells.	Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Kurume Univ, Sch Med, Dept Pediat 1, Kurume, Fukuoka 8300011, Japan; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; Kurume University; Stanford University	Oettgen, HC (corresponding author), Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	hans.oettgen@childrens.harvard.edu		Tsai, Mindy/0000-0002-8421-4721	NCI NIH HHS [R01 CA72074] Funding Source: Medline; NIAID NIH HHS [R37 AI23990, 1-R01-AI054471] Funding Source: Medline; PHS HHS [P01 H267674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054471, R37AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Ban M, 2001, TOXICOL LETT, V118, P129, DOI 10.1016/S0378-4274(00)00280-0; Becke FM, 2001, EUR CYTOKINE NETW, V12, P45; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; Cumberbatch M, 1999, ARCH DERMATOL RES, V291, P357, DOI 10.1007/s004030050422; CUMBERBATCH M, 2001, IN VIVO ASSAYS LANGE, P331; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Eglite S, 2003, J IMMUNOL, V170, P2680, DOI 10.4049/jimmunol.170.5.2680; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Geba GP, 1996, J IMMUNOL, V157, P557; Gordon JR, 2000, J ALLERGY CLIN IMMUN, V106, P110; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; GRAZIANO FM, 1983, J IMMUNOL, V131, P2675; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; HA TY, 1986, INT ARCH ALLER A IMM, V80, P85, DOI 10.1159/000234031; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hope JC, 2000, EUR J IMMUNOL, V30, P197, DOI 10.1002/1521-4141(200001)30:1<197::AID-IMMU197>3.3.CO;2-0; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Matsuda H, 1997, J IMMUNOL, V158, P2891; MATSUDA H, 1995, INT ARCH ALLERGY IMM, V107, P364, DOI 10.1159/000237034; MEKORI YA, 1987, CELL IMMUNOL, V109, P39, DOI 10.1016/0008-8749(87)90290-5; MEKORI YA, 1985, J IMMUNOL, V135, P879; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mizumoto N, 2001, IMMUNOBIOLOGY, V204, P477, DOI 10.1078/0171-2985-00057; Nagai H, 1999, INT ARCH ALLERGY IMM, V118, P285, DOI 10.1159/000024101; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Paliwal V, 2002, J IMMUNOL, V169, P4113, DOI 10.4049/jimmunol.169.8.4113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PTAK W, 1991, J IMMUNOL, V146, P3929; Redegeld FA, 2002, NAT MED, V8, P694, DOI 10.1038/nm722; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; Sawada K, 1997, CLIN EXP ALLERGY, V27, P225; SHOMICK LP, 1996, J EXP MED, V183, P1427; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; THOMAS WR, 1983, J IMMUNOL, V130, P2565; Tsuji RF, 2002, J EXP MED, V196, P1277, DOI 10.1084/jem.20020649; Wang BH, 2002, J IMMUNOL, V168, P3303, DOI 10.4049/jimmunol.168.7.3303; Wang BH, 1997, J IMMUNOL, V159, P6148; Webb EF, 1998, J INVEST DERMATOL, V111, P86, DOI 10.1046/j.1523-1747.1998.00239.x; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yamazaki S, 1998, EXP DERMATOL, V7, P35, DOI 10.1111/j.1600-0625.1998.tb00300.x	53	153	156	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2004	20	4					381	392		10.1016/S1074-7613(04)00080-9	http://dx.doi.org/10.1016/S1074-7613(04)00080-9			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084268	Bronze			2022-12-18	WOS:000221442800005
J	Egawa, T; Kawabata, K; Kawamoto, H; Amada, K; Okamoto, R; Fujii, N; Kishimoto, T; Katsura, Y; Nagasawa, T				Egawa, T; Kawabata, K; Kawamoto, H; Amada, K; Okamoto, R; Fujii, N; Kishimoto, T; Katsura, Y; Nagasawa, T			The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE FETAL LIVER; MOUSE BONE-MARROW; RECEPTOR CXCR4; MOLECULAR-CLONING; IN-VIVO; TARGETED DISRUPTION; ALPHA-4 INTEGRINS; MICE LACKING; HIV-1 ENTRY	Environmental factors essential for the first stages of B lymphopoiesis remain elusive. Here, we report that immediately after commitment to B lineage, precursors become dependent on a chemokine SDF-1 and its receptor CXCR4 using mutant and radiation chimeric mice. In bone marrow, generation of the earliest identifiable B cell precursor populations requires CXCR4. In fetal liver, we identified Lin(-)CD19(-)c-kit(+)IL7R alpha (+)AA4.1(+), the earliest unipotent B cell precursor population, and found that its development was severely affected in SDF-1(-/-) embryos but not in IL-7(-/-) embryos. Lin(-) T cell progenitors appeared normal in SDF-1(-/-) embryos. Moreover, SDF-1 exhibited specific biologic activities on the earliest B cell precursors. SDF-1 provides the first example of a cytokine responsible for the earliest B lineage stages.	Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Immunol, Izumi Ku, Osaka 5941101, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Immunol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; Osaka Univ, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Nagasawa, T (corresponding author), Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Immunol, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.		Kishimoto, Tadamitsu/C-8470-2009	Nagasawa, Takashi/0000-0002-1085-0960				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 1999, J EXP MED, V189, P735, DOI 10.1084/jem.189.4.735; ALUTI A, 1997, J EXP MED, V185, P111; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; LIN H, 1995, NATURE, V376, P253; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohmura K, 1999, J IMMUNOL, V163, P4788; OKADA S, 1992, BLOOD, V80, P3044; Osawa M, 1996, J IMMUNOL, V156, P3207; Osmond DG, 1998, IMMUNOL TODAY, V19, P65, DOI 10.1016/S0167-5699(97)01203-6; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeda S, 1997, BLOOD, V89, P518, DOI 10.1182/blood.V89.2.518; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	51	153	161	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2001	15	2					323	334		10.1016/S1074-7613(01)00185-6	http://dx.doi.org/10.1016/S1074-7613(01)00185-6			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	467RH	11520466	Bronze			2022-12-18	WOS:000170717200013
J	Pan, C; Baumgarth, N; Parnes, JR				Pan, C; Baumgarth, N; Parnes, JR			CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation	IMMUNITY			English	Article							STIMULATORY FACTOR-I; LYN-DEFICIENT MICE; SIGNAL-TRANSDUCTION MOLECULE; TYROSINE-PHOSPHATASE SHP-1; SURFACE PROTEIN CD72; AUTOIMMUNE-DISEASE; LYMPHOCYTE DEVELOPMENT; CD22-DEFICIENT MICE; NEGATIVE SELECTION; GERMINAL-CENTERS	CD72, a B cell surface protein of the C-type lectin superfamily, recruits the tyrosine phosphatase SHP-1 through its ITIM motif(s). Using CD72-deficient (CD72(-/-)) mice, we demonstrate that CD72 is a nonredundant regulator of B cell development. In the bone marrow of CD72(-/-) mice, there was a reduction in the number of mature recirculating B cells and an accumulation of pre-B cells. In the periphery of CD72(-/-) mice, there were fewer mature B-2 cells and more B-l cells. In addition, CD72 is a negative regulator of B cell activation, as CD72(-/-) B cells were hyperproliferative in response to various stimuli and showed enhanced kinetics in their intracellular Ca2+ response following IgM cross-linking.	Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Parnes, JR (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.		Baumgarth, Nicole/AAI-6949-2020		NCI NIH HHS [CA68675] Funding Source: Medline; NIAID NIH HHS [AI-07290, AI-09462] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi T, 1998, J IMMUNOL, V160, P4662; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; CAMPBELL MA, 1995, SCAND J IMMUNOL, V41, P563; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; EGAN SE, 1993, NATURE, V363, P83; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; GRUPP SA, 1987, CELL IMMUNOL, V110, P131, DOI 10.1016/0008-8749(87)90107-9; Hardy R.R., 1986, HDB EXPT IMMUNOLOGY, P311; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; LAURINDO I, 1987, CELL IMMUNOL, V108, P473, DOI 10.1016/0008-8749(87)90229-2; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; NAKAYAMA E, 1989, P NATL ACAD SCI USA, V86, P1352, DOI 10.1073/pnas.86.4.1352; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Nomura T, 1996, INT IMMUNOL, V8, P867, DOI 10.1093/intimm/8.6.867; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; PEZZUTTO A, 1990, LEUKOCYTE TYPING 4, P178; POLLA BS, 1988, J MOL CELL IMMUNOL, V3, P363; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Robinson WH, 1997, IMMUNOGENETICS, V45, P195, DOI 10.1007/s002510050189; Roederer M, 1996, CYTOMETRY, V24, P191, DOI 10.1002/(SICI)1097-0320(19960701)24:3<191::AID-CYTO1>3.0.CO;2-L; Roederer M, 1997, CYTOMETRY, V29, P328, DOI 10.1002/(SICI)1097-0320(19971201)29:4<328::AID-CYTO10>3.0.CO;2-W; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; SATO S, 1995, P NATL ACAD SCI USA, V92, P11558, DOI 10.1073/pnas.92.25.11558; Sato S, 1996, J IMMUNOL, V157, P4371; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SIDMAN CL, 1986, SCIENCE, V232, P1423, DOI 10.1126/science.3487115; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; SNOW EC, 1986, J IMMUNOL, V137, P1793; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; SUBBARAO B, 1988, CELL IMMUNOL, V112, P329, DOI 10.1016/0008-8749(88)90302-4; Subbarao B, 1982, Immunol Rev, V69, P81; SUBBARAO B, 1984, J EXP MED, V159, P1796, DOI 10.1084/jem.159.6.1796; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Venkataraman C, 1998, EUR J IMMUNOL, V28, P3003; Venkataraman C, 1998, J IMMUNOL, V160, P3322; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; YAKURA H, 1986, J IMMUNOL, V137, P1475; YAKURA H, 1988, J IMMUNOL, V141, P875; YAKURA H, 1981, J EXP MED, V153, P129, DOI 10.1084/jem.153.1.129; YING H, 1995, J IMMUNOL, V154, P2743	56	153	156	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1999	11	4					495	506		10.1016/S1074-7613(00)80124-7	http://dx.doi.org/10.1016/S1074-7613(00)80124-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549631	Bronze			2022-12-18	WOS:000083343100011
J	Akkaraju, S; Ho, WY; Leong, D; Canaan, K; Davis, MM; Goodnow, CC				Akkaraju, S; Ho, WY; Leong, D; Canaan, K; Davis, MM; Goodnow, CC			A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis	IMMUNITY			English	Article							RECEPTOR TRANSGENIC MICE; MYELIN BASIC-PROTEIN; PANCREATIC BETA-CELLS; DEPENDENT DIABETES-MELLITUS; II-RESTRICTED PRESENTATION; REACTIVE LYMPHOCYTES-B; APOPTOSIS IN-VIVO; HEN EGG LYSOZYME; PERIPHERAL TOLERANCE; DIFFERENTIAL EXPRESSION	T cell receptor (TCR) transgenic mice specific for hen egg lysozyme (HEL) were crossed with mice expressing HEL on the thyroid epithelium, on pancreatic islet beta cells, or systemically. Depending on the pattern of HEL expression, deletion of double-positive thymocytes ranged from minimal to complete, and peripheral CD4 cells exhibited graded reduction in TCR expression, in vitro responsiveness, and in vivo helper ability. CD4 cells were least tolerant in TCR/thyroid-HEL and TCR/islet-HEL mice, which developed an extensive lymphocytic thyroiditis or insulitis that nevertheless did not eliminate HEL-expressing endocrine cells. Autoreactive CD4 clones thus escape the thymus under a range of circumstances, retain sufficient function to initiate subclinical autoimmune inflammation when self-antigens are concentrated in the thyroid or pancreas, and may regulate progression of subclinical inflammation to destructive autoimmune disease.			Akkaraju, S (corresponding author), STANFORD UNIV, SCH MED, BECKMAN CTR, DEPT MICROBIOL & IMMUNOL, PROGRAM IMMUNOL, STANFORD, CA 94305 USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155; Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036535, P01AI019512] Funding Source: NIH RePORTER; NIAID NIH HHS [AI19512, AI36535] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; ALFERINK J, 1995, INT IMMUNOL, V7, P331, DOI 10.1093/intimm/7.2.331; ALLEN PM, 1984, J IMMUNOL, V132, P1077; ALTMANN DM, 1991, IMMUNOL TODAY, V12, P267, DOI 10.1016/0167-5699(91)90124-C; ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; ARNOLD B, 1994, TRANSGENESIS TARGETE, P135; AVVEDIMENTO VE, 1985, EUR J BIOCHEM, V149, P467, DOI 10.1111/j.1432-1033.1985.tb08948.x; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BLACKMAN MA, 1990, NATURE, V345, P540, DOI 10.1038/345540a0; BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x; BOHME J, 1989, SCIENCE, V244, P1179, DOI 10.1126/science.2499048; BROOKS A, 1991, P NATL ACAD SCI USA, V88, P3290, DOI 10.1073/pnas.88.8.3290; BROOKS AG, 1993, J IMMUNOL, V150, P3690; BURKLY LC, 1990, SCIENCE, V248, P1364, DOI 10.1126/science.1694042; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; DEGERMANN S, 1994, EUR J IMMUNOL, V24, P3155, DOI 10.1002/eji.1830241236; DILLON SR, 1995, IMMUNITY, V3, P321, DOI 10.1016/1074-7613(95)90117-5; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; FIELDS LE, 1992, P NATL ACAD SCI USA, V89, P5730, DOI 10.1073/pnas.89.13.5730; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; GEIGER T, 1992, P NATL ACAD SCI USA, V89, P2985, DOI 10.1073/pnas.89.7.2985; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; GRIMA B, 1992, J NEUROCHEM, V59, P2318; GUERDER S, 1994, IMMUNITY, V1, P155; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HEATH WR, 1993, J EXP MED, V178, P1807, DOI 10.1084/jem.178.5.1807; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; HEATH WR, 1995, J IMMUNOL, V155, P2339; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; JAMESON BA, 1994, NATURE, V368, P744, DOI 10.1038/368744a0; JOHNSON NA, 1989, J IMMUNOL, V142, P3298; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KISLELOW P, 1988, NATURE, V333, P742; KONG YM, 1989, CLIN EXP IMMUNOL, V77, P428; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; MARTIN L, 1993, J IMMUNOL, V150, P1234; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; MATHISEN PM, 1993, P NATL ACAD SCI USA, V90, P10125, DOI 10.1073/pnas.90.21.10125; MIETHKE T, 1994, EUR J IMMUNOL, V24, P1893, DOI 10.1002/eji.1830240827; MILLER JFAP, 1993, IMMUNOL REV, V133, P131, DOI 10.1111/j.1600-065X.1993.tb01514.x; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; Munthe LA, 1995, SCAND J IMMUNOL, V42, P651, DOI 10.1111/j.1365-3083.1995.tb03708.x; MURPHY KM, 1989, P NATL ACAD SCI USA, V86, P10034, DOI 10.1073/pnas.86.24.10034; MUSTI AM, 1986, P NATL ACAD SCI USA, V83, P323, DOI 10.1073/pnas.83.2.323; Oehen S, 1996, J EXP MED, V183, P2617, DOI 10.1084/jem.183.6.2617; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; PARISH NM, 1995, IMMUNOL REV, V144, P269, DOI 10.1111/j.1600-065X.1995.tb00073.x; PATERSON PHILIP Y., 1966, ADVANCE IMMUNOL, V5, P131, DOI 10.1016/S0065-2776(08)60273-4; PERKINS DL, 1994, CELL IMMUNOL, V156, P310, DOI 10.1006/cimm.1994.1177; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Poplonski L, 1996, EUR J IMMUNOL, V26, P601, DOI 10.1002/eji.1830260315; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; ROCHA B, 1995, J EXP MED, V181, P993, DOI 10.1084/jem.181.3.993; ROMAN LM, 1990, CELL, V61, P383, DOI 10.1016/0092-8674(90)90521-F; SCHONRICH G, 1992, INT IMMUNOL, V4, P581, DOI 10.1093/intimm/4.5.581; SCHONRICH G, 1992, EUR J IMMUNOL, V22, P1687, DOI 10.1002/eji.1830220704; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; VASQUEZ NJ, 1992, J EXP MED, V175, P1307, DOI 10.1084/jem.175.5.1307; WEETMAN AP, 1991, AUTOIMMUNE ENDOCRINE; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; WIETIES K, 1990, P NATL ACAD SCI USA, V87, P6604, DOI 10.1073/pnas.87.17.6604; WRAITH DC, 1989, CELL, V57, P709, DOI 10.1016/0092-8674(89)90786-1; YAGI H, 1992, EUR J IMMUNOL, V22, P2387, DOI 10.1002/eji.1830220931; YULE TD, 1993, J IMMUNOL, V151, P3057; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zhang L, 1996, J EXP MED, V183, P2065, DOI 10.1084/jem.183.5.2065; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	96	153	154	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1997	7	2					255	271		10.1016/S1074-7613(00)80528-2	http://dx.doi.org/10.1016/S1074-7613(00)80528-2			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT492	9285410	Bronze			2022-12-18	WOS:A1997XT49200009
J	Hertz, M; Nemazee, D				Hertz, M; Nemazee, D			BCR ligation induces receptor editing in IgM(+)IgD(-) bone marrow B cells in vitro	IMMUNITY			English	Article							GENE REARRANGEMENT; ESCAPE TOLERANCE; LYMPHOCYTES; SELF; EXPRESSION; CHAIN; DELETION; DEATH; MODEL	The ability of BCR cross-linking to stimulate receptor editing was analyzed in vitro using bone marrow B cells from immunoglobulin (Ig) transgenic (Tg) and non-Tg mice. In cultured Ig-Tg cells, BCR ligation induced receptor editing as measured by up-regulation of RAG gene expression, light chain gene DNA rearrangements, and expression of lambda-light chain protein in cells that previously expressed kappa. In the culture conditions used, BCR ligation induced light chain rearrangements in most immature IgM(+)IgD(-) bone marrow B cells in the absence of significant cell death or cell growth. Receptor editing in non-Tg B cells was also documented in cultures treated with anti-immunoglobulin. These results provide direct evidence for the ability of BCR ligation to stimulate immunoglobulin tight chain gene rearrangements in immature B cells.	UNIV COLORADO,DEPT PEDIAT,DIV BASIC SCI,NATL JEWISH MED & RES CTR,DENVER,CO 80206; UNIV COLORADO,CTR HLTH SCI,DENVER,CO 80206	National Jewish Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033608, P01AI022295, K04AI001161] Funding Source: NIH RePORTER; NIAID NIH HHS [K04 AI01161, R01 AI033608, P01 AI22295, R01 AI 33608] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAKAWA H, 1995, INT IMMUNOL, V8, P91; Best Cory G., 1995, Methods (Orlando), V8, P3, DOI 10.1006/meth.1995.1039; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MA A, 1992, EMBO J, V11, P2727, DOI 10.1002/j.1460-2075.1992.tb05338.x; Monroe JG, 1996, J IMMUNOL, V156, P2657; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; NISITANI S, 1993, J EXP MED, V178, P1247, DOI 10.1084/jem.178.4.1247; NORVELL A, 1995, J IMMUNOL, V154, P4404; NOSSAL GJV, 1975, J EXP MED, V141, P904; PRAK EL, 1994, J EXP MED, V180, P1805, DOI 10.1084/jem.180.5.1805; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Radic MZ, 1996, IMMUNITY, V5, P505, DOI 10.1016/S1074-7613(00)80266-6; RAFF MC, 1975, J EXP MED, V142, P1052, DOI 10.1084/jem.142.5.1052; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SIDMAN CL, 1975, NATURE, V257, P149, DOI 10.1038/257149a0; STORB U, 1994, IMMUNOL RES, V13, P291, DOI 10.1007/BF02935620; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VERKOCZY LK, 1995, J IMMUNOL, V154, P5136; WEINER HL, 1976, J IMMUNOL, V116, P1656	31	153	158	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	APR	1997	6	4					429	436		10.1016/S1074-7613(00)80286-1	http://dx.doi.org/10.1016/S1074-7613(00)80286-1			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XC619	9133422	Bronze			2022-12-18	WOS:A1997XC61900008
J	Schultheiss, C; Paschold, L; Simnica, D; Mohme, M; Willscher, E; von Wenserski, L; Scholz, R; Wieters, I; Dahlke, C; Tolosa, E; Sedding, DG; Ciesek, S; Addo, M; Binder, M				Schultheiss, Christoph; Paschold, Lisa; Simnica, Donjete; Mohme, Malte; Willscher, Edith; von Wenserski, Lisa; Scholz, Rebekka; Wieters, Imke; Dahlke, Christine; Tolosa, Eva; Sedding, Daniel G.; Ciesek, Sandra; Addo, Marylyn; Binder, Mascha			Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease	IMMUNITY			English	Article							CORONAVIRUS; HETEROGENEITY; EXPRESSION; ANTIBODIES; PNEUMONIA; SYSTEM	We profiled adaptive immunity in COVID-19 patients with active infection or after recovery and created a repository of currently >14 million B and T cell receptor (BCR and TCR) sequences from the blood of these patients. The B cell response showed converging IGHV3-driven BCR clusters closely associated with SARS-CoV-2 antibodies. Clonality and skewing of TCR repertoires were associated with interferon type I and III responses, early CD4(+) and CD8(+) T cell activation, and counterregulation by the co-receptors BTLA, Tim-3, PD-1, TIGIT, and CD73. Tfh, Th17-like, and nonconventional (but not classical antiviral) Th1 cell polarizations were induced. SARS-CoV-2-specific T cell responses were driven by TCR clusters shared between patients with a characteristic trajectory of clonotypes and traceability over the disease course. Our data provide fundamental insight into adaptive immunity to SARS-CoV-2 with the actively updated repository providing a resource for the scientific community urgently needed to inform therapeutic concepts and vaccine development.	[Schultheiss, Christoph; Paschold, Lisa; Simnica, Donjete; Willscher, Edith; von Wenserski, Lisa; Scholz, Rebekka; Binder, Mascha] Martin Luther Univ Halle Wittenberg, Dept Internal Med 4, Oncol Hematol, D-06120 Halle, Saale, Germany; [Mohme, Malte] Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurosurg, D-20246 Hamburg, Germany; [Wieters, Imke] Univ Hosp Frankfurt, Dept Internal Med 2, Infect Dis, D-60596 Frankfurt, Germany; [Dahlke, Christine; Addo, Marylyn] Univ Med Ctr Hamburg Eppendorf, Div Infect Dis, Dept Med 1, D-20246 Hamburg, Germany; [Dahlke, Christine; Addo, Marylyn] Bernhard Nocht Inst Trop Med, Dept Clin Immunol Infect Dis, D-20359 Hamburg, Germany; [Tolosa, Eva] Univ Med Ctr Hamburg Eppendorf, Dept Immunol, D-20246 Hamburg, Germany; [Sedding, Daniel G.] Martin Luther Univ Halle Wittenberg, Univ Hosp, Dept Cardiol & Intens Care Med, Mid German Heart Ctr, D-06120 Halle, Saale, Germany; [Ciesek, Sandra] Goethe Univ Frankfurt, Univ Hosp, Inst Med Virol, D-60596 Frankfurt, Germany; [Ciesek, Sandra] Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol, D-60596 Frankfurt, Germany; [Ciesek, Sandra] German Ctr Infect Res DZIF, External Partner Site Frankfurt, D-60596 Frankfurt, Germany	Martin Luther University Halle Wittenberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Martin Luther University Halle Wittenberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft; German Center for Infection Research	Binder, M (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Internal Med 4, Oncol Hematol, D-06120 Halle, Saale, Germany.	mascha.binder@uk-halle.de	Addo, Marylyn M./GNP-2548-2022; Schultheiß, Christoph/GZA-7479-2022	Schultheiß, Christoph/0000-0001-9789-5776; Addo, Marylyn/0000-0003-2836-9224; von Wenserski, Lisa/0000-0003-1963-0398; Simnica, Donjete/0000-0003-2286-1381; Dahlke, Christine/0000-0002-2056-9195; Binder, Mascha/0000-0003-0663-3004; Scholz, Rebekka/0000-0003-2077-0718	German Research Foundation [CRC 841]; Martin-Luther-University, Halle (Saale)	German Research Foundation(German Research Foundation (DFG)); Martin-Luther-University, Halle (Saale)	We thank the following investigators and advisors for contributing patients and samples, technical assistance, supporting lab facilities, biobanking, ethical, and other input: Nuray Akyuez, Samiya Al-Robaiy, Wolfgang Altermann, Herrmann Behre, Mildred Borrmann, Johanna Brandner, Christine Dierks, Jochen Dutzmann, Johann Fabian Eberhardt, Stephan Eisenmann, Lena Engels, Laura Glau, Katrin Hoffmann, Mareike Holz, Petra Hubner, Ulla Kasten-Pisula, Katharina Kolbe, Kerstin Korber-Fehrl, Katrin Lamszus, Beatrice Ludwig-Kraus, Cecile L. Maire, Sabine Matutat, Lutz P. M_uller, Undine Musielinsky, Alexander Navarrete Santos and the FACS Core Facility Halle, Sebastian Nuding, Gerald Schlaf, Henning Seismann, Marta Siedlecki, Alexander Stein, Maria Vehreschild, Maxi Wass, Christoph Wosiek, Tanja Zeller, and Andela Zic. Moreover, we thank all of the patients and donors after recovery from COVID-19 for donating their blood for this project. This project was partially funded by the CRC 841 of the German Research Foundation (to M.B.) and by the Martin-Luther-University, Halle (Saale).	Aeffner F, 2015, AM J PHYSIOL-LUNG C, V309, pL1313, DOI 10.1152/ajplung.00130.2015; Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bruggemann M, 2019, LEUKEMIA, V33, P2241, DOI 10.1038/s41375-019-0496-7; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Elhanati Y, 2018, IMMUNOL REV, V284, P167, DOI 10.1111/imr.12665; Gautreau G, 2017, BIOINFORMATICS, V33, P779, DOI 10.1093/bioinformatics/btw708; Gil A, 2015, J VIROL, V89, P4102, DOI 10.1128/JVI.03020-14; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou H, 2020, CLIN EXP IMMUNOL, V201, P76, DOI 10.1111/cei.13450; Huang H, 2020, NAT BIOTECHNOL, V38, P1194, DOI 10.1038/s41587-020-0505-4; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Ko JH, 2017, DIAGN MICR INFEC DIS, V89, P106, DOI 10.1016/j.diagmicrobio.2017.07.006; Kreuzaler M, 2012, J IMMUNOL, V188, P497, DOI 10.4049/jimmunol.1102321; Lee N, 2006, J CLIN VIROL, V35, P179, DOI 10.1016/j.jcv.2005.07.005; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mamedov IZ, 2020, LONGITUDINAL HIGH TH, DOI DOI 10.1101/2020.05.18.100545; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; McKechnie JL, 2020, CELL HOST MICROBE, V27, P863, DOI 10.1016/j.chom.2020.05.009; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Minervina AA, 2020, ELIFE, V9, DOI 10.7554/eLife.53704; Nielsen S.C.A., 2020, BIORXIV, DOI DOI 10.21203/RS.3.RS-27220/V1; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Sallusto F, 2016, ANNU REV IMMUNOL, V34, P317, DOI 10.1146/annurev-immunol-032414-112056; Sethna Z, 2019, BIOINFORMATICS, V35, P2974, DOI 10.1093/bioinformatics/btz035; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Simnica D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01897; Simnica D, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1644110; Sjostrand M, 2016, J IMMUNOL, V196, P91, DOI 10.4049/jimmunol.1501061; Speranza E, 2018, J INFECT DIS, V218, pS508, DOI 10.1093/infdis/jiy352; Tan W, 2020, VIRAL KINETICS ANTIB, DOI 10.1101/2020.03.24.20042382; Tangye SG, 2002, J IMMUNOL, V169, P4298, DOI 10.4049/jimmunol.169.8.4298; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VanDuijn MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01286; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wu YL, 2020, CELL HOST MICROBE, V27, P891, DOI 10.1016/j.chom.2020.04.023; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	60	152	155	6	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					442	+		10.1016/j.immuni.2020.06.024	http://dx.doi.org/10.1016/j.immuni.2020.06.024			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32668194	Green Published, Bronze			2022-12-18	WOS:000561190600020
J	Wu, CQ; Lu, W; Zhang, Y; Zhang, GY; Shi, XY; Hisada, Y; Grover, SP; Zhang, XY; Li, L; Xiang, BG; Shi, JM; Li, XA; Daugherty, A; Smyth, SS; Kirchhofer, D; Shiroishi, T; Shao, F; Mackman, N; Wei, YN; Li, ZY				Wu, Congqing; Lu, Wei; Zhang, Yan; Zhang, Guoying; Shi, Xuyan; Hisada, Yohei; Grover, Steven P.; Zhang, Xinyi; Li, Lan; Xiang, Binggang; Shi, Jumei; Li, Xiang-An; Daugherty, Alan; Smyth, Susan S.; Kirchhofer, Daniel; Shiroishi, Toshihiko; Shao, Feng; Mackman, Nigel; Wei, Yinan; Li, Zhenyu			Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis	IMMUNITY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; TISSUE FACTOR; GASDERMIN-D; PORE FORMATION; CASPASE-11; COAGULATION; MEMBRANE; GSDMD; RECEPTORS; SECRETION	Inflammasome activation and subsequent pyroptosis are critical defense mechanisms against microbes. However, overactivation of inflammasome leads to death of the host. Although recent studies have uncovered the mechanism of pyroptosis following inflammasome activation, how pyroptotic cell death drives pathogenesis, eventually leading to death of the host, is unknown. Here, we identified inflammasome activation as a trigger for blood clotting through pyroptosis. We have shown that canonical inflammasome activation by the conserved type III secretion system (T3SS) rod proteins from Gram-negative bacteria or noncanonical inflammasome activation by lipopolysaccharide (LPS) induced systemic blood clotting and massive thrombosis in tissues. Following inflammasome activation, pyroptotic macrophages released tissue factor (TF), an essential initiator of coagulation cascades. Genetic or pharmacological inhibition of TF abolishes inflammasome-mediated blood clotting and protects against death. Our data reveal that blood clotting is the major cause of host death following inflammasome activation and demonstrate that inflammasome bridges inflammation with thrombosis.	[Wu, Congqing; Zhang, Yan; Zhang, Guoying; Xiang, Binggang; Daugherty, Alan; Smyth, Susan S.; Li, Zhenyu] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA; [Lu, Wei; Zhang, Xinyi; Li, Lan; Wei, Yinan] Univ Kentucky, Dept Chem, Coll Arts & Sci, Lexington, KY 40506 USA; [Shi, Xuyan; Shao, Feng] Natl Inst Biol Sci, Beijing, Peoples R China; [Hisada, Yohei; Grover, Steven P.; Mackman, Nigel] Univ N Carolina, Div Hematol & Oncol, Dept Med, McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Shi, Jumei] Tongji Univ, Sch Med, Dept Hematol, Shanghai Peoples Hosp 10,Canc Ctr, Shanghai, Peoples R China; [Li, Xiang-An; Daugherty, Alan] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Smyth, Susan S.] Vet Affairs Med Ctr, Lexington, KY USA; [Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Shiroishi, Toshihiko] Natl Inst Genet, Mammalian Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka, Japan	University of Kentucky; University of Kentucky; National Institute of Biological Sciences, Beijing; University of North Carolina; University of North Carolina Chapel Hill; Tongji University; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; Roche Holding; Genentech; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Li, ZY (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA.; Wei, YN (corresponding author), Univ Kentucky, Dept Chem, Coll Arts & Sci, Lexington, KY 40506 USA.	yinan.wei@uky.edu; zhenyuli08@uky.edu	Daugherty, Alan/C-8282-2009; HISADA, YOHEI/I-1237-2019	Daugherty, Alan/0000-0003-2093-3775; HISADA, YOHEI/0000-0001-9157-0524; Grover, Steven/0000-0001-8709-8394; Wu, Congqing/0000-0001-7725-7881; Zhang, Yan/0000-0003-0472-3399	AHA Great Rivers Affiliate Postdoctoral Fellowship [16POST31140008]; National Natural Science Foundation of China [81372391]; NIH [R01 GM121796]; AHA Great Rivers Affiliate [17GRNT33410327]; NSF [CHE-1709381]; NIH/NIAID [R56 AI137020, R21 AI142063]; NIH/NHLBI [R01 HL142640, R01 HL123927]; NIH/NIGMS Institutional Development Award [P20GM103527];  [K99HL145117]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL145117, R01HL142640, R01HL123927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI137020, R21AI142063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, R01GM121796] Funding Source: NIH RePORTER	AHA Great Rivers Affiliate Postdoctoral Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Great Rivers Affiliate(American Heart Association); NSF(National Science Foundation (NSF)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIGMS Institutional Development Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.W. is supported by AHA Great Rivers Affiliate Postdoctoral Fellowship 16POST31140008 and is a K99 awardee (K99HL145117; NHLBI). J.S. is supported by National Natural Science Foundation of China 81372391. X.L. is supported by NIH R01 GM121796. Y.W. is supported by AHA Great Rivers Affiliate Grant-in-Aid 17GRNT33410327, NSF CHE-1709381, NIH/NIAID R56 AI137020 and R21 AI142063, and NIH/NHLBI R01 HL142640. Z.L. is supported by NIH/NHLBI R01 HL123927 and R01 HL142640. Dr. Wendy Katz provided help with tissue paraffin embedding and sectioning and was supported by NIH/NIGMS Institutional Development Award P20GM103527. Dr. Thomas Wilkop at UK Light Microscopy Core provided help with intravital microscopy. Dr. Wei Li at Marshall University provided help with isolation of mouse cremaster muscle. Dr. Hartmut Weiler at Medical College of Wisconsin and Dr. Rodney M. Camire at the University of Pennsylvania provided fibrin antibodies.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; BACH R, 1981, J BIOL CHEM, V256, P8324; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Effenberger-Neidnicht K, 2018, INFLAMMATION, V41, P1569, DOI 10.1007/s10753-018-0810-y; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franco RF, 2000, BLOOD, V96, P554; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Fujii T, 2008, GENESIS, V46, P418, DOI 10.1002/dvg.20412; Fujishima S, 2014, J INFECT CHEMOTHER, V20, P115, DOI 10.1016/j.jiac.2013.09.003; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc12783; Grover SP, 2018, ARTERIOSCL THROM VAS, V38, P709, DOI 10.1161/ATVBAHA.117.309846; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kirchhofer D, 2005, J THROMB HAEMOST, V3, P1098, DOI 10.1111/j.1538-7836.2005.01253.x; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; Liaw PC, 2016, BLOOD REV, V30, P257, DOI 10.1016/j.blre.2015.12.004; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; PARISE LV, 1984, J PHARMACOL EXP THER, V228, P240; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rothmeier AS, 2015, J CLIN INVEST, V125, P1471, DOI 10.1172/JCI79329; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Venugopal A, 2014, INDIAN J ANAESTH, V58, P603, DOI 10.4103/0019-5049.144666; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wada H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-15; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhao Y, 2016, J EXP MED, V213, P647, DOI 10.1084/jem.20160006; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	63	152	158	22	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1401	+		10.1016/j.immuni.2019.04.003	http://dx.doi.org/10.1016/j.immuni.2019.04.003			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31076358	Bronze, Green Accepted			2022-12-18	WOS:000471876100012
J	Bengsch, B; Ohtani, T; Khan, O; Setty, M; Manne, S; O'Brien, S; Gherardini, PF; Herati, RS; Huang, AC; Chang, KM; Newell, EW; Bovenschen, N; Pe'er, D; Albelda, SM; Wherry, EJ				Bengsch, Bertram; Ohtani, Takuya; Khan, Omar; Setty, Manu; Manne, Sasikanth; O'Brien, Shaun; Gherardini, Pier Federico; Herati, Ramin Sedaghat; Huang, Alexander C.; Chang, Kyong-Mi; Newell, Evan W.; Bovenschen, Niels; Pe'er, Dana; Albelda, Steven M.; Wherry, E. John			Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells	IMMUNITY			English	Article							PERSISTENCE; PROGENITOR; STABILITY; MELANOMA	Exhausted CD8 T (Tex) cells are immunotherapy targets in chronic infection and cancer, but a comprehensive assessment of Tex cell diversity in human disease is lacking. Here, we developed a transcriptomic- and epigenetic-guided mass cytometry approach to define core exhaustion-specific genes and disease-induced changes in Tex cells in HIV and human cancer. Single-cell proteomic profiling identified 9 distinct Tex cell clusters using phenotypic, functional, transcription factor, and inhibitory receptor co-expression patterns. An exhaustion severity metric was developed and integrated with high-dimensional phenotypes to define Tex cell clusters that were present in healthy subjects, common across chronic infection and cancer or enriched in either disease, linked to disease severity, and changed with HIV therapy. Combinatorial patterns of immunotherapy targets on different Tex cell clusters were also defined. This approach and associated datasets present a resource for investigating human Tex cell biology, with implications for immune monitoring and immunomodulation in chronic infections, autoimmunity, and cancer.	[Bengsch, Bertram; Khan, Omar; Manne, Sasikanth; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bengsch, Bertram; Ohtani, Takuya; Khan, Omar; Manne, Sasikanth; Herati, Ramin Sedaghat; Huang, Alexander C.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [O'Brien, Shaun; Herati, Ramin Sedaghat; Huang, Alexander C.; Chang, Kyong-Mi; Albelda, Steven M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bengsch, Bertram; Khan, Omar; Huang, Alexander C.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chang, Kyong-Mi] Corporal Michael J Crescenz Dept Vet Affairs Med, Philadelphia, PA USA; [Bovenschen, Niels] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bovenschen, Niels] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Newell, Evan W.] Agency Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Gherardini, Pier Federico] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Bengsch, Bertram] Univ Med Ctr Freiburg, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Freiburg, Germany; [Bengsch, Bertram] BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Setty, Manu; Pe'er, Dana] Sloan Kettering Inst, Program Computat & Syst Biol, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Freiburg; Memorial Sloan Kettering Cancer Center	Bengsch, B; Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bengsch, B; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Bengsch, B; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA.	bertram.bengsch@uniklinik-freiburg.de; wherry@pennmedicine.upenn.edu	Bengsch, Bertram/ABF-2142-2020; Newell, Evan W/F-9711-2012; Wherry, John/ABI-1280-2020	Bengsch, Bertram/0000-0003-2552-740X; Newell, Evan W/0000-0002-2889-243X; Setty, Manu/0000-0002-0344-2627; Pe'er, Dana/0000-0002-9259-8817; Herati, Ramin/0000-0003-2613-4050; Khan, Omar/0000-0002-7641-6163	German Research Foundation [BE5496/1-1, BE5496/1-2]; Measey Research Fellowship; Lung Cancer Immunobiology Translational Center of Excellence of the Abramson Cancer Center; NIH [AI105343, AI082630, AI112521, AI115712, AI117718, AI108545, AI117950]; Parker Institute for Cancer Immunotherapy;  [F30AI129263];  [T32CA009615-26];  [T32-CA009140]; NATIONAL CANCER INSTITUTE [P30CA016520, T32CA009615, T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI108545, R01AI115712, U19AI082630, F30AI129263, P01AI112521, P30AI045008, R21AI117718, R01AI105343, K08AI114852, U19AI117950] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Measey Research Fellowship; Lung Cancer Immunobiology Translational Center of Excellence of the Abramson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Gudonis, M. Cummins, and the UPenn Center for AIDS Research (P30-AI-045008) for HIV patient samples, the UPenn Human Immunology Core for HC samples (P30-CA016520), the Corporal Michael J. Crescenz VA Medical Center Research Program for shared use of its CyTOF mass cytometer, the NIH tetramer core for HLA/peptide monomers, and H. Pircher for the KLRG1 antibody. B.B. was supported by the German Research Foundation (BE5496/1-1 and BE5496/1-2), O.K. by F30AI129263, A.C.H. by T32CA009615-26 and a Measey Research Fellowship, and S.O. by T32-CA009140. This work was partially supported by the Lung Cancer Immunobiology Translational Center of Excellence of the Abramson Cancer Center (S. O., S.M. A., and E.J.W.). This work was supported by grants from the NIH (AI105343, AI082630, AI112521, AI115712, AI117718, AI108545, and AI117950) and the Parker Institute for Cancer Immunotherapy to E.J.W.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Melchiotti R, 2017, CYTOM PART A, V91A, P73, DOI 10.1002/cyto.a.23001; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	35	152	157	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					1029	+		10.1016/j.immuni.2018.04.026	http://dx.doi.org/10.1016/j.immuni.2018.04.026			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768164	Green Accepted, Bronze			2022-12-18	WOS:000432488600021
J	Gamliel, M; Goldman-Wohl, D; Isaacson, B; Gur, C; Stein, N; Yamin, R; Berger, M; Grunewald, M; Keshet, E; Rais, Y; Bornstein, C; David, E; Jelinski, A; Eisenberg, I; Greenfield, C; Ben-David, A; Imbar, T; Gilad, R; Haimov-Kochman, R; Mankuta, D; Elami-Suzin, M; Amit, I; Hanna, JH; Yagel, S; Mandelboim, O				Gamliel, Moriya; Goldman-Wohl, Debra; Isaacson, Batya; Gur, Chamutal; Stein, Natan; Yamin, Rachel; Berger, Michael; Grunewald, Myriam; Keshet, Eli; Rais, Yoach; Bornstein, Chamutal; David, Eyal; Jelinski, Adam; Eisenberg, Iris; Greenfield, Caryn; Ben-David, Arbel; Imbar, Tal; Gilad, Ronit; Haimov-Kochman, Ronit; Mankuta, David; Elami-Suzin, Matan; Amit, Ido; Hanna, Jacob H.; Yagel, Simcha; Mandelboim, Ofer			Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HUMAN CYTOMEGALOVIRUS-INFECTION; INTERFERON-GAMMA; HLA-G; KIR REPERTOIRE; HUMAN DECIDUA; FCR-GAMMA; RECEPTOR; PREECLAMPSIA; BLOOD	Natural killer cells (NKs) are abundant in the human decidua, regulating trophoblast invasion and angiogenesis. Several diseases of poor placental development are associated with first pregnancies, so we thus looked to characterize differences in decidual NKs (dNKs) in first versus repeated pregnancies. We discovered a population found in repeated pregnancies, which has a unique transcriptome and epigenetic signature, and is characterized by high expression of the receptors NKG2C and LILRB1. We named these cells Pregnancy Trained decidual NK cells (PTdNKs). PTdNKs have open chromatin around the enhancers of IFNG and VEGFA. Activation of PTdNKs led to increased production and secretion of IFN-gamma and VEGF alpha, with the latter supporting vascular sprouting and tumor growth. The precursors of PTdNKs seem to be found in the endometrium. Because repeated pregnancies are associated with improved placentation, we propose that PTdNKs, which are present primarily in repeated pregnancies, might be involved in proper placentation.	[Gamliel, Moriya; Isaacson, Batya; Gur, Chamutal; Stein, Natan; Yamin, Rachel; Berger, Michael; Mandelboim, Ofer] Hebrew Univ Jerusalem, Fac Med, IMRIC, Concern Fdn Labs,Lautenberg Ctr Immunol & Canc Re, Jerusalem, Israel; [Goldman-Wohl, Debra; Eisenberg, Iris; Greenfield, Caryn; Ben-David, Arbel; Imbar, Tal; Gilad, Ronit; Haimov-Kochman, Ronit; Yagel, Simcha] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Magda & Richard Hoffman Ctr Human Placenta Res, Jerusalem, Israel; [Grunewald, Myriam; Keshet, Eli] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Jerusalem, Israel; [Rais, Yoach; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Bornstein, Chamutal; David, Eyal; Jelinski, Adam; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Mankuta, David; Elami-Suzin, Matan] Hadassah Univ Hosp, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Concern Fdn Labs,Lautenberg Ctr Immunol & Canc Re, Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Keshet, Eli/GQR-0445-2022; Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Mandelboim, Ofer/0000-0002-9354-1855; Stein, Natan/0000-0002-5083-0542	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant [320473-BacNK]; European Research Council; Flight Attendant Medical Research Council (FAMRI); Israel Science Foundation (ISF-ICORE program); Israel Science Foundation (ISF-NFSC program); Israel Science Foundation (ISF-Regular program); Israel Science Foundation (ISF-Morasha program); ICRF; HFSP; New York Stem Cell Foundation (NYSCF); Hoffman Leadership and Responsibility fund, at the Hebrew University	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant(European Research Council (ERC)); European Research Council(European Research Council (ERC)European Commission); Flight Attendant Medical Research Council (FAMRI); Israel Science Foundation (ISF-ICORE program); Israel Science Foundation (ISF-NFSC program); Israel Science Foundation (ISF-Regular program); Israel Science Foundation (ISF-Morasha program); ICRF; HFSP(Human Frontier Science Program); New York Stem Cell Foundation (NYSCF); Hoffman Leadership and Responsibility fund, at the Hebrew University	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement number 320473-BacNK. Further support came from the Israel Science Foundation, the GIF foundation, the Lewis family foundation, the ICRF professorship grant, the Helmholtz Israel grant and the Rosetrees Trust (all to O.M.). J.H.H. is supported by European Research Council, Flight Attendant Medical Research Council (FAMRI), Israel Science Foundation (ISF-ICORE, ISF-NFSC, ISF-Regular & ISF-Morasha programs), ICRF, and HFSP & New York Stem Cell Foundation (NYSCF). J.H.H. is a New York Stem Cell Foundation (NYSCF)-Robertson Investigator. We wish to thank the Bioinformatics Unit of the I-CORE Computation Center at the Hebrew University and Hadassah for the transcriptome analysis and Dr. Shari Orlanski for analyzing part of the epigenetic data. O.M. is a Crown Professor of Molecular Immunology. M. Gamliel is supported by the Hoffman Leadership and Responsibility fund, at the Hebrew University.	Apps R, 2007, EUR J IMMUNOL, V37, P1924, DOI 10.1002/eji.200737089; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Bachmayer N, 2009, AM J REPROD IMMUNOL, V62, P147, DOI 10.1111/j.1600-0897.2009.00724.x; Banerjee S, 2005, J CLIN ENDOCR METAB, V90, P944, DOI 10.1210/jc.2004-1113; Berrien-Elliott MM, 2015, J INNATE IMMUN, V7, P563, DOI 10.1159/000382019; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Bueno-Sanchez JC, 2013, J REPROD IMMUNOL, V97, P223, DOI 10.1016/j.jri.2012.11.007; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; El Costa H, 2009, J REPROD IMMUNOL, V82, P142, DOI 10.1016/j.jri.2009.06.123; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hwang I, 2012, INT IMMUNOL, V24, P793, DOI 10.1093/intimm/dxs080; Ivarsson MA, 2017, MUCOSAL IMMUNOL, V10, P322, DOI 10.1038/mi.2016.50; Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Keppel MP, 2013, J IMMUNOL, V190, P4754, DOI 10.4049/jimmunol.1201742; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Male V, 2011, EUR J IMMUNOL, V41, P3017, DOI 10.1002/eji.201141445; Manaster I, 2008, J IMMUNOL, V181, P1869, DOI 10.4049/jimmunol.181.3.1869; Marlin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030017; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Okada S, 2000, MOL HUM REPROD, V6, P75, DOI 10.1093/molehr/6.1.75; PAULESU L, 1994, J REPROD IMMUNOL, V27, P37, DOI 10.1016/0165-0378(94)90013-2; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Prefumo F, 2006, FERTIL STERIL, V85, P1032, DOI 10.1016/j.fertnstert.2005.09.055; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Rizzo R, 2011, CELL MOL LIFE SCI, V68, P341, DOI 10.1007/s00018-010-0578-1; Rolle A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003548; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Weisblum Y, 2015, VIROLOGY, V485, P289, DOI 10.1016/j.virol.2015.06.023; Yeh CC, 2013, REPROD SCI, V20, P339, DOI 10.1177/1933719112450330; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	57	152	161	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					951	+		10.1016/j.immuni.2018.03.030	http://dx.doi.org/10.1016/j.immuni.2018.03.030			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768178	Bronze			2022-12-18	WOS:000432488600015
J	Krishnamurty, AT; Thouvenel, CD; Portugal, S; Keitany, GJ; Kim, KS; Holder, A; Crompton, PD; Rawlings, DJ; Pepper, M				Krishnamurty, Akshay T.; Thouvenel, Christopher D.; Portugal, Silvia; Keitany, Gladys J.; Kim, Karen S.; Holder, Anthony; Crompton, Peter D.; Rawlings, David J.; Pepper, Marion			Somatically Hypermutated Plasmodium-Specific IgM(+) Memory B Cells Are Rapid, Plastic, Early Responders upon Malaria Rechallenge	IMMUNITY			English	Article							MEROZOITE SURFACE PROTEIN-1; CD4(+) T-CELLS; PLASMA-CELLS; IMMUNOLOGICAL MEMORY; PARASITE DEVELOPMENT; IMMUNE-RESPONSES; ANTIBODY-LEVELS; IN-VITRO; FALCIPARUM; ANTIGEN	Humoral immunity consists of pre-existing antibodies expressed by long-lived plasma cells and rapidly reactive memory B cells (MBC). Recent studies of MBC development and function after protein immunization have uncovered significant MBC heterogeneity. To clarify functional roles for distinct MBC subsets during malaria infection, we generated tetramers that identify Plasmodium-specific MBCs in both humans and mice. Long-lived murine Plasmodium-specific MBCs consisted of three populations: somatically hypermutated immunoglobulin M+ (IgM +) and IgG(+) MBC subsets and an unmutated IgD(+) MBC population. Rechallenge experiments revealed that high affinity, somatically hypermutated Plasmodium-specific IgM(+) MBCs proliferated and gave rise to antibody-secreting cells that dominated the early secondary response to parasite rechallenge. IgM (+) MBCs also gave rise to T cell-dependent IgM(+) and IgG(+) B220(+) CD138(+) plasmablasts or T cell-independent B220-CD138(+) IgM(+) plasma cells. Thus, even in competition with IgG(+) MBCs, IgM(+) MBCs are rapid, plastic, early responders to a secondary Plasmodium rechallenge and should be targeted by vaccine strategies.	[Krishnamurty, Akshay T.; Keitany, Gladys J.; Kim, Karen S.; Rawlings, David J.; Pepper, Marion] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98109 USA; [Thouvenel, Christopher D.; Rawlings, David J.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Portugal, Silvia; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20892 USA; [Holder, Anthony] Francis Crick Inst, Mill Hill Lab, Ridgeway,Mill Hill, London NW7 1AA, England	University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pepper, M (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98109 USA.	mpepper@uw.edu	Rawlings, David/CAI-4751-2022; Crompton, Peter/N-1130-2016; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Krishnamurty, Akshay/0000-0001-5382-1417; Portugal, Silvia/0000-0003-4567-9101	NIH [T32-AI10667701];  [R01AI108626-01A-A87299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155, T32AI106677, R01AI108626] Funding Source: NIH RePORTER; The Francis Crick Institute [10097] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Francis Crick Institute	We thank Dr. J. Langhorne and D. Perez-Mazliah for providing recombinant MSP1 constructs and technical assistance, Dr. J. Rayner for providing P. falciparum AMA1 protein, and Drs. M. Bevan and B. Hondowicz for reviewing the manuscript and providing valuable discussion. We also thank Drs. O. Doumbo and B. Traore and the residents of Kambila, Mali, for helping acquire human PBMC samples. This work was supported by grants to M.P. (NIH R01AI108626-01A-A87299), A.T.K. (NIH T32-AI10667701), D.J.R. (Seattle Children's Research Institute, Center for Immunity and Immunotherapies [CIIT]; the CIIT, Program for Cell and Gene Therapy; and the Benaroya Family Gift Fund) and P.D.C. (NIH, Division of Intramural Research, National Institute of Allergy and Infectious Diseases).	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; Benson MJ, 2009, J EXP MED, V206, P2013, DOI 10.1084/jem.20090667; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bortnick A, 2012, J IMMUNOL, V188, P5389, DOI 10.4049/jimmunol.1102808; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2005, PARASITE IMMUNOL, V27, P171, DOI 10.1111/j.1365-3024.2005.00760.x; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kolhatkar NS, 2015, J EXP MED, V212, P1663, DOI 10.1084/jem.20150585; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Obukhanych TV, 2006, J EXP MED, V203, P305, DOI 10.1084/jem.20052036; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Schwartz MA, 2014, J IMMUNOL, V193, P3492, DOI 10.4049/jimmunol.1400798; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; VONESCHEN KB, 1974, J EXP MED, V140, P1604, DOI 10.1084/jem.140.6.1604; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	57	152	153	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					402	414		10.1016/j.immuni.2016.06.014	http://dx.doi.org/10.1016/j.immuni.2016.06.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27473412	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-18	WOS:000382267300020
J	Legoux, FP; Lim, JB; Cauley, AW; Dikiy, S; Ertelt, J; Mariani, TJ; Sparwasser, T; Way, SS; Moon, JJ				Legoux, Francois P.; Lim, Jong-Baeck; Cauley, Andrew W.; Dikiy, Stanislav; Ertelt, James; Mariani, Thomas J.; Sparwasser, Tim; Way, Sing Sing; Moon, James J.			CD4(+) T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion	IMMUNITY			English	Article							PERIPHERAL TOLERANCE; IMMUNE-RESPONSE; CLONAL DELETION; SELECTION; PHENOTYPE; FOXP3(+); SUBSETS; MEMORY; AIRE; DIFFERENTIATION	Deletion of self-antigen-specific T cells during thymic development provides protection from autoimmunity. However, it is unclear how efficiently this occurs for tissue-restricted self antigens, or how immune tolerance is maintained for self-antigen-specific T cells that routinely escape deletion. Here we show that endogenous CD4(+) T cells with specificity for a set of tissue-restricted self antigens were not deleted at all. For pancreatic self antigen, this resulted in an absence of steady-state tolerance, while for the lung and intestine, tolerance was maintained by the enhanced presence of thymically-derived antigen-specific Foxp3(+) regulatory T (Treg) cells. Unlike deletional tolerance, Treg cell-mediated tolerance was broken by successive antigen challenges. These findings reveal that for some tissue-restricted self antigens, tolerance relies entirely on nondeletional mechanisms that are less durable than T cell deletion. This might explain why autoimmunity is often tissue-specific, and it offers a rationale for cancer vaccine strategies targeting tissue-restricted tumor antigens.	[Legoux, Francois P.; Lim, Jong-Baeck; Cauley, Andrew W.; Moon, James J.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Legoux, Francois P.; Lim, Jong-Baeck; Cauley, Andrew W.; Moon, James J.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Charlestown, MA 02129 USA; [Legoux, Francois P.; Lim, Jong-Baeck; Cauley, Andrew W.; Moon, James J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Dikiy, Stanislav] Howard Hughes Med Inst, Ludwig Ctr, New York, NY 10065 USA; [Dikiy, Stanislav] Program Immunol, New York, NY 10065 USA; [Dikiy, Stanislav] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Ertelt, James; Way, Sing Sing] Childrens Hosp Res Fdn, Div Infect Dis, Cincinnati, OH 45229 USA; [Ertelt, James; Way, Sing Sing] Perinatal Inst, Cincinnati, OH 45229 USA; [Ertelt, James; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Mariani, Thomas J.] Div Neonatol, Rochester, NY 14642 USA; [Mariani, Thomas J.] Pediat Mol & Personalized Med Program, Rochester, NY 14642 USA; [Mariani, Thomas J.] Univ Rochester, Rochester, NY 14642 USA; [Sparwasser, Tim] TWINCORE Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Rochester; Helmholtz Association; Helmholtz-Center for Infection Research	Moon, JJ (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA.	jjmoon@mgh.harvard.edu	Sparwasser, Tim/AAF-7085-2019; Dikiy, Stanislav/GWR-2104-2022; Sparwasser, Tim D/AAA-4306-2022; moon, james/F-1031-2014	Sparwasser, Tim/0000-0001-5645-902X; Legoux, Francois/0000-0003-4304-7637; moon, james/0000-0001-8071-1491; Dikiy, Stanislav/0000-0002-8287-6561; Way, Sing Sing/0000-0001-8948-1952; Lim, Jong-Baeck/0000-0003-0419-0422	National Institutes of Health [R01 AI100934, R01 AI087830, R21 AI112186, U19 AI095261, P30 DK043351, R01 AI107020]; Burroughs Wellcome Fund; William F. Milton Fund; Philippe Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087830, U19AI095261, R21AI112186, R01AI100934, R01AI107020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); William F. Milton Fund; Philippe Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Yen, A. Han, and J. Im for assistance with mice and tetramers, C. Luo and R. Mylvaganam for assistance with flow cytometry, F. Marangoni for advice on irradiation bone marrow chimeras, M. Byrne for advice on quantitative RT-PCR, M. Jenkins and J. Mclachlan for advice on epitope mapping, B. Fife for advice on pancreas preps, M. Pepper for advice on lung preps, A. Rudensky for support with Foxp3<SUP>Delta CNS1</SUP> mouse experiments, and R. Anthony, T. Mempel, and A. Luster for critical review of the manuscript. This work was supported by the National Institutes of Health (R01 AI100934, R01 AI087830, and R21 AI112186 to S.S.W.; U19 AI095261, P30 DK043351, and R01 AI107020 to J.J.M.), the Burroughs Wellcome Fund (to S.S.W.), the William F. Milton Fund (to J.J.M.), and the Philippe Foundation (to F.P.L.).	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Legoux FP, 2012, JOVE-J VIS EXP, DOI 10.3791/4420; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Metzger TC, 2011, IMMUNOL REV, V241, P89, DOI 10.1111/j.1600-065X.2011.01008.x; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wirnsberger G, 2011, IMMUNOL CELL BIOL, V89, P45, DOI 10.1038/icb.2010.123; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	43	152	153	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					896	908		10.1016/j.immuni.2015.10.011	http://dx.doi.org/10.1016/j.immuni.2015.10.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26572061	Green Accepted, Bronze			2022-12-18	WOS:000366846000011
J	Gomez-Rodriguez, J; Sahu, N; Handon, R; Davidson, TS; Anderson, SM; Kirby, MR; August, A; Schwartzberg, PL				Gomez-Rodriguez, Julio; Sahu, Nisebita; Handon, Robin; Davidson, Todd S.; Anderson, Stacie M.; Kirby, Martha R.; August, Avery; Schwartzberg, Pamela L.			Differential Expression of Interleukin-17A and-17F Is Coupled to T Cell Receptor Signaling via Inducible T Cell Kinase	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; TEC-FAMILY KINASES; ROR-GAMMA-T; MICE LACKING; TGF-BETA; IL-17 PRODUCTION; TYROSINE KINASE; GENE-EXPRESSION; ALLERGIC-ASTHMA; TH2 DEVELOPMENT	T helper 17 (Th17) cells play major roles in autoimmunity and bacterial infections, yet how T cell receptor (TCR) signaling affects Th17 cell differentiation is relatively unknown. We demonstrate that CD4(+) T cells lacking ltk, a tyrosine kinase required for full TCR-induced phospholipase C-gamma (PLC-gamma 1) activation, exhibit decreased interleukin-17A (IL-17A) expression in vitro and in vivo, despite relatively normal expression of retinoic acid receptor-related orphan receptor-gamma T (ROR-gamma T) and IL-17F. IL-17A expression was rescued by pharmacologically induced Ca2+ influx or constitutively activated nuclear factor of activated T cells (NFAT). Conversely, decreased TCR stimulation or calcineurin inhibition preferentially reduced IL-17A expression. We further found that the promoter of Il17a but not Il17f has a conserved NFAT binding site that bound NFATc1 in wild-type but not ltk-deficient cells, even though both exhibited open chromatin conformations. Finally, ltk(-/-) mice also showed differential regulation of IL-17A and IL-17F in vivo. Our results suggest that ltk specifically couples TCR signaling to Il17a expression and the differential regulation of Th17 cell cytokines through NFATc1.	[Gomez-Rodriguez, Julio; Handon, Robin; Anderson, Stacie M.; Kirby, Martha R.; Schwartzberg, Pamela L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Sahu, Nisebita] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Davidson, Todd S.] NIAID, NIH, Bethesda, MD 20892 USA; [Sahu, Nisebita; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	pams@mail.nih.gov			NHGRI, NIH; NIH [A1051626]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, ZICHG200350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626] Funding Source: NIH RePORTER	NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the Schwartzberg laboratory, J. Zhu, H. Yamane and J. Cote-Sierra for advice and helpful discussions; D. Littman, N. Clipstone, and L. Berg for retroviral constructs and mice, J. Fekecs and D. Leja for graphics assistance, and J. O'Shea, J. Zhu, J. Cannons and W. Paul for critical reading of the manuscript. This work was supported by funding from the intramural research program of the NHGRI, NIH (to PLS) and NIH grant A1051626 (to AA).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BOHJANEN PR, 1990, P NATL ACAD SCI USA, V87, P5283, DOI 10.1073/pnas.87.14.5283; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Glimcher LH, 2000, GENE DEV, V14, P1693; Gomez-Rodriguez J, 2007, IMMUNOL REV, V218, P45, DOI 10.1111/j.1600-065X.2007.00534.x; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hermann-Kleiter N, 2008, IMMUNITY, V29, P205, DOI 10.1016/j.immuni.2008.06.008; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu XKK, 2005, MOL CELLS, V20, P339; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; NAORA H, 1994, J IMMUNOL, V152, P5691; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schwartzberg PL, 2005, NAT REV IMMUNOL, V5, P284, DOI 10.1038/nri1591; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang C, 2008, CYTOKINE, V42, P345, DOI 10.1016/j.cyto.2008.03.006; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	51	152	158	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2009	31	4					587	597		10.1016/j.immuni.2009.07.009	http://dx.doi.org/10.1016/j.immuni.2009.07.009			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19818650	Green Accepted, Bronze			2022-12-18	WOS:000271403900010
J	Hao, ZY; Duncan, GS; Seagal, J; Su, YW; Hong, C; Haight, J; Chen, NJ; Elia, A; Wakeham, A; Li, WY; Liepa, J; Wood, GA; Casola, S; Rajewsky, K; Mak, TW				Hao, Zhenyue; Duncan, Gordon S.; Seagal, Jane; Su, Yu-Wen; Hong, Claire; Haight, Jillian; Chen, Nien-Jung; Elia, Andrew; Wakeham, Andrew; Li, Wanda Y.; Liepa, Jennifer; Wood, Geoffrey A.; Casola, Stefano; Rajewsky, Klaus; Mak, Tak W.			Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis	IMMUNITY			English	Article							NEGATIVE SELECTION; CLONAL SELECTION; GENE; RESPONSES; MUTATIONS; ANTIGEN; CD28; AUTOIMMUNITY; MRL-FAS(LPR); REQUIREMENT	Fas is highly expressed in activated and germinal center (GC) B cells but can potentially be inactivated by misguided somatic hypermutation. We employed conditional Fas-deficient mice to investigate the physiological functions of Fas in various B cell subsets. B cell-specific Fas-deficient mice developed fatal lymphoproliferation due to activation of B cells and T cells. Ablation of Fas specifically in GC B cells reproduced the phenotype, indicating that the lymphoproliferation initiates in the GC environment. B cell-specific Fas-deficient mice also showed an accumulation of IgG1(+) memory B cells expressing high amounts of CD80 and the expansion of CD28-expressing CD4(+) Th cells. Blocking T cell-B cell interaction and GC formation completely prevented the fatal lymphoproliferation. Thus, Fas-mediated selection of GC B cells and the resulting memory B cell compartment is essential for maintaining the homeostasis of both T and B lymphocytes.	[Hao, Zhenyue; Duncan, Gordon S.; Su, Yu-Wen; Hong, Claire; Haight, Jillian; Chen, Nien-Jung; Elia, Andrew; Wakeham, Andrew; Li, Wanda Y.; Liepa, Jennifer; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 2C1, Canada; [Seagal, Jane; Rajewsky, Klaus] Immune Dis Inst Biomed Res, Boston, MA 02115 USA; [Seagal, Jane; Rajewsky, Klaus] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wood, Geoffrey A.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Casola, Stefano] IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy; [Mak, Tak W.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; [Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Guelph; IFOM - FIRC Institute of Molecular Oncology; University of Toronto; University of Toronto	Hao, ZY (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 2C1, Canada.	zhenyuehao@gmail.com; tmak@uhnres.utoronto.ca	Casola, Stefano/O-3922-2014; Casola, Stefano/AAN-8319-2021; Duncan, Gordon/AIE-7011-2022; Su, Yu-Wen/E-8804-2010; Wood, Geoffrey/ABB-2052-2021	Casola, Stefano/0000-0001-5580-0986; Wood, Geoffrey/0000-0003-1756-8607; Rajewsky, Klaus/0000-0002-6633-6370; Silvester, Jennifer/0000-0001-6087-4066	Terry Fox Cancer Foundation; Canadian Institutes of Health Research,; Leukemia and Lymphoma Society; Deutsche Forschungsgemeinschaft [SFB 243]; National Institutes of Health (USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636, R01AI037526] Funding Source: NIH RePORTER	Terry Fox Cancer Foundation; Canadian Institutes of Health Research,(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank various Mak lab members for technical assistance, T. Calzascia for help with Th 17 cell differentiation, Toronto Centre for Phenogenomics for help with histology, and M. Saunders for scientific editing. This work was supported by grants to T.W.M. from the Terry Fox Cancer Foundation, Canadian Institutes of Health Research, and Leukemia and Lymphoma Society; to Z.H. from Canadian Institutes of Health Research; and to K.R. from the Deutsche Forschungsgemeinschaft through SFB 243 and the National Institutes of Health (USA).	Barreiro R, 2004, J IMMUNOL, V173, P1519, DOI 10.4049/jimmunol.173.3.1519; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fukuyama H, 2002, EUR J IMMUNOL, V32, P223, DOI 10.1002/1521-4141(200201)32:1<223::AID-IMMU223>3.0.CO;2-4; Hande S, 1998, IMMUNITY, V8, P189, DOI 10.1016/S1074-7613(00)80471-9; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hennino A, 2001, J EXP MED, V193, P447, DOI 10.1084/jem.193.4.447; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Krammer P H, 1999, Adv Immunol, V71, P163; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lamoureux JL, 2007, J EXP MED, V204, P2853, DOI 10.1084/jem.20071268; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Linton P J, 1992, Semin Immunol, V4, P3; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Seagal J, 2003, J EXP MED, V198, P1609, DOI 10.1084/jem.20030357; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Tada Y, 1999, J IMMUNOL, V163, P3153; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802	41	152	154	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					615	627		10.1016/j.immuni.2008.07.016	http://dx.doi.org/10.1016/j.immuni.2008.07.016			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18835195	Green Accepted, Bronze			2022-12-18	WOS:000260316700014
J	Alves, NL; Derks, IAM; Berk, E; Spijker, R; van Lier, RAW; Eldering, E				Alves, Nuno L.; Derks, Ingrid A. M.; Berk, Erik; Spijker, Rene; van Lier, Rene A. W.; Eldering, Eric			The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells	IMMUNITY			English	Article							BH3-ONLY PROTEINS PUMA; FAMILY-MEMBER BIM; BCL-2 FAMILY; CUTTING EDGE; MITOCHONDRIAL DYSFUNCTION; BH3 DOMAINS; EXPRESSION; DEATH; NOXA; SURVIVAL	Throughout lymphocyte development, cellular persistence and expansion are tightly regulated by survival and apoptosis. Within the Bcl-2 family, distinct apoptogenic BH3-only members like Bid, Bim, and Puma appear to function in specific cell death pathways. We found that naive human T cells after mitogenic activation, apart from expected protective Bcl-2 members, also rapidly upregulate the BH3-only protein Noxa in a p53-independent fashion. The specific role of Noxa became! apparent during glucose limitation and involves interaction with the labile Bcl-2 homolog Mcl-1. Knockdown of Noxa or Mcl-1 results in protection or susceptibility, respectively, to apoptosis induced by glucose deprivation. Declining Mcl-1 levels and apoptosis induction are inversely correlated to Noxa levels and prevented by readdition of glucose. We propose that the Noxa/Mcl-1 axis is an apoptosis rheostat in dividing cells, in a selective pathway that functions to restrain lymphocyte expansion and can be triggered by glucose deprivation.	Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1005 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1005 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Eldering, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1005 AZ Amsterdam, Netherlands.	e.eldering@amc.uva.nl	Spijker, Rene/AAB-5165-2019; Alves, Nuno/J-9980-2013	Spijker, Rene/0000-0003-4445-1201; Alves, Nuno/0000-0002-1567-8389; van Lier, Rene/0000-0002-3201-7144				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alves NL, 2005, J IMMUNOL, V175, P755, DOI 10.4049/jimmunol.175.2.755; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Arens R, 2005, J IMMUNOL, V174, P5915, DOI 10.4049/jimmunol.174.10.5915; Boesen-de Cock JGR, 1999, J BIOL CHEM, V274, P14255, DOI 10.1074/jbc.274.20.14255; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burr JS, 2001, J IMMUNOL, V166, P5331, DOI 10.4049/jimmunol.166.9.5331; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Eldering E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng153; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Flinterman M, 2005, J BIOL CHEM, V280, P5945, DOI 10.1074/jbc.M406661200; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Gonzalez J, 2003, BLOOD, V101, P2679, DOI 10.1182/blood-2002-04-1229; GORNEZBOUGIE P, 2005, EUR J IMMUNOL, V35, P971; Hamann D, 1996, BLOOD, V88, P3513, DOI 10.1182/blood.V88.9.3513.bloodjournal8893513; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Kabra NH, 2001, P NATL ACAD SCI USA, V98, P6307, DOI 10.1073/pnas.111158698; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Kerstan A, 2004, J IMMUNOL, V172, P1341, DOI 10.4049/jimmunol.172.3.1341; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mackus WJM, 2005, LEUKEMIA, V19, P427, DOI 10.1038/sj.leu.2403623; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Qin JZ, 2004, MOL CANCER THER, V3, P895; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sandalova E, 2004, P NATL ACAD SCI USA, V101, P3011, DOI 10.1073/pnas.0400005101; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vander Heiden MG, 1999, MOL CELL, V3, P159; VANLIER RAW, 1991, EUR J IMMUNOL, V21, P1775, DOI 10.1002/eji.1830210731; Verschelde C, 2003, CELL DEATH DIFFER, V10, P1059, DOI 10.1038/sj.cdd.4401265; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Villunger A, 2004, P NATL ACAD SCI USA, V101, P7052, DOI 10.1073/pnas.0305757101; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Williams A, 2005, WEB INF SYST ENG INT, V2, P3, DOI 10.1007/0-387-27727-7_1; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	61	152	153	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					703	716		10.1016/j.immuni.2006.03.018	http://dx.doi.org/10.1016/j.immuni.2006.03.018			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782027	Bronze			2022-12-18	WOS:000238592200009
J	Thoulouze, MI; Sol-Foulon, N; Blanchet, F; Dautry-Varsat, A; Schwartz, O; Alcover, A				Thoulouze, Maria Isabel; Sol-Foulon, Nathalie; Blanchet, Fabien; Dautry-Varsat, Alice; Schwartz, Olivier; Alcover, Andres			Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse	IMMUNITY			English	Article							T-CELL-ACTIVATION; HIV-1 NEF; DOWN-REGULATION; VIRAL INFECTIVITY; MHC-I; CD4; PROTEIN; LCK; TCR; KINASE	HIV-1-infected lymphocytes improperly respond to T cell antigen receptor (TCR) stimulation. To document this phenomenon, we studied the capacity of HIV-1-infected lymphocytes to form immunological synapses. We show here that HIV-1-infected T cells poorly conjugated with antigen-presenting cells, and when they formed conjugates, the synapses were abnormal. TCR and Lck accumulated in the recycling endosomal compartment, and their clustering at the synapse was severely reduced. These phenomena were, to a large extent, caused by Nef, a viral protein affecting intracellular trafficking and signaling pathways. Concomitantly, in HIV-infected cells, tyrosine phosphorylation at the synapse and the patterns of tyrosine phosphorylated proteins were disturbed in a Nef-dependent manner. These findings underscore the importance of Lck and TCR endosomal trafficking in synapse formation and early T cell signaling. Alteration of endocytic and signaling networks at the immunological synapse likely impacts the function and fate of HIV-1-infected cells.	Inst Pasteur, Unite Rech Assoc 1930, CNRS, Grp Viruses & Immun, F-75724 Paris 15, France; Inst Pasteur, Unite Rech Assoc 2582, CNRS, Unite Biol Interact Cellulaires, F-75724 Paris, France; Inst Pasteur, Unite Biol Cellulaire Lymphocytes, F-75724 Paris 15, France; INRA, Unite Virol & Immunol Mol, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schwartz, O (corresponding author), Inst Pasteur, Unite Rech Assoc 1930, CNRS, Grp Viruses & Immun, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	schwartz@pasteur.fr; aalcover@pasteur.fr	Blanchet, Fabien/AAL-1379-2021; Thoulouze, Maria-Isabel/AAK-6761-2021; Schwartz, Olivier/AAZ-3765-2021	Thoulouze, Maria-Isabel/0000-0002-1780-0421; Schwartz, Olivier/0000-0002-0729-1475; BLANCHET, Fabien/0000-0003-3168-0697; Alcover, Andres/0000-0002-9507-3450; Sol-Foulon, Nathalie/0000-0002-2643-0311				Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Das SR, 2005, INDIAN J MED RES, V121, P315; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Dietrich J, 2002, J IMMUNOL, V168, P5434, DOI 10.4049/jimmunol.168.11.5434; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Krogsgaard M, 2003, SEMIN IMMUNOL, V15, P307, DOI 10.1016/j.smim.2003.09.002; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Marechal V, 1998, J VIROL, V72, P2208; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; NIEDERGANG F, 1995, J BIOL CHEM, V270, P12839, DOI 10.1074/jbc.270.21.12839; Niedergang F, 1998, J IMMUNOL, V161, P6054; NIEDERGANG F, 1997, RES IMMUNOL, V148, P225; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Sol-Foulon N, 2004, J BIOL CHEM, V279, P31398, DOI 10.1074/jbc.M401621200; Swigut T, 2003, J VIROL, V77, P8116, DOI 10.1128/JVI.77.14.8116-8126.2003; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Vidal K, 1999, J IMMUNOL, V163, P4811; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Williams SAF, 2005, TRENDS MICROBIOL, V13, P137, DOI 10.1016/j.tim.2005.02.006; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489	55	152	157	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					547	561		10.1016/j.immuni.2006.02.016	http://dx.doi.org/10.1016/j.immuni.2006.02.016			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713973	Bronze, Green Submitted			2022-12-18	WOS:000237970100012
J	Daniels, MA; Levine, L; Miller, JD; Moser, JM; Lukacher, AE; Altman, JD; Kavathas, P; Hogquist, KA; Jameson, SC				Daniels, MA; Levine, L; Miller, JD; Moser, JM; Lukacher, AE; Altman, JD; Kavathas, P; Hogquist, KA; Jameson, SC			CD8 binding to MHC class I molecules is influenced by maturation and T cell glycosylation	IMMUNITY			English	Article							CORECEPTOR FUNCTION; PEANUT AGGLUTININ; POSITIVE SELECTION; MOUSE THYMOCYTES; RECEPTOR; ACTIVATION; COMPLEX; EXPRESSION; LYMPHOCYTES; INFECTION	CD8 serves both as an adhesion molecule for class I MHC molecules and as a coreceptor with the TCR for T cell activation. Here we study the developmental regulation of CD8-mediated binding to noncognate peptide/MHC ligands (i.e., those not bound by the TCR). We show that CD8's ability to bind soluble class I MHC tetramers and to mediate T cell adhesion under shear flow conditions diminishes as double-positive thymocytes mature into CD8(+) T cells. Furthermore, we provide evidence that this decreased CD8 binding results from increased T cell sialylation upon T cell maturation. These data suggest that CD8's ability to interact with class I MHC is not fixed and is developmentally regulated through the T cell's glycosylation state.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA; Yale Univ, Sch Med, Dept Lab Med, Immunobiol Sect, New Haven, CT 06520 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; Yale University; Emory University; Emory University; Emory University	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.		Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Daniels, Mark/0000-0002-5175-9901; Hogquist, Kristin/0000-0001-9963-5687	NCI NIH HHS [R01 CA48115] Funding Source: Medline; NIAID NIH HHS [T32 AI07313, R01 AI38903] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA048115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI038903] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anel A, 1996, EUR J IMMUNOL, V26, P2310, DOI 10.1002/eji.1830261007; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Block MS, 2001, J IMMUNOL, V167, P821, DOI 10.4049/jimmunol.167.2.821; Bosselut R, 2000, IMMUNITY, V12, P409, DOI 10.1016/S1074-7613(00)80193-4; Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; CASABO LG, 1994, J IMMUNOL, V152, P397; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Devine L, 1999, J IMMUNOL, V162, P846; FOWLKES BJ, 1980, J IMMUNOL, V125, P623; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; INGOLD AL, 1991, NATURE, V352, P721, DOI 10.1038/352721a0; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KANE KP, 1993, J IMMUNOL, V150, P4788; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Lukacher AE, 1999, J IMMUNOL, V163, P3369; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OROURKE AM, 1993, IMMUNOL TODAY, V14, P183; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; PEREIRA MEA, 1976, CARBOHYD RES, V51, P107; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; SUN JR, 1995, J EXP MED, V182, P1275, DOI 10.1084/jem.182.5.1275; Thome M, 1996, EUR J IMMUNOL, V26, P2093, DOI 10.1002/eji.1830260920; Tsujimura K, 2001, J IMMUNOL, V167, P759, DOI 10.4049/jimmunol.167.2.759; Varki A., 1999, ESSENTIALS GLYCOBIOL; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wong P, 2001, J EXP MED, V193, P1179, DOI 10.1084/jem.193.10.1179; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; ZAMOYSKA R, 1994, IMMUNITY, V1, P243, DOI 10.1016/1074-7613(94)90075-2	57	152	152	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2001	15	6					1051	1061		10.1016/S1074-7613(01)00252-7	http://dx.doi.org/10.1016/S1074-7613(01)00252-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	506GK	11754824	Bronze			2022-12-18	WOS:000172961400017
J	BRUNO, L; KIRBERG, J; VONBOEHMER, H				BRUNO, L; KIRBERG, J; VONBOEHMER, H			ON THE CELLULAR BASIS OF IMMUNOLOGICAL T-CELL MEMORY	IMMUNITY			English	Article							IMMUNE-RESPONSE; TRANSGENIC MICE; ANTIGEN; DELETION; DIFFERENTIATION; LYMPHOCYTES; PERSISTENCE; TOLERANCE; ABSENCE; NAIVE	We have studied memory in T cell receptor (TCR) transgenic mice expressing a D-b-restricted TCR specific for the male peptide (H-Y). CD8(+) T cells from female TCR transgenic C57BL/6 (B6) mice were activated by transferring them into X-irradiated male (B6 x bm12)F1 hybrid recipients. Subsequently, they were highly purified by cell sorting and transferred for various lengths of time into female B6 nu/nu recipient mice. Other nu/nu recipient mice received highly purified naive T cells expressing the transgenic TCR. The functional potential of naive and ''memory'' T cells was analyzed by stimulation with male cells in vivo. The results show that memory cells can be derived from activated T cells and persist in the absence of antigen for at least 13 weeks. Naive and memory T cells differ in that memory T cells give a more vigorous and sustained response than naive T cells.			BRUNO, L (corresponding author), BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND.							ASHWORTH A, 1989, NUCLEIC ACIDS RES, V17, P2864, DOI 10.1093/nar/17.7.2864; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; DYALINAS DP, 1983, J IMMUNOL, V131, P2445; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; HUGHES EN, 1981, J BIOL CHEM, V256, P7023; KIRBERG J, 1993, EUR J IMMUNOL, V23, P1963, DOI 10.1002/eji.1830230835; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KLEIN J, 1983, IMMUNOGENETICS, V17, P553, DOI 10.1007/BF00366126; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; MAIER B, 1986, J MOL CELL IMMUNOL, V2, P293; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SCHITTEK B, 1990, NATURE, V364, P749; SPRENT J, 1976, CELL IMMUNOL, V21, P314, DOI 10.1016/0008-8749(76)90059-9; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891	23	152	154	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1995	2	1					37	43		10.1016/1074-7613(95)90077-2	http://dx.doi.org/10.1016/1074-7613(95)90077-2			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600301	Bronze			2022-12-18	WOS:A1995QC59300004
J	Goronzy, JJ; Weyand, CM				Goronzy, Jorg J.; Weyand, Cornelia M.			Successful and Maladaptive T Cell Aging	IMMUNITY			English	Review							INFLUENZA VACCINE; REPERTOIRE DIVERSITY; EFFECTOR FUNCTIONS; DENDRITIC CELLS; ELDERLY PERSONS; IMMUNE-SYSTEM; ANTIGEN PRESENTATION; SEASONAL INFLUENZA; CD28 EXPRESSION; DOWN-REGULATION	Throughout life, the T cell system adapts to shifting resources and demands, resulting in a fundamentally restructured immune system in older individuals. Here we review the cellular and molecular features of an aged immune system and discuss the trade-offs inherent to these adaptive mechanisms. Processes include homeostatic proliferation that maintains compartment size at the expense of partial loss in stemness and incomplete differentiation and the activation of negative regulatory programs, which constrain effector T cell expansion and prevent increasing oligoclonality but also interfere with memory cell generation. We propose that immune failure occurs when adaptive strategies developed by the aging T cell system fail and also discuss how, in some settings, the programs associated with T cell aging culminates in a maladaptive response that directly contributes to chronic inflammatory disease.	[Goronzy, Jorg J.; Weyand, Cornelia M.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Goronzy, Jorg J.; Weyand, Cornelia M.] Palo Alto Vet Adm Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA	Stanford University	Goronzy, JJ; Weyand, CM (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Goronzy, JJ; Weyand, CM (corresponding author), Palo Alto Vet Adm Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA.	jgoronzy@stanford.edu; cweyand@stanford.edu	Weyand, Cornelia/AAH-3343-2021	Goronzy, Jorg/0000-0001-7670-1856	NIH [R01 AR042527, R01 HL117913, R01 AI108906, P01 HL129941, R01 AI108891, R01 AG045779, U19 AI057266, I01 BX001669]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL129941, R01HL117913, R01HL063919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108906, U19AI057266, R01AI108891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045779] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001669] Funding Source: NIH RePORTER; VA [5I01BX001669-02, 5I01BX001669-04] Funding Source: Federal RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs)	This work was supported by the NIH (R01 AR042527, R01 HL117913, R01 AI108906, and P01 HL129941 to C.M.W. and R01 AI108891, R01 AG045779, U19 AI057266, and I01 BX001669 to J.J.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bai AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9819; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Beavis PA, 2015, CANCER IMMUNOL RES, V3, P506, DOI 10.1158/2326-6066.CIR-14-0211; Beavis PA, 2013, P NATL ACAD SCI USA, V110, P14711, DOI 10.1073/pnas.1308209110; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Beyer M, 2016, NAT IMMUNOL, V17, P593, DOI 10.1038/ni.3399; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Bignon A, 2015, BLOOD, V125, P2507, DOI 10.1182/blood-2014-08-598565; Briceno O, 2016, AGING CELL, V15, P14, DOI 10.1111/acel.12384; Britanova OV, 2016, J IMMUNOL, V196, P5005, DOI 10.4049/jimmunol.1600005; Britanova OV, 2014, J IMMUNOL, V192, P2689, DOI 10.4049/jimmunol.1302064; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Carney EF, 2012, J IMMUNOL, V189, P261, DOI 10.4049/jimmunol.1101909; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chen GB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00121; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cukalac T, 2014, P NATL ACAD SCI USA, V111, P1485, DOI 10.1073/pnas.1323736111; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Derhovanessian E, 2014, J IMMUNOL, V193, P3624, DOI 10.4049/jimmunol.1303361; Deshpande NR, 2015, ELIFE, V4, DOI 10.7554/eLife.05949; Desponds J, 2016, P NATL ACAD SCI USA, V113, P274, DOI 10.1073/pnas.1512977112; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Domnich A, 2017, VACCINE, V35, P513, DOI 10.1016/j.vaccine.2016.12.011; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Fujii H, 2009, P NATL ACAD SCI USA, V106, P4360, DOI 10.1073/pnas.0811332106; Fulop T, 2014, CURR OPIN IMMUNOL, V29, P105, DOI 10.1016/j.coi.2014.05.007; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gil A, 2015, J VIROL, V89, P4102, DOI 10.1128/JVI.03020-14; Gomez I, 2004, EXP GERONTOL, V39, P597, DOI 10.1016/j.exger.2003.11.018; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Goronzy JJ, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0242-3; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Henel G, 2006, BLOOD, V107, P4449, DOI 10.1182/blood-2005-06-2519; Henson SM, 2015, EUR J IMMUNOL, V45, P1441, DOI 10.1002/eji.201445312; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Herati RS, 2014, J IMMUNOL, V193, P3528, DOI 10.4049/jimmunol.1302503; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Johnson PLF, 2012, P NATL ACAD SCI USA, V109, P21432, DOI 10.1073/pnas.1209283110; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Lamar DL, 2010, BLOOD, V115, P3278, DOI 10.1182/blood-2009-09-243493; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Laydon D. J., 2015, PHILOS T R SOC LON B, V370, P370; Lazuardi L, 2009, BIOGERONTOLOGY, V10, P191, DOI 10.1007/s10522-008-9167-1; Le Page A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-2; Lee KA, 2016, AGING CELL, V15, P291, DOI 10.1111/acel.12435; Lelic A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003076; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; Levin MJ, 2012, CURR OPIN IMMUNOL, V24, P494, DOI 10.1016/j.coi.2012.06.002; Li GJ, 2015, J IMMUNOL, V195, P865, DOI 10.4049/jimmunol.1402389; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Li HM, 2016, J LEUKOCYTE BIOL, V99, P505, DOI 10.1189/jlb.6A0215-071RR; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Lin Y, 2015, CLIN SCI, V128, P367, DOI 10.1042/CS20140481; Linterman MA, 2014, IMMUNOL CELL BIOL, V92, P72, DOI 10.1038/icb.2013.77; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lythe G, 2016, J THEOR BIOL, V389, P214, DOI 10.1016/j.jtbi.2015.10.016; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Meijers RWJ, 2017, J CLIN IMMUNOL, V37, P133, DOI 10.1007/s10875-016-0363-5; Mittal D, 2014, CANCER RES, V74, P3652, DOI 10.1158/0008-5472.CAN-14-0957; Mohanty S, 2015, J INFECT DIS, V211, P1174, DOI 10.1093/infdis/jiu573; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Najarro K, 2015, J INFECT DIS, V212, P1261, DOI 10.1093/infdis/jiv202; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Ndifon W, 2016, J IMMUNOL, V196, P4999, DOI 10.4049/jimmunol.1502343; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Nishijima TF, 2016, CANCER TREAT REV, V45, P30, DOI 10.1016/j.ctrv.2016.02.006; Nobile M, 2004, BLOOD, V104, P470, DOI 10.1182/blood-2003-12-4265; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pereira BI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00445; Phadwal K, 2012, AUTOPHAGY, V8, P677, DOI 10.4161/auto.18935; Pinti M, 2016, EUR J IMMUNOL, V46, P2286, DOI 10.1002/eji.201546178; Pourgheysari B, 2007, J VIROL, V81, P7759, DOI 10.1128/JVI.01262-06; Qi Q, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005892; Qi Q, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1725; Qi Q, 2014, P NATL ACAD SCI USA, V111, P13139, DOI 10.1073/pnas.1409155111; Quinn KM, 2016, P NATL ACAD SCI USA, V113, P1333, DOI 10.1073/pnas.1525167113; Renkema KR, 2014, J IMMUNOL, V192, P151, DOI 10.4049/jimmunol.1301453; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Reynolds LM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1522-4; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sansoni P, 2014, EXP GERONTOL, V55, P54, DOI 10.1016/j.exger.2014.03.020; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sauce D, 2012, J IMMUNOL, V189, P5541, DOI 10.4049/jimmunol.1201235; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Sell S, 2014, VIRAL IMMUNOL, V27, P484, DOI 10.1089/vim.2014.0077; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Su DM, 2013, CURR OPIN IMMUNOL, V25, P498, DOI 10.1016/j.coi.2013.05.018; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Thompson JD, 2016, STATISTICS FOR BIOINFORMATICS: METHODS FOR MULTIPLE SEQUENCE ALIGNMENT, P1; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van den Broek T, 2016, J CLIN INVEST, V126, P1126, DOI 10.1172/JCI84997; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; van Leeuwen EMM, 2006, J IMMUNOL, V177, P4998, DOI 10.4049/jimmunol.177.8.4998; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2015, J INVEST DERMATOL, V135, P1752, DOI 10.1038/jid.2015.63; Waickman AT, 2012, CANCER IMMUNOL IMMUN, V61, P917, DOI 10.1007/s00262-011-1155-7; Wallace DL, 2004, J IMMUNOL, V173, P1787, DOI 10.4049/jimmunol.173.3.1787; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Warrington KJ, 2001, ARTHRITIS RHEUM, V44, P13, DOI 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6; Wen ZK, 2016, J CLIN INVEST, V126, P1953, DOI 10.1172/JCI84181; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Westera L, 2015, AGING CELL, V14, P219, DOI 10.1111/acel.12311; Westera L, 2013, BLOOD, V122, P2205, DOI 10.1182/blood-2013-03-488411; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zarnitsyna VI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00165	160	151	154	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					364	378		10.1016/j.immuni.2017.03.010	http://dx.doi.org/10.1016/j.immuni.2017.03.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329703	Bronze, Green Accepted			2022-12-18	WOS:000396818100010
J	Attanasio, J; Wherry, EJ				Attanasio, John; Wherry, E. John			Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease	IMMUNITY			English	Review							T-CELL RESPONSES; HERPESVIRUS ENTRY MEDIATOR; LYMPHOCYTE-ACTIVATION; INHIBITORY RECEPTOR; PD-1 EXPRESSION; PROGRAMMED DEATH-1; VIRUS-INFECTION; CUTTING EDGE; THERAPEUTIC BLOCKADE; NEGATIVE REGULATION	Costimulatory and inhibitory receptors play a key role in regulating immune responses to infections. Recent translation of knowledge about inhibitory receptors such as CTLA-4 and PD-1 into the cancer clinic highlights the opportunities to manipulate these pathways to treat human disease. Studies in infectious disease have provided key insights into the specific roles of these pathways and the effects of their manipulation. Here, recent studies are discussed that have addressed how major inhibitory and costimulatory pathways play a role in regulating immune responses during acute and chronic infections. Mechanistic insights from studies of infectious disease provide opportunities to further expand our toolkit to treat cancer and chronic infections in the clinic.	[Attanasio, John; Wherry, E. John] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Attanasio, John; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020		National Institutes of Health [AI105343, AI112521, AI082630, AI115712, AI117950, AI108545]; Parker Institute for Cancer Immunotherapy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, U19AI117950, P01AI108545, P01AI112521, R01AI105343, R01AI115712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of Wherry laboratory for helpful discussions. E.J.W. is supported by the National Institutes of Health (grants AI105343, AI112521, AI082630, AI115712, AI117950, and AI108545) and the Parker Institute for Cancer Immunotherapy. E.J.W. has a patent licensing agreement on the PD-1 pathway.	Allie SR, 2011, J IMMUNOL, V186, P6280, DOI 10.4049/jimmunol.1003870; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Andreasen SO, 2000, J IMMUNOL, V164, P3689, DOI 10.4049/jimmunol.164.7.3689; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Bachmann MF, 1998, J IMMUNOL, V160, P95; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bloch-Queyrat C, 2005, J EXP MED, V202, P181, DOI 10.1084/jem.20050449; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Boettler T, 2012, VIRAL IMMUNOL, V25, P232, DOI 10.1089/vim.2011.0079; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Cecchinato V, 2008, J IMMUNOL, V180, P5439, DOI 10.4049/jimmunol.180.8.5439; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Clouthier DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004517; Clouthier DL, 2014, J IMMUNOL, V193, P5033, DOI 10.4049/jimmunol.1401002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; CUNNINGHAM AJ, 1977, SCAND J IMMUNOL, V6, P1, DOI 10.1111/j.1365-3083.1977.tb00317.x; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Flores M, 2015, J IMMUNOL, V194, P4240, DOI 10.4049/jimmunol.1401296; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Gardiner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063818; Garidou L, 2012, J VIROL, V86, P7060, DOI 10.1128/JVI.00164-12; Gerner MY, 2013, J IMMUNOL, V191, P1011, DOI 10.4049/jimmunol.1300652; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kassu A, 2009, CLIN IMMUNOL, V132, P234, DOI 10.1016/j.clim.2009.03.531; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Kim MV, 2013, IMMUNITY, V39, P286, DOI 10.1016/j.immuni.2013.07.013; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Lafon M, 2008, J IMMUNOL, V180, P7506, DOI 10.4049/jimmunol.180.11.7506; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; McMahon CW, 2002, J IMMUNOL, V169, P1444, DOI 10.4049/jimmunol.169.3.1444; McNally B, 2013, J VIROL, V87, P12916, DOI 10.1128/JVI.02423-13; McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032; Michelini RH, 2013, J EXP MED, V210, P1189, DOI 10.1084/jem.20130392; Miura K, 2016, EXPERT REV VACCINES, V15, P765, DOI 10.1586/14760584.2016.1141680; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Mooney JM, 2004, J IMMUNOL, V173, P3953, DOI 10.4049/jimmunol.173.6.3953; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Muhammad A, 2009, J IMMUNOL, V182, P7672, DOI 10.4049/jimmunol.0800691; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Orr MT, 2011, CURR TOP MICROBIOL, V350, P67, DOI 10.1007/82_2010_85; Paley MA, 2013, J LEUKOCYTE BIOL, V93, P307, DOI 10.1189/jlb.0812400; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pascutti MF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004675; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Porichis F, 2014, J VIROL, V88, P2508, DOI 10.1128/JVI.02034-13; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Raue HP, 2007, J LEUKOCYTE BIOL, V81, P1165, DOI 10.1189/jlb.0806535; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Richter K, 2010, INT IMMUNOL, V22, P13, DOI 10.1093/intimm/dxp107; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Scott P, 2002, CURR OPIN IMMUNOL, V14, P466, DOI 10.1016/S0952-7915(02)00353-9; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Seung E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077780; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Song AH, 2005, J IMMUNOL, V175, P3534, DOI 10.4049/jimmunol.175.6.3534; Song JX, 2008, J IMMUNOL, V180, P7240, DOI 10.4049/jimmunol.180.11.7240; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Stiles KM, 2010, J VIROL, V84, P11646, DOI 10.1128/JVI.01550-10; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; Tan JT, 1999, J IMMUNOL, V163, P4859; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vezys V, 2011, J IMMUNOL, V187, P1634, DOI 10.4049/jimmunol.1100077; VINETZ JM, 1990, J IMMUNOL, V144, P1069; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Whitmire JK, 1999, J IMMUNOL, V163, P3194; Wieland A, 2015, IMMUNITY, V42, P367, DOI 10.1016/j.immuni.2015.01.009; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Wu B, 2013, PARASITOL RES, V112, P2511, DOI 10.1007/s00436-013-3416-1; Xu DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056539; Yamada DH, 2015, IMMUNITY, V42, P379, DOI 10.1016/j.immuni.2015.01.005; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Yu QG, 2006, J IMMUNOL, V176, P2486, DOI 10.4049/jimmunol.176.4.2486; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zander RA, 2015, CELL HOST MICROBE, V17, P628, DOI 10.1016/j.chom.2015.03.007; Zehn D, 2015, ADV EXP MED BIOL, V850, P137, DOI 10.1007/978-3-319-15774-0_10; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	197	151	160	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1052	1068		10.1016/j.immuni.2016.04.022	http://dx.doi.org/10.1016/j.immuni.2016.04.022			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192569	Green Accepted, Bronze			2022-12-18	WOS:000376478500007
J	Jacquemin, C; Schmitt, N; Contin-Bordes, C; Liu, Y; Narayanan, P; Seneschal, J; Maurouard, T; Dougall, D; Davizon, ES; Dumortier, H; Douchet, I; Raffray, L; Richez, C; Lazaro, E; Duffau, P; Truchetet, ME; Khoryati, L; Mercie, P; Couzi, L; Merville, P; Schaeverbeke, T; Viallard, JF; Pellegrin, JL; Moreau, JF; Muller, S; Zurawski, S; Coffman, RL; Pascual, V; Ueno, H; Blanco, P				Jacquemin, Clement; Schmitt, Nathalie; Contin-Bordes, Cecile; Liu, Yang; Narayanan, Priya; Seneschal, Julien; Maurouard, Typhanie; Dougall, David; Davizon, Emily Spence; Dumortier, Helene; Douchet, Isabelle; Raffray, Loic; Richez, Christophe; Lazaro, Estibaliz; Duffau, Pierre; Truchetet, Marie-Elise; Khoryati, Liliane; Mercie, Patrick; Couzi, Lionel; Merville, Pierre; Schaeverbeke, Thierry; Viallard, Jean-Francois; Pellegrin, Jean-Luc; Moreau, Jean-Francois; Muller, Sylviane; Zurawski, Sandy; Coffman, Robert L.; Pascual, Virginia; Ueno, Hideki; Blanco, Patrick			OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response	IMMUNITY			English	Article							CELL-DIFFERENTIATION; B-CELL; DENDRITIC CELLS; MESSENGER-RNAS; RECEPTOR; ICOS; INDUCTION; EXPRESSION; IL-21; ERYTHEMATOSUS	Increased activity of T follicular helper (Tfh) cells plays a major pathogenic role in systemic lupus erythematosus (SLE). However, the mechanisms that cause aberrant Tfh cell responses in SLE remain elusive. Here we showed the OX40 ligand (OX40L)-OX40 axis contributes to the aberrant Tfh response in SLE. OX40L was expressed by myeloid antigen-presenting cells (APCs), but not B cells, in blood and in inflamed tissues in adult and pediatric SLE patients. The frequency of circulating OX40L-expressing myeloid APCs positively correlated with disease activity and the frequency of ICOS+ blood Tfh cells in SLE. OX40 signals promoted naive and memory CD4(+) T cells to express multiple Tfh cell molecules and were sufficient to induce them to become functional B cell helpers. Immune complexes containing RNA induced OX40L expression on myeloid APCs via TLR7 activation. Our study provides a rationale to target the OX40L-OX40 axis as a therapeutic modality for SLE.	[Jacquemin, Clement; Contin-Bordes, Cecile; Seneschal, Julien; Richez, Christophe; Lazaro, Estibaliz; Duffau, Pierre; Truchetet, Marie-Elise; Khoryati, Liliane; Mercie, Patrick; Couzi, Lionel; Merville, Pierre; Schaeverbeke, Thierry; Viallard, Jean-Francois; Pellegrin, Jean-Luc; Moreau, Jean-Francois; Blanco, Patrick] Univ Bordeaux, UMR CNRS 5164, CIRID, F-33000 Bordeaux, France; [Jacquemin, Clement; Contin-Bordes, Cecile; Douchet, Isabelle; Richez, Christophe; Lazaro, Estibaliz; Duffau, Pierre; Truchetet, Marie-Elise; Khoryati, Liliane; Merville, Pierre; Moreau, Jean-Francois; Blanco, Patrick] CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; [Schmitt, Nathalie; Liu, Yang; Narayanan, Priya; Maurouard, Typhanie; Dougall, David; Davizon, Emily Spence; Zurawski, Sandy; Pascual, Virginia; Ueno, Hideki; Blanco, Patrick] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Contin-Bordes, Cecile; Seneschal, Julien; Raffray, Loic; Richez, Christophe; Lazaro, Estibaliz; Duffau, Pierre; Truchetet, Marie-Elise; Mercie, Patrick; Couzi, Lionel; Merville, Pierre; Schaeverbeke, Thierry; Viallard, Jean-Francois; Pellegrin, Jean-Luc; Moreau, Jean-Francois; Blanco, Patrick] CHU Bordeaux, F-33076 Bordeaux, France; [Dumortier, Helene; Muller, Sylviane] CNRS, Inst Biol Mol & Cellulaire, Immunopathol & Therapeut Chem Lab Excellence MEDA, F-67081 Strasbourg, France; [Dumortier, Helene; Muller, Sylviane] Univ Strasbourg, F-67081 Strasbourg, France; [Muller, Sylviane] Univ Strasbourg, Inst Adv Study, F-67081 Strasbourg, France; [Coffman, Robert L.] Dynavax Technol Corp, Berkeley, CA 94710 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Baylor Scott & White Health; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ueno, H (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	hidekiu@baylorhealth.edu; patrick.blanco@chu-bordeaux.fr	JACQUEMIN, Clement/AAA-1618-2022; Ueno, Hideki/L-1237-2016; Pascual, Virginia/ABD-3099-2020	Ueno, Hideki/0000-0001-7747-0738; Seneschal, Julien/0000-0003-1139-0908; Schmitt, Nathalie/0000-0001-9993-2788	Centre national pour la Recherche Scientifique; Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Ministere de la Recherche et de l'Enseignement superieur; NIH [U19-AI057234, U19-AI082715, U19-AI089987]; Alliance for Lupus Research; Baylor Health Care System; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715, U19AI057234, U19AI089987] Funding Source: NIH RePORTER	Centre national pour la Recherche Scientifique; Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Ministere de la Recherche et de l'Enseignement superieur; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Baylor Health Care System; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J-C. Caron, K. Eschel, M. Gassie, N. Pic, and C. Cognet for the technical help for flow cytometry. We thank E. Kowalski, S. Coquery, N. Loof, and K. Kayembe for cell sorting. We thank K. Palucka and Y.-J. Liu for discussions. We thank S. Clayton for confocal imaging. This study was supported by research funding from Centre national pour la Recherche Scientifique, the Societe Francaise de Rhumatologie and Arthritis Fondation Courtin; Ministere de la Recherche et de l'Enseignement superieur; NIH grants U19-AI057234, U19-AI082715, U19-AI089987, Alliance for Lupus Research, and Baylor Health Care System.	Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Boettler T, 2013, J IMMUNOL, V191, P5026, DOI 10.4049/jimmunol.1300013; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO;2-8; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Byun M, 2013, J EXP MED, V210, P1743, DOI 10.1084/jem.20130592; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Delgado-Vega AM, 2009, GENES IMMUN, V10, P248, DOI 10.1038/gene.2008.95; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Kalled SL, 1998, J IMMUNOL, V160, P2158; Karulf M, 2010, J IMMUNOL, V185, P4856, DOI 10.4049/jimmunol.1000404; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kopf M, 1999, IMMUNITY, V11, P699, DOI 10.1016/S1074-7613(00)80144-2; Kshirsagar S, 2013, ARTHRITIS RHEUM-US, V65, P2996, DOI 10.1002/art.38089; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Liarski VM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008146; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marriott CL, 2014, EUR J IMMUNOL, V44, P2437, DOI 10.1002/eji.201344211; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Murata K, 2002, J IMMUNOL, V169, P4628, DOI 10.4049/jimmunol.169.8.4628; Murphy G, 2013, LANCET, V382, P809, DOI 10.1016/S0140-6736(13)60889-2; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; So T, 2011, J IMMUNOL, V186, P3547, DOI 10.4049/jimmunol.1003156; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Witsch EJ, 2002, EUR J IMMUNOL, V32, P2680, DOI 10.1002/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Zhang JY, 2013, EUR J IMMUNOL, V43, P1953, DOI 10.1002/eji.201243097	69	151	160	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1159	1170		10.1016/j.immuni.2015.05.012	http://dx.doi.org/10.1016/j.immuni.2015.05.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26070486	Green Accepted, Bronze			2022-12-18	WOS:000356362800019
J	Slutter, B; Pewe, LL; Kaech, SM; Harty, JT				Sluetter, Bram; Pewe, Lecia L.; Kaech, Susan M.; Harty, John T.			Lung Airway-Surveilling CXCR3(hi) Memory CD8(+) T Cells Are Critical for Protection against Influenza A Virus	IMMUNITY			English	Article							RESIDENT MEMORY; CUTTING EDGE; HETEROSUBTYPIC IMMUNITY; SELECTIVE EXPRESSION; BET; EFFECTOR; ANTIGEN; CD4(+); INFECTION; LYMPHOCYTES	Inducing memory CD8(+) T cells specific for conserved antigens from influenza A virus (IAV) is a potential strategy for broadly protective vaccines. Here we show that memory CD8(+) T cells in the airways played an important role in early control of IAV. Expression of the chemokine receptor CXCR3 was critical for memory CD8(+) T cells to populate the airways during the steady state and vaccination approaches were designed to favor the establishment of memory CD8(+) T cells in the airways. Specifically, we found that interleukin-12 (IL-12) signaling shortly after immunization limited CXCR3 expression on memory CD8(+) T cells. Neutralization of IL-12 or adjuvants that did not induce high amounts of IL-12 enhanced CXCR3 expression, sustained airway localization of memory CD8(+) T cells, and resulted in superior protection against IAV.	[Sluetter, Bram; Pewe, Lecia L.; Harty, John T.] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Iowa; University of Iowa; University of Iowa; Yale University; Howard Hughes Medical Institute	Harty, JT (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Harty, John/0000-0001-7266-2802	NWO Rubicon Fellowship; Howard Hughes Medical Institute; National Institutes of Health [AI42676, AI100527, AI106776]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100527, R01AI085515, R56AI106776, R37AI042767] Funding Source: NIH RePORTER	NWO Rubicon Fellowship(Netherlands Organization for Scientific Research (NWO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Nolz, V. Badovinac, and S. Perlman for critical comments on the manuscript, P. Lauer for recombinant Listeria, and J. Bennink for recombinant vaccinia viruses. We also thank L. Hancox and C. Varga for research support. This work was supported by a NWO Rubicon Fellowship (B. S.), the Howard Hughes Medical Institute (S. M. K.), and National Institutes of Health grants AI42676, AI100527, and AI106776 to J.T.H.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Anderson KG, 2012, J IMMUNOL, V189, P2702, DOI 10.4049/jimmunol.1201682; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Corbin GA, 2004, J IMMUNOL, V173, P5679, DOI 10.4049/jimmunol.173.9.5679; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Gebhardt T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00340; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Keppler SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040865; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Lewis MD, 2007, MOL CELL BIOL, V27, P8510, DOI 10.1128/MCB.01615-07; LIANG SH, 1994, J IMMUNOL, V152, P1653; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paats MS, 2013, EUR RESPIR J, V41, P1378, DOI 10.1183/09031936.00060112; Papiris SA, 2005, CHEST, V128, P2971, DOI 10.1378/chest.128.4.2971; Pham NLL, 2010, P NATL ACAD SCI USA, V107, P12198, DOI 10.1073/pnas.1004661107; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2009, VACCINE, V27, P6103, DOI 10.1016/j.vaccine.2009.08.025; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; Slutter B, 2013, J IMMUNOL, V190, P3854, DOI 10.4049/jimmunol.1202790; STEINHOFF MC, 1993, J CLIN MICROBIOL, V31, P836, DOI 10.1128/JCM.31.4.836-838.1993; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; WEILAND JE, 1989, PATHOLOGY, V21, P59, DOI 10.3109/00313028909059532; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	53	151	156	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					939	948		10.1016/j.immuni.2013.09.013	http://dx.doi.org/10.1016/j.immuni.2013.09.013			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238342	Green Accepted, Bronze			2022-12-18	WOS:000330950600015
J	Ferguson, AL; Mann, JK; Omarjee, S; Ndung'u, T; Walker, BD; Chakraborty, AK				Ferguson, Andrew L.; Mann, Jaclyn K.; Omarjee, Saleha; Ndung'u, Thumbi; Walker, Bruce D.; Chakraborty, Arup K.			Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design	IMMUNITY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; REPLICATION CAPACITY; CLASS-I; ELITE CONTROLLERS; LYMPHOCYTE ESCAPE; VACCINE DESIGN; HLA ALLELES; P24 GAG; INFECTION	A prophylactic or therapeutic vaccine offers the best hope to curb the HIV-AIDS epidemic gripping sub-Saharan Africa, but it remains elusive. A major challenge is the extreme viral sequence variability among strains. Systematic means to guide immunogen design for highly variable pathogens like HIV are not available. Using computational models, we have developed an approach to translate available viral sequence data into quantitative landscapes of viral fitness as a function of the amino acid sequences of its constituent proteins. Predictions emerging from our computationally defined landscapes for the proteins of HIV-1 clade B Gag were positively tested against new in vitro fitness measurements and were consistent with previously defined in vitro measurements and clinical observations. These landscapes chart the peaks and valleys of viral fitness as protein sequences change and inform the design of immunogens and therapies that can target regions of the virus most vulnerable to selection pressure.	[Ferguson, Andrew L.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Ferguson, Andrew L.; Ndung'u, Thumbi; Walker, Bruce D.; Chakraborty, Arup K.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02129 USA; [Ferguson, Andrew L.; Ndung'u, Thumbi; Walker, Bruce D.; Chakraborty, Arup K.] Harvard Univ, Boston, MA 02129 USA; [Mann, Jaclyn K.; Omarjee, Saleha; Ndung'u, Thumbi] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, ZA-4013 Durban, South Africa; [Mann, Jaclyn K.; Omarjee, Saleha; Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4013 Durban, South Africa; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; University of Kwazulu Natal; University of Kwazulu Natal; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu		Ndung'u, Thumbi/0000-0003-2962-3992; Ferguson, Andrew/0000-0002-8829-9726	Ragon Institute; National Institutes of Health Director's Pioneers Award; NIH [AI30914]; Howard Hughes Medical Institute; South African Department of Science and Technology/National Research Foundation Research Chair Initiative; Ragon Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R37AI067073, UM1AI100663, R01AI030914] Funding Source: NIH RePORTER	Ragon Institute; National Institutes of Health Director's Pioneers Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); South African Department of Science and Technology/National Research Foundation Research Chair Initiative; Ragon Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Todd Allen, Herman Eisen, and John Barton for fruitful discussions. Financial support was provided by the Ragon Institute (B. D. W., A. K. C., J.K.M., S.O., T.N.), a National Institutes of Health Director's Pioneers Award (A. K. C.), NIH Award AI30914 (B. D. W.), the Howard Hughes Medical Institute (B. D. W., T.N.), the South African Department of Science and Technology/National Research Foundation Research Chair Initiative (J.K.M., S.O., T.N.), and a Ragon Postdoctoral Fellowship (A.L.F.).	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Arora J., 2011, INTRO OPTIMUM DESIGN, Vthird; Autran B, 2008, AIDS, V22, P1313, DOI 10.1097/QAD.0b013e3282fdce94; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; FRAHM N, 2008, HIV MOL IMMUNOLOGY 2, P3; Friedrich D, 2011, JAIDS-J ACQ IMM DEF, V58, P248, DOI 10.1097/QAI.0b013e318228f992; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hendel H, 1999, J IMMUNOL, V162, P6942; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Remakus S, 2012, J VIROL, V86, P9748, DOI 10.1128/JVI.00981-12; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Tkacik G., 2006, ARXIVQBIO0611072; Tkaik G., 2009, ARXIV09125409; Trachtenberg E.A., 2001, REV ROLE HUMAN LEUKO; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	52	151	156	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					606	617		10.1016/j.immuni.2012.11.022	http://dx.doi.org/10.1016/j.immuni.2012.11.022			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521886	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000330941500023
J	Yogev, N; Frommer, F; Lukas, D; Kautz-Neu, K; Karram, K; Ielo, D; von Stebut, E; Probst, HC; van den Broek, M; Riethmacher, D; Birnberg, T; Blank, T; Reizis, B; Korn, T; Wiendl, H; Jung, S; Prinz, M; Kurschus, FC; Waisman, A				Yogev, Nir; Frommer, Friederike; Lukas, Dominika; Kautz-Neu, Kordula; Karram, Khalad; Ielo, Daniele; von Stebut, Esther; Probst, Hans-Christian; van den Broek, Manes; Riethmacher, Dieter; Birnberg, Tal; Blank, Thomas; Reizis, Boris; Korn, Thomas; Wiendl, Heinz; Jung, Steffen; Prinz, Marco; Kurschus, Florian C.; Waisman, Ari			Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor(+) Regulatory T Cells	IMMUNITY			English	Article							IN-VIVO; ANTIGEN PRESENTATION; CD8(+); TOLERANCE; DEPLETION; ABLATION; INDUCTION; DISEASES; DEC-205; CD4(+)	Mature dendritic cells (DCs) are established as unrivaled antigen-presenting cells (APCs) in the initiation of immune responses, whereas steady-state DCs induce peripheral T cell tolerance. Using various genetic approaches, we depleted CD11c(+). DCs in mice and induced autoinnmune CNS inflammation. Unexpectedly, mice lacking DCs developed aggravated disease compared to control mice. Furthermore, when we engineered DCs to present a CNS-associated autoantigen in an induced manner, we found robust tolerance that prevented disease, which coincided with an upregulation of the PD-1 receptor on antigen-specific T cells. Additionally, we showed that PD-1 was necessary for DC-mediated induction of regulatory T cells. Our results show that a reduction of DCs interferes with tolerance, resulting in a stronger inflammatory response, and that other APC populations could compensate for the loss of immunogenic APC function in DC-depleted mice.	[Yogev, Nir; Frommer, Friederike; Lukas, Dominika; Karram, Khalad; Ielo, Daniele; Kurschus, Florian C.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, D-55131 Mainz, Germany; [Kautz-Neu, Kordula; von Stebut, Esther] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55131 Mainz, Germany; [Probst, Hans-Christian] Johannes Gutenberg Univ Mainz, Inst Immunol, Univ Med Ctr, D-55131 Mainz, Germany; [van den Broek, Manes] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Riethmacher, Dieter] Univ Southampton, Div Human Genet, Southampton SO16 6YD, Hants, England; [Birnberg, Tal; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Blank, Thomas; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Blank, Thomas] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, D-48149 Munster, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Zurich; University Zurich Hospital; University of Southampton; Weizmann Institute of Science; University of Freiburg; University of Freiburg; Columbia University; Technical University of Munich; University of Munster	Yogev, N (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, D-55131 Mainz, Germany.	yogev@uni-mainz.de; waisman@uni-mainz.de	Wiendl, Heinz/AAX-6041-2021; Korn, Thomas/AAE-6960-2019; Kurschus, Florian C./AAP-9777-2020; Jung, Steffen/K-1409-2012; Waisman, Ari/C-7383-2015; Kurschus, Florian/B-2838-2014; Riethmacher, Dieter/AAP-2227-2021; Riethmacher, Dieter/AAB-8690-2022; van den Broek, Maries/G-4128-2016	Korn, Thomas/0000-0002-3633-0955; Kurschus, Florian C./0000-0001-7550-0681; Jung, Steffen/0000-0003-4290-5716; Waisman, Ari/0000-0003-4304-8234; Riethmacher, Dieter/0000-0002-4206-5529; van den Broek, Maries/0000-0002-9489-3692; Wiendl, Heinz/0000-0003-4310-3432; Reizis, Boris/0000-0003-1140-7853; PROBST, Hans Christian/0000-0002-7926-0651	Immunology Center of Excellence Mainz (FZI); German Research Foundation (DFG) [GRK 1043, WA 1600/3-1, SFB/TR 52]; DFG research group [FOR1336]; German Ministry for Education and Research (BMBF, Consortium UNDERSTANDMS, as part of the "German Competence Network of MS")	Immunology Center of Excellence Mainz (FZI); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG research group(German Research Foundation (DFG)); German Ministry for Education and Research (BMBF, Consortium UNDERSTANDMS, as part of the "German Competence Network of MS")(Federal Ministry of Education & Research (BMBF))	We would like to thank I. Mufazalov, C. Steigerwald, and C. Couto Garcia for help and support in the performance of experiments and data analysis, and P. Adams, A. Heinen, and M. Snetkova for their excellent technical assistance. We are also very grateful to A. Young, J. Masri, and B. Becher for their careful correction of the manuscript. D.L. was supported by a fellowship from the Immunology Center of Excellence Mainz (FZI) and D.I. by a fellowship from the German Research Foundation (DFG) graduate school GRK 1043. This work was supported by the DFG grants WA 1600/3-1 and SFB/TR 52 to A.W., the DFG research group grant FOR1336 to A.W., S.J., and M.P, and by the German Ministry for Education and Research (BMBF, Consortium UNDERSTANDMS, as part of the "German Competence Network of MS") to A.W., H.W., and M.P.	Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Horste GMZ, 2010, J IMMUNOL METHODS, V354, P80, DOI 10.1016/j.jim.2010.01.012; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kenna TJ, 2008, BLOOD, V111, P2091, DOI 10.1182/blood-2007-07-103200; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Serafini B, 2000, AM J PATHOL, V157, P1991, DOI 10.1016/S0002-9440(10)64838-9; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Waisman A, 2009, EUR J IMMUNOL, V39, P1448, DOI 10.1002/eji.200939541; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	49	151	157	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					264	275		10.1016/j.immuni.2012.05.025	http://dx.doi.org/10.1016/j.immuni.2012.05.025			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22902234	Bronze, Green Accepted			2022-12-18	WOS:000308261800011
J	Nitta, T; Murata, S; Sasaki, K; Fujii, H; Ripen, AM; Ishimaru, N; Koyasu, S; Tanaka, K; Takahama, Y				Nitta, Takeshi; Murata, Shigeo; Sasaki, Katsuhiro; Fujii, Hideki; Ripen, Adiratna Mat; Ishimaru, Naozumi; Koyasu, Shigeo; Tanaka, Keiji; Takahama, Yousuke			Thymoproteasome Shapes Immunocompetent Repertoire of CD8(+) T Cells	IMMUNITY			English	Article							MHC CLASS-I; THYMOCYTE-POSITIVE SELECTION; THYMIC EPITHELIAL-CELLS; NEGATIVE SELECTION; ANTIGEN PRESENTATION; PROTEASOME SUBUNIT; PEPTIDE LIGANDS; MICE LACKING; CATHEPSIN-L; A VIRUS	How self-peptides displayed in the thymus contribute to the development of immunocompetent and self-protective T cells is largely unknown. In contrast, the role of thymic self-peptides in eliminating self-reactive T cells and thereby preventing autoimmunity is well established. A type of proteasome, termed thymoproteasome, is specifically expressed by thymic cortical epithelial cells (cTECs) and is required for the generation of optimal cellularity of CD8(+) T cells. Here, we show that cTECs displayed thymoproteasome-specific peptide-MHC class I complexes essential for the positive selection of major and diverse repertoire of MHC class I-restricted T cells. CD8(+) T cells generated in the absence of thymoproteasomes displayed a markedly altered T cell receptor repertoire that was defective in both allogeneic and antiviral responses. These results demonstrate that thymoproteasome-dependent self-peptide production is required for the development of an immunocompetent repertoire of CD8(+) T cells.	[Nitta, Takeshi; Ripen, Adiratna Mat; Takahama, Yousuke] Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 7708503, Japan; [Ishimaru, Naozumi] Univ Tokushima, Dept Pathol, Inst Hlth Biosci, Tokushima 7708503, Japan; [Murata, Shigeo] Univ Tokyo, Lab Prot Metab, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Sasaki, Katsuhiro; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 1568506, Japan; [Fujii, Hideki; Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Koyasu, Shigeo] Japan Soc Promot Sci, Res Ctr Sci Syst, Tokyo 1028472, Japan	Tokushima University; Tokushima University; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Keio University; Japan Society for the Promotion of Science	Takahama, Y (corresponding author), Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 7708503, Japan.	takahama@genome.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010; Koyasu, Shigeo/J-5583-2015; Ripen, Adiratna Mat/AAM-3965-2021; Murata, Shigeo/A-1426-2010; Ripen, Adiratna Mat/C-5987-2013	Takahama, Yousuke/0000-0002-4992-9174; Koyasu, Shigeo/0000-0001-9585-3038; Murata, Shigeo/0000-0002-3177-3503; Mat Ripen, Adiratna/0000-0001-5690-8008	MEXT; Specially Promoted Research; Astellas Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [22590437] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Specially Promoted Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Astellas Foundation(Astellas Pharmaceuticals); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Nitta and I. Ohigashi for technical help; T. Hansen, H. Scott, and K. Yasutomo for reagents; R. Germain for discussion and reagents; and A. Singer for reading the manuscript. This study was supported by a MEXT Grant-in-Aid for Scientific Research on Priority Area "Immunological Self" (to Y.T.), Specially Promoted Research (to S.M. and K.T.), Astellas Foundation (to Y.T.), and The Mitsubishi Foundation (to S.M.).	Agenes F, 2008, J EXP MED, V205, P2735, DOI 10.1084/jem.20070467; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Burgevin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002402; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Huseby ES, 2008, MOL IMMUNOL, V45, P599, DOI 10.1016/j.molimm.2006.03.025; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kedzierska K, 2006, P NATL ACAD SCI USA, V103, P9184, DOI 10.1073/pnas.0603289103; Kirberg J, 2008, J IMMUNOL, V181, P1207, DOI 10.4049/jimmunol.181.2.1207; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Li J, 2007, J IMMUNOL, V179, P1605, DOI 10.4049/jimmunol.179.3.1605; Li W, 2005, IMMUNITY, V23, P375, DOI 10.1016/j.immuni.2005.09.002; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; Lilic M, 2002, J IMMUNOL, V169, P4945, DOI 10.4049/jimmunol.169.9.4945; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Martinic MM, 2003, P NATL ACAD SCI USA, V100, P1861, DOI 10.1073/pnas.252641399; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Mozdzanowska K, 1997, VIROLOGY, V239, P217, DOI 10.1006/viro.1997.8882; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Oono T, 2001, J CLIN INVEST, V108, P1589, DOI 10.1172/JCI13256; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; SCOLLAY R, 1988, IMMUNOL REV, V104, P81, DOI 10.1111/j.1600-065X.1988.tb00760.x; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Siggs OM, 2006, CURR OPIN IMMUNOL, V18, P175, DOI 10.1016/j.coi.2006.01.001; Singer A., 1986, PROG IMMUNOL, V6, P60; Stambas J, 2007, J IMMUNOL, V178, P1285, DOI 10.4049/jimmunol.178.3.1285; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; Takahama Y, 2008, TRENDS IMMUNOL, V29, P251, DOI 10.1016/j.it.2008.03.003; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; Ueno Tomoo, 2005, Methods Mol Biol, V290, P117; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756; Zerrahn J, 1999, P NATL ACAD SCI USA, V96, P11470, DOI 10.1073/pnas.96.20.11470; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; Zinkernagel RM, 1999, P NATL ACAD SCI USA, V96, P8092, DOI 10.1073/pnas.96.14.8092; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	80	151	154	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					29	40		10.1016/j.immuni.2009.10.009	http://dx.doi.org/10.1016/j.immuni.2009.10.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20045355	Bronze			2022-12-18	WOS:000274119900009
J	Meier, D; Bornmann, C; Chappaz, S; Schmutz, S; Otten, LA; Ceredig, R; Acha-Orbea, H; Finke, D				Meier, Dominik; Bornmann, Caroline; Chappaz, Stephane; Schmutz, Sandrine; Otten, Luc A.; Ceredig, Rhodri; Acha-Orbea, Hans; Finke, Daniela			Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; IL-7 RECEPTOR-ALPHA; PEYERS-PATCHES; T-CELLS; B-CELL; LYMPHOTOXIN ALPHA/BETA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; DENDRITIC CELLS; TRANSGENIC MICE	Development of Peyer's patches and lymph nodes requires the interaction between CD4(+) CD3(-) IL-7R alpha(+) lymphoid-tissue inducer (LTi) and VCAM-1(+) organizer cells. Here we showed that by promoting their survival, enhanced expression of interleukin-7 (IL-7) in transgenic mice resulted in accumulation of LTi cells. With increased IL-7 availability, de novo formation of VCAM-11(+) Peyer's patch anlagen occurred along the entire fetal gut resulting in a 5-fold increase in Peyer's patch numbers. IL-7 overexpression also led to formation of multiple organized ectopic lymph nodes and cecal patches. After immunization, ectopic lymph nodes developed normal T cell-dependent B cell responses and germinal centers. Mice overexpressing IL-7 but lacking either ROR gamma, a factor required for LTi cell generation, or lymphotoxin alpha(1)beta(2) 02 had neither Peyer's patches nor ectopic lymph nodes. Therefore, by controlling LTi cell numbers, IL-7 can regulate the formation of both normal and ectopic lymphoid organs.	Univ Basel, Ctr Biomed, Div Dev Immunol, Dept Clin & Biol Sci DKBW, CH-4058 Basel, Switzerland; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Univ Franche Comte, INSERM, U645, EFS, F-25000 Besancon, France	University of Basel; University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Finke, D (corresponding author), Univ Basel, Ctr Biomed, Div Dev Immunol, Dept Clin & Biol Sci DKBW, CH-4058 Basel, Switzerland.	daniela.finke@unibas.ch	Ceredig, Rhodri/A-7077-2010	Chappaz, Stephane/0000-0003-0574-7544; Ceredig, Rhodri/0000-0002-4393-727X				Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ardavin C, 1999, J IMMUNOL, V162, P2538; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; Kuprash DV, 2005, EUR J IMMUNOL, V35, P1592, DOI 10.1002/eji.200526119; Laky K, 2000, J EXP MED, V191, P1569, DOI 10.1084/jem.191.9.1569; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Mertsching E, 1996, EUR J IMMUNOL, V26, P28, DOI 10.1002/eji.1830260105; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; Otten LA, 2003, J IMMUNOL, V170, P1150, DOI 10.4049/jimmunol.170.3.1150; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Traggiai E, 2001, J NEUROIMMUNOL, V121, P111, DOI 10.1016/S0165-5728(01)00433-7; van Roon JAG, 2005, ARTHRITIS RHEUM, V52, P1700, DOI 10.1002/art.21045; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	40	151	159	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					643	654		10.1016/j.immuni.2007.04.009	http://dx.doi.org/10.1016/j.immuni.2007.04.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521585	Bronze			2022-12-18	WOS:000246895900016
J	Dupre, L; Aiuti, A; Trifari, S; Martino, S; Saracco, P; Bordignon, C; Roncarolo, MG				Dupre, L; Aiuti, A; Trifari, S; Martino, S; Saracco, P; Bordignon, C; Roncarolo, MG			Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation	IMMUNITY			English	Article							T-CELL ACTIVATION; PRIMARY HUMAN MACROPHAGES; ARP2/3 COMPLEX; ACTIN CYTOSKELETON; TYROSINE PHOSPHORYLATION; FUNCTIONAL RAFTS; GENE-TRANSFER; WASP; CDC42; POLYMERIZATION	Immunological synapse assembly relies on the clustering of lipid rafts and is required for optimal T cell activation. We demonstrate that the Wiskott-Aldrich syndrome protein (WASP) is recruited to lipid rafts immediately after TCR and CD28 triggering and is required for the movements of lipid rafts. T cells from Wiskott-Aldrich syndrome (WAS) patients, lacking WASP, proliferate poorly after TCR/CD28 activation and have impaired capacities to cluster the lipid raft marker GM1 and to upregulate GM1 cell surface expression. T cell proliferation and lipid raft clustering are restored by retroviral transfer of the WASP gene. These results demonstrate that WASP plays a central role in the movements of lipid rafts and identify a potential mechanism underlying the T cell defect affecting WAS patients.	San Raffaele Telethon Inst Gene Therapy, HSR TIGET, I-20132 Milan, Italy; Univ Turin, Dept Pediat, I-10126 Turin, Italy; Univ Vita Salute, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Turin; Vita-Salute San Raffaele University	Roncarolo, MG (corresponding author), San Raffaele Telethon Inst Gene Therapy, HSR TIGET, Via Olgettina 58, I-20132 Milan, Italy.	m.roncarolo@hsr.it	dupre, loic/L-8174-2014; AIUTI, ALESSANDRO/K-3918-2016	dupre, loic/0000-0002-7278-6503; AIUTI, ALESSANDRO/0000-0002-5398-1717; RONCAROLO, Maria Grazia/0000-0002-2193-9186	Telethon [TGT06S01, TGT00A02] Funding Source: Medline	Telethon(Fondazione Telethon)		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BACCHETTA R, 1993, J CLIN INVEST, V91, P1067, DOI 10.1172/JCI116264; Badolato R, 1998, J IMMUNOL, V161, P1026; Binks M, 1998, EUR J IMMUNOL, V28, P3259; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; Cory GOC, 1996, J IMMUNOL, V157, P3791; DERRY JMJ, 1994, CELL, V79, P923; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Gallego MD, 1997, BLOOD, V90, P3089, DOI 10.1182/blood.V90.8.3089; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lanzavecchia A, 2000, CURR OPIN IMMUNOL, V12, P92, DOI 10.1016/S0952-7915(99)00056-4; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2001, INFECT IMMUN, V69, P1739, DOI 10.1128/IAI.69.3.1739-1746.2001; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; MAVILIO F, 1994, BLOOD, V83, P1988; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nonoyama S, 1998, CURR OPIN IMMUNOL, V10, P407, DOI 10.1016/S0952-7915(98)80113-1; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Scherbina A, 1999, J IMMUNOL, V163, P6314; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Valensin S, 2002, EUR J IMMUNOL, V32, P435, DOI 10.1002/1521-4141(200202)32:2<435::AID-IMMU435>3.0.CO;2-H; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang JY, 2002, P NATL ACAD SCI USA, V99, P2240, DOI 10.1073/pnas.042686099; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	54	151	157	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2002	17	2					157	166		10.1016/S1074-7613(02)00360-6	http://dx.doi.org/10.1016/S1074-7613(02)00360-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	587XL	12196287	Bronze			2022-12-18	WOS:000177669400004
J	Morel, L; Tian, XH; Croker, BP; Wakeland, EK				Morel, L; Tian, XH; Croker, BP; Wakeland, EK			Epistatic modifiers of autoimmunity in a murine model of lupus nephritis	IMMUNITY			English	Article							CONGENIC MOUSE STRAINS; NEW-ZEALAND MICE; GENETIC DISSECTION; SUSCEPTIBILITY GENES; ERYTHEMATOSUS; DISEASE; LINKAGE; GENOME; SLE; PATHOGENESIS	Sle1 and Sle3 are NZW-derived loci that mediate lupus nephritis on a C57BL/6 background. The absence of severe autoimmunity in NZW suggests that the NZW genome suppresses these genes. (B6.NZMc1[Sle1] x NZW)F1 hybrids develop severe humoral autoimmunity and fatal lupus nephritis, indicating that suppression of Sle1 from NZW is recessive. Linkage analysis identified four epistatic modifiers, Sles1-4, whose cumulative effect accounted for the benign autoimmunity in NZW. The specific suppression of Sle1 but not Sle2 or Sle3 by Sles1 was directly demonstrated via the production and analysis of bicongenic strains. Moreover, Sles1 was sufficient to completely suppress autoimmunity initiated by Sle1 in B6.NZMc1 x NZW hybrids. These results demonstrate the complex epistatic interactions of loci augmenting and suppressing systemic autoimmunity.	Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Mammalian Genet, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Morel, L (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.							Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DRAKE CG, 1994, P NATL ACAD SCI USA, V91, P4062, DOI 10.1073/pnas.91.9.4062; DRAKE CG, 1995, IMMUNOL REV, V144, P51, DOI 10.1111/j.1600-065X.1995.tb00065.x; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; Izui S, 1994, Int Rev Immunol, V11, P211, DOI 10.3109/08830189409061728; Jacob CO, 1996, J IMMUNOL, V156, P3043; KONO DH, 1994, P NATL ACAD SCI USA, V91, P10168, DOI 10.1073/pnas.91.21.10168; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Mohan C, 1999, J IMMUNOL, V162, P6492; Mohan C, 1997, J IMMUNOL, V159, P454; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; Morel L, 1997, J IMMUNOL, V158, P6019; Morel L, 1999, MAMM GENOME, V10, P176; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Rozzo SJ, 1999, J IMMUNOL, V162, P2623; RUDOFSKY UH, 1993, LAB INVEST, V68, P419; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; Sobel ES, 1999, J IMMUNOL, V162, P2415; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THEOFILOPOULOS AN, 1993, SYSTEMIC LUPUS ERYTH, P121; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Vyse TJ, 1998, J IMMUNOL, V160, P2757; Wakeland EK, 1997, J CLIN IMMUNOL, V17, P272, DOI 10.1023/A:1027370514198; Winchester R., 1992, SYSTEMIC LUPUS ERYTH, P65; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616	34	151	151	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	1999	11	2					131	139		10.1016/S1074-7613(00)80088-6	http://dx.doi.org/10.1016/S1074-7613(00)80088-6			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	232RH	10485648	Bronze			2022-12-18	WOS:000082383400002
J	Manning, TC; Schlueter, CJ; Brodnicki, TC; Parke, EA; Speir, JA; Garcia, KC; Teyton, L; Wilson, IA; Kranz, DM				Manning, TC; Schlueter, CJ; Brodnicki, TC; Parke, EA; Speir, JA; Garcia, KC; Teyton, L; Wilson, IA; Kranz, DM			Alanine scanning mutagenesis of an alpha beta T cell receptor: Mapping the energy of antigen recognition	IMMUNITY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CRYSTAL-STRUCTURE; LYMPHOCYTES-T; MONOCLONAL-ANTIBODIES; BINDING-PROPERTIES; ESCHERICHIA-COLI; INTERACTION SITE; CHAIN; PEPTIDE; SPECIFICITY	The T cell receptor (TCR) from the alloreactive T lymphocyte 2C recognizes a nonamer peptide QL9 complexed with the MHC class I molecule H2-L-d. Forty-two single-site alanine substitutions of the 2C TCR were analyzed for binding to QL9/L-d and anti-TCR antibodies. The results provided a detailed energy map of T cell antigen recognition and indicated that the pMHC and clonotypic antibody epitopes on the TCR were similar. Although residues in each V alpha and V beta CDR are important in binding pMHC, the most significant energy for the TCR/QL9/L-d interaction was contributed by CDRs 1 and 2 of both alpha and beta chains. The extent to which the individual energy contributions are directed at class I helices or peptide was also assessed.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Scaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55767] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BEHLKE MA, 1987, J EXP MED, V165, P257, DOI 10.1084/jem.165.1.257; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Braden BC, 1996, J MOL BIOL, V264, P137, DOI 10.1006/jmbi.1996.0629; Brodnicki TC, 1996, MOL IMMUNOL, V33, P253, DOI 10.1016/0161-5890(95)00142-5; CLARKSON T, 1995, SCIENCE, V267, P383; CONNOLLY JM, 1994, P NATL ACAD SCI USA, V91, P11482, DOI 10.1073/pnas.91.24.11482; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DIGIUSTO DL, 1994, MOL IMMUNOL, V31, P693, DOI 10.1016/0161-5890(94)90179-1; Eisen HN, 1996, ADV PROTEIN CHEM, V49, P1, DOI 10.1016/S0065-3233(08)60487-8; FIELDS BA, 1995, SCIENCE, V270, P1821, DOI 10.1126/science.270.5243.1821; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HONG SC, 1992, CELL, V69, P999, DOI 10.1016/0092-8674(92)90618-M; HOO WFS, 1992, P NATL ACAD SCI USA, V89, P4759, DOI 10.1073/pnas.89.10.4759; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; KASIBHATLA S, 1993, J IMMUNOL, V151, P3140; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P7922, DOI 10.1073/pnas.81.24.7922; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Manning TC, 1997, J IMMUNOL, V159, P4665; OZATO K, 1980, J IMMUNOL, V125, P2473; PATTEN P, 1984, NATURE, V312, P40, DOI 10.1038/312040a0; PATTEN PA, 1993, J IMMUNOL, V150, P2281; PULLEN AM, 1990, CELL, V61, P1365, DOI 10.1016/0092-8674(90)90700-O; PULLEN AM, 1991, J EXP MED, V173, P1183, DOI 10.1084/jem.173.5.1183; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Schlueter CJ, 1996, J MOL BIOL, V256, P859, DOI 10.1006/jmbi.1996.0132; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SCHODIN BA, 1993, J BIOL CHEM, V268, P25722; Schodin BA, 1996, MOL IMMUNOL, V33, P819, DOI 10.1016/0161-5890(96)00038-7; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; SPEIR JA, 1998, IN PRESS IMMUNITY, V8; STAERZ UD, 1985, J IMMUNOL, V134, P3994; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TJOA BA, 1994, MOL IMMUNOL, V31, P705, DOI 10.1016/0161-5890(94)90144-9; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	50	151	163	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	1998	8	4					413	425		10.1016/S1074-7613(00)80547-6	http://dx.doi.org/10.1016/S1074-7613(00)80547-6			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586632	Bronze			2022-12-18	WOS:000073348000004
J	Gorman, JR; vanderStoep, N; Monroe, R; Cogne, M; Davidson, L; Alt, FW				Gorman, JR; vanderStoep, N; Monroe, R; Cogne, M; Davidson, L; Alt, FW			The Ig kappa 3' enhancer influences the ratio of Ig kappa versus Ig lambda B lymphocytes	IMMUNITY			English	Article							BETA-GLOBIN LOCUS; IMMUNOGLOBULIN GENE-EXPRESSION; CHAIN INTRON ENHANCER; LIGHT-CHAIN; TRANSGENIC MICE; CONTROL REGION; ALLELIC EXCLUSION; TARGETED DELETION; CELL DEVELOPMENT; CONSTANT REGION	We generated mice harboring germline mutations in which the enhancer element located 9 kb 3' of the immunoglobulin kappa light chain gene (3'E(kappa)) was replaced either by a single loxP site (3'E(kappa)Delta) or by a neomycin resistance gene (3'E(kappa)N). Mice homozygous for the 3'E(kappa)Delta mutation had substantially reduced numbers of kappa-expressing B cells and increased numbers of lambda-expressing B cells accompanied by decreased kappa versus lambda gene rearrangement. In these mutant mice, kappa expression was reduced in resting B cells, but was normal in activated B cells. The homozygous 3'E(kappa)N mutation resulted in a similar but more pronounced phenotype. Both mutations acted in cis. These studies show that the 3'E(kappa) is critical for establishing the normal kappa/lambda ratio, but is not absolutely essential for kappa gene rearrangement or, surprisingly, for normal kappa expression in activated B cells. These studies also imply the existence of additional regulatory elements that have overlapping function with the 3'E(kappa) element.	HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; CTR BLOOD RES, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Gorman, JR (corresponding author), CHILDRENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA.		cogné, michel/D-7370-2015	cogné, michel/0000-0002-8519-4427	PHS HHS [A.I.20047] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ALT FW, 1980, CELL, V21, P1, DOI 10.1016/0092-8674(80)90109-9; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; BLASQUEZ VC, 1992, J BIOL CHEM, V267, P23888; BLASQUEZ VC, 1989, J BIOL CHEM, V264, P21183; BORIES JC, 1996, IN PRESS P NATL ACAD; BOUVIER G, 1996, IN PRESS P NATL ACAD; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; CALAME K, 1995, IMMUNOGLOBULIN GENES, P397; CALAME KL, 1985, ANNU REV IMMUNOL, V3, P159, DOI 10.1146/annurev.iy.03.040185.001111; CARMACK CE, 1991, J IMMUNOL, V147, P2024; CHEN JZ, 1994, CURR OPIN IMMUNOL, V6, P313, DOI 10.1016/0952-7915(94)90107-4; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; EMORINE L, 1983, NATURE, V304, P447, DOI 10.1038/304447a0; Ferradini L, 1996, SCIENCE, V271, P1416, DOI 10.1126/science.271.5254.1416; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; FULTON R, 1993, NUCLEIC ACIDS RES, V21, P4941, DOI 10.1093/nar/21.21.4941; FULTON R, 1994, NUCLEIC ACIDS RES, V22, P4216, DOI 10.1093/nar/22.20.4216; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KORSMEYER SJ, 1982, J EXP MED, V156, P975, DOI 10.1084/jem.156.4.975; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LANGMAN RE, 1995, IMMUNOL TODAY, V16, P141, DOI 10.1016/0167-5699(95)80131-6; LANSFORD R, 1996, MOL IMMUNOL, P1; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MEYER KB, 1990, NUCLEIC ACIDS RES, V18, P5609, DOI 10.1093/nar/18.19.5609; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MOORE MW, 1985, P NATL ACAD SCI USA, V82, P6211, DOI 10.1073/pnas.82.18.6211; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MULLER B, 1990, EUR J IMMUNOL, V20, P1409, DOI 10.1002/eji.1830200631; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; OKADA A, 1995, IMMUNOGLOBULIN GENES, P205; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PARSLOW TG, 1982, NATURE, V299, P449, DOI 10.1038/299449a0; PICARD D, 1984, NATURE, V307, P80, DOI 10.1038/307080a0; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; RITCHIE KA, 1984, NATURE, V312, P517, DOI 10.1038/312517a0; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SELSING E, 1995, IMMUNOGLOBULIN GENES, P193; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; STORB U, 1984, NATURE, V310, P238, DOI 10.1038/310238a0; Storb U, 1992, Curr Top Microbiol Immunol, V182, P137; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	64	151	167	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1996	5	3					241	252		10.1016/S1074-7613(00)80319-2	http://dx.doi.org/10.1016/S1074-7613(00)80319-2			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VJ797	8808679	Bronze			2022-12-18	WOS:A1996VJ79700006
J	Smith, KJ; Reid, SW; Stuart, DI; McMichael, AJ; Jones, EY; Bell, JI				Smith, KJ; Reid, SW; Stuart, DI; McMichael, AJ; Jones, EY; Bell, JI			An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501	IMMUNITY			English	Article							HISTOCOMPATIBILITY ANTIGEN; PEPTIDE ANTIGENS; VIRAL PEPTIDES; MOLECULES; SUGGESTS; HLA-B35; RESOLUTION; HLA-A2; RECOGNITION; COMPLEXES	The crystal structure of the human major histocompatibility complex class I B allele HLA B*3501 complexed with the 8-mer peptide epitope HIV1 Nef 75-82 (VPLRPMTY) has been determined at 2.0 Angstrom resolution. Comparison with the crystal structure of the closely related allele HLA B*5301 reveals the structural basis for the tyrosine specificity of the B*3501 F pocket. The structure also reveals a novel conformation of the 8-mer peptide within the binding groove. The positions of the peptide N and C termini are nonstandard, but the classic pattern of hydrogen bonding to nonpolymorphic MHC class I residues is maintained, at the N terminus by addition of a water molecule, and at the C terminus by a substantial shift in the alpha 2 helix.	JOHN RADCLIFFE HOSP, INST MOLEC MED, NUFFIELD DEPT CLIN MED, MOLEC IMMUNOL GRP, OXFORD OX3 9DU, ENGLAND; UNIV OXFORD, MOLEC BIOPHYS LAB, OXFORD OX1 3QU, ENGLAND; UNIV OXFORD, OXFORD CTR MOLEC SCI, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND	University of Oxford; University of Oxford; University of Oxford			Jones, Yvonne/N-8111-2019; Smith, Katie Elizabeth/GXH-2114-2022; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Stuart, David/0000-0002-3426-4210	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSOPP CEM, 1991, HUM IMMUNOL, V30, P105, DOI 10.1016/0198-8859(91)90078-N; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRUGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; CULMANNPENCIOLELLI B, 1994, J VIROL, V68, P7336, DOI 10.1128/JVI.68.11.7336-7343.1994; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FALK K, 1993, IMMUNOGENETICS, V38, P161, DOI 10.1007/BF00190906; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HAYASHI H, 1989, J IMMUNOL, V142, P306; HAYASHI H, 1990, IMMUNOGENETICS, V32, P195, DOI 10.1007/BF02114973; HILL A, 1993, IMMUNOGENETICS, V37, P95; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; OOBA T, 1989, IMMUNOGENETICS, V30, P76, DOI 10.1007/BF02421534; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; RAULET DH, 1995, CELL, V82, P697, DOI 10.1016/0092-8674(95)90466-2; REID SW, 1996, IN PRESS FEBS LETT; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; SMITH KJ, 1996, IMMUNITY, V4; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WAN AM, 1986, J IMMUNOL, V137, P3671; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	44	151	154	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1996	4	3					203	213		10.1016/S1074-7613(00)80429-X	http://dx.doi.org/10.1016/S1074-7613(00)80429-X			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624811	Bronze			2022-12-18	WOS:A1996UC01800002
J	Xia, PY; Wang, S; Ye, BQ; Du, Y; Li, C; Xiong, Z; Qu, Y; Fan, ZS				Xia, Pengyan; Wang, Shuo; Ye, Buqing; Du, Ying; Li, Chong; Xiong, Zhen; Qu, Yuan; Fan, Zusen			A Circular RNA Protects Dormant Hematopoietic Stem Cells from DNA Sensor cGAS-Mediated Exhaustion	IMMUNITY			English	Article							CYCLIC GMP-AMP; CYTOSOLIC DNA; AUTOIMMUNE-DISEASE; INNATE IMMUNITY; SELF-RENEWAL; IN-VIVO; SYNTHASE; 2ND-MESSENGER; ACTIVATION; PATHWAY	Disrupting the balance between self-renewal and differentiation of hematopoietic stem cells (HSCs) leads to bone marrow failure or hematologic malignancy. However, how HSCs sustain their quiescent state and avoid type I interferon (IFN)-mediated exhaustion remains elusive. Here we defined a circular RNA that we named cia-cGAS that was highly expressed in the nucleus of long-term (LT)-HSCs. Cia-cGAS deficiency in mice caused elevated expression of type I IFNs in bone marrow and led to decreased numbers of dormant LT-HSCs. Under homeostatic conditions, cia-cGAS bound DNA sensor cGAS in the nucleus to block its synthase activity, thereby protecting dormant LT-HSCs from cGAS-mediated exhaustion. Moreover, cia-cGAS harbored a stronger binding affinity to cGAS than self-DNA did and consequently suppressed cGAS-mediated production of type I IFNs in LT-HSCs. Our findings reveal a mechanism by which cia-cGAS inhibits nuclear cGAS by blocking its enzymatic activity and preventing cGAS from recognizing self-DNA to maintain host homeostasis.	[Xia, Pengyan; Wang, Shuo; Ye, Buqing; Du, Ying; Li, Chong; Xiong, Zhen; Qu, Yuan; Fan, Zusen] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab Infect & Immun CAS, Beijing 100101, Peoples R China; [Xiong, Zhen; Qu, Yuan; Fan, Zusen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, S; Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab Infect & Immun CAS, Beijing 100101, Peoples R China.; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangshuo@moon.ibp.ac.cn; fanz@moon.ibp.ac.cn			National Natural Science Foundation of China [91640203, 31530093, 31429001, 81722023, 31770939, 31570872, 81601361, 31671531, 31471386, 31771638]; Beijing Natural Science Foundation [718006]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDB19030203, XDA12020219]; Youth Innovation Promotion Association CAS [2015073]; China Postdoctoral Science Foundation [2015M571141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Strategic Priority Research Programs of the Chinese Academy of Sciences; Youth Innovation Promotion Association CAS; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank J. Hao, J. Wang, J. Jia, C. Jiang, X. Ding, and Y. Teng for technical support; L. Yang, J. Wu, and L. He for plasmid construction and bone marrow transplantation; S. Meng for mouse maintenance and propagation; and X. Zhu and C. Li for discussion and advice on the manuscript. We thank J. Li (Cnkingbio Company Ltd, Beijing, China) for technical support. We are very grateful to Drs. F. Shao and D. Portnoy for providing Ifnar1-deficient mice. Microarray experiments were performed by KangChen Bio-tech, Shanghai, China. This work was supported by the National Natural Science Foundation of China (91640203, 31530093, 31429001, 81722023, 31770939, 31570872, 81601361, 31671531, 31471386, 31771638), Beijing Natural Science Foundation (718006), the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203, XDA12020219), Youth Innovation Promotion Association CAS (2015073) to S.W., and the China Postdoctoral Science Foundation to P.X. (2015M571141).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Petkovic S, 2015, NUCLEIC ACIDS RES, V43, P2454, DOI 10.1093/nar/gkv045; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Vicens Q, 2014, CELL, V159, P13, DOI 10.1016/j.cell.2014.09.005; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia PY, 2016, PROTEIN CELL, V7, P777, DOI 10.1007/s13238-016-0320-3; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoh SM, 2015, CELL, V161, P1293, DOI 10.1016/j.cell.2015.04.050; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	53	150	162	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					688	+		10.1016/j.immuni.2018.03.016	http://dx.doi.org/10.1016/j.immuni.2018.03.016			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29625897	Bronze			2022-12-18	WOS:000430198900016
J	Godec, J; Tan, Y; Liberzon, A; Tamayo, P; Bhattacharya, S; Butte, AJ; Mesirov, JP; Haining, WN				Godec, Jernej; Tan, Yan; Liberzon, Arthur; Tamayo, Pablo; Bhattacharya, Sanchita; Butte, Atul J.; Mesirov, Jill P.; Haining, W. Nicholas			Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation	IMMUNITY			English	Article							CD8(+) T-CELLS; GENE-EXPRESSION; DATABASE; MODELS	Gene-expression profiling has become a mainstay in immunology, but subtle changes in gene networks related to biological processes are hard to discern when comparing various datasets. For instance, conservation of the transcriptional response to sepsis in mouse models and human disease remains controversial. To improve transcriptional analysis in immunology, we created ImmuneSigDB: a manually annotated compendium of similar to 5,000 gene-sets from diverse cell states, experimental manipulations, and genetic perturbations in immunology. Analysis using ImmuneSigDB identified signatures induced in activated myeloid cells and differentiating lymphocytes that were highly conserved between humans and mice. Sepsis triggered conserved patterns of gene expression in humans and mouse models. However, we also identified species-specific biological processes in the sepsis transcriptional response: although both species upregulated phagocytosis-related genes, a mitosis signature was specific to humans. ImmuneSigDB enables granular analysis of transcriptomic data to improve biological understanding of immune processes of the human and mouse immune systems.	[Godec, Jernej; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Godec, Jernej] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Tan, Yan; Liberzon, Arthur; Tamayo, Pablo; Mesirov, Jill P.; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tan, Yan; Mesirov, Jill P.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Bhattacharya, Sanchita; Butte, Atul J.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94158 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	nicholas_haining@dfci.harvard.edu	Mesirov, Jill/AGF-7626-2022; Tan, Yan/N-5672-2017		Infrastructure and Opportunity Grant from the Human Immunology Project Consortium [U19 AI090023]; NIAID Bioinformatics Support Contract [HHSN272201200028C, R01CA154480, R01CA121941, R01GM074024, U54CA112962]; Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE [R01CA121941, U54CA112962, U24CA194107, R01CA154480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	Infrastructure and Opportunity Grant from the Human Immunology Project Consortium; NIAID Bioinformatics Support Contract; Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Arlene H. Sharpe, William Kim, and Aravind Subramanian for useful discussions. This work was supported by an Infrastructure and Opportunity Grant from the Human Immunology Project Consortium (to A.J.B., J.P.M., and W.N.H.), by U19 AI090023 to W.N.H.; NIAID Bioinformatics Support Contract HHSN272201200028C to A.J.B.; R01CA154480, R01CA121941, R01GM074024, and U54CA112962 to P.T. and J.P.M.; and the Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology to J.G.	Abazeed ME, 2013, CANCER RES, V73, P6289, DOI 10.1158/0008-5472.CAN-13-1616; Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Gilad Y., 2015, F1000RESEARCH, V4; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2015, P NATL ACAD SCI USA, V112, pE346, DOI 10.1073/pnas.1416629111; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Warren HS, 2015, P NATL ACAD SCI USA, V112, pE345, DOI 10.1073/pnas.1414857111	40	150	152	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					194	206		10.1016/j.immuni.2015.12.006	http://dx.doi.org/10.1016/j.immuni.2015.12.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26795250	Bronze, Green Accepted			2022-12-18	WOS:000368347000023
J	Askenase, MH; Han, SJ; Byrd, AL; da Fonseca, DM; Bouladoux, N; Wilhelm, C; Konkel, JE; Hand, TW; Lacerda-Queiroz, N; Su, XZ; Trinchieri, G; Grainger, JR; Belkaid, Y				Askenase, Michael H.; Han, Seong-Ji; Byrd, Allyson L.; da Fonseca, Denise Morais; Bouladoux, Nicolas; Wilhelm, Christoph; Konkel, Joanne E.; Hand, Timothy W.; Lacerda-Queiroz, Norinne; Su, Xin-zhuan; Trinchieri, Giorgio; Grainger, John R.; Belkaid, Yasmine			Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection	IMMUNITY			English	Article							CD8-ALPHA(+) DENDRITIC CELLS; INFLAMMATORY MONOCYTES; TOXOPLASMA-GONDII; T-CELLS; MACROPHAGES; HOMEOSTASIS; GAMMA; DIFFERENTIATION; PROGENITOR; RESISTANCE	Tissue-infiltrating Ly6C(hi) monocytes play diverse roles in immunity, ranging from pathogen killing to immune regulation. How and where this diversity of function is imposed remains poorly understood. Here we show that during acute gastrointestinal infection, priming of monocytes for regulatory function preceded systemic inflammation and was initiated prior to bone marrow egress. Notably, natural killer (NK) cell-derived IFN-gamma promoted a regulatory program in monocyte progenitors during development. Early bone marrow NK cell activation was controlled by systemic interleukin-12 (IL-12) produced by Batf3-dependent dendritic cells (DCs) in the mucosal-associated lymphoid tissue (MALT). This work challenges the paradigm that monocyte function is dominantly imposed by local signals after tissue recruitment, and instead proposes a sequential model of differentiation in which monocytes are pre-emptively educated during development in the bone marrow to promote their tissue-specific function.	[Askenase, Michael H.; Han, Seong-Ji; Byrd, Allyson L.; da Fonseca, Denise Morais; Bouladoux, Nicolas; Wilhelm, Christoph; Hand, Timothy W.; Grainger, John R.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab,NIH, Bethesda, MD 20892 USA; [Askenase, Michael H.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Byrd, Allyson L.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Konkel, Joanne E.; Grainger, John R.] Univ Manchester, MCCIR, Manchester M13 9NT, Lancs, England; [Konkel, Joanne E.; Grainger, John R.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Trinchieri, Giorgio] NCI, Expt Immunol Lab, Head Canc & Inflammat Program, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Manchester; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grainger, JR (corresponding author), NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	john.grainger-2@manchester.ac.uk; ybelkaid@niaid.nih.gov	Fonseca, Denise/E-7419-2012; Trinchieri, Giorgio/F-9369-2015; Hand, Timothy W/AAH-1216-2021; Wilhelm, Christoph/ABE-7176-2020	Fonseca, Denise/0000-0001-8310-0186; Trinchieri, Giorgio/0000-0001-5892-7464; Hand, Timothy W/0000-0002-2684-9462; Wilhelm, Christoph/0000-0002-9839-0291; Belkaid, Yasmine/0000-0001-9962-3571; Grainger, John/0000-0002-4052-5923; Bouladoux, Nicolas/0000-0003-1593-671X; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research of NIAID; Wellcome Trust; Royal Society [104195/Z/14/Z]; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC011152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132, ZIAAI000892, ZIAAI001194] Funding Source: NIH RePORTER	Division of Intramural Research of NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of NIAID. J.R.G. is a Sir Henry Dale fellow, jointly funded by The Wellcome Trust and The Royal Society (grant number 104195/Z/14/Z). We thank the NIAID animal facility staff, Dr. K. Holmes, Dr. E. Stregevsky, N. Bubunenko, M. Solano-Dias, J. LeGrand, and K. Beacht, for technical assistance. We also thank Dr. A. J. Radtke, Dr. M. Guilliams, Dr. J. Hettinger, and Dr. M. Feuerer for technical advice and discussion. Dr. G. Hart and Dr. E.O. Long graciously provided the protocol for NK depletion as well as purified antibody to perform this study. Dr. I. E. Brodsky generously provided Y. pseudotuberculosis. Additionally, we thank Dr. S. Henri and Dr. S. Tamoutounour for thoughtful discussions and critical reading of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; D'Aveni M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010435; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Doolan DL, 1999, J IMMUNOL, V163, P884; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Washino T, 2012, INFECT IMMUN, V80, P1437, DOI 10.1128/IAI.05680-11; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	40	150	153	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1130	1142		10.1016/j.immuni.2015.05.011	http://dx.doi.org/10.1016/j.immuni.2015.05.011			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26070484	Green Accepted, Bronze			2022-12-18	WOS:000356362800017
J	Gulen, MF; Kang, ZZ; Bulek, K; Youzhong, W; Kim, TW; Chen, Y; Altuntas, CZ; Bak-Jensen, KS; McGeachy, MJ; Do, JS; Xiao, H; Delgoffe, GM; Min, BK; Powell, JD; Tuohy, VK; Cua, DJ; Li, XX				Gulen, Muhammet F.; Kang, Zizhen; Bulek, Katarzyna; Youzhong, Wan; Kim, Tae Whan; Chen, Yi; Altuntas, Cengiz Z.; Bak-Jensen, Kristian Sass; McGeachy, Mandy J.; Do, Jeong-Su; Xiao, Hui; Delgoffe, Greg M.; Min, Booki; Powell, Jonathan D.; Tuohy, Vincent K.; Cua, Daniel J.; Li, Xiaoxia			The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase Activation	IMMUNITY			English	Article							CD4 T-CELLS; NEGATIVE REGULATOR; IL-17 PRODUCTION; TGF-BETA; INFLAMMATION; DIFFERENTIATION; CYTOKINE; EFFECTOR; LINEAGE; IL-23	Interleukin-1 (IL-1)-mediated signaling in T cells is essential for T helper 17 (Th17) cell differentiation. We showed here that SIGIRR, a negative regulator of IL-1 receptor and Toll-like receptor signaling, was induced during Th17 cell lineage commitment and governed Th17 cell differentiation and expansion through its inhibitory effects on IL-1 signaling. The absence of SIGIRR in T cells resulted in increased Th17 cell polarization in vivo upon myelin oligodendrocyte glycoprotein (MOG(35-55)) peptide immunization. Recombinant IL-1 promoted a marked increase in the proliferation of SIGIRR-deficient T cells under an in vitro Th17 cell-polarization condition. Importantly, we detected increased IL-1-induced phosphorylation of JNK and mTOR kinase in SIGIRR-deficient Th17 cells compared to wild-type Th17 cells. IL-1-induced proliferation was abolished in mTOR-deficient Th17 cells, indicating the essential role of mTOR activation. Our results demonstrate an important mechanism by which SIGIRR controls Th17 cell expansion and effector function through the IL-1-induced mTOR signaling pathway.	[Chen, Yi; Bak-Jensen, Kristian Sass; McGeachy, Mandy J.; Cua, Daniel J.] Schering Plough Biopharma, Merck Res Labs, Palo Alto, CA 94304 USA; [Gulen, Muhammet F.; Kang, Zizhen; Bulek, Katarzyna; Youzhong, Wan; Kim, Tae Whan; Altuntas, Cengiz Z.; Do, Jeong-Su; Xiao, Hui; Min, Booki; Tuohy, Vincent K.; Li, Xiaoxia] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Gulen, Muhammet F.; Li, Xiaoxia] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Delgoffe, Greg M.; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 20205 USA	Merck & Company; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Johns Hopkins University; Johns Hopkins Medicine	Cua, DJ (corresponding author), Schering Plough Biopharma, Merck Res Labs, 901 Calif Ave, Palo Alto, CA 94304 USA.	daniel.cua@spcorp.com; lix@ccf.org	Do, Jeong su/G-9483-2014; Bulek, Katarzyna/L-7517-2015; Delgoffe, Greg M./HCH-2805-2022	Delgoffe, Greg M./0000-0002-2957-8135; Do, Jeong-su/0000-0002-2375-2585; Gulen, Muhammet/0000-0002-7139-6781; , Zizhen/0000-0001-5621-8912	NIH [RO1 AI060632]; National Multiple Sclerosis Society; NATIONAL CANCER INSTITUTE [R01CA140350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060632, R01AI077610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NIH (RO1 AI060632 to X.L.) and a grant from National Multiple Sclerosis Society (X.L.). The plasmid p5' CD2/coding-CD2 and p3' CD2 was provided by D. Kioussis of the National Institute for Medical Research, London, UK. Cre-GFP-RV was a generous gift from W. Paul at National Institutes of Health. We thank J. Thomas (UT Southwestern) for providing us with the IRAK1<SUP>-/-</SUP> mice and W.-c. Yeh (Amgen) for providing us with the IRAK4<SUP>-/-</SUP> mice.	Andoh A, 2005, J GASTROENTEROL, V40, P802, DOI 10.1007/s00535-005-1632-x; Bamba S, 2003, J GASTROENTEROL, V38, P548, DOI 10.1007/s00535-002-1101-8; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bozza S, 2008, J IMMUNOL, V180, P4022, DOI 10.4049/jimmunol.180.6.4022; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Chabaud M, 2000, CYTOKINE, V12, P1092, DOI 10.1006/cyto.2000.0681; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Gonzalez-Garcia I, 2009, J IMMUNOL, V182, P2665, DOI 10.4049/jimmunol.0802221; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Laan M, 1999, J IMMUNOL, V162, P2347; LANG G, 1988, EMBO J, V7, P1675, DOI 10.1002/j.1460-2075.1988.tb02995.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li XX, 1999, MOL CELL BIOL, V19, P4643; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Taylor PC, 2003, CURR OPIN PHARMACOL, V3, P323, DOI 10.1016/S1471-4892(03)00032-8; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yang GH, 2008, PRESENCE-TELEOP VIRT, V17, P29, DOI 10.1162/pres.17.1.29; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	57	150	152	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					54	66		10.1016/j.immuni.2009.12.003	http://dx.doi.org/10.1016/j.immuni.2009.12.003			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20060329	Green Accepted, Bronze			2022-12-18	WOS:000274119900011
J	Wojciechowski, W; Harris, DP; Sprague, F; Mousseau, B; Makris, M; Kusser, K; Honjo, T; Mohrs, K; Mohrs, M; Randall, T; Lund, FE				Wojciechowski, Wojciech; Harris, David P.; Sprague, Frank; Mousseau, Betty; Makris, Melissa; Kusser, Kim; Honjo, Tasuko; Mohrs, Katie; Mohrs, Markus; Randall, Troy; Lund, Frances E.			Cytokine-Producing Effector B Cells Regulate Type 2 Immunity to H. polygyrus	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; IFN-GAMMA PRODUCTION; MEMORY CD4 CELLS; T-CELLS; IN-VIVO; NEMATOSPIROIDES-DUBIUS; HELMINTH INFECTION; TNF-ALPHA; MICE	Immunity to the intestinal parasite Heligomosomoides polygyrus is dependent on the successful generation of T helper 2 (Th2) memory cells. We showed that B cells contribute to immunity against H. Polygyrus by producing antibody (Ab) and by promoting expansion and differentiation of primary and memory Th2 cells. We also demonstrated that cytokine-producing effector B cells were essential for effective immunity to H. polygyrus. Tumor necrosis factor alpha production by B cells was necessary for sustained Ab production, whereas interleukin 2 production by B cells was necessary for Th2 cell expansion and differentiation. These results show that B cells mediate protection from pathogens not only by presenting antigen and secreting antibody but also by producing cytokines that regulate the quality and magnitude of humoral and cellular immune responses.	[Wojciechowski, Wojciech; Harris, David P.; Sprague, Frank; Mousseau, Betty; Makris, Melissa; Kusser, Kim; Mohrs, Katie; Mohrs, Markus; Randall, Troy; Lund, Frances E.] Trudeau Inst, Saranac Lake, NY 12983 USA; [Honjo, Tasuko] Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Trudeau Institute; Kyoto University	Lund, FE (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14642 USA.	frances_lund@urmc.rochester.edu	Honjo, Tasuku/N-4470-2016	Wojciechowski, Wojciech/0000-0002-3272-9635	National Institutes of Health [AI-50844, AI-68056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050844, R01AI068056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like tothank John Kearney (University ofAlabama-Birmingham) for providing ltMTMD4 mice, Ronald Corley (Boston University) for providing ps mice, and Rachael Gerstein (University of Massachusetts) for providing Aicda-1- mice. This manuscript is dedicated to the memory of Frank Sprague, who played an instrumental role in the completion of this project. This work was funded by the National Institutes of Health (grants Al-50844 and AI-68056) and the Trudeau Institute.	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Baumgarth N, 2008, CURR TOP MICROBIOL, V319, P41; BEHNKE JM, 1981, PARASITE IMMUNOL, V3, P249, DOI 10.1111/j.1365-3024.1981.tb00404.x; Boes M, 1998, J IMMUNOL, V160, P4776; Cambridge G, 2004, ARTHRITIS RHEUM-US, V50, pS645; Cardillo F, 2007, IMMUNOLOGY, V122, P584, DOI 10.1111/j.1365-2567.2007.02677.x; Cazzola M, 2006, CURR OPIN ALLERGY CL, V6, P43, DOI 10.1097/01.all.0000199798.10047.74; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen XJ, 2008, ARCH IMMUNOL THER EX, V56, P77, DOI 10.1007/s00005-008-0014-5; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Ekkens MJ, 2003, J IMMUNOL, V170, P384, DOI 10.4049/jimmunol.170.1.384; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Gillan V, 2005, INT IMMUNOL, V17, P373, DOI 10.1093/intimm/dxh217; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; HEINZEL FP, 1993, J IMMUNOL, V150, P3924; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Kumazaki K, 2007, J IMMUNOL, V178, P2192, DOI 10.4049/jimmunol.178.4.2192; Lee BO, 2003, J IMMUNOL, V171, P5707, DOI 10.4049/jimmunol.171.11.5707; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Liu ZG, 2004, IMMUNOL REV, V201, P57, DOI 10.1111/j.0105-2896.2004.00186.x; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lund Frances E., 2005, V8, P25; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; Menard LC, 2007, J IMMUNOL, V179, P4857, DOI 10.4049/jimmunol.179.7.4857; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; PENTTILA IA, 1984, IMMUNOLOGY, V53, P147; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Ronet C, 2008, J IMMUNOL, V180, P4825, DOI 10.4049/jimmunol.180.7.4825; Stephens R, 2006, PARASITE IMMUNOL, V28, P25, DOI 10.1111/j.1365-3024.2006.00767.x; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513	53	150	157	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					421	433		10.1016/j.immuni.2009.01.006	http://dx.doi.org/10.1016/j.immuni.2009.01.006			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19249230	Bronze, Green Accepted			2022-12-18	WOS:000264405500014
J	Weant, AE; Michalek, RD; Khan, IU; Holbrook, BC; Willingham, MC; Grayson, JM				Weant, Ashley E.; Michalek, Ryan D.; Khan, Islam U.; Holbrook, Beth C.; Willingham, Mark C.; Grayson, Jason M.			Apoptosis regulators bim and fas function concurrently to control autoimmunity and CD8(+) T cell contraction	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; FAMILY MEMBER BIM; VIRAL-INFECTION; CYTOCHROME-C; BCL-2 FAMILY; BH3-ONLY PROTEINS; IMMUNE-RESPONSE; DEATH RECEPTOR; LPR MICE; PROTEASE	Throughout most of adult life, lymphocyte number remains constant because of a balance of proliferation and apoptosis. Mutation of Bim, a proapoptotic protein in the intrinsic death pathway, or Fas, a tumor necrosis factor receptor (TNFR) superfamily member of the extrinsic pathway, results in late-onset autoimmunity and increased antigen-specific CD8(+) T cell responses during viral infection. However, virus-specific immune responses eventually return to amounts comparable to those for nonmutant mice. Here, we show that loss of both Bim and Fas function resulted in a synergistic disruption of lymphoid homeostasis, rapid-onset autoimmunity, and organ-specific blocks on contraction of antiviral immune responses. When lymphocytic choriomeningitis virus (LCMV)-specific immune responses were quantitated, double-mutant mice had 100-fold more antigen-specific memory CD8(+) T cells in their lymph nodes than wild-type mice. Our results demonstrate that multiple death pathways function concurrently to prevent autoimmunity and downsize T cell responses.	[Weant, Ashley E.; Michalek, Ryan D.; Holbrook, Beth C.; Grayson, Jason M.] Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Khan, Islam U.] Wake Forest Univ, Sch Med, Rheumatol Sect, Winston Salem, NC 27157 USA; [Willingham, Mark C.] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Grayson, JM (corresponding author), Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	jgrayson@wfubmc.edu		Holbrook, Beth/0000-0001-6026-695X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039501] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI 07401] Funding Source: Medline; NIAMS NIH HHS [R01 AR 039501] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Craxton A, 2007, EUR J IMMUNOL, V37, P2715, DOI 10.1002/eji.200737327; DAVIGNON JL, 1985, J IMMUNOL, V135, P2423; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fas SC, 2006, CURR DIRECT AUTOIMMU, V9, P1; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; ITCH N, 1991, CELL, V66, P233; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nguyen LT, 2000, EUR J IMMUNOL, V30, P683, DOI 10.1002/1521-4141(200002)30:2<683::AID-IMMU683>3.3.CO;2-X; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Pinkoski MJ, 2006, CURR DIRECT AUTOIMMU, V9, P55; RAZVI ES, 1995, AM J PATHOL, V147, P79; REAP EA, 1995, J IMMUNOL, V155, P5455; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Tebo AE, 2005, J VIROL, V79, P12703, DOI 10.1128/JVI.79.20.12703-12713.2005; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; WATANABEFUKUNAG.R, 1992, NATURE, V356, P317; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	150	153	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					218	230		10.1016/j.immuni.2007.12.014	http://dx.doi.org/10.1016/j.immuni.2007.12.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275832	Bronze			2022-12-18	WOS:000253275000012
J	Wuerffe, R; Wang, L; Grigera, F; Manis, J; Selsing, E; Perlot, T; Alt, FW; Cogne, M; Pinaud, E; Kenter, AL				Wuerffe, Robert; Wang, Lili; Grigera, Fernando; Manis, John; Selsing, Erik; Perlot, Thomas; Alt, Frederick W.; Cogne, Michel; Pinaud, Eric; Kenter, Amy L.			S-S Synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase	IMMUNITY			English	Article							DOUBLE-STRAND BREAKS; REGION RECOMBINATION; IGH LOCUS; B-CELLS; AID; MU; SITES; HYPERMUTATION; MECHANISM; DOMAINS	Molecular mechanisms underlying synapsis of activation-induced deaminase (AID)-targeted S regions during class switch recombination (CSR) are poorly understood. By using chromosome conformation capture techniques, we found that in B cells, the E mu and 3'E alpha enhancers were in close spatial proximity, forming a unique chromosomal loop configuration. B cell activa tion led to recruitment of the germline transcript (GLT) promoters to the E mu:3'E alpha complex in a cytokine-dependent fashion. This structure facilitated S-S synapsis because S mu was proximal to Et and a downstream S region was corecruited with the targeted GLT promoter to E mu:3'E alpha. We propose that GILT promoter association with the E mu:3'E alpha complex creates an architectural scaffolding that promotes S-S synapsis during CSR and that these interactions are stabilized by AID. Thus, the S-S synaptosome is formed as a result of the self-organizing transcription system that regulates GILT expression and may serve to guard against spurious chromosomal translocations.	Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Harvard Med Sch, Childrens Hosp, Dept Pathol, Joint Program Transfusion Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Dept Pathol, Program Immunol, Boston, MA 02111 USA; Harvard Med Sch, Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst,Dept Genet, Boston, MA 02115 USA; Univ Vienna, A-1010 Vienna, Austria; Univ Limoges, Immunol Lab, F-87025 Limoges, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Tufts University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; University of Vienna; Universite de Limoges	Kenter, AL (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	star1@uic.edu	cogné, michel/D-7370-2015; PINAUD, Eric/O-8443-2016	cogné, michel/0000-0002-8519-4427; PINAUD, Eric/0000-0001-7405-9273	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052400, R01AI024465] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA092615] Funding Source: Medline; NIAID NIH HHS [AI052400, AI24465, R01 AI024465, R01 AI052400, R01 AI052400-05A2] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Catalan N, 2003, J IMMUNOL, V171, P2504, DOI 10.4049/jimmunol.171.5.2504; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kenter AL, 2005, CURR TOP MICROBIOL, V290, P171; Kenter AL, 2004, J EXP MED, V199, P617, DOI 10.1084/jem.20031935; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Ma LM, 2002, J IMMUNOL, V168, P2835, DOI 10.4049/jimmunol.168.6.2835; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wang LL, 2006, J EXP MED, V203, P215, DOI 10.1084/jem.20051774; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhou J, 2002, P NATL ACAD SCI USA, V99, P13693, DOI 10.1073/pnas.212392399	44	150	166	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					711	722		10.1016/j.immuni.2007.09.007	http://dx.doi.org/10.1016/j.immuni.2007.09.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	17980632	Green Accepted, Bronze			2022-12-18	WOS:000251269000006
J	van Niel, G; Wubbolts, R; ten Broeke, T; Buschow, SI; Ossendorp, FA; Melief, CJ; Raposo, G; van Balkom, BW; Stoorvogel, W				van Niel, Guillaume; Wubbolts, Richard; ten Broeke, Toine; Buschow, Sonja I.; Ossendorp, Ferry A.; Melief, Cornelis J.; Raposo, Graca; van Balkom, Bas W.; Stoorvogel, Willem			Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination	IMMUNITY			English	Article							ANTIGEN PRESENTATION PATHWAY; INVARIANT CHAIN DEGRADATION; CATHEPSIN-S CONTROLS; IN-VIVO; MULTIVESICULAR BODIES; STRUCTURAL-CHANGES; T-CELLS; MOLECULES; COMPLEX; PROTEIN	Dendritic cells (DCs) initiate adaptive immune responses by activating T cells via cognate interactions between MHC-peptide complexes and T cell receptors. In immature DCs, MHC class II is predominantly stored in late endocytic compartments, where it has a short half-life because of degradation. In contrast, mature DCs recruit MHC class II to the plasma membrane. We here demonstrate that in immature DCs, the beta-chain of MHC class II was oligoubiquitinated after proteolytic processing of the associated invariant chain in endosomes and that this modification was required for efficient endocytosis and sorting into luminal vesicles of multivesicular bodies. Ubiquitination of MHC class II was suppressed in lipopolysaccharide-activated DCs. Mutated MHC class II lacking its ubiquitination site was expressed at the plasma membrane, irrespective of DC maturation. Together, these data provide a molecular basis for the regulation of MHC class H-mediated antigen presentation by DCs.	Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; Univ Utrecht, Dept Cell Biol, Med Ctr, NL-3584 CX Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; CNRS, Inst Curie, UMR 144, F-75248 Paris, France	Utrecht University; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite	Stoorvogel, W (corresponding author), Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, POB 80-176, NL-3508 TD Utrecht, Netherlands.		van Niel, Guillaume/HCI-8445-2022; Buschow, Sonja/AAD-3567-2020; van Niel, Guillaume/A-6585-2011; Wubbolts, Richard/ABH-6667-2020; Buschow, Sonja I/F-3777-2010	van Niel, Guillaume/0000-0002-8651-9705; Wubbolts, Richard/0000-0001-8661-7594; Buschow, Sonja/0000-0002-7907-8315; Raposo, graca/0000-0001-9590-1298				Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x; Barois N, 1998, J CELL SCI, V111, P1791; Barois N, 1997, J BIOL CHEM, V272, P3641, DOI 10.1074/jbc.272.6.3641; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Beers C, 2005, J IMMUNOL, V174, P1205, DOI 10.4049/jimmunol.174.3.1205; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HARDING CV, 1990, EUR J IMMUNOL, V20, P323, DOI 10.1002/eji.1830200214; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Laufer TM, 1997, J IMMUNOL, V159, P5914; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Neumann J, 2001, J BIOL CHEM, V276, P13469, DOI 10.1074/jbc.M010629200; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; van Balkom BWM, 2005, J PROTEOME RES, V4, P958, DOI 10.1021/pr050036w; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	50	150	162	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2006	25	6					885	894		10.1016/j.immuni.2006.11.001	http://dx.doi.org/10.1016/j.immuni.2006.11.001			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174123	Bronze			2022-12-18	WOS:000243087500008
J	Wong, P; Pamer, EG				Wong, P; Pamer, EG			Feedback regulation of pathogen-specific T cell priming	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; LISTERIA-MONOCYTOGENES INFECTION; PEPTIDE-MHC COMPLEXES; MALARIA LIVER STAGES; IN-VIVO; DENDRITIC CELLS; BACTERIAL-INFECTION; CLONAL EXPANSION; VIRUS-INFECTION; CUTTING EDGE	MHC class I-restricted antigen presentation is an essential step in the priming of CD8 T lymphocytes during immune responses to infection. While microbial growth and clearance have been accurately measured in mammalian hosts, the duration of functional antigen presentation during infection remains undefined in vivo. Herein we characterize the activation of naive and memory T cells at different times during bacterial infection. Surprisingly, the host's ability to prime T cells is of much shorter duration than bacterial infection, inversely correlating with the development of pathogen-specific cytolytic T lymphocytes. Our studies demonstrate a feedback mechanism that limits the duration of effective in vivo antigen presentation, thereby modulating T cell responses by temporally restricting recruitment of naive T cells into the immune response.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Infect Dis Serv, Dept Med,Immunol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Infect Dis Serv, Dept Med,Immunol Program, New York, NY 10021 USA.	pamere@mskcc.org		Wong, Phillip/0000-0002-6360-849X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042135, R37AI039031, R01AI039031] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-42135, AI-39031] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bajenoff M, 2002, J IMMUNOL, V168, P1723, DOI 10.4049/jimmunol.168.4.1723; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1999, IMMUNOL LETT, V65, P93, DOI 10.1016/S0165-2478(98)00130-8; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Harty JT, 1996, INFECT IMMUN, V64, P3632, DOI 10.1128/IAI.64.9.3632-3640.1996; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KARNATH AT, 2002, BLOOD, V100, P1734; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Kostense S, 2001, EUR J IMMUNOL, V31, P677, DOI 10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lee WT, 2002, J IMMUNOL, V168, P1682, DOI 10.4049/jimmunol.168.4.1682; Lenz LL, 2000, J EXP MED, V192, P1135, DOI 10.1084/jem.192.8.1135; Loyer V, 1999, J IMMUNOL, V163, P6462; Ludewig B, 2001, EUR J IMMUNOL, V31, P1772, DOI 10.1002/1521-4141(200106)31:6<1772::AID-IMMU1772>3.3.CO;2-#; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NICKOL AD, 1977, INFECT IMMUN, V18, P636, DOI 10.1128/IAI.18.3.636-645.1977; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; PAMER EG, 1994, J IMMUNOL, V152, P686; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Ronchese F, 2001, J EXP MED, V194, pF23, DOI 10.1084/jem.194.5.F23; Sad S, 1996, J EXP MED, V184, P1543, DOI 10.1084/jem.184.4.1543; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; SLIJTS AJ, 1996, J IMMUNOL, V156, P683; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vijh S, 1997, J IMMUNOL, V158, P3366; Vogel TU, 2001, J VIROL, V75, P2458, DOI 10.1128/JVI.75.5.2458-2461.2001; Wallace ME, 2000, IMMUNITY, V12, P547, DOI 10.1016/S1074-7613(00)80206-X; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	52	150	166	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2003	18	4					499	511		10.1016/S1074-7613(03)00081-5	http://dx.doi.org/10.1016/S1074-7613(03)00081-5			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	669LZ	12705853	Bronze			2022-12-18	WOS:000182353900006
J	Wagner, H				Wagner, H			Toll meets bacterial CpG-DNA	IMMUNITY			English	Review							NF-KAPPA-B; ACTIVATION; REQUIRES; MOTIFS; CELLS		Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Technical University of Munich	Wagner, H (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Trogerstr 9, D-81675 Munich, Germany.							Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BAUER S, 2001, P NATL ACAD SCI US; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Chu WM, 2000, CELL, V103, P909, DOI 10.1016/S0092-8674(00)00194-X; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Inohara N, 2000, J BIOL CHEM, V275, P27823; Krieg AM, 2000, IMMUNOL TODAY, V21, P521, DOI 10.1016/S0167-5699(00)01719-9; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168	20	150	155	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					499	502		10.1016/S1074-7613(01)00144-3	http://dx.doi.org/10.1016/S1074-7613(01)00144-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371352	Bronze			2022-12-18	WOS:000168880900002
J	Hatzivassiliou, G; Miller, I; Takizawa, J; Palanisamy, N; Rao, PH; Iida, S; Tagawa, S; Taniwaki, M; Russo, J; Neri, A; Cattoretti, G; Clynes, R; Mendelsohn, C; Chaganti, RSK; Dalla-Favera, R				Hatzivassiliou, G; Miller, I; Takizawa, J; Palanisamy, N; Rao, PH; Iida, S; Tagawa, S; Taniwaki, M; Russo, J; Neri, A; Cattoretti, G; Clynes, R; Mendelsohn, C; Chaganti, RSK; Dalla-Favera, R			IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy	IMMUNITY			English	Article							NON-HODGKINS-LYMPHOMA; MULTIPLE-MYELOMA; T(1-14)(Q21-Q32) TRANSLOCATION; CLINICAL CORRELATIONS; INHIBITORY RECEPTORS; CYTOGENETIC ANALYSIS; BURKITTS-LYMPHOMA; MARGINAL ZONE; PECAM-1 CD31; FC RECEPTOR	Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin C alpha domain to produce a chimeric IRTA1/C alpha fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis.	Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Inst Canc Genet, Dept Med, New York, NY 10032 USA; Columbia Univ, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Canc Genet Lab, Cell Biol Program, New York, NY 10021 USA; Osaka City Univ, Sch Med, Suita, Osaka 565, Japan; Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto, Japan; Univ Milan, Osped Maggiore, IRCCS, Lab Ematol Sperimentale & Genet, Milan, Italy	Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Osaka Metropolitan University; Kyoto Prefectural University of Medicine; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	rd10@columbia.edu	Palanisamy, Nallasivam/ABC-8844-2020; Mendelsohn, Cathy/H-4280-2016; Neri, Antonino/I-9690-2014	Palanisamy, Nallasivam/0000-0002-0633-9772; Mendelsohn, Cathy/0000-0002-4026-4073; Neri, Antonino/0000-0001-9047-5912; Cattoretti, Giorgio/0000-0003-3799-3221	NATIONAL CANCER INSTITUTE [R01CA034775, U01CA037295, R37CA037295, R01CA037295, R01CA080814] Funding Source: NIH RePORTER; NCI NIH HHS [CA34775, CA37295, CA80814, CA66699] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; AvetLoiseau H, 1997, GENE CHROMOSOME CANC, V19, P124, DOI 10.1002/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Callanan MB, 2000, P NATL ACAD SCI USA, V97, P309, DOI 10.1073/pnas.97.1.309; Chesi M, 2000, ANN ONCOL, V11, P131, DOI 10.1023/A:1008300325610; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; DALLAFAVERA R, 2001, CANC PRINCIPLES PRAC, P2215; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; DeWolfPeeters C, 1997, LEUKEMIA LYMPHOMA, V26, P467, DOI 10.3109/10428199709050883; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; Dierlamm J, 1996, BLOOD, V87, P299; DRAKOPOLI CN, 1997, CURRENT PROTOCOLS HU; DUBIN G, 1991, J VIROL, V65, P7046, DOI 10.1128/JVI.65.12.7046-7050.1991; Dyomin VG, 2000, BLOOD, V95, P2666; ETON O, 1989, LEUKEMIA, V3, P729; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; Gilles F, 2000, BLOOD, V95, P2930, DOI 10.1182/blood.V95.9.2930.009k39_2930_2936; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; HAMILTON MS, 1990, BRIT J HAEMATOL, V75, P378, DOI 10.1111/j.1365-2141.1990.tb04352.x; JACKSON N, 1989, CLIN EXP IMMUNOL, V75, P93; JERNBERG H, 1987, INT J CANCER, V40, P811, DOI 10.1002/ijc.2910400618; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; KEMPKES B, 1995, EMBO J, V14, P88, DOI 10.1002/j.1460-2075.1995.tb06978.x; KORNBLAU SM, 1991, HEMATOL ONCOL, V9, P63; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; MAGRATH IT, 1980, JNCI-J NATL CANCER I, V64, P465; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; OFFIT K, 1991, BLOOD, V77, P1508; POLITO P, 1995, INT J CANCER, V61, P370, DOI 10.1002/ijc.2910610316; Pruneri G, 2000, AM J PATHOL, V156, P1505, DOI 10.1016/S0002-9440(10)65022-5; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Rao PH, 1998, BLOOD, V92, P234, DOI 10.1182/blood.V92.1.234.413k22_234_240; RAO PH, 1993, GENOMICS, V16, P426, DOI 10.1006/geno.1993.1206; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; Sawyer JR, 1998, BLOOD, V91, P1732, DOI 10.1182/blood.V91.5.1732.1732_1732_1741; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; SWERDLOW SH, 1995, HUM PATHOL, V26, P999, DOI 10.1016/0046-8177(95)90090-X; TAGAWA S, 1990, LEUKEMIA, V4, P600; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHANGPENG J, 1995, BLOOD, V85, P203, DOI 10.1182/blood.V85.1.203.bloodjournal851203; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881; YU LM, 1990, J IMMUNOL, V145, P3932; ZHANG XG, 1994, BLOOD, V83, P3654	54	150	177	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2001	14	3					277	289		10.1016/S1074-7613(01)00109-1	http://dx.doi.org/10.1016/S1074-7613(01)00109-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	419QE	11290337	Bronze			2022-12-18	WOS:000167959500007
J	Kiani, A; Viola, JPB; Lichtman, AH; Rao, A				Kiani, A; Viola, JPB; Lichtman, AH; Rao, A			Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1	IMMUNITY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; T-CELLS; NF-AT; INTERFERON-GAMMA; MESSENGER-RNA; INTERLEUKIN-4; EXPRESSION; RESPONSES; CYTOKINE; LYMPHOCYTES	Transcription factors of the NFAT family play a critical role in the immune response by activating the expression of cytokines and other inducible genes in antigen-stimulated cells. Here we show that a member of this family, NFAT1, is involved in down-regulating the late phase of IL-4 gene transcription, thus inhibiting T helper 2 responses. Whereas stimulated T cells from wild-type mice show a transient increase and then a rapid decline in the steady-state levels of IL-4 mRNA in vitro, the levels of IL-4 gene transcripts in NFAT1-deficient T cells are maintained at high levels under the same conditions. Consistent with this observation, NFAT1(-/-) mice are more susceptible to infection with Leishmania major. This report provides evidence that NFAT proteins regulate not only the initiation but also the termination of gene transcription.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Immunol Res Div, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Viola, Joao P.B./AAP-4125-2020	Viola, Joao P.B./0000-0002-0698-3146	NATIONAL CANCER INSTITUTE [R01CA042471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA42471] Funding Source: Medline; NIAID NIH HHS [P01 AI35297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Casolaro V, 1996, CURR OPIN IMMUNOL, V8, P796, DOI 10.1016/S0952-7915(96)80007-0; CASTIGLI E, 1993, P NATL ACAD SCI USA, V90, P4728, DOI 10.1073/pnas.90.10.4728; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DOKTER WHA, 1993, BLOOD, V81, P35; ENDO TA, 1997, NATURE, V387, P92; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; GOLLOB KJ, 1994, J IMMUNOL, V152, P5180; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAO A, 1991, CRIT REV IMMUNOL, V10, P495; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rincon Mercedes, 1997, Genes and Function, V1, P51; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SHAW J, 1988, J IMMUNOL, V140, P2243; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.iy.13.040195.001343; UMLAUF SW, 1995, MOL CELL BIOL, V15, P3197; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Vicari AP, 1996, IMMUNOL TODAY, V17, P71, DOI 10.1016/0167-5699(96)80582-2; Wong B, 1997, CURR OPIN IMMUNOL, V9, P358, DOI 10.1016/S0952-7915(97)80082-9; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	64	150	152	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1997	7	6					849	860		10.1016/S1074-7613(00)80403-3	http://dx.doi.org/10.1016/S1074-7613(00)80403-3			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YQ128	9430230	Bronze			2022-12-18	WOS:000071351300012
J	Smith, KJ; Reid, SW; Harlos, K; McMichael, AJ; Stuart, DI; Bell, JI; Jones, EY				Smith, KJ; Reid, SW; Harlos, K; McMichael, AJ; Stuart, DI; Bell, JI; Jones, EY			Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53	IMMUNITY			English	Article							CYTOTOXIC LYMPHOCYTES-T; HISTOCOMPATIBILITY ANTIGENS; CRYSTAL-STRUCTURE; ALPHA-3 DOMAIN; VIRAL PEPTIDES; SEVERE MALARIA; RECOGNITION; MOLECULE; HLA-A2; RESOLUTION	The structure of the human MHC class I molecule HLA-B53 complexed to two nonameric peptide epitopes (from the malaria parasite P. falciparum and the HIV2 gag protein) has been determined by X-ray crystallography at 2.3 Angstrom resolution. The structures reveal the architecture of a Pro-specific B pocket common to many HLA-B alleles. Relative to other alleles, the B53 peptide-binding groove is widened by a significant (up to 1.25 Angstrom) shift in the position of the al helix. Within this groove, bound water molecules, acting in concert with the side chains of polymorphic residues, provide the functional malleability of the MHC, which enables the high affinity/low specificity binding of multiple peptide epitopes.	JOHN RADCLIFFE HOSP, INST MOLEC MED, NUFFIELD DEPT CLIN MED, MOLEC IMMUNOL GRP, OXFORD OX3 9DU, ENGLAND; UNIV OXFORD, MOLEC BIOPHYS LAB, OXFORD OX1 3QU, ENGLAND; UNIV OXFORD, OXFORD CTR MOLEC SCI, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND	University of Oxford; University of Oxford; University of Oxford			Smith, Katie Elizabeth/GXH-2114-2022; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Stuart, David/0000-0002-3426-4210	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSOPP CEM, 1991, HUM IMMUNOL, V30, P105, DOI 10.1016/0198-8859(91)90078-N; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BRUGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; COLLINS EJ, 1994, NATURE, V371, P626, DOI 10.1038/371626a0; CONNOLLY JM, 1990, P NATL ACAD SCI USA, V87, P2137, DOI 10.1073/pnas.87.6.2137; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; ELLIOTT T, 1993, CURR BIOL, V3, P854, DOI 10.1016/0960-9822(93)90219-E; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GOTCH F, 1993, J IMMUNOL, V151, P3361; GUO HC, 1993, P NATL ACAD SCI USA, V90, P8053, DOI 10.1073/pnas.90.17.8053; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; REID SW, 1996, IN PRESS FEBS LETT; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUTTON J, 1993, EUR J IMMUNOL, V23, P447, DOI 10.1002/eji.1830230222; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; YAMAMOTO J, 1990, P NATL ACAD SCI USA, V87, P2583, DOI 10.1073/pnas.87.7.2583; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403	45	150	154	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1996	4	3					215	228		10.1016/S1074-7613(00)80430-6	http://dx.doi.org/10.1016/S1074-7613(00)80430-6			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UC018	8624812	Bronze			2022-12-18	WOS:A1996UC01800003
J	LI, TJ; TSUKADA, S; SATTERTHWAITE, A; HAVLIK, MH; PARK, H; TAKATSU, K; WITTE, ON				LI, TJ; TSUKADA, S; SATTERTHWAITE, A; HAVLIK, MH; PARK, H; TAKATSU, K; WITTE, ON			ACTIVATION OF BRUTONS TYROSINE KINASE (BTK) BY A POINT MUTATION IN ITS PLECKSTRIN HOMOLOGY (PH) DOMAIN	IMMUNITY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; SIGNALING PROTEINS; REGULATORY DOMAIN; MESSENGER-RNA; B-CELLS; C-ABL; GENE; EXPRESSION	Bruton's tyrosine kinase (BTK) is a nonreceptor tyrosine kinase critical for B cell development and function. Mutations in BTK result in X-linked agammaglobulinemia (XLA) in humans and X-linked immunodeficiency (rid) in mice. Using a random mutagenesis scheme, we isolated a gain-of-function mutant called BTK* whose expression drives growth of NIH 3T3 cells in soft agar. BTK* results from a single point mutation in the pleck-strin homology (PH) domain, where a Glu is replaced by Lys at residue 41. BTK* shows an increase in phosphorylation on tyrosine residues and an increase in membrane targeting. Transforming activity requires kinase activity, a putative autophosphorylation site, and a functional PH domain. Mutation of the SH2 or SH3 domains did not affect the activity of BTK*. Expression of BTK* could also relieve IL-5 dependence of a a lineage cell line. These results show that transformation activation and regulation of BTK are critically dependent on the PH domain.	UNIV CALIF LOS ANGELES, HOWARD HUGHES MED INST, LOS ANGELES, CA 90095 USA; UNIV CALIF LOS ANGELES, DEPT MICROBIOL & MOLEC GENET, LOS ANGELES, CA 90095 USA; UNIV TOKYO, DEPT IMMUNOL, MINATO KU, TOKYO 108, JAPAN	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Tokyo	LI, TJ (corresponding author), UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90095 USA.				NATIONAL CANCER INSTITUTE [P01CA012800] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09056, CA-12800] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; BOLEN JB, 1993, ONCOGENE, V8, P2025; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; CIFUENTES ME, 1994, J BIOL CHEM, V269, P1945; DEWEERS M, 1994, HUM MOL GENET, V3, P161, DOI 10.1093/hmg/3.1.161; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIBSON TJ, 1994, TIBS, V20, P349; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; GREGORY RJ, 1987, MOL CELL BIOL, V7, P2119, DOI 10.1128/MCB.7.6.2119; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASBOLD J, 1994, EUR J IMMUNOL, V24, P152, DOI 10.1002/eji.1830240123; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; HITOSHI Y, 1993, INT IMMUNOL, V5, P1183, DOI 10.1093/intimm/5.9.1183; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; KATO JY, 1986, MOL CELL BIOL, V6, P4155, DOI 10.1128/MCB.6.12.4155; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOIKE M, 1995, INT IMMUNOL, V7, P21, DOI 10.1093/intimm/7.1.21; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEVY JB, 1989, MOL CELL BIOL, V9, P3332, DOI 10.1128/MCB.9.8.3332; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MANO H, 1990, ONCOGENE, V5, P1781; MANO H, 1993, ONCOGENE, V8, P417; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OBRIEN MC, 1990, MOL CELL BIOL, V10, P2855, DOI 10.1128/MCB.10.6.2855; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RUVKUN G, 1991, DEVELOPMENT, P47; SAFFRAN DC, 1994, NEW ENGL J MED, V330, P1488, DOI 10.1056/NEJM199405263302104; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TAKAKI S, 1990, EMBO J, V9, P4367, DOI 10.1002/j.1460-2075.1990.tb07886.x; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TRAVERSE S, 1993, ONCOGENE, V8, P3175; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; YAMASHITA Y, 1995, IN PRESS IMMUNOLOGY; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; ZHU QL, 1994, J EXP MED, V180, P461, DOI 10.1084/jem.180.2.461	66	150	167	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	1995	2	5					451	460		10.1016/1074-7613(95)90026-8	http://dx.doi.org/10.1016/1074-7613(95)90026-8			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QZ430	7538439	Bronze			2022-12-18	WOS:A1995QZ43000003
J	JIANG, H; WARE, R; STALL, A; FLAHERTY, L; CHESS, T; PERNIS, B				JIANG, H; WARE, R; STALL, A; FLAHERTY, L; CHESS, T; PERNIS, B			MURINE CD8(+) T-CELLS THAT SPECIFICALLY DELETE AUTOLOGOUS CD4(+) T-CELLS EXPRESSING V-BETA-8 TCR - A ROLE OF THE Q-ALPHA-1 MOLECULE	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BETA-2-MICROGLOBULIN DEFICIENT MICE; ENTEROTOXIN-B; VACCINATION; IMMUNOGLOBULIN; RECOGNITION; APOPTOSIS; DISEASE; COMPLEX	Interactions mediated by TCRs expressed on different T cell subsets may play a role in immunoregulation. To investigate this idea, we studied the regulation of superantigen-induced TCR Vp-restricted responses. We asked whether the in vivo regulation of CD4(+) V beta 8(+) T cells following SEB injection is controlled by CD8(+) T cells. We found that in mice deficient in CD8(+) T cells, the down-regulation of CD4(+) V beta 8(+) T cells below baseline is not observed. Moreover, following SEB administration, CD8(+) T cells emerge that preferentially kill subpopulations of activated CD4(+) V beta 8(+) but not CD4(+) V beta 8(+) T cells in vitro. This TCR V beta-specific cytotoxicity is dependent on beta 2-microglobulin and is inhibited by antisera specific for Qa-l but not by antibody to MHC class la. These data suggest the idea that the specificity of immune regulation may involve CD8(+) T cell recognition of TCR V beta determinants and Qa-1 molecules expressed on CD4(+) T cells.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,D AXELROD INST PUBL HLTH,ALBANY,NY 12201	Columbia University; Columbia University; State University of New York (SUNY) System; Wadsworth Center					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024748, R01AI014969] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 14969, R37 AI 24748] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; BOYSE EA, 1972, TRANSPLANTATION, V13, P431, DOI 10.1097/00007890-197204000-00013; COHEN IR, 1988, IMMUNOL TODAY, V9, P332, DOI 10.1016/0167-5699(88)91330-8; EARDLEY DD, 1978, J EXP MED, V147, P1106, DOI 10.1084/jem.147.4.1106; GLASEBROOK AL, 1979, NATURE, V278, P171, DOI 10.1038/278171a0; GONZALO JA, 1994, J IMMUNOL, V152, P1597; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; JIANG H, 1982, SCIENCE, V256, P1213; JOYCE S, 1994, J EXP MED, V179, P579, DOI 10.1084/jem.179.2.579; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KIMURA H, 1984, NATURE, V308, P463, DOI 10.1038/308463a0; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; LOHSE AW, 1989, SCIENCE, V244, P820, DOI 10.1126/science.2471264; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MCCORMACK JE, 1994, P NATL ACAD SCI USA, V91, P2086, DOI 10.1073/pnas.91.6.2086; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MULLER D, 1992, SCIENCE, V255, P1576, DOI 10.1126/science.1347959; OFFNER H, 1991, SCIENCE, V251, P430, DOI 10.1126/science.1989076; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; STALLCUP KC, 1981, J IMMUNOL, V127, P923; STANTON TH, 1979, IMMUNOGENETICS, V3, P525; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STROYNOWSKI I, 1990, ANNU REV IMMUNOL, V8, P501, DOI 10.1146/annurev.iy.08.040190.002441; SUN D, 1988, NATURE, V332, P843, DOI 10.1038/332843a0; TAKAHASHI S, 1989, EUR J IMMUNOL, V19, P1911, DOI 10.1002/eji.1830191023; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WARE R, 1995, IMMUNITY, V2; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; ZHANG JW, 1993, SCIENCE, V261, P1451, DOI 10.1126/science.7690157; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	37	150	156	0	1	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					185	194		10.1016/S1074-7613(95)80079-4	http://dx.doi.org/10.1016/S1074-7613(95)80079-4			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895175	Bronze			2022-12-18	WOS:A1995QH13200007
J	Seydoux, E; Homad, LJ; MacCamy, AJ; Parks, KR; Hurlburt, NK; Jennewein, MF; Akins, NR; Stuart, AB; Wan, YH; Feng, JL; Whaley, RE; Singh, S; Boeckh, M; Cohen, KW; McElrath, MJ; Englund, JA; Chu, HY; Pancera, M; McGuire, AT; Stamatatos, L				Seydoux, Emilie; Homad, Leah J.; MacCamy, Anna J.; Parks, K. Rachael; Hurlburt, Nicholas K.; Jennewein, Madeleine F.; Akins, Nicholas R.; Stuart, Andrew B.; Wan, Yu-Hsin; Feng, Junli; Whaley, Rachael E.; Singh, Suruchi; Boeckh, Michael; Cohen, Kristen W.; McElrath, M. Juliana; Englund, Janet A.; Chu, Helen Y.; Pancera, Marie; McGuire, Andrew T.; Stamatatos, Leonidas			Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation	IMMUNITY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MONOCLONAL-ANTIBODIES; SARS CORONAVIRUS; STRUCTURAL BASIS; B-CELLS; RECEPTOR; SPIKE; PROTEIN	Antibody responses develop following SARS-CoV-2 infection, but little is known about their epitope specificities, clonality, binding affinities, epitopes, and neutralizing activity. We isolated B cells specific for the SARSCoV-2 envelope glycoprotein spike (S) from a COVID-19-infected subject 21 days after the onset of clinical disease. 45 S-specific monoclonal antibodies were generated. They had undergone minimal somatic mutation with limited clonal expansion, and three bound the receptor-binding domain (RBD). Two antibodies neutralized SARS-CoV-2. The most potent antibody bound the RBD and prevented binding to the ACE2 receptor, while the other bound outside the RBD. Thus, most anti-S antibodies that were generated in this patient during the first weeks of COVID-19 infection were non-neutralizing and target epitopes outside the RBD. Antibodies that disrupt the SARS-CoV-2 S-ACE2 interaction can potently neutralize the virus without undergoing extensive maturation. Such antibodies have potential preventive and/or therapeutic potential and can serve as templates for vaccine design.	[Seydoux, Emilie; Homad, Leah J.; MacCamy, Anna J.; Parks, K. Rachael; Hurlburt, Nicholas K.; Jennewein, Madeleine F.; Akins, Nicholas R.; Stuart, Andrew B.; Wan, Yu-Hsin; Feng, Junli; Whaley, Rachael E.; Singh, Suruchi; Boeckh, Michael; Cohen, Kristen W.; McElrath, M. Juliana; Pancera, Marie; McGuire, Andrew T.; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Parks, K. Rachael; McElrath, M. Juliana; McGuire, Andrew T.; Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Boeckh, Michael; McElrath, M. Juliana; Chu, Helen Y.] Univ Washington, Dept Med, Seattle, WA USA; [Englund, Janet A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Englund, Janet A.] Seattle Childrens Res, Seattle, WA USA; [Pancera, Marie] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pancera, M; McGuire, AT; Stamatatos, L (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccines & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; McGuire, AT; Stamatatos, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Pancera, M (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mpancera@fredhutch.org; amcguire@fredhutch.org; lstamata@fredhutch.org	Boeckh, Michael/AAA-1607-2022; Singh, Suruchi/AFZ-0966-2022	Singh, Suruchi/0000-0002-4306-9345; Seydoux, Emilie/0000-0003-1021-4056; Hurlburt, Nicholas/0000-0001-9891-916X; MacCamy, Anna/0000-0001-5552-9209	Vaccine and Infectious Disease Division [CR3022 mAb]	Vaccine and Infectious Disease Division	We thank Dr. McLellan for providing the SARS-CoV and SARS-CoV-2 S2P and RBD plasmids and Dr. Neil King for providing the rhesus ACE2-Fc fusion protein and the CR3022 mAb. We thank Todd Haight and Melinda Akoto for specimen processing. The repository of samples collected from patients infected with endemic corona viruses is supported by the Vaccine and Infectious Disease Division. We thank Sarah Ameny for assistance with B cell sorting. This work was supported by generous donations to Fred Hutch COVID-19 Research Fund.	Bernat NV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00660; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cao ZL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-299; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI 10.1007/978-3-540-35306-5_10; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311; Okba NMA, 2020, EMERG INFECT DIS, V26, P1024, DOI 10.3201/eid2605.190921; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; PageS H., 2018, BIOSTRINGS EFFICIENT; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; R Development Core Team, 2017, R LANG ENV STAT COMP; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Snijder J, 2018, IMMUNITY, V48, P799, DOI 10.1016/j.immuni.2018.03.026; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Tang XC, 2014, P NATL ACAD SCI USA, V111, pE2018, DOI 10.1073/pnas.1402074111; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; WHO, 2020, WHO ANNOUNCES COVID; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Ying TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9223; Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092	44	149	149	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					98	+		10.1016/j.immuni.2020.06.001	http://dx.doi.org/10.1016/j.immuni.2020.06.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32561270	Green Published, Bronze			2022-12-18	WOS:000551116800012
J	Luo, W; Weisel, F; Shlomchik, MJ				Luo, Wei; Weisel, Florian; Shlomchik, Mark J.			B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells	IMMUNITY			English	Article							NF-KAPPA-B; CENTER SELECTION; IMMUNE-RESPONSES; CENTER LIGHT; ENGAGEMENT; REGULATOR; SURVIVAL; REVEALS; IMMUNOGLOBULIN; MAINTENANCE	Positive selection of germinal center (GC) B cells is driven by B cell receptor (BCR) affinity and requires help from follicular T helper cells. The transcription factors c-Myc and Foxo1 are critical for GC B cell selection and survival. However, how different affinity-related signaling events control these transcription factors in a manner that links to selection is unknown. Here we showed that GC B cells reprogram CD40 and BCR signaling to transduce via NF-kappa B and Foxo1, respectively, whereas naive B cells propagate both signals downstream of either receptor. Although either BCR or CD40 ligation induced c-Myc in naive B cells, both signals were required to highly induce c-Myc, a critical mediator of GC B cell survival and cell cycle reentry. Thus, GC B cells rewire their signaling to enhance selection stringency via a requirement for both antigen receptor- and T cell-mediated signals to induce mediators of positive selection.	[Luo, Wei; Weisel, Florian; Shlomchik, Mark J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020; Luo, Wei/ABD-3082-2021	Shlomchik, Mark J./0000-0002-2152-0959; Luo, Wei/0000-0003-2826-1723	NIH [R01 AI105018, R01 AI043603, 1S10OD011925-01, 1S10OD019942-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105018, R01AI043603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD019942, S10OD011925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Ari Melnick and Lee Ann Sinha for critical reading of the manuscript. We thank Dr. Ari Waisman for making available to us the IgMi mice. We thank Bill Hawse for many useful discussions. We thank Laura Conter and Nikita Trivedi for supporting experimental procedures. Supported by NIH grants R01 AI105018, R01 AI043603, 1S10OD011925-01, and 1S10OD019942-01.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Dang CV, 1999, MOL CELL BIOL, V19, P1; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; DeFranco AL, 2016, IMMUNOL CELL BIOL, V94, P918, DOI 10.1038/icb.2016.78; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hamel KM, 2012, AUTOIMMUNITY, V45, P333, DOI 10.3109/08916934.2012.665524; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Hobeika E, 2015, EMBO J, V34, P925, DOI 10.15252/embj.201489732; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Koopman G, 1997, EUR J IMMUNOL, V27, P1, DOI 10.1002/eji.1830270102; LAROSA FA, 1994, MOL CELL BIOL, V14, P1039, DOI 10.1128/MCB.14.2.1039; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Mizuno T, 2005, J IMMUNOL, V174, P6062, DOI 10.4049/jimmunol.174.10.6062; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Shlomchik MJ, 2012, IMMUNOL REV, V247, P5, DOI 10.1111/j.1600-065X.2012.01125.x; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	54	149	150	6	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					313	+		10.1016/j.immuni.2018.01.008	http://dx.doi.org/10.1016/j.immuni.2018.01.008			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29396161	Green Accepted, Bronze			2022-12-18	WOS:000425507800016
J	Mildner, A; Schonheit, J; Giladi, A; David, E; Lara-Astiaso, D; Lorenzo-Vivas, E; Paul, F; Chappell-Maor, L; Priller, J; Leutz, A; Amit, I; Jung, S				Mildner, Alexander; Schoenheit, Joerg; Giladi, Amir; David, Eyal; Lara-Astiaso, David; Lorenzo-Vivas, Erika; Paul, Franziska; Chappell-Maor, Louise; Priller, Josef; Leutz, Achim; Amit, Ido; Jung, Steffen			Genomic Characterization of Murine Monocytes Reveals C/EBP beta Transcription Factor Dependence of Ly6C(-) Cells	IMMUNITY			English	Article							BLOOD MONOCYTES; DENDRITIC CELLS; BONE-MARROW; LY6C(LOW) MONOCYTES; PERIPHERAL-BLOOD; DIFFERENTIATION; MACROPHAGES; CHROMATIN; HETEROGENEITY; HOMEOSTASIS	Monocytes are circulating, short-lived mononuclear phagocytes, which in mice and man comprise two main subpopulations. Murine Ly6C(+) monocytes display developmental plasticity and are recruited to complement tissue-resident macrophages and dendritic cells on demand. Murine vascular Ly6C(-) monocytes patrol the endothelium, act as scavengers, and support vessel wall repair. Here we characterized population and single cell transcriptomes, as well as enhancer and promoter landscapes of the murine monocyte compartment. Single cell RNA-seq and transplantation experiments confirmed homeostatic default differentiation of Ly6C(+) into Ly6C(-) monocytes. The main two subsets were homogeneous, but linked by a more heterogeneous differentiation intermediate. We show that monocyte differentiation occurred through de novo enhancer establishment and activation of pre-established (poised) enhancers. Generation of Ly6C(-) monocytes involved induction of the transcription factor C/EBP beta and C/EBP beta-deficient mice lacked Ly6C(-) monocytes. Mechanistically, C/EBP beta bound the Nr4a1 promoter and controlled expression of this established monocyte survival factor.	[Mildner, Alexander; Giladi, Amir; David, Eyal; Lara-Astiaso, David; Lorenzo-Vivas, Erika; Paul, Franziska; Chappell-Maor, Louise; Amit, Ido; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Mildner, Alexander; Schoenheit, Joerg; Leutz, Achim] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Priller, Josef] Charite, Dept Neuropsychiat, D-10117 Berlin, Germany; [Priller, Josef] Charite, Lab Mol Psychiat, D-10117 Berlin, Germany	Weizmann Institute of Science; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mildner, A; Amit, I; Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.; Mildner, A (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	alexander.mildner@mdc-berlin.de; ido.amit@weizmann.ac.il; s.jung@weizmann.ac.il	mildner, alexander/GQA-3761-2022; Mildner, Alexander/ABG-6122-2020; Leutz, Achim/K-9643-2013; mildner, alexander/AAF-9451-2022; Priller, Josef/ABW-3835-2022; Jung, Steffen/K-1409-2012; mildner, alexander/AFK-2161-2022	mildner, alexander/0000-0002-2019-8427; Leutz, Achim/0000-0001-8259-927X; mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Priller, Josef/0000-0001-7596-0979; Paul, Franziska/0000-0003-0344-6764; Lorenzo Vivas, Erika/0000-0002-8150-5902	Israeli Science Foundation [887/11]; European Research Council (AdvERC grant) [340345]; BSF; Deutsche Forschungsgemeinschaft [CRC/TRR167 "NeuroMac"]; DFG [MI1328]; Clore Scholarship; European Research Council [724471-HemTree2.0]; Israel Science Foundation; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; MRC [MC_PC_16031] Funding Source: UKRI	Israeli Science Foundation(Israel Science Foundation); European Research Council (AdvERC grant); BSF(US-Israel Binational Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Clore Scholarship; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all members of the Jung laboratory, as well as Simon Yona for helpful discussion. We further thank the staff of the Weizmann Animal facility and the members of the FACS facility for expert advice. Work in the Jung laboratory was supported by the Israeli Science Foundation (887/11), the European Research Council (AdvERC grant 340345), the BSF and the Deutsche Forschungsgemeinschaft (CRC/TRR167 "NeuroMac" (for S.J., I.A.). A.M is a Heisenberg fellow supported by the DFG (MI1328). A.G. is supported by a Clore Scholarship. I.A. is supported by the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; the Israel Science Foundation; the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; the Helen and Martin Kimmel award for innovative investigation; a Minerva Stiftung research grant and the Israeli Ministry of Science, Technology, and Space.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Begay V, 2015, J MOL MED, V93, P39, DOI 10.1007/s00109-014-1215-5; Bornstein C, 2014, MOL CELL, V56, P749, DOI 10.1016/j.molcel.2014.10.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; El-Asmar B, 2009, J MOL ENDOCRINOL, V42, P131, DOI 10.1677/JME-08-0016; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kim KW, 2016, J EXP MED, V213, P1951, DOI 10.1084/jem.20160486; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sugimoto C, 2015, J IMMUNOL, V195, P1774, DOI 10.4049/jimmunol.1500522; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tamura A, 2015, BIOCHEM BIOPH RES CO, V464, P654, DOI 10.1016/j.bbrc.2015.07.045; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827	49	149	151	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					849	+		10.1016/j.immuni.2017.04.018	http://dx.doi.org/10.1016/j.immuni.2017.04.018			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514690	Bronze, Green Accepted			2022-12-18	WOS:000401316300019
J	Dominguez-Sola, D; Kung, J; Holmes, AB; Wells, VA; Mo, TW; Basso, K; Dalla-Favera, R				Dominguez-Sola, David; Kung, Jennifer; Holmes, Antony B.; Wells, Victoria A.; Mo, Tongwei; Basso, Katia; Dalla-Favera, Riccardo			The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program	IMMUNITY			English	Article							PLASMA-CELL DIFFERENTIATION; CLASS-SWITCH RECOMBINATION; B-CELLS; AFFINITY MATURATION; BCL6; EXPRESSION; DYNAMICS; GENES; IDENTIFICATION; CONTRIBUTES	The pathways regulating formation of the germinal center (GC) dark zone (DZ) and light zone (LZ) are unknown. In this study we show that FOXO1 transcription factor expression was restricted to the GC DZ and was required for DZ formation, since its absence in mice led to the loss of DZ gene programs and the formation of LZ-only GCs. FOXO1-negative GC B cells displayed normal somatic hypermutation but defective affinity maturation and class switch recombination. The function of FOXO1 in sustaining the DZ program involved the trans-activation of the chemokine receptor CXCR4, and cooperation with the BCL6 transcription factor in the trans-repression of genes involved in immune activation, DNA repair, and plasma cell differentiation. These results also have implications for the role of FOXO1 in lymphomagenesis because they suggest that constitutive FOXO1 activity might be required for the oncogenic activity of deregulated BCL6 expression.	[Dominguez-Sola, David; Holmes, Antony B.; Wells, Victoria A.; Mo, Tongwei; Basso, Katia; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Basso, Katia; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Dominguez-Sola, D (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	david.dominguez-sola@mssm.edu; rd10@cumc.columbia.edu		Dominguez-Sola, David/0000-0001-9569-8402	National Cancer Institute/NIH; Louis Sklarow Memorial Fund; NIH/NCI [R00 CA151827]; NATIONAL CANCER INSTITUTE [R00CA151827] Funding Source: NIH RePORTER	National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louis Sklarow Memorial Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr. Sandrine Sander and Dr. Klaus Rajewsky for sharing unpublished data and for discussions. We thank Dr. Domenico Accili for providing access to the Foxo1<SUP>fl/fl</SUP> mouse strain; Kristie Gordon, Chenghong Liu, and Carl Constant at the Herbert Irving Comprehensive Cancer Center Flow Cytometry Shared Resource for technical expertise and guidance in cell sorting and flow cytometry analysis; and Vladan Miljkovic for help in processing the gene expression samples. We are also thankful for the expertise and insightful advice provided by Dr. Ulf Klein, Dr. Gabriel D. Victora, and Dr. Laura Pasqualucci while developing this project. We also thank Sofija Vlasevska for technical help and Dr. Celine Lefevbre and Dr. Mukesh Bansal for the initial analysis of B cell gene networks via MARINa and MINDy. Funding provided by the National Cancer Institute/NIH (to R.D.-F.), and the Louis Sklarow Memorial Fund (to D.D.-S.). D.D.-S. is a NIH/NCI K99/R00 Pathway to Independence awardee (R00 CA151827).	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Cattoretti G, 2013, J PATHOL, V229, P430, DOI 10.1002/path.4141; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Oprea M, 1997, J IMMUNOL, V158, P5155; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vogel MJ, 2014, BLOOD, V124, P3118, DOI 10.1182/blood-2014-07-590570; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681	57	149	150	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1064	1074		10.1016/j.immuni.2015.10.015	http://dx.doi.org/10.1016/j.immuni.2015.10.015			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26620759	Bronze			2022-12-18	WOS:000366846600011
J	Yao, SY; Buzo, BF; Pham, D; Jiang, L; Taparowsky, EJ; Kaplan, MH; Sun, J				Yao, Shuyu; Buzo, Bruno Fernando; Pham, Duy; Jiang, Li; Taparowsky, Elizabeth J.; Kaplan, Mark H.; Sun, Jie			Interferon Regulatory Factor 4 Sustains CD8(+) T Cell Expansion and Effector Differentiation	IMMUNITY			English	Article							NF-KAPPA-B; EXPRESSION; IRF4; TRANSCRIPTION; INFECTION; ACTIVATION; RESPONSES; ANTIGEN; VIRUS; MTOR	Upon infection, CD8(+) T cells undergo a stepwise process of early activation, expansion, and differentiation into effector cells. How these phases are transcriptionally regulated is incompletely defined. Here, we report that interferon regulatory factor 4 (IRF4), dispensable for early CD8(+) T cell activation, was vital for sustaining the expansion and effector differentiation of CD8(+) T cells. Mechanistically, IRF4 promoted the expression and function of Blimp1 and T-bet, two transcription factors required for CD8(+) T cell effector differentiation, and simultaneously repressed genes that mediate cell cycle arrest and apoptosis. Selective ablation of Irf4 in peripheral CD8(+) T cells impaired antiviral CD8(+) T cell responses, viral clearance, and CD8(+) T cell-mediated host recovery from influenza infection. IRF4 expression was regulated by T cell receptor (TCR) signaling strength via mammalian target of rapamycin (mTOR). Our data reveal that IRF4 translates differential strength of TCR signaling into different quantitative and qualitative CD8(+) T cell responses.	[Yao, Shuyu; Buzo, Bruno Fernando; Pham, Duy; Jiang, Li; Kaplan, Mark H.; Sun, Jie] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Yao, Shuyu; Buzo, Bruno Fernando; Pham, Duy; Jiang, Li; Kaplan, Mark H.; Sun, Jie] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Taparowsky, Elizabeth J.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sun, J (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.	sun32@iupui.edu			US National Institutes of Health [T32 HL007910, AI099753, AI045515, CA114381]; Showalter trust funds; NATIONAL CANCER INSTITUTE [R01CA114381] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099753, R56AI045515, R01AI057459, R01AI045515] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter trust funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Hufford for critical reading of the manuscript. We thank National Institutes of Health tetramer facility and D. Hildeman for reagents. This work was supported by the US National Institutes of Health grants (T32 HL007910 to D. P., AI099753 to J.S., AI045515 to M. H. K., and CA114381 to E.J.T.) and Showalter trust funds (to J.S.).	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Pham D, 2012, J IMMUNOL, V189, P832, DOI 10.4049/jimmunol.1200854; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Geng DG, 2010, BLOOD, V116, P3494, DOI 10.1182/blood-2010-02-268169; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Hou YC, 2012, AM J PHYSIOL-LUNG C, V302, pL174, DOI 10.1152/ajplung.00066.2011; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; HUPRIKAR J, 1980, J VIROL METHODS, V1, P117, DOI 10.1016/0166-0934(80)90020-8; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kurtulus S, 2011, J IMMUNOL, V186, P5729, DOI 10.4049/jimmunol.1100102; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Olson MR, 2010, IUBMB LIFE, V62, P519, DOI 10.1002/iub.351; Prlic M, 2011, J IMMUNOL, V187, P1542, DOI 10.4049/jimmunol.1100907; Rao RR, 2010, CELL CYCLE, V9, P2996, DOI 10.4161/cc.9.15.12359; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ream RM, 2010, J IMMUNOL, V184, P2401, DOI 10.4049/jimmunol.0902448; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Vigano S., 2012, CLIN DEV IMMUNOL, V2012, DOI DOI 10.1155/2012/153863; Visekruna A, 2013, EUR J IMMUNOL, V43, P606, DOI 10.1002/eji.201242825; Wang Q, 2001, J EXP MED, V194, P1721, DOI 10.1084/jem.194.12.1721; Xu WD, 2012, AUTOIMMUN REV, V11, P918, DOI 10.1016/j.autrev.2012.08.011; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	44	149	152	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					833	845		10.1016/j.immuni.2013.10.007	http://dx.doi.org/10.1016/j.immuni.2013.10.007			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24211184	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000330950600007
J	Gao, S; von der Malsburg, A; Dick, A; Faelber, K; Schroder, GF; Haller, O; Kochs, G; Daumke, O				Gao, Song; von der Malsburg, Alexander; Dick, Alexej; Faelber, Katja; Schroeder, Gunnar F.; Haller, Otto; Kochs, Georg; Daumke, Oliver			Structure of Myxovirus Resistance Protein A Reveals Intra- and Intermolecular Domain Interactions Required for the Antiviral Function	IMMUNITY			English	Article							HUMAN MXA GTPASE; INFLUENZA-VIRUS; CRYSTAL-STRUCTURE; CONFERS RESISTANCE; INHIBITION; MODEL; DIMERIZATION; EXPRESSION; LOCALIZES; COMPLEX	Human myxovirus resistance protein 1 (MxA) is an interferon-induced dynamin-like GTPase that acts as a cell-autonomous host restriction factor against many viral pathogens including influenza viruses. To study the molecular principles of its antiviral activity, we determined the crystal structure of nucleotide-free MxA, which showed an extended three-domain architecture. The central bundle signaling element (BSE) connected the amino-terminal GTPase domain with the stalk via two hinge regions. MxA oligomerized in the crystal via the stalk and the BSE, which in turn interacted with the stalk of the neighboring monomer. We demonstrated that the intra- and intermolecular domain interplay between the BSE and stalk was essential for oligomerization and the antiviral function of MxA. Based on these results, we propose a structural model for the mechano-chemical coupling in ring-like MxA oligomers as the principle mechanism for this unique antiviral effector protein.	[Gao, Song; Dick, Alexej; Faelber, Katja; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Gao, Song] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [von der Malsburg, Alexander; Haller, Otto; Kochs, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-79104 Freiburg, Germany; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Daumke, Oliver] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Freiburg; Helmholtz Association; Research Center Julich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gao, S (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	song.gao@mdc-berlin.de; oliver.daumke@mdc-berlin.de	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Dick, Alexej/0000-0003-0580-1897; Gao, Song/0000-0001-7427-6681	Deutsche Forschungsgemeinschaft [SFB 740/TP C7, SFB958/A12, Ko1579/8-1]; International Human Frontier Science Program Organization; EMBO	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO))	This project was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 740/TP C7 and SFB958/A12 to O.D. and Ko1579/8-1 to G.K.), by a Career Development Fellowship of The International Human Frontier Science Program Organization, and by the EMBO Young Investigator Program to O.D. We are grateful to A. Brunger for providing us with the prerelease of CNS version 1.3, the BESSY staff at beamline BL14.1 and SLS staff at beamline X06SA for help with data collection, and S. Werner, S. Paeschke, and S. Gruber for technical assistance.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; ARNHEITER H, 1988, EMBO J, V7, P1315, DOI 10.1002/j.1460-2075.1988.tb02946.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt OG, 2001, EXP CELL RES, V271, P286, DOI 10.1006/excr.2001.5380; FAELBER K, 2011, NATURE IN PRESS, DOI DOI 10.1038/NATURE10369; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Johannes L, 1997, J VIROL, V71, P9792, DOI 10.1128/JVI.71.12.9792-9795.1997; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Landis H, 1998, J VIROL, V72, P1516, DOI 10.1128/JVI.72.2.1516-1522.1998; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MELEN K, 1992, J BIOL CHEM, V267, P25898; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mundt E, 2007, J GEN VIROL, V88, P1319, DOI 10.1099/vir.0.82526-0; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SPEISER DE, 1990, P NATL ACAD SCI USA, V87, P2021, DOI 10.1073/pnas.87.5.2021; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Wisskirchen C, 2011, J BIOL CHEM, V286, P34743, DOI 10.1074/jbc.M111.251843; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x; ZURCHER T, 1992, J VIROL, V66, P5059	58	149	150	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					514	525		10.1016/j.immuni.2011.07.012	http://dx.doi.org/10.1016/j.immuni.2011.07.012			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	21962493	Bronze			2022-12-18	WOS:000296657700011
J	Nairz, M; Schroll, A; Moschen, AR; Sonnweber, T; Theurl, M; Theurl, I; Taub, N; Jamnig, C; Neurauter, D; Huber, LA; Tilg, H; Moser, PL; Weiss, G				Nairz, Manfred; Schroll, Andrea; Moschen, Alexander R.; Sonnweber, Thomas; Theurl, Milan; Theurl, Igor; Taub, Nicole; Jamnig, Christina; Neurauter, Daniela; Huber, Lukas A.; Tilg, Herbert; Moser, Patrizia L.; Weiss, Guenter			Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-kappa B-Inducible Immune Pathways	IMMUNITY			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; CARBAMYLATED ERYTHROPOIETIN; IRON; ANEMIA; PROTECTS; MODEL; JAK2; INFLAMMATION	Erythropoietin (EPO) is the principal cytokine regulating erythropoiesis through its receptor, EPOR. Interestingly, EPORs are also found on immune cells with incompletely understood functions. Here, we show that EPO inhibits the induction of proinflammatory genes including tumor necrosis factor (TNF)-alpha and inducible nitric oxide (NO) synthase in activated macrophages, which is mechanistically attributable to blockage of nuclear factor (NF)-kappa B p65 activation by EPO. Accordingly, in systemic Salmonella infection, treatment of mice with EPO results in reduced survival and impaired pathogen clearance because of diminished formation of antimicrobial effector molecules such as TNF-alpha and NO. However, neutralization of endogenous EPO or genetic ablation of Epor promotes Salmonella elimination. In contrast, in chemically induced colitis, EPO-EPOR interaction decreases the production of NF-kappa B-inducible immune mediators, thus limiting tissue damage and ameliorating disease severity. These immune-modulatory effects of EPO may be of therapeutic relevance in infectious and inflammatory diseases.	[Nairz, Manfred; Schroll, Andrea; Sonnweber, Thomas; Theurl, Milan; Theurl, Igor; Jamnig, Christina; Neurauter, Daniela; Weiss, Guenter] Innsbruck Med Univ, Dept Internal Med Clin Immunol & Infect Dis 1, A-6020 Innsbruck, Austria; [Moschen, Alexander R.; Tilg, Herbert] Innsbruck Med Univ, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria; [Theurl, Milan] Innsbruck Med Univ, Dept Ophthalmol, A-6020 Innsbruck, Austria; [Taub, Nicole; Huber, Lukas A.] Innsbruck Med Univ, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Moser, Patrizia L.] Innsbruck Med Univ, Dept Pathol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Weiss, G (corresponding author), Innsbruck Med Univ, Dept Internal Med Clin Immunol & Infect Dis 1, A-6020 Innsbruck, Austria.	guenter.weiss@i-med.ac.at	Huber, Lukas Alfons/AAM-3499-2021; Schroll, Andrea/AHE-20413-2022; Moschen, Alexander/ABF-2267-2021	Moschen, Alexander R/0000-0003-3598-7848; Schider, Nicole/0000-0002-3579-3667; Huber, Lukas Alfons/0000-0003-1116-2120; Weiss, Guenter/0000-0003-0709-2158; Nairz, Manfred/0000-0001-9103-7041	European Union; Austrian Research Fund, FWF [P-23551]; Medical University of Innsbruck; Amgen Inc., Thousand Oaks, California, U.S.A.	European Union(European Commission); Austrian Research Fund, FWF(Austrian Science Fund (FWF)); Medical University of Innsbruck; Amgen Inc., Thousand Oaks, California, U.S.A.(Amgen)	The authors are grateful to K. Auer, S. Berger, I. Brosch, S. Engl, B. Enrich, D. Hilber, M. Seifert, and U. Stanzl for excellent technical support. The authors are indebted to K.R. Morris and E.D. Chan (Department of Medicine, University of Texas-Houston Health Science Center, Houston, Texas, USA) as well as T. Bittorf (Institute of Medical Biochemistry, University of Rostock, Germany) for generously providing luciferase constructs. The authors would like to thank T. Sakai (Experimental Animal Division, RIKEN BioResource Center, Ibaraki, Japan), N. Suzuki and M. Yamamato (Center for TARA, University of Tsukuba, Tsukuba, Japan) for providing Epor<SUP>-/-</SUP> rescued mice. This work was supported by grants from the European Union (EUROIRON 1, G.W.) and the Austrian Research Fund, FWF (P-23551, G.W.) and a IFTZ grant by the Medical University of Innsbruck (L.A.H. and N.T.). G.W. received research support for a study on cellular iron transport from Amgen Inc., Thousand Oaks, California, U.S.A. which is unrelated to the topic of this manuscript.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aoshiba K, 2009, CRIT CARE MED, V37, P889, DOI 10.1097/CCM.0b013e31819b8371; Asquith MJ, 2010, GASTROENTEROLOGY, V139, P519, DOI 10.1053/j.gastro.2010.04.045; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Bunn HF, 2007, BLOOD, V109, P868, DOI 10.1182/blood-2006-08-019083; Carvalho G, 2005, ONCOGENE, V24, P737, DOI 10.1038/sj.onc.1208205; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Erbayraktar S, 2006, MOL MED, V12, P74, DOI 10.2119/2006-00042.Erbayraktar; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Imamura R, 2007, BIOCHEM BIOPH RES CO, V353, P786, DOI 10.1016/j.bbrc.2006.12.099; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kaltwasser JP, 2001, J RHEUMATOL, V28, P2430; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Ludwig H, 2009, J CLIN ONCOL, V27, P2838, DOI 10.1200/JCO.2008.19.1130; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Theurl I, 2006, BLOOD, V107, P4142, DOI 10.1182/blood-2005-08-3364; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; Weiss G, 1997, BLOOD, V89, P680, DOI 10.1182/blood.V89.2.680; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Zhang YXL, 2009, MOL CELL, V33, P266, DOI 10.1016/j.molcel.2008.11.026; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	46	149	157	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					61	74		10.1016/j.immuni.2011.01.002	http://dx.doi.org/10.1016/j.immuni.2011.01.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21256055	Green Published, hybrid			2022-12-18	WOS:000287336600010
J	O Atherly, L; Lucas, JA; Felices, M; Yin, CC; Reiner, SL; Berg, LJ				O Atherly, Luana; Lucas, Julie A.; Felices, Martin; Yin, Catherine C.; Reiner, Steven L.; Berg, Leslie J.			The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8(+) T cells	IMMUNITY			English	Article							NF-KAPPA-B; CUTTING EDGE; POSITIVE SELECTION; HEMATOPOIETIC-CELLS; LINEAGE COMMITMENT; DEFICIENT MICE; ACTIVATION; THYMOCYTES; EFFECTOR; DIFFERENTIATION	The Tec family tyrosine kinases, Itk and Rlk, are expressed in thymocytes and peripheral T cells and regulate thresholds of T cell receptor signaling. Yet little is known about the specific role of Itk- and Rlk-dependent signals in CD8(+) T cell maturation. We show here that Itk(-/-) and Rlk(-/-)Itk(-/-) mice were nearly devoid of conventional CDW T cells and, instead, contained a large population of CD8(+) T cells that bear striking similarity to lineages of innate lymphocytes. Itk(-/-) and Rlk(-/-)Itk(-/-) CD8(+) thymocytes and T cells were CD44(hi), CD122(+), and NK1.1(+); were able to produce interferon-gamma directly ex vivo; and were dependent on interieukin-15. Itk(-/-) and Rlk(-/-)Itk(-/-) CD8(+) thymocytes expressed abundant transcripts for the T box transcription factor, eomesodermin, correlating with their phenotype and function. These data indicate a critical role for Itk and Rlk in conventional CD8(+) T cell development in the thymus.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	leslie.berg@umassmed.edu			NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037584] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37584, AI0161699] Funding Source: Medline; NCPDCID CDC HHS [CI00101] Funding Source: Medline	NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS		AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Bendelac A, 2004, NAT IMMUNOL, V5, P557, DOI 10.1038/ni0604-557; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berg LJ, 2001, CURR OPIN IMMUNOL, V13, P232, DOI 10.1016/S0952-7915(00)00209-0; BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Chong MMW, 2003, IMMUNITY, V18, P475, DOI 10.1016/S1074-7613(03)00078-5; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Cookson S, 2003, BLOOD, V102, P2195, DOI 10.1182/blood-2003-01-0232; Das G, 2001, J IMMUNOL, V167, P2004, DOI 10.4049/jimmunol.167.4.2004; Eberl G, 1999, J IMMUNOL, V163, P4091; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Ilangumaran S, 2003, BLOOD, V102, P4115, DOI 10.1182/blood-2003-01-0175; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419; Kennedy P, 2000, LAT TRADE, V8, P15; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Langtangen H.P., 2003, T COM SCI E, V1; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; MICHIE SA, 1989, THYMUS, V13, P141; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Picca CC, 2005, CURR OPIN IMMUNOL, V17, P131, DOI 10.1016/j.coi.2005.01.003; Ranson T, 2003, P NATL ACAD SCI USA, V100, P2663, DOI 10.1073/pnas.0535482100; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schuler T, 2004, J IMMUNOL, V172, P15, DOI 10.4049/jimmunol.172.1.15; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Vasseur F, 2001, EUR J IMMUNOL, V31, P3038, DOI 10.1002/1521-4141(2001010)31:10<3038::AID-IMMU3038>3.0.CO;2-3; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	54	149	150	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					79	91		10.1016/j.immuni.2006.05.012	http://dx.doi.org/10.1016/j.immuni.2006.05.012			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860759	Bronze			2022-12-18	WOS:000239713000012
J	Manivel, V; Sahoo, NC; Salunke, DM; Rao, KVS				Manivel, V; Sahoo, NC; Salunke, DM; Rao, KVS			Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site	IMMUNITY			English	Article							EGG-WHITE LYSOZYME; B-CELL RESPONSES; CROSS-REACTIVE IDIOTYPE; PEPTIDE EPITOPE; SOMATIC HYPERMUTATION; AFFINITY MATURATION; MONOCLONAL-ANTIBODY; RECEPTOR; RECOGNITION; REPERTOIRE	Although affinity maturation constitutes an integral part of T-dependent humoral responses, its structural basis is less well understood. We compared the physicochemical properties of antigen binding of several independent antibody panels derived from both germline and secondary responses. We found that antibody maturation essentially reflects modulations in entropy-control of the association, but not dissociation, step of the binding. This influence stems from variations in conformational heterogeneity of the antigen-combining site, which in turn regulates both the affinity and specificity for antigen. Thus, the simple device of manipulating conformational flexibility of paratope provides a mechanism wherein the transition from a degenerate recognition capability to a high-fidelity effector response is readily achieved, with the minimum of somatic mutations.	Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.							Agarwal A, 1996, J IMMUNOL, V157, P2779; Agarwal A, 1997, J IMMUNOL, V159, P1077; AREVALO JH, 1994, J MOL BIOL, V241, P663, DOI 10.1006/jmbi.1994.1543; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Braden BC, 1996, J MOL BIOL, V257, P889, DOI 10.1006/jmbi.1996.0209; Brown M, 2000, J EXP MED, V191, P2101, DOI 10.1084/jem.191.12.2101; CAPRA JD, 1982, IMMUNOL TODAY, V3, P332, DOI 10.1016/0167-5699(82)90018-4; CASSON LP, 1995, J IMMUNOL, V155, P5647; Chong LT, 1999, P NATL ACAD SCI USA, V96, P14330, DOI 10.1073/pnas.96.25.14330; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hodgkin PD, 1998, IMMUNOLOGIST, V6, P223; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; Kelsoe G, 1995, ADV IMMUNOL, V60, P267, DOI 10.1016/S0065-2776(08)60587-8; LEE C, 1992, CURR BIOL, V2, P217; Liu YJ, 1997, IMMUNOL REV, V156, P111, DOI 10.1111/j.1600-065X.1997.tb00963.x; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Nakra P, 2000, J IMMUNOL, V164, P5615, DOI 10.4049/jimmunol.164.11.5615; Nayak BP, 1998, J IMMUNOL, V161, P3510; NEWMAN MA, 1992, J IMMUNOL, V149, P3260; PARHAMISEREN B, 1990, J IMMUNOL, V145, P2340; PewznerJung Y, 1996, J IMMUNOL, V156, P3065; Rao KVS, 1999, APMIS, V107, P807, DOI 10.1111/j.1699-0463.1999.tb01476.x; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; ROOST HP, 1995, P NATL ACAD SCI USA, V92, P1257, DOI 10.1073/pnas.92.5.1257; Shannon M, 1998, SCIENCE, V279, P1159, DOI 10.1126/science.279.5354.1159; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STROSBERG AD, 1991, CURR OPIN BIOTECH, V2, P30, DOI 10.1016/0958-1669(91)90058-D; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; Vora KA, 1997, J IMMUNOL, V159, P2116; VORA KA, 1995, J EXP MED, V181, P271, DOI 10.1084/jem.181.1.271; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; WONG YW, 1995, J IMMUNOL, V154, P3351; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; Yang PL, 1999, J MOL BIOL, V294, P1191, DOI 10.1006/jmbi.1999.3197; YSEM X, 1998, NAT STRUCT BIOL, V5, P412	44	149	154	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					611	620		10.1016/S1074-7613(00)00061-3	http://dx.doi.org/10.1016/S1074-7613(00)00061-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114374	Bronze			2022-12-18	WOS:000165598500004
J	Riviere, I; Sunshine, MJ; Littman, DR				Riviere, I; Sunshine, MJ; Littman, DR			Regulation of IL-4 expression by activation of individual alleles	IMMUNITY			English	Article							CD4(+) T-CELLS; CYTOKINE GENE-EXPRESSION; IN-VIVO; PHENOTYPE DEVELOPMENT; T-HELPER-2 POPULATIONS; IL-4-PRODUCING CELLS; LEISHMANIA-MAJOR; IFN-GAMMA; INTERLEUKIN-4; TRANSCRIPTION	To study the in vivo role of IL-4-expressing cells, we developed a strategy to tag these cells, by generating mice in which one IL-4 allele was replaced with a cDNA encoding the human CD2 (huCD2) cell-surface molecule. Expression of the huCD2 reporter was, like IL-4, restricted to the appropriately polarized T helper 2 cells. However, most of the cells expressed only the IL-4 or the targeted allele. Analysis of the frequency of monoallelic versus biallelic expression suggests that the activation of each individual allele is regulated by a stochastic process whose probability can be augmented by increasing the strength of signal delivered through the TCR. Allele-specific activation may be a general feature of cytokine regulation that contributes to the functional diversity within T helper cell subpopulations.	New York Univ, Med Ctr, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Howard Hughes Medical Institute; New York University	Riviere, I (corresponding author), New York Univ, Med Ctr, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA.	riviere@saturn.med.nyu.edu		Sunshine, Mary Jean/0000-0002-2188-7881				BOULAY JL, 1992, CURR OPIN IMMUNOL, V4, P294, DOI 10.1016/0952-7915(92)90079-T; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; BUCY RP, 1995, P NATL ACAD SCI USA, V92, P7565, DOI 10.1073/pnas.92.16.7565; CARDING SR, 1989, P NATL ACAD SCI USA, V86, P3342, DOI 10.1073/pnas.86.9.3342; Chensue SW, 1997, J IMMUNOL, V159, P3565; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HAHN WC, 1993, J EXP MED, V178, P1831, DOI 10.1084/jem.178.5.1831; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; HENKEL G, 1994, P NATL ACAD SCI USA, V91, P7737, DOI 10.1073/pnas.91.16.7737; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hogarth PJ, 1998, J IMMUNOL, V160, P5436; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Huang H, 1998, J EXP MED, V187, P1305, DOI 10.1084/jem.187.8.1305; Huang H, 1997, J IMMUNOL, V159, P3731; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KELSO A, 1995, EUR J IMMUNOL, V25, P1168, DOI 10.1002/eji.1830250506; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lederer JA, 1996, J EXP MED, V184, P397, DOI 10.1084/jem.184.2.397; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Lerner A, 1996, EMBO J, V15, P5876, DOI 10.1002/j.1460-2075.1996.tb00974.x; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Macaulay AE, 1997, J IMMUNOL, V158, P4171; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; MCKENZIE ANJ, 1993, J IMMUNOL, V150, P5436; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; Miner KT, 1998, J IMMUNOL, V160, P5280; Monteyne P, 1997, J IMMUNOL, V159, P2616; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PETERSON A, 1987, NATURE, V329, P842, DOI 10.1038/329842a0; PFEIFER K, 1994, GENE DEV, V8, P1867, DOI 10.1101/gad.8.16.1867; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; SAD S, 1994, J IMMUNOL, V153, P3514; Sambrook J, 1989, MOL CLONING LAB MANU, V1, P1; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zheng LX, 1998, J IMMUNOL, V160, P763; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	58	149	149	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	1998	9	2					217	228		10.1016/S1074-7613(00)80604-4	http://dx.doi.org/10.1016/S1074-7613(00)80604-4			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	114LE	9729042	hybrid			2022-12-18	WOS:000075610300008
J	Gentek, R; Ghigo, C; Hoeffel, G; Bulle, MJ; Msallam, R; Gautier, G; Launay, P; Chen, JM; Ginhoux, F; Bajenoff, M				Gentek, Rebecca; Ghigo, Clement; Hoeffel, Guillaume; Bulle, Maxime Jacques; Msallam, Rasha; Gautier, Gregory; Launay, Pierre; Chen, Jinmiao; Ginhoux, Florent; Bajenoff, Marc			Hemogenic Endothelial Fate Mapping Reveals Dual Developmental Origin of Mast Cells	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; IN-VIVO; YOLK-SAC; IRRADIATED MICE; DENDRITIC CELLS; STEM-CELLS; SKIN; PRECURSORS; EXPRESSION; SYSTEM	Hematopoiesis occurs in distinct waves. "Definitive'' hematopoietic stem cells (HSCs) with the potential for all blood lineages emerge in the aorta-gonado-mesonephros, while "primitive'' progenitors, whose potential is thought to be limited to erythrocytes, megakaryocytes, and macrophages, arise earlier in the yolk sac (YS). Here, we questioned whether other YS lineages exist that have not been identified, partially owing to limitations of current lineage tracing models. We established the use of Cdh5-CreERT2 for hematopoietic fate mapping, which revealed the YS origin of mast cells (MCs). YS-derived MCs were replaced by definitive MCs, which maintained themselves independently from the bone marrow in the adult. Replacement occurred with tissue-specific kinetics. MCs in the embryonic skin, but not other organs, remained largely YS derived prenatally and were phenotypically and transcriptomically distinct from definite adult MCs. We conclude that within myeloid lineages, dual hematopoietic origin is shared between macrophages and MCs.	[Gentek, Rebecca; Ghigo, Clement; Hoeffel, Guillaume; Bulle, Maxime Jacques; Bajenoff, Marc] Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France; [Hoeffel, Guillaume; Msallam, Rasha; Chen, Jinmiao; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Gautier, Gregory; Launay, Pierre] Univ Paris Diderot, INSERM U1149, Sorbonne Paris Cite, Lab Excellence INFLAMEX, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Gentek, R; Bajenoff, M (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.	gentek@ciml.univ-mrs.fr; bajenoff@ciml.univ-mrs.fr	Chen, Jinmiao/ABE-5601-2021; Launay, Pierre/AAH-7076-2019; Hoeffel, Guillaume/ABG-4881-2021	Hoeffel, Guillaume/0000-0002-2534-4972; Gentek, Rebecca/0000-0001-6574-7242	French National Research Agency [ANR-10-INBS-04]; Agence National pour la Recherche [ANR-10-INBS-04-01, ANR-10-INBS-0009]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [647257-STROMA]; EMBO YIP; Singapore Immunology Network (SIgN) core funding; Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRF-NRFI001-02]; INSERM; CNRS; Aix-Marseille University	French National Research Agency(French National Research Agency (ANR)); Agence National pour la Recherche(French National Research Agency (ANR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore Immunology Network (SIgN) core funding; Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University	We thank the CIML core facilities for animal housing, flow cytometry, and imaging (PICSL, ImagImm, member of the national infrastructure France-BioImaging supported by the French National Research Agency [ANR-10-INBS-04]). Cdh5-CreERT2 mice were kindly provided by Ralf Adams (Muenster, Germany) and Mcpt5-Cre and "RMB" mice were generous gifts from Axel Roers (Dresden, Germany) and Pierre Launay (Paris, France), respectively. We also thank Matthieu Jung from the IGBMC (Strasbourg, France) for preliminary data analysis. This study was funded by grants from the Agence National pour la Recherche (ANR-10-INBS-04-01 France Bio Imaging, ANR-10-INBS-0009 "France Genomique" consortium) and from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program grant agreement no. 647257-STROMA. F.G. is an EMBO YIP awardee and is supported by Singapore Immunology Network (SIgN) core funding as well as a Singapore National Research Foundation Senior Investigatorship (NRFI) NRF2016NRF-NRFI001-02. This work was supported by institutional grants from INSERM, CNRS, and Aix-Marseille University to the CIML. The study also benefited from data provided through the Immunological Genome (ImmGen) consortium. Riccarda Stork is acknowledged for creating artwork. We thank Myriam Baratin for providing critical feedback on the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; BERGSTRESSER PR, 1984, J INVEST DERMATOL, V83, P214, DOI 10.1111/1523-1747.ep12263584; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; CARTER BG, 1977, INT ARCH ALLER A IMM, V54, P378, DOI 10.1159/000231851; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Crivellato E, 2011, IMMUNOL LETT, V141, P10, DOI 10.1016/j.imlet.2011.06.008; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Ehrlich P, 1877, ARCH MIKROSK ANAT, V13, P263; Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713; FUKUZUMI T, 1990, EXP HEMATOL, V18, P843; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; HATANAKA K, 1979, BLOOD, V53, P142; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KITAMURA Y, 1979, BLOOD, V53, P1085; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; Lacaud G, 2017, EXP HEMATOL, V49, P19, DOI 10.1016/j.exphem.2016.12.009; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Liu J, 2014, ONCOL REP, V31, P442, DOI 10.3892/or.2013.2824; Liu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17569; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; MATSUDA H, 1981, J CELL PHYSIOL, V108, P409, DOI 10.1002/jcp.1041080315; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Meyer N, 2017, SCI REP-UK, V7, DOI 10.1038/srep45106; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Ngkelo A, 2016, J EXP MED, V213, P1353, DOI 10.1084/jem.20160081; PADAWER J, 1974, EXP MOL PATHOL, V20, P269, DOI 10.1016/0014-4800(74)90059-8; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Peschke K, 2015, METHODS MOL BIOL, V1220, P403, DOI 10.1007/978-1-4939-1568-2_25; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/NMETH.1309, 10.1038/nmeth.1309]; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Zhu Y, 2017, IMMUNITY, V47, P597, DOI 10.1016/j.immuni.2017.08.018; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	56	148	150	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1160	+		10.1016/j.immuni.2018.04.025	http://dx.doi.org/10.1016/j.immuni.2018.04.025			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29858009	Bronze			2022-12-18	WOS:000436456900015
J	Mortier, E; Advincula, R; Kim, L; Chmura, S; Barrera, J; Reizis, B; Malynn, BA; Ma, A				Mortier, Erwan; Advincula, Rommel; Kim, Leesun; Chmura, Stephen; Barrera, Julio; Reizis, Boris; Malynn, Barbara A.; Ma, Averil			Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8(+) T Cell Subsets	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; BONE-MARROW; CUTTING EDGE; IN-VIVO; TRANSGENIC MICE; MEMORY; IL-15; EXPRESSION; IL-15R-ALPHA; PROLIFERATION	Interleukin-15 receptor alpha (IL-15R alpha) is a pleiotropically expressed molecule that chaperones and transpresents IL-15 to NK and T cells. To investigate whether IL-15R alpha presented by different cells perform distinct physiological functions, we have generated four lines of mice lacking IL-15R alpha in various cell types. We find that IL-15R alpha expression on macrophages but not dendritic cells (DCs) supports the early transition of antigen specific effector CID T cells to memory cells. After memory CD8(+) T cell differentiation, IL-15R alpha expression on DCs selectively supports central memory CD8(+) T cells, whereas IL-15R alpha expression on macrophages supports both central and effector memory CD8(+) T cells. By contrast, mice lacking IL-15R alpha on macrophages, DCs, or both, exhibit equivalent defects in NK cell homeostasis and activation. These studies define unique roles for macrophage expression of IL-15R alpha and show that NK cells rely upon distinct IL-15R alpha dependent IL-15 signals than memory CD8(+) T cells. Moreover, they demonstrate the diversity, specification, and geographic restriction of cytokine signals.	[Mortier, Erwan; Advincula, Rommel; Kim, Leesun; Chmura, Stephen; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Reizis, Boris] Columbia Univ, Dept Microbiol, New York, NY 10032 USA	University of California System; University of California San Francisco; Columbia University	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Mortier, Erwan/AAH-7925-2021; Mortier, Erwan/B-2189-2009; Mortier, Erwan/ABG-6465-2021	Mortier, Erwan/0000-0002-6321-6488; Reizis, Boris/0000-0003-1140-7853	NIH [AI45860]; Association pour la Recherche sur le Cancer; Cancer Research Institute; Kenneth Rainin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Cancer Research Institute; Kenneth Rainin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH AI45860 (A.M.), fellowships from the Association pour la Recherche sur le Cancer (E.M.) and the Irvington Institute Fellowship Program of the Cancer Research Institute (E.M.), and the Kenneth Rainin Foundation. We thank the UCSF Transgenic and Targeted Mutagenesis Core Facility for injections of targeted ESCs and the UCSF Liver Center Flow Cytometry Core Facility. E.M. performed most of the experiments and helped write the manuscript. R.A. performed mouse breeding. L.K. performed gene expression studies of intestinal epithelial cells. J.B. provided outstanding technical assistance. B.R. generated and provided Cd11c-Cre mice. S.C. generated the IL-15Ro alpha flox gene targeting construct. B.A.M. performed gene targeting in ESCs, as well as flpE-mediated removal of neomycin from targeted ESCs to generate IL-15R alpha-flox mice and helped write the manuscript. A. M. directed the project and wrote the manuscript along with E.M and B.A.M.	Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kamimura D, 2007, J EXP MED, V204, P1803, DOI 10.1084/jem.20070543; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Klonowski KD, 2005, SEMIN IMMUNOL, V17, P219, DOI 10.1016/j.smim.2005.02.004; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Stonier SW, 2008, BLOOD, V112, P4546, DOI 10.1182/blood-2008-05-156307; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yajima T, 2001, EUR J IMMUNOL, V31, P757, DOI 10.1002/1521-4141(200103)31:3<757::AID-IMMU757>3.0.CO;2-Q; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	45	148	151	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2009	31	5					811	822		10.1016/j.immuni.2009.09.017	http://dx.doi.org/10.1016/j.immuni.2009.09.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19913445	Bronze			2022-12-18	WOS:000272097900015
J	Janetzki, S; Britten, CM; Kalos, M; Levitsky, HI; Maecker, HT; Melief, CJM; Old, LJ; Romero, P; Hoos, A; Davis, MM				Janetzki, Sylvia; Britten, Cedrik M.; Kalos, Michael; Levitsky, Hyam I.; Maecker, Holden T.; Melief, Cornelius J. M.; Old, Lloyd J.; Romero, Pedro; Hoos, Axel; Davis, Mark M.			"MIATA"-Minimal Information about T Cell Assays	IMMUNITY			English	Letter									[Maecker, Holden T.; Davis, Mark M.] Stanford Univ, Med Ctr, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Janetzki, Sylvia] ZellNet Consulting Inc, Ft Lee, NJ 07024 USA; [Britten, Cedrik M.] Johannes Gutenberg Univ Mainz, Dept Med 3, D-55131 Mainz, Germany; [Kalos, Michael] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Levitsky, Hyam I.] Johns Hopkins Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Melief, Cornelius J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; [Old, Lloyd J.] Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA; [Romero, Pedro] Univ Hosp CHUV, Lausanne Branch, Ludwig Inst Canc Res, Div Clin Oncoimmunol, CH-1011 Lausanne, Switzerland; [Hoos, Axel] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Johannes Gutenberg University of Mainz; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Bristol-Myers Squibb; Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Med Ctr, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Romero, Pedro/S-6015-2017	Romero, Pedro/0000-0002-9688-2882; Davis, Mark/0000-0001-6868-657X	NIAID NIH HHS [U19 AI090019, U19 AI057229] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090019, U19AI057229] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Britten CM, 2008, CANCER IMMUNOL IMMUN, V57, P285, DOI 10.1007/s00262-007-0379-z; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Hoos A, 2007, J IMMUNOTHER, V30, P1, DOI 10.1097/01.cji.0000211341.88835.ae; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411	8	148	152	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					527	528		10.1016/j.immuni.2009.09.007	http://dx.doi.org/10.1016/j.immuni.2009.09.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833080	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000271403900001
J	Eckmann, L; Karin, M				Eckmann, L; Karin, M			NOD2 and Crohn's disease: Loss or gain of function?	IMMUNITY			English	Review							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; COLORECTAL-CANCER; CARD15 MUTATIONS; PANETH CELLS; EXPRESSION; GENE; SUSCEPTIBILITY; MACROPHAGES	The human nucleotide binding and oligomerization domain (NOD)-containing protein family consists of some 25 members related to the Apaf-1/Ced-4 family of apoptosis regulators and certain plant disease-resistance genes (Inohara et al., 2004). One member, NOD2 (CARD15), has gained recent prominence through its association with increased susceptibility to several clinically important human inflammatory diseases, especially Crohn's disease (CD). NOD2 is a cytoplasmic molecule involved in sensing microbial cell wall components and regulating inflammatory processes and apoptosis. This review focuses on recent insights into the functions of normal and variant NOD2 proteins and the pathogenetic mechanisms underlying NOD2-associated inflammatory diseases.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Eckmann, L (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	leckmann@ucsd.edu; karinoffice@ucsd.edu			NCRR NIH HHS [RR17030] Funding Source: Medline; NIAID NIH HHS [AI61712] Funding Source: Medline; NIDDK NIH HHS [DK35108] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Alhopuro P, 2004, CANCER RES, V64, P7245, DOI 10.1158/0008-5472.CAN-04-2364; Barnes EW, 1905, P LOND MATH SOC, V2, P280, DOI 10.1112/plms/s2-2.1.280; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brant SR, 2004, INFLAMM BOWEL DIS, V10, P300, DOI 10.1097/00054725-200405000-00019; Caradonna L, 2000, AM J GASTROENTEROL, V95, P1495; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huzarski T, 2005, BREAST CANCER RES TR, V89, P91, DOI 10.1007/s10549-004-1250-y; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Isaacs KL, 2004, GASTROENTEROL CLIN N, V33, P335, DOI 10.1016/j.gtc.2004.02.006; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kurzawski G, 2004, CANCER RES, V64, P1604, DOI 10.1158/0008-5472.CAN-03-3791; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mamula P, 2003, GASTROENTEROL CLIN N, V32, P967, DOI 10.1016/S0889-8553(03)00046-3; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Siegel V, 2001, DEV CELL, V1, P1, DOI 10.1016/S1534-5807(01)00021-1; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yoo NJ, 2002, BIOCHEM BIOPH RES CO, V299, P652, DOI 10.1016/S0006-291X(02)02714-6; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100	50	148	154	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					661	667		10.1016/j.immuni.2005.06.004	http://dx.doi.org/10.1016/j.immuni.2005.06.004			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963781	Bronze			2022-12-18	WOS:000230180300004
J	Badour, K; Zhang, JY; Shi, F; McGavin, MKH; Rampersad, V; Hardy, LA; Field, D; Siminovitch, KA				Badour, K; Zhang, JY; Shi, F; McGavin, MKH; Rampersad, V; Hardy, LA; Field, D; Siminovitch, KA			The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse	IMMUNITY			English	Article							T-CELL ACTIVATION; TOXIC LYMPHOCYTES-T; KINASE C-THETA; TYROSINE-PHOSPHATASE; ARP2/3 COMPLEX; ANTIGEN RECOGNITION; TARGET-CELLS; N-WASP; RECEPTOR; PEST	The Wiskoft-Aldrich syndrome protein (WASP) couples actin cytoskeletal rearrangement to T cell activation, but the mechanisms involved are unknown. Here, we show that antigen-induced formation of T cell:APC conjugates and synapses is abrogated in WASp-deficient T cells and that CD2 engagement evokes interactions between the proline-rich region required for WASp translocation to the synapse and the PSTPIP1 adaptor SH3 domain and between the PSTPIp1 coiled-coil domain and both CD2 and another CD2-binding adaptor, CD2AP. The induced colocalization of these proteins at the synapse is disrupted by expression of coiled-coil domain-deleted PSTPIP1. These data, together with the impairment in CD2-induced actin polymerization observed in WASp-deficient cells, suggest that PSTPIP1 acts downstream of CD2/CD2AP to link CD2 engagement to the WASp-evoked actin polymerization required for synapse formation and T cell activation.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Immunol, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON, Canada; Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Toronto Gen Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Siminovitch, KA (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada.	ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013					Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BIERER BE, 1988, J EXP MED, V168, P1145, DOI 10.1084/jem.168.3.1145; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cory GOC, 1996, J IMMUNOL, V157, P3791; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; DANIELIAN S, 1991, EUR J IMMUNOL, V21, P1967, DOI 10.1002/eji.1830210828; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; KUPFER H, 1994, J EXP MED, V179, P1507, DOI 10.1084/jem.179.5.1507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; PANTALEO G, 1987, EUR J IMMUNOL, V17, P55, DOI 10.1002/eji.1830170110; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; RYSER JE, 1982, J IMMUNOL, V128, P1159; Sasada T, 2001, J IMMUNOL, V166, P2394, DOI 10.4049/jimmunol.166.4.2394; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; She HY, 1997, MOL BIOL CELL, V8, P1709, DOI 10.1091/mbc.8.9.1709; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yang HL, 2001, J BIOL CHEM, V276, P18775, DOI 10.1074/jbc.M009852200; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Zaru R, 2002, J IMMUNOL, V168, P4287, DOI 10.4049/jimmunol.168.9.4287; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang JY, 2002, P NATL ACAD SCI USA, V99, P2240, DOI 10.1073/pnas.042686099; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	57	148	156	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2003	18	1					141	154		10.1016/S1074-7613(02)00516-2	http://dx.doi.org/10.1016/S1074-7613(02)00516-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	643KN	12530983	Bronze			2022-12-18	WOS:000180860600014
J	Sousa, CRE; Yap, G; Schulz, O; Rogers, N; Schito, M; Aliberti, J; Hieny, S; Sher, A				Sousa, CRE; Yap, G; Schulz, O; Rogers, N; Schito, M; Aliberti, J; Hieny, S; Sher, A			Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology	IMMUNITY			English	Article							TOXOPLASMA-GONDII; IN-VIVO; T-CELLS; IFN-GAMMA; INTERLEUKIN-10-DEFICIENT MICE; MONOCLONAL-ANTIBODIES; ENDOTOXIN TOLERANCE; CYTOKINE PRODUCTION; MEDIATED-IMMUNITY; INDUCED APOPTOSIS	Interleukin-12 plays a major role in immunity to intracellular pathogens by governing the development of IFN gamma-dependent host resistance. Nevertheless, unregulated IL-12 synthesis can lead to immunopathology, an outcome prevented by the concurrent expression of interleukin-10. Dendritic cells (DC) are an important source of the initial IL-12 stimulated by microbial agents. Here, we show that, following systemic triggering, DC can no longer be restimulated to produce IL-12 in vivo while continuing to respond in vitro. When infected with Toxoplasma gondii during this refractory state, mice mount impaired acute IFN gamma responses and, in the case of IL-10-deficient animals, are protected from cytokine-induced mortality. These findings demonstrate a previously unrecognized form of immunologic paralysis involving DC that can protect from infection-induced immunopathology.	Imperial Canc Res Fund, Immunobiol Lab, London WC2A 3PX, England; NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Cancer Research UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sousa, CRE (corresponding author), Imperial Canc Res Fund, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@icrf.icnet.uk; alan_sher@nih.gov	Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Aliberti, Julio/I-7354-2013; Aliberti, Julio/G-4565-2012	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Aliberti, Julio/0000-0003-3420-8478; Schulz, Oliver/0000-0002-1493-3341; Rogers, Neil/0000-0001-8977-7585				Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; De Smedt T, 1998, J IMMUNOL, V161, P4476; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gazzinelli RT, 1998, BRAZ J MED BIOL RES, V31, P89, DOI 10.1590/S0100-879X1998000100012; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Kalinski P, 1997, J IMMUNOL, V159, P28; Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO;2-T; Kronin V, 1996, J IMMUNOL, V157, P3819; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Leng SX, 1997, J IMMUNOL, V159, P2161; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Neyer LE, 1997, INFECT IMMUN, V65, P1675, DOI 10.1128/IAI.65.5.1675-1682.1997; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Rieser C, 1998, BLOOD, V91, P3112, DOI 10.1182/blood.V91.9.3112.3112_3112_3117; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Sher A, 1995, CIBA F SYMP, V195, P95; Shortman K, 1997, CIBA F SYMP, V204, P130; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; Sousa CRE, 1999, J IMMUNOL, V162, P6552; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sousa CRE, 1999, CURR OPIN IMMUNOL, V11, P392, DOI 10.1016/S0952-7915(99)80066-1; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; SWIGGARD WJ, 1991, CURRENT PROTOCOLS IM; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Vieira PL, 1998, J IMMUNOL, V161, P5245; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	40	148	149	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	1999	11	5					637	647		10.1016/S1074-7613(00)80138-7	http://dx.doi.org/10.1016/S1074-7613(00)80138-7			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591188	Bronze			2022-12-18	WOS:000083952200015
J	Rabinowitz, JD; Beeson, C; Wulfing, C; Tate, K; Allen, PM; Davis, MM; McConnell, HM				Rabinowitz, JD; Beeson, C; Wulfing, C; Tate, K; Allen, PM; Davis, MM; McConnell, HM			Altered T cell receptor ligands trigger a subset of early T cell signals	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; II-PEPTIDE COMPLEXES; MONOCLONAL-ANTIBODY; EXTRACELLULAR ACIDIFICATION; ANTAGONIST PEPTIDES; PARTIAL AGONISTS; EARLY STEPS; IN-VITRO; ACTIVATION	TCR ligands are complexes of peptides and MHC proteins on the surfaces of APCs. Some of these ligands cause T cell proliferation (agonists), while others block it (antagonists). We compared the acid release, calcium flux, and proliferation response of helper T cells to a variety of ligands. We found that all agonist ligands but not most antagonist ligands trigger acid release, a general indicator of early cellular activation. Only a subset of ligands triggering acid release cause sustained calcium flux, and only a subset of these ligands cause T cell proliferation. Antagonist ligands and anti-CD4 antibodies both effectively block T cell proliferation. However, significantly greater antagonist ligand or antibody concentrations are required to block acid release and initial calcium influx. These data demonstrate a hierarchy of early T cell signaling steps and show that altered TCR ligands can initiate some steps while blocking the completion of others.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305; WASHINGTON UNIV,SCH MED,CTR IMMUNOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Howard Hughes Medical Institute; Stanford University; Washington University (WUSTL); Washington University (WUSTL)	Rabinowitz, JD (corresponding author), STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305, USA.		Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Davis, Mark/0000-0001-6868-657X; Wuelfing, Christoph/0000-0002-6156-9861				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; AGRAWAL NGB, 1995, BIOPHYS J, V69, P1178, DOI 10.1016/S0006-3495(95)79992-1; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALRAMADI BK, 1995, J IMMUNOL, V155, P662; BEESON C, 1996, IN PRESS J EXP MED; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; CHALUPNY NJ, 1991, EMBO J, V10, P1201, DOI 10.1002/j.1460-2075.1991.tb08061.x; CHRISTIANICK ER, 1991, NATURE, V352, P64; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DESAI DM, 1990, NATURE, V348, P66, DOI 10.1038/348066a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DIEZOREJAS R, 1994, EMBO J, V13, P90, DOI 10.1002/j.1460-2075.1994.tb06238.x; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; DONNADIEU E, 1992, J IMMUNOL, V148, P2643; EVAVOLD BD, 1994, P NATL ACAD SCI USA, V91, P2300, DOI 10.1073/pnas.91.6.2300; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FRANCO A, 1994, EUR J IMMUNOL, V24, P940, DOI 10.1002/eji.1830240424; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; GLALCHENHAUS N, 1991, CELL, V64, P511; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; ISHIOKA GY, 1994, J IMMUNOL, V152, P4310; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KUCHROO VK, 1994, J IMMUNOL, V153, P3326; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; LORENZ RG, 1989, NATURE, V337, P560, DOI 10.1038/337560a0; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Margulies DH, 1996, NATURE, V381, P558, DOI 10.1038/381558a0; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCCONNELL HM, 1995, P NATL ACAD SCI USA, V92, P2750, DOI 10.1073/pnas.92.7.2750; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; NAG B, 1992, J IMMUNOL, V148, P2040; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; REAY PA, 1994, J IMMUNOL, V152, P3946; ROTNES JS, 1994, EUR J IMMUNOL, V24, P851, DOI 10.1002/eji.1830240412; RUPPERT J, 1993, P NATL ACAD SCI USA, V90, P2671, DOI 10.1073/pnas.90.7.2671; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STUMBLES P, 1995, J EXP MED, V182, P5, DOI 10.1084/jem.182.1.5; TORIGOE C, 1995, IMMUNOL LETT, V46, P75, DOI 10.1016/0165-2478(95)00023-X; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Vidal K, 1996, J EXP MED, V183, P1311, DOI 10.1084/jem.183.4.1311; WADA HG, 1993, J CELL PHYSIOL, V154, P129, DOI 10.1002/jcp.1041540116; WALDOR MK, 1985, SCIENCE, V227, P415, DOI 10.1126/science.3155574; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WEISS MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6836, DOI 10.1073/pnas.81.21.6836; WETTSTEIN DA, 1991, J EXP MED, V174, P219, DOI 10.1084/jem.174.1.219; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; YOON ST, 1994, IMMUNITY, V1, P563; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	70	148	151	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1996	5	2					125	135		10.1016/S1074-7613(00)80489-6	http://dx.doi.org/10.1016/S1074-7613(00)80489-6			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VE589	8769476	Bronze			2022-12-18	WOS:A1996VE58900003
J	Delassus, S; Cumano, A				Delassus, S; Cumano, A			Circulation of hematopoietic progenitors in the mouse embryo	IMMUNITY			English	Article							LYMPHOCYTE-B PRECURSORS; STEM-CELLS; FETAL LIVER; YOLK-SAC; STROMAL CELLS; INVITRO; DIFFERENTIATION; PROLIFERATION; ENRICHMENT; SYSTEM	We used a sensitive in vitro culture system to follow, in embryonic blood, the number and state of commitment of B cell precursors along ontogeny. We describe a wave of circulating multipotent progenitors, first detectable at day 10 of gestation, and reaching a maximum in absolute numbers at day 12. They are undetectable by day 14 of gestation, when committed B cell precursors can be detected in fetal liver. Embryonic marrow contains B cell progenitors by day 15. We propose that fetal liver, thymus, and bone marrow are colonized by the same wave of multipotent hematopoietic cells and define embryonic blood at day 11 of gestation as an important source of multipotent hematopoietic cells, virtually deprived of committed and mature contaminants.			Delassus, S (corresponding author), INST PASTEUR,UNITE BIOL MOLEC GENE,25 RUE DR ROUX,PARIS 15,FRANCE.			Cumano, Ana/0000-0002-4578-959X				COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1990, EUR J IMMUNOL, V20, P2183, DOI 10.1002/eji.1830201006; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; CUMANO A, 1993, P NATL ACAD SCI USA, V90, P6429, DOI 10.1073/pnas.90.14.6429; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; DZIERZAK E, 1995, IN PRESS TRENDS GENE; FONTAINEPERUS JC, 1981, J IMMUNOL, V126, P2310; FORNI L, 1979, IMMUNOLOGICAL METHOD; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; HOUSSAINT E, 1981, CELL DIFFER DEV, V10, P243, DOI 10.1016/0045-6039(81)90007-5; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; KEE BL, 1994, INT IMMUNOL, V6, P401, DOI 10.1093/intimm/6.3.401; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; KINCADE P, 1989, ANNU REV IMMUNOL, V47, P111; KINCADE PW, 1981, J IMMUNOL, V127, P2262; KODAMA H, 1992, J EXP MED, V176, P351, DOI 10.1084/jem.176.2.351; LEDOUARIN NM, 1984, CELL, V38, P353, DOI 10.1016/0092-8674(84)90490-2; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MELCHERS F, 1979, NATURE, V277, P219, DOI 10.1038/277219a0; MOORE MAS, 1967, J EXP MED, V126, P715, DOI 10.1084/jem.126.4.715; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; OGAWA M, 1993, BLOOD, V81, P2844; OKADA S, 1991, BLOOD, V78, P1706; OWEN JJT, 1969, J EXP MED, V129, P431, DOI 10.1084/jem.129.2.431; PAIGE CJ, 1979, J EXP MED, V150, P548, DOI 10.1084/jem.150.3.548; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SAUTER H, 1988, J EXP MED, V168, P1511, DOI 10.1084/jem.168.4.1511; SCHUPPEL R, 1987, EUR J IMMUNOL, V17, P739, DOI 10.1002/eji.1830170527; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; SOLVASON N, 1991, INT IMMUNOL, V3, P543, DOI 10.1093/intimm/3.6.543; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STALL AM, 1984, J IMMUNOL, V132, P787; STEINBERG C, 1985, IMMUNOL METH, V3, P317; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; TOLES JF, 1989, P NATL ACAD SCI USA, V86, P7456, DOI 10.1073/pnas.86.19.7456; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; TYAN ML, 1968, J IMMUNOL, V101, P446; YASUNAGA M, 1995, J EXP MED, V182, P315, DOI 10.1084/jem.182.2.315	50	148	149	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JAN	1996	4	1					97	106		10.1016/S1074-7613(00)80302-7	http://dx.doi.org/10.1016/S1074-7613(00)80302-7			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TT319	8574856	Bronze			2022-12-18	WOS:A1996TT31900010
J	Dahlgren, MW; Jones, SW; Cautivo, KM; Dubinin, A; Ortiz-Carpena, JF; Farhat, S; Yu, KS; Lee, K; Wang, CQ; Molofsky, AV; Tward, AD; Krummel, MF; Peng, T; Molofsky, AB				Dahlgren, Madelene W.; Jones, Stephen W.; Cautivo, Kelly M.; Dubinin, Alexandra; Ortiz-Carpena, Jorge F.; Farhat, Sepideh; Yu, Kevin S.; Lee, Katharine; Wang, Chaoqun; Molofsky, Anna, V; Tward, Aaron D.; Krummel, Matthew F.; Peng, Tien; Molofsky, Ari B.			Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches	IMMUNITY			English	Article							TYPE-2 IMMUNITY; INTERLEUKIN-33; EXPRESSION; IL-33; NODE; INFLAMMATION; PROGENITORS; ACTIVATION; PERICYTES; INJURY	Type 2 lymphocytes promote both physiologic tissue remodeling and allergic pathology, yet their physical tissue niches are poorly described. Here, we used quantitative imaging to define the tissue niches of group 2 innate lymphoid cells (ILC2s), which are critical instigators of type 2 immunity. We identified a dominant adventitial niche around lung bronchi and larger vessels in multiple tissues, where ILC2s localized with subsets of dendritic and regulatory T cells. However, ILC2s were most intimately associated with adventitial stromal cells (ASCs), a mesenchymal fibroblast-like subset that expresses interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP). In vitro, ASCs produced TSLP that supported ILC2 accumulation and activation. ILC2s and IL-13 drove reciprocal ASC expansion and IL-33 expression. During helminth infection, ASC depletion impaired lung ILC2 and Th2 cell accumulation and function, which are in part dependent on ASC-derived IL-33. These data indicate that adventitial niches are conserved sites where ASCs regulate type 2 lymphocyte expansion and function.	[Dahlgren, Madelene W.; Jones, Stephen W.; Cautivo, Kelly M.; Dubinin, Alexandra; Ortiz-Carpena, Jorge F.; Farhat, Sepideh; Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Wang, Chaoqun; Peng, Tien] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Yu, Kevin S.; Lee, Katharine; Tward, Aaron D.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Molofsky, Anna, V] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Molofsky, AB (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Molofsky, AB (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.	ari.molofsky@ucsf.edu		Dubinin, Alexandra/0000-0001-6297-9099; Ortiz-Carpena, Jorge F./0000-0002-7727-9674; Cautivo, Kelly/0000-0003-4434-2814	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K08DK101604]; National Heart, Lung, and Blood Institute (NLHBI) [R56HL142701]; Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; UCSF Department of Laboratory Medicine; UCSF Program for Breakthrough Biomedical Research; American Cancer Society [PF-15-157-01-CSM]; Swedish Society for Medical Research; UCSF Bold & Basic fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL142701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101604] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NLHBI); Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; UCSF Department of Laboratory Medicine; UCSF Program for Breakthrough Biomedical Research; American Cancer Society(American Cancer Society); Swedish Society for Medical Research; UCSF Bold & Basic fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of California, San Francisco (UCSF) Biological Imaging and Development Core and members Adam Fries and Kyle Marchuk (confocal microscopy and analysis); the UCSF Institute for Human Genetics and members Eunice Wan and Dedeepya Vaka (scRNA-seq); Satoru Joshita and Marco Colonna (IL-33mcherry mice); Dean Sheppard and Tom Arnold (Col1A1GFP mice); Richard M. Locksley and Adrian Erlebacher (comments and discussion); Z.E. Wang (cell sorting); and H.E. Liang (assistance with N. brasiliensis stocks). A.B.M. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, K08DK101604), the National Heart, Lung, and Blood Institute (NLHBI, R56HL142701), the Larry L. Hillblom Foundation, the Sandler Asthma Basic Research Center, the UCSF Department of Laboratory Medicine, and a grant from the UCSF Program for Breakthrough Biomedical Research; S.W.J. is supported by the American Cancer Society post-doctoral fellowship (PF-15-157-01-CSM); and M.W.D. is supported by the Swedish Society for Medical Research and a UCSF Bold & Basic fellowship.	Benias PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23062-6; Cano E, 2017, CELL STEM CELL, V20, P296, DOI 10.1016/j.stem.2017.02.005; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang JE, 2015, TRENDS IMMUNOL, V36, P30, DOI 10.1016/j.it.2014.11.003; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Endo Y, 2015, IMMUNITY, V42, P294, DOI 10.1016/j.immuni.2015.01.016; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Kashiwagi M, 2017, NAT IMMUNOL, V18, P334, DOI 10.1038/ni.3661; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lambrecht BN, 2017, NAT IMMUNOL, V18, P1076, DOI 10.1038/ni.3829; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oldham M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907968; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schraufnagel DE, 2003, AM J PHYSIOL-LUNG C, V284, pL891, DOI 10.1152/ajplung.00333.2002; Schuijs MJ, 2018, ANN NY ACAD SCI, V1417, P87, DOI 10.1111/nyas.13604; Shinoda K, 2016, P NATL ACAD SCI USA, V113, pE2842, DOI 10.1073/pnas.1512600113; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Yang YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11385; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	53	147	147	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					707	+		10.1016/j.immuni.2019.02.002	http://dx.doi.org/10.1016/j.immuni.2019.02.002			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30824323	Green Accepted, Bronze			2022-12-18	WOS:000461660500020
J	Proto, JD; Doran, AC; Gusarova, G; Yurdagul, A; Sozen, E; Subramanian, M; Islam, MN; Rymond, CC; Du, J; Hook, J; Kuriakose, G; Bhattacharya, J; Tabas, I				Proto, Jonathan D.; Doran, Amanda C.; Gusarova, Galina; Yurdagul, Arif, Jr.; Sozen, Erdi; Subramanian, Manikandan; Islam, Mohammad N.; Rymond, Christina C.; Du, Jasper; Hook, Jaime; Kuriakose, George; Bhattacharya, Jahar; Tabas, Ira			Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution	IMMUNITY			English	Article							APOPTOTIC CELLS; ATHEROSCLEROSIS; PHAGOCYTOSIS; RECEPTOR; INTERLEUKIN-10; MECHANISMS; SUPPRESSION; NEUTROPHILS; LYMPHOCYTE; ACTIVATION	Regulatory T (Treg) cell responses and apoptotic cell clearance (efferocytosis) represent critical arms of the inflammation resolution response. We sought to determine whether these processes might be linked through Treg-cell-mediated enhancement of efferocytosis. In zymosan-induced peritonitis and lipopolysaccharide-induced lung injury, Treg cells increased early in resolution, and Treg cell depletion decreased efferocytosis. In advanced atherosclerosis, where defective efferocytosis drives disease progression, Treg cell expansion improved efferocytosis. Mechanistic studies revealed the following sequence: (1) Treg cells secreted interleukin-13 (IL-13), which stimulated IL-10 production in macrophages; (2) autocrine-paracrine signaling by IL-10 induced Vav1 in macrophages; and (3) Vav1 activated Rac1 to promote apoptotic cell engulfment. In summary, Treg cells promote macrophage efferocytosis during inflammation resolution via a transcellular signaling pathway that enhances apoptotic cell internalization. These findings suggest an expanded role of Treg cells in inflammation resolution and provide a mechanistic basis for Treg-cell-enhancement strategies for non-resolving inflammatory diseases.	[Proto, Jonathan D.; Doran, Amanda C.; Gusarova, Galina; Yurdagul, Arif, Jr.; Sozen, Erdi; Subramanian, Manikandan; Islam, Mohammad N.; Rymond, Christina C.; Du, Jasper; Hook, Jaime; Kuriakose, George; Bhattacharya, Jahar; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Bhattacharya, Jahar; Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Sozen, Erdi] Marmara Univ, Dept Biochem, Istanbul, Turkey; [Proto, Jonathan D.] Sanofi, Framingham, MA USA; [Subramanian, Manikandan] CSIR Inst Genom & Integrat Biol, New Delhi, India	Columbia University; Columbia University; Columbia University; Marmara University; Sanofi-Aventis; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Tabas, I (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.; Tabas, I (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	iat1@columbia.edu	Sozen, Erdi/AAS-6375-2020; Hook, Jaime/GPF-9153-2022	Hook, Jaime/0000-0002-6630-0060; Subramanian, Manikandan/0000-0002-2608-3890; Islam, Mohammad Naimul/0000-0001-7929-9444	NIH [HL007343, HL122730, DoD-PR150672, HL132412, HL075662, HL127464, 5P30DK063608, P30CA013696]; American Heart Association; Scientific and Technological Research Council of Turkey (TUBITAK); Stony Wold-Herbert Fund Inc.; BIDEB 2214/A Program; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122730, R01HL132412, R01HL075662, T32HL007343, R01HL127464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Stony Wold-Herbert Fund Inc.; BIDEB 2214/A Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Andrew McKenzie of the Medical Research Council for his generous donation of the Il13<SUP>-/-</SUP> mice used in this study. This work was supported by NIH T32 post-doctoral training grant HL007343 (J.D.P. and A.Y.), American Heart Association Fellow-to-Faculty Transition Awards (A.C.D. and J.H.), a grant from the Scientific and Technological Research Council of Turkey (TUBITAK), a grant from the BIDEB 2214/A Program (E.S.), a Grant-in-Aid from the American Heart Association (M.N.I.), a Stony Wold-Herbert Fund Inc. Research Fellowship (J.H.), and NIH grants HL122730 and DoD-PR150672 (J.B.) and HL132412, HL075662, and HL127464 (I.T.). These studies used the resources of the Columbia Diabetes and Endocrinology Research Center and Columbia Cancer Center flow core facilities, funded in part through NIH center grants 5P30DK063608 and P30CA013696, respectively.	Aggarwal NR, 2014, J IMMUNOL, V192, P4453, DOI 10.4049/jimmunol.1400146; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fichtner-Feigl S, 2014, J IMMUNOL, V192, P3969, DOI 10.4049/jimmunol.1301072; Foks AC, 2011, ATHEROSCLEROSIS, V218, P53, DOI 10.1016/j.atherosclerosis.2011.04.029; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; George J, 2012, ATHEROSCLEROSIS, V222, P519, DOI 10.1016/j.atherosclerosis.2012.03.016; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Kambayashi T, 1996, CELL IMMUNOL, V171, P153, DOI 10.1006/cimm.1996.0186; Liu Y, 2006, ATHEROSCLEROSIS, V188, P19, DOI 10.1016/j.atherosclerosis.2005.10.029; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Michalski MN, 2016, J CELL BIOCHEM, V117, P2697, DOI 10.1002/jcb.25567; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Mondal S, 2011, J IMMUNOL, V187, P5783, DOI 10.4049/jimmunol.1100484; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Ochoa-Reparaz J, 2008, J IMMUNOL, V181, P954, DOI 10.4049/jimmunol.181.2.954; Ogden CA, 2005, J IMMUNOL, V174, P3015, DOI 10.4049/jimmunol.174.5.3015; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Dinh TN, 2012, CIRCULATION, V126, P1256, DOI 10.1161/CIRCULATIONAHA.112.099044; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tziakas DN, 2007, ATHEROSCLEROSIS, V193, P196, DOI 10.1016/j.atherosclerosis.2006.06.016; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Yurdagul A, 2018, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00086	46	147	148	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					666	+		10.1016/j.immuni.2018.07.015	http://dx.doi.org/10.1016/j.immuni.2018.07.015			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30291029	Bronze, Green Accepted			2022-12-18	WOS:000447386700013
J	Godfrey, DI; Le Nours, J; Andrews, DM; Uldrich, AP; Rossjohn, J				Godfrey, Dale I.; Le Nours, Jerome; Andrews, Daniel M.; Uldrich, Adam P.; Rossjohn, Jamie			Unconventional T Cell Targets for Cancer Immunotherapy	IMMUNITY			English	Review							INVARIANT NKT CELLS; BACILLUS-CALMETTE-GUERIN; NATURAL-KILLER-CELLS; ALPHA-GALACTOSYLCERAMIDE KRN7000; ANTIGEN-PRESENTING CELLS; HLA-G EXPRESSION; PHASE-I; ANTITUMOR-ACTIVITY; TUMOR-CELLS; CUTTING EDGE	Most studies on the immunotherapeutic potential of T cells have focused on CD8 and CD4 T cells that recognize peptide antigens (Ag) presented by polymorphic major histocompatibility complex (MHC) class I and MHC class II molecules, respectively. However, unconventional T cells, which interact with MHC class Ib and MHC-I like molecules, are also implicated in tumor immunity, although their role therein is unclear. These include unconventional T cells targeting MHC class Ib molecules such as HLA-E and its murine ortholog Qa-1b, natural killer T (NKT) cells, mucosal associated invariant T (MAIT) cells, and gamma delta T cells. Here, we review the current understanding of the roles of these unconventional T cells in tumor immunity and discuss why further studies into the immunotherapeutic potential of these cells is warranted.	[Godfrey, Dale I.; Uldrich, Adam P.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Godfrey, Dale I.; Uldrich, Adam P.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Andrews, Daniel M.] Monash Univ, Dept Immunol & Pathol, Cent Clin Sch, Melbourne, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; University of Melbourne; Monash University; Monash University; Monash University; Monash University; Cardiff University	Godfrey, DI (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Godfrey, DI (corresponding author), Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	godfrey@unimelb.edu.au; jamie.rossjohn@monash.edu	Uldrich, Adam/AAX-3785-2020; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Godfrey, Dale/0000-0002-3009-5472; Le Nours, Jerome/0000-0002-2221-7636; Andrews, Dan/0000-0002-5896-7885; ULDRICH, ADAM/0000-0002-6350-5976	Australian Research Council; National Health and Medical Research Council; Worldwide cancer research fund [16-1106]; Cancer Council Victoria; ARC Future Fellowships [FT140100278, FT160100074]; ARC Laureate Fellowship; NHMRC Senior Principal Research Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Worldwide cancer research fund; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); ARC Future Fellowships(Australian Research Council); ARC Laureate Fellowship(Australian Research Council); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and National Health and Medical Research Council, the Worldwide cancer research fund (16-1106) and the Cancer Council Victoria. A.P.U. and J.L.N. are supported by ARC Future Fellowships (FT140100278 and FT160100074), J.R. is supported by an ARC Laureate Fellowship, D.I.G. is supported by an NHMRC Senior Principal Research Fellowship.	Abe Y, 2009, EXP HEMATOL, V37, P956, DOI 10.1016/j.exphem.2009.04.008; Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Anderson RJ, 2015, CHEM SCI, V6, P5120, DOI 10.1039/c4sc03599b; Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Thu NLA, 2016, HUM IMMUNOL, V77, P711, DOI 10.1016/j.humimm.2016.02.012; Aoki T, 2017, CYTOTHERAPY, V19, P473, DOI 10.1016/j.jcyt.2017.01.002; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Awad W., 2018, IMMUNOL CELL BIOL; Bagchi S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1213932; Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Bellone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008646; Ben Youssef G, 2018, J EXP MED, V215, P459, DOI 10.1084/jem.20171739; Benevolo M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-184; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Bennouna J, 2010, CANCER IMMUNOL IMMUN, V59, P1521, DOI 10.1007/s00262-010-0879-0; Beziat V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00507; Bialasiewicz AA, 1999, BRIT J OPHTHALMOL, V83, P1069, DOI 10.1136/bjo.83.9.1069; Birkholz A, 2015, J BIOL CHEM, V290, P17206, DOI 10.1074/jbc.M115.654814; Birkinshaw RW, 2015, NAT IMMUNOL, V16, P258, DOI 10.1038/ni.3098; Bjordahl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042635; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Bouet-Toussaint F, 2008, CANCER IMMUNOL IMMUN, V57, P531, DOI 10.1007/s00262-007-0391-3; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brennan PJ, 2017, P NATL ACAD SCI USA, V114, P8348, DOI 10.1073/pnas.1705882114; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Cameron G., 2018, IMMUNOL CELL BIOL; Caocci G, 2017, LEUKEMIA RES, V61, P1, DOI 10.1016/j.leukres.2017.08.005; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Catamo E, 2014, HUM IMMUNOL, V75, P1225, DOI 10.1016/j.humimm.2014.09.019; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Chen LL, 2014, J IMMUNOL, V193, P1427, DOI 10.4049/jimmunol.1302048; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Chiang EY, 2005, J IMMUNOL, V174, P5367, DOI 10.4049/jimmunol.174.9.5367; Chiang EY, 2004, J IMMUNOL, V173, P4394, DOI 10.4049/jimmunol.173.7.4394; Chiang EY, 2002, J IMMUNOL, V168, P2200, DOI 10.4049/jimmunol.168.5.2200; CHOUDHARY A, 1995, J IMMUNOL, V154, P3932; Coelho AVC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038263; Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.3.CO;2-O; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cordova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049878; Correia DV, 2011, BLOOD, V118, P992, DOI 10.1182/blood-2011-02-339135; Corvaisier M, 2005, J IMMUNOL, V175, P5481, DOI 10.4049/jimmunol.175.8.5481; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Cui JW, 2015, CYTOTHERAPY, V17, P979, DOI 10.1016/j.jcyt.2015.03.605; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; Dashtsoodol N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153347; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Kruijf EM, 2010, J IMMUNOL, V185, P7452, DOI 10.4049/jimmunol.1002629; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; De Santo C, 2010, NAT IMMUNOL, V11, P1039, DOI 10.1038/ni.1942; Deniger DC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00636; Deniger DC, 2014, CLIN CANCER RES, V20, P5708, DOI 10.1158/1078-0432.CCR-13-3451; Dhodapkar MV, 2017, J IMMUNOL, V198, P1015, DOI 10.4049/jimmunol.1601399; Dias BR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-116; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dulberger CL, 2017, IMMUNITY, V46, P1018, DOI 10.1016/j.immuni.2017.06.002; Durgan K, 2011, CANCER IMMUNOL IMMUN, V60, P547, DOI 10.1007/s00262-010-0963-5; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; ELLIS SA, 1990, J IMMUNOL, V144, P731; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Ferreira LMR, 2017, TRENDS IMMUNOL, V38, P272, DOI 10.1016/j.it.2017.01.009; Fleming C, 2017, TRENDS CANCER, V3, P561, DOI 10.1016/j.trecan.2017.06.003; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gasser O, 2017, IMMUNOTHER, V67, P285; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gherardin N. A., 2018, IMMUNOL CELL BIOL; Gherardin NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22130-1; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gillessen S, 2003, P NATL ACAD SCI USA, V100, P8874, DOI 10.1073/pnas.1033098100; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gooden M, 2011, P NATL ACAD SCI USA, V108, P10656, DOI 10.1073/pnas.1100354108; Gorini F, 2017, BLOOD, V129, P3440, DOI 10.1182/blood-2016-11-751065; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Guillaume N, 2013, LEUKEMIA RES, V37, P473, DOI 10.1016/j.leukres.2012.12.021; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Harada A, 2015, PATHOL INT, V65, P569, DOI 10.1111/pin.12343; Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.3.CO;2-L; Heczey A, 2014, BLOOD, V124, P2824, DOI 10.1182/blood-2013-11-541235; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hishiki T, 2018, PEDIATR SURG INT, V34, P195, DOI 10.1007/s00383-017-4189-x; Howson LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02540-x; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Inman BA, 2008, J IMMUNOL, V180, P3578, DOI 10.4049/jimmunol.180.5.3578; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Iwasaki M, 2011, EUR J IMMUNOL, V41, P345, DOI 10.1002/eji.201040959; Izhak L, 2013, CANCER RES, V73, P1514, DOI 10.1158/0008-5472.CAN-12-2567; Izumi T, 2013, CYTOTHERAPY, V15, P481, DOI 10.1016/j.jcyt.2012.12.004; Jiang J, 2014, AM J RESP CRIT CARE, V190, P329, DOI 10.1164/rccm.201401-0106OC; Joly E, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-2; Joosten SA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2695396; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kammertoens T, 2012, INT J CANCER, V131, P1499, DOI 10.1002/ijc.27411; Kasmar AG, 2013, J IMMUNOL, V191, P4499, DOI 10.4049/jimmunol.1301660; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kawashima T, 2003, J IMMUNOL, V170, P5345, DOI 10.4049/jimmunol.170.11.5345; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kerzerho J, 2012, J IMMUNOL, V188, P2254, DOI 10.4049/jimmunol.1103049; Kirana C, 2017, INT J CANCER, V140, P2577, DOI 10.1002/ijc.30667; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Kobayashi E, 1995, ONCOL RES, V7, P529; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; KOLLER BH, 1988, J IMMUNOL, V141, P897; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kren L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-58; Kren L, 2011, NEUROPATHOLOGY, V31, P129, DOI 10.1111/j.1440-1789.2010.01149.x; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Kunzmann V, 2000, BLOOD, V96, P384; Kurioka A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01031; Kuriyama Y, 2000, LEUKEMIA LYMPHOMA, V39, P321, DOI 10.3109/10428190009065831; Kurosaki M, 2011, CANCER IMMUNOL IMMUN, V60, P207, DOI 10.1007/s00262-010-0932-z; Lamb L S Jr, 1996, J Hematother, V5, P503, DOI 10.1089/scd.1.1996.5.503; Lamb LS, 2001, BONE MARROW TRANSPL, V27, P601, DOI 10.1038/sj.bmt.1702830; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Lang JM, 2011, CANCER IMMUNOL IMMUN, V60, P1447, DOI 10.1007/s00262-011-1049-8; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Le Nours J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10570; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Lepore M, 2014, J EXP MED, V211, P1360, DOI 10.1084/jem.20140410; Li JB, 2017, ONCOTARGET, V8, P48854, DOI 10.18632/oncotarget.16457; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Lin A, 2010, J CELL MOL MED, V14, P2162, DOI 10.1111/j.1582-4934.2009.00917.x; Ling LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20358; Liu ZY, 2008, J IMMUNOL, V180, P6044, DOI 10.4049/jimmunol.180.9.6044; Liu ZY, 2005, J UROLOGY, V173, P1552, DOI 10.1097/01.ju.0000154355.45816.0b; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Ly D, 2013, J EXP MED, V210, P729, DOI 10.1084/jem.20120624; Ma CL, 2012, J IMMUNOL, V189, P5029, DOI 10.4049/jimmunol.1201892; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; McEwen-Smith RM, 2015, CANCER IMMUNOL RES, V3, P425, DOI 10.1158/2326-6066.CIR-15-0062; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Metelitsa LS, 2011, CLIN IMMUNOL, V140, P119, DOI 10.1016/j.clim.2010.10.005; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Motohashi S, 2009, J IMMUNOL, V182, P2492, DOI 10.4049/jimmunol.0800126; Nagato K, 2012, J CLIN IMMUNOL, V32, P1071, DOI 10.1007/s10875-012-9697-9; Nair S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01178; Chuc AEN, 2012, J CANCER RES CLIN, V138, P1427, DOI 10.1007/s00432-012-1251-x; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Nicol A, 2000, IMMUNOLOGY, V99, P229, DOI 10.1046/j.1365-2567.2000.00952.x; Nicol AJ, 2011, BRIT J CANCER, V105, P778, DOI 10.1038/bjc.2011.293; Nicol AJ, 2011, CLIN CANCER RES, V17, P5140, DOI 10.1158/1078-0432.CCR-10-3105; Nieda M, 2004, BLOOD, V103, P383, DOI 10.1182/blood-2003-04-1155; Nishikawa H, 2005, P NATL ACAD SCI USA, V102, P9253, DOI 10.1073/pnas.0503852102; O'Konek JJ, 2011, J CLIN INVEST, V121, P683, DOI 10.1172/JCI42314; Oliveira CC, 2010, J EXP MED, V207, P207, DOI 10.1084/jem.20091429; Paget C, 2012, J IMMUNOL, V188, P3928, DOI 10.4049/jimmunol.1103582; Park JE, 2008, IMMUNOLOGY, V123, P145, DOI 10.1111/j.1365-2567.2007.02760.x; Park Y, 2012, TISSUE ANTIGENS, V79, P97, DOI 10.1111/j.1399-0039.2011.01814.x; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Patil RS, 2016, INT J CANCER, V139, P869, DOI 10.1002/ijc.30134; Pellicci DG, 2014, J EXP MED, V211, P2599, DOI 10.1084/jem.20141764; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Peterfalvi A, 2008, INT IMMUNOL, V20, P1517, DOI 10.1093/intimm/dxn111; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Pressey JG, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004909; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Renukaradhya GJ, 2006, INT J CANCER, V118, P3045, DOI 10.1002/ijc.21764; Richter J, 2013, BLOOD, V121, P423, DOI 10.1182/blood-2012-06-435503; Rodgers JR, 2005, NAT REV IMMUNOL, V5, P459, DOI 10.1038/nri1635; Rong L, 2016, WORLD J GASTROENTERO, V22, P3573, DOI 10.3748/wjg.v22.i13.3573; Rouas-Freiss N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1342023; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Shahine A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1384; Shaler CR, 2017, CANCER IMMUNOL IMMUN, V66, P1563, DOI 10.1007/s00262-017-2050-7; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shobu T, 2006, J REPROD IMMUNOL, V72, P18, DOI 10.1016/j.jri.2006.02.001; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Speir M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14690-5; STANTON TH, 1978, J EXP MED, V148, P963, DOI 10.1084/jem.148.4.963; Stirnemann K, 2008, J CLIN INVEST, V118, P994, DOI 10.1172/JCI33249; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Sundstrom P, 2015, J IMMUNOL, V195, P3472, DOI 10.4049/jimmunol.1500258; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Swets M, 2016, HUM IMMUNOL, V77, P773, DOI 10.1016/j.humimm.2016.03.001; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; Takeuchi A, 2011, EUR J IMMUNOL, V41, P246, DOI 10.1002/eji.201040773; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Tefit JN, 2014, VACCINE, V32, P6138, DOI 10.1016/j.vaccine.2014.08.070; Teixeira AC, 2013, TISSUE ANTIGENS, V81, P408, DOI 10.1111/tan.12097; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Tian GW, 2016, J CLIN INVEST, V126, P2341, DOI 10.1172/JCI83476; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Toia F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149570; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Uchida T, 2008, CANCER IMMUNOL IMMUN, V57, P337, DOI 10.1007/s00262-007-0373-5; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Ussher J. E., 2018, IMMUNOL CELL BIOL; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Van Rhijn I, 2016, P NATL ACAD SCI USA, V113, P380, DOI 10.1073/pnas.1520947112; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Veerapen N, 2010, BIOORG MED CHEM LETT, V20, P3223, DOI 10.1016/j.bmcl.2010.04.079; Versluis MAC, 2017, EUR J CANCER, V86, P285, DOI 10.1016/j.ejca.2017.09.008; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wada I, 2014, CANCER MED-US, V3, P362, DOI 10.1002/cam4.196; Wang YY, 2015, J NEUROIMMUNOL, V282, P1, DOI 10.1016/j.jneuroim.2015.02.013; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Wilhelm M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-45; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Won EJ, 2016, ONCOTARGET, V7, P76274, DOI 10.18632/oncotarget.11187; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Wun K. S., 2018, NAT IMMUNOL; Wun KS, 2012, J BIOL CHEM, V287, P39139, DOI 10.1074/jbc.M112.412320; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014; Yazdi MT, 2016, ONCOTARGET, V7, P3467; Zabijak L, 2015, CANCER IMMUNOL IMMUN, V64, P1601, DOI 10.1007/s00262-015-1764-7; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27375; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112	265	147	153	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2018	48	3					453	473		10.1016/j.immuni.2018.03.009	http://dx.doi.org/10.1016/j.immuni.2018.03.009			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FZ9GB	29562195	Green Accepted, Bronze			2022-12-18	WOS:000427916900004
J	Honda, T; Egen, JG; Lammermann, T; Kastenmuller, W; Torabi-Parizi, P; Germain, RN				Honda, Tetsuya; Egen, Jackson G.; Laemmermann, Tim; Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Germain, Ronald N.			Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues	IMMUNITY			English	Article							LYMPH-NODES; DENDRITIC CELLS; IMMUNE-SYSTEM; STOP-SIGNAL; IN-VIVO; MYCOBACTERIAL GRANULOMAS; IMMUNOLOGICAL SYNAPSE; MOTILITY; DYNAMICS; CD4(+)	Activated T cells must mediate effector responses sufficiently to clear pathogens while avoiding excessive tissue damage. Here we have combined dynamic intravital microscopy with ex vivo assessments of T cell cytokine responses to generate a detailed spatiotemporal picture of CD4(+) T cell effector regulation in the skin. In response to antigen, effector T cells arrested transiently on antigen-presenting cells, briefly producing cytokine and then resuming migration. Antigen recognition led to upregulation of the programmed death-1 (PD-1) glycoprotein by T cells and blocking its canonical ligand, programmed death-ligand 1 (PD-L1), lengthened the duration of migration arrest and cytokine production, showing that PD-1 interaction with PD-L1 is a major negative feedback regulator of antigen responsiveness. We speculate that the immune system employs T cell recruitment, transient activation, and rapid desensitization to allow the T cell response to rapidly adjust to changes in antigen presentation and minimize collateral injury to the host.	[Honda, Tetsuya; Egen, Jackson G.; Laemmermann, Tim; Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Crit Care Med Dept, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Lämmermann, Tim/AAD-7453-2022; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Egen, Jackson/0000-0003-2053-0837	NIAID; NIH; Uehara Memorial Foundation; HFSP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000758, ZIAAI000545] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); HFSP(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank G.J. Freeman for anti-PD-L2 blocking antibody; D. L. Barber for PD-1-deficient mice; and N. Subramanian, M. Clatworthy, H. Qi, M. Bajenoff, and N. Peters for helpful discussions and/or technical advice. This work was supported by the Intramural Research Program of NIAID, NIH, the Uehara Memorial Foundation (T.H.), and an HFSP Long-term Fellowship (T.L).	Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Downey J, 2008, IMMUNOL LETT, V115, P70, DOI 10.1016/j.imlet.2007.09.004; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Masters BR, 2004, J BIOMED OPT, V9, P1265, DOI 10.1117/1.1806135; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sancho D, 2002, IMMUNOL REV, V189, P84, DOI 10.1034/j.1600-065X.2002.18908.x; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; Schneider H, 2008, EUR J IMMUNOL, V38, P40, DOI 10.1002/eji.200737423; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Schreiber HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011453; Segel LA, 1999, J IMMUNOL, V163, P1342; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Utzny C, 2006, CELL BIOCHEM BIOPHYS, V46, P101, DOI 10.1385/CBB:46:2:101; Valitutti S, 2010, FEBS LETT, V584, P4851, DOI 10.1016/j.febslet.2010.10.010; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	54	147	151	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					235	247		10.1016/j.immuni.2013.11.017	http://dx.doi.org/10.1016/j.immuni.2013.11.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24440150	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000331637600011
J	Bosma, A; Abdel-Gadir, A; Isenberg, DA; Jury, EC; Mauri, C				Bosma, Anneleen; Abdel-Gadir, Azza; Isenberg, David A.; Jury, Elizabeth C.; Mauri, Claudia			Lipid-Antigen Presentation by CD1d(+) B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NKT CELLS; RHEUMATOID-ARTHRITIS; ENDOSOMAL TRAFFICKING; AUTOIMMUNE-DISEASE; DEPLETION THERAPY; PERIPHERAL-BLOOD; DENDRITIC CELLS; INKT CELLS; ACTIVATION	B cells perform many immunological functions, including presenting lipid antigen to CD1d-restricted invariant natural killer T (iNKT) cells, known to contribute to maintaining tolerance in autoimmunity. Patients with systemic lupus erythematous (SLE) display dysregulated B cell responses and reduced peripheral iNKT cell frequencies. The significance of these defects and how they relate to SLE pathogenesis remain elusive. We report that B cells are essential for iNKT cell expansion and activation in healthy donors but fail to exert a similar effect in SLE patients. Defective B cell-mediated stimulation of iNKT cells in SLE patients was associated with altered CD1d recycling, a defect recapitulated in B cells from healthy donors after stimulation with interferon-alpha (IFN-alpha) and anti-immunoglobulin (Ig). iNKT cell number and function were restored in SLE patients responding to anti-CD20 treatment upon normalization of CD1d expression exclusively in repopulated immature B cells. We propose that healthy B cells are pivotal for iNKT cell homeostasis.	[Bosma, Anneleen; Abdel-Gadir, Azza; Isenberg, David A.; Jury, Elizabeth C.; Mauri, Claudia] UCL, Div Med, Ctr Rheumatol Res, London WC1E 6JF, England	University of London; University College London	Jury, EC (corresponding author), UCL, Div Med, Ctr Rheumatol Res, Rayne Bldg,4th Floor,Room 419,5 Univ St, London WC1E 6JF, England.	e.jury@ucl.ac.uk; c.mauri@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Isenberg, David/0000-0001-9514-2455; Abdel-Gadir, Azza/0000-0003-4210-9445; Mauri, Claudia/0000-0001-9761-2625; Jury, Elizabeth/0000-0002-2389-3396	Arthritis Research UK [MP/17707, 19367, 18106]; Nuffield Foundation; Versus Arthritis [19314, 18106, 17707] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Nuffield Foundation; Versus Arthritis(Versus Arthritis)	This work is funded by an Arthritis Research UK programme grant to C.M. (MP/17707) and Arthritis Research UK equipment grant (19367) to C.M. and E.C.J. A.B. is funded by the Nuffield Foundation, and E.C.J. and part of this work is funded by an Arthritis Research UK Career Development award to E.C.J. (18106).	Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bezbradica JS, 2005, J IMMUNOL, V174, P4696, DOI 10.4049/jimmunol.174.8.4696; Bialecki E, 2009, J IMMUNOL, V182, P6105, DOI 10.4049/jimmunol.0802273; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Isenberg D, 2006, NAT CLIN PRACT RHEUM, V2, P145, DOI 10.1038/ncprheum0116; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI200213605; Lang GA, 2008, BLOOD, V111, P2158, DOI 10.1182/blood-2007-10-117309; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Leandro MJ, 2005, RHEUMATOLOGY, V44, P1542, DOI 10.1093/rheumatology/kei080; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Ly D, 2006, J IMMUNOL, V177, P3695, DOI 10.4049/jimmunol.177.6.3695; Mars LT, 2004, TRENDS IMMUNOL, V25, P471, DOI 10.1016/j.it.2004.07.001; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Ng KP, 2007, ANN RHEUM DIS, V66, P1259, DOI 10.1136/ard.2006.067124; Pace L, 2010, J IMMUNOL, V184, P5969, DOI 10.4049/jimmunol.0900526; Parekh VV, 2009, J IMMUNOL, V182, P2816, DOI 10.4049/jimmunol.0803648; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sfikakis PP, 2007, CLIN IMMUNOL, V123, P66, DOI 10.1016/j.clim.2006.12.006; Tonti E, 2009, BLOOD, V113, P370, DOI 10.1182/blood-2008-06-166249; Tudhope SJ, 2010, ANN RHEUM DIS, V69, P1873, DOI 10.1136/ard.2009.125849; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Wermeling F, 2010, J EXP MED, V207, P943, DOI 10.1084/jem.20091314; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Wither J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2505; Yang JQ, 2011, J IMMUNOL, V186, P1512, DOI 10.4049/jimmunol.1002373; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364	46	147	154	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					477	490		10.1016/j.immuni.2012.02.008	http://dx.doi.org/10.1016/j.immuni.2012.02.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22406267	hybrid, Green Published			2022-12-18	WOS:000302048400018
J	Isogawa, M; Furuichi, Y; Chisari, FV				Isogawa, M; Furuichi, Y; Chisari, FV			Oscillating CD8(+) T cell effector functions after antigen recognition in the liver	IMMUNITY			English	Article							HEPATITIS-B-VIRUS; VIRAL-INFECTIONS; TRANSGENIC MICE; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; SURFACE-ANTIGEN; IN-VIVO; C VIRUS; ACTIVATION; RECEPTOR	When hepatitis B virus (HBV)-specific CD8(+) cytotoxic T lymphocytes (CTLs) are adoptively transferred into HBV transgenic mice, they enter the liver, recognize antigen, secrete interferon gamma (IFN gamma), inhibit viral replication, and kill their target cells, causing hepatitis. In the current study, we examined the impact of antigen recognition on the evolution of the activation phenotype, antiviral effector functions, expansion and contraction kinetics, and compartmentalization of the transferred CTLs. The results reveal that noncytolytic and cytolytic effector functions and expansion-contraction kinetics of the CTLs are regulated asynchronously and in an oscillatory manner as a consequence of antigen recognition in the liver and in association with PD-1 upregulation. We suggest that such oscillations maximize viral clearance and minimize tissue injury during HBV infection and that poor coordination of these events could lead to viral persistence and chronic liver disease.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Chisari, FV (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fchisari@scripps.edu	Chisari, Francis V/A-3086-2008; Furuichi, Yoshihiro/AAS-4980-2020; Isogawa, Masanori/AAN-8969-2021	Furuichi, Yoshihiro/0000-0002-8986-9823; Isogawa, Masanori/0000-0001-8730-4303; Chisari, Francis/0000-0002-4832-1044	NCI NIH HHS [CA40489] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040489, R37CA040489] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; BERKE G, 1995, CELL, V81, P9, DOI 10.1016/0092-8674(95)90365-8; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; DEPPER JM, 1985, P NATL ACAD SCI USA, V82, P4230, DOI 10.1073/pnas.82.12.4230; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Ishikawa T, 1998, J IMMUNOL, V161, P5842; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kakimi K, 2002, J VIROL, V76, P8609, DOI 10.1128/JVI.76.17.8609-8620.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Kuhrober A, 1997, INT IMMUNOL, V9, P1203, DOI 10.1093/intimm/9.8.1203; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; MORIYAMA T, 1990, SCIENCE, V248, P361, DOI 10.1126/science.1691527; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Pien GC, 2002, J IMMUNOL, V169, P5827, DOI 10.4049/jimmunol.169.10.5827; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schirmbeck R, 2003, EUR J IMMUNOL, V33, P2429, DOI 10.1002/eji.200324125; Sette AD, 2001, J IMMUNOL, V166, P1389, DOI 10.4049/jimmunol.166.2.1389; Slifka MK, 2000, IMMUNITY, V12, P451, DOI 10.1016/S1074-7613(00)80197-1; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; TESTI R, 1989, J IMMUNOL, V143, P1123; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	47	147	160	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2005	23	1					53	63		10.1016/j.immuni.2005.05.005	http://dx.doi.org/10.1016/j.immuni.2005.05.005			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	952SC	16039579	Bronze			2022-12-18	WOS:000231024800008
J	Lovett-Racke, AE; Rocchini, AE; Choy, J; Northrop, SC; Hussain, RZ; Ratts, RB; Sikder, D; Racke, MK				Lovett-Racke, AE; Rocchini, AE; Choy, J; Northrop, SC; Hussain, RZ; Ratts, RB; Sikder, D; Racke, MK			Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA; INTERFERON-GAMMA; TRANSCRIPTION FACTOR; CELL-ACTIVATION; MICE; INDUCTION; INFLAMMATION	As a means of developing therapies that target the pathogenic T cells in multiple sclerosis (MS) without compromising the immune system or eliciting systemic side effects, we investigated the use of T-bet-specific antisense oligonucleotides and small interfering RNAs (siRNA) to silence T-bet expression in autoreactive encephalitogenic T cells and evaluated the biological consequences of this suppression in experimental autoimmune encephalomyelitis, a model for MS. The T-bet-specific AS oligonucleotide and siRNA suppressed T-bet expression, IFNgamma production, and STAT1 levels during antigen-specific T cell differentiation. In vitro suppression of T-bet during differentiation of myelin-specific T cells and in vivo administration of a T-bet-specific antisense oligonucleotide or siRNA inhibited disease. T-bet was shown to bind the IFNgamma and STAT1 promoters, but did not regulate the IL-12/STAT4 pathway. Since T-bet regulates IFNgamma production in CD4+ T cells, but to a lesser extent in most other IFNgamma-producing cells, T-bet may be a target for therapeutics for Th1-mediated diseases.	Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lovett-Racke, AE (corresponding author), Univ Texas, SW Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	amy.lovett-racke@utsouthwestern.edu	Lovett-Racke, Amy/E-3545-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037513, K24NS044250] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037513, K24 NS044250] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; BILLIAU A, 1988, J IMMUNOL, V140, P1506; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; DUONG TT, 1992, CELL IMMUNOL, V145, P311, DOI 10.1016/0008-8749(92)90334-L; DUONG TT, 1994, J NEUROIMMUNOL, V53, P101, DOI 10.1016/0165-5728(94)90069-8; Ferber IA, 1996, J IMMUNOL, V156, P5; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Finotto S, 2001, J EXP MED, V193, P1247, DOI 10.1084/jem.193.11.1247; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Hadidi S, 2002, TRANSPLANTATION, V73, P1771, DOI 10.1097/00007890-200206150-00013; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heremans H, 1996, EUR J IMMUNOL, V26, P2393, DOI 10.1002/eji.1830261019; LUBLIN FD, 1993, AUTOIMMUNITY, V16, P267, DOI 10.3109/08916939309014645; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Melanitou E, 2003, ANN NY ACAD SCI, V1005, P187, DOI 10.1196/annals.1288.024; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; OLSSON T, 1992, J NEUROIMMUNOL, V40, P211, DOI 10.1016/0165-5728(92)90135-8; RACKE MK, 1995, J IMMUNOL, V154, P450; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Schlaak JF, 2001, SCAND J IMMUNOL, V54, P396, DOI 10.1046/j.1365-3083.2001.00986.x; SHI Y, 1994, CIRCULATION, V90, P944, DOI 10.1161/01.CIR.90.2.944; Shier P, 2000, IMMUNOGENETICS, V51, P771, DOI 10.1007/s002510000212; Siebler J, 2003, HEPATOLOGY, V38, P1573, DOI 10.1016/j.hep.2003.09.020; SULLIVAN BM, 2000, CELL, V100, P655; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153	38	147	158	5	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2004	21	5					719	731		10.1016/j.immuni.2004.09.010	http://dx.doi.org/10.1016/j.immuni.2004.09.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539157	Bronze			2022-12-18	WOS:000225365000012
J	Ye, M; Iwasaki, H; Laiosa, CV; Stadtfeld, M; Xie, HF; Heck, S; Clausen, BE; Akashi, K; Graf, T				Ye, M; Iwasaki, H; Laiosa, CV; Stadtfeld, M; Xie, HF; Heck, S; Clausen, BE; Akashi, K; Graf, T			Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential	IMMUNITY			English	Article							LINEAGE; DIFFERENTIATION; GRANULOCYTES; COMMITMENT; PLASTICITY; MICE	Single cell PCR studies showed that hematopoietic stem cells (HSCs) express a variety of lineage-affiliated genes. However, it remains unclear whether these cells exhibiting "lineage priming" represent bona fide stem cells or a subpopulation earmarked for differentiation. Here we have used a Cre-Lox approach to follow the fate of cells expressing a lineage-affiliated marker. We crossed lysozyme Cre mice with yellow fluorescent protein (EYFP) reporter mice and found EYFP gene expression not only in myelomonocytic cells but also in a fraction of HSCs as well as B cells and T cells. Transplantation of EYFP+ HSCs into primary and secondary recipients generated mice in which all hematopoietic cells were EYFP+. In contrast, crosses between CD19 Cre and lck Cre mice with reporter mice showed no EYFP expression in HSCs or intermediate progenitors. Our results demonstrate that lysozyme expression does not mark myeloid commitment and that longterm repopulation potential is maintained in primed HSCs.	Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Graf, T (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	graf@aecom.yu.edu	CLAUSEN, Björn Erik/A-8229-2010; Graf, Thomas/B-4252-2015	CLAUSEN, Björn Erik/0000-0002-2484-7842; Graf, Thomas/0000-0003-2774-4117; Stadtfeld, Matthias/0000-0002-5852-9906	NCI NIH HHS [CA072009, R01 CA89590-01] Funding Source: Medline; NIDDK NIH HHS [DK061320, DK050654] Funding Source: Medline; NINDS NIH HHS [R01 NS43881-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA072009, R01CA089590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061320, P01DK050654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043881] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Corbel C, 2002, DEV BIOL, V243, P301, DOI 10.1006/dbio.2001.0553; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Faust N, 2000, BLOOD, V96, P719; Feng YQ, 1999, MOL CELL BIOL, V19, P4907; Ganz T, 2003, BLOOD, V101, P2388, DOI 10.1182/blood-2002-07-2319; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kontaraki J, 2000, GENE DEV, V14, P2106; Kyewski B, 2002, TRENDS IMMUNOL, V23, P364, DOI 10.1016/S1471-4906(02)02248-2; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	31	147	148	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2003	19	5					689	699		10.1016/S1074-7613(03)00299-1	http://dx.doi.org/10.1016/S1074-7613(03)00299-1			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614856	Bronze			2022-12-18	WOS:000186672200009
J	Liblau, RS; Wong, FS; Mars, LT; Santamaria, P				Liblau, RS; Wong, FS; Mars, LT; Santamaria, P			Autoreactive CD8 T cells in organ-specific autoimmunity: Emerging targets for therapeutic intervention	IMMUNITY			English	Article							NONOBESE DIABETIC MICE; MULTIPLE-SCLEROSIS; ACTIVATION; IDENTIFICATION; EXPRESSION; APOPTOSIS; RESPONSES; PERFORIN; RECEPTOR; COMPLEX	The importance of CD8 T cells in the pathogenesis of organ-specific autoimmune diseases has not previously been well recognized. Recent evidence, however, indicates that autoreactive CD8 T cells can contribute substantially to tissue damage in both murine and human autoimmune disorders. As such, these T cells now become an attractive target for therapeutic intervention.	Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England; Toulouse Univ Hosp, INSERM U563, Toulouse, France; Toulouse Univ Hosp, Immunol Lab, Toulouse, France; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Bristol; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; University of Calgary	Wong, FS (corresponding author), Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England.	susan.wong@bristol.ac.uk; psantama@ucalgary.ca	Mars, Lennart T/K-7593-2014; Santamaria, Pere/ABF-6823-2021; Liblau, Roland/J-3530-2014	Mars, Lennart T/0000-0001-7997-1974; LIBLAU, Roland/0000-0001-5477-5475; Wong, F. Susan/0000-0002-2812-8845				Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Garza KM, 2002, EUR J IMMUNOL, V32, P885, DOI 10.1002/1521-4141(200203)32:3<885::AID-IMMU885>3.0.CO;2-E; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Green EA, 2000, J EXP MED, V191, P225, DOI 10.1084/jem.191.2.225; Green EA, 2000, IMMUNITY, V12, P459, DOI 10.1016/S1074-7613(00)80198-3; Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Kanagawa O, 2000, J IMMUNOL, V164, P5466, DOI 10.4049/jimmunol.164.10.5466; Kita H, 2002, J EXP MED, V195, P113, DOI 10.1084/jem.20010956; Medana IM, 2000, EUR J IMMUNOL, V30, P3623, DOI 10.1002/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F; Moriwaki M, 1999, DIABETOLOGIA, V42, P1332, DOI 10.1007/s001250051446; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Pakala SV, 1999, J EXP MED, V189, P1053, DOI 10.1084/jem.189.7.1053; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seewaldt S, 2000, DIABETES, V49, P1801, DOI 10.2337/diabetes.49.11.1801; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Suvannavejh GC, 2000, J CLIN INVEST, V105, P223, DOI 10.1172/JCI8561; Utz PJ, 1997, J EXP MED, V185, P843, DOI 10.1084/jem.185.5.843; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Vizler C, 1999, IMMUNOL REV, V169, P81; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	30	147	152	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2002	17	1					1	6		10.1016/S1074-7613(02)00338-2	http://dx.doi.org/10.1016/S1074-7613(02)00338-2			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	579PR	12150886	Bronze			2022-12-18	WOS:000177187500001
J	Ye, SK; Agata, Y; Lee, HC; Kurooka, H; Kitamura, T; Shimizu, A; Honjo, T; Ikuta, K				Ye, SK; Agata, Y; Lee, HC; Kurooka, H; Kitamura, T; Shimizu, A; Honjo, T; Ikuta, K			The IL-7 receptor controls the accessibility of the TCR gamma locus by Stat5 and histone acetylation	IMMUNITY			English	Article							INTERLEUKIN-7 RECEPTOR; V(D)J RECOMBINATION; GERMLINE TRANSCRIPTION; GENE REARRANGEMENT; ENHANCER; PROTEIN; ALPHA; P300; PCAF; INDUCTION	The IL-7 receptor (IL-7R) plays critical roles in expansion and V(D)J recombination during lymphocyte development. Here we demonstrate that cytokine stimulation rapidly recruits Stat5 and transcriptional coactivators to the Jy germline promoter and induces histone acetylation, germline transcription, and accessibility in Ba/F3 cells. We also show that histone acetylation of the TCR gamma locus is significantly reduced in IL-7R-deficient thymocytes and that the introduction of active Stat5 restores the histone acetylation and accessibility of the locus. Furthermore, treatment with histone deacetylase inhibitor recovers the histone acetylation and accessibility in IL-7R-deficient thymocytes. Therefore, these results suggest that Stat5 may recruit the transcriptional coactivators to the Jy germline promoter and control the accessibility of the TCR gamma locus by histone acetylation.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068507, Japan; Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Tokyo 1080071, Japan	Kyoto University; Kyoto University; University of Tokyo	Ikuta, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	ikuta@mfour.med.kyoto-u.ac.jp	Kitamura, Toshio/AAA-2071-2021; Honjo, Tasuku/N-4470-2016; Ye, Sang Kyu/J-2768-2012	Ikuta, Koichi/0000-0003-1319-1021; Agata, Yasutoshi/0000-0001-9642-6994				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Baker JE, 1999, J EXP MED, V190, P669, DOI 10.1084/jem.190.5.669; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Constantinescu A, 1997, J EXP MED, V185, P609, DOI 10.1084/jem.185.4.609; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lee HC, 2001, J IMMUNOL, V167, P320, DOI 10.4049/jimmunol.167.1.320; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; Makino K, 1996, COLLOID SURFACE B, V8, P93, DOI 10.1016/S0927-7765(96)01313-6; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Schlissel MS, 2000, J EXP MED, V191, P1045, DOI 10.1084/jem.191.6.1045; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Sleckman BP, 1998, IMMUNOL REV, V165, P121, DOI 10.1111/j.1600-065X.1998.tb01235.x; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; Whitelaw CBA, 1999, CYTOTECHNOLOGY, V31, P3, DOI 10.1023/A:1008044517150; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	36	147	147	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2001	15	5					813	823		10.1016/S1074-7613(01)00230-8	http://dx.doi.org/10.1016/S1074-7613(01)00230-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	498UE	11728342	Bronze			2022-12-18	WOS:000172528200013
J	Homann, D; Holz, A; Bot, A; Coon, B; Wolfe, T; Petersen, J; Dyrberg, TP; Grusby, MJ; von Herrath, MG				Homann, D; Holz, A; Bot, A; Coon, B; Wolfe, T; Petersen, J; Dyrberg, TP; Grusby, MJ; von Herrath, MG			Autoreactive CD4(+) T cells protect from autoimmune diabetes via bystander suppression using the IL-4/stat6 pathway	IMMUNITY			English	Article							MYELIN BASIC-PROTEIN; RESTRICTED CROSS-PRESENTATION; ORAL TOLERANCE; TRANSGENIC MICE; INDUCED ARTHRITIS; IMMUNE-RESPONSES; INTERFERON-GAMMA; VIRUS-INFECTION; IGE RESPONSES; II COLLAGEN	Targeted immune regulation can be achieved by use of tissue-specific T cells and offers the potential for organ-specific suppression of destructive autoimmune processes. Here, we report the generation and characterization of insulin B chain-specific "autoreactive" CD4(+) regulatory T cells that locally suppress diabetogenic T cell responses against an unrelated self-antigen (viral transgene) in a virus-induced model for type 1 diabetes. Interleukin 4 (IL-4) is essential for prevention of diabetes since regulatory T cells cannot be induced in the absence of IL-4 or stat6 (IL-4 signaling pathway). Our observations demonstrate that autoreactive regulatory T cells can suppress autoreactive destructive T cell activity of differential antigenic specificity locally in the pancreatic draining lymph node, probably via cytokine-mediated modulation of antigen-presenting cells.	Scripps Res Inst, Div Virol, Dept Neuropharmacol, La Jolla, CA 92037 USA; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Sch Publ Hlth, Dept Med, Boston, MA 02115 USA	Scripps Research Institute; Novo Nordisk; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	von Herrath, MG (corresponding author), Scripps Res Inst, Div Virol, Dept Neuropharmacol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	matthias@scripps.edu		Homann, Dirk/0000-0002-7622-5754; Holz, Andreas/0000-0002-8886-0915	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040171, R01AI040171, R01AI044451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK051091, R01DK051091] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40171, AI44451] Funding Source: Medline; NIDDK NIH HHS [DK51091] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKHTAR I, 1995, J EXP MED, V182, P87, DOI 10.1084/jem.182.1.87; ALSABBAGH A, 1994, EUR J IMMUNOL, V24, P2104, DOI 10.1002/eji.1830240926; BERGEROT I, 1994, J AUTOIMMUN, V7, P655, DOI 10.1006/jaut.1994.1050; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, J IMMUNOL, V155, P910; Chen YH, 1996, P NATL ACAD SCI USA, V93, P388, DOI 10.1073/pnas.93.1.388; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Gallichan WS, 1999, J IMMUNOL, V163, P1696; GARSIDE P, 1995, INT IMMUNOL, V7, P501, DOI 10.1093/intimm/7.3.501; GARSIDE P, 1995, J IMMUNOL, V154, P5649; Harrison LC, 1996, J EXP MED, V184, P2167, DOI 10.1084/jem.184.6.2167; Herbelin A, 1998, J IMMUNOL, V161, P2620; Homann D, 1999, J IMMUNOL, V163, P1833; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Ihle JN, 1998, ANN NY ACAD SCI, V865, P1, DOI 10.1111/j.1749-6632.1998.tb11157.x; Inobe J, 1998, EUR J IMMUNOL, V28, P2780, DOI 10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kapp JA, 1997, RES IMMUNOL, V148, P561, DOI 10.1016/S0923-2494(98)80150-8; Ke Y, 1997, J IMMUNOL, V158, P3610; Kurts C, 1999, NATURE, V398, P341, DOI 10.1038/18692; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; LEE MS, 1994, J CLIN INVEST, V93, P1332, DOI 10.1172/JCI117092; LIDER O, 1989, J IMMUNOL, V142, P748; Maron R, 1998, CLIN IMMUNOL IMMUNOP, V87, P85, DOI 10.1006/clin.1997.4506; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; MCMENAMIN C, 1995, J IMMUNOL, V154, P4390; Mengel J, 1995, IMMUNOL LETT, V48, P97, DOI 10.1016/0165-2478(95)02451-4; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; MILLER A, 1993, J IMMUNOL, V151, P7307; MUIR A, 1995, J CLIN INVEST, V95, P628, DOI 10.1172/JCI117707; NUSSENBLATT RB, 1990, J IMMUNOL, V144, P1689; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Polanski M, 1997, J AUTOIMMUN, V10, P339, DOI 10.1006/jaut.1997.0148; SEMPE P, 1994, DIABETOLOGIA, V37, P337, DOI 10.1007/BF00408468; Tada Y, 1996, J IMMUNOL, V156, P4520; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; VONHERRATH MG, 1994, J EXP MED, V180, P1901, DOI 10.1084/jem.180.5.1901; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; vonHerrath MG, 1996, J CLIN INVEST, V98, P1324, DOI 10.1172/JCI118919; vonHerrath MG, 1997, J EXP MED, V185, P531, DOI 10.1084/jem.185.3.531; VONHERRATH MG, 1997, ENDOCRINOL DIABETES, V105, P24; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; WILDNER G, 1995, EUR J IMMUNOL, V25, P1292, DOI 10.1002/eji.1830250524; Yoshida H, 1998, CLIN IMMUNOL IMMUNOP, V87, P282, DOI 10.1006/clin.1998.4538; YOSHINO S, 1995, ARTHRITIS RHEUM, V38, P1092, DOI 10.1002/art.1780380811; ZHANG ZYJ, 1990, J IMMUNOL, V145, P2489	50	147	153	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	1999	11	4					463	472		10.1016/S1074-7613(00)80121-1	http://dx.doi.org/10.1016/S1074-7613(00)80121-1			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549628	Bronze			2022-12-18	WOS:000083343100008
J	MINAMI, Y; NAKAGAWA, Y; KAWAHARA, A; MIYAZAKI, T; SADA, K; YAMAMURA, H; TANIGUCHI, T				MINAMI, Y; NAKAGAWA, Y; KAWAHARA, A; MIYAZAKI, T; SADA, K; YAMAMURA, H; TANIGUCHI, T			PROTEIN-TYROSINE KINASE SYK IS ASSOCIATED WITH AND ACTIVATED BY THE IL-2 RECEPTOR - POSSIBLE LINK WITH THE C-MYC INDUCTION PATHWAY	IMMUNITY			English	Article							CELL-ANTIGEN RECEPTOR; HUMAN INTERLEUKIN-2 RECEPTOR; T-CELL; BETA-CHAIN; SIGNAL-TRANSDUCTION; ZETA-CHAIN; SRC-FAMILY; GROWTH SIGNAL; GAMMA-CHAIN; GENE	The IL-2 receptor (IL-2R) consists of three subunits, the IL-2R alpha, IL-2R beta, and IL-2R gamma chains. The IL-2-induced proliferative signals emanate from the cytoplasmic domains of IL-2R beta and IL-2R gamma, but the nature and function of the signaling molecules that transmit these signals are not fully understood. Here, we report that Syk protein tyrosine kinase (PTK) is physically associated with IL-2R in peripheral blood lymphocytes. cDNA expression studies further revealed that this association is critical for the IL-2-induced activation of Syk PTK, which occurs primarily via the serinerich region of the IL-2R beta chain, which is essential for proliferative signal transmission. Furthermore, we provide evidence that in the hematopoietic cell line, BAF-BO3, the activation of Syk PTK results in the induction of the c-myc gene, an event critical for the cell proliferation. Thus, Syk PTK may be a critical integral member of the signaling molecules engaged by the IL-2R.	FUKUI MED SCH, DEPT BIOCHEM, MATSUOKA, FUKUI 91011, JAPAN	University of Fukui	MINAMI, Y (corresponding author), OSAKA UNIV, INST MOLEC & CELLULAR BIOL, 1-3 YAMADA OKA, SUITA, OSAKA 565, JAPAN.		Miyazaki, Tadaaki/D-9368-2012; Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100				AGARWAL A, 1993, J BIOL CHEM, V268, P15900; ASAHI M, 1993, J BIOL CHEM, V268, P23334; AUGUSTINE JA, 1991, MOL CELL BIOL, V11, P4431, DOI 10.1128/MCB.11.9.4431; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; CAMBIER JC, 1992, CURR OPIN IMMUNOL, V4, P257, DOI 10.1016/0952-7915(92)90074-O; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; COUTURE C, 1994, MOL CELL BIOL, V14, P5249, DOI 10.1128/MCB.14.8.5249; DOI T, 1989, EUR J IMMUNOL, V19, P2375, DOI 10.1002/eji.1830191229; EARDLEY DD, 1991, SCIENCE, V251, P78, DOI 10.1126/science.1824727; GREENE WC, 1986, ANNU REV IMMUNOL, V4, P69, DOI 10.1146/annurev.iy.04.040186.000441; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HATAKEYAMA M, 1992, P NATL ACAD SCI USA, V89, P2022, DOI 10.1073/pnas.89.6.2022; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; KAWAHARA A, 1994, MOL CELL BIOL, V14, P5433, DOI 10.1128/MCB.14.8.5433; KIENER PA, 1993, J BIOL CHEM, V268, P24442; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LAW CL, 1994, J BIOL CHEM, V269, P12310; MANO H, 1990, ONCOGENE, V5, P1781; MASLINSKI W, 1992, J BIOL CHEM, V267, P15281; MERIDA I, 1991, J IMMUNOL, V147, P2202; MERIDA I, 1990, P NATL ACAD SCI USA, V87, P9421, DOI 10.1073/pnas.87.23.9421; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.iy.11.040193.001333; MINAMI Y, 1993, EMBO J, V12, P759, DOI 10.1002/j.1460-2075.1993.tb05710.x; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; OKAMOTO Y, 1990, P NATL ACAD SCI USA, V87, P6584, DOI 10.1073/pnas.87.17.6584; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; QIN SF, 1994, FEBS LETT, V345, P233, DOI 10.1016/0014-5793(94)00450-1; REMILLARD B, 1991, J BIOL CHEM, V266, P14167; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SATOH T, 1992, J BIOL CHEM, V267, P25423; SHIBUYA H, 1990, NUCLEIC ACIDS RES, V18, P3697, DOI 10.1093/nar/18.13.3697; SHIBUYA H, 1992, CELL, V70, P57, DOI 10.1016/0092-8674(92)90533-I; SHIMOMURA R, 1993, BIOCHEM BIOPH RES CO, V192, P252, DOI 10.1006/bbrc.1993.1407; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; TRUITT KE, 1994, J BIOL CHEM, V269, P5937; TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YAMADA N, 1993, BIOCHEM BIOPH RES CO, V192, P231, DOI 10.1006/bbrc.1993.1404; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x; ZMUIDZINAS A, 1991, MOL CELL BIOL, V11, P2794, DOI 10.1128/MCB.11.5.2794	63	147	150	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	1995	2	1					89	100		10.1016/1074-7613(95)90081-0	http://dx.doi.org/10.1016/1074-7613(95)90081-0			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QC593	7600304	Bronze			2022-12-18	WOS:A1995QC59300008
J	Painter, MM; Mathew, D; Goel, RR; Apostolidis, SA; Pattekar, A; Kuthuru, O; Baxter, AE; Herati, RS; Oldridge, DA; Gouma, S; Hicks, P; Dysinger, S; Lundgreen, KA; Kuri-Cervantes, L; Adamski, S; Hicks, A; Korte, S; Giles, JR; Weirick, ME; McAllister, CM; Dougherty, J; Long, S; D'Andrea, K; Hamilton, JT; Betts, MR; Bates, P; Hensley, SE; Grifoni, A; Weiskopf, D; Sette, A; Greenplate, AR; Wherry, EJ				Painter, Mark M.; Mathew, Divij; Goel, Rishi R.; Apostolidis, Sokratis A.; Pattekar, Ajinkya; Kuthuru, Oliva; Baxter, Amy E.; Herati, Ramin S.; Oldridge, Derek A.; Gouma, Sigrid; Hicks, Philip; Dysinger, Sarah; Lundgreen, Kendall A.; Kuri-Cervantes, Leticia; Adamski, Sharon; Hicks, Amanda; Korte, Scott; Giles, Josephine R.; Weirick, Madison E.; McAllister, Christopher M.; Dougherty, Jeanette; Long, Sherea; D'Andrea, Kurt; Hamilton, Jacob T.; Betts, Michael R.; Bates, Paul; Hensley, Scott E.; Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro; Greenplate, Allison R.; Wherry, E. John			Rapid induction of antigen-specific CD4(+) T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination	IMMUNITY			English	Article							PROTECTIVE IMMUNITY; HUMAN EFFECTOR; MEMORY; RESPONSES; DISTINCT; DIFFERENTIATION; IDENTIFICATION; PHENOTYPE; INFECTION; SMALLPOX	SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific T cell analyses on healthy SARS-CoV-2-naive and recovered individuals prior to and following mRNA prime and boost vaccination. Vaccination induced rapid antigen-specific CD4(+) T cell responses in naive subjects after the first dose, whereas CD8(+) T cell responses developed gradually and were variable in magnitude. Vaccine-induced Th1 and Tfh cell responses following the first dose correlated with post-boost CD8(+) T cells and neutralizing antibodies, respectively. Integrated analysis revealed coordinated immune responses with distinct trajectories in SARS-CoV-2-naive and recovered individuals. Last, whereas booster vaccination improved T cell responses in SARS-CoV-2- naive subjects, the second dose had little effect in SARS-CoV-2-recovered individuals. These findings highlight the role of rapidly primed CD4(+) T cells in coordinating responses to the second vaccine dose in SARS-CoV-2-naive individuals.	[Painter, Mark M.; Mathew, Divij; Goel, Rishi R.; Apostolidis, Sokratis A.; Kuthuru, Oliva; Baxter, Amy E.; Oldridge, Derek A.; Kuri-Cervantes, Leticia; Giles, Josephine R.; Dougherty, Jeanette; Long, Sherea; D'Andrea, Kurt; Betts, Michael R.; Greenplate, Allison R.; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Painter, Mark M.; Mathew, Divij; Goel, Rishi R.; Apostolidis, Sokratis A.; Pattekar, Ajinkya; Adamski, Sharon; Hicks, Amanda; Korte, Scott; Hamilton, Jacob T.; Greenplate, Allison R.; Wherry, E. John] Univ Penn, Immune Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA; [Apostolidis, Sokratis A.] Univ Penn, Div Rheumatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Herati, Ramin S.] NYU, NYU Langone Vaccine Ctr, Dept Med, Sch Med, New York, NY 10016 USA; [Oldridge, Derek A.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gouma, Sigrid; Hicks, Philip; Dysinger, Sarah; Lundgreen, Kendall A.; Kuri-Cervantes, Leticia; Weirick, Madison E.; McAllister, Christopher M.; Hamilton, Jacob T.; Betts, Michael R.; Bates, Paul; Hensley, Scott E.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; New York University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; La Jolla Institute for Immunology	Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Immune Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu	Pattekar, Ajinkya/AHC-7838-2022; Sette, Alessandro/AFO-8916-2022; Pattekar, Dr. Ajinkya/AHC-7868-2022	Pattekar, Ajinkya/0000-0002-1416-1230; Pattekar, Dr. Ajinkya/0000-0002-1416-1230; Hamilton, Jacob/0000-0003-1277-6925; Painter, Mark M./0000-0002-0180-2748; McAllister, Christopher/0000-0002-0011-4089	NIH [AI105343, AI108545, AI155577, AI149680, AI152236, AI082630, HL143613, T32 AR076951-01, T32 CA009140, T32 AI055400, U19AI082630, 75N9301900065]; Allen Institute for Immunology; Cancer Research Institute-Mark Foundation Fellowship; Chen Family Research Fund; Parker Institute for Cancer Immunotherapy; Penn Center for Research on Coronavirus and Other Emerging Pathogens; University of Pennsylvania Perelman School of Medicine COVID Fund; University of Pennsylvania Perelman School of Medicine 21st Century Scholar Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute for Immunology; Cancer Research Institute-Mark Foundation Fellowship; Chen Family Research Fund; Parker Institute for Cancer Immunotherapy; Penn Center for Research on Coronavirus and Other Emerging Pathogens; University of Pennsylvania Perelman School of Medicine COVID Fund; University of Pennsylvania Perelman School of Medicine 21st Century Scholar Fund	We would like to thank the study participants for their generosity in making the study possible. We also thank Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak, the University of Pennsylvania Flow Cytometry Core, and the members of the Wherry lab for helpful discussions and feedback. This work was supported by grants from the NIH (AI105343, AI082630, AI108545, AI155577, and AI149680 to E.J.W.; AI152236 to P.B.; AI082630 to R.S.H.; HL143613 to J.R.G.; T32 AR076951-01 to S.A.A.; T32 CA009140 to J.R.G. and D.M.; T32 AI055400 to P.H.; and U19AI082630 to S.E.H. and E.J.W.), funding from the Allen Institute for Immunology (to S.A.A. and E.J.W.), a Cancer Research Institute-Mark Foundation Fellowship (to J.R.G.), the Chen Family Research Fund (to S.A.A.), the Parker Institute for Cancer Immunotherapy (to J.R.G. and E.J.W.), the Penn Center for Research on Coronavirus and Other Emerging Pathogens (to P.B.), the University of Pennsylvania Perelman School of Medicine COVID Fund (to R.R.G. and E.J.W.), the University of Pennsylvania Perelman School of Medicine 21st Century Scholar Fund (to R.R.G.), and a philanthropic gift from Jeffrey Lurie, Joel Embiid, Josh Harris, and David Blitzer (to S.E.H.). Work in the Wherry lab is supported by the Parker Institute for Cancer Immunotherapy. This work was also supported by NIH contract 75N9301900065 (to D.W. and A.S.).	Abu Jabal K, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.6.2100096; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Angyal A., 2021, OBSERVATIONAL COHORT; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bange EM, 2021, NAT MED, V27, P1280, DOI 10.1038/s41591-021-01386-7; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bradley T., 2021, 2021020321251078 MED, V2021; Camara C., 2021, 20210322436441 BIORX; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kalimuddin S, 2021, MED-CAMBRIDGE, V2, P682, DOI 10.1016/j.medj.2021.04.003; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Krawczyk CM, 2007, INFECT IMMUN, V75, P3556, DOI 10.1128/IAI.00086-07; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Levi R., 2021, CAUTIONARY NOTE RECA, DOI 10.1101/2021.02.01.21250923; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mazzoni A., 2021, 2021030521252590 MED; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Prendecki M, 2021, LANCET, V397, P1178, DOI 10.1016/S0140-6736(21)00502-X; Reiss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186998; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Samanovic Marie I, 2021, medRxiv, DOI 10.1101/2021.02.07.21251311; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Tarke A., 20210227433180 BIORX, V2021; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Woldemeskel BA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149335; Wu F, 2020, SSRN ELECT, DOI [10.1101/2020.03.30.20047365, DOI 10.2139/SSRN.3566211, https://doi.org/10.1101/2020.03.30.20047365]; Wurm H, 2020, MULT SCLER J, V26, P1261, DOI 10.1177/1352458520943791; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006	51	146	148	9	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2133	+		10.1016/j.immuni.2021.08.001	http://dx.doi.org/10.1016/j.immuni.2021.08.001		SEP 2021	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34453880	Green Published, Bronze			2022-12-18	WOS:000695789800019
J	Dougan, M; Dranoff, G; Dougan, SK				Dougan, Michael; Dranoff, Glenn; Dougan, Stephanie K.			GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation	IMMUNITY			English	Review							COLONY-STIMULATING FACTOR; RECEPTOR-ALPHA-CHAIN; ACUTE MYELOID-LEUKEMIA; CELL-REPLACING FACTOR; COMMON BETA-SUBUNIT; EOSINOPHIL DIFFERENTIATION FACTOR; HIGH-AFFINITY BINDING; BONE-MARROW-CELLS; MOLECULAR-CLONING; GROWTH-FACTOR	The beta common chain cytokines GM-CSF, IL-3, and IL-5 regulate varied inflammatory responses that promote the rapid clearance of pathogens but also contribute to pathology in chronic inflammation. Therapeutic interventions manipulating these cytokines are approved for use in some cancers as well as allergic and autoimmune disease, and others show promising early clinical activity. These approaches are based on our understanding of the inflammatory roles of these cytokir-s; however, GM-CSF also participates in the resolution of inflammation, and IL-3 and IL-5 may also have such properties. Here, we review the functions of the beta common cytokines in health and disease. We discuss preclinical and clinical data, highlighting the potential inherent in targeting these cytokine pathways, the limitations, and the important gaps understanding of the basic biology of this cytokine family.	[Dougan, Michael] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA; [Dougan, Michael] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dranoff, Glenn] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Dougan, Stephanie K.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Dougan, Stephanie K.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Dougan, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA.; Dougan, M (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Dranoff, G (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.; Dougan, SK (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Dougan, SK (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	mldougan@partners.org; glenn.dranoff@novartis.com; stephanie_dougan@dfci.harvard.edu			American Gastroenterological Association Research Scholars Award; NIH/NIDDK [1 K08 DK114563-01]; Hale Center for Pancreatic Cancer Research; Ludwig Center at Harvard;  [U01 CA224146-01]; NATIONAL CANCER INSTITUTE [U01CA224146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK114563] Funding Source: NIH RePORTER	American Gastroenterological Association Research Scholars Award; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hale Center for Pancreatic Cancer Research; Ludwig Center at Harvard; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.D. received funding from an American Gastroenterological Association Research Scholars Award and NIH/NIDDK grant 1 K08 DK114563-01. S.K.D. was funded by the Hale Center for Pancreatic Cancer Research, the Ludwig Center at Harvard, and grant U01 CA224146-01 and is a Pew -Stewart Scholar for Cancer Research.	Adachi T, 1999, J IMMUNOL, V162, P1496; Al-Hussaini M, 2016, BLOOD, V127, P122, DOI 10.1182/blood-2014-05-575704; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; AZUMA C, 1986, NUCLEIC ACIDS RES, V14, P9149, DOI 10.1093/nar/14.22.9149; Ballestrero A, 1999, J CLIN ONCOL, V17, P1296, DOI 10.1200/JCO.1999.17.4.1296; Barry SC, 1997, BLOOD, V89, P842, DOI 10.1182/blood.V89.3.842; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; BELL AL, 1995, RHEUMATOL INT, V14, P177, DOI 10.1007/BF00262295; Bhattacharya P, 2011, J LEUKOCYTE BIOL, V89, P235, DOI 10.1189/jlb.0310154; Bjermer L, 2016, CHEST, V150, P789, DOI 10.1016/j.chest.2016.03.032; Bommareddy PK, 2017, AM J CLIN DERMATOL, V18, P1, DOI 10.1007/s40257-016-0238-9; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Broughton SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02633-7; Broughton SE, 2016, STRUCTURE, V24, P1271, DOI 10.1016/j.str.2016.05.017; Broughton SE, 2014, ACTA CRYSTALLOGR F, V70, P358, DOI 10.1107/S2053230X14002593; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Burmester GR, 2018, ARTHRITIS RHEUMATOL, V70, P679, DOI 10.1002/art.40420; Burmester GR, 2017, ANN RHEUM DIS, V76, P1020, DOI 10.1136/annrheumdis-2016-210624; Busfield SJ, 2014, LEUKEMIA, V28, P2213, DOI 10.1038/leu.2014.128; CAMPBELL HD, 1987, P NATL ACAD SCI USA, V84, P6629, DOI 10.1073/pnas.84.19.6629; Carr PD, 2006, ACTA CRYSTALLOGR F, V62, P509, DOI 10.1107/S1744309106016812; Carr PD, 2014, BIOCHEM J, V463, P393, DOI 10.1042/BJ20140863; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Carrieri PB, 1998, IMMUNOPHARM IMMUNOT, V20, P373, DOI 10.3109/08923979809034820; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; Chitta S, 2008, IMMUNOL LETT, V116, P41, DOI 10.1016/j.imlet.2007.11.013; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Cook AD, 2011, ARTHRITIS RHEUM-US, V63, P2340, DOI 10.1002/art.30354; CORNELIS S, 1995, EUR J IMMUNOL, V25, P1857, DOI 10.1002/eji.1830250710; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Dabritz J, 2015, J IMMUNOL, V194, P2424, DOI 10.4049/jimmunol.1401482; Dahl ME, 2000, GENES CELLS, V5, P143, DOI 10.1046/j.1365-2443.2000.00312.x; Dey R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005188; Dougan M, 2011, J CLIN INVEST, V121, P2436, DOI 10.1172/JCI44796; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Dranoff G, 1997, HUM GENE THER, V8, P111, DOI 10.1089/hum.1997.8.1-111; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duncker PC, 2018, J IMMUNOL, V200, P966, DOI 10.4049/jimmunol.1701484; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Enzler T, 2007, BLOOD, V110, P954, DOI 10.1182/blood-2006-08-043786; Evans CA, 2002, BLOOD, V100, P3164, DOI 10.1182/blood-2001-12-0235; Feng YP, 1996, J MOL BIOL, V259, P524, DOI 10.1006/jmbi.1996.0337; Finotti G, 2016, CYTOKINE, V86, P124, DOI 10.1016/j.cyto.2016.08.005; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; FUNG MC, 1984, NATURE, V307, P233, DOI 10.1038/307233a0; GANSER A, 1991, AM J CLIN ONCOL-CANC, V14, pS51, DOI 10.1097/00000421-199112001-00010; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Gopisetty A, 2013, J IMMUNOL, V190, P5516, DOI 10.4049/jimmunol.1202298; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0; Goyal G, 2018, CANCER IMMUNOL RES, V6, P723, DOI 10.1158/2326-6066.CIR-17-0612; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Greven DEA, 2015, ANN RHEUM DIS, V74, P1924, DOI 10.1136/annrheumdis-2014-205234; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; He SZ, 2015, LEUKEMIA LYMPHOMA, V56, P1406, DOI 10.3109/10428194.2014.956316; HERCUS TR, 1994, P NATL ACAD SCI USA, V91, P5838, DOI 10.1073/pnas.91.13.5838; Hibbs ML, 2007, J IMMUNOL, V178, P6435, DOI 10.4049/jimmunol.178.10.6435; Hiroi T, 1999, J IMMUNOL, V162, P821; Hirota K, 2018, IMMUNITY, V48, P1220, DOI 10.1016/j.immuni.2018.04.009; HITOSHI Y, 1991, INT IMMUNOL, V3, P135, DOI 10.1093/intimm/3.2.135; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; HODI FS, 2014, JAMA-J AM MED ASSOC, V312, P1744, DOI [DOI 10.1001/JAMA.2014.13943, DOI 10.1001/jama.2014.13943]; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; Hwang K, 2013, HISTOPATHOLOGY, V62, P764, DOI 10.1111/his.12079; ICHIHARA M, 1995, EMBO J, V14, P939, DOI 10.1002/j.1460-2075.1995.tb07075.x; IHLE JN, 1982, J IMMUNOL, V129, P2431; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Ishino T, 2008, CYTOKINE, V42, P179, DOI 10.1016/j.cyto.2007.12.010; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; JOHANSON K, 1995, J BIOL CHEM, V270, P9459, DOI 10.1074/jbc.270.16.9459; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kavuru MS, 2000, AM J RESP CRIT CARE, V161, P1143, DOI 10.1164/ajrccm.161.4.9906044; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KINDLER V, 1986, P NATL ACAD SCI USA, V83, P1001, DOI 10.1073/pnas.83.4.1001; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Klein BK, 1997, J BIOL CHEM, V272, P22630, DOI 10.1074/jbc.272.36.22630; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; KOENDERMAN L, 1993, BLOOD, V81, P2413; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; KURIMOTO Y, 1989, J EXP MED, V170, P467, DOI 10.1084/jem.170.2.467; Kusano S, 2012, PROTEIN SCI, V21, P850, DOI 10.1002/pro.2072; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Liu KQ, 2015, LIFE SCI, V122, P59, DOI 10.1016/j.lfs.2014.10.013; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; LOPEZ AF, 1992, P NATL ACAD SCI USA, V89, P11842, DOI 10.1073/pnas.89.24.11842; Luke JJ, 2015, CANCER IMMUNOL RES, V3, P986, DOI 10.1158/2326-6066.CIR-15-0066; Mach N, 1998, BLOOD, V91, P778; Masuda A, 2002, J IMMUNOL, V169, P3801, DOI 10.4049/jimmunol.169.7.3801; MATSUMOTO R, 1989, IMMUNOLOGY, V66, P32; MCKENZIE ANJ, 1991, EMBO J, V10, P1193, DOI 10.1002/j.1460-2075.1991.tb08060.x; Mehta HM, 2015, J IMMUNOL, V195, P1341, DOI 10.4049/jimmunol.1500861; METCALF D, 1974, J CELL PHYSIOL, V84, P275, DOI 10.1002/jcp.1040840214; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; METCALF D, 1983, BLOOD, V61, P999; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Morton Thomas A., 1994, Journal of Molecular Recognition, V7, P47, DOI 10.1002/jmr.300070107; Nair P, 2017, NEW ENGL J MED, V376, P2448, DOI 10.1056/NEJMoa1703501; Nishinakamura R, 1996, BLOOD, V88, P2458, DOI 10.1182/blood.V88.7.2458.bloodjournal8872458; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; OKAYAMA Y, 1993, CLIN EXP ALLERGY, V23, P901, DOI 10.1111/j.1365-2222.1993.tb00274.x; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; OShaughnessy JA, 1996, BLOOD, V87, P2205, DOI 10.1182/blood.V87.6.2205.bloodjournal8762205; Palmeri S, 1999, HAEMATOLOGICA, V84, P1016; Panousis C, 2016, MABS-AUSTIN, V8, P436, DOI 10.1080/19420862.2015.1119352; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; Patino E, 2011, STRUCTURE, V19, P1864, DOI 10.1016/j.str.2011.08.015; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; PLUZNIK DH, 1966, EXP CELL RES, V43, P553, DOI 10.1016/0014-4827(66)90026-7; Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Salter BM, 2015, J ALLERGY CLIN IMMUN, V136, P1636, DOI 10.1016/j.jaci.2015.03.039; SANDERSON CJ, 1986, P NATL ACAD SCI USA, V83, P437, DOI 10.1073/pnas.83.2.437; SANDERSON CJ, 1985, J EXP MED, V162, P60, DOI 10.1084/jem.162.1.60; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Scibek JJ, 2002, ANAL BIOCHEM, V307, P258, DOI 10.1016/S0003-2697(02)00043-X; SEDGWICK JB, 1995, J ALLERGY CLIN IMMUN, V96, P375, DOI 10.1016/S0091-6749(95)70057-9; Sharma M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan0829; Sheih A, 2017, MUCOSAL IMMUNOL, V10, P705, DOI 10.1038/mi.2016.90; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; SWAIN SL, 1982, J EXP MED, V156, P1821, DOI 10.1084/jem.156.6.1821; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; TAKAKI S, 1994, MOL CELL BIOL, V14, P7404, DOI 10.1128/MCB.14.11.7404; TAKATSU K, 1980, J IMMUNOL, V124, P2414; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Tettamanti S, 2013, BRIT J HAEMATOL, V161, P389, DOI 10.1111/bjh.12282; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; TOMIOKA K, 1993, J IMMUNOL, V151, P4989; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227; VITETTA ES, 1984, IMMUNOL REV, V78, P137, DOI 10.1111/j.1600-065X.1984.tb00480.x; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Waghray M, 2016, CANCER DISCOV, V6, P886, DOI 10.1158/2159-8290.CD-15-0947; WARREN DJ, 1985, IMMUNOLOGY, V54, P615; Weaver CH, 2000, J CLIN ONCOL, V18, P43, DOI 10.1200/JCO.2000.18.1.43; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Wechsler ME, 2017, NEW ENGL J MED, V376, P1921, DOI 10.1056/NEJMoa1702079; WEISS M, 1993, BLOOD, V82, P3298; WELLS TNC, 1994, ANN NY ACAD SCI, V725, P118, DOI 10.1111/j.1749-6632.1994.tb39796.x; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Wu C, 2018, J CLIN INVEST, V128, P3425, DOI 10.1172/JCI97973; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yanagibashi T, 2017, CYTOKINE, V98, P59, DOI 10.1016/j.cyto.2016.11.011; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; Zaks-Zilberman M, 2008, J BIOL CHEM, V283, P13398, DOI 10.1074/jbc.M710230200	189	146	152	10	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					796	811		10.1016/j.immuni.2019.03.022	http://dx.doi.org/10.1016/j.immuni.2019.03.022			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995500	Bronze			2022-12-18	WOS:000464660800004
J	Bunker, JJ; Bendelac, A				Bunker, Jeffrey J.; Bendelac, Albert			IgA Responses to Microbiota	IMMUNITY			English	Review							SEGMENTED FILAMENTOUS BACTERIA; SECRETORY IMMUNOGLOBULIN-A; MEMORY B-CELLS; CLASS SWITCH RECOMBINATION; MUCOSAL IMMUNE-SYSTEM; FOXP3(+) T-CELLS; FC-ALPHA-RI; PLASMA-CELLS; PEYERS-PATCHES; GUT IGA	Various immune mechanisms are deployed in the mucosa to confront the immense diversity of resident bacteria. A substantial fraction of the commensal microbiota is coated with immunoglobulin A (IgA) antibodies, and recent findings have established the identities of these bacteria under homeostatic and disease conditions. Here we review the current understanding of IgA biology, and present a framework wherein two distinct types of humoral immunity coexist in the gastrointestinal mucosa. Homeostatic IgA responses employ a polyreactive repertoire to bind a broad but taxonomically distinct subset of microbiota. In contrast, mucosal pathogens and vaccines elicit high-affinity, T cell-dependent antibody responses. This model raises fundamental questions including how polyreactive IgA specificities are generated, how these antibodies exert effector functions, and how they exist together with other immune responses during homeostasis and disease.	[Bunker, Jeffrey J.; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bunker, Jeffrey J.; Bendelac, Albert] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Bendelac, A (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Bunker, Jeffrey/0000-0002-9351-7003	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038339, F30AI124476, R37AI038339, R01AI108643, U01AI125250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bakema JE, 2011, MUCOSAL IMMUNOL, V4, P612, DOI 10.1038/mi.2011.36; BARROS MD, 1985, ALLERGOL IMMUNOPATH, V13, P331; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bergqvist P, 2010, J IMMUNOL, V184, P3545, DOI 10.4049/jimmunol.0901895; Blanc P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13600; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Dzidic M, 2017, J ALLERGY CLIN IMMUN, V139, P1017, DOI 10.1016/j.jaci.2016.06.047; Fadlallah J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1217; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fernandez MI, 2003, IMMUNITY, V18, P739, DOI 10.1016/S1074-7613(03)00122-5; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Gerth AJ, 2004, GASTROENTEROLOGY, V126, P1115, DOI 10.1053/j.gastro.2004.01.013; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; GUYGRAND D, 1975, J IMMUNOL, V115, P361; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hendrickx APA, 2015, MBIO, V6, DOI 10.1128/mBio.01346-15; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iversen R, 2017, CELL REP, V20, P2357, DOI 10.1016/j.celrep.2017.08.036; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kanai T, 2006, INFLAMM BOWEL DIS, V12, P89, DOI 10.1097/01.MIB.0000197237.21387.mL; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; KLEMOLA T, 1988, J PEDIATR GASTR NUTR, V7, P537, DOI 10.1097/00005176-198807000-00010; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; Kroese F G, 1996, Semin Immunol, V8, P11, DOI 10.1006/smim.1996.0003; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; Mathias A, 2011, J BIOL CHEM, V286, P17239, DOI 10.1074/jbc.M110.209015; MATTIOLI CA, 1973, J EXP MED, V138, P452, DOI 10.1084/jem.138.2.452; MCWILLIAMS M, 1977, J EXP MED, V145, P866, DOI 10.1084/jem.145.4.866; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moro-Sibilot L, 2016, GASTROENTEROLOGY, V151, P311, DOI 10.1053/j.gastro.2016.04.014; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Murphy K., 2016, JANEWAYS IMMUNOBIOLO, DOI DOI 10.1201/9781315533247; Mussmann R, 1996, EUR J IMMUNOL, V26, P2823, DOI 10.1002/eji.1830261205; Ng EK, 2003, MEDIAT INFLAMM, V12, P3, DOI 10.1080/0962935031000096917; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Peterson DA, 2015, J BIOL CHEM, V290, P12630, DOI 10.1074/jbc.M114.633800; Phalipon A, 2003, TRENDS IMMUNOL, V24, P55, DOI 10.1016/S1471-4906(02)00031-5; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Prigent J, 2016, EUR J IMMUNOL, V46, P2340, DOI 10.1002/eji.201646446; Quan CP, 1997, INFECT IMMUN, V65, P3997, DOI 10.1128/IAI.65.10.3997-4004.1997; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Rollenske T, 2018, NAT IMMUNOL, V19, P617, DOI 10.1038/s41590-018-0106-2; ROUX ME, 1977, J EXP MED, V146, P1311, DOI 10.1084/jem.146.5.1311; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Schickel JN, 2017, J EXP MED, V214, P1991, DOI 10.1084/jem.20160201; Shimoda M, 1999, IMMUNOLOGY, V97, P9, DOI 10.1046/j.1365-2567.1999.00755.x; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285; STOKES CR, 1975, NATURE, V255, P745, DOI 10.1038/255745a0; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Uo M, 2013, GUT, V62, P1734, DOI 10.1136/gutjnl-2012-303063; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Viladomiu M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9655; WALKER WA, 1977, NEW ENGL J MED, V297, P767, DOI 10.1056/NEJM197710062971407; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Wang Y, 2017, MUCOSAL IMMUNOL, V10, P373, DOI 10.1038/mi.2016.57; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; WEISZCARRINGTON P, 1977, J IMMUNOL, V119, P1306; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wilmore JR, 2018, CELL HOST MICROBE, V23, P302, DOI 10.1016/j.chom.2018.01.005; Wilson E, 2004, J EXP MED, V200, P805, DOI 10.1084/jem.20041069; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	141	146	147	5	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					211	224		10.1016/j.immuni.2018.08.011	http://dx.doi.org/10.1016/j.immuni.2018.08.011			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134201	Green Accepted, Bronze			2022-12-18	WOS:000442354500008
J	Yu, XY; Buttgereit, A; Lelios, I; Utz, SG; Cansever, D; Becher, B; Greter, M				Yu, Xueyang; Buttgereit, Anne; Lelios, Iva; Utz, Sebastian G.; Cansever, Dilay; Becher, Burkhard; Greter, Melanie			The Cytokine TGF-beta Promotes the Development and Homeostasis of Alveolar Macrophages	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; EPIDERMAL LANGERHANS CELLS; GM-CSF; GROWTH-FACTOR; DENDRITIC CELLS; FETAL MONOCYTES; PPAR-GAMMA; EXPRESSION PROFILES; GENE-EXPRESSION; MICE	Alveolar macrophages (AMs) derive from fetal liver monocytes, which colonize the lung during embryonic development and give rise to fully mature AMs perinatally. AM differentiation requires granulocyte macrophage colony-stimulating factor (GM-CSF), but whether additional factors are involved in AM regulation is not known. Here we report that AMs, in contrast to most other tissue macrophages, were also dependent on transforming growth factor-beta receptor (TGF-beta R) signaling. Conditional deletion of TGF-beta R in mice at different time points halted the development and differentiation of AMs. In adult mice, TGF-beta was also critical for AM homeostasis. The source of TGF-beta was AMs themselves, indicative of an autocrine loop that promotes AM self-maintenance. Mechanistically, TGF-beta R signaling resulted in upregulation of PPAR-gamma, a signature transcription factor essential for the development of AMs. These findings reveal an additional layer of complexity regarding the guidance cues, which govern the genesis, maturation, and survival of AMs.	[Yu, Xueyang; Buttgereit, Anne; Lelios, Iva; Utz, Sebastian G.; Cansever, Dilay; Becher, Burkhard; Greter, Melanie] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland	University of Zurich	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	greter@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Yu, Xueyang/0000-0003-1372-5353; Greter, Melanie/0000-0002-7220-5369	Swiss National Science Foundation [BSSGI0_155832, PP00P3_144781, 310030_170320, 316030_150768]; NeuroKine; ATECT	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NeuroKine; ATECT	This work was supported by grants from the Swiss National Science Foundation (BSSGI0_155832, PP00P3_144781, 310030_170320, 316030_150768 for M.G. and B.B.) and NeuroKine, ATECT (B.B.). We thank Vinko Tosevski and Florian Mair for technical help and flow cytometry sorting; the flow cytometry core facility; Jennifer Jaberg, Sabrina Nemetz, Mirjam Lutz, and Jan Candreia for technical support; Petra Paul, Florent Ginhoux and Zhaoyuan Liu for reagents and discussions; Manfred Kopf, Steffen Jung, and Martin Hausmann for providing mice; the Microbiology and Immunology PhD program; Jelena Kuuhn-Georgijevic and Lennart Opitz for performing the next generation sequencing analysis at the Functional Genomics Center Zurich (FGCZ).	Abnaof K, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-55; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coker RK, 1996, EUR RESPIR J, V9, P2501, DOI 10.1183/09031936.96.09122501; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dove DE, 2005, AM J PHYSIOL-CELL PH, V288, pC586, DOI 10.1152/ajpcell.00210.2004; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Lu RQ, 2001, J BIOL CHEM, V276, P45491, DOI 10.1074/jbc.C100421200; LUNDGREN CH, 1994, CIRCULATION, V90, P1927, DOI 10.1161/01.CIR.90.4.1927; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; RAMIREZ A, 2012, PPAR RES, pNIL1, DOI DOI 10.1155/2012/375876; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Watari K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19470; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zahner SP, 2011, J IMMUNOL, V187, P5069, DOI 10.4049/jimmunol.1101880; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414	64	146	147	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					903	+		10.1016/j.immuni.2017.10.007	http://dx.doi.org/10.1016/j.immuni.2017.10.007			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29126797	Bronze, Green Submitted			2022-12-18	WOS:000416483700014
J	Licona-Limon, P; Henao-Mejia, J; Temann, AU; Gagliani, N; Licona-Limon, I; Ishigame, H; Hao, LM; Herbert, DR; Flavell, RA				Licona-Limon, Paula; Henao-Mejia, Jorge; Temann, Angela U.; Gagliani, Nicola; Licona-Limon, Ileana; Ishigame, Harumichi; Hao, Liming; Herbert, De'Broski R.; Flavell, Richard A.			Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection	IMMUNITY			English	Article							T-CELLS; TGF-BETA; MAST-CELLS; IL-9; EXPRESSION; INTERLEUKIN-9; RESPONSES; PROMOTES; DIFFERENTIATION; EOSINOPHILIA	Type 2 inflammatory cytokines, including interleukin-4 (IL-4), IL-5, IL-9, and IL-13, drive the characteristic features of immunity against parasitic worms and allergens. Whether IL-9 serves an essential role in the initiation of host-protective responses is controversial, and the importance of IL-9-versus IL-4-producing CD4(+) effector T cells in type 2 immunity is incompletely defined. Herein, we generated IL-9-deficient and IL-9-fluorescent reporter mice that demonstrated an essential role for this cytokine in the early type 2 immunity against Nippostrongylus brasiliensis. Whereas T helper 9 (Th9) cells and type 2 innate lymphoid cells (ILC2s) were major sources of infection-induced IL-9 production, the adoptive transfer of Th9 cells, but not Th2 cells, caused rapid worm expulsion, marked basophilia, and increased mast cell numbers in Rag2-deficient hosts. Taken together, our data show a critical and nonredundant role for Th9 cells and IL-9 in host-protective type 2 immunity against parasitic worm infection.	[Licona-Limon, Paula; Henao-Mejia, Jorge; Gagliani, Nicola; Licona-Limon, Ileana; Ishigame, Harumichi; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Temann, Angela U.] Fraunhofer Ctr Mol Biotechnol, Newark, DE 19711 USA; [Hao, Liming] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Herbert, De'Broski R.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94110 USA; [Herbert, De'Broski R.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Herbert, De'Broski R.] Ctr Trauma, San Francisco, CA 94110 USA; [Licona-Limon, Ileana] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico	Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Universidad Nacional Autonoma de Mexico	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Herbert, De'Broski/J-7357-2012; Herbert, DeBroski/AAD-3035-2019	Herbert, De'Broski/0000-0002-2449-5365; Herbert, DeBroski/0000-0002-2449-5365; Gagliani, Nicola/0000-0001-8514-1395	PEW Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083204] Funding Source: NIH RePORTER	PEW Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Strowig and N. Palm for critical reading of the manuscript and helpful discussion, J. Stein and L. Evangelisti for help in the generation of mouse strains, T. Taylor and G. Tokmoulina for help with cell sorting, and C. Lieber for help in submitting the manuscript. R. A. F is an investigator of the Howard Hughes Medical Institute. P. L. L was supported by a postdoctoral fellowship from PEW Charitable Trust: PEW Latin American Fellow Program in Biomedical Sciences.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dodd JS, 2009, J IMMUNOL, V183, P7006, DOI 10.4049/jimmunol.0900085; Dong Q, 1999, EUR J IMMUNOL, V29, P2130, DOI 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Fallon PG, 2000, INFECT IMMUN, V68, P6005, DOI 10.1128/IAI.68.10.6005-6011.2000; Faulkner H, 1997, EUR J IMMUNOL, V27, P2536, DOI 10.1002/eji.1830271011; Faulkner H, 1998, INFECT IMMUN, V66, P3832, DOI 10.1128/IAI.66.8.3832-3840.1998; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Knoops L, 2005, J IMMUNOL, V175, P335, DOI 10.4049/jimmunol.175.1.335; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PETITFRERE C, 1993, IMMUNOLOGY, V79, P146; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073/pnas.97.2.767; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; SCHMITT E, 1994, J IMMUNOL, V153, P3989; SCHMITT E, 1989, EUR J IMMUNOL, V19, P2167, DOI 10.1002/eji.1830191130; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wilhelm C, 2012, NAT IMMUNOL, V13, P637, DOI 10.1038/ni.2303; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Yao WG, 2011, J ALLERGY CLIN IMMUN, V128, P1357, DOI 10.1016/j.jaci.2011.06.019	48	146	151	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					744	757		10.1016/j.immuni.2013.07.020	http://dx.doi.org/10.1016/j.immuni.2013.07.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138883	Bronze, Green Accepted			2022-12-18	WOS:000330950000015
J	Brain, O; Owens, BMJ; Pichulik, T; Allan, P; Khatamzas, E; Leslie, A; Steevels, T; Sharma, S; Mayer, A; Catuneanu, AM; Morton, V; Sun, MY; Jewell, D; Coccia, M; Harrison, O; Maloy, K; Schonefeldt, S; Bornschein, S; Liston, A; Simmons, A				Brain, Oliver; Owens, Benjamin M. J.; Pichulik, Tica; Allan, Philip; Khatamzas, Elham; Leslie, Alasdair; Steevels, Tessa; Sharma, Sameer; Mayer, Alice; Catuneanu, Ana Maria; Morton, Victoria; Sun, Mei-Yi; Jewell, Derek; Coccia, Margherita; Harrison, Oliver; Maloy, Kevin; Schoenefeldt, Susann; Bornschein, Simon; Liston, Adrian; Simmons, Alison			The Intracellular Sensor NOD2 Induces MicroRNA-29 Expression in Human Dendritic Cells to Limit IL-23 Release	IMMUNITY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INNATE IMMUNE-RESPONSES; HUMAN MONOCYTIC CELLS; HELPER T-CELLS; NF-KAPPA-B; CROHNS-DISEASE; ESCHERICHIA-COLI; INTESTINAL INFLAMMATION; INTERFERON-GAMMA; LYMPHOID-CELLS	NOD2 is an intracellular sensor that contributes to immune defense and inflammation. Here we investigated whether NOD2 mediates its effects through control of microRNAs (miRNAs). miR-29 expression was upregulated in human dendritic cells (DCs) in response to NOD2 signals, and miR-29 regulated the expression of multiple immune mediators. In particular, miR-29 downregulated interleukin-23 (IL-23) by targeting IL-12p40 directly and IL-23p19 indirectly, likely via reduction of ATF2. DSS-induced colitis was worse in miR-29-deficient mice and was associated with elevated IL-23 and T helper 17 signature cytokines in the intestinal mucosa. Crohn's disease (CD) patient DCs expressing NOD2 polymorphisms failed to induce miR-29 upon pattern recognition receptor stimulation and showed enhanced release of IL-12p40 on exposure to adherent invasive E. coli. Therefore, we suggest that loss of miR-29-mediated immunoregulation in CD DCs might contribute to elevated IL-23 in this disease.	[Brain, Oliver; Owens, Benjamin M. J.; Allan, Philip; Steevels, Tessa; Sharma, Sameer; Catuneanu, Ana Maria; Morton, Victoria; Jewell, Derek; Simmons, Alison] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DS, England; [Brain, Oliver; Pichulik, Tica; Allan, Philip; Khatamzas, Elham; Leslie, Alasdair; Steevels, Tessa; Sharma, Sameer; Mayer, Alice; Catuneanu, Ana Maria; Morton, Victoria; Sun, Mei-Yi; Simmons, Alison] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; [Coccia, Margherita; Harrison, Oliver; Maloy, Kevin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Schoenefeldt, Susann; Bornschein, Simon; Liston, Adrian] VIB, Autoimmune Genet Lab, B-3000 Louvain, Belgium; [Schoenefeldt, Susann; Bornschein, Simon; Liston, Adrian] Univ Louvain, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	University of Oxford; University of Oxford; University of Oxford; Flanders Institute for Biotechnology (VIB)	Simmons, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DS, England.	alison.simmons@imm.ox.ac.uk	Liston, Adrian/G-8606-2013; Mayer, A/AAM-2083-2021	Liston, Adrian/0000-0002-6272-4085; Mayer, A/0000-0002-6859-0612; Maloy, Kevin/0000-0001-5795-7688; Coccia, Margherita/0000-0003-1947-4735; Simmons, Alison/0000-0003-3454-0710; leslie, alasdair/0000-0003-2538-6467; Allan, Philip/0000-0003-2682-772X; Owens, Benjamin/0000-0003-4710-6841	UK Medical Research Council; UK Higher Education Funding Council; Oxford NIHR Biomedical Research Centre; Sir Jules Thorn Trust; Wellcome Trust; Marie Curie Fellowship; Digestive Disorders Foundation; National Association for Crohn's and Colitis; Barbour Trust in Memory of Simon Ash; VIB; European Research Council; Medical Research Council [MC_UU_12010/7] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; MRC [MC_UU_12010/7] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Higher Education Funding Council; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Sir Jules Thorn Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Fellowship(European Commission); Digestive Disorders Foundation; National Association for Crohn's and Colitis; Barbour Trust in Memory of Simon Ash; VIB; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Fiona Powrie and Holm Uhlig for helpful discussions and our Crohn's patients who generously gave blood samples for this study. The authors are supported by the UK Medical Research Council (T. P., A. S.), the UK Higher Education Funding Council, Oxford NIHR Biomedical Research Centre, and the Sir Jules Thorn Trust (A. S.), the Wellcome Trust (B.M.J.O., S. S., P. A., E. K., A. S., K. M.), Marie Curie Fellowship (T. S.), Digestive Disorders Foundation and National Association for Crohn's and Colitis and The Barbour Trust in Memory of Simon Ash (O.B.), the VIB and the European Research Council (A.L.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lapaquette P, 2012, CELL MICROBIOL, V14, P791, DOI 10.1111/j.1462-5822.2012.01768.x; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Polidoros AN, 2009, PHYSIOL PLANTARUM, V137, P342, DOI 10.1111/j.1399-3054.2009.01284.x; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Yang SH, 2001, INFECT IMMUN, V69, P2045, DOI 10.1128/IAI.69.4.2045-2053.2001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	54	146	155	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					521	536		10.1016/j.immuni.2013.08.035	http://dx.doi.org/10.1016/j.immuni.2013.08.035			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054330	Bronze			2022-12-18	WOS:000330949600015
J	Mitoma, H; Hanabuchi, S; Kim, T; Bao, MS; Zhang, ZQ; Sugimoto, N; Liu, YJ				Mitoma, Hiroki; Hanabuchi, Shino; Kim, Taeil; Bao, Musheng; Zhang, Zhiqiang; Sugimoto, Naoshi; Liu, Yong-Jun			The DHX33 RNA Helicase Senses Cytosolic RNA and Activates the NLRP3 Inflammasome	IMMUNITY			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; RIG-I; DENDRITIC CELLS; ANTIVIRAL RESPONSES; INTRACELLULAR DNA; CYTOPLASMIC DNA; BACTERIAL RNA; CASPASE-1; RECOGNITION	The NLRP3 inflammasome plays a major role in innate immune responses by activating caspase-1, resulting in secretion of interleukin-18 (IL-18) and IL-1 beta. Although cytosolic double-stranded RNA (dsRNA) and bacterial RNA are known to activate the NLRP3 inflammasome, the upstream sensor is unknown. We investigated the potential function of DExD/H-box RNA helicase family members (previously shown to sense cytosolic DNA and RNA to induce type 1 interferon responses) in RNA-induced NLRP3 inflammasome activation. Among the helicase family members tested, we found that targeting of DHX33 expression by short hairpin RNA efficiently blocked the activation of caspase-1 and secretion of IL-18 and IL-1 beta in human macrophages that were activated by cytosolic poly I:C, reoviral RNA, or bacterial RNA. DHX33 bound dsRNA via the helicase C domain. DHX33 interacted with NLRP3 and formed the inflammasome complex following stimulation with RNA. We therefore identified DHX33 as a cytosolic RNA sensor that activates the NLRP3 inflammasome.	[Mitoma, Hiroki; Hanabuchi, Shino; Kim, Taeil; Bao, Musheng; Zhang, Zhiqiang; Sugimoto, Naoshi; Liu, Yong-Jun] Baylor Hlth Care Syst, Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Mitoma, Hiroki; Hanabuchi, Shino; Kim, Taeil; Bao, Musheng; Zhang, Zhiqiang; Sugimoto, Naoshi; Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Dept Immunol, Houston, TX 77054 USA	Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Liu, YJ (corresponding author), Baylor Hlth Care Syst, Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA.	yong-jun.liu@baylorhealth.edu	Hanabuchi, Shino/AAI-8676-2021		US National Institutes of Health [R37 AI091947]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI091947] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank M. Wentz (MD Anderson Cancer Center) and C. Harrod (Baylor Institute for Immunology Research) for critical reading of the manuscript, S. Clayton (Baylor Institute for Immunology Research) for technical assistance, and all colleagues in our laboratory for helpful discussions. H. M. is a Research Fellow of the Japan Society for the Promotion of Science in Tokyo, Japan. This work was supported by the US National Institutes of Health (R37 AI091947).	Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez I, 2002, J GEN VIROL, V83, P1445, DOI [10.1099/0022-1317-83-6-1445, 10.1099/vir.0.18337-0]; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang NN, 2008, P NATL ACAD SCI USA, V105, P10553, DOI 10.1073/pnas.0804895105; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	44	146	150	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					123	135		10.1016/j.immuni.2013.07.001	http://dx.doi.org/10.1016/j.immuni.2013.07.001			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23871209	Bronze, Green Accepted			2022-12-18	WOS:000330948300013
J	Sakai, J; Li, JY; Subramanian, KK; Mondal, S; Bajrami, B; Hattori, H; Jia, YH; Dickinson, BC; Zhong, J; Ye, KQ; Chang, CJ; Ho, YS; Zhou, J; Luo, HBR				Sakai, Jiro; Li, Jingyu; Subramanian, Kulandayan K.; Mondal, Subhanjan; Bajrami, Besnik; Hattori, Hidenori; Jia, Yonghui; Dickinson, Bryan C.; Zhong, Jia; Ye, Keqiang; Chang, Christopher J.; Ho, Ye-Shih; Zhou, Jun; Luo, Hongbo R.			Reactive Oxygen Species-Induced Actin Glutathionylation Controls Actin Dynamics in Neutrophils	IMMUNITY			English	Article							S-GLUTATHIONYLATION; SIGNAL-TRANSDUCTION; LUNG INFLAMMATION; BETA-ACTIN; REDOX; GLUTAREDOXIN; MICE	The regulation of actin dynamics is pivotal for cellular processes such as cell adhesion, migration, and phagocytosis and thus is crucial for neutrophils to fulfill their roles in innate immunity. Many factors have been implicated in signal-induced actin polymerization, but the essential nature of the potential negative modulators are still poorly understood. Here we report that NADPH oxidase-dependent physiologically generated reactive oxygen species (ROS) negatively regulate actin polymerization in stimulated neutrophils via driving reversible actin glutathionylation. Disruption of glutaredoxin 1 (Grx1), an enzyme that catalyzes actin deglutathionylation, increased actin glutathionylation, attenuated actin polymerization, and consequently impaired neutrophil polarization, chemotaxis, adhesion, and phagocytosis. Consistently, Grx1-deficient murine neutrophils showed impaired in vivo recruitment to sites of inflammation and reduced bactericidal capability. Together, these results present a physiological role for glutaredoxin and ROS- induced reversible actin glutathionylation in regulation of actin dynamics in neutrophils.	[Sakai, Jiro; Li, Jingyu; Subramanian, Kulandayan K.; Mondal, Subhanjan; Bajrami, Besnik; Hattori, Hidenori; Jia, Yonghui; Zhong, Jia; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sakai, Jiro; Li, Jingyu; Subramanian, Kulandayan K.; Mondal, Subhanjan; Bajrami, Besnik; Hattori, Hidenori; Jia, Yonghui; Zhong, Jia; Luo, Hongbo R.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Sakai, Jiro; Li, Jingyu; Subramanian, Kulandayan K.; Mondal, Subhanjan; Bajrami, Besnik; Hattori, Hidenori; Jia, Yonghui; Zhong, Jia; Luo, Hongbo R.] Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA; [Li, Jingyu; Zhou, Jun] Nankai Univ, Tianjin Key Lab Prot Sci, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Ye, Keqiang] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30307 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Ho, Ye-Shih] Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI 48202 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Nankai University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Emory University; Wayne State University; Wayne State University	Luo, HBR (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	hongbo.luo@childrens.harvard.edu	Li, Jingyu/GSD-1924-2022; Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260; Sakai, Jiro/0000-0002-2526-2766	NIH [HL085100, GM076084, GM 79465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085100, P01HL095489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076084, R01GM079465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Silberstein, J. Manis, and L. Chai for helpful discussions and Y. Janssen-Heininger (The University of Vermont) for preparing and sending Grx1<SUP>-/-</SUP> mice. H.R.L. is supported by NIH grants HL085100 and GM076084. C.J.C. is supported by NIH GM 79465 and is an investigator with the Howard Hughes Medical Institute. J.S., J.L., and K.K.S. designed and carried out experiments, analyzed data, and prepared the manuscript. B.B., S.M., H.H., Y.J., KY., and J.Z. helped with designing experiments, analyzing data, and evaluating the manuscript. J.Z. bred mice. B.C.D. and C.J.C. synthesized and provided PF6-AM and Y.-S.H. provided Grx1<SUP>-/-</SUP> mice. H.R.L. designed experiments, analyzed data, and wrote the paper.	Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; Clavreul N, 2006, ARTERIOSCL THROM VAS, V26, P2454, DOI 10.1161/01.ATV.0000242791.28953.4c; Dalle-Donne I, 2003, FREE RADICAL BIO MED, V34, P23, DOI 10.1016/S0891-5849(02)01182-6; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; Hattori H, 2007, BLOOD, V110, P640, DOI 10.1182/blood-2006-11-059048; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Johansson Magnus, 2007, BMC Biochemistry, V8, P26, DOI 10.1186/1471-2091-8-26; Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Leichert LI, 2006, ANTIOXID REDOX SIGN, V8, P763, DOI 10.1089/ars.2006.8.763; Loefgren S, 2008, INVEST OPHTH VIS SCI, V49, P4497, DOI 10.1167/iovs.07-1404; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Subramanian KK, 2009, HUM ANAT PHYSIOL, P127; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014	33	146	151	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					1037	1049		10.1016/j.immuni.2012.08.017	http://dx.doi.org/10.1016/j.immuni.2012.08.017			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23159440	Bronze, Green Accepted			2022-12-18	WOS:000312575000012
J	Zeng, X; Wei, YL; Huang, J; Newell, EW; Yu, HX; Kidd, BA; Kuhns, MS; Waters, RW; Davis, MM; Weaver, CT; Chien, YH				Zeng, Xun; Wei, Yu-Ling; Huang, Jun; Newell, Evan W.; Yu, Hongxiang; Kidd, Brian A.; Kuhns, Michael S.; Waters, Ray W.; Davis, Mark M.; Weaver, Casey T.; Chien, Yueh-hsiu			gamma delta T Cells Recognize a Microbial Encoded B Cell Antigen to Initiate a Rapid Antigen-Specific Interleukin-17 Response	IMMUNITY			English	Article							INTERFERON-GAMMA; STRUCTURAL BASIS; IMMUNE-RESPONSE; RECEPTORS; MEMORY; INFECTION; BINDING; PHYCOERYTHRIN; PLASTICITY; SIGNALS	gamma delta T cells contribute uniquely to immune competence. Nevertheless, how they function remains an enigma. It is unclear what most gamma delta T cells recognize, what is required for them to mount an immune response, and how the gamma delta T cell response is integrated into host immune defense. Here, we report that a noted B cell antigen, the algae protein phycoerythrin (PE), is a murine and human gamma delta T cell antigen. Employing this specificity, we demonstrated that antigen recognition activated naive gamma delta T cells to make interleukin-17 and respond to cytokine signals that perpetuate the response. High frequencies of antigen-specific gamma delta T cells in naive animals and their ability to mount effector response without extensive clonal expansion allow gamma delta T cells to initiate a swift, substantial response. These results underscore the adaptability of lymphocyte antigen receptors and suggest an antigen-driven rapid response in protective immunity prior to the maturation of classical adaptive immunity.	[Zeng, Xun; Wei, Yu-Ling; Huang, Jun; Newell, Evan W.; Kidd, Brian A.; Kuhns, Michael S.; Davis, Mark M.; Chien, Yueh-hsiu] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Yu, Hongxiang] Stanford Univ, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.; Chien, Yueh-hsiu] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Waters, Ray W.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Davis, Mark M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Stanford University; Stanford University; Stanford University; United States Department of Agriculture (USDA); Howard Hughes Medical Institute; University of Alabama System; University of Alabama Birmingham	Chien, YH (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	chien@stanford.edu	Newell, Evan W/F-9711-2012; Zeng, Xun/HHM-7791-2022	Newell, Evan W/0000-0002-2889-243X; Davis, Mark/0000-0001-6868-657X; Weaver, Casey/0000-0002-2180-1793; Kidd, Brian/0000-0003-2110-1145	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI080829, T32AI007290, U19AI090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Pereira, L. Puddington, and L. Lefrancois for V gamma specific antibodies; R. Hardy for anti-PE monoclonal antibody; D. Cua for IL-23R-GFP.KI reporter mouse spleen; F. Fang for the FQQ1 gamma delta TCR transfectant; K. Jensen for advice and encouragement at an earlier stage of this work; S. Davis for manuscript editing; the Burt and Marion Avery endowment; and the National Institutes of Health for grant support (to Y.C.). Author contributions are as follows: X.Z., Y.-L.W., J.H., E.W.N., H.Y., B.A.K., and Y.-H.C. designed experiments; X.Z., Y.-L.W., J.H., E.W.N., H.Y., and B.A.K. carried out experiments, with J.H., E.W.N., H.Y., and B.A.K. contributing equivalently to this work. M.S.K., R.W.W., M.M.D., and C.T.W. provided unique protocols, reagents, and/or equipment; Y.-H.C. and B.A.K. wrote the manuscript with input from all authors.	APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; DeFranco A., 2007, IMMUNITY IMMUNE RESP; Deng L, 2010, P NATL ACAD SCI USA, V107, P13408, DOI 10.1073/pnas.1005475107; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kapsenberg ML, 2009, IMMUNITY, V31, P181, DOI 10.1016/j.immuni.2009.08.004; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; R Core Team, 2017, R LANGUAGE ENVIRONME; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; TAKIZAWA F, 1993, J IMMUNOL METHODS, V162, P269, DOI 10.1016/0022-1759(93)90392-K; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; vanVugt MJ, 1996, BLOOD, V88, P2358, DOI 10.1182/blood.V88.6.2358.bloodjournal8862358; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; WU CJ, 1991, IMMUNOLOGY, V72, P48; Xu B, 2011, P NATL ACAD SCI USA, V108, P2414, DOI 10.1073/pnas.1015433108; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	42	146	147	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 21	2012	37	3					524	534		10.1016/j.immuni.2012.06.011	http://dx.doi.org/10.1016/j.immuni.2012.06.011			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22960222	Bronze, Green Accepted			2022-12-18	WOS:000309199000016
J	Husebye, H; Aune, MH; Stenvik, J; Samstad, E; Skjeldal, F; Halaas, O; Nilsen, NJ; Stenmark, H; Latz, E; Lien, E; Mollnes, TE; Bakke, O; Espevik, T				Husebye, Harald; Aune, Marie Hjelmseth; Stenvik, Jorgen; Samstad, Eivind; Skjeldal, Frode; Halaas, Oyvind; Nilsen, Nadra J.; Stenmark, Harald; Latz, Eicke; Lien, Egil; Mollnes, Tom Eirik; Bakke, Oddmund; Espevik, Terje			The Rab11a GTPase Controls Toll-like Receptor 4-Induced Activation of Interferon Regulatory Factor-3 on Phagosomes	IMMUNITY			English	Article							GRAM-NEGATIVE BACTERIA; GOLGI-APPARATUS; EPITHELIAL-CELLS; LIPOPOLYSACCHARIDE; PHAGOCYTOSIS; TLR4; PATHWAYS; COMPLEX; MD-2; TOLL-LIKE-RECEPTOR-4	Toll-like receptor 4 (TLR4) is indispensable for recognition of Gram-negative bacteria We described a trafficking pathway for TLR4 from the endocytic recycling compartment (ERC) to E coli phagosomes We found a prominent colocalization between TLR4 and the small GTPase Rab11a in the ERC, and Rab11a was involved in the recruitment of TLR4 to phagosomes in a process requiring TLR4 signaling Also, Toll-receptor-associated molecule (TRAM) and interferon regulatory factor-3 (IRF3) localized to E coli phagosomes and internalization of E coli was required for a robust interleron-beta induction Suppression of Rab11a reduced TLR4 in the ERC and on phagosomes leading to inhibition of the IRF3 signaling pathway induced by E coli, whereas activation of the transcription factor NF-kappa B was unaffected Moreover, Rab11a silencing reduced the amount of TRAM on phagosomes Thus, Rab11a is an important regulator of TLR4 and TRAM transport to E coli phagosomes thereby controlling IRF3 activation from this compartment	[Husebye, Harald; Aune, Marie Hjelmseth; Stenvik, Jorgen; Samstad, Eivind; Halaas, Oyvind; Nilsen, Nadra J.; Stenmark, Harald; Latz, Eicke; Lien, Egil; Espevik, Terje] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway; [Mollnes, Tom Eirik] Univ Oslo, Univ Hosp, Rikshosp, Inst Immunol, N-0027 Oslo, Norway; [Skjeldal, Frode; Bakke, Oddmund] Univ Oslo, Dept Mol Biosci, Ctr Immune Regulat, N-0316 Oslo, Norway; [Stenmark, Harald] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway; [Latz, Eicke] Univ Bonn, Biomed Ctr, Inst Innate Immun, D-53127 Bonn, Germany; [Lien, Egil] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Bakke, Oddmund] Univ Bergen, Gade Inst, N-5021 Bergen, Norway; [Espevik, Terje] St Olavs Hosp, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; University of Bergen; Norwegian University of Science & Technology (NTNU)	Espevik, T (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7489 Trondheim, Norway.		Stenmark, Harald/B-8868-2008; Latz, Eicke/H-3951-2014; Nilsen, Nadra/G-5592-2017; Halaas, Øyvind/O-2197-2015; Mollnes, Tom/ABI-5183-2020	Latz, Eicke/0000-0003-1488-5666; Nilsen, Nadra/0000-0003-0407-1060; Halaas, Øyvind/0000-0002-7968-2483; Husebye, Harald/0000-0002-8828-1059; Bakke, Oddmund/0000-0003-4843-7626	Norwegian Research Council; Norwegian Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318, R01AI083713] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Norwegian Research Council and the Norwegian Cancer Society The imaging experiments have been per formed with equipment and expertise located at the NORMic subcellular imaging nodes in Trondheim and in Oslo	Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Espevik T, 2003, SCAND J INFECT DIS, V35, P660, DOI 10.1080/00365540310016493; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; Halaas O, 2007, ADV EXP MED BIOL, V598, P35; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862; JOHNSTON RB, 1969, J EXP MED, V129, P1275, DOI 10.1084/jem.129.6.1275; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lapierre LA, 2003, EXP CELL RES, V290, P322, DOI 10.1016/S0014-4827(03)00340-9; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Misaki R, 2007, BIOCHEM BIOPH RES CO, V360, P580, DOI 10.1016/j.bbrc.2007.06.101; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Uronen-Hansson H, 2004, IMMUNOLOGY, V111, P173, DOI 10.1111/j.0019-2805.2003.01803.x; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Wei J, 2009, BIOCHEMISTRY-US, V48, P549, DOI 10.1021/bi8020197; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	36	146	149	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 29	2010	33	4					583	596		10.1016/j.immuni.2010.09.010	http://dx.doi.org/10.1016/j.immuni.2010.09.010			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	681GU	20933442	Bronze			2022-12-18	WOS:000284300200015
J	Di Paolo, NC; Miao, EA; Iwakura, Y; Murali-Krishna, K; Aderem, A; Flavell, RA; Papayannopoulou, T; Shayakhmetov, DM				Di Paolo, Nelson C.; Miao, Edward A.; Iwakura, Yoichiro; Murali-Krishna, Kaja; Aderem, Alan; Flavell, Richard A.; Papayannopoulou, Thalia; Shayakhmetov, Dmitry M.			Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1 alpha-Mediated Proinflammatory Macrophage Response In Vivo	IMMUNITY			English	Article							VASCULAR ENDOTHELIAL-CELLS; INNATE IMMUNE-RESPONSE; ADENOVIRAL VECTORS; MICE DEFICIENT; EPITHELIAL-CELLS; GENE-EXPRESSION; RIG-I; ACTIVATION; INFECTION; TOXICITY	The recognition of viral components by host pattern-recognition receptors triggers the induction of the antiviral innate immune response. Toll-like receptor 9 (TLR9) and NLRP3 inflammasome were shown to be the principal specific sensors of viral double-stranded DNA. Here we present evidence that macrophages in vivo activated an innate immune response to a double-stranded DNA virus, adenovirus (Ad), independently of TLR9 or NLRP3 inflammasome. In response to Ad, macrophage-derived IL-1 alpha triggered IL-1RI-dependent production of a defined set of proinflammatory cytokines and chemokines. The IL-1 alpha-mediated response required a selective interaction of virus arginine-glycine-aspartic acid (RGD) motifs with macrophage beta(3) integrins. Thus, these data identify IL-1 alpha-IL-1RI as a key pathway allowing for the activation of proinflammatory responses to the virus, independently of its genomic nucleic acid recognition.	[Di Paolo, Nelson C.; Shayakhmetov, Dmitry M.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Murali-Krishna, Kaja] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Papayannopoulou, Thalia] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Aderem, Alan] Inst Syst Biol, Seattle, WA 98103 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB); University of Tokyo; Japan Science & Technology Agency (JST); Howard Hughes Medical Institute; Yale University; Yale University	Shayakhmetov, DM (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	dshax@u.washington.edu	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Miao, Edward/0000-0001-7295-3490; Kaja, Murali Krishna/0000-0002-6275-1710	US NIH [A1025032, A1062853, A1064882, A1065429]; NATIONAL CANCER INSTITUTE [R01CA141439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064882, R21AI062853, R01AI065429, R37AI025032, R01AI025032] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are thankful to C. Wilson (University of Washington, Seattle, WA) for stimulating discussions. We are grateful to S. Akira (Osaka University, Japan) and J.-I. Inoue (University of Tokyo, Japan) for providing knockout mice. We are thankful to A. Byrnes (US Food and Drug Administration) for providing ts 1 virus. We are grateful to M. Barry and S. Hoffher (Mayo Clinic, Rochester, MN) for asHughes Medical Institute. This study was supported by US NIH grants A1025032 to A.A. and A1062853, A1064882, and A1065429 to D.M.S.	Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Chang CH, 2003, CELL IMMUNOL, V221, P37, DOI 10.1016/S0008-8749(03)00058-3; Chang CH, 2002, J VIROL, V76, P427, DOI 10.1128/JVI.76.1.427-431.2002; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Mosier DE, 2000, IMMUNOL RES, V21, P253, DOI 10.1385/IR:21:2-3:253; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Schoggins JW, 2006, J VIROL, V80, P10634, DOI 10.1128/JVI.01359-06; Shayakhmetov DM, 2005, J IMMUNOL, V174, P7310, DOI 10.4049/jimmunol.174.11.7310; Shayakhmetov DM, 2005, J VIROL, V79, P1053, DOI 10.1128/JVI.79.2.1053-1061.2005; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Worgall S, 1997, HUM GENE THER, V8, P37, DOI 10.1089/hum.1997.8.1-37; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06; Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505; Zubieta C, 2005, MOL CELL, V17, P319, DOI 10.1016/j.molcel.2005.01.004	45	146	151	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					110	121		10.1016/j.immuni.2009.04.015	http://dx.doi.org/10.1016/j.immuni.2009.04.015			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19576795	Bronze, Green Accepted			2022-12-18	WOS:000268219900016
J	Johnson, K; Hashimshony, T; Sawai, CM; Pongubala, JMR; Skok, JA; Aifantis, L; Singh, H				Johnson, Kristen; Hashimshony, Tamar; Sawai, Catherine M.; Pongubala, Jagan M. R.; Skok, Jane A.; Aifantis, Lannis; Singh, Harinder			Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling	IMMUNITY			English	Article							B-CELL DEVELOPMENT; KAPPA LOCUS ACTIVATION; LYMPHOCYTE DEVELOPMENT; GENE REARRANGEMENTS; INTRONIC ENHANCER; BONE-MARROW; DIFFERENTIATION; EXPRESSION; PROTEIN; STAGE	Productive rearrangement of the immunoglobulin heavy-chain locus triggers a major developmental checkpoint that promotes limited clonal expansion of pre-B cells, thereby culminating in cell-cycle arrest and rearrangement of light-chain loci. By using Irf4(-/-) Irf8(-/-) pre-B cells, we demonstrated that two pathways converge to synergistically drive light-chain rearrangement, but not simply as a consequence of cell-cycle exit. One pathway was directly dependent on transcription factor IRF-4, whose expression was elevated by pre-B cell receptor signaling. IRF-4 targeted the immunoglobulin 3 ' E kappa and E lambda enhancers and positioned a kappa allele away from pericentromeric heterochromatin. The other pathway was triggered by attenuation of IL-7 signaling and activated the iE kappa enhancer via binding of the transcription factor E2A. IRF-4 also regulated expression of chemokine receptor Cxcr4 and promoted migration of pre-B cells in response to the chemokine ligand CXCL12. We propose that IRF-4 coordinates the two pathways regulating light-chain recombination by positioning pre-B cells away from IL-7-expressing stromal cells.	[Pongubala, Jagan M. R.; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Johnson, Kristen; Hashimshony, Tamar; Pongubala, Jagan M. R.; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Sawai, Catherine M.; Aifantis, Lannis] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Sawai, Catherine M.; Skok, Jane A.; Aifantis, Lannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, London W1T 4JF, England	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; New York University; University of London; University College London	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, 929 East 57th St,GCIS W522, Chicago, IL 60637 USA.	hsingh@uchicago.edu	Sawai, Catherine M/E-5023-2018; Skok, Jane/ABF-7249-2020	Sawai, Catherine M/0000-0002-2509-474X; Skok, Jane/0000-0002-4145-1516	NATIONAL CANCER INSTITUTE [R01CA105129] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01CA105129] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; GRAWUNDER U, 1993, INT IMMUNOL, V5, P1609, DOI 10.1093/intimm/5.12.1609; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2004, J EXP MED, V200, P1205, DOI 10.1084/jem.20041135; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lazorchak AS, 2006, MOL CELL BIOL, V26, P810, DOI 10.1128/MCB.26.3.810-821.2006; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Milne CD, 2004, EUR J IMMUNOL, V34, P2647, DOI 10.1002/eji.200425400; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Sato H, 2004, J IMMUNOL, V172, P4858, DOI 10.4049/jimmunol.172.8.4858; Schlissel MS, 2004, IMMUNOL REV, V200, P215, DOI 10.1111/j.0105-2896.2004.00157.x; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Van de Wiele CJV, 2004, J IMMUNOL, V172, P4235, DOI 10.4049/jimmunol.172.7.4235; Xu SL, 2007, BLOOD, V109, P3377, DOI 10.1182/blood-2006-07-036418; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	40	146	149	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					335	345		10.1016/j.immuni.2007.12.019	http://dx.doi.org/10.1016/j.immuni.2007.12.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18280186	Bronze			2022-12-18	WOS:000254142500011
J	Neuenhahn, M; Kerksiek, KM; Nauerth, M; Suhre, MH; Schiemann, M; Gebhardt, FE; Stemberger, C; Panthel, K; Schroder, S; Chakraborty, T; Jung, S; Hochrein, H; Russmann, H; Brocker, T; Busch, DH				Neuenhahn, Michael; Kerksiek, Kristen M.; Nauerth, Magdalena; Suhre, Michael H.; Schiemann, Matthias; Gebhardt, Friedemann E.; Stemberger, Christian; Panthel, Klaus; Schroeder, Samira; Chakraborty, Trinad; Jung, Steffen; Hochrein, Hubertus; Ruessmann, Holger; Brocker, Thomas; Busch, Dirk H.			CD8 alpha(+) dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen	IMMUNITY			English	Article							SPLENIC MARGINAL ZONE; IN-VIVO DEPLETION; CD8(+) T-CELLS; BACTERIAL-INFECTION; CROSS-PRESENTATION; IMMUNE-RESPONSES; SURFACE PROTEIN; E-CADHERIN; ANTIGEN; POPULATIONS	In addition to their bridging function between innate and adaptive immunity, dendritic cells (DCs) may also contribute to primary resistance against infection. Here we analyzed the role of DCs during infection with Listeria monocytogenes by performing systemic in vivo depletion of these cells. We showed that CD8 alpha(+) DCs were crucial for L. monocytogenes spreading and proliferation in the spleen. Efficient and rapid uptake of L. monocytogenes by CD8 alpha(+) DCs required the small GTPase Rac1 and is a general characteristic of this DC subpopulation in filtering particles out of the blood. Thus, CD8 alpha(+) DCs appear to play an important role for efficient bacterial entry into the spleen, which is of relevance for subsequent immune responses.	Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Inst Hlth & Environm, GSF, Clin Cooperat Grp Antigen Specif Immunotherapy, D-85764 Neuherberg, Germany; Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; Univ Giessen, Inst Med Microbiol, D-35392 Giessen, Germany; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Justus Liebig University Giessen; Weizmann Institute of Science	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	dirk.busch@lrz.tum.de	Jung, Steffen/K-1409-2012; Suhre, Michael H./C-5145-2009; Hochrein, Hubertus/L-3697-2013	Jung, Steffen/0000-0003-4290-5716; Suhre, Michael H./0000-0002-2279-7765; Brocker, Thomas/0000-0001-7060-5433; Hochrein, Hubertus/0000-0001-9904-1934				Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chaussabel D, 2003, LAB INVEST, V83, P1373, DOI 10.1097/01.LAB.0000087587.93781.6F; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Engelich G, 2001, J LEUKOCYTE BIOL, V69, P50; GAIDANO G, 1990, LEUKEMIA, V4, P682; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HUSTER KM, 2004, NOVEL VACCINATION ST, P89; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; O'Keeffe M, 2003, BLOOD, V101, P1453, DOI 10.1182/blood-2002-03-0974; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Schiemann M, 2003, EUR J IMMUNOL, V33, P2875, DOI 10.1002/eji.200324224; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; Wang YQ, 2006, INT J MOL MED, V17, P637; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	49	146	147	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					619	630		10.1016/j.immuni.2006.07.017	http://dx.doi.org/10.1016/j.immuni.2006.07.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17027298	Bronze			2022-12-18	WOS:000241481500013
J	Li, PW; Willie, ST; Bauer, S; Morris, DL; Spies, T; Strong, RK				Li, PW; Willie, ST; Bauer, S; Morris, DL; Spies, T; Strong, RK			Crystal structure of the MHC class I homolog MIC-A, a gamma delta T cell ligand	IMMUNITY			English	Article							NEONATAL FC RECEPTOR; TRANSFERRIN RECEPTOR; NUCLEOTIDE-SEQUENCE; MOLECULES; COMPLEX; RECOGNITION; GENE; GAMMA/DELTA; EXPRESSION; PEPTIDES	The major histocompatibility complex (MHC) class I homolog MIC-A functions as a stress-inducible antigen that is recognized by a subset of gamma delta T cells independent of beta(2)-microglobulin and bound peptides. Its crystal structure reveals a dramatically altered MHC class I fold, both in detail and overall domain organization. The only remnant of a peptide-binding groove is a small cavity formed as the result of disordering a large section of one of the groove-defining helices. Loss of beta(2)-microglobulin binding is due to a restructuring of the interaction interfaces. Structural mapping of sequence variation suggests potential receptor binding sites on the underside of the platform on the side opposite of the surface recognized by alpha beta T cell receptors on MHC class I-peptide complexes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Strong, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Bauer, Stefan/0000-0002-8462-1845	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030581, R37AI030581] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30581] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allison J P, 1990, Semin Immunol, V2, P59; Bahram S, 1996, IMMUNOGENETICS, V44, P80, DOI 10.1007/s002510050092; Bahram S, 1996, IMMUNOGENETICS, V43, P230, DOI 10.1007/BF00587305; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1998, ACTA CRYSTALLOGR D, V54, P451, DOI 10.1107/S0907444997015229; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.biochem.59.1.253; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; BRUNGER AT, 1987, X PLOR VERSION 3 1 S; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CHIEN YH, 1995, CURR BIOL, V5, P1116, DOI 10.1016/S0960-9822(95)00225-9; Collaborative Computational Project, 1994, ACTA CRYST D, V50, P760; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Fodil N, 1996, IMMUNOGENETICS, V44, P351, DOI 10.1007/s002510050136; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; RAMMENSEE HG, 1993, CURR OPIN IMMUNOL, V5, P35, DOI 10.1016/0952-7915(93)90078-7; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Steinle A, 1998, P NATL ACAD SCI USA, V95, P12510, DOI 10.1073/pnas.95.21.12510; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	36	146	165	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	1999	10	5					577	584		10.1016/S1074-7613(00)80057-6	http://dx.doi.org/10.1016/S1074-7613(00)80057-6			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	203LP	10367903	Bronze			2022-12-18	WOS:000080709400009
J	Radic, MZ; Zouali, M				Radic, MZ; Zouali, M			Receptor editing, immune diversification, and self-tolerance	IMMUNITY			English	Review							IMMUNOGLOBULIN HEAVY-CHAIN; KAPPA-GENE REARRANGEMENT; B-CELL DIFFERENTIATION; LYN-DEFICIENT MICE; MOUSE BONE-MARROW; DELETION MECHANISM; AUTOIMMUNE-DISEASE; ESCAPE TOLERANCE; VK GENES; DNA	Over the last few years, our knowledge of the mechanisms that control the development of B cells and shape their repertoire has expanded rapidly, with description of a number of novel cellular and molecular pathways. Among these, receptor editing is unique because it enables B cells to alter their immunoglobulin variable (V) region genes and, consequently, change the specificity of the B cell receptor (BCR) expressed at their surface. This remarkable property provides clues to long-standing questions pertaining to the fate of cells developing in the bone marrow, The majority of B lymphocytes that arise in the bone marrow do not migrate to peripheral organs to participate in an immune response but, instead, undergo apoptosis and are disposed of by resident macrophages (Osmond et al., 1994), Two reasons for the death of immature B cells are the nonproductive assembly of the heavy (H) or light (L) chain gene segments and the generation of BCR that react against self, A third, related reason is that B cells may undergo apoptosis after they have exhausted their potential for additional V gene rearrangements. The displacement of productive rearrangements by additional, productive rearrangements on the same allele may be accomplished by secondary rearrangement at the H chain locus resulting in H chain replacement, or by secondary L chain V gene rearrangements, resulting in L chain editing. Thus, receptor editing depends on the capacity of variable light (VL) and heavy (VH) genes to undergo successive rearrangements. It may provide an alternative to apoptosis of immature B lymphocytes in the bone marrow if it occurs during the 16-18 hr period after cross-linking of the BCR, but before irreversible commitment to apoptosis (Rothstein, 1996), As will be discussed here, secondary rearrangements have now been described in a number of systems. Although formal proof that they are triggered by antigen encounter is lacking, mounting evidence suggests that some secondary rearrangements are a result of receptor engagement. Receptor editing not only diversifies the repertoire, but also may allow B cells to avoid high affinity autorecognition. Hence, receptor editing has implications with regard to maintenance of B cell tolerance and, possibly, to the induction of pathogenic autoimmunity.	INST PASTEUR,DEPT IMMUNOL,F-75015 PARIS,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Radic, MZ (corresponding author), ALLEGHENY UNIV HLTH SCI,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19129, USA.			Zouali, Moncef/0000-0002-8225-456X; Radic, Marko/0000-0002-8004-282X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034881] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34881] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENSIMON C, 1994, EMBO J, V13, P2951, DOI 10.1002/j.1460-2075.1994.tb06593.x; BROKAW JL, 1992, INT IMMUNOL, V4, P197, DOI 10.1093/intimm/4.2.197; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CATON AJ, 1990, J EXP MED, V172, P815, DOI 10.1084/jem.172.3.815; CHEN C, 1994, J IMMUNOL, V152, P1970; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; CHEN C, 1997, IN PRESS IMMUNITY; COMBRIATO G, 1991, EUR J IMMUNOL, V21, P1513, DOI 10.1002/eji.1830210627; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; COVEY LR, 1990, INT IMMUNOL, V2, P579, DOI 10.1093/intimm/2.6.579; DEANE M, 1990, NUCLEIC ACIDS RES, V18, P1652, DOI 10.1093/nar/18.6.1652; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GHIA P, 1995, EUR J IMMUNOL, V25, P3108, DOI 10.1002/eji.1830251118; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hikida M, 1996, SCIENCE, V274, P2092, DOI 10.1126/science.274.5295.2092; HUBER C, 1992, EUR J IMMUNOL, V22, P1561, DOI 10.1002/eji.1830220632; Huck S, 1996, CLIN IMMUNOL IMMUNOP, V80, P1, DOI 10.1006/clin.1996.0087; HUCK S, 1997, IN PRESS ANN NY ACAD; KEYNA U, 1995, J IMMUNOL, V155, P5536; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KOMISAR JL, 1989, J IMMUNOL, V143, P340; LEVY S, 1989, J EXP MED, V170, P1, DOI 10.1084/jem.170.1.1; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Maybaum TA, 1996, J IMMUNOL, V157, P1474; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; PETTERMAN C, 1996, J CLIN INVEST, V97, P2251; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263; Rothstein TL, 1996, CURR OPIN IMMUNOL, V8, P362, DOI 10.1016/S0952-7915(96)80126-9; Rubio CF, 1996, J IMMUNOL, V157, P65; SELSING E, 1984, NUCLEIC ACIDS RES, V12, P4229, DOI 10.1093/nar/12.10.4229; SHAPIRO MA, 1987, J IMMUNOL, V139, P3834; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; TAKI S, 1995, EUR J IMMUNOL, V25, P1888, DOI 10.1002/eji.1830250715; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; USUDA S, 1992, EMBO J, V11, P611, DOI 10.1002/j.1460-2075.1992.tb05093.x; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Ye J, 1996, EMBO J, V15, P1524, DOI 10.1002/j.1460-2075.1996.tb00496.x; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; ZOUALI M, 1987, EUR J IMMUNOL, V17, P509, DOI 10.1002/eji.1830170412; ZOUALI M, 1994, NAT GENET, V7, P118, DOI 10.1038/ng0694-118; ZOUALI M, 1994, AUTOIMMUNITY EXPT AS, P302	55	146	146	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	DEC	1996	5	6					505	511		10.1016/S1074-7613(00)80266-6	http://dx.doi.org/10.1016/S1074-7613(00)80266-6			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WA651	8986711	Bronze			2022-12-18	WOS:A1996WA65100002
